,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
3709,GO:0007272,2.87722549458186e-14,1,14,113,ensheathment of neurons,BP,CLDN11;SOX10;PLLP;FA2H;MAG;PLP1;MYRF;NKX6-2;KLK6;SH3TC2;MAL;UGT8;CNTN2;MBP
4059,GO:0008366,2.87722549458186e-14,1,14,113,axon ensheathment,BP,CLDN11;SOX10;PLLP;FA2H;MAG;PLP1;MYRF;NKX6-2;KLK6;SH3TC2;MAL;UGT8;CNTN2;MBP
10791,GO:0042552,5.26877908842765e-13,1,13,111,myelination,BP,SOX10;PLLP;FA2H;MAG;PLP1;MYRF;NKX6-2;KLK6;SH3TC2;MAL;UGT8;CNTN2;MBP
7013,GO:0022010,7.60299703516346e-13,1,7,17,central nervous system myelination,BP,SOX10;FA2H;MAG;PLP1;MYRF;NKX6-2;CNTN2
8307,GO:0032291,7.60299703516346e-13,1,7,17,axon ensheathment in central nervous system,BP,SOX10;FA2H;MAG;PLP1;MYRF;NKX6-2;CNTN2
10551,GO:0042063,5.8329751442817e-10,0.999999999953119,14,244,gliogenesis,BP,ERBB3;LRP2;SOX10;FA2H;MAG;PLP1;MYRF;EGFR;NKX6-2;SLC45A3;SH3TC2;BOK;CNTN2;GJC2
6707,GO:0019911,1.37890767654741e-09,0.99999999999401,5,10,structural constituent of myelin sheath,MF,PLLP;PLP1;MOBP;MAL;MBP
5123,GO:0014003,2.30610465725457e-09,0.999999999952645,7,38,oligodendrocyte development,BP,SOX10;FA2H;MAG;PLP1;MYRF;NKX6-2;CNTN2
11129,GO:0043209,2.85182766677472e-09,0.99999999981186,11,158,myelin sheath,CC,CLDN11;PLLP;TUBB4A;MAG;PLP1;ERMN;MOBP;MYO1D;CNTN2;MBP;GJC2
13200,GO:0048709,3.38106945976322e-09,0.999999999868155,9,87,oligodendrocyte differentiation,BP,SOX10;FA2H;MAG;PLP1;MYRF;NKX6-2;SLC45A3;BOK;CNTN2
4663,GO:0010001,3.80757942008432e-09,0.999999999699378,12,190,glial cell differentiation,BP,ERBB3;SOX10;FA2H;MAG;PLP1;MYRF;EGFR;NKX6-2;SLC45A3;SH3TC2;BOK;CNTN2
3762,GO:0007417,9.5220492130313e-09,0.999999998197699,23,878,central nervous system development,BP,ARX;DCX;LRP2;SOX10;FA2H;MAG;PLP1;MYRF;HAPLN2;MOG;EGFR;NKX6-2;SLC45A3;KLK6;KNDC1;MAL;UGT8;MYO1D;BOK;CNTN2;APOD;MBP;GJC2
6898,GO:0021782,9.65331570663634e-09,0.999999999530971,9,92,glial cell development,BP,SOX10;FA2H;MAG;PLP1;MYRF;EGFR;NKX6-2;SH3TC2;CNTN2
3751,GO:0007399,9.69007784807994e-08,0.99999997260155,35,2100,nervous system development,BP,ARX;CLDN11;NGFR;ERBB3;DCX;LRP2;SOX10;PLLP;FA2H;MAG;PLP1;MYRF;HAPLN2;RAPGEF5;MOG;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;KLK6;MOBP;SH3TC2;GJB1;KNDC1;MAL;UGT8;MYO1D;BOK;S1PR5;CNTN2;GLDN;APOD;MBP;GJC2
13209,GO:0048731,2.24020744757838e-07,0.999999926160964,50,4025,system development,BP,ARX;CRLF1;ANLN;CLDN11;NGFR;ERBB3;DCX;LRP2;CAPN3;COL9A3;SOX10;PLLP;FA2H;MAG;BVES;PPL;PLP1;MYRF;HAPLN2;PDGFRA;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;ADAMTS4;NNMT;GREM1;KLK6;MOBP;SH3TC2;GJB1;KNDC1;MAL;RASGRP1;DMRT2;UGT8;MYO1D;BOK;S1PR5;CNTN2;GLDN;APOD;MBP;SMOC1;GJC2
11581,GO:0044304,2.75058864317974e-07,0.999999987428176,7,62,main axon,CC,TUBB4A;MAG;ERMN;MYO1D;CNTN2;MBP;GJC2
13269,GO:0048856,3.86912277405654e-07,0.999999868387001,56,4939,anatomical structure development,BP,ARX;CRLF1;ANLN;CLDN11;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;CAPN3;COL9A3;SOX10;PLLP;FA2H;MAG;BVES;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;CPM;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;ADAMTS4;EDIL3;NNMT;GREM1;KLK6;MOBP;SH3TC2;GJB1;KNDC1;MAL;RASGRP1;DMRT2;UGT8;MYO1D;BOK;S1PR5;CNTN2;GLDN;APOD;MBP;SMOC1;GJC2
3711,GO:0007275,4.91100099740505e-07,0.999999831760411,53,4533,multicellular organism development,BP,ARX;CRLF1;ANLN;CLDN11;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;CAPN3;COL9A3;SOX10;PLLP;FA2H;MAG;BVES;PPL;PLP1;MYRF;HAPLN2;PDGFRA;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;ADAMTS4;EDIL3;NNMT;GREM1;KLK6;MOBP;SH3TC2;GJB1;KNDC1;MAL;RASGRP1;DMRT2;UGT8;MYO1D;BOK;S1PR5;CNTN2;GLDN;APOD;MBP;SMOC1;GJC2
8941,GO:0033269,1.21449254359329e-06,0.999999997988638,3,4,internode region of axon,CC,TUBB4A;ERMN;MBP
16633,GO:0071944,2.5288550478302e-06,0.999999077686462,50,4376,cell periphery,CC,ANLN;CLDN11;NGFR;ERBB3;CDH19;LRP2;NKAIN1;FOLH1;TF;CAPN3;MLC1;MAG;BVES;PLCL1;RGS4;ATP10B;PPL;PLP1;PDGFRA;CPM;ERMN;SLC31A2;ENPP2;MOG;PCSK6;EGFR;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SLC45A3;SLC5A11;MOBP;SH3TC2;GJB1;MAL;RASGRP1;UGT8;MYO1D;S1PR5;GPR62;CNTN2;ANKS1B;GLDN;NKAIN2;OPALIN;MBP;GJC2;TMEM235
5130,GO:0014013,2.85909412775284e-06,0.999999808222595,7,98,regulation of gliogenesis,BP,LRP2;SOX10;MAG;NKX6-2;SLC45A3;CNTN2;GJC2
8469,GO:0032502,4.26365210064889e-06,0.999998398717301,56,5296,developmental process,BP,ARX;CRLF1;ANLN;CLDN11;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;CAPN3;COL9A3;SOX10;PLLP;FA2H;MAG;BVES;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;CPM;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;ADAMTS4;EDIL3;NNMT;GREM1;KLK6;MOBP;SH3TC2;GJB1;KNDC1;MAL;RASGRP1;DMRT2;UGT8;MYO1D;BOK;S1PR5;CNTN2;GLDN;APOD;MBP;SMOC1;GJC2
7011,GO:0022008,7.5503375476948e-06,0.999997738838337,25,1446,neurogenesis,BP,ARX;NGFR;ERBB3;DCX;LRP2;SOX10;FA2H;MAG;PLP1;MYRF;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;KLK6;SH3TC2;KNDC1;UGT8;BOK;S1PR5;CNTN2;GLDN;APOD;GJC2
10632,GO:0042246,1.05667685229958e-05,0.99999956038929,5,50,tissue regeneration,BP,CAPN3;GJA1;FZD7;KLK6;APOD
3765,GO:0007422,1.19504462786454e-05,0.9999992446822,6,74,peripheral nervous system development,BP,ERBB3;SOX10;FA2H;HAPLN2;SH3TC2;UGT8
7743,GO:0031224,1.85617740693238e-05,0.999992677762582,46,4249,intrinsic component of membrane,CC,CLDN11;NGFR;ERBB3;CDH19;LRP2;NKAIN1;FOLH1;MLC1;PLLP;FA2H;MAG;BVES;ATP10B;PLP1;MYRF;PDGFRA;CPM;SLC31A2;ENPP2;MOG;EGFR;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;MAL;SUSD5;UGT8;BOK;TMEM125;TMEM151A;S1PR5;GPR62;AATK;CNTN2;GLDN;NKAIN2;OPALIN;GJC2;TMEM235;TMEM88B
5132,GO:0014015,2.08795725356965e-05,0.99999899323064,5,54,positive regulation of gliogenesis,BP,LRP2;SOX10;MAG;NKX6-2;GJC2
2827,GO:0005886,2.15787980566701e-05,0.999991396504122,47,4280,plasma membrane,CC,CLDN11;NGFR;ERBB3;CDH19;LRP2;NKAIN1;FOLH1;TF;CAPN3;MLC1;MAG;BVES;PLCL1;RGS4;ATP10B;PPL;PLP1;PDGFRA;CPM;SLC31A2;ENPP2;MOG;PCSK6;EGFR;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SLC45A3;SLC5A11;SH3TC2;GJB1;MAL;RASGRP1;UGT8;MYO1D;S1PR5;GPR62;CNTN2;ANKS1B;GLDN;NKAIN2;OPALIN;MBP;GJC2;TMEM235
5663,GO:0016021,2.28781977317523e-05,0.999990918720826,45,4139,integral component of membrane,CC,CLDN11;NGFR;ERBB3;CDH19;LRP2;NKAIN1;FOLH1;MLC1;PLLP;FA2H;MAG;BVES;ATP10B;PLP1;MYRF;PDGFRA;SLC31A2;ENPP2;MOG;EGFR;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;MAL;SUSD5;UGT8;BOK;TMEM125;TMEM151A;S1PR5;GPR62;AATK;CNTN2;GLDN;NKAIN2;OPALIN;GJC2;TMEM235;TMEM88B
2506,GO:0005243,2.43639015228449e-05,0.999999751407987,3,10,gap junction channel activity,MF,GJA1;GJB1;GJC2
2849,GO:0005922,5.13434765087478e-05,0.999999268831712,3,14,connexin complex,CC,GJA1;GJB1;GJC2
7693,GO:0031099,5.45333667510141e-05,0.999994103364541,7,161,regeneration,BP,CAPN3;EGFR;GJA1;FZD7;NNMT;KLK6;APOD
11133,GO:0043218,5.58321565320252e-05,0.999999193966253,3,13,compact myelin,CC,PLLP;MAG;MBP
3625,GO:0007155,5.71909730704586e-05,0.999982690096812,20,1161,cell adhesion,BP,CLDN11;ERBB3;CDH19;MAG;BVES;HAPLN2;PDGFRA;MOG;EGFR;CNTNAP4;FZD7;EDIL3;GREM1;RASGRP1;SUSD5;CNTN2;GLDN;APOD;MBP;COL28A1
13063,GO:0048468,5.89565307833127e-05,0.999979105991973,27,1852,cell development,BP,ARX;NGFR;LRP2;CAPN3;SOX10;FA2H;MAG;BVES;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;KLK6;SH3TC2;KNDC1;UGT8;S1PR5;CNTN2;GLDN;APOD;GJC2
7044,GO:0022610,6.20629215801446e-05,0.999981097790774,20,1168,biological adhesion,BP,CLDN11;ERBB3;CDH19;MAG;BVES;HAPLN2;PDGFRA;MOG;EGFR;CNTNAP4;FZD7;EDIL3;GREM1;RASGRP1;SUSD5;CNTN2;GLDN;APOD;MBP;COL28A1
7976,GO:0031641,7.79588656780282e-05,0.999996966338208,4,34,regulation of myelination,BP,SOX10;MAG;MYRF;NKX6-2
7978,GO:0031643,7.8627524835204e-05,0.999998725018861,3,13,positive regulation of myelination,BP,SOX10;MAG;MYRF
8942,GO:0033270,8.42506610408291e-05,0.999998625854009,3,12,paranode region of axon,CC,MAG;ERMN;GJC2
13279,GO:0048869,8.44597679689079e-05,0.999964837953525,41,3667,cellular developmental process,BP,ARX;ANLN;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;CAPN3;SOX10;FA2H;MAG;BVES;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;ERMN;ENPP2;PCSK6;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;KLK6;SH3TC2;KNDC1;MAL;RASGRP1;UGT8;BOK;S1PR5;CNTN2;GLDN;APOD;SMOC1;GJC2
11649,GO:0044425,0.000103470462713405,0.999955001795189,52,5383,membrane part,CC,CLDN11;NGFR;ERBB3;CDH19;LRP2;NKAIN1;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;MAG;BVES;ATP10B;PLP1;MYRF;PDGFRA;CPM;SLC31A2;ENPP2;MOG;EGFR;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;MAL;RASGRP1;SUSD5;UGT8;MYO1D;BOK;TMEM125;TMEM151A;S1PR5;GPR62;AATK;CNTN2;ANKS1B;GLDN;NKAIN2;OPALIN;GJC2;TMEM235;TMEM88B
7061,GO:0022829,0.000109728206721142,0.999997911255286,3,17,wide pore channel activity,MF,GJA1;GJB1;GJC2
8468,GO:0032501,0.000135556917187418,0.999940226144052,56,5937,multicellular organismal process,BP,ARX;CRLF1;ANLN;CLDN11;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;TF;CAPN3;COL9A3;SOX10;PLLP;FA2H;MAG;BVES;PPL;PLP1;MYRF;HAPLN2;PDGFRA;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;NKX6-2;GJA1;PIEZO2;FZD7;SLC45A3;ADAMTS4;EDIL3;NNMT;GREM1;KLK6;MOBP;SH3TC2;GJB1;KNDC1;MAL;RASGRP1;DMRT2;UGT8;MYO1D;BOK;S1PR5;CNTN2;GLDN;APOD;MBP;SMOC1;GJC2
19899,GO:1903763,0.000146797058143287,0.999999660700865,2,3,gap junction channel activity involved in cell communication by electrical coupling,MF,GJA1;GJC2
20833,GO:1905867,0.000149195926010711,0.999999508731272,2,4,epididymis development,BP,GJA1;GJB1
11132,GO:0043217,0.000177669335404364,0.999996140541075,3,14,myelin maintenance,BP,FA2H;MYRF;SH3TC2
2484,GO:0005198,0.000202081752846835,0.999952145778855,12,596,structural molecule activity,MF,CLDN11;CAPN3;COL9A3;PLLP;TUBB4A;BVES;PPL;PLP1;HAPLN2;MOBP;MAL;MBP
15812,GO:0070447,0.000204393307576192,0.999999441828285,2,3,positive regulation of oligodendrocyte progenitor proliferation,BP,LRP2;GJC2
8784,GO:0032989,0.000233264144859051,0.99992568900969,18,1033,cellular component morphogenesis,BP,ARX;NGFR;CDH19;LRP2;CAPN3;MAG;BVES;LDB3;PDGFRA;ERMN;ENPP2;EGFR;GJA1;FZD7;GREM1;KNDC1;UGT8;CNTN2
8302,GO:0032286,0.000273500725578995,0.999998777904482,2,4,central nervous system myelin maintenance,BP,FA2H;MYRF
7191,GO:0030154,0.000317061762323657,0.99986026960295,38,3484,cell differentiation,BP,ARX;ANLN;NGFR;EYA2;ERBB3;DCX;LRP2;CAPN3;SOX10;FA2H;MAG;BVES;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;PCSK6;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;KLK6;SH3TC2;KNDC1;MAL;RASGRP1;UGT8;BOK;S1PR5;CNTN2;GLDN;APOD;SMOC1;GJC2
2848,GO:0005921,0.000355288636938266,0.999989472580253,3,24,gap junction,CC,GJA1;GJB1;GJC2
11912,GO:0045178,0.000399550759117094,0.999975519449088,4,49,basal part of cell,CC,CLDN11;ERBB3;TF;EGFR
13213,GO:0048738,0.000412265582814208,0.999937734272028,7,186,cardiac muscle tissue development,BP,ERBB3;LRP2;BVES;PDGFRA;GJA1;FZD7;GREM1
7981,GO:0031646,0.000420214738119001,0.999986864295629,3,23,positive regulation of neurological system process,BP,SOX10;MAG;MYRF
5819,GO:0016324,0.000428145516313584,0.999924021442143,8,267,apical plasma membrane,CC,ERBB3;LRP2;TF;MLC1;EGFR;GJA1;MAL;TMEM235
5182,GO:0014706,0.000473896707115642,0.999903706810689,9,332,striated muscle tissue development,BP,EYA2;ERBB3;LRP2;CAPN3;BVES;PDGFRA;GJA1;FZD7;GREM1
6933,GO:0021853,0.000524260400139799,0.999996222186835,2,5,cerebral cortex GABAergic interneuron migration,BP,ARX;CNTN2
20477,GO:1904936,0.000524260400139799,0.999996222186835,2,5,interneuron migration,BP,ARX;CNTN2
14421,GO:0055037,0.000529414128991714,0.999931275385281,6,152,recycling endosome,CC,TF;MLC1;SLC31A2;FZD7;SH3TC2;BOK
11250,GO:0043403,0.000529709740325965,0.999981802329899,3,27,skeletal muscle tissue regeneration,BP,CAPN3;GJA1;FZD7
12138,GO:0045685,0.000542670753213905,0.999963548634739,4,61,regulation of glial cell differentiation,BP,MAG;NKX6-2;SLC45A3;CNTN2
5821,GO:0016328,0.000558315515668612,0.999962353804858,4,56,lateral plasma membrane,CC,ERBB3;BVES;GJA1;GJB1
15134,GO:0061024,0.000588392382132285,0.999824821848722,14,806,membrane organization,BP,EYA2;LRP2;TF;PLLP;FA2H;ATP10B;MYRF;EGFR;SH3TC2;MAL;BOK;CNTN2;GLDN;MBP
11882,GO:0045121,0.000588965931333198,0.999890169498657,8,286,membrane raft,CC,MLC1;PLLP;MAG;BVES;EGFR;GJA1;MAL;MYO1D
18093,GO:0098857,0.000604636407057781,0.999886787122494,8,287,membrane microdomain,CC,MLC1;PLLP;MAG;BVES;EGFR;GJA1;MAL;MYO1D
13192,GO:0048699,0.000623686430537505,0.99977152063844,20,1353,generation of neurons,BP,ARX;NGFR;DCX;LRP2;SOX10;MAG;PLP1;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;KLK6;KNDC1;UGT8;S1PR5;CNTN2;GLDN;APOD;GJC2
13496,GO:0050793,0.000637604557508751,0.999734554690149,27,2208,regulation of developmental process,BP,ARX;NGFR;ERBB3;LRP2;CAPN3;SOX10;MAG;BVES;MYRF;PDGFRA;ERMN;ENPP2;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;KLK6;KNDC1;RASGRP1;DMRT2;S1PR5;CNTN2;MBP;SMOC1;GJC2
6957,GO:0021894,0.000643111338950376,0.999994408706181,2,6,cerebral cortex GABAergic interneuron development,BP,ARX;CNTN2
14857,GO:0060537,0.000651780106251828,0.999861433603124,9,346,muscle tissue development,BP,EYA2;ERBB3;LRP2;CAPN3;BVES;PDGFRA;GJA1;FZD7;GREM1
17960,GO:0098589,0.000747396984938592,0.999855356470241,8,296,membrane region,CC,MLC1;PLLP;MAG;BVES;EGFR;GJA1;MAL;MYO1D
13060,GO:0048406,0.000790625463445392,0.999992368675895,2,6,nerve growth factor binding,MF,NGFR;PCSK6
13199,GO:0048708,0.00100702550320394,0.999919847773122,4,67,astrocyte differentiation,BP,MAG;PLP1;EGFR;CNTN2
14416,GO:0055024,0.0010086513192477,0.999919728948929,4,66,regulation of cardiac muscle tissue development,BP,ERBB3;GJA1;FZD7;GREM1
5750,GO:0016202,0.00105505691736614,0.999877559192322,5,115,regulation of striated muscle tissue development,BP,ERBB3;CAPN3;GJA1;FZD7;GREM1
625,GO:0001766,0.00105706445638973,0.999986661344991,2,9,membrane raft polarization,BP,PLLP;MAL
7945,GO:0031580,0.00105706445638973,0.999986661344991,2,9,membrane raft distribution,BP,PLLP;MAL
13788,GO:0051239,0.00109796956775354,0.999513278529528,29,2566,regulation of multicellular organismal process,BP,ARX;NGFR;ERBB3;LRP2;CAPN3;SOX10;FA2H;MAG;BVES;MYRF;PDGFRA;ENPP2;MOG;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;KLK6;KNDC1;RASGRP1;DMRT2;S1PR5;CNTN2;APOD;MBP;SMOC1;GJC2
13144,GO:0048634,0.00112349770657579,0.999867705605582,5,117,regulation of muscle organ development,BP,ERBB3;CAPN3;GJA1;FZD7;GREM1
5340,GO:0015144,0.00112411831600322,0.999949136422653,3,33,carbohydrate transmembrane transporter activity,MF,SLC45A3;SLC5A11;TMEM144
4753,GO:0010454,0.00112443605456858,0.999985037985818,2,10,negative regulation of cell fate commitment,BP,NKX6-2;FZD7
19080,GO:1901861,0.00115735129844661,0.999862805585659,5,117,regulation of muscle tissue development,BP,ERBB3;CAPN3;GJA1;FZD7;GREM1
21182,GO:2000026,0.00121470679274025,0.999509010760911,22,1712,regulation of multicellular organismal development,BP,NGFR;ERBB3;LRP2;CAPN3;SOX10;MAG;MYRF;ENPP2;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;KLK6;KNDC1;RASGRP1;DMRT2;S1PR5;CNTN2;MBP;GJC2
16218,GO:0071260,0.00129745015097036,0.999888908997114,4,76,cellular response to mechanical stimulus,BP,MAG;EGFR;GJA1;PIEZO2
18299,GO:0099612,0.00134658733327849,0.999982017973787,2,7,protein localization to axon,BP,UGT8;CNTN2
14021,GO:0051665,0.00137441973089183,0.999979750063648,2,10,membrane raft localization,BP,PLLP;MAL
6921,GO:0021826,0.00138335583898971,0.999980545916012,2,8,substrate-independent telencephalic tangential migration,BP,ARX;CNTN2
6924,GO:0021830,0.00138335583898971,0.999980545916012,2,8,interneuron migration from the subpallium to the cortex,BP,ARX;CNTN2
6929,GO:0021843,0.00138335583898971,0.999980545916012,2,8,substrate-independent telencephalic tangential interneuron migration,BP,ARX;CNTN2
1866,GO:0004180,0.00140199512362764,0.999931001998155,3,37,carboxypeptidase activity,MF,FOLH1;CPM;CNDP1
15809,GO:0070444,0.00143480291543626,0.999979444389574,2,8,oligodendrocyte progenitor proliferation,BP,LRP2;GJC2
15810,GO:0070445,0.00143480291543626,0.999979444389574,2,8,regulation of oligodendrocyte progenitor proliferation,BP,LRP2;GJC2
11911,GO:0045177,0.00152322813427599,0.999670096703146,8,324,apical part of cell,CC,ERBB3;LRP2;TF;MLC1;EGFR;GJA1;MAL;TMEM235
2842,GO:0005911,0.00160726357770886,0.999610381295983,9,402,cell-cell junction,CC,CLDN11;CDH19;MLC1;BVES;PPL;GJA1;GJB1;OPALIN;GJC2
6955,GO:0021892,0.00167252119376954,0.999972772168833,2,10,cerebral cortex GABAergic interneuron differentiation,BP,ARX;CNTN2
6664,GO:0019838,0.00169731781856641,0.999780124964056,5,128,growth factor binding,MF,NGFR;ERBB3;PDGFRA;PCSK6;EGFR
4638,GO:0009925,0.00173411710745724,0.99990870697514,3,33,basal plasma membrane,CC,ERBB3;TF;EGFR
326,GO:0000902,0.00186295695849944,0.999347637560909,15,941,cell morphogenesis,BP,ARX;NGFR;CDH19;LRP2;MAG;BVES;ERMN;ENPP2;EGFR;GJA1;FZD7;GREM1;KNDC1;UGT8;CNTN2
9589,GO:0035051,0.00195783763755384,0.999738406573352,5,119,cardiocyte differentiation,BP,BVES;PDGFRA;EGFR;FZD7;GREM1
5785,GO:0016264,0.0019858773880011,0.999964716796465,2,10,gap junction assembly,BP,GJA1;GJB1
13064,GO:0048469,0.00206810939620626,0.99971898282125,5,146,cell maturation,BP,SOX10;PLP1;GJA1;CNTN2;GLDN
7638,GO:0031012,0.00211146472113962,0.999466839594523,9,431,extracellular matrix,CC,COL9A3;HAPLN2;PCSK6;ADAMTS4;EDIL3;GLDN;SPOCK3;SMOC1;COL28A1
12668,GO:0046850,0.00218404846262871,0.99987407613206,3,39,regulation of bone remodeling,BP,EGFR;GJA1;GREM1
20585,GO:1905207,0.00227625489728765,0.999866835095184,3,39,regulation of cardiocyte differentiation,BP,EGFR;FZD7;GREM1
12220,GO:0045843,0.00239205270224455,0.999857047034903,3,42,negative regulation of striated muscle tissue development,BP,CAPN3;GJA1;FZD7
11070,GO:0043121,0.00239625148350997,0.999953144702677,2,10,neurotrophin binding,MF,NGFR;PCSK6
17632,GO:0097154,0.00244235705376692,0.999950250861504,2,12,GABAergic neuron differentiation,BP,ARX;CNTN2
5144,GO:0014037,0.00247625320760644,0.99985143806571,3,36,Schwann cell differentiation,BP,ERBB3;FA2H;SH3TC2
13145,GO:0048635,0.00258986882935136,0.999840642460867,3,43,negative regulation of muscle organ development,BP,CAPN3;GJA1;FZD7
4656,GO:0009986,0.0025936614038156,0.999217720236655,11,638,cell surface,CC,NGFR;CDH19;LRP2;FOLH1;TF;CPM;MOG;PCSK6;EGFR;GREM1;CNTN2
21264,GO:2000179,0.00264869785784535,0.999836318766575,3,40,positive regulation of neural precursor cell proliferation,BP,LRP2;SOX10;GJC2
19081,GO:1901862,0.00271131288967715,0.999830262127196,3,44,negative regulation of muscle tissue development,BP,CAPN3;GJA1;FZD7
8303,GO:0032287,0.00274460680502814,0.999943707959346,2,9,peripheral nervous system myelin maintenance,BP,FA2H;SH3TC2
2611,GO:0005516,0.00302188512699665,0.99944630663847,6,186,calmodulin binding,MF,NGFR;RGS4;EGFR;PHKG1;MYO1D;MBP
5171,GO:0014066,0.00302547074498148,0.999671775229222,4,88,regulation of phosphatidylinositol 3-kinase signaling,BP,ERBB3;PDGFRA;EGFR;RASGRP1
5592,GO:0015868,0.00308734646524605,0.999927584076982,2,14,purine ribonucleotide transport,BP,GJA1;GJB1
9375,GO:0034443,0.00323352243636036,1,1,1,negative regulation of lipoprotein oxidation,BP,APOD
14892,GO:0060588,0.00323352243636036,1,1,1,negative regulation of lipoprotein lipid oxidation,BP,APOD
11004,GO:0043005,0.0032679745166299,0.99874442522556,16,1140,neuron projection,CC,NGFR;DCX;LRP2;TUBB4A;MAG;ERMN;CNTNAP4;LGI3;KNDC1;MYO1D;CNTN2;ANKS1B;GLDN;APOD;MBP;GJC2
11902,GO:0045161,0.0032754259676777,0.999922481423262,2,12,neuronal ion channel clustering,BP,CNTN2;GLDN
4622,GO:0009888,0.00327768070063022,0.998609927152167,20,1618,tissue development,BP,ARX;CRLF1;EYA2;ERBB3;LRP2;CAPN3;SOX10;FA2H;BVES;PPL;HAPLN2;PDGFRA;PCSK6;EGFR;GJA1;FZD7;GREM1;KLK6;DMRT2;APOD
13664,GO:0051049,0.00330848648626389,0.998595593161411,20,1637,regulation of transport,BP,NGFR;ERBB3;NKAIN1;TF;CAPN3;MLC1;BVES;SLC31A2;EGFR;GJA1;KCNJ6;GREM1;LGI3;SH3TC2;RASGRP1;BOK;NKAIN2;APOD;MBP;GJC2
13106,GO:0048546,0.00345373819757995,0.999764180501347,3,45,digestive tract morphogenesis,BP,SOX10;PDGFRA;EGFR
5589,GO:0015865,0.00367446746543385,0.999904988964485,2,15,purine nucleotide transport,BP,GJA1;GJB1
3900,GO:0008112,0.00380745682577081,1,1,1,nicotinamide N-methyltransferase activity,MF,NNMT
7498,GO:0030760,0.00380745682577081,1,1,1,pyridine N-methyltransferase activity,MF,NNMT
6064,GO:0016805,0.00389077399824407,0.999895654396499,2,16,dipeptidase activity,MF,FOLH1;CNDP1
9295,GO:0034329,0.00409222327086573,0.999200805898786,6,216,cell junction assembly,BP,CDH19;GJA1;GREM1;GJB1;UGT8;APOD
6867,GO:0021700,0.00418640903261666,0.999177825525723,6,232,developmental maturation,BP,SOX10;PLP1;GJA1;GREM1;CNTN2;GLDN
19262,GO:1902311,0.00418982373365766,1,1,1,regulation of copper ion transmembrane transport,BP,SLC31A2
20586,GO:1905208,0.00424683331343034,0.99988270134222,2,14,negative regulation of cardiocyte differentiation,BP,EGFR;FZD7
7769,GO:0031267,0.00433057817009109,0.998686757792816,10,529,small GTPase binding,MF,ANLN;NGFR;ERBB3;PEX5L;PDGFRA;RAPGEF5;EGFR;MOBP;KNDC1;RASGRP1
13750,GO:0051179,0.00444656221851993,0.997611572863612,49,5679,localization,BP,ARX;ANLN;NGFR;EYA2;ERBB3;DCX;LRP2;NKAIN1;TF;CAPN3;SOX10;MLC1;PLLP;TUBB4A;MAG;BVES;PEX5L;ATP10B;PDGFRA;SLC31A2;ENPP2;PCSK6;EGFR;GJA1;PIEZO2;KCNJ6;SNX22;TMSB15A;SLC45A3;SLC5A11;TMEM144;GREM1;MOBP;LGI3;SH3TC2;GJB1;MAL;RASGRP1;UGT8;MYO1D;BOK;CNTN2;ANKS1B;DNAH17;NKAIN2;APOD;SPOCK3;MBP;GJC2
3764,GO:0007420,0.00453238381806903,0.998527631319854,11,656,brain development,BP,ARX;LRP2;PLP1;EGFR;KNDC1;MYO1D;BOK;CNTN2;APOD;MBP;GJC2
12070,GO:0045595,0.00460405167729055,0.998024301320799,19,1545,regulation of cell differentiation,BP,NGFR;LRP2;CAPN3;SOX10;MAG;PDGFRA;EGFR;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;KLK6;KNDC1;RASGRP1;S1PR5;CNTN2;SMOC1;GJC2
5085,GO:0010959,0.00460961684397131,0.998929959665499,7,325,regulation of metal ion transport,BP,NKAIN1;TF;CAPN3;SLC31A2;GJA1;NKAIN2;GJC2
7296,GO:0030296,0.00479427694572267,0.999857890541385,2,15,protein tyrosine kinase activator activity,MF,ERBB3;GREM1
9257,GO:0034219,0.00482275918074418,0.999401748395522,4,102,carbohydrate transmembrane transport,BP,NGFR;SLC45A3;SLC5A11;TMEM144
7020,GO:0022029,0.00489721064177202,0.999619863761722,3,49,telencephalon cell migration,BP,ARX;EGFR;CNTN2
11938,GO:0045216,0.00505609061112471,0.998968190376251,6,225,cell-cell junction organization,BP,CDH19;GJA1;GREM1;GJB1;UGT8;APOD
11676,GO:0044459,0.0050998743489988,0.997538431425057,26,2421,plasma membrane part,CC,NGFR;ERBB3;CDH19;LRP2;FOLH1;TF;CAPN3;MLC1;MAG;BVES;PDGFRA;SLC31A2;ENPP2;MOG;EGFR;GJA1;CNTNAP4;KCNJ6;SLC5A11;GJB1;MAL;MYO1D;CNTN2;ANKS1B;GJC2;TMEM235
2762,GO:0005783,0.0052551807523033,0.997715068008219,19,1648,endoplasmic reticulum,CC,LRP2;TF;COL9A3;MLC1;FA2H;ATP10B;MYRF;PCSK6;EGFR;GJA1;KLK6;GJB1;MAL;RASGRP1;MYO1D;BOK;APOD;TMEM235;COL28A1
13270,GO:0048857,0.00530566507692669,0.999573716793131,3,57,neural nucleus development,BP,ARX;PLP1;MBP
4858,GO:0010642,0.00537649165505441,0.99982973081807,2,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFRA;APOD
21323,GO:2000287,0.00539113052361405,1,1,1,positive regulation of myotome development,BP,DMRT2
21325,GO:2000290,0.00539113052361405,1,1,1,regulation of myotome development,BP,DMRT2
2578,GO:0005402,0.00539760949658967,0.999827642581405,2,17,carbohydrate:cation symporter activity,MF,SLC45A3;SLC5A11
13727,GO:0051146,0.00558547416560485,0.998835930791144,6,233,striated muscle cell differentiation,BP,CAPN3;BVES;LDB3;PDGFRA;FZD7;GREM1
6950,GO:0021885,0.00582362419505473,0.999517799868541,3,52,forebrain cell migration,BP,ARX;EGFR;CNTN2
17790,GO:0097453,0.00583509385704437,1,1,1,mesaxon,CC,MAG
20881,GO:1990015,0.00583509385704437,1,1,1,ensheathing process,CC,MAG
764,GO:0001949,0.00588244626622997,1,1,1,sebaceous gland cell differentiation,BP,FA2H
17099,GO:0080132,0.00588244626622997,1,1,1,fatty acid alpha-hydroxylase activity,MF,FA2H
14178,GO:0051960,0.00598710359314129,0.99787511845492,12,768,regulation of nervous system development,BP,NGFR;LRP2;SOX10;MAG;MYRF;NKX6-2;SLC45A3;KLK6;KNDC1;S1PR5;CNTN2;GJC2
17809,GO:0097489,0.00622525004624164,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
14401,GO:0055007,0.00623231538080418,0.999170116807114,4,95,cardiac muscle cell differentiation,BP,BVES;PDGFRA;FZD7;GREM1
20346,GO:1904700,0.0063143777818323,1,1,1,granulosa cell apoptotic process,BP,BOK
20351,GO:1904708,0.0063143777818323,1,1,1,regulation of granulosa cell apoptotic process,BP,BOK
20248,GO:1904492,0.00631912485962177,1,1,1,Ac-Asp-Glu binding,MF,FOLH1
20249,GO:1904493,0.00631912485962177,1,1,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,FOLH1
9188,GO:0034103,0.00638365369959123,0.999451167286916,3,59,regulation of tissue remodeling,BP,EGFR;GJA1;GREM1
3461,GO:0006862,0.00641715457398936,0.999772633141053,2,20,nucleotide transport,BP,GJA1;GJB1
14632,GO:0060231,0.00663794693572142,0.999760664334149,2,20,mesenchymal to epithelial transition,BP,FZD7;GREM1
3580,GO:0007043,0.00671856804049751,0.999083162087168,4,109,cell-cell junction assembly,BP,CDH19;GJA1;GJB1;UGT8
5062,GO:0010927,0.0067930028655783,0.999072751637961,4,96,cellular component assembly involved in morphogenesis,BP,CAPN3;LDB3;PDGFRA;UGT8
2626,GO:0005540,0.00687347314312692,0.999748760492626,2,19,hyaluronic acid binding,MF,HAPLN2;SUSD5
6925,GO:0021831,0.00687604237943035,1,1,1,embryonic olfactory bulb interneuron precursor migration,BP,ARX
4139,GO:0008489,0.00692599417125247,1,1,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,UGT8
12793,GO:0047263,0.00692599417125247,1,1,1,N-acylsphingosine galactosyltransferase activity,MF,UGT8
2416,GO:0005088,0.00693753629196887,0.998487188268975,6,235,Ras guanyl-nucleotide exchange factor activity,MF,ERBB3;PDGFRA;RAPGEF5;EGFR;KNDC1;RASGRP1
14696,GO:0060322,0.00694898488001812,0.99760601026053,11,695,head development,BP,ARX;LRP2;PLP1;EGFR;KNDC1;MYO1D;BOK;CNTN2;APOD;MBP;GJC2
11020,GO:0043025,0.00705868171296769,0.99802764376379,8,428,neuronal cell body,CC,TUBB4A;ERMN;KNDC1;MYO1D;CNTN2;APOD;MBP;GJC2
13475,GO:0050767,0.00709010542341199,0.99755069708619,11,689,regulation of neurogenesis,BP,NGFR;LRP2;SOX10;MAG;NKX6-2;SLC45A3;KLK6;KNDC1;S1PR5;CNTN2;GJC2
1524,GO:0003294,0.00721582044836589,1,1,1,atrial ventricular junction remodeling,BP,GJA1
4715,GO:0010232,0.00721582044836589,1,1,1,vascular transport,BP,GJA1
4861,GO:0010645,0.00721582044836589,1,1,1,regulation of cell communication by chemical coupling,BP,GJA1
4867,GO:0010652,0.00721582044836589,1,1,1,positive regulation of cell communication by chemical coupling,BP,GJA1
14584,GO:0060156,0.00721582044836589,1,1,1,milk ejection reflex,BP,GJA1
14458,GO:0055103,0.00732218247143622,1,1,1,ligase regulator activity,MF,CAPN3
7944,GO:0031579,0.0073224098793907,0.999720167976004,2,22,membrane raft organization,BP,PLLP;MAL
18735,GO:1900383,0.00733650112956369,1,1,1,regulation of synaptic plasticity by receptor localization to synapse,BP,ANKS1B
4752,GO:0010453,0.00739286147332715,0.999715160849602,2,23,regulation of cell fate commitment,BP,NKX6-2;FZD7
598,GO:0001715,0.0075316415865502,1,1,1,ectodermal cell fate specification,BP,FZD7
10860,GO:0042665,0.0075316415865502,1,1,1,regulation of ectodermal cell fate specification,BP,FZD7
10861,GO:0042666,0.0075316415865502,1,1,1,negative regulation of ectodermal cell fate specification,BP,FZD7
21400,GO:2000383,0.0075316415865502,1,1,1,regulation of ectoderm development,BP,FZD7
21401,GO:2000384,0.0075316415865502,1,1,1,negative regulation of ectoderm development,BP,FZD7
9777,GO:0035498,0.00753955016754619,1,1,1,carnosine metabolic process,BP,CARNS1
9778,GO:0035499,0.00753955016754619,1,1,1,carnosine biosynthetic process,BP,CARNS1
12854,GO:0047730,0.00753955016754619,1,1,1,carnosine synthase activity,MF,CARNS1
18337,GO:0102102,0.00753955016754619,1,1,1,homocarnosine synthase activity,MF,CARNS1
18659,GO:1900158,0.00755197375972166,1,1,1,negative regulation of bone mineralization involved in bone maturation,BP,GREM1
10361,GO:0038034,0.0075588961010481,0.999306431751539,3,67,signal transduction in absence of ligand,BP,EYA2;ERBB3;BOK
17658,GO:0097192,0.0075588961010481,0.999306431751539,3,67,extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA2;ERBB3;BOK
13690,GO:0051094,0.00756392706425156,0.996906692865051,15,1161,positive regulation of developmental process,BP,ARX;NGFR;ERBB3;LRP2;CAPN3;SOX10;MAG;MYRF;ENPP2;NKX6-2;GJA1;GREM1;RASGRP1;DMRT2;GJC2
6167,GO:0017016,0.00782252199869858,0.997583443598078,9,487,Ras GTPase binding,MF,ANLN;NGFR;ERBB3;PDGFRA;RAPGEF5;EGFR;MOBP;KNDC1;RASGRP1
7979,GO:0031644,0.00795096287525354,0.999257966380643,3,64,regulation of neurological system process,BP,SOX10;MAG;MYRF
12221,GO:0045844,0.00802707565204912,0.999249797804801,3,60,positive regulation of striated muscle tissue development,BP,ERBB3;GJA1;GREM1
13146,GO:0048636,0.00802707565204912,0.999249797804801,3,60,positive regulation of muscle organ development,BP,ERBB3;GJA1;GREM1
12717,GO:0046934,0.00804907893336725,0.999246589742354,3,61,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,ERBB3;PDGFRA;EGFR
13085,GO:0048513,0.00806206383144293,0.99583846197983,29,2913,animal organ development,BP,ARX;CRLF1;ANLN;ERBB3;LRP2;CAPN3;COL9A3;SOX10;FA2H;BVES;PPL;PLP1;PDGFRA;PCSK6;EGFR;NKX6-2;GJA1;FZD7;NNMT;GREM1;KNDC1;RASGRP1;MYO1D;BOK;CNTN2;APOD;MBP;SMOC1;GJC2
7214,GO:0030182,0.00812937527259013,0.99655214538343,16,1230,neuron differentiation,BP,ARX;NGFR;LRP2;MAG;PLP1;EGFR;NKX6-2;GJA1;FZD7;KLK6;KNDC1;UGT8;S1PR5;CNTN2;GLDN;APOD
2386,GO:0005018,0.00818541531683758,1,1,1,platelet-derived growth factor alpha-receptor activity,MF,PDGFRA
8939,GO:0033267,0.00828932462027241,0.997852462418162,7,340,axon part,CC,TUBB4A;MAG;ERMN;MYO1D;CNTN2;MBP;GJC2
7362,GO:0030424,0.00833707477549876,0.997397138194973,9,516,axon,CC,LRP2;TUBB4A;MAG;ERMN;MYO1D;CNTN2;GLDN;MBP;GJC2
13456,GO:0050730,0.00838935580663176,0.998407852348148,5,202,regulation of peptidyl-tyrosine phosphorylation,BP,CRLF1;ERBB3;ENPP2;EGFR;GREM1
19082,GO:1901863,0.00846952498836058,0.999192424237831,3,61,positive regulation of muscle tissue development,BP,ERBB3;GJA1;GREM1
10300,GO:0036477,0.008480737022629,0.996995286020505,11,725,somatodendritic compartment,CC,LRP2;TUBB4A;ERMN;CNTNAP4;KNDC1;MYO1D;CNTN2;ANKS1B;APOD;MBP;GJC2
16182,GO:0071206,0.00855540925590918,1,1,1,establishment of protein localization to juxtaparanode region of axon,BP,CNTN2
5170,GO:0014065,0.00858325767216239,0.99874197392602,4,116,phosphatidylinositol 3-kinase signaling,BP,ERBB3;PDGFRA;EGFR;RASGRP1
5662,GO:0016020,0.00878644821043469,0.995093713822064,60,7647,membrane,CC,CLDN11;NGFR;ERBB3;CDH19;LRP2;NKAIN1;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;MAG;BVES;PEX5L;PLCL1;RGS4;ATP10B;PPL;PLP1;MYRF;PDGFRA;CPM;SLC31A2;ENPP2;MOG;PCSK6;EGFR;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SNX22;SLC45A3;SLC5A11;TMEM144;SH3TC2;GJB1;MAL;RASGRP1;SUSD5;UGT8;MYO1D;BOK;TMEM125;TMEM151A;S1PR5;GPR62;AATK;CNTN2;ANKS1B;GLDN;NKAIN2;OPALIN;MBP;GJC2;TMEM235;TMEM88B
2638,GO:0005578,0.00887662344011839,0.997670231233841,7,340,proteinaceous extracellular matrix,CC,COL9A3;HAPLN2;ADAMTS4;GLDN;SPOCK3;SMOC1;COL28A1
13791,GO:0051246,0.00888533756739546,0.995551204462571,25,2458,regulation of protein metabolic process,BP,CRLF1;NGFR;ERBB3;LRP2;CAPN3;PLCL1;RGS4;PDGFRA;ENPP2;EGFR;ST18;CNDP1;GJA1;FZD7;GREM1;PPP1R14A;KNDC1;RASGRP1;BOK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
3530,GO:0006970,0.00890104646203761,0.999133687503452,3,66,response to osmotic stress,BP,CAPN3;MLC1;EGFR
10550,GO:0042060,0.00911402909086145,0.997337181464155,8,460,wound healing,BP,ERBB3;CAPN3;PDGFRA;EGFR;GJA1;FZD7;KLK6;APOD
1867,GO:0004181,0.00919496102008051,0.999602139288223,2,24,metallocarboxypeptidase activity,MF,FOLH1;CPM
14337,GO:0052813,0.00926991847076658,0.999085170965208,3,64,phosphatidylinositol bisphosphate kinase activity,MF,ERBB3;PDGFRA;EGFR
13792,GO:0051247,0.0093616729947354,0.995864165444006,17,1455,positive regulation of protein metabolic process,BP,CRLF1;NGFR;ERBB3;LRP2;CAPN3;PDGFRA;ENPP2;EGFR;ST18;GJA1;FZD7;GREM1;KNDC1;RASGRP1;BOK;CNTN2;MBP
6958,GO:0021895,0.00937502930373228,0.999592730892904,2,22,cerebral cortex neuron differentiation,BP,ARX;CNTN2
9296,GO:0034330,0.00949283181522433,0.997785919601134,6,257,cell junction organization,BP,CDH19;GJA1;GREM1;GJB1;UGT8;APOD
3786,GO:0007517,0.00952087021604082,0.997467083491127,7,347,muscle organ development,BP,ERBB3;LRP2;CAPN3;BVES;GJA1;FZD7;GREM1
4548,GO:0009611,0.00952095781963836,0.996961815693768,9,563,response to wounding,BP,ERBB3;CAPN3;PLLP;PDGFRA;EGFR;GJA1;FZD7;KLK6;APOD
14609,GO:0060191,0.00969470103529533,0.999024942916685,3,70,regulation of lipase activity,BP,PDGFRA;PCSK6;EGFR
11318,GO:0043524,0.00998444675344988,0.998467872933342,4,131,negative regulation of neuron apoptotic process,BP,CRLF1;ERBB3;MAG;BOK
13704,GO:0051119,0.0101190543603805,0.999539791935006,2,24,sugar transmembrane transporter activity,MF,SLC45A3;SLC5A11
13155,GO:0048646,0.0101998128301941,0.995955098932252,13,942,anatomical structure formation involved in morphogenesis,BP,NGFR;EYA2;LRP2;CAPN3;LDB3;PDGFRA;ENPP2;FZD7;GREM1;KNDC1;DMRT2;UGT8;APOD
18475,GO:0120039,0.010273765683751,0.996459122892118,10,612,plasma membrane bounded cell projection morphogenesis,BP,ARX;NGFR;LRP2;MAG;ENPP2;EGFR;GJA1;KNDC1;UGT8;CNTN2
4221,GO:0008643,0.0103226936560807,0.998401018847915,4,129,carbohydrate transport,BP,NGFR;SLC45A3;SLC5A11;TMEM144
13846,GO:0051336,0.0103371426156842,0.995747006255581,14,1111,regulation of hydrolase activity,BP,NGFR;BVES;RGS4;PDGFRA;PCSK6;EGFR;ST18;PPP1R14A;RASGRP1;MYO1D;BOK;SPOCK3;MBP;COL28A1
13280,GO:0048870,0.010339516645384,0.995493058983547,16,1317,cell motility,BP,ARX;ANLN;ERBB3;DCX;SOX10;MAG;BVES;PDGFRA;ENPP2;EGFR;GJA1;GREM1;CNTN2;DNAH17;APOD;SPOCK3
14025,GO:0051674,0.010339516645384,0.995493058983547,16,1317,localization of cell,BP,ARX;ANLN;ERBB3;DCX;SOX10;MAG;BVES;PDGFRA;ENPP2;EGFR;GJA1;GREM1;CNTN2;DNAH17;APOD;SPOCK3
13271,GO:0048858,0.0103538126298188,0.996427306148308,10,613,cell projection morphogenesis,BP,ARX;NGFR;LRP2;MAG;ENPP2;EGFR;GJA1;KNDC1;UGT8;CNTN2
4856,GO:0010640,0.0103655841892994,0.999525531217825,2,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,PDGFRA;APOD
3506,GO:0006928,0.0104088442923916,0.995064448205711,20,1753,movement of cell or subcellular component,BP,ARX;ANLN;NGFR;ERBB3;DCX;SOX10;MAG;BVES;PDGFRA;ENPP2;EGFR;GJA1;GREM1;MOBP;RASGRP1;MYO1D;CNTN2;DNAH17;APOD;SPOCK3
21220,GO:2000098,0.0104614870700645,0.999972782038333,1,2,negative regulation of smooth muscle cell-matrix adhesion,BP,APOD
5818,GO:0016323,0.0105279616559839,0.99788953630083,5,194,basolateral plasma membrane,CC,ERBB3;TF;MLC1;EGFR;MYO1D
13884,GO:0051402,0.0106094058504699,0.997867323103758,5,208,neuron apoptotic process,BP,CRLF1;NGFR;ERBB3;MAG;BOK
9371,GO:0034439,0.0106419815254285,0.999971832151659,1,2,lipoprotein lipid oxidation,BP,APOD
9374,GO:0034442,0.0106419815254285,0.999971832151659,1,2,regulation of lipoprotein oxidation,BP,APOD
10603,GO:0042160,0.0106419815254285,0.999971832151659,1,2,lipoprotein modification,BP,APOD
10604,GO:0042161,0.0106419815254285,0.999971832151659,1,2,lipoprotein oxidation,BP,APOD
14891,GO:0060587,0.0106419815254285,0.999971832151659,1,2,regulation of lipoprotein lipid oxidation,BP,APOD
5184,GO:0014717,0.0108203096507231,0.999970877577573,1,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,CAPN3
5185,GO:0014718,0.0108203096507231,0.999970877577573,1,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,CAPN3
5269,GO:0014901,0.0108203096507231,0.999970877577573,1,2,satellite cell activation involved in skeletal muscle regeneration,BP,CAPN3
7123,GO:0030030,0.01098384313397,0.995062341016988,17,1386,cell projection organization,BP,ARX;ANLN;NGFR;LRP2;TUBB4A;MAG;PLP1;ERMN;ENPP2;EGFR;GJA1;KLK6;KNDC1;UGT8;CNTN2;GLDN;APOD
11147,GO:0043235,0.0110199391069221,0.996984329145762,7,354,receptor complex,CC,ERBB3;LRP2;TF;PEX5L;PDGFRA;EGFR;GPR62
21416,GO:2000405,0.0110447505337246,0.9999696534312,1,2,negative regulation of T cell migration,BP,APOD
12168,GO:0045745,0.0110748946365439,0.999468164112261,2,27,positive regulation of G-protein coupled receptor protein signaling pathway,BP,KLK6;CNTN2
11005,GO:0043006,0.0110979758912711,0.999969359411504,1,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
2489,GO:0005215,0.0112031033439833,0.995344911978644,14,1100,transporter activity,MF,LRP2;TF;MLC1;ATP10B;SLC31A2;GJA1;PIEZO2;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;APOD;GJC2
592,GO:0001708,0.0112672737692867,0.998800033329804,3,76,cell fate specification,BP,EYA2;NKX6-2;FZD7
12667,GO:0046849,0.0113326351979272,0.998791756287669,3,73,bone remodeling,BP,EGFR;GJA1;GREM1
4549,GO:0009612,0.0114446898850856,0.997657809793081,5,197,response to mechanical stimulus,BP,MAG;PPL;EGFR;GJA1;PIEZO2
8290,GO:0032270,0.0114889583557321,0.99493063836573,16,1366,positive regulation of cellular protein metabolic process,BP,CRLF1;NGFR;ERBB3;LRP2;CAPN3;PDGFRA;ENPP2;EGFR;ST18;FZD7;GREM1;KNDC1;RASGRP1;BOK;CNTN2;MBP
11044,GO:0043066,0.0115314551863836,0.995729775645088,11,812,negative regulation of apoptotic process,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;SOX10;MAG;PDGFRA;EGFR;GREM1;BOK
15281,GO:0061351,0.0115358656917641,0.998154647139519,4,128,neural precursor cell proliferation,BP,ARX;LRP2;SOX10;GJC2
18656,GO:1900154,0.0115468516763412,0.999966823080612,1,2,regulation of bone trabecula formation,BP,GREM1
18657,GO:1900155,0.0115468516763412,0.999966823080612,1,2,negative regulation of bone trabecula formation,BP,GREM1
14418,GO:0055026,0.0117813053490685,0.99941841898865,2,25,negative regulation of cardiac muscle tissue development,BP,GJA1;FZD7
10415,GO:0038131,0.0118428848246769,0.999965094856775,1,2,neuregulin receptor activity,MF,ERBB3
2841,GO:0005905,0.0118465961405054,0.998719765811789,3,66,clathrin-coated pit,CC,LRP2;TF;EGFR
16111,GO:0070997,0.0119204004107239,0.997076334112084,6,297,neuron death,BP,CRLF1;NGFR;ERBB3;MAG;KLK6;BOK
13132,GO:0048608,0.0119434360420805,0.996678378583739,7,381,reproductive structure development,BP,LRP2;COL9A3;PDGFRA;EGFR;GJA1;GJB1;BOK
9569,GO:0035004,0.0120254176459665,0.998691598829086,3,69,phosphatidylinositol 3-kinase activity,MF,ERBB3;PDGFRA;EGFR
14783,GO:0060429,0.0120315255984423,0.995124320168414,13,1008,epithelium development,BP,ARX;CRLF1;LRP2;SOX10;FA2H;PPL;HAPLN2;PCSK6;EGFR;GJA1;FZD7;GREM1;DMRT2
8785,GO:0032990,0.0120884445877725,0.995728508884591,10,631,cell part morphogenesis,BP,ARX;NGFR;LRP2;MAG;ENPP2;EGFR;GJA1;KNDC1;UGT8;CNTN2
12071,GO:0045596,0.0121417123002491,0.995968847836802,9,576,negative regulation of cell differentiation,BP,NGFR;CAPN3;SOX10;MAG;EGFR;NKX6-2;FZD7;GREM1;CNTN2
10583,GO:0042127,0.0122372124358827,0.994560527612815,16,1410,regulation of cell proliferation,BP,ARX;CRLF1;NGFR;ERBB3;LRP2;SOX10;FA2H;PDGFRA;EGFR;ST18;GJA1;FZD7;GREM1;BOK;APOD;GJC2
13641,GO:0051020,0.0122866293699031,0.995647971322475,10,623,GTPase binding,MF,ANLN;NGFR;ERBB3;PEX5L;PDGFRA;RAPGEF5;EGFR;MOBP;KNDC1;RASGRP1
12246,GO:0045907,0.0123527451589399,0.999371990084055,2,27,positive regulation of vasoconstriction,BP,EGFR;GJA1
15322,GO:0061458,0.0123867433860785,0.996530437013668,7,384,reproductive system development,BP,LRP2;COL9A3;PDGFRA;EGFR;GJA1;GJB1;BOK
11047,GO:0043069,0.0125964090124404,0.99527536369599,11,823,negative regulation of programmed cell death,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;SOX10;MAG;PDGFRA;EGFR;GREM1;BOK
2172,GO:0004714,0.0126356980581,0.998602274696529,3,65,transmembrane receptor protein tyrosine kinase activity,MF,ERBB3;PDGFRA;EGFR
20108,GO:1904207,0.0127113839337398,0.999959769778718,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,MBP
20109,GO:1904209,0.0127113839337398,0.999959769778718,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,MBP
21262,GO:2000177,0.0127527025051126,0.998580996478985,3,71,regulation of neural precursor cell proliferation,BP,LRP2;SOX10;GJC2
2379,GO:0005006,0.0127900719566264,0.99995926852319,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
13201,GO:0048710,0.0129110460628175,0.999328249872894,2,27,regulation of astrocyte differentiation,BP,MAG;CNTN2
17580,GO:0097058,0.0129134525360918,0.999944675410783,1,3,CRLF-CLCF1 complex,CC,CRLF1
15166,GO:0061061,0.0129297738915314,0.995663416215425,9,559,muscle structure development,BP,ERBB3;LRP2;CAPN3;BVES;LDB3;PDGFRA;GJA1;FZD7;GREM1
5077,GO:0010950,0.012940735362636,0.99785290240081,4,154,positive regulation of endopeptidase activity,BP,NGFR;ST18;BOK;MBP
10931,GO:0042803,0.0129614873201377,0.995367123098195,10,731,protein homodimerization activity,MF,ERBB3;CDH19;MAG;PDGFRA;GREM1;GPD1;GJB1;RASGRP1;DMRT2;BOK
20337,GO:1904685,0.013096952231349,0.99995728379487,1,2,positive regulation of metalloendopeptidase activity,BP,MBP
14281,GO:0052548,0.0131620917633261,0.996698175109605,6,337,regulation of endopeptidase activity,BP,NGFR;ST18;BOK;SPOCK3;MBP;COL28A1
18658,GO:1900157,0.0132459675239789,0.999956302904464,1,2,regulation of bone mineralization involved in bone maturation,BP,GREM1
11646,GO:0044421,0.0133799384856597,0.992790598098717,29,3312,extracellular region part,CC,CRLF1;CLDN11;BCAS1;ERBB3;LRP2;FOLH1;TF;COL9A3;PLLP;TUBB4A;PPL;HAPLN2;CPM;ERMN;ENPP2;PCSK6;EGFR;GJA1;ADAMTS4;EDIL3;GREM1;GPD1;KLK6;MYO1D;GLDN;APOD;SPOCK3;SMOC1;COL28A1
13457,GO:0050731,0.0135455963588961,0.997723531710622,4,148,positive regulation of peptidyl-tyrosine phosphorylation,BP,CRLF1;ERBB3;ENPP2;GREM1
15806,GO:0070435,0.0135608254133054,0.999954193486625,1,2,Shc-EGFR complex,CC,EGFR
623,GO:0001764,0.0136113180774665,0.997713955764797,4,130,neuron migration,BP,ARX;DCX;GJA1;CNTN2
4927,GO:0010750,0.0137729723896819,0.999952743954991,1,2,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
12228,GO:0045862,0.0138616999272774,0.996484804398044,6,320,positive regulation of proteolysis,BP,NGFR;CAPN3;ST18;BOK;CNTN2;MBP
11575,GO:0044297,0.0138948133397895,0.995625313709199,8,490,cell body,CC,TUBB4A;ERMN;KNDC1;MYO1D;CNTN2;APOD;MBP;GJC2
21622,GO:2000725,0.0138976510537501,0.999248477437272,2,27,regulation of cardiac muscle cell differentiation,BP,FZD7;GREM1
7259,GO:0030239,0.0139254069531282,0.99840474703405,3,63,myofibril assembly,BP,CAPN3;LDB3;PDGFRA
16507,GO:0071695,0.0140668879748052,0.997612095071697,4,138,anatomical structure maturation,BP,GJA1;GREM1;CNTN2;GLDN
18467,GO:0120025,0.0141656001162985,0.993067463640822,20,1807,plasma membrane bounded cell projection,CC,ANLN;NGFR;DCX;LRP2;TUBB4A;MAG;BVES;LDB3;ERMN;CNTNAP4;LGI3;KNDC1;MYO1D;CNTN2;ANKS1B;GLDN;DNAH17;APOD;MBP;GJC2
8408,GO:0032431,0.014178489092027,0.99993326671016,1,3,activation of phospholipase A2 activity,BP,EGFR
4859,GO:0010643,0.0142459749169681,0.999949430197643,1,2,cell communication by chemical coupling,BP,GJA1
1198,GO:0002686,0.0142694710282501,0.999209365837644,2,33,negative regulation of leukocyte migration,BP,GREM1;APOD
2750,GO:0005768,0.0143043510007176,0.994534994066251,11,813,endosome,CC,NGFR;LRP2;TF;MLC1;SLC31A2;EGFR;GJA1;FZD7;SH3TC2;MYO1D;BOK
16305,GO:0071393,0.0143520623967896,0.99994867144204,1,2,cellular response to progesterone stimulus,BP,SOX10
1932,GO:0004367,0.0143696844190274,0.999948544855144,1,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,GPD1
12390,GO:0046168,0.0143696844190274,0.999948544855144,1,2,glycerol-3-phosphate catabolic process,BP,GPD1
18737,GO:1900390,0.0144057964566521,0.99993110273634,1,3,regulation of iron ion import,BP,TF
2608,GO:0005509,0.0144765343893426,0.995053023416859,9,560,calcium ion binding,MF,CDH19;LRP2;CAPN3;TUBB4A;ENPP2;EDIL3;RASGRP1;SPOCK3;SMOC1
15734,GO:0070315,0.0145336924560079,0.999947359178639,1,2,G1 to G0 transition involved in cell differentiation,BP,CAPN3
2636,GO:0005576,0.0145542327574398,0.991938567992191,32,3793,extracellular region,CC,CRLF1;CLDN11;NGFR;BCAS1;ERBB3;LRP2;FOLH1;TF;COL9A3;PLLP;TUBB4A;PPL;HAPLN2;CPM;ERMN;ENPP2;PCSK6;EGFR;CNDP1;GJA1;ADAMTS4;EDIL3;GREM1;GPD1;KLK6;LGI3;MYO1D;GLDN;APOD;SPOCK3;SMOC1;COL28A1
6967,GO:0021912,0.0145882438754575,0.999929340686053,1,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,NKX6-2
2404,GO:0005052,0.014705114005675,0.999946105363516,1,2,peroxisome matrix targeting signal-1 binding,MF,PEX5L
1933,GO:0004368,0.0148006084346787,0.999945400447757,1,2,glycerol-3-phosphate dehydrogenase activity,MF,GPD1
2980,GO:0006127,0.0148006084346787,0.999945400447757,1,2,glycerophosphate shuttle,BP,GPD1
6129,GO:0016901,0.0148006084346787,0.999945400447757,1,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,GPD1
20090,GO:1904170,0.0148326078500452,0.999945163203876,1,2,regulation of bleb assembly,BP,ANLN
20091,GO:1904172,0.0148326078500452,0.999945163203876,1,2,positive regulation of bleb assembly,BP,ANLN
8723,GO:0032902,0.014866424227655,0.999944911925832,1,2,nerve growth factor production,BP,PCSK6
6949,GO:0021884,0.0148797021365707,0.999164286517383,2,28,forebrain neuron development,BP,ARX;CNTN2
3975,GO:0008233,0.0148881205290776,0.995252538357304,8,518,peptidase activity,MF,FOLH1;CAPN3;MYRF;CPM;PCSK6;CNDP1;ADAMTS4;KLK6
589,GO:0001705,0.0149852606259843,0.999944024301935,1,2,ectoderm formation,BP,FZD7
596,GO:0001712,0.0149852606259843,0.999944024301935,1,2,ectodermal cell fate commitment,BP,FZD7
7874,GO:0031434,0.0150196714089135,0.998225751255896,3,69,mitogen-activated protein kinase kinase binding,MF,ERBB3;PDGFRA;EGFR
9562,GO:0034986,0.0150774187345316,0.999943331024462,1,2,iron chaperone activity,MF,TF
17382,GO:0090291,0.0150839654150222,0.999943281612201,1,2,negative regulation of osteoclast proliferation,BP,GREM1
8288,GO:0032268,0.0150934824921685,0.992244857585061,23,2295,regulation of cellular protein metabolic process,BP,CRLF1;NGFR;ERBB3;LRP2;CAPN3;PLCL1;RGS4;PDGFRA;ENPP2;EGFR;ST18;CNDP1;FZD7;GREM1;PPP1R14A;KNDC1;RASGRP1;BOK;CNTN2;SPOCK3;MBP;GJC2;COL28A1
15019,GO:0060795,0.0151023130371743,0.99914053164602,2,31,cell fate commitment involved in formation of primary germ layer,BP,EYA2;FZD7
7804,GO:0031315,0.0151263413016088,0.999942961247687,1,2,extrinsic component of mitochondrial outer membrane,CC,SOX10
13790,GO:0051241,0.0153096272305728,0.993829918870516,12,950,negative regulation of multicellular organismal process,BP,NGFR;CAPN3;SOX10;MAG;PDGFRA;EGFR;NKX6-2;GJA1;FZD7;GREM1;CNTN2;APOD
15080,GO:0060931,0.0154201657138694,0.999940714904186,1,2,sinoatrial node cell development,BP,BVES
2753,GO:0005771,0.0154261121718865,0.999107206445837,2,35,multivesicular body,CC,EGFR;GJA1
13789,GO:0051240,0.0154750900674928,0.992930489764682,16,1393,positive regulation of multicellular organismal process,BP,ARX;NGFR;ERBB3;LRP2;SOX10;MAG;MYRF;ENPP2;EGFR;NKX6-2;GJA1;GREM1;RASGRP1;DMRT2;MBP;GJC2
3556,GO:0007009,0.0155045801731257,0.998143914408083,3,73,plasma membrane organization,BP,FA2H;MYRF;SH3TC2
9974,GO:0035790,0.015655874943082,0.99993888125042,1,2,platelet-derived growth factor receptor-alpha signaling pathway,BP,PDGFRA
17173,GO:0086075,0.0157050830013258,0.999938494894043,1,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,GJA1
4860,GO:0010644,0.0159373668639324,0.99907389426586,2,27,cell communication by electrical coupling,BP,GJA1;GJC2
16832,GO:0072275,0.0160308639151936,0.999935906070598,1,2,metanephric glomerulus morphogenesis,BP,PDGFRA
16833,GO:0072276,0.0160308639151936,0.999935906070598,1,2,metanephric glomerulus vasculature morphogenesis,BP,PDGFRA
16834,GO:0072277,0.0160308639151936,0.999935906070598,1,2,metanephric glomerular capillary formation,BP,PDGFRA
9037,GO:0033590,0.0162339887784395,0.999912433403224,1,3,response to cobalamin,BP,EGFR
7014,GO:0022011,0.0162638419320686,0.99904921647948,2,25,myelination in peripheral nervous system,BP,FA2H;SH3TC2
8308,GO:0032292,0.0162638419320686,0.99904921647948,2,25,peripheral nervous system axon ensheathment,BP,FA2H;SH3TC2
2640,GO:0005581,0.0162671577417454,0.998014213957891,3,78,collagen trimer,CC,COL9A3;GLDN;COL28A1
8849,GO:0033106,0.0162913534924672,0.99991181115709,1,3,cis-Golgi network membrane,CC,BOK
13062,GO:0048408,0.0164593102666399,0.999909976535023,1,3,epidermal growth factor binding,MF,EGFR
14397,GO:0055002,0.0164631392090285,0.99707330790836,4,135,striated muscle cell development,BP,CAPN3;BVES;LDB3;PDGFRA
12899,GO:0048015,0.0165227064755893,0.997057541042818,4,141,phosphatidylinositol-mediated signaling,BP,ERBB3;PDGFRA;EGFR;RASGRP1
21219,GO:2000097,0.0165268493581722,0.999909233428839,1,3,regulation of smooth muscle cell-matrix adhesion,BP,APOD
14666,GO:0060284,0.01667868444666,0.993483438692345,11,785,regulation of cell development,BP,NGFR;LRP2;SOX10;MAG;NKX6-2;SLC45A3;KLK6;KNDC1;S1PR5;CNTN2;GJC2
21093,GO:1990769,0.0168372023752738,0.999905779169783,1,3,proximal neuron projection,CC,GJC2
19401,GO:1902722,0.0168434456497144,0.999905709014581,1,3,positive regulation of prolactin secretion,BP,EGFR
20750,GO:1905576,0.0170736912906528,0.999903103384164,1,3,ganglioside GT1b binding,MF,MAG
4766,GO:0010470,0.0171827310070774,0.99895178766666,2,32,regulation of gastrulation,BP,FZD7;MBP
5530,GO:0015748,0.0172854672718419,0.997837845954263,3,84,organophosphate ester transport,BP,ATP10B;GJA1;GJB1
7730,GO:0031175,0.0174338044696092,0.992846874306681,12,886,neuron projection development,BP,ARX;NGFR;LRP2;MAG;PLP1;EGFR;GJA1;KLK6;KNDC1;UGT8;CNTN2;APOD
7392,GO:0030510,0.0174994920606218,0.997802799059827,3,81,regulation of BMP signaling pathway,BP,LRP2;PCSK6;GREM1
3798,GO:0007548,0.0176251851202837,0.995975908784242,5,232,sex differentiation,BP,LRP2;COL9A3;PDGFRA;DMRT2;BOK
12901,GO:0048017,0.0177118545949358,0.996778839123632,4,144,inositol lipid-mediated signaling,BP,ERBB3;PDGFRA;EGFR;RASGRP1
8267,GO:0032228,0.0177310457793757,0.998903798224345,2,30,regulation of synaptic transmission, GABAergic,BP,PLCL1;CNTNAP4
19090,GO:1901888,0.0178621970092335,0.997740638212254,3,80,regulation of cell junction assembly,BP,GJA1;GREM1;APOD
14280,GO:0052547,0.017924069474763,0.995186117975167,6,360,regulation of peptidase activity,BP,NGFR;ST18;BOK;SPOCK3;MBP;COL28A1
4568,GO:0009653,0.0180718426942103,0.990441752813615,24,2350,anatomical structure morphogenesis,BP,ARX;NGFR;EYA2;CDH19;LRP2;CAPN3;SOX10;MAG;BVES;LDB3;PDGFRA;CPM;ERMN;ENPP2;EGFR;GJA1;FZD7;GREM1;KNDC1;DMRT2;UGT8;CNTN2;APOD;MBP
17380,GO:0090289,0.0181955639295779,0.999889895153403,1,3,regulation of osteoclast proliferation,BP,GREM1
5079,GO:0010952,0.0182812604849593,0.996635784982534,4,171,positive regulation of peptidase activity,BP,NGFR;ST18;BOK;MBP
5006,GO:0010863,0.0184160981877241,0.998836498379871,2,31,positive regulation of phospholipase C activity,BP,PDGFRA;EGFR
14595,GO:0060168,0.0184584803809023,0.99988667668964,1,3,positive regulation of adenosine receptor signaling pathway,BP,CNTN2
10504,GO:0040011,0.0185473467512364,0.991149813329088,17,1527,locomotion,BP,ARX;ANLN;NGFR;ERBB3;DCX;SOX10;MAG;BVES;PDGFRA;ENPP2;EGFR;GJA1;GREM1;CNTN2;DNAH17;APOD;SPOCK3
12814,GO:0047391,0.0186256784080116,0.999884605630741,1,3,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,ENPP2
1441,GO:0003163,0.0186286044063979,0.999884569218415,1,3,sinoatrial node development,BP,BVES
15073,GO:0060921,0.0186286044063979,0.999884569218415,1,3,sinoatrial node cell differentiation,BP,BVES
754,GO:0001937,0.018723672096787,0.998804816315411,2,32,negative regulation of endothelial cell proliferation,BP,NGFR;GJA1
13163,GO:0048666,0.0187654382620267,0.991933840915442,13,1004,neuron development,BP,ARX;NGFR;LRP2;MAG;PLP1;EGFR;GJA1;KLK6;KNDC1;UGT8;CNTN2;GLDN;APOD
19968,GO:1903899,0.0188278094638591,0.999882076605674,1,3,positive regulation of PERK-mediated unfolded protein response,BP,BOK
6968,GO:0021913,0.0189058336851767,0.999866301200065,1,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,NKX6-2
3875,GO:0008065,0.0190522627459864,0.999879235888119,1,3,establishment of blood-nerve barrier,BP,HAPLN2
18473,GO:0120036,0.0193165890448017,0.990940048324019,16,1355,plasma membrane bounded cell projection organization,BP,ARX;ANLN;NGFR;LRP2;TUBB4A;MAG;PLP1;ENPP2;EGFR;GJA1;KLK6;KNDC1;UGT8;CNTN2;GLDN;APOD
5122,GO:0014002,0.0193296185708399,0.998747125429624,2,31,astrocyte development,BP,PLP1;EGFR
10864,GO:0042692,0.019436609859694,0.994691714540595,6,308,muscle cell differentiation,BP,CAPN3;BVES;LDB3;PDGFRA;FZD7;GREM1
5150,GO:0014044,0.0194993969984075,0.998737022402235,2,28,Schwann cell development,BP,FA2H;SH3TC2
2385,GO:0005017,0.0196593981127467,0.999871380949487,1,3,platelet-derived growth factor-activated receptor activity,MF,PDGFRA
1355,GO:0002931,0.020037643345958,0.998672292349379,2,33,response to ischemia,BP,BVES;GJA1
7268,GO:0030258,0.0200381541610141,0.995271670391893,5,243,lipid modification,BP,ERBB3;FA2H;PDGFRA;EGFR;APOD
4148,GO:0008506,0.0200579961253317,0.999866088206731,1,3,sucrose:proton symporter activity,MF,SLC45A3
4156,GO:0008515,0.0200579961253317,0.999866088206731,1,3,sucrose transmembrane transporter activity,MF,SLC45A3
4569,GO:0009669,0.0200579961253317,0.999866088206731,1,3,sucrose:cation symporter activity,MF,SLC45A3
5344,GO:0015154,0.0200579961253317,0.999866088206731,1,3,disaccharide transmembrane transporter activity,MF,SLC45A3
5345,GO:0015157,0.0200579961253317,0.999866088206731,1,3,oligosaccharide transmembrane transporter activity,MF,SLC45A3
5535,GO:0015766,0.0200579961253317,0.999866088206731,1,3,disaccharide transport,BP,SLC45A3
5536,GO:0015770,0.0200579961253317,0.999866088206731,1,3,sucrose transport,BP,SLC45A3
5537,GO:0015772,0.0200579961253317,0.999866088206731,1,3,oligosaccharide transport,BP,SLC45A3
12140,GO:0045687,0.0201907388165921,0.998650026942039,2,37,positive regulation of glial cell differentiation,BP,MAG;NKX6-2
2653,GO:0005594,0.0202557082867219,0.999863422946278,1,3,collagen type IX trimer,CC,COL9A3
20229,GO:1904447,0.0204731843430323,0.99989522393008,1,2,folic acid import across plasma membrane,BP,LRP2
5131,GO:0014014,0.0205667537525446,0.998612961902836,2,36,negative regulation of gliogenesis,BP,SOX10;NKX6-2
10995,GO:0042995,0.0206049177322264,0.989507915960268,20,1877,cell projection,CC,ANLN;NGFR;DCX;LRP2;TUBB4A;MAG;BVES;LDB3;ERMN;CNTNAP4;LGI3;KNDC1;MYO1D;CNTN2;ANKS1B;GLDN;DNAH17;APOD;MBP;GJC2
17059,GO:0072741,0.0209849235079701,0.999853363518083,1,3,protein localization to cell division site,BP,ANLN
19583,GO:1903119,0.0209849235079701,0.999853363518083,1,3,protein localization to actin cytoskeleton,BP,ANLN
20250,GO:1904498,0.0209849235079701,0.999853363518083,1,3,protein localization to mitotic actomyosin contractile ring,BP,ANLN
20931,GO:1990179,0.0209849235079701,0.999853363518083,1,3,protein localization to actomyosin contractile ring,BP,ANLN
7548,GO:0030855,0.0210508752497808,0.992848888082854,8,536,epithelial cell differentiation,BP,ARX;FA2H;PPL;HAPLN2;PCSK6;GJA1;FZD7;GREM1
18718,GO:1900274,0.0210510958774049,0.998568188336286,2,33,regulation of phospholipase C activity,BP,PDGFRA;EGFR
5310,GO:0015091,0.021269989828246,0.999849332952382,1,3,ferric iron transmembrane transporter activity,MF,TF
16931,GO:0072510,0.021269989828246,0.999849332952382,1,3,trivalent inorganic cation transmembrane transporter activity,MF,TF
2168,GO:0004709,0.0216214868027227,0.997063341324897,3,78,MAP kinase kinase kinase activity,MF,ERBB3;PDGFRA;EGFR
9041,GO:0033594,0.0216629075345744,0.999824255868881,1,4,response to hydroxyisoflavone,BP,EGFR
3783,GO:0007507,0.0217754851486306,0.992560011446245,8,493,heart development,BP,ERBB3;LRP2;BVES;PDGFRA;EGFR;GJA1;FZD7;GREM1
18837,GO:1901184,0.0218195707795043,0.997016792715917,3,90,regulation of ERBB signaling pathway,BP,ERBB3;EGFR;SH3TC2
3740,GO:0007354,0.0218557475355186,0.999821098293332,1,4,zygotic determination of anterior/posterior axis, embryo,BP,PCSK6
14519,GO:0060054,0.0219370944165727,0.999819757803584,1,4,positive regulation of epithelial cell proliferation involved in wound healing,BP,FZD7
14866,GO:0060548,0.022090734797745,0.990992676650611,11,896,negative regulation of cell death,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;SOX10;MAG;PDGFRA;EGFR;GREM1;BOK
2413,GO:0005085,0.0220959999095807,0.993789932220985,6,306,guanyl-nucleotide exchange factor activity,MF,ERBB3;PDGFRA;RAPGEF5;EGFR;KNDC1;RASGRP1
14594,GO:0060167,0.0221334478754303,0.999816501347125,1,4,regulation of adenosine receptor signaling pathway,BP,CNTN2
4490,GO:0009331,0.0222268267388498,0.999835400600489,1,3,glycerol-3-phosphate dehydrogenase complex,CC,GPD1
6454,GO:0019199,0.0222393518663888,0.996945279347478,3,80,transmembrane receptor protein kinase activity,MF,ERBB3;PDGFRA;EGFR
3980,GO:0008238,0.0222493450754191,0.996932236507449,3,95,exopeptidase activity,MF,FOLH1;CPM;CNDP1
6882,GO:0021762,0.022399420517161,0.998414269184468,2,39,substantia nigra development,BP,PLP1;MBP
3979,GO:0008237,0.0224363655541032,0.995612327557046,4,162,metallopeptidase activity,MF,FOLH1;CPM;CNDP1;ADAMTS4
14396,GO:0055001,0.0225219553071932,0.995595166471817,4,150,muscle cell development,BP,CAPN3;BVES;LDB3;PDGFRA
7463,GO:0030665,0.0227470942165176,0.996834790231223,3,99,clathrin-coated vesicle membrane,CC,LRP2;TF;EGFR
6989,GO:0021953,0.0228761512548482,0.995498918105333,4,165,central nervous system neuron differentiation,BP,ARX;NKX6-2;KNDC1;CNTN2
17307,GO:0090191,0.022988274699552,0.999801981237615,1,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
1504,GO:0003257,0.0232052967765777,0.999820509444373,1,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,GREM1
18860,GO:1901228,0.0232052967765777,0.999820509444373,1,3,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,GREM1
12706,GO:0046915,0.0232645461124865,0.99832302041993,2,37,transition metal ion transmembrane transporter activity,MF,TF;SLC31A2
13462,GO:0050748,0.023307899700465,0.999796408666576,1,4,negative regulation of lipoprotein metabolic process,BP,APOD
10385,GO:0038086,0.0233827342564826,0.99981773925698,1,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,PDGFRA
10387,GO:0038091,0.0233827342564826,0.99981773925698,1,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,PDGFRA
18055,GO:0098797,0.0235660927470131,0.991825078939519,8,536,plasma membrane protein complex,CC,CDH19;TF;EGFR;GJA1;KCNJ6;GJB1;CNTN2;GJC2
11904,GO:0045163,0.0236742908359803,0.999813140855714,1,3,clustering of voltage-gated potassium channels,BP,CNTN2
3489,GO:0006898,0.0237148104953873,0.994155279551532,5,254,receptor-mediated endocytosis,BP,LRP2;TF;ENPP2;GREM1;CNTN2
17808,GO:0097487,0.0237211541268833,0.99978908790622,1,4,multivesicular body, internal vesicle,CC,EGFR
13246,GO:0048812,0.0237558972349853,0.991168246289856,9,598,neuron projection morphogenesis,BP,ARX;NGFR;LRP2;MAG;EGFR;GJA1;KNDC1;UGT8;CNTN2
7139,GO:0030054,0.0238129035893495,0.989100140902138,14,1176,cell junction,CC,CLDN11;CDH19;MLC1;BVES;PPL;PDGFRA;EGFR;GJA1;CNTNAP4;LGI3;GJB1;ANKS1B;OPALIN;GJC2
5129,GO:0014012,0.0243155477739323,0.999763648999266,1,5,peripheral nervous system axon regeneration,BP,APOD
9843,GO:0035594,0.0243463306009608,0.999777764629813,1,4,ganglioside binding,MF,MAG
17793,GO:0097458,0.0243954385731819,0.988225941840703,16,1425,neuron part,CC,NGFR;DCX;LRP2;TUBB4A;MAG;ERMN;CNTNAP4;LGI3;KNDC1;MYO1D;CNTN2;ANKS1B;GLDN;APOD;MBP;GJC2
17970,GO:0098609,0.0243967947917506,0.99088415457307,9,650,cell-cell adhesion,BP,CLDN11;CDH19;MAG;BVES;PDGFRA;EGFR;RASGRP1;GLDN;MBP
12671,GO:0046854,0.0244246739920147,0.996514132587391,3,91,phosphatidylinositol phosphorylation,BP,ERBB3;PDGFRA;EGFR
16795,GO:0072210,0.0244514644731751,0.998192197569741,2,36,metanephric nephron development,BP,PDGFRA;GREM1
11441,GO:0043949,0.0244984822390704,0.998179271035238,2,40,regulation of cAMP-mediated signaling,BP,PEX5L;GPR62
6292,GO:0018108,0.0246746595808004,0.992884781770364,6,335,peptidyl-tyrosine phosphorylation,BP,CRLF1;ERBB3;PDGFRA;ENPP2;EGFR;GREM1
10679,GO:0042325,0.0247096250554438,0.988329858249315,15,1343,regulation of phosphorylation,BP,CRLF1;NGFR;ERBB3;PLCL1;RGS4;PDGFRA;ENPP2;EGFR;FZD7;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;GJC2
19695,GO:1903367,0.024774008065963,0.999754606097668,1,5,positive regulation of fear response,BP,GJA1
21731,GO:2000987,0.024774008065963,0.999754606097668,1,5,positive regulation of behavioral fear response,BP,GJA1
13476,GO:0050768,0.025007042117696,0.993754100717763,5,245,negative regulation of neurogenesis,BP,NGFR;SOX10;MAG;NKX6-2;CNTN2
2424,GO:0005102,0.0250219167109334,0.988467128972327,14,1311,signaling receptor binding,MF,CRLF1;LRP2;TF;MAG;PLCL1;PDGFRA;MOG;EGFR;GJA1;FZD7;EDIL3;GREM1;BOK;ANKS1B
2625,GO:0005539,0.0250756587545886,0.994921407886374,4,180,glycosaminoglycan binding,MF,HAPLN2;PCSK6;SUSD5;SPOCK3
2973,GO:0006116,0.0251644650349208,0.999762494414099,1,4,NADH oxidation,BP,GPD1
4662,GO:0009996,0.0251732857790513,0.999746590805431,1,5,negative regulation of cell fate specification,BP,FZD7
8428,GO:0032455,0.0252550832141165,0.999760771507825,1,4,nerve growth factor processing,BP,PCSK6
9856,GO:0035609,0.0254237970573455,0.999757547014457,1,4,C-terminal protein deglutamylation,BP,FOLH1
6324,GO:0018212,0.0254989454143641,0.992591482054064,6,338,peptidyl-tyrosine modification,BP,CRLF1;ERBB3;PDGFRA;ENPP2;EGFR;GREM1
18853,GO:1901215,0.0256317334232709,0.994775406154491,4,176,negative regulation of neuron death,BP,CRLF1;ERBB3;MAG;BOK
21595,GO:2000672,0.0256475090460536,0.999753237731175,1,4,negative regulation of motor neuron apoptotic process,BP,CRLF1
131,GO:0000268,0.0256741884482871,0.999752721254148,1,4,peroxisome targeting sequence binding,MF,PEX5L
8707,GO:0032879,0.0258078892166903,0.986008166655231,23,2369,regulation of localization,BP,NGFR;ERBB3;NKAIN1;TF;CAPN3;MLC1;BVES;PDGFRA;SLC31A2;ENPP2;EGFR;GJA1;KCNJ6;GREM1;LGI3;SH3TC2;RASGRP1;BOK;NKAIN2;APOD;SPOCK3;MBP;GJC2
10413,GO:0038128,0.0258532095158944,0.9980265364088,2,38,ERBB2 signaling pathway,BP,ERBB3;EGFR
19815,GO:1903588,0.0259188759637574,0.999747958971552,1,4,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
9531,GO:0034756,0.0260020537320625,0.999729538159281,1,5,regulation of iron ion transport,BP,TF
17201,GO:0090027,0.0261484289878918,0.999743449489271,1,4,negative regulation of monocyte chemotaxis,BP,GREM1
5230,GO:0014834,0.0261548904798475,0.999743321970622,1,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,FZD7
12900,GO:0048016,0.0262005294221773,0.997990146094451,2,36,inositol phosphate-mediated signaling,BP,ERBB3;GPR62
16468,GO:0071638,0.0263018849526749,0.999723230607767,1,5,negative regulation of monocyte chemotactic protein-1 production,BP,APOD
7720,GO:0031133,0.0263077535040794,0.999740295847125,1,4,regulation of axon diameter,BP,CNTN2
12459,GO:0046394,0.0265842549276886,0.992196550017714,6,375,carboxylic acid biosynthetic process,BP,FOLH1;FA2H;PLP1;SLC45A3;GPD1;CARNS1
11786,GO:0044853,0.0266158234109661,0.996073464001412,3,93,plasma membrane raft,CC,MLC1;BVES;MYO1D
5928,GO:0016560,0.0266515928555697,0.999733423548341,1,4,protein import into peroxisome matrix, docking,BP,PEX5L
1413,GO:0003104,0.0268084668695571,0.999730257959499,1,4,positive regulation of glomerular filtration,BP,GJA1
5682,GO:0016053,0.0269113890721452,0.992078293694003,6,376,organic acid biosynthetic process,BP,FOLH1;FA2H;PLP1;SLC45A3;GPD1;CARNS1
6880,GO:0021759,0.0271023746050438,0.999724276260614,1,4,globus pallidus development,BP,ARX
17109,GO:0080184,0.0271057519754176,0.999705956869894,1,5,response to phenylpropanoid,BP,EGFR
1368,GO:0003006,0.0271123866603628,0.990342152928234,8,559,developmental process involved in reproduction,BP,LRP2;COL9A3;PDGFRA;EGFR;GJA1;GJB1;DMRT2;BOK
11171,GO:0043269,0.0272077949863196,0.990301740391419,8,559,regulation of ion transport,BP,NKAIN1;TF;CAPN3;SLC31A2;GJA1;KCNJ6;NKAIN2;GJC2
8407,GO:0032430,0.0272574386724052,0.999702638082286,1,5,positive regulation of phospholipase A2 activity,BP,EGFR
1502,GO:0003254,0.0272746989073393,0.997855455588576,2,39,regulation of membrane depolarization,BP,GJA1;BOK
15164,GO:0061055,0.0272890534955855,0.999720442450893,1,4,myotome development,BP,DMRT2
15186,GO:0061098,0.0274502562292674,0.997836418992643,2,38,positive regulation of protein tyrosine kinase activity,BP,ERBB3;GREM1
4222,GO:0008645,0.027623565696694,0.99586243421948,3,98,hexose transmembrane transport,BP,NGFR;SLC45A3;SLC5A11
15076,GO:0060926,0.0276398005762378,0.999713166746085,1,4,cardiac pacemaker cell development,BP,BVES
15255,GO:0061302,0.0278350461806476,0.99968982803226,1,5,smooth muscle cell-matrix adhesion,BP,APOD
9874,GO:0035633,0.027995858153511,0.99970568413333,1,4,maintenance of permeability of blood-brain barrier,BP,MBP
16213,GO:0071253,0.028001306710069,0.999705568873489,1,4,connexin binding,MF,GJA1
17740,GO:0097360,0.0281064668662044,0.999703339820821,1,4,chorionic trophoblast cell proliferation,BP,BOK
18924,GO:1901382,0.0281064668662044,0.999703339820821,1,4,regulation of chorionic trophoblast cell proliferation,BP,BOK
3350,GO:0006682,0.0281114578097065,0.999683601160915,1,5,galactosylceramide biosynthetic process,BP,UGT8
6531,GO:0019375,0.0281114578097065,0.999683601160915,1,5,galactolipid biosynthetic process,BP,UGT8
10681,GO:0042327,0.0281145563941684,0.988104642252727,11,894,positive regulation of phosphorylation,BP,CRLF1;NGFR;ERBB3;PDGFRA;ENPP2;EGFR;FZD7;GREM1;GPD1;KNDC1;RASGRP1
18572,GO:1900019,0.0281180081598715,0.999703094664909,1,4,regulation of protein kinase C activity,BP,EGFR
18573,GO:1900020,0.0281180081598715,0.999703094664909,1,4,positive regulation of protein kinase C activity,BP,EGFR
5659,GO:0016015,0.0282174257573738,0.999668020448083,1,6,morphogen activity,MF,GREM1
14417,GO:0055025,0.0283284279124983,0.997729244393416,2,38,positive regulation of cardiac muscle tissue development,BP,ERBB3;GREM1
5531,GO:0015749,0.0285342172272175,0.995671870441852,3,99,monosaccharide transmembrane transport,BP,NGFR;SLC45A3;SLC5A11
17471,GO:0090521,0.0286086647255017,0.999692577511285,1,4,glomerular visceral epithelial cell migration,BP,ANLN
6904,GO:0021795,0.0286410407935565,0.997690647143066,2,38,cerebral cortex cell migration,BP,ARX;EGFR
16717,GO:0072103,0.0287237726514086,0.999690083353447,1,4,glomerulus vasculature morphogenesis,BP,PDGFRA
16718,GO:0072104,0.0287237726514086,0.999690083353447,1,4,glomerular capillary formation,BP,PDGFRA
13689,GO:0051093,0.028868229306205,0.988276352022596,10,778,negative regulation of developmental process,BP,NGFR;CAPN3;SOX10;MAG;EGFR;NKX6-2;GJA1;FZD7;GREM1;CNTN2
12162,GO:0045739,0.0288906981058871,0.997650892925128,2,42,positive regulation of DNA repair,BP,EYA2;EGFR
8719,GO:0032898,0.028960636246076,0.999684918897071,1,4,neurotrophin production,BP,PCSK6
10790,GO:0042551,0.0289995399182268,0.997643723975101,2,39,neuron maturation,BP,CNTN2;GLDN
4754,GO:0010455,0.0290806365909238,0.999647276261953,1,6,positive regulation of cell fate commitment,BP,NKX6-2
3954,GO:0008199,0.0294757719813102,0.999637568375848,1,6,ferric iron binding,MF,TF
2438,GO:0005127,0.0294798387081433,0.999651852315902,1,5,ciliary neurotrophic factor receptor binding,MF,CRLF1
15334,GO:0061502,0.0297725911535775,0.999666887402925,1,4,early endosome to recycling endosome transport,BP,MYO1D
11260,GO:0043415,0.0298515735458208,0.999642962030821,1,5,positive regulation of skeletal muscle tissue regeneration,BP,CAPN3
11261,GO:0043416,0.0298515735458208,0.999642962030821,1,5,regulation of skeletal muscle tissue regeneration,BP,CAPN3
15246,GO:0061218,0.0299776258141366,0.999639921644466,1,5,negative regulation of mesonephros development,BP,GREM1
907,GO:0002158,0.03024641843312,0.999633394765057,1,5,osteoclast proliferation,BP,GREM1
4627,GO:0009893,0.0304542222077115,0.982577544970089,27,2964,positive regulation of metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;BVES;PLP1;MYRF;PDGFRA;ENPP2;EGFR;ST18;GJA1;FZD7;SLC45A3;GREM1;GPD1;KNDC1;RASGRP1;DMRT2;BOK;CNTN2;MBP;GJC2
7105,GO:0030001,0.0305004511104397,0.987500131354687,10,781,metal ion transport,BP,LRP2;NKAIN1;TF;CAPN3;SLC31A2;GJA1;KCNJ6;SLC5A11;NKAIN2;GJC2
12600,GO:0046660,0.0305977534422578,0.995229512787895,3,103,female sex differentiation,BP,LRP2;COL9A3;PDGFRA
21683,GO:2000821,0.0306174389279271,0.999624288039224,1,5,regulation of grooming behavior,BP,CNTNAP4
11317,GO:0043523,0.0306422679837027,0.993399084204435,4,185,regulation of neuron apoptotic process,BP,CRLF1;ERBB3;MAG;BOK
5186,GO:0014719,0.0307473565476709,0.999621072454996,1,5,skeletal muscle satellite cell activation,BP,CAPN3
15072,GO:0060920,0.0308088319867188,0.99961954604296,1,5,cardiac pacemaker cell differentiation,BP,BVES
12129,GO:0045667,0.0308647008187095,0.995170191010023,3,105,regulation of osteoblast differentiation,BP,GJA1;GREM1;SMOC1
3890,GO:0008092,0.0309749173643993,0.986697764152976,11,846,cytoskeletal protein binding,MF,ANLN;CDH19;DCX;CAPN3;LDB3;ERMN;EGFR;GJA1;TMSB15A;MOBP;MYO1D
18025,GO:0098742,0.0311667869521654,0.993259538621497,4,166,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN11;CDH19;MAG;MBP
15150,GO:0061041,0.0312921888080755,0.99507422947169,3,109,regulation of wound healing,BP,CAPN3;PDGFRA;GJA1
4651,GO:0009967,0.0313482148293106,0.984728140339553,15,1428,positive regulation of signal transduction,BP,CRLF1;NGFR;ERBB3;PDGFRA;EGFR;ST18;GJA1;FZD7;GREM1;KLK6;MAL;RASGRP1;BOK;GPR62;CNTN2
4961,GO:0010810,0.031402014543501,0.993188956068676,4,174,regulation of cell-substrate adhesion,BP,FZD7;EDIL3;GREM1;APOD
913,GO:0002175,0.0314865492351208,0.999627155026048,1,4,protein localization to paranode region of axon,BP,UGT8
20573,GO:1905167,0.0318091225910303,0.99966140314767,1,3,positive regulation of lysosomal protein catabolic process,BP,LRP2
4083,GO:0008406,0.0319001190892038,0.993042683658794,4,184,gonad development,BP,LRP2;COL9A3;PDGFRA;BOK
11552,GO:0044255,0.032245304057395,0.986058131797016,11,953,cellular lipid metabolic process,BP,ERBB3;LRP2;FA2H;PLP1;PDGFRA;ENPP2;EGFR;SLC45A3;GPD1;UGT8;APOD
8279,GO:0032252,0.0323154645373364,0.999607125311835,1,4,secretory granule localization,BP,RASGRP1
7041,GO:0022604,0.032450061496602,0.98895595385525,7,442,regulation of cell morphogenesis,BP,NGFR;MAG;BVES;ERMN;ENPP2;KNDC1;CNTN2
13125,GO:0048589,0.0325996844686233,0.987974630490119,8,545,developmental growth,BP,ARX;CAPN3;SOX10;MAG;GJA1;FZD7;KLK6;APOD
21594,GO:2000671,0.0329783748706441,0.999563685444145,1,5,regulation of motor neuron apoptotic process,BP,CRLF1
17961,GO:0098590,0.0330938585585662,0.985091206051367,12,977,plasma membrane region,CC,ERBB3;LRP2;TF;MLC1;BVES;EGFR;GJA1;CNTNAP4;MAL;MYO1D;ANKS1B;TMEM235
15551,GO:0070011,0.0331935966186094,0.988641743611564,7,494,peptidase activity, acting on L-amino acid peptides,MF,FOLH1;CAPN3;CPM;PCSK6;CNDP1;ADAMTS4;KLK6
4926,GO:0010749,0.0332376212563868,0.999556751105201,1,5,regulation of nitric oxide mediated signal transduction,BP,EGFR
3312,GO:0006633,0.0332382548713208,0.994636752944678,3,120,fatty acid biosynthetic process,BP,FA2H;PLP1;SLC45A3
10384,GO:0038085,0.0334561906794903,0.999550861731055,1,5,vascular endothelial growth factor binding,MF,PDGFRA
14179,GO:0051961,0.0334693624204575,0.990973476609704,5,264,negative regulation of nervous system development,BP,NGFR;SOX10;MAG;NKX6-2;CNTN2
4598,GO:0009790,0.0337595845739727,0.985300940335157,11,892,embryo development,BP,EYA2;LRP2;SOX10;PDGFRA;PCSK6;EGFR;GJA1;FZD7;GREM1;DMRT2;MBP
5547,GO:0015798,0.0337871177776521,0.999570254735747,1,4,myo-inositol transport,BP,SLC5A11
10045,GO:0035926,0.0337962968235666,0.999541619159341,1,5,chemokine (C-C motif) ligand 2 secretion,BP,MBP
11180,GO:0043280,0.0338102038260674,0.994507060383198,3,122,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NGFR;ST18;BOK
12992,GO:0048260,0.0338199773107863,0.997002289632926,2,44,positive regulation of receptor-mediated endocytosis,BP,TF;GREM1
12660,GO:0046834,0.0342325409926834,0.994426738021835,3,103,lipid phosphorylation,BP,ERBB3;PDGFRA;EGFR
2786,GO:0005826,0.0342570848072151,0.999528944696868,1,5,actomyosin contractile ring,CC,ANLN
11893,GO:0045137,0.0343231505080661,0.992340175954445,4,189,development of primary sexual characteristics,BP,LRP2;COL9A3;PDGFRA;BOK
2152,GO:0004689,0.0343532017914777,0.999526278799142,1,5,phosphorylase kinase activity,MF,PHKG1
2870,GO:0005964,0.0343532017914777,0.999526278799142,1,5,phosphorylase kinase complex,CC,PHKG1
4786,GO:0010518,0.034374873805664,0.996923954895456,2,45,positive regulation of phospholipase activity,BP,PDGFRA;EGFR
7101,GO:0023056,0.0346969504307618,0.982491236425213,16,1574,positive regulation of signaling,BP,CRLF1;NGFR;ERBB3;BVES;PDGFRA;EGFR;ST18;GJA1;FZD7;GREM1;KLK6;MAL;RASGRP1;BOK;GPR62;CNTN2
12750,GO:0046983,0.0350419145975868,0.984070404890194,12,1108,protein dimerization activity,MF,CRLF1;ERBB3;CDH19;MAG;PDGFRA;EGFR;GREM1;GPD1;GJB1;RASGRP1;DMRT2;BOK
9195,GO:0034113,0.0351359062676722,0.996816209268985,2,46,heterotypic cell-cell adhesion,BP,GLDN;MBP
14142,GO:0051902,0.0352724694289253,0.999479788970911,1,6,negative regulation of mitochondrial depolarization,BP,BOK
20094,GO:1904180,0.0352724694289253,0.999479788970911,1,6,negative regulation of membrane depolarization,BP,BOK
14158,GO:0051932,0.0353981887401195,0.996786703568938,2,43,synaptic transmission, GABAergic,BP,PLCL1;CNTNAP4
2579,GO:0005412,0.0355598411099724,0.999471216697725,1,6,glucose:sodium symporter activity,MF,SLC5A11
5914,GO:0016530,0.0355623391156938,0.999456189223748,1,7,metallochaperone activity,MF,TF
17734,GO:0097345,0.0359104698755806,0.996693621670266,2,53,mitochondrial outer membrane permeabilization,BP,EYA2;BOK
19694,GO:1903365,0.0359253813560773,0.999444949905399,1,7,regulation of fear response,BP,GJA1
21684,GO:2000822,0.0359253813560773,0.999444949905399,1,7,regulation of behavioral fear response,BP,GJA1
19400,GO:1902715,0.035939950800974,0.999459768884728,1,6,positive regulation of interferon-gamma secretion,BP,RASGRP1
9952,GO:0035749,0.0361520812704203,0.999453326045549,1,6,myelin sheath adaxonal region,CC,MAG
14936,GO:0060676,0.0361580535984778,0.999453144092816,1,6,ureteric bud formation,BP,GREM1
2401,GO:0005047,0.0361814406789964,0.999452431287196,1,6,signal recognition particle binding,MF,TF
12939,GO:0048146,0.0361856596075737,0.996664086876919,2,48,positive regulation of fibroblast proliferation,BP,PDGFRA;EGFR
16187,GO:0071214,0.036211962923115,0.990020743533411,5,288,cellular response to abiotic stimulus,BP,CAPN3;MAG;EGFR;GJA1;PIEZO2
18403,GO:0104004,0.036211962923115,0.990020743533411,5,288,cellular response to environmental stimulus,BP,CAPN3;MAG;EGFR;GJA1;PIEZO2
6174,GO:0017034,0.0363697529968156,0.999468587111139,1,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF5
15768,GO:0070374,0.0364656813829244,0.991703038229657,4,198,positive regulation of ERK1 and ERK2 cascade,BP,ERBB3;PDGFRA;EGFR;RASGRP1
7198,GO:0030162,0.0365642744883298,0.986199549794223,8,636,regulation of proteolysis,BP,NGFR;CAPN3;ST18;BOK;CNTN2;SPOCK3;MBP;COL28A1
7396,GO:0030514,0.0368688964042119,0.996573509566766,2,45,negative regulation of BMP signaling pathway,BP,LRP2;GREM1
15814,GO:0070459,0.0368814493616293,0.999414793231669,1,7,prolactin secretion,BP,EGFR
14180,GO:0051962,0.0369141100225275,0.987087983104487,7,460,positive regulation of nervous system development,BP,NGFR;LRP2;SOX10;MAG;MYRF;NKX6-2;GJC2
12305,GO:0045995,0.0370061777541274,0.99378539875979,3,108,regulation of embryonic development,BP,FZD7;DMRT2;MBP
2040,GO:0004528,0.0375156814974982,0.999410985069304,1,6,phosphodiesterase I activity,MF,ENPP2
6647,GO:0019800,0.0376378111508969,0.999407114614888,1,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,SPOCK3
17657,GO:0097191,0.0377701885937592,0.991307838744945,4,206,extrinsic apoptotic signaling pathway,BP,EYA2;ERBB3;MAL;BOK
9674,GO:0035272,0.037923746795827,0.996416265620539,2,47,exocrine system development,BP,SOX10;EGFR
18608,GO:1900086,0.0379606886775953,0.999420696296862,1,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,GREM1
4844,GO:0010626,0.0380115020336932,0.999419132114947,1,5,negative regulation of Schwann cell proliferation,BP,SOX10
14737,GO:0060373,0.0381597181461951,0.999414557356465,1,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,GJA1
15733,GO:0070314,0.0383491395539514,0.999384315845815,1,6,G1 to G0 transition,BP,CAPN3
19174,GO:1902110,0.0385304107413967,0.996310915610023,2,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,EYA2;BOK
10416,GO:0038132,0.0385714417858822,0.999401753648924,1,5,neuregulin binding,MF,ERBB3
20534,GO:1905050,0.0385749277240209,0.999359389068656,1,7,positive regulation of metallopeptidase activity,BP,MBP
5938,GO:0016576,0.0386588524536788,0.99937425273555,1,6,histone dephosphorylation,BP,EYA2
2571,GO:0005375,0.0386837226451363,0.999373441066214,1,6,copper ion transmembrane transporter activity,MF,SLC31A2
9750,GO:0035434,0.0386837226451363,0.999373441066214,1,6,copper ion transmembrane transport,BP,SLC31A2
21366,GO:2000343,0.0387781473498503,0.999339238201645,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
15626,GO:0070141,0.0389503037564938,0.999364707301163,1,6,response to UV-A,BP,EGFR
21413,GO:2000402,0.039090570472502,0.999342013912392,1,7,negative regulation of lymphocyte migration,BP,APOD
6473,GO:0019220,0.0391258497002299,0.979948407306135,16,1554,regulation of phosphate metabolic process,BP,CRLF1;NGFR;ERBB3;PLCL1;RGS4;PDGFRA;ENPP2;EGFR;FZD7;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;MYO1D;GJC2
13669,GO:0051054,0.0391881838895543,0.990879012005986,4,201,positive regulation of DNA metabolic process,BP,EYA2;PDGFRA;EGFR;GREM1
16495,GO:0071676,0.0392014396106552,0.999356423379642,1,6,negative regulation of mononuclear cell migration,BP,GREM1
4903,GO:0010721,0.039240409314537,0.988955649647661,5,277,negative regulation of cell development,BP,NGFR;SOX10;MAG;NKX6-2;CNTN2
19922,GO:1903800,0.0392877874025959,0.999335306046389,1,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR
12496,GO:0046476,0.0393996443296751,0.999331486143084,1,7,glycosylceramide biosynthetic process,BP,UGT8
14023,GO:0051668,0.0395900312368368,0.993168485430256,3,114,localization within membrane,BP,PLLP;MAL;ANKS1B
17919,GO:0097755,0.0397880405740122,0.996131558617312,2,51,positive regulation of blood vessel diameter,BP,EGFR;GJA1
3243,GO:0006548,0.0400016825272671,0.999310735633032,1,7,histidine catabolic process,BP,CARNS1
14333,GO:0052805,0.0400016825272671,0.999310735633032,1,7,imidazole-containing compound catabolic process,BP,CARNS1
4616,GO:0009855,0.0403008352372004,0.992994555366606,3,117,determination of bilateral symmetry,BP,PCSK6;GJA1;GREM1
4190,GO:0008584,0.0403032198072154,0.99299488819243,3,116,male gonad development,BP,LRP2;COL9A3;BOK
18794,GO:1901029,0.0404609563177399,0.999280173503751,1,8,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
21735,GO:2001015,0.0406022875534892,0.999309214602767,1,6,negative regulation of skeletal muscle cell differentiation,BP,CAPN3
4603,GO:0009799,0.0408634816735726,0.992857234602655,3,118,specification of symmetry,BP,PCSK6;GJA1;GREM1
12163,GO:0045740,0.0408754392752422,0.9959671957764,2,51,positive regulation of DNA replication,BP,PDGFRA;EGFR
3749,GO:0007389,0.0409188463594044,0.986718204360622,6,395,pattern specification process,BP,LRP2;PCSK6;NKX6-2;GJA1;GREM1;DMRT2
10359,GO:0038031,0.0409549166552485,0.999297063364326,1,6,non-canonical Wnt signaling pathway via JNK cascade,BP,FZD7
7826,GO:0031344,0.0411538058202163,0.984112763529597,8,571,regulation of cell projection organization,BP,ANLN;NGFR;MAG;ERMN;ENPP2;KLK6;KNDC1;CNTN2
4003,GO:0008277,0.0412282390326451,0.992763999386161,3,123,regulation of G-protein coupled receptor protein signaling pathway,BP,RGS4;KLK6;CNTN2
19393,GO:1902686,0.0412337756519749,0.995900276685484,2,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,EYA2;BOK
21009,GO:1990459,0.0413167886205919,0.999264286598901,1,7,transferrin receptor binding,MF,TF
12539,GO:0046546,0.0413320019543299,0.992743965457854,3,117,development of primary male sexual characteristics,BP,LRP2;COL9A3;BOK
16290,GO:0071374,0.0415298213436548,0.999277021749867,1,6,cellular response to parathyroid hormone stimulus,BP,GJA1
18250,GO:0099518,0.0415362300424521,0.995878888758017,2,46,vesicle cytoskeletal trafficking,BP,MOBP;RASGRP1
11677,GO:0044463,0.0416823833799989,0.979400001651244,14,1261,cell projection part,CC,LRP2;TUBB4A;MAG;BVES;ERMN;CNTNAP4;KNDC1;MYO1D;CNTN2;ANKS1B;DNAH17;APOD;MBP;GJC2
18474,GO:0120038,0.0416823833799989,0.979400001651244,14,1261,plasma membrane bounded cell projection part,CC,LRP2;TUBB4A;MAG;BVES;ERMN;CNTNAP4;KNDC1;MYO1D;CNTN2;ANKS1B;DNAH17;APOD;MBP;GJC2
20179,GO:1904352,0.041808131406922,0.999296191500085,1,5,positive regulation of protein catabolic process in the vacuole,BP,LRP2
7647,GO:0031032,0.0418091315001526,0.99008109158195,4,179,actomyosin structure organization,BP,ANLN;CAPN3;LDB3;PDGFRA
21499,GO:2000542,0.0418625286730806,0.999244559239657,1,7,negative regulation of gastrulation,BP,FZD7
7750,GO:0031232,0.0420092429548498,0.999239210568595,1,7,extrinsic component of external side of plasma membrane,CC,TF
15313,GO:0061438,0.0420405229662979,0.999258978001544,1,6,renal system vasculature morphogenesis,BP,PDGFRA
15314,GO:0061439,0.0420405229662979,0.999258978001544,1,6,kidney vasculature morphogenesis,BP,PDGFRA
13747,GO:0051174,0.0421879228656378,0.978164777448497,16,1568,regulation of phosphorus metabolic process,BP,CRLF1;NGFR;ERBB3;PLCL1;RGS4;PDGFRA;ENPP2;EGFR;FZD7;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;MYO1D;GJC2
16181,GO:0071205,0.0422133686449852,0.999282360536064,1,5,protein localization to juxtaparanode region of axon,BP,CNTN2
10993,GO:0042989,0.0425510984965313,0.999180767570644,1,10,sequestering of actin monomers,BP,TMSB15A
9197,GO:0034115,0.042622989108332,0.99920051620923,1,8,negative regulation of heterotypic cell-cell adhesion,BP,MBP
15896,GO:0070587,0.042622989108332,0.99920051620923,1,8,regulation of cell-cell adhesion involved in gastrulation,BP,MBP
5210,GO:0014807,0.0429849484480224,0.999203151691402,1,7,regulation of somitogenesis,BP,DMRT2
329,GO:0000912,0.0430568764946983,0.99922239564541,1,6,assembly of actomyosin apparatus involved in cytokinesis,BP,ANLN
330,GO:0000915,0.0430568764946983,0.99922239564541,1,6,actomyosin contractile ring assembly,BP,ANLN
2764,GO:0005785,0.0431084562619242,0.999182045531353,1,8,signal recognition particle receptor complex,CC,TF
13211,GO:0048733,0.0431142458683894,0.99922030396852,1,6,sebaceous gland development,BP,FA2H
8682,GO:0032825,0.0431200580288266,0.999198091547633,1,7,positive regulation of natural killer cell differentiation,BP,RASGRP1
11111,GO:0043184,0.0434684488617892,0.999184968391694,1,7,vascular endothelial growth factor receptor 2 binding,MF,GREM1
4827,GO:0010604,0.0436177916971315,0.974532770787561,25,2772,positive regulation of macromolecule metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;BVES;PLP1;MYRF;PDGFRA;ENPP2;EGFR;ST18;GJA1;FZD7;GREM1;KNDC1;RASGRP1;DMRT2;BOK;CNTN2;MBP;GJC2
21067,GO:1990712,0.0436759231587807,0.999177101787042,1,7,HFE-transferrin receptor complex,CC,TF
4842,GO:0010624,0.0437366445565294,0.999197427642906,1,6,regulation of Schwann cell proliferation,BP,SOX10
11128,GO:0043208,0.0437688383266113,0.999173566349201,1,7,glycosphingolipid binding,MF,MAG
9977,GO:0035794,0.0438176929471965,0.995492938028075,2,59,positive regulation of mitochondrial membrane permeability,BP,EYA2;BOK
16760,GO:0072172,0.0439434348089009,0.999149775020763,1,8,mesonephric tubule formation,BP,GREM1
7040,GO:0022603,0.0439699807684292,0.980021851232706,11,945,regulation of anatomical structure morphogenesis,BP,NGFR;MAG;BVES;ERMN;ENPP2;FZD7;GREM1;KNDC1;DMRT2;CNTN2;MBP
19172,GO:1902108,0.0440766600668996,0.995451709673088,2,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,EYA2;BOK
18606,GO:1900084,0.0441985130431297,0.999180233982951,1,6,regulation of peptidyl-tyrosine autophosphorylation,BP,GREM1
4880,GO:0010668,0.0442075035856785,0.99917989745765,1,6,ectodermal cell differentiation,BP,FZD7
14611,GO:0060193,0.04421058475914,0.995440634155504,2,54,positive regulation of lipase activity,BP,PDGFRA;EGFR
12995,GO:0048263,0.0442988423492742,0.999135846403033,1,8,determination of dorsal identity,BP,GREM1
13498,GO:0050795,0.0443388282917926,0.995417955918827,2,55,regulation of behavior,BP,GJA1;CNTNAP4
10979,GO:0042954,0.0443943614840269,0.999172887257726,1,6,lipoprotein transporter activity,MF,LRP2
20797,GO:1905710,0.0445229578575071,0.995378465872638,2,60,positive regulation of membrane permeability,BP,EYA2;BOK
17572,GO:0097049,0.0446097224052028,0.999141219805364,1,7,motor neuron apoptotic process,BP,CRLF1
15220,GO:0061156,0.0447362680470108,0.999159981577124,1,6,pulmonary artery morphogenesis,BP,LRP2
7118,GO:0030020,0.0447397552213604,0.999159849425423,1,6,extracellular matrix structural constituent conferring tensile strength,MF,COL9A3
9457,GO:0034638,0.0447619590694885,0.999117523815976,1,8,phosphatidylcholine catabolic process,BP,ENPP2
1503,GO:0003256,0.0448477501009799,0.999155751558225,1,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,GREM1
2652,GO:0005593,0.0450112578286949,0.999149527934403,1,6,FACIT collagen trimer,CC,COL9A3
20335,GO:1904683,0.0451425994208621,0.999144511798652,1,6,regulation of metalloendopeptidase activity,BP,MBP
1367,GO:0003002,0.0452033110935863,0.986772823400432,5,308,regionalization,BP,LRP2;PCSK6;NKX6-2;GREM1;DMRT2
4805,GO:0010562,0.0452219426627042,0.979356558930689,11,974,positive regulation of phosphorus metabolic process,BP,CRLF1;NGFR;ERBB3;PDGFRA;ENPP2;EGFR;FZD7;GREM1;GPD1;KNDC1;RASGRP1
12272,GO:0045937,0.0452219426627042,0.979356558930689,11,974,positive regulation of phosphate metabolic process,BP,CRLF1;NGFR;ERBB3;PDGFRA;ENPP2;EGFR;FZD7;GREM1;GPD1;KNDC1;RASGRP1
15706,GO:0070268,0.0454578190786888,0.995229526468166,2,59,cornification,BP,PPL;PCSK6
3434,GO:0006812,0.0455113436655077,0.979202633703585,11,976,cation transport,BP,LRP2;NKAIN1;TF;CAPN3;SLC31A2;GJA1;PIEZO2;KCNJ6;SLC5A11;NKAIN2;GJC2
4785,GO:0010517,0.0456554254722071,0.995213141199465,2,52,regulation of phospholipase activity,BP,PDGFRA;EGFR
18634,GO:1900122,0.0456915702798268,0.999080154453248,1,8,positive regulation of receptor binding,BP,PLCL1
18838,GO:1901185,0.0457635751491979,0.995193082511429,2,53,negative regulation of ERBB signaling pathway,BP,ERBB3;EGFR
7256,GO:0030235,0.0459591191714509,0.999087990663663,1,7,nitric-oxide synthase regulator activity,MF,EGFR
6946,GO:0021879,0.0460988181875398,0.995138512130229,2,53,forebrain neuron differentiation,BP,ARX;CNTN2
10362,GO:0038036,0.0461211405782432,0.999062619681445,1,8,sphingosine-1-phosphate receptor activity,MF,S1PR5
5881,GO:0016477,0.0462716772671514,0.977385780349254,13,1198,cell migration,BP,ARX;ANLN;DCX;SOX10;MAG;BVES;PDGFRA;ENPP2;EGFR;GJA1;GREM1;CNTN2;APOD
2284,GO:0004865,0.0462795207735311,0.999029529989144,1,10,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14A
2752,GO:0005770,0.0464462304457316,0.988584220054223,4,219,late endosome,CC,TF;SLC31A2;EGFR;GJA1
9855,GO:0035608,0.0464508909178033,0.999068186655553,1,7,protein deglutamylation,BP,FOLH1
7019,GO:0022028,0.0464606586774128,0.999093340963506,1,6,tangential migration from the subventricular zone to the olfactory bulb,BP,ARX
21631,GO:2000739,0.0465480090967815,0.999089896262326,1,6,regulation of mesenchymal stem cell differentiation,BP,PDGFRA
3349,GO:0006681,0.0466412849538135,0.999041162081185,1,8,galactosylceramide metabolic process,BP,UGT8
6530,GO:0019374,0.0466412849538135,0.999041162081185,1,8,galactolipid metabolic process,BP,UGT8
751,GO:0001934,0.0467065336620492,0.979416920992425,10,855,positive regulation of protein phosphorylation,BP,CRLF1;NGFR;ERBB3;PDGFRA;ENPP2;EGFR;FZD7;GREM1;KNDC1;RASGRP1
6853,GO:0021684,0.0467351323426634,0.999056641230727,1,7,cerebellar granular layer formation,BP,KNDC1
6870,GO:0021707,0.0467351323426634,0.999056641230727,1,7,cerebellar granule cell differentiation,BP,KNDC1
6479,GO:0019229,0.0469513678549463,0.994998725217252,2,53,regulation of vasoconstriction,BP,EGFR;GJA1
19398,GO:1902713,0.0472004474106678,0.999017819012449,1,8,regulation of interferon-gamma secretion,BP,RASGRP1
3432,GO:0006810,0.0472646876973164,0.970433440941819,36,4455,transport,BP,NGFR;EYA2;ERBB3;LRP2;NKAIN1;TF;CAPN3;MLC1;PLLP;BVES;PEX5L;ATP10B;SLC31A2;ENPP2;PCSK6;EGFR;GJA1;PIEZO2;KCNJ6;SNX22;SLC45A3;SLC5A11;TMEM144;GREM1;MOBP;LGI3;SH3TC2;GJB1;RASGRP1;MYO1D;BOK;CNTN2;NKAIN2;APOD;MBP;GJC2
16813,GO:0072239,0.0473463759201193,0.999031568162843,1,7,metanephric glomerulus vasculature development,BP,PDGFRA
7297,GO:0030297,0.0474859873627159,0.999025794326831,1,7,transmembrane receptor protein tyrosine kinase activator activity,MF,GREM1
16883,GO:0072359,0.0475649559305014,0.978110728663236,11,921,circulatory system development,BP,NGFR;ERBB3;LRP2;BVES;PDGFRA;ENPP2;EGFR;GJA1;FZD7;GREM1;APOD
21764,GO:2001056,0.0477123347542503,0.991118065379981,3,137,positive regulation of cysteine-type endopeptidase activity,BP,NGFR;ST18;BOK
3208,GO:0006508,0.0478439994479496,0.975323362340807,15,1529,proteolysis,BP,NGFR;FOLH1;CAPN3;MYRF;CPM;PCSK6;ST18;CNDP1;ADAMTS4;KLK6;BOK;CNTN2;SPOCK3;MBP;COL28A1
13442,GO:0050714,0.0478649781562791,0.988127434564561,4,209,positive regulation of protein secretion,BP,EGFR;GJA1;RASGRP1;MBP
8669,GO:0032808,0.0480325095581007,0.999003023857947,1,7,lacrimal gland development,BP,SOX10
9872,GO:0035630,0.0480451637574803,0.999002493453909,1,7,bone mineralization involved in bone maturation,BP,GREM1
11780,GO:0044837,0.0480543145025242,0.999002109808497,1,7,actomyosin contractile ring organization,BP,ANLN
3977,GO:0008235,0.0481222236373616,0.994799282687526,2,55,metalloexopeptidase activity,MF,FOLH1;CPM
12892,GO:0048008,0.0481526215144521,0.99481400936279,2,48,platelet-derived growth factor receptor signaling pathway,BP,PDGFRA;APOD
10358,GO:0038030,0.0481853458948943,0.998996608065439,1,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,FZD7
5885,GO:0016485,0.0483554232119526,0.987958069803563,4,226,protein processing,BP,CPM;PCSK6;KLK6;CNTN2
17699,GO:0097264,0.0483660822324785,0.998988994013518,1,7,self proteolysis,BP,CAPN3
7990,GO:0031659,0.0484485963953915,0.998985508106588,1,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR
13115,GO:0048565,0.0486020713949339,0.990900249676616,3,122,digestive tract development,BP,SOX10;PDGFRA;EGFR
5347,GO:0015166,0.0488216946258982,0.998948520141548,1,8,polyol transmembrane transporter activity,MF,SLC5A11
15895,GO:0070586,0.0488949208529258,0.998928842957761,1,9,cell-cell adhesion involved in gastrulation,BP,MBP
19531,GO:1903011,0.0490608754675574,0.998959450568197,1,7,negative regulation of bone development,BP,GREM1
21409,GO:2000394,0.0491915215704198,0.998953846881333,1,7,positive regulation of lamellipodium morphogenesis,BP,ENPP2
7595,GO:0030913,0.0493901946025934,0.998945295964857,1,7,paranodal junction assembly,BP,UGT8
13665,GO:0051050,0.0493910484712857,0.978020393378919,10,862,positive regulation of transport,BP,TF;CAPN3;MLC1;EGFR;GJA1;GREM1;RASGRP1;BOK;MBP;GJC2
8406,GO:0032429,0.049679824857514,0.998910865362606,1,8,regulation of phospholipase A2 activity,BP,EGFR
3179,GO:0006468,0.050016230385345,0.973042151687069,17,1717,protein phosphorylation,BP,CRLF1;NGFR;ERBB3;PLCL1;RGS4;CDK18;PDGFRA;ENPP2;EGFR;FZD7;PHKG1;GREM1;KNDC1;RASGRP1;AATK;MBP;GJC2
5603,GO:0015884,0.0503265665195256,0.998882039891726,1,8,folic acid transport,BP,LRP2
4963,GO:0010812,0.0503941883573998,0.994425568055989,2,51,negative regulation of cell-substrate adhesion,BP,FZD7;APOD
14735,GO:0060371,0.0504915053916404,0.998897251431038,1,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,GJA1
6954,GO:0021891,0.0509063494231713,0.998878870817456,1,7,olfactory bulb interneuron development,BP,ARX
21364,GO:2000341,0.0509403395911204,0.998822112019349,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
16716,GO:0072102,0.0509504910912224,0.998876905894908,1,7,glomerulus morphogenesis,BP,PDGFRA
12994,GO:0048262,0.0510684540358627,0.99883050880044,1,9,determination of dorsal/ventral asymmetry,BP,GREM1
5127,GO:0014010,0.0513698942565638,0.998858148987522,1,7,Schwann cell proliferation,BP,SOX10
10382,GO:0038083,0.051390951883165,0.994250679841908,2,52,peptidyl-tyrosine autophosphorylation,BP,EGFR;GREM1
749,GO:0001932,0.0514030766836106,0.974477136026394,13,1230,regulation of protein phosphorylation,BP,CRLF1;NGFR;ERBB3;PLCL1;RGS4;PDGFRA;ENPP2;EGFR;FZD7;GREM1;KNDC1;RASGRP1;GJC2
4218,GO:0008635,0.0515985245826318,0.998805859522243,1,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,BOK
2389,GO:0005021,0.0518012377856099,0.998838692678736,1,7,vascular endothelial growth factor-activated receptor activity,MF,PDGFRA
20220,GO:1904427,0.0518053411854913,0.994159673962067,2,59,positive regulation of calcium ion transmembrane transport,BP,CAPN3;GJC2
10500,GO:0040007,0.0520095945775771,0.976645023478967,10,858,growth,BP,ARX;CAPN3;SOX10;MAG;EGFR;GJA1;FZD7;GREM1;KLK6;APOD
14137,GO:0051897,0.0522474566000061,0.989923089281014,3,131,positive regulation of protein kinase B signaling,BP,ERBB3;PDGFRA;EGFR
11546,GO:0044241,0.0523300770991115,0.998771410146993,1,9,lipid digestion,BP,ARX
11903,GO:0045162,0.0524354705416691,0.998809780004635,1,7,clustering of voltage-gated sodium channels,BP,GLDN
19545,GO:1903034,0.052486663624898,0.989856532233213,3,133,regulation of response to wounding,BP,CAPN3;PDGFRA;GJA1
2751,GO:0005769,0.0525468809369262,0.983979616050113,5,308,early endosome,CC,TF;MLC1;EGFR;GJA1;BOK
3242,GO:0006547,0.0525980099273324,0.998758667907107,1,9,histidine metabolic process,BP,CARNS1
16157,GO:0071107,0.052742472068147,0.998770963044768,1,8,response to parathyroid hormone,BP,GJA1
8182,GO:0032059,0.0527952322734652,0.998768477360791,1,8,bleb,CC,ANLN
11937,GO:0045214,0.0528454259342102,0.994031098730598,2,43,sarcomere organization,BP,CAPN3;LDB3
3972,GO:0008219,0.0528846523896057,0.970824457126707,18,1956,cell death,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;SOX10;MAG;PPL;PDGFRA;PCSK6;EGFR;ST18;GJA1;SLC5A11;GREM1;KLK6;MAL;BOK
10159,GO:0036122,0.0529117127487476,0.998743663692973,1,9,BMP binding,MF,GREM1
18570,GO:1900016,0.0530190046352198,0.998738510874362,1,9,negative regulation of cytokine production involved in inflammatory response,BP,APOD
14429,GO:0055065,0.0531365893940943,0.979876723841523,7,543,metal ion homeostasis,BP,TF;CAPN3;PDGFRA;SLC31A2;EGFR;GJA1;BOK
7952,GO:0031589,0.0531785901669436,0.983738818292983,5,295,cell-substrate adhesion,BP,BVES;FZD7;EDIL3;GREM1;APOD
19773,GO:1903524,0.0531786799968347,0.993913099750136,2,61,positive regulation of blood circulation,BP,EGFR;GJA1
13883,GO:0051400,0.0533775550375157,0.998721212973839,1,9,BH domain binding,MF,BOK
6601,GO:0019674,0.053381604553823,0.993870369258247,2,64,NAD metabolic process,BP,NNMT;GPD1
8845,GO:0033089,0.0535714400466173,0.998711809094269,1,9,positive regulation of T cell differentiation in thymus,BP,RASGRP1
19335,GO:1902533,0.0537522205601776,0.975717828519421,10,901,positive regulation of intracellular signal transduction,BP,CRLF1;NGFR;ERBB3;PDGFRA;EGFR;GJA1;FZD7;RASGRP1;BOK;GPR62
1868,GO:0004185,0.0537541436549664,0.998702915350501,1,9,serine-type carboxypeptidase activity,MF,CPM
19224,GO:1902237,0.0541765766867214,0.998666037219821,1,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK
14133,GO:0051893,0.0546662301767121,0.993669281450152,2,53,regulation of focal adhesion assembly,BP,GREM1;APOD
17253,GO:0090109,0.0546662301767121,0.993669281450152,2,53,regulation of cell-substrate junction assembly,BP,GREM1;APOD
15154,GO:0061045,0.0553280246160701,0.993527232513101,2,61,negative regulation of wound healing,BP,PDGFRA;GJA1
10867,GO:0042698,0.0553941370219184,0.993517734832414,2,60,ovulation cycle,BP,PDGFRA;EGFR
3632,GO:0007162,0.0554669086580229,0.985567376729584,4,222,negative regulation of cell adhesion,BP,ERBB3;FZD7;APOD;MBP
7255,GO:0030234,0.0554678944344744,0.974803006003948,10,903,enzyme regulator activity,MF,ERBB3;CAPN3;RGS4;EGFR;GREM1;PPP1R14A;MAL;RASGRP1;SPOCK3;COL28A1
1425,GO:0003139,0.055669252879144,0.998607809420887,1,9,secondary heart field specification,BP,LRP2
11905,GO:0045165,0.0556777083954681,0.985493048394467,4,225,cell fate commitment,BP,ARX;EYA2;NKX6-2;FZD7
5117,GO:0012501,0.0557088395336482,0.969543136386626,17,1832,programmed cell death,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;SOX10;MAG;PPL;PDGFRA;PCSK6;EGFR;ST18;GJA1;SLC5A11;GREM1;MAL;BOK
18778,GO:1900750,0.0557809540862508,0.998559244271739,1,12,oligopeptide binding,MF,FOLH1
14469,GO:0055123,0.0558191535922944,0.988947600103373,3,130,digestive system development,BP,SOX10;PDGFRA;EGFR
17545,GO:0097001,0.0558735711544004,0.998580232398138,1,10,ceramide binding,MF,MAG
18877,GO:1901264,0.055925952770418,0.993408948758572,2,65,carbohydrate derivative transport,BP,GJA1;GJB1
19966,GO:1903897,0.056027636623148,0.998589629888965,1,9,regulation of PERK-mediated unfolded protein response,BP,BOK
9098,GO:0033691,0.0560502493227202,0.998610160283278,1,8,sialic acid binding,MF,MAG
13086,GO:0048514,0.0561064529331315,0.978501251428425,7,515,blood vessel morphogenesis,BP,NGFR;LRP2;PDGFRA;ENPP2;GJA1;GREM1;APOD
16211,GO:0071248,0.0564269907900043,0.988766251949607,3,142,cellular response to metal ion,BP,TF;CAPN3;EGFR
6362,GO:0018410,0.0564680545000087,0.993309509612296,2,65,C-terminal protein amino acid modification,BP,FOLH1;CPM
19814,GO:1903587,0.0565493042920454,0.998562952125291,1,9,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
8834,GO:0033077,0.0565566362461651,0.993305348230196,2,60,T cell differentiation in thymus,BP,FZD7;RASGRP1
10669,GO:0042308,0.0567100733694985,0.998536930876426,1,10,negative regulation of protein import into nucleus,BP,APOD
20293,GO:1904590,0.0567100733694985,0.998536930876426,1,10,negative regulation of protein import,BP,APOD
8605,GO:0032725,0.0568288046537313,0.99853073088084,1,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,RASGRP1
20571,GO:1905165,0.0568454869697285,0.99859868669846,1,7,regulation of lysosomal protein catabolic process,BP,LRP2
2161,GO:0004702,0.0568904135052111,0.988664668511398,3,118,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,ERBB3;PDGFRA;EGFR
12823,GO:0047484,0.0570402200901548,0.998537613617171,1,9,regulation of response to osmotic stress,BP,MLC1
14332,GO:0052803,0.057101636192063,0.998516433198115,1,10,imidazole-containing compound metabolic process,BP,CARNS1
16982,GO:0072584,0.0571429062790319,0.998532284862911,1,9,caveolin-mediated endocytosis,BP,MLC1
8680,GO:0032823,0.0571561263883206,0.998513569172552,1,10,regulation of natural killer cell differentiation,BP,RASGRP1
16922,GO:0072497,0.0572554520465728,0.998549059018964,1,8,mesenchymal stem cell differentiation,BP,PDGFRA
9298,GO:0034332,0.0573845374736344,0.988522387921844,3,121,adherens junction organization,BP,CDH19;GREM1;APOD
13477,GO:0050769,0.0574841076295523,0.979745692599811,6,406,positive regulation of neurogenesis,BP,NGFR;LRP2;SOX10;MAG;NKX6-2;GJC2
4067,GO:0008381,0.0575310862877323,0.998512051279792,1,9,mechanosensitive ion channel activity,MF,PIEZO2
16034,GO:0070886,0.0576746059829887,0.998504534561826,1,9,positive regulation of calcineurin-NFAT signaling cascade,BP,ERBB3
18426,GO:0106058,0.0576746059829887,0.998504534561826,1,9,positive regulation of calcineurin-mediated signaling,BP,ERBB3
1276,GO:0002793,0.0582802411280959,0.984587501042596,4,227,positive regulation of peptide secretion,BP,EGFR;GJA1;RASGRP1;MBP
13233,GO:0048771,0.0582920590486738,0.988248980457541,3,136,tissue remodeling,BP,EGFR;GJA1;GREM1
7099,GO:0023051,0.0583173063087402,0.964351659054331,27,3168,regulation of signaling,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;BVES;PEX5L;PLCL1;RGS4;PDGFRA;PCSK6;EGFR;ST18;GJA1;CNTNAP4;FZD7;GREM1;KLK6;SH3TC2;MAL;RASGRP1;BOK;GPR62;CNTN2;APOD
2635,GO:0005575,0.0585352825207238,1,96,15065,cellular_component,CC,ARX;CRLF1;ANLN;CLDN11;PLEKHH1;NGFR;EYA2;BCAS1;ERBB3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;CPM;RAPGEF5;ERMN;SLC31A2;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SNX22;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;MOBP;LGI3;SH3TC2;GJB1;KNDC1;MAL;CARNS1;RASGRP1;DMRT2;SUSD5;UGT8;MYO1D;BOK;TMEM125;TMEM151A;S1PR5;GPR62;AATK;CNTN2;ANKS1B;GLDN;DNAH17;NKAIN2;APOD;SPOCK3;OPALIN;MBP;SMOC1;GJC2;TMEM235;TMEM88B;COL28A1
7866,GO:0031424,0.0586177872131325,0.992898834247677,2,70,keratinization,BP,PPL;PCSK6
506,GO:0001553,0.0586597958878429,0.998452413164237,1,9,luteinization,BP,PDGFRA
8553,GO:0032642,0.0586692432601272,0.992895535633766,2,67,regulation of chemokine production,BP,APOD;MBP
13122,GO:0048584,0.0587830841673826,0.967127668000264,18,1979,positive regulation of response to stimulus,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;PDGFRA;MOG;EGFR;ST18;GJA1;FZD7;GREM1;KLK6;MAL;RASGRP1;BOK;GPR62;CNTN2
16361,GO:0071472,0.0588759382949271,0.998440855990383,1,9,cellular response to salt stress,BP,CAPN3
1633,GO:0003779,0.0590758213080762,0.97905115524313,6,386,actin binding,MF,ANLN;ERMN;EGFR;TMSB15A;MOBP;MYO1D
7384,GO:0030500,0.059236765812188,0.992806133146008,2,60,regulation of bone mineralization,BP,GJA1;GREM1
14755,GO:0060394,0.0593140314738995,0.99839787742087,1,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,GREM1
16230,GO:0071281,0.0593504504403786,0.998395886835524,1,10,cellular response to iron ion,BP,TF
2944,GO:0006072,0.0594281518977548,0.998435508874314,1,8,glycerol-3-phosphate metabolic process,BP,GPD1
2475,GO:0005172,0.0595241021122939,0.998386378006924,1,10,vascular endothelial growth factor receptor binding,MF,GREM1
21535,GO:2000587,0.0595582829738373,0.998428568959689,1,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFRA
1417,GO:0003128,0.0596931322573802,0.998377094631099,1,10,heart field specification,BP,LRP2
8926,GO:0033234,0.0598942403586145,0.998366013995132,1,10,negative regulation of protein sumoylation,BP,CAPN3
6852,GO:0021683,0.0599185407963787,0.998384489789769,1,9,cerebellar granular layer morphogenesis,BP,KNDC1
9647,GO:0035239,0.0599624105457621,0.973611641709411,9,736,tube morphogenesis,BP,NGFR;LRP2;SOX10;PDGFRA;ENPP2;EGFR;GJA1;GREM1;APOD
2572,GO:0005381,0.0602888676377111,0.998344158726615,1,10,iron ion transmembrane transporter activity,MF,TF
19708,GO:1903391,0.0606848272866497,0.992543460336823,2,56,regulation of adherens junction organization,BP,GREM1;APOD
6909,GO:0021800,0.0608108351137558,0.998360965795696,1,8,cerebral cortex tangential migration,BP,ARX
14531,GO:0060068,0.0608526565039144,0.998333118356567,1,9,vagina development,BP,LRP2
12699,GO:0046902,0.0608814511403399,0.992468098943238,2,70,regulation of mitochondrial membrane permeability,BP,EYA2;BOK
17313,GO:0090197,0.0610896695082271,0.998299351828572,1,10,positive regulation of chemokine secretion,BP,MBP
7138,GO:0030050,0.0612347452492073,0.998337756084954,1,8,vesicle transport along actin filament,BP,MOBP
1406,GO:0003093,0.0612365026552203,0.998291069703086,1,10,regulation of glomerular filtration,BP,GJA1
16443,GO:0071605,0.0612535831157377,0.998259055268109,1,12,monocyte chemotactic protein-1 production,BP,APOD
16467,GO:0071637,0.0612535831157377,0.998259055268109,1,12,regulation of monocyte chemotactic protein-1 production,BP,APOD
8292,GO:0032272,0.0621253937094926,0.992244695801114,2,63,negative regulation of protein polymerization,BP,TUBB4A;TMSB15A
11135,GO:0043220,0.0621520895328071,0.99823896121288,1,10,Schmidt-Lanterman incisure,CC,MAG
13784,GO:0051234,0.062175936278244,0.960082145989381,36,4549,establishment of localization,BP,NGFR;EYA2;ERBB3;LRP2;NKAIN1;TF;CAPN3;MLC1;PLLP;BVES;PEX5L;ATP10B;SLC31A2;ENPP2;PCSK6;EGFR;GJA1;PIEZO2;KCNJ6;SNX22;SLC45A3;SLC5A11;TMEM144;GREM1;MOBP;LGI3;SH3TC2;GJB1;RASGRP1;MYO1D;BOK;CNTN2;NKAIN2;APOD;MBP;GJC2
12601,GO:0046661,0.0621883846627255,0.987129484168147,3,139,male sex differentiation,BP,LRP2;COL9A3;BOK
5591,GO:0015867,0.0622775207236001,0.998231760167266,1,10,ATP transport,BP,GJA1
4863,GO:0010647,0.0624881587030108,0.966536210556882,15,1567,positive regulation of cell communication,BP,CRLF1;NGFR;ERBB3;PDGFRA;EGFR;ST18;GJA1;FZD7;GREM1;KLK6;MAL;RASGRP1;BOK;GPR62;CNTN2
3324,GO:0006650,0.06258633402149,0.979961738608653,5,331,glycerophospholipid metabolic process,BP,ERBB3;PDGFRA;ENPP2;EGFR;GPD1
14298,GO:0052646,0.0634574740677072,0.998185514104991,1,9,alditol phosphate metabolic process,BP,GPD1
15639,GO:0070167,0.0635707253742512,0.991962141749373,2,63,regulation of biomineral tissue development,BP,GJA1;GREM1
6761,GO:0021521,0.0636394856978101,0.998134313270317,1,11,ventral spinal cord interneuron specification,BP,NKX6-2
14878,GO:0060573,0.0636394856978101,0.998134313270317,1,11,cell fate specification involved in pattern specification,BP,NKX6-2
5173,GO:0014068,0.0636850841300161,0.991948601809029,2,60,positive regulation of phosphatidylinositol 3-kinase signaling,BP,ERBB3;PDGFRA
8556,GO:0032645,0.0637539676657727,0.998127512440461,1,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,RASGRP1
13071,GO:0048484,0.0637804499696028,0.998144305390974,1,10,enteric nervous system development,BP,SOX10
6943,GO:0021872,0.0637936060764675,0.991918236159365,2,63,forebrain generation of neurons,BP,ARX;CNTN2
12250,GO:0045913,0.063975713960539,0.991894553285632,2,59,positive regulation of carbohydrate metabolic process,BP,SLC45A3;GPD1
14864,GO:0060546,0.064323277983852,0.998112186609146,1,10,negative regulation of necroptotic process,BP,BOK
21777,GO:2001135,0.064345738328145,0.998133712059779,1,9,regulation of endocytic recycling,BP,BVES
5544,GO:0015791,0.0644012735493071,0.998107548451433,1,10,polyol transport,BP,SLC5A11
16971,GO:0072567,0.0645390357314321,0.998064865928195,1,12,chemokine (C-X-C motif) ligand 2 production,BP,MBP
2561,GO:0005351,0.0647967334526227,0.998083941875186,1,10,carbohydrate:proton symporter activity,MF,SLC45A3
15203,GO:0061134,0.0648807508370516,0.986317715047642,3,161,peptidase regulator activity,MF,MAL;SPOCK3;COL28A1
1486,GO:0003223,0.0649634901155715,0.998126389593072,1,8,ventricular compact myocardium morphogenesis,BP,LRP2
7694,GO:0031100,0.0653081738087037,0.991596557241332,2,71,animal organ regeneration,BP,EGFR;NNMT
9096,GO:0033689,0.0653441869393974,0.998074591521928,1,9,negative regulation of osteoblast proliferation,BP,GREM1
12669,GO:0046851,0.0656618025650154,0.998012309648936,1,11,negative regulation of bone remodeling,BP,GREM1
13130,GO:0048598,0.0656735450974292,0.97392885778275,7,542,embryonic morphogenesis,BP,EYA2;LRP2;PDGFRA;GJA1;FZD7;GREM1;MBP
13479,GO:0050771,0.0657782429915752,0.991532793818095,2,60,negative regulation of axonogenesis,BP,NGFR;MAG
7386,GO:0030502,0.0657786867451918,0.998005137071052,1,11,negative regulation of bone mineralization,BP,GREM1
5810,GO:0016310,0.0659068398665678,0.962080917508139,19,2081,phosphorylation,BP,CRLF1;NGFR;ERBB3;PLCL1;RGS4;CDK18;PDGFRA;ENPP2;EGFR;FZD7;PHKG1;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;AATK;MBP;GJC2
541,GO:0001618,0.0659129760054384,0.991493361277099,2,64,virus receptor activity,MF,MOG;EGFR
18404,GO:0104005,0.0659129760054384,0.991493361277099,2,64,hijacked molecular function,MF,MOG;EGFR
786,GO:0001973,0.0660044832065071,0.997974855089068,1,12,adenosine receptor signaling pathway,BP,CNTN2
3433,GO:0006811,0.0660480195963155,0.965091610325742,14,1419,ion transport,BP,LRP2;NKAIN1;TF;CAPN3;MLC1;PLLP;ATP10B;SLC31A2;GJA1;PIEZO2;KCNJ6;SLC5A11;NKAIN2;GJC2
7706,GO:0031115,0.0662350029958387,0.997977008476893,1,11,negative regulation of microtubule polymerization,BP,TUBB4A
18631,GO:1900119,0.0664069659576048,0.997949766481602,1,12,positive regulation of execution phase of apoptosis,BP,BOK
20177,GO:1904350,0.0665885784123919,0.997999583810801,1,9,regulation of protein catabolic process in the vacuole,BP,LRP2
3978,GO:0008236,0.066959042296601,0.985696076136714,3,163,serine-type peptidase activity,MF,CPM;PCSK6;KLK6
14422,GO:0055038,0.0670386880298416,0.991257407347437,2,67,recycling endosome membrane,CC,FZD7;BOK
5460,GO:0015467,0.0671000397302284,0.997943464214736,1,10,G-protein activated inward rectifier potassium channel activity,MF,KCNJ6
15108,GO:0060982,0.0671355498287075,0.997966148779754,1,9,coronary artery morphogenesis,BP,LRP2
6760,GO:0021520,0.0671666801194225,0.997901978211577,1,12,spinal cord motor neuron cell fate specification,BP,NKX6-2
17312,GO:0090196,0.0675608767580516,0.997894131353585,1,11,regulation of chemokine secretion,BP,MBP
8527,GO:0032604,0.0675955050936298,0.997874754451242,1,12,granulocyte macrophage colony-stimulating factor production,BP,RASGRP1
21840,GO:2001235,0.0676160081515412,0.985497476194752,3,164,positive regulation of apoptotic signaling pathway,BP,ST18;MAL;BOK
8525,GO:0032602,0.0676446969870136,0.99111650554554,2,74,chemokine production,BP,APOD;MBP
365,GO:0000980,0.0681001976542997,0.991040711588064,2,67,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,ARX;SOX10
10854,GO:0042659,0.0681243301009925,0.997858394226026,1,11,regulation of cell fate specification,BP,FZD7
15608,GO:0070106,0.0689999705891644,0.997802243876625,1,11,interleukin-27-mediated signaling pathway,BP,CRLF1
1570,GO:0003376,0.069005176785946,0.997783992601128,1,12,sphingosine-1-phosphate signaling pathway,BP,S1PR5
17470,GO:0090520,0.069005176785946,0.997783992601128,1,12,sphingolipid mediated signaling pathway,BP,S1PR5
790,GO:0001977,0.0692461809775799,0.997768280500332,1,12,renal system process involved in regulation of blood volume,BP,GJA1
2174,GO:0004716,0.0692903972978471,0.997831658206861,1,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR
7391,GO:0030509,0.0697853738492742,0.984862712569589,3,142,BMP signaling pathway,BP,LRP2;PCSK6;GREM1
7295,GO:0030295,0.0698203560213999,0.990679767202082,2,69,protein kinase activator activity,MF,ERBB3;GREM1
14717,GO:0060346,0.0698907158444436,0.997766422721863,1,10,bone trabecula formation,BP,GREM1
8183,GO:0032060,0.0700632752753151,0.997733056160976,1,11,bleb assembly,BP,ANLN
11363,GO:0043588,0.0702612171513498,0.980236561207051,4,241,skin development,BP,FA2H;PPL;PCSK6;EGFR
453,GO:0001206,0.0705070933889552,0.997726306858609,1,10,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,ARX
13460,GO:0050746,0.0706970706391832,0.997672485906103,1,12,regulation of lipoprotein metabolic process,BP,APOD
12151,GO:0045723,0.0707536644689337,0.99765277456512,1,13,positive regulation of fatty acid biosynthetic process,BP,SLC45A3
14742,GO:0060379,0.0707695185728666,0.997709116001522,1,10,cardiac muscle cell myoblast differentiation,BP,GREM1
10412,GO:0038127,0.0708303377479902,0.984543993594693,3,141,ERBB signaling pathway,BP,ERBB3;EGFR;SH3TC2
20563,GO:1905146,0.0710131753227371,0.997693095045738,1,10,lysosomal protein catabolic process,BP,LRP2
8746,GO:0032930,0.0710800293465707,0.99763077577404,1,13,positive regulation of superoxide anion generation,BP,EGFR
11107,GO:0043178,0.0711412409035612,0.990403253554345,2,69,alcohol binding,MF,PLCL1;APOD
8487,GO:0032536,0.071248085327395,0.997654664301145,1,11,regulation of cell projection size,BP,CNTN2
11571,GO:0044291,0.0717457996010643,0.990297777503347,2,62,cell-cell contact zone,CC,GJA1;OPALIN
6253,GO:0017171,0.0718982334950944,0.984185760811616,3,167,serine hydrolase activity,MF,CPM;PCSK6;KLK6
7305,GO:0030308,0.07196189904587,0.984179366642106,3,154,negative regulation of cell growth,BP,MAG;GJA1;GREM1
17485,GO:0090559,0.0720239523753413,0.990198690883814,2,76,regulation of membrane permeability,BP,EYA2;BOK
2847,GO:0005916,0.0721018020853044,0.997620814336983,1,10,fascia adherens,CC,GJA1
11539,GO:0044224,0.0722901586702512,0.997608191820034,1,10,juxtaparanode region of axon,CC,CNTN2
3781,GO:0007501,0.072354860629445,0.997543834625123,1,13,mesodermal cell fate specification,BP,EYA2
15550,GO:0070008,0.0723956152531293,0.99755771082372,1,12,serine-type exopeptidase activity,MF,CPM
8677,GO:0032816,0.072426344467973,0.997538911885445,1,13,positive regulation of natural killer cell activation,BP,RASGRP1
17175,GO:0086080,0.0724306966415543,0.997598751445136,1,10,protein binding involved in heterotypic cell-cell adhesion,MF,GLDN
3472,GO:0006878,0.0724778428054046,0.997535362309719,1,13,cellular copper ion homeostasis,BP,SLC31A2
10930,GO:0042802,0.0725721714843475,0.961090295037025,14,1494,identical protein binding,MF,CLDN11;ERBB3;CDH19;SOX10;MAG;PDGFRA;EGFR;GREM1;GPD1;GJB1;RASGRP1;DMRT2;BOK;CNTN2
5926,GO:0016558,0.072760764467437,0.997532665872841,1,12,protein import into peroxisome matrix,BP,PEX5L
15185,GO:0061097,0.0728136394628186,0.990054795657984,2,67,regulation of protein tyrosine kinase activity,BP,ERBB3;GREM1
10671,GO:0042310,0.0729877045829349,0.990014613490146,2,68,vasoconstriction,BP,EGFR;GJA1
14865,GO:0060547,0.0731003672152528,0.997492246151058,1,13,negative regulation of necrotic cell death,BP,BOK
7413,GO:0030546,0.0732047923980994,0.99752220016478,1,11,receptor activator activity,MF,GREM1
3775,GO:0007494,0.0733911699606684,0.99750938765433,1,11,midgut development,BP,EGFR
4650,GO:0009966,0.0736505418632002,0.954795380196501,24,2831,regulation of signal transduction,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;PEX5L;RGS4;PDGFRA;PCSK6;EGFR;ST18;GJA1;FZD7;GREM1;KLK6;SH3TC2;MAL;RASGRP1;BOK;GPR62;CNTN2;APOD
13854,GO:0051345,0.0736819985715532,0.967960055807168,8,682,positive regulation of hydrolase activity,BP,NGFR;RGS4;PDGFRA;EGFR;ST18;RASGRP1;BOK;MBP
1201,GO:0002689,0.0737121258554085,0.997434681008481,1,14,negative regulation of leukocyte chemotaxis,BP,GREM1
13605,GO:0050954,0.0740146531591873,0.983548359431101,3,147,sensory perception of mechanical stimulus,BP,LRP2;PIEZO2;MBP
13554,GO:0050877,0.0740755217315427,0.966030008198211,9,810,nervous system process,BP,LRP2;SOX10;MAG;MYRF;EGFR;NKX6-2;PIEZO2;CNTN2;MBP
17035,GO:0072697,0.0740939702249856,0.997460767933607,1,11,protein localization to cell cortex,BP,ANLN
13855,GO:0051346,0.0741517787374318,0.97507961161207,5,367,negative regulation of hydrolase activity,BP,NGFR;PPP1R14A;MYO1D;SPOCK3;COL28A1
21739,GO:2001022,0.0742128839269647,0.989740041421119,2,72,positive regulation of response to DNA damage stimulus,BP,EYA2;EGFR
3738,GO:0007351,0.0742621323427452,0.997428308535643,1,12,tripartite regional subdivision,BP,PCSK6
4197,GO:0008595,0.0742621323427452,0.997428308535643,1,12,anterior/posterior axis specification, embryo,BP,PCSK6
21534,GO:2000586,0.0745704560678659,0.997452653193706,1,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFRA
3785,GO:0007512,0.0747654969726167,0.997392822777892,1,12,adult heart development,BP,GJA1
5086,GO:0010960,0.0749001816662584,0.997429745325131,1,10,magnesium ion homeostasis,BP,EGFR
1439,GO:0003161,0.0750422683616637,0.997373204581065,1,12,cardiac conduction system development,BP,BVES
16068,GO:0070938,0.0754809425685824,0.997363397679631,1,11,contractile ring,CC,ANLN
21623,GO:2000726,0.0758423094116877,0.99733771875846,1,11,negative regulation of cardiac muscle cell differentiation,BP,FZD7
18851,GO:1901213,0.0759908176338719,0.997305394945412,1,12,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,GREM1
21407,GO:2000392,0.0762333320641975,0.997309788132474,1,11,regulation of lamellipodium morphogenesis,BP,ENPP2
16805,GO:0072224,0.0765015673277501,0.997290541373089,1,11,metanephric glomerulus development,BP,PDGFRA
3470,GO:0006875,0.0765662018722204,0.970999303070689,6,479,cellular metal ion homeostasis,BP,TF;CAPN3;PDGFRA;SLC31A2;GJA1;BOK
7461,GO:0030662,0.0765685254458262,0.982724285075082,3,162,coated vesicle membrane,CC,LRP2;TF;EGFR
1547,GO:0003337,0.0765927307196317,0.997243228123685,1,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,GREM1
11910,GO:0045176,0.0766568439430508,0.997279367478156,1,11,apical protein localization,BP,MAL
9314,GO:0034356,0.0768117727495456,0.997245988393013,1,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NNMT
9684,GO:0035295,0.0768933974954601,0.962943852378888,10,899,tube development,BP,CRLF1;NGFR;LRP2;SOX10;PDGFRA;ENPP2;EGFR;GJA1;GREM1;APOD
17368,GO:0090277,0.0769404225954792,0.989126362492968,2,79,positive regulation of peptide hormone secretion,BP,EGFR;GJA1
8208,GO:0032102,0.077001916751316,0.977659486880883,4,259,negative regulation of response to external stimulus,BP,PDGFRA;GJA1;GREM1;APOD
15640,GO:0070168,0.0770432650067067,0.997210219695862,1,13,negative regulation of biomineral tissue development,BP,GREM1
14509,GO:0060044,0.0771495377573065,0.997221353104216,1,12,negative regulation of cardiac muscle cell proliferation,BP,GJA1
13939,GO:0051503,0.0771584798308936,0.997201745994844,1,13,adenine nucleotide transport,BP,GJA1
19546,GO:1903035,0.0776970053867258,0.988974518613147,2,73,negative regulation of response to wounding,BP,PDGFRA;GJA1
6953,GO:0021889,0.0779843421936141,0.997159980837282,1,12,olfactory bulb interneuron differentiation,BP,ARX
18247,GO:0099515,0.0781475177995181,0.997198488366624,1,10,actin filament-based transport,BP,MOBP
11482,GO:0044057,0.078216321110188,0.970217861508718,6,465,regulation of system process,BP,SOX10;MAG;BVES;MYRF;EGFR;GJA1
4862,GO:0010646,0.0782359993865035,0.950932228121739,26,3117,regulation of cell communication,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;PEX5L;PLCL1;RGS4;PDGFRA;PCSK6;EGFR;ST18;GJA1;CNTNAP4;FZD7;GREM1;KLK6;SH3TC2;MAL;RASGRP1;BOK;GPR62;CNTN2;APOD
10904,GO:0042759,0.0784248773900546,0.997127315591208,1,12,long-chain fatty acid biosynthetic process,BP,PLP1
11885,GO:0045125,0.0785030176645837,0.997070501703218,1,15,bioactive lipid receptor activity,MF,S1PR5
13628,GO:0051004,0.0785479215389951,0.997067099383729,1,15,regulation of lipoprotein lipase activity,BP,PCSK6
18616,GO:1900103,0.0785978336104144,0.997094770098321,1,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,BOK
3310,GO:0006629,0.0788305044723774,0.959238231843577,12,1245,lipid metabolic process,BP,ERBB3;LRP2;FA2H;PLCL1;PLP1;PDGFRA;ENPP2;EGFR;SLC45A3;GPD1;UGT8;APOD
13151,GO:0048642,0.0789292215143037,0.997069847797885,1,13,negative regulation of skeletal muscle tissue development,BP,CAPN3
6990,GO:0021954,0.0789374407775112,0.988713648736365,2,68,central nervous system neuron development,BP,ARX;CNTN2
5921,GO:0016540,0.0792896355976699,0.997042618029443,1,13,protein autoprocessing,BP,KLK6
12938,GO:0048145,0.0793151533591321,0.988604811567461,2,76,regulation of fibroblast proliferation,BP,PDGFRA;EGFR
4184,GO:0008565,0.0793300725873258,0.988598784962532,2,77,protein transporter activity,MF,LRP2;MLC1
8580,GO:0032682,0.079428848089245,0.996986895685068,1,16,negative regulation of chemokine production,BP,APOD
9763,GO:0035461,0.07949452809355,0.997070988749275,1,11,vitamin transmembrane transport,BP,LRP2
20532,GO:1905048,0.0796308027891112,0.997016722794491,1,13,regulation of metallopeptidase activity,BP,MBP
7192,GO:0030155,0.0797081798194068,0.966918079145164,7,583,regulation of cell adhesion,BP,ERBB3;FZD7;EDIL3;GREM1;RASGRP1;APOD;MBP
6737,GO:0019992,0.079809770319599,0.997023372938291,1,12,diacylglycerol binding,MF,RASGRP1
5705,GO:0016101,0.079879499762142,0.988475000985796,2,77,diterpenoid metabolic process,BP,LRP2;EGFR
17710,GO:0097286,0.0800639743242568,0.996983676586715,1,13,iron ion import,BP,TF
7849,GO:0031399,0.0802894131732461,0.955402730377973,15,1579,regulation of protein modification process,BP,CRLF1;NGFR;ERBB3;CAPN3;PLCL1;RGS4;PDGFRA;ENPP2;EGFR;FZD7;GREM1;PPP1R14A;KNDC1;RASGRP1;GJC2
11064,GO:0043112,0.080299860104155,0.981527731417181,3,159,receptor metabolic process,BP,BVES;GREM1;CNTN2
7078,GO:0022857,0.0805277760362213,0.960853949993466,10,931,transmembrane transporter activity,MF,TF;SLC31A2;GJA1;PIEZO2;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;GJC2
5674,GO:0016043,0.0806810682282262,0.946053435223728,43,5585,cellular component organization,BP,ARX;ANLN;NGFR;EYA2;CDH19;LRP2;TF;CAPN3;COL9A3;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;ATP10B;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;ERMN;ENPP2;EGFR;GJA1;FZD7;TMSB15A;ADAMTS4;GREM1;KLK6;SH3TC2;GJB1;KNDC1;MAL;RASGRP1;UGT8;BOK;CNTN2;GLDN;APOD;MBP
16206,GO:0071241,0.080871678660688,0.981335754492934,3,164,cellular response to inorganic substance,BP,TF;CAPN3;EGFR
12936,GO:0048143,0.0809030362363519,0.996939972541527,1,12,astrocyte activation,BP,EGFR
6850,GO:0021681,0.0809272762158299,0.996917256333233,1,13,cerebellar granular layer development,BP,KNDC1
17920,GO:0097756,0.0809730438248694,0.988241683173042,2,72,negative regulation of blood vessel diameter,BP,EGFR;GJA1
12991,GO:0048259,0.0811480305038454,0.988201881655887,2,72,regulation of receptor-mediated endocytosis,BP,TF;GREM1
17311,GO:0090195,0.0811517777115816,0.996899861530138,1,13,chemokine secretion,BP,MBP
13202,GO:0048711,0.0812555380255549,0.996873790998115,1,14,positive regulation of astrocyte differentiation,BP,MAG
12027,GO:0045445,0.0812901567940353,0.988157651628934,2,76,myoblast differentiation,BP,CAPN3;GREM1
2728,GO:0005741,0.0815189359886646,0.981125519634539,3,163,mitochondrial outer membrane,CC,SOX10;GJA1;BOK
7856,GO:0031406,0.0815239928136541,0.981114955573217,3,171,carboxylic acid binding,MF,MAG;HAPLN2;SUSD5
12937,GO:0048144,0.0815267629349159,0.988100862053284,2,77,fibroblast proliferation,BP,PDGFRA;EGFR
12186,GO:0045780,0.0817754305173454,0.996851274804298,1,13,positive regulation of bone resorption,BP,EGFR
12670,GO:0046852,0.0817754305173454,0.996851274804298,1,13,positive regulation of bone remodeling,BP,EGFR
6463,GO:0019209,0.0821001566207789,0.987975273490157,2,75,kinase activator activity,MF,ERBB3;GREM1
16534,GO:0071772,0.0821365933239187,0.980935691202876,3,153,response to BMP,BP,LRP2;PCSK6;GREM1
16535,GO:0071773,0.0821365933239187,0.980935691202876,3,153,cellular response to BMP stimulus,BP,LRP2;PCSK6;GREM1
16863,GO:0072330,0.0822996553594854,0.975578135097496,4,269,monocarboxylic acid biosynthetic process,BP,FA2H;PLP1;SLC45A3;GPD1
13061,GO:0048407,0.0824412436714753,0.996846203729398,1,11,platelet-derived growth factor binding,MF,PDGFRA
3948,GO:0008191,0.0824869476438803,0.996760716983529,1,15,metalloendopeptidase inhibitor activity,MF,SPOCK3
4007,GO:0008283,0.0825167119034702,0.953156993934078,16,1774,cell proliferation,BP,ARX;CRLF1;NGFR;ERBB3;LRP2;SOX10;FA2H;PDGFRA;EGFR;ST18;GJA1;FZD7;GREM1;BOK;APOD;GJC2
13335,GO:0050321,0.0827885326149141,0.996771516274533,1,13,tau-protein kinase activity,MF,PHKG1
15139,GO:0061029,0.0830632649575409,0.996749709944972,1,13,eyelid development in camera-type eye,BP,EGFR
3652,GO:0007186,0.0833597967676584,0.962774474529192,8,771,G-protein coupled receptor signaling pathway,BP,PLCL1;RGS4;ENPP2;FZD7;KLK6;S1PR5;GPR62;CNTN2
2051,GO:0004551,0.0837504642510621,0.996644606415439,1,16,nucleotide diphosphatase activity,MF,ENPP2
3838,GO:0007625,0.0837767797658188,0.996656978582894,1,15,grooming behavior,BP,CNTNAP4
743,GO:0001921,0.0839008995834503,0.996682756626294,1,13,positive regulation of receptor recycling,BP,BVES
17595,GO:0097090,0.0845491738110578,0.99665322075609,1,12,presynaptic membrane organization,BP,CNTN2
15766,GO:0070372,0.0846676903943043,0.97463921782386,4,262,regulation of ERK1 and ERK2 cascade,BP,ERBB3;PDGFRA;EGFR;RASGRP1
7852,GO:0031402,0.0847902943613936,0.996633790128759,1,12,sodium ion binding,MF,CAPN3
8744,GO:0032928,0.0847978865308499,0.996558784773611,1,16,regulation of superoxide anion generation,BP,EGFR
8171,GO:0032045,0.0849507329409951,0.996597846373432,1,13,guanyl-nucleotide exchange factor complex,CC,KNDC1
14407,GO:0055013,0.0850223111876291,0.987360929331191,2,59,cardiac muscle cell development,BP,BVES;PDGFRA
13667,GO:0051052,0.0850789920001435,0.970259972179212,5,359,regulation of DNA metabolic process,BP,EYA2;PDGFRA;EGFR;GJA1;GREM1
11106,GO:0043177,0.0853258132844969,0.979855639075883,3,173,organic acid binding,MF,MAG;HAPLN2;SUSD5
3502,GO:0006919,0.0854578604526381,0.987166125890909,2,86,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NGFR;BOK
13510,GO:0050811,0.0854825900958159,0.996534466658883,1,14,GABA receptor binding,MF,PLCL1
334,GO:0000921,0.0854902188309887,0.996553781682555,1,13,septin ring assembly,BP,ANLN
7988,GO:0031657,0.0857721248793473,0.996510563624413,1,14,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR
8264,GO:0032225,0.0858315302300571,0.996488231133964,1,15,regulation of synaptic transmission, dopaminergic,BP,CNTNAP4
2667,GO:0005615,0.0862593553890123,0.94605371532476,24,3125,extracellular space,CC,CRLF1;CLDN11;BCAS1;ERBB3;LRP2;FOLH1;TF;PLLP;TUBB4A;PPL;CPM;ERMN;ENPP2;PCSK6;EGFR;GJA1;ADAMTS4;EDIL3;GREM1;GPD1;KLK6;MYO1D;GLDN;APOD
12428,GO:0046328,0.0863270470159146,0.979540061167054,3,157,regulation of JNK cascade,BP,EGFR;FZD7;RASGRP1
14432,GO:0055070,0.086634487678216,0.996405598048492,1,16,copper ion homeostasis,BP,SLC31A2
13990,GO:0051604,0.0869793350532044,0.973693157903844,4,286,protein maturation,BP,CPM;PCSK6;KLK6;CNTN2
14884,GO:0060579,0.0875348292860523,0.996345091222709,1,15,ventral spinal cord interneuron fate commitment,BP,NKX6-2
14886,GO:0060581,0.0875348292860523,0.996345091222709,1,15,cell fate commitment involved in pattern specification,BP,NKX6-2
18041,GO:0098772,0.0876135832607093,0.951640393028528,14,1545,molecular function regulator,MF,CRLF1;ERBB3;CAPN3;RGS4;PDGFRA;RAPGEF5;EGFR;GREM1;PPP1R14A;KNDC1;MAL;RASGRP1;SPOCK3;COL28A1
16309,GO:0071397,0.0877116908129348,0.996393748446562,1,12,cellular response to cholesterol,BP,MLC1
3640,GO:0007171,0.0880232054365191,0.996342969374014,1,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,GREM1
5285,GO:0015020,0.0880358702158369,0.996320747854023,1,14,glucuronosyltransferase activity,MF,UGT8
19920,GO:1903798,0.0884412699364231,0.996286206082472,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR
7872,GO:0031432,0.0887109620965958,0.996263134709331,1,14,titin binding,MF,CAPN3
15050,GO:0060850,0.0887162501842248,0.996227792411543,1,16,regulation of transcription involved in cell fate commitment,BP,NKX6-2
7585,GO:0030900,0.0888221443910145,0.968565153879311,5,351,forebrain development,BP,ARX;LRP2;EGFR;MYO1D;CNTN2
17301,GO:0090185,0.0890180530887617,0.996218036975253,1,15,negative regulation of kidney development,BP,GREM1
18472,GO:0120035,0.0892789723623833,0.96196135796845,7,562,regulation of plasma membrane bounded cell projection organization,BP,ANLN;NGFR;MAG;ENPP2;KLK6;KNDC1;CNTN2
3576,GO:0007039,0.0895392952160851,0.996191811074144,1,14,protein catabolic process in the vacuole,BP,LRP2
1127,GO:0002544,0.0897819273842121,0.996120345504743,1,17,chronic inflammatory response,BP,GJA1
2487,GO:0005201,0.0897899754570471,0.986189029517468,2,68,extracellular matrix structural constituent,MF,COL9A3;HAPLN2
3607,GO:0007096,0.0897998099797613,0.996133487333632,1,16,regulation of exit from mitosis,BP,ANLN
14645,GO:0060253,0.0898300004296245,0.996166614504215,1,14,negative regulation of glial cell proliferation,BP,SOX10
7583,GO:0030898,0.0900741862634737,0.99619337129829,1,12,actin-dependent ATPase activity,MF,MYO1D
855,GO:0002070,0.0900971708230391,0.996124187221026,1,15,epithelial cell maturation,BP,GJA1
4902,GO:0010720,0.0905423870292899,0.964206614839891,6,463,positive regulation of cell development,BP,NGFR;LRP2;SOX10;MAG;NKX6-2;GJC2
9196,GO:0034114,0.0905978983402501,0.996048280216743,1,17,regulation of heterotypic cell-cell adhesion,BP,MBP
7722,GO:0031143,0.0907249470412327,0.99608850603401,1,14,pseudopodium,CC,LDB3
10985,GO:0042981,0.0909062505180524,0.950624897752458,13,1399,regulation of apoptotic process,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;SOX10;MAG;PDGFRA;EGFR;ST18;GREM1;MAL;BOK
11256,GO:0043410,0.0909114958692748,0.964015255356731,6,484,positive regulation of MAPK cascade,BP,NGFR;ERBB3;PDGFRA;EGFR;FZD7;RASGRP1
18852,GO:1901214,0.0911405848492814,0.972008217094637,4,266,regulation of neuron death,BP,CRLF1;ERBB3;MAG;BOK
15309,GO:0061430,0.0917539127984915,0.996020671295128,1,13,bone trabecula morphogenesis,BP,GREM1
2838,GO:0005901,0.0918911496659771,0.985658472440043,2,73,caveola,CC,MLC1;BVES
9975,GO:0035791,0.0920094713565184,0.995998077534041,1,13,platelet-derived growth factor receptor-beta signaling pathway,BP,PDGFRA
9189,GO:0034104,0.0922819294827597,0.995912917893543,1,16,negative regulation of tissue remodeling,BP,GREM1
7586,GO:0030901,0.0924002468425982,0.985501055408285,2,83,midbrain development,BP,PLP1;MBP
7167,GO:0030122,0.0925442588387703,0.995927205912059,1,14,AP-2 adaptor complex,CC,EGFR
9535,GO:0034762,0.0925597475274896,0.963194532413615,6,476,regulation of transmembrane transport,BP,NGFR;CAPN3;SLC31A2;GJA1;KCNJ6;GJC2
3379,GO:0006721,0.0925957999477385,0.985447245753794,2,85,terpenoid metabolic process,BP,LRP2;EGFR
16746,GO:0072148,0.0926859824291923,0.995894183527675,1,15,epithelial cell fate commitment,BP,ARX
594,GO:0001710,0.0927935288168254,0.995850955320056,1,17,mesodermal cell fate commitment,BP,EYA2
12574,GO:0046625,0.0929506252743258,0.995852411797867,1,16,sphingolipid binding,MF,MAG
17006,GO:0072643,0.093205309481003,0.995847216695439,1,15,interferon-gamma secretion,BP,RASGRP1
12072,GO:0045597,0.0932938927697942,0.95520153362179,9,834,positive regulation of cell differentiation,BP,NGFR;LRP2;SOX10;MAG;NKX6-2;GJA1;GREM1;RASGRP1;GJC2
14444,GO:0055085,0.0934345041488821,0.949026333922916,13,1359,transmembrane transport,BP,NGFR;LRP2;CAPN3;PEX5L;SLC31A2;GJA1;PIEZO2;KCNJ6;SLC45A3;SLC5A11;TMEM144;GJB1;GJC2
3582,GO:0007045,0.0935074591212154,0.985267855019617,2,71,cell-substrate adherens junction assembly,BP,GREM1;APOD
12920,GO:0048041,0.0935074591212154,0.985267855019617,2,71,focal adhesion assembly,BP,GREM1;APOD
14440,GO:0055080,0.0936270237107562,0.959644018737851,7,620,cation homeostasis,BP,TF;CAPN3;PDGFRA;SLC31A2;EGFR;GJA1;BOK
13110,GO:0048557,0.0936970670511116,0.995784326878629,1,16,embryonic digestive tract morphogenesis,BP,PDGFRA
836,GO:0002043,0.0939098522744238,0.995783056858329,1,15,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
3737,GO:0007350,0.0939455331716869,0.995779793984171,1,15,blastoderm segmentation,BP,PCSK6
7282,GO:0030278,0.093982255330275,0.976906524010562,3,168,regulation of ossification,BP,GJA1;GREM1;SMOC1
16837,GO:0072283,0.0940736282356459,0.99576806943241,1,15,metanephric renal vesicle morphogenesis,BP,GREM1
7180,GO:0030136,0.0940971246286995,0.97686514413768,3,169,clathrin-coated vesicle,CC,LRP2;TF;EGFR
13734,GO:0051153,0.0941449322820106,0.98507153247413,2,82,regulation of striated muscle cell differentiation,BP,FZD7;GREM1
2900,GO:0006006,0.0943218469121956,0.976782827667751,3,172,glucose metabolic process,BP,SLC45A3;GPD1;APOD
12628,GO:0046716,0.0946556235375972,0.99571458703657,1,15,muscle cell cellular homeostasis,BP,CAPN3
5826,GO:0016338,0.0946833680842662,0.995662584043074,1,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11
5902,GO:0016505,0.0948748868046257,0.995659300048757,1,17,peptidase activator activity involved in apoptotic process,MF,MAL
11442,GO:0043950,0.0949045814773814,0.99562885987277,1,19,positive regulation of cAMP-mediated signaling,BP,GPR62
5078,GO:0010951,0.0950127123640054,0.976521300029441,3,189,negative regulation of endopeptidase activity,BP,NGFR;SPOCK3;COL28A1
8792,GO:0033002,0.095012943467437,0.976547635675589,3,167,muscle cell proliferation,BP,EGFR;GJA1;APOD
16057,GO:0070920,0.0953233829348123,0.995652794379924,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,EGFR
11045,GO:0043067,0.0955811376980805,0.947655467297671,13,1411,regulation of programmed cell death,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;SOX10;MAG;PDGFRA;EGFR;ST18;GREM1;MAL;BOK
7556,GO:0030864,0.0959907801923983,0.984643982476317,2,72,cortical actin cytoskeleton,CC,ANLN;MOBP
7738,GO:0031210,0.0961849003255688,0.995536370680725,1,17,phosphatidylcholine binding,MF,RASGRP1
13623,GO:0050997,0.0961849003255688,0.995536370680725,1,17,quaternary ammonium group binding,MF,RASGRP1
822,GO:0002028,0.0964334643354513,0.984500146355369,2,81,regulation of sodium ion transport,BP,NKAIN1;NKAIN2
14113,GO:0051861,0.0967949108876181,0.995478520816642,1,17,glycolipid binding,MF,MAG
14400,GO:0055006,0.0968262934300922,0.984469828343265,2,64,cardiac cell development,BP,BVES;PDGFRA
4008,GO:0008284,0.096910884898078,0.955293209455647,8,761,positive regulation of cell proliferation,BP,CRLF1;LRP2;SOX10;PDGFRA;EGFR;FZD7;GREM1;GJC2
10978,GO:0042953,0.0970667622658969,0.99553730977927,1,13,lipoprotein transport,BP,LRP2
11800,GO:0044872,0.0970667622658969,0.99553730977927,1,13,lipoprotein localization,BP,LRP2
21624,GO:2000727,0.0970798379047,0.995468567224771,1,16,positive regulation of cardiac muscle cell differentiation,BP,GREM1
7122,GO:0030029,0.0971917104069905,0.955153005731015,8,680,actin filament-based process,BP,ANLN;CAPN3;LDB3;PDGFRA;ERMN;GJA1;TMSB15A;MOBP
7699,GO:0031106,0.0977854099369352,0.995420998245498,1,15,septin ring organization,BP,ANLN
9378,GO:0034446,0.0978157559544958,0.984155852478708,2,79,substrate adhesion-dependent cell spreading,BP,BVES;FZD7
21866,GO:2001269,0.0978910565912245,0.995358055738309,1,18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,ST18
515,GO:0001568,0.0979004290817503,0.957363315370812,7,586,blood vessel development,BP,NGFR;LRP2;PDGFRA;ENPP2;GJA1;GREM1;APOD
17199,GO:0090025,0.0981330650986179,0.99533464527339,1,18,regulation of monocyte chemotaxis,BP,GREM1
2397,GO:0005041,0.0984588408116433,0.99540590267507,1,13,low-density lipoprotein particle receptor activity,MF,LRP2
3743,GO:0007369,0.0987800945850607,0.97521897288288,3,165,gastrulation,BP,EYA2;FZD7;MBP
1407,GO:0003094,0.0993294597650877,0.995272438071088,1,15,glomerular filtration,BP,GJA1
7173,GO:0030128,0.0994751659286028,0.995258291815664,1,15,clathrin coat of endocytic vesicle,CC,EGFR
13090,GO:0048520,0.0994772480924478,0.995203504199541,1,18,positive regulation of behavior,BP,GJA1
637,GO:0001779,0.0995160340008595,0.995215754746682,1,17,natural killer cell differentiation,BP,RASGRP1
5621,GO:0015919,0.0997316500861787,0.995212757547347,1,16,peroxisomal membrane transport,BP,PEX5L
7964,GO:0031623,0.0997928116891207,0.98362919121973,2,85,receptor internalization,BP,GREM1;CNTN2
15942,GO:0070679,0.0998738464016584,0.995270300710214,1,13,inositol 1,4,5 trisphosphate binding,MF,PLCL1
2465,GO:0005161,0.100161273437924,0.995215114548356,1,14,platelet-derived growth factor receptor binding,MF,PDGFRA
2104,GO:0004620,0.100327766290108,0.983493898786154,2,84,phospholipase activity,MF,PLCL1;ENPP2
3345,GO:0006677,0.100447234717962,0.995107697702471,1,18,glycosylceramide metabolic process,BP,UGT8
18062,GO:0098805,0.100648298231507,0.943216597976542,14,1523,whole membrane,CC,LRP2;TF;SOX10;MLC1;PLLP;MAG;BVES;PEX5L;EGFR;GJA1;FZD7;MAL;MYO1D;BOK
14414,GO:0055022,0.100791946945837,0.995108432643912,1,16,negative regulation of cardiac muscle tissue growth,BP,GJA1
15201,GO:0061117,0.100791946945837,0.995108432643912,1,16,negative regulation of heart growth,BP,GJA1
16699,GO:0072079,0.100801287876208,0.995072482366826,1,18,nephron tubule formation,BP,GREM1
15765,GO:0070371,0.101048485518756,0.967840913253526,4,278,ERK1 and ERK2 cascade,BP,ERBB3;PDGFRA;EGFR;RASGRP1
18040,GO:0098771,0.101059975469491,0.955640466676247,7,631,inorganic ion homeostasis,BP,TF;CAPN3;PDGFRA;SLC31A2;EGFR;GJA1;BOK
19011,GO:1901655,0.101149670654171,0.983283650539032,2,83,cellular response to ketone,BP,SOX10;EGFR
6755,GO:0021514,0.101381938854071,0.99503111607387,1,17,ventral spinal cord interneuron differentiation,BP,NKX6-2
14140,GO:0051900,0.101545879754768,0.994997994534484,1,18,regulation of mitochondrial depolarization,BP,BOK
13212,GO:0048736,0.101894710598605,0.974100636306516,3,165,appendage development,BP,GJA1;GREM1;SMOC1
14599,GO:0060173,0.101894710598605,0.974100636306516,3,165,limb development,BP,GJA1;GREM1;SMOC1
14135,GO:0051895,0.102016977071351,0.995007978624839,1,15,negative regulation of focal adhesion assembly,BP,APOD
1398,GO:0003071,0.102269564297297,0.994925041665555,1,18,renal system process involved in regulation of systemic arterial blood pressure,BP,GJA1
558,GO:0001656,0.102438499511261,0.982953656630111,2,81,metanephros development,BP,PDGFRA;GREM1
4177,GO:0008544,0.102543821722498,0.967197954901696,4,280,epidermis development,BP,FA2H;PPL;PCSK6;EGFR
13925,GO:0051480,0.102932803658578,0.967027492128094,4,284,regulation of cytosolic calcium ion concentration,BP,CAPN3;PDGFRA;GJA1;BOK
7808,GO:0031325,0.103095294600123,0.934618150887727,23,2766,positive regulation of cellular metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;BVES;MYRF;PDGFRA;ENPP2;EGFR;ST18;FZD7;SLC45A3;GREM1;GPD1;KNDC1;RASGRP1;DMRT2;BOK;CNTN2;MBP
8327,GO:0032331,0.103149523732898,0.994852853651639,1,17,negative regulation of chondrocyte differentiation,BP,GREM1
13207,GO:0048729,0.103321280078922,0.954418274836818,7,593,tissue morphogenesis,BP,EYA2;LRP2;SOX10;EGFR;GJA1;FZD7;GREM1
3307,GO:0006625,0.103397866374421,0.994827546322122,1,17,protein targeting to peroxisome,BP,PEX5L
17013,GO:0072662,0.103397866374421,0.994827546322122,1,17,protein localization to peroxisome,BP,PEX5L
17014,GO:0072663,0.103397866374421,0.994827546322122,1,17,establishment of protein localization to peroxisome,BP,PEX5L
9680,GO:0035282,0.103464808974733,0.982676809553698,2,83,segmentation,BP,PCSK6;DMRT2
14136,GO:0051896,0.103574805936027,0.97347755420631,3,174,regulation of protein kinase B signaling,BP,ERBB3;PDGFRA;EGFR
17269,GO:0090136,0.103717874121081,0.994836736336984,1,15,epithelial cell-cell adhesion,BP,BVES
4634,GO:0009913,0.103719237762549,0.973416756558325,3,180,epidermal cell differentiation,BP,FA2H;PPL;PCSK6
17306,GO:0090190,0.103753638317945,0.994791178938637,1,17,positive regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
8241,GO:0032185,0.103835684045885,0.994802453545148,1,16,septin cytoskeleton organization,BP,ANLN
4798,GO:0010544,0.103985462400001,0.994767410321939,1,17,negative regulation of platelet activation,BP,PDGFRA
4645,GO:0009953,0.104187862853247,0.982466541016195,2,89,dorsal/ventral pattern formation,BP,NKX6-2;GREM1
437,GO:0001158,0.10448993884907,0.982395550407823,2,86,enhancer sequence-specific DNA binding,MF,ARX;SOX10
4762,GO:0010466,0.104547622118046,0.973094558015199,3,196,negative regulation of peptidase activity,BP,NGFR;SPOCK3;COL28A1
16032,GO:0070884,0.104786849608678,0.994704854325099,1,16,regulation of calcineurin-NFAT signaling cascade,BP,ERBB3
18424,GO:0106056,0.104786849608678,0.994704854325099,1,16,regulation of calcineurin-mediated signaling,BP,ERBB3
7410,GO:0030540,0.104872268688755,0.994696043225882,1,16,female genitalia development,BP,LRP2
15099,GO:0060973,0.10494877265493,0.99466804029348,1,17,cell migration involved in heart development,BP,BVES
10353,GO:0038024,0.104989222765511,0.982279747691807,2,81,cargo receptor activity,MF,LRP2;ENPP2
7100,GO:0023052,0.105410745467074,0.927835124697083,41,5462,signaling,BP,CRLF1;NGFR;EYA2;ERBB3;DCX;LRP2;CAPN3;SOX10;BVES;PEX5L;PLCL1;RGS4;PLP1;PDGFRA;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;ST18;GJA1;CNTNAP4;FZD7;PHKG1;GREM1;KLK6;SH3TC2;GJB1;KNDC1;MAL;RASGRP1;SUSD5;BOK;S1PR5;GPR62;CNTN2;APOD;SPOCK3;MBP;SMOC1;GJC2
5080,GO:0010954,0.105745440741643,0.994566986064686,1,18,positive regulation of protein processing,BP,CNTN2
8128,GO:0031968,0.105848616997965,0.972635002488688,3,181,organelle outer membrane,CC,SOX10;GJA1;BOK
11436,GO:0043931,0.106008124541332,0.994627995147785,1,14,ossification involved in bone maturation,BP,GREM1
13409,GO:0050678,0.106156891242292,0.965635128616067,4,278,regulation of epithelial cell proliferation,BP,NGFR;EGFR;GJA1;FZD7
13478,GO:0050770,0.106206544361488,0.972531521780838,3,162,regulation of axonogenesis,BP,NGFR;MAG;CNTN2
17669,GO:0097205,0.106270056246367,0.994550775803332,1,16,renal filtration,BP,GJA1
12569,GO:0046620,0.106821245583132,0.981785853069612,2,82,regulation of organ growth,BP,ARX;GJA1
12283,GO:0045954,0.107012866957878,0.994416646859829,1,19,positive regulation of natural killer cell mediated cytotoxicity,BP,RASGRP1
10694,GO:0042359,0.107099492515751,0.99440741855174,1,19,vitamin D metabolic process,BP,LRP2
17779,GO:0097435,0.107336329264214,0.952211825542353,7,592,supramolecular fiber organization,BP,CAPN3;TUBB4A;LDB3;PDGFRA;ERMN;TMSB15A;GREM1
8940,GO:0033268,0.107375775350354,0.994458273952969,1,15,node of Ranvier,CC,CNTN2
809,GO:0002009,0.107576724223957,0.955492291960575,6,498,morphogenesis of an epithelium,BP,LRP2;SOX10;EGFR;GJA1;FZD7;GREM1
17780,GO:0097440,0.10759732154463,0.994434903865779,1,15,apical dendrite,CC,MYO1D
12652,GO:0046823,0.107636182635355,0.994350067503916,1,19,negative regulation of nucleocytoplasmic transport,BP,APOD
6698,GO:0019899,0.107841493806993,0.933756629604459,19,2133,enzyme binding,MF,ANLN;NGFR;ERBB3;DCX;NKAIN1;MAG;PEX5L;LDB3;PDGFRA;RAPGEF5;EGFR;GJA1;ADAMTS4;PHKG1;MOBP;KNDC1;RASGRP1;BOK;MBP
16867,GO:0072337,0.107901597686286,0.994357374709038,1,17,modified amino acid transport,BP,LRP2
2840,GO:0005903,0.107946399884304,0.981482157410791,2,82,brush border,CC,LRP2;MYO1D
19148,GO:1902043,0.107965555503138,0.994350544328282,1,17,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
708,GO:0001871,0.108284049068117,0.994280430036631,1,19,pattern binding,MF,ENPP2
7264,GO:0030247,0.108284049068117,0.994280430036631,1,19,polysaccharide binding,MF,ENPP2
2106,GO:0004622,0.108422992269754,0.99428249641762,1,18,lysophospholipase activity,MF,ENPP2
4664,GO:0010002,0.108532610957312,0.994311300692045,1,16,cardioblast differentiation,BP,GREM1
4945,GO:0010769,0.108572720388433,0.964593752262687,4,260,regulation of cell morphogenesis involved in differentiation,BP,NGFR;MAG;KNDC1;CNTN2
19709,GO:1903392,0.108848434728717,0.994277446066281,1,16,negative regulation of adherens junction organization,BP,APOD
10232,GO:0036315,0.10909430031146,0.994275649400308,1,15,cellular response to sterol,BP,MLC1
15360,GO:0061564,0.109302669118675,0.954597993982491,6,471,axon development,BP,ARX;NGFR;MAG;PLP1;CNTN2;APOD
6682,GO:0019867,0.109328653238853,0.971341249253337,3,183,outer membrane,CC,SOX10;GJA1;BOK
10319,GO:0036499,0.109653561881734,0.99411606095266,1,20,PERK-mediated unfolded protein response,BP,BOK
7966,GO:0031625,0.109720152938792,0.964061236678894,4,292,ubiquitin protein ligase binding,MF,NGFR;ERBB3;EGFR;BOK
11655,GO:0044432,0.109836423641937,0.941491255425397,11,1174,endoplasmic reticulum part,CC,TF;COL9A3;FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;RASGRP1;BOK;COL28A1
4191,GO:0008585,0.109878177967609,0.980941825429049,2,86,female gonad development,BP,COL9A3;PDGFRA
17656,GO:0097190,0.109985965948486,0.954207431942033,6,552,apoptotic signaling pathway,BP,NGFR;EYA2;ERBB3;ST18;MAL;BOK
16356,GO:0071467,0.110077097836043,0.994085381482754,1,19,cellular response to pH,BP,GJA1
11355,GO:0043574,0.110137778249208,0.994096324338076,1,18,peroxisomal transport,BP,PEX5L
8838,GO:0033081,0.110207029169284,0.994055255522401,1,20,regulation of T cell differentiation in thymus,BP,RASGRP1
21656,GO:2000778,0.110253459169435,0.994066012647459,1,19,positive regulation of interleukin-6 secretion,BP,MBP
15103,GO:0060977,0.110433494000516,0.994131194410005,1,15,coronary vasculature morphogenesis,BP,LRP2
3884,GO:0008081,0.110483266252183,0.980786546337972,2,83,phosphoric diester hydrolase activity,MF,PLCL1;ENPP2
16379,GO:0071496,0.110696988391497,0.963629302996687,4,292,cellular response to external stimulus,BP,MAG;EGFR;GJA1;PIEZO2
12502,GO:0046486,0.110936465755157,0.958046398093243,5,397,glycerolipid metabolic process,BP,ERBB3;PDGFRA;ENPP2;EGFR;GPD1
12203,GO:0045821,0.111150182013991,0.994027545841332,1,16,positive regulation of glycolytic process,BP,GPD1
13765,GO:0051197,0.111150182013991,0.994027545841332,1,16,positive regulation of coenzyme metabolic process,BP,GPD1
18632,GO:1900120,0.111291693592423,0.993935145835228,1,20,regulation of receptor binding,BP,PLCL1
7200,GO:0030165,0.111334497903502,0.980555958515842,2,82,PDZ domain binding,MF,GJA1;FZD7
14125,GO:0051882,0.111475612210055,0.993914655471045,1,20,mitochondrial depolarization,BP,BOK
2407,GO:0005057,0.111518633264119,0.970550297972701,3,163,signal transducer activity, downstream of receptor,MF,ERBB3;PDGFRA;EGFR
14862,GO:0060544,0.111566595750884,0.993904505673165,1,20,regulation of necroptotic process,BP,BOK
13065,GO:0048471,0.112232885140242,0.949478317446759,7,630,perinuclear region of cytoplasm,CC,TF;MLC1;LDB3;EGFR;MOBP;AATK;APOD
3953,GO:0008198,0.112315960916594,0.993805672512963,1,21,ferrous iron binding,MF,TF
15251,GO:0061298,0.112391252886037,0.993890489577183,1,16,retina vasculature development in camera-type eye,BP,PDGFRA
17020,GO:0072673,0.112404457643782,0.993865955414401,1,17,lamellipodium morphogenesis,BP,ENPP2
2563,GO:0005355,0.112466101903584,0.993820202040365,1,19,glucose transmembrane transporter activity,MF,SLC5A11
12495,GO:0046475,0.112574180649685,0.993808061816668,1,19,glycerophospholipid catabolic process,BP,ENPP2
2486,GO:0005200,0.112650813260331,0.980156515351857,2,92,structural constituent of cytoskeleton,MF,TUBB4A;PPL
12707,GO:0046916,0.11272962156896,0.980111691066763,2,100,cellular transition metal ion homeostasis,BP,TF;SLC31A2
16095,GO:0070977,0.112783714946528,0.993873138697232,1,15,bone maturation,BP,GREM1
9839,GO:0035588,0.112850442650956,0.993731626809113,1,22,G-protein coupled purinergic receptor signaling pathway,BP,CNTN2
15604,GO:0070102,0.112976645225392,0.993801975991101,1,17,interleukin-6-mediated signaling pathway,BP,ST18
760,GO:0001944,0.113124894397091,0.948985026255006,7,610,vasculature development,BP,NGFR;LRP2;PDGFRA;ENPP2;GJA1;GREM1;APOD
3056,GO:0006282,0.113296309897052,0.97998620509703,2,89,regulation of DNA repair,BP,EYA2;EGFR
6771,GO:0021533,0.113391422631445,0.993755380762015,1,17,cell differentiation in hindbrain,BP,KNDC1
13149,GO:0048640,0.113495350561807,0.979944661159595,2,85,negative regulation of developmental growth,BP,MAG;GJA1
3442,GO:0006825,0.1138174111582,0.993650601600394,1,20,copper ion transport,BP,SLC31A2
16697,GO:0072077,0.114058526418462,0.993658950523568,1,18,renal vesicle morphogenesis,BP,GREM1
3553,GO:0007006,0.114801850890077,0.979522762127399,2,103,mitochondrial membrane organization,BP,EYA2;BOK
4567,GO:0009651,0.11484421286884,0.993532975529309,1,20,response to salt stress,BP,CAPN3
3880,GO:0008076,0.115102049590106,0.979486478415881,2,87,voltage-gated potassium channel complex,CC,KCNJ6;CNTN2
20647,GO:1905331,0.115581063165042,0.993484703696154,1,18,negative regulation of morphogenesis of an epithelium,BP,GREM1
9299,GO:0034333,0.115772244524303,0.979320557205565,2,81,adherens junction assembly,BP,GREM1;APOD
14155,GO:0051928,0.11580560635348,0.979261245211633,2,95,positive regulation of calcium ion transport,BP,CAPN3;GJC2
7187,GO:0030148,0.11582534427412,0.979265057841622,2,92,sphingolipid biosynthetic process,BP,FA2H;UGT8
6111,GO:0016881,0.116009930317132,0.993415643766091,1,19,acid-amino acid ligase activity,MF,CARNS1
1229,GO:0002717,0.116068729410308,0.993375310913585,1,21,positive regulation of natural killer cell mediated immunity,BP,RASGRP1
7252,GO:0030228,0.116090375971695,0.993472337766042,1,16,lipoprotein particle receptor activity,MF,LRP2
16929,GO:0072507,0.116123112068712,0.955468685040715,5,413,divalent inorganic cation homeostasis,BP,CAPN3;PDGFRA;EGFR;GJA1;BOK
12619,GO:0046697,0.116144911580361,0.993399969494108,1,19,decidualization,BP,GJA1
11181,GO:0043281,0.116358774149183,0.968647402623019,3,204,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NGFR;ST18;BOK
3511,GO:0006935,0.116389347808205,0.950810975875251,6,530,chemotaxis,BP,ARX;NGFR;PDGFRA;ENPP2;GREM1;CNTN2
17305,GO:0090189,0.116489419665704,0.993342155282169,1,20,regulation of branching involved in ureteric bud morphogenesis,BP,GREM1
778,GO:0001965,0.116732462694584,0.993297622994695,1,21,G-protein alpha-subunit binding,MF,RGS4
1871,GO:0004198,0.116787432210605,0.993307279881489,1,20,calcium-dependent cysteine-type endopeptidase activity,MF,CAPN3
10683,GO:0042330,0.116813247560098,0.950583240100517,6,531,taxis,BP,ARX;NGFR;PDGFRA;ENPP2;GREM1;CNTN2
12538,GO:0046545,0.1169459436637,0.978953457974486,2,90,development of primary female sexual characteristics,BP,COL9A3;PDGFRA
13746,GO:0051173,0.117055001208246,0.925151313581837,22,2668,positive regulation of nitrogen compound metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;MYRF;PDGFRA;ENPP2;EGFR;ST18;GJA1;FZD7;GREM1;GPD1;KNDC1;RASGRP1;DMRT2;BOK;CNTN2;MBP
1610,GO:0003705,0.117371019406955,0.978825501273449,2,92,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,ARX;SOX10
19530,GO:1903010,0.117417432461432,0.993251244279832,1,19,regulation of bone development,BP,GREM1
150,GO:0000302,0.117461136623838,0.968219692795781,3,206,response to reactive oxygen species,BP,PDGFRA;EGFR;APOD
8675,GO:0032814,0.117552940443604,0.993186096856346,1,22,regulation of natural killer cell activation,BP,RASGRP1
21734,GO:2001014,0.117640538144794,0.993245076506021,1,18,regulation of skeletal muscle cell differentiation,BP,CAPN3
21864,GO:2001267,0.11769621683766,0.993155524217346,1,23,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,ST18
7469,GO:0030673,0.117724075989025,0.993283053381335,1,16,axolemma,CC,MYO1D
5342,GO:0015149,0.117758322432298,0.99319299910412,1,20,hexose transmembrane transporter activity,MF,SLC5A11
2768,GO:0005789,0.117814997046814,0.940618118372266,9,932,endoplasmic reticulum membrane,CC,TF;FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;RASGRP1;BOK
18519,GO:0140058,0.117866616549093,0.993266404033852,1,16,neuron projection arborization,BP,LRP2
16703,GO:0072087,0.11801887828752,0.993180347430046,1,19,renal vesicle development,BP,GREM1
10841,GO:0042629,0.118248884015977,0.993118353442858,1,21,mast cell granule,CC,RASGRP1
7515,GO:0030813,0.118264730541743,0.9931942497929,1,17,positive regulation of nucleotide catabolic process,BP,GPD1
5409,GO:0015294,0.118272900138691,0.978588814338606,2,86,solute:cation symporter activity,MF,SLC45A3;SLC5A11
11361,GO:0043586,0.118348008523867,0.993141386367854,1,19,tongue development,BP,EGFR
18629,GO:1900117,0.118740853919215,0.993059661636941,1,21,regulation of execution phase of apoptosis,BP,BOK
19674,GO:1903319,0.118766854393362,0.99307321590422,1,20,positive regulation of protein maturation,BP,CNTN2
4947,GO:0010771,0.118780183401176,0.978443220915288,2,86,negative regulation of cell morphogenesis involved in differentiation,BP,NGFR;MAG
3750,GO:0007398,0.118788230686517,0.993109573571208,1,18,ectoderm development,BP,FZD7
3700,GO:0007263,0.118803794855494,0.993052133998953,1,21,nitric oxide mediated signal transduction,BP,EGFR
16882,GO:0072358,0.118983897435961,0.945675711637277,7,618,cardiovascular system development,BP,NGFR;LRP2;PDGFRA;ENPP2;GJA1;GREM1;APOD
16572,GO:0071840,0.119141387006894,0.917163211851821,43,5788,cellular component organization or biogenesis,BP,ARX;ANLN;NGFR;EYA2;CDH19;LRP2;TF;CAPN3;COL9A3;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;ATP10B;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;ERMN;ENPP2;EGFR;GJA1;FZD7;TMSB15A;ADAMTS4;GREM1;KLK6;SH3TC2;GJB1;KNDC1;MAL;RASGRP1;UGT8;BOK;CNTN2;GLDN;APOD;MBP
6719,GO:0019955,0.119332640191403,0.978249520276746,2,96,cytokine binding,MF,CRLF1;GREM1
12139,GO:0045686,0.119589840751454,0.992957764531433,1,21,negative regulation of glial cell differentiation,BP,NKX6-2
14476,GO:0060004,0.119597527167121,0.993013176746988,1,18,reflex,BP,GJA1
8925,GO:0033233,0.119741504811718,0.992939479697107,1,21,regulation of protein sumoylation,BP,CAPN3
7176,GO:0030132,0.119946892881885,0.992950464228232,1,19,clathrin coat of coated pit,CC,EGFR
18073,GO:0098827,0.120182700417371,0.939169767444832,9,936,endoplasmic reticulum subcompartment,CC,TF;FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;RASGRP1;BOK
15243,GO:0061213,0.120206027066257,0.992900391828126,1,20,positive regulation of mesonephros development,BP,GREM1
22,GO:0000041,0.120582005569724,0.977875618497036,2,100,transition metal ion transport,BP,TF;SLC31A2
14684,GO:0060307,0.120775827773822,0.992871573372722,1,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,GJA1
8480,GO:0032526,0.120839726737138,0.97780967711192,2,97,response to retinoic acid,BP,GJA1;FZD7
5059,GO:0010923,0.120890626079217,0.977821924849456,2,89,negative regulation of phosphatase activity,BP,PPP1R14A;MYO1D
18671,GO:1900180,0.121108126988108,0.97774451376108,2,93,regulation of protein localization to nucleus,BP,NGFR;APOD
6712,GO:0019932,0.12119925886487,0.958887765774492,4,300,second-messenger-mediated signaling,BP,ERBB3;PEX5L;EGFR;GPR62
7285,GO:0030282,0.121308079828132,0.977686262091025,2,93,bone mineralization,BP,GJA1;GREM1
13147,GO:0048638,0.122387402475298,0.958359311718901,4,280,regulation of developmental growth,BP,ARX;CAPN3;MAG;GJA1
3378,GO:0006720,0.122465746943775,0.97731677916036,2,103,isoprenoid metabolic process,BP,LRP2;EGFR
3501,GO:0006915,0.12262260742741,0.927287418875905,15,1756,apoptotic process,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;SOX10;MAG;PDGFRA;EGFR;ST18;GJA1;SLC5A11;GREM1;MAL;BOK
11630,GO:0044389,0.12338327558107,0.957878329637926,4,305,ubiquitin-like protein ligase binding,MF,NGFR;ERBB3;EGFR;BOK
21563,GO:2000637,0.123486039211015,0.992498168762479,1,20,positive regulation of gene silencing by miRNA,BP,EGFR
3321,GO:0006644,0.123945915311953,0.951519450203686,5,414,phospholipid metabolic process,BP,ERBB3;PDGFRA;ENPP2;EGFR;GPD1
6181,GO:0017049,0.123959047993593,0.99243920586043,1,20,GTP-Rho binding,MF,ANLN
15069,GO:0060914,0.124097901548104,0.99238712026556,1,22,heart formation,BP,LRP2
13443,GO:0050715,0.124426117562699,0.976747268677345,2,100,positive regulation of cytokine secretion,BP,RASGRP1;MBP
2505,GO:0005242,0.124600883055018,0.992358810875342,1,20,inward rectifier potassium channel activity,MF,KCNJ6
559,GO:0001657,0.12463727806595,0.976711206023006,2,92,ureteric bud development,BP,CRLF1;GREM1
2394,GO:0005031,0.12474564069156,0.992276287989963,1,24,tumor necrosis factor-activated receptor activity,MF,NGFR
2396,GO:0005035,0.12474564069156,0.992276287989963,1,24,death receptor activity,MF,NGFR
6864,GO:0021697,0.125022339753277,0.992326192332717,1,19,cerebellar cortex formation,BP,KNDC1
5341,GO:0015145,0.125101086356007,0.992277357519588,1,21,monosaccharide transmembrane transporter activity,MF,SLC5A11
7496,GO:0030742,0.125290778566844,0.992221108611761,1,23,GTP-dependent protein binding,MF,RAPGEF5
11254,GO:0043408,0.125314685685463,0.942039991336597,7,654,regulation of MAPK cascade,BP,NGFR;ERBB3;RGS4;PDGFRA;EGFR;FZD7;RASGRP1
5410,GO:0015295,0.12550594959926,0.992226076471428,1,21,solute:proton symporter activity,MF,SLC45A3
6308,GO:0018193,0.125530729664934,0.931441112950997,11,1147,peptidyl-amino acid modification,BP,CRLF1;ERBB3;FOLH1;CAPN3;PLCL1;PDGFRA;ENPP2;EGFR;PHKG1;GREM1;SPOCK3
21676,GO:2000810,0.125577038124673,0.99223568458938,1,20,regulation of bicellular tight junction assembly,BP,GJA1
6321,GO:0018209,0.125648068927648,0.956844972794336,4,286,peptidyl-serine modification,BP,PLCL1;EGFR;PHKG1;SPOCK3
9538,GO:0034765,0.125951749275516,0.950498844717331,5,404,regulation of ion transmembrane transport,BP,CAPN3;SLC31A2;GJA1;KCNJ6;GJC2
3694,GO:0007254,0.12623821597791,0.964794015919517,3,187,JNK cascade,BP,EGFR;FZD7;RASGRP1
21316,GO:2000278,0.126300278525718,0.97620216801511,2,96,regulation of DNA biosynthetic process,BP,GJA1;GREM1
9190,GO:0034105,0.126487408188707,0.992083843115384,1,22,positive regulation of tissue remodeling,BP,EGFR
2171,GO:0004713,0.1269448717867,0.96454074240009,3,170,protein tyrosine kinase activity,MF,ERBB3;PDGFRA;EGFR
3666,GO:0007202,0.12701308720742,0.992016289479887,1,22,activation of phospholipase C activity,BP,EGFR
3356,GO:0006688,0.127372499012483,0.991969929005511,1,22,glycosphingolipid biosynthetic process,BP,UGT8
7851,GO:0031401,0.127593821256749,0.932190084897222,10,1039,positive regulation of protein modification process,BP,CRLF1;NGFR;ERBB3;PDGFRA;ENPP2;EGFR;FZD7;GREM1;KNDC1;RASGRP1
13762,GO:0051194,0.127681306730152,0.991988043661747,1,19,positive regulation of cofactor metabolic process,BP,GPD1
4845,GO:0010628,0.127710253483463,0.923780510306999,15,1691,positive regulation of gene expression,BP,ARX;NGFR;ERBB3;CAPN3;SOX10;PLP1;MYRF;EGFR;ST18;GJA1;FZD7;GREM1;DMRT2;CNTN2;GJC2
18672,GO:1900181,0.127767361148146,0.991936363179407,1,21,negative regulation of protein localization to nucleus,BP,APOD
551,GO:0001649,0.127974120846732,0.964091668150707,3,191,osteoblast differentiation,BP,GJA1;GREM1;SMOC1
2288,GO:0004871,0.128105598755797,0.929757971512115,11,1194,signal transducer activity,MF,NGFR;ERBB3;CAPN3;PLCL1;PDGFRA;EGFR;GJA1;FZD7;GREM1;S1PR5;GPR62
16659,GO:0072012,0.128297383166537,0.991867656026772,1,21,glomerulus vasculature development,BP,PDGFRA
2675,GO:0005640,0.128402560349488,0.99187346465561,1,20,nuclear outer membrane,CC,BOK
16751,GO:0072163,0.128479584543685,0.975557772856743,2,93,mesonephric epithelium development,BP,CRLF1;GREM1
16752,GO:0072164,0.128479584543685,0.975557772856743,2,93,mesonephric tubule development,BP,CRLF1;GREM1
15147,GO:0061037,0.128583798072747,0.991812645733475,1,22,negative regulation of cartilage development,BP,GREM1
13636,GO:0051015,0.128693206091689,0.963844284109879,3,167,actin filament binding,MF,ERMN;EGFR;MYO1D
14139,GO:0051899,0.12890171182045,0.975445642662909,2,89,membrane depolarization,BP,GJA1;BOK
2144,GO:0004674,0.129606623772793,0.943632774755239,6,475,protein serine/threonine kinase activity,MF,ERBB3;CDK18;PDGFRA;EGFR;PHKG1;AATK
10613,GO:0042175,0.129633989459904,0.933320753192273,9,949,nuclear outer membrane-endoplasmic reticulum membrane network,CC,TF;FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;RASGRP1;BOK
20324,GO:1904659,0.129986190472165,0.97509724550257,2,94,glucose transmembrane transport,BP,NGFR;SLC5A11
14578,GO:0060148,0.130339102080861,0.99160012350511,1,21,positive regulation of posttranscriptional gene silencing,BP,EGFR
7107,GO:0030003,0.130603645282257,0.943044156784697,6,554,cellular cation homeostasis,BP,TF;CAPN3;PDGFRA;SLC31A2;GJA1;BOK
5239,GO:0014850,0.131259008157181,0.991478097885154,1,21,response to muscle activity,BP,CAPN3
839,GO:0002052,0.131556254701069,0.991458918849387,1,20,positive regulation of neuroblast proliferation,BP,SOX10
1634,GO:0003785,0.131629502082345,0.991363213289715,1,25,actin monomer binding,MF,TMSB15A
9504,GO:0034705,0.131687973404209,0.974577181283542,2,94,potassium channel complex,CC,KCNJ6;CNTN2
7865,GO:0031420,0.131740847116948,0.99145698857262,1,19,alkali metal ion binding,MF,CAPN3
21870,GO:2001273,0.132155724798679,0.991378892957768,1,20,regulation of glucose import in response to insulin stimulus,BP,NGFR
15245,GO:0061217,0.132710416034779,0.991247507331159,1,23,regulation of mesonephros development,BP,GREM1
10665,GO:0042303,0.132780244553491,0.974226586294642,2,98,molting cycle,BP,FA2H;EGFR
10844,GO:0042633,0.132780244553491,0.974226586294642,2,98,hair cycle,BP,FA2H;EGFR
672,GO:0001823,0.132821580717385,0.974220961028387,2,96,mesonephros development,BP,CRLF1;GREM1
10792,GO:0042554,0.13319733581977,0.991150900546453,1,25,superoxide anion generation,BP,EGFR
19091,GO:1901889,0.133276922218974,0.991228165258655,1,20,negative regulation of cell junction assembly,BP,APOD
5070,GO:0010939,0.133386908745438,0.991098910434685,1,27,regulation of necrotic cell death,BP,BOK
6754,GO:0021513,0.133459910921347,0.991145801130246,1,23,spinal cord dorsal/ventral patterning,BP,NKX6-2
13494,GO:0050790,0.133460565984135,0.917439017623809,17,2016,regulation of catalytic activity,BP,NGFR;ERBB3;CAPN3;BVES;RGS4;PDGFRA;PCSK6;EGFR;ST18;GREM1;PPP1R14A;RASGRP1;MYO1D;BOK;SPOCK3;MBP;COL28A1
3581,GO:0007044,0.133659528357354,0.973998392904873,2,87,cell-substrate junction assembly,BP,GREM1;APOD
833,GO:0002040,0.133799688580146,0.973925951919606,2,94,sprouting angiogenesis,BP,NGFR;GREM1
8700,GO:0032872,0.13386473086284,0.961692707463076,3,193,regulation of stress-activated MAPK cascade,BP,EGFR;FZD7;RASGRP1
14153,GO:0051924,0.133927819524027,0.961654572049066,3,201,regulation of calcium ion transport,BP,CAPN3;GJA1;GJC2
3523,GO:0006954,0.134038074731719,0.941115462398028,6,591,inflammatory response,BP,NGFR;PLP1;EGFR;GJA1;RASGRP1;APOD
6700,GO:0019901,0.134147540656222,0.936906902685406,7,625,protein kinase binding,MF,ERBB3;DCX;MAG;LDB3;PDGFRA;EGFR;GJA1
17127,GO:0086014,0.134488180365265,0.991113669224319,1,18,atrial cardiac muscle cell action potential,BP,GJA1
17137,GO:0086026,0.134488180365265,0.991113669224319,1,18,atrial cardiac muscle cell to AV node cell signaling,BP,GJA1
17166,GO:0086066,0.134488180365265,0.991113669224319,1,18,atrial cardiac muscle cell to AV node cell communication,BP,GJA1
11007,GO:0043009,0.134698514878281,0.94077036936851,6,528,chordate embryonic development,BP,LRP2;SOX10;PDGFRA;EGFR;GJA1;DMRT2
3639,GO:0007169,0.135163151094486,0.936301259126027,7,648,transmembrane receptor protein tyrosine kinase signaling pathway,BP,NGFR;ERBB3;PDGFRA;EGFR;GREM1;SH3TC2;APOD
622,GO:0001763,0.135168090315572,0.961165654446383,3,187,morphogenesis of a branching structure,BP,SOX10;ERMN;GREM1
9689,GO:0035305,0.135257752532595,0.973468644481894,2,95,negative regulation of dephosphorylation,BP,PPP1R14A;MYO1D
7082,GO:0022890,0.135401041616524,0.940378514374805,6,523,inorganic cation transmembrane transporter activity,MF,TF;SLC31A2;PIEZO2;KCNJ6;SLC45A3;SLC5A11
741,GO:0001919,0.135466003020904,0.990888520966954,1,22,regulation of receptor recycling,BP,BVES
15726,GO:0070302,0.13548765618653,0.961022047642617,3,194,regulation of stress-activated protein kinase signaling cascade,BP,EGFR;FZD7;RASGRP1
2807,GO:0005858,0.135819649429837,0.990962054657584,1,17,axonemal dynein complex,CC,DNAH17
4219,GO:0008637,0.136090851056404,0.973147165454389,2,114,apoptotic mitochondrial changes,BP,EYA2;BOK
9697,GO:0035326,0.136399583012904,0.973092969998126,2,100,enhancer binding,MF,ARX;SOX10
13501,GO:0050801,0.136707003317976,0.935378965279589,7,683,ion homeostasis,BP,TF;CAPN3;PDGFRA;SLC31A2;EGFR;GJA1;BOK
99,GO:0000188,0.137086276223343,0.990628075626009,1,24,inactivation of MAPK activity,BP,RGS4
17406,GO:0090322,0.137986565199595,0.990457558301231,1,27,regulation of superoxide metabolic process,BP,EGFR
13614,GO:0050974,0.138035258154111,0.990511497714823,1,23,detection of mechanical stimulus involved in sensory perception,BP,PIEZO2
776,GO:0001963,0.138372753473408,0.990416160986611,1,26,synaptic transmission, dopaminergic,BP,CNTNAP4
11627,GO:0044381,0.138451253979692,0.990492056799717,1,21,glucose import in response to insulin stimulus,BP,NGFR
13242,GO:0048799,0.138900332513362,0.990476601191369,1,19,animal organ maturation,BP,GREM1
15958,GO:0070723,0.138953071535681,0.990443948705575,1,20,response to cholesterol,BP,MLC1
874,GO:0002092,0.139206502605426,0.990364399694396,1,22,positive regulation of receptor internalization,BP,GREM1
14715,GO:0060343,0.1395915521673,0.990290465622139,1,23,trabecula formation,BP,GREM1
8304,GO:0032288,0.140053315073981,0.990287839679977,1,20,myelin assembly,BP,UGT8
3468,GO:0006873,0.140118234647186,0.937697565909704,6,565,cellular ion homeostasis,BP,TF;CAPN3;PDGFRA;SLC31A2;GJA1;BOK
15312,GO:0061437,0.1402622988309,0.990194375009066,1,23,renal system vasculature development,BP,PDGFRA
15315,GO:0061440,0.1402622988309,0.990194375009066,1,23,kidney vasculature development,BP,PDGFRA
19415,GO:1902745,0.14035027269672,0.990201046156144,1,22,positive regulation of lamellipodium organization,BP,ENPP2
21415,GO:2000404,0.140740479448957,0.990049316137044,1,28,regulation of T cell migration,BP,APOD
3760,GO:0007413,0.141829949519642,0.99003294013849,1,20,axonal fasciculation,BP,CNTN2
18418,GO:0106030,0.141829949519642,0.99003294013849,1,20,neuron projection fasciculation,BP,CNTN2
16787,GO:0072202,0.141887599361624,0.98995946387214,1,23,cell differentiation involved in metanephros development,BP,GREM1
12691,GO:0046887,0.142408918093788,0.971140352343401,2,112,positive regulation of hormone secretion,BP,EGFR;GJA1
9095,GO:0033688,0.142453784475309,0.98987694118245,1,23,regulation of osteoblast proliferation,BP,GREM1
11972,GO:0045296,0.142986066194455,0.948544260892087,4,309,cadherin binding,MF,ANLN;CDH19;PPL;EGFR
8471,GO:0032506,0.143362838848389,0.989743698165093,1,23,cytokinetic process,BP,ANLN
18614,GO:1900101,0.143412014660624,0.989700986742359,1,25,regulation of endoplasmic reticulum unfolded protein response,BP,BOK
12630,GO:0046718,0.143432014851129,0.970831424353415,2,105,viral entry into host cell,BP,MOG;EGFR
3675,GO:0007214,0.143452849814607,0.989730454886182,1,23,gamma-aminobutyric acid signaling pathway,BP,PLCL1
18304,GO:0099625,0.143481534967151,0.989746415421583,1,22,ventricular cardiac muscle cell membrane repolarization,BP,GJA1
7559,GO:0030867,0.14392404058158,0.989581242274017,1,28,rough endoplasmic reticulum membrane,CC,TF
5395,GO:0015267,0.144034091473573,0.940993247004025,5,413,channel activity,MF,GJA1;PIEZO2;KCNJ6;GJB1;GJC2
7057,GO:0022803,0.144034091473573,0.940993247004025,5,413,passive transmembrane transporter activity,MF,GJA1;PIEZO2;KCNJ6;GJB1;GJC2
2660,GO:0005604,0.144132068785811,0.970673720872498,2,88,basement membrane,CC,SMOC1;COL28A1
14876,GO:0060571,0.144369022471355,0.989543294604882,1,26,morphogenesis of an epithelial fold,BP,EGFR
17243,GO:0090092,0.14438837397368,0.957269841320653,3,203,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;PCSK6;GREM1
10935,GO:0042813,0.144415045950156,0.989608769472703,1,22,Wnt-activated receptor activity,MF,FZD7
19465,GO:1902895,0.144523320316019,0.989572264535472,1,23,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,NGFR
18302,GO:0099623,0.144642841567124,0.989575033800225,1,22,regulation of cardiac muscle cell membrane repolarization,BP,GJA1
16226,GO:0071276,0.144798353050777,0.989404324976709,1,32,cellular response to cadmium ion,BP,EGFR
1863,GO:0004175,0.144854449420259,0.947604170907785,4,335,endopeptidase activity,MF,CAPN3;PCSK6;ADAMTS4;KLK6
8093,GO:0031904,0.144956350899675,0.989440798576872,1,27,endosome lumen,CC,LRP2
12127,GO:0045665,0.145547204839987,0.956786329004051,3,196,negative regulation of neuron differentiation,BP,NGFR;MAG;CNTN2
8864,GO:0033135,0.145559307172907,0.970134843234335,2,106,regulation of peptidyl-serine phosphorylation,BP,PLCL1;EGFR
17164,GO:0086064,0.145642512151695,0.989426302646962,1,22,cell communication by electrical coupling involved in cardiac conduction,BP,GJA1
5072,GO:0010941,0.145917761563263,0.914073229431778,13,1524,regulation of cell death,BP,CRLF1;NGFR;EYA2;ERBB3;CAPN3;SOX10;MAG;PDGFRA;EGFR;ST18;GREM1;MAL;BOK
12895,GO:0048011,0.145984429211867,0.989335134611308,1,24,neurotrophin TRK receptor signaling pathway,BP,NGFR
16014,GO:0070851,0.146144809336034,0.96993616620821,2,108,growth factor receptor binding,MF,PDGFRA;GREM1
5803,GO:0016298,0.146203545917163,0.969923628222995,2,106,lipase activity,MF,PLCL1;ENPP2
19854,GO:1903671,0.146585940038379,0.98926385097552,1,23,negative regulation of sprouting angiogenesis,BP,NGFR
7263,GO:0030246,0.146734832685797,0.956235981094819,3,223,carbohydrate binding,MF,MAG;ENPP2;CNTN2
6502,GO:0019318,0.147070919654162,0.956109889160594,3,210,hexose metabolic process,BP,SLC45A3;GPD1;APOD
20587,GO:1905209,0.147072844319612,0.989170917574566,1,24,positive regulation of cardiocyte differentiation,BP,GREM1
21234,GO:2000116,0.147262804529922,0.956003474656739,3,227,regulation of cysteine-type endopeptidase activity,BP,NGFR;ST18;BOK
766,GO:0001952,0.147956257841363,0.969376281663961,2,98,regulation of cell-matrix adhesion,BP,GREM1;APOD
3635,GO:0007165,0.148119363606706,0.895604093937478,37,5032,signal transduction,BP,CRLF1;NGFR;EYA2;ERBB3;DCX;LRP2;CAPN3;SOX10;PEX5L;PLCL1;RGS4;PLP1;PDGFRA;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;ST18;GJA1;FZD7;PHKG1;GREM1;KLK6;SH3TC2;KNDC1;MAL;RASGRP1;SUSD5;BOK;S1PR5;GPR62;CNTN2;APOD;SPOCK3;MBP;SMOC1
4756,GO:0010458,0.148236966428593,0.988943368766695,1,27,exit from mitosis,BP,ANLN
12504,GO:0046488,0.148438903594584,0.955534281351971,3,201,phosphatidylinositol metabolic process,BP,ERBB3;PDGFRA;EGFR
70,GO:0000146,0.148511437743121,0.989071834196035,1,19,microfilament motor activity,MF,MYO1D
12932,GO:0048103,0.148697222371321,0.988964909380206,1,22,somatic stem cell division,BP,FZD7
6752,GO:0021511,0.148826039706302,0.988885301189106,1,25,spinal cord patterning,BP,NKX6-2
4631,GO:0009897,0.149244295839558,0.95516375816892,3,215,external side of plasma membrane,CC,LRP2;TF;MOG
17248,GO:0090101,0.149248534109864,0.968928228187991,2,103,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;GREM1
7313,GO:0030318,0.149277718047494,0.988876049314862,1,22,melanocyte differentiation,BP,SOX10
2881,GO:0005980,0.149753939576554,0.988780882600377,1,23,glycogen catabolic process,BP,PHKG1
7785,GO:0031293,0.14991422672959,0.988735953881768,1,24,membrane protein intracellular domain proteolysis,BP,NGFR
3624,GO:0007154,0.150340752994397,0.893261406241818,40,5474,cell communication,BP,CRLF1;NGFR;EYA2;ERBB3;DCX;LRP2;CAPN3;SOX10;PEX5L;PLCL1;RGS4;PLP1;PDGFRA;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;ST18;GJA1;CNTNAP4;FZD7;PHKG1;GREM1;KLK6;SH3TC2;GJB1;KNDC1;MAL;RASGRP1;SUSD5;BOK;S1PR5;GPR62;CNTN2;APOD;SPOCK3;MBP;SMOC1;GJC2
11293,GO:0043491,0.150616057652098,0.954580180932027,3,207,protein kinase B signaling,BP,ERBB3;PDGFRA;EGFR
2285,GO:0004866,0.150654672899112,0.968398182067532,2,122,endopeptidase inhibitor activity,MF,SPOCK3;COL28A1
10845,GO:0042634,0.150690771202415,0.988596732700486,1,25,regulation of hair cycle,BP,FA2H
8482,GO:0032528,0.150754784907551,0.988625960750713,1,23,microvillus organization,BP,GLDN
4600,GO:0009792,0.151054002265938,0.931423993179227,6,546,embryo development ending in birth or egg hatching,BP,LRP2;SOX10;PDGFRA;EGFR;GJA1;DMRT2
753,GO:0001936,0.151392829892117,0.968200669597969,2,106,regulation of endothelial cell proliferation,BP,NGFR;GJA1
1751,GO:0004012,0.151433770897128,0.988594430488765,1,20,phospholipid-translocating ATPase activity,MF,ATP10B
12302,GO:0045992,0.151476630045982,0.988473946416402,1,25,negative regulation of embryonic development,BP,FZD7
9656,GO:0035250,0.151478611635566,0.988439930644134,1,27,UDP-galactosyltransferase activity,MF,UGT8
9838,GO:0035587,0.152655292171898,0.988211475937659,1,30,purinergic receptor signaling pathway,BP,CNTN2
10505,GO:0040012,0.152763338143536,0.921852881730078,8,805,regulation of locomotion,BP,ERBB3;BVES;PDGFRA;ENPP2;EGFR;GREM1;APOD;SPOCK3
82,GO:0000165,0.152955176357884,0.9217256211969,8,827,MAPK cascade,BP,NGFR;ERBB3;RGS4;PDGFRA;EGFR;FZD7;RASGRP1;MBP
21798,GO:2001171,0.153007754935811,0.988252062081873,1,24,positive regulation of ATP biosynthetic process,BP,GPD1
12263,GO:0045926,0.15320846961244,0.953428386605119,3,219,negative regulation of growth,BP,MAG;GJA1;GREM1
3404,GO:0006760,0.15351411856207,0.988102283514295,1,28,folic acid-containing compound metabolic process,BP,FOLH1
6315,GO:0018200,0.154149163494392,0.988000673702373,1,28,peptidyl-glutamic acid modification,BP,FOLH1
5886,GO:0016486,0.154252984662911,0.987999617654598,1,27,peptide hormone processing,BP,PCSK6
19779,GO:1903532,0.154704496874504,0.942697275436539,4,324,positive regulation of secretion by cell,BP,EGFR;GJA1;RASGRP1;MBP
8892,GO:0033173,0.154941368768681,0.9879441183059,1,24,calcineurin-NFAT signaling cascade,BP,ERBB3
12211,GO:0045834,0.155213105785672,0.966889823263088,2,111,positive regulation of lipid metabolic process,BP,PDGFRA;SLC45A3
16279,GO:0071356,0.155441438728683,0.952403917711754,3,250,cellular response to tumor necrosis factor,BP,NGFR;ST18;GPD1
19222,GO:1902235,0.15585934846357,0.987709930784073,1,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,BOK
21838,GO:2001233,0.156157048834509,0.94193469230217,4,355,regulation of apoptotic signaling pathway,BP,EYA2;ST18;MAL;BOK
9094,GO:0033687,0.156179112894075,0.987706011754757,1,26,osteoblast proliferation,BP,GREM1
3053,GO:0006275,0.156257851426711,0.966543121247057,2,108,regulation of DNA replication,BP,PDGFRA;EGFR
7142,GO:0030057,0.156453125847149,0.987746402558856,1,22,desmosome,CC,PPL
2300,GO:0004888,0.156453649640818,0.92345666888099,7,729,transmembrane signaling receptor activity,MF,NGFR;ERBB3;PDGFRA;EGFR;FZD7;S1PR5;GPR62
6300,GO:0018149,0.15655957462757,0.987610822074671,1,28,peptide cross-linking,BP,SPOCK3
16830,GO:0072273,0.156653570420381,0.987647621079125,1,25,metanephric nephron morphogenesis,BP,GREM1
4458,GO:0009251,0.156706871200376,0.987659251067319,1,24,glucan catabolic process,BP,PHKG1
12570,GO:0046621,0.156726001734582,0.987656144964155,1,24,negative regulation of organ growth,BP,GJA1
3637,GO:0007167,0.157185165770195,0.915692824163995,9,929,enzyme linked receptor protein signaling pathway,BP,NGFR;ERBB3;LRP2;PDGFRA;PCSK6;EGFR;GREM1;SH3TC2;APOD
3436,GO:0006814,0.157224078426641,0.951681835642325,3,202,sodium ion transport,BP,NKAIN1;SLC5A11;NKAIN2
1436,GO:0003158,0.157242747356372,0.966212429423625,2,106,endothelium development,BP,HAPLN2;GJA1
6762,GO:0021522,0.157470538605767,0.987446628588468,1,29,spinal cord motor neuron differentiation,BP,NKX6-2
18059,GO:0098801,0.157829140135275,0.987419155253592,1,27,regulation of renal system process,BP,GJA1
3742,GO:0007368,0.157935827203,0.96596242017395,2,109,determination of left/right symmetry,BP,PCSK6;GJA1
7419,GO:0030552,0.15812736789769,0.987427484072334,1,24,cAMP binding,MF,BVES
2855,GO:0005930,0.158364685178012,0.965845879719614,2,101,axoneme,CC,TUBB4A;DNAH17
9685,GO:0035296,0.15837630566697,0.965796164811006,2,113,regulation of tube diameter,BP,EGFR;GJA1
17914,GO:0097746,0.15837630566697,0.965796164811006,2,113,regulation of blood vessel diameter,BP,EGFR;GJA1
7170,GO:0030125,0.1588348817379,0.987271097607212,1,26,clathrin vesicle coat,CC,EGFR
487,GO:0001525,0.159056911405876,0.93275847514921,5,434,angiogenesis,BP,NGFR;PDGFRA;ENPP2;GREM1;APOD
10231,GO:0036314,0.159146664185225,0.987282520871356,1,23,response to sterol,BP,MLC1
18569,GO:1900015,0.159323966832528,0.987172203015699,1,27,regulation of cytokine production involved in inflammatory response,BP,APOD
4186,GO:0008569,0.159385814217274,0.98739536294454,1,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,DNAH17
15204,GO:0061135,0.159682463503922,0.965297658883562,2,128,endopeptidase regulator activity,MF,SPOCK3;COL28A1
1430,GO:0003148,0.159802970331281,0.987130040093406,1,25,outflow tract septum morphogenesis,BP,LRP2
20320,GO:1904646,0.160016031635023,0.987094616924143,1,25,cellular response to amyloid-beta,BP,NGFR
7744,GO:0031225,0.160024845360019,0.965183848931191,2,126,anchored component of membrane,CC,CPM;CNTN2
14643,GO:0060251,0.160327201676844,0.987042789317649,1,25,regulation of glial cell proliferation,BP,SOX10
13405,GO:0050673,0.160447635852594,0.939769980384957,4,325,epithelial cell proliferation,BP,NGFR;EGFR;GJA1;FZD7
7363,GO:0030425,0.160999606862273,0.925585052194741,6,543,dendrite,CC,LRP2;CNTNAP4;KNDC1;MYO1D;ANKS1B;APOD
17553,GO:0097014,0.161004496199057,0.964924820142064,2,102,ciliary plasm,CC,TUBB4A;DNAH17
13504,GO:0050804,0.16118124024612,0.939400996334264,4,317,modulation of chemical synaptic transmission,BP,PLCL1;EGFR;CNTNAP4;CNTN2
18230,GO:0099177,0.16118124024612,0.939400996334264,4,317,regulation of trans-synaptic signaling,BP,PLCL1;EGFR;CNTNAP4;CNTN2
10383,GO:0038084,0.161430730234054,0.986858097448127,1,25,vascular endothelial growth factor signaling pathway,BP,PDGFRA
17785,GO:0097447,0.161455318116161,0.925314079602921,6,544,dendritic tree,CC,LRP2;CNTNAP4;KNDC1;MYO1D;ANKS1B;APOD
2844,GO:0005913,0.162065784590765,0.964540857073044,2,105,cell-cell adherens junction,CC,CDH19;GJA1
7004,GO:0021987,0.16232646831451,0.964457705467381,2,103,cerebral cortex development,BP,ARX;EGFR
7741,GO:0031214,0.162411117552032,0.964392793795547,2,112,biomineral tissue development,BP,GJA1;GREM1
8118,GO:0031954,0.162535833813303,0.986671747087009,1,25,positive regulation of protein autophosphorylation,BP,GREM1
11126,GO:0043204,0.162551508265291,0.964336361981439,2,114,perikaryon,CC,KNDC1;GJC2
3503,GO:0006921,0.162581023971236,0.9865767583244,1,30,cellular component disassembly involved in execution phase of apoptosis,BP,BOK
12260,GO:0045923,0.162728646193111,0.986582834226553,1,28,positive regulation of fatty acid metabolic process,BP,SLC45A3
11549,GO:0044247,0.162938057299186,0.986603574459489,1,25,cellular polysaccharide catabolic process,BP,PHKG1
735,GO:0001912,0.163033879517867,0.986472049413659,1,32,positive regulation of leukocyte mediated cytotoxicity,BP,RASGRP1
13735,GO:0051154,0.16316985367603,0.986507641621775,1,28,negative regulation of striated muscle cell differentiation,BP,FZD7
10644,GO:0042269,0.163283868646277,0.986442517549229,1,31,regulation of natural killer cell mediated cytotoxicity,BP,RASGRP1
1968,GO:0004435,0.163301843581499,0.986563796647872,1,24,phosphatidylinositol phospholipase C activity,MF,PLCL1
2436,GO:0005125,0.163832455464729,0.963790674300074,2,149,cytokine activity,MF,CRLF1;GREM1
17772,GO:0097421,0.16390295060672,0.986322791537901,1,32,liver regeneration,BP,EGFR
13198,GO:0048706,0.163975190681844,0.963830646611223,2,115,embryonic skeletal system development,BP,PDGFRA;DMRT2
14437,GO:0055076,0.164049666772064,0.963775438431441,2,124,transition metal ion homeostasis,BP,TF;SLC31A2
12680,GO:0046875,0.164194593096121,0.986349811059299,1,27,ephrin receptor binding,MF,ANKS1B
7358,GO:0030414,0.164340869095063,0.963663518768857,2,127,peptidase inhibitor activity,MF,SPOCK3;COL28A1
17902,GO:0097720,0.164559762275082,0.986306177475797,1,26,calcineurin-mediated signaling,BP,ERBB3
13411,GO:0050680,0.164581399270655,0.963634082888104,2,110,negative regulation of epithelial cell proliferation,BP,NGFR;GJA1
491,GO:0001533,0.164950355400091,0.986185320801871,1,29,cornified envelope,CC,PPL
13157,GO:0048660,0.16511956559979,0.96342837274697,2,114,regulation of smooth muscle cell proliferation,BP,EGFR;APOD
3840,GO:0007628,0.165142666540732,0.986205822001233,1,26,adult walking behavior,BP,CNTN2
11098,GO:0043168,0.165286739635284,0.890071106898143,21,2541,anion binding,MF,ERBB3;FOLH1;TUBB4A;MAG;BVES;PLCL1;CDK18;ATP10B;HAPLN2;PDGFRA;PCSK6;EGFR;FZD7;SNX22;PHKG1;CARNS1;RASGRP1;SUSD5;MYO1D;AATK;DNAH17
16996,GO:0072604,0.165700173426572,0.986072086840686,1,28,interleukin-6 secretion,BP,MBP
13274,GO:0048863,0.165803732689582,0.947764948659926,3,234,stem cell differentiation,BP,SOX10;PDGFRA;GREM1
13162,GO:0048665,0.166639062694485,0.985861043708002,1,31,neuron fate specification,BP,NKX6-2
11660,GO:0044440,0.167381125044327,0.928060040042888,5,464,endosomal part,CC,LRP2;TF;EGFR;FZD7;BOK
134,GO:0000272,0.167616090424333,0.985775636344477,1,26,polysaccharide catabolic process,BP,PHKG1
6930,GO:0021846,0.167616220762794,0.985775613489861,1,26,cell proliferation in forebrain,BP,ARX
13088,GO:0048518,0.167620055318383,0.880163108556222,37,5067,positive regulation of biological process,BP,ARX;CRLF1;ANLN;NGFR;EYA2;ERBB3;LRP2;TF;CAPN3;SOX10;MLC1;MAG;BVES;PLP1;MYRF;PDGFRA;ENPP2;MOG;EGFR;ST18;NKX6-2;GJA1;FZD7;SLC45A3;EDIL3;GREM1;GPD1;KLK6;KNDC1;MAL;RASGRP1;DMRT2;BOK;GPR62;CNTN2;MBP;GJC2
4688,GO:0010092,0.168058632354013,0.985642231020235,1,29,specification of animal organ identity,BP,LRP2
7224,GO:0030198,0.168091538363519,0.935823797670488,4,310,extracellular matrix organization,BP,COL9A3;HAPLN2;ADAMTS4;GREM1
13804,GO:0051259,0.168239279975602,0.927569037417882,5,470,protein complex oligomerization,BP,MLC1;GJA1;GJB1;RASGRP1;BOK
17219,GO:0090066,0.168432736508639,0.927472344643355,5,449,regulation of anatomical structure size,BP,MAG;EGFR;GJA1;TMSB15A;CNTN2
20319,GO:1904645,0.168496566045677,0.985600752525653,1,27,response to amyloid-beta,BP,NGFR
11981,GO:0045332,0.168504871684091,0.985689969353608,1,23,phospholipid translocation,BP,ATP10B
7555,GO:0030863,0.168626160163379,0.96222744304885,2,101,cortical cytoskeleton,CC,ANLN;MOBP
3571,GO:0007031,0.169164097022707,0.985414846331861,1,31,peroxisome organization,BP,PEX5L
2149,GO:0004683,0.170542244153039,0.98521799428619,1,28,calmodulin-dependent protein kinase activity,MF,PHKG1
20062,GO:1904064,0.170888877575076,0.961343912240161,2,117,positive regulation of cation transmembrane transport,BP,CAPN3;GJC2
4064,GO:0008378,0.170891209583168,0.985105384592068,1,31,galactosyltransferase activity,MF,UGT8
18822,GO:1901099,0.171096042649499,0.985053836548423,1,32,negative regulation of signal transduction in absence of ligand,BP,EYA2
21845,GO:2001240,0.171096042649499,0.985053836548423,1,32,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA2
2850,GO:0005923,0.171324557560795,0.961215988617403,2,109,bicellular tight junction,CC,CLDN11;BVES
588,GO:0001704,0.171501674918855,0.961147443242576,2,110,formation of primary germ layer,BP,EYA2;FZD7
556,GO:0001654,0.171538035371039,0.934002796506605,4,319,eye development,BP,PDGFRA;EGFR;GJA1;SMOC1
17514,GO:0090659,0.172298125478153,0.984921021793467,1,27,walking behavior,BP,CNTN2
13557,GO:0050880,0.172448264713565,0.960761430164296,2,121,regulation of blood vessel size,BP,EGFR;GJA1
13156,GO:0048659,0.172514398990965,0.960751144997806,2,117,smooth muscle cell proliferation,BP,EGFR;APOD
2480,GO:0005178,0.172827438952369,0.960655413454337,2,112,integrin binding,MF,EGFR;EDIL3
16407,GO:0071549,0.172851443221202,0.984735026985399,1,32,cellular response to dexamethasone stimulus,BP,EGFR
10501,GO:0040008,0.173334738793932,0.918152848245901,6,592,regulation of growth,BP,ARX;CAPN3;MAG;EGFR;GJA1;GREM1
19811,GO:1903580,0.173625121123171,0.984641645618046,1,29,positive regulation of ATP metabolic process,BP,GPD1
12160,GO:0045737,0.17364529629611,0.984589668658255,1,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR
9626,GO:0035150,0.173741907294776,0.960283653894264,2,122,regulation of tube size,BP,EGFR;GJA1
21312,GO:2000273,0.173816559350329,0.984606593019615,1,29,positive regulation of signaling receptor activity,BP,GREM1
5097,GO:0010975,0.174319636423847,0.924119077764724,5,428,regulation of neuron projection development,BP,NGFR;MAG;KLK6;KNDC1;CNTN2
1119,GO:0002534,0.174338130814735,0.984493568243232,1,30,cytokine production involved in inflammatory response,BP,APOD
469,GO:0001501,0.174399208137182,0.924057390443384,5,450,skeletal system development,BP,HAPLN2;PDGFRA;ADAMTS4;GREM1;DMRT2
13751,GO:0051180,0.174730096240388,0.984421349026942,1,30,vitamin transport,BP,LRP2
1227,GO:0002715,0.174771343131178,0.984367895837289,1,33,regulation of natural killer cell mediated immunity,BP,RASGRP1
17977,GO:0098632,0.174828075163677,0.98438698895813,1,31,cell-cell adhesion mediator activity,MF,GLDN
9251,GO:0034204,0.174944479458038,0.984508184306068,1,24,lipid translocation,BP,ATP10B
13530,GO:0050850,0.17601686887125,0.984136501492422,1,33,positive regulation of calcium-mediated signaling,BP,ERBB3
327,GO:0000904,0.176133373095345,0.911164065577873,7,661,cell morphogenesis involved in differentiation,BP,ARX;NGFR;MAG;BVES;FZD7;KNDC1;CNTN2
6518,GO:0019359,0.176313792223437,0.959344006484646,2,119,nicotinamide nucleotide biosynthetic process,BP,NNMT;GPD1
6520,GO:0019363,0.176313792223437,0.959344006484646,2,119,pyridine nucleotide biosynthetic process,BP,NNMT;GPD1
13032,GO:0048333,0.176606947751089,0.984073050800408,1,30,mesodermal cell differentiation,BP,EYA2
243,GO:0000578,0.176613518663581,0.984055210805077,1,31,embryonic axis specification,BP,PCSK6
725,GO:0001893,0.17673195398812,0.984049706170633,1,30,maternal placenta development,BP,GJA1
19395,GO:1902692,0.176745986059973,0.984104412068703,1,27,regulation of neuroblast proliferation,BP,SOX10
2542,GO:0005319,0.176845691333212,0.959153739104141,2,117,lipid transporter activity,MF,ATP10B;APOD
12430,GO:0046330,0.176998448954956,0.959100693770091,2,116,positive regulation of JNK cascade,BP,FZD7;RASGRP1
713,GO:0001881,0.177075994035822,0.983985362913604,1,30,receptor recycling,BP,BVES
7087,GO:0023014,0.177391538389696,0.905932358463343,8,855,signal transduction by protein phosphorylation,BP,NGFR;ERBB3;RGS4;PDGFRA;EGFR;FZD7;RASGRP1;MBP
568,GO:0001667,0.177673769022101,0.930725424176672,4,333,ameboidal-type cell migration,BP,ANLN;SOX10;ENPP2;GREM1
2606,GO:0005506,0.177960795207094,0.958694235083462,2,130,iron ion binding,MF,TF;FA2H
8751,GO:0032941,0.177987820525142,0.98376661539636,1,33,secretion by tissue,BP,GJA1
4502,GO:0009395,0.178042834172902,0.983786915797951,1,31,phospholipid catabolic process,BP,ENPP2
10794,GO:0042558,0.178048603668197,0.98374114627296,1,34,pteridine-containing compound metabolic process,BP,FOLH1
19470,GO:1902904,0.178385162940246,0.95858351229243,2,116,negative regulation of supramolecular fiber organization,BP,TUBB4A;TMSB15A
2283,GO:0004864,0.178483520722211,0.983687807176859,1,32,protein phosphatase inhibitor activity,MF,PPP1R14A
16494,GO:0071675,0.178523816652893,0.983651171446154,1,34,regulation of mononuclear cell migration,BP,GREM1
15632,GO:0070160,0.178633226361304,0.958506678717314,2,112,occluding junction,CC,CLDN11;BVES
10512,GO:0040019,0.178802776648886,0.983678522472695,1,29,positive regulation of embryonic development,BP,DMRT2
11740,GO:0044743,0.178937615388893,0.983534810659921,1,37,protein transmembrane import into intracellular organelle,BP,PEX5L
7175,GO:0030131,0.179025215510145,0.983636441916678,1,29,clathrin adaptor complex,CC,EGFR
14667,GO:0060285,0.179128109074469,0.983598686543297,1,30,cilium-dependent cell motility,BP,DNAH17
13116,GO:0048566,0.179136557793821,0.983563973040575,1,32,embryonic digestive tract development,BP,PDGFRA
2108,GO:0004629,0.179374912722868,0.98361089243498,1,27,phospholipase C activity,MF,PLCL1
13662,GO:0051047,0.179666249834112,0.929643380028039,4,345,positive regulation of secretion,BP,EGFR;GJA1;RASGRP1;MBP
2891,GO:0005996,0.180063633110064,0.941112840586883,3,235,monosaccharide metabolic process,BP,SLC45A3;GPD1;APOD
6863,GO:0021696,0.180279788464332,0.983417846820208,1,28,cerebellar cortex morphogenesis,BP,KNDC1
4035,GO:0008324,0.180422805471957,0.91382197306721,6,578,cation transmembrane transporter activity,MF,TF;SLC31A2;PIEZO2;KCNJ6;SLC45A3;SLC5A11
17745,GO:0097367,0.180426060645292,0.882962557339473,17,1994,carbohydrate derivative binding,MF,ERBB3;TUBB4A;MAG;BVES;CDK18;ATP10B;HAPLN2;PDGFRA;PCSK6;EGFR;PHKG1;CARNS1;SUSD5;MYO1D;AATK;DNAH17;SPOCK3
7816,GO:0031333,0.180500442927945,0.957778041768465,2,119,negative regulation of protein complex assembly,BP,TUBB4A;TMSB15A
12197,GO:0045807,0.180616746015898,0.957719802302092,2,123,positive regulation of endocytosis,BP,TF;GREM1
14186,GO:0051968,0.180745718370955,0.983328930204391,1,28,positive regulation of synaptic transmission, glutamatergic,BP,EGFR
4009,GO:0008285,0.181057621040702,0.91341530827229,6,610,negative regulation of cell proliferation,BP,NGFR;SOX10;ST18;GJA1;GREM1;APOD
13204,GO:0048713,0.181393778707751,0.983116641820272,1,33,regulation of oligodendrocyte differentiation,BP,SLC45A3
6713,GO:0019933,0.181502452297273,0.95737489539845,2,126,cAMP-mediated signaling,BP,PEX5L;GPR62
11884,GO:0045124,0.181722174040404,0.983085219135482,1,31,regulation of bone resorption,BP,EGFR
4797,GO:0010543,0.181754405634806,0.983096595067986,1,30,regulation of platelet activation,BP,PDGFRA
815,GO:0002020,0.181880475773411,0.957288783738655,2,111,protease binding,MF,ADAMTS4;MBP
7270,GO:0030260,0.182069567002066,0.957177479095904,2,121,entry into host cell,BP,MOG;EGFR
11638,GO:0044409,0.182069567002066,0.957177479095904,2,121,entry into host,BP,MOG;EGFR
14098,GO:0051806,0.182069567002066,0.957177479095904,2,121,entry into cell of other organism involved in symbiotic interaction,BP,MOG;EGFR
14105,GO:0051828,0.182069567002066,0.957177479095904,2,121,entry into other organism involved in symbiotic interaction,BP,MOG;EGFR
4646,GO:0009954,0.182230441617061,0.982970453698178,1,32,proximal/distal pattern formation,BP,GREM1
2156,GO:0004693,0.18224270176018,0.982937850816827,1,34,cyclin-dependent protein serine/threonine kinase activity,MF,CDK18
9032,GO:0033572,0.182362266480307,0.982900811473397,1,35,transferrin transport,BP,TF
1873,GO:0004252,0.182562076565657,0.956936144235245,2,138,serine-type endopeptidase activity,MF,PCSK6;KLK6
9439,GO:0034612,0.182566547659703,0.939871248597593,3,268,response to tumor necrosis factor,BP,NGFR;ST18;GPD1
3424,GO:0006796,0.182719416652582,0.875760464281598,22,2861,phosphate-containing compound metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;PLCL1;RGS4;CDK18;PDGFRA;ENPP2;EGFR;FZD7;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;MYO1D;AATK;MBP;GJC2
1129,GO:0002548,0.182745201909494,0.982767294751604,1,40,monocyte chemotaxis,BP,GREM1
752,GO:0001935,0.182893128056101,0.956868440185911,2,120,endothelial cell proliferation,BP,NGFR;GJA1
2427,GO:0005109,0.183084500788578,0.98278890585608,1,33,frizzled binding,MF,FZD7
3387,GO:0006734,0.183149036225266,0.982747574079325,1,35,NADH metabolic process,BP,GPD1
5901,GO:0016504,0.183330658785259,0.982712095571666,1,35,peptidase activator activity,MF,MAL
21248,GO:2000146,0.18339908526895,0.93952928747769,3,228,negative regulation of cell motility,BP,GREM1;APOD;SPOCK3
20648,GO:1905332,0.183422691821418,0.982773431373947,1,30,positive regulation of morphogenesis of an epithelium,BP,GREM1
4676,GO:0010039,0.183579088186342,0.982708195519396,1,32,response to iron ion,BP,TF
16942,GO:0072525,0.18383135298771,0.956503669256312,2,122,pyridine-containing compound biosynthetic process,BP,NNMT;GPD1
17112,GO:0085029,0.184196861923822,0.982622349897861,1,30,extracellular matrix assembly,BP,HAPLN2
12264,GO:0045927,0.184657309641542,0.938930807022544,3,224,positive regulation of growth,BP,ARX;CAPN3;EGFR
5046,GO:0010907,0.184688815734892,0.982566208091238,1,28,positive regulation of glucose metabolic process,BP,SLC45A3
16304,GO:0071392,0.184794240326616,0.982454040541654,1,33,cellular response to estradiol stimulus,BP,EGFR
7825,GO:0031343,0.185769144402702,0.982193439158486,1,38,positive regulation of cell killing,BP,RASGRP1
686,GO:0001838,0.186068274666804,0.955661839536304,2,118,embryonic epithelial tube formation,BP,LRP2;GREM1
13525,GO:0050839,0.186151689016643,0.917198855997483,5,460,cell adhesion molecule binding,MF,ANLN;CDH19;PPL;EGFR;EDIL3
21298,GO:2000249,0.186192540279465,0.982147877114222,1,35,regulation of actin cytoskeleton reorganization,BP,PDGFRA
16277,GO:0071354,0.186546131528905,0.982141007793401,1,31,cellular response to interleukin-6,BP,ST18
18536,GO:0140104,0.186685897262985,0.981988034255475,1,40,molecular carrier activity,MF,TF
11342,GO:0043552,0.186728614160619,0.982123316543561,1,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,PDGFRA
5829,GO:0016342,0.186778105063667,0.982154632697353,1,28,catenin complex,CC,CDH19
14683,GO:0060306,0.186788049956548,0.982131374351101,1,29,regulation of membrane repolarization,BP,GJA1
2828,GO:0005887,0.18680098629888,0.887131182969591,12,1405,integral component of plasma membrane,CC,NGFR;ERBB3;FOLH1;MAG;PDGFRA;SLC31A2;ENPP2;EGFR;GJA1;KCNJ6;SLC5A11;CNTN2
10891,GO:0042743,0.186950412580144,0.981935063559359,1,40,hydrogen peroxide metabolic process,BP,EGFR
6466,GO:0019212,0.187129319738137,0.981975640385869,1,34,phosphatase inhibitor activity,MF,PPP1R14A
7801,GO:0031312,0.187402077673768,0.981953057231266,1,32,extrinsic component of organelle membrane,CC,SOX10
17798,GO:0097472,0.187771794643429,0.981832354353654,1,35,cyclin-dependent protein kinase activity,MF,CDK18
1548,GO:0003338,0.187797218453855,0.981891621207333,1,31,metanephros morphogenesis,BP,GREM1
495,GO:0001539,0.188031447290286,0.98184472413773,1,31,cilium or flagellum-dependent cell motility,BP,DNAH17
15512,GO:0061900,0.188271606040251,0.981796572000969,1,31,glial cell activation,BP,EGFR
471,GO:0001503,0.188489113532719,0.924845911961572,4,344,ossification,BP,EGFR;GJA1;GREM1;SMOC1
6237,GO:0017147,0.188706349183891,0.981709230802166,1,31,Wnt-protein binding,MF,FZD7
16359,GO:0071470,0.188710918566028,0.981690535489283,1,32,cellular response to osmotic stress,BP,CAPN3
17901,GO:0097718,0.188768406139429,0.981715720532351,1,30,disordered domain specific binding,MF,GJA1
19602,GO:1903169,0.189038214537388,0.95448684551883,2,125,regulation of calcium ion transmembrane transport,BP,CAPN3;GJC2
14825,GO:0060485,0.189964800279573,0.936339700275135,3,232,mesenchyme development,BP,ERBB3;SOX10;GREM1
10714,GO:0042398,0.189967701699576,0.981374507514545,1,36,cellular modified amino acid biosynthetic process,BP,CARNS1
12126,GO:0045664,0.190073264441847,0.907829813496273,6,568,regulation of neuron differentiation,BP,NGFR;MAG;KLK6;KNDC1;S1PR5;CNTN2
4652,GO:0009968,0.190401000893667,0.889976508271509,10,1145,negative regulation of signal transduction,BP,EYA2;ERBB3;LRP2;SOX10;RGS4;PDGFRA;EGFR;GREM1;BOK;APOD
3410,GO:0006775,0.190465132506701,0.981259651763835,1,37,fat-soluble vitamin metabolic process,BP,LRP2
17617,GO:0097120,0.19054096888576,0.981320047408171,1,32,receptor localization to synapse,BP,ANKS1B
2769,GO:0005790,0.190630501781291,0.981319958160399,1,31,smooth endoplasmic reticulum,CC,MYO1D
3894,GO:0008104,0.190930138104352,0.872427826135912,19,2423,protein localization,BP,ANLN;NGFR;LRP2;TF;CAPN3;MLC1;PLLP;PEX5L;EGFR;GJA1;SNX22;TMSB15A;SH3TC2;MAL;RASGRP1;UGT8;CNTN2;APOD;MBP
11183,GO:0043292,0.191023742583237,0.935850755659922,3,216,contractile fiber,CC,CAPN3;LDB3;GJA1
10666,GO:0042304,0.191208120821171,0.981150719100265,1,34,regulation of fatty acid biosynthetic process,BP,SLC45A3
18795,GO:1901030,0.191317748863566,0.98108507448943,1,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
18283,GO:0099568,0.191394275717021,0.914103694308033,5,441,cytoplasmic region,CC,ANLN;TUBB4A;ERMN;MOBP;DNAH17
5408,GO:0015293,0.191398874786869,0.953588124908501,2,119,symporter activity,MF,SLC45A3;SLC5A11
7702,GO:0031111,0.192177104714555,0.980985429050675,1,32,negative regulation of microtubule polymerization or depolymerization,BP,TUBB4A
1060,GO:0002437,0.192399081794245,0.980837027562212,1,39,inflammatory response to antigenic stimulus,BP,RASGRP1
13713,GO:0051128,0.192669540793058,0.872314610042541,18,2217,regulation of cellular component organization,BP,ANLN;NGFR;TF;TUBB4A;MAG;BVES;PDGFRA;ERMN;ENPP2;EGFR;GJA1;TMSB15A;GREM1;KLK6;KNDC1;BOK;CNTN2;APOD
13866,GO:0051371,0.192743063859883,0.981316769649054,1,18,muscle alpha-actinin binding,MF,LDB3
6890,GO:0021772,0.192812567498226,0.980873157944877,1,31,olfactory bulb development,BP,ARX
17328,GO:0090218,0.193268147501876,0.98076051085988,1,32,positive regulation of lipid kinase activity,BP,PDGFRA
20846,GO:1905898,0.193516234112644,0.980659516353339,1,35,positive regulation of response to endoplasmic reticulum stress,BP,BOK
18095,GO:0098862,0.193819791976406,0.952631142579199,2,120,cluster of actin-based cell projections,CC,LRP2;MYO1D
21317,GO:2000279,0.194120698364811,0.980583764432541,1,32,negative regulation of DNA biosynthetic process,BP,GJA1
13714,GO:0051129,0.194892768169863,0.904778359293371,6,600,negative regulation of cellular component organization,BP,NGFR;TUBB4A;MAG;TMSB15A;BOK;APOD
14191,GO:0051973,0.195162110785672,0.980316181367013,1,35,positive regulation of telomerase activity,BP,GREM1
18301,GO:0099622,0.19528031615766,0.980341957899237,1,32,cardiac muscle cell membrane repolarization,BP,GJA1
12489,GO:0046467,0.195337599236421,0.951978171806238,2,134,membrane lipid biosynthetic process,BP,FA2H;UGT8
20042,GO:1904031,0.195352924755304,0.980261177973645,1,36,positive regulation of cyclin-dependent protein kinase activity,BP,EGFR
17405,GO:0090317,0.195506340299813,0.980228950096192,1,36,negative regulation of intracellular protein transport,BP,APOD
3865,GO:0008047,0.195512566173063,0.911617320650479,5,469,enzyme activator activity,MF,ERBB3;RGS4;GREM1;MAL;RASGRP1
12039,GO:0045503,0.195580875595294,0.980476437333464,1,24,dynein light chain binding,MF,DNAH17
15704,GO:0070266,0.195758073069768,0.98017600730401,1,36,necroptotic process,BP,BOK
19125,GO:1901990,0.195869036709007,0.920725653303025,4,376,regulation of mitotic cell cycle phase transition,BP,ANLN;TUBB4A;EGFR;GJC2
7320,GO:0030326,0.195908953777161,0.951794206902133,2,122,embryonic limb morphogenesis,BP,GJA1;GREM1
9616,GO:0035113,0.195908953777161,0.951794206902133,2,122,embryonic appendage morphogenesis,BP,GJA1;GREM1
3636,GO:0007166,0.196259066886468,0.86715799390146,20,2604,cell surface receptor signaling pathway,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;SOX10;PLP1;PDGFRA;MOG;PCSK6;EGFR;ST18;FZD7;GREM1;SH3TC2;MAL;SUSD5;BOK;CNTN2;APOD
13979,GO:0051592,0.196300716937683,0.951672330620247,2,114,response to calcium ion,BP,CAPN3;EGFR
13793,GO:0051248,0.196621619414779,0.889021461136708,9,1031,negative regulation of protein metabolic process,BP,NGFR;CAPN3;RGS4;EGFR;GREM1;PPP1R14A;APOD;SPOCK3;COL28A1
13728,GO:0051147,0.196979105237975,0.951347975542326,2,127,regulation of muscle cell differentiation,BP,FZD7;GREM1
564,GO:0001662,0.197407854611956,0.979842447157625,1,35,behavioral fear response,BP,GJA1
933,GO:0002209,0.197407854611956,0.979842447157625,1,35,behavioral defense response,BP,GJA1
17132,GO:0086019,0.197484276854608,0.979940354904516,1,29,cell-cell signaling involved in cardiac conduction,BP,GJA1
16285,GO:0071363,0.197595343166323,0.903064307812046,6,602,cellular response to growth factor stimulus,BP,NGFR;LRP2;PDGFRA;PCSK6;EGFR;GREM1
13817,GO:0051281,0.197706479774473,0.979763643743572,1,36,positive regulation of release of sequestered calcium ion into cytosol,BP,CAPN3
7241,GO:0030216,0.197775627352083,0.951007718528898,2,133,keratinocyte differentiation,BP,PPL;PCSK6
5493,GO:0015682,0.197783411991997,0.979718972938992,1,38,ferric iron transport,BP,TF
16933,GO:0072512,0.197783411991997,0.979718972938992,1,38,trivalent inorganic cation transport,BP,TF
3469,GO:0006874,0.19793890114402,0.919575921057205,4,366,cellular calcium ion homeostasis,BP,CAPN3;PDGFRA;GJA1;BOK
6699,GO:0019900,0.19796174309116,0.896986780377061,7,700,kinase binding,MF,ERBB3;DCX;MAG;LDB3;PDGFRA;EGFR;GJA1
17378,GO:0090287,0.198129173801572,0.932302493453871,3,232,regulation of cellular response to growth factor stimulus,BP,LRP2;PCSK6;GREM1
4472,GO:0009268,0.198157937357404,0.97966744193612,1,36,response to pH,BP,GJA1
13600,GO:0050931,0.198253890969267,0.979714507181237,1,32,pigment cell differentiation,BP,SOX10
7005,GO:0021988,0.198789107912946,0.979600439697902,1,32,olfactory lobe development,BP,ARX
6775,GO:0021537,0.198789740432639,0.931981330699664,3,227,telencephalon development,BP,ARX;EGFR;CNTN2
21412,GO:2000401,0.198889241291656,0.979456727988274,1,40,regulation of lymphocyte migration,BP,APOD
767,GO:0001953,0.199044093234191,0.979565747060546,1,31,negative regulation of cell-matrix adhesion,BP,APOD
9540,GO:0034767,0.199754951467431,0.950229095661751,2,128,positive regulation of ion transmembrane transport,BP,CAPN3;GJC2
6222,GO:0017124,0.199903745728161,0.950196629081139,2,121,SH3 domain binding,MF,LRP2;GJA1
9356,GO:0034405,0.200263912227949,0.979265533838243,1,33,response to fluid shear stress,BP,GJA1
3705,GO:0007268,0.200360399804644,0.901302803354357,6,603,chemical synaptic transmission,BP,PLCL1;PLP1;EGFR;CNTNAP4;CNTN2;MBP
18128,GO:0098916,0.200360399804644,0.901302803354357,6,603,anterograde trans-synaptic signaling,BP,PLCL1;PLP1;EGFR;CNTNAP4;CNTN2;MBP
17300,GO:0090184,0.200624965769143,0.979153185212454,1,35,positive regulation of kidney development,BP,GREM1
13074,GO:0048487,0.200675638041867,0.979126414372863,1,36,beta-tubulin binding,MF,GJA1
8207,GO:0032101,0.200843075705441,0.900973694903684,6,646,regulation of response to external stimulus,BP,CAPN3;PDGFRA;EGFR;GJA1;GREM1;APOD
8914,GO:0033209,0.20086748658619,0.94968080889082,2,161,tumor necrosis factor-mediated signaling pathway,BP,NGFR;ST18
11600,GO:0044331,0.201152869226265,0.979073558771512,1,33,cell-cell adhesion mediated by cadherin,BP,CDH19
3326,GO:0006654,0.201185663359055,0.979066458385937,1,33,phosphatidic acid biosynthetic process,BP,GPD1
19463,GO:1902893,0.20180678271494,0.978950820583516,1,32,regulation of pri-miRNA transcription by RNA polymerase II,BP,NGFR
13776,GO:0051223,0.20188969026233,0.900319586444718,6,614,regulation of protein transport,BP,EGFR;GJA1;SH3TC2;RASGRP1;APOD;MBP
16763,GO:0072175,0.201975001397715,0.949337297046349,2,126,epithelial tube formation,BP,LRP2;GREM1
13933,GO:0051494,0.20214660237235,0.949267499737442,2,126,negative regulation of cytoskeleton organization,BP,TUBB4A;TMSB15A
510,GO:0001558,0.202441733198048,0.917037244499588,4,365,regulation of cell growth,BP,MAG;EGFR;GJA1;GREM1
6715,GO:0019935,0.202546442974241,0.949071780840525,2,135,cyclic-nucleotide-mediated signaling,BP,PEX5L;GPR62
15968,GO:0070741,0.202554498600955,0.9787337650914,1,35,response to interleukin-6,BP,ST18
872,GO:0002090,0.202636639464858,0.978715809835199,1,35,regulation of receptor internalization,BP,GREM1
3768,GO:0007435,0.202863820719444,0.978683220042634,1,34,salivary gland morphogenesis,BP,EGFR
14398,GO:0055003,0.203212316039236,0.979028304532159,1,20,cardiac myofibril assembly,BP,PDGFRA
18264,GO:0099537,0.203926721675959,0.899017535234553,6,606,trans-synaptic signaling,BP,PLCL1;PLP1;EGFR;CNTNAP4;CNTN2;MBP
5461,GO:0015485,0.204297223038027,0.978319170472422,1,37,cholesterol binding,MF,APOD
10436,GO:0038179,0.204517130108981,0.978302505176809,1,35,neurotrophin signaling pathway,BP,NGFR
8109,GO:0031941,0.205027483061717,0.978173087842805,1,36,filamentous actin,CC,TMSB15A
8090,GO:0031901,0.205132159678006,0.948038856874664,2,128,early endosome membrane,CC,EGFR;BOK
17379,GO:0090288,0.20517245039342,0.948030164112713,2,126,negative regulation of cellular response to growth factor stimulus,BP,LRP2;GREM1
18263,GO:0099536,0.205227240974298,0.898180753584612,6,607,synaptic signaling,BP,PLCL1;PLP1;EGFR;CNTNAP4;CNTN2;MBP
11665,GO:0044447,0.205372072633675,0.978236591793195,1,29,axoneme part,CC,DNAH17
13688,GO:0051092,0.206236142426497,0.947558421747211,2,135,positive regulation of NF-kappaB transcription factor activity,BP,CAPN3;GREM1
6579,GO:0019538,0.206379896537795,0.849011907269548,36,5080,protein metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;PLCL1;RGS4;CDK18;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;CNDP1;GJA1;FZD7;ADAMTS4;PHKG1;GREM1;PPP1R14A;KLK6;KNDC1;RASGRP1;BOK;AATK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
21247,GO:2000145,0.206692351028324,0.891163634958805,7,741,regulation of cell motility,BP,ERBB3;PDGFRA;ENPP2;EGFR;GREM1;APOD;SPOCK3
3704,GO:0007267,0.206765403818235,0.872519479643705,12,1447,cell-cell signaling,BP,SOX10;PLCL1;PLP1;EGFR;GJA1;CNTNAP4;FZD7;GREM1;GJB1;CNTN2;MBP;GJC2
12493,GO:0046473,0.20723830392012,0.977714650638854,1,34,phosphatidic acid metabolic process,BP,GPD1
5126,GO:0014009,0.207384402122719,0.977681899470628,1,34,glial cell proliferation,BP,SOX10
12041,GO:0045505,0.207900180709622,0.977700924355,1,28,dynein intermediate chain binding,MF,DNAH17
10824,GO:0042596,0.208258245480922,0.977434295335609,1,37,fear response,BP,GJA1
4012,GO:0008289,0.208798240745935,0.89586523506634,6,626,lipid binding,MF,MAG;FZD7;SNX22;MAL;RASGRP1;APOD
5286,GO:0015026,0.209095077494558,0.977261126848795,1,36,coreceptor activity,MF,NGFR
13159,GO:0048662,0.209613785296504,0.977096941384153,1,39,negative regulation of smooth muscle cell proliferation,BP,APOD
17025,GO:0072678,0.209787874009082,0.976993873457286,1,44,T cell migration,BP,APOD
13885,GO:0051403,0.210923260474688,0.925780431677644,3,243,stress-activated MAPK cascade,BP,EGFR;FZD7;RASGRP1
15544,GO:0065009,0.211018501581431,0.853433845755719,22,2938,regulation of molecular function,BP,CRLF1;NGFR;ERBB3;CAPN3;BVES;PLCL1;RGS4;PDGFRA;RAPGEF5;PCSK6;EGFR;ST18;GJA1;GREM1;PPP1R14A;KNDC1;RASGRP1;MYO1D;BOK;SPOCK3;MBP;COL28A1
12178,GO:0045765,0.211097718466348,0.925684991939623,3,246,regulation of angiogenesis,BP,NGFR;ENPP2;GREM1
14435,GO:0055074,0.211336782435783,0.911936342359613,4,376,calcium ion homeostasis,BP,CAPN3;PDGFRA;GJA1;BOK
7399,GO:0030517,0.211416262646396,0.976767749347845,1,34,negative regulation of axon extension,BP,MAG
5827,GO:0016339,0.211958677308648,0.976663055923065,1,33,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,CDH19
4847,GO:0010631,0.211997759511142,0.925231952755633,3,239,epithelial cell migration,BP,ANLN;ENPP2;GREM1
17714,GO:0097300,0.21259781246038,0.976383829030188,1,41,programmed necrotic cell death,BP,BOK
11186,GO:0043296,0.212612531416754,0.94494330760685,2,124,apical junction complex,CC,CLDN11;BVES
10710,GO:0042383,0.212671074553673,0.944918656100829,2,124,sarcolemma,CC,CAPN3;BVES
17265,GO:0090132,0.212821770980916,0.924802893088441,3,240,epithelium migration,BP,ANLN;ENPP2;GREM1
11645,GO:0044420,0.212931737269322,0.944856255349604,2,114,extracellular matrix component,CC,SMOC1;COL28A1
12169,GO:0045746,0.21299207362391,0.976320430611412,1,39,negative regulation of Notch signaling pathway,BP,EGFR
8369,GO:0032386,0.213459323555745,0.910712636701382,4,371,regulation of intracellular transport,BP,MLC1;BVES;SH3TC2;APOD
1197,GO:0002685,0.213502460075626,0.944448832555157,2,159,regulation of leukocyte migration,BP,GREM1;APOD
8429,GO:0032456,0.2141046236191,0.976147112654614,1,34,endocytic recycling,BP,BVES
9441,GO:0034614,0.2142184294925,0.944180204831301,2,147,cellular response to reactive oxygen species,BP,PDGFRA;EGFR
12167,GO:0045744,0.214500038765658,0.97595468920032,1,40,negative regulation of G-protein coupled receptor protein signaling pathway,BP,RGS4
21573,GO:2000648,0.214601935213332,0.976012181633844,1,35,positive regulation of stem cell proliferation,BP,SOX10
13625,GO:0050999,0.214676379532068,0.975928022478405,1,39,regulation of nitric-oxide synthase activity,BP,EGFR
722,GO:0001890,0.214814454484654,0.943964650843036,2,136,placenta development,BP,EGFR;GJA1
6811,GO:0021587,0.214831287728147,0.975977824792397,1,34,cerebellum morphogenesis,BP,KNDC1
12130,GO:0045668,0.21491342198144,0.975887924344361,1,38,negative regulation of osteoblast differentiation,BP,GREM1
7418,GO:0030551,0.214961567723481,0.975928196194623,1,35,cyclic nucleotide binding,MF,BVES
8507,GO:0032570,0.215310248096079,0.975750769789349,1,41,response to progesterone,BP,SOX10
644,GO:0001786,0.215768107774878,0.975703701890678,1,37,phosphatidylserine binding,MF,RASGRP1
11569,GO:0044283,0.21591412714467,0.89120613764493,6,674,small molecule biosynthetic process,BP,FOLH1;FA2H;PLP1;SLC45A3;GPD1;CARNS1
7466,GO:0030669,0.21617292495793,0.975547516566946,1,41,clathrin-coated endocytic vesicle membrane,CC,EGFR
18966,GO:1901564,0.216191122421497,0.839639079119588,41,5974,organonitrogen compound metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;FA2H;PLCL1;RGS4;CDK18;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;CNDP1;GJA1;FZD7;ADAMTS4;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;KNDC1;CARNS1;RASGRP1;UGT8;BOK;AATK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
3667,GO:0007204,0.216255441762275,0.922983306080872,3,257,positive regulation of cytosolic calcium ion concentration,BP,CAPN3;PDGFRA;GJA1
16653,GO:0072006,0.216807072949813,0.9431521876367,2,127,nephron development,BP,PDGFRA;GREM1
15534,GO:0062013,0.217230738170308,0.942910524711211,2,143,positive regulation of small molecule metabolic process,BP,SLC45A3;GPD1
3861,GO:0008038,0.21767635212828,0.975351834655225,1,32,neuron recognition,BP,CNTN2
3488,GO:0006897,0.21773325510445,0.890032288106745,6,632,endocytosis,BP,LRP2;TF;MLC1;ENPP2;GREM1;CNTN2
16406,GO:0071548,0.218237351787494,0.975057366777438,1,41,response to dexamethasone,BP,EGFR
18316,GO:0099738,0.21831155564766,0.97515798859656,1,34,cell cortex region,CC,ANLN
8920,GO:0033218,0.219053822472061,0.92148794012944,3,273,amide binding,MF,FOLH1;MAG;PEX5L
17263,GO:0090130,0.219258750781138,0.921426210094993,3,245,tissue migration,BP,ANLN;ENPP2;GREM1
14508,GO:0060043,0.219335956159856,0.974874934743152,1,36,regulation of cardiac muscle cell proliferation,BP,GJA1
12639,GO:0046777,0.219460545092017,0.921357862283751,3,226,protein autophosphorylation,BP,PDGFRA;EGFR;GREM1
1632,GO:0003777,0.219996098673199,0.941858280568481,2,112,microtubule motor activity,MF,MYO1D;DNAH17
14713,GO:0060341,0.220058578999091,0.88211319581248,7,761,regulation of cellular localization,BP,NGFR;CAPN3;MLC1;BVES;EGFR;SH3TC2;APOD
13752,GO:0051181,0.220107153118474,0.974608845227423,1,41,cofactor transport,BP,LRP2
14048,GO:0051716,0.220886050150587,0.835389499217961,43,6193,cellular response to stimulus,BP,CRLF1;NGFR;EYA2;ERBB3;DCX;LRP2;TF;CAPN3;SOX10;MLC1;MAG;PEX5L;PLCL1;RGS4;PLP1;PDGFRA;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;ST18;GJA1;PIEZO2;FZD7;PHKG1;GREM1;GPD1;PPP1R14A;KLK6;SH3TC2;KNDC1;MAL;RASGRP1;SUSD5;BOK;S1PR5;GPR62;CNTN2;APOD;SPOCK3;MBP;SMOC1
12227,GO:0045861,0.220953408439064,0.920481015280478,3,275,negative regulation of proteolysis,BP,NGFR;SPOCK3;COL28A1
3423,GO:0006793,0.221091871581675,0.845349742362012,22,2947,phosphorus metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;PLCL1;RGS4;CDK18;PDGFRA;ENPP2;EGFR;FZD7;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;MYO1D;AATK;MBP;GJC2
3767,GO:0007431,0.221671343369623,0.974277047952484,1,38,salivary gland development,BP,EGFR
16693,GO:0072073,0.221750525110134,0.941012752249882,2,130,kidney epithelium development,BP,CRLF1;GREM1
7745,GO:0031226,0.221954449114724,0.86117321655315,12,1460,intrinsic component of plasma membrane,CC,NGFR;ERBB3;FOLH1;MAG;PDGFRA;SLC31A2;ENPP2;EGFR;GJA1;KCNJ6;SLC5A11;CNTN2
14177,GO:0051959,0.222031077321794,0.974388878740825,1,29,dynein light intermediate chain binding,MF,DNAH17
6758,GO:0021517,0.222081313033329,0.974130552412934,1,41,ventral spinal cord development,BP,NKX6-2
13435,GO:0050707,0.222256370382813,0.940733197752602,2,146,regulation of cytokine secretion,BP,RASGRP1;MBP
16012,GO:0070848,0.222315557243079,0.887012435007331,6,626,response to growth factor,BP,NGFR;LRP2;PDGFRA;PCSK6;EGFR;GREM1
3821,GO:0007605,0.222522071646449,0.940665418609843,2,133,sensory perception of sound,BP,LRP2;MBP
21849,GO:2001244,0.222710309010265,0.973889977103641,1,48,positive regulation of intrinsic apoptotic signaling pathway,BP,BOK
17976,GO:0098631,0.222777851003137,0.973975589761515,1,40,cell adhesion mediator activity,MF,GLDN
18992,GO:1901618,0.223170712029775,0.973879536783003,1,40,organic hydroxy compound transmembrane transporter activity,MF,SLC5A11
967,GO:0002279,0.223311151505399,0.973815815073204,1,42,mast cell activation involved in immune response,BP,RASGRP1
11192,GO:0043303,0.223311151505399,0.973815815073204,1,42,mast cell degranulation,BP,RASGRP1
13083,GO:0048511,0.224546448349107,0.918596730009284,3,258,rhythmic process,BP,NGFR;PDGFRA;EGFR
6235,GO:0017145,0.224804941910806,0.973528532839349,1,37,stem cell division,BP,FZD7
13436,GO:0050708,0.224821845731855,0.904039608618597,4,374,regulation of protein secretion,BP,EGFR;GJA1;RASGRP1;MBP
11041,GO:0043062,0.224913316342304,0.904005688620649,4,356,extracellular structure organization,BP,COL9A3;HAPLN2;ADAMTS4;GREM1
8702,GO:0032874,0.225084156171945,0.939535133418283,2,136,positive regulation of stress-activated MAPK cascade,BP,FZD7;RASGRP1
7179,GO:0030135,0.225267042675252,0.918208064164942,3,260,coated vesicle,CC,LRP2;TF;EGFR
11564,GO:0044275,0.225552578250393,0.973309152382112,1,39,cellular carbohydrate catabolic process,BP,PHKG1
2402,GO:0005048,0.225712872486834,0.973269449070499,1,39,signal sequence binding,MF,PEX5L
6807,GO:0021575,0.226497983003089,0.973109664529904,1,37,hindbrain morphogenesis,BP,KNDC1
17238,GO:0090087,0.226636259978457,0.884133123807529,6,642,regulation of peptide transport,BP,EGFR;GJA1;SH3TC2;RASGRP1;APOD;MBP
21190,GO:2000045,0.226925693568868,0.938692247760004,2,145,regulation of G1/S transition of mitotic cell cycle,BP,EGFR;GJC2
21844,GO:2001239,0.226988704157695,0.972878107557982,1,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA2
4641,GO:0009948,0.227018192554605,0.972884189858535,1,43,anterior/posterior axis specification,BP,PCSK6
8748,GO:0032934,0.227153286220548,0.972879329837612,1,41,sterol binding,MF,APOD
10144,GO:0036094,0.227179296062034,0.845309034040538,18,2253,small molecule binding,MF,ERBB3;TUBB4A;MAG;BVES;PLCL1;CDK18;ATP10B;HAPLN2;PDGFRA;EGFR;PHKG1;GPD1;CARNS1;SUSD5;MYO1D;AATK;DNAH17;APOD
13729,GO:0051148,0.227262693160614,0.972867545333021,1,40,negative regulation of muscle cell differentiation,BP,FZD7
18793,GO:1901028,0.227457231794908,0.97273556403103,1,46,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
15728,GO:0070304,0.227718447506978,0.938371946274706,2,137,positive regulation of stress-activated protein kinase signaling cascade,BP,FZD7;RASGRP1
17391,GO:0090303,0.227800836242827,0.972702364550771,1,42,positive regulation of wound healing,BP,CAPN3
7222,GO:0030195,0.228504323702976,0.97249768147557,1,44,negative regulation of blood coagulation,BP,PDGFRA
18592,GO:1900047,0.228504323702976,0.97249768147557,1,44,negative regulation of hemostasis,BP,PDGFRA
19413,GO:1902743,0.228551605324547,0.972578386476787,1,38,regulation of lamellipodium organization,BP,ENPP2
21841,GO:2001236,0.228857401066828,0.937834379255243,2,146,regulation of extrinsic apoptotic signaling pathway,BP,EYA2;MAL
1380,GO:0003018,0.228893943043885,0.937825236390398,2,144,vascular process in circulatory system,BP,EGFR;GJA1
7128,GO:0030036,0.229399186562053,0.882311750591104,6,598,actin cytoskeleton organization,BP,ANLN;CAPN3;LDB3;PDGFRA;ERMN;TMSB15A
18859,GO:1901224,0.229556521634359,0.9722456259059,1,43,positive regulation of NIK/NF-kappaB signaling,BP,EGFR
19122,GO:1901987,0.229572181287512,0.901178627783298,4,400,regulation of cell cycle phase transition,BP,ANLN;TUBB4A;EGFR;GJC2
7039,GO:0022602,0.229679785330725,0.972276577537106,1,39,ovulation cycle process,BP,PDGFRA
3269,GO:0006575,0.229872913046256,0.937341342233405,2,159,cellular modified amino acid metabolic process,BP,FOLH1;CARNS1
947,GO:0002244,0.230133142259449,0.937225430195437,2,159,hematopoietic progenitor cell differentiation,BP,ANLN;BVES
13768,GO:0051205,0.230174630727889,0.97204920840087,1,46,protein insertion into membrane,BP,EGFR
5099,GO:0010977,0.23018186632593,0.937291614045704,2,134,negative regulation of neuron projection development,BP,NGFR;MAG
12826,GO:0047496,0.230574083251469,0.972067731098196,1,38,vesicle transport along microtubule,BP,RASGRP1
1467,GO:0003197,0.230978465462015,0.971947218123153,1,39,endocardial cushion development,BP,ERBB3
10549,GO:0042059,0.231054948247703,0.971894761012954,1,41,negative regulation of epidermal growth factor receptor signaling pathway,BP,EGFR
13070,GO:0048483,0.231392503212429,0.971841765032011,1,39,autonomic nervous system development,BP,SOX10
12749,GO:0046982,0.232116750627499,0.899645281934737,4,404,protein heterodimerization activity,MF,CRLF1;ERBB3;EGFR;BOK
7696,GO:0031103,0.232480315708124,0.97154655183636,1,40,axon regeneration,BP,APOD
1071,GO:0002448,0.232510791495632,0.971478041418879,1,44,mast cell mediated immunity,BP,RASGRP1
7643,GO:0031018,0.232645943678622,0.971472222215729,1,42,endocrine pancreas development,BP,NKX6-2
15386,GO:0061614,0.232963197434883,0.971457839333996,1,38,pri-miRNA transcription by RNA polymerase II,BP,NGFR
16926,GO:0072503,0.233319029475585,0.898926798883005,4,397,cellular divalent inorganic cation homeostasis,BP,CAPN3;PDGFRA;GJA1;BOK
15703,GO:0070265,0.233687221227706,0.971123701799766,1,48,necrotic cell death,BP,BOK
3540,GO:0006984,0.233816693315842,0.971170509979758,1,42,ER-nucleus signaling pathway,BP,BOK
21121,GO:1990841,0.234083549651992,0.971169344101481,1,38,promoter-specific chromatin binding,MF,SOX10
13812,GO:0051271,0.234210831092698,0.913380470461113,3,255,negative regulation of cellular component movement,BP,GREM1;APOD;SPOCK3
13775,GO:0051222,0.234328164451967,0.898330173202793,4,384,positive regulation of protein transport,BP,EGFR;GJA1;RASGRP1;MBP
15537,GO:0065002,0.234390454964016,0.97092973752892,1,49,intracellular protein transmembrane transport,BP,PEX5L
17565,GO:0097035,0.234951711467349,0.970964095088168,1,37,regulation of membrane lipid distribution,BP,ATP10B
19883,GO:1903727,0.235016692474773,0.970859449985049,1,42,positive regulation of phospholipid metabolic process,BP,PDGFRA
3758,GO:0007411,0.235650134689886,0.912631015150873,3,236,axon guidance,BP,ARX;NGFR;CNTN2
3812,GO:0007595,0.235913181314366,0.970676221341223,1,39,lactation,BP,GJA1
4974,GO:0010823,0.236610447353609,0.9703996005954,1,45,negative regulation of mitochondrion organization,BP,BOK
9625,GO:0035148,0.236641821670263,0.934363097782163,2,140,tube formation,BP,LRP2;GREM1
18136,GO:0098927,0.236725606527904,0.970446255182541,1,40,vesicle-mediated transport between endosomal compartments,BP,MYO1D
7117,GO:0030018,0.237111912492227,0.934242756993357,2,120,Z disc,CC,CAPN3;LDB3
13243,GO:0048806,0.237645912790228,0.97020470069762,1,40,genitalia development,BP,LRP2
671,GO:0001822,0.237774611594534,0.911442785240186,3,246,kidney development,BP,CRLF1;PDGFRA;GREM1
16286,GO:0071364,0.238796597276764,0.969919212997782,1,39,cellular response to epidermal growth factor stimulus,BP,EGFR
7704,GO:0031113,0.238960391737185,0.969840611808528,1,41,regulation of microtubule polymerization,BP,TUBB4A
10777,GO:0042531,0.239156941233621,0.969688077082034,1,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,CRLF1
13516,GO:0050819,0.23935726161006,0.969647306725658,1,47,negative regulation of coagulation,BP,PDGFRA
17806,GO:0097485,0.239435941969669,0.910542878004617,3,238,neuron projection guidance,BP,ARX;NGFR;CNTN2
10642,GO:0042267,0.239779951577724,0.969522124517399,1,48,natural killer cell mediated cytotoxicity,BP,RASGRP1
17100,GO:0080134,0.240008844443312,0.853922357627747,10,1237,regulation of response to stress,BP,EYA2;CAPN3;MLC1;PDGFRA;EGFR;GJA1;FZD7;RASGRP1;BOK;APOD
6756,GO:0021515,0.240162377712741,0.969445797605873,1,46,cell differentiation in spinal cord,BP,NKX6-2
19771,GO:1903522,0.240199429886506,0.910076288090103,3,260,regulation of blood circulation,BP,BVES;EGFR;GJA1
7558,GO:0030866,0.240275408463384,0.969526844346109,1,39,cortical actin cytoskeleton organization,BP,ANLN
4690,GO:0010107,0.240584999732449,0.96942601916217,1,40,potassium ion import,BP,KCNJ6
17122,GO:0086009,0.240661472950304,0.969405610612709,1,40,membrane repolarization,BP,GJA1
7136,GO:0030048,0.241120708685463,0.932406216786757,2,121,actin filament-based movement,BP,GJA1;MOBP
13661,GO:0051046,0.241375146348391,0.874184053531394,6,657,regulation of secretion,BP,ERBB3;EGFR;GJA1;LGI3;RASGRP1;MBP
9638,GO:0035196,0.241629664271477,0.969146578453316,1,40,production of miRNAs involved in gene silencing by miRNA,BP,EGFR
10043,GO:0035924,0.242003289529472,0.969028659229059,1,41,cellular response to vascular endothelial growth factor stimulus,BP,PDGFRA
3337,GO:0006665,0.242064137158407,0.931843257901412,2,150,sphingolipid metabolic process,BP,FA2H;UGT8
7182,GO:0030139,0.242327924572755,0.908866264911494,3,276,endocytic vesicle,CC,LRP2;TF;EGFR
4518,GO:0009435,0.242557832596329,0.96878896690794,1,47,NAD biosynthetic process,BP,NNMT
11052,GO:0043086,0.242688702721815,0.873271364447948,6,688,negative regulation of catalytic activity,BP,NGFR;RGS4;PPP1R14A;MYO1D;SPOCK3;COL28A1
15664,GO:0070201,0.243163596874457,0.872962885167163,6,656,regulation of establishment of protein localization,BP,EGFR;GJA1;SH3TC2;RASGRP1;APOD;MBP
11341,GO:0043551,0.243192133603117,0.96872601100251,1,40,regulation of phosphatidylinositol 3-kinase activity,BP,PDGFRA
8116,GO:0031952,0.243596194528734,0.96863552633786,1,39,regulation of protein autophosphorylation,BP,GREM1
6783,GO:0021545,0.243641679503485,0.968569528247586,1,42,cranial nerve development,BP,ERBB3
684,GO:0001836,0.244188180273068,0.968265517030509,1,54,release of cytochrome c from mitochondria,BP,BOK
12923,GO:0048066,0.244220272740913,0.968412491791812,1,42,developmental pigmentation,BP,SOX10
7230,GO:0030204,0.244468196196671,0.968362207646911,1,41,chondroitin sulfate metabolic process,BP,SPOCK3
17241,GO:0090090,0.244735980391184,0.930568054707314,2,161,negative regulation of canonical Wnt signaling pathway,BP,SOX10;GREM1
18244,GO:0099512,0.245328193261331,0.864529606025793,7,752,supramolecular fiber,CC,DCX;CAPN3;TUBB4A;LDB3;GJA1;TMSB15A;DNAH17
14190,GO:0051972,0.245425025170887,0.968036924869219,1,45,regulation of telomerase activity,BP,GREM1
12123,GO:0045661,0.246004799725191,0.967863580674641,1,46,regulation of myoblast differentiation,BP,CAPN3
6289,GO:0018105,0.246228254826349,0.90672308702067,3,255,peptidyl-serine phosphorylation,BP,PLCL1;EGFR;PHKG1
8477,GO:0032515,0.246538932801737,0.967716728206104,1,46,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R14A
7921,GO:0031526,0.246777050969765,0.96771337729969,1,42,brush border membrane,CC,LRP2
9999,GO:0035850,0.246854810374293,0.967709454299666,1,41,epithelial cell differentiation involved in kidney development,BP,GREM1
5822,GO:0016331,0.247008206183644,0.929572045745661,2,143,morphogenesis of embryonic epithelium,BP,LRP2;GREM1
2767,GO:0005788,0.247246154484844,0.90612817220734,3,267,endoplasmic reticulum lumen,CC,TF;COL9A3;COL28A1
7155,GO:0030101,0.247576378611551,0.967390186005205,1,49,natural killer cell activation,BP,RASGRP1
2142,GO:0004672,0.248016642766242,0.86966644122908,6,597,protein kinase activity,MF,ERBB3;CDK18;PDGFRA;EGFR;PHKG1;AATK
3788,GO:0007519,0.248472003451491,0.928858189588203,2,150,skeletal muscle tissue development,BP,CAPN3;BVES
2412,GO:0005080,0.249557448683342,0.966926485469052,1,43,protein kinase C binding,MF,LDB3
9613,GO:0035107,0.249966525330096,0.928185721249611,2,142,appendage morphogenesis,BP,GJA1;GREM1
9614,GO:0035108,0.249966525330096,0.928185721249611,2,142,limb morphogenesis,BP,GJA1;GREM1
18907,GO:1901342,0.250380817494646,0.904353798796121,3,269,regulation of vasculature development,BP,NGFR;ENPP2;GREM1
8326,GO:0032330,0.250548338710903,0.966666711046287,1,42,regulation of chondrocyte differentiation,BP,GREM1
733,GO:0001910,0.250692647547982,0.966484312917255,1,52,regulation of leukocyte mediated cytotoxicity,BP,RASGRP1
1118,GO:0002532,0.250894367206859,0.966491066341453,1,47,production of molecular mediator involved in inflammatory response,BP,APOD
10352,GO:0038023,0.251202867827201,0.860317770344485,7,829,signaling receptor activity,MF,NGFR;ERBB3;PDGFRA;EGFR;FZD7;S1PR5;GPR62
14549,GO:0060089,0.251202867827201,0.860317770344485,7,829,molecular transducer activity,MF,NGFR;ERBB3;PDGFRA;EGFR;FZD7;S1PR5;GPR62
13193,GO:0048701,0.25175010589268,0.966311971749644,1,43,embryonic cranial skeleton morphogenesis,BP,PDGFRA
13387,GO:0050654,0.251898867913551,0.966270052765417,1,43,chondroitin sulfate proteoglycan metabolic process,BP,SPOCK3
13591,GO:0050922,0.251963422025755,0.966219471636567,1,45,negative regulation of chemotaxis,BP,GREM1
13736,GO:0051155,0.252272906873696,0.966102373049597,1,47,positive regulation of striated muscle cell differentiation,BP,GREM1
12611,GO:0046686,0.252539329175815,0.965919416736394,1,56,response to cadmium ion,BP,EGFR
10986,GO:0042982,0.252925789684239,0.965932017112983,1,46,amyloid precursor protein metabolic process,BP,KLK6
16493,GO:0071674,0.253009804983567,0.965795876769311,1,55,mononuclear cell migration,BP,GREM1
6519,GO:0019362,0.253484350740715,0.926459053128358,2,157,pyridine nucleotide metabolic process,BP,NNMT;GPD1
12509,GO:0046496,0.253484350740715,0.926459053128358,2,157,nicotinamide nucleotide metabolic process,BP,NNMT;GPD1
21843,GO:2001238,0.253655879182154,0.965682371868644,1,49,positive regulation of extrinsic apoptotic signaling pathway,BP,MAL
19432,GO:1902806,0.253726292530891,0.926347111674615,2,156,regulation of cell cycle G1/S phase transition,BP,EGFR;GJC2
16553,GO:0071806,0.25375926023252,0.965592908526769,1,54,protein transmembrane transport,BP,PEX5L
14442,GO:0055082,0.253854992398161,0.865576917374386,6,682,cellular chemical homeostasis,BP,TF;CAPN3;PDGFRA;SLC31A2;GJA1;BOK
18200,GO:0099081,0.254054909770935,0.858306341536907,7,759,supramolecular polymer,CC,DCX;CAPN3;TUBB4A;LDB3;GJA1;TMSB15A;DNAH17
20060,GO:1904062,0.25416951470492,0.902188095743186,3,274,regulation of cation transmembrane transport,BP,CAPN3;SLC31A2;GJC2
1631,GO:0003774,0.254252708411631,0.926216992714944,2,128,motor activity,MF,MYO1D;DNAH17
9669,GO:0035265,0.254299486657836,0.926127946328886,2,142,organ growth,BP,ARX;GJA1
6697,GO:0019898,0.254394550776044,0.902074050006809,3,266,extrinsic component of membrane,CC,CDH19;TF;SOX10
12516,GO:0046503,0.254656903054195,0.965396536844567,1,49,glycerolipid catabolic process,BP,ENPP2
4792,GO:0010524,0.254857084191025,0.965339218855386,1,49,positive regulation of calcium ion transport into cytosol,BP,CAPN3
10506,GO:0040013,0.254918404434421,0.901772425967524,3,267,negative regulation of locomotion,BP,GREM1;APOD;SPOCK3
18199,GO:0099080,0.255463449374788,0.857294978778053,7,760,supramolecular complex,CC,DCX;CAPN3;TUBB4A;LDB3;GJA1;TMSB15A;DNAH17
1274,GO:0002791,0.256198042394277,0.884798491965125,4,400,regulation of peptide secretion,BP,EGFR;GJA1;RASGRP1;MBP
12548,GO:0046579,0.256425490524291,0.964931479414281,1,46,positive regulation of Ras protein signal transduction,BP,RASGRP1
7655,GO:0031050,0.257786341785302,0.964587802554577,1,43,dsRNA fragmentation,BP,EGFR
16056,GO:0070918,0.257786341785302,0.964587802554577,1,43,production of small RNA involved in gene silencing by RNA,BP,EGFR
7692,GO:0031098,0.258153923203238,0.899909702426536,3,269,stress-activated protein kinase signaling cascade,BP,EGFR;FZD7;RASGRP1
942,GO:0002228,0.258177961907246,0.964341968272748,1,52,natural killer cell mediated immunity,BP,RASGRP1
15102,GO:0060976,0.258225754325916,0.964497750780092,1,41,coronary vasculature development,BP,LRP2
8602,GO:0032722,0.258664791411196,0.964225456079319,1,50,positive regulation of chemokine production,BP,MBP
13121,GO:0048583,0.259318789575846,0.810227181304089,26,3641,regulation of response to stimulus,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;MLC1;PEX5L;RGS4;PDGFRA;MOG;PCSK6;EGFR;ST18;GJA1;FZD7;GREM1;KLK6;SH3TC2;MAL;RASGRP1;BOK;GPR62;CNTN2;APOD
16013,GO:0070849,0.259456465990329,0.964102306091239,1,43,response to epidermal growth factor,BP,EGFR
8633,GO:0032768,0.259734623917789,0.963926337890856,1,49,regulation of monooxygenase activity,BP,EGFR
835,GO:0002042,0.259932446244472,0.963928818109544,1,45,cell migration involved in sprouting angiogenesis,BP,GREM1
13020,GO:0048306,0.260146778030638,0.963731236754987,1,55,calcium-dependent protein binding,MF,MYO1D
617,GO:0001755,0.261253901534648,0.963524630613452,1,46,neural crest cell migration,BP,SOX10
14003,GO:0051641,0.261415908477118,0.816132184573622,19,2548,cellular localization,BP,ANLN;NGFR;CAPN3;MLC1;PLLP;TUBB4A;BVES;PEX5L;EGFR;TMSB15A;MOBP;SH3TC2;MAL;RASGRP1;UGT8;MYO1D;CNTN2;ANKS1B;APOD
12571,GO:0046622,0.261442047315945,0.96350250058835,1,44,positive regulation of organ growth,BP,ARX
4864,GO:0010648,0.261447109638269,0.837673985382471,10,1238,negative regulation of cell communication,BP,EYA2;ERBB3;LRP2;SOX10;RGS4;PDGFRA;EGFR;GREM1;BOK;APOD
8001,GO:0031674,0.26178021427807,0.922569139561685,2,131,I band,CC,CAPN3;LDB3
4883,GO:0010676,0.261828807435913,0.963388480645314,1,44,positive regulation of cellular carbohydrate metabolic process,BP,SLC45A3
7164,GO:0030119,0.262382693892289,0.963207696338987,1,45,AP-type membrane coat adaptor complex,CC,EGFR
14858,GO:0060538,0.26243894556881,0.922136828019679,2,156,skeletal muscle organ development,BP,CAPN3;BVES
13210,GO:0048732,0.262683909326705,0.88068581554548,4,398,gland development,BP,SOX10;FA2H;EGFR;GJA1
6862,GO:0021695,0.262755606063677,0.96311444733342,1,44,cerebellar cortex development,BP,KNDC1
5302,GO:0015075,0.263613559966222,0.851392847764484,7,793,ion transmembrane transporter activity,MF,TF;SLC31A2;GJA1;PIEZO2;KCNJ6;SLC45A3;SLC5A11
2818,GO:0005875,0.263837578327258,0.921513650209718,2,141,microtubule associated complex,CC,DCX;DNAH17
8817,GO:0033036,0.263935878393385,0.812657805126623,20,2703,macromolecule localization,BP,ANLN;NGFR;LRP2;TF;CAPN3;MLC1;PLLP;PEX5L;ATP10B;EGFR;GJA1;SNX22;TMSB15A;SH3TC2;MAL;RASGRP1;UGT8;CNTN2;APOD;MBP
7225,GO:0030199,0.264293470096903,0.962675433555357,1,43,collagen fibril organization,BP,GREM1
10667,GO:0042306,0.264302230065677,0.962604637647243,1,47,regulation of protein import into nucleus,BP,APOD
2879,GO:0005978,0.264498766903921,0.962595949465813,1,44,glycogen biosynthetic process,BP,PHKG1
4457,GO:0009250,0.264498766903921,0.962595949465813,1,44,glucan biosynthetic process,BP,PHKG1
7102,GO:0023057,0.264625729931889,0.835230538755199,10,1242,negative regulation of signaling,BP,EYA2;ERBB3;LRP2;SOX10;RGS4;PDGFRA;EGFR;GREM1;BOK;APOD
13286,GO:0048878,0.264753760918517,0.844499314763179,8,971,chemical homeostasis,BP,NGFR;TF;CAPN3;PDGFRA;SLC31A2;EGFR;GJA1;BOK
6612,GO:0019722,0.265023889990851,0.92087180683067,2,155,calcium-mediated signaling,BP,ERBB3;EGFR
12056,GO:0045576,0.265121456541011,0.962288590009843,1,52,mast cell activation,BP,RASGRP1
12030,GO:0045453,0.26516115228392,0.962317469307906,1,49,bone resorption,BP,EGFR
19547,GO:1903036,0.265291173867453,0.962264280543318,1,50,positive regulation of response to wounding,BP,CAPN3
16941,GO:0072524,0.265874252328174,0.920426755267449,2,162,pyridine-containing compound metabolic process,BP,NNMT;GPD1
13150,GO:0048641,0.265965060793339,0.962122211716551,1,46,regulation of skeletal muscle tissue development,BP,CAPN3
9692,GO:0035308,0.266900076181347,0.961779295790985,1,50,negative regulation of protein dephosphorylation,BP,PPP1R14A
17299,GO:0090183,0.267189249328098,0.961721084847029,1,48,regulation of kidney development,BP,GREM1
13092,GO:0048522,0.267275618283987,0.799557509013578,32,4532,positive regulation of cellular process,BP,CRLF1;ANLN;NGFR;EYA2;ERBB3;LRP2;TF;CAPN3;SOX10;MAG;BVES;MYRF;PDGFRA;ENPP2;EGFR;ST18;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;GPD1;KLK6;KNDC1;MAL;RASGRP1;DMRT2;BOK;GPR62;CNTN2;MBP;GJC2
16650,GO:0072001,0.268779672822099,0.893727014084137,3,262,renal system development,BP,CRLF1;PDGFRA;GREM1
13410,GO:0050679,0.270315033263081,0.918235116278446,2,158,positive regulation of epithelial cell proliferation,BP,EGFR;FZD7
8608,GO:0032729,0.270409914569955,0.960643789514287,1,55,positive regulation of interferon-gamma production,BP,RASGRP1
14404,GO:0055010,0.270423581387431,0.960785188649516,1,45,ventricular cardiac muscle tissue morphogenesis,BP,LRP2
5287,GO:0015030,0.270549182900714,0.960625664057624,1,53,Cajal body,CC,ANKS1B
8289,GO:0032269,0.270598704180655,0.840130445709251,8,978,negative regulation of cellular protein metabolic process,BP,NGFR;CAPN3;RGS4;EGFR;GREM1;PPP1R14A;SPOCK3;COL28A1
10600,GO:0042157,0.270973961885641,0.917866495360929,2,169,lipoprotein metabolic process,BP,CPM;APOD
3427,GO:0006801,0.271010140918276,0.960447117622565,1,56,superoxide metabolic process,BP,EGFR
13562,GO:0050885,0.271085697405167,0.960600161215546,1,44,neuromuscular process controlling balance,BP,NKX6-2
15998,GO:0070830,0.271268194834159,0.960475341062612,1,48,bicellular tight junction assembly,BP,GJA1
13822,GO:0051287,0.271460303409898,0.960308068234452,1,56,NAD binding,MF,GPD1
727,GO:0001895,0.27187685092954,0.960229172376811,1,52,retina homeostasis,BP,TF
6109,GO:0016879,0.272054630821196,0.960232591831368,1,48,ligase activity, forming carbon-nitrogen bonds,MF,CARNS1
14413,GO:0055021,0.272908017188627,0.959984505900552,1,47,regulation of cardiac muscle tissue growth,BP,GJA1
15297,GO:0061383,0.272969444687458,0.959982433012098,1,46,trabecula morphogenesis,BP,GREM1
7695,GO:0031102,0.273536389003735,0.959757282103464,1,49,neuron projection regeneration,BP,APOD
3443,GO:0006826,0.273862954428897,0.959585731942997,1,54,iron ion transport,BP,TF
14124,GO:0051881,0.273867702008699,0.959526286093094,1,59,regulation of mitochondrial membrane potential,BP,BOK
14503,GO:0060038,0.273972925207503,0.95967048856243,1,46,cardiac muscle cell proliferation,BP,GJA1
10776,GO:0042509,0.274118647683576,0.959481372653587,1,56,regulation of tyrosine phosphorylation of STAT protein,BP,CRLF1
10711,GO:0042391,0.274409853759391,0.873120098979309,4,401,regulation of membrane potential,BP,BVES;GJA1;PIEZO2;BOK
19572,GO:1903078,0.274752321772857,0.959410060343182,1,47,positive regulation of protein localization to plasma membrane,BP,EGFR
11340,GO:0043550,0.274950101174247,0.959348185762344,1,47,regulation of lipid kinase activity,BP,PDGFRA
10743,GO:0042445,0.275811958884882,0.915392451131796,2,180,hormone metabolic process,BP,PCSK6;KLK6
13882,GO:0051393,0.276457242496715,0.959215214580305,1,33,alpha-actinin binding,MF,LDB3
13396,GO:0050663,0.276660826686976,0.914996374525929,2,169,cytokine secretion,BP,RASGRP1;MBP
14945,GO:0060688,0.27734094768878,0.95853280519511,1,51,regulation of morphogenesis of a branching structure,BP,GREM1
15851,GO:0070527,0.277358765160209,0.958512876124532,1,52,platelet aggregation,BP,PDGFRA
2968,GO:0006109,0.277491606287275,0.914625818762686,2,155,regulation of carbohydrate metabolic process,BP,SLC45A3;GPD1
20646,GO:1905330,0.277934662860924,0.914340701497896,2,171,regulation of morphogenesis of an epithelium,BP,FZD7;GREM1
7823,GO:0031341,0.278053790663358,0.958194769393292,1,60,regulation of cell killing,BP,RASGRP1
19333,GO:1902531,0.278242879075471,0.814501563544351,13,1671,regulation of intracellular signal transduction,BP,CRLF1;NGFR;ERBB3;CAPN3;PEX5L;RGS4;PDGFRA;EGFR;GJA1;FZD7;RASGRP1;BOK;GPR62
4057,GO:0008360,0.278547455128905,0.914091369755013,2,154,regulation of cell shape,BP,BVES;ERMN
15572,GO:0070059,0.278900504033929,0.957995573711105,1,54,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,BOK
13526,GO:0050840,0.278903777014869,0.958083210856084,1,48,extracellular matrix binding,MF,SMOC1
20483,GO:1904951,0.278956942779279,0.870124628944723,4,419,positive regulation of establishment of protein localization,BP,EGFR;GJA1;RASGRP1;MBP
7163,GO:0030118,0.278991577697668,0.958055245383919,1,48,clathrin coat,CC,EGFR
13148,GO:0048639,0.279561820543035,0.913585343446066,2,151,positive regulation of developmental growth,BP,ARX;CAPN3
5681,GO:0016052,0.279594296419191,0.913520389695427,2,163,carbohydrate catabolic process,BP,PHKG1;GPD1
3386,GO:0006733,0.280012973217185,0.9132738859146,2,172,oxidoreduction coenzyme metabolic process,BP,NNMT;GPD1
8370,GO:0032387,0.280528890227368,0.957448565046308,1,56,negative regulation of intracellular transport,BP,APOD
14532,GO:0060070,0.280706696272813,0.886544357922764,3,293,canonical Wnt signaling pathway,BP,SOX10;FZD7;GREM1
20292,GO:1904589,0.280949718382805,0.957381193633531,1,51,regulation of protein import,BP,APOD
13811,GO:0051270,0.282581426350341,0.837435838591798,7,813,regulation of cellular component movement,BP,ERBB3;PDGFRA;ENPP2;EGFR;GREM1;APOD;SPOCK3
6696,GO:0019897,0.282693256867006,0.911937649023032,2,160,extrinsic component of plasma membrane,CC,CDH19;TF
2278,GO:0004857,0.282936210418595,0.88515373060934,3,317,enzyme inhibitor activity,MF,PPP1R14A;SPOCK3;COL28A1
4665,GO:0010008,0.283303962281405,0.867249499906667,4,427,endosome membrane,CC,TF;EGFR;FZD7;BOK
5057,GO:0010921,0.283532319455167,0.91151999925277,2,156,regulation of phosphatase activity,BP,PPP1R14A;MYO1D
12520,GO:0046513,0.283617365927948,0.956475368252085,1,54,ceramide biosynthetic process,BP,UGT8
7827,GO:0031345,0.283650027561898,0.911450859754959,2,158,negative regulation of cell projection organization,BP,NGFR;MAG
3204,GO:0006501,0.283921503265563,0.956337634719918,1,57,C-terminal protein lipidation,BP,CPM
7512,GO:0030810,0.284128977464911,0.956282373839806,1,56,positive regulation of nucleotide biosynthetic process,BP,GPD1
18731,GO:1900373,0.284128977464911,0.956282373839806,1,56,positive regulation of purine nucleotide biosynthetic process,BP,GPD1
5180,GO:0014704,0.284291276161231,0.956365446503687,1,47,intercalated disc,CC,GJA1
7536,GO:0030837,0.28467467854805,0.956173890425029,1,51,negative regulation of actin filament polymerization,BP,TMSB15A
3699,GO:0007260,0.284890954534018,0.956008675434308,1,58,tyrosine phosphorylation of STAT protein,BP,CRLF1
7310,GO:0030315,0.28493562747038,0.956213332518393,1,44,T-tubule,CC,CAPN3
19146,GO:1902041,0.286346418613635,0.955568335146804,1,55,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
9815,GO:0035556,0.286373470956839,0.795375134017374,19,2556,intracellular signal transduction,BP,CRLF1;NGFR;ERBB3;DCX;CAPN3;PEX5L;PLCL1;RGS4;PDGFRA;RAPGEF5;EGFR;GJA1;FZD7;PHKG1;KNDC1;RASGRP1;BOK;GPR62;MBP
11008,GO:0043010,0.286657400261373,0.882958120125782,3,275,camera-type eye development,BP,PDGFRA;EGFR;GJA1
19010,GO:1901654,0.286845763447553,0.909732963260588,2,173,response to ketone,BP,SOX10;EGFR
10769,GO:0042493,0.287139259987332,0.834006664555838,7,876,response to drug,BP,LRP2;SOX10;EGFR;GJA1;NNMT;PPP1R14A;APOD
7557,GO:0030865,0.287166762725388,0.955388061034472,1,49,cortical cytoskeleton organization,BP,ANLN
9082,GO:0033674,0.287297786860762,0.851660976905209,5,543,positive regulation of kinase activity,BP,ERBB3;PDGFRA;EGFR;GREM1;RASGRP1
4968,GO:0010817,0.28742505646652,0.864495291083331,4,443,regulation of hormone levels,BP,PCSK6;EGFR;GJA1;KLK6
18857,GO:1901222,0.287978334091935,0.955029031529145,1,55,regulation of NIK/NF-kappaB signaling,BP,EGFR
11983,GO:0045334,0.288867277636072,0.954695108117446,1,58,clathrin-coated endocytic vesicle,CC,EGFR
2399,GO:0005044,0.288916960969557,0.95479187151228,1,50,scavenger receptor activity,MF,ENPP2
21737,GO:2001020,0.288992745109509,0.908615383982652,2,171,regulation of response to DNA damage stimulus,BP,EYA2;EGFR
12468,GO:0046427,0.289331186096841,0.954528404316133,1,59,positive regulation of JAK-STAT cascade,BP,CRLF1
15125,GO:0061005,0.289575929582488,0.95457254560893,1,50,cell differentiation involved in kidney development,BP,GREM1
6781,GO:0021543,0.289826258216161,0.908240100911344,2,155,pallium development,BP,ARX;EGFR
8133,GO:0031982,0.290687705169279,0.78354647708118,26,3837,vesicle,CC,CLDN11;NGFR;BCAS1;LRP2;FOLH1;TF;MLC1;PLLP;TUBB4A;ATP10B;PPL;CPM;ERMN;SLC31A2;EGFR;GJA1;FZD7;SNX22;EDIL3;GPD1;KLK6;LGI3;SH3TC2;MYO1D;BOK;APOD
13589,GO:0050920,0.290688347205108,0.907689055167571,2,181,regulation of chemotaxis,BP,PDGFRA;GREM1
13617,GO:0050982,0.290780455832615,0.954433125152001,1,38,detection of mechanical stimulus,BP,PIEZO2
16253,GO:0071320,0.291950893299979,0.953812068786142,1,48,cellular response to cAMP,BP,GPD1
3557,GO:0007010,0.292203915277715,0.813697024229968,10,1189,cytoskeleton organization,BP,ANLN;CAPN3;TUBB4A;PPL;LDB3;PDGFRA;ERMN;TMSB15A;UGT8;CNTN2
20457,GO:1904894,0.29237160200415,0.953495213095161,1,60,positive regulation of STAT cascade,BP,CRLF1
726,GO:0001894,0.292439584227842,0.906789856957326,2,173,tissue homeostasis,BP,TF;EGFR
2286,GO:0004867,0.293029269013579,0.953261019153119,1,61,serine-type endopeptidase inhibitor activity,MF,COL28A1
10033,GO:0035904,0.293504596140193,0.953306635594628,1,47,aorta development,BP,LRP2
17115,GO:0086002,0.294041757634984,0.95314437022457,1,46,cardiac muscle cell action potential involved in contraction,BP,GJA1
5609,GO:0015893,0.294081962389781,0.905900424267313,2,178,drug transport,BP,LRP2;GJA1
18245,GO:0099513,0.294106934501643,0.84685174060804,5,545,polymeric cytoskeletal fiber,CC,DCX;TUBB4A;GJA1;TMSB15A;DNAH17
3473,GO:0006879,0.294844443639464,0.95267946186939,1,58,cellular iron ion homeostasis,BP,TF
15783,GO:0070405,0.294860115597158,0.9526616183949,1,59,ammonium ion binding,MF,RASGRP1
7036,GO:0022414,0.295184907127244,0.815947727140129,9,1156,reproductive process,BP,CLDN11;LRP2;COL9A3;PDGFRA;EGFR;GJA1;GJB1;DMRT2;BOK
14754,GO:0060393,0.295259677672663,0.952563990353642,1,56,regulation of pathway-restricted SMAD protein phosphorylation,BP,GREM1
7165,GO:0030120,0.295539646996004,0.952496660865385,1,54,vesicle coat,CC,EGFR
13672,GO:0051057,0.296017474031888,0.952348156794814,1,53,positive regulation of small GTPase mediated signal transduction,BP,RASGRP1
2759,GO:0005778,0.296494304402242,0.952127420217369,1,57,peroxisomal membrane,CC,PEX5L
8092,GO:0031903,0.296494304402242,0.952127420217369,1,57,microbody membrane,CC,PEX5L
2,GO:0000003,0.297079127940562,0.814459097630655,9,1159,reproduction,BP,CLDN11;LRP2;COL9A3;PDGFRA;EGFR;GJA1;GJB1;DMRT2;BOK
3680,GO:0007219,0.29804061870263,0.903804168776439,2,172,Notch signaling pathway,BP,EGFR;SUSD5
7489,GO:0030705,0.298257060214416,0.903739446815057,2,159,cytoskeleton-dependent intracellular transport,BP,MOBP;RASGRP1
16299,GO:0071385,0.298597671178246,0.951401640216169,1,57,cellular response to glucocorticoid stimulus,BP,EGFR
420,GO:0001101,0.300122682323912,0.874540531760922,3,309,response to acid chemical,BP,EGFR;GJA1;FZD7
7289,GO:0030286,0.300518702612971,0.950879464853438,1,48,dynein complex,CC,DNAH17
1489,GO:0003229,0.300774405154768,0.950735834082917,1,51,ventricular cardiac muscle tissue development,BP,LRP2
2777,GO:0005801,0.300786044274512,0.95068330687933,1,54,cis-Golgi network,CC,BOK
717,GO:0001885,0.300873990193414,0.950668134142865,1,53,endothelial cell development,BP,HAPLN2
13123,GO:0048585,0.301147665164758,0.802489521081779,11,1437,negative regulation of response to stimulus,BP,EYA2;ERBB3;LRP2;SOX10;RGS4;PDGFRA;EGFR;GJA1;GREM1;BOK;APOD
560,GO:0001658,0.301339068259114,0.950489915252851,1,54,branching involved in ureteric bud morphogenesis,BP,GREM1
12693,GO:0046889,0.301616742412799,0.950335534892085,1,58,positive regulation of lipid biosynthetic process,BP,SLC45A3
11626,GO:0044380,0.301928801618177,0.950367927428367,1,49,protein localization to cytoskeleton,BP,ANLN
8739,GO:0032922,0.302193614126227,0.950256765087737,1,50,circadian regulation of gene expression,BP,NGFR
4675,GO:0010038,0.302806417910445,0.872853655040619,3,306,response to metal ion,BP,TF;CAPN3;EGFR
14775,GO:0060420,0.302975729300282,0.949930827989335,1,53,regulation of heart growth,BP,GJA1
18518,GO:0140056,0.302994429241644,0.901132516760243,2,170,organelle localization by membrane tethering,BP,TUBB4A;BVES
13154,GO:0048645,0.303293138847202,0.949745390474572,1,58,animal organ formation,BP,LRP2
11666,GO:0044448,0.304095672374222,0.900586833822792,2,157,cell cortex part,CC,ANLN;MOBP
5221,GO:0014823,0.304793420151894,0.949241997513183,1,56,response to activity,BP,CAPN3
6692,GO:0019887,0.305378472055668,0.89978441224958,2,183,protein kinase regulator activity,MF,ERBB3;GREM1
4617,GO:0009880,0.305596887278701,0.948956192121871,1,56,embryonic pattern specification,BP,PCSK6
19853,GO:1903670,0.305603684287884,0.948968673359293,1,55,regulation of sprouting angiogenesis,BP,NGFR
763,GO:0001947,0.305909725214337,0.948859596549448,1,55,heart looping,BP,GJA1
14571,GO:0060135,0.30610328539587,0.948775589720928,1,56,maternal process involved in female pregnancy,BP,GJA1
2437,GO:0005126,0.306158427800892,0.8992935351621,2,204,cytokine receptor binding,MF,CRLF1;GREM1
20189,GO:1904377,0.306198835842926,0.948788050615615,1,53,positive regulation of protein localization to cell periphery,BP,EGFR
4455,GO:0009247,0.30668728321162,0.948463716514613,1,64,glycolipid biosynthetic process,BP,UGT8
13160,GO:0048663,0.306688675316726,0.948511345086858,1,60,neuron fate commitment,BP,NKX6-2
17996,GO:0098657,0.306735949726874,0.827398700073656,6,709,import into cell,BP,LRP2;TF;MLC1;ENPP2;GREM1;CNTN2
12948,GO:0048168,0.306856956559911,0.948569699212871,1,52,regulation of neuronal synaptic plasticity,BP,CNTN2
11051,GO:0043085,0.307178194414287,0.801710924078551,10,1279,positive regulation of catalytic activity,BP,NGFR;ERBB3;RGS4;PDGFRA;EGFR;ST18;GREM1;RASGRP1;BOK;MBP
586,GO:0001701,0.307447642423249,0.86993084890033,3,293,in utero embryonic development,BP,SOX10;EGFR;GJA1
8158,GO:0032024,0.307538133020274,0.94819387797713,1,61,positive regulation of insulin secretion,BP,GJA1
3311,GO:0006631,0.307546968590564,0.869807914553066,3,327,fatty acid metabolic process,BP,FA2H;PLP1;SLC45A3
2633,GO:0005548,0.307903619888214,0.948194577325247,1,52,phospholipid transporter activity,MF,ATP10B
6171,GO:0017022,0.308467762971159,0.947898724791559,1,58,myosin binding,MF,MOBP
10617,GO:0042180,0.308563535518222,0.897983266492927,2,199,cellular ketone metabolic process,BP,SLC45A3;GPD1
6175,GO:0017038,0.308804325940676,0.897914277331913,2,179,protein import,BP,PEX5L;APOD
12131,GO:0045669,0.309330140677124,0.947616224630175,1,56,positive regulation of osteoblast differentiation,BP,GJA1
5489,GO:0015672,0.309362167627606,0.849598351989409,4,443,monovalent inorganic cation transport,BP,NKAIN1;KCNJ6;SLC5A11;NKAIN2
9537,GO:0034764,0.310463081475225,0.897026455113856,2,171,positive regulation of transmembrane transport,BP,CAPN3;GJC2
16298,GO:0071384,0.31154227200806,0.94674310912253,1,61,cellular response to corticosteroid stimulus,BP,EGFR
14750,GO:0060389,0.311671072160473,0.94672257328764,1,59,pathway-restricted SMAD protein phosphorylation,BP,GREM1
4026,GO:0008307,0.311691830344564,0.947016151140116,1,43,structural constituent of muscle,MF,CAPN3
13493,GO:0050789,0.312037269023522,0.759757575009614,64,9735,regulation of biological process,BP,ARX;CRLF1;ANLN;NGFR;EYA2;ERBB3;DCX;LRP2;NKAIN1;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;PLP1;MYRF;PDGFRA;RAPGEF5;ERMN;SLC31A2;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;CNTNAP4;FZD7;KCNJ6;TMSB15A;SLC45A3;EDIL3;PHKG1;GREM1;GPD1;PPP1R14A;KLK6;LGI3;SH3TC2;KNDC1;MAL;RASGRP1;DMRT2;SUSD5;MYO1D;BOK;S1PR5;GPR62;CNTN2;NKAIN2;APOD;SPOCK3;MBP;SMOC1;GJC2;COL28A1
2856,GO:0005938,0.313255693546208,0.866233185714983,3,280,cell cortex,CC,ANLN;ERMN;MOBP
5678,GO:0016049,0.313674551924503,0.846612770505683,4,437,cell growth,BP,MAG;EGFR;GJA1;GREM1
17716,GO:0097306,0.313887057950054,0.946002670611329,1,53,cellular response to alcohol,BP,MLC1
17165,GO:0086065,0.314075157432874,0.945951052787976,1,52,cell communication involved in cardiac conduction,BP,GJA1
8396,GO:0032418,0.314849706894992,0.94551463935062,1,62,lysosome localization,BP,RASGRP1
11187,GO:0043297,0.315159003081576,0.945469133493587,1,57,apical junction assembly,BP,GJA1
13174,GO:0048678,0.315222301992142,0.945376684613048,1,62,response to axon injury,BP,APOD
97,GO:0000186,0.315404940378906,0.94544278806647,1,53,activation of MAPKK activity,BP,EGFR
3646,GO:0007178,0.315653487085938,0.864642264218679,3,300,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,LRP2;PCSK6;GREM1
10932,GO:0042805,0.315752684744167,0.94558470284591,1,41,actinin binding,MF,LDB3
7283,GO:0030279,0.315929456110588,0.945140652901002,1,60,negative regulation of ossification,BP,GREM1
12424,GO:0046324,0.31667441120529,0.94492221441318,1,56,regulation of glucose import,BP,NGFR
9906,GO:0035690,0.316744693752114,0.86390866826466,3,314,cellular response to drug,BP,SOX10;EGFR;PPP1R14A
8517,GO:0032589,0.31676385711819,0.944938738343273,1,53,neuron projection membrane,CC,MYO1D
2323,GO:0004930,0.316982112186943,0.86369046894041,3,355,G-protein coupled receptor activity,MF,FZD7;S1PR5;GPR62
11496,GO:0044093,0.317441156491515,0.785545306266831,12,1584,positive regulation of molecular function,BP,NGFR;ERBB3;CAPN3;PLCL1;RGS4;PDGFRA;EGFR;ST18;GREM1;RASGRP1;BOK;MBP
12062,GO:0045582,0.317756190764667,0.944408232283313,1,64,positive regulation of T cell differentiation,BP,RASGRP1
15294,GO:0061371,0.317921268029477,0.944426610548294,1,58,determination of heart left/right asymmetry,BP,GJA1
8626,GO:0032760,0.317989354589149,0.944320914597751,1,64,positive regulation of tumor necrosis factor production,BP,RASGRP1
8689,GO:0032835,0.318059435246211,0.944438351875577,1,54,glomerulus development,BP,PDGFRA
15145,GO:0061035,0.31817569610288,0.944361997701353,1,56,regulation of cartilage development,BP,GREM1
3755,GO:0007405,0.318536036904747,0.944277413304123,1,53,neuroblast proliferation,BP,SOX10
17023,GO:0072676,0.318723821859116,0.943968575387914,1,71,lymphocyte migration,BP,APOD
618,GO:0001756,0.319561900871064,0.943826134076762,1,57,somitogenesis,BP,DMRT2
3836,GO:0007623,0.319690529500396,0.891810993352146,2,182,circadian rhythm,BP,NGFR;EGFR
13569,GO:0050896,0.320152986898382,0.749167814545417,49,7420,response to stimulus,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;DCX;LRP2;TF;CAPN3;SOX10;MLC1;PLLP;MAG;BVES;PEX5L;PLCL1;RGS4;PPL;PLP1;PDGFRA;RAPGEF5;ENPP2;MOG;PCSK6;EGFR;ST18;GJA1;PIEZO2;FZD7;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;SH3TC2;KNDC1;MAL;RASGRP1;SUSD5;BOK;S1PR5;GPR62;CNTN2;APOD;SPOCK3;MBP;SMOC1;GJC2
2955,GO:0006094,0.320328353850567,0.943405417488642,1,67,gluconeogenesis,BP,GPD1
21153,GO:1990939,0.320696997486181,0.943564165521725,1,48,ATP-dependent microtubule motor activity,MF,DNAH17
7213,GO:0030178,0.322505421023523,0.890168048074115,2,194,negative regulation of Wnt signaling pathway,BP,SOX10;GREM1
16706,GO:0072091,0.322934470708045,0.94254868785042,1,57,regulation of stem cell proliferation,BP,SOX10
18054,GO:0098796,0.323036004347361,0.79955699476693,8,1052,membrane protein complex,CC,CDH19;TF;EGFR;GJA1;KCNJ6;GJB1;CNTN2;GJC2
17367,GO:0090276,0.323065612536118,0.889881937477667,2,184,regulation of peptide hormone secretion,BP,EGFR;GJA1
8691,GO:0032838,0.323382501911706,0.88975942944054,2,169,plasma membrane bounded cell projection cytoplasm,CC,TUBB4A;DNAH17
7858,GO:0031410,0.323715514965508,0.77159050335251,15,2091,cytoplasmic vesicle,CC,NGFR;LRP2;TF;MLC1;ATP10B;SLC31A2;EGFR;GJA1;FZD7;SNX22;KLK6;LGI3;SH3TC2;MYO1D;BOK
21527,GO:2000573,0.323855760902481,0.942110876223338,1,63,positive regulation of DNA biosynthetic process,BP,GREM1
7029,GO:0022406,0.324107765198906,0.889303888661733,2,179,membrane docking,BP,TUBB4A;BVES
5617,GO:0015914,0.324359956706646,0.94198817297641,1,58,phospholipid transport,BP,ATP10B
10510,GO:0040017,0.32500134271078,0.838636456654677,4,452,positive regulation of locomotion,BP,BVES;PDGFRA;ENPP2;EGFR
4644,GO:0009952,0.325038967144382,0.888751017993491,2,184,anterior/posterior pattern specification,BP,PCSK6;DMRT2
14935,GO:0060675,0.325088459732083,0.941693336228841,1,59,ureteric bud morphogenesis,BP,GREM1
8623,GO:0032755,0.325358780740646,0.941520575146343,1,64,positive regulation of interleukin-6 production,BP,MBP
13164,GO:0048667,0.325430133680164,0.824115530144761,5,538,cell morphogenesis involved in neuron differentiation,BP,ARX;NGFR;MAG;KNDC1;CNTN2
2631,GO:0005546,0.325833552193298,0.941391702055441,1,60,phosphatidylinositol-4,5-bisphosphate binding,MF,FZD7
17897,GO:0097708,0.326132083157419,0.769534576236912,15,2094,intracellular vesicle,CC,NGFR;LRP2;TF;MLC1;ATP10B;SLC31A2;EGFR;GJA1;FZD7;SNX22;KLK6;LGI3;SH3TC2;MYO1D;BOK
10886,GO:0042733,0.327227196932766,0.940852736355094,1,60,embryonic digit morphogenesis,BP,GJA1
19796,GO:1903557,0.327417658080981,0.940699204226036,1,66,positive regulation of tumor necrosis factor superfamily cytokine production,BP,RASGRP1
8708,GO:0032880,0.327620466513644,0.802936175411501,7,867,regulation of protein localization,BP,NGFR;EGFR;GJA1;SH3TC2;RASGRP1;APOD;MBP
21839,GO:2001234,0.32775136961199,0.887143379808227,2,197,negative regulation of apoptotic signaling pathway,BP,EYA2;BOK
16759,GO:0072171,0.328114013684023,0.94050829881815,1,60,mesonephric tubule morphogenesis,BP,GREM1
16227,GO:0071277,0.32813108939926,0.940516573718082,1,59,cellular response to calcium ion,BP,CAPN3
557,GO:0001655,0.32991832916628,0.855284964958959,3,295,urogenital system development,BP,CRLF1;PDGFRA;GREM1
15206,GO:0061138,0.330359204738526,0.88571464071991,2,174,morphogenesis of a branching epithelium,BP,SOX10;GREM1
9059,GO:0033619,0.330689365991663,0.939472677566527,1,62,membrane protein proteolysis,BP,NGFR
16870,GO:0072341,0.330694521624223,0.939394359498943,1,68,modified amino acid binding,MF,RASGRP1
12491,GO:0046470,0.330739283840819,0.939354221310237,1,70,phosphatidylcholine metabolic process,BP,ENPP2
17607,GO:0097110,0.331093669846551,0.939357750528068,1,59,scaffold protein binding,MF,GJA1
12678,GO:0046873,0.331371278864129,0.834138437028091,4,418,metal ion transmembrane transporter activity,MF,TF;SLC31A2;KCNJ6;SLC5A11
14873,GO:0060562,0.331553634857634,0.854182700008086,3,301,epithelial tube morphogenesis,BP,LRP2;GJA1;GREM1
12270,GO:0045935,0.331671258185271,0.773670599262729,12,1600,positive regulation of nucleobase-containing compound metabolic process,BP,NGFR;EYA2;CAPN3;SOX10;MYRF;PDGFRA;EGFR;ST18;FZD7;GREM1;GPD1;DMRT2
6052,GO:0016787,0.332030206640875,0.762147825974734,16,2236,hydrolase activity,MF,EYA2;FOLH1;CAPN3;TUBB4A;PLCL1;ATP10B;MYRF;CPM;ENPP2;PCSK6;CNDP1;ADAMTS4;KLK6;CARNS1;MYO1D;DNAH17
6503,GO:0019319,0.332080237934098,0.938825018446818,1,70,hexose biosynthetic process,BP,GPD1
13756,GO:0051186,0.33251938707568,0.833212485731467,4,513,cofactor metabolic process,BP,FOLH1;EGFR;NNMT;GPD1
1551,GO:0003341,0.332665794018995,0.938707419301336,1,61,cilium movement,BP,DNAH17
870,GO:0002088,0.332811452385384,0.938679926924969,1,59,lens development in camera-type eye,BP,GJA1
20452,GO:1904888,0.333225245059126,0.938515997799204,1,59,cranial skeletal system development,BP,PDGFRA
15930,GO:0070664,0.333419189793573,0.93831684518796,1,68,negative regulation of leukocyte proliferation,BP,GREM1
6232,GO:0017137,0.333560164041462,0.883863239244553,2,170,Rab GTPase binding,MF,NGFR;MOBP
6116,GO:0016887,0.333650563144733,0.832514174498936,4,410,ATPase activity,MF,ATP10B;CARNS1;MYO1D;DNAH17
12210,GO:0045833,0.333928703612279,0.938138482483154,1,66,negative regulation of lipid metabolic process,BP,APOD
16513,GO:0071702,0.334016018852834,0.758304649836957,17,2410,organic substance transport,BP,NGFR;LRP2;TF;MLC1;PEX5L;ATP10B;EGFR;GJA1;SNX22;SLC45A3;SLC5A11;TMEM144;SH3TC2;GJB1;RASGRP1;APOD;MBP
14914,GO:0060627,0.334499960184426,0.831850268351032,4,452,regulation of vesicle-mediated transport,BP,TF;BVES;GREM1;LGI3
5243,GO:0014855,0.334657512961147,0.937946635662653,1,59,striated muscle cell proliferation,BP,GJA1
3562,GO:0007018,0.334952874578791,0.851925646909279,3,292,microtubule-based movement,BP,RASGRP1;MYO1D;DNAH17
7759,GO:0031253,0.334954610134827,0.851911649958429,3,298,cell projection membrane,CC,LRP2;BVES;MYO1D
11251,GO:0043405,0.335429994115786,0.851558466845918,3,315,regulation of MAP kinase activity,BP,RGS4;EGFR;RASGRP1
10039,GO:0035914,0.335990596694595,0.937383227626117,1,61,skeletal muscle cell differentiation,BP,CAPN3
591,GO:0001707,0.336332694748554,0.937231391491854,1,62,mesoderm formation,BP,EYA2
18673,GO:1900182,0.336557288464071,0.937141218020979,1,62,positive regulation of protein localization to nucleus,BP,NGFR
1370,GO:0003008,0.336965939076265,0.773006470893831,11,1463,system process,BP,LRP2;SOX10;MAG;BVES;MYRF;EGFR;NKX6-2;GJA1;PIEZO2;CNTN2;MBP
20043,GO:1904035,0.337227523144269,0.936843590475914,1,64,regulation of epithelial cell apoptotic process,BP,BOK
1428,GO:0003143,0.337588146016636,0.936741138736794,1,61,embryonic heart tube morphogenesis,BP,GJA1
139,GO:0000287,0.338923639839957,0.880635233884772,2,186,magnesium ion binding,MF,EYA2;ATP10B
1220,GO:0002708,0.339237914510685,0.935943929532356,1,71,positive regulation of lymphocyte mediated immunity,BP,RASGRP1
2969,GO:0006110,0.339689998763935,0.935890581858756,1,61,regulation of glycolytic process,BP,GPD1
17116,GO:0086003,0.33990567856029,0.935885802073444,1,56,cardiac muscle cell contraction,BP,GJA1
12295,GO:0045981,0.339944182002902,0.935645520727356,1,72,positive regulation of nucleotide metabolic process,BP,GPD1
18756,GO:1900544,0.339944182002902,0.935645520727356,1,72,positive regulation of purine nucleotide metabolic process,BP,GPD1
16240,GO:0071300,0.340013178672783,0.935715696048522,1,64,cellular response to retinoic acid,BP,FZD7
3385,GO:0006732,0.340153812842033,0.84831155775747,3,348,coenzyme metabolic process,BP,FOLH1;NNMT;GPD1
14036,GO:0051701,0.340478049657064,0.879696153492076,2,190,interaction with host,BP,MOG;EGFR
17101,GO:0080135,0.340552705116513,0.812714183328806,5,602,regulation of cellular response to stress,BP,EYA2;EGFR;FZD7;RASGRP1;BOK
16281,GO:0071359,0.341141029325665,0.935284478208974,1,62,cellular response to dsRNA,BP,EGFR
16202,GO:0071230,0.341895738588022,0.934990903199713,1,61,cellular response to amino acid stimulus,BP,EGFR
13261,GO:0048844,0.342027814067615,0.93498539789202,1,58,artery morphogenesis,BP,LRP2
11253,GO:0043407,0.342521106197908,0.93465015636415,1,67,negative regulation of MAP kinase activity,BP,RGS4
13226,GO:0048762,0.343147871106733,0.878115679462303,2,186,mesenchymal cell differentiation,BP,SOX10;GREM1
8233,GO:0032155,0.343590981756477,0.934294501862562,1,61,cell division site part,CC,ANLN
9099,GO:0033692,0.343871961354437,0.934178660132131,1,61,cellular polysaccharide biosynthetic process,BP,PHKG1
732,GO:0001909,0.344254332039921,0.933823209194923,1,77,leukocyte mediated cytotoxicity,BP,RASGRP1
16607,GO:0071897,0.344759337033385,0.877129286390698,2,191,DNA biosynthetic process,BP,GJA1;GREM1
4203,GO:0008610,0.344845727832269,0.809431983906793,5,625,lipid biosynthetic process,BP,FA2H;PLP1;SLC45A3;GPD1;UGT8
8291,GO:0032271,0.344880131770487,0.877049371294573,2,193,regulation of protein polymerization,BP,TUBB4A;TMSB15A
9020,GO:0033555,0.345930459513489,0.933253607584097,1,66,multicellular organismal response to stress,BP,GJA1
7086,GO:0022904,0.346159078611988,0.932874644077976,1,97,respiratory electron transport chain,BP,GPD1
5435,GO:0015370,0.346444489924946,0.933112549537502,1,61,solute:sodium symporter activity,MF,SLC5A11
13031,GO:0048332,0.347285461089338,0.932716500114683,1,64,mesoderm morphogenesis,BP,EYA2
6469,GO:0019216,0.347314105482482,0.843463695596974,3,324,regulation of lipid metabolic process,BP,PDGFRA;SLC45A3;APOD
849,GO:0002064,0.348684290864422,0.874792137210399,2,182,epithelial cell development,BP,HAPLN2;GJA1
16201,GO:0071229,0.348824230366089,0.874683446868629,2,188,cellular response to acid chemical,BP,EGFR;FZD7
3355,GO:0006687,0.349002051842709,0.931942158670976,1,68,glycosphingolipid metabolic process,BP,UGT8
486,GO:0001523,0.349166517461546,0.931847870740883,1,70,retinoid metabolic process,BP,LRP2
7220,GO:0030193,0.349463505129515,0.931722720395225,1,70,regulation of blood coagulation,BP,PDGFRA
18591,GO:1900046,0.349463505129515,0.931722720395225,1,70,regulation of hemostasis,BP,PDGFRA
137,GO:0000281,0.349657473825589,0.931721030021846,1,64,mitotic cytokinesis,BP,ANLN
12447,GO:0046364,0.34987188572347,0.931482884352584,1,76,monosaccharide biosynthetic process,BP,GPD1
3320,GO:0006643,0.350534832781566,0.873585824226331,2,204,membrane lipid metabolic process,BP,FA2H;UGT8
14642,GO:0060249,0.350770081017535,0.841060099963455,3,336,anatomical structure homeostasis,BP,TF;CAPN3;EGFR
7424,GO:0030574,0.351020566685074,0.931191460517636,1,61,collagen catabolic process,BP,KLK6
11379,GO:0043621,0.351072935025118,0.931340526680658,1,52,protein self-association,MF,CNTN2
19676,GO:1903321,0.351335657336574,0.930930717420524,1,70,negative regulation of protein modification by small protein conjugation or removal,BP,CAPN3
19777,GO:1903530,0.351559593178346,0.804298099216773,5,611,regulation of secretion by cell,BP,EGFR;GJA1;LGI3;RASGRP1;MBP
9191,GO:0034109,0.352704223205403,0.930387304738113,1,67,homotypic cell-cell adhesion,BP,PDGFRA
6461,GO:0019207,0.353702403225449,0.871650466862741,2,203,kinase regulator activity,MF,ERBB3;GREM1
13003,GO:0048278,0.353716486301108,0.929928492381847,1,69,vesicle docking,BP,BVES
19881,GO:1903725,0.35384173230512,0.929915212712774,1,66,regulation of phospholipid metabolic process,BP,PDGFRA
18601,GO:1900076,0.353859643188314,0.929907546831913,1,66,regulation of cellular response to insulin stimulus,BP,NGFR
9687,GO:0035303,0.353900324093678,0.871599108311093,2,184,regulation of dephosphorylation,BP,PPP1R14A;MYO1D
448,GO:0001190,0.354192893146985,0.929793882127461,1,64,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,SOX10
7513,GO:0030811,0.35500187780582,0.92944684431004,1,64,regulation of nucleotide catabolic process,BP,GPD1
14768,GO:0060411,0.355252534929533,0.929354425801468,1,63,cardiac septum morphogenesis,BP,LRP2
12643,GO:0046785,0.355374015698799,0.929257622412702,1,66,microtubule polymerization,BP,TUBB4A
6774,GO:0021536,0.355555074553887,0.929126160116193,1,70,diencephalon development,BP,ARX
7055,GO:0022626,0.355564009015818,0.928781764667914,1,114,cytosolic ribosome,CC,APOD
4855,GO:0010639,0.356190315989427,0.83731055351747,3,327,negative regulation of organelle organization,BP,TUBB4A;TMSB15A;BOK
10614,GO:0042176,0.357193956300365,0.836598252910688,3,333,regulation of protein catabolic process,BP,LRP2;EGFR;GJA1
6693,GO:0019888,0.357330821870309,0.928346016728931,1,71,protein phosphatase regulator activity,MF,PPP1R14A
13197,GO:0048705,0.357572717080446,0.869294802540631,2,194,skeletal system morphogenesis,BP,PDGFRA;GREM1
5680,GO:0016051,0.357643328707045,0.8692190429909,2,203,carbohydrate biosynthetic process,BP,PHKG1;GPD1
13528,GO:0050848,0.357754852164111,0.928161980923308,1,71,regulation of calcium-mediated signaling,BP,ERBB3
1517,GO:0003281,0.358388395071685,0.928031500121173,1,61,ventricular septum development,BP,LRP2
13571,GO:0050900,0.358654034280276,0.835528900295813,3,361,leukocyte migration,BP,MAG;GREM1;APOD
13703,GO:0051117,0.358898655546118,0.927639883755557,1,73,ATPase binding,MF,NKAIN1
7641,GO:0031016,0.359354820149871,0.92749084810489,1,69,pancreas development,BP,NKX6-2
2823,GO:0005882,0.359457712423587,0.927420129964656,1,71,intermediate filament,CC,GJA1
5140,GO:0014032,0.359747549612889,0.927332721676844,1,68,neural crest cell development,BP,SOX10
10808,GO:0042578,0.360618116080808,0.834215104308855,3,323,phosphoric ester hydrolase activity,MF,EYA2;PLCL1;ENPP2
3757,GO:0007409,0.360743098548548,0.812596474636724,4,435,axonogenesis,BP,ARX;NGFR;MAG;CNTN2
11917,GO:0045184,0.361421434144228,0.74487397589865,13,1847,establishment of protein localization,BP,NGFR;LRP2;TF;MLC1;PEX5L;EGFR;GJA1;SNX22;SH3TC2;RASGRP1;CNTN2;APOD;MBP
7701,GO:0031110,0.362005157355286,0.926355841695406,1,67,regulation of microtubule polymerization or depolymerization,BP,TUBB4A
12089,GO:0045621,0.362028663804152,0.926243534382961,1,75,positive regulation of lymphocyte differentiation,BP,RASGRP1
21101,GO:1990782,0.362440088331628,0.926164065522597,1,67,protein tyrosine kinase binding,MF,GJA1
8560,GO:0032649,0.363479695787408,0.925547962129093,1,80,regulation of interferon-gamma production,BP,RASGRP1
14184,GO:0051966,0.363792496728443,0.925627161686158,1,63,regulation of synaptic transmission, glutamatergic,BP,EGFR
13515,GO:0050818,0.363799892396649,0.925471308115159,1,74,regulation of coagulation,BP,PDGFRA
4225,GO:0008652,0.364180755813131,0.925290471524369,1,75,cellular amino acid biosynthetic process,BP,FOLH1
16698,GO:0072078,0.364380719659721,0.92529056769283,1,68,nephron tubule morphogenesis,BP,GREM1
13850,GO:0051341,0.364718190480093,0.925028850266462,1,77,regulation of oxidoreductase activity,BP,EGFR
4978,GO:0010827,0.365289742709221,0.924900306882812,1,67,regulation of glucose transmembrane transport,BP,NGFR
20845,GO:1905897,0.365356362915102,0.924790626368391,1,73,regulation of response to endoplasmic reticulum stress,BP,BOK
4480,GO:0009306,0.365999747058891,0.808590701564334,4,477,protein secretion,BP,EGFR;GJA1;RASGRP1;MBP
13815,GO:0051279,0.366096619669554,0.924511862349538,1,69,regulation of release of sequestered calcium ion into cytosol,BP,CAPN3
4212,GO:0008625,0.367683863542304,0.923700863596703,1,77,extrinsic apoptotic signaling pathway via death domain receptors,BP,MAL
13730,GO:0051149,0.367774688112165,0.923706965802042,1,73,positive regulation of muscle cell differentiation,BP,GREM1
14410,GO:0055017,0.367814156745836,0.923770248313672,1,67,cardiac muscle tissue growth,BP,GJA1
11280,GO:0043470,0.367895053022659,0.92370527411342,1,69,regulation of carbohydrate catabolic process,BP,GPD1
1400,GO:0003073,0.368723656972854,0.923266950982276,1,74,regulation of systemic arterial blood pressure,BP,GJA1
5419,GO:0015318,0.369355565148329,0.778624465985679,6,750,inorganic molecular entity transmembrane transporter activity,MF,TF;SLC31A2;PIEZO2;KCNJ6;SLC45A3;SLC5A11
5303,GO:0015077,0.369535271753663,0.82786902166569,3,335,monovalent inorganic cation transmembrane transporter activity,MF,KCNJ6;SLC45A3;SLC5A11
21796,GO:2001169,0.369815815669647,0.922838247280855,1,69,regulation of ATP biosynthetic process,BP,GPD1
19934,GO:1903827,0.370031782368416,0.805537585749846,4,476,regulation of cellular protein localization,BP,NGFR;EGFR;SH3TC2;APOD
12158,GO:0045732,0.370692981024663,0.861031466918256,2,198,positive regulation of protein catabolic process,BP,LRP2;GJA1
9588,GO:0035050,0.370828650563433,0.922378731932913,1,69,embryonic heart tube development,BP,GJA1
14700,GO:0060326,0.370877163333476,0.860818953225222,2,227,cell chemotaxis,BP,PDGFRA;GREM1
20940,GO:1990204,0.371107018317963,0.92197828563574,1,96,oxidoreductase complex,CC,GPD1
7811,GO:0031328,0.371201207947215,0.739887138094128,12,1662,positive regulation of cellular biosynthetic process,BP,NGFR;CAPN3;SOX10;MYRF;PDGFRA;EGFR;ST18;FZD7;SLC45A3;GREM1;GPD1;DMRT2
13856,GO:0051347,0.371294092519678,0.788904302182126,5,614,positive regulation of transferase activity,BP,ERBB3;PDGFRA;EGFR;GREM1;RASGRP1
1474,GO:0003208,0.371968633955439,0.921874001091732,1,68,cardiac ventricle morphogenesis,BP,LRP2
12423,GO:0046323,0.372596410312266,0.921587300359218,1,68,glucose import,BP,NGFR
16704,GO:0072088,0.373938863077215,0.920943458844771,1,70,nephron epithelium morphogenesis,BP,GREM1
13158,GO:0048661,0.374414405605758,0.92069764867453,1,72,positive regulation of smooth muscle cell proliferation,BP,EGFR
13093,GO:0048523,0.374839324242198,0.707321712286406,28,4134,negative regulation of cellular process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;TUBB4A;MAG;RGS4;PDGFRA;EGFR;ST18;NKX6-2;GJA1;FZD7;TMSB15A;GREM1;PPP1R14A;MYO1D;BOK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
12469,GO:0046434,0.374844984067864,0.858334540160631,2,208,organophosphate catabolic process,BP,ENPP2;GPD1
2878,GO:0005977,0.375079094453826,0.920447399862781,1,68,glycogen metabolic process,BP,PHKG1
17114,GO:0086001,0.375187935080008,0.920477394520777,1,63,cardiac muscle cell action potential,BP,GJA1
13275,GO:0048864,0.375711276626376,0.920099317852807,1,72,stem cell development,BP,SOX10
1433,GO:0003151,0.375949941110349,0.920002405104885,1,71,outflow tract morphogenesis,BP,LRP2
7242,GO:0030217,0.375972868962826,0.857621589719877,2,204,T cell differentiation,BP,FZD7;RASGRP1
2039,GO:0004527,0.376615610000561,0.919667353355365,1,73,exonuclease activity,MF,ENPP2
17660,GO:0097194,0.376755660124347,0.91955310685252,1,77,execution phase of apoptosis,BP,BOK
11071,GO:0043122,0.376958135325949,0.856970817210939,2,208,regulation of I-kappaB kinase/NF-kappaB signaling,BP,CAPN3;GJA1
12226,GO:0045860,0.377990468142395,0.79945172867958,4,479,positive regulation of protein kinase activity,BP,ERBB3;EGFR;GREM1;RASGRP1
133,GO:0000271,0.378137580174622,0.919014876557543,1,69,polysaccharide biosynthetic process,BP,PHKG1
7116,GO:0030017,0.378170352451336,0.856276136044672,2,185,sarcomere,CC,CAPN3;LDB3
13576,GO:0050906,0.378688811228898,0.918548108926861,1,87,detection of stimulus involved in sensory perception,BP,PIEZO2
16865,GO:0072332,0.378713998401746,0.918617688801083,1,79,intrinsic apoptotic signaling pathway by p53 class mediator,BP,BOK
5139,GO:0014031,0.379310765445896,0.918424689098021,1,72,mesenchymal cell development,BP,SOX10
16898,GO:0072384,0.379735605238512,0.918268144286578,1,69,organelle transport along microtubule,BP,RASGRP1
2945,GO:0006073,0.380205750883383,0.918047679456568,1,69,cellular glucan metabolic process,BP,PHKG1
11480,GO:0044042,0.380205750883383,0.918047679456568,1,69,glucan metabolic process,BP,PHKG1
8866,GO:0033138,0.38021729079694,0.917936128783996,1,77,positive regulation of peptidyl-serine phosphorylation,BP,EGFR
14433,GO:0055072,0.380260001087228,0.917904323691375,1,78,iron ion homeostasis,BP,TF
2599,GO:0005496,0.381336074620502,0.917397649937513,1,78,steroid binding,MF,APOD
8486,GO:0032535,0.38135010334722,0.819338280024395,3,335,regulation of cellular component size,BP,MAG;TMSB15A;CNTN2
4544,GO:0009605,0.381854825210308,0.72700335388405,13,1879,response to external stimulus,BP,ARX;NGFR;CAPN3;MAG;PPL;PDGFRA;ENPP2;EGFR;GJA1;PIEZO2;GREM1;CNTN2;APOD
6470,GO:0019217,0.382442010665471,0.916937585062929,1,73,regulation of fatty acid metabolic process,BP,SLC45A3
8472,GO:0032507,0.382442644186949,0.916950850281081,1,72,maintenance of protein location in cell,BP,TMSB15A
2770,GO:0005791,0.382994913178703,0.916557760089211,1,83,rough endoplasmic reticulum,CC,TF
16670,GO:0072028,0.383623691928196,0.916390990466182,1,72,nephron morphogenesis,BP,GREM1
21396,GO:2000379,0.383650734639881,0.916301512236629,1,78,positive regulation of reactive oxygen species metabolic process,BP,EGFR
15271,GO:0061333,0.383878184990037,0.91627005898033,1,72,renal tubule morphogenesis,BP,GREM1
18024,GO:0098739,0.383945515451766,0.916281438396032,1,69,import across plasma membrane,BP,LRP2
17852,GO:0097581,0.38601108587039,0.915266653880738,1,71,lamellipodium organization,BP,ENPP2
6846,GO:0021675,0.386136518016748,0.915206591591667,1,71,nerve development,BP,ERBB3
18530,GO:0140096,0.386249546896891,0.717115724933031,15,2058,catalytic activity, acting on a protein,MF,EYA2;ERBB3;FOLH1;CAPN3;CDK18;MYRF;PDGFRA;CPM;PCSK6;EGFR;CNDP1;ADAMTS4;PHKG1;KLK6;AATK
8516,GO:0032588,0.386646107811325,0.914858445204901,1,79,trans-Golgi network membrane,CC,BOK
4625,GO:0009891,0.386730176134491,0.726299681423205,12,1684,positive regulation of biosynthetic process,BP,NGFR;CAPN3;SOX10;MYRF;PDGFRA;EGFR;ST18;FZD7;SLC45A3;GREM1;GPD1;DMRT2
6614,GO:0019725,0.388525163722687,0.762903747677402,6,813,cellular homeostasis,BP,TF;CAPN3;PDGFRA;SLC31A2;GJA1;BOK
39,GO:0000079,0.389630774412922,0.913372670817171,1,83,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR
5141,GO:0014033,0.390040234942102,0.913268993494328,1,75,neural crest cell differentiation,BP,SOX10
5476,GO:0015631,0.390498022230456,0.812640284553385,3,322,tubulin binding,MF,DCX;GJA1;MYO1D
2774,GO:0005796,0.390752000403666,0.912897259412943,1,77,Golgi lumen,CC,PCSK6
3811,GO:0007589,0.390885651918716,0.912819797804061,1,78,body fluid secretion,BP,GJA1
7828,GO:0031346,0.391107889290419,0.81217979660983,3,326,positive regulation of cell projection organization,BP,ANLN;NGFR;ENPP2
15162,GO:0061053,0.391497455661755,0.912587020734691,1,73,somite development,BP,DMRT2
10797,GO:0042562,0.392264397765434,0.912088855475071,1,83,hormone binding,MF,EGFR
5474,GO:0015629,0.393175360390313,0.787673752308262,4,459,actin cytoskeleton,CC,ANLN;TMSB15A;MOBP;MYO1D
19340,GO:1902554,0.39319182613973,0.911668065435564,1,80,serine/threonine protein kinase complex,CC,PHKG1
11749,GO:0044772,0.393677446484665,0.787213414433118,4,515,mitotic cell cycle phase transition,BP,ANLN;TUBB4A;EGFR;GJC2
3458,GO:0006855,0.393865277262335,0.911413582306713,1,74,drug transmembrane transport,BP,LRP2
10548,GO:0042058,0.394617484797085,0.911003381940315,1,77,regulation of epidermal growth factor receptor signaling pathway,BP,EGFR
4339,GO:0009108,0.395155119600947,0.84492027035486,2,221,coenzyme biosynthetic process,BP,NNMT;GPD1
9456,GO:0034637,0.395433108166386,0.910627010998992,1,75,cellular carbohydrate biosynthetic process,BP,PHKG1
5647,GO:0015980,0.395623048509419,0.844536696542264,2,244,energy derivation by oxidation of organic compounds,BP,PHKG1;GPD1
5406,GO:0015291,0.395835709740276,0.844530544290958,2,202,secondary active transmembrane transporter activity,MF,SLC45A3;SLC5A11
14774,GO:0060419,0.395979279131801,0.910370544828246,1,74,heart growth,BP,GJA1
3766,GO:0007423,0.396193202727726,0.785270559314276,4,480,sensory organ development,BP,PDGFRA;EGFR;GJA1;SMOC1
4047,GO:0008344,0.396559202571224,0.910055925938908,1,76,adult locomotory behavior,BP,CNTN2
7154,GO:0030100,0.396594731658111,0.843970541139331,2,215,regulation of endocytosis,BP,TF;GREM1
3630,GO:0007160,0.396822454166057,0.843898202407675,2,194,cell-matrix adhesion,BP,GREM1;APOD
15091,GO:0060964,0.396983098786261,0.909760372260629,1,83,regulation of gene silencing by miRNA,BP,EGFR
4602,GO:0009798,0.397447572767256,0.909552057943985,1,81,axis specification,BP,PCSK6
15402,GO:0061640,0.398787567240032,0.90893291170383,1,77,cytoskeleton-dependent cytokinesis,BP,ANLN
9153,GO:0033993,0.398824519583858,0.754321506322473,6,828,response to lipid,BP,NGFR;SOX10;MLC1;EGFR;GJA1;FZD7
6040,GO:0016773,0.398916739850835,0.754309937196756,6,721,phosphotransferase activity, alcohol group as acceptor,MF,ERBB3;CDK18;PDGFRA;EGFR;PHKG1;AATK
11271,GO:0043436,0.399437785811934,0.744035919908399,7,1020,oxoacid metabolic process,BP,FOLH1;FA2H;PLP1;SLC45A3;GPD1;CARNS1;SPOCK3
11092,GO:0043154,0.399505847940064,0.908467930491108,1,86,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NGFR
575,GO:0001676,0.399718442128049,0.908361251361388,1,86,long-chain fatty acid metabolic process,BP,PLP1
11172,GO:0043270,0.399952241711838,0.841689717050979,2,217,positive regulation of ion transport,BP,CAPN3;GJC2
8649,GO:0032787,0.40015876867603,0.782074323612241,4,532,monocarboxylic acid metabolic process,BP,FA2H;PLP1;SLC45A3;GPD1
12184,GO:0045778,0.40016887983741,0.908227823024022,1,78,positive regulation of ossification,BP,GJA1
8943,GO:0033273,0.400204314786087,0.908138716093941,1,84,response to vitamin,BP,EGFR
4899,GO:0010717,0.401663206835111,0.907475436973813,1,78,regulation of epithelial to mesenchymal transition,BP,GREM1
16967,GO:0072562,0.402004595808918,0.907140631710855,1,93,blood microparticle,CC,TF
11658,GO:0044438,0.402347235990198,0.907005138015341,1,89,microbody part,CC,PEX5L
11659,GO:0044439,0.402347235990198,0.907005138015341,1,89,peroxisomal part,CC,PEX5L
11215,GO:0043331,0.405080804622787,0.905740810094436,1,78,response to dsRNA,BP,EGFR
3344,GO:0006672,0.405841692134732,0.905278700163055,1,84,ceramide metabolic process,BP,UGT8
1870,GO:0004197,0.406294797813585,0.905069817511129,1,82,cysteine-type endopeptidase activity,MF,CAPN3
1273,GO:0002790,0.40642012638004,0.777106405839377,4,508,peptide secretion,BP,EGFR;GJA1;RASGRP1;MBP
5288,GO:0015031,0.406593048831454,0.708653900528877,12,1754,protein transport,BP,NGFR;LRP2;TF;MLC1;PEX5L;EGFR;GJA1;SNX22;SH3TC2;RASGRP1;APOD;MBP
3537,GO:0006979,0.407016178222912,0.800106710121028,3,390,response to oxidative stress,BP,PDGFRA;EGFR;APOD
8532,GO:0032609,0.407893664321198,0.904150586702766,1,91,interferon-gamma production,BP,RASGRP1
15840,GO:0070498,0.408274335769101,0.903907814428387,1,96,interleukin-1-mediated signaling pathway,BP,ST18
19038,GO:1901701,0.408423368309319,0.73636867824234,7,959,cellular response to oxygen-containing compound,BP,NGFR;SOX10;MLC1;PDGFRA;EGFR;FZD7;GPD1
20040,GO:1904029,0.408436862128642,0.903900505868872,1,88,regulation of cyclin-dependent protein kinase activity,BP,EGFR
8231,GO:0032153,0.408465463058274,0.904017263642084,1,77,cell division site,CC,ANLN
3933,GO:0008170,0.408560205874723,0.903916375830526,1,81,N-methyltransferase activity,MF,NNMT
1200,GO:0002688,0.409114650739179,0.90343924170283,1,100,regulation of leukocyte chemotaxis,BP,GREM1
14402,GO:0055008,0.409118443793173,0.903894557482438,1,64,cardiac muscle tissue morphogenesis,BP,LRP2
19570,GO:1903076,0.409222900525935,0.903586359240178,1,80,regulation of protein localization to plasma membrane,BP,EGFR
7148,GO:0030072,0.409713164003184,0.834969438418926,2,222,peptide hormone secretion,BP,EGFR;GJA1
1217,GO:0002705,0.409755363881918,0.903197401819843,1,90,positive regulation of leukocyte mediated immunity,BP,RASGRP1
8502,GO:0032559,0.410261766195498,0.709621821652817,11,1413,adenyl ribonucleotide binding,MF,ERBB3;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;AATK;DNAH17
759,GO:0001942,0.410591220570575,0.90286415659459,1,81,hair follicle development,BP,EGFR
2947,GO:0006082,0.410858959083204,0.734240629890822,7,1032,organic acid metabolic process,BP,FOLH1;FA2H;PLP1;SLC45A3;GPD1;CARNS1;SPOCK3
14577,GO:0060147,0.411129923226641,0.902525014470032,1,86,regulation of posttranscriptional gene silencing,BP,EGFR
15093,GO:0060966,0.411129923226641,0.902525014470032,1,86,regulation of gene silencing by RNA,BP,EGFR
5630,GO:0015931,0.411347696177293,0.833836923561914,2,221,nucleobase-containing compound transport,BP,GJA1;GJB1
7329,GO:0030336,0.411495924749532,0.833751491088119,2,216,negative regulation of cell migration,BP,GREM1;APOD
21183,GO:2000027,0.41188349145948,0.833430446595378,2,231,regulation of organ morphogenesis,BP,FZD7;GREM1
11667,GO:0044449,0.413043752757319,0.832735177009782,2,200,contractile fiber part,CC,CAPN3;LDB3
17725,GO:0097327,0.413550106839112,0.901282239479281,1,84,response to antineoplastic agent,BP,EGFR
15905,GO:0070613,0.41412189910919,0.900947656945784,1,87,regulation of protein processing,BP,CNTN2
5966,GO:0016616,0.414160600592656,0.900771001972262,1,104,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,GPD1
724,GO:0001892,0.414781220045325,0.900671519280263,1,81,embryonic placenta development,BP,EGFR
18983,GO:1901606,0.41494821657567,0.90042240804921,1,96,alpha-amino acid catabolic process,BP,CARNS1
18042,GO:0098773,0.414959618260453,0.900564926792106,1,82,skin epidermis development,BP,EGFR
5874,GO:0016459,0.416014901049692,0.900295799487628,1,64,myosin complex,CC,MYO1D
13764,GO:0051196,0.416598143536326,0.899724499029758,1,80,regulation of coenzyme metabolic process,BP,GPD1
6462,GO:0019208,0.417736312939648,0.899069959711574,1,84,phosphatase regulator activity,MF,PPP1R14A
3849,GO:0008016,0.418166232769864,0.829063550335734,2,219,regulation of heart contraction,BP,BVES;GJA1
7050,GO:0022617,0.418811141705846,0.898534652661899,1,81,extracellular matrix disassembly,BP,ADAMTS4
7421,GO:0030554,0.419224476438371,0.701585702534952,11,1425,adenyl nucleotide binding,MF,ERBB3;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;AATK;DNAH17
7027,GO:0022404,0.419562704281885,0.898107690729674,1,83,molting cycle process,BP,EGFR
7028,GO:0022405,0.419562704281885,0.898107690729674,1,83,hair cycle process,BP,EGFR
2971,GO:0006112,0.419863046521454,0.897985528987714,1,80,energy reserve metabolic process,BP,PHKG1
19809,GO:1903578,0.419983650633015,0.897882303614496,1,83,regulation of ATP metabolic process,BP,GPD1
460,GO:0001227,0.420275728017185,0.827563679246361,2,221,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,ARX;NKX6-2
13683,GO:0051087,0.420658011187045,0.897440227339841,1,90,chaperone binding,MF,LRP2
9502,GO:0034703,0.421159596566938,0.826994008508388,2,206,cation channel complex,CC,KCNJ6;CNTN2
11406,GO:0043687,0.421464597316418,0.788959861299545,3,394,post-translational protein modification,BP,FOLH1;TF;CPM
730,GO:0001906,0.421877870996159,0.896623866863361,1,108,cell killing,BP,RASGRP1
18471,GO:0120034,0.422396512845463,0.896610271692723,1,81,positive regulation of plasma membrane bounded cell projection assembly,BP,ANLN
19672,GO:1903317,0.422690356046934,0.896355499759658,1,89,regulation of protein maturation,BP,CNTN2
10652,GO:0042277,0.422960519544458,0.825588384192507,2,241,peptide binding,MF,FOLH1;PEX5L
17504,GO:0090630,0.42315279273154,0.896228670183467,1,79,activation of GTPase activity,BP,RASGRP1
13480,GO:0050772,0.423280430518993,0.89618816326623,1,77,positive regulation of axonogenesis,BP,NGFR
5045,GO:0010906,0.423635696512292,0.895940048341292,1,81,regulation of glucose metabolic process,BP,SLC45A3
13687,GO:0051091,0.424325772416575,0.824655008806622,2,228,positive regulation of DNA binding transcription factor activity,BP,CAPN3;GREM1
8198,GO:0032092,0.424383247987762,0.895495976360357,1,84,positive regulation of protein binding,BP,PLCL1
15042,GO:0060840,0.424679183927931,0.895444616233281,1,76,artery development,BP,LRP2
5304,GO:0015078,0.424780045851407,0.895131606034457,1,98,proton transmembrane transporter activity,MF,SLC45A3
13196,GO:0048704,0.424831000216249,0.895205193158157,1,88,embryonic skeletal system morphogenesis,BP,PDGFRA
15542,GO:0065007,0.42541173359137,0.658280917861243,66,10285,biological regulation,BP,ARX;CRLF1;ANLN;NGFR;EYA2;ERBB3;DCX;LRP2;NKAIN1;TF;CAPN3;SOX10;MLC1;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;ATP10B;PLP1;MYRF;PDGFRA;RAPGEF5;ERMN;SLC31A2;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;TMSB15A;SLC45A3;EDIL3;PHKG1;GREM1;GPD1;PPP1R14A;KLK6;LGI3;SH3TC2;KNDC1;MAL;RASGRP1;DMRT2;SUSD5;MYO1D;BOK;S1PR5;GPR62;CNTN2;NKAIN2;APOD;SPOCK3;MBP;SMOC1;GJC2;COL28A1
21235,GO:2000117,0.425478257419238,0.894779082636394,1,95,negative regulation of cysteine-type endopeptidase activity,BP,NGFR
3809,GO:0007586,0.425583254999278,0.894741615658292,1,93,digestion,BP,ARX
7831,GO:0031349,0.426217120100463,0.785232569776554,3,397,positive regulation of defense response,BP,EGFR;GJA1;RASGRP1
7115,GO:0030016,0.426558247722098,0.823142415706162,2,205,myofibril,CC,CAPN3;LDB3
16308,GO:0071396,0.42891648188406,0.758781953770471,4,523,cellular response to lipid,BP,SOX10;MLC1;EGFR;FZD7
9664,GO:0035258,0.429633604968139,0.892619247940773,1,84,steroid hormone receptor binding,MF,LRP2
13248,GO:0048814,0.429891089574374,0.892558885528463,1,78,regulation of dendrite morphogenesis,BP,KNDC1
13666,GO:0051051,0.430065244073483,0.782205119910175,3,392,negative regulation of transport,BP,ERBB3;BOK;APOD
11339,GO:0043549,0.431077235624924,0.726820086857021,6,803,regulation of kinase activity,BP,ERBB3;RGS4;PDGFRA;EGFR;GREM1;RASGRP1
3447,GO:0006835,0.431862089282268,0.891396743332749,1,83,dicarboxylic acid transport,BP,LRP2
5572,GO:0015833,0.432227798368926,0.6854619594815,12,1788,peptide transport,BP,NGFR;LRP2;TF;MLC1;PEX5L;EGFR;GJA1;SNX22;SH3TC2;RASGRP1;APOD;MBP
9412,GO:0034504,0.432307355809304,0.818907051140679,2,226,protein localization to nucleus,BP,NGFR;APOD
4790,GO:0010522,0.432729618050263,0.890851479732244,1,88,regulation of calcium ion transport into cytosol,BP,CAPN3
12687,GO:0046883,0.433178012972388,0.81824281658352,2,235,regulation of hormone secretion,BP,EGFR;GJA1
8756,GO:0032947,0.435071796407104,0.889643652653759,1,80,protein-containing complex scaffold activity,MF,CAPN3
5911,GO:0016525,0.435726891275018,0.889195220506576,1,86,negative regulation of angiogenesis,BP,NGFR
13455,GO:0050729,0.436335230622393,0.888711739457985,1,99,positive regulation of inflammatory response,BP,EGFR
16700,GO:0072080,0.436851712448818,0.888573231074021,1,85,nephron tubule development,BP,GREM1
6745,GO:0020037,0.437040145795971,0.888313100426009,1,99,heme binding,MF,FA2H
821,GO:0002027,0.437345537089157,0.888281293054167,1,86,regulation of heart rate,BP,BVES
11747,GO:0044770,0.438066224812577,0.75114597867857,4,545,cell cycle phase transition,BP,ANLN;TUBB4A;EGFR;GJC2
5118,GO:0012505,0.438118889880691,0.650586007810073,26,3974,endomembrane system,CC,NGFR;LRP2;TF;COL9A3;MLC1;FA2H;ATP10B;MYRF;SLC31A2;PCSK6;EGFR;GJA1;FZD7;KCNJ6;KLK6;LGI3;SH3TC2;GJB1;MAL;RASGRP1;MYO1D;BOK;APOD;OPALIN;TMEM235;COL28A1
20033,GO:1904019,0.438124160444205,0.887827618108655,1,87,epithelial cell apoptotic process,BP,BOK
6703,GO:0019904,0.438356446267122,0.733538445992309,5,657,protein domain specific binding,MF,LRP2;GJA1;FZD7;MYO1D;BOK
10887,GO:0042734,0.438599710642836,0.887696407605694,1,77,presynaptic membrane,CC,CNTNAP4
3437,GO:0006816,0.439056031421108,0.775075832800024,3,371,calcium ion transport,BP,CAPN3;GJA1;GJC2
9372,GO:0034440,0.439321718448888,0.887036254459993,1,97,lipid oxidation,BP,APOD
3113,GO:0006368,0.439512235138966,0.886927613769851,1,97,transcription elongation from RNA polymerase II promoter,BP,SOX10
6137,GO:0016925,0.439850340511104,0.886833212702907,1,88,protein sumoylation,BP,CAPN3
11556,GO:0044262,0.439876940339484,0.813358640361961,2,227,cellular carbohydrate metabolic process,BP,SLC45A3;PHKG1
4630,GO:0009896,0.441000246846911,0.7735202119984,3,367,positive regulation of catabolic process,BP,LRP2;GJA1;GPD1
4216,GO:0008630,0.44179712401646,0.885600035564676,1,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,BOK
20187,GO:1904375,0.442891230760501,0.885089959487671,1,88,regulation of protein localization to cell periphery,BP,EGFR
7398,GO:0030516,0.443252711260265,0.884960560655833,1,82,regulation of axon extension,BP,MAG
7850,GO:0031400,0.443295585255836,0.746760232806561,4,537,negative regulation of protein modification process,BP,CAPN3;RGS4;GREM1;PPP1R14A
15113,GO:0060993,0.443317935062193,0.884869115826566,1,86,kidney morphogenesis,BP,GREM1
14012,GO:0051651,0.443644146506179,0.884655798270868,1,88,maintenance of location in cell,BP,TMSB15A
691,GO:0001843,0.443755990611048,0.884629365502939,1,85,neural tube closure,BP,LRP2
3690,GO:0007249,0.444140177118194,0.810150118156707,2,241,I-kappaB kinase/NF-kappaB signaling,BP,CAPN3;GJA1
14772,GO:0060415,0.444147888625654,0.884587310429805,1,73,muscle tissue morphogenesis,BP,LRP2
2876,GO:0005975,0.444242182396705,0.745953973461756,4,544,carbohydrate metabolic process,BP,SLC45A3;PHKG1;GPD1;APOD
11559,GO:0044267,0.444357651071643,0.641067766580763,30,4620,cellular protein metabolic process,BP,CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;PLCL1;RGS4;CDK18;PDGFRA;CPM;ENPP2;EGFR;ST18;CNDP1;FZD7;PHKG1;GREM1;PPP1R14A;KNDC1;RASGRP1;BOK;AATK;CNTN2;SPOCK3;MBP;GJC2;COL28A1
21265,GO:2000181,0.444463471029162,0.884182195889067,1,88,negative regulation of blood vessel morphogenesis,BP,NGFR
4195,GO:0008593,0.444769056888096,0.883981127299983,1,90,regulation of Notch signaling pathway,BP,EGFR
6787,GO:0021549,0.44480262673907,0.884024120776773,1,85,cerebellum development,BP,KNDC1
15270,GO:0061326,0.445366765572639,0.883671177409737,1,87,renal tubule development,BP,GREM1
14907,GO:0060606,0.445409213751844,0.883659345659271,1,86,tube closure,BP,LRP2
40,GO:0000082,0.44595823148051,0.808797081149946,2,240,G1/S transition of mitotic cell cycle,BP,EGFR;GJC2
2512,GO:0005249,0.44630316761736,0.88313982585544,1,86,voltage-gated potassium channel activity,MF,KCNJ6
15034,GO:0060828,0.446803703521939,0.808151735817881,2,244,regulation of canonical Wnt signaling pathway,BP,SOX10;GREM1
2914,GO:0006029,0.446924250772207,0.882804741009953,1,84,proteoglycan metabolic process,BP,SPOCK3
6751,GO:0021510,0.447332898702342,0.88245509606524,1,93,spinal cord development,BP,NKX6-2
10835,GO:0042623,0.447570285747979,0.768238358691655,3,349,ATPase activity, coupled,MF,ATP10B;MYO1D;DNAH17
10955,GO:0042886,0.448535538811116,0.670456514074932,12,1809,amide transport,BP,NGFR;LRP2;TF;MLC1;PEX5L;EGFR;GJA1;SNX22;SH3TC2;RASGRP1;APOD;MBP
19474,GO:1902911,0.448929554605135,0.881520110629011,1,93,protein kinase complex,CC,PHKG1
11490,GO:0044087,0.449827015979259,0.710354295416698,6,809,regulation of cellular component biogenesis,BP,ANLN;TUBB4A;GJA1;TMSB15A;GREM1;APOD
8575,GO:0032675,0.449939417782021,0.880883082474234,1,97,regulation of interleukin-6 production,BP,MBP
2956,GO:0006096,0.450077264016408,0.880856611529344,1,92,glycolytic process,BP,GPD1
21842,GO:2001237,0.450173490870428,0.88076636979253,1,95,negative regulation of extrinsic apoptotic signaling pathway,BP,EYA2
5877,GO:0016462,0.450371057220309,0.709870245502705,6,811,pyrophosphatase activity,MF,TUBB4A;ATP10B;ENPP2;CARNS1;MYO1D;DNAH17
13454,GO:0050728,0.451204078564093,0.880106361204209,1,100,negative regulation of inflammatory response,BP,APOD
19483,GO:1902936,0.451384305120025,0.880108903091797,1,90,phosphatidylinositol bisphosphate binding,MF,FZD7
6072,GO:0016817,0.451496943403438,0.708868905373688,6,813,hydrolase activity, acting on acid anhydrides,MF,TUBB4A;ATP10B;ENPP2;CARNS1;MYO1D;DNAH17
6073,GO:0016818,0.451496943403438,0.708868905373688,6,813,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,TUBB4A;ATP10B;ENPP2;CARNS1;MYO1D;DNAH17
11801,GO:0044877,0.452047812731064,0.708380967698746,6,810,protein-containing complex binding,MF,TF;MLC1;ERMN;EGFR;EDIL3;MYO1D
12271,GO:0045936,0.452721985994802,0.738756073772491,4,540,negative regulation of phosphate metabolic process,BP,RGS4;GREM1;PPP1R14A;MYO1D
666,GO:0001817,0.453233180145814,0.738295208255899,4,563,regulation of cytokine production,BP,MOG;RASGRP1;APOD;MBP
13575,GO:0050905,0.45362433571699,0.878804886474506,1,88,neuromuscular process,BP,NKX6-2
9603,GO:0035091,0.453743877524908,0.802990244917591,2,224,phosphatidylinositol binding,MF,FZD7;SNX22
3403,GO:0006757,0.453784057050138,0.878649136812961,1,93,ATP generation from ADP,BP,GPD1
4806,GO:0010563,0.453885327891292,0.737760404880398,4,541,negative regulation of phosphorus metabolic process,BP,RGS4;GREM1;PPP1R14A;MYO1D
11282,GO:0043473,0.453949283261993,0.878550670699599,1,93,pigmentation,BP,SOX10
11557,GO:0044264,0.455378155704542,0.877758130939226,1,88,cellular polysaccharide metabolic process,BP,PHKG1
847,GO:0002062,0.455571820710384,0.877629427248176,1,89,chondrocyte differentiation,BP,GREM1
21240,GO:2000134,0.455900689014819,0.877350329465641,1,96,negative regulation of G1/S transition of mitotic cell cycle,BP,GJC2
19935,GO:1903828,0.456074348069319,0.877257131836782,1,95,negative regulation of cellular protein localization,BP,APOD
8882,GO:0033157,0.456648473245677,0.800721487409418,2,240,regulation of intracellular protein transport,BP,SH3TC2;APOD
15633,GO:0070161,0.456860053976933,0.735229222587796,4,524,anchoring junction,CC,CDH19;PPL;EGFR;GJA1
12028,GO:0045446,0.457161372481405,0.876662658054269,1,90,endothelial cell differentiation,BP,HAPLN2
3924,GO:0008150,0.457932770089302,0.697532013786684,90,14380,biological_process,BP,ARX;CRLF1;ANLN;CLDN11;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;CPM;RAPGEF5;ERMN;SLC31A2;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SNX22;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;MOBP;LGI3;SH3TC2;GJB1;KNDC1;MAL;CARNS1;RASGRP1;DMRT2;SUSD5;UGT8;MYO1D;BOK;TMEM125;S1PR5;GPR62;AATK;CNTN2;ANKS1B;GLDN;DNAH17;NKAIN2;APOD;SPOCK3;MBP;SMOC1;GJC2;COL28A1
9434,GO:0034599,0.458300327156128,0.799401357969217,2,258,cellular response to oxidative stress,BP,PDGFRA;EGFR
13761,GO:0051193,0.458388817972414,0.875874754431456,1,94,regulation of cofactor metabolic process,BP,GPD1
3825,GO:0007611,0.458429724546526,0.799413501381228,2,225,learning or memory,BP,EGFR;CNTN2
14533,GO:0060071,0.45926768407034,0.875220699591005,1,106,Wnt signaling pathway, planar cell polarity pathway,BP,FZD7
13978,GO:0051591,0.459436313964892,0.875276460686868,1,91,response to cAMP,BP,GPD1
10953,GO:0042866,0.461300204302584,0.874085097415631,1,96,pyruvate biosynthetic process,BP,GPD1
10624,GO:0042221,0.462140930386444,0.630089912375883,24,3764,response to chemical,BP,ARX;CRLF1;NGFR;LRP2;TF;CAPN3;SOX10;MLC1;PDGFRA;ENPP2;PCSK6;EGFR;ST18;GJA1;FZD7;NNMT;GREM1;GPD1;PPP1R14A;BOK;CNTN2;APOD;MBP;GJC2
3824,GO:0007610,0.462478618276583,0.730378337246933,4,529,behavior,BP,EGFR;GJA1;CNTNAP4;CNTN2
13153,GO:0048644,0.463101631627287,0.873215246202128,1,79,muscle organ morphogenesis,BP,LRP2
2628,GO:0005543,0.463170144388593,0.755324408151016,3,380,phospholipid binding,MF,FZD7;SNX22;RASGRP1
15575,GO:0070062,0.463376312762697,0.64623090189516,15,2442,extracellular exosome,CC,CLDN11;BCAS1;LRP2;FOLH1;TF;PLLP;TUBB4A;PPL;CPM;ERMN;GJA1;EDIL3;GPD1;MYO1D;APOD
11043,GO:0043065,0.463889544040898,0.729118786338866,4,563,positive regulation of apoptotic process,BP,NGFR;ST18;MAL;BOK
19433,GO:1902807,0.465346783791754,0.871569981285772,1,99,negative regulation of cell cycle G1/S phase transition,BP,GJC2
5964,GO:0016614,0.465819336805386,0.87110841186522,1,118,oxidoreductase activity, acting on CH-OH group of donors,MF,GPD1
4310,GO:0009063,0.466111188269084,0.870992068055742,1,110,cellular amino acid catabolic process,BP,CARNS1
18908,GO:1901343,0.466291176280847,0.87104236306651,1,94,negative regulation of vasculature development,BP,NGFR
5805,GO:0016301,0.466354766466998,0.695571860397113,6,785,kinase activity,MF,ERBB3;CDK18;PDGFRA;EGFR;PHKG1;AATK
7162,GO:0030117,0.466359583865994,0.870976844152853,1,96,membrane coat,CC,EGFR
13066,GO:0048475,0.466359583865994,0.870976844152853,1,96,coated membrane,CC,EGFR
5135,GO:0014020,0.466428404193178,0.870981625793516,1,92,primary neural tube formation,BP,LRP2
17292,GO:0090175,0.467031792077778,0.870438935452165,1,108,regulation of establishment of planar polarity,BP,FZD7
1376,GO:0003014,0.46740492119067,0.870328719030794,1,96,renal system process,BP,GJA1
11368,GO:0043603,0.467713123606238,0.694244780392414,6,965,cellular amide metabolic process,BP,FOLH1;CPM;PCSK6;EGFR;CARNS1;UGT8
6623,GO:0019752,0.468036860529182,0.693966995263973,6,932,carboxylic acid metabolic process,BP,FOLH1;FA2H;PLP1;SLC45A3;GPD1;CARNS1
12314,GO:0046031,0.468745892555761,0.869471862409711,1,98,ADP metabolic process,BP,GPD1
9704,GO:0035335,0.468951588090259,0.86940154996166,1,93,peptidyl-tyrosine dephosphorylation,BP,EYA2
8578,GO:0032680,0.46895942613975,0.869247956646727,1,107,regulation of tumor necrosis factor production,BP,RASGRP1
7460,GO:0030660,0.469334682014615,0.869022864498234,1,106,Golgi-associated vesicle membrane,CC,GJA1
12701,GO:0046906,0.469561926537824,0.868862279808461,1,108,tetrapyrrole binding,MF,FA2H
9655,GO:0035249,0.470341063955379,0.868598056650953,1,88,synaptic transmission, glutamatergic,BP,EGFR
21628,GO:2000736,0.470351918816939,0.86830766134878,1,115,regulation of stem cell differentiation,BP,PDGFRA
9258,GO:0034220,0.470636086694055,0.681065959749212,7,990,ion transmembrane transport,BP,LRP2;CAPN3;SLC31A2;GJA1;PIEZO2;KCNJ6;GJC2
13803,GO:0051258,0.47093856932903,0.789621533486536,2,250,protein polymerization,BP,TUBB4A;TMSB15A
16297,GO:0071383,0.471655516656355,0.789081418959298,2,243,cellular response to steroid hormone stimulus,BP,SOX10;EGFR
16316,GO:0071407,0.471971523124651,0.722099933243925,4,536,cellular response to organic cyclic compound,BP,SOX10;MLC1;EGFR;GPD1
1218,GO:0002706,0.471971786322324,0.867331427861292,1,110,regulation of lymphocyte mediated immunity,BP,RASGRP1
17899,GO:0097711,0.471989230777425,0.867462282460576,1,96,ciliary basal body-plasma membrane docking,BP,TUBB4A
2180,GO:0004725,0.472316741758503,0.867279744162835,1,94,protein tyrosine phosphatase activity,MF,EYA2
11782,GO:0044843,0.472377471316033,0.788483296526277,2,252,cell cycle G1/S phase transition,BP,EGFR;GJC2
10376,GO:0038061,0.47287382337261,0.866703903375082,1,117,NIK/NF-kappaB signaling,BP,EGFR
12651,GO:0046822,0.473394060669343,0.866564433867263,1,97,regulation of nucleocytoplasmic transport,BP,APOD
11046,GO:0043068,0.473443301622018,0.72077241517484,4,569,positive regulation of programmed cell death,BP,NGFR;ST18;MAL;BOK
7022,GO:0022037,0.47368567074224,0.866427765583955,1,93,metencephalon development,BP,KNDC1
11324,GO:0043534,0.475048803666362,0.865504230002819,1,98,blood vessel endothelial cell migration,BP,GREM1
1369,GO:0003007,0.475672833597247,0.785981090628288,2,224,heart morphogenesis,BP,LRP2;GJA1
14011,GO:0051650,0.475795975261169,0.785825898099534,2,239,establishment of vesicle localization,BP,MOBP;RASGRP1
3450,GO:0006839,0.475883708634258,0.785638427812451,2,277,mitochondrial transport,BP,EYA2;BOK
19797,GO:1903561,0.476041547734626,0.634211749761073,15,2458,extracellular vesicle,CC,CLDN11;BCAS1;LRP2;FOLH1;TF;PLLP;TUBB4A;PPL;CPM;ERMN;GJA1;EDIL3;GPD1;MYO1D;APOD
7927,GO:0031532,0.476051033533599,0.864844237080998,1,100,actin cytoskeleton reorganization,BP,PDGFRA
2825,GO:0005884,0.476822601438681,0.864374133515442,1,98,actin filament,CC,TMSB15A
11143,GO:0043230,0.476953802376711,0.633341720922834,15,2460,extracellular organelle,CC,CLDN11;BCAS1;LRP2;FOLH1;TF;PLLP;TUBB4A;PPL;CPM;ERMN;GJA1;EDIL3;GPD1;MYO1D;APOD
8548,GO:0032635,0.476984217771739,0.864196604298337,1,105,interleukin-6 production,BP,MBP
13118,GO:0048568,0.477138981626959,0.74351024924646,3,398,embryonic organ development,BP,PDGFRA;EGFR;GJA1
11097,GO:0043167,0.477262780972377,0.605445697421224,37,5527,ion binding,MF,EYA2;ERBB3;CDH19;LRP2;FOLH1;TF;CAPN3;FA2H;TUBB4A;MAG;BVES;PLCL1;CDK18;ATP10B;LDB3;HAPLN2;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;CNDP1;FZD7;SNX22;ADAMTS4;EDIL3;PHKG1;CARNS1;RASGRP1;DMRT2;SUSD5;MYO1D;AATK;DNAH17;SPOCK3;SMOC1
2817,GO:0005874,0.477550512828353,0.743192147413397,3,380,microtubule,CC,DCX;TUBB4A;DNAH17
5511,GO:0015711,0.477806675962834,0.742931957587019,3,403,organic anion transport,BP,LRP2;ATP10B;GJA1
19794,GO:1903555,0.478295017222743,0.863309363071994,1,110,regulation of tumor necrosis factor superfamily cytokine production,BP,RASGRP1
8551,GO:0032640,0.478784149244575,0.862995077671116,1,110,tumor necrosis factor production,BP,RASGRP1
3688,GO:0007229,0.480038458500718,0.862358052515209,1,94,integrin-mediated signaling pathway,BP,PLP1
11402,GO:0043666,0.480507742026062,0.861973641950977,1,101,regulation of phosphoprotein phosphatase activity,BP,PPP1R14A
7459,GO:0030659,0.480567004400038,0.69623574140339,5,714,cytoplasmic vesicle membrane,CC,LRP2;TF;ATP10B;EGFR;SNX22
7806,GO:0031323,0.480713335326582,0.602537673109962,36,5557,regulation of cellular metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;BVES;PLCL1;RGS4;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;SLC45A3;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;DMRT2;MYO1D;BOK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
7700,GO:0031109,0.48123320103621,0.861538194076753,1,98,microtubule polymerization or depolymerization,BP,TUBB4A
7210,GO:0030175,0.481916348926995,0.861183037785644,1,91,filopodium,CC,ERMN
7327,GO:0030334,0.482043301698882,0.694910345505577,5,698,regulation of cell migration,BP,PDGFRA;ENPP2;EGFR;GREM1;APOD
10615,GO:0042177,0.483022130839156,0.860301280083562,1,105,negative regulation of protein catabolic process,BP,EGFR
1872,GO:0004222,0.48333368236595,0.860210638213638,1,95,metalloendopeptidase activity,MF,ADAMTS4
1516,GO:0003279,0.486308598389657,0.858290869149382,1,93,cardiac septum development,BP,LRP2
11252,GO:0043406,0.486489361848063,0.777222976097286,2,249,positive regulation of MAP kinase activity,BP,EGFR;RASGRP1
12902,GO:0048018,0.488788636120476,0.775159735471467,2,324,receptor ligand activity,MF,CRLF1;GREM1
12466,GO:0046425,0.489153057163941,0.856224711897644,1,110,regulation of JAK-STAT cascade,BP,CRLF1
16656,GO:0072009,0.489376097741078,0.856192574517838,1,99,nephron epithelium development,BP,GREM1
15095,GO:0060968,0.489544755275764,0.856004222078845,1,106,regulation of gene silencing,BP,EGFR
15300,GO:0061387,0.489570816466756,0.856099668604599,1,96,regulation of extent of cell growth,BP,MAG
6157,GO:0016999,0.489647587487989,0.855778904251316,1,124,antibiotic metabolic process,BP,EGFR
4962,GO:0010811,0.490381097266966,0.855502309527251,1,101,positive regulation of cell-substrate adhesion,BP,EDIL3
11918,GO:0045185,0.49108128773802,0.855025008426746,1,102,maintenance of protein location,BP,TMSB15A
20455,GO:1904892,0.491346108429331,0.854756659623616,1,111,regulation of STAT cascade,BP,CRLF1
16516,GO:0071706,0.491655870412904,0.854522463681553,1,114,tumor necrosis factor superfamily cytokine production,BP,RASGRP1
7328,GO:0030335,0.492163015975795,0.730526666546988,3,410,positive regulation of cell migration,BP,PDGFRA;ENPP2;EGFR
13770,GO:0051209,0.492231236053431,0.854280116210697,1,100,release of sequestered calcium ion into cytosol,BP,CAPN3
13819,GO:0051283,0.492231236053431,0.854280116210697,1,100,negative regulation of sequestering of calcium ion,BP,CAPN3
2877,GO:0005976,0.493029440977047,0.853757588319923,1,99,polysaccharide metabolic process,BP,PHKG1
689,GO:0001841,0.494860331599208,0.852515630340839,1,100,neural tube formation,BP,LRP2
11122,GO:0043200,0.495042662895314,0.85233696641288,1,105,response to amino acid,BP,EGFR
13818,GO:0051282,0.496040646799593,0.851707413349945,1,101,regulation of sequestering of calcium ion,BP,CAPN3
4719,GO:0010256,0.49700674793274,0.726314766815561,3,392,endomembrane system organization,BP,FA2H;MYRF;SH3TC2
11016,GO:0043021,0.497020087331549,0.85095850457247,1,109,ribonucleoprotein complex binding,MF,TF
609,GO:0001736,0.497450040304398,0.850592521664929,1,117,establishment of planar polarity,BP,FZD7
3634,GO:0007164,0.497450040304398,0.850592521664929,1,117,establishment of tissue polarity,BP,FZD7
2992,GO:0006165,0.497642307176066,0.850536041000922,1,109,nucleoside diphosphate phosphorylation,BP,GPD1
17942,GO:0098552,0.497835744677059,0.725526467273617,3,426,side of membrane,CC,LRP2;TF;MOG
4882,GO:0010675,0.497934547223965,0.850389598004677,1,104,regulation of cellular carbohydrate metabolic process,BP,SLC45A3
21100,GO:1990778,0.49797692847403,0.767810901850958,2,251,protein localization to cell periphery,BP,ANLN;EGFR
18207,GO:0099094,0.498717721839562,0.849926416524505,1,98,ligand-gated cation channel activity,MF,KCNJ6
11876,GO:0045111,0.49890671008761,0.849706064689496,1,106,intermediate filament cytoskeleton,CC,GJA1
13758,GO:0051188,0.499627017527308,0.766369604987001,2,274,cofactor biosynthetic process,BP,NNMT;GPD1
8342,GO:0032355,0.500335496855444,0.848641424335477,1,115,response to estradiol,BP,EGFR
12060,GO:0045580,0.500558861383634,0.848516194888217,1,112,regulation of T cell differentiation,BP,RASGRP1
13547,GO:0050867,0.500646804425473,0.765490812312042,2,285,positive regulation of cell activation,BP,CAPN3;RASGRP1
8764,GO:0032963,0.501689553291519,0.847822367024897,1,104,collagen metabolic process,BP,KLK6
12265,GO:0045930,0.502135862493892,0.764257769372652,2,282,negative regulation of mitotic cell cycle,BP,EGFR;GJC2
20716,GO:1905477,0.502455082876116,0.847232354812197,1,110,positive regulation of protein localization to membrane,BP,EGFR
12225,GO:0045859,0.503608572982103,0.675081897484514,5,720,regulation of protein kinase activity,BP,ERBB3;RGS4;EGFR;GREM1;RASGRP1
14009,GO:0051648,0.504486208511493,0.762388253231384,2,251,vesicle localization,BP,MOBP;RASGRP1
3336,GO:0006664,0.504759286103664,0.845564145112773,1,118,glycolipid metabolic process,BP,UGT8
19761,GO:1903509,0.504759286103664,0.845564145112773,1,118,liposaccharide metabolic process,BP,UGT8
5119,GO:0012506,0.505047830027305,0.67373173296272,5,733,vesicle membrane,CC,LRP2;TF;ATP10B;EGFR;SNX22
17994,GO:0098655,0.505078920587045,0.673707233789969,5,727,cation transmembrane transport,BP,CAPN3;SLC31A2;PIEZO2;KCNJ6;GJC2
13769,GO:0051208,0.505806122653823,0.844975619847883,1,104,sequestering of calcium ion,BP,CAPN3
21249,GO:2000147,0.506250655542446,0.718073778040388,3,422,positive regulation of cell motility,BP,PDGFRA;ENPP2;EGFR
13453,GO:0050727,0.506499450832448,0.760594404854074,2,284,regulation of inflammatory response,BP,EGFR;APOD
12238,GO:0045893,0.507056592913953,0.630939035474987,9,1339,positive regulation of transcription, DNA-templated,BP,NGFR;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;DMRT2
19760,GO:1903508,0.507056592913953,0.630939035474987,9,1339,positive regulation of nucleic acid-templated transcription,BP,NGFR;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;DMRT2
14512,GO:0060047,0.507156114110597,0.760147912196433,2,250,heart contraction,BP,BVES;GJA1
2758,GO:0005777,0.507503502575398,0.843617775558462,1,122,peroxisome,CC,PEX5L
10809,GO:0042579,0.507503502575398,0.843617775558462,1,122,microbody,CC,PEX5L
19389,GO:1902680,0.508003548075596,0.630027917087969,9,1340,positive regulation of RNA biosynthetic process,BP,NGFR;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;DMRT2
16002,GO:0070838,0.509490534617185,0.715193020837135,3,412,divalent metal ion transport,BP,CAPN3;GJA1;GJC2
14309,GO:0052689,0.510296814827785,0.841663719211366,1,121,carboxylic ester hydrolase activity,MF,ENPP2
2618,GO:0005524,0.510345628670417,0.621659115126324,10,1377,ATP binding,MF,ERBB3;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;AATK;DNAH17
12719,GO:0046939,0.512936765670653,0.839848515311455,1,115,nucleotide phosphorylation,BP,GPD1
3778,GO:0007498,0.513343735856173,0.839588392323848,1,112,mesoderm development,BP,EYA2
16932,GO:0072511,0.513528399324543,0.711556214602615,3,415,divalent inorganic cation transport,BP,CAPN3;GJA1;GJC2
1377,GO:0003015,0.514088414725128,0.754257185308081,2,253,heart process,BP,BVES;GJA1
16705,GO:0072089,0.514886908138389,0.838575008591056,1,104,stem cell proliferation,BP,SOX10
8134,GO:0031983,0.515287600430195,0.753053182300726,2,316,vesicle lumen,CC,TF;EGFR
11279,GO:0043467,0.515629081996367,0.837999404311353,1,108,regulation of generation of precursor metabolites and energy,BP,GPD1
19171,GO:1902107,0.51577968256193,0.837792287754618,1,118,positive regulation of leukocyte differentiation,BP,RASGRP1
3401,GO:0006754,0.516054730106398,0.837623149518586,1,115,ATP biosynthetic process,BP,GPD1
3101,GO:0006354,0.5166825868989,0.837109290274928,1,122,DNA-templated transcription, elongation,BP,SOX10
13113,GO:0048562,0.516823130965497,0.75186557066914,2,268,embryonic organ morphogenesis,BP,PDGFRA;GJA1
9637,GO:0035195,0.517101351596272,0.836881376012777,1,114,gene silencing by miRNA,BP,EGFR
5811,GO:0016311,0.517721986176388,0.707762393154009,3,414,dephosphorylation,BP,EYA2;PPP1R14A;MYO1D
3405,GO:0006766,0.517866482487408,0.836248791527752,1,123,vitamin metabolic process,BP,LRP2
19932,GO:1903825,0.518206687596116,0.836158604393412,1,107,organic acid transmembrane transport,BP,LRP2
20526,GO:1905039,0.518206687596116,0.836158604393412,1,107,carboxylic acid transmembrane transport,BP,LRP2
7085,GO:0022900,0.519241284549581,0.835025140871807,1,158,electron transport chain,BP,GPD1
13564,GO:0050890,0.519355579781754,0.749729961604901,2,255,cognition,BP,EGFR;CNTN2
8498,GO:0032555,0.520308457989307,0.602095905944046,12,1724,purine ribonucleotide binding,MF,ERBB3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;AATK;DNAH17
3860,GO:0008037,0.520563624796731,0.834360017392801,1,116,cell recognition,BP,CNTN2
19762,GO:1903510,0.521091914806409,0.834047465426573,1,109,mucopolysaccharide metabolic process,BP,SPOCK3
19037,GO:1901700,0.521175071278949,0.617255476791757,9,1422,response to oxygen-containing compound,BP,NGFR;SOX10;MLC1;PDGFRA;EGFR;GJA1;FZD7;GPD1;APOD
3626,GO:0007156,0.522136642126311,0.8334618514365,1,95,homophilic cell adhesion via plasma membrane adhesion molecules,BP,CDH19
12683,GO:0046879,0.522992712930396,0.746509992319261,2,277,hormone secretion,BP,EGFR;GJA1
4362,GO:0009135,0.523058414931157,0.832571393697475,1,113,purine nucleoside diphosphate metabolic process,BP,GPD1
4402,GO:0009179,0.523058414931157,0.832571393697475,1,113,purine ribonucleoside diphosphate metabolic process,BP,GPD1
3177,GO:0006464,0.523396432821475,0.570507714890268,24,3694,cellular protein modification process,BP,CRLF1;NGFR;EYA2;ERBB3;FOLH1;TF;CAPN3;PLCL1;RGS4;CDK18;PDGFRA;CPM;ENPP2;EGFR;FZD7;PHKG1;GREM1;PPP1R14A;KNDC1;RASGRP1;AATK;SPOCK3;MBP;GJC2
10193,GO:0036211,0.523396432821475,0.570507714890268,24,3694,protein modification process,BP,CRLF1;NGFR;EYA2;ERBB3;FOLH1;TF;CAPN3;PLCL1;RGS4;CDK18;PDGFRA;CPM;ENPP2;EGFR;FZD7;PHKG1;GREM1;PPP1R14A;KNDC1;RASGRP1;AATK;SPOCK3;MBP;GJC2
13813,GO:0051272,0.523925829665776,0.702070314070472,3,433,positive regulation of cellular component movement,BP,PDGFRA;ENPP2;EGFR
7829,GO:0031347,0.524754112505789,0.674053737889086,4,626,regulation of defense response,BP,EGFR;GJA1;RASGRP1;APOD
16515,GO:0071705,0.525150717101374,0.593290352880355,13,2063,nitrogen compound transport,BP,NGFR;LRP2;TF;MLC1;PEX5L;EGFR;GJA1;SNX22;SH3TC2;GJB1;RASGRP1;APOD;MBP
3701,GO:0007264,0.525802733382695,0.673142875782572,4,553,small GTPase mediated signal transduction,BP,NGFR;RAPGEF5;KNDC1;RASGRP1
9673,GO:0035270,0.525887910764482,0.830435122010699,1,119,endocrine system development,BP,NKX6-2
8463,GO:0032496,0.526604563767708,0.743292045040957,2,302,response to lipopolysaccharide,BP,NGFR;GJA1
4407,GO:0009185,0.527988040785058,0.828920319316875,1,115,ribonucleoside diphosphate metabolic process,BP,GPD1
13545,GO:0050865,0.528711846247896,0.697619585019374,3,464,regulation of cell activation,BP,CAPN3;PDGFRA;RASGRP1
7412,GO:0030545,0.529138337442811,0.740969530613505,2,347,receptor regulator activity,MF,CRLF1;GREM1
13847,GO:0051338,0.52921728510762,0.636712913909928,6,898,regulation of transferase activity,BP,ERBB3;RGS4;PDGFRA;EGFR;GREM1;RASGRP1
3561,GO:0007017,0.529506407560105,0.650621413599047,5,708,microtubule-based process,BP,TUBB4A;RASGRP1;MYO1D;CNTN2;DNAH17
8496,GO:0032553,0.529746615445993,0.592812091650128,12,1736,ribonucleotide binding,MF,ERBB3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;AATK;DNAH17
6197,GO:0017076,0.53046738666729,0.59210006429248,12,1738,purine nucleotide binding,MF,ERBB3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;AATK;DNAH17
665,GO:0001816,0.530972161859447,0.668184975647208,4,621,cytokine production,BP,MOG;RASGRP1;APOD;MBP
3041,GO:0006260,0.53106201087276,0.739452677690906,2,275,DNA replication,BP,PDGFRA;EGFR
3951,GO:0008194,0.531338660958604,0.82639352227775,1,118,UDP-glycosyltransferase activity,MF,UGT8
8787,GO:0032993,0.531558857737699,0.826071278001593,1,137,protein-DNA complex,CC,ST18
7917,GO:0031514,0.531564015262953,0.826178578028288,1,123,motile cilium,CC,DNAH17
4536,GO:0009581,0.531646177313621,0.82630363518487,1,105,detection of external stimulus,BP,PIEZO2
1472,GO:0003206,0.531671902650062,0.82619404008088,1,113,cardiac chamber morphogenesis,BP,LRP2
3850,GO:0008017,0.531755806487532,0.738941523314788,2,246,microtubule binding,MF,DCX;MYO1D
5073,GO:0010942,0.532604499359326,0.666639908848074,4,616,positive regulation of cell death,BP,NGFR;ST18;MAL;BOK
7045,GO:0022612,0.53278863626269,0.82537717718188,1,111,gland morphogenesis,BP,EGFR
15694,GO:0070252,0.532924654080708,0.825435732521834,1,98,actin-mediated cell contraction,BP,GJA1
13497,GO:0050794,0.533802308644163,0.54945394075622,58,9170,regulation of cellular process,BP,ARX;CRLF1;ANLN;NGFR;EYA2;ERBB3;DCX;LRP2;TF;CAPN3;SOX10;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;PLP1;MYRF;PDGFRA;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;CNTNAP4;FZD7;TMSB15A;SLC45A3;PHKG1;GREM1;GPD1;PPP1R14A;KLK6;LGI3;SH3TC2;KNDC1;MAL;RASGRP1;DMRT2;SUSD5;MYO1D;BOK;S1PR5;GPR62;CNTN2;APOD;SPOCK3;MBP;SMOC1;GJC2;COL28A1
4425,GO:0009206,0.535045921898994,0.823538018872649,1,125,purine ribonucleoside triphosphate biosynthetic process,BP,GPD1
9636,GO:0035194,0.536182744016918,0.82272130095003,1,120,posttranscriptional gene silencing by RNA,BP,EGFR
9688,GO:0035304,0.536941994258813,0.822153684951568,1,119,regulation of protein dephosphorylation,BP,PPP1R14A
13281,GO:0048871,0.536983656697831,0.734181496432219,2,281,multicellular organismal homeostasis,BP,TF;EGFR
4372,GO:0009145,0.537333876122481,0.821791560935441,1,126,purine nucleoside triphosphate biosynthetic process,BP,GPD1
3817,GO:0007600,0.538415210252018,0.688601918641421,3,457,sensory perception,BP,LRP2;PIEZO2;MBP
1491,GO:0003231,0.538541654442484,0.821016723376804,1,111,cardiac ventricle development,BP,LRP2
7618,GO:0030968,0.539239628086827,0.820353008712233,1,124,endoplasmic reticulum unfolded protein response,BP,BOK
4537,GO:0009582,0.539616216709423,0.820228841807731,1,108,detection of abiotic stimulus,BP,PIEZO2
5865,GO:0016441,0.540225588465328,0.819624214723872,1,121,posttranscriptional gene silencing,BP,EGFR
16378,GO:0071495,0.54055514028185,0.60562627288191,8,1217,cellular response to endogenous stimulus,BP,NGFR;LRP2;SOX10;PCSK6;EGFR;GJA1;GREM1;GPD1
13874,GO:0051384,0.540877005955511,0.819044310004584,1,130,response to glucocorticoid,BP,EGFR
16611,GO:0071901,0.541082025085537,0.818928996827536,1,125,negative regulation of protein serine/threonine kinase activity,BP,RGS4
4635,GO:0009914,0.541385248491341,0.730220761472827,2,287,hormone transport,BP,EGFR;GJA1
2521,GO:0005267,0.541544461975202,0.818628530226348,1,119,potassium channel activity,MF,KCNJ6
3698,GO:0007259,0.54155852490274,0.818553003630542,1,126,JAK-STAT cascade,BP,CRLF1
3913,GO:0008134,0.54179722050945,0.657868618470024,4,597,transcription factor binding,MF,EYA2;LRP2;SOX10;ENPP2
13172,GO:0048675,0.541849121775093,0.818524323443095,1,107,axon extension,BP,MAG
6291,GO:0018107,0.542403601880462,0.818027427097474,1,113,peptidyl-threonine phosphorylation,BP,PHKG1
3735,GO:0007346,0.542887497720538,0.656800840149488,4,615,regulation of mitotic cell cycle,BP,ANLN;TUBB4A;EGFR;GJC2
17893,GO:0097696,0.543528819052978,0.817020651979445,1,127,STAT cascade,BP,CRLF1
4657,GO:0009987,0.544417365836657,0.573846742333178,83,13331,cellular process,BP,ARX;CRLF1;ANLN;CLDN11;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;CPM;RAPGEF5;ERMN;SLC31A2;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;MOBP;LGI3;SH3TC2;GJB1;KNDC1;MAL;CARNS1;RASGRP1;DMRT2;SUSD5;UGT8;MYO1D;BOK;S1PR5;GPR62;AATK;CNTN2;GLDN;DNAH17;APOD;SPOCK3;MBP;SMOC1;GJC2;COL28A1
3921,GO:0008144,0.544586428298172,0.582697202568779,11,1592,drug binding,MF,ERBB3;LRP2;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;AATK;DNAH17
8125,GO:0031965,0.544720572442237,0.727238457021658,2,278,nuclear membrane,CC,EGFR;BOK
7152,GO:0030098,0.546910608421144,0.725227477099588,2,286,lymphocyte differentiation,BP,FZD7;RASGRP1
12705,GO:0046914,0.547194522128027,0.619134248014487,6,931,transition metal ion binding,MF,TF;FA2H;CPM;ENPP2;ST18;RASGRP1
11294,GO:0043492,0.547917139035523,0.813768841059682,1,110,ATPase activity, coupled to movement of substances,MF,ATP10B
610,GO:0001738,0.548836638169007,0.812831339768087,1,132,morphogenesis of a polarized epithelium,BP,FZD7
17846,GO:0097553,0.549080195923796,0.812788046615753,1,116,calcium ion transmembrane import into cytosol,BP,CAPN3
13668,GO:0051053,0.549901693843423,0.812130022278356,1,117,negative regulation of DNA metabolic process,BP,GJA1
4554,GO:0009628,0.5499277475518,0.605286222346624,7,1099,response to abiotic stimulus,BP,CAPN3;MLC1;MAG;PPL;EGFR;GJA1;PIEZO2
4391,GO:0009165,0.550978299072361,0.721457056042905,2,307,nucleotide biosynthetic process,BP,NNMT;GPD1
6702,GO:0019903,0.551232789332687,0.811077609091592,1,117,protein phosphatase binding,MF,EGFR
4420,GO:0009201,0.551392661761169,0.810820106806117,1,131,ribonucleoside triphosphate biosynthetic process,BP,GPD1
17832,GO:0097529,0.551400870050787,0.810721879739456,1,143,myeloid leukocyte migration,BP,GREM1
4850,GO:0010634,0.551616712480589,0.810742699663461,1,120,positive regulation of epithelial cell migration,BP,ENPP2
1140,GO:0002576,0.551809807557913,0.81059956700608,1,119,platelet degranulation,BP,TF
7510,GO:0030808,0.551846414928435,0.810485755567513,1,128,regulation of nucleotide biosynthetic process,BP,GPD1
18729,GO:1900371,0.551846414928435,0.810485755567513,1,128,regulation of purine nucleotide biosynthetic process,BP,GPD1
3642,GO:0007173,0.551945279839656,0.810492054325657,1,119,epidermal growth factor receptor signaling pathway,BP,EGFR
11495,GO:0044092,0.553062365980539,0.613309870829751,6,967,negative regulation of molecular function,BP,NGFR;RGS4;PPP1R14A;MYO1D;SPOCK3;COL28A1
2953,GO:0006090,0.554065562598697,0.808736570505179,1,126,pyruvate metabolic process,BP,GPD1
162,GO:0000323,0.554106298748846,0.645895296063487,4,633,lytic vacuole,CC,LRP2;MLC1;GJA1;RASGRP1
2746,GO:0005764,0.554106298748846,0.645895296063487,4,633,lysosome,CC,LRP2;MLC1;GJA1;RASGRP1
21847,GO:2001242,0.554900626085269,0.807925094646595,1,144,regulation of intrinsic apoptotic signaling pathway,BP,BOK
685,GO:0001837,0.555466440716932,0.807634059343405,1,124,epithelial to mesenchymal transition,BP,GREM1
16270,GO:0071347,0.555551514758021,0.807389413423257,1,146,cellular response to interleukin-1,BP,ST18
6410,GO:0019058,0.555863715990168,0.717005565896002,2,291,viral life cycle,BP,MOG;EGFR
4673,GO:0010035,0.556100203394942,0.67178791514268,3,466,response to inorganic substance,BP,TF;CAPN3;EGFR
18883,GO:1901293,0.556343833972316,0.716506511603803,2,311,nucleoside phosphate biosynthetic process,BP,NNMT;GPD1
11982,GO:0045333,0.557002009188973,0.806124307813813,1,162,cellular respiration,BP,GPD1
3200,GO:0006497,0.557008329232641,0.806291302194915,1,136,protein lipidation,BP,CPM
2423,GO:0005096,0.557440192565709,0.715637401152412,2,263,GTPase activator activity,MF,RGS4;RASGRP1
4514,GO:0009411,0.557567726148089,0.805898621689292,1,129,response to UV,BP,EGFR
945,GO:0002237,0.558286713392139,0.714687620064056,2,318,response to molecule of bacterial origin,BP,NGFR;GJA1
3181,GO:0006470,0.558409515507751,0.714670790725943,2,283,protein dephosphorylation,BP,EYA2;PPP1R14A
3467,GO:0006869,0.558707562341821,0.714381554414234,2,287,lipid transport,BP,ATP10B;APOD
2772,GO:0005794,0.559009906517894,0.579801728388355,9,1391,Golgi apparatus,CC,LRP2;MYRF;PCSK6;EGFR;GJA1;KCNJ6;RASGRP1;BOK;OPALIN
12608,GO:0046683,0.559222808621143,0.80459690554768,1,125,response to organophosphorus,BP,GPD1
4800,GO:0010557,0.559634084605815,0.572913496359322,10,1569,positive regulation of macromolecule biosynthetic process,BP,NGFR;CAPN3;SOX10;MYRF;PDGFRA;EGFR;ST18;FZD7;GREM1;DMRT2
15897,GO:0070588,0.560337678148312,0.712895849362641,2,277,calcium ion transmembrane transport,BP,CAPN3;GJC2
16059,GO:0070925,0.561085190795386,0.619720565940938,5,753,organelle assembly,BP,ANLN;CAPN3;TUBB4A;LDB3;PDGFRA
362,GO:0000977,0.562143912862488,0.638013920394274,4,614,RNA polymerase II regulatory region sequence-specific DNA binding,MF,ARX;SOX10;NKX6-2;DMRT2
4621,GO:0009887,0.562202930401673,0.604221310711328,6,913,animal organ morphogenesis,BP,LRP2;PDGFRA;EGFR;GJA1;FZD7;GREM1
7031,GO:0022408,0.562821857712479,0.80157787622629,1,135,negative regulation of cell-cell adhesion,BP,MBP
3956,GO:0008201,0.563230186425911,0.801235264769945,1,136,heparin binding,MF,PCSK6
83,GO:0000166,0.563638266168262,0.554845276406969,13,1956,nucleotide binding,MF,ERBB3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;GPD1;CARNS1;MYO1D;AATK;DNAH17
18878,GO:1901265,0.564006325487327,0.554471857799091,13,1957,nucleoside phosphate binding,MF,ERBB3;TUBB4A;BVES;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;GPD1;CARNS1;MYO1D;AATK;DNAH17
13785,GO:0051235,0.564760274881951,0.708724257042775,2,287,maintenance of location,BP,CAPN3;TMSB15A
721,GO:0001889,0.566299965766471,0.798750416129997,1,131,liver development,BP,EGFR
10601,GO:0042158,0.566464605703358,0.798540466659045,1,140,lipoprotein biosynthetic process,BP,CPM
383,GO:0001012,0.56675674480955,0.633439407359359,4,617,RNA polymerase II regulatory region DNA binding,MF,ARX;SOX10;NKX6-2;DMRT2
8786,GO:0032991,0.567250738154723,0.522075037972568,28,4556,protein-containing complex,CC,CRLF1;ERBB3;CDH19;DCX;LRP2;TF;CAPN3;COL9A3;PEX5L;PDGFRA;EGFR;ST18;GJA1;KCNJ6;TMSB15A;PHKG1;GPD1;GJB1;KNDC1;MYO1D;GPR62;CNTN2;GLDN;DNAH17;APOD;MBP;GJC2;COL28A1
4242,GO:0008757,0.567747545514155,0.797542717154567,1,132,S-adenosylmethionine-dependent methyltransferase activity,MF,NNMT
9501,GO:0034702,0.568240974568085,0.705477163857269,2,276,ion channel complex,CC,KCNJ6;CNTN2
11673,GO:0044455,0.568754311042736,0.796444224302042,1,171,mitochondrial membrane part,CC,SOX10
3293,GO:0006606,0.568984218082666,0.796550490977576,1,128,protein import into nucleus,BP,APOD
4359,GO:0009132,0.570662731348366,0.795096197540047,1,134,nucleoside diphosphate metabolic process,BP,GPD1
16355,GO:0071466,0.571113574889202,0.794625064740417,1,146,cellular response to xenobiotic stimulus,BP,EGFR
16610,GO:0071900,0.571743256401345,0.656546307561536,3,466,regulation of protein serine/threonine kinase activity,BP,RGS4;EGFR;RASGRP1
12087,GO:0045619,0.572067350091241,0.79389355793411,1,137,regulation of lymphocyte differentiation,BP,RASGRP1
13799,GO:0051254,0.572409892411703,0.566223269801701,9,1409,positive regulation of RNA metabolic process,BP,NGFR;CAPN3;SOX10;MYRF;EGFR;ST18;FZD7;GREM1;DMRT2
4354,GO:0009127,0.572981430085444,0.793124667103495,1,137,purine nucleoside monophosphate biosynthetic process,BP,GPD1
4394,GO:0009168,0.572981430085444,0.793124667103495,1,137,purine ribonucleoside monophosphate biosynthetic process,BP,GPD1
16035,GO:0070887,0.573781878770231,0.532319662284687,17,2805,cellular response to chemical stimulus,BP,CRLF1;NGFR;LRP2;TF;CAPN3;SOX10;MLC1;PDGFRA;PCSK6;EGFR;ST18;GJA1;FZD7;GREM1;GPD1;PPP1R14A;BOK
6475,GO:0019222,0.574026501634284,0.509327393735095,37,5923,regulation of metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;BVES;PLCL1;RGS4;PLP1;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;SLC45A3;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;DMRT2;MYO1D;BOK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
3216,GO:0006520,0.574099265272187,0.699725883112407,2,341,cellular amino acid metabolic process,BP,FOLH1;CARNS1
7565,GO:0030879,0.574845583144738,0.791658855217522,1,125,mammary gland development,BP,GJA1
4808,GO:0010565,0.575306692898584,0.791083108766031,1,147,regulation of cellular ketone metabolic process,BP,SLC45A3
15126,GO:0061008,0.575444634136132,0.791068283120095,1,134,hepaticobiliary system development,BP,EGFR
19693,GO:1903364,0.575541266884781,0.791012804653122,1,131,positive regulation of cellular protein catabolic process,BP,LRP2
14002,GO:0051640,0.576187343053198,0.624009881782917,4,614,organelle localization,BP,TUBB4A;BVES;MOBP;RASGRP1
4369,GO:0009142,0.580240682598065,0.786900684880682,1,143,nucleoside triphosphate biosynthetic process,BP,GPD1
15538,GO:0065003,0.581440678345561,0.550691341928417,10,1656,protein-containing complex assembly,BP,ANLN;CAPN3;MLC1;TUBB4A;GJA1;TMSB15A;GREM1;GJB1;RASGRP1;BOK
11053,GO:0043087,0.581702137554093,0.646702226281648,3,436,regulation of GTPase activity,BP,BVES;RGS4;RASGRP1
7807,GO:0031324,0.582086351611598,0.532407339386348,14,2250,negative regulation of cellular metabolic process,BP,ARX;NGFR;CAPN3;SOX10;RGS4;EGFR;NKX6-2;GJA1;GREM1;PPP1R14A;MYO1D;APOD;SPOCK3;COL28A1
8699,GO:0032870,0.582283599940664,0.617833803211009,4,630,cellular response to hormone stimulus,BP,NGFR;SOX10;EGFR;GJA1
14513,GO:0060048,0.583211884087542,0.7845491162396,1,120,cardiac muscle contraction,BP,GJA1
8123,GO:0031960,0.584762447373232,0.782959602295353,1,147,response to corticosteroid,BP,EGFR
21394,GO:2000377,0.585335711064735,0.782475225656969,1,145,regulation of reactive oxygen species metabolic process,BP,EGFR
7407,GO:0030534,0.585404302379445,0.782542503311077,1,130,adult behavior,BP,CNTN2
17092,GO:0080090,0.586983783413746,0.497527592774808,34,5437,regulation of primary metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;PLCL1;RGS4;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;SLC45A3;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;DMRT2;BOK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
9445,GO:0034620,0.587405776319082,0.780696985571523,1,141,cellular response to unfolded protein,BP,BOK
405,GO:0001078,0.587778325986953,0.780420939063272,1,135,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NKX6-2
13777,GO:0051224,0.588156024943183,0.780014836397998,1,144,negative regulation of protein transport,BP,APOD
3848,GO:0008015,0.588247629113678,0.640071755136241,3,464,blood circulation,BP,BVES;EGFR;GJA1
6216,GO:0017111,0.588556936895416,0.591909165285196,5,769,nucleoside-triphosphatase activity,MF,TUBB4A;ATP10B;CARNS1;MYO1D;DNAH17
5684,GO:0016055,0.588727469221354,0.639574181649355,3,472,Wnt signaling pathway,BP,SOX10;FZD7;GREM1
14763,GO:0060402,0.589340326501877,0.779074761490192,1,132,calcium ion transport into cytosol,BP,CAPN3
18562,GO:0198738,0.591468987998714,0.636791836430654,3,474,cell-cell signaling by wnt,BP,SOX10;FZD7;GREM1
14506,GO:0060041,0.592279966672422,0.776512842519605,1,128,retina development in camera-type eye,BP,PDGFRA
1215,GO:0002703,0.592649112681558,0.775983452393833,1,152,regulation of leukocyte mediated immunity,BP,RASGRP1
7587,GO:0030902,0.592991364143234,0.775851171297072,1,131,hindbrain development,BP,KNDC1
8229,GO:0032147,0.592996095428925,0.681418327376064,2,303,activation of protein kinase activity,BP,EGFR;GREM1
13089,GO:0048519,0.59349566183074,0.495198957811502,28,4564,negative regulation of biological process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;TUBB4A;MAG;RGS4;PDGFRA;EGFR;ST18;NKX6-2;GJA1;FZD7;TMSB15A;GREM1;PPP1R14A;MYO1D;BOK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
13745,GO:0051172,0.593570170569833,0.524123376124158,13,2109,negative regulation of nitrogen compound metabolic process,BP,ARX;NGFR;CAPN3;SOX10;RGS4;EGFR;NKX6-2;GJA1;GREM1;PPP1R14A;APOD;SPOCK3;COL28A1
13133,GO:0048609,0.593712201063046,0.606126085006554,4,657,multicellular organismal reproductive process,BP,CLDN11;PDGFRA;EGFR;GJA1
1375,GO:0003013,0.594397739940121,0.633819071511615,3,468,circulatory system process,BP,BVES;EGFR;GJA1
2519,GO:0005261,0.594695541717276,0.679777374251208,2,288,cation channel activity,MF,PIEZO2;KCNJ6
9440,GO:0034613,0.595872485822577,0.535770938699207,10,1648,cellular protein localization,BP,ANLN;NGFR;CAPN3;PEX5L;EGFR;TMSB15A;SH3TC2;UGT8;CNTN2;APOD
3826,GO:0007612,0.596245751399865,0.772961451431801,1,129,learning,BP,CNTN2
7652,GO:0031047,0.59722874895278,0.771976791964294,1,140,gene silencing by RNA,BP,EGFR
3970,GO:0008217,0.598317940159371,0.770922722579791,1,149,regulation of blood pressure,BP,GJA1
13744,GO:0051171,0.598560242138499,0.486184155799887,33,5304,regulation of nitrogen compound metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;PLCL1;RGS4;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;GREM1;GPD1;PPP1R14A;KNDC1;RASGRP1;DMRT2;BOK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
6322,GO:0018210,0.598726472759026,0.770697081730934,1,132,peptidyl-threonine modification,BP,PHKG1
20482,GO:1904950,0.598924267491493,0.770381957086444,1,148,negative regulation of establishment of protein localization,BP,APOD
2806,GO:0005856,0.599941983630884,0.521563078401609,12,1863,cytoskeleton,CC,ANLN;PLEKHH1;DCX;TUBB4A;PPL;LDB3;ERMN;GJA1;TMSB15A;MOBP;MYO1D;DNAH17
1604,GO:0003690,0.600349604019062,0.579675327987753,5,799,double-stranded DNA binding,MF,ARX;SOX10;EGFR;NKX6-2;DMRT2
8758,GO:0032956,0.60042202722897,0.673997727423759,2,306,regulation of actin cytoskeleton organization,BP,PDGFRA;TMSB15A
19469,GO:1902903,0.600748552462817,0.673663682709958,2,308,regulation of supramolecular fiber organization,BP,TUBB4A;TMSB15A
8470,GO:0032504,0.600980938273212,0.598596858591655,4,665,multicellular organism reproduction,BP,CLDN11;PDGFRA;EGFR;GJA1
475,GO:0001508,0.601101499064167,0.768572195308408,1,129,action potential,BP,GJA1
4383,GO:0009156,0.601131910253119,0.76837028250432,1,149,ribonucleoside monophosphate biosynthetic process,BP,GPD1
7830,GO:0031348,0.601611875675937,0.767918049006005,1,151,negative regulation of defense response,BP,APOD
13481,GO:0050773,0.602765795219687,0.767064438085086,1,128,regulation of dendrite development,BP,KNDC1
18000,GO:0098662,0.603036372318415,0.596476303033077,4,644,inorganic cation transmembrane transport,BP,CAPN3;SLC31A2;KCNJ6;GJC2
7304,GO:0030307,0.60313874561422,0.766593577491689,1,142,positive regulation of cell growth,BP,EGFR
15960,GO:0070727,0.60345407161079,0.527855331877293,10,1658,cellular macromolecule localization,BP,ANLN;NGFR;CAPN3;PEX5L;EGFR;TMSB15A;SH3TC2;UGT8;CNTN2;APOD
7161,GO:0030111,0.603561414828761,0.670794098850025,2,320,regulation of Wnt signaling pathway,BP,SOX10;GREM1
7532,GO:0030833,0.604371616057019,0.765422548912074,1,147,regulation of actin filament polymerization,BP,TMSB15A
7464,GO:0030666,0.604574974140636,0.765197836950397,1,152,endocytic vesicle membrane,CC,EGFR
6597,GO:0019637,0.60479734797649,0.560465621543842,6,1043,organophosphate metabolic process,BP,ERBB3;PDGFRA;ENPP2;EGFR;NNMT;GPD1
11255,GO:0043409,0.605284658188871,0.764614957736569,1,143,negative regulation of MAPK cascade,BP,RGS4
5094,GO:0010970,0.605731021026723,0.764255636679785,1,137,transport along microtubule,BP,RASGRP1
18213,GO:0099111,0.605731021026723,0.764255636679785,1,137,microtubule-based transport,BP,RASGRP1
1211,GO:0002699,0.60616050453409,0.763694647337667,1,158,positive regulation of immune effector process,BP,RASGRP1
9821,GO:0035567,0.606231118846515,0.763686783857795,1,150,non-canonical Wnt signaling pathway,BP,FZD7
14647,GO:0060255,0.606239104338194,0.477653621234368,34,5491,regulation of macromolecule metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;BVES;PLCL1;RGS4;PLP1;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;GREM1;PPP1R14A;KNDC1;RASGRP1;DMRT2;BOK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
15873,GO:0070555,0.606345274523737,0.763472152127762,1,166,response to interleukin-1,BP,ST18
4946,GO:0010770,0.606578735424566,0.763510606590355,1,133,positive regulation of cell morphogenesis involved in differentiation,BP,NGFR
12179,GO:0045766,0.607195668791701,0.762842230960514,1,144,positive regulation of angiogenesis,BP,GREM1
5400,GO:0015276,0.607228839451415,0.762909435979212,1,133,ligand-gated ion channel activity,MF,KCNJ6
7063,GO:0022834,0.607228839451415,0.762909435979212,1,133,ligand-gated channel activity,MF,KCNJ6
7030,GO:0022407,0.607525974011857,0.666727409357737,2,337,regulation of cell-cell adhesion,BP,RASGRP1;MBP
5017,GO:0010876,0.607800479125959,0.666499159762663,2,317,lipid localization,BP,ATP10B;APOD
19870,GO:1903708,0.608023365713245,0.762020120491295,1,151,positive regulation of hemopoiesis,BP,RASGRP1
5884,GO:0016482,0.608472847216367,0.761727686419155,1,136,cytosolic transport,BP,MYO1D
7485,GO:0030695,0.60904942591893,0.665296056798833,2,293,GTPase regulator activity,MF,RGS4;RASGRP1
7071,GO:0022843,0.609096136467198,0.761167088509155,1,134,voltage-gated cation channel activity,MF,KCNJ6
13247,GO:0048813,0.609165230655197,0.761152402627002,1,129,dendrite morphogenesis,BP,KNDC1
19117,GO:1901981,0.609182961469787,0.761049212651544,1,138,phosphatidylinositol phosphate binding,MF,FZD7
19318,GO:1902495,0.609555859189663,0.664759649676835,2,299,transmembrane transporter complex,CC,KCNJ6;CNTN2
7434,GO:0030595,0.609990876174044,0.760056261193704,1,171,leukocyte chemotaxis,BP,GREM1
18469,GO:0120032,0.610016801516005,0.760245794416803,1,141,regulation of plasma membrane bounded cell projection assembly,BP,ANLN
8135,GO:0031984,0.610097983102985,0.527140079450068,9,1497,organelle subcompartment,CC,TF;FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;RASGRP1;BOK
15272,GO:0061337,0.610235641013445,0.760077191245977,1,137,cardiac conduction,BP,GJA1
13506,GO:0050806,0.610403192640614,0.75988514536302,1,141,positive regulation of synaptic transmission,BP,EGFR
395,GO:0001047,0.610435673216538,0.75987236956093,1,139,core promoter binding,MF,ST18
11257,GO:0043412,0.611134194317912,0.481270683728926,24,3860,macromolecule modification,BP,CRLF1;NGFR;EYA2;ERBB3;FOLH1;TF;CAPN3;PLCL1;RGS4;CDK18;PDGFRA;CPM;ENPP2;EGFR;FZD7;PHKG1;GREM1;PPP1R14A;KNDC1;RASGRP1;AATK;SPOCK3;MBP;GJC2
13743,GO:0051170,0.611359539651883,0.758925180725442,1,149,import into nucleus,BP,APOD
9879,GO:0035639,0.611666238428775,0.513908139320151,11,1684,purine ribonucleoside triphosphate binding,MF,ERBB3;TUBB4A;CDK18;ATP10B;PDGFRA;EGFR;PHKG1;CARNS1;MYO1D;AATK;DNAH17
13546,GO:0050866,0.611767556420169,0.758490854979278,1,156,negative regulation of cell activation,BP,PDGFRA
5177,GO:0014074,0.612194907963196,0.758207788181997,1,141,response to purine-containing compound,BP,GPD1
4973,GO:0010822,0.614091301851606,0.756304877616483,1,156,positive regulation of mitochondrion organization,BP,BOK
13932,GO:0051493,0.61489640215613,0.612561458209047,3,475,regulation of cytoskeleton organization,BP,TUBB4A;PDGFRA;TMSB15A
9663,GO:0035257,0.615740156080544,0.754838600309975,1,144,nuclear hormone receptor binding,MF,LRP2
12694,GO:0046890,0.615889420018497,0.754640857492117,1,151,regulation of lipid biosynthetic process,BP,SLC45A3
14831,GO:0060491,0.615935214390308,0.754662176572077,1,143,regulation of cell projection assembly,BP,ANLN
6039,GO:0016772,0.617592025612267,0.546996858117468,6,936,transferase activity, transferring phosphorus-containing groups,MF,ERBB3;CDK18;PDGFRA;EGFR;PHKG1;AATK
14762,GO:0060401,0.617661835849367,0.753029742577407,1,142,cytosolic calcium ion transport,BP,CAPN3
7203,GO:0030168,0.617705140538132,0.752930371016103,1,149,platelet activation,BP,PDGFRA
6105,GO:0016874,0.619335721882689,0.751365108113587,1,150,ligase activity,MF,CARNS1
20965,GO:1990351,0.619967094171539,0.653986186905462,2,307,transporter complex,CC,KCNJ6;CNTN2
4351,GO:0009124,0.620486084086088,0.750195385371478,1,159,nucleoside monophosphate biosynthetic process,BP,GPD1
4807,GO:0010564,0.62117545211497,0.577311584922351,4,670,regulation of cell cycle process,BP,ANLN;TUBB4A;EGFR;GJC2
7814,GO:0031331,0.621278137586052,0.652597167648463,2,314,positive regulation of cellular catabolic process,BP,LRP2;GPD1
11656,GO:0044433,0.621425070049134,0.522566275336287,8,1376,cytoplasmic vesicle part,CC,LRP2;TF;ATP10B;EGFR;GJA1;FZD7;SNX22;BOK
7058,GO:0022804,0.62159795060367,0.652280262336009,2,308,active transmembrane transporter activity,MF,SLC45A3;SLC5A11
2795,GO:0005840,0.622156261968109,0.748249360325059,1,228,ribosome,CC,APOD
4765,GO:0010469,0.6229455831201,0.650663901106912,2,397,regulation of signaling receptor activity,BP,CRLF1;GREM1
3601,GO:0007088,0.623296041305827,0.747545516905363,1,151,regulation of mitotic nuclear division,BP,ANLN
4392,GO:0009166,0.623824339093622,0.74699597265656,1,156,nucleotide catabolic process,BP,GPD1
19936,GO:1903829,0.624461856210505,0.649226382255684,2,326,positive regulation of cellular protein localization,BP,NGFR;EGFR
20714,GO:1905475,0.624560450515691,0.746304283134877,1,153,regulation of protein localization to membrane,BP,EGFR
11530,GO:0044212,0.626012573346506,0.552489655192755,5,817,transcription regulatory region DNA binding,MF,ARX;SOX10;ST18;NKX6-2;DMRT2
13223,GO:0048754,0.626240250341606,0.744742689246635,1,144,branching morphogenesis of an epithelial tube,BP,GREM1
16612,GO:0071902,0.626650411778007,0.646914982695455,2,328,positive regulation of protein serine/threonine kinase activity,BP,EGFR;RASGRP1
399,GO:0001067,0.627306325079451,0.551096978871739,5,818,regulatory region nucleic acid binding,MF,ARX;SOX10;ST18;NKX6-2;DMRT2
10067,GO:0035967,0.627368292554659,0.743536916454767,1,157,cellular response to topologically incorrect protein,BP,BOK
11072,GO:0043123,0.628092477841215,0.742805846443545,1,160,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,GJA1
7043,GO:0022607,0.628732632000895,0.47763545693253,16,2631,cellular component assembly,BP,ANLN;CDH19;CAPN3;MLC1;TUBB4A;LDB3;HAPLN2;PDGFRA;GJA1;TMSB15A;GREM1;GJB1;RASGRP1;UGT8;BOK;APOD
7229,GO:0030203,0.629374635916704,0.741646463738594,1,147,glycosaminoglycan metabolic process,BP,SPOCK3
3800,GO:0007565,0.629972073239711,0.740957715414374,1,160,female pregnancy,BP,GJA1
16245,GO:0071310,0.63064393521202,0.481556987245541,14,2366,cellular response to organic substance,BP,CRLF1;NGFR;LRP2;SOX10;MLC1;PDGFRA;PCSK6;EGFR;ST18;GJA1;FZD7;GREM1;GPD1;BOK
7065,GO:0022836,0.631165262884254,0.642166382596673,2,314,gated channel activity,MF,PIEZO2;KCNJ6
2776,GO:0005798,0.631874495642529,0.739056410237958,1,163,Golgi-associated vesicle,CC,GJA1
17582,GO:0097060,0.633139881221993,0.640093000817533,2,303,synaptic membrane,CC,CNTNAP4;ANKS1B
6658,GO:0019827,0.634630265810721,0.736429519002552,1,148,stem cell population maintenance,BP,FZD7
1471,GO:0003205,0.63634860354297,0.734727328135494,1,146,cardiac chamber development,BP,LRP2
18824,GO:1901136,0.637099430206251,0.733813993359004,1,167,carbohydrate derivative catabolic process,BP,GPD1
18882,GO:1901292,0.6372995555289,0.733646988081852,1,162,nucleoside phosphate catabolic process,BP,GPD1
12187,GO:0045785,0.638563952234406,0.634131080403902,2,353,positive regulation of cell adhesion,BP,EDIL3;RASGRP1
5305,GO:0015079,0.639598321149785,0.731395231105695,1,153,potassium ion transmembrane transporter activity,MF,KCNJ6
7131,GO:0030041,0.639700725848166,0.731230992405848,1,161,actin filament polymerization,BP,TMSB15A
4628,GO:0009894,0.639960381623637,0.537343435267059,5,855,regulation of catabolic process,BP,LRP2;EGFR;GJA1;GPD1;BOK
18018,GO:0098727,0.640078481161393,0.730933398675564,1,150,maintenance of cell number,BP,FZD7
18754,GO:1900542,0.640616480130382,0.730281417896945,1,164,regulation of purine nucleotide metabolic process,BP,GPD1
5306,GO:0015081,0.642110505782028,0.728929932432679,1,143,sodium ion transmembrane transporter activity,MF,SLC5A11
366,GO:0000981,0.64222721903046,0.520381305079575,6,1013,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,ARX;SOX10;MYRF;ST18;NKX6-2;DMRT2
11678,GO:0044464,0.642335285689154,0.495103766521041,87,14059,cell part,CC,ARX;CRLF1;ANLN;CLDN11;PLEKHH1;NGFR;EYA2;BCAS1;ERBB3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;PLP1;MYRF;PDGFRA;CPM;RAPGEF5;ERMN;SLC31A2;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SNX22;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;MOBP;LGI3;SH3TC2;GJB1;KNDC1;MAL;CARNS1;RASGRP1;DMRT2;UGT8;MYO1D;BOK;S1PR5;GPR62;AATK;CNTN2;ANKS1B;GLDN;DNAH17;NKAIN2;APOD;OPALIN;MBP;GJC2;TMEM235;COL28A1
13499,GO:0050796,0.642338397333039,0.728565453217136,1,159,regulation of insulin secretion,BP,GJA1
6970,GO:0021915,0.643802201901381,0.727140885926487,1,150,neural tube development,BP,LRP2
3852,GO:0008021,0.644458762563587,0.726339953689922,1,167,synaptic vesicle,CC,LGI3
11119,GO:0043197,0.645057627211628,0.725861978458765,1,149,dendritic spine,CC,ANKS1B
1600,GO:0003682,0.645387753419527,0.579669550986859,3,495,chromatin binding,MF,ARX;SOX10;EGFR
8126,GO:0031966,0.646638330287796,0.57814240476233,3,619,mitochondrial membrane,CC,SOX10;GJA1;BOK
13695,GO:0051099,0.64686428081381,0.723891979034461,1,163,positive regulation of binding,BP,PLCL1
668,GO:0001819,0.647522756395807,0.624353037755608,2,362,positive regulation of cytokine production,BP,RASGRP1;MBP
13532,GO:0050852,0.647810304593602,0.722786111777344,1,183,T cell receptor signaling pathway,BP,MOG
16321,GO:0071417,0.647965311435598,0.576814438325566,3,499,cellular response to organonitrogen compound,BP,NGFR;EGFR;GPD1
328,GO:0000910,0.648512657957965,0.722230795072061,1,157,cytokinesis,BP,ANLN
3976,GO:0008234,0.648925854779069,0.72179429726921,1,158,cysteine-type peptidase activity,MF,CAPN3
20032,GO:1904018,0.649209362266314,0.721477243129353,1,161,positive regulation of vasculature development,BP,GREM1
20917,GO:1990138,0.650221717270469,0.72054613539699,1,146,neuron projection extension,BP,MAG
11586,GO:0044309,0.650891477338773,0.719804153559956,1,151,neuron spine,CC,ANKS1B
2982,GO:0006140,0.65128526805611,0.719250535345454,1,170,regulation of nucleotide metabolic process,BP,GPD1
4587,GO:0009749,0.651323297023113,0.719245058542839,1,165,response to glucose,BP,GJA1
4716,GO:0010243,0.651503585915644,0.524630542381184,5,863,response to organonitrogen compound,BP,NGFR;EGFR;GJA1;NNMT;GPD1
3541,GO:0006986,0.651822780940071,0.718681623760859,1,171,response to unfolded protein,BP,BOK
17640,GO:0097164,0.65244842313725,0.717969707227897,1,180,ammonium ion metabolic process,BP,ENPP2
2909,GO:0006022,0.652472954226343,0.718093170547824,1,158,aminoglycan metabolic process,BP,SPOCK3
68,GO:0000139,0.653013894523323,0.542564688611183,4,685,Golgi membrane,CC,EGFR;GJA1;RASGRP1;BOK
3874,GO:0008064,0.653196542713541,0.717274775987416,1,166,regulation of actin polymerization or depolymerization,BP,TMSB15A
2669,GO:0005623,0.653563345163319,0.483242557270658,87,14077,cell,CC,ARX;CRLF1;ANLN;CLDN11;PLEKHH1;NGFR;EYA2;BCAS1;ERBB3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;PLP1;MYRF;PDGFRA;CPM;RAPGEF5;ERMN;SLC31A2;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;CNTNAP4;PIEZO2;FZD7;KCNJ6;SNX22;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;MOBP;LGI3;SH3TC2;GJB1;KNDC1;MAL;CARNS1;RASGRP1;DMRT2;UGT8;MYO1D;BOK;S1PR5;GPR62;AATK;CNTN2;ANKS1B;GLDN;DNAH17;NKAIN2;APOD;OPALIN;MBP;GJC2;TMEM235;COL28A1
13896,GO:0051427,0.65375550792273,0.716701208251227,1,164,hormone receptor binding,MF,LRP2
2843,GO:0005912,0.655144729235218,0.568803686000063,3,509,adherens junction,CC,CDH19;EGFR;GJA1
7382,GO:0030496,0.655644026941173,0.714738345052008,1,160,midbody,CC,ANLN
1195,GO:0002683,0.656758296901181,0.614105753077242,2,368,negative regulation of immune system process,BP,GREM1;APOD
361,GO:0000976,0.657098309481882,0.538000522168175,4,685,transcription regulatory region sequence-specific DNA binding,MF,ARX;SOX10;NKX6-2;DMRT2
17715,GO:0097305,0.65729610933626,0.712908405783476,1,171,response to alcohol,BP,MLC1
2726,GO:0005739,0.658072979482941,0.482741311681478,8,1557,mitochondrion,CC,EYA2;SOX10;PPL;GJA1;GPD1;KLK6;MOBP;BOK
7318,GO:0030324,0.658709066085612,0.711490375203343,1,159,lung development,BP,EGFR
11654,GO:0044431,0.659262326425245,0.515991642316481,5,858,Golgi apparatus part,CC,PCSK6;EGFR;GJA1;RASGRP1;BOK
4586,GO:0009746,0.66002525758928,0.710010722965381,1,169,response to hexose,BP,GJA1
7531,GO:0030832,0.660159657670318,0.70988073051162,1,167,regulation of actin filament length,BP,TMSB15A
15929,GO:0070663,0.660685247662183,0.709180135368643,1,189,regulation of leukocyte proliferation,BP,GREM1
2754,GO:0005773,0.662897973330779,0.531443942688835,4,723,vacuole,CC,LRP2;MLC1;GJA1;RASGRP1
13550,GO:0050870,0.663662612488112,0.705983622008103,1,187,positive regulation of T cell activation,BP,RASGRP1
13772,GO:0051216,0.664097304882933,0.705647456707696,1,166,cartilage development,BP,GREM1
13663,GO:0051048,0.665700863089175,0.703820162283994,1,179,negative regulation of secretion,BP,ERBB3
3215,GO:0006518,0.665953027315765,0.527927192968783,4,805,peptide metabolic process,BP,CPM;PCSK6;EGFR;CARNS1
4058,GO:0008361,0.666114015560932,0.703526791338174,1,157,regulation of cell size,BP,MAG
13105,GO:0048545,0.667059666271948,0.602490053311701,2,362,response to steroid hormone,BP,SOX10;EGFR
11547,GO:0044242,0.667709587583012,0.701587024852442,1,186,cellular lipid catabolic process,BP,ENPP2
14893,GO:0060589,0.668064152595324,0.601413675952487,2,334,nucleoside-triphosphatase regulator activity,MF,RGS4;RASGRP1
11929,GO:0045202,0.668368818108207,0.505758476704625,5,835,synapse,CC,EGFR;CNTNAP4;LGI3;CNTN2;ANKS1B
7317,GO:0030323,0.668415028071871,0.70096689953652,1,163,respiratory tube development,BP,EGFR
3439,GO:0006820,0.668764406120946,0.553359095901026,3,529,anion transport,BP,LRP2;ATP10B;GJA1
14079,GO:0051783,0.670241275550893,0.698903079598644,1,171,regulation of nuclear division,BP,ANLN
6034,GO:0016758,0.670864820060749,0.698188783288132,1,175,transferase activity, transferring hexosyl groups,MF,UGT8
9284,GO:0034284,0.670878495008214,0.698180328246224,1,174,response to monosaccharide,BP,GJA1
3040,GO:0006259,0.671175123012464,0.50253818535938,5,898,DNA metabolic process,BP,EYA2;PDGFRA;EGFR;GJA1;GREM1
11332,GO:0043542,0.671512229989139,0.697514918674724,1,169,endothelial cell migration,BP,GREM1
11663,GO:0044445,0.672103953393297,0.696554348619525,1,227,cytosolic part,CC,APOD
12277,GO:0045944,0.672550774589538,0.486645068161611,6,1037,positive regulation of transcription by RNA polymerase II,BP,NGFR;SOX10;EGFR;ST18;GREM1;DMRT2
7761,GO:0031256,0.673452587999396,0.695448551195244,1,158,leading edge membrane,CC,MYO1D
2177,GO:0004721,0.673850706484782,0.694936643458052,1,167,phosphoprotein phosphatase activity,MF,EYA2
15842,GO:0070507,0.674175230807907,0.694605449368046,1,163,regulation of microtubule cytoskeleton organization,BP,TUBB4A
4742,GO:0010389,0.674421708738547,0.694176446708879,1,186,regulation of G2/M transition of mitotic cell cycle,BP,TUBB4A
3516,GO:0006941,0.675158578326639,0.693532796749612,1,160,striated muscle contraction,BP,GJA1
8770,GO:0032970,0.676121873943567,0.592105173592201,2,347,regulation of actin filament-based process,BP,PDGFRA;TMSB15A
18051,GO:0098793,0.676240156391263,0.591943346523144,2,357,presynapse,CC,CNTNAP4;LGI3
15773,GO:0070382,0.676468756811549,0.691919324935061,1,181,exocytic vesicle,CC,LGI3
6244,GO:0017157,0.67784880561335,0.690408843002332,1,175,regulation of exocytosis,BP,LGI3
11567,GO:0044281,0.679897908005445,0.445030512719687,10,1880,small molecule metabolic process,BP,LRP2;FOLH1;FA2H;PLP1;SLC45A3;NNMT;GPD1;CARNS1;APOD;SPOCK3
12947,GO:0048167,0.680237150540442,0.687792831765843,1,164,regulation of synaptic plasticity,BP,CNTN2
2727,GO:0005740,0.681711452722368,0.538259483857351,3,655,mitochondrial envelope,CC,SOX10;GJA1;BOK
3931,GO:0008168,0.683318846146919,0.684163876750918,1,182,methyltransferase activity,MF,NNMT
1072,GO:0002449,0.683608571546023,0.683762134041276,1,194,lymphocyte mediated immunity,BP,RASGRP1
19550,GO:1903039,0.683709597734282,0.683635686081242,1,196,positive regulation of leukocyte cell-cell adhesion,BP,RASGRP1
6701,GO:0019902,0.684265006277169,0.683192356202693,1,166,phosphatase binding,MF,EGFR
11727,GO:0044706,0.685696590040902,0.681408741036174,1,187,multi-multicellular organism process,BP,GJA1
18060,GO:0098802,0.686146167466746,0.680975227433559,1,174,plasma membrane receptor complex,CC,TF
12700,GO:0046903,0.686996391360153,0.450351474537395,8,1439,secretion,BP,ERBB3;TF;PCSK6;EGFR;GJA1;LGI3;RASGRP1;MBP
12702,GO:0046907,0.68754921921655,0.442499919714723,9,1616,intracellular transport,BP,NGFR;MLC1;BVES;PEX5L;MOBP;SH3TC2;RASGRP1;MYO1D;APOD
14719,GO:0060348,0.687665863819496,0.67925827154653,1,169,bone development,BP,GREM1
18982,GO:1901605,0.689247212222217,0.677228058950681,1,201,alpha-amino acid metabolic process,BP,CARNS1
10066,GO:0035966,0.689321781181595,0.677208071065363,1,189,response to topologically incorrect protein,BP,BOK
7151,GO:0030097,0.690128894318405,0.500090159697907,4,747,hemopoiesis,BP,ANLN;BVES;FZD7;RASGRP1
3996,GO:0008270,0.692682790950431,0.49711271037716,4,719,zinc ion binding,MF,CPM;ENPP2;ST18;RASGRP1
2031,GO:0004518,0.692983118949086,0.672911099378029,1,193,nuclease activity,MF,ENPP2
17998,GO:0098660,0.694355345042162,0.49514245499712,4,719,inorganic ion transmembrane transport,BP,CAPN3;SLC31A2;KCNJ6;GJC2
3807,GO:0007584,0.694904146696529,0.670645517843454,1,194,response to nutrient,BP,EGFR
5581,GO:0015850,0.69519605688359,0.670324247857332,1,190,organic hydroxy compound transport,BP,SLC5A11
565,GO:0001664,0.696143759205415,0.669087082211449,1,212,G-protein coupled receptor binding,MF,FZD7
13686,GO:0051090,0.696677989129274,0.56770515745233,2,379,regulation of DNA binding transcription factor activity,BP,CAPN3;GREM1
9355,GO:0034404,0.698051926305933,0.666893805498623,1,198,nucleobase-containing small molecule biosynthetic process,BP,GPD1
21119,GO:1990837,0.698088617668068,0.490726401003539,4,721,sequence-specific double-stranded DNA binding,MF,ARX;SOX10;NKX6-2;DMRT2
3926,GO:0008154,0.699239562804147,0.665542240311425,1,187,actin polymerization or depolymerization,BP,TMSB15A
8977,GO:0033365,0.699416968113812,0.489105347352131,4,780,protein localization to organelle,BP,ANLN;NGFR;PEX5L;APOD
4335,GO:0009100,0.700467271034082,0.563124960512898,2,374,glycoprotein metabolic process,BP,PCSK6;SPOCK3
7149,GO:0030073,0.700564186039347,0.663964174632048,1,186,insulin secretion,BP,GJA1
5747,GO:0016197,0.703533578379247,0.660410535596091,1,183,endosomal transport,BP,BVES
19126,GO:1901991,0.703817695533159,0.659934220266063,1,206,negative regulation of mitotic cell cycle phase transition,BP,GJC2
2778,GO:0005802,0.704441883382776,0.659273886640686,1,189,trans-Golgi network,CC,BOK
3839,GO:0007626,0.705352921707568,0.658247321103617,1,177,locomotory behavior,BP,CNTN2
19419,GO:1902749,0.706592968224667,0.656585676328658,1,202,regulation of cell cycle G2/M phase transition,BP,TUBB4A
2852,GO:0005925,0.706887549630226,0.555252176328584,2,381,focal adhesion,CC,EGFR;GJA1
6180,GO:0017048,0.707158093647707,0.65614812058786,1,164,Rho GTPase binding,MF,ANLN
750,GO:0001933,0.707165982284718,0.554896322752666,2,387,negative regulation of protein phosphorylation,BP,RGS4;GREM1
6023,GO:0016741,0.707200987286122,0.655888763212,1,194,transferase activity, transferring one-carbon groups,MF,NNMT
19675,GO:1903320,0.707762680172549,0.655196686527694,1,195,regulation of protein modification by small protein conjugation or removal,BP,CAPN3
403,GO:0001076,0.708353957605179,0.654540548643279,1,184,transcription factor activity, RNA polymerase II transcription factor binding,MF,SOX10
11269,GO:0043434,0.708381762710351,0.553400601635985,2,385,response to peptide hormone,BP,NGFR;GJA1
2954,GO:0006091,0.708837072151063,0.552746919843046,2,433,generation of precursor metabolites and energy,BP,PHKG1;GPD1
10576,GO:0042110,0.70894206644064,0.552671432221335,2,403,T cell activation,BP,FZD7;RASGRP1
18094,GO:0098858,0.70961235128349,0.653044157753901,1,177,actin-based cell projection,CC,ERMN
2851,GO:0005924,0.71000640738539,0.551392726369557,2,384,cell-substrate adherens junction,CC,EGFR;GJA1
4848,GO:0010632,0.710055753035355,0.65245145179458,1,184,regulation of epithelial cell migration,BP,ENPP2
3559,GO:0007015,0.71045458871791,0.550892110565067,2,360,actin filament organization,BP,ERMN;TMSB15A
4551,GO:0009617,0.710490798919838,0.550700563016117,2,432,response to bacterium,BP,NGFR;GJA1
8698,GO:0032869,0.710996727734932,0.651272731488131,1,187,cellular response to insulin stimulus,BP,NGFR
4584,GO:0009743,0.712519875400935,0.649340694290803,1,195,response to carbohydrate,BP,GJA1
14860,GO:0060541,0.71255890423509,0.649360387750184,1,184,respiratory system development,BP,EGFR
11241,GO:0043393,0.713610036002047,0.647981831162948,1,196,regulation of protein binding,BP,PLCL1
16551,GO:0071804,0.714738928119173,0.646631075278665,1,187,cellular potassium ion transport,BP,KCNJ6
16552,GO:0071805,0.714738928119173,0.646631075278665,1,187,potassium ion transmembrane transport,BP,KCNJ6
7140,GO:0030055,0.715111239930446,0.545028389038076,2,387,cell-substrate junction,CC,EGFR;GJA1
11661,GO:0044441,0.716433595951174,0.543399522601392,2,374,ciliary part,CC,TUBB4A;DNAH17
9005,GO:0033500,0.717156440381983,0.643545495608218,1,197,carbohydrate homeostasis,BP,NGFR
10821,GO:0042593,0.717156440381983,0.643545495608218,1,197,glucose homeostasis,BP,NGFR
2507,GO:0005244,0.71780194982778,0.642814762117778,1,184,voltage-gated ion channel activity,MF,KCNJ6
7062,GO:0022832,0.71780194982778,0.642814762117778,1,184,voltage-gated channel activity,MF,KCNJ6
12916,GO:0048037,0.717881517706077,0.541463471692057,2,433,cofactor binding,MF,FA2H;GPD1
11337,GO:0043547,0.718295402559725,0.541084386864401,2,363,positive regulation of GTPase activity,BP,RGS4;RASGRP1
4972,GO:0010821,0.721176603486881,0.638403174068027,1,209,regulation of mitochondrion organization,BP,BOK
11653,GO:0044430,0.721485208386008,0.410443554347688,8,1393,cytoskeletal part,CC,ANLN;DCX;TUBB4A;GJA1;TMSB15A;MOBP;MYO1D;DNAH17
667,GO:0001818,0.72275283853077,0.636376366014441,1,213,negative regulation of cytokine production,BP,APOD
4576,GO:0009719,0.722792571309654,0.408886161361683,8,1450,response to endogenous stimulus,BP,NGFR;LRP2;SOX10;PCSK6;EGFR;GJA1;GREM1;GPD1
13531,GO:0050851,0.723004637463111,0.63601646908002,1,221,antigen receptor-mediated signaling pathway,BP,MOG
13098,GO:0048534,0.726546230940207,0.456250820248512,4,785,hematopoietic or lymphoid organ development,BP,ANLN;BVES;FZD7;RASGRP1
19031,GO:1901681,0.727859496348436,0.629828993060648,1,210,sulfur compound binding,MF,PCSK6
19123,GO:1901988,0.727973579388543,0.62963647824198,1,219,negative regulation of cell cycle phase transition,BP,GJC2
16990,GO:0072593,0.728455864082561,0.629026037052741,1,216,reactive oxygen species metabolic process,BP,EGFR
4828,GO:0010605,0.728474348800106,0.376434482835068,13,2356,negative regulation of macromolecule metabolic process,BP,ARX;NGFR;CAPN3;SOX10;RGS4;EGFR;NKX6-2;GJA1;GREM1;PPP1R14A;APOD;SPOCK3;COL28A1
8711,GO:0032886,0.729435009062777,0.627900111088094,1,190,regulation of microtubule-based process,BP,TUBB4A
9877,GO:0035637,0.732623986111318,0.623735251297868,1,190,multicellular organismal signaling,BP,GJA1
21232,GO:2000113,0.733075311515727,0.405119807813645,7,1285,negative regulation of cellular macromolecule biosynthetic process,BP,ARX;CAPN3;SOX10;EGFR;NKX6-2;GJA1;GREM1
11160,GO:0043254,0.734328965912337,0.520468361426585,2,404,regulation of protein complex assembly,BP,TUBB4A;TMSB15A
3703,GO:0007266,0.734530815601469,0.621233130477539,1,189,Rho protein signal transduction,BP,NGFR
7104,GO:0023061,0.734561891234092,0.520171234598571,2,401,signal release,BP,EGFR;GJA1
8750,GO:0032940,0.735027578206045,0.402754020783011,7,1334,secretion by cell,BP,TF;PCSK6;EGFR;GJA1;LGI3;RASGRP1;MBP
15533,GO:0062012,0.735604685953016,0.518766834811855,2,425,regulation of small molecule metabolic process,BP,SLC45A3;GPD1
13124,GO:0048588,0.736948107266335,0.618026730558957,1,190,developmental cell growth,BP,MAG
12317,GO:0046034,0.737621579271488,0.616891856731394,1,236,ATP metabolic process,BP,GPD1
4558,GO:0009636,0.738187049923298,0.515360039115341,2,442,response to toxic substance,BP,MBP;GJC2
15543,GO:0065008,0.738402367699751,0.350008476745009,19,3342,regulation of biological quality,BP,NGFR;EYA2;TF;CAPN3;MAG;BVES;ATP10B;PDGFRA;ERMN;SLC31A2;PCSK6;EGFR;GJA1;PIEZO2;TMSB15A;KLK6;BOK;CNTN2;MBP
20556,GO:1905114,0.738490227868905,0.468901901952226,3,584,cell surface receptor signaling pathway involved in cell-cell signaling,BP,SOX10;FZD7;GREM1
7032,GO:0022409,0.738729351936915,0.61546303060068,1,225,positive regulation of cell-cell adhesion,BP,RASGRP1
5746,GO:0016192,0.739292117058305,0.376633843404087,10,1818,vesicle-mediated transport,BP,LRP2;TF;MLC1;BVES;ENPP2;GREM1;LGI3;RASGRP1;MYO1D;CNTN2
18049,GO:0098791,0.740126222273431,0.439329008525221,4,769,Golgi subcompartment,CC,EGFR;GJA1;RASGRP1;BOK
10820,GO:0042592,0.740899018096319,0.387296543101504,8,1514,homeostatic process,BP,NGFR;TF;CAPN3;PDGFRA;SLC31A2;EGFR;GJA1;BOK
14464,GO:0055114,0.74203696213583,0.436852219652632,4,874,oxidation-reduction process,BP,FA2H;PHKG1;GPD1;APOD
2490,GO:0005216,0.742802759346096,0.509385419701246,2,386,ion channel activity,MF,PIEZO2;KCNJ6
363,GO:0000978,0.742967647252604,0.509131526284982,2,403,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,SOX10;NKX6-2
6238,GO:0017148,0.742995907090487,0.609826173362542,1,206,negative regulation of translation,BP,EGFR
5873,GO:0016458,0.746086093858652,0.605597112657514,1,212,gene silencing,BP,EGFR
4626,GO:0009892,0.746549125907995,0.352165922924671,14,2559,negative regulation of metabolic process,BP,ARX;NGFR;CAPN3;SOX10;RGS4;EGFR;NKX6-2;GJA1;GREM1;PPP1R14A;MYO1D;APOD;SPOCK3;COL28A1
19035,GO:1901698,0.746690197168159,0.412523045474047,5,965,response to nitrogen compound,BP,NGFR;EGFR;GJA1;NNMT;GPD1
15927,GO:0070661,0.746921814643866,0.604346097868166,1,235,leukocyte proliferation,BP,GREM1
10680,GO:0042326,0.747028989585037,0.503698218732243,2,420,negative regulation of phosphorylation,BP,RGS4;GREM1
13715,GO:0051130,0.74965423281118,0.39534587080484,6,1122,positive regulation of cellular component organization,BP,ANLN;NGFR;TF;ENPP2;GREM1;BOK
7066,GO:0022838,0.751663687842459,0.497528953277617,2,395,substrate-specific channel activity,MF,PIEZO2;KCNJ6
11489,GO:0044085,0.751779692540575,0.340715968416318,16,2889,cellular component biogenesis,BP,ANLN;CDH19;CAPN3;MLC1;TUBB4A;LDB3;HAPLN2;PDGFRA;GJA1;TMSB15A;GREM1;GJB1;RASGRP1;UGT8;BOK;APOD
19036,GO:1901699,0.753222370300378,0.449790101520314,3,589,cellular response to nitrogen compound,BP,NGFR;EGFR;GPD1
1111,GO:0002521,0.753791081464312,0.494597717653018,2,424,leukocyte differentiation,BP,FZD7;RASGRP1
13991,GO:0051606,0.75423383299954,0.59428862818262,1,224,detection of stimulus,BP,PIEZO2
2671,GO:0005635,0.754687994646682,0.493389353320761,2,420,nuclear envelope,CC,EGFR;BOK
3435,GO:0006813,0.756941470596355,0.590557265055173,1,211,potassium ion transport,BP,KCNJ6
19169,GO:1902105,0.757040808971618,0.590350900210561,1,224,regulation of leukocyte differentiation,BP,RASGRP1
13555,GO:0050878,0.757332217933587,0.489780921256276,2,426,regulation of body fluid levels,BP,PDGFRA;GJA1
19691,GO:1903362,0.757478935636919,0.58975297317152,1,220,regulation of cellular protein catabolic process,BP,LRP2
4513,GO:0009410,0.758524305443871,0.588201663890715,1,236,response to xenobiotic stimulus,BP,EGFR
8209,GO:0032103,0.758737123817074,0.587854746053059,1,247,positive regulation of response to external stimulus,BP,EGFR
6234,GO:0017144,0.75954990167128,0.441338923166638,3,690,drug metabolic process,BP,EGFR;GPD1;CARNS1
369,GO:0000987,0.759715625042317,0.486539761366458,2,416,proximal promoter sequence-specific DNA binding,MF,SOX10;NKX6-2
13796,GO:0051251,0.760338265949498,0.585598603339858,1,243,positive regulation of lymphocyte activation,BP,RASGRP1
6474,GO:0019221,0.761099555433785,0.439280967482987,3,687,cytokine-mediated signaling pathway,BP,CRLF1;NGFR;ST18
7084,GO:0022898,0.761927040982902,0.583448188018544,1,218,regulation of transmembrane transporter activity,BP,GJA1
4379,GO:0009152,0.762032038891224,0.583212875915765,1,236,purine ribonucleotide biosynthetic process,BP,GPD1
19554,GO:1903047,0.762746031455774,0.410330854970481,4,802,mitotic cell cycle process,BP,ANLN;TUBB4A;EGFR;GJC2
1110,GO:0002520,0.76285718813241,0.41017177578745,4,824,immune system development,BP,ANLN;BVES;FZD7;RASGRP1
15320,GO:0061448,0.763483191775405,0.581209100896874,1,220,connective tissue development,BP,GREM1
3104,GO:0006357,0.76367423682502,0.342672131721146,11,2033,regulation of transcription by RNA polymerase II,BP,ARX;NGFR;LRP2;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;GREM1;DMRT2
11438,GO:0043933,0.763799957271677,0.347216469032432,10,1936,protein-containing complex subunit organization,BP,ANLN;CAPN3;MLC1;TUBB4A;GJA1;TMSB15A;GREM1;GJB1;RASGRP1;BOK
8371,GO:0032388,0.76588913447064,0.577722775104837,1,224,positive regulation of intracellular transport,BP,MLC1
5683,GO:0016054,0.767024344556514,0.575960586535837,1,251,organic acid catabolic process,BP,CARNS1
12460,GO:0046395,0.767024344556514,0.575960586535837,1,251,carboxylic acid catabolic process,BP,CARNS1
2991,GO:0006164,0.767316281187293,0.575581650005126,1,240,purine nucleotide biosynthetic process,BP,GPD1
42,GO:0000086,0.76754023558231,0.57526927083273,1,237,G2/M transition of mitotic cell cycle,BP,TUBB4A
9275,GO:0034249,0.767853066754143,0.57488458083873,1,222,negative regulation of cellular amide metabolic process,BP,EGFR
14015,GO:0051656,0.768122829799951,0.474896600320726,2,423,establishment of organelle localization,BP,MOBP;RASGRP1
14871,GO:0060560,0.768173031195958,0.574499347348997,1,207,developmental growth involved in morphogenesis,BP,MAG
12494,GO:0046474,0.77001013051453,0.571732180347814,1,223,glycerophospholipid biosynthetic process,BP,GPD1
17011,GO:0072659,0.771053244979445,0.570217967167405,1,220,protein localization to plasma membrane,BP,EGFR
16991,GO:0072594,0.771135218799852,0.470567644053222,2,493,establishment of protein localization to organelle,BP,PEX5L;APOD
7982,GO:0031647,0.771953177796215,0.568818438520097,1,236,regulation of protein stability,BP,TF
3180,GO:0006469,0.772822016482219,0.56753742722549,1,236,negative regulation of protein kinase activity,BP,RGS4
4801,GO:0010558,0.773564834246942,0.355236117588168,7,1346,negative regulation of macromolecule biosynthetic process,BP,ARX;CAPN3;SOX10;EGFR;NKX6-2;GJA1;GREM1
5831,GO:0016358,0.774590851514166,0.565066702208224,1,207,dendrite development,BP,KNDC1
4424,GO:0009205,0.775052091698465,0.564122319230071,1,264,purine ribonucleoside triphosphate metabolic process,BP,GPD1
6033,GO:0016757,0.778304793452872,0.559358277301284,1,240,transferase activity, transferring glycosyl groups,MF,UGT8
4464,GO:0009260,0.77986132495463,0.556978760173855,1,249,ribonucleotide biosynthetic process,BP,GPD1
19008,GO:1901652,0.780363809459919,0.457544516737168,2,446,response to peptide,BP,NGFR;GJA1
7911,GO:0031503,0.78084094362244,0.555568375699073,1,233,protein-containing complex localization,BP,ANKS1B
8387,GO:0032409,0.781264437953985,0.55493675863206,1,231,regulation of transporter activity,BP,GJA1
17275,GO:0090150,0.782156063120463,0.553378521723468,1,285,establishment of protein localization to membrane,BP,EGFR
16939,GO:0072522,0.782391910793429,0.553139619300933,1,251,purine-containing compound biosynthetic process,BP,GPD1
4371,GO:0009144,0.782892102163531,0.552304915708658,1,271,purine nucleoside triphosphate metabolic process,BP,GPD1
4418,GO:0009199,0.783019777650026,0.552113969090315,1,270,ribonucleoside triphosphate metabolic process,BP,GPD1
12457,GO:0046390,0.783767638066223,0.551040465685689,1,252,ribose phosphate biosynthetic process,BP,GPD1
8697,GO:0032868,0.787626807529571,0.545174964781054,1,238,response to insulin,BP,NGFR
13395,GO:0050662,0.788359156026185,0.543960207167258,1,258,coenzyme binding,MF,GPD1
19548,GO:1903037,0.788372356623092,0.543928482555304,1,261,regulation of leukocyte cell-cell adhesion,BP,RASGRP1
18455,GO:0110053,0.788564802082715,0.543733429397748,1,236,regulation of actin filament organization,BP,TMSB15A
11781,GO:0044839,0.789033805462029,0.542938299043807,1,252,cell cycle G2/M phase transition,BP,TUBB4A
6055,GO:0016791,0.791055159750209,0.539857278911418,1,237,phosphatase activity,MF,EYA2
9081,GO:0033673,0.792632168435417,0.537334192399026,1,250,negative regulation of kinase activity,BP,RGS4
6053,GO:0016788,0.793252189729113,0.395245631955442,3,662,hydrolase activity, acting on ester bonds,MF,EYA2;PLCL1;ENPP2
3521,GO:0006952,0.793709008512505,0.339096735136352,6,1317,defense response,BP,NGFR;PLP1;EGFR;GJA1;RASGRP1;APOD
14010,GO:0051649,0.793983068685143,0.309965873448348,10,1941,establishment of localization in cell,BP,NGFR;CAPN3;MLC1;BVES;PEX5L;MOBP;SH3TC2;RASGRP1;MYO1D;APOD
4629,GO:0009895,0.794666496170629,0.534163039731374,1,243,negative regulation of catabolic process,BP,EGFR
5175,GO:0014070,0.795225612777051,0.366882920726779,4,847,response to organic cyclic compound,BP,SOX10;MLC1;EGFR;GPD1
11369,GO:0043604,0.795602060898257,0.391855813211494,3,750,amide biosynthetic process,BP,EGFR;CARNS1;UGT8
3957,GO:0008202,0.795690901152124,0.532463595184523,1,263,steroid metabolic process,BP,LRP2
3552,GO:0007005,0.797454469128073,0.432487984797498,2,513,mitochondrion organization,BP,EYA2;BOK
15426,GO:0061695,0.798460251284427,0.528106314546799,1,251,transferase complex, transferring phosphorus-containing groups,CC,PHKG1
1695,GO:0003924,0.799163757999957,0.526902441784982,1,272,GTPase activity,MF,TUBB4A
4393,GO:0009167,0.799943007801229,0.52562982839017,1,279,purine ribonucleoside monophosphate metabolic process,BP,GPD1
17393,GO:0090305,0.800319259811619,0.52507444587059,1,265,nucleic acid phosphodiester bond hydrolysis,BP,ENPP2
3055,GO:0006281,0.800474261989099,0.428029724164756,2,475,DNA repair,BP,EYA2;EGFR
4353,GO:0009126,0.800596936148041,0.52457611631329,1,280,purine nucleoside monophosphate metabolic process,BP,GPD1
4671,GO:0010033,0.800804241431954,0.28451732360463,15,2868,response to organic substance,BP,CRLF1;NGFR;LRP2;SOX10;MLC1;PDGFRA;PCSK6;EGFR;ST18;GJA1;FZD7;NNMT;GREM1;GPD1;BOK
17995,GO:0098656,0.800809651989891,0.524405481318864,1,236,anion transmembrane transport,BP,LRP2
5174,GO:0014069,0.800988092125727,0.524192460935834,1,221,postsynaptic density,CC,ANKS1B
16864,GO:0072331,0.801235999279972,0.523622099529462,1,259,signal transduction by p53 class mediator,BP,BOK
11813,GO:0045017,0.801405925071621,0.523400855590708,1,246,glycerolipid biosynthetic process,BP,GPD1
17659,GO:0097193,0.802597122652263,0.521387405357834,1,269,intrinsic apoptotic signaling pathway,BP,BOK
1208,GO:0002696,0.802890481223218,0.520891563186637,1,275,positive regulation of leukocyte activation,BP,RASGRP1
3702,GO:0007265,0.803063739676453,0.424191581357909,2,441,Ras protein signal transduction,BP,NGFR;RASGRP1
18286,GO:0099572,0.803284515372711,0.520472094106167,1,223,postsynaptic specialization,CC,ANKS1B
5673,GO:0016042,0.80395835875099,0.519165967303306,1,273,lipid catabolic process,BP,ENPP2
11350,GO:0043565,0.805036217569316,0.336423389508912,5,1030,sequence-specific DNA binding,MF,ARX;SOX10;MYRF;NKX6-2;DMRT2
4368,GO:0009141,0.806157963902125,0.515520196362345,1,291,nucleoside triphosphate metabolic process,BP,GPD1
9558,GO:0034976,0.806787660860623,0.514591065327932,1,261,response to endoplasmic reticulum stress,BP,BOK
11934,GO:0045211,0.808037349229411,0.512657479717976,1,233,postsynaptic membrane,CC,ANKS1B
8299,GO:0032279,0.808343867775303,0.512187227898737,1,226,asymmetric synapse,CC,ANKS1B
9544,GO:0034774,0.808455490058555,0.511722517518531,1,299,secretory granule lumen,CC,TF
18165,GO:0098984,0.811939010090619,0.506214109667989,1,229,neuron to neuron synapse,CC,ANKS1B
7810,GO:0031327,0.811955798042267,0.305591145100948,7,1410,negative regulation of cellular biosynthetic process,BP,ARX;CAPN3;SOX10;EGFR;NKX6-2;GJA1;GREM1
12677,GO:0046872,0.81235069354543,0.259931727712091,21,3677,metal ion binding,MF,EYA2;CDH19;LRP2;FOLH1;TF;CAPN3;FA2H;TUBB4A;ATP10B;LDB3;CPM;ENPP2;ST18;CNDP1;ADAMTS4;EDIL3;CARNS1;RASGRP1;DMRT2;SPOCK3;SMOC1
12237,GO:0045892,0.812510245337255,0.326190770334612,5,1050,negative regulation of transcription, DNA-templated,BP,ARX;CAPN3;SOX10;NKX6-2;GREM1
4387,GO:0009161,0.813232577326282,0.503810386826634,1,291,ribonucleoside monophosphate metabolic process,BP,GPD1
13543,GO:0050863,0.814137498614965,0.502318661244368,1,283,regulation of T cell activation,BP,RASGRP1
3803,GO:0007568,0.815936151029653,0.499345466336296,1,267,aging,BP,APOD
4578,GO:0009725,0.817619439126632,0.335552537729028,4,888,response to hormone,BP,NGFR;SOX10;EGFR;GJA1
4226,GO:0008654,0.818118814520253,0.495661426976767,1,263,phospholipid biosynthetic process,BP,GPD1
5667,GO:0016032,0.818779117159013,0.358290602881575,3,736,viral process,BP,PDGFRA;MOG;EGFR
13857,GO:0051348,0.819127855148332,0.493898894509497,1,275,negative regulation of transferase activity,BP,RGS4
12547,GO:0046578,0.819451819148126,0.493513279279816,1,234,regulation of Ras protein signal transduction,BP,RASGRP1
5098,GO:0010976,0.819717207535493,0.493013719808771,1,244,positive regulation of neuron projection development,BP,NGFR
4624,GO:0009890,0.821054698463847,0.293451990337991,7,1430,negative regulation of biosynthetic process,BP,ARX;CAPN3;SOX10;EGFR;NKX6-2;GJA1;GREM1
18505,GO:0140014,0.822672655882578,0.487902231761357,1,252,mitotic nuclear division,BP,ANLN
16268,GO:0071345,0.823200668001427,0.327529529500309,4,952,cellular response to cytokine stimulus,BP,CRLF1;NGFR;ST18;GPD1
14618,GO:0060205,0.823272500058867,0.486656430888806,1,315,cytoplasmic vesicle lumen,CC,TF
10514,GO:0040029,0.823483348318873,0.486445749745703,1,266,regulation of gene expression, epigenetic,BP,EGFR
3629,GO:0007159,0.825001245130526,0.483729513266575,1,290,leukocyte cell-cell adhesion,BP,RASGRP1
4350,GO:0009123,0.826607874418827,0.480879185256815,1,306,nucleoside monophosphate metabolic process,BP,GPD1
17009,GO:0072657,0.826840541285357,0.387210064318726,2,530,protein localization to membrane,BP,CAPN3;EGFR
5580,GO:0015849,0.827650933380969,0.479166848569849,1,270,organic acid transport,BP,LRP2
12721,GO:0046942,0.827650933380969,0.479166848569849,1,270,carboxylic acid transport,BP,LRP2
18968,GO:1901566,0.828588464933742,0.276210493930448,8,1765,organonitrogen compound biosynthetic process,BP,FOLH1;FA2H;CPM;EGFR;NNMT;GPD1;CARNS1;UGT8
2854,GO:0005929,0.83160199729727,0.37963243345291,2,485,cilium,CC,TUBB4A;DNAH17
4517,GO:0009416,0.832519874613296,0.470533063440844,1,275,response to light stimulus,BP,EGFR
19759,GO:1903507,0.835071375892258,0.29456860400849,5,1087,negative regulation of nucleic acid-templated transcription,BP,ARX;CAPN3;SOX10;NKX6-2;GREM1
19388,GO:1902679,0.835785185840105,0.293548685843233,5,1089,negative regulation of RNA biosynthetic process,BP,ARX;CAPN3;SOX10;NKX6-2;GREM1
1209,GO:0002697,0.837404867757332,0.461661143248425,1,301,regulation of immune effector process,BP,RASGRP1
18967,GO:1901565,0.83832784189351,0.289894088808753,5,1130,organonitrogen compound catabolic process,BP,LRP2;ENPP2;EGFR;GJA1;CARNS1
11662,GO:0044444,0.839255329806636,0.21578620562659,49,8623,cytoplasmic part,CC,CRLF1;ANLN;NGFR;EYA2;DCX;LRP2;TF;CAPN3;COL9A3;SOX10;MLC1;FA2H;TUBB4A;PEX5L;RGS4;ATP10B;PPL;LDB3;MYRF;ERMN;SLC31A2;PCSK6;EGFR;CNDP1;GJA1;FZD7;KCNJ6;SNX22;PHKG1;NNMT;GPD1;PPP1R14A;KLK6;MOBP;LGI3;SH3TC2;GJB1;MAL;CARNS1;RASGRP1;MYO1D;BOK;AATK;ANKS1B;DNAH17;APOD;OPALIN;TMEM235;COL28A1
7034,GO:0022411,0.839827694728682,0.36617046893649,2,530,cellular component disassembly,BP,ADAMTS4;BOK
11099,GO:0043169,0.840055666094323,0.225962004968669,21,3756,cation binding,MF,EYA2;CDH19;LRP2;FOLH1;TF;CAPN3;FA2H;TUBB4A;ATP10B;LDB3;CPM;ENPP2;ST18;CNDP1;ADAMTS4;EDIL3;CARNS1;RASGRP1;DMRT2;SPOCK3;SMOC1
3111,GO:0006366,0.84264103693741,0.243262976621702,11,2202,transcription by RNA polymerase II,BP,ARX;NGFR;LRP2;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;GREM1;DMRT2
5960,GO:0016604,0.84280150366631,0.321840666672021,3,704,nuclear body,CC,RAPGEF5;ADAMTS4;ANKS1B
5075,GO:0010948,0.843392622521902,0.450676978537336,1,304,negative regulation of cell cycle process,BP,GJC2
1595,GO:0003674,0.843619106251012,0.259214167521321,87,14390,molecular_function,MF,ARX;CRLF1;ANLN;CLDN11;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;CPM;RAPGEF5;ERMN;SLC31A2;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;PIEZO2;FZD7;KCNJ6;SNX22;TMSB15A;SLC45A3;ADAMTS4;SLC5A11;TMEM144;EDIL3;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;MOBP;LGI3;GJB1;KNDC1;MAL;CARNS1;RASGRP1;DMRT2;SUSD5;UGT8;MYO1D;BOK;TMEM125;S1PR5;GPR62;AATK;CNTN2;ANKS1B;GLDN;DNAH17;APOD;SPOCK3;MBP;SMOC1;GJC2;COL28A1
16291,GO:0071375,0.844246584001369,0.449158314537756,1,283,cellular response to peptide hormone stimulus,BP,NGFR
3813,GO:0007596,0.845149225793815,0.447446659861031,1,293,blood coagulation,BP,PDGFRA
13514,GO:0050817,0.847453705491789,0.443128686329397,1,295,coagulation,BP,PDGFRA
9446,GO:0034622,0.847666995936346,0.291519881332201,4,969,cellular protein-containing complex assembly,BP,ANLN;TUBB4A;TMSB15A;GREM1
12269,GO:0045934,0.847809355725803,0.26522023914106,6,1290,negative regulation of nucleobase-containing compound metabolic process,BP,ARX;CAPN3;SOX10;NKX6-2;GJA1;GREM1
3816,GO:0007599,0.849406896980237,0.439437462783101,1,298,hemostasis,BP,PDGFRA
111,GO:0000226,0.849437329616798,0.350202056479894,2,491,microtubule cytoskeleton organization,BP,TUBB4A;CNTN2
3533,GO:0006974,0.850022284411737,0.310484148989565,3,745,cellular response to DNA damage stimulus,BP,EYA2;EGFR;BOK
11635,GO:0044403,0.851857436138796,0.307549008913467,3,790,symbiont process,BP,PDGFRA;MOG;EGFR
11864,GO:0045089,0.852567467071126,0.433392744057966,1,309,positive regulation of innate immune response,BP,RASGRP1
4777,GO:0010506,0.852843239446983,0.432912313941421,1,293,regulation of autophagy,BP,BOK
13508,GO:0050808,0.8535413037265,0.431670648903032,1,265,synapse organization,BP,CNTN2
1053,GO:0002429,0.854851627748577,0.428972232251719,1,321,immune response-activating cell surface receptor signaling pathway,BP,MOG
11674,GO:0044456,0.855837669701316,0.301257778322379,3,704,synapse part,CC,CNTNAP4;LGI3;ANKS1B
4347,GO:0009117,0.858911286179554,0.333900929470794,2,591,nucleotide metabolic process,BP,NNMT;GPD1
18468,GO:0120031,0.859179892476887,0.333523724951342,2,509,plasma membrane bounded cell projection assembly,BP,ANLN;TUBB4A
3479,GO:0006886,0.861263832948347,0.270762569759468,4,1002,intracellular protein transport,BP,NGFR;PEX5L;SH3TC2;APOD
3422,GO:0006790,0.861427356117601,0.416104267079724,1,333,sulfur compound metabolic process,BP,SPOCK3
8282,GO:0032259,0.861830876541351,0.415377558507523,1,306,methylation,BP,NNMT
8127,GO:0031967,0.862211206589805,0.269277343422188,4,1054,organelle envelope,CC,SOX10;EGFR;GJA1;BOK
8131,GO:0031975,0.862211206589805,0.269277343422188,4,1054,envelope,CC,SOX10;EGFR;GJA1;BOK
11644,GO:0044419,0.86253415127784,0.290381758670975,3,814,interspecies interaction between organisms,BP,PDGFRA;MOG;EGFR
3400,GO:0006753,0.863034140136918,0.32671980809861,2,598,nucleoside phosphate metabolic process,BP,NNMT;GPD1
633,GO:0001775,0.86354045844023,0.252887285124807,5,1208,cell activation,BP,CAPN3;PDGFRA;EGFR;FZD7;RASGRP1
17959,GO:0098588,0.866544035515791,0.219066524021531,9,1891,bounding membrane of organelle,CC,LRP2;TF;SOX10;PEX5L;EGFR;GJA1;FZD7;RASGRP1;BOK
1614,GO:0003713,0.867151526077306,0.40474324750426,1,306,transcription coactivator activity,MF,SOX10
12593,GO:0046649,0.867257719170497,0.319313075185597,2,568,lymphocyte activation,BP,FZD7;RASGRP1
7124,GO:0030031,0.868862100550573,0.316513919216586,2,523,cell projection assembly,BP,ANLN;TUBB4A
2610,GO:0005515,0.869387035795781,0.181034357590023,59,10245,protein binding,MF,CRLF1;ANLN;CLDN11;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;NKAIN1;TF;CAPN3;SOX10;MLC1;PLLP;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;PLP1;PDGFRA;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;GJA1;FZD7;KCNJ6;TMSB15A;ADAMTS4;SLC5A11;EDIL3;PHKG1;GREM1;GPD1;KLK6;MOBP;GJB1;KNDC1;MAL;RASGRP1;DMRT2;MYO1D;BOK;CNTN2;ANKS1B;GLDN;DNAH17;APOD;MBP;SMOC1
7812,GO:0031329,0.869754788904005,0.278568517284439,3,763,regulation of cellular catabolic process,BP,LRP2;GPD1;BOK
9185,GO:0034097,0.86986367091223,0.257334495539777,4,1031,response to cytokine,BP,CRLF1;NGFR;ST18;GPD1
2619,GO:0005525,0.87019701566806,0.398478781874814,1,337,GTP binding,MF,TUBB4A
12620,GO:0046700,0.872293599878493,0.310288986152153,2,616,heterocycle catabolic process,BP,GPD1;CARNS1
8493,GO:0032550,0.872688165223783,0.393359851888279,1,340,purine ribonucleoside binding,MF,TUBB4A
11560,GO:0044270,0.873166997842999,0.308716690779027,2,618,cellular nitrogen compound catabolic process,BP,GPD1;CARNS1
12188,GO:0045786,0.873922151174543,0.307397493654953,2,571,negative regulation of cell cycle,BP,EGFR;GJC2
715,GO:0001883,0.874920862250831,0.388729418476457,1,343,purine nucleoside binding,MF,TUBB4A
3499,GO:0006913,0.875560201960353,0.38744392962418,1,324,nucleocytoplasmic transport,BP,APOD
5889,GO:0016491,0.876366194536871,0.302907689030339,2,646,oxidoreductase activity,MF,FA2H;GPD1
8492,GO:0032549,0.876641572293561,0.385136306668019,1,344,ribonucleoside binding,MF,TUBB4A
13694,GO:0051098,0.87709961019433,0.384202124785638,1,333,regulation of binding,BP,PLCL1
13798,GO:0051253,0.87734455587048,0.231911101741741,5,1163,negative regulation of RNA metabolic process,BP,ARX;CAPN3;SOX10;NKX6-2;GREM1
13742,GO:0051169,0.877498162514491,0.383380220155415,1,327,nuclear transport,BP,APOD
11652,GO:0044429,0.877906683238347,0.264878755561927,3,910,mitochondrial part,CC,SOX10;GJA1;BOK
13833,GO:0051301,0.878847954038008,0.298454564847081,2,561,cell division,BP,ANLN;FZD7
135,GO:0000278,0.880077851033274,0.241098133765644,4,974,mitotic cell cycle,BP,ANLN;TUBB4A;EGFR;GJC2
1262,GO:0002768,0.88064428164863,0.376672975200702,1,351,immune response-regulating cell surface receptor signaling pathway,BP,MOG
9019,GO:0033554,0.880756920391945,0.203806795381857,8,1785,cellular response to stress,BP,EYA2;CAPN3;PDGFRA;EGFR;FZD7;RASGRP1;BOK;APOD
19009,GO:1901653,0.881031713000585,0.375911714124853,1,324,cellular response to peptide,BP,NGFR
6553,GO:0019439,0.881231156221161,0.294013256864832,2,633,aromatic compound catabolic process,BP,GPD1;CARNS1
714,GO:0001882,0.88179113765438,0.374227605707434,1,351,nucleoside binding,MF,TUBB4A
7067,GO:0022839,0.882204732088984,0.37344103775441,1,311,ion gated channel activity,MF,KCNJ6
8822,GO:0033043,0.882954900847426,0.223217035501414,5,1159,regulation of organelle organization,BP,ANLN;TUBB4A;PDGFRA;TMSB15A;BOK
3512,GO:0006936,0.8841790425364,0.369170834045129,1,321,muscle contraction,BP,GJA1
8504,GO:0032561,0.884431243470424,0.368548706223454,1,354,guanyl ribonucleotide binding,MF,TUBB4A
6394,GO:0019001,0.885292274715724,0.366683424572432,1,355,guanyl nucleotide binding,MF,TUBB4A
12189,GO:0045787,0.886657690716788,0.363755523383088,1,337,positive regulation of cell cycle,BP,EGFR
3480,GO:0006887,0.887042098964966,0.249331145203149,3,817,exocytosis,BP,TF;LGI3;RASGRP1
2730,GO:0005743,0.88778706643741,0.361108343780798,1,436,mitochondrial inner membrane,CC,BOK
2747,GO:0005765,0.88779750097208,0.361260390993414,1,339,lysosomal membrane,CC,LRP2
18090,GO:0098852,0.88779750097208,0.361260390993414,1,339,lytic vacuole membrane,CC,LRP2
3292,GO:0006605,0.888360696938545,0.359915765457955,1,394,protein targeting,BP,PEX5L
7199,GO:0030163,0.890449587897587,0.243427079622326,3,806,protein catabolic process,BP,LRP2;EGFR;GJA1
13794,GO:0051249,0.890469936643066,0.355309087599782,1,370,regulation of lymphocyte activation,BP,RASGRP1
12128,GO:0045666,0.89128379989878,0.35361335620455,1,321,positive regulation of neuron differentiation,BP,NGFR
7177,GO:0030133,0.891623750379165,0.352775947086783,1,356,transport vesicle,CC,LGI3
11033,GO:0043043,0.891952882793216,0.273894336091227,2,672,peptide biosynthetic process,BP,EGFR;CARNS1
3520,GO:0006950,0.892987719271254,0.164223617747911,16,3332,response to stress,BP,NGFR;EYA2;ERBB3;CAPN3;MLC1;PLLP;BVES;PLP1;PDGFRA;EGFR;GJA1;FZD7;KLK6;RASGRP1;BOK;APOD
18913,GO:1901361,0.893187613843268,0.271547777597025,2,657,organic cyclic compound catabolic process,BP,GPD1;CARNS1
17447,GO:0090407,0.895351517087458,0.267429385915194,2,611,organophosphate biosynthetic process,BP,NNMT;GPD1
11863,GO:0045088,0.895662910437613,0.343693614200107,1,364,regulation of innate immune response,BP,RASGRP1
11568,GO:0044282,0.896621796857611,0.341469851460771,1,390,small molecule catabolic process,BP,CARNS1
4846,GO:0010629,0.897474181959975,0.184619630360422,7,1637,negative regulation of gene expression,BP,ARX;CAPN3;SOX10;EGFR;NKX6-2;GJA1;GREM1
1031,GO:0002376,0.89867706948617,0.166601425137063,11,2481,immune system process,BP,ANLN;NGFR;MAG;BVES;ENPP2;MOG;FZD7;GREM1;RASGRP1;APOD;MBP
18241,GO:0099503,0.899309783374757,0.227773040515299,3,879,secretory vesicle,CC,TF;KLK6;LGI3
13486,GO:0050778,0.899770931759369,0.258836747288803,2,637,positive regulation of immune response,BP,MOG;RASGRP1
14658,GO:0060271,0.899945815392927,0.333955565535721,1,341,cilium assembly,BP,TUBB4A
5962,GO:0016607,0.904120166345667,0.324194496043858,1,361,nuclear speck,CC,ADAMTS4
14445,GO:0055086,0.904891416771731,0.248721038414803,2,674,nucleobase-containing small molecule metabolic process,BP,NNMT;GPD1
19868,GO:1903706,0.905974207044086,0.319768952759197,1,388,regulation of hemopoiesis,BP,RASGRP1
6318,GO:0018205,0.906407416631777,0.318799716749409,1,357,peptidyl-lysine modification,BP,CAPN3
13671,GO:0051056,0.906626124451127,0.318349609076571,1,326,regulation of small GTPase mediated signal transduction,BP,RASGRP1
11754,GO:0044782,0.906999534655493,0.317402177228469,1,352,cilium organization,BP,TUBB4A
1609,GO:0003700,0.907567945310998,0.175466133577847,6,1412,DNA binding transcription factor activity,MF,ARX;SOX10;MYRF;ST18;NKX6-2;DMRT2
1638,GO:0003824,0.911940640011268,0.129303666669849,27,5217,catalytic activity,MF,EYA2;ERBB3;FOLH1;CAPN3;FA2H;TUBB4A;PLCL1;CDK18;ATP10B;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;CNDP1;ADAMTS4;PHKG1;NNMT;GPD1;KLK6;LGI3;CARNS1;UGT8;MYO1D;AATK;DNAH17
14041,GO:0051707,0.912417767743032,0.233555854691691,2,688,response to other organism,BP,NGFR;GJA1
11127,GO:0043207,0.913111673030154,0.232136863986426,2,690,response to external biotic stimulus,BP,NGFR;GJA1
18823,GO:1901135,0.913278672544289,0.185459460378153,4,1121,carbohydrate derivative metabolic process,BP,PCSK6;GPD1;UGT8;SPOCK3
3145,GO:0006417,0.915798856804521,0.295947017348511,1,387,regulation of translation,BP,EGFR
136,GO:0000280,0.915960798766822,0.295580944153677,1,367,nuclear division,BP,ANLN
7026,GO:0022402,0.916393822613718,0.169102853258926,5,1259,cell cycle process,BP,ANLN;CAPN3;TUBB4A;EGFR;GJC2
7686,GO:0031090,0.917940681524568,0.136406606953099,12,2684,organelle membrane,CC,LRP2;TF;SOX10;FA2H;PEX5L;ATP10B;EGFR;GJA1;FZD7;SNX22;RASGRP1;BOK
2755,GO:0005774,0.918275837470971,0.289752905285915,1,392,vacuolar membrane,CC,LRP2
6681,GO:0019866,0.919264566885872,0.287137325670676,1,486,organelle inner membrane,CC,BOK
3714,GO:0007283,0.91954467987838,0.286543410764823,1,399,spermatogenesis,BP,CLDN11
14055,GO:0051726,0.923465536906351,0.167423062839095,4,1091,regulation of cell cycle,BP,ANLN;TUBB4A;EGFR;GJC2
367,GO:0000982,0.925163030667907,0.272146988578044,1,390,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NKX6-2
2725,GO:0005737,0.925836461609536,0.108407134015319,57,10204,cytoplasm,CC,CRLF1;ANLN;NGFR;EYA2;BCAS1;ERBB3;DCX;LRP2;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;FA2H;TUBB4A;MAG;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;MYRF;PDGFRA;ERMN;SLC31A2;PCSK6;EGFR;CNDP1;GJA1;FZD7;KCNJ6;SNX22;TMSB15A;PHKG1;NNMT;GPD1;PPP1R14A;KLK6;MOBP;LGI3;SH3TC2;GJB1;MAL;CARNS1;RASGRP1;MYO1D;BOK;AATK;ANKS1B;DNAH17;APOD;OPALIN;TMEM235;COL28A1
4487,GO:0009314,0.925840842081186,0.270360837823359,1,402,response to radiation,BP,EGFR
1206,GO:0002694,0.925907286324598,0.270145577952557,1,431,regulation of leukocyte activation,BP,RASGRP1
7758,GO:0031252,0.926280317345063,0.26927083136153,1,367,cell leading edge,CC,MYO1D
7995,GO:0031667,0.927870102450154,0.265003387972887,1,422,response to nutrient levels,BP,EGFR
4545,GO:0009607,0.928282565929578,0.200179215441949,2,726,response to biotic stimulus,BP,NGFR;GJA1
1374,GO:0003012,0.929081556812566,0.261836417212159,1,394,muscle system process,BP,GJA1
12973,GO:0048232,0.929545822044634,0.260565293391642,1,418,male gamete generation,BP,CLDN11
4377,GO:0009150,0.931637911416714,0.25491384756091,1,454,purine ribonucleotide metabolic process,BP,GPD1
18825,GO:1901137,0.932014959060108,0.19204281428115,2,688,carbohydrate derivative biosynthetic process,BP,GPD1;UGT8
9274,GO:0034248,0.935661299113651,0.243979009655383,1,430,regulation of cellular amide metabolic process,BP,EGFR
13006,GO:0048285,0.936069753528238,0.242883291053097,1,407,organelle fission,BP,ANLN
18989,GO:1901615,0.93683383898095,0.240728142100918,1,436,organic hydroxy compound metabolic process,BP,LRP2
4463,GO:0009259,0.937523189811401,0.238772592165512,1,469,ribonucleotide metabolic process,BP,GPD1
2990,GO:0006163,0.937564993047372,0.238653938211269,1,471,purine nucleotide metabolic process,BP,GPD1
11833,GO:0045055,0.938001030784675,0.178672081479379,2,715,regulated exocytosis,BP,TF;RASGRP1
1252,GO:0002757,0.938281421285729,0.236675339529206,1,451,immune response-activating signal transduction,BP,MOG
7184,GO:0030141,0.938481268659926,0.177568764337073,2,750,secretory granule,CC,TF;KLK6
4659,GO:0009991,0.938910390415316,0.234912734639236,1,450,response to extracellular stimulus,BP,EGFR
6606,GO:0019693,0.942175909285034,0.225611985186642,1,483,ribose phosphate metabolic process,BP,GPD1
5932,GO:0016570,0.94383725310475,0.220899839973679,1,419,histone modification,BP,EYA2
284,GO:0000785,0.944897039044503,0.217780601045392,1,452,chromatin,CC,SOX10
5931,GO:0016569,0.946998815031967,0.21164167398359,1,427,covalent chromatin modification,BP,EYA2
3500,GO:0006914,0.947110485990544,0.211276668061343,1,457,autophagy,BP,BOK
15516,GO:0061919,0.947110485990544,0.211276668061343,1,457,process utilizing autophagic mechanism,BP,BOK
16938,GO:0072521,0.94797905020098,0.20865941164333,1,499,purine-containing compound metabolic process,BP,GPD1
1259,GO:0002764,0.949122693432796,0.205262362549726,1,481,immune response-regulating signaling pathway,BP,MOG
19334,GO:1902532,0.949732785152293,0.203453694786137,1,458,negative regulation of intracellular signal transduction,BP,RGS4
11188,GO:0043299,0.949847840694806,0.20306203553159,1,505,leukocyte degranulation,BP,RASGRP1
18974,GO:1901575,0.952025189389546,0.0963469790186626,7,1894,organic substance catabolic process,BP,LRP2;ENPP2;EGFR;GJA1;PHKG1;GPD1;CARNS1
963,GO:0002275,0.952336760582666,0.19549631293173,1,513,myeloid cell activation involved in immune response,BP,RASGRP1
4304,GO:0009057,0.952510152413774,0.112597439524024,4,1231,macromolecule catabolic process,BP,LRP2;EGFR;GJA1;PHKG1
1067,GO:0002444,0.952995046681262,0.193472621797274,1,516,myeloid leukocyte mediated immunity,BP,RASGRP1
18052,GO:0098794,0.953346089396836,0.192469444019689,1,435,postsynapse,CC,ANKS1B
1194,GO:0002682,0.954330633980309,0.10895302752009,4,1285,regulation of immune system process,BP,MOG;GREM1;RASGRP1;APOD
11492,GO:0044089,0.955390193331591,0.186084236038499,1,464,positive regulation of cellular component biogenesis,BP,ANLN
4303,GO:0009056,0.956312517714358,0.0833336812306934,9,2313,catabolic process,BP,LRP2;ENPP2;EGFR;GJA1;PHKG1;GPD1;KLK6;CARNS1;BOK
954,GO:0002253,0.956844862455927,0.181463859072891,1,509,activation of immune response,BP,MOG
4831,GO:0010608,0.958027982814914,0.177702119848322,1,509,posttranscriptional regulation of gene expression,BP,EGFR
59,GO:0000122,0.958793232220533,0.129150777871685,2,752,negative regulation of transcription by RNA polymerase II,BP,ARX;NKX6-2
11726,GO:0044703,0.959442981483785,0.127499246913247,2,787,multi-organism reproductive process,BP,CLDN11;GJA1
13484,GO:0050776,0.962098507455759,0.120716366889907,2,836,regulation of immune response,BP,MOG;RASGRP1
2598,GO:0005488,0.964289019690238,0.0600801263797026,73,12745,binding,MF,ARX;CRLF1;ANLN;CLDN11;NGFR;EYA2;ERBB3;CDH19;DCX;LRP2;NKAIN1;FOLH1;TF;CAPN3;SOX10;MLC1;PLLP;FA2H;TUBB4A;MAG;BVES;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;PLP1;MYRF;HAPLN2;PDGFRA;CPM;RAPGEF5;ERMN;ENPP2;MOG;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;KCNJ6;SNX22;TMSB15A;ADAMTS4;SLC5A11;EDIL3;PHKG1;GREM1;GPD1;KLK6;MOBP;GJB1;KNDC1;MAL;CARNS1;RASGRP1;DMRT2;SUSD5;MYO1D;BOK;AATK;CNTN2;ANKS1B;GLDN;DNAH17;APOD;SPOCK3;MBP;SMOC1
11657,GO:0044437,0.965624144985728,0.152670378814397,1,533,vacuolar part,CC,LRP2
9470,GO:0034655,0.966135863042486,0.150898991712983,1,578,nucleobase-containing compound catabolic process,BP,GPD1
3712,GO:0007276,0.966606080956463,0.149321626504536,1,528,gamete generation,BP,CLDN11
11555,GO:0044260,0.966928022859625,0.0515138804704314,38,7383,cellular macromolecule metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;SOX10;BVES;PLCL1;RGS4;CDK18;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;PHKG1;GREM1;PPP1R14A;KNDC1;RASGRP1;DMRT2;BOK;AATK;CNTN2;SPOCK3;MBP;GJC2;COL28A1
11669,GO:0044451,0.966962255307158,0.0919049191326515,3,1032,nucleoplasm part,CC,RAPGEF5;ADAMTS4;ANKS1B
4764,GO:0010468,0.968488215121796,0.0533791065293062,19,4149,regulation of gene expression,BP,ARX;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;PLP1;MYRF;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2;CNTN2;GJC2
7809,GO:0031326,0.96884995962248,0.0533072915474112,18,3977,regulation of cellular biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PDGFRA;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;GPD1;DMRT2
1613,GO:0003712,0.969024334582708,0.140935324792603,1,531,transcription cofactor activity,MF,SOX10
962,GO:0002274,0.970191936239838,0.136784546595776,1,589,myeloid leukocyte activation,BP,RASGRP1
1196,GO:0002684,0.9718817432946,0.0946993475083577,2,888,positive regulation of immune system process,BP,MOG;RASGRP1
11141,GO:0043228,0.972777128638977,0.0481875891741049,16,3670,non-membrane-bounded organelle,CC,ANLN;PLEKHH1;DCX;CAPN3;SOX10;TUBB4A;PPL;LDB3;ERMN;GJA1;TMSB15A;KLK6;MOBP;MYO1D;DNAH17;APOD
11145,GO:0043232,0.972777128638977,0.0481875891741049,16,3670,intracellular non-membrane-bounded organelle,CC,ANLN;PLEKHH1;DCX;CAPN3;SOX10;TUBB4A;PPL;LDB3;ERMN;GJA1;TMSB15A;KLK6;MOBP;MYO1D;DNAH17;APOD
2789,GO:0005829,0.972938769189849,0.0457146184951722,21,4614,cytosol,CC,CRLF1;NGFR;EYA2;DCX;CAPN3;TUBB4A;PEX5L;RGS4;PPL;MYRF;CNDP1;GJA1;PHKG1;NNMT;GPD1;PPP1R14A;CARNS1;RASGRP1;MYO1D;ANKS1B;APOD
4623,GO:0009889,0.974123180808392,0.0450295305431314,18,4038,regulation of biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PDGFRA;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;SLC45A3;GREM1;GPD1;DMRT2
3141,GO:0006412,0.9750033962321,0.119274169954658,1,652,translation,BP,EGFR
6472,GO:0019219,0.975700095387482,0.0429674004320106,17,3857,regulation of nucleobase-containing compound metabolic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PDGFRA;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;GPD1;DMRT2
18537,GO:0140110,0.97692195761713,0.0531994751782669,6,1754,transcription regulator activity,MF,ARX;SOX10;MYRF;ST18;NKX6-2;DMRT2
5475,GO:0015630,0.977064979841509,0.0676166582204106,3,1074,microtubule cytoskeleton,CC,DCX;TUBB4A;DNAH17
3524,GO:0006955,0.977802056067444,0.0545415995297883,5,1710,immune response,BP,NGFR;ENPP2;MOG;RASGRP1;MBP
1023,GO:0002366,0.978014314277808,0.107866905590884,1,630,leukocyte activation involved in immune response,BP,RASGRP1
3102,GO:0006355,0.978104592114111,0.0406290326910944,14,3344,regulation of transcription, DNA-templated,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2
4854,GO:0010638,0.978572038225499,0.105724848672165,1,588,positive regulation of organelle organization,BP,BOK
958,GO:0002263,0.978638077220038,0.105449136615023,1,633,cell activation involved in immune response,BP,RASGRP1
11100,GO:0043170,0.97920627361399,0.0334415599801656,42,8205,macromolecule metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;SOX10;BVES;PLCL1;RGS4;CDK18;PLP1;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;ADAMTS4;PHKG1;GREM1;PPP1R14A;KLK6;KNDC1;RASGRP1;DMRT2;BOK;AATK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
19758,GO:1903506,0.979473739681214,0.0383173540212737,14,3363,regulation of nucleic acid-templated transcription,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2
21782,GO:2001141,0.979774453427741,0.0378074382847054,14,3368,regulation of RNA biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2
371,GO:0000989,0.981272250863876,0.0950405031122017,1,603,transcription factor activity, transcription factor binding,MF,SOX10
21231,GO:2000112,0.981371847141865,0.0341203655175671,16,3756,regulation of cellular macromolecule biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PDGFRA;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2
9469,GO:0034654,0.981668246863336,0.0332254036966816,17,3989,nucleobase-containing compound biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;DMRT2
370,GO:0000988,0.981776486761481,0.0930019008142781,1,607,transcription factor activity, protein binding,MF,SOX10
6022,GO:0016740,0.981844396326645,0.0394738944636311,8,2206,transferase activity,MF,ERBB3;CDK18;PDGFRA;EGFR;PHKG1;NNMT;UGT8;AATK
21136,GO:1990904,0.982884546022669,0.0884381405061428,1,719,ribonucleoprotein complex,CC,APOD
6718,GO:0019953,0.983303856162284,0.0867295269110495,1,641,sexual reproduction,BP,CLDN11
11551,GO:0044249,0.983346458037637,0.0283647467989174,26,5703,cellular biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;FOLH1;CAPN3;SOX10;FA2H;PLP1;MYRF;PDGFRA;CPM;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;SLC45A3;PHKG1;NNMT;GREM1;GPD1;CARNS1;DMRT2;UGT8
1066,GO:0002443,0.9836605807321,0.0852325107092226,1,688,leukocyte mediated immunity,BP,RASGRP1
6298,GO:0018130,0.984622445657259,0.028290548383505,17,4046,heterocycle biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;DMRT2
3429,GO:0006807,0.9846375701954,0.0252460397916714,45,8864,nitrogen compound metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;PLCL1;RGS4;CDK18;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;ADAMTS4;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;KNDC1;CARNS1;RASGRP1;DMRT2;UGT8;BOK;AATK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
6552,GO:0019438,0.985093915035322,0.0274948987431587,17,4053,aromatic compound biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;DMRT2
4799,GO:0010556,0.9857492043919,0.0267116567785344,16,3837,regulation of macromolecule biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PDGFRA;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2
3098,GO:0006351,0.986722046671827,0.0257736412653687,14,3495,transcription, DNA-templated,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2
18975,GO:1901576,0.98706444035699,0.0224566856346055,26,5780,organic substance biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;FOLH1;CAPN3;SOX10;FA2H;PLP1;MYRF;PDGFRA;CPM;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;SLC45A3;PHKG1;NNMT;GREM1;GPD1;CARNS1;DMRT2;UGT8
17881,GO:0097659,0.987366608025926,0.0246286321174306,14,3509,nucleic acid-templated transcription,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2
11553,GO:0044257,0.98762966684776,0.0681518021683077,1,676,cellular protein catabolic process,BP,LRP2
8638,GO:0032774,0.987903994680538,0.0236695975955531,14,3522,RNA biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2
14039,GO:0051704,0.987922860664831,0.0300289509239143,6,2043,multi-organism process,BP,CLDN11;NGFR;PDGFRA;MOG;EGFR;GJA1
11545,GO:0044238,0.988661931246093,0.0190543673688819,47,9272,primary metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;PLCL1;RGS4;CDK18;PLP1;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;SLC45A3;ADAMTS4;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;KNDC1;CARNS1;RASGRP1;DMRT2;UGT8;BOK;AATK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
3583,GO:0007049,0.988889085563511,0.0297298203571228,5,1712,cell cycle,BP,ANLN;CAPN3;TUBB4A;EGFR;GJC2
11862,GO:0045087,0.98912240009512,0.0613866634410393,1,750,innate immune response,BP,RASGRP1
3085,GO:0006325,0.989312170020808,0.060530028416139,1,676,chromatin organization,BP,EYA2
4305,GO:0009058,0.989313019149515,0.0188155091039567,26,5840,biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;FOLH1;CAPN3;SOX10;FA2H;PLP1;MYRF;PDGFRA;CPM;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;SLC45A3;PHKG1;NNMT;GREM1;GPD1;CARNS1;DMRT2;UGT8
19317,GO:1902494,0.989590422146608,0.0343842587514833,3,1318,catalytic complex,CC,PHKG1;GPD1;DNAH17
11561,GO:0044271,0.989900102121042,0.0188115549784398,19,4604,cellular nitrogen compound biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;CARNS1;DMRT2;UGT8
18914,GO:1901362,0.989985120417832,0.0190824363835835,17,4175,organic cyclic compound biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;DMRT2
11550,GO:0044248,0.990031750891611,0.0253150912405209,6,2061,cellular catabolic process,BP,LRP2;ENPP2;PHKG1;GPD1;CARNS1;BOK
11976,GO:0045321,0.990034584515753,0.0398490168209123,2,1074,leukocyte activation,BP,FZD7;RASGRP1
4763,GO:0010467,0.990261194974225,0.0178588678879146,21,4942,gene expression,BP,ARX;NGFR;EYA2;ERBB3;LRP2;CAPN3;SOX10;PLP1;MYRF;CPM;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;KLK6;DMRT2;CNTN2;GJC2
13797,GO:0051252,0.990689957397728,0.0186263848196138,14,3566,regulation of RNA metabolic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2
20942,GO:1990234,0.992100512675996,0.0472508116877516,1,744,transferase complex,CC,PHKG1
16514,GO:0071704,0.992628065822356,0.0127730829098667,48,9561,organic substance metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;BVES;PLCL1;RGS4;CDK18;PLP1;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;SLC45A3;ADAMTS4;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;KNDC1;CARNS1;RASGRP1;DMRT2;UGT8;BOK;AATK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
11544,GO:0044237,0.993115688920879,0.0119742429430187,47,9434,cellular metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;BVES;PLCL1;RGS4;CDK18;PLP1;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;SLC45A3;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KNDC1;CARNS1;RASGRP1;DMRT2;UGT8;MYO1D;BOK;AATK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
1597,GO:0003677,0.993725578709516,0.0158592359106622,7,2247,DNA binding,MF,ARX;SOX10;MYRF;EGFR;ST18;NKX6-2;DMRT2
11650,GO:0044427,0.994036756044975,0.0374413807446638,1,786,chromosomal part,CC,SOX10
3546,GO:0006996,0.994228106832406,0.0122288974713543,13,3478,organelle organization,BP,ANLN;EYA2;CAPN3;TUBB4A;PEX5L;PPL;LDB3;PDGFRA;ERMN;TMSB15A;UGT8;BOK;CNTN2
3127,GO:0006396,0.995306401504368,0.0306541013919914,1,893,RNA processing,BP,EGFR
2721,GO:0005730,0.995888475600022,0.0274333477372579,1,877,nucleolus,CC,KLK6
8419,GO:0032446,0.996216159277673,0.0255844659137754,1,845,protein modification by small protein conjugation,BP,CAPN3
9462,GO:0034645,0.996873456347101,0.00641607192725594,18,4682,cellular macromolecule biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PDGFRA;CPM;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;PHKG1;GREM1;DMRT2
3925,GO:0008152,0.997416750277528,0.00479697727234854,49,10000,metabolic process,BP,ARX;CRLF1;NGFR;EYA2;ERBB3;LRP2;FOLH1;TF;CAPN3;SOX10;FA2H;BVES;PLCL1;RGS4;CDK18;PLP1;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;SLC45A3;ADAMTS4;PHKG1;NNMT;GREM1;GPD1;PPP1R14A;KLK6;KNDC1;CARNS1;RASGRP1;DMRT2;UGT8;MYO1D;BOK;AATK;CNTN2;APOD;SPOCK3;MBP;GJC2;COL28A1
2711,GO:0005694,0.99760634531412,0.01735394012219,1,900,chromosome,CC,SOX10
953,GO:0002252,0.997999048766242,0.014887248232905,1,1003,immune effector process,BP,RASGRP1
4306,GO:0009059,0.99800571711571,0.00421940378813693,18,4792,macromolecule biosynthetic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PDGFRA;CPM;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;PHKG1;GREM1;DMRT2
17637,GO:0097159,0.998072085235614,0.00391920653127766,22,5427,organic cyclic compound binding,MF,ARX;ERBB3;SOX10;FA2H;TUBB4A;BVES;CDK18;ATP10B;MYRF;PDGFRA;ENPP2;EGFR;ST18;NKX6-2;PHKG1;GPD1;CARNS1;DMRT2;MYO1D;AATK;DNAH17;APOD
12500,GO:0046483,0.99838387365507,0.0033529259804374,21,5453,heterocycle metabolic process,BP,ARX;NGFR;EYA2;LRP2;FOLH1;CAPN3;SOX10;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;CARNS1;DMRT2
11558,GO:0044265,0.998538628151049,0.0113659152688452,1,1025,cellular macromolecule catabolic process,BP,LRP2
3381,GO:0006725,0.99861620868203,0.00289897867508043,21,5492,cellular aromatic compound metabolic process,BP,ARX;NGFR;EYA2;LRP2;FOLH1;CAPN3;SOX10;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;CARNS1;DMRT2
11648,GO:0044424,0.998667987113127,0.00280440813304319,67,12617,intracellular part,CC,ARX;CRLF1;ANLN;PLEKHH1;NGFR;EYA2;BCAS1;ERBB3;DCX;LRP2;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;FA2H;TUBB4A;MAG;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;MYRF;PDGFRA;RAPGEF5;ERMN;SLC31A2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;KCNJ6;SNX22;TMSB15A;ADAMTS4;PHKG1;NNMT;GPD1;PPP1R14A;KLK6;MOBP;LGI3;SH3TC2;GJB1;KNDC1;MAL;CARNS1;RASGRP1;DMRT2;UGT8;MYO1D;BOK;AATK;ANKS1B;DNAH17;APOD;OPALIN;MBP;TMEM235;COL28A1
18915,GO:1901363,0.998837636749288,0.00246157073776372,21,5362,heterocyclic compound binding,MF,ARX;ERBB3;SOX10;FA2H;TUBB4A;BVES;CDK18;ATP10B;MYRF;PDGFRA;ENPP2;EGFR;ST18;NKX6-2;PHKG1;GPD1;CARNS1;DMRT2;MYO1D;AATK;DNAH17
15922,GO:0070647,0.998855100310895,0.00920627843216119,1,1011,protein modification by small protein conjugation or removal,BP,CAPN3
9459,GO:0034641,0.998866188146814,0.00236146844145547,23,5944,cellular nitrogen compound metabolic process,BP,ARX;NGFR;EYA2;LRP2;FOLH1;CAPN3;SOX10;MYRF;PDGFRA;CPM;ENPP2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;CARNS1;DMRT2;UGT8
11140,GO:0043227,0.999015548084571,0.00196778147684521,55,11108,membrane-bounded organelle,CC,ARX;ANLN;CLDN11;NGFR;EYA2;BCAS1;LRP2;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;PLLP;FA2H;TUBB4A;PEX5L;RGS4;CDK18;ATP10B;PPL;MYRF;PDGFRA;CPM;RAPGEF5;ERMN;SLC31A2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;KCNJ6;SNX22;ADAMTS4;EDIL3;GPD1;KLK6;MOBP;LGI3;SH3TC2;GJB1;MAL;RASGRP1;DMRT2;UGT8;MYO1D;BOK;ANKS1B;APOD;OPALIN;MBP;TMEM235;COL28A1
17392,GO:0090304,0.99905121565512,0.00213524760734813,17,4768,nucleic acid metabolic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;GREM1;DMRT2
2668,GO:0005622,0.999129742550428,0.00190581206621089,68,12823,intracellular,CC,ARX;CRLF1;ANLN;PLEKHH1;NGFR;EYA2;BCAS1;ERBB3;DCX;LRP2;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;FA2H;TUBB4A;MAG;PEX5L;PLCL1;RGS4;CDK18;ATP10B;PPL;LDB3;MYRF;PDGFRA;RAPGEF5;ERMN;SLC31A2;PCSK6;EGFR;ST18;NKX6-2;CNDP1;GJA1;FZD7;KCNJ6;SNX22;TMSB15A;ADAMTS4;PHKG1;NNMT;GPD1;PPP1R14A;KLK6;MOBP;LGI3;SH3TC2;GJB1;KNDC1;MAL;CARNS1;RASGRP1;DMRT2;UGT8;MYO1D;BOK;GPR62;AATK;ANKS1B;DNAH17;APOD;OPALIN;MBP;TMEM235;COL28A1
18912,GO:1901360,0.999318336010088,0.0014906109402666,21,5667,organic cyclic compound metabolic process,BP,ARX;NGFR;EYA2;LRP2;FOLH1;CAPN3;SOX10;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;CARNS1;DMRT2
13814,GO:0051276,0.999396779006735,0.00526850161616597,1,1087,chromosome organization,BP,EYA2
2981,GO:0006139,0.999435835080585,0.00127592683646429,19,5311,nucleobase-containing compound metabolic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PDGFRA;ENPP2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;NNMT;GREM1;GPD1;DMRT2
8130,GO:0031974,0.999477910298524,0.00123862771448991,16,4779,membrane-enclosed lumen,CC,ANLN;NGFR;EYA2;LRP2;TF;COL9A3;SOX10;MYRF;RAPGEF5;PCSK6;EGFR;GJA1;ADAMTS4;KLK6;ANKS1B;COL28A1
11146,GO:0043233,0.999477910298524,0.00123862771448991,16,4779,organelle lumen,CC,ANLN;NGFR;EYA2;LRP2;TF;COL9A3;SOX10;MYRF;RAPGEF5;PCSK6;EGFR;GJA1;ADAMTS4;KLK6;ANKS1B;COL28A1
15553,GO:0070013,0.999477910298524,0.00123862771448991,16,4779,intracellular organelle lumen,CC,ANLN;NGFR;EYA2;LRP2;TF;COL9A3;SOX10;MYRF;RAPGEF5;PCSK6;EGFR;GJA1;ADAMTS4;KLK6;ANKS1B;COL28A1
2680,GO:0005654,0.99947951088443,0.00147992902319773,9,3247,nucleoplasm,CC,ANLN;NGFR;EYA2;SOX10;MYRF;RAPGEF5;GJA1;ADAMTS4;ANKS1B
5689,GO:0016070,0.999499869391521,0.00123481562623779,14,4325,RNA metabolic process,BP,ARX;NGFR;EYA2;LRP2;CAPN3;SOX10;MYRF;PCSK6;EGFR;ST18;NKX6-2;FZD7;GREM1;DMRT2
11139,GO:0043226,0.999529894601803,0.00100590287317722,60,11884,organelle,CC,ARX;ANLN;CLDN11;PLEKHH1;NGFR;EYA2;BCAS1;DCX;LRP2;FOLH1;TF;CAPN3;COL9A3;SOX10;MLC1;PLLP;FA2H;TUBB4A;PEX5L;RGS4;CDK18;ATP10B;PPL;LDB3;MYRF;PDGFRA;CPM;RAPGEF5;ERMN;SLC31A2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;KCNJ6;SNX22;TMSB15A;ADAMTS4;EDIL3;GPD1;KLK6;MOBP;LGI3;SH3TC2;GJB1;MAL;RASGRP1;DMRT2;UGT8;MYO1D;BOK;ANKS1B;DNAH17;APOD;OPALIN;MBP;TMEM235;COL28A1
11142,GO:0043229,0.999708345104567,0.000623265273526975,54,11114,intracellular organelle,CC,ARX;ANLN;PLEKHH1;NGFR;EYA2;DCX;LRP2;TF;CAPN3;COL9A3;SOX10;MLC1;FA2H;TUBB4A;PEX5L;RGS4;CDK18;ATP10B;PPL;LDB3;MYRF;PDGFRA;RAPGEF5;ERMN;SLC31A2;PCSK6;EGFR;ST18;NKX6-2;GJA1;FZD7;KCNJ6;SNX22;TMSB15A;ADAMTS4;GPD1;KLK6;MOBP;LGI3;SH3TC2;GJB1;MAL;RASGRP1;DMRT2;UGT8;MYO1D;BOK;ANKS1B;DNAH17;APOD;OPALIN;MBP;TMEM235;COL28A1
11651,GO:0044428,0.999810006282113,0.000522501178470752,12,4097,nuclear part,CC,ANLN;NGFR;EYA2;SOX10;MYRF;RAPGEF5;EGFR;GJA1;ADAMTS4;KLK6;BOK;ANKS1B
11144,GO:0043231,0.999844136641328,0.000336931284220762,43,9668,intracellular membrane-bounded organelle,CC,ARX;ANLN;NGFR;EYA2;LRP2;TF;CAPN3;COL9A3;SOX10;MLC1;FA2H;TUBB4A;PEX5L;RGS4;CDK18;ATP10B;PPL;MYRF;PDGFRA;RAPGEF5;PCSK6;EGFR;ST18;NKX6-2;GJA1;KCNJ6;ADAMTS4;GPD1;KLK6;MOBP;GJB1;MAL;RASGRP1;DMRT2;UGT8;MYO1D;BOK;ANKS1B;APOD;OPALIN;MBP;TMEM235;COL28A1
8132,GO:0031981,0.999890458999932,0.000332105746103917,10,3776,nuclear lumen,CC,ANLN;NGFR;EYA2;SOX10;MYRF;RAPGEF5;GJA1;ADAMTS4;KLK6;ANKS1B
2670,GO:0005634,0.999944733927903,0.000135610639022521,23,6483,nucleus,CC,ARX;ANLN;NGFR;EYA2;CAPN3;SOX10;TUBB4A;RGS4;CDK18;PPL;MYRF;PDGFRA;RAPGEF5;EGFR;ST18;NKX6-2;GJA1;ADAMTS4;KLK6;DMRT2;BOK;ANKS1B;MBP
1596,GO:0003676,0.999980974397777,7.00205840129224e-05,8,3641,nucleic acid binding,MF,ARX;SOX10;MYRF;ENPP2;EGFR;ST18;NKX6-2;DMRT2
11647,GO:0044422,0.999987294066246,3.14919075062745e-05,32,8352,organelle part,CC,ANLN;NGFR;EYA2;DCX;LRP2;TF;CAPN3;COL9A3;SOX10;FA2H;TUBB4A;PEX5L;ATP10B;LDB3;MYRF;RAPGEF5;PCSK6;EGFR;GJA1;FZD7;SNX22;TMSB15A;ADAMTS4;KLK6;MOBP;GJB1;RASGRP1;MYO1D;BOK;ANKS1B;DNAH17;COL28A1
11664,GO:0044446,0.999993764520557,1.60873985831878e-05,30,8154,intracellular organelle part,CC,ANLN;NGFR;EYA2;DCX;LRP2;TF;COL9A3;SOX10;FA2H;TUBB4A;PEX5L;ATP10B;MYRF;RAPGEF5;PCSK6;EGFR;GJA1;FZD7;SNX22;TMSB15A;ADAMTS4;KLK6;MOBP;GJB1;RASGRP1;MYO1D;BOK;ANKS1B;DNAH17;COL28A1
17369,GO:0090278,0.999999999999989,0.777307734204521,0,41,negative regulation of peptide hormone secretion,BP,
8935,GO:0033260,0.999999999999992,0.749609220685758,0,49,nuclear DNA replication,BP,
19603,GO:1903170,0.999999999999999,0.819955330131434,0,34,negative regulation of calcium ion transmembrane transport,BP,
21461,GO:2000484,0.999999999999999,0.928301161646995,0,14,positive regulation of interleukin-8 secretion,BP,
1,GO:0000002,1,0.843350706936966,0,26,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.994252459065971,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.98865634785945,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.993301131169352,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.946852562385818,0,8,single strand break repair,BP,
7,GO:0000014,1,0.952388244964315,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.979576400988684,0,4,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.645987214592377,0,66,regulation of DNA recombination,BP,
10,GO:0000019,1,0.974000422403853,0,4,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.936573106735459,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.976901605395316,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.979354688261191,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.882925821575209,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.94153314031398,0,17,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.879305399938936,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.995805808593524,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.985357659939206,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.987010945498691,0,3,acyl binding,MF,
20,GO:0000036,1,0.994083656276557,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.830977788217088,0,30,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.565998851280987,0,88,autophagosome assembly,BP,
24,GO:0000048,1,0.988243989590435,0,2,peptidyltransferase activity,MF,
25,GO:0000049,1,0.713212190360727,0,55,tRNA binding,MF,
26,GO:0000050,1,0.938418713457484,0,12,urea cycle,BP,
27,GO:0000052,1,0.949146492622279,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.995687939955043,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.935954270990026,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.959891095168062,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.966003875287154,0,7,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.766862107253374,0,43,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.904616991137279,0,18,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.962707965891151,0,6,L-ornithine transmembrane transporter activity,MF,
35,GO:0000070,1,0.368318774884567,0,143,mitotic sister chromatid segregation,BP,
36,GO:0000075,1,0.258603526066051,0,211,cell cycle checkpoint,BP,
37,GO:0000076,1,0.909095106408721,0,16,DNA replication checkpoint,BP,
38,GO:0000077,1,0.387020945355288,0,147,DNA damage checkpoint,BP,
41,GO:0000083,1,0.8402002264106,0,28,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.994652381026544,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.799417155119627,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.910315259934043,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.941231022863118,0,10,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.957926338493678,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.966960107985511,0,5,sulfur amino acid transport,BP,
49,GO:0000103,1,0.983040329744581,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.981008682933304,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.986884344910075,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.93991880358173,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.980680425917774,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.992502012370885,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.985082193356987,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
56,GO:0000118,1,0.658443334590295,0,60,histone deacetylase complex,CC,
57,GO:0000120,1,0.972238292405789,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.992777080918084,0,1,glycerol-1-phosphatase activity,MF,
60,GO:0000123,1,0.61817954398145,0,75,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.940422299286409,0,11,SAGA complex,CC,
62,GO:0000125,1,0.978752178971277,0,3,PCAF complex,CC,
63,GO:0000126,1,0.982596780243472,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.961194139175826,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.875296594950647,0,20,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.894067884442031,0,17,Golgi cis cisterna,CC,
67,GO:0000138,1,0.963494474490934,0,7,Golgi trans cisterna,CC,
69,GO:0000145,1,0.880529981051666,0,18,exocyst,CC,
71,GO:0000147,1,0.965760887148933,0,5,actin cortical patch assembly,BP,
72,GO:0000149,1,0.448334556863351,0,122,SNARE binding,MF,
73,GO:0000150,1,0.954389193622163,0,8,recombinase activity,MF,
74,GO:0000151,1,0.150758475557648,0,289,ubiquitin ligase complex,CC,
75,GO:0000152,1,0.79633062452573,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.933068890644977,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.847951934919785,0,31,rRNA modification,BP,
78,GO:0000155,1,0.954885901316301,0,6,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.882158865317209,0,19,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.947705829935306,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.932392332887137,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.996460027391501,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.986381307926723,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.967699645214044,0,6,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.996057642867236,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.83155205439636,0,30,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.946867083533399,0,13,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.921768779606416,0,15,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.886416691511117,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.979152508936509,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.930954271785759,0,10,rDNA binding,MF,
94,GO:0000183,1,0.908771327891844,0,18,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.596757631887609,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.889582236015749,0,18,activation of MAPKKK activity,BP,
98,GO:0000187,1,0.426528266568525,0,133,activation of MAPK activity,BP,
100,GO:0000209,1,0.15755863185578,0,290,protein polyubiquitination,BP,
101,GO:0000210,1,0.992540856473463,0,1,NAD+ diphosphatase activity,MF,
102,GO:0000212,1,0.932681306146524,0,10,meiotic spindle organization,BP,
103,GO:0000213,1,0.980380100137299,0,4,tRNA-intron endonuclease activity,MF,
104,GO:0000214,1,0.980859887399988,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000215,1,0.990186913645804,0,2,tRNA 2'-phosphotransferase activity,MF,
106,GO:0000217,1,0.853252776167479,0,24,DNA secondary structure binding,MF,
107,GO:0000220,1,0.964978413725575,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
108,GO:0000221,1,0.979950902244257,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
109,GO:0000224,1,0.993833810292443,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
110,GO:0000225,1,0.996745562875406,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000228,1,0.0333178227953621,0,513,nuclear chromosome,CC,
113,GO:0000229,1,0.992961484206027,0,2,cytoplasmic chromosome,CC,
114,GO:0000235,1,0.943253382882185,0,8,astral microtubule,CC,
115,GO:0000242,1,0.864809792706476,0,20,pericentriolar material,CC,
116,GO:0000243,1,0.961309539788662,0,8,commitment complex,CC,
117,GO:0000244,1,0.920315072642345,0,12,spliceosomal tri-snRNP complex assembly,BP,
118,GO:0000245,1,0.707473446044888,0,57,spliceosomal complex assembly,BP,
119,GO:0000246,1,0.992431021941977,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000247,1,0.996743704416587,0,1,C-8 sterol isomerase activity,MF,
121,GO:0000248,1,0.98576439445561,0,2,C-5 sterol desaturase activity,MF,
122,GO:0000250,1,0.992434831481106,0,1,lanosterol synthase activity,MF,
123,GO:0000252,1,0.996150435644657,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
124,GO:0000253,1,0.989718933066641,0,3,3-keto sterol reductase activity,MF,
125,GO:0000254,1,0.983194505225295,0,3,C-4 methylsterol oxidase activity,MF,
126,GO:0000255,1,0.973766950634432,0,4,allantoin metabolic process,BP,
127,GO:0000256,1,0.996394880504088,0,1,allantoin catabolic process,BP,
128,GO:0000257,1,0.99651203050754,0,1,nitrilase activity,MF,
129,GO:0000262,1,0.996159312681433,0,1,mitochondrial chromosome,CC,
130,GO:0000266,1,0.788389389826257,0,34,mitochondrial fission,BP,
132,GO:0000270,1,0.993788180962365,0,2,peptidoglycan metabolic process,BP,
138,GO:0000285,1,0.974745913492019,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
140,GO:0000288,1,0.63387043636673,0,74,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
141,GO:0000289,1,0.778473058345856,0,36,nuclear-transcribed mRNA poly(A) tail shortening,BP,
142,GO:0000290,1,0.954531415784725,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
143,GO:0000291,1,0.836854636827556,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000293,1,0.979009478561989,0,3,ferric-chelate reductase activity,MF,
145,GO:0000294,1,0.985674576243675,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
146,GO:0000295,1,0.93623875312755,0,11,adenine nucleotide transmembrane transporter activity,MF,
147,GO:0000296,1,0.994483939307815,0,1,spermine transport,BP,
148,GO:0000298,1,0.978556250983495,0,4,endopolyphosphatase activity,MF,
149,GO:0000301,1,0.975352179463419,0,4,retrograde transport, vesicle recycling within Golgi,BP,
151,GO:0000303,1,0.869609063608168,0,27,response to superoxide,BP,
152,GO:0000305,1,0.853088276595403,0,30,response to oxygen radical,BP,
153,GO:0000306,1,0.972333677352458,0,4,extrinsic component of vacuolar membrane,CC,
154,GO:0000307,1,0.799689899793712,0,39,cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000308,1,0.984824005805147,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
156,GO:0000309,1,0.9803653610122,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000313,1,0.729217967053928,0,82,organellar ribosome,CC,
158,GO:0000314,1,0.90428354736288,0,27,organellar small ribosomal subunit,CC,
159,GO:0000315,1,0.824154035027039,0,50,organellar large ribosomal subunit,CC,
160,GO:0000320,1,0.984917869199144,0,2,re-entry into mitotic cell cycle,BP,
161,GO:0000322,1,0.983569611477359,0,3,storage vacuole,CC,
163,GO:0000333,1,0.984471887498374,0,2,telomerase catalytic core complex,CC,
164,GO:0000334,1,0.99660517633972,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
165,GO:0000338,1,0.953404293196118,0,10,protein deneddylation,BP,
166,GO:0000339,1,0.913767026620731,0,15,RNA cap binding,MF,
167,GO:0000340,1,0.954111705968737,0,7,RNA 7-methylguanosine cap binding,MF,
168,GO:0000346,1,0.926651843709392,0,13,transcription export complex,CC,
169,GO:0000347,1,0.970215783724669,0,6,THO complex,CC,
170,GO:0000349,1,0.987884840072754,0,2,generation of catalytic spliceosome for first transesterification step,BP,
171,GO:0000350,1,0.98674113740516,0,3,generation of catalytic spliceosome for second transesterification step,BP,
172,GO:0000354,1,0.984304014879955,0,2,cis assembly of pre-catalytic spliceosome,BP,
173,GO:0000375,1,0.151242506927506,0,315,RNA splicing, via transesterification reactions,BP,
174,GO:0000377,1,0.153809675059029,0,312,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
175,GO:0000379,1,0.984934251186625,0,3,tRNA-type intron splice site recognition and cleavage,BP,
176,GO:0000380,1,0.700078928632461,0,54,alternative mRNA splicing, via spliceosome,BP,
177,GO:0000381,1,0.758183985583322,0,42,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000384,1,0.992115946173453,0,2,first spliceosomal transesterification activity,MF,
179,GO:0000386,1,0.980143200172956,0,3,second spliceosomal transesterification activity,MF,
180,GO:0000387,1,0.812761027056331,0,38,spliceosomal snRNP assembly,BP,
181,GO:0000389,1,0.963365716827652,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.989804969098501,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.974784956395676,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.916405076937609,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.962891571204238,0,6,mRNA 5'-splice site recognition,BP,
186,GO:0000398,1,0.153809675059029,0,312,mRNA splicing, via spliceosome,BP,
187,GO:0000400,1,0.902022878441291,0,16,four-way junction DNA binding,MF,
188,GO:0000403,1,0.955818215597541,0,6,Y-form DNA binding,MF,
189,GO:0000404,1,0.977796903529154,0,3,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.949734637362185,0,7,bubble DNA binding,MF,
191,GO:0000406,1,0.985184951217608,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.796593090733654,0,33,phagophore assembly site,CC,
193,GO:0000408,1,0.976174512989633,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.991707510812988,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.991707510812988,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000412,1,0.993097417335772,0,1,histone peptidyl-prolyl isomerization,BP,
197,GO:0000413,1,0.852129081668376,0,31,protein peptidyl-prolyl isomerization,BP,
198,GO:0000414,1,0.967001388547184,0,4,regulation of histone H3-K36 methylation,BP,
199,GO:0000415,1,0.991886709663564,0,1,negative regulation of histone H3-K36 methylation,BP,
200,GO:0000416,1,0.992481741560679,0,1,positive regulation of histone H3-K36 methylation,BP,
201,GO:0000417,1,0.992455646340497,0,1,HIR complex,CC,
202,GO:0000421,1,0.832072155039463,0,31,autophagosome membrane,CC,
203,GO:0000422,1,0.606169890008039,0,80,autophagy of mitochondrion,BP,
204,GO:0000423,1,0.882420359153186,0,18,mitophagy,BP,
205,GO:0000428,1,0.449599988691321,0,132,DNA-directed RNA polymerase complex,CC,
206,GO:0000429,1,0.977944070128873,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
207,GO:0000430,1,0.986122667525255,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000431,1,0.991707510812988,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000432,1,0.986122667525255,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
210,GO:0000435,1,0.991707510812988,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
211,GO:0000436,1,0.977944070128873,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
212,GO:0000438,1,0.987624194474275,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
213,GO:0000439,1,0.955639037088432,0,8,core TFIIH complex,CC,
214,GO:0000444,1,0.974571473216841,0,4,MIS12/MIND type complex,CC,
215,GO:0000445,1,0.970215783724669,0,6,THO complex part of transcription export complex,CC,
216,GO:0000447,1,0.951292244262626,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000448,1,0.991772369983355,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
218,GO:0000451,1,0.992257145941235,0,1,rRNA 2'-O-methylation,BP,
219,GO:0000453,1,0.992257145941235,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
220,GO:0000454,1,0.989672850858605,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
221,GO:0000455,1,0.990815962710577,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
222,GO:0000459,1,0.967558560743444,0,7,exonucleolytic trimming involved in rRNA processing,BP,
223,GO:0000460,1,0.839290828377038,0,32,maturation of 5.8S rRNA,BP,
224,GO:0000461,1,0.993873417428158,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000462,1,0.819071636110522,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000463,1,0.95561256939427,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000466,1,0.888763637262065,0,21,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000467,1,0.967558560743444,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000469,1,0.870652099961641,0,25,cleavage involved in rRNA processing,BP,
230,GO:0000470,1,0.892942575085968,0,22,maturation of LSU-rRNA,BP,
231,GO:0000472,1,0.978673265681607,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000478,1,0.915615235777308,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
233,GO:0000479,1,0.921081431248901,0,13,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000480,1,0.960636638552223,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
235,GO:0000481,1,0.992502714070778,0,1,maturation of 5S rRNA,BP,
236,GO:0000491,1,0.959610091590345,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
237,GO:0000492,1,0.970289785263346,0,6,box C/D snoRNP assembly,BP,
238,GO:0000493,1,0.988996737070693,0,2,box H/ACA snoRNP assembly,BP,
239,GO:0000494,1,0.99673146754899,0,1,box C/D snoRNA 3'-end processing,BP,
240,GO:0000495,1,0.993734703919287,0,1,box H/ACA snoRNA 3'-end processing,BP,
241,GO:0000502,1,0.74804175165303,0,62,proteasome complex,CC,
242,GO:0000506,1,0.958967357253798,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
244,GO:0000700,1,0.97902862305945,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.992209110212968,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.98125414959624,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.993035302767104,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.979134186479094,0,3,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.953430753648261,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.970514097916139,0,4,meiotic mismatch repair,BP,
251,GO:0000711,1,0.99643854227221,0,1,meiotic DNA repair synthesis,BP,
252,GO:0000712,1,0.918592590995053,0,13,resolution of meiotic recombination intermediates,BP,
253,GO:0000715,1,0.885263866958659,0,23,nucleotide-excision repair, DNA damage recognition,BP,
254,GO:0000717,1,0.881052312583083,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
255,GO:0000718,1,0.995905916601267,0,1,nucleotide-excision repair, DNA damage removal,BP,
256,GO:0000720,1,0.981795050901576,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
257,GO:0000722,1,0.910643134840612,0,14,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.400379982414706,0,144,telomere maintenance,BP,
259,GO:0000724,1,0.496626659965972,0,104,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.493275571995808,0,105,recombinational repair,BP,
261,GO:0000726,1,0.655929896538807,0,64,non-recombinational repair,BP,
262,GO:0000727,1,0.971818439086334,0,5,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.858673063425565,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.940881250386197,0,10,DNA recombinase assembly,BP,
265,GO:0000731,1,0.644122548836255,0,68,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.835713238691037,0,25,strand displacement,BP,
267,GO:0000733,1,0.939960094472203,0,9,DNA strand renaturation,BP,
268,GO:0000737,1,0.857962457594627,0,26,DNA catabolic process, endonucleolytic,BP,
269,GO:0000738,1,0.975982833933652,0,4,DNA catabolic process, exonucleolytic,BP,
270,GO:0000741,1,0.995863968126632,0,1,karyogamy,BP,
271,GO:0000768,1,0.782836983709901,0,37,syncytium formation by plasma membrane fusion,BP,
272,GO:0000773,1,0.996874428829302,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
273,GO:0000774,1,0.93943029605039,0,11,adenyl-nucleotide exchange factor activity,MF,
274,GO:0000775,1,0.306319941627427,0,181,chromosome, centromeric region,CC,
275,GO:0000776,1,0.448766357759884,0,125,kinetochore,CC,
276,GO:0000777,1,0.547864350855289,0,96,condensed chromosome kinetochore,CC,
277,GO:0000778,1,0.933235356935475,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000779,1,0.511598726416526,0,107,condensed chromosome, centromeric region,CC,
279,GO:0000780,1,0.887266287357078,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000781,1,0.417919346632233,0,135,chromosome, telomeric region,CC,
281,GO:0000782,1,0.932482502301109,0,11,telomere cap complex,CC,
282,GO:0000783,1,0.932482502301109,0,11,nuclear telomere cap complex,CC,
283,GO:0000784,1,0.50546010505193,0,105,nuclear chromosome, telomeric region,CC,
285,GO:0000786,1,0.817753617503796,0,47,nucleosome,CC,
286,GO:0000788,1,0.943682826501776,0,14,nuclear nucleosome,CC,
287,GO:0000789,1,0.996789971389564,0,1,cytoplasmic chromatin,CC,
288,GO:0000790,1,0.142348246728341,0,306,nuclear chromatin,CC,
289,GO:0000791,1,0.838780289724444,0,30,euchromatin,CC,
290,GO:0000792,1,0.641317332517959,0,68,heterochromatin,CC,
291,GO:0000793,1,0.267736138894435,0,194,condensed chromosome,CC,
292,GO:0000794,1,0.549384861370554,0,82,condensed nuclear chromosome,CC,
293,GO:0000795,1,0.82794858939044,0,31,synaptonemal complex,CC,
294,GO:0000796,1,0.947154417513207,0,7,condensin complex,CC,
295,GO:0000797,1,0.992335412816956,0,1,condensin core heterodimer,CC,
296,GO:0000798,1,0.967951584756659,0,5,nuclear cohesin complex,CC,
297,GO:0000799,1,0.977030564273381,0,3,nuclear condensin complex,CC,
298,GO:0000800,1,0.917764598150699,0,13,lateral element,CC,
299,GO:0000801,1,0.965739210808534,0,6,central element,CC,
300,GO:0000803,1,0.851312708667579,0,25,sex chromosome,CC,
301,GO:0000805,1,0.952854289581901,0,7,X chromosome,CC,
302,GO:0000806,1,0.986913989756945,0,2,Y chromosome,CC,
303,GO:0000808,1,0.94149162348737,0,9,origin recognition complex,CC,
304,GO:0000811,1,0.981936965107019,0,3,GINS complex,CC,
305,GO:0000812,1,0.941508199339897,0,10,Swr1 complex,CC,
306,GO:0000813,1,0.943130090331191,0,10,ESCRT I complex,CC,
307,GO:0000814,1,0.985948633665648,0,3,ESCRT II complex,CC,
308,GO:0000815,1,0.936594172645227,0,12,ESCRT III complex,CC,
309,GO:0000818,1,0.9885509403791,0,2,nuclear MIS12/MIND complex,CC,
310,GO:0000819,1,0.220712803879214,0,223,sister chromatid segregation,BP,
311,GO:0000820,1,0.96977850466976,0,5,regulation of glutamine family amino acid metabolic process,BP,
312,GO:0000821,1,0.985585883521138,0,2,regulation of arginine metabolic process,BP,
313,GO:0000822,1,0.975498302464264,0,3,inositol hexakisphosphate binding,MF,
314,GO:0000823,1,0.995761624930694,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
315,GO:0000824,1,0.995761624930694,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
316,GO:0000825,1,0.995761624930694,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
317,GO:0000827,1,0.967077140655471,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
318,GO:0000828,1,0.967077140655471,0,5,inositol hexakisphosphate kinase activity,MF,
319,GO:0000829,1,0.967077140655471,0,5,inositol heptakisphosphate kinase activity,MF,
320,GO:0000831,1,0.993330953314391,0,1,inositol hexakisphosphate 6-kinase activity,MF,
321,GO:0000832,1,0.967077140655471,0,5,inositol hexakisphosphate 5-kinase activity,MF,
322,GO:0000835,1,0.959343611874633,0,6,ER ubiquitin ligase complex,CC,
323,GO:0000836,1,0.966715570312778,0,5,Hrd1p ubiquitin ligase complex,CC,
324,GO:0000839,1,0.980922630316112,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
325,GO:0000900,1,0.910667257013751,0,13,translation repressor activity, mRNA regulatory element binding,MF,
331,GO:0000916,1,0.994780093997994,0,1,actomyosin contractile ring contraction,BP,
332,GO:0000917,1,0.995635638159014,0,1,division septum assembly,BP,
333,GO:0000920,1,0.910587184195265,0,17,cell separation after cytokinesis,BP,
335,GO:0000922,1,0.387821444762282,0,142,spindle pole,CC,
336,GO:0000923,1,0.963826880477219,0,5,equatorial microtubule organizing center,CC,
337,GO:0000928,1,0.993301131169352,0,1,gamma-tubulin small complex, spindle pole body,CC,
338,GO:0000930,1,0.876858395119676,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.949440715768808,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.601331401655793,0,79,P-body,CC,
341,GO:0000938,1,0.970901738197326,0,4,GARP complex,CC,
342,GO:0000939,1,0.984442514068358,0,3,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.915132665779725,0,13,condensed chromosome outer kinetochore,CC,
344,GO:0000941,1,0.994581681901921,0,1,condensed nuclear chromosome inner kinetochore,CC,
345,GO:0000942,1,0.977317568413849,0,4,condensed nuclear chromosome outer kinetochore,CC,
346,GO:0000956,1,0.352911780325404,0,200,nuclear-transcribed mRNA catabolic process,BP,
347,GO:0000957,1,0.964416837323836,0,5,mitochondrial RNA catabolic process,BP,
348,GO:0000958,1,0.978957812349059,0,3,mitochondrial mRNA catabolic process,BP,
349,GO:0000959,1,0.774225556565664,0,41,mitochondrial RNA metabolic process,BP,
350,GO:0000960,1,0.971747512897638,0,4,regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000961,1,0.985149737165208,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000962,1,0.986397853053107,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000963,1,0.91189670552672,0,16,mitochondrial RNA processing,BP,
354,GO:0000964,1,0.976446343633515,0,4,mitochondrial RNA 5'-end processing,BP,
355,GO:0000965,1,0.971401561603778,0,5,mitochondrial RNA 3'-end processing,BP,
356,GO:0000966,1,0.888844307994021,0,21,RNA 5'-end processing,BP,
357,GO:0000967,1,0.978673265681607,0,3,rRNA 5'-end processing,BP,
358,GO:0000972,1,0.956997845073708,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000973,1,0.981048594635229,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000974,1,0.929273617633372,0,13,Prp19 complex,CC,
364,GO:0000979,1,0.797652200918848,0,36,RNA polymerase II core promoter sequence-specific DNA binding,MF,
368,GO:0000983,1,0.862155072511093,0,21,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
372,GO:0000990,1,0.943204559182091,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.98845148369923,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.985773547405259,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.836256567187999,0,28,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.995797045269469,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.967553746014943,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0001002,1,0.985773547405259,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
379,GO:0001003,1,0.985773547405259,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
380,GO:0001007,1,0.969813718220862,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
381,GO:0001010,1,0.876023813942191,0,19,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001011,1,0.991187848886634,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
384,GO:0001013,1,0.948709210911273,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001016,1,0.957438886270538,0,7,RNA polymerase III regulatory region DNA binding,MF,
386,GO:0001018,1,0.988242068045589,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
387,GO:0001025,1,0.973078837108664,0,3,RNA polymerase III transcription factor binding,MF,
388,GO:0001026,1,0.982596780243472,0,2,TFIIIB-type transcription factor activity,MF,
389,GO:0001030,1,0.964828334589093,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
390,GO:0001031,1,0.964828334589093,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
391,GO:0001032,1,0.974180060139948,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001034,1,0.995738068414682,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
393,GO:0001042,1,0.962269624746098,0,5,RNA polymerase I core binding,MF,
394,GO:0001046,1,0.562907490374479,0,85,core promoter sequence-specific DNA binding,MF,
396,GO:0001054,1,0.946019188402609,0,11,RNA polymerase I activity,MF,
397,GO:0001055,1,0.948950683183825,0,11,RNA polymerase II activity,MF,
398,GO:0001056,1,0.925273624165444,0,15,RNA polymerase III activity,MF,
400,GO:0001069,1,0.984665541513533,0,2,regulatory region RNA binding,MF,
401,GO:0001074,1,0.993709469022338,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
402,GO:0001075,1,0.949117362056426,0,7,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
404,GO:0001077,1,0.180329799481165,0,259,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,
406,GO:0001079,1,0.994866756232826,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
407,GO:0001080,1,0.994866756232826,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
408,GO:0001083,1,0.957064060124271,0,6,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
409,GO:0001084,1,0.993709469022338,0,1,transcription factor activity, TFIID-class binding,MF,
410,GO:0001085,1,0.411901981023648,0,138,RNA polymerase II transcription factor binding,MF,
411,GO:0001087,1,0.991187848886634,0,1,transcription factor activity, TFIIB-class binding,MF,
412,GO:0001091,1,0.902994640812314,0,16,RNA polymerase II basal transcription factor binding,MF,
413,GO:0001093,1,0.97896366416549,0,3,TFIIB-class transcription factor binding,MF,
414,GO:0001094,1,0.947413390581167,0,9,TFIID-class transcription factor binding,MF,
415,GO:0001096,1,0.99249004022242,0,1,TFIIF-class transcription factor binding,MF,
416,GO:0001097,1,0.980997453851466,0,3,TFIIH-class transcription factor binding,MF,
417,GO:0001098,1,0.764219368808421,0,43,basal transcription machinery binding,MF,
418,GO:0001099,1,0.764219368808421,0,43,basal RNA polymerase II transcription machinery binding,MF,
419,GO:0001100,1,0.993301131169352,0,1,negative regulation of exit from mitosis,BP,
421,GO:0001102,1,0.739312227447651,0,47,RNA polymerase II activating transcription factor binding,MF,
422,GO:0001103,1,0.818096313870136,0,32,RNA polymerase II repressing transcription factor binding,MF,
423,GO:0001104,1,0.509696887046326,0,101,RNA polymerase II transcription cofactor activity,MF,
424,GO:0001105,1,0.743058179997521,0,43,RNA polymerase II transcription coactivator activity,MF,
425,GO:0001106,1,0.832188455316897,0,28,RNA polymerase II transcription corepressor activity,MF,
426,GO:0001112,1,0.992890599892214,0,1,DNA-templated transcriptional open complex formation,BP,
427,GO:0001113,1,0.992890599892214,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
428,GO:0001120,1,0.992890599892214,0,1,protein-DNA complex remodeling,BP,
429,GO:0001128,1,0.996535056442991,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
430,GO:0001129,1,0.971690218907419,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
431,GO:0001132,1,0.971690218907419,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
432,GO:0001133,1,0.882180851444252,0,18,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
433,GO:0001134,1,0.820104161251443,0,28,transcription factor activity, transcription factor recruiting,MF,
434,GO:0001135,1,0.949919318425771,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
435,GO:0001147,1,0.982681486952745,0,2,transcription termination site sequence-specific DNA binding,MF,
436,GO:0001156,1,0.973078837108664,0,3,TFIIIC-class transcription factor binding,MF,
438,GO:0001160,1,0.982681486952745,0,2,transcription termination site DNA binding,MF,
439,GO:0001161,1,0.927804422411504,0,12,intronic transcription regulatory region sequence-specific DNA binding,MF,
440,GO:0001162,1,0.93989269289584,0,10,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
441,GO:0001163,1,0.948709210911273,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
442,GO:0001164,1,0.948709210911273,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
443,GO:0001165,1,0.99238545082059,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
444,GO:0001172,1,0.984328801280324,0,2,transcription, RNA-templated,BP,
445,GO:0001179,1,0.995607336243042,0,1,RNA polymerase I transcription factor binding,MF,
446,GO:0001181,1,0.992477684421548,0,1,transcription factor activity, core RNA polymerase I binding,MF,
447,GO:0001188,1,0.948709210911273,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
449,GO:0001191,1,0.746479936338536,0,46,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
450,GO:0001192,1,0.996948110285361,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
451,GO:0001193,1,0.996948110285361,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
452,GO:0001205,1,0.826248613846464,0,30,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
454,GO:0001221,1,0.755267442158129,0,40,transcription cofactor binding,MF,
455,GO:0001222,1,0.913268854059059,0,14,transcription corepressor binding,MF,
456,GO:0001223,1,0.863535788359587,0,20,transcription coactivator binding,MF,
457,GO:0001224,1,0.975884572426849,0,3,RNA polymerase II transcription cofactor binding,MF,
458,GO:0001225,1,0.98311666368505,0,2,RNA polymerase II transcription coactivator binding,MF,
459,GO:0001226,1,0.992645008216672,0,1,RNA polymerase II transcription corepressor binding,MF,
461,GO:0001228,1,0.0808963258631829,0,383,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,
462,GO:0001300,1,0.985574263538245,0,2,chronological cell aging,BP,
463,GO:0001302,1,0.96280909186578,0,6,replicative cell aging,BP,
464,GO:0001306,1,0.996853128847878,0,1,age-dependent response to oxidative stress,BP,
465,GO:0001315,1,0.996853128847878,0,1,age-dependent response to reactive oxygen species,BP,
466,GO:0001325,1,0.903235796433306,0,14,formation of extrachromosomal circular DNA,BP,
467,GO:0001401,1,0.988491379014274,0,2,mitochondrial sorting and assembly machinery complex,CC,
468,GO:0001405,1,0.972112404210505,0,5,presequence translocase-associated import motor,CC,
470,GO:0001502,1,0.899702310139432,0,17,cartilage condensation,BP,
472,GO:0001504,1,0.822152712458851,0,30,neurotransmitter uptake,BP,
473,GO:0001505,1,0.150711204272041,0,285,regulation of neurotransmitter levels,BP,
474,GO:0001507,1,0.98668712770664,0,2,acetylcholine catabolic process in synaptic cleft,BP,
476,GO:0001510,1,0.706291871754177,0,57,RNA methylation,BP,
477,GO:0001512,1,0.996756579508189,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
478,GO:0001514,1,0.951254440591269,0,8,selenocysteine incorporation,BP,
479,GO:0001515,1,0.98255981321725,0,4,opioid peptide activity,MF,
480,GO:0001516,1,0.893556094845033,0,22,prostaglandin biosynthetic process,BP,
481,GO:0001517,1,0.957579489164806,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
482,GO:0001518,1,0.892920903105527,0,14,voltage-gated sodium channel complex,CC,
483,GO:0001519,1,0.992481381771526,0,1,peptide amidation,BP,
484,GO:0001520,1,0.981465578053214,0,3,outer dense fiber,CC,
485,GO:0001522,1,0.916568346667559,0,18,pseudouridine synthesis,BP,
488,GO:0001527,1,0.931445732299011,0,10,microfibril,CC,
489,GO:0001530,1,0.882366762117606,0,23,lipopolysaccharide binding,MF,
490,GO:0001532,1,0.992661300941135,0,1,interleukin-21 receptor activity,MF,
492,GO:0001534,1,0.972666032720735,0,4,radial spoke,CC,
493,GO:0001536,1,0.979222317535912,0,3,radial spoke stalk,CC,
494,GO:0001537,1,0.972293957708348,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
496,GO:0001540,1,0.705646565855915,0,55,amyloid-beta binding,MF,
497,GO:0001541,1,0.736144656295847,0,49,ovarian follicle development,BP,
498,GO:0001542,1,0.933403111650167,0,9,ovulation from ovarian follicle,BP,
499,GO:0001543,1,0.991480075983204,0,1,ovarian follicle rupture,BP,
500,GO:0001544,1,0.991561935059876,0,1,initiation of primordial ovarian follicle growth,BP,
501,GO:0001545,1,0.992454087486977,0,1,primary ovarian follicle growth,BP,
502,GO:0001546,1,0.985738965468846,0,3,preantral ovarian follicle growth,BP,
503,GO:0001547,1,0.959537741783612,0,6,antral ovarian follicle growth,BP,
504,GO:0001550,1,0.98457959068172,0,2,ovarian cumulus expansion,BP,
505,GO:0001552,1,0.995412128310007,0,1,ovarian follicle atresia,BP,
507,GO:0001554,1,0.962226516794679,0,5,luteolysis,BP,
508,GO:0001555,1,0.981688338045716,0,3,oocyte growth,BP,
509,GO:0001556,1,0.883997097572325,0,20,oocyte maturation,BP,
511,GO:0001560,1,0.976139880756445,0,3,regulation of cell growth by extracellular stimulus,BP,
512,GO:0001561,1,0.957267068134637,0,8,fatty acid alpha-oxidation,BP,
513,GO:0001562,1,0.902999499629886,0,20,response to protozoan,BP,
514,GO:0001567,1,0.996501600474205,0,1,cholesterol 25-hydroxylase activity,MF,
516,GO:0001569,1,0.818724235332289,0,31,branching involved in blood vessel morphogenesis,BP,
517,GO:0001570,1,0.608003397532351,0,73,vasculogenesis,BP,
518,GO:0001572,1,0.992338946920648,0,1,lactosylceramide biosynthetic process,BP,
519,GO:0001573,1,0.89901053574308,0,17,ganglioside metabolic process,BP,
520,GO:0001574,1,0.939246905242183,0,10,ganglioside biosynthetic process,BP,
521,GO:0001575,1,0.990552614385026,0,2,globoside metabolic process,BP,
522,GO:0001576,1,0.995027959827431,0,1,globoside biosynthetic process,BP,
523,GO:0001578,1,0.585993527267002,0,78,microtubule bundle formation,BP,
524,GO:0001579,1,0.985565026435752,0,2,medium-chain fatty acid transport,BP,
525,GO:0001580,1,0.916824503797552,0,21,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
526,GO:0001581,1,0.992854331384343,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
527,GO:0001582,1,0.993782080934776,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
528,GO:0001587,1,0.99235290429817,0,1,Gq/11-coupled serotonin receptor activity,MF,
529,GO:0001588,1,0.980206755613546,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
530,GO:0001591,1,0.983692881862545,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
531,GO:0001595,1,0.987919446556528,0,3,angiotensin receptor activity,MF,
532,GO:0001596,1,0.994386584782081,0,1,angiotensin type I receptor activity,MF,
533,GO:0001601,1,0.981605098878751,0,3,peptide YY receptor activity,MF,
534,GO:0001602,1,0.975990597221149,0,5,pancreatic polypeptide receptor activity,MF,
535,GO:0001604,1,0.99307631633318,0,2,urotensin II receptor activity,MF,
536,GO:0001605,1,0.985886265503875,0,3,adrenomedullin receptor activity,MF,
537,GO:0001607,1,0.987791087929186,0,2,neuromedin U receptor activity,MF,
538,GO:0001608,1,0.935206137259947,0,13,G-protein coupled nucleotide receptor activity,MF,
539,GO:0001609,1,0.967435623150911,0,6,G-protein coupled adenosine receptor activity,MF,
540,GO:0001614,1,0.900165288446963,0,20,purinergic nucleotide receptor activity,MF,
542,GO:0001621,1,0.996340169893696,0,1,ADP receptor activity,MF,
543,GO:0001626,1,0.992653386403797,0,1,nociceptin receptor activity,MF,
544,GO:0001631,1,0.970021944989149,0,6,cysteinyl leukotriene receptor activity,MF,
545,GO:0001632,1,0.988877956716705,0,2,leukotriene B4 receptor activity,MF,
546,GO:0001635,1,0.98277440592865,0,3,calcitonin gene-related peptide receptor activity,MF,
547,GO:0001637,1,0.873726272797162,0,24,G-protein coupled chemoattractant receptor activity,MF,
548,GO:0001640,1,0.954629857839462,0,6,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
549,GO:0001641,1,0.986070232978868,0,2,group II metabotropic glutamate receptor activity,MF,
550,GO:0001642,1,0.977075640234953,0,3,group III metabotropic glutamate receptor activity,MF,
552,GO:0001650,1,0.448809942724983,0,127,fibrillar center,CC,
553,GO:0001651,1,0.99673146754899,0,1,dense fibrillar component,CC,
554,GO:0001652,1,0.974886376506857,0,5,granular component,CC,
555,GO:0001653,1,0.525123693525516,0,118,peptide receptor activity,MF,
561,GO:0001659,1,0.79622850947619,0,36,temperature homeostasis,BP,
562,GO:0001660,1,0.940201420161667,0,10,fever generation,BP,
563,GO:0001661,1,0.96518751519984,0,5,conditioned taste aversion,BP,
566,GO:0001665,1,0.969344444464985,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
567,GO:0001666,1,0.135201800092171,0,324,response to hypoxia,BP,
569,GO:0001669,1,0.609115234896828,0,83,acrosomal vesicle,CC,
570,GO:0001671,1,0.865388784075665,0,26,ATPase activator activity,MF,
571,GO:0001672,1,0.935021688812924,0,9,regulation of chromatin assembly or disassembly,BP,
572,GO:0001673,1,0.935508622137157,0,11,male germ cell nucleus,CC,
573,GO:0001674,1,0.988913624321413,0,2,female germ cell nucleus,CC,
574,GO:0001675,1,0.943911846203237,0,8,acrosome assembly,BP,
576,GO:0001678,1,0.453909984831129,0,123,cellular glucose homeostasis,BP,
577,GO:0001680,1,0.994521917273774,0,1,tRNA 3'-terminal CCA addition,BP,
578,GO:0001681,1,0.993173986888723,0,1,sialate O-acetylesterase activity,MF,
579,GO:0001682,1,0.941579181933288,0,12,tRNA 5'-leader removal,BP,
580,GO:0001692,1,0.986398643414964,0,3,histamine metabolic process,BP,
581,GO:0001694,1,0.994159629741388,0,1,histamine biosynthetic process,BP,
582,GO:0001695,1,0.996930452377055,0,1,histamine catabolic process,BP,
583,GO:0001696,1,0.9098187827794,0,16,gastric acid secretion,BP,
584,GO:0001697,1,0.993214545325937,0,1,histamine-induced gastric acid secretion,BP,
585,GO:0001698,1,0.990305839034786,0,2,gastrin-induced gastric acid secretion,BP,
587,GO:0001702,1,0.834421855117614,0,25,gastrulation with mouth forming second,BP,
590,GO:0001706,1,0.700528733897462,0,53,endoderm formation,BP,
593,GO:0001709,1,0.790548451918349,0,37,cell fate determination,BP,
595,GO:0001711,1,0.914455019606173,0,15,endodermal cell fate commitment,BP,
597,GO:0001714,1,0.960004165076267,0,8,endodermal cell fate specification,BP,
599,GO:0001716,1,0.99511690002609,0,1,L-amino-acid oxidase activity,MF,
600,GO:0001725,1,0.692427456483193,0,52,stress fiber,CC,
601,GO:0001726,1,0.333940342083334,0,157,ruffle,CC,
602,GO:0001727,1,0.965925487744573,0,5,lipid kinase activity,MF,
603,GO:0001729,1,0.985482814607898,0,2,ceramide kinase activity,MF,
604,GO:0001730,1,0.976691581875759,0,4,2'-5'-oligoadenylate synthetase activity,MF,
605,GO:0001731,1,0.947005245411244,0,8,formation of translation preinitiation complex,BP,
606,GO:0001732,1,0.987616714186131,0,2,formation of cytoplasmic translation initiation complex,BP,
607,GO:0001733,1,0.978792279874015,0,4,galactosylceramide sulfotransferase activity,MF,
608,GO:0001735,1,0.986042984025935,0,2,prenylcysteine oxidase activity,MF,
611,GO:0001739,1,0.971305872807685,0,5,sex chromatin,CC,
612,GO:0001740,1,0.981389741569641,0,3,Barr body,CC,
613,GO:0001741,1,0.93082534480536,0,12,XY body,CC,
614,GO:0001743,1,0.977320164708511,0,3,optic placode formation,BP,
615,GO:0001750,1,0.644528813043634,0,66,photoreceptor outer segment,CC,
616,GO:0001754,1,0.770644492173716,0,38,eye photoreceptor cell differentiation,BP,
619,GO:0001757,1,0.971073777176277,0,5,somite specification,BP,
620,GO:0001758,1,0.964281987265002,0,7,retinal dehydrogenase activity,MF,
621,GO:0001759,1,0.902544945934381,0,18,organ induction,BP,
624,GO:0001765,1,0.949683380824627,0,9,membrane raft assembly,BP,
626,GO:0001767,1,0.936598678995427,0,10,establishment of lymphocyte polarity,BP,
627,GO:0001768,1,0.944495515387936,0,9,establishment of T cell polarity,BP,
628,GO:0001770,1,0.99164404293775,0,1,establishment of natural killer cell polarity,BP,
629,GO:0001771,1,0.923956352597196,0,13,immunological synapse formation,BP,
630,GO:0001772,1,0.824483662057563,0,32,immunological synapse,CC,
631,GO:0001773,1,0.88545241022224,0,24,myeloid dendritic cell activation,BP,
632,GO:0001774,1,0.848804925364611,0,25,microglial cell activation,BP,
634,GO:0001776,1,0.611430249387467,0,80,leukocyte homeostasis,BP,
635,GO:0001777,1,0.9863559616253,0,3,T cell homeostatic proliferation,BP,
636,GO:0001778,1,0.963461323871082,0,5,plasma membrane repair,BP,
638,GO:0001780,1,0.909433841454173,0,14,neutrophil homeostasis,BP,
639,GO:0001781,1,0.957402772470786,0,7,neutrophil apoptotic process,BP,
640,GO:0001782,1,0.838257509354382,0,28,B cell homeostasis,BP,
641,GO:0001783,1,0.873506271957209,0,22,B cell apoptotic process,BP,
642,GO:0001784,1,0.782474530683587,0,35,phosphotyrosine residue binding,MF,
643,GO:0001785,1,0.986366618018412,0,2,prostaglandin J receptor activity,MF,
645,GO:0001787,1,0.960409354721794,0,7,natural killer cell proliferation,BP,
646,GO:0001788,1,0.996140606907986,0,1,antibody-dependent cellular cytotoxicity,BP,
647,GO:0001791,1,0.995899685542201,0,1,IgM binding,MF,
648,GO:0001792,1,0.992432376350149,0,1,polymeric immunoglobulin receptor activity,MF,
649,GO:0001794,1,0.98552060644908,0,3,type IIa hypersensitivity,BP,
650,GO:0001796,1,0.98552060644908,0,3,regulation of type IIa hypersensitivity,BP,
651,GO:0001797,1,0.996140606907986,0,1,negative regulation of type IIa hypersensitivity,BP,
652,GO:0001798,1,0.989339282133525,0,2,positive regulation of type IIa hypersensitivity,BP,
653,GO:0001802,1,0.990697947127855,0,2,type III hypersensitivity,BP,
654,GO:0001803,1,0.990697947127855,0,2,regulation of type III hypersensitivity,BP,
655,GO:0001805,1,0.990697947127855,0,2,positive regulation of type III hypersensitivity,BP,
656,GO:0001806,1,0.984552764988858,0,3,type IV hypersensitivity,BP,
657,GO:0001807,1,0.991645711137292,0,2,regulation of type IV hypersensitivity,BP,
658,GO:0001808,1,0.995152468087667,0,1,negative regulation of type IV hypersensitivity,BP,
659,GO:0001809,1,0.996476339746668,0,1,positive regulation of type IV hypersensitivity,BP,
660,GO:0001810,1,0.986874081729062,0,3,regulation of type I hypersensitivity,BP,
661,GO:0001811,1,0.996140606907986,0,1,negative regulation of type I hypersensitivity,BP,
662,GO:0001812,1,0.990697947127855,0,2,positive regulation of type I hypersensitivity,BP,
663,GO:0001813,1,0.996140606907986,0,1,regulation of antibody-dependent cellular cytotoxicity,BP,
664,GO:0001814,1,0.996140606907986,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
669,GO:0001820,1,0.946469211698272,0,10,serotonin secretion,BP,
670,GO:0001821,1,0.953894509054094,0,9,histamine secretion,BP,
673,GO:0001824,1,0.715923468100486,0,54,blastocyst development,BP,
674,GO:0001825,1,0.856916279990303,0,25,blastocyst formation,BP,
675,GO:0001826,1,0.95631938503773,0,6,inner cell mass cell differentiation,BP,
676,GO:0001827,1,0.984558513223269,0,2,inner cell mass cell fate commitment,BP,
677,GO:0001828,1,0.978977876258557,0,3,inner cell mass cellular morphogenesis,BP,
678,GO:0001829,1,0.928794311698124,0,12,trophectodermal cell differentiation,BP,
679,GO:0001831,1,0.986827805496353,0,2,trophectodermal cellular morphogenesis,BP,
680,GO:0001832,1,0.893261714359605,0,16,blastocyst growth,BP,
681,GO:0001833,1,0.925479753760886,0,11,inner cell mass cell proliferation,BP,
682,GO:0001834,1,0.984941644625849,0,2,trophectodermal cell proliferation,BP,
683,GO:0001835,1,0.992673220942937,0,1,blastocyst hatching,BP,
687,GO:0001839,1,0.962904467419536,0,6,neural plate morphogenesis,BP,
688,GO:0001840,1,0.939828990630987,0,9,neural plate development,BP,
690,GO:0001842,1,0.959483361520454,0,7,neural fold formation,BP,
692,GO:0001844,1,0.834884399579454,0,32,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
693,GO:0001845,1,0.931193203637218,0,12,phagolysosome assembly,BP,
694,GO:0001846,1,0.925353874729026,0,12,opsonin binding,MF,
695,GO:0001847,1,0.974852361916547,0,4,opsonin receptor activity,MF,
696,GO:0001848,1,0.906826465408153,0,15,complement binding,MF,
697,GO:0001849,1,0.96356230998973,0,6,complement component C1q binding,MF,
698,GO:0001850,1,0.995684485069618,0,1,complement component C3a binding,MF,
699,GO:0001851,1,0.972124284366843,0,4,complement component C3b binding,MF,
700,GO:0001855,1,0.987009019374987,0,2,complement component C4b binding,MF,
701,GO:0001856,1,0.9943542605683,0,1,complement component C5a binding,MF,
702,GO:0001861,1,0.990796430774423,0,1,complement component C4b receptor activity,MF,
703,GO:0001865,1,0.947338423037602,0,8,NK T cell differentiation,BP,
704,GO:0001866,1,0.974863078503959,0,5,NK T cell proliferation,BP,
705,GO:0001867,1,0.954798206286033,0,9,complement activation, lectin pathway,BP,
706,GO:0001868,1,0.987932317658328,0,2,regulation of complement activation, lectin pathway,BP,
707,GO:0001869,1,0.987932317658328,0,2,negative regulation of complement activation, lectin pathway,BP,
709,GO:0001872,1,0.99542713020967,0,1,(1->3)-beta-D-glucan binding,MF,
710,GO:0001875,1,0.968092835256802,0,5,lipopolysaccharide receptor activity,MF,
711,GO:0001878,1,0.979629522740005,0,4,response to yeast,BP,
712,GO:0001880,1,0.979523660115494,0,3,Mullerian duct regression,BP,
716,GO:0001884,1,0.985988118280085,0,2,pyrimidine nucleoside binding,MF,
718,GO:0001886,1,0.932957326547316,0,10,endothelial cell morphogenesis,BP,
719,GO:0001887,1,0.967724674021265,0,5,selenium compound metabolic process,BP,
720,GO:0001888,1,0.985134791749837,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
723,GO:0001891,1,0.878371393210962,0,21,phagocytic cup,CC,
728,GO:0001897,1,0.988076646067103,0,2,cytolysis by symbiont of host cells,BP,
729,GO:0001905,1,0.976382719173198,0,3,activation of membrane attack complex,BP,
731,GO:0001907,1,0.973993419349311,0,5,killing by symbiont of host cells,BP,
734,GO:0001911,1,0.925428674442306,0,14,negative regulation of leukocyte mediated cytotoxicity,BP,
736,GO:0001913,1,0.867544817701088,0,27,T cell mediated cytotoxicity,BP,
737,GO:0001914,1,0.901966354769437,0,20,regulation of T cell mediated cytotoxicity,BP,
738,GO:0001915,1,0.963168370158895,0,6,negative regulation of T cell mediated cytotoxicity,BP,
739,GO:0001916,1,0.944030012656917,0,12,positive regulation of T cell mediated cytotoxicity,BP,
740,GO:0001917,1,0.784876121776392,0,36,photoreceptor inner segment,CC,
742,GO:0001920,1,0.974367218095654,0,4,negative regulation of receptor recycling,BP,
744,GO:0001922,1,0.977162037005178,0,3,B-1 B cell homeostasis,BP,
745,GO:0001923,1,0.981443587052581,0,3,B-1 B cell differentiation,BP,
746,GO:0001927,1,0.979390444312847,0,3,exocyst assembly,BP,
747,GO:0001928,1,0.994570809837383,0,1,regulation of exocyst assembly,BP,
748,GO:0001931,1,0.922182548538408,0,13,uropod,CC,
755,GO:0001938,1,0.600814600171977,0,78,positive regulation of endothelial cell proliferation,BP,
756,GO:0001939,1,0.960215511614116,0,6,female pronucleus,CC,
757,GO:0001940,1,0.965099062568929,0,5,male pronucleus,CC,
758,GO:0001941,1,0.786005186326654,0,35,postsynaptic membrane organization,BP,
761,GO:0001945,1,0.843200035571139,0,24,lymph vessel development,BP,
762,GO:0001946,1,0.899837698963034,0,15,lymphangiogenesis,BP,
765,GO:0001951,1,0.971228132028924,0,4,intestinal D-glucose absorption,BP,
768,GO:0001954,1,0.740976726312679,0,45,positive regulation of cell-matrix adhesion,BP,
769,GO:0001955,1,0.948099950242726,0,8,blood vessel maturation,BP,
770,GO:0001956,1,0.913288788835954,0,13,positive regulation of neurotransmitter secretion,BP,
771,GO:0001957,1,0.961353436737417,0,6,intramembranous ossification,BP,
772,GO:0001958,1,0.845696207630088,0,25,endochondral ossification,BP,
773,GO:0001959,1,0.416770921414983,0,143,regulation of cytokine-mediated signaling pathway,BP,
774,GO:0001960,1,0.777079265896643,0,44,negative regulation of cytokine-mediated signaling pathway,BP,
775,GO:0001961,1,0.764918867972742,0,44,positive regulation of cytokine-mediated signaling pathway,BP,
777,GO:0001964,1,0.845956521420216,0,24,startle response,BP,
779,GO:0001966,1,0.996517200073745,0,1,thigmotaxis,BP,
780,GO:0001967,1,0.927517284200503,0,11,suckling behavior,BP,
781,GO:0001968,1,0.839702922001244,0,25,fibronectin binding,MF,
782,GO:0001969,1,0.976382719173198,0,3,regulation of activation of membrane attack complex,BP,
783,GO:0001970,1,0.984815103457236,0,2,positive regulation of activation of membrane attack complex,BP,
784,GO:0001971,1,0.991438953408975,0,1,negative regulation of activation of membrane attack complex,BP,
785,GO:0001972,1,0.927769499902975,0,12,retinoic acid binding,MF,
787,GO:0001974,1,0.768279360677101,0,39,blood vessel remodeling,BP,
788,GO:0001975,1,0.855095323073107,0,24,response to amphetamine,BP,
789,GO:0001976,1,0.934484858843745,0,11,neurological system process involved in regulation of systemic arterial blood pressure,BP,
791,GO:0001978,1,0.9947760239733,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
792,GO:0001979,1,0.995962037024349,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
793,GO:0001980,1,0.996963535337559,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
794,GO:0001983,1,0.9947760239733,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
795,GO:0001985,1,0.9947760239733,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
796,GO:0001990,1,0.835630278498549,0,30,regulation of systemic arterial blood pressure by hormone,BP,
797,GO:0001991,1,0.915748507135671,0,14,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
798,GO:0001992,1,0.975466908804614,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
799,GO:0001993,1,0.947365498875435,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
800,GO:0001994,1,0.977361591518498,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
801,GO:0001996,1,0.975191748266032,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
802,GO:0001997,1,0.98796268130764,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
803,GO:0001998,1,0.995466866228212,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
804,GO:0001999,1,0.97177013675995,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
805,GO:0002001,1,0.97177013675995,0,4,renin secretion into blood stream,BP,
806,GO:0002002,1,0.942367634545419,0,10,regulation of angiotensin levels in blood,BP,
807,GO:0002003,1,0.942367634545419,0,10,angiotensin maturation,BP,
808,GO:0002007,1,0.995962037024349,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
810,GO:0002011,1,0.703485200218711,0,50,morphogenesis of an epithelial sheet,BP,
811,GO:0002016,1,0.963500957662851,0,6,regulation of blood volume by renin-angiotensin,BP,
812,GO:0002017,1,0.995561971803455,0,1,regulation of blood volume by renal aldosterone,BP,
813,GO:0002018,1,0.988154894689267,0,2,renin-angiotensin regulation of aldosterone production,BP,
814,GO:0002019,1,0.983445644859308,0,3,regulation of renal output by angiotensin,BP,
816,GO:0002021,1,0.888885526607916,0,19,response to dietary excess,BP,
817,GO:0002023,1,0.9950970686153,0,1,reduction of food intake in response to dietary excess,BP,
818,GO:0002024,1,0.952142173212454,0,8,diet induced thermogenesis,BP,
819,GO:0002025,1,0.98201111752564,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
820,GO:0002026,1,0.850165552886093,0,25,regulation of the force of heart contraction,BP,
823,GO:0002029,1,0.915075993348481,0,16,desensitization of G-protein coupled receptor protein signaling pathway,BP,
824,GO:0002030,1,0.993071618371732,0,1,inhibitory G-protein coupled receptor phosphorylation,BP,
825,GO:0002031,1,0.930437382485186,0,13,G-protein coupled receptor internalization,BP,
826,GO:0002032,1,0.990688421386054,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
827,GO:0002034,1,0.978309370194986,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
828,GO:0002035,1,0.979079518795309,0,3,brain renin-angiotensin system,BP,
829,GO:0002036,1,0.966549316254351,0,5,regulation of L-glutamate import across plasma membrane,BP,
830,GO:0002037,1,0.994934170977434,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
831,GO:0002038,1,0.994551789174507,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
832,GO:0002039,1,0.63138369804809,0,68,p53 binding,MF,
834,GO:0002041,1,0.994481228676278,0,1,intussusceptive angiogenesis,BP,
837,GO:0002046,1,0.996886610073032,0,1,opsin binding,MF,
838,GO:0002051,1,0.968564439296944,0,4,osteoblast fate commitment,BP,
840,GO:0002053,1,0.827752696722683,0,27,positive regulation of mesenchymal cell proliferation,BP,
841,GO:0002054,1,0.979478020455305,0,4,nucleobase binding,MF,
842,GO:0002055,1,0.997009080962846,0,1,adenine binding,MF,
843,GO:0002058,1,0.994926097674938,0,1,uracil binding,MF,
844,GO:0002059,1,0.994926097674938,0,1,thymine binding,MF,
845,GO:0002060,1,0.98447395839729,0,3,purine nucleobase binding,MF,
846,GO:0002061,1,0.994926097674938,0,1,pyrimidine nucleobase binding,MF,
848,GO:0002063,1,0.846772378761682,0,23,chondrocyte development,BP,
850,GO:0002065,1,0.523820495819081,0,99,columnar/cuboidal epithelial cell differentiation,BP,
851,GO:0002066,1,0.715511403739889,0,51,columnar/cuboidal epithelial cell development,BP,
852,GO:0002067,1,0.756708249423239,0,43,glandular epithelial cell differentiation,BP,
853,GO:0002068,1,0.857081246128021,0,23,glandular epithelial cell development,BP,
854,GO:0002069,1,0.969848756105784,0,6,columnar/cuboidal epithelial cell maturation,BP,
856,GO:0002071,1,0.989586687921893,0,2,glandular epithelial cell maturation,BP,
857,GO:0002072,1,0.938518694563023,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
858,GO:0002074,1,0.964220227309746,0,5,extraocular skeletal muscle development,BP,
859,GO:0002076,1,0.895211488830698,0,17,osteoblast development,BP,
860,GO:0002077,1,0.996505525970935,0,1,acrosome matrix dispersal,BP,
861,GO:0002079,1,0.974547595214203,0,4,inner acrosomal membrane,CC,
862,GO:0002080,1,0.895756015418521,0,18,acrosomal membrane,CC,
863,GO:0002081,1,0.984636749607812,0,2,outer acrosomal membrane,CC,
864,GO:0002082,1,0.914650455885016,0,15,regulation of oxidative phosphorylation,BP,
865,GO:0002083,1,0.996075538658658,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
866,GO:0002084,1,0.948786468924139,0,9,protein depalmitoylation,BP,
867,GO:0002085,1,0.975083806164091,0,4,inhibition of neuroepithelial cell differentiation,BP,
868,GO:0002086,1,0.989551421677564,0,2,diaphragm contraction,BP,
869,GO:0002087,1,0.924160962255975,0,12,regulation of respiratory gaseous exchange by neurological system process,BP,
871,GO:0002089,1,0.886819499568699,0,16,lens morphogenesis in camera-type eye,BP,
873,GO:0002091,1,0.945087008770187,0,9,negative regulation of receptor internalization,BP,
875,GO:0002093,1,0.923461089994075,0,12,auditory receptor cell morphogenesis,BP,
876,GO:0002094,1,0.988742690581053,0,2,polyprenyltransferase activity,MF,
877,GO:0002097,1,0.910819555154632,0,16,tRNA wobble base modification,BP,
878,GO:0002098,1,0.934429726807513,0,12,tRNA wobble uridine modification,BP,
879,GO:0002100,1,0.991925574439524,0,1,tRNA wobble adenosine to inosine editing,BP,
880,GO:0002101,1,0.982686759299049,0,3,tRNA wobble cytosine modification,BP,
881,GO:0002102,1,0.799181346120542,0,32,podosome,CC,
882,GO:0002113,1,0.994494784777485,0,1,interleukin-33 binding,MF,
883,GO:0002114,1,0.987007597854961,0,2,interleukin-33 receptor activity,MF,
884,GO:0002115,1,0.90156557779689,0,16,store-operated calcium entry,BP,
885,GO:0002116,1,0.914059334667212,0,11,semaphorin receptor complex,CC,
886,GO:0002118,1,0.956207830898487,0,7,aggressive behavior,BP,
887,GO:0002121,1,0.985363919126716,0,2,inter-male aggressive behavior,BP,
888,GO:0002125,1,0.988137658278571,0,2,maternal aggressive behavior,BP,
889,GO:0002127,1,0.996413716674221,0,1,tRNA wobble base cytosine methylation,BP,
890,GO:0002133,1,0.980858613905767,0,2,polycystin complex,CC,
891,GO:0002134,1,0.985988118280085,0,2,UTP binding,MF,
892,GO:0002135,1,0.993816488377012,0,1,CTP binding,MF,
893,GO:0002138,1,0.955557741945568,0,8,retinoic acid biosynthetic process,BP,
894,GO:0002139,1,0.969694434595914,0,4,stereocilia coupling link,CC,
895,GO:0002140,1,0.991541698684007,0,1,stereocilia tip link,CC,
896,GO:0002141,1,0.977968294341,0,3,stereocilia ankle link,CC,
897,GO:0002142,1,0.977968294341,0,3,stereocilia ankle link complex,CC,
898,GO:0002143,1,0.980477560407312,0,4,tRNA wobble position uridine thiolation,BP,
899,GO:0002144,1,0.994987860626357,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
900,GO:0002148,1,0.992696090740811,0,1,hypochlorous acid metabolic process,BP,
901,GO:0002149,1,0.992696090740811,0,1,hypochlorous acid biosynthetic process,BP,
902,GO:0002151,1,0.953985513675647,0,6,G-quadruplex RNA binding,MF,
903,GO:0002152,1,0.992567525681996,0,1,bile acid conjugation,BP,
904,GO:0002153,1,0.994134617520726,0,1,steroid receptor RNA activator RNA binding,MF,
905,GO:0002154,1,0.963920051855835,0,5,thyroid hormone mediated signaling pathway,BP,
906,GO:0002155,1,0.980751274319879,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
908,GO:0002159,1,0.969602197840025,0,4,desmosome assembly,BP,
909,GO:0002161,1,0.929127769016286,0,11,aminoacyl-tRNA editing activity,MF,
910,GO:0002162,1,0.940962844006636,0,8,dystroglycan binding,MF,
911,GO:0002169,1,0.986346342231241,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
912,GO:0002174,1,0.993022200579954,0,1,mammary stem cell proliferation,BP,
914,GO:0002176,1,0.971923367194414,0,6,male germ cell proliferation,BP,
915,GO:0002177,1,0.962508457513235,0,7,manchette,CC,
916,GO:0002178,1,0.936212591480421,0,11,palmitoyltransferase complex,CC,
917,GO:0002181,1,0.664552284758556,0,84,cytoplasmic translation,BP,
918,GO:0002182,1,0.936145871435898,0,10,cytoplasmic translational elongation,BP,
919,GO:0002183,1,0.895747189257387,0,18,cytoplasmic translational initiation,BP,
920,GO:0002184,1,0.984855866809551,0,2,cytoplasmic translational termination,BP,
921,GO:0002188,1,0.975902563646034,0,3,translation reinitiation,BP,
922,GO:0002189,1,0.993835050519025,0,1,ribose phosphate diphosphokinase complex,CC,
923,GO:0002190,1,0.977284380994935,0,5,cap-independent translational initiation,BP,
924,GO:0002191,1,0.983179997109181,0,3,cap-dependent translational initiation,BP,
925,GO:0002192,1,0.993040089609704,0,2,IRES-dependent translational initiation of linear mRNA,BP,
926,GO:0002193,1,0.977359378315815,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
927,GO:0002194,1,0.99284618617602,0,1,hepatocyte cell migration,BP,
928,GO:0002196,1,0.99551717899644,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
929,GO:0002199,1,0.957233332993563,0,8,zona pellucida receptor complex,CC,
930,GO:0002200,1,0.681277622264704,0,57,somatic diversification of immune receptors,BP,
931,GO:0002204,1,0.776966969547283,0,39,somatic recombination of immunoglobulin genes involved in immune response,BP,
932,GO:0002208,1,0.776966969547283,0,39,somatic diversification of immunoglobulins involved in immune response,BP,
934,GO:0002215,1,0.989518908128801,0,2,defense response to nematode,BP,
935,GO:0002218,1,0.195312390217674,0,265,activation of innate immune response,BP,
936,GO:0002220,1,0.537028773085914,0,110,innate immune response activating cell surface receptor signaling pathway,BP,
937,GO:0002221,1,0.355798334049271,0,161,pattern recognition receptor signaling pathway,BP,
938,GO:0002223,1,0.543758977124821,0,107,stimulatory C-type lectin receptor signaling pathway,BP,
939,GO:0002224,1,0.452489058500789,0,125,toll-like receptor signaling pathway,BP,
940,GO:0002225,1,0.991888295367153,0,2,positive regulation of antimicrobial peptide production,BP,
941,GO:0002227,1,0.943817490124835,0,15,innate immune response in mucosa,BP,
943,GO:0002230,1,0.87992129616625,0,21,positive regulation of defense response to virus by host,BP,
944,GO:0002232,1,0.990833063934843,0,2,leukocyte chemotaxis involved in inflammatory response,BP,
946,GO:0002238,1,0.985960988365223,0,2,response to molecule of fungal origin,BP,
948,GO:0002246,1,0.965945990295922,0,6,wound healing involved in inflammatory response,BP,
949,GO:0002248,1,0.969596004890436,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
950,GO:0002249,1,0.971761189568891,0,5,lymphocyte anergy,BP,
951,GO:0002250,1,0.152011703983468,0,311,adaptive immune response,BP,
952,GO:0002251,1,0.905039609122403,0,23,organ or tissue specific immune response,BP,
955,GO:0002254,1,0.984554078053798,0,3,kinin cascade,BP,
956,GO:0002260,1,0.698458456917842,0,60,lymphocyte homeostasis,BP,
957,GO:0002262,1,0.435610407135267,0,133,myeloid cell homeostasis,BP,
959,GO:0002265,1,0.972820530673087,0,3,astrocyte activation involved in immune response,BP,
960,GO:0002266,1,0.984658559200854,0,3,follicular dendritic cell activation,BP,
961,GO:0002268,1,0.988473929445262,0,2,follicular dendritic cell differentiation,BP,
964,GO:0002276,1,0.987450529762165,0,2,basophil activation involved in immune response,BP,
965,GO:0002277,1,0.984230563221586,0,3,myeloid dendritic cell activation involved in immune response,BP,
966,GO:0002278,1,0.978538247292134,0,4,eosinophil activation involved in immune response,BP,
968,GO:0002281,1,0.94505022598242,0,9,macrophage activation involved in immune response,BP,
969,GO:0002282,1,0.986354553987463,0,2,microglial cell activation involved in immune response,BP,
970,GO:0002283,1,0.0646438678161499,0,465,neutrophil activation involved in immune response,BP,
971,GO:0002285,1,0.431928308039271,0,132,lymphocyte activation involved in immune response,BP,
972,GO:0002286,1,0.631411705392282,0,73,T cell activation involved in immune response,BP,
973,GO:0002287,1,0.72565017686375,0,50,alpha-beta T cell activation involved in immune response,BP,
974,GO:0002290,1,0.993137509183141,0,1,gamma-delta T cell activation involved in immune response,BP,
975,GO:0002291,1,0.955905409832741,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
976,GO:0002292,1,0.704828199775334,0,55,T cell differentiation involved in immune response,BP,
977,GO:0002293,1,0.72565017686375,0,50,alpha-beta T cell differentiation involved in immune response,BP,
978,GO:0002294,1,0.730500417436018,0,49,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
979,GO:0002295,1,0.92514764891855,0,13,T-helper cell lineage commitment,BP,
980,GO:0002296,1,0.984236197557555,0,2,T-helper 1 cell lineage commitment,BP,
981,GO:0002298,1,0.99601637846675,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
982,GO:0002299,1,0.996217372547348,0,1,alpha-beta intraepithelial T cell differentiation,BP,
983,GO:0002300,1,0.996217372547348,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
984,GO:0002302,1,0.993381992170083,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
985,GO:0002304,1,0.996217372547348,0,1,gamma-delta intraepithelial T cell differentiation,BP,
986,GO:0002305,1,0.996217372547348,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
987,GO:0002309,1,0.979725648906655,0,4,T cell proliferation involved in immune response,BP,
988,GO:0002312,1,0.677872894207383,0,61,B cell activation involved in immune response,BP,
989,GO:0002313,1,0.904187378593343,0,17,mature B cell differentiation involved in immune response,BP,
990,GO:0002314,1,0.983106018564374,0,3,germinal center B cell differentiation,BP,
991,GO:0002315,1,0.937900455116539,0,9,marginal zone B cell differentiation,BP,
992,GO:0002316,1,0.988603210312126,0,2,follicular B cell differentiation,BP,
993,GO:0002317,1,0.988661004382408,0,3,plasma cell differentiation,BP,
994,GO:0002318,1,0.96527463325901,0,5,myeloid progenitor cell differentiation,BP,
995,GO:0002320,1,0.887937933780231,0,18,lymphoid progenitor cell differentiation,BP,
996,GO:0002322,1,0.965292709170312,0,5,B cell proliferation involved in immune response,BP,
997,GO:0002323,1,0.955050508631237,0,8,natural killer cell activation involved in immune response,BP,
998,GO:0002325,1,0.992968745186011,0,2,natural killer cell differentiation involved in immune response,BP,
999,GO:0002326,1,0.973952637638716,0,3,B cell lineage commitment,BP,
1000,GO:0002327,1,0.94381474862346,0,7,immature B cell differentiation,BP,
1001,GO:0002328,1,0.92862860429657,0,10,pro-B cell differentiation,BP,
1002,GO:0002329,1,0.966663472891003,0,4,pre-B cell differentiation,BP,
1003,GO:0002331,1,0.981924026557406,0,2,pre-B cell allelic exclusion,BP,
1004,GO:0002332,1,0.992119038566604,0,1,transitional stage B cell differentiation,BP,
1005,GO:0002333,1,0.992119038566604,0,1,transitional one stage B cell differentiation,BP,
1006,GO:0002335,1,0.880639441139238,0,21,mature B cell differentiation,BP,
1007,GO:0002337,1,0.98906975685714,0,2,B-1a B cell differentiation,BP,
1008,GO:0002339,1,0.985418661534531,0,3,B cell selection,BP,
1009,GO:0002343,1,0.993624508574376,0,1,peripheral B cell selection,BP,
1010,GO:0002344,1,0.993624508574376,0,1,B cell affinity maturation,BP,
1011,GO:0002347,1,0.907404456316236,0,17,response to tumor cell,BP,
1012,GO:0002349,1,0.969327345104805,0,6,histamine production involved in inflammatory response,BP,
1013,GO:0002351,1,0.98256984041642,0,3,serotonin production involved in inflammatory response,BP,
1014,GO:0002352,1,0.991742049696314,0,2,B cell negative selection,BP,
1015,GO:0002353,1,0.984554078053798,0,3,plasma kallikrein-kinin cascade,BP,
1016,GO:0002355,1,0.994122799710093,0,1,detection of tumor cell,BP,
1017,GO:0002357,1,0.98063078320552,0,3,defense response to tumor cell,BP,
1018,GO:0002358,1,0.996978827162998,0,1,B cell homeostatic proliferation,BP,
1019,GO:0002360,1,0.87668861885793,0,21,T cell lineage commitment,BP,
1020,GO:0002361,1,0.978349100309698,0,4,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1021,GO:0002362,1,0.994362334624006,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1022,GO:0002363,1,0.908850586770638,0,16,alpha-beta T cell lineage commitment,BP,
1024,GO:0002367,1,0.635771223704062,0,76,cytokine production involved in immune response,BP,
1025,GO:0002368,1,0.988073330984597,0,2,B cell cytokine production,BP,
1026,GO:0002369,1,0.839460588574576,0,30,T cell cytokine production,BP,
1027,GO:0002370,1,0.986050925546731,0,2,natural killer cell cytokine production,BP,
1028,GO:0002371,1,0.959421303634352,0,6,dendritic cell cytokine production,BP,
1029,GO:0002373,1,0.996910278869543,0,1,plasmacytoid dendritic cell cytokine production,BP,
1030,GO:0002374,1,0.902619674388572,0,16,cytokine secretion involved in immune response,BP,
1032,GO:0002377,1,0.596384751789208,0,86,immunoglobulin production,BP,
1033,GO:0002378,1,0.978151371933517,0,3,immunoglobulin biosynthetic process,BP,
1034,GO:0002380,1,0.992400592479863,0,1,immunoglobulin secretion involved in immune response,BP,
1035,GO:0002381,1,0.756969407299067,0,44,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1036,GO:0002384,1,0.989190314601399,0,2,hepatic immune response,BP,
1037,GO:0002385,1,0.914938941818512,0,21,mucosal immune response,BP,
1038,GO:0002386,1,0.98792214019864,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1039,GO:0002396,1,0.982298423799235,0,5,MHC protein complex assembly,BP,
1040,GO:0002397,1,0.995476737313982,0,1,MHC class I protein complex assembly,BP,
1041,GO:0002399,1,0.986762430039927,0,4,MHC class II protein complex assembly,BP,
1042,GO:0002407,1,0.879923113705196,0,22,dendritic cell chemotaxis,BP,
1043,GO:0002408,1,0.981075941355218,0,4,myeloid dendritic cell chemotaxis,BP,
1044,GO:0002414,1,0.983802768077484,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1045,GO:0002415,1,0.98792214019864,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1046,GO:0002416,1,0.995830793908088,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1047,GO:0002418,1,0.922633370493404,0,14,immune response to tumor cell,BP,
1048,GO:0002420,1,0.950428282647657,0,9,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1049,GO:0002423,1,0.950428282647657,0,9,natural killer cell mediated immune response to tumor cell,BP,
1050,GO:0002424,1,0.98702288681421,0,2,T cell mediated immune response to tumor cell,BP,
1051,GO:0002426,1,0.996679748692367,0,1,immunoglobulin production in mucosal tissue,BP,
1052,GO:0002428,1,0.985403979115038,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1054,GO:0002430,1,0.955052446175649,0,8,complement receptor mediated signaling pathway,BP,
1055,GO:0002431,1,0.616019161110966,0,75,Fc receptor mediated stimulatory signaling pathway,BP,
1056,GO:0002432,1,0.992413716827767,0,1,granuloma formation,BP,
1057,GO:0002433,1,0.633961848358558,0,70,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1058,GO:0002434,1,0.990092926489004,0,2,immune complex clearance,BP,
1059,GO:0002436,1,0.990092926489004,0,2,immune complex clearance by monocytes and macrophages,BP,
1061,GO:0002438,1,0.902839737429735,0,19,acute inflammatory response to antigenic stimulus,BP,
1062,GO:0002439,1,0.983144043775615,0,4,chronic inflammatory response to antigenic stimulus,BP,
1063,GO:0002440,1,0.398646566274685,0,153,production of molecular mediator of immune response,BP,
1064,GO:0002441,1,0.969327345104805,0,6,histamine secretion involved in inflammatory response,BP,
1065,GO:0002442,1,0.98256984041642,0,3,serotonin secretion involved in inflammatory response,BP,
1068,GO:0002445,1,0.98552060644908,0,3,type II hypersensitivity,BP,
1069,GO:0002446,1,0.0607569528007189,0,475,neutrophil mediated immunity,BP,
1070,GO:0002447,1,0.978538247292134,0,4,eosinophil mediated immunity,BP,
1073,GO:0002450,1,0.996140606907986,0,1,B cell antigen processing and presentation,BP,
1074,GO:0002455,1,0.813975790968073,0,37,humoral immune response mediated by circulating immunoglobulin,BP,
1075,GO:0002456,1,0.649051838832231,0,74,T cell mediated immunity,BP,
1076,GO:0002457,1,0.969202214609685,0,5,T cell antigen processing and presentation,BP,
1077,GO:0002458,1,0.989350158730273,0,2,peripheral T cell tolerance induction,BP,
1078,GO:0002460,1,0.299174412570725,0,200,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1079,GO:0002461,1,0.983806584168037,0,3,tolerance induction dependent upon immune response,BP,
1080,GO:0002465,1,0.989350158730273,0,2,peripheral tolerance induction,BP,
1081,GO:0002467,1,0.909283267333658,0,15,germinal center formation,BP,
1082,GO:0002468,1,0.951872188570272,0,9,dendritic cell antigen processing and presentation,BP,
1083,GO:0002474,1,0.647271930111628,0,88,antigen processing and presentation of peptide antigen via MHC class I,BP,
1084,GO:0002475,1,0.952326826095734,0,8,antigen processing and presentation via MHC class Ib,BP,
1085,GO:0002476,1,0.988488537340957,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1086,GO:0002477,1,0.996879897455132,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1087,GO:0002478,1,0.413035252694007,0,163,antigen processing and presentation of exogenous peptide antigen,BP,
1088,GO:0002479,1,0.729106789631198,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1089,GO:0002480,1,0.967285422891296,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1090,GO:0002481,1,0.996879897455132,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1091,GO:0002483,1,0.95166578399917,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1092,GO:0002488,1,0.992455981102177,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1093,GO:0002489,1,0.992455981102177,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1094,GO:0002495,1,0.563866562944324,0,96,antigen processing and presentation of peptide antigen via MHC class II,BP,
1095,GO:0002501,1,0.985493493969806,0,4,peptide antigen assembly with MHC protein complex,BP,
1096,GO:0002502,1,0.995476737313982,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1097,GO:0002503,1,0.989971867620109,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1098,GO:0002504,1,0.559366920456975,0,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1099,GO:0002505,1,0.993416986470028,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1100,GO:0002506,1,0.993416986470028,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1101,GO:0002507,1,0.870484728389679,0,23,tolerance induction,BP,
1102,GO:0002508,1,0.98859068675654,0,2,central tolerance induction,BP,
1103,GO:0002509,1,0.994959703324487,0,1,central tolerance induction to self antigen,BP,
1104,GO:0002510,1,0.993599055136015,0,1,central B cell tolerance induction,BP,
1105,GO:0002513,1,0.969638516924287,0,5,tolerance induction to self antigen,BP,
1106,GO:0002514,1,0.986017729369333,0,2,B cell tolerance induction,BP,
1107,GO:0002517,1,0.932613085188255,0,12,T cell tolerance induction,BP,
1108,GO:0002518,1,0.996699166694483,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1109,GO:0002519,1,0.990435840753068,0,2,natural killer cell tolerance induction,BP,
1112,GO:0002522,1,0.989029167786631,0,2,leukocyte migration involved in immune response,BP,
1113,GO:0002523,1,0.939561740649936,0,11,leukocyte migration involved in inflammatory response,BP,
1114,GO:0002524,1,0.9591036168998,0,8,hypersensitivity,BP,
1115,GO:0002525,1,0.983988730446825,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1116,GO:0002526,1,0.488047543634016,0,126,acute inflammatory response,BP,
1117,GO:0002528,1,0.98433670625597,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1120,GO:0002536,1,0.98729998688109,0,3,respiratory burst involved in inflammatory response,BP,
1121,GO:0002537,1,0.98365733749631,0,2,nitric oxide production involved in inflammatory response,BP,
1122,GO:0002538,1,0.986575533895787,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1123,GO:0002540,1,0.986575533895787,0,2,leukotriene production involved in inflammatory response,BP,
1124,GO:0002541,1,0.984087295727455,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1125,GO:0002542,1,0.98971278603781,0,2,Factor XII activation,BP,
1126,GO:0002543,1,0.986705385274363,0,2,activation of blood coagulation via clotting cascade,BP,
1128,GO:0002545,1,0.995557158342342,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1130,GO:0002551,1,0.944219869436429,0,10,mast cell chemotaxis,BP,
1131,GO:0002553,1,0.969327345104805,0,6,histamine secretion by mast cell,BP,
1132,GO:0002554,1,0.98256984041642,0,3,serotonin secretion by platelet,BP,
1133,GO:0002560,1,0.992442474285194,0,1,basophil mediated immunity,BP,
1134,GO:0002561,1,0.992442474285194,0,1,basophil degranulation,BP,
1135,GO:0002562,1,0.710113295013042,0,51,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1136,GO:0002566,1,0.923064597810775,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1137,GO:0002568,1,0.95909461501982,0,5,somatic diversification of T cell receptor genes,BP,
1138,GO:0002572,1,0.985360674361066,0,2,pro-T cell differentiation,BP,
1139,GO:0002573,1,0.338933584600429,0,171,myeloid leukocyte differentiation,BP,
1141,GO:0002577,1,0.916832968652724,0,17,regulation of antigen processing and presentation,BP,
1142,GO:0002578,1,0.96200559962328,0,7,negative regulation of antigen processing and presentation,BP,
1143,GO:0002579,1,0.957210030327541,0,9,positive regulation of antigen processing and presentation,BP,
1144,GO:0002580,1,0.975117468338676,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1145,GO:0002581,1,0.981224039676951,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1146,GO:0002582,1,0.99377780643614,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1147,GO:0002583,1,0.974192636413356,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1148,GO:0002584,1,0.980293477787569,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1149,GO:0002585,1,0.99377780643614,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1150,GO:0002586,1,0.982916048136797,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1151,GO:0002587,1,0.989070943747404,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1152,GO:0002588,1,0.99377780643614,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1153,GO:0002589,1,0.99112655757296,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1154,GO:0002590,1,0.99112655757296,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1155,GO:0002604,1,0.951872188570272,0,9,regulation of dendritic cell antigen processing and presentation,BP,
1156,GO:0002605,1,0.988238198258491,0,2,negative regulation of dendritic cell antigen processing and presentation,BP,
1157,GO:0002606,1,0.963205623994553,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1158,GO:0002622,1,0.996140606907986,0,1,regulation of B cell antigen processing and presentation,BP,
1159,GO:0002625,1,0.991087607711561,0,2,regulation of T cell antigen processing and presentation,BP,
1160,GO:0002626,1,0.995399585953174,0,1,negative regulation of T cell antigen processing and presentation,BP,
1161,GO:0002634,1,0.944675262046113,0,9,regulation of germinal center formation,BP,
1162,GO:0002635,1,0.98373058945976,0,2,negative regulation of germinal center formation,BP,
1163,GO:0002636,1,0.989928890680967,0,3,positive regulation of germinal center formation,BP,
1164,GO:0002637,1,0.737642435156855,0,52,regulation of immunoglobulin production,BP,
1165,GO:0002638,1,0.936903120871404,0,10,negative regulation of immunoglobulin production,BP,
1166,GO:0002639,1,0.825847325531066,0,34,positive regulation of immunoglobulin production,BP,
1167,GO:0002640,1,0.993301131169352,0,1,regulation of immunoglobulin biosynthetic process,BP,
1168,GO:0002642,1,0.993301131169352,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1169,GO:0002643,1,0.905613477028455,0,16,regulation of tolerance induction,BP,
1170,GO:0002644,1,0.994969096673003,0,1,negative regulation of tolerance induction,BP,
1171,GO:0002645,1,0.94642832006262,0,9,positive regulation of tolerance induction,BP,
1172,GO:0002646,1,0.993599055136015,0,1,regulation of central tolerance induction,BP,
1173,GO:0002648,1,0.993599055136015,0,1,positive regulation of central tolerance induction,BP,
1174,GO:0002649,1,0.992370342052644,0,1,regulation of tolerance induction to self antigen,BP,
1175,GO:0002651,1,0.992370342052644,0,1,positive regulation of tolerance induction to self antigen,BP,
1176,GO:0002652,1,0.988790968358179,0,2,regulation of tolerance induction dependent upon immune response,BP,
1177,GO:0002654,1,0.994362334624006,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1178,GO:0002658,1,0.994362334624006,0,1,regulation of peripheral tolerance induction,BP,
1179,GO:0002660,1,0.994362334624006,0,1,positive regulation of peripheral tolerance induction,BP,
1180,GO:0002661,1,0.986017729369333,0,2,regulation of B cell tolerance induction,BP,
1181,GO:0002663,1,0.986017729369333,0,2,positive regulation of B cell tolerance induction,BP,
1182,GO:0002664,1,0.943393852312482,0,10,regulation of T cell tolerance induction,BP,
1183,GO:0002666,1,0.960966413063214,0,7,positive regulation of T cell tolerance induction,BP,
1184,GO:0002667,1,0.971761189568891,0,5,regulation of T cell anergy,BP,
1185,GO:0002669,1,0.982628359142513,0,3,positive regulation of T cell anergy,BP,
1186,GO:0002673,1,0.657513003151586,0,73,regulation of acute inflammatory response,BP,
1187,GO:0002674,1,0.948690367070889,0,9,negative regulation of acute inflammatory response,BP,
1188,GO:0002675,1,0.873706556625271,0,25,positive regulation of acute inflammatory response,BP,
1189,GO:0002676,1,0.960190419812256,0,8,regulation of chronic inflammatory response,BP,
1190,GO:0002677,1,0.975499048277341,0,4,negative regulation of chronic inflammatory response,BP,
1191,GO:0002678,1,0.984310904963652,0,4,positive regulation of chronic inflammatory response,BP,
1192,GO:0002679,1,0.959850803318672,0,7,respiratory burst involved in defense response,BP,
1193,GO:0002681,1,0.95909461501982,0,5,somatic recombination of T cell receptor gene segments,BP,
1199,GO:0002687,1,0.544815367169418,0,113,positive regulation of leukocyte migration,BP,
1202,GO:0002690,1,0.666412679124716,0,79,positive regulation of leukocyte chemotaxis,BP,
1203,GO:0002691,1,0.876972055284644,0,22,regulation of cellular extravasation,BP,
1204,GO:0002692,1,0.955431314648019,0,8,negative regulation of cellular extravasation,BP,
1205,GO:0002693,1,0.925501840453295,0,12,positive regulation of cellular extravasation,BP,
1207,GO:0002695,1,0.435759632533906,0,138,negative regulation of leukocyte activation,BP,
1210,GO:0002698,1,0.571083766254158,0,93,negative regulation of immune effector process,BP,
1212,GO:0002700,1,0.537678513041162,0,104,regulation of production of molecular mediator of immune response,BP,
1213,GO:0002701,1,0.836810538850508,0,30,negative regulation of production of molecular mediator of immune response,BP,
1214,GO:0002702,1,0.672441245943985,0,68,positive regulation of production of molecular mediator of immune response,BP,
1216,GO:0002704,1,0.791993235868645,0,41,negative regulation of leukocyte mediated immunity,BP,
1219,GO:0002707,1,0.839819582170676,0,31,negative regulation of lymphocyte mediated immunity,BP,
1221,GO:0002709,1,0.767384175440701,0,48,regulation of T cell mediated immunity,BP,
1222,GO:0002710,1,0.922896342168138,0,15,negative regulation of T cell mediated immunity,BP,
1223,GO:0002711,1,0.849627218182137,0,29,positive regulation of T cell mediated immunity,BP,
1224,GO:0002712,1,0.78144154046973,0,41,regulation of B cell mediated immunity,BP,
1225,GO:0002713,1,0.945376998455397,0,9,negative regulation of B cell mediated immunity,BP,
1226,GO:0002714,1,0.849207640780028,0,28,positive regulation of B cell mediated immunity,BP,
1228,GO:0002716,1,0.939923957140649,0,11,negative regulation of natural killer cell mediated immunity,BP,
1230,GO:0002718,1,0.698740191248739,0,60,regulation of cytokine production involved in immune response,BP,
1231,GO:0002719,1,0.888223393053117,0,21,negative regulation of cytokine production involved in immune response,BP,
1232,GO:0002720,1,0.809381469696176,0,35,positive regulation of cytokine production involved in immune response,BP,
1233,GO:0002721,1,0.993624508574376,0,1,regulation of B cell cytokine production,BP,
1234,GO:0002724,1,0.883726734452233,0,21,regulation of T cell cytokine production,BP,
1235,GO:0002725,1,0.969788755697136,0,6,negative regulation of T cell cytokine production,BP,
1236,GO:0002726,1,0.9178833187004,0,14,positive regulation of T cell cytokine production,BP,
1237,GO:0002727,1,0.986050925546731,0,2,regulation of natural killer cell cytokine production,BP,
1238,GO:0002728,1,0.99240604884072,0,1,negative regulation of natural killer cell cytokine production,BP,
1239,GO:0002729,1,0.993596753435299,0,1,positive regulation of natural killer cell cytokine production,BP,
1240,GO:0002730,1,0.96691831791338,0,5,regulation of dendritic cell cytokine production,BP,
1241,GO:0002731,1,0.989108724906745,0,2,negative regulation of dendritic cell cytokine production,BP,
1242,GO:0002732,1,0.992401750145569,0,1,positive regulation of dendritic cell cytokine production,BP,
1243,GO:0002736,1,0.996910278869543,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1244,GO:0002737,1,0.996910278869543,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1245,GO:0002739,1,0.923336146109352,0,13,regulation of cytokine secretion involved in immune response,BP,
1246,GO:0002740,1,0.974868579836846,0,5,negative regulation of cytokine secretion involved in immune response,BP,
1247,GO:0002741,1,0.954142550497835,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1248,GO:0002752,1,0.991767693132645,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1249,GO:0002753,1,0.705619166509573,0,52,cytoplasmic pattern recognition receptor signaling pathway,BP,
1250,GO:0002755,1,0.798157175668362,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
1251,GO:0002756,1,0.833853418237578,0,30,MyD88-independent toll-like receptor signaling pathway,BP,
1253,GO:0002758,1,0.218924770222977,0,248,innate immune response-activating signal transduction,BP,
1254,GO:0002759,1,0.980161548593059,0,4,regulation of antimicrobial humoral response,BP,
1255,GO:0002760,1,0.991888295367153,0,2,positive regulation of antimicrobial humoral response,BP,
1256,GO:0002761,1,0.534789064617792,0,97,regulation of myeloid leukocyte differentiation,BP,
1257,GO:0002762,1,0.758951155967437,0,41,negative regulation of myeloid leukocyte differentiation,BP,
1258,GO:0002763,1,0.769132693798631,0,42,positive regulation of myeloid leukocyte differentiation,BP,
1260,GO:0002765,1,0.961977644034943,0,7,immune response-inhibiting signal transduction,BP,
1261,GO:0002767,1,0.966665237709988,0,6,immune response-inhibiting cell surface receptor signaling pathway,BP,
1263,GO:0002769,1,0.991021508784907,0,2,natural killer cell inhibitory signaling pathway,BP,
1264,GO:0002774,1,0.979162775163395,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1265,GO:0002775,1,0.981407664670373,0,4,antimicrobial peptide production,BP,
1266,GO:0002777,1,0.996919956817348,0,1,antimicrobial peptide biosynthetic process,BP,
1267,GO:0002778,1,0.981407664670373,0,4,antibacterial peptide production,BP,
1268,GO:0002780,1,0.996919956817348,0,1,antibacterial peptide biosynthetic process,BP,
1269,GO:0002784,1,0.98444027965561,0,3,regulation of antimicrobial peptide production,BP,
1270,GO:0002785,1,0.99249170944401,0,1,negative regulation of antimicrobial peptide production,BP,
1271,GO:0002786,1,0.98444027965561,0,3,regulation of antibacterial peptide production,BP,
1272,GO:0002787,1,0.99249170944401,0,1,negative regulation of antibacterial peptide production,BP,
1275,GO:0002792,1,0.51713835735496,0,108,negative regulation of peptide secretion,BP,
1277,GO:0002803,1,0.991888295367153,0,2,positive regulation of antibacterial peptide production,BP,
1278,GO:0002812,1,0.996919956817348,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1279,GO:0002818,1,0.99695154376261,0,1,intracellular defense response,BP,
1280,GO:0002819,1,0.494418691643718,0,120,regulation of adaptive immune response,BP,
1281,GO:0002820,1,0.811716367481083,0,34,negative regulation of adaptive immune response,BP,
1282,GO:0002821,1,0.656766948988483,0,73,positive regulation of adaptive immune response,BP,
1283,GO:0002822,1,0.527688607154532,0,109,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1284,GO:0002823,1,0.826541973624826,0,31,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1285,GO:0002824,1,0.674020503655131,0,69,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1286,GO:0002825,1,0.898698995205052,0,19,regulation of T-helper 1 type immune response,BP,
1287,GO:0002826,1,0.958812577342379,0,7,negative regulation of T-helper 1 type immune response,BP,
1288,GO:0002827,1,0.937181637452356,0,12,positive regulation of T-helper 1 type immune response,BP,
1289,GO:0002828,1,0.853954651226806,0,27,regulation of type 2 immune response,BP,
1290,GO:0002829,1,0.934896192043894,0,11,negative regulation of type 2 immune response,BP,
1291,GO:0002830,1,0.917738111736377,0,15,positive regulation of type 2 immune response,BP,
1292,GO:0002831,1,0.510760133311011,0,109,regulation of response to biotic stimulus,BP,
1293,GO:0002832,1,0.791270392493945,0,38,negative regulation of response to biotic stimulus,BP,
1294,GO:0002833,1,0.814424740715782,0,34,positive regulation of response to biotic stimulus,BP,
1295,GO:0002834,1,0.938087974587394,0,11,regulation of response to tumor cell,BP,
1296,GO:0002835,1,0.986985757467744,0,2,negative regulation of response to tumor cell,BP,
1297,GO:0002836,1,0.957583800452144,0,8,positive regulation of response to tumor cell,BP,
1298,GO:0002837,1,0.938087974587394,0,11,regulation of immune response to tumor cell,BP,
1299,GO:0002838,1,0.986985757467744,0,2,negative regulation of immune response to tumor cell,BP,
1300,GO:0002839,1,0.957583800452144,0,8,positive regulation of immune response to tumor cell,BP,
1301,GO:0002840,1,0.98702288681421,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1302,GO:0002842,1,0.994413575099473,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1303,GO:0002849,1,0.994362334624006,0,1,regulation of peripheral T cell tolerance induction,BP,
1304,GO:0002851,1,0.994362334624006,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1305,GO:0002855,1,0.950428282647657,0,9,regulation of natural killer cell mediated immune response to tumor cell,BP,
1306,GO:0002856,1,0.986985757467744,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1307,GO:0002857,1,0.962965445530971,0,7,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1308,GO:0002858,1,0.950428282647657,0,9,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1309,GO:0002859,1,0.986985757467744,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1310,GO:0002860,1,0.962965445530971,0,7,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1311,GO:0002861,1,0.9093172891038,0,19,regulation of inflammatory response to antigenic stimulus,BP,
1312,GO:0002862,1,0.957897189899614,0,9,negative regulation of inflammatory response to antigenic stimulus,BP,
1313,GO:0002863,1,0.949307021315907,0,10,positive regulation of inflammatory response to antigenic stimulus,BP,
1314,GO:0002864,1,0.944327510750284,0,11,regulation of acute inflammatory response to antigenic stimulus,BP,
1315,GO:0002865,1,0.979839868690439,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1316,GO:0002866,1,0.963764535632457,0,7,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1317,GO:0002870,1,0.971761189568891,0,5,T cell anergy,BP,
1318,GO:0002874,1,0.988603249959286,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1319,GO:0002875,1,0.996097850892239,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1320,GO:0002876,1,0.992476345880554,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1321,GO:0002877,1,0.983988730446825,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1322,GO:0002878,1,0.992740900067808,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1323,GO:0002879,1,0.991184499578086,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1324,GO:0002880,1,0.995557158342342,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1325,GO:0002882,1,0.995557158342342,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1326,GO:0002883,1,0.966015113652989,0,7,regulation of hypersensitivity,BP,
1327,GO:0002884,1,0.991311588961668,0,2,negative regulation of hypersensitivity,BP,
1328,GO:0002885,1,0.974484106513682,0,5,positive regulation of hypersensitivity,BP,
1329,GO:0002886,1,0.776710720587463,0,43,regulation of myeloid leukocyte mediated immunity,BP,
1330,GO:0002887,1,0.946074770529981,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1331,GO:0002888,1,0.885265304157524,0,21,positive regulation of myeloid leukocyte mediated immunity,BP,
1332,GO:0002889,1,0.78144154046973,0,41,regulation of immunoglobulin mediated immune response,BP,
1333,GO:0002890,1,0.945376998455397,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1334,GO:0002891,1,0.849207640780028,0,28,positive regulation of immunoglobulin mediated immune response,BP,
1335,GO:0002892,1,0.98552060644908,0,3,regulation of type II hypersensitivity,BP,
1336,GO:0002893,1,0.996140606907986,0,1,negative regulation of type II hypersensitivity,BP,
1337,GO:0002894,1,0.989339282133525,0,2,positive regulation of type II hypersensitivity,BP,
1338,GO:0002895,1,0.993599055136015,0,1,regulation of central B cell tolerance induction,BP,
1339,GO:0002897,1,0.993599055136015,0,1,positive regulation of central B cell tolerance induction,BP,
1340,GO:0002901,1,0.982810252082326,0,4,mature B cell apoptotic process,BP,
1341,GO:0002902,1,0.903872152248898,0,17,regulation of B cell apoptotic process,BP,
1342,GO:0002903,1,0.937602881013358,0,11,negative regulation of B cell apoptotic process,BP,
1343,GO:0002904,1,0.984961068268856,0,3,positive regulation of B cell apoptotic process,BP,
1344,GO:0002905,1,0.982810252082326,0,4,regulation of mature B cell apoptotic process,BP,
1345,GO:0002906,1,0.982810252082326,0,4,negative regulation of mature B cell apoptotic process,BP,
1346,GO:0002911,1,0.971761189568891,0,5,regulation of lymphocyte anergy,BP,
1347,GO:0002913,1,0.982628359142513,0,3,positive regulation of lymphocyte anergy,BP,
1348,GO:0002920,1,0.747107558274718,0,52,regulation of humoral immune response,BP,
1349,GO:0002921,1,0.936556698717158,0,10,negative regulation of humoral immune response,BP,
1350,GO:0002922,1,0.945787387469573,0,12,positive regulation of humoral immune response,BP,
1351,GO:0002923,1,0.955292413637358,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1352,GO:0002924,1,0.970079659858087,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1353,GO:0002925,1,0.984761463573029,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1354,GO:0002930,1,0.987617356273543,0,2,trabecular meshwork development,BP,
1356,GO:0002933,1,0.985113960995693,0,3,lipid hydroxylation,BP,
1357,GO:0002934,1,0.934273415065773,0,9,desmosome organization,BP,
1358,GO:0002940,1,0.988096958275445,0,2,tRNA N2-guanine methylation,BP,
1359,GO:0002943,1,0.979478429245826,0,4,tRNA dihydrouridine synthesis,BP,
1360,GO:0002944,1,0.98578573685844,0,2,cyclin K-CDK12 complex,CC,
1361,GO:0002945,1,0.986286560054069,0,2,cyclin K-CDK13 complex,CC,
1362,GO:0002946,1,0.996413716674221,0,1,tRNA C5-cytosine methylation,BP,
1363,GO:0002947,1,0.992448468844915,0,1,tumor necrosis factor receptor superfamily complex,CC,
1364,GO:0002949,1,0.98636308406088,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1365,GO:0002950,1,0.980866976730619,0,3,ceramide phosphoethanolamine synthase activity,MF,
1366,GO:0002951,1,0.988243989590435,0,2,leukotriene-C(4) hydrolase,MF,
1371,GO:0003009,1,0.806690225532231,0,38,skeletal muscle contraction,BP,
1372,GO:0003010,1,0.970183519752901,0,5,voluntary skeletal muscle contraction,BP,
1373,GO:0003011,1,0.981918372553899,0,3,involuntary skeletal muscle contraction,BP,
1378,GO:0003016,1,0.832688895701846,0,29,respiratory system process,BP,
1379,GO:0003017,1,0.990862123322003,0,1,lymph circulation,BP,
1381,GO:0003025,1,0.978361873759344,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1382,GO:0003026,1,0.993301131169352,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1383,GO:0003027,1,0.995962037024349,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1384,GO:0003029,1,0.995962037024349,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1385,GO:0003032,1,0.987343005531103,0,2,detection of oxygen,BP,
1386,GO:0003044,1,0.789176896461478,0,40,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1387,GO:0003050,1,0.992306774688942,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1388,GO:0003051,1,0.979079518795309,0,3,angiotensin-mediated drinking behavior,BP,
1389,GO:0003056,1,0.952114959894275,0,7,regulation of vascular smooth muscle contraction,BP,
1390,GO:0003057,1,0.972425441773645,0,5,regulation of the force of heart contraction by chemical signal,BP,
1391,GO:0003058,1,0.996658647993507,0,1,hormonal regulation of the force of heart contraction,BP,
1392,GO:0003062,1,0.960759968890588,0,6,regulation of heart rate by chemical signal,BP,
1393,GO:0003064,1,0.988401669543234,0,2,regulation of heart rate by hormone,BP,
1394,GO:0003065,1,0.995770534416899,0,1,positive regulation of heart rate by epinephrine,BP,
1395,GO:0003068,1,0.996853128847878,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1396,GO:0003069,1,0.996853128847878,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1397,GO:0003070,1,0.996853128847878,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1399,GO:0003072,1,0.978309370194986,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1401,GO:0003081,1,0.89224466416722,0,19,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1402,GO:0003083,1,0.997026923975853,0,1,negative regulation of renal output by angiotensin,BP,
1403,GO:0003084,1,0.948699121589967,0,9,positive regulation of systemic arterial blood pressure,BP,
1404,GO:0003085,1,0.927226175782596,0,13,negative regulation of systemic arterial blood pressure,BP,
1405,GO:0003091,1,0.815494175139055,0,29,renal water homeostasis,BP,
1408,GO:0003095,1,0.995893432936279,0,1,pressure natriuresis,BP,
1409,GO:0003096,1,0.968717551465657,0,5,renal sodium ion transport,BP,
1410,GO:0003097,1,0.969477107441585,0,5,renal water transport,BP,
1411,GO:0003099,1,0.984661133326763,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1412,GO:0003100,1,0.967541802567906,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1414,GO:0003105,1,0.978847583954303,0,4,negative regulation of glomerular filtration,BP,
1415,GO:0003106,1,0.997026923975853,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1416,GO:0003127,1,0.983257819963219,0,2,detection of nodal flow,BP,
1418,GO:0003129,1,0.981160288522574,0,4,heart induction,BP,
1419,GO:0003130,1,0.988578460723288,0,2,BMP signaling pathway involved in heart induction,BP,
1420,GO:0003131,1,0.993199948660582,0,1,mesodermal-endodermal cell signaling,BP,
1421,GO:0003133,1,0.988578460723288,0,2,endodermal-mesodermal cell signaling,BP,
1422,GO:0003134,1,0.988578460723288,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1423,GO:0003137,1,0.996741839541675,0,1,Notch signaling pathway involved in heart induction,BP,
1424,GO:0003138,1,0.99191017537253,0,1,primary heart field specification,BP,
1426,GO:0003140,1,0.957965999716473,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1427,GO:0003142,1,0.994332754053465,0,1,cardiogenic plate morphogenesis,BP,
1429,GO:0003147,1,0.99683593418832,0,1,neural crest cell migration involved in heart formation,BP,
1431,GO:0003149,1,0.946162506819929,0,9,membranous septum morphogenesis,BP,
1432,GO:0003150,1,0.965800900158838,0,5,muscular septum morphogenesis,BP,
1434,GO:0003156,1,0.825993191791069,0,32,regulation of animal organ formation,BP,
1435,GO:0003157,1,0.930091417486012,0,11,endocardium development,BP,
1437,GO:0003159,1,0.912339851265608,0,15,morphogenesis of an endothelium,BP,
1438,GO:0003160,1,0.96497437326233,0,6,endocardium morphogenesis,BP,
1440,GO:0003162,1,0.978502468532788,0,3,atrioventricular node development,BP,
1442,GO:0003164,1,0.96930940680597,0,5,His-Purkinje system development,BP,
1443,GO:0003165,1,0.987608944258896,0,2,Purkinje myocyte development,BP,
1444,GO:0003166,1,0.977018381406573,0,4,bundle of His development,BP,
1445,GO:0003167,1,0.992352169424254,0,1,atrioventricular bundle cell differentiation,BP,
1446,GO:0003168,1,0.995461921104387,0,1,Purkinje myocyte differentiation,BP,
1447,GO:0003169,1,0.9833961157991,0,2,coronary vein morphogenesis,BP,
1448,GO:0003170,1,0.761256031639891,0,38,heart valve development,BP,
1449,GO:0003171,1,0.851345733284136,0,23,atrioventricular valve development,BP,
1450,GO:0003172,1,0.99191017537253,0,1,sinoatrial valve development,BP,
1451,GO:0003174,1,0.928801929424478,0,10,mitral valve development,BP,
1452,GO:0003175,1,0.957538030445727,0,6,tricuspid valve development,BP,
1453,GO:0003176,1,0.968299813023164,0,6,aortic valve development,BP,
1454,GO:0003177,1,0.926122806684925,0,11,pulmonary valve development,BP,
1455,GO:0003179,1,0.782210803148445,0,34,heart valve morphogenesis,BP,
1456,GO:0003180,1,0.968299813023164,0,6,aortic valve morphogenesis,BP,
1457,GO:0003181,1,0.859258969433619,0,21,atrioventricular valve morphogenesis,BP,
1458,GO:0003183,1,0.928801929424478,0,10,mitral valve morphogenesis,BP,
1459,GO:0003184,1,0.926122806684925,0,11,pulmonary valve morphogenesis,BP,
1460,GO:0003185,1,0.99191017537253,0,1,sinoatrial valve morphogenesis,BP,
1461,GO:0003186,1,0.961239049009494,0,5,tricuspid valve morphogenesis,BP,
1462,GO:0003188,1,0.923810428932524,0,12,heart valve formation,BP,
1463,GO:0003190,1,0.94897838030778,0,7,atrioventricular valve formation,BP,
1464,GO:0003192,1,0.973881141694935,0,3,mitral valve formation,BP,
1465,GO:0003193,1,0.996151325838614,0,1,pulmonary valve formation,BP,
1466,GO:0003195,1,0.986244533001159,0,2,tricuspid valve formation,BP,
1468,GO:0003198,1,0.904139661600517,0,16,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1469,GO:0003199,1,0.978296290429931,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1470,GO:0003203,1,0.827463101524146,0,29,endocardial cushion morphogenesis,BP,
1473,GO:0003207,1,0.931936511986822,0,11,cardiac chamber formation,BP,
1475,GO:0003209,1,0.819177013699555,0,28,cardiac atrium morphogenesis,BP,
1476,GO:0003210,1,0.996741839541675,0,1,cardiac atrium formation,BP,
1477,GO:0003211,1,0.942527809552182,0,9,cardiac ventricle formation,BP,
1478,GO:0003213,1,0.982928462565804,0,2,cardiac right atrium morphogenesis,BP,
1479,GO:0003214,1,0.911561164278939,0,13,cardiac left ventricle morphogenesis,BP,
1480,GO:0003215,1,0.883494313020675,0,18,cardiac right ventricle morphogenesis,BP,
1481,GO:0003218,1,0.992495045100237,0,1,cardiac left ventricle formation,BP,
1482,GO:0003219,1,0.981172529417001,0,3,cardiac right ventricle formation,BP,
1483,GO:0003220,1,0.978323826791481,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1484,GO:0003221,1,0.978323497231075,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1485,GO:0003222,1,0.889055468593489,0,16,ventricular trabecula myocardium morphogenesis,BP,
1487,GO:0003226,1,0.990307837328522,0,1,right ventricular compact myocardium morphogenesis,BP,
1488,GO:0003228,1,0.961553895612325,0,6,atrial cardiac muscle tissue development,BP,
1490,GO:0003230,1,0.795550191061223,0,32,cardiac atrium development,BP,
1492,GO:0003235,1,0.996741839541675,0,1,sinus venosus development,BP,
1493,GO:0003236,1,0.996741839541675,0,1,sinus venosus morphogenesis,BP,
1494,GO:0003241,1,0.97668652427447,0,4,growth involved in heart morphogenesis,BP,
1495,GO:0003245,1,0.988980978038618,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1496,GO:0003247,1,0.99608114730034,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1497,GO:0003249,1,0.980677308097029,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003250,1,0.980677308097029,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1499,GO:0003251,1,0.991018675731716,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1500,GO:0003252,1,0.989565884840775,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1501,GO:0003253,1,0.962868258339623,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1505,GO:0003259,1,0.996741839541675,0,1,cardioblast anterior-lateral migration,BP,
1506,GO:0003260,1,0.996741839541675,0,1,cardioblast migration,BP,
1507,GO:0003263,1,0.946816987892471,0,9,cardioblast proliferation,BP,
1508,GO:0003264,1,0.93809990040319,0,10,regulation of cardioblast proliferation,BP,
1509,GO:0003266,1,0.944299220132582,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1510,GO:0003270,1,0.990798481679787,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1511,GO:0003272,1,0.87385370309134,0,21,endocardial cushion formation,BP,
1512,GO:0003273,1,0.969112920094744,0,4,cell migration involved in endocardial cushion formation,BP,
1513,GO:0003274,1,0.9777671412156,0,3,endocardial cushion fusion,BP,
1514,GO:0003275,1,0.980932598473696,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1515,GO:0003278,1,0.96553530418465,0,6,apoptotic process involved in heart morphogenesis,BP,
1518,GO:0003283,1,0.878620163695478,0,18,atrial septum development,BP,
1519,GO:0003284,1,0.970462685900948,0,4,septum primum development,BP,
1520,GO:0003285,1,0.988070172244519,0,2,septum secundum development,BP,
1521,GO:0003289,1,0.970462685900948,0,4,atrial septum primum morphogenesis,BP,
1522,GO:0003290,1,0.992574904599504,0,1,atrial septum secundum morphogenesis,BP,
1523,GO:0003292,1,0.98759098048717,0,2,cardiac septum cell differentiation,BP,
1525,GO:0003298,1,0.895003329683085,0,17,physiological muscle hypertrophy,BP,
1526,GO:0003299,1,0.853143547436527,0,22,muscle hypertrophy in response to stress,BP,
1527,GO:0003300,1,0.569153076720858,0,69,cardiac muscle hypertrophy,BP,
1528,GO:0003301,1,0.895003329683085,0,17,physiological cardiac muscle hypertrophy,BP,
1529,GO:0003306,1,0.951735914809693,0,8,Wnt signaling pathway involved in heart development,BP,
1530,GO:0003307,1,0.974141730754645,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1531,GO:0003308,1,0.979728128769312,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1532,GO:0003309,1,0.857709108717117,0,23,type B pancreatic cell differentiation,BP,
1533,GO:0003310,1,0.963111604872951,0,6,pancreatic A cell differentiation,BP,
1534,GO:0003312,1,0.98872384978076,0,2,pancreatic PP cell differentiation,BP,
1535,GO:0003318,1,0.996741839541675,0,1,cell migration to the midline involved in heart development,BP,
1536,GO:0003321,1,0.95811665053344,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1537,GO:0003322,1,0.991711616449939,0,1,pancreatic A cell development,BP,
1538,GO:0003323,1,0.882801197529217,0,19,type B pancreatic cell development,BP,
1539,GO:0003326,1,0.98872384978076,0,2,pancreatic A cell fate commitment,BP,
1540,GO:0003327,1,0.995070552042379,0,1,type B pancreatic cell fate commitment,BP,
1541,GO:0003329,1,0.98872384978076,0,2,pancreatic PP cell fate commitment,BP,
1542,GO:0003330,1,0.98707617309094,0,2,regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003331,1,0.98707617309094,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1544,GO:0003333,1,0.622407127580572,0,71,amino acid transmembrane transport,BP,
1545,GO:0003334,1,0.936087627247613,0,10,keratinocyte development,BP,
1546,GO:0003335,1,0.996558705449531,0,1,corneocyte development,BP,
1549,GO:0003339,1,0.953725893384504,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003340,1,0.982105161539357,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1552,GO:0003342,1,0.988400789848187,0,2,proepicardium development,BP,
1553,GO:0003343,1,0.988400789848187,0,2,septum transversum development,BP,
1554,GO:0003344,1,0.934916364350037,0,9,pericardium morphogenesis,BP,
1555,GO:0003345,1,0.992466302044398,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1556,GO:0003348,1,0.960002306839158,0,6,cardiac endothelial cell differentiation,BP,
1557,GO:0003350,1,0.982443820254341,0,3,pulmonary myocardium development,BP,
1558,GO:0003351,1,0.895711399725938,0,19,epithelial cilium movement,BP,
1559,GO:0003352,1,0.9122185578667,0,13,regulation of cilium movement,BP,
1560,GO:0003353,1,0.992925829466537,0,1,positive regulation of cilium movement,BP,
1561,GO:0003356,1,0.928912810009109,0,10,regulation of cilium beat frequency,BP,
1562,GO:0003357,1,0.961448341816587,0,6,noradrenergic neuron differentiation,BP,
1563,GO:0003358,1,0.987247640327046,0,2,noradrenergic neuron development,BP,
1564,GO:0003359,1,0.993995508641689,0,1,noradrenergic neuron fate commitment,BP,
1565,GO:0003360,1,0.957855127957345,0,6,brainstem development,BP,
1566,GO:0003365,1,0.975197721556787,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1567,GO:0003366,1,0.985318357518583,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1568,GO:0003373,1,0.947781341424449,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1569,GO:0003374,1,0.947781341424449,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1571,GO:0003382,1,0.827883107294183,0,27,epithelial cell morphogenesis,BP,
1572,GO:0003383,1,0.97611389532168,0,3,apical constriction,BP,
1573,GO:0003400,1,0.994815341582593,0,1,regulation of COPII vesicle coating,BP,
1574,GO:0003401,1,0.823353446654978,0,29,axis elongation,BP,
1575,GO:0003402,1,0.959797809440273,0,6,planar cell polarity pathway involved in axis elongation,BP,
1576,GO:0003404,1,0.986563349645849,0,2,optic vesicle morphogenesis,BP,
1577,GO:0003406,1,0.963784200971067,0,5,retinal pigment epithelium development,BP,
1578,GO:0003407,1,0.695203345396495,0,53,neural retina development,BP,
1579,GO:0003408,1,0.976397495530095,0,3,optic cup formation involved in camera-type eye development,BP,
1580,GO:0003409,1,0.992637558925108,0,1,optic cup structural organization,BP,
1581,GO:0003413,1,0.934826188513687,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1582,GO:0003414,1,0.992469759015209,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1583,GO:0003415,1,0.970792346337367,0,4,chondrocyte hypertrophy,BP,
1584,GO:0003416,1,0.863846121455803,0,22,endochondral bone growth,BP,
1585,GO:0003417,1,0.908003741355913,0,15,growth plate cartilage development,BP,
1586,GO:0003418,1,0.962548181512997,0,6,growth plate cartilage chondrocyte differentiation,BP,
1587,GO:0003419,1,0.980791153101548,0,4,growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003420,1,0.986910439729501,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1589,GO:0003421,1,0.992466034638323,0,1,growth plate cartilage axis specification,BP,
1590,GO:0003422,1,0.984991940316119,0,2,growth plate cartilage morphogenesis,BP,
1591,GO:0003429,1,0.992469759015209,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1592,GO:0003430,1,0.985611788867159,0,2,growth plate cartilage chondrocyte growth,BP,
1593,GO:0003431,1,0.97268435103904,0,4,growth plate cartilage chondrocyte development,BP,
1594,GO:0003433,1,0.96026170728893,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1598,GO:0003678,1,0.725130507128883,0,45,DNA helicase activity,MF,
1599,GO:0003680,1,0.944144524732075,0,10,AT DNA binding,MF,
1601,GO:0003684,1,0.654426415053277,0,66,damaged DNA binding,MF,
1602,GO:0003688,1,0.911142092620792,0,14,DNA replication origin binding,MF,
1603,GO:0003689,1,0.956241481009885,0,8,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.944066685223585,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.994770596407704,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.955193908706498,0,7,satellite DNA binding,MF,
1608,GO:0003697,1,0.542499873552178,0,96,single-stranded DNA binding,MF,
1611,GO:0003707,1,0.681928015025737,0,56,steroid hormone receptor activity,MF,
1612,GO:0003708,1,0.953935319651202,0,7,retinoic acid receptor activity,MF,
1615,GO:0003714,1,0.251845101041545,0,210,transcription corepressor activity,MF,
1616,GO:0003720,1,0.947966076367332,0,8,telomerase activity,MF,
1617,GO:0003721,1,0.9924574167577,0,1,telomerase RNA reverse transcriptase activity,MF,
1618,GO:0003723,1,5.74419581785134e-05,0,1533,RNA binding,MF,
1619,GO:0003724,1,0.637338980844883,0,65,RNA helicase activity,MF,
1620,GO:0003725,1,0.637640242446707,0,66,double-stranded RNA binding,MF,
1621,GO:0003726,1,0.979054393227566,0,3,double-stranded RNA adenosine deaminase activity,MF,
1622,GO:0003727,1,0.606296768226575,0,77,single-stranded RNA binding,MF,
1623,GO:0003729,1,0.296626929165181,0,190,mRNA binding,MF,
1624,GO:0003730,1,0.647630716509822,0,63,mRNA 3'-UTR binding,MF,
1625,GO:0003735,1,0.580388105016221,0,153,structural constituent of ribosome,MF,
1626,GO:0003743,1,0.751490330444804,0,50,translation initiation factor activity,MF,
1627,GO:0003746,1,0.899515716862211,0,18,translation elongation factor activity,MF,
1628,GO:0003747,1,0.961288679241003,0,6,translation release factor activity,MF,
1629,GO:0003755,1,0.852129081668376,0,31,peptidyl-prolyl cis-trans isomerase activity,MF,
1630,GO:0003756,1,0.895469064925936,0,17,protein disulfide isomerase activity,MF,
1635,GO:0003796,1,0.990214954848212,0,3,lysozyme activity,MF,
1636,GO:0003810,1,0.96045994343754,0,6,protein-glutamine gamma-glutamyltransferase activity,MF,
1637,GO:0003823,1,0.790047892502454,0,46,antigen binding,MF,
1639,GO:0003826,1,0.989427024531245,0,2,alpha-ketoacid dehydrogenase activity,MF,
1640,GO:0003827,1,0.986249427519944,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1641,GO:0003828,1,0.956537861759692,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1642,GO:0003829,1,0.984755357354524,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003830,1,0.992290680394885,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1644,GO:0003831,1,0.951303138855549,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1645,GO:0003834,1,0.993301131169352,0,1,beta-carotene 15,15'-monooxygenase activity,MF,
1646,GO:0003835,1,0.984242989171897,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1647,GO:0003836,1,0.964608381102844,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1648,GO:0003837,1,0.995075861974963,0,1,beta-ureidopropionase activity,MF,
1649,GO:0003839,1,0.983095374407979,0,4,gamma-glutamylcyclotransferase activity,MF,
1650,GO:0003841,1,0.890415353533281,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1651,GO:0003842,1,0.992673220942937,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1652,GO:0003844,1,0.992800822324919,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1653,GO:0003845,1,0.992027254177661,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1654,GO:0003846,1,0.98657207231553,0,2,2-acylglycerol O-acyltransferase activity,MF,
1655,GO:0003847,1,0.977596855612198,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1656,GO:0003854,1,0.984295427370462,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.953888089322716,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.985673874915443,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.995440834172303,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.989427024531245,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.988139089146914,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.992316013745567,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.991796058531711,0,2,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.989567629566123,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.979193244606889,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.973310721195314,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.99691333883606,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.98836460204835,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.984959633322113,0,2,AMP deaminase activity,MF,
1670,GO:0003877,1,0.994970437972119,0,1,ATP adenylyltransferase activity,MF,
1671,GO:0003878,1,0.992421877872673,0,1,ATP citrate synthase activity,MF,
1672,GO:0003880,1,0.982100346570024,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1673,GO:0003881,1,0.995576368996329,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1674,GO:0003882,1,0.994054924576628,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1675,GO:0003883,1,0.985812196581232,0,2,CTP synthase activity,MF,
1676,GO:0003884,1,0.992279651859073,0,2,D-amino-acid oxidase activity,MF,
1677,GO:0003886,1,0.977251569326108,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1678,GO:0003887,1,0.839571918803433,0,27,DNA-directed DNA polymerase activity,MF,
1679,GO:0003896,1,0.984235397352197,0,3,DNA primase activity,MF,
1680,GO:0003899,1,0.801388768849587,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1681,GO:0003905,1,0.996804189000364,0,1,alkylbase DNA N-glycosylase activity,MF,
1682,GO:0003906,1,0.93863688094174,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1683,GO:0003908,1,0.996631302655776,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1684,GO:0003909,1,0.955960382126306,0,7,DNA ligase activity,MF,
1685,GO:0003910,1,0.960803841672575,0,6,DNA ligase (ATP) activity,MF,
1686,GO:0003912,1,0.995151153811128,0,1,DNA nucleotidylexotransferase activity,MF,
1687,GO:0003916,1,0.958260191051673,0,6,DNA topoisomerase activity,MF,
1688,GO:0003917,1,0.973457580826969,0,4,DNA topoisomerase type I activity,MF,
1689,GO:0003918,1,0.984392572558478,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1690,GO:0003919,1,0.995332519286809,0,1,FMN adenylyltransferase activity,MF,
1691,GO:0003920,1,0.991864217608117,0,2,GMP reductase activity,MF,
1692,GO:0003921,1,0.994018683935231,0,1,GMP synthase activity,MF,
1693,GO:0003922,1,0.994018683935231,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1694,GO:0003923,1,0.971183979498364,0,5,GPI-anchor transamidase activity,MF,
1696,GO:0003933,1,0.995380704394329,0,1,GTP cyclohydrolase activity,MF,
1697,GO:0003934,1,0.995380704394329,0,1,GTP cyclohydrolase I activity,MF,
1698,GO:0003937,1,0.99500391878438,0,1,IMP cyclohydrolase activity,MF,
1699,GO:0003938,1,0.989891672843913,0,2,IMP dehydrogenase activity,MF,
1700,GO:0003939,1,0.993856193451521,0,1,L-iditol 2-dehydrogenase activity,MF,
1701,GO:0003940,1,0.994744803162151,0,1,L-iduronidase activity,MF,
1702,GO:0003941,1,0.986641444603498,0,3,L-serine ammonia-lyase activity,MF,
1703,GO:0003943,1,0.986757383383633,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1704,GO:0003944,1,0.99470948027479,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1705,GO:0003945,1,0.977464331223584,0,4,N-acetyllactosamine synthase activity,MF,
1706,GO:0003947,1,0.992910862531799,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1707,GO:0003948,1,0.995027959827431,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1708,GO:0003950,1,0.881931075550339,0,19,NAD+ ADP-ribosyltransferase activity,MF,
1709,GO:0003951,1,0.889541577709168,0,16,NAD+ kinase activity,MF,
1710,GO:0003952,1,0.99407312798456,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1711,GO:0003953,1,0.9926843300588,0,2,NAD+ nucleosidase activity,MF,
1712,GO:0003954,1,0.866707804452467,0,40,NADH dehydrogenase activity,MF,
1713,GO:0003955,1,0.98335917556002,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1714,GO:0003956,1,0.988874443033,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1715,GO:0003957,1,0.992368179275643,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1716,GO:0003958,1,0.957716972455764,0,6,NADPH-hemoprotein reductase activity,MF,
1717,GO:0003960,1,0.982455173510237,0,4,NADPH:quinone reductase activity,MF,
1718,GO:0003962,1,0.995869264340929,0,1,cystathionine gamma-synthase activity,MF,
1719,GO:0003963,1,0.988137383223491,0,2,RNA-3'-phosphate cyclase activity,MF,
1720,GO:0003964,1,0.947966076367332,0,8,RNA-directed DNA polymerase activity,MF,
1721,GO:0003968,1,0.984328801280324,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1722,GO:0003972,1,0.993301131169352,0,1,RNA ligase (ATP) activity,MF,
1723,GO:0003973,1,0.987867971419951,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1724,GO:0003974,1,0.996127095638696,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1725,GO:0003975,1,0.994877562264452,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1726,GO:0003976,1,0.983729651433617,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1727,GO:0003977,1,0.987011076513278,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1728,GO:0003978,1,0.996127095638696,0,1,UDP-glucose 4-epimerase activity,MF,
1729,GO:0003979,1,0.992718025735101,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1730,GO:0003980,1,0.982503498492649,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1731,GO:0003983,1,0.994880262686372,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1732,GO:0003985,1,0.98407439729955,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1733,GO:0003986,1,0.984868881785776,0,4,acetyl-CoA hydrolase activity,MF,
1734,GO:0003987,1,0.978377868340592,0,3,acetate-CoA ligase activity,MF,
1735,GO:0003988,1,0.970207188340943,0,6,acetyl-CoA C-acyltransferase activity,MF,
1736,GO:0003989,1,0.990810363332533,0,1,acetyl-CoA carboxylase activity,MF,
1737,GO:0003990,1,0.987842183342351,0,2,acetylcholinesterase activity,MF,
1738,GO:0003991,1,0.995070552042379,0,1,acetylglutamate kinase activity,MF,
1739,GO:0003993,1,0.971858046876406,0,6,acid phosphatase activity,MF,
1740,GO:0003994,1,0.985910963026397,0,2,aconitate hydratase activity,MF,
1741,GO:0003995,1,0.91098855729859,0,15,acyl-CoA dehydrogenase activity,MF,
1742,GO:0003996,1,0.972705194352761,0,5,acyl-CoA ligase activity,MF,
1743,GO:0003997,1,0.969075829000796,0,5,acyl-CoA oxidase activity,MF,
1744,GO:0003998,1,0.993731433069854,0,2,acylphosphatase activity,MF,
1745,GO:0003999,1,0.997009080962846,0,1,adenine phosphoribosyltransferase activity,MF,
1746,GO:0004000,1,0.942967402018241,0,9,adenosine deaminase activity,MF,
1747,GO:0004001,1,0.995118220351649,0,1,adenosine kinase activity,MF,
1748,GO:0004003,1,0.796914733668715,0,32,ATP-dependent DNA helicase activity,MF,
1749,GO:0004004,1,0.641938011551446,0,64,ATP-dependent RNA helicase activity,MF,
1750,GO:0004008,1,0.983091726782038,0,2,copper-exporting ATPase activity,MF,
1752,GO:0004013,1,0.97935567774736,0,3,adenosylhomocysteinase activity,MF,
1753,GO:0004014,1,0.992663131368205,0,1,adenosylmethionine decarboxylase activity,MF,
1754,GO:0004016,1,0.901406111230643,0,13,adenylate cyclase activity,MF,
1755,GO:0004017,1,0.948248273617687,0,8,adenylate kinase activity,MF,
1756,GO:0004018,1,0.996348587845657,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1757,GO:0004019,1,0.989122526602325,0,2,adenylosuccinate synthase activity,MF,
1758,GO:0004020,1,0.986322848322612,0,2,adenylylsulfate kinase activity,MF,
1759,GO:0004021,1,0.988031489449761,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1760,GO:0004022,1,0.973833737834209,0,5,alcohol dehydrogenase (NAD) activity,MF,
1761,GO:0004024,1,0.988829814024526,0,2,alcohol dehydrogenase activity, zinc-dependent,MF,
1762,GO:0004027,1,0.996672441072503,0,1,alcohol sulfotransferase activity,MF,
1763,GO:0004028,1,0.956403562790549,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1764,GO:0004029,1,0.903174909837536,0,15,aldehyde dehydrogenase (NAD) activity,MF,
1765,GO:0004030,1,0.964043918343212,0,6,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1766,GO:0004031,1,0.992305815492825,0,1,aldehyde oxidase activity,MF,
1767,GO:0004032,1,0.959951389945182,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1768,GO:0004033,1,0.895823614142153,0,25,aldo-keto reductase (NADP) activity,MF,
1769,GO:0004034,1,0.993969875847883,0,1,aldose 1-epimerase activity,MF,
1770,GO:0004035,1,0.986892204094562,0,2,alkaline phosphatase activity,MF,
1771,GO:0004037,1,0.996394880504088,0,1,allantoicase activity,MF,
1772,GO:0004040,1,0.984020329563005,0,3,amidase activity,MF,
1773,GO:0004042,1,0.995070552042379,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1774,GO:0004043,1,0.992516020550558,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1775,GO:0004044,1,0.992478712309567,0,1,amidophosphoribosyltransferase activity,MF,
1776,GO:0004045,1,0.983478084350297,0,4,aminoacyl-tRNA hydrolase activity,MF,
1777,GO:0004046,1,0.978492484431954,0,5,aminoacylase activity,MF,
1778,GO:0004047,1,0.991400235320713,0,2,aminomethyltransferase activity,MF,
1779,GO:0004051,1,0.993782080934776,0,1,arachidonate 5-lipoxygenase activity,MF,
1780,GO:0004052,1,0.981775085525923,0,3,arachidonate 12-lipoxygenase activity,MF,
1781,GO:0004053,1,0.991720959930088,0,2,arginase activity,MF,
1782,GO:0004055,1,0.995687939955043,0,1,argininosuccinate synthase activity,MF,
1783,GO:0004056,1,0.995279996679251,0,1,argininosuccinate lyase activity,MF,
1784,GO:0004057,1,0.994687732034828,0,1,arginyltransferase activity,MF,
1785,GO:0004058,1,0.99520874528529,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1786,GO:0004059,1,0.996365237812487,0,1,aralkylamine N-acetyltransferase activity,MF,
1787,GO:0004060,1,0.988203276756012,0,3,arylamine N-acetyltransferase activity,MF,
1788,GO:0004061,1,0.99596705023946,0,1,arylformamidase activity,MF,
1789,GO:0004062,1,0.961259294436422,0,9,aryl sulfotransferase activity,MF,
1790,GO:0004063,1,0.992569746274064,0,2,aryldialkylphosphatase activity,MF,
1791,GO:0004064,1,0.974850763612129,0,6,arylesterase activity,MF,
1792,GO:0004065,1,0.928302783173639,0,11,arylsulfatase activity,MF,
1793,GO:0004066,1,0.988417760778122,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1794,GO:0004067,1,0.989886946677199,0,2,asparaginase activity,MF,
1795,GO:0004069,1,0.989000260681641,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1796,GO:0004070,1,0.983774239246103,0,2,aspartate carbamoyltransferase activity,MF,
1797,GO:0004074,1,0.993775994357859,0,2,biliverdin reductase activity,MF,
1798,GO:0004075,1,0.984678199166409,0,2,biotin carboxylase activity,MF,
1799,GO:0004077,1,0.992001434575794,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1800,GO:0004078,1,0.992001434575794,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1801,GO:0004079,1,0.992001434575794,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1802,GO:0004080,1,0.992001434575794,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1803,GO:0004081,1,0.990231419238039,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1804,GO:0004082,1,0.984397138446713,0,4,bisphosphoglycerate mutase activity,MF,
1805,GO:0004084,1,0.987362207660561,0,2,branched-chain-amino-acid transaminase activity,MF,
1806,GO:0004085,1,0.995461921104387,0,1,butyryl-CoA dehydrogenase activity,MF,
1807,GO:0004087,1,0.983774239246103,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1808,GO:0004088,1,0.983774239246103,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1809,GO:0004089,1,0.939926474261473,0,13,carbonate dehydratase activity,MF,
1810,GO:0004090,1,0.983132922658151,0,5,carbonyl reductase (NADPH) activity,MF,
1811,GO:0004092,1,0.993209963159979,0,1,carnitine O-acetyltransferase activity,MF,
1812,GO:0004095,1,0.972332595665842,0,4,carnitine O-palmitoyltransferase activity,MF,
1813,GO:0004096,1,0.979609501479986,0,4,catalase activity,MF,
1814,GO:0004098,1,0.995503748672337,0,1,cerebroside-sulfatase activity,MF,
1815,GO:0004102,1,0.994010947946704,0,1,choline O-acetyltransferase activity,MF,
1816,GO:0004103,1,0.98958006824326,0,2,choline kinase activity,MF,
1817,GO:0004104,1,0.981388815008879,0,3,cholinesterase activity,MF,
1818,GO:0004105,1,0.988371952236553,0,2,choline-phosphate cytidylyltransferase activity,MF,
1819,GO:0004108,1,0.99295610486543,0,1,citrate (Si)-synthase activity,MF,
1820,GO:0004109,1,0.98739778276083,0,2,coproporphyrinogen oxidase activity,MF,
1821,GO:0004111,1,0.976168365394718,0,5,creatine kinase activity,MF,
1822,GO:0004112,1,0.848637119380556,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1823,GO:0004113,1,0.992239246230427,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1824,GO:0004114,1,0.855285544404038,0,22,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1825,GO:0004115,1,0.891009896445929,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1826,GO:0004117,1,0.980867592510664,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1827,GO:0004118,1,0.975157731724911,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1828,GO:0004119,1,0.984482701577462,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1829,GO:0004122,1,0.993678504419862,0,1,cystathionine beta-synthase activity,MF,
1830,GO:0004123,1,0.995869264340929,0,1,cystathionine gamma-lyase activity,MF,
1831,GO:0004126,1,0.953001490775287,0,10,cytidine deaminase activity,MF,
1832,GO:0004127,1,0.973214173386541,0,4,cytidylate kinase activity,MF,
1833,GO:0004128,1,0.961158601435364,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1834,GO:0004129,1,0.926870888205205,0,22,cytochrome-c oxidase activity,MF,
1835,GO:0004132,1,0.995182628565951,0,1,dCMP deaminase activity,MF,
1836,GO:0004133,1,0.991602832809476,0,1,glycogen debranching enzyme activity,MF,
1837,GO:0004134,1,0.991602832809476,0,1,4-alpha-glucanotransferase activity,MF,
1838,GO:0004135,1,0.991602832809476,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1839,GO:0004137,1,0.986003042179941,0,2,deoxycytidine kinase activity,MF,
1840,GO:0004138,1,0.996861800316227,0,1,deoxyguanosine kinase activity,MF,
1841,GO:0004139,1,0.995905916601267,0,1,deoxyribose-phosphate aldolase activity,MF,
1842,GO:0004140,1,0.989638682597854,0,2,dephospho-CoA kinase activity,MF,
1843,GO:0004142,1,0.983315291136978,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1844,GO:0004143,1,0.926257514986168,0,10,diacylglycerol kinase activity,MF,
1845,GO:0004144,1,0.98657207231553,0,2,diacylglycerol O-acyltransferase activity,MF,
1846,GO:0004145,1,0.98857385519182,0,3,diamine N-acetyltransferase activity,MF,
1847,GO:0004146,1,0.989302366579502,0,2,dihydrofolate reductase activity,MF,
1848,GO:0004148,1,0.992509688600802,0,1,dihydrolipoyl dehydrogenase activity,MF,
1849,GO:0004149,1,0.993158192156007,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1850,GO:0004151,1,0.983774239246103,0,2,dihydroorotase activity,MF,
1851,GO:0004152,1,0.995081168639373,0,1,dihydroorotate dehydrogenase activity,MF,
1852,GO:0004155,1,0.996056695280523,0,1,6,7-dihydropteridine reductase activity,MF,
1853,GO:0004157,1,0.987356358776103,0,2,dihydropyrimidinase activity,MF,
1854,GO:0004161,1,0.989594518402589,0,2,dimethylallyltranstransferase activity,MF,
1855,GO:0004163,1,0.99574819382497,0,1,diphosphomevalonate decarboxylase activity,MF,
1856,GO:0004164,1,0.995766084159503,0,1,diphthine synthase activity,MF,
1857,GO:0004165,1,0.979209759184008,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1858,GO:0004167,1,0.988468272113449,0,3,dopachrome isomerase activity,MF,
1859,GO:0004168,1,0.994731220617639,0,1,dolichol kinase activity,MF,
1860,GO:0004169,1,0.975957939475426,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1861,GO:0004170,1,0.995578762176172,0,1,dUTP diphosphatase activity,MF,
1862,GO:0004174,1,0.987031093806899,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1864,GO:0004176,1,0.97225788935641,0,4,ATP-dependent peptidase activity,MF,
1865,GO:0004177,1,0.756414578284215,0,43,aminopeptidase activity,MF,
1869,GO:0004190,1,0.901893379914462,0,18,aspartic-type endopeptidase activity,MF,
1874,GO:0004298,1,0.941330707331773,0,18,threonine-type endopeptidase activity,MF,
1875,GO:0004300,1,0.958517505711468,0,8,enoyl-CoA hydratase activity,MF,
1876,GO:0004301,1,0.965756916405824,0,7,epoxide hydrolase activity,MF,
1877,GO:0004303,1,0.963291255536862,0,9,estradiol 17-beta-dehydrogenase activity,MF,
1878,GO:0004304,1,0.991100720001675,0,2,estrone sulfotransferase activity,MF,
1879,GO:0004305,1,0.975882575579008,0,4,ethanolamine kinase activity,MF,
1880,GO:0004306,1,0.995614437581349,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1881,GO:0004307,1,0.991455870980644,0,2,ethanolaminephosphotransferase activity,MF,
1882,GO:0004308,1,0.971587534320376,0,5,exo-alpha-sialidase activity,MF,
1883,GO:0004309,1,0.970281286045039,0,4,exopolyphosphatase activity,MF,
1884,GO:0004310,1,0.99497714214688,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1885,GO:0004311,1,0.981256934806692,0,3,farnesyltranstransferase activity,MF,
1886,GO:0004312,1,0.940356621910007,0,10,fatty acid synthase activity,MF,
1887,GO:0004313,1,0.991128561445219,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1888,GO:0004314,1,0.986562307662375,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1889,GO:0004315,1,0.987777169758983,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1890,GO:0004316,1,0.991128561445219,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1891,GO:0004317,1,0.991128561445219,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1892,GO:0004319,1,0.991128561445219,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1893,GO:0004320,1,0.987005565230565,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1894,GO:0004321,1,0.977994870607273,0,4,fatty-acyl-CoA synthase activity,MF,
1895,GO:0004322,1,0.965556383336062,0,5,ferroxidase activity,MF,
1896,GO:0004324,1,0.995518397400478,0,1,ferredoxin-NADP+ reductase activity,MF,
1897,GO:0004325,1,0.991580315830242,0,1,ferrochelatase activity,MF,
1898,GO:0004326,1,0.993952009125385,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1899,GO:0004329,1,0.98510437534437,0,2,formate-tetrahydrofolate ligase activity,MF,
1900,GO:0004331,1,0.973310721195314,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1901,GO:0004332,1,0.98647835214444,0,3,fructose-bisphosphate aldolase activity,MF,
1902,GO:0004333,1,0.995766084159503,0,1,fumarate hydratase activity,MF,
1903,GO:0004334,1,0.996384597526019,0,1,fumarylacetoacetase activity,MF,
1904,GO:0004335,1,0.98928019509441,0,2,galactokinase activity,MF,
1905,GO:0004336,1,0.993062132645521,0,1,galactosylceramidase activity,MF,
1906,GO:0004337,1,0.989594518402589,0,2,geranyltranstransferase activity,MF,
1907,GO:0004339,1,0.991836183999699,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1908,GO:0004340,1,0.96373068129907,0,5,glucokinase activity,MF,
1909,GO:0004341,1,0.995445805928028,0,1,gluconolactonase activity,MF,
1910,GO:0004342,1,0.989962061745204,0,2,glucosamine-6-phosphate deaminase activity,MF,
1911,GO:0004343,1,0.992462380097242,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1912,GO:0004344,1,0.990883996459635,0,1,glucose dehydrogenase activity,MF,
1913,GO:0004345,1,0.985282527812147,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1914,GO:0004346,1,0.981908319341345,0,3,glucose-6-phosphatase activity,MF,
1915,GO:0004347,1,0.995030627496594,0,1,glucose-6-phosphate isomerase activity,MF,
1916,GO:0004348,1,0.982766973232787,0,3,glucosylceramidase activity,MF,
1917,GO:0004349,1,0.992547456931827,0,1,glutamate 5-kinase activity,MF,
1918,GO:0004350,1,0.992547456931827,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1919,GO:0004351,1,0.980422500430874,0,3,glutamate decarboxylase activity,MF,
1920,GO:0004352,1,0.98696274242595,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1921,GO:0004353,1,0.98696274242595,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1922,GO:0004356,1,0.984662673929916,0,2,glutamate-ammonia ligase activity,MF,
1923,GO:0004357,1,0.985373189026314,0,2,glutamate-cysteine ligase activity,MF,
1924,GO:0004359,1,0.98022721366616,0,3,glutaminase activity,MF,
1925,GO:0004360,1,0.98402842818528,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1926,GO:0004361,1,0.995936749986247,0,1,glutaryl-CoA dehydrogenase activity,MF,
1927,GO:0004362,1,0.994538208048522,0,1,glutathione-disulfide reductase activity,MF,
1928,GO:0004363,1,0.995496401693055,0,1,glutathione synthase activity,MF,
1929,GO:0004364,1,0.913076728195302,0,24,glutathione transferase activity,MF,
1930,GO:0004365,1,0.996574502845011,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1931,GO:0004366,1,0.97868966491429,0,3,glycerol-3-phosphate O-acyltransferase activity,MF,
1934,GO:0004370,1,0.982911631143413,0,2,glycerol kinase activity,MF,
1935,GO:0004372,1,0.988682996123051,0,2,glycine hydroxymethyltransferase activity,MF,
1936,GO:0004373,1,0.985381093994009,0,2,glycogen (starch) synthase activity,MF,
1937,GO:0004375,1,0.992470124072084,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1938,GO:0004376,1,0.976130899473588,0,4,glycolipid mannosyltransferase activity,MF,
1939,GO:0004377,1,0.993841257482236,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1940,GO:0004378,1,0.9930684450796,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1941,GO:0004379,1,0.984674949137127,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1942,GO:0004380,1,0.99618387510306,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1943,GO:0004381,1,0.99618387510306,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1944,GO:0004382,1,0.987693687937997,0,2,guanosine-diphosphatase activity,MF,
1945,GO:0004383,1,0.908463242212933,0,12,guanylate cyclase activity,MF,
1946,GO:0004385,1,0.910138643988533,0,13,guanylate kinase activity,MF,
1947,GO:0004386,1,0.354841842887579,0,143,helicase activity,MF,
1948,GO:0004392,1,0.992126650157578,0,2,heme oxygenase (decyclizing) activity,MF,
1949,GO:0004394,1,0.992444572665874,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1950,GO:0004395,1,0.996630186162235,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1951,GO:0004396,1,0.96373068129907,0,5,hexokinase activity,MF,
1952,GO:0004397,1,0.992755481679136,0,1,histidine ammonia-lyase activity,MF,
1953,GO:0004398,1,0.994159629741388,0,1,histidine decarboxylase activity,MF,
1954,GO:0004402,1,0.708465244224182,0,50,histone acetyltransferase activity,MF,
1955,GO:0004407,1,0.751171388549281,0,43,histone deacetylase activity,MF,
1956,GO:0004408,1,0.994489361464139,0,1,holocytochrome-c synthase activity,MF,
1957,GO:0004411,1,0.995444563568732,0,1,homogentisate 1,2-dioxygenase activity,MF,
1958,GO:0004415,1,0.965649367414258,0,6,hyalurononglucosaminidase activity,MF,
1959,GO:0004416,1,0.989183905775666,0,2,hydroxyacylglutathione hydrolase activity,MF,
1960,GO:0004418,1,0.996365237812487,0,1,hydroxymethylbilane synthase activity,MF,
1961,GO:0004419,1,0.990216971521104,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1962,GO:0004420,1,0.992397911966453,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1963,GO:0004421,1,0.986756899213672,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1964,GO:0004422,1,0.991896295476022,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1965,GO:0004423,1,0.992065429834921,0,1,iduronate-2-sulfatase activity,MF,
1966,GO:0004427,1,0.988867471317191,0,3,inorganic diphosphatase activity,MF,
1967,GO:0004430,1,0.970146429934726,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1969,GO:0004438,1,0.891759119211894,0,15,phosphatidylinositol-3-phosphatase activity,MF,
1970,GO:0004439,1,0.943129777230498,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1971,GO:0004441,1,0.995021287493055,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1972,GO:0004445,1,0.965713025948127,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1973,GO:0004446,1,0.993166936961311,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1974,GO:0004447,1,0.99298843700369,0,1,iodide peroxidase activity,MF,
1975,GO:0004448,1,0.976423462723806,0,5,isocitrate dehydrogenase activity,MF,
1976,GO:0004449,1,0.986008986019253,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1977,GO:0004450,1,0.990279884945463,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1978,GO:0004452,1,0.994907241611646,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1979,GO:0004454,1,0.994141191431396,0,1,ketohexokinase activity,MF,
1980,GO:0004457,1,0.971773540695192,0,6,lactate dehydrogenase activity,MF,
1981,GO:0004458,1,0.988899097315319,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1982,GO:0004459,1,0.982684199692995,0,4,L-lactate dehydrogenase activity,MF,
1983,GO:0004461,1,0.984519971857342,0,3,lactose synthase activity,MF,
1984,GO:0004462,1,0.995144578831723,0,1,lactoylglutathione lyase activity,MF,
1985,GO:0004463,1,0.995067895863287,0,1,leukotriene-A4 hydrolase activity,MF,
1986,GO:0004464,1,0.988055015174303,0,4,leukotriene-C4 synthase activity,MF,
1987,GO:0004465,1,0.964654453610948,0,6,lipoprotein lipase activity,MF,
1988,GO:0004466,1,0.971761367650528,0,5,long-chain-acyl-CoA dehydrogenase activity,MF,
1989,GO:0004467,1,0.920525836496653,0,12,long-chain fatty acid-CoA ligase activity,MF,
1990,GO:0004468,1,0.969598722749122,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1991,GO:0004470,1,0.976418702961248,0,4,malic enzyme activity,MF,
1992,GO:0004471,1,0.979727507884313,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1993,GO:0004473,1,0.979727507884313,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1994,GO:0004474,1,0.992077520282848,0,1,malate synthase activity,MF,
1995,GO:0004475,1,0.996141503205617,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1996,GO:0004476,1,0.995805808593524,0,1,mannose-6-phosphate isomerase activity,MF,
1997,GO:0004477,1,0.974219340035119,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1998,GO:0004478,1,0.98583986038647,0,2,methionine adenosyltransferase activity,MF,
1999,GO:0004479,1,0.99335320816281,0,1,methionyl-tRNA formyltransferase activity,MF,
2000,GO:0004482,1,0.991939458536388,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2001,GO:0004483,1,0.986646673054992,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2002,GO:0004484,1,0.992404684548203,0,1,mRNA guanylyltransferase activity,MF,
2003,GO:0004485,1,0.986346342231241,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2004,GO:0004486,1,0.992547058090461,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2005,GO:0004487,1,0.981580638895914,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2006,GO:0004488,1,0.974219340035119,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2007,GO:0004489,1,0.991621391484965,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2008,GO:0004490,1,0.996166374536362,0,1,methylglutaconyl-CoA hydratase activity,MF,
2009,GO:0004491,1,0.994769239365915,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2010,GO:0004492,1,0.994955675359441,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2011,GO:0004493,1,0.99695022923682,0,1,methylmalonyl-CoA epimerase activity,MF,
2012,GO:0004494,1,0.992982712111732,0,1,methylmalonyl-CoA mutase activity,MF,
2013,GO:0004496,1,0.995069224053367,0,1,mevalonate kinase activity,MF,
2014,GO:0004497,1,0.633785954045396,0,76,monooxygenase activity,MF,
2015,GO:0004498,1,0.993952009125385,0,1,calcidiol 1-monooxygenase activity,MF,
2016,GO:0004499,1,0.971359805873082,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2017,GO:0004500,1,0.986236723096999,0,2,dopamine beta-monooxygenase activity,MF,
2018,GO:0004502,1,0.992290432243899,0,1,kynurenine 3-monooxygenase activity,MF,
2019,GO:0004504,1,0.992481381771526,0,1,peptidylglycine monooxygenase activity,MF,
2020,GO:0004505,1,0.984673564099359,0,3,phenylalanine 4-monooxygenase activity,MF,
2021,GO:0004506,1,0.992941138183459,0,1,squalene monooxygenase activity,MF,
2022,GO:0004509,1,0.995189167543329,0,1,steroid 21-monooxygenase activity,MF,
2023,GO:0004510,1,0.990006342372104,0,2,tryptophan 5-monooxygenase activity,MF,
2024,GO:0004511,1,0.995498852347711,0,1,tyrosine 3-monooxygenase activity,MF,
2025,GO:0004512,1,0.994557222865409,0,1,inositol-3-phosphate synthase activity,MF,
2026,GO:0004513,1,0.994429790342927,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2027,GO:0004514,1,0.982030397238521,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2028,GO:0004515,1,0.97263755089244,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2029,GO:0004516,1,0.993301131169352,0,1,nicotinate phosphoribosyltransferase activity,MF,
2030,GO:0004517,1,0.978237606765904,0,3,nitric-oxide synthase activity,MF,
2032,GO:0004519,1,0.501545020165073,0,118,endonuclease activity,MF,
2033,GO:0004520,1,0.755957766705827,0,47,endodeoxyribonuclease activity,MF,
2034,GO:0004521,1,0.753995779567829,0,51,endoribonuclease activity,MF,
2035,GO:0004522,1,0.990195005093918,0,3,ribonuclease A activity,MF,
2036,GO:0004523,1,0.972989137373299,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2037,GO:0004525,1,0.972257904446764,0,4,ribonuclease III activity,MF,
2038,GO:0004526,1,0.94529646124886,0,11,ribonuclease P activity,MF,
2041,GO:0004529,1,0.891403145609496,0,19,exodeoxyribonuclease activity,MF,
2042,GO:0004530,1,0.983275913513173,0,2,deoxyribonuclease I activity,MF,
2043,GO:0004531,1,0.992016799123501,0,2,deoxyribonuclease II activity,MF,
2044,GO:0004532,1,0.807797282472351,0,34,exoribonuclease activity,MF,
2045,GO:0004534,1,0.974191322021,0,3,5'-3' exoribonuclease activity,MF,
2046,GO:0004535,1,0.918277467821165,0,12,poly(A)-specific ribonuclease activity,MF,
2047,GO:0004536,1,0.67965128134346,0,65,deoxyribonuclease activity,MF,
2048,GO:0004540,1,0.583552387449311,0,94,ribonuclease activity,MF,
2049,GO:0004549,1,0.919756010554285,0,16,tRNA-specific ribonuclease activity,MF,
2050,GO:0004550,1,0.914019707918511,0,17,nucleoside diphosphate kinase activity,MF,
2052,GO:0004553,1,0.61917625933188,0,76,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2053,GO:0004556,1,0.990888155496655,0,2,alpha-amylase activity,MF,
2054,GO:0004557,1,0.988944406241911,0,2,alpha-galactosidase activity,MF,
2055,GO:0004558,1,0.976901605395316,0,3,alpha-1,4-glucosidase activity,MF,
2056,GO:0004559,1,0.908346248496119,0,13,alpha-mannosidase activity,MF,
2057,GO:0004560,1,0.9899845089198,0,2,alpha-L-fucosidase activity,MF,
2058,GO:0004561,1,0.9932893754567,0,1,alpha-N-acetylglucosaminidase activity,MF,
2059,GO:0004563,1,0.969365664809171,0,5,beta-N-acetylhexosaminidase activity,MF,
2060,GO:0004565,1,0.963293137338253,0,6,beta-galactosidase activity,MF,
2061,GO:0004566,1,0.982666162317071,0,3,beta-glucuronidase activity,MF,
2062,GO:0004567,1,0.992623937227321,0,1,beta-mannosidase activity,MF,
2063,GO:0004568,1,0.96687297948573,0,6,chitinase activity,MF,
2064,GO:0004569,1,0.992387620804496,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2065,GO:0004571,1,0.950985341686459,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2066,GO:0004572,1,0.984236655228734,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2067,GO:0004573,1,0.993391351428194,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2068,GO:0004574,1,0.992505115734521,0,1,oligo-1,6-glucosidase activity,MF,
2069,GO:0004576,1,0.950717226991259,0,10,oligosaccharyl transferase activity,MF,
2070,GO:0004577,1,0.989721576197194,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2071,GO:0004578,1,0.992461598478919,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2072,GO:0004579,1,0.953838693100998,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2073,GO:0004581,1,0.996729082973446,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2074,GO:0004582,1,0.99019149291884,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2075,GO:0004583,1,0.972080694478099,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2076,GO:0004584,1,0.994287180162626,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2077,GO:0004585,1,0.996056695280523,0,1,ornithine carbamoyltransferase activity,MF,
2078,GO:0004586,1,0.980933750612083,0,3,ornithine decarboxylase activity,MF,
2079,GO:0004587,1,0.99530696507739,0,1,ornithine-oxo-acid transaminase activity,MF,
2080,GO:0004588,1,0.993551159478482,0,1,orotate phosphoribosyltransferase activity,MF,
2081,GO:0004590,1,0.993551159478482,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2082,GO:0004591,1,0.973984984540956,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2083,GO:0004594,1,0.975649481768167,0,4,pantothenate kinase activity,MF,
2084,GO:0004595,1,0.99446226306756,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2085,GO:0004596,1,0.936172409048854,0,11,peptide alpha-N-acetyltransferase activity,MF,
2086,GO:0004597,1,0.992498740042784,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2087,GO:0004598,1,0.992481381771526,0,1,peptidylamidoglycolate lyase activity,MF,
2088,GO:0004601,1,0.831408421911348,0,38,peroxidase activity,MF,
2089,GO:0004602,1,0.941625318040006,0,16,glutathione peroxidase activity,MF,
2090,GO:0004603,1,0.996743704416587,0,1,phenylethanolamine N-methyltransferase activity,MF,
2091,GO:0004605,1,0.97927158370531,0,3,phosphatidate cytidylyltransferase activity,MF,
2092,GO:0004607,1,0.996523619597102,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2093,GO:0004608,1,0.996874428829302,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2094,GO:0004609,1,0.988443932427539,0,2,phosphatidylserine decarboxylase activity,MF,
2095,GO:0004610,1,0.995261942944646,0,1,phosphoacetylglucosamine mutase activity,MF,
2096,GO:0004611,1,0.98886621968352,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2097,GO:0004613,1,0.98886621968352,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2098,GO:0004614,1,0.966121302502916,0,5,phosphoglucomutase activity,MF,
2099,GO:0004615,1,0.991015603700866,0,2,phosphomannomutase activity,MF,
2100,GO:0004616,1,0.983290380949916,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2101,GO:0004617,1,0.995207441959663,0,1,phosphoglycerate dehydrogenase activity,MF,
2102,GO:0004618,1,0.994117553733768,0,1,phosphoglycerate kinase activity,MF,
2103,GO:0004619,1,0.984397138446713,0,4,phosphoglycerate mutase activity,MF,
2105,GO:0004621,1,0.994485294736201,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2107,GO:0004623,1,0.865474922856708,0,26,phospholipase A2 activity,MF,
2109,GO:0004630,1,0.965765152445769,0,6,phospholipase D activity,MF,
2110,GO:0004631,1,0.99659352314916,0,1,phosphomevalonate kinase activity,MF,
2111,GO:0004632,1,0.996632974104703,0,1,phosphopantothenate--cysteine ligase activity,MF,
2112,GO:0004633,1,0.994676855768885,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2113,GO:0004634,1,0.979576400988684,0,4,phosphopyruvate hydratase activity,MF,
2114,GO:0004637,1,0.992558086927429,0,1,phosphoribosylamine-glycine ligase activity,MF,
2115,GO:0004638,1,0.992610488389052,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2116,GO:0004639,1,0.992610488389052,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2117,GO:0004641,1,0.992558086927429,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2118,GO:0004642,1,0.992187253738381,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2119,GO:0004643,1,0.99500391878438,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2120,GO:0004644,1,0.992558086927429,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2121,GO:0004645,1,0.960528683960006,0,6,phosphorylase activity,MF,
2122,GO:0004647,1,0.986337881413349,0,3,phosphoserine phosphatase activity,MF,
2123,GO:0004648,1,0.994943583603057,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2124,GO:0004649,1,0.988443310308035,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2125,GO:0004651,1,0.988507861631692,0,2,polynucleotide 5'-phosphatase activity,MF,
2126,GO:0004652,1,0.935426847865059,0,9,polynucleotide adenylyltransferase activity,MF,
2127,GO:0004653,1,0.877850541185268,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2128,GO:0004654,1,0.992382517855332,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2129,GO:0004655,1,0.992724168840102,0,1,porphobilinogen synthase activity,MF,
2130,GO:0004656,1,0.976219064554295,0,4,procollagen-proline 4-dioxygenase activity,MF,
2131,GO:0004657,1,0.994676855768885,0,1,proline dehydrogenase activity,MF,
2132,GO:0004658,1,0.989723747822911,0,2,propionyl-CoA carboxylase activity,MF,
2133,GO:0004659,1,0.911853393610382,0,15,prenyltransferase activity,MF,
2134,GO:0004660,1,0.989377311108967,0,2,protein farnesyltransferase activity,MF,
2135,GO:0004661,1,0.973617596005635,0,5,protein geranylgeranyltransferase activity,MF,
2136,GO:0004662,1,0.989562684743077,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2137,GO:0004663,1,0.980095030012196,0,4,Rab geranylgeranyltransferase activity,MF,
2138,GO:0004666,1,0.984744509759225,0,2,prostaglandin-endoperoxide synthase activity,MF,
2139,GO:0004667,1,0.993110699494595,0,2,prostaglandin-D synthase activity,MF,
2140,GO:0004668,1,0.972412065440938,0,4,protein-arginine deiminase activity,MF,
2141,GO:0004671,1,0.992339824465662,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2143,GO:0004673,1,0.952031427655227,0,7,protein histidine kinase activity,MF,
2145,GO:0004675,1,0.890767161951135,0,15,transmembrane receptor protein serine/threonine kinase activity,MF,
2146,GO:0004676,1,0.991657922458636,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2147,GO:0004677,1,0.972303664148431,0,3,DNA-dependent protein kinase activity,MF,
2148,GO:0004679,1,0.953104952604244,0,7,AMP-activated protein kinase activity,MF,
2150,GO:0004686,1,0.99152708568041,0,1,elongation factor-2 kinase activity,MF,
2151,GO:0004687,1,0.968491509105334,0,4,myosin light chain kinase activity,MF,
2153,GO:0004690,1,0.94183664442784,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2154,GO:0004691,1,0.95605208079123,0,6,cAMP-dependent protein kinase activity,MF,
2155,GO:0004692,1,0.985138007351703,0,2,cGMP-dependent protein kinase activity,MF,
2157,GO:0004694,1,0.970686367205382,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2158,GO:0004697,1,0.89404537886002,0,15,protein kinase C activity,MF,
2159,GO:0004698,1,0.976171551967863,0,3,calcium-dependent protein kinase C activity,MF,
2160,GO:0004699,1,0.978114694060372,0,3,calcium-independent protein kinase C activity,MF,
2162,GO:0004703,1,0.976606851392198,0,4,G-protein coupled receptor kinase activity,MF,
2163,GO:0004704,1,0.969255357209213,0,5,NF-kappaB-inducing kinase activity,MF,
2164,GO:0004705,1,0.981431350797352,0,3,JUN kinase activity,MF,
2165,GO:0004706,1,0.977372856152047,0,3,JUN kinase kinase kinase activity,MF,
2166,GO:0004707,1,0.916648950101733,0,14,MAP kinase activity,MF,
2167,GO:0004708,1,0.908257932341733,0,15,MAP kinase kinase activity,MF,
2169,GO:0004711,1,0.949354532022844,0,7,ribosomal protein S6 kinase activity,MF,
2170,GO:0004712,1,0.765220351500517,0,41,protein serine/threonine/tyrosine kinase activity,MF,
2173,GO:0004715,1,0.718222051042625,0,49,non-membrane spanning protein tyrosine kinase activity,MF,
2175,GO:0004719,1,0.980913859052311,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2176,GO:0004720,1,0.95852142267952,0,6,protein-lysine 6-oxidase activity,MF,
2178,GO:0004722,1,0.648202681353231,0,67,protein serine/threonine phosphatase activity,MF,
2179,GO:0004723,1,0.949913342996805,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2181,GO:0004726,1,0.950630497090073,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2182,GO:0004727,1,0.991732860268434,0,2,prenylated protein tyrosine phosphatase activity,MF,
2183,GO:0004728,1,0.993704684941535,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2184,GO:0004729,1,0.995867147666841,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2185,GO:0004730,1,0.99602606982278,0,1,pseudouridylate synthase activity,MF,
2186,GO:0004731,1,0.98651127645954,0,2,purine-nucleoside phosphorylase activity,MF,
2187,GO:0004733,1,0.992549878178608,0,1,pyridoxamine-phosphate oxidase activity,MF,
2188,GO:0004735,1,0.991528662342021,0,2,pyrroline-5-carboxylate reductase activity,MF,
2189,GO:0004736,1,0.992456443935857,0,1,pyruvate carboxylase activity,MF,
2190,GO:0004738,1,0.967737623453035,0,5,pyruvate dehydrogenase activity,MF,
2191,GO:0004739,1,0.988882282688302,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2192,GO:0004740,1,0.971225266243078,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2193,GO:0004741,1,0.976405765963674,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2194,GO:0004742,1,0.992422775419686,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2195,GO:0004743,1,0.986231480705538,0,2,pyruvate kinase activity,MF,
2196,GO:0004744,1,0.993643172738194,0,1,retinal isomerase activity,MF,
2197,GO:0004745,1,0.941267477406182,0,12,retinol dehydrogenase activity,MF,
2198,GO:0004747,1,0.996701175514299,0,1,ribokinase activity,MF,
2199,GO:0004748,1,0.977794937981061,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2200,GO:0004749,1,0.978655909067322,0,4,ribose phosphate diphosphokinase activity,MF,
2201,GO:0004750,1,0.994459555014854,0,1,ribulose-phosphate 3-epimerase activity,MF,
2202,GO:0004751,1,0.9956636590875,0,1,ribose-5-phosphate isomerase activity,MF,
2203,GO:0004753,1,0.992041729878396,0,1,saccharopine dehydrogenase activity,MF,
2204,GO:0004756,1,0.988274835385018,0,2,selenide, water dikinase activity,MF,
2205,GO:0004757,1,0.996383120466399,0,1,sepiapterin reductase activity,MF,
2206,GO:0004758,1,0.966670372519949,0,5,serine C-palmitoyltransferase activity,MF,
2207,GO:0004760,1,0.996145082840474,0,1,serine-pyruvate transaminase activity,MF,
2208,GO:0004766,1,0.99661892436362,0,1,spermidine synthase activity,MF,
2209,GO:0004767,1,0.971176025700123,0,5,sphingomyelin phosphodiesterase activity,MF,
2210,GO:0004768,1,0.978779675823263,0,3,stearoyl-CoA 9-desaturase activity,MF,
2211,GO:0004769,1,0.996743704416587,0,1,steroid delta-isomerase activity,MF,
2212,GO:0004771,1,0.948176190957984,0,8,sterol esterase activity,MF,
2213,GO:0004772,1,0.992578354811395,0,1,sterol O-acyltransferase activity,MF,
2214,GO:0004773,1,0.99188425673333,0,1,steryl-sulfatase activity,MF,
2215,GO:0004774,1,0.985563886671465,0,3,succinate-CoA ligase activity,MF,
2216,GO:0004775,1,0.991208421430055,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2217,GO:0004776,1,0.990703529970293,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2218,GO:0004777,1,0.992256882334399,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2219,GO:0004778,1,0.996099695549445,0,1,succinyl-CoA hydrolase activity,MF,
2220,GO:0004779,1,0.986322848322612,0,2,sulfate adenylyltransferase activity,MF,
2221,GO:0004781,1,0.986322848322612,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2222,GO:0004782,1,0.993443196935179,0,1,sulfinoalanine decarboxylase activity,MF,
2223,GO:0004784,1,0.980971953999442,0,5,superoxide dismutase activity,MF,
2224,GO:0004788,1,0.994295209234908,0,1,thiamine diphosphokinase activity,MF,
2225,GO:0004790,1,0.993786976600625,0,1,thioether S-methyltransferase activity,MF,
2226,GO:0004791,1,0.9603272056011,0,8,thioredoxin-disulfide reductase activity,MF,
2227,GO:0004792,1,0.987227054138462,0,3,thiosulfate sulfurtransferase activity,MF,
2228,GO:0004793,1,0.988682996123051,0,2,threonine aldolase activity,MF,
2229,GO:0004794,1,0.992617348933743,0,2,L-threonine ammonia-lyase activity,MF,
2230,GO:0004795,1,0.994958360817384,0,1,threonine synthase activity,MF,
2231,GO:0004796,1,0.994965071858846,0,1,thromboxane-A synthase activity,MF,
2232,GO:0004797,1,0.988468433210536,0,2,thymidine kinase activity,MF,
2233,GO:0004798,1,0.989732068931043,0,2,thymidylate kinase activity,MF,
2234,GO:0004799,1,0.996176901233646,0,1,thymidylate synthase activity,MF,
2235,GO:0004800,1,0.986927000388662,0,2,thyroxine 5'-deiodinase activity,MF,
2236,GO:0004801,1,0.996653265674664,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2237,GO:0004802,1,0.988591255398142,0,2,transketolase activity,MF,
2238,GO:0004803,1,0.992455307730231,0,1,transposase activity,MF,
2239,GO:0004806,1,0.893325752066113,0,18,triglyceride lipase activity,MF,
2240,GO:0004807,1,0.996378677163137,0,1,triose-phosphate isomerase activity,MF,
2241,GO:0004809,1,0.98352334294844,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2242,GO:0004810,1,0.994521917273774,0,1,tRNA adenylyltransferase activity,MF,
2243,GO:0004812,1,0.763170060427434,0,44,aminoacyl-tRNA ligase activity,MF,
2244,GO:0004813,1,0.980583891103228,0,3,alanine-tRNA ligase activity,MF,
2245,GO:0004814,1,0.985193209807802,0,3,arginine-tRNA ligase activity,MF,
2246,GO:0004815,1,0.987010180270997,0,2,aspartate-tRNA ligase activity,MF,
2247,GO:0004816,1,0.987675768443306,0,2,asparagine-tRNA ligase activity,MF,
2248,GO:0004817,1,0.989174043555621,0,2,cysteine-tRNA ligase activity,MF,
2249,GO:0004818,1,0.984806462702861,0,2,glutamate-tRNA ligase activity,MF,
2250,GO:0004819,1,0.986433540900467,0,2,glutamine-tRNA ligase activity,MF,
2251,GO:0004820,1,0.989517616050866,0,2,glycine-tRNA ligase activity,MF,
2252,GO:0004821,1,0.989301071084104,0,2,histidine-tRNA ligase activity,MF,
2253,GO:0004822,1,0.984976014377416,0,2,isoleucine-tRNA ligase activity,MF,
2254,GO:0004823,1,0.984822349403225,0,2,leucine-tRNA ligase activity,MF,
2255,GO:0004824,1,0.994970437972119,0,1,lysine-tRNA ligase activity,MF,
2256,GO:0004825,1,0.986183440855765,0,2,methionine-tRNA ligase activity,MF,
2257,GO:0004826,1,0.972614638361672,0,5,phenylalanine-tRNA ligase activity,MF,
2258,GO:0004827,1,0.983481755670889,0,3,proline-tRNA ligase activity,MF,
2259,GO:0004828,1,0.990602208597386,0,2,serine-tRNA ligase activity,MF,
2260,GO:0004829,1,0.980136604924368,0,3,threonine-tRNA ligase activity,MF,
2261,GO:0004830,1,0.986734759811013,0,2,tryptophan-tRNA ligase activity,MF,
2262,GO:0004831,1,0.987661760113193,0,2,tyrosine-tRNA ligase activity,MF,
2263,GO:0004832,1,0.97742313352824,0,3,valine-tRNA ligase activity,MF,
2264,GO:0004833,1,0.992175661441217,0,2,tryptophan 2,3-dioxygenase activity,MF,
2265,GO:0004835,1,0.992255298382966,0,1,tubulin-tyrosine ligase activity,MF,
2266,GO:0004838,1,0.993322940911282,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2267,GO:0004839,1,0.963833841238017,0,5,ubiquitin activating enzyme activity,MF,
2268,GO:0004842,1,0.0568243988665826,0,422,ubiquitin-protein transferase activity,MF,
2269,GO:0004843,1,0.6069811104073,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2270,GO:0004844,1,0.976972216093084,0,5,uracil DNA N-glycosylase activity,MF,
2271,GO:0004849,1,0.974460831108359,0,5,uridine kinase activity,MF,
2272,GO:0004850,1,0.989903774481056,0,2,uridine phosphorylase activity,MF,
2273,GO:0004852,1,0.996519773532753,0,1,uroporphyrinogen-III synthase activity,MF,
2274,GO:0004853,1,0.99648037433837,0,1,uroporphyrinogen decarboxylase activity,MF,
2275,GO:0004854,1,0.984451325457926,0,2,xanthine dehydrogenase activity,MF,
2276,GO:0004855,1,0.992085240994721,0,1,xanthine oxidase activity,MF,
2277,GO:0004856,1,0.992486392628356,0,1,xylulokinase activity,MF,
2279,GO:0004859,1,0.96701390667054,0,8,phospholipase inhibitor activity,MF,
2280,GO:0004860,1,0.581475111642294,0,89,protein kinase inhibitor activity,MF,
2281,GO:0004861,1,0.939757698503032,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2282,GO:0004862,1,0.950100976433041,0,9,cAMP-dependent protein kinase inhibitor activity,MF,
2287,GO:0004869,1,0.798102726627801,0,42,cysteine-type endopeptidase inhibitor activity,MF,
2289,GO:0004873,1,0.992754897862276,0,2,asialoglycoprotein receptor activity,MF,
2290,GO:0004874,1,0.984330499725219,0,2,aryl hydrocarbon receptor activity,MF,
2291,GO:0004875,1,0.960350724962672,0,7,complement receptor activity,MF,
2292,GO:0004876,1,0.995384487152049,0,1,complement component C3a receptor activity,MF,
2293,GO:0004877,1,0.990796430774423,0,1,complement component C3b receptor activity,MF,
2294,GO:0004878,1,0.987692820230951,0,2,complement component C5a receptor activity,MF,
2295,GO:0004879,1,0.728893016887765,0,46,nuclear receptor activity,MF,
2296,GO:0004882,1,0.985583528588772,0,2,androgen receptor activity,MF,
2297,GO:0004883,1,0.99180591099737,0,1,glucocorticoid receptor activity,MF,
2298,GO:0004886,1,0.98203248610278,0,3,9-cis retinoic acid receptor activity,MF,
2299,GO:0004887,1,0.961763665168678,0,6,thyroid hormone receptor activity,MF,
2301,GO:0004890,1,0.892275861094733,0,17,GABA-A receptor activity,MF,
2302,GO:0004896,1,0.602225503017779,0,82,cytokine receptor activity,MF,
2303,GO:0004897,1,0.971200513982285,0,4,ciliary neurotrophic factor receptor activity,MF,
2304,GO:0004900,1,0.995630940447391,0,1,erythropoietin receptor activity,MF,
2305,GO:0004904,1,0.97160026093279,0,5,interferon receptor activity,MF,
2306,GO:0004905,1,0.988448432552715,0,2,type I interferon receptor activity,MF,
2307,GO:0004906,1,0.989634947225425,0,2,interferon-gamma receptor activity,MF,
2308,GO:0004908,1,0.957300859547678,0,7,interleukin-1 receptor activity,MF,
2309,GO:0004909,1,0.987691742582807,0,2,interleukin-1, Type I, activating receptor activity,MF,
2310,GO:0004910,1,0.989388283054475,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2311,GO:0004911,1,0.981520763108817,0,3,interleukin-2 receptor activity,MF,
2312,GO:0004912,1,0.992330941924007,0,1,interleukin-3 receptor activity,MF,
2313,GO:0004913,1,0.99049756710286,0,2,interleukin-4 receptor activity,MF,
2314,GO:0004914,1,0.98757217001565,0,2,interleukin-5 receptor activity,MF,
2315,GO:0004915,1,0.985219392564075,0,2,interleukin-6 receptor activity,MF,
2316,GO:0004917,1,0.992011019987462,0,2,interleukin-7 receptor activity,MF,
2317,GO:0004918,1,0.987341282607998,0,2,interleukin-8 receptor activity,MF,
2318,GO:0004920,1,0.970057523991299,0,5,interleukin-10 receptor activity,MF,
2319,GO:0004921,1,0.992717156463654,0,1,interleukin-11 receptor activity,MF,
2320,GO:0004923,1,0.983219140185317,0,2,leukemia inhibitory factor receptor activity,MF,
2321,GO:0004924,1,0.975839637632264,0,3,oncostatin-M receptor activity,MF,
2322,GO:0004925,1,0.989702413803439,0,1,prolactin receptor activity,MF,
2324,GO:0004931,1,0.962557089800266,0,7,extracellularly ATP-gated cation channel activity,MF,
2325,GO:0004935,1,0.943937971827364,0,10,adrenergic receptor activity,MF,
2326,GO:0004936,1,0.971088775048277,0,5,alpha-adrenergic receptor activity,MF,
2327,GO:0004937,1,0.982999311481993,0,3,alpha1-adrenergic receptor activity,MF,
2328,GO:0004938,1,0.987885625926886,0,2,alpha2-adrenergic receptor activity,MF,
2329,GO:0004939,1,0.98201111752564,0,3,beta-adrenergic receptor activity,MF,
2330,GO:0004940,1,0.993151250186111,0,1,beta1-adrenergic receptor activity,MF,
2331,GO:0004941,1,0.99516559747793,0,1,beta2-adrenergic receptor activity,MF,
2332,GO:0004945,1,0.987919446556528,0,3,angiotensin type II receptor activity,MF,
2333,GO:0004946,1,0.996448996988249,0,1,bombesin receptor activity,MF,
2334,GO:0004947,1,0.989075860269668,0,2,bradykinin receptor activity,MF,
2335,GO:0004948,1,0.984854556269035,0,2,calcitonin receptor activity,MF,
2336,GO:0004949,1,0.980470853414434,0,3,cannabinoid receptor activity,MF,
2337,GO:0004950,1,0.873726272797162,0,24,chemokine receptor activity,MF,
2338,GO:0004951,1,0.990964452819406,0,2,cholecystokinin receptor activity,MF,
2339,GO:0004952,1,0.964219102430307,0,7,dopamine neurotransmitter receptor activity,MF,
2340,GO:0004953,1,0.909049930605688,0,17,icosanoid receptor activity,MF,
2341,GO:0004954,1,0.937162983830551,0,11,prostanoid receptor activity,MF,
2342,GO:0004955,1,0.942311593001377,0,10,prostaglandin receptor activity,MF,
2343,GO:0004956,1,0.986366618018412,0,2,prostaglandin D receptor activity,MF,
2344,GO:0004957,1,0.965137147062966,0,6,prostaglandin E receptor activity,MF,
2345,GO:0004958,1,0.98554417389609,0,2,prostaglandin F receptor activity,MF,
2346,GO:0004960,1,0.994539565949337,0,1,thromboxane receptor activity,MF,
2347,GO:0004961,1,0.994539565949337,0,1,thromboxane A2 receptor activity,MF,
2348,GO:0004962,1,0.984958440945941,0,2,endothelin receptor activity,MF,
2349,GO:0004965,1,0.977107314923308,0,3,G-protein coupled GABA receptor activity,MF,
2350,GO:0004966,1,0.955459529108044,0,10,galanin receptor activity,MF,
2351,GO:0004967,1,0.988828806882372,0,2,glucagon receptor activity,MF,
2352,GO:0004968,1,0.9924362840838,0,1,gonadotropin-releasing hormone receptor activity,MF,
2353,GO:0004969,1,0.967872394889966,0,5,histamine receptor activity,MF,
2354,GO:0004970,1,0.859170590197407,0,19,ionotropic glutamate receptor activity,MF,
2355,GO:0004971,1,0.969186228897871,0,4,AMPA glutamate receptor activity,MF,
2356,GO:0004972,1,0.942758271326839,0,7,NMDA glutamate receptor activity,MF,
2357,GO:0004974,1,0.970021944989149,0,6,leukotriene receptor activity,MF,
2358,GO:0004977,1,0.981839816577183,0,4,melanocortin receptor activity,MF,
2359,GO:0004979,1,0.995597841356715,0,1,beta-endorphin receptor activity,MF,
2360,GO:0004980,1,0.989260107967772,0,2,melanocyte-stimulating hormone receptor activity,MF,
2361,GO:0004982,1,0.98590558924669,0,3,N-formyl peptide receptor activity,MF,
2362,GO:0004983,1,0.951406752789264,0,9,neuropeptide Y receptor activity,MF,
2363,GO:0004984,1,0.929467419582657,0,18,olfactory receptor activity,MF,
2364,GO:0004985,1,0.961054410367529,0,8,opioid receptor activity,MF,
2365,GO:0004990,1,0.992422224104015,0,1,oxytocin receptor activity,MF,
2366,GO:0004991,1,0.988361121944817,0,2,parathyroid hormone receptor activity,MF,
2367,GO:0004992,1,0.980965853694557,0,3,platelet activating factor receptor activity,MF,
2368,GO:0004993,1,0.931703363454642,0,13,G-protein coupled serotonin receptor activity,MF,
2369,GO:0004994,1,0.977800598664514,0,4,somatostatin receptor activity,MF,
2370,GO:0004995,1,0.982765008289862,0,3,tachykinin receptor activity,MF,
2371,GO:0004996,1,0.989143560902235,0,2,thyroid-stimulating hormone receptor activity,MF,
2372,GO:0004998,1,0.985383319895897,0,2,transferrin receptor activity,MF,
2373,GO:0004999,1,0.981874444762883,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2374,GO:0005000,1,0.964040667428397,0,6,vasopressin receptor activity,MF,
2375,GO:0005001,1,0.880872037275741,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2376,GO:0005003,1,0.873343005242975,0,19,ephrin receptor activity,MF,
2377,GO:0005004,1,0.94794355293339,0,7,GPI-linked ephrin receptor activity,MF,
2378,GO:0005005,1,0.885097826230085,0,17,transmembrane-ephrin receptor activity,MF,
2380,GO:0005007,1,0.963243193272723,0,5,fibroblast growth factor-activated receptor activity,MF,
2381,GO:0005008,1,0.991790182429373,0,1,hepatocyte growth factor-activated receptor activity,MF,
2382,GO:0005009,1,0.990906393116566,0,1,insulin-activated receptor activity,MF,
2383,GO:0005010,1,0.965847158709657,0,4,insulin-like growth factor-activated receptor activity,MF,
2384,GO:0005011,1,0.984860728493298,0,2,macrophage colony-stimulating factor receptor activity,MF,
2387,GO:0005019,1,0.988432306964907,0,2,platelet-derived growth factor beta-receptor activity,MF,
2388,GO:0005020,1,0.992249190269564,0,1,stem cell factor receptor activity,MF,
2390,GO:0005024,1,0.939856357842313,0,8,transforming growth factor beta-activated receptor activity,MF,
2391,GO:0005025,1,0.969805357355062,0,4,transforming growth factor beta receptor activity, type I,MF,
2392,GO:0005026,1,0.992370342052644,0,1,transforming growth factor beta receptor activity, type II,MF,
2393,GO:0005030,1,0.970322439583355,0,4,neurotrophin receptor activity,MF,
2395,GO:0005034,1,0.992753094597018,0,1,osmosensor activity,MF,
2398,GO:0005042,1,0.953127345063369,0,6,netrin receptor activity,MF,
2400,GO:0005046,1,0.989637911908882,0,2,KDEL sequence binding,MF,
2403,GO:0005049,1,0.941411643203741,0,8,nuclear export signal receptor activity,MF,
2405,GO:0005053,1,0.996339401540323,0,1,peroxisome matrix targeting signal-2 binding,MF,
2406,GO:0005055,1,0.990875145336206,0,2,laminin receptor activity,MF,
2408,GO:0005068,1,0.932500620571298,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2409,GO:0005070,1,0.694809145380403,0,57,SH3/SH2 adaptor activity,MF,
2410,GO:0005072,1,0.925633327886329,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2411,GO:0005078,1,0.943798211057561,0,7,MAP-kinase scaffold activity,MF,
2414,GO:0005086,1,0.862269792819268,0,20,ARF guanyl-nucleotide exchange factor activity,MF,
2415,GO:0005087,1,0.98010576524074,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2417,GO:0005089,1,0.542414648433556,0,77,Rho guanyl-nucleotide exchange factor activity,MF,
2418,GO:0005090,1,0.994815341582593,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2419,GO:0005092,1,0.923351496799251,0,14,GDP-dissociation inhibitor activity,MF,
2420,GO:0005093,1,0.988325900756676,0,2,Rab GDP-dissociation inhibitor activity,MF,
2421,GO:0005094,1,0.989232993647581,0,3,Rho GDP-dissociation inhibitor activity,MF,
2422,GO:0005095,1,0.916382934789095,0,14,GTPase inhibitor activity,MF,
2425,GO:0005104,1,0.891312043266853,0,20,fibroblast growth factor receptor binding,MF,
2426,GO:0005105,1,0.987546053001771,0,3,type 1 fibroblast growth factor receptor binding,MF,
2428,GO:0005111,1,0.990053980200383,0,3,type 2 fibroblast growth factor receptor binding,MF,
2429,GO:0005112,1,0.852909123002528,0,21,Notch binding,MF,
2430,GO:0005113,1,0.957404812521794,0,7,patched binding,MF,
2431,GO:0005114,1,0.953101728855377,0,7,type II transforming growth factor beta receptor binding,MF,
2432,GO:0005115,1,0.992057652763443,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2433,GO:0005119,1,0.976604255587505,0,3,smoothened binding,MF,
2434,GO:0005123,1,0.909272631278737,0,16,death receptor binding,MF,
2435,GO:0005124,1,0.981222891361985,0,4,scavenger receptor binding,MF,
2439,GO:0005128,1,0.989241606181274,0,2,erythropoietin receptor binding,MF,
2440,GO:0005130,1,0.996290751187902,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2441,GO:0005131,1,0.971930245701833,0,4,growth hormone receptor binding,MF,
2442,GO:0005134,1,0.982053793458131,0,3,interleukin-2 receptor binding,MF,
2443,GO:0005135,1,0.99265911996969,0,1,interleukin-3 receptor binding,MF,
2444,GO:0005136,1,0.988652137279539,0,2,interleukin-4 receptor binding,MF,
2445,GO:0005137,1,0.994818050822592,0,1,interleukin-5 receptor binding,MF,
2446,GO:0005138,1,0.95977176240168,0,7,interleukin-6 receptor binding,MF,
2447,GO:0005139,1,0.988988418990663,0,2,interleukin-7 receptor binding,MF,
2448,GO:0005141,1,0.996097850892239,0,1,interleukin-10 receptor binding,MF,
2449,GO:0005142,1,0.994311284947471,0,1,interleukin-11 receptor binding,MF,
2450,GO:0005143,1,0.984004440196701,0,3,interleukin-12 receptor binding,MF,
2451,GO:0005144,1,0.996613227145749,0,1,interleukin-13 receptor binding,MF,
2452,GO:0005146,1,0.98853314391308,0,2,leukemia inhibitory factor receptor binding,MF,
2453,GO:0005147,1,0.99560970525256,0,1,oncostatin-M receptor binding,MF,
2454,GO:0005148,1,0.996708649374044,0,1,prolactin receptor binding,MF,
2455,GO:0005149,1,0.933045740129507,0,11,interleukin-1 receptor binding,MF,
2456,GO:0005150,1,0.98832484457009,0,2,interleukin-1, Type I receptor binding,MF,
2457,GO:0005151,1,0.988024963730386,0,2,interleukin-1, Type II receptor binding,MF,
2458,GO:0005152,1,0.987554111799456,0,2,interleukin-1 receptor antagonist activity,MF,
2459,GO:0005153,1,0.986134165168467,0,2,interleukin-8 receptor binding,MF,
2460,GO:0005154,1,0.820445471383187,0,29,epidermal growth factor receptor binding,MF,
2461,GO:0005157,1,0.986263132256677,0,3,macrophage colony-stimulating factor receptor binding,MF,
2462,GO:0005158,1,0.850983692899462,0,21,insulin receptor binding,MF,
2463,GO:0005159,1,0.918025521706099,0,13,insulin-like growth factor receptor binding,MF,
2464,GO:0005160,1,0.755660197980391,0,45,transforming growth factor beta receptor binding,MF,
2466,GO:0005163,1,0.996835169272308,0,1,nerve growth factor receptor binding,MF,
2467,GO:0005164,1,0.86231275776009,0,29,tumor necrosis factor receptor binding,MF,
2468,GO:0005165,1,0.932070069789478,0,11,neurotrophin receptor binding,MF,
2469,GO:0005166,1,0.987148972312285,0,3,neurotrophin p75 receptor binding,MF,
2470,GO:0005167,1,0.944247928885169,0,8,neurotrophin TRK receptor binding,MF,
2471,GO:0005168,1,0.954413738378694,0,6,neurotrophin TRKA receptor binding,MF,
2472,GO:0005169,1,0.98164391453731,0,3,neurotrophin TRKB receptor binding,MF,
2473,GO:0005170,1,0.992208033586699,0,1,neurotrophin TRKC receptor binding,MF,
2474,GO:0005171,1,0.990404848638604,0,2,hepatocyte growth factor receptor binding,MF,
2476,GO:0005173,1,0.976397521208336,0,3,stem cell factor receptor binding,MF,
2477,GO:0005174,1,0.990204399177956,0,2,CD40 receptor binding,MF,
2478,GO:0005175,1,0.997032435821031,0,1,CD27 receptor binding,MF,
2479,GO:0005176,1,0.983487562200168,0,3,ErbB-2 class receptor binding,MF,
2481,GO:0005179,1,0.725204276375217,0,69,hormone activity,MF,
2482,GO:0005183,1,0.993036711293047,0,2,gonadotropin hormone-releasing hormone activity,MF,
2483,GO:0005184,1,0.925364286825343,0,20,neuropeptide hormone activity,MF,
2485,GO:0005199,1,0.992596190531154,0,1,structural constituent of cell wall,MF,
2488,GO:0005212,1,0.951749223980623,0,13,structural constituent of eye lens,MF,
2491,GO:0005217,1,0.782745162190663,0,31,intracellular ligand-gated ion channel activity,MF,
2492,GO:0005219,1,0.960083790340893,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2493,GO:0005220,1,0.970931017977315,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2494,GO:0005221,1,0.937797615291391,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2495,GO:0005222,1,0.944084173606526,0,8,intracellular cAMP activated cation channel activity,MF,
2496,GO:0005223,1,0.960324421270675,0,6,intracellular cGMP activated cation channel activity,MF,
2497,GO:0005225,1,0.930950868166382,0,10,volume-sensitive anion channel activity,MF,
2498,GO:0005227,1,0.842160343399361,0,27,calcium activated cation channel activity,MF,
2499,GO:0005228,1,0.98443251054066,0,2,intracellular sodium activated potassium channel activity,MF,
2500,GO:0005229,1,0.880159575701023,0,18,intracellular calcium activated chloride channel activity,MF,
2501,GO:0005230,1,0.636356167462281,0,68,extracellular ligand-gated ion channel activity,MF,
2502,GO:0005231,1,0.733639311610134,0,46,excitatory extracellular ligand-gated ion channel activity,MF,
2503,GO:0005234,1,0.859632644443968,0,19,extracellularly glutamate-gated ion channel activity,MF,
2504,GO:0005237,1,0.900763583641317,0,15,inhibitory extracellular ligand-gated ion channel activity,MF,
2508,GO:0005245,1,0.747849506745345,0,41,voltage-gated calcium channel activity,MF,
2509,GO:0005246,1,0.835238519252661,0,30,calcium channel regulator activity,MF,
2510,GO:0005247,1,0.934254108859375,0,10,voltage-gated chloride channel activity,MF,
2511,GO:0005248,1,0.832089732995654,0,23,voltage-gated sodium channel activity,MF,
2513,GO:0005250,1,0.9725232980106,0,4,A-type (transient outward) potassium channel activity,MF,
2514,GO:0005251,1,0.838682557651197,0,26,delayed rectifier potassium channel activity,MF,
2515,GO:0005252,1,0.992459378806887,0,1,open rectifier potassium channel activity,MF,
2516,GO:0005253,1,0.56858394965753,0,86,anion channel activity,MF,
2517,GO:0005254,1,0.613677388820943,0,73,chloride channel activity,MF,
2518,GO:0005260,1,0.99195842197487,0,1,intracellularly ATP-gated chloride channel activity,MF,
2520,GO:0005262,1,0.433722445877993,0,112,calcium channel activity,MF,
2522,GO:0005272,1,0.713902202770877,0,44,sodium channel activity,MF,
2523,GO:0005275,1,0.988267222632248,0,2,amine transmembrane transporter activity,MF,
2524,GO:0005277,1,0.983753563125591,0,3,acetylcholine transmembrane transporter activity,MF,
2525,GO:0005280,1,0.97442289874886,0,4,amino acid:proton symporter activity,MF,
2526,GO:0005283,1,0.888114178116272,0,17,amino acid:sodium symporter activity,MF,
2527,GO:0005287,1,0.985799436843644,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2528,GO:0005289,1,0.985799436843644,0,2,high-affinity arginine transmembrane transporter activity,MF,
2529,GO:0005290,1,0.980707185577228,0,3,L-histidine transmembrane transporter activity,MF,
2530,GO:0005292,1,0.985799436843644,0,2,high-affinity lysine transmembrane transporter activity,MF,
2531,GO:0005294,1,0.990660807007433,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2532,GO:0005295,1,0.985871378742581,0,2,neutral amino acid:sodium symporter activity,MF,
2533,GO:0005298,1,0.984957603405454,0,2,proline:sodium symporter activity,MF,
2534,GO:0005302,1,0.992755481679136,0,1,L-tyrosine transmembrane transporter activity,MF,
2535,GO:0005308,1,0.984956934237111,0,2,creatine transmembrane transporter activity,MF,
2536,GO:0005309,1,0.992522306292902,0,1,creatine:sodium symporter activity,MF,
2537,GO:0005310,1,0.785494524331206,0,35,dicarboxylic acid transmembrane transporter activity,MF,
2538,GO:0005313,1,0.90385234703691,0,14,L-glutamate transmembrane transporter activity,MF,
2539,GO:0005314,1,0.95327626068987,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2540,GO:0005315,1,0.969678638428179,0,4,inorganic phosphate transmembrane transporter activity,MF,
2541,GO:0005316,1,0.992646386227553,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2543,GO:0005324,1,0.973297011405567,0,5,long-chain fatty acid transporter activity,MF,
2544,GO:0005326,1,0.725939237865805,0,47,neurotransmitter transporter activity,MF,
2545,GO:0005328,1,0.849000727166473,0,23,neurotransmitter:sodium symporter activity,MF,
2546,GO:0005329,1,0.959774598840603,0,6,dopamine transmembrane transporter activity,MF,
2547,GO:0005330,1,0.977623254114857,0,3,dopamine:sodium symporter activity,MF,
2548,GO:0005332,1,0.975297607313444,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2549,GO:0005333,1,0.982221713079887,0,3,norepinephrine transmembrane transporter activity,MF,
2550,GO:0005334,1,0.992601219484349,0,1,norepinephrine:sodium symporter activity,MF,
2551,GO:0005335,1,0.992393455043034,0,1,serotonin:sodium symporter activity,MF,
2552,GO:0005337,1,0.966295096786023,0,6,nucleoside transmembrane transporter activity,MF,
2553,GO:0005338,1,0.931953855624146,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2554,GO:0005342,1,0.410573968792844,0,137,organic acid transmembrane transporter activity,MF,
2555,GO:0005343,1,0.839505859706822,0,26,organic acid:sodium symporter activity,MF,
2556,GO:0005344,1,0.953870221648995,0,13,oxygen carrier activity,MF,
2557,GO:0005345,1,0.971976777178353,0,5,purine nucleobase transmembrane transporter activity,MF,
2558,GO:0005346,1,0.93623875312755,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2559,GO:0005347,1,0.951333460051611,0,8,ATP transmembrane transporter activity,MF,
2560,GO:0005350,1,0.98281725536332,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2562,GO:0005353,1,0.994400074224895,0,1,fructose transmembrane transporter activity,MF,
2564,GO:0005362,1,0.987219806642988,0,2,low-affinity glucose:sodium symporter activity,MF,
2565,GO:0005365,1,0.981564995602851,0,2,myo-inositol transmembrane transporter activity,MF,
2566,GO:0005366,1,0.991673827508376,0,1,myo-inositol:proton symporter activity,MF,
2567,GO:0005367,1,0.989807175050979,0,1,myo-inositol:sodium symporter activity,MF,
2568,GO:0005368,1,0.991840820277884,0,1,taurine transmembrane transporter activity,MF,
2569,GO:0005369,1,0.991840820277884,0,1,taurine:sodium symporter activity,MF,
2570,GO:0005372,1,0.941570506048552,0,11,water transmembrane transporter activity,MF,
2573,GO:0005384,1,0.956451807980655,0,6,manganese ion transmembrane transporter activity,MF,
2574,GO:0005385,1,0.886243504380006,0,19,zinc ion transmembrane transporter activity,MF,
2575,GO:0005388,1,0.893696338281407,0,14,calcium-transporting ATPase activity,MF,
2576,GO:0005391,1,0.928408014780642,0,12,sodium:potassium-exchanging ATPase activity,MF,
2577,GO:0005395,1,0.991547032987947,0,1,eye pigment precursor transporter activity,MF,
2580,GO:0005415,1,0.989842727751895,0,2,nucleoside:sodium symporter activity,MF,
2581,GO:0005416,1,0.875554532719594,0,19,amino acid:cation symporter activity,MF,
2582,GO:0005427,1,0.992484065920251,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2583,GO:0005432,1,0.959895376767427,0,6,calcium:sodium antiporter activity,MF,
2584,GO:0005436,1,0.962025025846237,0,6,sodium:phosphate symporter activity,MF,
2585,GO:0005451,1,0.910661891518545,0,13,monovalent cation:proton antiporter activity,MF,
2586,GO:0005452,1,0.84116177671497,0,26,inorganic anion exchanger activity,MF,
2587,GO:0005456,1,0.995716548218036,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2588,GO:0005457,1,0.984502714288858,0,2,GDP-fucose transmembrane transporter activity,MF,
2589,GO:0005459,1,0.992635567496564,0,2,UDP-galactose transmembrane transporter activity,MF,
2590,GO:0005461,1,0.991855684452126,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2591,GO:0005462,1,0.986638549374941,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2592,GO:0005464,1,0.991737863007027,0,1,UDP-xylose transmembrane transporter activity,MF,
2593,GO:0005471,1,0.98897197754835,0,2,ATP:ADP antiporter activity,MF,
2594,GO:0005476,1,0.984562432243191,0,3,carnitine:acyl carnitine antiporter activity,MF,
2595,GO:0005477,1,0.9925232450604,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2596,GO:0005483,1,0.980707869850427,0,3,soluble NSF attachment protein activity,MF,
2597,GO:0005484,1,0.81501349480965,0,36,SNAP receptor activity,MF,
2600,GO:0005497,1,0.981688497435292,0,4,androgen binding,MF,
2601,GO:0005499,1,0.973856619765137,0,4,vitamin D binding,MF,
2602,GO:0005501,1,0.881724681602605,0,23,retinoid binding,MF,
2603,GO:0005502,1,0.975954119296958,0,4,11-cis retinal binding,MF,
2604,GO:0005503,1,0.987712229338497,0,2,all-trans retinal binding,MF,
2605,GO:0005504,1,0.88993251634353,0,24,fatty acid binding,MF,
2607,GO:0005507,1,0.760147953430713,0,49,copper ion binding,MF,
2609,GO:0005513,1,0.920778657284729,0,13,detection of calcium ion,BP,
2612,GO:0005518,1,0.663667322423027,0,59,collagen binding,MF,
2613,GO:0005519,1,0.992459190184057,0,1,cytoskeletal regulatory protein binding,MF,
2614,GO:0005520,1,0.840263599572672,0,29,insulin-like growth factor binding,MF,
2615,GO:0005521,1,0.898572239606196,0,15,lamin binding,MF,
2616,GO:0005522,1,0.925584300069633,0,10,profilin binding,MF,
2617,GO:0005523,1,0.930590178437847,0,13,tropomyosin binding,MF,
2620,GO:0005527,1,0.932747911579075,0,13,macrolide binding,MF,
2621,GO:0005528,1,0.932747911579075,0,13,FK506 binding,MF,
2622,GO:0005534,1,0.971145168667179,0,5,galactose binding,MF,
2623,GO:0005536,1,0.928070519714386,0,11,glucose binding,MF,
2624,GO:0005537,1,0.924147190479086,0,14,mannose binding,MF,
2627,GO:0005542,1,0.954452234013647,0,10,folic acid binding,MF,
2629,GO:0005544,1,0.732952617559731,0,48,calcium-dependent phospholipid binding,MF,
2630,GO:0005545,1,0.892800018369619,0,15,1-phosphatidylinositol binding,MF,
2632,GO:0005547,1,0.787920575957109,0,33,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2634,GO:0005549,1,0.985985608789513,0,4,odorant binding,MF,
2637,GO:0005577,1,0.95717516787921,0,7,fibrinogen complex,CC,
2639,GO:0005579,1,0.970894752703817,0,4,membrane attack complex,CC,
2641,GO:0005582,1,0.992214763777273,0,1,collagen type XV trimer,CC,
2642,GO:0005583,1,0.910597698732232,0,12,fibrillar collagen trimer,CC,
2643,GO:0005584,1,0.984249986374208,0,2,collagen type I trimer,CC,
2644,GO:0005585,1,0.992288691675843,0,1,collagen type II trimer,CC,
2645,GO:0005586,1,0.992149512083848,0,1,collagen type III trimer,CC,
2646,GO:0005587,1,0.950156899113086,0,6,collagen type IV trimer,CC,
2647,GO:0005588,1,0.974952048537036,0,3,collagen type V trimer,CC,
2648,GO:0005589,1,0.979899515349452,0,3,collagen type VI trimer,CC,
2649,GO:0005590,1,0.990815273091548,0,1,collagen type VII trimer,CC,
2650,GO:0005591,1,0.993621023232784,0,1,collagen type VIII trimer,CC,
2651,GO:0005592,1,0.983595594608913,0,2,collagen type XI trimer,CC,
2654,GO:0005595,1,0.990563442686377,0,1,collagen type XII trimer,CC,
2655,GO:0005596,1,0.991846442473034,0,1,collagen type XIV trimer,CC,
2656,GO:0005597,1,0.9921152450986,0,1,collagen type XVI trimer,CC,
2657,GO:0005598,1,0.993621023232784,0,1,short-chain collagen trimer,CC,
2658,GO:0005600,1,0.992856680424197,0,1,collagen type XIII trimer,CC,
2659,GO:0005602,1,0.993646471259058,0,2,complement component C1 complex,CC,
2661,GO:0005605,1,0.853260483766475,0,20,basal lamina,CC,
2662,GO:0005606,1,0.974312376282229,0,3,laminin-1 complex,CC,
2663,GO:0005607,1,0.984381415493273,0,2,laminin-2 complex,CC,
2664,GO:0005608,1,0.982828053185411,0,2,laminin-3 complex,CC,
2665,GO:0005610,1,0.973828607832492,0,3,laminin-5 complex,CC,
2666,GO:0005614,1,0.915581655230041,0,12,interstitial matrix,CC,
2672,GO:0005637,1,0.724940541363551,0,50,nuclear inner membrane,CC,
2673,GO:0005638,1,0.974455547858921,0,4,lamin filament,CC,
2674,GO:0005639,1,0.914022207877022,0,14,integral component of nuclear inner membrane,CC,
2676,GO:0005641,1,0.945426739990715,0,8,nuclear envelope lumen,CC,
2677,GO:0005642,1,0.96393415127552,0,5,annulate lamellae,CC,
2678,GO:0005643,1,0.599760294441596,0,76,nuclear pore,CC,
2679,GO:0005652,1,0.943308740889341,0,9,nuclear lamina,CC,
2681,GO:0005655,1,0.963860053158983,0,8,nucleolar ribonuclease P complex,CC,
2682,GO:0005656,1,0.985056757164688,0,3,nuclear pre-replicative complex,CC,
2683,GO:0005657,1,0.660386046679504,0,67,replication fork,CC,
2684,GO:0005658,1,0.962934557923107,0,6,alpha DNA polymerase:primase complex,CC,
2685,GO:0005662,1,0.919058473217042,0,14,DNA replication factor A complex,CC,
2686,GO:0005663,1,0.971849247493681,0,6,DNA replication factor C complex,CC,
2687,GO:0005664,1,0.94149162348737,0,9,nuclear origin of replication recognition complex,CC,
2688,GO:0005665,1,0.910008083366212,0,18,DNA-directed RNA polymerase II, core complex,CC,
2689,GO:0005666,1,0.915460615813279,0,17,DNA-directed RNA polymerase III complex,CC,
2690,GO:0005667,1,0.130491697766702,0,319,transcription factor complex,CC,
2691,GO:0005668,1,0.991081059921787,0,2,RNA polymerase transcription factor SL1 complex,CC,
2692,GO:0005669,1,0.814635944121782,0,36,transcription factor TFIID complex,CC,
2693,GO:0005671,1,0.91662066994755,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2694,GO:0005672,1,0.980908671110342,0,5,transcription factor TFIIA complex,CC,
2695,GO:0005673,1,0.989173585882298,0,2,transcription factor TFIIE complex,CC,
2696,GO:0005674,1,0.990191855128904,0,2,transcription factor TFIIF complex,CC,
2697,GO:0005675,1,0.939198732928267,0,12,holo TFIIH complex,CC,
2698,GO:0005677,1,0.944699335718521,0,8,chromatin silencing complex,CC,
2699,GO:0005680,1,0.888935286012434,0,21,anaphase-promoting complex,CC,
2700,GO:0005681,1,0.34581100673724,0,180,spliceosomal complex,CC,
2701,GO:0005682,1,0.87582253051634,0,22,U5 snRNP,CC,
2702,GO:0005683,1,0.974599595281196,0,7,U7 snRNP,CC,
2703,GO:0005684,1,0.731998922950143,0,57,U2-type spliceosomal complex,CC,
2704,GO:0005685,1,0.904438628006672,0,20,U1 snRNP,CC,
2705,GO:0005686,1,0.907456162955724,0,20,U2 snRNP,CC,
2706,GO:0005687,1,0.951301243620303,0,11,U4 snRNP,CC,
2707,GO:0005688,1,0.966243715880197,0,8,U6 snRNP,CC,
2708,GO:0005689,1,0.886696433823836,0,26,U12-type spliceosomal complex,CC,
2709,GO:0005690,1,0.994750234888056,0,1,U4atac snRNP,CC,
2710,GO:0005691,1,0.992418417671425,0,1,U6atac snRNP,CC,
2712,GO:0005697,1,0.876333235807354,0,22,telomerase holoenzyme complex,CC,
2713,GO:0005712,1,0.985425543685809,0,2,chiasma,CC,
2714,GO:0005713,1,0.994008371687069,0,1,recombination nodule,CC,
2715,GO:0005715,1,0.994008371687069,0,1,late recombination nodule,CC,
2716,GO:0005719,1,0.875619795668687,0,23,nuclear euchromatin,CC,
2717,GO:0005720,1,0.820451918805768,0,31,nuclear heterochromatin,CC,
2718,GO:0005721,1,0.877521280466074,0,19,pericentric heterochromatin,CC,
2719,GO:0005724,1,0.99608114730034,0,1,nuclear telomeric heterochromatin,CC,
2720,GO:0005726,1,0.969533212766888,0,4,perichromatin fibrils,CC,
2722,GO:0005731,1,0.995924480866609,0,1,nucleolus organizer region,CC,
2723,GO:0005732,1,0.915202388016965,0,20,small nucleolar ribonucleoprotein complex,CC,
2724,GO:0005736,1,0.938839274114175,0,12,DNA-directed RNA polymerase I complex,CC,
2729,GO:0005742,1,0.963588060089464,0,8,mitochondrial outer membrane translocase complex,CC,
2731,GO:0005744,1,0.943542183249064,0,11,mitochondrial inner membrane presequence translocase complex,CC,
2732,GO:0005745,1,0.986468541064654,0,2,m-AAA complex,CC,
2733,GO:0005746,1,0.747697467297063,0,76,mitochondrial respiratory chain,CC,
2734,GO:0005747,1,0.855776969073922,0,43,mitochondrial respiratory chain complex I,CC,
2735,GO:0005749,1,0.981008682933304,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2736,GO:0005750,1,0.951118670915537,0,11,mitochondrial respiratory chain complex III,CC,
2737,GO:0005751,1,0.960450708201758,0,13,mitochondrial respiratory chain complex IV,CC,
2738,GO:0005753,1,0.994739370677628,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2739,GO:0005757,1,0.981032697664078,0,4,mitochondrial permeability transition pore complex,CC,
2740,GO:0005758,1,0.704154960127575,0,69,mitochondrial intermembrane space,CC,
2741,GO:0005759,1,0.106439253030848,0,420,mitochondrial matrix,CC,
2742,GO:0005760,1,0.984875550630355,0,2,gamma DNA polymerase complex,CC,
2743,GO:0005761,1,0.729217967053928,0,82,mitochondrial ribosome,CC,
2744,GO:0005762,1,0.824154035027039,0,50,mitochondrial large ribosomal subunit,CC,
2745,GO:0005763,1,0.90428354736288,0,27,mitochondrial small ribosomal subunit,CC,
2748,GO:0005766,1,0.42488170946997,0,147,primary lysosome,CC,
2749,GO:0005767,1,0.931274501737314,0,13,secondary lysosome,CC,
2756,GO:0005775,1,0.386602828030253,0,158,vacuolar lumen,CC,
2757,GO:0005776,1,0.56705894752214,0,87,autophagosome,CC,
2760,GO:0005779,1,0.912131684369872,0,17,integral component of peroxisomal membrane,CC,
2761,GO:0005782,1,0.802004045037274,0,41,peroxisomal matrix,CC,
2763,GO:0005784,1,0.98500673223686,0,4,Sec61 translocon complex,CC,
2765,GO:0005786,1,0.971220552524572,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2766,GO:0005787,1,0.976324891347369,0,5,signal peptidase complex,CC,
2771,GO:0005793,1,0.49237816679183,0,113,endoplasmic reticulum-Golgi intermediate compartment,CC,
2773,GO:0005795,1,0.424122820167762,0,130,Golgi stack,CC,
2775,GO:0005797,1,0.956612500399178,0,8,Golgi medial cisterna,CC,
2779,GO:0005811,1,0.642062298974662,0,71,lipid droplet,CC,
2780,GO:0005813,1,0.0435902422582987,0,466,centrosome,CC,
2781,GO:0005814,1,0.444898755910895,0,118,centriole,CC,
2782,GO:0005815,1,0.0114419425575752,0,659,microtubule organizing center,CC,
2783,GO:0005816,1,0.957367862223269,0,6,spindle pole body,CC,
2784,GO:0005818,1,0.943253382882185,0,8,aster,CC,
2785,GO:0005819,1,0.130202521980077,0,305,spindle,CC,
2787,GO:0005827,1,0.966202266514894,0,5,polar microtubule,CC,
2788,GO:0005828,1,0.946731166175066,0,7,kinetochore microtubule,CC,
2790,GO:0005832,1,0.937561375380269,0,11,chaperonin-containing T-complex,CC,
2791,GO:0005833,1,0.96404511982597,0,11,hemoglobin complex,CC,
2792,GO:0005834,1,0.828227516204903,0,33,heterotrimeric G-protein complex,CC,
2793,GO:0005838,1,0.911100199056303,0,21,proteasome regulatory particle,CC,
2794,GO:0005839,1,0.928179928496395,0,19,proteasome core complex,CC,
2796,GO:0005844,1,0.693859512793227,0,69,polysome,CC,
2797,GO:0005845,1,0.936071406890024,0,11,mRNA cap binding complex,CC,
2798,GO:0005846,1,0.987255477195095,0,2,nuclear cap binding complex,CC,
2799,GO:0005847,1,0.898931707977914,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2800,GO:0005849,1,0.888067801971958,0,18,mRNA cleavage factor complex,CC,
2801,GO:0005850,1,0.971462449533396,0,4,eukaryotic translation initiation factor 2 complex,CC,
2802,GO:0005851,1,0.969330583122767,0,6,eukaryotic translation initiation factor 2B complex,CC,
2803,GO:0005852,1,0.915978167654375,0,17,eukaryotic translation initiation factor 3 complex,CC,
2804,GO:0005853,1,0.981666118738085,0,4,eukaryotic translation elongation factor 1 complex,CC,
2805,GO:0005854,1,0.989169054768234,0,2,nascent polypeptide-associated complex,CC,
2808,GO:0005859,1,0.793716282064447,0,23,muscle myosin complex,CC,
2809,GO:0005861,1,0.970683436847043,0,8,troponin complex,CC,
2810,GO:0005862,1,0.978631202818535,0,4,muscle thin filament tropomyosin,CC,
2811,GO:0005863,1,0.977183290051331,0,3,striated muscle myosin thick filament,CC,
2812,GO:0005865,1,0.775139764351149,0,30,striated muscle thin filament,CC,
2813,GO:0005868,1,0.873041580764398,0,22,cytoplasmic dynein complex,CC,
2814,GO:0005869,1,0.957130421663576,0,8,dynactin complex,CC,
2815,GO:0005871,1,0.689977676393584,0,50,kinesin complex,CC,
2816,GO:0005873,1,0.984363263516928,0,2,plus-end kinesin complex,CC,
2819,GO:0005876,1,0.681980797284929,0,57,spindle microtubule,CC,
2820,GO:0005879,1,0.972963345837236,0,4,axonemal microtubule,CC,
2821,GO:0005880,1,0.99638090108937,0,1,nuclear microtubule,CC,
2822,GO:0005881,1,0.697774593362075,0,54,cytoplasmic microtubule,CC,
2824,GO:0005883,1,0.947587344020835,0,7,neurofilament,CC,
2826,GO:0005885,1,0.952761369935653,0,11,Arp2/3 protein complex,CC,
2829,GO:0005889,1,0.985078075552567,0,2,potassium:proton exchanging ATPase complex,CC,
2830,GO:0005890,1,0.939714125613263,0,11,sodium:potassium-exchanging ATPase complex,CC,
2831,GO:0005891,1,0.753255547228633,0,40,voltage-gated calcium channel complex,CC,
2832,GO:0005892,1,0.907675839096872,0,16,acetylcholine-gated channel complex,CC,
2833,GO:0005895,1,0.994818050822592,0,1,interleukin-5 receptor complex,CC,
2834,GO:0005896,1,0.981985383628952,0,3,interleukin-6 receptor complex,CC,
2835,GO:0005898,1,0.992457094980409,0,1,interleukin-13 receptor complex,CC,
2836,GO:0005899,1,0.974177401724634,0,3,insulin receptor complex,CC,
2837,GO:0005900,1,0.985267109143379,0,2,oncostatin-M receptor complex,CC,
2839,GO:0005902,1,0.608690167166916,0,74,microvillus,CC,
2845,GO:0005914,1,0.992611081854854,0,1,spot adherens junction,CC,
2846,GO:0005915,1,0.948518723085726,0,7,zonula adherens,CC,
2853,GO:0005927,1,0.985408163779438,0,3,muscle tendon junction,CC,
2857,GO:0005940,1,0.921569942691216,0,12,septin ring,CC,
2858,GO:0005942,1,0.874298519667002,0,18,phosphatidylinositol 3-kinase complex,CC,
2859,GO:0005943,1,0.984607406004013,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2860,GO:0005944,1,0.984658752225855,0,2,phosphatidylinositol 3-kinase complex, class IB,CC,
2861,GO:0005945,1,0.985493194056801,0,2,6-phosphofructokinase complex,CC,
2862,GO:0005947,1,0.971344923642596,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2863,GO:0005952,1,0.957088898454126,0,7,cAMP-dependent protein kinase complex,CC,
2864,GO:0005953,1,0.989562684743077,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2865,GO:0005954,1,0.993987805599664,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2866,GO:0005955,1,0.968858719721294,0,4,calcineurin complex,CC,
2867,GO:0005956,1,0.990186267683005,0,2,protein kinase CK2 complex,CC,
2868,GO:0005958,1,0.977482361499158,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2869,GO:0005960,1,0.988806660692643,0,2,glycine cleavage complex,CC,
2871,GO:0005965,1,0.989377311108967,0,2,protein farnesyltransferase complex,CC,
2872,GO:0005967,1,0.979419617146097,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2873,GO:0005968,1,0.97567669599958,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2874,GO:0005969,1,0.991307049909903,0,1,serine-pyruvate aminotransferase complex,CC,
2875,GO:0005971,1,0.977794937981061,0,3,ribonucleoside-diphosphate reductase complex,CC,
2880,GO:0005979,1,0.840756371950653,0,23,regulation of glycogen biosynthetic process,BP,
2882,GO:0005981,1,0.973775733155713,0,4,regulation of glycogen catabolic process,BP,
2883,GO:0005982,1,0.991836183999699,0,1,starch metabolic process,BP,
2884,GO:0005983,1,0.991836183999699,0,1,starch catabolic process,BP,
2885,GO:0005984,1,0.944069870818203,0,9,disaccharide metabolic process,BP,
2886,GO:0005985,1,0.988786257677672,0,2,sucrose metabolic process,BP,
2887,GO:0005986,1,0.996253352559254,0,1,sucrose biosynthetic process,BP,
2888,GO:0005988,1,0.982045695610587,0,3,lactose metabolic process,BP,
2889,GO:0005989,1,0.982045695610587,0,3,lactose biosynthetic process,BP,
2890,GO:0005991,1,0.992991315674563,0,1,trehalose metabolic process,BP,
2892,GO:0005997,1,0.981206590945537,0,4,xylulose metabolic process,BP,
2893,GO:0005998,1,0.992486392628356,0,1,xylulose catabolic process,BP,
2894,GO:0005999,1,0.991641697766199,0,2,xylulose biosynthetic process,BP,
2895,GO:0006000,1,0.930166369547258,0,13,fructose metabolic process,BP,
2896,GO:0006001,1,0.976137610755857,0,4,fructose catabolic process,BP,
2897,GO:0006002,1,0.952710546938802,0,8,fructose 6-phosphate metabolic process,BP,
2898,GO:0006003,1,0.973310721195314,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2899,GO:0006004,1,0.906625096702103,0,14,fucose metabolic process,BP,
2901,GO:0006007,1,0.850448672213604,0,28,glucose catabolic process,BP,
2902,GO:0006011,1,0.961939371768173,0,6,UDP-glucose metabolic process,BP,
2903,GO:0006012,1,0.917182846269721,0,14,galactose metabolic process,BP,
2904,GO:0006013,1,0.949862388926448,0,8,mannose metabolic process,BP,
2905,GO:0006014,1,0.989096020906888,0,3,D-ribose metabolic process,BP,
2906,GO:0006015,1,0.98202398126728,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2907,GO:0006020,1,0.92475582972535,0,11,inositol metabolic process,BP,
2908,GO:0006021,1,0.975271626344246,0,4,inositol biosynthetic process,BP,
2910,GO:0006023,1,0.481314668828559,0,107,aminoglycan biosynthetic process,BP,
2911,GO:0006024,1,0.492391983930563,0,103,glycosaminoglycan biosynthetic process,BP,
2912,GO:0006026,1,0.675124358949735,0,60,aminoglycan catabolic process,BP,
2913,GO:0006027,1,0.698343656143122,0,54,glycosaminoglycan catabolic process,BP,
2915,GO:0006030,1,0.96687297948573,0,6,chitin metabolic process,BP,
2916,GO:0006032,1,0.96687297948573,0,6,chitin catabolic process,BP,
2917,GO:0006040,1,0.803557325338258,0,36,amino sugar metabolic process,BP,
2918,GO:0006041,1,0.977843329596907,0,4,glucosamine metabolic process,BP,
2919,GO:0006043,1,0.989962061745204,0,2,glucosamine catabolic process,BP,
2920,GO:0006044,1,0.908766560331575,0,15,N-acetylglucosamine metabolic process,BP,
2921,GO:0006045,1,0.984748638698277,0,2,N-acetylglucosamine biosynthetic process,BP,
2922,GO:0006046,1,0.985672245482398,0,3,N-acetylglucosamine catabolic process,BP,
2923,GO:0006047,1,0.915295256511415,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2924,GO:0006048,1,0.938561501560053,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2925,GO:0006049,1,0.993045006984047,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2926,GO:0006050,1,0.992559225976113,0,2,mannosamine metabolic process,BP,
2927,GO:0006051,1,0.992559225976113,0,2,N-acetylmannosamine metabolic process,BP,
2928,GO:0006054,1,0.940711734381263,0,11,N-acetylneuraminate metabolic process,BP,
2929,GO:0006055,1,0.996658647993507,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2930,GO:0006056,1,0.995805808593524,0,1,mannoprotein metabolic process,BP,
2931,GO:0006057,1,0.995805808593524,0,1,mannoprotein biosynthetic process,BP,
2932,GO:0006059,1,0.986884408865942,0,3,hexitol metabolic process,BP,
2933,GO:0006060,1,0.990337743761919,0,2,sorbitol metabolic process,BP,
2934,GO:0006061,1,0.996460027391501,0,1,sorbitol biosynthetic process,BP,
2935,GO:0006062,1,0.993856193451521,0,1,sorbitol catabolic process,BP,
2936,GO:0006063,1,0.957577787018173,0,8,uronic acid metabolic process,BP,
2937,GO:0006064,1,0.976204530142074,0,5,glucuronate catabolic process,BP,
2938,GO:0006065,1,0.979590534038106,0,3,UDP-glucuronate biosynthetic process,BP,
2939,GO:0006066,1,0.16950237118277,0,283,alcohol metabolic process,BP,
2940,GO:0006067,1,0.919515250637013,0,16,ethanol metabolic process,BP,
2941,GO:0006068,1,0.954584205337735,0,10,ethanol catabolic process,BP,
2942,GO:0006069,1,0.950868926663751,0,8,ethanol oxidation,BP,
2943,GO:0006071,1,0.929441063600939,0,12,glycerol metabolic process,BP,
2946,GO:0006081,1,0.674093539048799,0,69,cellular aldehyde metabolic process,BP,
2948,GO:0006083,1,0.977767870024755,0,3,acetate metabolic process,BP,
2949,GO:0006084,1,0.804117195519723,0,34,acetyl-CoA metabolic process,BP,
2950,GO:0006085,1,0.876264108354789,0,19,acetyl-CoA biosynthetic process,BP,
2951,GO:0006086,1,0.905426793297656,0,14,acetyl-CoA biosynthetic process from pyruvate,BP,
2952,GO:0006089,1,0.938769551268181,0,11,lactate metabolic process,BP,
2957,GO:0006097,1,0.990279884945463,0,2,glyoxylate cycle,BP,
2958,GO:0006098,1,0.920729791270844,0,17,pentose-phosphate shunt,BP,
2959,GO:0006099,1,0.849831426405732,0,29,tricarboxylic acid cycle,BP,
2960,GO:0006101,1,0.824194513130642,0,33,citrate metabolic process,BP,
2961,GO:0006102,1,0.976249568968925,0,5,isocitrate metabolic process,BP,
2962,GO:0006103,1,0.894261548735303,0,18,2-oxoglutarate metabolic process,BP,
2963,GO:0006104,1,0.967617489109248,0,6,succinyl-CoA metabolic process,BP,
2964,GO:0006105,1,0.935625731025695,0,11,succinate metabolic process,BP,
2965,GO:0006106,1,0.984812434486326,0,3,fumarate metabolic process,BP,
2966,GO:0006107,1,0.933605044450965,0,12,oxaloacetate metabolic process,BP,
2967,GO:0006108,1,0.963493144990181,0,7,malate metabolic process,BP,
2970,GO:0006111,1,0.840144925042033,0,26,regulation of gluconeogenesis,BP,
2972,GO:0006114,1,0.969471747661885,0,5,glycerol biosynthetic process,BP,
2974,GO:0006117,1,0.993734703919287,0,1,acetaldehyde metabolic process,BP,
2975,GO:0006119,1,0.650203095199638,0,98,oxidative phosphorylation,BP,
2976,GO:0006120,1,0.849480131026699,0,44,mitochondrial electron transport, NADH to ubiquinone,BP,
2977,GO:0006121,1,0.980951686368562,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2978,GO:0006122,1,0.936432870281384,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2979,GO:0006123,1,0.939838053085472,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2983,GO:0006144,1,0.877038336272862,0,22,purine nucleobase metabolic process,BP,
2984,GO:0006145,1,0.969700217074445,0,4,purine nucleobase catabolic process,BP,
2985,GO:0006147,1,0.992178296889712,0,1,guanine catabolic process,BP,
2986,GO:0006148,1,0.994151722015676,0,1,inosine catabolic process,BP,
2987,GO:0006152,1,0.967878735525828,0,6,purine nucleoside catabolic process,BP,
2988,GO:0006154,1,0.990035057679202,0,2,adenosine catabolic process,BP,
2989,GO:0006157,1,0.996256649183377,0,1,deoxyadenosine catabolic process,BP,
2993,GO:0006166,1,0.97653706488143,0,5,purine ribonucleoside salvage,BP,
2994,GO:0006167,1,0.971735577370129,0,6,AMP biosynthetic process,BP,
2995,GO:0006168,1,0.988929361647114,0,3,adenine salvage,BP,
2996,GO:0006169,1,0.995118220351649,0,1,adenosine salvage,BP,
2997,GO:0006171,1,0.708609878251484,0,55,cAMP biosynthetic process,BP,
2998,GO:0006172,1,0.987045282001675,0,2,ADP biosynthetic process,BP,
2999,GO:0006173,1,0.992506981441975,0,1,dADP biosynthetic process,BP,
3000,GO:0006174,1,0.993301131169352,0,1,dADP phosphorylation,BP,
3001,GO:0006175,1,0.995118220351649,0,1,dATP biosynthetic process,BP,
3002,GO:0006177,1,0.975995049180597,0,5,GMP biosynthetic process,BP,
3003,GO:0006178,1,0.991896295476022,0,2,guanine salvage,BP,
3004,GO:0006182,1,0.823529701985265,0,31,cGMP biosynthetic process,BP,
3005,GO:0006183,1,0.961047841820696,0,10,GTP biosynthetic process,BP,
3006,GO:0006185,1,0.99687648987947,0,1,dGDP biosynthetic process,BP,
3007,GO:0006186,1,0.993301131169352,0,1,dGDP phosphorylation,BP,
3008,GO:0006188,1,0.939643138854693,0,10,IMP biosynthetic process,BP,
3009,GO:0006189,1,0.961795877540252,0,6,'de novo' IMP biosynthetic process,BP,
3010,GO:0006193,1,0.996792089824971,0,1,ITP catabolic process,BP,
3011,GO:0006195,1,0.758984353899207,0,44,purine nucleotide catabolic process,BP,
3012,GO:0006196,1,0.984934419247651,0,2,AMP catabolic process,BP,
3013,GO:0006198,1,0.878065072937446,0,17,cAMP catabolic process,BP,
3014,GO:0006203,1,0.985012987368856,0,3,dGTP catabolic process,BP,
3015,GO:0006206,1,0.899385535117808,0,18,pyrimidine nucleobase metabolic process,BP,
3016,GO:0006207,1,0.957277793964284,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3017,GO:0006208,1,0.982579182626747,0,3,pyrimidine nucleobase catabolic process,BP,
3018,GO:0006210,1,0.982579182626747,0,3,thymine catabolic process,BP,
3019,GO:0006211,1,0.971781283437278,0,3,5-methylcytosine catabolic process,BP,
3020,GO:0006212,1,0.987746510447187,0,2,uracil catabolic process,BP,
3021,GO:0006213,1,0.803903243255446,0,43,pyrimidine nucleoside metabolic process,BP,
3022,GO:0006214,1,0.992784179551637,0,1,thymidine catabolic process,BP,
3023,GO:0006216,1,0.962440489092569,0,8,cytidine catabolic process,BP,
3024,GO:0006218,1,0.995723365047967,0,1,uridine catabolic process,BP,
3025,GO:0006220,1,0.801193217219529,0,45,pyrimidine nucleotide metabolic process,BP,
3026,GO:0006221,1,0.858795270721391,0,31,pyrimidine nucleotide biosynthetic process,BP,
3027,GO:0006222,1,0.945689747080996,0,10,UMP biosynthetic process,BP,
3028,GO:0006226,1,0.986939501884163,0,3,dUMP biosynthetic process,BP,
3029,GO:0006227,1,0.989732068931043,0,2,dUDP biosynthetic process,BP,
3030,GO:0006228,1,0.962731413217586,0,9,UTP biosynthetic process,BP,
3031,GO:0006231,1,0.985462849402617,0,3,dTMP biosynthetic process,BP,
3032,GO:0006233,1,0.989732068931043,0,2,dTDP biosynthetic process,BP,
3033,GO:0006235,1,0.982564002873824,0,4,dTTP biosynthetic process,BP,
3034,GO:0006238,1,0.996652184032161,0,1,CMP salvage,BP,
3035,GO:0006241,1,0.944905527295957,0,13,CTP biosynthetic process,BP,
3036,GO:0006244,1,0.940861059539998,0,13,pyrimidine nucleotide catabolic process,BP,
3037,GO:0006253,1,0.99677880066022,0,1,dCTP catabolic process,BP,
3038,GO:0006256,1,0.99302822103216,0,1,UDP catabolic process,BP,
3039,GO:0006258,1,0.991332218674697,0,2,UDP-glucose catabolic process,BP,
3042,GO:0006261,1,0.409300749683401,0,141,DNA-dependent DNA replication,BP,
3043,GO:0006264,1,0.934221525514656,0,10,mitochondrial DNA replication,BP,
3044,GO:0006265,1,0.941355723481574,0,9,DNA topological change,BP,
3045,GO:0006266,1,0.877887553574878,0,23,DNA ligation,BP,
3046,GO:0006267,1,0.985056757164688,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3047,GO:0006268,1,0.955182638412409,0,7,DNA unwinding involved in DNA replication,BP,
3048,GO:0006269,1,0.969292366877523,0,5,DNA replication, synthesis of RNA primer,BP,
3049,GO:0006270,1,0.768649069525052,0,42,DNA replication initiation,BP,
3050,GO:0006271,1,0.890362897814751,0,20,DNA strand elongation involved in DNA replication,BP,
3051,GO:0006272,1,0.980197897527678,0,3,leading strand elongation,BP,
3052,GO:0006273,1,0.934207141520075,0,11,lagging strand elongation,BP,
3054,GO:0006278,1,0.648775966738509,0,67,RNA-dependent DNA biosynthetic process,BP,
3057,GO:0006283,1,0.673941420773082,0,73,transcription-coupled nucleotide-excision repair,BP,
3058,GO:0006284,1,0.787780472425616,0,41,base-excision repair,BP,
3059,GO:0006285,1,0.954151664440046,0,10,base-excision repair, AP site formation,BP,
3060,GO:0006286,1,0.992971878291365,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3061,GO:0006287,1,0.967064254327483,0,5,base-excision repair, gap-filling,BP,
3062,GO:0006288,1,0.98425032535951,0,3,base-excision repair, DNA ligation,BP,
3063,GO:0006289,1,0.53104272381226,0,112,nucleotide-excision repair,BP,
3064,GO:0006290,1,0.957539971602,0,7,pyrimidine dimer repair,BP,
3065,GO:0006293,1,0.87984139355348,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3066,GO:0006294,1,0.851661770400314,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3067,GO:0006295,1,0.87984139355348,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3068,GO:0006296,1,0.811611174840285,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3069,GO:0006297,1,0.878975912814953,0,23,nucleotide-excision repair, DNA gap filling,BP,
3070,GO:0006298,1,0.824152980128858,0,30,mismatch repair,BP,
3071,GO:0006301,1,0.74770713893683,0,48,postreplication repair,BP,
3072,GO:0006302,1,0.287655654911322,0,189,double-strand break repair,BP,
3073,GO:0006303,1,0.682259768862341,0,58,double-strand break repair via nonhomologous end joining,BP,
3074,GO:0006304,1,0.555094054346176,0,93,DNA modification,BP,
3075,GO:0006305,1,0.688680794700936,0,54,DNA alkylation,BP,
3076,GO:0006306,1,0.688680794700936,0,54,DNA methylation,BP,
3077,GO:0006307,1,0.946990246771662,0,10,DNA dealkylation involved in DNA repair,BP,
3078,GO:0006308,1,0.811079290105845,0,35,DNA catabolic process,BP,
3079,GO:0006309,1,0.889258076803236,0,20,apoptotic DNA fragmentation,BP,
3080,GO:0006310,1,0.220638513135704,0,232,DNA recombination,BP,
3081,GO:0006311,1,0.972037510448761,0,4,meiotic gene conversion,BP,
3082,GO:0006312,1,0.858116439908502,0,23,mitotic recombination,BP,
3083,GO:0006313,1,0.992455307730231,0,1,transposition, DNA-mediated,BP,
3084,GO:0006323,1,0.39819484773483,0,142,DNA packaging,BP,
3086,GO:0006333,1,0.459112513492608,0,133,chromatin assembly or disassembly,BP,
3087,GO:0006334,1,0.610578988629023,0,91,nucleosome assembly,BP,
3088,GO:0006335,1,0.933981913253835,0,14,DNA replication-dependent nucleosome assembly,BP,
3089,GO:0006336,1,0.801046818827037,0,40,DNA replication-independent nucleosome assembly,BP,
3090,GO:0006337,1,0.895685680950931,0,17,nucleosome disassembly,BP,
3091,GO:0006338,1,0.368414033544897,0,159,chromatin remodeling,BP,
3092,GO:0006342,1,0.638573280816858,0,75,chromatin silencing,BP,
3093,GO:0006343,1,0.992468656963127,0,1,establishment of chromatin silencing,BP,
3094,GO:0006344,1,0.969437700100579,0,4,maintenance of chromatin silencing,BP,
3095,GO:0006346,1,0.905446167469348,0,14,methylation-dependent chromatin silencing,BP,
3096,GO:0006348,1,0.959057697506984,0,8,chromatin silencing at telomere,BP,
3097,GO:0006349,1,0.892818824219405,0,16,regulation of gene expression by genetic imprinting,BP,
3099,GO:0006352,1,0.249585607850911,0,225,DNA-templated transcription, initiation,BP,
3100,GO:0006353,1,0.538481740868197,0,107,DNA-templated transcription, termination,BP,
3103,GO:0006356,1,0.818494389103819,0,30,regulation of transcription by RNA polymerase I,BP,
3105,GO:0006359,1,0.834722761720408,0,27,regulation of transcription by RNA polymerase III,BP,
3106,GO:0006360,1,0.69577742042193,0,59,transcription by RNA polymerase I,BP,
3107,GO:0006361,1,0.826407826303539,0,35,transcription initiation from RNA polymerase I promoter,BP,
3108,GO:0006362,1,0.8498786991812,0,30,transcription elongation from RNA polymerase I promoter,BP,
3109,GO:0006363,1,0.850813832191137,0,30,termination of RNA polymerase I transcription,BP,
3110,GO:0006364,1,0.287186846555455,0,249,rRNA processing,BP,
3112,GO:0006367,1,0.33408752226747,0,177,transcription initiation from RNA polymerase II promoter,BP,
3114,GO:0006369,1,0.668251753469986,0,68,termination of RNA polymerase II transcription,BP,
3115,GO:0006370,1,0.846546348917835,0,31,7-methylguanosine mRNA capping,BP,
3116,GO:0006376,1,0.837294177371224,0,27,mRNA splice site selection,BP,
3117,GO:0006378,1,0.766788441228729,0,40,mRNA polyadenylation,BP,
3118,GO:0006379,1,0.849717374253229,0,27,mRNA cleavage,BP,
3119,GO:0006382,1,0.963948807858321,0,5,adenosine to inosine editing,BP,
3120,GO:0006383,1,0.725092138346843,0,53,transcription by RNA polymerase III,BP,
3121,GO:0006384,1,0.950539125170962,0,7,transcription initiation from RNA polymerase III promoter,BP,
3122,GO:0006386,1,0.996986037237837,0,1,termination of RNA polymerase III transcription,BP,
3123,GO:0006388,1,0.935537376728159,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3124,GO:0006390,1,0.920550484659188,0,13,mitochondrial transcription,BP,
3125,GO:0006391,1,0.983761609836009,0,3,transcription initiation from mitochondrial promoter,BP,
3126,GO:0006393,1,0.986646673054992,0,2,termination of mitochondrial transcription,BP,
3128,GO:0006397,1,0.0592855698798326,0,457,mRNA processing,BP,
3129,GO:0006398,1,0.969487286930456,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3130,GO:0006399,1,0.355491449113462,0,181,tRNA metabolic process,BP,
3131,GO:0006400,1,0.658364657747819,0,73,tRNA modification,BP,
3132,GO:0006401,1,0.131745737676075,0,362,RNA catabolic process,BP,
3133,GO:0006402,1,0.156957975792153,0,333,mRNA catabolic process,BP,
3134,GO:0006403,1,0.250978463296966,0,216,RNA localization,BP,
3135,GO:0006404,1,0.983477906626207,0,3,RNA import into nucleus,BP,
3136,GO:0006405,1,0.426033344935045,0,135,RNA export from nucleus,BP,
3137,GO:0006406,1,0.511627717564268,0,104,mRNA export from nucleus,BP,
3138,GO:0006407,1,0.984430747339174,0,3,rRNA export from nucleus,BP,
3139,GO:0006408,1,0.990902486578182,0,2,snRNA export from nucleus,BP,
3140,GO:0006409,1,0.811493101976235,0,31,tRNA export from nucleus,BP,
3142,GO:0006413,1,0.388546976580099,0,191,translational initiation,BP,
3143,GO:0006414,1,0.556220028927859,0,126,translational elongation,BP,
3144,GO:0006415,1,0.65203314721943,0,99,translational termination,BP,
3146,GO:0006418,1,0.748068078395873,0,49,tRNA aminoacylation for protein translation,BP,
3147,GO:0006419,1,0.980583891103228,0,3,alanyl-tRNA aminoacylation,BP,
3148,GO:0006420,1,0.985193209807802,0,3,arginyl-tRNA aminoacylation,BP,
3149,GO:0006421,1,0.980367232127906,0,3,asparaginyl-tRNA aminoacylation,BP,
3150,GO:0006422,1,0.994367719978937,0,1,aspartyl-tRNA aminoacylation,BP,
3151,GO:0006423,1,0.989174043555621,0,2,cysteinyl-tRNA aminoacylation,BP,
3152,GO:0006424,1,0.984806462702861,0,2,glutamyl-tRNA aminoacylation,BP,
3153,GO:0006425,1,0.986433540900467,0,2,glutaminyl-tRNA aminoacylation,BP,
3154,GO:0006426,1,0.989517616050866,0,2,glycyl-tRNA aminoacylation,BP,
3155,GO:0006427,1,0.989301071084104,0,2,histidyl-tRNA aminoacylation,BP,
3156,GO:0006428,1,0.984976014377416,0,2,isoleucyl-tRNA aminoacylation,BP,
3157,GO:0006429,1,0.984822349403225,0,2,leucyl-tRNA aminoacylation,BP,
3158,GO:0006430,1,0.994970437972119,0,1,lysyl-tRNA aminoacylation,BP,
3159,GO:0006431,1,0.986183440855765,0,2,methionyl-tRNA aminoacylation,BP,
3160,GO:0006432,1,0.972614638361672,0,5,phenylalanyl-tRNA aminoacylation,BP,
3161,GO:0006433,1,0.983481755670889,0,3,prolyl-tRNA aminoacylation,BP,
3162,GO:0006434,1,0.990602208597386,0,2,seryl-tRNA aminoacylation,BP,
3163,GO:0006435,1,0.980136604924368,0,3,threonyl-tRNA aminoacylation,BP,
3164,GO:0006436,1,0.986734759811013,0,2,tryptophanyl-tRNA aminoacylation,BP,
3165,GO:0006437,1,0.987661760113193,0,2,tyrosyl-tRNA aminoacylation,BP,
3166,GO:0006438,1,0.97742313352824,0,3,valyl-tRNA aminoacylation,BP,
3167,GO:0006446,1,0.634108610673166,0,74,regulation of translational initiation,BP,
3168,GO:0006447,1,0.980704733092754,0,3,regulation of translational initiation by iron,BP,
3169,GO:0006448,1,0.891492459745765,0,18,regulation of translational elongation,BP,
3170,GO:0006449,1,0.94800870783092,0,8,regulation of translational termination,BP,
3171,GO:0006450,1,0.905542971922718,0,18,regulation of translational fidelity,BP,
3172,GO:0006451,1,0.951254440591269,0,8,translational readthrough,BP,
3173,GO:0006452,1,0.981307859953332,0,3,translational frameshifting,BP,
3174,GO:0006457,1,0.273511642756885,0,225,protein folding,BP,
3175,GO:0006458,1,0.748748033259281,0,48,'de novo' protein folding,BP,
3176,GO:0006463,1,0.992479374198716,0,1,steroid hormone receptor complex assembly,BP,
3178,GO:0006465,1,0.897380474868336,0,20,signal peptide processing,BP,
3182,GO:0006471,1,0.853354588364371,0,26,protein ADP-ribosylation,BP,
3183,GO:0006473,1,0.326735867547126,0,174,protein acetylation,BP,
3184,GO:0006474,1,0.901537614478299,0,16,N-terminal protein amino acid acetylation,BP,
3185,GO:0006475,1,0.383208537214924,0,146,internal protein amino acid acetylation,BP,
3186,GO:0006476,1,0.52920994752582,0,95,protein deacetylation,BP,
3187,GO:0006477,1,0.960929743394156,0,6,protein sulfation,BP,
3188,GO:0006478,1,0.990545534710624,0,2,peptidyl-tyrosine sulfation,BP,
3189,GO:0006479,1,0.334060052971056,0,163,protein methylation,BP,
3190,GO:0006480,1,0.990232503031599,0,2,N-terminal protein amino acid methylation,BP,
3191,GO:0006481,1,0.982100346570024,0,3,C-terminal protein methylation,BP,
3192,GO:0006482,1,0.801527968390902,0,29,protein demethylation,BP,
3193,GO:0006486,1,0.216903802912724,0,236,protein glycosylation,BP,
3194,GO:0006487,1,0.588090102743201,0,89,protein N-linked glycosylation,BP,
3195,GO:0006488,1,0.88670920936862,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3196,GO:0006489,1,0.959551932080771,0,7,dolichyl diphosphate biosynthetic process,BP,
3197,GO:0006490,1,0.881241371698473,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3198,GO:0006491,1,0.878091422052212,0,18,N-glycan processing,BP,
3199,GO:0006493,1,0.508839240462688,0,101,protein O-linked glycosylation,BP,
3201,GO:0006498,1,0.96079955261086,0,6,N-terminal protein lipidation,BP,
3202,GO:0006499,1,0.969880505908843,0,4,N-terminal protein myristoylation,BP,
3203,GO:0006500,1,0.990640008650071,0,2,N-terminal protein palmitoylation,BP,
3205,GO:0006505,1,0.833854259574957,0,33,GPI anchor metabolic process,BP,
3206,GO:0006506,1,0.841448024408861,0,31,GPI anchor biosynthetic process,BP,
3207,GO:0006507,1,0.994485294736201,0,1,GPI anchor release,BP,
3209,GO:0006509,1,0.773193846127252,0,40,membrane protein ectodomain proteolysis,BP,
3210,GO:0006511,1,0.0299447790322428,0,539,ubiquitin-dependent protein catabolic process,BP,
3211,GO:0006513,1,0.655650753845741,0,63,protein monoubiquitination,BP,
3212,GO:0006515,1,0.849662002092897,0,25,protein quality control for misfolded or incompletely synthesized proteins,BP,
3213,GO:0006516,1,0.89957346170225,0,17,glycoprotein catabolic process,BP,
3214,GO:0006517,1,0.795094607909124,0,34,protein deglycosylation,BP,
3217,GO:0006521,1,0.782439234004667,0,55,regulation of cellular amino acid metabolic process,BP,
3218,GO:0006522,1,0.980431023083073,0,4,alanine metabolic process,BP,
3219,GO:0006524,1,0.980431023083073,0,4,alanine catabolic process,BP,
3220,GO:0006525,1,0.893308716595713,0,20,arginine metabolic process,BP,
3221,GO:0006526,1,0.96627340457221,0,6,arginine biosynthetic process,BP,
3222,GO:0006527,1,0.937797102074905,0,11,arginine catabolic process,BP,
3223,GO:0006528,1,0.975112874116385,0,5,asparagine metabolic process,BP,
3224,GO:0006529,1,0.988417760778122,0,2,asparagine biosynthetic process,BP,
3225,GO:0006530,1,0.989886946677199,0,2,asparagine catabolic process,BP,
3226,GO:0006531,1,0.947836110189957,0,10,aspartate metabolic process,BP,
3227,GO:0006532,1,0.989000260681641,0,2,aspartate biosynthetic process,BP,
3228,GO:0006533,1,0.985522922056734,0,3,aspartate catabolic process,BP,
3229,GO:0006534,1,0.924876666385578,0,13,cysteine metabolic process,BP,
3230,GO:0006535,1,0.993678504419862,0,1,cysteine biosynthetic process from serine,BP,
3231,GO:0006536,1,0.824288619984343,0,31,glutamate metabolic process,BP,
3232,GO:0006537,1,0.965907874914666,0,5,glutamate biosynthetic process,BP,
3233,GO:0006538,1,0.945309812945836,0,9,glutamate catabolic process,BP,
3234,GO:0006539,1,0.995508638316602,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3235,GO:0006540,1,0.980260236160536,0,3,glutamate decarboxylation to succinate,BP,
3236,GO:0006541,1,0.857582840158972,0,23,glutamine metabolic process,BP,
3237,GO:0006542,1,0.984662673929916,0,2,glutamine biosynthetic process,BP,
3238,GO:0006543,1,0.978654776994368,0,3,glutamine catabolic process,BP,
3239,GO:0006544,1,0.944274303669832,0,10,glycine metabolic process,BP,
3240,GO:0006545,1,0.984871253090805,0,3,glycine biosynthetic process,BP,
3241,GO:0006546,1,0.983934444878912,0,3,glycine catabolic process,BP,
3244,GO:0006549,1,0.968519580970226,0,5,isoleucine metabolic process,BP,
3245,GO:0006550,1,0.991026856044022,0,2,isoleucine catabolic process,BP,
3246,GO:0006551,1,0.9533256827736,0,8,leucine metabolic process,BP,
3247,GO:0006552,1,0.965532311275525,0,6,leucine catabolic process,BP,
3248,GO:0006553,1,0.919863864593048,0,13,lysine metabolic process,BP,
3249,GO:0006554,1,0.926221943586104,0,12,lysine catabolic process,BP,
3250,GO:0006555,1,0.886826656012798,0,20,methionine metabolic process,BP,
3251,GO:0006556,1,0.980946701140434,0,3,S-adenosylmethionine biosynthetic process,BP,
3252,GO:0006557,1,0.992663131368205,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3253,GO:0006558,1,0.954424694969346,0,10,L-phenylalanine metabolic process,BP,
3254,GO:0006559,1,0.954424694969346,0,10,L-phenylalanine catabolic process,BP,
3255,GO:0006560,1,0.963437372140627,0,7,proline metabolic process,BP,
3256,GO:0006561,1,0.979519233812798,0,4,proline biosynthetic process,BP,
3257,GO:0006562,1,0.983585395946637,0,3,proline catabolic process,BP,
3258,GO:0006563,1,0.94562085203343,0,11,L-serine metabolic process,BP,
3259,GO:0006564,1,0.970319839368014,0,6,L-serine biosynthetic process,BP,
3260,GO:0006565,1,0.980456866158695,0,4,L-serine catabolic process,BP,
3261,GO:0006566,1,0.983838038037752,0,4,threonine metabolic process,BP,
3262,GO:0006567,1,0.988823915230726,0,3,threonine catabolic process,BP,
3263,GO:0006568,1,0.955947500602917,0,9,tryptophan metabolic process,BP,
3264,GO:0006569,1,0.968447404784614,0,7,tryptophan catabolic process,BP,
3265,GO:0006570,1,0.963872743989863,0,8,tyrosine metabolic process,BP,
3266,GO:0006572,1,0.973761593163137,0,6,tyrosine catabolic process,BP,
3267,GO:0006573,1,0.946003218109739,0,9,valine metabolic process,BP,
3268,GO:0006574,1,0.980385131948993,0,4,valine catabolic process,BP,
3270,GO:0006576,1,0.776234981412175,0,47,cellular biogenic amine metabolic process,BP,
3271,GO:0006577,1,0.89448177330033,0,17,amino-acid betaine metabolic process,BP,
3272,GO:0006578,1,0.956131708743317,0,7,amino-acid betaine biosynthetic process,BP,
3273,GO:0006579,1,0.98080995780153,0,3,amino-acid betaine catabolic process,BP,
3274,GO:0006580,1,0.993468036731548,0,1,ethanolamine metabolic process,BP,
3275,GO:0006581,1,0.98668712770664,0,2,acetylcholine catabolic process,BP,
3276,GO:0006582,1,0.898191205780501,0,16,melanin metabolic process,BP,
3277,GO:0006583,1,0.99432335656293,0,1,melanin biosynthetic process from tyrosine,BP,
3278,GO:0006584,1,0.748138030244302,0,47,catecholamine metabolic process,BP,
3279,GO:0006585,1,0.995498852347711,0,1,dopamine biosynthetic process from tyrosine,BP,
3280,GO:0006586,1,0.938427075158511,0,13,indolalkylamine metabolic process,BP,
3281,GO:0006589,1,0.986236723096999,0,2,octopamine biosynthetic process,BP,
3282,GO:0006590,1,0.913077272546599,0,13,thyroid hormone generation,BP,
3283,GO:0006591,1,0.953700254635329,0,9,ornithine metabolic process,BP,
3284,GO:0006592,1,0.992547456931827,0,1,ornithine biosynthetic process,BP,
3285,GO:0006593,1,0.996056695280523,0,1,ornithine catabolic process,BP,
3286,GO:0006595,1,0.92871778878634,0,16,polyamine metabolic process,BP,
3287,GO:0006596,1,0.939519070987894,0,13,polyamine biosynthetic process,BP,
3288,GO:0006597,1,0.988667396583527,0,2,spermine biosynthetic process,BP,
3289,GO:0006598,1,0.976509970026131,0,6,polyamine catabolic process,BP,
3290,GO:0006600,1,0.945880032928947,0,10,creatine metabolic process,BP,
3291,GO:0006601,1,0.990596723476375,0,2,creatine biosynthetic process,BP,
3294,GO:0006607,1,0.860598968891433,0,20,NLS-bearing protein import into nucleus,BP,
3295,GO:0006610,1,0.943735295258696,0,8,ribosomal protein import into nucleus,BP,
3296,GO:0006611,1,0.332594672197368,0,173,protein export from nucleus,BP,
3297,GO:0006612,1,0.421669111648267,0,177,protein targeting to membrane,BP,
3298,GO:0006613,1,0.703489573289524,0,95,cotranslational protein targeting to membrane,BP,
3299,GO:0006614,1,0.727603481508262,0,90,SRP-dependent cotranslational protein targeting to membrane,BP,
3300,GO:0006616,1,0.974182256500268,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3301,GO:0006617,1,0.991567633426355,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3302,GO:0006620,1,0.958720529709777,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3303,GO:0006621,1,0.942302558740783,0,10,protein retention in ER lumen,BP,
3304,GO:0006622,1,0.877308290003895,0,19,protein targeting to lysosome,BP,
3305,GO:0006623,1,0.800151764685595,0,31,protein targeting to vacuole,BP,
3306,GO:0006624,1,0.992037692195369,0,2,vacuolar protein processing,BP,
3308,GO:0006626,1,0.465216348264751,0,135,protein targeting to mitochondrion,BP,
3309,GO:0006627,1,0.95919143641904,0,8,protein processing involved in protein targeting to mitochondrion,BP,
3313,GO:0006635,1,0.658727524537282,0,70,fatty acid beta-oxidation,BP,
3314,GO:0006636,1,0.802509477113059,0,40,unsaturated fatty acid biosynthetic process,BP,
3315,GO:0006637,1,0.579466474697694,0,91,acyl-CoA metabolic process,BP,
3316,GO:0006638,1,0.572201123713825,0,90,neutral lipid metabolic process,BP,
3317,GO:0006639,1,0.576408239125593,0,89,acylglycerol metabolic process,BP,
3318,GO:0006641,1,0.634230565894049,0,75,triglyceride metabolic process,BP,
3319,GO:0006642,1,0.967826565021609,0,4,triglyceride mobilization,BP,
3322,GO:0006646,1,0.913837700813238,0,14,phosphatidylethanolamine biosynthetic process,BP,
3323,GO:0006649,1,0.984374671383803,0,2,phospholipid transfer to membrane,BP,
3325,GO:0006651,1,0.988500504890162,0,2,diacylglycerol biosynthetic process,BP,
3327,GO:0006655,1,0.937971422975733,0,10,phosphatidylglycerol biosynthetic process,BP,
3328,GO:0006656,1,0.82564155625409,0,33,phosphatidylcholine biosynthetic process,BP,
3329,GO:0006657,1,0.961749348477691,0,7,CDP-choline pathway,BP,
3330,GO:0006658,1,0.867158960723846,0,24,phosphatidylserine metabolic process,BP,
3331,GO:0006659,1,0.97539257704897,0,4,phosphatidylserine biosynthetic process,BP,
3332,GO:0006660,1,0.995788244913725,0,1,phosphatidylserine catabolic process,BP,
3333,GO:0006661,1,0.398550262533874,0,136,phosphatidylinositol biosynthetic process,BP,
3334,GO:0006662,1,0.939121460567755,0,12,glycerol ether metabolic process,BP,
3335,GO:0006663,1,0.977141504595676,0,4,platelet activating factor biosynthetic process,BP,
3338,GO:0006666,1,0.992244370523612,0,1,3-keto-sphinganine metabolic process,BP,
3339,GO:0006667,1,0.983697629316182,0,3,sphinganine metabolic process,BP,
3340,GO:0006668,1,0.985668007465796,0,2,sphinganine-1-phosphate metabolic process,BP,
3341,GO:0006669,1,0.992981287633524,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3342,GO:0006670,1,0.937904219609172,0,11,sphingosine metabolic process,BP,
3343,GO:0006671,1,0.992417116191499,0,1,phytosphingosine metabolic process,BP,
3346,GO:0006678,1,0.956871480757346,0,7,glucosylceramide metabolic process,BP,
3347,GO:0006679,1,0.988388738548422,0,2,glucosylceramide biosynthetic process,BP,
3348,GO:0006680,1,0.980081801839801,0,3,glucosylceramide catabolic process,BP,
3351,GO:0006683,1,0.993062132645521,0,1,galactosylceramide catabolic process,BP,
3352,GO:0006684,1,0.926938424352021,0,13,sphingomyelin metabolic process,BP,
3353,GO:0006685,1,0.96852123786059,0,5,sphingomyelin catabolic process,BP,
3354,GO:0006686,1,0.965274726331786,0,6,sphingomyelin biosynthetic process,BP,
3357,GO:0006689,1,0.97110287638587,0,5,ganglioside catabolic process,BP,
3358,GO:0006690,1,0.624926011620079,0,86,icosanoid metabolic process,BP,
3359,GO:0006691,1,0.897951838708632,0,20,leukotriene metabolic process,BP,
3360,GO:0006692,1,0.832635697044236,0,34,prostanoid metabolic process,BP,
3361,GO:0006693,1,0.832635697044236,0,34,prostaglandin metabolic process,BP,
3362,GO:0006694,1,0.376772326873851,0,161,steroid biosynthetic process,BP,
3363,GO:0006695,1,0.672363419151705,0,62,cholesterol biosynthetic process,BP,
3364,GO:0006696,1,0.989896281911023,0,2,ergosterol biosynthetic process,BP,
3365,GO:0006699,1,0.820955939048588,0,32,bile acid biosynthetic process,BP,
3366,GO:0006700,1,0.886687972536449,0,20,C21-steroid hormone biosynthetic process,BP,
3367,GO:0006701,1,0.967052761270725,0,5,progesterone biosynthetic process,BP,
3368,GO:0006702,1,0.959089595544678,0,7,androgen biosynthetic process,BP,
3369,GO:0006703,1,0.953306884795359,0,10,estrogen biosynthetic process,BP,
3370,GO:0006704,1,0.923928209216006,0,13,glucocorticoid biosynthetic process,BP,
3371,GO:0006705,1,0.946436512021372,0,8,mineralocorticoid biosynthetic process,BP,
3372,GO:0006706,1,0.899005007901712,0,20,steroid catabolic process,BP,
3373,GO:0006707,1,0.951264030838889,0,9,cholesterol catabolic process,BP,
3374,GO:0006710,1,0.980595691015711,0,4,androgen catabolic process,BP,
3375,GO:0006711,1,0.995788244913725,0,1,estrogen catabolic process,BP,
3376,GO:0006713,1,0.995772756168533,0,1,glucocorticoid catabolic process,BP,
3377,GO:0006714,1,0.992836597858055,0,2,sesquiterpenoid metabolic process,BP,
3380,GO:0006722,1,0.994171506730886,0,1,triterpenoid metabolic process,BP,
3382,GO:0006726,1,0.981169549130346,0,3,eye pigment biosynthetic process,BP,
3383,GO:0006729,1,0.968730443725001,0,7,tetrahydrobiopterin biosynthetic process,BP,
3384,GO:0006730,1,0.828619072881571,0,33,one-carbon metabolic process,BP,
3388,GO:0006735,1,0.872208965982956,0,24,NADH regeneration,BP,
3389,GO:0006738,1,0.994151722015676,0,1,nicotinamide riboside catabolic process,BP,
3390,GO:0006739,1,0.838541607096699,0,33,NADP metabolic process,BP,
3391,GO:0006740,1,0.981199938169434,0,3,NADPH regeneration,BP,
3392,GO:0006741,1,0.974711726753579,0,4,NADP biosynthetic process,BP,
3393,GO:0006742,1,0.98630076939297,0,3,NADP catabolic process,BP,
3394,GO:0006743,1,0.930798635093513,0,15,ubiquinone metabolic process,BP,
3395,GO:0006744,1,0.937933634399064,0,14,ubiquinone biosynthetic process,BP,
3396,GO:0006747,1,0.995332519286809,0,1,FAD biosynthetic process,BP,
3397,GO:0006749,1,0.806275426118556,0,46,glutathione metabolic process,BP,
3398,GO:0006750,1,0.926211089404061,0,14,glutathione biosynthetic process,BP,
3399,GO:0006751,1,0.974980456818745,0,5,glutathione catabolic process,BP,
3402,GO:0006756,1,0.993301131169352,0,1,AMP phosphorylation,BP,
3406,GO:0006767,1,0.598641558171818,0,84,water-soluble vitamin metabolic process,BP,
3407,GO:0006768,1,0.937448556267517,0,10,biotin metabolic process,BP,
3408,GO:0006771,1,0.957167700509038,0,7,riboflavin metabolic process,BP,
3409,GO:0006772,1,0.977687883021192,0,4,thiamine metabolic process,BP,
3411,GO:0006776,1,0.95799443119419,0,7,vitamin A metabolic process,BP,
3412,GO:0006777,1,0.963536219595093,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3413,GO:0006778,1,0.839408457993413,0,31,porphyrin-containing compound metabolic process,BP,
3414,GO:0006779,1,0.872865361996573,0,23,porphyrin-containing compound biosynthetic process,BP,
3415,GO:0006780,1,0.991350270962457,0,2,uroporphyrinogen III biosynthetic process,BP,
3416,GO:0006781,1,0.994812632020403,0,1,succinyl-CoA pathway,BP,
3417,GO:0006782,1,0.961581423395655,0,8,protoporphyrinogen IX biosynthetic process,BP,
3418,GO:0006783,1,0.896889311267429,0,19,heme biosynthetic process,BP,
3419,GO:0006784,1,0.984641342938846,0,2,heme a biosynthetic process,BP,
3420,GO:0006787,1,0.985951138975038,0,4,porphyrin-containing compound catabolic process,BP,
3421,GO:0006788,1,0.992126650157578,0,2,heme oxidation,BP,
3425,GO:0006797,1,0.96364921775775,0,5,polyphosphate metabolic process,BP,
3426,GO:0006798,1,0.970281286045039,0,4,polyphosphate catabolic process,BP,
3428,GO:0006805,1,0.604870709443154,0,93,xenobiotic metabolic process,BP,
3430,GO:0006808,1,0.984389997066031,0,3,regulation of nitrogen utilization,BP,
3431,GO:0006809,1,0.695520941514689,0,58,nitric oxide biosynthetic process,BP,
3438,GO:0006817,1,0.884422473519067,0,18,phosphate ion transport,BP,
3440,GO:0006821,1,0.520338476478527,0,97,chloride transport,BP,
3441,GO:0006824,1,0.979026560448114,0,4,cobalt ion transport,BP,
3444,GO:0006828,1,0.928507441388197,0,10,manganese ion transport,BP,
3445,GO:0006829,1,0.863335168545547,0,23,zinc ion transport,BP,
3446,GO:0006833,1,0.915979752596237,0,15,water transport,BP,
3448,GO:0006836,1,0.215957261690181,0,230,neurotransmitter transport,BP,
3449,GO:0006837,1,0.917411576156625,0,15,serotonin transport,BP,
3451,GO:0006842,1,0.973994760117545,0,4,tricarboxylic acid transport,BP,
3452,GO:0006843,1,0.996145082840474,0,1,mitochondrial citrate transmembrane transport,BP,
3453,GO:0006844,1,0.989885042482089,0,2,acyl carnitine transport,BP,
3454,GO:0006848,1,0.975099758147644,0,4,pyruvate transport,BP,
3455,GO:0006850,1,0.986646673054992,0,2,mitochondrial pyruvate transmembrane transport,BP,
3456,GO:0006851,1,0.874419107611674,0,22,mitochondrial calcium ion transmembrane transport,BP,
3457,GO:0006853,1,0.937881399303581,0,9,carnitine shuttle,BP,
3459,GO:0006857,1,0.948330512060364,0,8,oligopeptide transport,BP,
3460,GO:0006858,1,0.9849695188835,0,3,extracellular transport,BP,
3462,GO:0006863,1,0.968492052116771,0,6,purine nucleobase transport,BP,
3463,GO:0006864,1,0.988774287912728,0,2,pyrimidine nucleotide transport,BP,
3464,GO:0006865,1,0.431654643531642,0,126,amino acid transport,BP,
3465,GO:0006867,1,0.987354852106516,0,2,asparagine transport,BP,
3466,GO:0006868,1,0.960728651011844,0,6,glutamine transport,BP,
3471,GO:0006876,1,0.992467204815628,0,1,cellular cadmium ion homeostasis,BP,
3474,GO:0006880,1,0.988914750344125,0,3,intracellular sequestering of iron ion,BP,
3475,GO:0006882,1,0.842892595003065,0,32,cellular zinc ion homeostasis,BP,
3476,GO:0006883,1,0.891443832322883,0,17,cellular sodium ion homeostasis,BP,
3477,GO:0006884,1,0.857586385566558,0,22,cell volume homeostasis,BP,
3478,GO:0006885,1,0.545466666769766,0,96,regulation of pH,BP,
3481,GO:0006888,1,0.302492939248003,0,186,ER to Golgi vesicle-mediated transport,BP,
3482,GO:0006890,1,0.597455781091636,0,79,retrograde vesicle-mediated transport, Golgi to ER,BP,
3483,GO:0006891,1,0.80878602710089,0,33,intra-Golgi vesicle-mediated transport,BP,
3484,GO:0006892,1,0.529693688947201,0,92,post-Golgi vesicle-mediated transport,BP,
3485,GO:0006893,1,0.727613014292723,0,47,Golgi to plasma membrane transport,BP,
3486,GO:0006895,1,0.863107235570697,0,19,Golgi to endosome transport,BP,
3487,GO:0006896,1,0.911183653847948,0,14,Golgi to vacuole transport,BP,
3490,GO:0006900,1,0.549644518266072,0,93,vesicle budding from membrane,BP,
3491,GO:0006901,1,0.658605915111873,0,66,vesicle coating,BP,
3492,GO:0006903,1,0.578173929178407,0,85,vesicle targeting,BP,
3493,GO:0006904,1,0.74063144693448,0,48,vesicle docking involved in exocytosis,BP,
3494,GO:0006906,1,0.380576548433993,0,149,vesicle fusion,BP,
3495,GO:0006907,1,0.89185695266735,0,18,pinocytosis,BP,
3496,GO:0006909,1,0.256350252176224,0,219,phagocytosis,BP,
3497,GO:0006910,1,0.920850850856898,0,14,phagocytosis, recognition,BP,
3498,GO:0006911,1,0.766470201648834,0,44,phagocytosis, engulfment,BP,
3504,GO:0006924,1,0.950093043086158,0,9,activation-induced cell death of T cells,BP,
3505,GO:0006925,1,0.901939150736719,0,17,inflammatory cell apoptotic process,BP,
3507,GO:0006929,1,0.843523201356658,0,25,substrate-dependent cell migration,BP,
3508,GO:0006930,1,0.950094823765475,0,8,substrate-dependent cell migration, cell extension,BP,
3509,GO:0006931,1,0.974587169035996,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3510,GO:0006933,1,0.983029322612358,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3513,GO:0006937,1,0.40325262289858,0,143,regulation of muscle contraction,BP,
3514,GO:0006939,1,0.544728232196239,0,94,smooth muscle contraction,BP,
3515,GO:0006940,1,0.712976782825724,0,55,regulation of smooth muscle contraction,BP,
3517,GO:0006942,1,0.58652999293582,0,80,regulation of striated muscle contraction,BP,
3518,GO:0006948,1,0.992802943897003,0,1,induction by virus of host cell-cell fusion,BP,
3519,GO:0006949,1,0.777052048730359,0,38,syncytium formation,BP,
3522,GO:0006953,1,0.824022844859275,0,36,acute-phase response,BP,
3525,GO:0006956,1,0.756235481827784,0,49,complement activation,BP,
3526,GO:0006957,1,0.938155016576453,0,10,complement activation, alternative pathway,BP,
3527,GO:0006958,1,0.855509516067396,0,26,complement activation, classical pathway,BP,
3528,GO:0006959,1,0.452322459100944,0,160,humoral immune response,BP,
3529,GO:0006968,1,0.765071555861946,0,49,cellular defense response,BP,
3531,GO:0006971,1,0.935476087863984,0,9,hypotonic response,BP,
3532,GO:0006972,1,0.877875070353233,0,20,hyperosmotic response,BP,
3534,GO:0006975,1,0.951890863225025,0,8,DNA damage induced protein phosphorylation,BP,
3535,GO:0006977,1,0.696123985450475,0,60,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3536,GO:0006978,1,0.887882709013993,0,19,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3538,GO:0006982,1,0.992772945217546,0,2,response to lipid hydroperoxide,BP,
3539,GO:0006983,1,0.933178016967931,0,10,ER overload response,BP,
3542,GO:0006987,1,0.949152078489245,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3543,GO:0006990,1,0.982467323772834,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3544,GO:0006991,1,0.932667842230182,0,10,response to sterol depletion,BP,
3545,GO:0006995,1,0.948832871168995,0,11,cellular response to nitrogen starvation,BP,
3547,GO:0006997,1,0.416216926658116,0,132,nucleus organization,BP,
3548,GO:0006998,1,0.592350922366453,0,81,nuclear envelope organization,BP,
3549,GO:0006999,1,0.900791203183459,0,15,nuclear pore organization,BP,
3550,GO:0007000,1,0.955539298957222,0,7,nucleolus organization,BP,
3551,GO:0007004,1,0.658856131284306,0,65,telomere maintenance via telomerase,BP,
3554,GO:0007007,1,0.893484268895249,0,22,inner mitochondrial membrane organization,BP,
3555,GO:0007008,1,0.992588626619601,0,1,outer mitochondrial membrane organization,BP,
3558,GO:0007014,1,0.992483603205204,0,1,actin ubiquitination,BP,
3560,GO:0007016,1,0.919022999386889,0,10,cytoskeletal anchoring at plasma membrane,BP,
3563,GO:0007019,1,0.769398704993428,0,38,microtubule depolymerization,BP,
3564,GO:0007020,1,0.838925061192736,0,25,microtubule nucleation,BP,
3565,GO:0007021,1,0.970042408870121,0,7,tubulin complex assembly,BP,
3566,GO:0007023,1,0.981031290067019,0,4,post-chaperonin tubulin folding pathway,BP,
3567,GO:0007026,1,0.862632347190474,0,22,negative regulation of microtubule depolymerization,BP,
3568,GO:0007028,1,0.934275704860375,0,9,cytoplasm organization,BP,
3569,GO:0007029,1,0.738422722684843,0,46,endoplasmic reticulum organization,BP,
3570,GO:0007030,1,0.407463398847653,0,128,Golgi organization,BP,
3572,GO:0007032,1,0.643599819248699,0,69,endosome organization,BP,
3573,GO:0007033,1,0.374412535425782,0,153,vacuole organization,BP,
3574,GO:0007034,1,0.440973077347914,0,123,vacuolar transport,BP,
3575,GO:0007035,1,0.879715481585772,0,22,vacuolar acidification,BP,
3577,GO:0007040,1,0.694831981359599,0,58,lysosome organization,BP,
3578,GO:0007041,1,0.528421085683394,0,93,lysosomal transport,BP,
3579,GO:0007042,1,0.964355486389279,0,8,lysosomal lumen acidification,BP,
3584,GO:0007050,1,0.226610491467463,0,235,cell cycle arrest,BP,
3585,GO:0007051,1,0.330755876142144,0,163,spindle organization,BP,
3586,GO:0007052,1,0.492302522514929,0,106,mitotic spindle organization,BP,
3587,GO:0007056,1,0.989465429225456,0,2,spindle assembly involved in female meiosis,BP,
3588,GO:0007057,1,0.989465429225456,0,2,spindle assembly involved in female meiosis I,BP,
3589,GO:0007059,1,0.110242599723966,0,328,chromosome segregation,BP,
3590,GO:0007060,1,0.973679119420355,0,4,male meiosis chromosome segregation,BP,
3591,GO:0007062,1,0.453418112205336,0,123,sister chromatid cohesion,BP,
3592,GO:0007063,1,0.875878927902887,0,19,regulation of sister chromatid cohesion,BP,
3593,GO:0007064,1,0.876856383366631,0,19,mitotic sister chromatid cohesion,BP,
3594,GO:0007066,1,0.996911506759971,0,1,female meiosis sister chromatid cohesion,BP,
3595,GO:0007072,1,0.995924480866609,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3596,GO:0007076,1,0.821567709023178,0,16,mitotic chromosome condensation,BP,
3597,GO:0007077,1,0.759440344384482,0,42,mitotic nuclear envelope disassembly,BP,
3598,GO:0007079,1,0.976555476951803,0,3,mitotic chromosome movement towards spindle pole,BP,
3599,GO:0007080,1,0.768659080329845,0,44,mitotic metaphase plate congression,BP,
3600,GO:0007084,1,0.948207256189082,0,10,mitotic nuclear envelope reassembly,BP,
3602,GO:0007089,1,0.973382301163349,0,4,traversing start control point of mitotic cell cycle,BP,
3603,GO:0007091,1,0.720167998513936,0,51,metaphase/anaphase transition of mitotic cell cycle,BP,
3604,GO:0007093,1,0.37685038611377,0,157,mitotic cell cycle checkpoint,BP,
3605,GO:0007094,1,0.822160143332049,0,31,mitotic spindle assembly checkpoint,BP,
3606,GO:0007095,1,0.876011383093642,0,19,mitotic G2 DNA damage checkpoint,BP,
3608,GO:0007097,1,0.861971520248017,0,19,nuclear migration,BP,
3609,GO:0007098,1,0.462679411202436,0,114,centrosome cycle,BP,
3610,GO:0007099,1,0.817421237251581,0,29,centriole replication,BP,
3611,GO:0007100,1,0.905265334143485,0,15,mitotic centrosome separation,BP,
3612,GO:0007113,1,0.986195744072924,0,3,endomitotic cell cycle,BP,
3613,GO:0007127,1,0.546697405978601,0,96,meiosis I,BP,
3614,GO:0007129,1,0.811588604081914,0,34,synapsis,BP,
3615,GO:0007130,1,0.906008122749958,0,16,synaptonemal complex assembly,BP,
3616,GO:0007131,1,0.75366611238171,0,44,reciprocal meiotic recombination,BP,
3617,GO:0007135,1,0.953050898144707,0,8,meiosis II,BP,
3618,GO:0007140,1,0.77856313600063,0,39,male meiotic nuclear division,BP,
3619,GO:0007141,1,0.899131637425468,0,18,male meiosis I,BP,
3620,GO:0007143,1,0.859320083647272,0,23,female meiotic nuclear division,BP,
3621,GO:0007144,1,0.959602785082818,0,7,female meiosis I,BP,
3622,GO:0007146,1,0.993301131169352,0,1,meiotic recombination nodule assembly,BP,
3623,GO:0007147,1,0.992499290341661,0,1,female meiosis II,BP,
3627,GO:0007157,1,0.741695935892964,0,43,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
3628,GO:0007158,1,0.88824781874285,0,16,neuron cell-cell adhesion,BP,
3631,GO:0007161,1,0.9655734534169,0,4,calcium-independent cell-matrix adhesion,BP,
3633,GO:0007163,1,0.257395087082161,0,196,establishment or maintenance of cell polarity,BP,
3638,GO:0007168,1,0.973858037373551,0,5,receptor guanylyl cyclase signaling pathway,BP,
3641,GO:0007172,1,0.949766393265202,0,8,signal complex assembly,BP,
3643,GO:0007174,1,0.99463878313656,0,1,epidermal growth factor catabolic process,BP,
3644,GO:0007175,1,0.914735304546517,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3645,GO:0007176,1,0.837775261267889,0,27,regulation of epidermal growth factor-activated receptor activity,BP,
3647,GO:0007179,1,0.336710021041497,0,162,transforming growth factor beta receptor signaling pathway,BP,
3648,GO:0007181,1,0.981415628658774,0,3,transforming growth factor beta receptor complex assembly,BP,
3649,GO:0007182,1,0.957633383780159,0,6,common-partner SMAD protein phosphorylation,BP,
3650,GO:0007183,1,0.909254555737645,0,14,SMAD protein complex assembly,BP,
3651,GO:0007185,1,0.95400410000893,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3653,GO:0007187,1,0.307740262675972,0,197,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,
3654,GO:0007188,1,0.349600079935172,0,171,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,
3655,GO:0007189,1,0.607996561655673,0,82,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
3656,GO:0007190,1,0.814609538196539,0,31,activation of adenylate cyclase activity,BP,
3657,GO:0007191,1,0.944805081589462,0,9,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3658,GO:0007193,1,0.598787461912454,0,77,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
3659,GO:0007194,1,0.876703943376373,0,21,negative regulation of adenylate cyclase activity,BP,
3660,GO:0007195,1,0.961876031887265,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3661,GO:0007196,1,0.931448267128039,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3662,GO:0007197,1,0.962767755920791,0,6,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3663,GO:0007198,1,0.980373100527784,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3664,GO:0007199,1,0.993733497795061,0,1,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3665,GO:0007200,1,0.575641477391567,0,97,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
3668,GO:0007205,1,0.848300774478054,0,25,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
3669,GO:0007206,1,0.983860372331876,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3670,GO:0007207,1,0.96518022569365,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3671,GO:0007208,1,0.985129076462313,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3672,GO:0007210,1,0.931703363454642,0,13,serotonin receptor signaling pathway,BP,
3673,GO:0007212,1,0.794962221097944,0,38,dopamine receptor signaling pathway,BP,
3674,GO:0007213,1,0.909349714617396,0,16,G-protein coupled acetylcholine receptor signaling pathway,BP,
3676,GO:0007215,1,0.544673943136427,0,85,glutamate receptor signaling pathway,BP,
3677,GO:0007216,1,0.896421377698343,0,15,G-protein coupled glutamate receptor signaling pathway,BP,
3678,GO:0007217,1,0.96765445452191,0,7,tachykinin receptor signaling pathway,BP,
3679,GO:0007218,1,0.63591969302563,0,89,neuropeptide signaling pathway,BP,
3681,GO:0007220,1,0.889977728290941,0,17,Notch receptor processing,BP,
3682,GO:0007221,1,0.867362731095218,0,18,positive regulation of transcription of Notch receptor target,BP,
3683,GO:0007223,1,0.757570407824284,0,38,Wnt signaling pathway, calcium modulating pathway,BP,
3684,GO:0007224,1,0.433881551756797,0,124,smoothened signaling pathway,BP,
3685,GO:0007225,1,0.992354159586394,0,1,patched ligand maturation,BP,
3686,GO:0007227,1,0.973702014760449,0,4,signal transduction downstream of smoothened,BP,
3687,GO:0007228,1,0.981100033372737,0,3,positive regulation of hh target transcription factor activity,BP,
3689,GO:0007231,1,0.984423734560889,0,3,osmosensory signaling pathway,BP,
3691,GO:0007250,1,0.894169608462701,0,18,activation of NF-kappaB-inducing kinase activity,BP,
3692,GO:0007252,1,0.908896330345112,0,14,I-kappaB phosphorylation,BP,
3693,GO:0007253,1,0.965676733756679,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3695,GO:0007256,1,0.953196365891424,0,6,activation of JNKK activity,BP,
3696,GO:0007257,1,0.797552611518303,0,32,activation of JUN kinase activity,BP,
3697,GO:0007258,1,0.974423949997973,0,4,JUN phosphorylation,BP,
3706,GO:0007269,1,0.388661240474797,0,139,neurotransmitter secretion,BP,
3707,GO:0007270,1,0.94277850826028,0,8,neuron-neuron synaptic transmission,BP,
3708,GO:0007271,1,0.823192980102594,0,32,synaptic transmission, cholinergic,BP,
3710,GO:0007274,1,0.84932029038863,0,26,neuromuscular synaptic transmission,BP,
3713,GO:0007281,1,0.295703326598485,0,191,germ cell development,BP,
3715,GO:0007284,1,0.98489766436194,0,2,spermatogonial cell division,BP,
3716,GO:0007286,1,0.540744544000876,0,100,spermatid development,BP,
3717,GO:0007288,1,0.936890192650467,0,10,sperm axoneme assembly,BP,
3718,GO:0007289,1,0.913455822981325,0,14,spermatid nucleus differentiation,BP,
3719,GO:0007290,1,0.992347933347364,0,1,spermatid nucleus elongation,BP,
3720,GO:0007291,1,0.99688394137046,0,1,sperm individualization,BP,
3721,GO:0007292,1,0.506688397392944,0,105,female gamete generation,BP,
3722,GO:0007296,1,0.971012156595541,0,4,vitellogenesis,BP,
3723,GO:0007308,1,0.986323748024219,0,2,oocyte construction,BP,
3724,GO:0007309,1,0.986323748024219,0,2,oocyte axis specification,BP,
3725,GO:0007314,1,0.986323748024219,0,2,oocyte anterior/posterior axis specification,BP,
3726,GO:0007315,1,0.986323748024219,0,2,pole plasm assembly,BP,
3727,GO:0007320,1,0.941085254431708,0,10,insemination,BP,
3728,GO:0007338,1,0.551844282557166,0,105,single fertilization,BP,
3729,GO:0007339,1,0.876523774745924,0,25,binding of sperm to zona pellucida,BP,
3730,GO:0007340,1,0.858866219917931,0,27,acrosome reaction,BP,
3731,GO:0007341,1,0.973979019348536,0,6,penetration of zona pellucida,BP,
3732,GO:0007342,1,0.961908565506764,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3733,GO:0007343,1,0.986209751281085,0,2,egg activation,BP,
3734,GO:0007344,1,0.995863968126632,0,1,pronuclear fusion,BP,
3736,GO:0007349,1,0.99688394137046,0,1,cellularization,BP,
3739,GO:0007352,1,0.980560614314641,0,3,zygotic specification of dorsal/ventral axis,BP,
3741,GO:0007356,1,0.985401633442315,0,3,thorax and anterior abdomen determination,BP,
3744,GO:0007371,1,0.992479643238667,0,1,ventral midline determination,BP,
3745,GO:0007379,1,0.913135751006995,0,15,segment specification,BP,
3746,GO:0007386,1,0.966799028050947,0,5,compartment pattern specification,BP,
3747,GO:0007387,1,0.993431429390365,0,1,anterior compartment pattern formation,BP,
3748,GO:0007388,1,0.993431429390365,0,1,posterior compartment specification,BP,
3752,GO:0007400,1,0.993995508641689,0,1,neuroblast fate determination,BP,
3753,GO:0007402,1,0.99141260400306,0,2,ganglion mother cell fate determination,BP,
3754,GO:0007403,1,0.99256729355413,0,1,glial cell fate determination,BP,
3756,GO:0007406,1,0.962718750759551,0,5,negative regulation of neuroblast proliferation,BP,
3759,GO:0007412,1,0.98925625349665,0,2,axon target recognition,BP,
3761,GO:0007416,1,0.397700179847952,0,123,synapse assembly,BP,
3763,GO:0007418,1,0.973235298960208,0,4,ventral midline development,BP,
3769,GO:0007439,1,0.986807575866726,0,2,ectodermal digestive tract development,BP,
3770,GO:0007440,1,0.926817209315339,0,10,foregut morphogenesis,BP,
3771,GO:0007442,1,0.952268053657399,0,7,hindgut morphogenesis,BP,
3772,GO:0007468,1,0.989008852558206,0,2,regulation of rhodopsin gene expression,BP,
3773,GO:0007492,1,0.599538035528127,0,76,endoderm development,BP,
3774,GO:0007493,1,0.986912852115954,0,2,endodermal cell fate determination,BP,
3776,GO:0007495,1,0.992727725152831,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3777,GO:0007497,1,0.984809256499819,0,2,posterior midgut development,BP,
3779,GO:0007499,1,0.992375659841673,0,1,ectoderm and mesoderm interaction,BP,
3780,GO:0007500,1,0.988844839991921,0,2,mesodermal cell fate determination,BP,
3782,GO:0007506,1,0.987654779185663,0,2,gonadal mesoderm development,BP,
3784,GO:0007509,1,0.991825233353765,0,1,mesoderm migration involved in gastrulation,BP,
3787,GO:0007518,1,0.990035402201084,0,2,myoblast fate determination,BP,
3789,GO:0007520,1,0.830574632656365,0,29,myoblast fusion,BP,
3790,GO:0007521,1,0.984559721540465,0,2,muscle cell fate determination,BP,
3791,GO:0007522,1,0.992014393311059,0,1,visceral muscle development,BP,
3792,GO:0007525,1,0.973968055705227,0,2,somatic muscle development,BP,
3793,GO:0007528,1,0.714654866072247,0,46,neuromuscular junction development,BP,
3794,GO:0007529,1,0.984962222657954,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3795,GO:0007530,1,0.877136176975219,0,21,sex determination,BP,
3796,GO:0007538,1,0.984701732587259,0,2,primary sex determination,BP,
3797,GO:0007542,1,0.984701732587259,0,2,primary sex determination, germ-line,BP,
3799,GO:0007549,1,0.916592760392475,0,12,dosage compensation,BP,
3802,GO:0007567,1,0.903458408728046,0,16,parturition,BP,
3804,GO:0007569,1,0.53769654650171,0,96,cell aging,BP,
3805,GO:0007571,1,0.996853128847878,0,1,age-dependent general metabolic decline,BP,
3806,GO:0007576,1,0.993814020161978,0,1,nucleolar fragmentation,BP,
3808,GO:0007585,1,0.68755754346922,0,60,respiratory gaseous exchange,BP,
3810,GO:0007588,1,0.737616037628924,0,50,excretion,BP,
3814,GO:0007597,1,0.92314952143388,0,15,blood coagulation, intrinsic pathway,BP,
3815,GO:0007598,1,0.977425957849659,0,4,blood coagulation, extrinsic pathway,BP,
3818,GO:0007601,1,0.353342643258447,0,164,visual perception,BP,
3819,GO:0007602,1,0.783738590344756,0,41,phototransduction,BP,
3820,GO:0007603,1,0.847552486412617,0,26,phototransduction, visible light,BP,
3822,GO:0007606,1,0.627840713762179,0,87,sensory perception of chemical stimulus,BP,
3823,GO:0007608,1,0.806581730264313,0,39,sensory perception of smell,BP,
3827,GO:0007613,1,0.476864344726365,0,105,memory,BP,
3828,GO:0007614,1,0.947666379559549,0,9,short-term memory,BP,
3829,GO:0007616,1,0.784169792437616,0,34,long-term memory,BP,
3830,GO:0007617,1,0.89318863098311,0,18,mating behavior,BP,
3831,GO:0007618,1,0.82041493941513,0,32,mating,BP,
3832,GO:0007619,1,0.981252629591094,0,3,courtship behavior,BP,
3833,GO:0007620,1,0.906707338638306,0,16,copulation,BP,
3834,GO:0007621,1,0.980102897346988,0,3,negative regulation of female receptivity,BP,
3835,GO:0007622,1,0.791018044422564,0,40,rhythmic behavior,BP,
3837,GO:0007624,1,0.992446663876071,0,1,ultradian rhythm,BP,
3841,GO:0007631,1,0.605492360782018,0,85,feeding behavior,BP,
3842,GO:0007632,1,0.703457741286246,0,49,visual behavior,BP,
3843,GO:0007634,1,0.994080945791643,0,1,optokinetic behavior,BP,
3844,GO:0007635,1,0.904397024514033,0,14,chemosensory behavior,BP,
3845,GO:0007638,1,0.902809530171374,0,13,mechanosensory behavior,BP,
3846,GO:0008009,1,0.880430412492803,0,32,chemokine activity,MF,
3847,GO:0008013,1,0.557981736557961,0,79,beta-catenin binding,MF,
3851,GO:0008020,1,0.960585644796779,0,8,G-protein coupled photoreceptor activity,MF,
3853,GO:0008022,1,0.300829197485539,0,183,protein C-terminus binding,MF,
3854,GO:0008023,1,0.721433202916781,0,48,transcription elongation factor complex,CC,
3855,GO:0008024,1,0.946097418458761,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3856,GO:0008026,1,0.530594840870252,0,91,ATP-dependent helicase activity,MF,
3857,GO:0008028,1,0.734847004081903,0,49,monocarboxylic acid transmembrane transporter activity,MF,
3858,GO:0008033,1,0.514565739189823,0,118,tRNA processing,BP,
3859,GO:0008035,1,0.963000677197017,0,7,high-density lipoprotein particle binding,MF,
3862,GO:0008043,1,0.993633232305479,0,2,intracellular ferritin complex,CC,
3863,GO:0008045,1,0.863210902533205,0,21,motor neuron axon guidance,BP,
3864,GO:0008046,1,0.949050327528805,0,7,axon guidance receptor activity,MF,
3866,GO:0008048,1,0.98683294094439,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3867,GO:0008049,1,0.995493949383634,0,1,male courtship behavior,BP,
3868,GO:0008050,1,0.985694886310749,0,2,female courtship behavior,BP,
3869,GO:0008052,1,0.9968737390535,0,1,sensory organ boundary specification,BP,
3870,GO:0008053,1,0.890071697096149,0,21,mitochondrial fusion,BP,
3871,GO:0008057,1,0.99151779419405,0,1,eye pigment granule organization,BP,
3872,GO:0008061,1,0.959835287427784,0,7,chitin binding,MF,
3873,GO:0008063,1,0.959871178536304,0,6,Toll signaling pathway,BP,
3876,GO:0008066,1,0.807599950189523,0,27,glutamate receptor activity,MF,
3877,GO:0008068,1,0.99295610486543,0,1,extracellularly glutamate-gated chloride channel activity,MF,
3878,GO:0008073,1,0.989215128955935,0,3,ornithine decarboxylase inhibitor activity,MF,
3879,GO:0008074,1,0.908463242212933,0,12,guanylate cyclase complex, soluble,CC,
3881,GO:0008078,1,0.985466213793506,0,3,mesodermal cell migration,BP,
3882,GO:0008079,1,0.961288679241003,0,6,translation termination factor activity,MF,
3883,GO:0008080,1,0.609964277751125,0,77,N-acetyltransferase activity,MF,
3885,GO:0008083,1,0.487317673240696,0,133,growth factor activity,MF,
3886,GO:0008088,1,0.692925579342196,0,54,axo-dendritic transport,BP,
3887,GO:0008089,1,0.786826486740198,0,37,anterograde axonal transport,BP,
3888,GO:0008090,1,0.946015233527364,0,8,retrograde axonal transport,BP,
3889,GO:0008091,1,0.932269848328308,0,8,spectrin,CC,
3891,GO:0008093,1,0.922057988045168,0,12,cytoskeletal adaptor activity,MF,
3892,GO:0008094,1,0.583970459114629,0,78,DNA-dependent ATPase activity,MF,
3893,GO:0008097,1,0.958555398578903,0,10,5S rRNA binding,MF,
3895,GO:0008106,1,0.923289571470189,0,19,alcohol dehydrogenase (NADP+) activity,MF,
3896,GO:0008107,1,0.992436627667326,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3897,GO:0008108,1,0.996545095529736,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3898,GO:0008109,1,0.98501800092137,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3899,GO:0008111,1,0.995327418841667,0,1,alpha-methylacyl-CoA racemase activity,MF,
3901,GO:0008113,1,0.992905319363894,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3902,GO:0008115,1,0.994149087961217,0,1,sarcosine oxidase activity,MF,
3903,GO:0008116,1,0.992128560546459,0,1,prostaglandin-I synthase activity,MF,
3904,GO:0008117,1,0.992076282745167,0,1,sphinganine-1-phosphate aldolase activity,MF,
3905,GO:0008118,1,0.994661899343857,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3906,GO:0008119,1,0.992673982207911,0,1,thiopurine S-methyltransferase activity,MF,
3907,GO:0008120,1,0.996090449691365,0,1,ceramide glucosyltransferase activity,MF,
3908,GO:0008121,1,0.97223210766193,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3909,GO:0008124,1,0.991136344120667,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3910,GO:0008126,1,0.993173986888723,0,1,acetylesterase activity,MF,
3911,GO:0008127,1,0.996592347946841,0,1,quercetin 2,3-dioxygenase activity,MF,
3912,GO:0008131,1,0.965669687930751,0,5,primary amine oxidase activity,MF,
3914,GO:0008135,1,0.604284029372454,0,84,translation factor activity, RNA binding,MF,
3915,GO:0008137,1,0.874586678911802,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3916,GO:0008138,1,0.788287146753099,0,40,protein tyrosine/serine/threonine phosphatase activity,MF,
3917,GO:0008139,1,0.853969838121132,0,22,nuclear localization sequence binding,MF,
3918,GO:0008140,1,0.953125223537418,0,8,cAMP response element binding protein binding,MF,
3919,GO:0008142,1,0.964042107605119,0,5,oxysterol binding,MF,
3920,GO:0008143,1,0.897663495331592,0,16,poly(A) binding,MF,
3922,GO:0008146,1,0.750383213168402,0,47,sulfotransferase activity,MF,
3923,GO:0008147,1,0.994112229766896,0,2,structural constituent of bone,MF,
3927,GO:0008156,1,0.804682258680554,0,32,negative regulation of DNA replication,BP,
3928,GO:0008157,1,0.881551258821894,0,19,protein phosphatase 1 binding,MF,
3929,GO:0008158,1,0.980861904516039,0,3,hedgehog receptor activity,MF,
3930,GO:0008160,1,0.993645514640259,0,1,protein tyrosine phosphatase activator activity,MF,
3932,GO:0008169,1,0.982580166140457,0,3,C-methyltransferase activity,MF,
3934,GO:0008171,1,0.895271206891166,0,18,O-methyltransferase activity,MF,
3935,GO:0008172,1,0.963114795249011,0,6,S-methyltransferase activity,MF,
3936,GO:0008173,1,0.729513947992712,0,51,RNA methyltransferase activity,MF,
3937,GO:0008174,1,0.945173264715414,0,9,mRNA methyltransferase activity,MF,
3938,GO:0008175,1,0.84355573970312,0,27,tRNA methyltransferase activity,MF,
3939,GO:0008176,1,0.992386880423274,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3940,GO:0008177,1,0.981008682933304,0,4,succinate dehydrogenase (ubiquinone) activity,MF,
3941,GO:0008179,1,0.914809403074516,0,13,adenylate cyclase binding,MF,
3942,GO:0008180,1,0.817848737058657,0,33,COP9 signalosome,CC,
3943,GO:0008184,1,0.978377349657531,0,3,glycogen phosphorylase activity,MF,
3944,GO:0008186,1,0.637076366855241,0,65,RNA-dependent ATPase activity,MF,
3945,GO:0008187,1,0.857919056744423,0,23,poly-pyrimidine tract binding,MF,
3946,GO:0008188,1,0.788345154821974,0,46,neuropeptide receptor activity,MF,
3947,GO:0008190,1,0.939874501186639,0,10,eukaryotic initiation factor 4E binding,MF,
3949,GO:0008192,1,0.981547199382325,0,3,RNA guanylyltransferase activity,MF,
3950,GO:0008193,1,0.989060281651963,0,2,tRNA guanylyltransferase activity,MF,
3952,GO:0008195,1,0.976727296528895,0,3,phosphatidate phosphatase activity,MF,
3955,GO:0008200,1,0.829227939811428,0,31,ion channel inhibitor activity,MF,
3958,GO:0008203,1,0.467504250870827,0,119,cholesterol metabolic process,BP,
3959,GO:0008204,1,0.989896281911023,0,2,ergosterol metabolic process,BP,
3960,GO:0008206,1,0.768021122686059,0,43,bile acid metabolic process,BP,
3962,GO:0008209,1,0.885339007542288,0,21,androgen metabolic process,BP,
3963,GO:0008210,1,0.906382047551251,0,18,estrogen metabolic process,BP,
3964,GO:0008211,1,0.894471735443323,0,20,glucocorticoid metabolic process,BP,
3965,GO:0008212,1,0.946436512021372,0,8,mineralocorticoid metabolic process,BP,
3966,GO:0008213,1,0.334060052971056,0,163,protein alkylation,BP,
3967,GO:0008214,1,0.801527968390902,0,29,protein dealkylation,BP,
3968,GO:0008215,1,0.968625685402296,0,7,spermine metabolic process,BP,
3969,GO:0008216,1,0.965739571175357,0,8,spermidine metabolic process,BP,
3971,GO:0008218,1,0.99254237541719,0,1,bioluminescence,BP,
3973,GO:0008227,1,0.82956682626276,0,32,G-protein coupled amine receptor activity,MF,
3974,GO:0008228,1,0.958029785603302,0,7,opsonization,BP,
3981,GO:0008239,1,0.937932512472723,0,11,dipeptidyl-peptidase activity,MF,
3982,GO:0008240,1,0.977646135798375,0,3,tripeptidyl-peptidase activity,MF,
3983,GO:0008241,1,0.992599248135765,0,1,peptidyl-dipeptidase activity,MF,
3984,GO:0008242,1,0.947405430279314,0,9,omega peptidase activity,MF,
3985,GO:0008250,1,0.941900999298447,0,12,oligosaccharyltransferase complex,CC,
3986,GO:0008251,1,0.985364571252158,0,2,tRNA-specific adenosine deaminase activity,MF,
3987,GO:0008252,1,0.916981651882122,0,14,nucleotidase activity,MF,
3988,GO:0008253,1,0.930321764520092,0,12,5'-nucleotidase activity,MF,
3989,GO:0008254,1,0.991597917173308,0,1,3'-nucleotidase activity,MF,
3990,GO:0008260,1,0.988249285597292,0,2,3-oxoacid CoA-transferase activity,MF,
3991,GO:0008263,1,0.986717095606258,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3992,GO:0008265,1,0.993379919360459,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3993,GO:0008266,1,0.883944784072117,0,19,poly(U) RNA binding,MF,
3994,GO:0008267,1,0.991307423890705,0,1,poly-glutamine tract binding,MF,
3995,GO:0008269,1,0.990255898609645,0,2,JAK pathway signal transduction adaptor activity,MF,
3997,GO:0008271,1,0.929820002434078,0,10,secondary active sulfate transmembrane transporter activity,MF,
3998,GO:0008272,1,0.918830546919345,0,12,sulfate transport,BP,
3999,GO:0008273,1,0.971907489713814,0,4,calcium, potassium:sodium antiporter activity,MF,
4000,GO:0008274,1,0.949440715768808,0,7,gamma-tubulin ring complex,CC,
4001,GO:0008275,1,0.971035947549135,0,4,gamma-tubulin small complex,CC,
4002,GO:0008276,1,0.600026794954672,0,77,protein methyltransferase activity,MF,
4004,GO:0008278,1,0.930769650190895,0,10,cohesin complex,CC,
4005,GO:0008281,1,0.984714881660784,0,2,sulfonylurea receptor activity,MF,
4006,GO:0008282,1,0.972033478958292,0,4,inward rectifying potassium channel,CC,
4010,GO:0008286,1,0.460374503292002,0,118,insulin receptor signaling pathway,BP,
4011,GO:0008287,1,0.746750571705447,0,44,protein serine/threonine phosphatase complex,CC,
4013,GO:0008290,1,0.958140119023365,0,7,F-actin capping protein complex,CC,
4014,GO:0008291,1,0.980345646829303,0,3,acetylcholine metabolic process,BP,
4015,GO:0008292,1,0.99357385075076,0,1,acetylcholine biosynthetic process,BP,
4016,GO:0008294,1,0.981882282158593,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4017,GO:0008295,1,0.980126797966768,0,4,spermidine biosynthetic process,BP,
4018,GO:0008296,1,0.946271251086511,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4019,GO:0008297,1,0.954945600120222,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4020,GO:0008298,1,0.933112335313661,0,12,intracellular mRNA localization,BP,
4021,GO:0008299,1,0.854188494222923,0,27,isoprenoid biosynthetic process,BP,
4022,GO:0008300,1,0.96422452403123,0,7,isoprenoid catabolic process,BP,
4023,GO:0008301,1,0.895385688269301,0,18,DNA binding, bending,MF,
4024,GO:0008305,1,0.78866009259407,0,32,integrin complex,CC,
4025,GO:0008306,1,0.630489178114468,0,67,associative learning,BP,
4027,GO:0008308,1,0.910814409701586,0,16,voltage-gated anion channel activity,MF,
4028,GO:0008309,1,0.979138028511778,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4029,GO:0008310,1,0.968447191446522,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4030,GO:0008311,1,0.991669710868634,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4031,GO:0008312,1,0.966104490297722,0,7,7S RNA binding,MF,
4032,GO:0008318,1,0.957803644328854,0,7,protein prenyltransferase activity,MF,
4033,GO:0008320,1,0.942555461691542,0,13,protein transmembrane transporter activity,MF,
4034,GO:0008321,1,0.978082967474611,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4036,GO:0008327,1,0.90862997529011,0,15,methyl-CpG binding,MF,
4037,GO:0008328,1,0.710753005882242,0,49,ionotropic glutamate receptor complex,CC,
4038,GO:0008329,1,0.921915704691229,0,14,signaling pattern recognition receptor activity,MF,
4039,GO:0008330,1,0.979000675661775,0,4,protein tyrosine/threonine phosphatase activity,MF,
4040,GO:0008331,1,0.907041886312569,0,12,high voltage-gated calcium channel activity,MF,
4041,GO:0008332,1,0.969053920578988,0,4,low voltage-gated calcium channel activity,MF,
4042,GO:0008333,1,0.709211468951431,0,52,endosome to lysosome transport,BP,
4043,GO:0008334,1,0.868677069681778,0,24,histone mRNA metabolic process,BP,
4044,GO:0008336,1,0.995537833604515,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4045,GO:0008340,1,0.919554583550447,0,11,determination of adult lifespan,BP,
4046,GO:0008343,1,0.962131430295273,0,8,adult feeding behavior,BP,
4048,GO:0008347,1,0.782240182985466,0,38,glial cell migration,BP,
4049,GO:0008348,1,0.99249170944401,0,1,negative regulation of antimicrobial humoral response,BP,
4050,GO:0008349,1,0.92191906546755,0,11,MAP kinase kinase kinase kinase activity,MF,
4051,GO:0008352,1,0.993542143301884,0,1,katanin complex,CC,
4052,GO:0008353,1,0.916558093906078,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4053,GO:0008354,1,0.953516102332911,0,7,germ cell migration,BP,
4054,GO:0008355,1,0.984903921571483,0,2,olfactory learning,BP,
4055,GO:0008356,1,0.886264227937996,0,18,asymmetric cell division,BP,
4056,GO:0008358,1,0.986323748024219,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4060,GO:0008373,1,0.88025203729211,0,20,sialyltransferase activity,MF,
4061,GO:0008374,1,0.77750414257553,0,37,O-acyltransferase activity,MF,
4062,GO:0008375,1,0.713311593445146,0,53,acetylglucosaminyltransferase activity,MF,
4063,GO:0008376,1,0.744840050620391,0,44,acetylgalactosaminyltransferase activity,MF,
4065,GO:0008379,1,0.98388648979758,0,5,thioredoxin peroxidase activity,MF,
4066,GO:0008380,1,0.0847885506657741,0,406,RNA splicing,BP,
4068,GO:0008384,1,0.985041387740134,0,2,IkappaB kinase activity,MF,
4069,GO:0008385,1,0.945433253873569,0,9,IkappaB kinase complex,CC,
4070,GO:0008386,1,0.995335067531889,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4071,GO:0008387,1,0.994513774897628,0,1,steroid 7-alpha-hydroxylase activity,MF,
4072,GO:0008389,1,0.99169577782094,0,2,coumarin 7-hydroxylase activity,MF,
4073,GO:0008391,1,0.963569116011856,0,8,arachidonic acid monooxygenase activity,MF,
4074,GO:0008392,1,0.963569116011856,0,8,arachidonic acid epoxygenase activity,MF,
4075,GO:0008395,1,0.890796264775414,0,22,steroid hydroxylase activity,MF,
4076,GO:0008396,1,0.988744558232746,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4077,GO:0008397,1,0.992461277037728,0,1,sterol 12-alpha-hydroxylase activity,MF,
4078,GO:0008398,1,0.992839298677542,0,1,sterol 14-demethylase activity,MF,
4079,GO:0008401,1,0.980914352555013,0,3,retinoic acid 4-hydroxylase activity,MF,
4080,GO:0008403,1,0.992738137552516,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4081,GO:0008404,1,0.99560970525256,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4082,GO:0008405,1,0.99560970525256,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4084,GO:0008408,1,0.742422774061435,0,48,3'-5' exonuclease activity,MF,
4085,GO:0008409,1,0.891337249596709,0,16,5'-3' exonuclease activity,MF,
4086,GO:0008410,1,0.977398051084477,0,4,CoA-transferase activity,MF,
4087,GO:0008413,1,0.992242494598362,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4088,GO:0008417,1,0.919458441528753,0,12,fucosyltransferase activity,MF,
4089,GO:0008418,1,0.99678053621062,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4090,GO:0008419,1,0.993562478370875,0,1,RNA lariat debranching enzyme activity,MF,
4091,GO:0008420,1,0.952270862335674,0,8,CTD phosphatase activity,MF,
4092,GO:0008422,1,0.975911504566239,0,4,beta-glucosidase activity,MF,
4093,GO:0008424,1,0.992645008216672,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4094,GO:0008425,1,0.996630186162235,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4095,GO:0008426,1,0.986052154521577,0,3,protein kinase C inhibitor activity,MF,
4096,GO:0008427,1,0.987783402427512,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4097,GO:0008428,1,0.980920705989079,0,3,ribonuclease inhibitor activity,MF,
4098,GO:0008429,1,0.953337755969886,0,9,phosphatidylethanolamine binding,MF,
4099,GO:0008430,1,0.976245961956894,0,4,selenium binding,MF,
4100,GO:0008431,1,0.986520177346468,0,2,vitamin E binding,MF,
4101,GO:0008432,1,0.95000300186806,0,8,JUN kinase binding,MF,
4102,GO:0008434,1,0.99236004392278,0,1,calcitriol receptor activity,MF,
4103,GO:0008437,1,0.995249011931214,0,1,thyrotropin-releasing hormone activity,MF,
4104,GO:0008440,1,0.968930183236932,0,5,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4105,GO:0008441,1,0.985671457567761,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4106,GO:0008442,1,0.995315923746389,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4107,GO:0008443,1,0.953053638225846,0,7,phosphofructokinase activity,MF,
4108,GO:0008444,1,0.994744803162151,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4109,GO:0008445,1,0.996116196177621,0,1,D-aspartate oxidase activity,MF,
4110,GO:0008446,1,0.996006629242402,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4111,GO:0008448,1,0.995667141506491,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4112,GO:0008449,1,0.976990917017791,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4113,GO:0008452,1,0.993301131169352,0,1,RNA ligase activity,MF,
4114,GO:0008453,1,0.982842699369127,0,3,alanine-glyoxylate transaminase activity,MF,
4115,GO:0008454,1,0.981012976754631,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4116,GO:0008455,1,0.993443196935179,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4117,GO:0008456,1,0.992481453401396,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4118,GO:0008457,1,0.992449078772832,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4119,GO:0008458,1,0.992672461604809,0,1,carnitine O-octanoyltransferase activity,MF,
4120,GO:0008459,1,0.986169900088376,0,2,chondroitin 6-sulfotransferase activity,MF,
4121,GO:0008460,1,0.995493949383634,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4122,GO:0008465,1,0.996659719288177,0,1,glycerate dehydrogenase activity,MF,
4123,GO:0008466,1,0.988367730115849,0,2,glycogenin glucosyltransferase activity,MF,
4124,GO:0008467,1,0.966373807254291,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4125,GO:0008469,1,0.948511897730128,0,9,histone-arginine N-methyltransferase activity,MF,
4126,GO:0008470,1,0.992377939948087,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4127,GO:0008474,1,0.944837816436748,0,10,palmitoyl-(protein) hydrolase activity,MF,
4128,GO:0008475,1,0.9784645608709,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4129,GO:0008476,1,0.990545534710624,0,2,protein-tyrosine sulfotransferase activity,MF,
4130,GO:0008478,1,0.991540631056991,0,1,pyridoxal kinase activity,MF,
4131,GO:0008479,1,0.983101173451406,0,4,queuine tRNA-ribosyltransferase activity,MF,
4132,GO:0008480,1,0.992630650743975,0,1,sarcosine dehydrogenase activity,MF,
4133,GO:0008481,1,0.988609706164564,0,2,sphinganine kinase activity,MF,
4134,GO:0008482,1,0.994365027039753,0,1,sulfite oxidase activity,MF,
4135,GO:0008483,1,0.901446980492147,0,17,transaminase activity,MF,
4136,GO:0008484,1,0.89514087065639,0,16,sulfuric ester hydrolase activity,MF,
4137,GO:0008486,1,0.978556250983495,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4138,GO:0008488,1,0.99274043831216,0,1,gamma-glutamyl carboxylase activity,MF,
4140,GO:0008493,1,0.995601405461948,0,1,tetracycline transmembrane transporter activity,MF,
4141,GO:0008494,1,0.934138312789476,0,11,translation activator activity,MF,
4142,GO:0008495,1,0.992931778905928,0,1,protoheme IX farnesyltransferase activity,MF,
4143,GO:0008496,1,0.992435124705559,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4144,GO:0008499,1,0.927772221400493,0,12,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4145,GO:0008502,1,0.980689496422547,0,4,melatonin receptor activity,MF,
4146,GO:0008503,1,0.933827976215248,0,10,benzodiazepine receptor activity,MF,
4147,GO:0008504,1,0.942352859437112,0,9,monoamine transmembrane transporter activity,MF,
4149,GO:0008507,1,0.992510217060222,0,1,sodium:iodide symporter activity,MF,
4150,GO:0008508,1,0.983485950030158,0,4,bile acid:sodium symporter activity,MF,
4151,GO:0008509,1,0.1349174240281,0,302,anion transmembrane transporter activity,MF,
4152,GO:0008510,1,0.931646792734272,0,9,sodium:bicarbonate symporter activity,MF,
4153,GO:0008511,1,0.984137077846956,0,2,sodium:potassium:chloride symporter activity,MF,
4154,GO:0008513,1,0.984340425473803,0,3,secondary active organic cation transmembrane transporter activity,MF,
4155,GO:0008514,1,0.26865219855253,0,201,organic anion transmembrane transporter activity,MF,
4157,GO:0008517,1,0.964555088036897,0,6,folic acid transmembrane transporter activity,MF,
4158,GO:0008518,1,0.993181085075676,0,1,reduced folate carrier activity,MF,
4159,GO:0008519,1,0.842743668596515,0,28,ammonium transmembrane transporter activity,MF,
4160,GO:0008520,1,0.991687952864058,0,1,L-ascorbate:sodium symporter activity,MF,
4161,GO:0008521,1,0.99354439408096,0,1,acetyl-CoA transmembrane transporter activity,MF,
4162,GO:0008523,1,0.992635234378355,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4163,GO:0008525,1,0.944563156793969,0,8,phosphatidylcholine transporter activity,MF,
4164,GO:0008526,1,0.945024901746698,0,8,phosphatidylinositol transporter activity,MF,
4165,GO:0008527,1,0.942787370484297,0,14,taste receptor activity,MF,
4166,GO:0008528,1,0.529087095489437,0,117,G-protein coupled peptide receptor activity,MF,
4167,GO:0008531,1,0.993443196935179,0,1,riboflavin kinase activity,MF,
4168,GO:0008532,1,0.953904097721413,0,8,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4169,GO:0008534,1,0.984993195817656,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4170,GO:0008535,1,0.874019160481373,0,24,respiratory chain complex IV assembly,BP,
4171,GO:0008536,1,0.790626806291981,0,33,Ran GTPase binding,MF,
4172,GO:0008537,1,0.98654284090926,0,3,proteasome activator complex,CC,
4173,GO:0008540,1,0.944692356995128,0,12,proteasome regulatory particle, base subcomplex,CC,
4174,GO:0008541,1,0.971627647496264,0,7,proteasome regulatory particle, lid subcomplex,CC,
4175,GO:0008542,1,0.727598299031784,0,44,visual learning,BP,
4176,GO:0008543,1,0.527466063077528,0,99,fibroblast growth factor receptor signaling pathway,BP,
4178,GO:0008545,1,0.985125816043958,0,2,JUN kinase kinase activity,MF,
4179,GO:0008553,1,0.923414178705832,0,13,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4180,GO:0008554,1,0.99234309375677,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4181,GO:0008555,1,0.992195847973256,0,1,chloride-transporting ATPase activity,MF,
4182,GO:0008556,1,0.928408014780642,0,12,potassium-transporting ATPase activity,MF,
4183,GO:0008559,1,0.954547674090035,0,6,xenobiotic transmembrane transporting ATPase activity,MF,
4185,GO:0008568,1,0.933938112512332,0,10,microtubule-severing ATPase activity,MF,
4187,GO:0008574,1,0.808414248313137,0,30,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4188,GO:0008579,1,0.992221718031098,0,1,JUN kinase phosphatase activity,MF,
4189,GO:0008582,1,0.964327685264271,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4192,GO:0008589,1,0.600508796265992,0,73,regulation of smoothened signaling pathway,BP,
4193,GO:0008591,1,0.995741448477009,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4194,GO:0008592,1,0.992682484055807,0,1,regulation of Toll signaling pathway,BP,
4196,GO:0008594,1,0.984966092651211,0,2,photoreceptor cell morphogenesis,BP,
4198,GO:0008597,1,0.982869861434007,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4199,GO:0008603,1,0.959236963389618,0,7,cAMP-dependent protein kinase regulator activity,MF,
4200,GO:0008607,1,0.981764914788943,0,3,phosphorylase kinase regulator activity,MF,
4201,GO:0008608,1,0.828971799844286,0,30,attachment of spindle microtubules to kinetochore,BP,
4202,GO:0008609,1,0.99143476648256,0,1,alkylglycerone-phosphate synthase activity,MF,
4204,GO:0008611,1,0.970315755154716,0,5,ether lipid biosynthetic process,BP,
4205,GO:0008612,1,0.981114066771492,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4206,GO:0008614,1,0.987530742659709,0,2,pyridoxine metabolic process,BP,
4207,GO:0008615,1,0.987530742659709,0,2,pyridoxine biosynthetic process,BP,
4208,GO:0008616,1,0.986509954226983,0,3,queuosine biosynthetic process,BP,
4209,GO:0008617,1,0.996861800316227,0,1,guanosine metabolic process,BP,
4210,GO:0008622,1,0.973108802719034,0,5,epsilon DNA polymerase complex,CC,
4211,GO:0008623,1,0.98617451353814,0,2,CHRAC,CC,
4213,GO:0008626,1,0.972964300203603,0,6,granzyme-mediated apoptotic signaling pathway,BP,
4214,GO:0008627,1,0.949764144732715,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4215,GO:0008628,1,0.987017339307591,0,3,hormone-mediated apoptotic signaling pathway,BP,
4217,GO:0008631,1,0.774951306710888,0,42,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4220,GO:0008641,1,0.936396453995606,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4223,GO:0008649,1,0.918585705302301,0,15,rRNA methyltransferase activity,MF,
4224,GO:0008650,1,0.992513475725912,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4227,GO:0008655,1,0.943585683410141,0,12,pyrimidine-containing compound salvage,BP,
4228,GO:0008656,1,0.918741929599191,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4229,GO:0008670,1,0.99282913722075,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4230,GO:0008689,1,0.996630186162235,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4231,GO:0008700,1,0.993301131169352,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4232,GO:0008705,1,0.990259096404492,0,1,methionine synthase activity,MF,
4233,GO:0008709,1,0.996902485895895,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4234,GO:0008721,1,0.993980113814259,0,1,D-serine ammonia-lyase activity,MF,
4235,GO:0008725,1,0.996804189000364,0,1,DNA-3-methyladenine glycosylase activity,MF,
4236,GO:0008732,1,0.988682996123051,0,2,L-allo-threonine aldolase activity,MF,
4237,GO:0008745,1,0.996902801562181,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4238,GO:0008746,1,0.989198949778549,0,2,NAD(P)+ transhydrogenase activity,MF,
4239,GO:0008747,1,0.996221607387185,0,1,N-acetylneuraminate lyase activity,MF,
4240,GO:0008750,1,0.992368179275643,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4241,GO:0008753,1,0.992555292239397,0,1,NADPH dehydrogenase (quinone) activity,MF,
4243,GO:0008761,1,0.992217274027167,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4244,GO:0008768,1,0.996952328863723,0,1,UDP-sugar diphosphatase activity,MF,
4245,GO:0008775,1,0.995691390191125,0,1,acetate CoA-transferase activity,MF,
4246,GO:0008781,1,0.9925447307419,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4247,GO:0008783,1,0.994733937475265,0,1,agmatinase activity,MF,
4248,GO:0008785,1,0.996211421052208,0,1,alkyl hydroperoxide reductase activity,MF,
4249,GO:0008792,1,0.993301131169352,0,1,arginine decarboxylase activity,MF,
4250,GO:0008794,1,0.996926999526087,0,1,arsenate reductase (glutaredoxin) activity,MF,
4251,GO:0008796,1,0.990231419238039,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4252,GO:0008798,1,0.986375570601934,0,2,beta-aspartyl-peptidase activity,MF,
4253,GO:0008802,1,0.992516020550558,0,1,betaine-aldehyde dehydrogenase activity,MF,
4254,GO:0008803,1,0.996877857029031,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4255,GO:0008808,1,0.992472606649392,0,1,cardiolipin synthase activity,MF,
4256,GO:0008812,1,0.992496073151331,0,1,choline dehydrogenase activity,MF,
4257,GO:0008817,1,0.992447215025984,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4258,GO:0008821,1,0.955045797077163,0,8,crossover junction endodeoxyribonuclease activity,MF,
4259,GO:0008823,1,0.966961711771361,0,5,cupric reductase activity,MF,
4260,GO:0008829,1,0.995700567959264,0,1,dCTP deaminase activity,MF,
4261,GO:0008832,1,0.992714561063159,0,1,dGTPase activity,MF,
4262,GO:0008841,1,0.993952009125385,0,1,dihydrofolate synthase activity,MF,
4263,GO:0008843,1,0.994421680846751,0,1,endochitinase activity,MF,
4264,GO:0008852,1,0.99319182321762,0,1,exodeoxyribonuclease I activity,MF,
4265,GO:0008853,1,0.980153577780544,0,4,exodeoxyribonuclease III activity,MF,
4266,GO:0008859,1,0.996899630008723,0,1,exoribonuclease II activity,MF,
4267,GO:0008865,1,0.96373068129907,0,5,fructokinase activity,MF,
4268,GO:0008887,1,0.992683268650641,0,1,glycerate kinase activity,MF,
4269,GO:0008889,1,0.965483309744395,0,5,glycerophosphodiester phosphodiesterase activity,MF,
4270,GO:0008890,1,0.996178647990857,0,1,glycine C-acetyltransferase activity,MF,
4271,GO:0008891,1,0.995859720278206,0,1,glycolate oxidase activity,MF,
4272,GO:0008892,1,0.992178296889712,0,1,guanine deaminase activity,MF,
4273,GO:0008893,1,0.996838979329863,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4274,GO:0008894,1,0.993377849116555,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4275,GO:0008897,1,0.993140926620316,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4276,GO:0008900,1,0.981472614008633,0,3,potassium:proton exchanging ATPase activity,MF,
4277,GO:0008903,1,0.996784848030021,0,1,hydroxypyruvate isomerase activity,MF,
4278,GO:0008905,1,0.996141503205617,0,1,mannose-phosphate guanylyltransferase activity,MF,
4279,GO:0008934,1,0.973513003680732,0,4,inositol monophosphate 1-phosphatase activity,MF,
4280,GO:0008940,1,0.979180372502372,0,3,nitrate reductase activity,MF,
4281,GO:0008941,1,0.989323696694354,0,2,nitric oxide dioxygenase activity,MF,
4282,GO:0008948,1,0.975808498957846,0,4,oxaloacetate decarboxylase activity,MF,
4283,GO:0008955,1,0.992460639830349,0,1,peptidoglycan glycosyltransferase activity,MF,
4284,GO:0008962,1,0.98900173330352,0,2,phosphatidylglycerophosphatase activity,MF,
4285,GO:0008963,1,0.994877562264452,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4286,GO:0008967,1,0.988018780533415,0,2,phosphoglycolate phosphatase activity,MF,
4287,GO:0008970,1,0.95026560941589,0,9,phosphatidylcholine 1-acylhydrolase activity,MF,
4288,GO:0008973,1,0.992676277590487,0,1,phosphopentomutase activity,MF,
4289,GO:0008988,1,0.986646673054992,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4290,GO:0008995,1,0.993704684941535,0,1,ribonuclease E activity,MF,
4291,GO:0009000,1,0.994016104075872,0,1,selenocysteine lyase activity,MF,
4292,GO:0009007,1,0.992489858766722,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4293,GO:0009008,1,0.966642145802388,0,5,DNA-methyltransferase activity,MF,
4294,GO:0009013,1,0.992256882334399,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4295,GO:0009019,1,0.972413368931738,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4296,GO:0009020,1,0.99536680713459,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4297,GO:0009032,1,0.996037623304787,0,1,thymidine phosphorylase activity,MF,
4298,GO:0009041,1,0.982952915057098,0,3,uridylate kinase activity,MF,
4299,GO:0009048,1,0.925615208363128,0,10,dosage compensation by inactivation of X chromosome,BP,
4300,GO:0009051,1,0.986656240836724,0,3,pentose-phosphate shunt, oxidative branch,BP,
4301,GO:0009052,1,0.974474281289782,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4302,GO:0009055,1,0.622006289525267,0,101,electron transfer activity,MF,
4307,GO:0009060,1,0.684064633114129,0,74,aerobic respiration,BP,
4308,GO:0009061,1,0.994196639149985,0,1,anaerobic respiration,BP,
4309,GO:0009062,1,0.538110619261724,0,104,fatty acid catabolic process,BP,
4311,GO:0009064,1,0.660540432690945,0,69,glutamine family amino acid metabolic process,BP,
4312,GO:0009065,1,0.844625443931526,0,28,glutamine family amino acid catabolic process,BP,
4313,GO:0009066,1,0.725511704584574,0,55,aspartate family amino acid metabolic process,BP,
4314,GO:0009067,1,0.87203338435806,0,22,aspartate family amino acid biosynthetic process,BP,
4315,GO:0009068,1,0.886813009894786,0,21,aspartate family amino acid catabolic process,BP,
4316,GO:0009069,1,0.816251042335587,0,36,serine family amino acid metabolic process,BP,
4317,GO:0009070,1,0.921701647644154,0,15,serine family amino acid biosynthetic process,BP,
4318,GO:0009071,1,0.948761865400261,0,11,serine family amino acid catabolic process,BP,
4319,GO:0009072,1,0.890255854418329,0,24,aromatic amino acid family metabolic process,BP,
4320,GO:0009074,1,0.920370823391928,0,18,aromatic amino acid family catabolic process,BP,
4321,GO:0009078,1,0.980431023083073,0,4,pyruvate family amino acid metabolic process,BP,
4322,GO:0009080,1,0.980431023083073,0,4,pyruvate family amino acid catabolic process,BP,
4323,GO:0009081,1,0.862782203489936,0,24,branched-chain amino acid metabolic process,BP,
4324,GO:0009082,1,0.987362207660561,0,2,branched-chain amino acid biosynthetic process,BP,
4325,GO:0009083,1,0.882856687029914,0,21,branched-chain amino acid catabolic process,BP,
4326,GO:0009084,1,0.900156560103781,0,17,glutamine family amino acid biosynthetic process,BP,
4327,GO:0009085,1,0.98523667897767,0,2,lysine biosynthetic process,BP,
4328,GO:0009086,1,0.930109092289622,0,12,methionine biosynthetic process,BP,
4329,GO:0009087,1,0.992576374188195,0,1,methionine catabolic process,BP,
4330,GO:0009088,1,0.994958360817384,0,1,threonine biosynthetic process,BP,
4331,GO:0009092,1,0.978618702340697,0,4,homoserine metabolic process,BP,
4332,GO:0009093,1,0.986015500433808,0,3,cysteine catabolic process,BP,
4333,GO:0009098,1,0.987362207660561,0,2,leucine biosynthetic process,BP,
4334,GO:0009099,1,0.987362207660561,0,2,valine biosynthetic process,BP,
4336,GO:0009101,1,0.128056456445052,0,312,glycoprotein biosynthetic process,BP,
4337,GO:0009106,1,0.988548828395936,0,2,lipoate metabolic process,BP,
4338,GO:0009107,1,0.996009560096059,0,1,lipoate biosynthetic process,BP,
4340,GO:0009109,1,0.927559823701147,0,14,coenzyme catabolic process,BP,
4341,GO:0009110,1,0.8824261996752,0,21,vitamin biosynthetic process,BP,
4342,GO:0009111,1,0.946238239273294,0,10,vitamin catabolic process,BP,
4343,GO:0009112,1,0.79442725539373,0,39,nucleobase metabolic process,BP,
4344,GO:0009113,1,0.927030584020223,0,13,purine nucleobase biosynthetic process,BP,
4345,GO:0009115,1,0.984451325457926,0,2,xanthine catabolic process,BP,
4346,GO:0009116,1,0.522783431066622,0,113,nucleoside metabolic process,BP,
4348,GO:0009119,1,0.577765829374254,0,94,ribonucleoside metabolic process,BP,
4349,GO:0009120,1,0.970600813007288,0,6,deoxyribonucleoside metabolic process,BP,
4352,GO:0009125,1,0.943693401599021,0,11,nucleoside monophosphate catabolic process,BP,
4355,GO:0009128,1,0.953710724322404,0,9,purine nucleoside monophosphate catabolic process,BP,
4356,GO:0009129,1,0.920671788181392,0,16,pyrimidine nucleoside monophosphate metabolic process,BP,
4357,GO:0009130,1,0.924209654393428,0,15,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4358,GO:0009131,1,0.996175152280907,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4360,GO:0009133,1,0.968801083865621,0,6,nucleoside diphosphate biosynthetic process,BP,
4361,GO:0009134,1,0.96677258627746,0,6,nucleoside diphosphate catabolic process,BP,
4363,GO:0009136,1,0.983961816734402,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4364,GO:0009137,1,0.983426650350816,0,3,purine nucleoside diphosphate catabolic process,BP,
4365,GO:0009138,1,0.98283113618808,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4366,GO:0009139,1,0.989732068931043,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4367,GO:0009140,1,0.99302822103216,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4370,GO:0009143,1,0.936474225783607,0,12,nucleoside triphosphate catabolic process,BP,
4373,GO:0009146,1,0.970347168918634,0,6,purine nucleoside triphosphate catabolic process,BP,
4374,GO:0009147,1,0.90774412510979,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4375,GO:0009148,1,0.920639187816325,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4376,GO:0009149,1,0.992371656135295,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4378,GO:0009151,1,0.949039328734783,0,10,purine deoxyribonucleotide metabolic process,BP,
4380,GO:0009153,1,0.984576032288076,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4381,GO:0009154,1,0.815183826493212,0,31,purine ribonucleotide catabolic process,BP,
4382,GO:0009155,1,0.973470852236335,0,5,purine deoxyribonucleotide catabolic process,BP,
4384,GO:0009157,1,0.956897451301081,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4385,GO:0009158,1,0.956787538748166,0,8,ribonucleoside monophosphate catabolic process,BP,
4386,GO:0009159,1,0.989501639655106,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4388,GO:0009162,1,0.943887830209821,0,12,deoxyribonucleoside monophosphate metabolic process,BP,
4389,GO:0009163,1,0.813441983864726,0,41,nucleoside biosynthetic process,BP,
4390,GO:0009164,1,0.87115057804865,0,27,nucleoside catabolic process,BP,
4395,GO:0009169,1,0.956787538748166,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4396,GO:0009170,1,0.99687648987947,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4397,GO:0009173,1,0.945689747080996,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4398,GO:0009174,1,0.945689747080996,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4399,GO:0009176,1,0.973560482321799,0,6,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4400,GO:0009177,1,0.977299398864183,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4401,GO:0009178,1,0.996175152280907,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4403,GO:0009180,1,0.983961816734402,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4404,GO:0009181,1,0.983426650350816,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4405,GO:0009182,1,0.982777994399657,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4406,GO:0009183,1,0.989406632724438,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4408,GO:0009186,1,0.972685079244259,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4409,GO:0009187,1,0.477885671835957,0,116,cyclic nucleotide metabolic process,BP,
4410,GO:0009188,1,0.983961816734402,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4411,GO:0009189,1,0.979246351020568,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4412,GO:0009190,1,0.625580900428235,0,77,cyclic nucleotide biosynthetic process,BP,
4413,GO:0009191,1,0.973338018965456,0,5,ribonucleoside diphosphate catabolic process,BP,
4414,GO:0009193,1,0.99302822103216,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4415,GO:0009195,1,0.99302822103216,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4416,GO:0009196,1,0.989732068931043,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4417,GO:0009197,1,0.989732068931043,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4419,GO:0009200,1,0.925186489293151,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4421,GO:0009202,1,0.971215003396914,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4422,GO:0009203,1,0.996792089824971,0,1,ribonucleoside triphosphate catabolic process,BP,
4423,GO:0009204,1,0.966042804646897,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4426,GO:0009207,1,0.996792089824971,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4427,GO:0009208,1,0.930972924891716,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4428,GO:0009209,1,0.93698750827151,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4429,GO:0009211,1,0.97506729418464,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4430,GO:0009212,1,0.982564002873824,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4431,GO:0009213,1,0.992371656135295,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4432,GO:0009214,1,0.860316801034859,0,20,cyclic nucleotide catabolic process,BP,
4433,GO:0009215,1,0.95620754081563,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4434,GO:0009216,1,0.988451715026915,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4435,GO:0009217,1,0.973470852236335,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4436,GO:0009218,1,0.886295884736906,0,23,pyrimidine ribonucleotide metabolic process,BP,
4437,GO:0009219,1,0.917346809276915,0,19,pyrimidine deoxyribonucleotide metabolic process,BP,
4438,GO:0009220,1,0.898294463159597,0,21,pyrimidine ribonucleotide biosynthetic process,BP,
4439,GO:0009221,1,0.96394181528822,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4440,GO:0009222,1,0.99302822103216,0,1,pyrimidine ribonucleotide catabolic process,BP,
4441,GO:0009223,1,0.947470317253219,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4442,GO:0009224,1,0.996652184032161,0,1,CMP biosynthetic process,BP,
4443,GO:0009225,1,0.811613672848803,0,36,nucleotide-sugar metabolic process,BP,
4444,GO:0009226,1,0.882866312565124,0,23,nucleotide-sugar biosynthetic process,BP,
4445,GO:0009227,1,0.984436886311677,0,3,nucleotide-sugar catabolic process,BP,
4446,GO:0009229,1,0.994295209234908,0,1,thiamine diphosphate biosynthetic process,BP,
4447,GO:0009231,1,0.993443196935179,0,1,riboflavin biosynthetic process,BP,
4448,GO:0009233,1,0.985271065349853,0,2,menaquinone metabolic process,BP,
4449,GO:0009234,1,0.992495045100237,0,1,menaquinone biosynthetic process,BP,
4450,GO:0009235,1,0.891807481664393,0,19,cobalamin metabolic process,BP,
4451,GO:0009236,1,0.977802541801409,0,3,cobalamin biosynthetic process,BP,
4452,GO:0009237,1,0.993040395456706,0,1,siderophore metabolic process,BP,
4453,GO:0009240,1,0.982433004222649,0,4,isopentenyl diphosphate biosynthetic process,BP,
4454,GO:0009245,1,0.994083656276557,0,2,lipid A biosynthetic process,BP,
4456,GO:0009249,1,0.973396072812548,0,8,protein lipoylation,BP,
4459,GO:0009253,1,0.993788180962365,0,2,peptidoglycan catabolic process,BP,
4460,GO:0009256,1,0.964118939257677,0,5,10-formyltetrahydrofolate metabolic process,BP,
4461,GO:0009257,1,0.98510437534437,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4462,GO:0009258,1,0.98431678062586,0,2,10-formyltetrahydrofolate catabolic process,BP,
4465,GO:0009261,1,0.809488483238281,0,32,ribonucleotide catabolic process,BP,
4466,GO:0009262,1,0.847708036189786,0,33,deoxyribonucleotide metabolic process,BP,
4467,GO:0009263,1,0.927982875540185,0,14,deoxyribonucleotide biosynthetic process,BP,
4468,GO:0009264,1,0.918541527799652,0,18,deoxyribonucleotide catabolic process,BP,
4469,GO:0009265,1,0.949068353290593,0,11,2'-deoxyribonucleotide biosynthetic process,BP,
4470,GO:0009266,1,0.250073851425687,0,216,response to temperature stimulus,BP,
4471,GO:0009267,1,0.435698114091652,0,130,cellular response to starvation,BP,
4473,GO:0009295,1,0.776056852620085,0,41,nucleoid,CC,
4474,GO:0009298,1,0.983050387091279,0,4,GDP-mannose biosynthetic process,BP,
4475,GO:0009299,1,0.852098609985094,0,25,mRNA transcription,BP,
4476,GO:0009301,1,0.674752837208565,0,66,snRNA transcription,BP,
4477,GO:0009303,1,0.848058649813035,0,27,rRNA transcription,BP,
4478,GO:0009304,1,0.95398250762569,0,7,tRNA transcription,BP,
4479,GO:0009305,1,0.992001434575794,0,1,protein biotinylation,BP,
4481,GO:0009308,1,0.533487886558273,0,121,amine metabolic process,BP,
4482,GO:0009309,1,0.901297876284015,0,21,amine biosynthetic process,BP,
4483,GO:0009310,1,0.894595501004552,0,21,amine catabolic process,BP,
4484,GO:0009311,1,0.628361146837981,0,73,oligosaccharide metabolic process,BP,
4485,GO:0009312,1,0.789099283604205,0,38,oligosaccharide biosynthetic process,BP,
4486,GO:0009313,1,0.932123446936108,0,11,oligosaccharide catabolic process,BP,
4488,GO:0009328,1,0.976865346586892,0,4,phenylalanine-tRNA ligase complex,CC,
4489,GO:0009330,1,0.984630156806716,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4491,GO:0009346,1,0.992421877872673,0,1,citrate lyase complex,CC,
4492,GO:0009353,1,0.996559931641343,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4493,GO:0009360,1,0.993456117494156,0,1,DNA polymerase III complex,CC,
4494,GO:0009368,1,0.991062735521032,0,2,endopeptidase Clp complex,CC,
4495,GO:0009372,1,0.992651266995692,0,1,quorum sensing,BP,
4496,GO:0009374,1,0.963616495252133,0,5,biotin binding,MF,
4497,GO:0009378,1,0.962483302689727,0,5,four-way junction helicase activity,MF,
4498,GO:0009383,1,0.985902967222671,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4499,GO:0009384,1,0.992217274027167,0,1,N-acylmannosamine kinase activity,MF,
4500,GO:0009386,1,0.990629672803773,0,2,translational attenuation,BP,
4501,GO:0009394,1,0.870557180574518,0,29,2'-deoxyribonucleotide metabolic process,BP,
4503,GO:0009396,1,0.94931829131251,0,9,folic acid-containing compound biosynthetic process,BP,
4504,GO:0009397,1,0.973810048538613,0,4,folic acid-containing compound catabolic process,BP,
4505,GO:0009398,1,0.993443196935179,0,1,FMN biosynthetic process,BP,
4506,GO:0009400,1,0.993168694928202,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4507,GO:0009403,1,0.977541750234253,0,4,toxin biosynthetic process,BP,
4508,GO:0009404,1,0.89536680866167,0,20,toxin metabolic process,BP,
4509,GO:0009405,1,0.984266079678441,0,2,pathogenesis,BP,
4510,GO:0009407,1,0.979257274272868,0,5,toxin catabolic process,BP,
4511,GO:0009408,1,0.356086782691316,0,159,response to heat,BP,
4512,GO:0009409,1,0.766998695654054,0,43,response to cold,BP,
4515,GO:0009414,1,0.961662106430275,0,7,response to water deprivation,BP,
4516,GO:0009415,1,0.928098678736273,0,12,response to water,BP,
4519,GO:0009436,1,0.989471769569514,0,2,glyoxylate catabolic process,BP,
4520,GO:0009437,1,0.92022460956434,0,13,carnitine metabolic process,BP,
4521,GO:0009438,1,0.976463901837585,0,5,methylglyoxal metabolic process,BP,
4522,GO:0009439,1,0.993139498544596,0,2,cyanate metabolic process,BP,
4523,GO:0009440,1,0.993139498544596,0,2,cyanate catabolic process,BP,
4524,GO:0009441,1,0.984430510248448,0,3,glycolate metabolic process,BP,
4525,GO:0009443,1,0.991540631056991,0,1,pyridoxal 5'-phosphate salvage,BP,
4526,GO:0009444,1,0.992214624099705,0,1,pyruvate oxidation,BP,
4527,GO:0009445,1,0.965687391634397,0,7,putrescine metabolic process,BP,
4528,GO:0009446,1,0.97183083354065,0,5,putrescine biosynthetic process,BP,
4529,GO:0009447,1,0.989672639353332,0,3,putrescine catabolic process,BP,
4530,GO:0009448,1,0.971637565081739,0,4,gamma-aminobutyric acid metabolic process,BP,
4531,GO:0009449,1,0.979221442558548,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4532,GO:0009450,1,0.984631779801513,0,2,gamma-aminobutyric acid catabolic process,BP,
4533,GO:0009451,1,0.471802299590126,0,130,RNA modification,BP,
4534,GO:0009452,1,0.840174586499261,0,32,7-methylguanosine RNA capping,BP,
4535,GO:0009566,1,0.456404869211918,0,133,fertilization,BP,
4538,GO:0009583,1,0.72119211009571,0,53,detection of light stimulus,BP,
4539,GO:0009584,1,0.764074228034766,0,43,detection of visible light,BP,
4540,GO:0009590,1,0.995126137564412,0,1,detection of gravity,BP,
4541,GO:0009593,1,0.671368288814159,0,77,detection of chemical stimulus,BP,
4542,GO:0009595,1,0.881755690366103,0,19,detection of biotic stimulus,BP,
4543,GO:0009597,1,0.968429111177095,0,5,detection of virus,BP,
4546,GO:0009608,1,0.989312683699372,0,2,response to symbiont,BP,
4547,GO:0009609,1,0.989312683699372,0,2,response to symbiotic bacterium,BP,
4550,GO:0009615,1,0.199590317047968,0,267,response to virus,BP,
4552,GO:0009620,1,0.84353993919641,0,36,response to fungus,BP,
4553,GO:0009624,1,0.993661962459947,0,1,response to nematode,BP,
4555,GO:0009629,1,0.946960682459867,0,10,response to gravity,BP,
4556,GO:0009631,1,0.992268375099963,0,1,cold acclimation,BP,
4557,GO:0009635,1,0.940756050334282,0,11,response to herbicide,BP,
4559,GO:0009637,1,0.985164778240319,0,2,response to blue light,BP,
4560,GO:0009642,1,0.929377233215423,0,11,response to light intensity,BP,
4561,GO:0009644,1,0.987299740229587,0,2,response to high light intensity,BP,
4562,GO:0009645,1,0.99254237541719,0,1,response to low light intensity stimulus,BP,
4563,GO:0009646,1,0.992642954865686,0,1,response to absence of light,BP,
4564,GO:0009648,1,0.861317363121942,0,24,photoperiodism,BP,
4565,GO:0009649,1,0.852053267941416,0,26,entrainment of circadian clock,BP,
4566,GO:0009650,1,0.926727474845807,0,13,UV protection,BP,
4570,GO:0009673,1,0.992492089328607,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4571,GO:0009674,1,0.984137077846956,0,2,potassium:sodium symporter activity,MF,
4572,GO:0009692,1,0.993661962459947,0,1,ethylene metabolic process,BP,
4573,GO:0009698,1,0.97323145047359,0,6,phenylpropanoid metabolic process,BP,
4574,GO:0009712,1,0.748138030244302,0,47,catechol-containing compound metabolic process,BP,
4575,GO:0009713,1,0.89158676936858,0,19,catechol-containing compound biosynthetic process,BP,
4577,GO:0009720,1,0.992951308200165,0,1,detection of hormone stimulus,BP,
4579,GO:0009726,1,0.976325925301169,0,3,detection of endogenous stimulus,BP,
4580,GO:0009730,1,0.978628510619759,0,4,detection of carbohydrate stimulus,BP,
4581,GO:0009732,1,0.978628510619759,0,4,detection of hexose stimulus,BP,
4582,GO:0009737,1,0.992422500170589,0,1,response to abscisic acid,BP,
4583,GO:0009738,1,0.992422500170589,0,1,abscisic acid-activated signaling pathway,BP,
4585,GO:0009744,1,0.971765046450359,0,4,response to sucrose,BP,
4588,GO:0009750,1,0.951401211272049,0,8,response to fructose,BP,
4589,GO:0009753,1,0.986263631734964,0,4,response to jasmonic acid,BP,
4590,GO:0009755,1,0.262256448112091,0,203,hormone-mediated signaling pathway,BP,
4591,GO:0009756,1,0.961564605248236,0,7,carbohydrate mediated signaling,BP,
4592,GO:0009757,1,0.974292764415228,0,5,hexose mediated signaling,BP,
4593,GO:0009758,1,0.991018280753426,0,1,carbohydrate utilization,BP,
4594,GO:0009785,1,0.985164778240319,0,2,blue light signaling pathway,BP,
4595,GO:0009786,1,0.974884952366175,0,4,regulation of asymmetric cell division,BP,
4596,GO:0009787,1,0.992422500170589,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4597,GO:0009789,1,0.992422500170589,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4599,GO:0009791,1,0.544572137744666,0,84,post-embryonic development,BP,
4601,GO:0009794,1,0.975373194542287,0,4,regulation of mitotic cell cycle, embryonic,BP,
4604,GO:0009804,1,0.97323145047359,0,6,coumarin metabolic process,BP,
4605,GO:0009810,1,0.994706762123157,0,1,stilbene metabolic process,BP,
4606,GO:0009812,1,0.96938283284657,0,6,flavonoid metabolic process,BP,
4607,GO:0009814,1,0.994725786414989,0,1,defense response, incompatible interaction,BP,
4608,GO:0009817,1,0.994725786414989,0,1,defense response to fungus, incompatible interaction,BP,
4609,GO:0009820,1,0.977099431300504,0,5,alkaloid metabolic process,BP,
4610,GO:0009822,1,0.992124958901325,0,2,alkaloid catabolic process,BP,
4611,GO:0009826,1,0.987496179620233,0,2,unidimensional cell growth,BP,
4612,GO:0009838,1,0.975149388485837,0,5,abscission,BP,
4613,GO:0009841,1,0.994297886910635,0,1,mitochondrial endopeptidase Clp complex,CC,
4614,GO:0009850,1,0.992412591984155,0,2,auxin metabolic process,BP,
4615,GO:0009852,1,0.992412591984155,0,2,auxin catabolic process,BP,
4618,GO:0009881,1,0.946329216163869,0,10,photoreceptor activity,MF,
4619,GO:0009882,1,0.985164778240319,0,2,blue light photoreceptor activity,MF,
4620,GO:0009886,1,0.931426961426491,0,11,post-embryonic animal morphogenesis,BP,
4632,GO:0009898,1,0.323202531289385,0,170,cytoplasmic side of plasma membrane,CC,
4633,GO:0009912,1,0.970695616042284,0,5,auditory receptor cell fate commitment,BP,
4636,GO:0009918,1,0.993554549492272,0,1,sterol delta7 reductase activity,MF,
4637,GO:0009922,1,0.960403079992839,0,6,fatty acid elongase activity,MF,
4639,GO:0009931,1,0.933759980270907,0,10,calcium-dependent protein serine/threonine kinase activity,MF,
4640,GO:0009946,1,0.986030834360399,0,3,proximal/distal axis specification,BP,
4642,GO:0009949,1,0.996195995110822,0,1,polarity specification of anterior/posterior axis,BP,
4643,GO:0009950,1,0.890208811311108,0,17,dorsal/ventral axis specification,BP,
4647,GO:0009955,1,0.994717633968953,0,1,adaxial/abaxial pattern specification,BP,
4648,GO:0009956,1,0.992463485224567,0,1,radial pattern formation,BP,
4649,GO:0009957,1,0.978287069360983,0,3,epidermal cell fate specification,BP,
4653,GO:0009972,1,0.962440489092569,0,8,cytidine deamination,BP,
4654,GO:0009975,1,0.887441253711712,0,16,cyclase activity,MF,
4655,GO:0009982,1,0.932197250961923,0,13,pseudouridine synthase activity,MF,
4658,GO:0009988,1,0.747105324558202,0,53,cell-cell recognition,BP,
4660,GO:0009992,1,0.994784163446866,0,1,cellular water homeostasis,BP,
4661,GO:0009994,1,0.76562722137447,0,43,oocyte differentiation,BP,
4666,GO:0010009,1,0.968296730701441,0,5,cytoplasmic side of endosome membrane,CC,
4667,GO:0010015,1,0.996992964303392,0,1,root morphogenesis,BP,
4668,GO:0010021,1,0.99275644032942,0,1,amylopectin biosynthetic process,BP,
4669,GO:0010025,1,0.987257508094376,0,2,wax biosynthetic process,BP,
4670,GO:0010032,1,0.961695574767024,0,5,meiotic chromosome condensation,BP,
4672,GO:0010034,1,0.992523560294151,0,1,response to acetate,BP,
4674,GO:0010037,1,0.992817507062025,0,1,response to carbon dioxide,BP,
4677,GO:0010040,1,0.977217296385821,0,4,response to iron(II) ion,BP,
4678,GO:0010041,1,0.971358323831342,0,5,response to iron(III) ion,BP,
4679,GO:0010042,1,0.899273272674554,0,16,response to manganese ion,BP,
4680,GO:0010043,1,0.778974292092515,0,49,response to zinc ion,BP,
4681,GO:0010044,1,0.970453661907376,0,5,response to aluminum ion,BP,
4682,GO:0010045,1,0.991472133559773,0,1,response to nickel cation,BP,
4683,GO:0010046,1,0.962707910709822,0,6,response to mycotoxin,BP,
4684,GO:0010053,1,0.996992964303392,0,1,root epidermal cell differentiation,BP,
4685,GO:0010054,1,0.996992964303392,0,1,trichoblast differentiation,BP,
4686,GO:0010070,1,0.994149087961217,0,1,zygote asymmetric cell division,BP,
4687,GO:0010085,1,0.995041290819372,0,1,polarity specification of proximal/distal axis,BP,
4689,GO:0010106,1,0.995399585953174,0,1,cellular response to iron ion starvation,BP,
4691,GO:0010121,1,0.99530696507739,0,1,arginine catabolic process to proline via ornithine,BP,
4692,GO:0010124,1,0.992412591984155,0,2,phenylacetate catabolic process,BP,
4693,GO:0010133,1,0.987388674484204,0,2,proline catabolic process to glutamate,BP,
4694,GO:0010138,1,0.977310031730133,0,5,pyrimidine ribonucleotide salvage,BP,
4695,GO:0010139,1,0.996121655979269,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4696,GO:0010142,1,0.986756899213672,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4697,GO:0010155,1,0.929687840419981,0,15,regulation of proton transport,BP,
4698,GO:0010157,1,0.991378338251748,0,1,response to chlorate,BP,
4699,GO:0010159,1,0.980926858507496,0,3,specification of animal organ position,BP,
4700,GO:0010160,1,0.9968737390535,0,1,formation of animal organ boundary,BP,
4701,GO:0010164,1,0.996121655979269,0,1,response to cesium ion,BP,
4702,GO:0010165,1,0.788371314333099,0,35,response to X-ray,BP,
4703,GO:0010166,1,0.987257508094376,0,2,wax metabolic process,BP,
4704,GO:0010171,1,0.724948452625831,0,47,body morphogenesis,BP,
4705,GO:0010172,1,0.920280652939595,0,11,embryonic body morphogenesis,BP,
4706,GO:0010181,1,0.931379659231533,0,11,FMN binding,MF,
4707,GO:0010182,1,0.974292764415228,0,5,sugar mediated signaling pathway,BP,
4708,GO:0010189,1,0.996005651130617,0,1,vitamin E biosynthetic process,BP,
4709,GO:0010193,1,0.978306367224184,0,4,response to ozone,BP,
4710,GO:0010212,1,0.397933862896731,0,142,response to ionizing radiation,BP,
4711,GO:0010216,1,0.962696212863208,0,5,maintenance of DNA methylation,BP,
4712,GO:0010224,1,0.906739388421996,0,17,response to UV-B,BP,
4713,GO:0010225,1,0.915952472480677,0,13,response to UV-C,BP,
4714,GO:0010226,1,0.875708344513449,0,22,response to lithium ion,BP,
4717,GO:0010248,1,0.927175043174889,0,13,establishment or maintenance of transmembrane electrochemical gradient,BP,
4718,GO:0010255,1,0.974292764415228,0,5,glucose mediated signaling pathway,BP,
4720,GO:0010257,1,0.801202981078916,0,55,NADH dehydrogenase complex assembly,BP,
4721,GO:0010259,1,0.839984170818275,0,25,multicellular organism aging,BP,
4722,GO:0010265,1,0.961524480611288,0,6,SCF complex assembly,BP,
4723,GO:0010266,1,0.981379449619317,0,3,response to vitamin B1,BP,
4724,GO:0010269,1,0.968519323800013,0,5,response to selenium ion,BP,
4725,GO:0010273,1,0.962413862703542,0,11,detoxification of copper ion,BP,
4726,GO:0010286,1,0.975985827186553,0,5,heat acclimation,BP,
4727,GO:0010288,1,0.876639965220935,0,21,response to lead ion,BP,
4728,GO:0010309,1,0.996012485730794,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4729,GO:0010310,1,0.928375912672829,0,14,regulation of hydrogen peroxide metabolic process,BP,
4730,GO:0010314,1,0.936418638291123,0,10,phosphatidylinositol-5-phosphate binding,MF,
4731,GO:0010324,1,0.690697110396289,0,61,membrane invagination,BP,
4732,GO:0010332,1,0.71076940678841,0,52,response to gamma radiation,BP,
4733,GO:0010335,1,0.992400924180365,0,1,response to non-ionic osmotic stress,BP,
4734,GO:0010340,1,0.963352347500869,0,6,carboxyl-O-methyltransferase activity,MF,
4735,GO:0010348,1,0.993301131169352,0,1,lithium:proton antiporter activity,MF,
4736,GO:0010359,1,0.935456919053608,0,9,regulation of anion channel activity,BP,
4737,GO:0010360,1,0.978922721596957,0,3,negative regulation of anion channel activity,BP,
4738,GO:0010369,1,0.910389344752286,0,14,chromocenter,CC,
4739,GO:0010370,1,0.987730689495986,0,2,perinucleolar chromocenter,CC,
4740,GO:0010385,1,0.966441915900533,0,5,double-stranded methylated DNA binding,MF,
4741,GO:0010387,1,0.987816254190821,0,2,COP9 signalosome assembly,BP,
4743,GO:0010390,1,0.833745271513966,0,27,histone monoubiquitination,BP,
4744,GO:0010412,1,0.992623937227321,0,1,mannan metabolic process,BP,
4745,GO:0010420,1,0.996630186162235,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4746,GO:0010421,1,0.934073842285639,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4747,GO:0010428,1,0.992037345695859,0,1,methyl-CpNpG binding,MF,
4748,GO:0010430,1,0.992361773595713,0,1,fatty acid omega-oxidation,BP,
4749,GO:0010446,1,0.988200397524544,0,2,response to alkaline pH,BP,
4750,GO:0010447,1,0.887737179319569,0,19,response to acidic pH,BP,
4751,GO:0010452,1,0.935010534308545,0,9,histone H3-K36 methylation,BP,
4755,GO:0010457,1,0.919002084416036,0,11,centriole-centriole cohesion,BP,
4757,GO:0010459,1,0.957382338574482,0,9,negative regulation of heart rate,BP,
4758,GO:0010460,1,0.874550389729486,0,22,positive regulation of heart rate,BP,
4759,GO:0010463,1,0.727021698685556,0,46,mesenchymal cell proliferation,BP,
4760,GO:0010464,1,0.786324471311854,0,35,regulation of mesenchymal cell proliferation,BP,
4761,GO:0010465,1,0.985289101859203,0,2,nerve growth factor receptor activity,MF,
4767,GO:0010477,1,0.992675510529021,0,1,response to sulfur dioxide,BP,
4768,GO:0010481,1,0.988979583273992,0,2,epidermal cell division,BP,
4769,GO:0010482,1,0.988979583273992,0,2,regulation of epidermal cell division,BP,
4770,GO:0010484,1,0.968101533808716,0,4,H3 histone acetyltransferase activity,MF,
4771,GO:0010485,1,0.879704781320824,0,18,H4 histone acetyltransferase activity,MF,
4772,GO:0010494,1,0.744877764658448,0,42,cytoplasmic stress granule,CC,
4773,GO:0010496,1,0.995256774042177,0,1,intercellular transport,BP,
4774,GO:0010498,1,0.0636731536490333,0,436,proteasomal protein catabolic process,BP,
4775,GO:0010499,1,0.915720605048452,0,21,proteasomal ubiquitin-independent protein catabolic process,BP,
4776,GO:0010501,1,0.747818418259751,0,44,RNA secondary structure unwinding,BP,
4778,GO:0010507,1,0.641596419953299,0,67,negative regulation of autophagy,BP,
4779,GO:0010508,1,0.513408720295644,0,98,positive regulation of autophagy,BP,
4780,GO:0010509,1,0.992149512083848,0,1,polyamine homeostasis,BP,
4781,GO:0010510,1,0.917691922786055,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4782,GO:0010511,1,0.958726408846299,0,7,regulation of phosphatidylinositol biosynthetic process,BP,
4783,GO:0010512,1,0.986465749066039,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4784,GO:0010513,1,0.971884012813165,0,5,positive regulation of phosphatidylinositol biosynthetic process,BP,
4787,GO:0010519,1,0.970296871239262,0,5,negative regulation of phospholipase activity,BP,
4788,GO:0010520,1,0.978998707602896,0,3,regulation of reciprocal meiotic recombination,BP,
4789,GO:0010521,1,0.982912179846352,0,3,telomerase inhibitor activity,MF,
4791,GO:0010523,1,0.905906104779972,0,17,negative regulation of calcium ion transport into cytosol,BP,
4793,GO:0010528,1,0.900929396788779,0,17,regulation of transposition,BP,
4794,GO:0010529,1,0.900929396788779,0,17,negative regulation of transposition,BP,
4795,GO:0010533,1,0.982907654778792,0,4,regulation of activation of Janus kinase activity,BP,
4796,GO:0010536,1,0.990593584183576,0,2,positive regulation of activation of Janus kinase activity,BP,
4802,GO:0010559,1,0.803785604870984,0,36,regulation of glycoprotein biosynthetic process,BP,
4803,GO:0010560,1,0.884288638662282,0,19,positive regulation of glycoprotein biosynthetic process,BP,
4804,GO:0010561,1,0.945305626943409,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4809,GO:0010566,1,0.921592318147043,0,13,regulation of ketone biosynthetic process,BP,
4810,GO:0010569,1,0.833143111820171,0,27,regulation of double-strand break repair via homologous recombination,BP,
4811,GO:0010571,1,0.953335011607399,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4812,GO:0010572,1,0.965203899817278,0,5,positive regulation of platelet activation,BP,
4813,GO:0010573,1,0.819523133852456,0,31,vascular endothelial growth factor production,BP,
4814,GO:0010574,1,0.826097553713055,0,30,regulation of vascular endothelial growth factor production,BP,
4815,GO:0010575,1,0.844391136819163,0,25,positive regulation of vascular endothelial growth factor production,BP,
4816,GO:0010578,1,0.993772309651798,0,1,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4817,GO:0010585,1,0.99544704789982,0,1,glutamine secretion,BP,
4818,GO:0010586,1,0.862867547249366,0,22,miRNA metabolic process,BP,
4819,GO:0010587,1,0.963099835357879,0,5,miRNA catabolic process,BP,
4820,GO:0010591,1,0.835236035935822,0,27,regulation of lamellipodium assembly,BP,
4821,GO:0010592,1,0.904172875594457,0,15,positive regulation of lamellipodium assembly,BP,
4822,GO:0010593,1,0.984264494145005,0,2,negative regulation of lamellipodium assembly,BP,
4823,GO:0010594,1,0.420676425426018,0,130,regulation of endothelial cell migration,BP,
4824,GO:0010595,1,0.578226002258823,0,83,positive regulation of endothelial cell migration,BP,
4825,GO:0010596,1,0.759160644448559,0,42,negative regulation of endothelial cell migration,BP,
4826,GO:0010603,1,0.941221532006395,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4829,GO:0010606,1,0.960124993791014,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4830,GO:0010607,1,0.995361743123371,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4832,GO:0010609,1,0.987733849241041,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4833,GO:0010610,1,0.991100420811145,0,1,regulation of mRNA stability involved in response to stress,BP,
4834,GO:0010611,1,0.741623055466182,0,44,regulation of cardiac muscle hypertrophy,BP,
4835,GO:0010612,1,0.94049636267632,0,8,regulation of cardiac muscle adaptation,BP,
4836,GO:0010613,1,0.836592705594747,0,26,positive regulation of cardiac muscle hypertrophy,BP,
4837,GO:0010614,1,0.900307458224514,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4838,GO:0010615,1,0.984987372790287,0,2,positive regulation of cardiac muscle adaptation,BP,
4839,GO:0010616,1,0.954837829913172,0,6,negative regulation of cardiac muscle adaptation,BP,
4840,GO:0010621,1,0.986218202391638,0,3,negative regulation of transcription by transcription factor localization,BP,
4841,GO:0010623,1,0.928052350096716,0,12,programmed cell death involved in cell development,BP,
4843,GO:0010625,1,0.994051030917859,0,1,positive regulation of Schwann cell proliferation,BP,
4849,GO:0010633,1,0.691001840893937,0,57,negative regulation of epithelial cell migration,BP,
4851,GO:0010635,1,0.951614015638493,0,8,regulation of mitochondrial fusion,BP,
4852,GO:0010636,1,0.985684876004719,0,2,positive regulation of mitochondrial fusion,BP,
4853,GO:0010637,1,0.971830032372294,0,5,negative regulation of mitochondrial fusion,BP,
4857,GO:0010641,1,0.964091787535872,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4865,GO:0010649,1,0.921607433536816,0,12,regulation of cell communication by electrical coupling,BP,
4866,GO:0010650,1,0.983006570336077,0,2,positive regulation of cell communication by electrical coupling,BP,
4868,GO:0010656,1,0.820197946626928,0,32,negative regulation of muscle cell apoptotic process,BP,
4869,GO:0010657,1,0.704225085521902,0,55,muscle cell apoptotic process,BP,
4870,GO:0010658,1,0.813223561991486,0,32,striated muscle cell apoptotic process,BP,
4871,GO:0010659,1,0.824569826533451,0,30,cardiac muscle cell apoptotic process,BP,
4872,GO:0010660,1,0.720326519661327,0,52,regulation of muscle cell apoptotic process,BP,
4873,GO:0010661,1,0.883113444587619,0,19,positive regulation of muscle cell apoptotic process,BP,
4874,GO:0010662,1,0.826064969025972,0,30,regulation of striated muscle cell apoptotic process,BP,
4875,GO:0010663,1,0.939524603695784,0,9,positive regulation of striated muscle cell apoptotic process,BP,
4876,GO:0010664,1,0.87261720446495,0,22,negative regulation of striated muscle cell apoptotic process,BP,
4877,GO:0010665,1,0.83758850760903,0,28,regulation of cardiac muscle cell apoptotic process,BP,
4878,GO:0010666,1,0.939524603695784,0,9,positive regulation of cardiac muscle cell apoptotic process,BP,
4879,GO:0010667,1,0.891569009218903,0,19,negative regulation of cardiac muscle cell apoptotic process,BP,
4881,GO:0010669,1,0.880338248366808,0,20,epithelial structure maintenance,BP,
4884,GO:0010677,1,0.829276070683229,0,29,negative regulation of cellular carbohydrate metabolic process,BP,
4885,GO:0010692,1,0.935041255527441,0,9,regulation of alkaline phosphatase activity,BP,
4886,GO:0010693,1,0.980787697586575,0,3,negative regulation of alkaline phosphatase activity,BP,
4887,GO:0010694,1,0.953366643177106,0,6,positive regulation of alkaline phosphatase activity,BP,
4888,GO:0010698,1,0.98958921260457,0,2,acetyltransferase activator activity,MF,
4889,GO:0010700,1,0.973886231629067,0,5,negative regulation of norepinephrine secretion,BP,
4890,GO:0010701,1,0.9800113908221,0,3,positive regulation of norepinephrine secretion,BP,
4891,GO:0010705,1,0.985738503600596,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4892,GO:0010710,1,0.982817108139347,0,3,regulation of collagen catabolic process,BP,
4893,GO:0010711,1,0.996995071867497,0,1,negative regulation of collagen catabolic process,BP,
4894,GO:0010712,1,0.832197232896637,0,31,regulation of collagen metabolic process,BP,
4895,GO:0010713,1,0.9587521097038,0,8,negative regulation of collagen metabolic process,BP,
4896,GO:0010714,1,0.884382156491016,0,20,positive regulation of collagen metabolic process,BP,
4897,GO:0010715,1,0.909394850394422,0,13,regulation of extracellular matrix disassembly,BP,
4898,GO:0010716,1,0.977619073849479,0,4,negative regulation of extracellular matrix disassembly,BP,
4900,GO:0010718,1,0.739288915698418,0,44,positive regulation of epithelial to mesenchymal transition,BP,
4901,GO:0010719,1,0.860594055359236,0,26,negative regulation of epithelial to mesenchymal transition,BP,
4904,GO:0010722,1,0.991617546258839,0,1,regulation of ferrochelatase activity,BP,
4905,GO:0010724,1,0.974918329913873,0,4,regulation of definitive erythrocyte differentiation,BP,
4906,GO:0010725,1,0.988971287464569,0,2,regulation of primitive erythrocyte differentiation,BP,
4907,GO:0010726,1,0.987971660712028,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4908,GO:0010727,1,0.961616325522491,0,7,negative regulation of hydrogen peroxide metabolic process,BP,
4909,GO:0010728,1,0.974705939855204,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4910,GO:0010729,1,0.995194394064524,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4911,GO:0010730,1,0.979413633920029,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4912,GO:0010731,1,0.991431907766257,0,2,protein glutathionylation,BP,
4913,GO:0010732,1,0.991431907766257,0,2,regulation of protein glutathionylation,BP,
4914,GO:0010734,1,0.991431907766257,0,2,negative regulation of protein glutathionylation,BP,
4915,GO:0010735,1,0.973023138714908,0,4,positive regulation of transcription via serum response element binding,BP,
4916,GO:0010736,1,0.987923259130261,0,2,serum response element binding,MF,
4917,GO:0010737,1,0.771870150481595,0,26,protein kinase A signaling,BP,
4918,GO:0010738,1,0.880159105179555,0,18,regulation of protein kinase A signaling,BP,
4919,GO:0010739,1,0.965760075503748,0,6,positive regulation of protein kinase A signaling,BP,
4920,GO:0010742,1,0.827274645603623,0,29,macrophage derived foam cell differentiation,BP,
4921,GO:0010743,1,0.851897953706645,0,25,regulation of macrophage derived foam cell differentiation,BP,
4922,GO:0010744,1,0.91596563771671,0,14,positive regulation of macrophage derived foam cell differentiation,BP,
4923,GO:0010745,1,0.930116137186465,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4924,GO:0010746,1,0.969458853586166,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4925,GO:0010748,1,0.969458853586166,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4928,GO:0010751,1,0.980266342689165,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4929,GO:0010752,1,0.984549964223067,0,2,regulation of cGMP-mediated signaling,BP,
4930,GO:0010754,1,0.992067293338691,0,1,negative regulation of cGMP-mediated signaling,BP,
4931,GO:0010755,1,0.947617482369138,0,10,regulation of plasminogen activation,BP,
4932,GO:0010756,1,0.976345736503955,0,5,positive regulation of plasminogen activation,BP,
4933,GO:0010757,1,0.970582972477117,0,5,negative regulation of plasminogen activation,BP,
4934,GO:0010758,1,0.899998065539839,0,18,regulation of macrophage chemotaxis,BP,
4935,GO:0010759,1,0.942367991087211,0,10,positive regulation of macrophage chemotaxis,BP,
4936,GO:0010760,1,0.975197426773302,0,5,negative regulation of macrophage chemotaxis,BP,
4937,GO:0010761,1,0.764501232917688,0,38,fibroblast migration,BP,
4938,GO:0010762,1,0.826185462175772,0,28,regulation of fibroblast migration,BP,
4939,GO:0010763,1,0.926357280079109,0,11,positive regulation of fibroblast migration,BP,
4940,GO:0010764,1,0.952072954473565,0,8,negative regulation of fibroblast migration,BP,
4941,GO:0010765,1,0.815577463854313,0,31,positive regulation of sodium ion transport,BP,
4942,GO:0010766,1,0.907349752091872,0,14,negative regulation of sodium ion transport,BP,
4943,GO:0010767,1,0.976973045580244,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4944,GO:0010768,1,0.983377132252557,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4948,GO:0010789,1,0.993301131169352,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4949,GO:0010792,1,0.965927770746732,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4950,GO:0010793,1,0.964202970851084,0,5,regulation of mRNA export from nucleus,BP,
4951,GO:0010795,1,0.996630186162235,0,1,regulation of ubiquinone biosynthetic process,BP,
4952,GO:0010796,1,0.986718984009431,0,3,regulation of multivesicular body size,BP,
4953,GO:0010797,1,0.996685946296863,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4954,GO:0010799,1,0.770168463472198,0,39,regulation of peptidyl-threonine phosphorylation,BP,
4955,GO:0010800,1,0.829556898634434,0,28,positive regulation of peptidyl-threonine phosphorylation,BP,
4956,GO:0010801,1,0.913375098440518,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
4957,GO:0010803,1,0.731338350717251,0,54,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4958,GO:0010804,1,0.919727067026723,0,17,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4959,GO:0010807,1,0.960469672945678,0,6,regulation of synaptic vesicle priming,BP,
4960,GO:0010808,1,0.991876724317752,0,1,positive regulation of synaptic vesicle priming,BP,
4964,GO:0010813,1,0.988648275219947,0,2,neuropeptide catabolic process,BP,
4965,GO:0010814,1,0.992263439134161,0,1,substance P catabolic process,BP,
4966,GO:0010815,1,0.975067923676,0,4,bradykinin catabolic process,BP,
4967,GO:0010816,1,0.992263439134161,0,1,calcitonin catabolic process,BP,
4969,GO:0010818,1,0.90418447876528,0,20,T cell chemotaxis,BP,
4970,GO:0010819,1,0.947882248516659,0,10,regulation of T cell chemotaxis,BP,
4971,GO:0010820,1,0.950995873970696,0,9,positive regulation of T cell chemotaxis,BP,
4975,GO:0010824,1,0.767404349305798,0,39,regulation of centrosome duplication,BP,
4976,GO:0010825,1,0.957411775336023,0,6,positive regulation of centrosome duplication,BP,
4977,GO:0010826,1,0.924555820693007,0,12,negative regulation of centrosome duplication,BP,
4979,GO:0010828,1,0.75370799902344,0,40,positive regulation of glucose transmembrane transport,BP,
4980,GO:0010829,1,0.908751123229278,0,16,negative regulation of glucose transmembrane transport,BP,
4981,GO:0010830,1,0.751106706776167,0,46,regulation of myotube differentiation,BP,
4982,GO:0010831,1,0.856232544893402,0,25,positive regulation of myotube differentiation,BP,
4983,GO:0010832,1,0.919053353779719,0,14,negative regulation of myotube differentiation,BP,
4984,GO:0010833,1,0.6150457903282,0,75,telomere maintenance via telomere lengthening,BP,
4985,GO:0010835,1,0.964796762371955,0,6,regulation of protein ADP-ribosylation,BP,
4986,GO:0010836,1,0.986156097350866,0,3,negative regulation of protein ADP-ribosylation,BP,
4987,GO:0010837,1,0.840031861440285,0,25,regulation of keratinocyte proliferation,BP,
4988,GO:0010838,1,0.95318864685014,0,7,positive regulation of keratinocyte proliferation,BP,
4989,GO:0010839,1,0.922610565421846,0,11,negative regulation of keratinocyte proliferation,BP,
4990,GO:0010840,1,0.981502724739047,0,4,regulation of circadian sleep/wake cycle, wakefulness,BP,
4991,GO:0010841,1,0.985730175578864,0,3,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4992,GO:0010842,1,0.865867747531315,0,19,retina layer formation,BP,
4993,GO:0010845,1,0.986144829050517,0,2,positive regulation of reciprocal meiotic recombination,BP,
4994,GO:0010847,1,0.971616310231835,0,4,regulation of chromatin assembly,BP,
4995,GO:0010848,1,0.985128484905941,0,2,regulation of chromatin disassembly,BP,
4996,GO:0010849,1,0.994739370677628,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4997,GO:0010851,1,0.975065293392801,0,5,cyclase regulator activity,MF,
4998,GO:0010853,1,0.982492835055411,0,4,cyclase activator activity,MF,
4999,GO:0010854,1,0.99244149251448,0,1,adenylate cyclase regulator activity,MF,
5000,GO:0010855,1,0.99244149251448,0,1,adenylate cyclase inhibitor activity,MF,
5001,GO:0010856,1,0.99264846696249,0,1,adenylate cyclase activator activity,MF,
5002,GO:0010857,1,0.927723500083161,0,11,calcium-dependent protein kinase activity,MF,
5003,GO:0010858,1,0.987783402427512,0,3,calcium-dependent protein kinase regulator activity,MF,
5004,GO:0010859,1,0.992419276287048,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5005,GO:0010862,1,0.75731159171799,0,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
5007,GO:0010866,1,0.911770683081637,0,15,regulation of triglyceride biosynthetic process,BP,
5008,GO:0010867,1,0.935891154409798,0,11,positive regulation of triglyceride biosynthetic process,BP,
5009,GO:0010868,1,0.984897930694549,0,2,negative regulation of triglyceride biosynthetic process,BP,
5010,GO:0010869,1,0.885077016398019,0,19,regulation of receptor biosynthetic process,BP,
5011,GO:0010870,1,0.940193462810224,0,11,positive regulation of receptor biosynthetic process,BP,
5012,GO:0010871,1,0.963970451292901,0,5,negative regulation of receptor biosynthetic process,BP,
5013,GO:0010872,1,0.960349511931007,0,8,regulation of cholesterol esterification,BP,
5014,GO:0010873,1,0.973693606236502,0,6,positive regulation of cholesterol esterification,BP,
5015,GO:0010874,1,0.890211080716379,0,18,regulation of cholesterol efflux,BP,
5016,GO:0010875,1,0.917301377383597,0,13,positive regulation of cholesterol efflux,BP,
5018,GO:0010877,1,0.991291331515911,0,2,lipid transport involved in lipid storage,BP,
5019,GO:0010878,1,0.899792289311414,0,15,cholesterol storage,BP,
5020,GO:0010879,1,0.994551789174507,0,1,cholesterol transport involved in cholesterol storage,BP,
5021,GO:0010880,1,0.841726005685207,0,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5022,GO:0010881,1,0.886701489429916,0,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
5023,GO:0010882,1,0.857831442849787,0,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,
5024,GO:0010883,1,0.777295286781631,0,40,regulation of lipid storage,BP,
5025,GO:0010884,1,0.882028008079243,0,20,positive regulation of lipid storage,BP,
5026,GO:0010885,1,0.911497876883161,0,13,regulation of cholesterol storage,BP,
5027,GO:0010886,1,0.948208796488119,0,7,positive regulation of cholesterol storage,BP,
5028,GO:0010887,1,0.961304938429849,0,6,negative regulation of cholesterol storage,BP,
5029,GO:0010888,1,0.90541964779515,0,16,negative regulation of lipid storage,BP,
5030,GO:0010889,1,0.933535428461509,0,12,regulation of sequestering of triglyceride,BP,
5031,GO:0010890,1,0.966948667208083,0,7,positive regulation of sequestering of triglyceride,BP,
5032,GO:0010891,1,0.965456554267011,0,5,negative regulation of sequestering of triglyceride,BP,
5033,GO:0010893,1,0.918031283733771,0,13,positive regulation of steroid biosynthetic process,BP,
5034,GO:0010894,1,0.876557078270731,0,22,negative regulation of steroid biosynthetic process,BP,
5035,GO:0010896,1,0.959627361845524,0,8,regulation of triglyceride catabolic process,BP,
5036,GO:0010897,1,0.980879598270003,0,3,negative regulation of triglyceride catabolic process,BP,
5037,GO:0010898,1,0.978337805911193,0,5,positive regulation of triglyceride catabolic process,BP,
5038,GO:0010899,1,0.982887185184076,0,3,regulation of phosphatidylcholine catabolic process,BP,
5039,GO:0010900,1,0.997080498363937,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5040,GO:0010901,1,0.993960190456427,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5041,GO:0010902,1,0.997016154711541,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5042,GO:0010903,1,0.996934985808316,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5043,GO:0010904,1,0.994769239365915,0,1,regulation of UDP-glucose catabolic process,BP,
5044,GO:0010905,1,0.994769239365915,0,1,negative regulation of UDP-glucose catabolic process,BP,
5047,GO:0010908,1,0.978481617383083,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5048,GO:0010909,1,0.978481617383083,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5049,GO:0010911,1,0.951819217174588,0,7,regulation of isomerase activity,BP,
5050,GO:0010912,1,0.951819217174588,0,7,positive regulation of isomerase activity,BP,
5051,GO:0010915,1,0.990325170967559,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5052,GO:0010916,1,0.990325170967559,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5053,GO:0010917,1,0.958312399602779,0,8,negative regulation of mitochondrial membrane potential,BP,
5054,GO:0010918,1,0.955742813276679,0,8,positive regulation of mitochondrial membrane potential,BP,
5055,GO:0010919,1,0.925960945919948,0,12,regulation of inositol phosphate biosynthetic process,BP,
5056,GO:0010920,1,0.99315298119977,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5058,GO:0010922,1,0.82101325372456,0,28,positive regulation of phosphatase activity,BP,
5060,GO:0010924,1,0.99315298119977,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5061,GO:0010925,1,0.99315298119977,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5063,GO:0010931,1,0.991222950786381,0,1,macrophage tolerance induction,BP,
5064,GO:0010932,1,0.991222950786381,0,1,regulation of macrophage tolerance induction,BP,
5065,GO:0010933,1,0.991222950786381,0,1,positive regulation of macrophage tolerance induction,BP,
5066,GO:0010934,1,0.91482659022526,0,14,macrophage cytokine production,BP,
5067,GO:0010935,1,0.927425787804606,0,12,regulation of macrophage cytokine production,BP,
5068,GO:0010936,1,0.968025316281717,0,5,negative regulation of macrophage cytokine production,BP,
5069,GO:0010938,1,0.99249364207351,0,1,cytoplasmic microtubule depolymerization,BP,
5071,GO:0010940,1,0.975104487351886,0,6,positive regulation of necrotic cell death,BP,
5074,GO:0010944,1,0.954621119983719,0,8,negative regulation of transcription by competitive promoter binding,BP,
5076,GO:0010949,1,0.993517530070233,0,1,negative regulation of intestinal phytosterol absorption,BP,
5081,GO:0010955,1,0.800824725162893,0,35,negative regulation of protein processing,BP,
5082,GO:0010956,1,0.979987378762707,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5083,GO:0010957,1,0.971179434906436,0,5,negative regulation of vitamin D biosynthetic process,BP,
5084,GO:0010958,1,0.960490293191471,0,6,regulation of amino acid import across plasma membrane,BP,
5087,GO:0010961,1,0.970297363094395,0,4,cellular magnesium ion homeostasis,BP,
5088,GO:0010962,1,0.840756371950653,0,23,regulation of glucan biosynthetic process,BP,
5089,GO:0010963,1,0.990149281217877,0,2,regulation of L-arginine import,BP,
5090,GO:0010965,1,0.718013572366485,0,52,regulation of mitotic sister chromatid separation,BP,
5091,GO:0010966,1,0.969419735917677,0,4,regulation of phosphate transport,BP,
5092,GO:0010967,1,0.99596705023946,0,1,regulation of polyamine biosynthetic process,BP,
5093,GO:0010968,1,0.964518494271696,0,6,regulation of microtubule nucleation,BP,
5095,GO:0010971,1,0.874890075979961,0,21,positive regulation of G2/M transition of mitotic cell cycle,BP,
5096,GO:0010972,1,0.638607306156228,0,86,negative regulation of G2/M transition of mitotic cell cycle,BP,
5100,GO:0010979,1,0.986357781624212,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5101,GO:0010980,1,0.986357781624212,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5102,GO:0010982,1,0.986973365646374,0,2,regulation of high-density lipoprotein particle clearance,BP,
5103,GO:0010983,1,0.986973365646374,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5104,GO:0010984,1,0.921583814778043,0,15,regulation of lipoprotein particle clearance,BP,
5105,GO:0010985,1,0.96248281504409,0,7,negative regulation of lipoprotein particle clearance,BP,
5106,GO:0010986,1,0.97546044704606,0,4,positive regulation of lipoprotein particle clearance,BP,
5107,GO:0010988,1,0.95027677339623,0,9,regulation of low-density lipoprotein particle clearance,BP,
5108,GO:0010989,1,0.971888456256328,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5109,GO:0010990,1,0.959403244674866,0,6,regulation of SMAD protein complex assembly,BP,
5110,GO:0010991,1,0.966696950664659,0,5,negative regulation of SMAD protein complex assembly,BP,
5111,GO:0010992,1,0.957461912349306,0,7,ubiquitin recycling,BP,
5112,GO:0010994,1,0.972433210756688,0,5,free ubiquitin chain polymerization,BP,
5113,GO:0010996,1,0.866098070493618,0,21,response to auditory stimulus,BP,
5114,GO:0010997,1,0.968319585633429,0,5,anaphase-promoting complex binding,MF,
5115,GO:0010998,1,0.935563868344847,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5116,GO:0010999,1,0.992405087241669,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5120,GO:0012507,1,0.719548821022171,0,57,ER to Golgi transport vesicle membrane,CC,
5121,GO:0012510,1,0.918454869451094,0,14,trans-Golgi network transport vesicle membrane,CC,
5124,GO:0014004,1,0.977992004492973,0,3,microglia differentiation,BP,
5125,GO:0014005,1,0.977992004492973,0,3,microglia development,BP,
5128,GO:0014011,1,0.993301131169352,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5133,GO:0014016,1,0.982057101731297,0,3,neuroblast differentiation,BP,
5134,GO:0014017,1,0.993995508641689,0,1,neuroblast fate commitment,BP,
5136,GO:0014022,1,0.97828615073932,0,3,neural plate elongation,BP,
5137,GO:0014028,1,0.988413596883922,0,2,notochord formation,BP,
5138,GO:0014029,1,0.93282653111104,0,11,neural crest formation,BP,
5142,GO:0014034,1,0.981688512345977,0,3,neural crest cell fate commitment,BP,
5143,GO:0014036,1,0.989201225499542,0,2,neural crest cell fate specification,BP,
5145,GO:0014038,1,0.980120068768229,0,3,regulation of Schwann cell differentiation,BP,
5146,GO:0014040,1,0.984191390652216,0,2,positive regulation of Schwann cell differentiation,BP,
5147,GO:0014041,1,0.937727196179624,0,9,regulation of neuron maturation,BP,
5148,GO:0014042,1,0.968075781569605,0,4,positive regulation of neuron maturation,BP,
5149,GO:0014043,1,0.980751290569965,0,3,negative regulation of neuron maturation,BP,
5151,GO:0014045,1,0.973989849250344,0,4,establishment of endothelial blood-brain barrier,BP,
5152,GO:0014046,1,0.874277027266777,0,22,dopamine secretion,BP,
5153,GO:0014047,1,0.755028088920614,0,41,glutamate secretion,BP,
5154,GO:0014048,1,0.911970560765901,0,14,regulation of glutamate secretion,BP,
5155,GO:0014049,1,0.946699837830667,0,8,positive regulation of glutamate secretion,BP,
5156,GO:0014050,1,0.970380451914612,0,5,negative regulation of glutamate secretion,BP,
5157,GO:0014051,1,0.93363076246216,0,9,gamma-aminobutyric acid secretion,BP,
5158,GO:0014052,1,0.958325039063855,0,6,regulation of gamma-aminobutyric acid secretion,BP,
5159,GO:0014053,1,0.992316013745567,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5160,GO:0014054,1,0.97313336194876,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5161,GO:0014055,1,0.981546351929454,0,3,acetylcholine secretion, neurotransmission,BP,
5162,GO:0014056,1,0.981546351929454,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5163,GO:0014057,1,0.987954841043685,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5164,GO:0014059,1,0.874277027266777,0,22,regulation of dopamine secretion,BP,
5165,GO:0014060,1,0.981517369087419,0,4,regulation of epinephrine secretion,BP,
5166,GO:0014061,1,0.932670879158963,0,12,regulation of norepinephrine secretion,BP,
5167,GO:0014062,1,0.963265578916639,0,7,regulation of serotonin secretion,BP,
5168,GO:0014063,1,0.977236768531481,0,4,negative regulation of serotonin secretion,BP,
5169,GO:0014064,1,0.992393455043034,0,1,positive regulation of serotonin secretion,BP,
5172,GO:0014067,1,0.93830334981178,0,10,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5176,GO:0014072,1,0.836681820424349,0,30,response to isoquinoline alkaloid,BP,
5178,GO:0014075,1,0.791241711791897,0,36,response to amine,BP,
5179,GO:0014701,1,0.923630210273251,0,9,junctional sarcoplasmic reticulum membrane,CC,
5181,GO:0014705,1,0.992436398828994,0,1,C zone,CC,
5183,GO:0014707,1,0.989387839231507,0,2,branchiomeric skeletal muscle development,BP,
5187,GO:0014721,1,0.970183519752901,0,5,twitch skeletal muscle contraction,BP,
5188,GO:0014722,1,0.967444041972244,0,6,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5189,GO:0014724,1,0.98457111892148,0,2,regulation of twitch skeletal muscle contraction,BP,
5190,GO:0014728,1,0.991986201570728,0,1,regulation of the force of skeletal muscle contraction,BP,
5191,GO:0014731,1,0.941813817472215,0,7,spectrin-associated cytoskeleton,CC,
5192,GO:0014732,1,0.960991504865575,0,7,skeletal muscle atrophy,BP,
5193,GO:0014733,1,0.924638403143411,0,11,regulation of skeletal muscle adaptation,BP,
5194,GO:0014734,1,0.978257267132187,0,3,skeletal muscle hypertrophy,BP,
5195,GO:0014735,1,0.983468785450545,0,3,regulation of muscle atrophy,BP,
5196,GO:0014736,1,0.98753920332933,0,2,negative regulation of muscle atrophy,BP,
5197,GO:0014737,1,0.995878759521773,0,1,positive regulation of muscle atrophy,BP,
5198,GO:0014738,1,0.984169834708022,0,3,regulation of muscle hyperplasia,BP,
5199,GO:0014739,1,0.99704236964217,0,1,positive regulation of muscle hyperplasia,BP,
5200,GO:0014740,1,0.987089676991755,0,2,negative regulation of muscle hyperplasia,BP,
5201,GO:0014741,1,0.886975388633793,0,18,negative regulation of muscle hypertrophy,BP,
5202,GO:0014742,1,0.836592705594747,0,26,positive regulation of muscle hypertrophy,BP,
5203,GO:0014743,1,0.730618818760626,0,46,regulation of muscle hypertrophy,BP,
5204,GO:0014744,1,0.969239186225685,0,5,positive regulation of muscle adaptation,BP,
5205,GO:0014745,1,0.923237045132523,0,11,negative regulation of muscle adaptation,BP,
5206,GO:0014802,1,0.97504923668316,0,4,terminal cisterna,CC,
5207,GO:0014804,1,0.995359209047032,0,1,terminal cisterna lumen,CC,
5208,GO:0014805,1,0.983697066686238,0,4,smooth muscle adaptation,BP,
5209,GO:0014806,1,0.990277700540437,0,2,smooth muscle hyperplasia,BP,
5211,GO:0014808,1,0.82228009526037,0,28,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5212,GO:0014809,1,0.97413666477326,0,5,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5213,GO:0014810,1,0.996991258759462,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5214,GO:0014812,1,0.594797501760221,0,74,muscle cell migration,BP,
5215,GO:0014813,1,0.994559939956312,0,1,skeletal muscle satellite cell commitment,BP,
5216,GO:0014816,1,0.949185911468453,0,7,skeletal muscle satellite cell differentiation,BP,
5217,GO:0014819,1,0.934973358470149,0,11,regulation of skeletal muscle contraction,BP,
5218,GO:0014820,1,0.947182928392931,0,9,tonic smooth muscle contraction,BP,
5219,GO:0014821,1,0.906235110410507,0,18,phasic smooth muscle contraction,BP,
5220,GO:0014822,1,0.993784527936572,0,1,detection of wounding,BP,
5222,GO:0014824,1,0.958232140523542,0,7,artery smooth muscle contraction,BP,
5223,GO:0014825,1,0.996976979760557,0,1,stomach fundus smooth muscle contraction,BP,
5224,GO:0014826,1,0.977964746859767,0,4,vein smooth muscle contraction,BP,
5225,GO:0014827,1,0.966979913966453,0,6,intestine smooth muscle contraction,BP,
5226,GO:0014828,1,0.992249190269564,0,1,distal stomach smooth muscle contraction,BP,
5227,GO:0014829,1,0.877968797543808,0,19,vascular smooth muscle contraction,BP,
5228,GO:0014831,1,0.935726414720849,0,11,gastro-intestinal system smooth muscle contraction,BP,
5229,GO:0014832,1,0.955840998459345,0,7,urinary bladder smooth muscle contraction,BP,
5231,GO:0014835,1,0.987006469082638,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5232,GO:0014839,1,0.992105478553756,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5233,GO:0014841,1,0.912590718815668,0,13,skeletal muscle satellite cell proliferation,BP,
5234,GO:0014842,1,0.920489759970157,0,12,regulation of skeletal muscle satellite cell proliferation,BP,
5235,GO:0014843,1,0.991753800282021,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5236,GO:0014846,1,0.984610929747062,0,2,esophagus smooth muscle contraction,BP,
5237,GO:0014847,1,0.996976979760557,0,1,proximal stomach smooth muscle contraction,BP,
5238,GO:0014848,1,0.955840998459345,0,7,urinary tract smooth muscle contraction,BP,
5240,GO:0014852,1,0.993131557145256,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5241,GO:0014853,1,0.993131557145256,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5242,GO:0014854,1,0.920384949920806,0,13,response to inactivity,BP,
5244,GO:0014856,1,0.909115911145215,0,14,skeletal muscle cell proliferation,BP,
5245,GO:0014857,1,0.916985190052984,0,13,regulation of skeletal muscle cell proliferation,BP,
5246,GO:0014858,1,0.980834138344626,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5247,GO:0014859,1,0.97836589390698,0,3,negative regulation of skeletal muscle cell proliferation,BP,
5248,GO:0014861,1,0.992194706378963,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5249,GO:0014862,1,0.991986201570728,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5250,GO:0014866,1,0.849473652064986,0,12,skeletal myofibril assembly,BP,
5251,GO:0014870,1,0.93520068952294,0,10,response to muscle inactivity,BP,
5252,GO:0014873,1,0.989637815042641,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5253,GO:0014874,1,0.913716903417812,0,14,response to stimulus involved in regulation of muscle adaptation,BP,
5254,GO:0014876,1,0.996489721076576,0,1,response to injury involved in regulation of muscle adaptation,BP,
5255,GO:0014877,1,0.941511698714945,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5256,GO:0014878,1,0.976019378623347,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5257,GO:0014883,1,0.96202303350156,0,6,transition between fast and slow fiber,BP,
5258,GO:0014886,1,0.992663498870438,0,1,transition between slow and fast fiber,BP,
5259,GO:0014887,1,0.853143547436527,0,22,cardiac muscle adaptation,BP,
5260,GO:0014888,1,0.761771187276804,0,41,striated muscle adaptation,BP,
5261,GO:0014889,1,0.932482682519467,0,12,muscle atrophy,BP,
5262,GO:0014891,1,0.954628030758025,0,8,striated muscle atrophy,BP,
5263,GO:0014894,1,0.941511698714945,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5264,GO:0014895,1,0.997026923975853,0,1,smooth muscle hypertrophy,BP,
5265,GO:0014896,1,0.556283047635685,0,73,muscle hypertrophy,BP,
5266,GO:0014897,1,0.561782130723702,0,71,striated muscle hypertrophy,BP,
5267,GO:0014898,1,0.853143547436527,0,22,cardiac muscle hypertrophy in response to stress,BP,
5268,GO:0014900,1,0.980465532859882,0,4,muscle hyperplasia,BP,
5270,GO:0014902,1,0.558669142591272,0,89,myotube differentiation,BP,
5271,GO:0014904,1,0.817991752867754,0,31,myotube cell development,BP,
5272,GO:0014908,1,0.987692666627342,0,2,myotube differentiation involved in skeletal muscle regeneration,BP,
5273,GO:0014909,1,0.638117483498499,0,63,smooth muscle cell migration,BP,
5274,GO:0014910,1,0.673070318281333,0,55,regulation of smooth muscle cell migration,BP,
5275,GO:0014911,1,0.803712744102587,0,30,positive regulation of smooth muscle cell migration,BP,
5276,GO:0014912,1,0.868371884874567,0,21,negative regulation of smooth muscle cell migration,BP,
5277,GO:0014916,1,0.977147884129838,0,3,regulation of lung blood pressure,BP,
5278,GO:0015002,1,0.926870888205205,0,22,heme-copper terminal oxidase activity,MF,
5279,GO:0015012,1,0.831659008347289,0,25,heparan sulfate proteoglycan biosynthetic process,BP,
5280,GO:0015014,1,0.954197125046185,0,6,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5281,GO:0015015,1,0.957997872864234,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5282,GO:0015016,1,0.968757501048926,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5283,GO:0015018,1,0.984448870799818,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5284,GO:0015019,1,0.992237891552214,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5289,GO:0015035,1,0.912005328127887,0,20,protein disulfide oxidoreductase activity,MF,
5290,GO:0015036,1,0.838437643921194,0,36,disulfide oxidoreductase activity,MF,
5291,GO:0015037,1,0.941711095083578,0,13,peptide disulfide oxidoreductase activity,MF,
5292,GO:0015038,1,0.981435108363582,0,5,glutathione disulfide oxidoreductase activity,MF,
5293,GO:0015039,1,0.995518397400478,0,1,NADPH-adrenodoxin reductase activity,MF,
5294,GO:0015052,1,0.993587567316847,0,1,beta3-adrenergic receptor activity,MF,
5295,GO:0015054,1,0.994947615481502,0,1,gastrin receptor activity,MF,
5296,GO:0015056,1,0.98975823460364,0,2,corticotrophin-releasing factor receptor activity,MF,
5297,GO:0015057,1,0.965966108118729,0,5,thrombin-activated receptor activity,MF,
5298,GO:0015065,1,0.985720945121673,0,3,uridine nucleotide receptor activity,MF,
5299,GO:0015067,1,0.993711863794798,0,1,amidinotransferase activity,MF,
5300,GO:0015068,1,0.993711863794798,0,1,glycine amidinotransferase activity,MF,
5301,GO:0015074,1,0.935159092608599,0,10,DNA integration,BP,
5307,GO:0015085,1,0.368615373336899,0,133,calcium ion transmembrane transporter activity,MF,
5308,GO:0015086,1,0.992444082065594,0,1,cadmium ion transmembrane transporter activity,MF,
5309,GO:0015087,1,0.992444082065594,0,1,cobalt ion transmembrane transporter activity,MF,
5311,GO:0015093,1,0.977580258625352,0,3,ferrous iron transmembrane transporter activity,MF,
5312,GO:0015094,1,0.992444082065594,0,1,lead ion transmembrane transporter activity,MF,
5313,GO:0015095,1,0.895714502731195,0,16,magnesium ion transmembrane transporter activity,MF,
5314,GO:0015098,1,0.99551717899644,0,1,molybdate ion transmembrane transporter activity,MF,
5315,GO:0015101,1,0.861763313720393,0,25,organic cation transmembrane transporter activity,MF,
5316,GO:0015103,1,0.372109146860636,0,146,inorganic anion transmembrane transporter activity,MF,
5317,GO:0015105,1,0.996610935824499,0,1,arsenite transmembrane transporter activity,MF,
5318,GO:0015106,1,0.853252161284252,0,21,bicarbonate transmembrane transporter activity,MF,
5319,GO:0015108,1,0.56281178536568,0,84,chloride transmembrane transporter activity,MF,
5320,GO:0015111,1,0.977430034069664,0,3,iodide transmembrane transporter activity,MF,
5321,GO:0015112,1,0.9935602102931,0,1,nitrate transmembrane transporter activity,MF,
5322,GO:0015114,1,0.923342380802587,0,11,phosphate ion transmembrane transporter activity,MF,
5323,GO:0015116,1,0.925667849528423,0,11,sulfate transmembrane transporter activity,MF,
5324,GO:0015117,1,0.995537833604515,0,1,thiosulfate transmembrane transporter activity,MF,
5325,GO:0015119,1,0.980351961643986,0,3,hexose phosphate transmembrane transporter activity,MF,
5326,GO:0015125,1,0.923612188790905,0,13,bile acid transmembrane transporter activity,MF,
5327,GO:0015126,1,0.99234309375677,0,1,canalicular bile acid transmembrane transporter activity,MF,
5328,GO:0015127,1,0.992276848613409,0,1,bilirubin transmembrane transporter activity,MF,
5329,GO:0015129,1,0.967999403788745,0,5,lactate transmembrane transporter activity,MF,
5330,GO:0015130,1,0.99244707801265,0,1,mevalonate transmembrane transporter activity,MF,
5331,GO:0015131,1,0.995537833604515,0,1,oxaloacetate transmembrane transporter activity,MF,
5332,GO:0015132,1,0.992438093863437,0,1,prostaglandin transmembrane transporter activity,MF,
5333,GO:0015136,1,0.992625835691004,0,1,sialic acid transmembrane transporter activity,MF,
5334,GO:0015137,1,0.973994760117545,0,4,citrate transmembrane transporter activity,MF,
5335,GO:0015139,1,0.993137509183141,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5336,GO:0015140,1,0.99134906196649,0,2,malate transmembrane transporter activity,MF,
5337,GO:0015141,1,0.980810940647604,0,3,succinate transmembrane transporter activity,MF,
5338,GO:0015142,1,0.973994760117545,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5339,GO:0015143,1,0.974951392553545,0,5,urate transmembrane transporter activity,MF,
5343,GO:0015152,1,0.994979822721855,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5346,GO:0015165,1,0.945141840468604,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5348,GO:0015168,1,0.974609946915333,0,5,glycerol transmembrane transporter activity,MF,
5349,GO:0015171,1,0.624833874883323,0,72,amino acid transmembrane transporter activity,MF,
5350,GO:0015172,1,0.90385234703691,0,14,acidic amino acid transmembrane transporter activity,MF,
5351,GO:0015173,1,0.979991133980495,0,3,aromatic amino acid transmembrane transporter activity,MF,
5352,GO:0015174,1,0.933363272921007,0,11,basic amino acid transmembrane transporter activity,MF,
5353,GO:0015175,1,0.830026400442286,0,29,neutral amino acid transmembrane transporter activity,MF,
5354,GO:0015179,1,0.706221120031272,0,53,L-amino acid transmembrane transporter activity,MF,
5355,GO:0015180,1,0.966286326900331,0,5,L-alanine transmembrane transporter activity,MF,
5356,GO:0015181,1,0.962328504409637,0,6,arginine transmembrane transporter activity,MF,
5357,GO:0015182,1,0.987354852106516,0,2,L-asparagine transmembrane transporter activity,MF,
5358,GO:0015183,1,0.974614628204277,0,4,L-aspartate transmembrane transporter activity,MF,
5359,GO:0015184,1,0.980868959327781,0,3,L-cystine transmembrane transporter activity,MF,
5360,GO:0015185,1,0.969200827003964,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5361,GO:0015186,1,0.9679249359625,0,5,L-glutamine transmembrane transporter activity,MF,
5362,GO:0015187,1,0.962430540495734,0,6,glycine transmembrane transporter activity,MF,
5363,GO:0015189,1,0.962328504409637,0,6,L-lysine transmembrane transporter activity,MF,
5364,GO:0015190,1,0.993291327786763,0,1,L-leucine transmembrane transporter activity,MF,
5365,GO:0015191,1,0.993291327786763,0,1,L-methionine transmembrane transporter activity,MF,
5366,GO:0015193,1,0.963718652057431,0,5,L-proline transmembrane transporter activity,MF,
5367,GO:0015194,1,0.952176438337901,0,9,L-serine transmembrane transporter activity,MF,
5368,GO:0015195,1,0.992429197414442,0,1,L-threonine transmembrane transporter activity,MF,
5369,GO:0015196,1,0.994008371687069,0,1,L-tryptophan transmembrane transporter activity,MF,
5370,GO:0015203,1,0.990271315953972,0,2,polyamine transmembrane transporter activity,MF,
5371,GO:0015204,1,0.966373364547681,0,6,urea transmembrane transporter activity,MF,
5372,GO:0015205,1,0.963895279071055,0,6,nucleobase transmembrane transporter activity,MF,
5373,GO:0015207,1,0.98897197754835,0,2,adenine transmembrane transporter activity,MF,
5374,GO:0015215,1,0.908547445161311,0,16,nucleotide transmembrane transporter activity,MF,
5375,GO:0015216,1,0.929102268685895,0,12,purine nucleotide transmembrane transporter activity,MF,
5376,GO:0015217,1,0.945445480720221,0,9,ADP transmembrane transporter activity,MF,
5377,GO:0015218,1,0.988774287912728,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5378,GO:0015220,1,0.960059697179172,0,6,choline transmembrane transporter activity,MF,
5379,GO:0015222,1,0.981168551567203,0,3,serotonin transmembrane transporter activity,MF,
5380,GO:0015226,1,0.967645825374822,0,6,carnitine transmembrane transporter activity,MF,
5381,GO:0015227,1,0.989885042482089,0,2,acyl carnitine transmembrane transporter activity,MF,
5382,GO:0015228,1,0.981257186100733,0,3,coenzyme A transmembrane transporter activity,MF,
5383,GO:0015229,1,0.991687952864058,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5384,GO:0015230,1,0.987489459399559,0,2,FAD transmembrane transporter activity,MF,
5385,GO:0015232,1,0.946721021966688,0,8,heme transporter activity,MF,
5386,GO:0015234,1,0.98115863754553,0,3,thiamine transmembrane transporter activity,MF,
5387,GO:0015238,1,0.545941356069684,0,93,drug transmembrane transporter activity,MF,
5388,GO:0015245,1,0.950309643867261,0,8,fatty acid transmembrane transporter activity,MF,
5389,GO:0015247,1,0.977046165884273,0,3,aminophospholipid transmembrane transporter activity,MF,
5390,GO:0015248,1,0.854853897442877,0,25,sterol transporter activity,MF,
5391,GO:0015250,1,0.948736621544986,0,10,water channel activity,MF,
5392,GO:0015252,1,0.982498466156694,0,3,proton channel activity,MF,
5393,GO:0015254,1,0.981140652884939,0,4,glycerol channel activity,MF,
5394,GO:0015265,1,0.981236434745842,0,3,urea channel activity,MF,
5396,GO:0015269,1,0.904274978789704,0,17,calcium-activated potassium channel activity,MF,
5397,GO:0015271,1,0.89706776921649,0,15,outward rectifier potassium channel activity,MF,
5398,GO:0015272,1,0.965991410843557,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5399,GO:0015275,1,0.977841494792048,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5401,GO:0015277,1,0.962008396381647,0,5,kainate selective glutamate receptor activity,MF,
5402,GO:0015278,1,0.841543510615282,0,21,calcium-release channel activity,MF,
5403,GO:0015279,1,0.934758089327135,0,9,store-operated calcium channel activity,MF,
5404,GO:0015280,1,0.945262581238751,0,8,ligand-gated sodium channel activity,MF,
5405,GO:0015288,1,0.97114708919728,0,6,porin activity,MF,
5407,GO:0015292,1,0.993301131169352,0,1,uniporter activity,MF,
5411,GO:0015296,1,0.925488428750502,0,10,anion:cation symporter activity,MF,
5412,GO:0015297,1,0.597031468689713,0,76,antiporter activity,MF,
5413,GO:0015298,1,0.806121452109743,0,31,solute:cation antiporter activity,MF,
5414,GO:0015299,1,0.881966207999384,0,18,solute:proton antiporter activity,MF,
5415,GO:0015301,1,0.824142280856074,0,28,anion:anion antiporter activity,MF,
5416,GO:0015307,1,0.983401449657084,0,3,drug:proton antiporter activity,MF,
5417,GO:0015315,1,0.980351961643986,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5418,GO:0015317,1,0.995994853546049,0,1,phosphate:proton symporter activity,MF,
5420,GO:0015319,1,0.978253395336282,0,3,sodium:inorganic phosphate symporter activity,MF,
5421,GO:0015321,1,0.965920975771069,0,5,sodium-dependent phosphate transmembrane transporter activity,MF,
5422,GO:0015322,1,0.992484065920251,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5423,GO:0015327,1,0.990660807007433,0,1,cystine:glutamate antiporter activity,MF,
5424,GO:0015328,1,0.990660807007433,0,1,cystine secondary active transmembrane transporter activity,MF,
5425,GO:0015333,1,0.980725338618842,0,3,peptide:proton symporter activity,MF,
5426,GO:0015343,1,0.993301131169352,0,1,siderophore transmembrane transporter activity,MF,
5427,GO:0015347,1,0.855710805672175,0,24,sodium-independent organic anion transmembrane transporter activity,MF,
5428,GO:0015349,1,0.971743593575423,0,4,thyroid hormone transmembrane transporter activity,MF,
5429,GO:0015350,1,0.985084848697347,0,2,methotrexate transmembrane transporter activity,MF,
5430,GO:0015355,1,0.938413550430362,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5431,GO:0015362,1,0.992453472055975,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5432,GO:0015367,1,0.995792649700092,0,1,oxoglutarate:malate antiporter activity,MF,
5433,GO:0015368,1,0.925607481034564,0,11,calcium:cation antiporter activity,MF,
5434,GO:0015369,1,0.992169266120572,0,1,calcium:proton antiporter activity,MF,
5436,GO:0015373,1,0.970003632534443,0,4,anion:sodium symporter activity,MF,
5437,GO:0015375,1,0.985871378742581,0,2,glycine:sodium symporter activity,MF,
5438,GO:0015377,1,0.93897990571543,0,8,cation:chloride symporter activity,MF,
5439,GO:0015378,1,0.984137077846956,0,2,sodium:chloride symporter activity,MF,
5440,GO:0015379,1,0.93897990571543,0,8,potassium:chloride symporter activity,MF,
5441,GO:0015382,1,0.993079601576071,0,1,sodium:sulfate symporter activity,MF,
5442,GO:0015385,1,0.917416143349917,0,12,sodium:proton antiporter activity,MF,
5443,GO:0015386,1,0.929841969986593,0,10,potassium:proton antiporter activity,MF,
5444,GO:0015389,1,0.989842727751895,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5445,GO:0015390,1,0.994665978507157,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5446,GO:0015391,1,0.989842727751895,0,2,nucleobase:cation symporter activity,MF,
5447,GO:0015399,1,0.489122400619048,0,103,primary active transmembrane transporter activity,MF,
5448,GO:0015405,1,0.489122400619048,0,103,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5449,GO:0015410,1,0.977744588247184,0,3,manganese-transporting ATPase activity,MF,
5450,GO:0015420,1,0.991874756835951,0,1,cobalamin-transporting ATPase activity,MF,
5451,GO:0015421,1,0.992524512966404,0,1,oligopeptide-transporting ATPase activity,MF,
5452,GO:0015431,1,0.991874756835951,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5453,GO:0015432,1,0.984922840427387,0,2,bile acid-exporting ATPase activity,MF,
5454,GO:0015433,1,0.985047056314648,0,2,peptide antigen-transporting ATPase activity,MF,
5455,GO:0015439,1,0.992950625600058,0,1,heme-transporting ATPase activity,MF,
5456,GO:0015440,1,0.970828329519425,0,4,peptide-transporting ATPase activity,MF,
5457,GO:0015450,1,0.973216534642234,0,6,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5458,GO:0015459,1,0.751322022066821,0,46,potassium channel regulator activity,MF,
5459,GO:0015464,1,0.889061889968674,0,19,acetylcholine receptor activity,MF,
5462,GO:0015489,1,0.990271315953972,0,2,putrescine transmembrane transporter activity,MF,
5463,GO:0015491,1,0.819610630415455,0,28,cation:cation antiporter activity,MF,
5464,GO:0015495,1,0.993750423488146,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5465,GO:0015499,1,0.993554549492272,0,1,formate transmembrane transporter activity,MF,
5466,GO:0015501,1,0.95327626068987,0,7,glutamate:sodium symporter activity,MF,
5467,GO:0015526,1,0.980351961643986,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5468,GO:0015538,1,0.992625835691004,0,1,sialic acid:proton symporter activity,MF,
5469,GO:0015556,1,0.951884002508868,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5470,GO:0015562,1,0.973887198764047,0,4,efflux transmembrane transporter activity,MF,
5471,GO:0015578,1,0.99404454712609,0,1,mannose transmembrane transporter activity,MF,
5472,GO:0015605,1,0.864609566074194,0,23,organophosphate ester transmembrane transporter activity,MF,
5473,GO:0015616,1,0.967196262176773,0,4,DNA translocase activity,MF,
5477,GO:0015633,1,0.995011938762366,0,1,zinc-transporting ATPase activity,MF,
5478,GO:0015636,1,0.994427086769477,0,1,short-chain fatty acid transmembrane transporter activity,MF,
5479,GO:0015643,1,0.952151609258329,0,9,toxic substance binding,MF,
5480,GO:0015645,1,0.895283429048192,0,17,fatty acid ligase activity,MF,
5481,GO:0015651,1,0.944537342946181,0,10,quaternary ammonium group transmembrane transporter activity,MF,
5482,GO:0015658,1,0.993291327786763,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5483,GO:0015660,1,0.993554549492272,0,1,formate efflux transmembrane transporter activity,MF,
5484,GO:0015662,1,0.77105820202766,0,38,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5485,GO:0015665,1,0.990101806520995,0,2,alcohol transmembrane transporter activity,MF,
5486,GO:0015669,1,0.934322715116067,0,17,gas transport,BP,
5487,GO:0015670,1,0.985143353565401,0,3,carbon dioxide transport,BP,
5488,GO:0015671,1,0.948420806073875,0,14,oxygen transport,BP,
5490,GO:0015677,1,0.943328161655858,0,8,copper ion import,BP,
5491,GO:0015679,1,0.983539518533096,0,2,plasma membrane copper ion transport,BP,
5492,GO:0015680,1,0.98587487993976,0,3,intracellular copper ion transport,BP,
5494,GO:0015684,1,0.977580258625352,0,3,ferrous iron transport,BP,
5495,GO:0015688,1,0.985133124042761,0,3,iron chelate transport,BP,
5496,GO:0015689,1,0.99551717899644,0,1,molybdate ion transport,BP,
5497,GO:0015691,1,0.973090660628538,0,4,cadmium ion transport,BP,
5498,GO:0015692,1,0.992444082065594,0,1,lead ion transport,BP,
5499,GO:0015693,1,0.888715201442065,0,17,magnesium ion transport,BP,
5500,GO:0015694,1,0.992276848613409,0,1,mercury ion transport,BP,
5501,GO:0015695,1,0.787537407400054,0,39,organic cation transport,BP,
5502,GO:0015696,1,0.59680645847245,0,86,ammonium transport,BP,
5503,GO:0015697,1,0.925275273834675,0,13,quaternary ammonium group transport,BP,
5504,GO:0015698,1,0.337356950020441,0,160,inorganic anion transport,BP,
5505,GO:0015700,1,0.996610935824499,0,1,arsenite transport,BP,
5506,GO:0015701,1,0.77785426297558,0,41,bicarbonate transport,BP,
5507,GO:0015705,1,0.960053187297776,0,5,iodide transport,BP,
5508,GO:0015706,1,0.9935602102931,0,1,nitrate transport,BP,
5509,GO:0015707,1,0.992467204815628,0,1,nitrite transport,BP,
5510,GO:0015709,1,0.995537833604515,0,1,thiosulfate transport,BP,
5512,GO:0015712,1,0.965583814445159,0,6,hexose phosphate transport,BP,
5513,GO:0015718,1,0.426794854781709,0,134,monocarboxylic acid transport,BP,
5514,GO:0015721,1,0.85818919587077,0,25,bile acid and bile salt transport,BP,
5515,GO:0015722,1,0.970377463472598,0,4,canalicular bile acid transport,BP,
5516,GO:0015723,1,0.992276848613409,0,1,bilirubin transport,BP,
5517,GO:0015724,1,0.993554549492272,0,1,formate transport,BP,
5518,GO:0015727,1,0.960667593311602,0,6,lactate transport,BP,
5519,GO:0015728,1,0.99244707801265,0,1,mevalonate transport,BP,
5520,GO:0015729,1,0.995537833604515,0,1,oxaloacetate transport,BP,
5521,GO:0015732,1,0.922178262747875,0,13,prostaglandin transport,BP,
5522,GO:0015734,1,0.991840820277884,0,1,taurine transport,BP,
5523,GO:0015739,1,0.992625835691004,0,1,sialic acid transport,BP,
5524,GO:0015740,1,0.917638207091213,0,12,C4-dicarboxylate transport,BP,
5525,GO:0015742,1,0.983973511230657,0,3,alpha-ketoglutarate transport,BP,
5526,GO:0015743,1,0.995537833604515,0,1,malate transport,BP,
5527,GO:0015744,1,0.980810940647604,0,3,succinate transport,BP,
5528,GO:0015746,1,0.973994760117545,0,4,citrate transport,BP,
5529,GO:0015747,1,0.968873341777085,0,6,urate transport,BP,
5532,GO:0015755,1,0.994400074224895,0,1,fructose transmembrane transport,BP,
5533,GO:0015760,1,0.965583814445159,0,6,glucose-6-phosphate transport,BP,
5534,GO:0015761,1,0.99404454712609,0,1,mannose transmembrane transport,BP,
5538,GO:0015780,1,0.926859987551965,0,13,nucleotide-sugar transmembrane transport,BP,
5539,GO:0015782,1,0.995716548218036,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5540,GO:0015783,1,0.984502714288858,0,2,GDP-fucose transmembrane transport,BP,
5541,GO:0015786,1,0.994538208048522,0,1,UDP-glucose transmembrane transport,BP,
5542,GO:0015787,1,0.991855684452126,0,1,UDP-glucuronic acid transmembrane transport,BP,
5543,GO:0015790,1,0.991737863007027,0,1,UDP-xylose transmembrane transport,BP,
5545,GO:0015793,1,0.974609946915333,0,5,glycerol transport,BP,
5546,GO:0015797,1,0.993554549492272,0,1,mannitol transport,BP,
5548,GO:0015800,1,0.665202549580784,0,59,acidic amino acid transport,BP,
5549,GO:0015801,1,0.967370326495871,0,5,aromatic amino acid transport,BP,
5550,GO:0015802,1,0.931560713467953,0,12,basic amino acid transport,BP,
5551,GO:0015803,1,0.972428152103756,0,4,branched-chain amino acid transport,BP,
5552,GO:0015804,1,0.807282527338887,0,33,neutral amino acid transport,BP,
5553,GO:0015805,1,0.994652381026544,0,1,S-adenosyl-L-methionine transport,BP,
5554,GO:0015807,1,0.675230322277717,0,60,L-amino acid transport,BP,
5555,GO:0015808,1,0.966286326900331,0,5,L-alanine transport,BP,
5556,GO:0015809,1,0.954024419785401,0,8,arginine transport,BP,
5557,GO:0015810,1,0.98119846394584,0,3,aspartate transmembrane transport,BP,
5558,GO:0015811,1,0.980868959327781,0,3,L-cystine transport,BP,
5559,GO:0015812,1,0.911791933941607,0,13,gamma-aminobutyric acid transport,BP,
5560,GO:0015813,1,0.850603376847098,0,23,L-glutamate transmembrane transport,BP,
5561,GO:0015816,1,0.947153499235453,0,8,glycine transport,BP,
5562,GO:0015817,1,0.987331747136659,0,2,histidine transport,BP,
5563,GO:0015819,1,0.995542675341178,0,1,lysine transport,BP,
5564,GO:0015820,1,0.978997371184936,0,3,leucine transport,BP,
5565,GO:0015821,1,0.993291327786763,0,1,methionine transport,BP,
5566,GO:0015822,1,0.96144362751141,0,6,ornithine transport,BP,
5567,GO:0015824,1,0.948638959806569,0,7,proline transport,BP,
5568,GO:0015825,1,0.952176438337901,0,9,L-serine transport,BP,
5569,GO:0015826,1,0.992429197414442,0,1,threonine transport,BP,
5570,GO:0015827,1,0.981208923908672,0,3,tryptophan transport,BP,
5571,GO:0015828,1,0.992755481679136,0,1,tyrosine transport,BP,
5573,GO:0015837,1,0.653988864835115,0,71,amine transport,BP,
5574,GO:0015838,1,0.947917418414266,0,9,amino-acid betaine transport,BP,
5575,GO:0015840,1,0.966677461937845,0,6,urea transport,BP,
5576,GO:0015842,1,0.979522666945852,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5577,GO:0015844,1,0.685693294099694,0,63,monoamine transport,BP,
5578,GO:0015846,1,0.962453013698733,0,7,polyamine transport,BP,
5579,GO:0015847,1,0.990271315953972,0,2,putrescine transport,BP,
5582,GO:0015851,1,0.960439227281143,0,7,nucleobase transport,BP,
5583,GO:0015853,1,0.985426961994111,0,3,adenine transport,BP,
5584,GO:0015855,1,0.98281725536332,0,3,pyrimidine nucleobase transport,BP,
5585,GO:0015858,1,0.959701947330544,0,7,nucleoside transport,BP,
5586,GO:0015860,1,0.994665978507157,0,1,purine nucleoside transmembrane transport,BP,
5587,GO:0015862,1,0.994373107407282,0,1,uridine transport,BP,
5588,GO:0015864,1,0.989068788683508,0,2,pyrimidine nucleoside transport,BP,
5590,GO:0015866,1,0.945445480720221,0,9,ADP transport,BP,
5593,GO:0015870,1,0.975237568698687,0,4,acetylcholine transport,BP,
5594,GO:0015871,1,0.950695008280569,0,7,choline transport,BP,
5595,GO:0015872,1,0.810589394584333,0,35,dopamine transport,BP,
5596,GO:0015874,1,0.902350450117892,0,17,norepinephrine transport,BP,
5597,GO:0015876,1,0.99354439408096,0,1,acetyl-CoA transport,BP,
5598,GO:0015878,1,0.992635234378355,0,1,biotin transport,BP,
5599,GO:0015879,1,0.962773429865631,0,7,carnitine transport,BP,
5600,GO:0015880,1,0.981257186100733,0,3,coenzyme A transport,BP,
5601,GO:0015881,1,0.984956934237111,0,2,creatine transmembrane transport,BP,
5602,GO:0015882,1,0.991687952864058,0,1,L-ascorbic acid transmembrane transport,BP,
5604,GO:0015886,1,0.946721021966688,0,8,heme transport,BP,
5605,GO:0015887,1,0.992635234378355,0,1,pantothenate transmembrane transport,BP,
5606,GO:0015888,1,0.978220569824561,0,3,thiamine transport,BP,
5607,GO:0015889,1,0.966365206274348,0,6,cobalamin transport,BP,
5608,GO:0015891,1,0.985133124042761,0,3,siderophore transport,BP,
5610,GO:0015904,1,0.995601405461948,0,1,tetracycline transport,BP,
5611,GO:0015908,1,0.63460162253362,0,72,fatty acid transport,BP,
5612,GO:0015909,1,0.731245069962261,0,51,long-chain fatty acid transport,BP,
5613,GO:0015910,1,0.98698534043127,0,2,peroxisomal long-chain fatty acid import,BP,
5614,GO:0015911,1,0.963900580678356,0,5,plasma membrane long-chain fatty acid transport,BP,
5615,GO:0015912,1,0.994427086769477,0,1,short-chain fatty acid transport,BP,
5616,GO:0015913,1,0.994427086769477,0,1,short-chain fatty acid import,BP,
5618,GO:0015916,1,0.99354439408096,0,1,fatty-acyl-CoA transport,BP,
5619,GO:0015917,1,0.968793914756806,0,4,aminophospholipid transport,BP,
5620,GO:0015918,1,0.622253442114804,0,74,sterol transport,BP,
5622,GO:0015920,1,0.98919179695164,0,2,lipopolysaccharide transport,BP,
5623,GO:0015922,1,0.996116196177621,0,1,aspartate oxidase activity,MF,
5624,GO:0015923,1,0.901639548313658,0,14,mannosidase activity,MF,
5625,GO:0015924,1,0.935986852128048,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5626,GO:0015925,1,0.952639231604611,0,8,galactosidase activity,MF,
5627,GO:0015926,1,0.932021359315938,0,10,glucosidase activity,MF,
5628,GO:0015928,1,0.9899845089198,0,2,fucosidase activity,MF,
5629,GO:0015929,1,0.925052280671446,0,13,hexosaminidase activity,MF,
5631,GO:0015932,1,0.80562696286011,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5632,GO:0015934,1,0.651470322706771,0,113,large ribosomal subunit,CC,
5633,GO:0015935,1,0.770326897085333,0,69,small ribosomal subunit,CC,
5634,GO:0015936,1,0.917646421156101,0,15,coenzyme A metabolic process,BP,
5635,GO:0015937,1,0.948716748176397,0,10,coenzyme A biosynthetic process,BP,
5636,GO:0015938,1,0.996861800316227,0,1,coenzyme A catabolic process,BP,
5637,GO:0015939,1,0.953983617553554,0,8,pantothenate metabolic process,BP,
5638,GO:0015942,1,0.965692407618692,0,6,formate metabolic process,BP,
5639,GO:0015949,1,0.84598434964594,0,32,nucleobase-containing small molecule interconversion,BP,
5640,GO:0015950,1,0.991864217608117,0,2,purine nucleotide interconversion,BP,
5641,GO:0015951,1,0.991864217608117,0,2,purine ribonucleotide interconversion,BP,
5642,GO:0015959,1,0.959869426420853,0,7,diadenosine polyphosphate metabolic process,BP,
5643,GO:0015960,1,0.980907950682336,0,3,diadenosine polyphosphate biosynthetic process,BP,
5644,GO:0015961,1,0.978556250983495,0,4,diadenosine polyphosphate catabolic process,BP,
5645,GO:0015965,1,0.980907950682336,0,3,diadenosine tetraphosphate metabolic process,BP,
5646,GO:0015966,1,0.980907950682336,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5648,GO:0015985,1,0.951983041478354,0,9,energy coupled proton transport, down electrochemical gradient,BP,
5649,GO:0015986,1,0.951983041478354,0,9,ATP synthesis coupled proton transport,BP,
5650,GO:0015988,1,0.851656144735203,0,28,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5651,GO:0015990,1,0.996988667748439,0,1,electron transport coupled proton transport,BP,
5652,GO:0015991,1,0.854232756767153,0,27,ATP hydrolysis coupled proton transport,BP,
5653,GO:0016004,1,0.949310842345555,0,9,phospholipase activator activity,MF,
5654,GO:0016005,1,0.986060571300787,0,2,phospholipase A2 activator activity,MF,
5655,GO:0016010,1,0.877539900361379,0,20,dystrophin-associated glycoprotein complex,CC,
5656,GO:0016011,1,0.959267746744578,0,7,dystroglycan complex,CC,
5657,GO:0016012,1,0.966909001923931,0,6,sarcoglycan complex,CC,
5658,GO:0016013,1,0.977099750583763,0,4,syntrophin complex,CC,
5660,GO:0016018,1,0.946750944784057,0,10,cyclosporin A binding,MF,
5661,GO:0016019,1,0.993084432646092,0,2,peptidoglycan receptor activity,MF,
5664,GO:0016024,1,0.925730174535285,0,11,CDP-diacylglycerol biosynthetic process,BP,
5665,GO:0016028,1,0.992497123153588,0,1,rhabdomere,CC,
5666,GO:0016031,1,0.992588626619601,0,1,tRNA import into mitochondrion,BP,
5668,GO:0016034,1,0.996545095529736,0,1,maleylacetoacetate isomerase activity,MF,
5669,GO:0016035,1,0.986985985962935,0,2,zeta DNA polymerase complex,CC,
5670,GO:0016036,1,0.994539565949337,0,1,cellular response to phosphate starvation,BP,
5671,GO:0016037,1,0.993316960022668,0,1,light absorption,BP,
5672,GO:0016038,1,0.993316960022668,0,1,absorption of visible light,BP,
5675,GO:0016045,1,0.930547234179424,0,10,detection of bacterium,BP,
5676,GO:0016046,1,0.992116156280336,0,1,detection of fungus,BP,
5677,GO:0016048,1,0.8913650414632,0,18,detection of temperature stimulus,BP,
5679,GO:0016050,1,0.0867470877402747,0,371,vesicle organization,BP,
5685,GO:0016056,1,0.862561721561005,0,23,rhodopsin mediated signaling pathway,BP,
5686,GO:0016062,1,0.993764998892189,0,1,adaptation of rhodopsin mediated signaling,BP,
5687,GO:0016064,1,0.586274222745383,0,90,immunoglobulin mediated immune response,BP,
5688,GO:0016068,1,0.986874081729062,0,3,type I hypersensitivity,BP,
5690,GO:0016071,1,0.00988532665430119,0,774,mRNA metabolic process,BP,
5691,GO:0016072,1,0.235694407771531,0,279,rRNA metabolic process,BP,
5692,GO:0016073,1,0.619449543266305,0,84,snRNA metabolic process,BP,
5693,GO:0016074,1,0.951080043185282,0,12,snoRNA metabolic process,BP,
5694,GO:0016075,1,0.916639805907281,0,16,rRNA catabolic process,BP,
5695,GO:0016077,1,0.991997791072666,0,1,snoRNA catabolic process,BP,
5696,GO:0016078,1,0.973443983596232,0,6,tRNA catabolic process,BP,
5697,GO:0016079,1,0.554562640396043,0,86,synaptic vesicle exocytosis,BP,
5698,GO:0016080,1,0.969414333251919,0,4,synaptic vesicle targeting,BP,
5699,GO:0016081,1,0.936625836272115,0,9,synaptic vesicle docking,BP,
5700,GO:0016082,1,0.898958029901651,0,15,synaptic vesicle priming,BP,
5701,GO:0016093,1,0.960001760126394,0,8,polyprenol metabolic process,BP,
5702,GO:0016094,1,0.978675930290086,0,3,polyprenol biosynthetic process,BP,
5703,GO:0016095,1,0.986426756574856,0,3,polyprenol catabolic process,BP,
5704,GO:0016098,1,0.992210286423507,0,2,monoterpenoid metabolic process,BP,
5706,GO:0016102,1,0.949153563966005,0,9,diterpenoid biosynthetic process,BP,
5707,GO:0016103,1,0.984240766752279,0,3,diterpenoid catabolic process,BP,
5708,GO:0016107,1,0.992836597858055,0,2,sesquiterpenoid catabolic process,BP,
5709,GO:0016108,1,0.980222496191121,0,3,tetraterpenoid metabolic process,BP,
5710,GO:0016109,1,0.993643172738194,0,1,tetraterpenoid biosynthetic process,BP,
5711,GO:0016114,1,0.920928561707003,0,14,terpenoid biosynthetic process,BP,
5712,GO:0016115,1,0.977189088562514,0,5,terpenoid catabolic process,BP,
5713,GO:0016116,1,0.980222496191121,0,3,carotenoid metabolic process,BP,
5714,GO:0016117,1,0.993643172738194,0,1,carotenoid biosynthetic process,BP,
5715,GO:0016119,1,0.986494355593659,0,2,carotene metabolic process,BP,
5716,GO:0016121,1,0.993147797100392,0,1,carotene catabolic process,BP,
5717,GO:0016122,1,0.986834077515774,0,2,xanthophyll metabolic process,BP,
5718,GO:0016123,1,0.993643172738194,0,1,xanthophyll biosynthetic process,BP,
5719,GO:0016125,1,0.428428315124091,0,134,sterol metabolic process,BP,
5720,GO:0016126,1,0.652389266153188,0,68,sterol biosynthetic process,BP,
5721,GO:0016127,1,0.951264030838889,0,9,sterol catabolic process,BP,
5722,GO:0016128,1,0.983515281238437,0,3,phytosteroid metabolic process,BP,
5723,GO:0016129,1,0.983515281238437,0,3,phytosteroid biosynthetic process,BP,
5724,GO:0016131,1,0.993554549492272,0,1,brassinosteroid metabolic process,BP,
5725,GO:0016132,1,0.993554549492272,0,1,brassinosteroid biosynthetic process,BP,
5726,GO:0016137,1,0.921507072918209,0,17,glycoside metabolic process,BP,
5727,GO:0016139,1,0.955988525500631,0,8,glycoside catabolic process,BP,
5728,GO:0016149,1,0.992487400433381,0,1,translation release factor activity, codon specific,MF,
5729,GO:0016150,1,0.996116196177621,0,1,translation release factor activity, codon nonspecific,MF,
5730,GO:0016151,1,0.990535193706429,0,2,nickel cation binding,MF,
5731,GO:0016153,1,0.992595365123463,0,1,urocanate hydratase activity,MF,
5732,GO:0016154,1,0.996037623304787,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5733,GO:0016155,1,0.98431678062586,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5734,GO:0016160,1,0.982797958412058,0,3,amylase activity,MF,
5735,GO:0016165,1,0.98793514136284,0,2,linoleate 13S-lipoxygenase activity,MF,
5736,GO:0016167,1,0.983812752296866,0,2,glial cell-derived neurotrophic factor receptor activity,MF,
5737,GO:0016174,1,0.958713642185032,0,6,NAD(P)H oxidase activity,MF,
5738,GO:0016175,1,0.954862941369966,0,8,superoxide-generating NADPH oxidase activity,MF,
5739,GO:0016176,1,0.955259052751858,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5740,GO:0016180,1,0.873970081370533,0,23,snRNA processing,BP,
5741,GO:0016182,1,0.992336742575057,0,1,synaptic vesicle budding from endosome,BP,
5742,GO:0016185,1,0.976794856278203,0,3,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5743,GO:0016188,1,0.925888604644939,0,11,synaptic vesicle maturation,BP,
5744,GO:0016189,1,0.991307049909903,0,1,synaptic vesicle to endosome fusion,BP,
5745,GO:0016191,1,0.9640923743886,0,5,synaptic vesicle uncoating,BP,
5748,GO:0016198,1,0.957456583408687,0,6,axon choice point recognition,BP,
5749,GO:0016199,1,0.9688587281937,0,4,axon midline choice point recognition,BP,
5751,GO:0016206,1,0.987440731538708,0,2,catechol O-methyltransferase activity,MF,
5752,GO:0016208,1,0.945646808877339,0,10,AMP binding,MF,
5753,GO:0016209,1,0.705833511718282,0,71,antioxidant activity,MF,
5754,GO:0016211,1,0.984662673929916,0,2,ammonia ligase activity,MF,
5755,GO:0016212,1,0.988745648061107,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5756,GO:0016213,1,0.992754525211575,0,1,linoleoyl-CoA desaturase activity,MF,
5757,GO:0016215,1,0.978779675823263,0,3,acyl-CoA desaturase activity,MF,
5758,GO:0016222,1,0.986918709934154,0,2,procollagen-proline 4-dioxygenase complex,CC,
5759,GO:0016226,1,0.907364455028108,0,20,iron-sulfur cluster assembly,BP,
5760,GO:0016229,1,0.895875707233299,0,25,steroid dehydrogenase activity,MF,
5761,GO:0016230,1,0.989018744794076,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5762,GO:0016231,1,0.992262656016188,0,1,beta-N-acetylglucosaminidase activity,MF,
5763,GO:0016232,1,0.993222840332087,0,1,HNK-1 sulfotransferase activity,MF,
5764,GO:0016233,1,0.762961693758596,0,42,telomere capping,BP,
5765,GO:0016234,1,0.588144771201403,0,77,inclusion body,CC,
5766,GO:0016235,1,0.75491994316508,0,41,aggresome,CC,
5767,GO:0016236,1,0.17230160659563,0,279,macroautophagy,BP,
5768,GO:0016237,1,0.992302199609755,0,1,lysosomal microautophagy,BP,
5769,GO:0016239,1,0.671937956868644,0,58,positive regulation of macroautophagy,BP,
5770,GO:0016240,1,0.974684534915531,0,4,autophagosome membrane docking,BP,
5771,GO:0016241,1,0.366557896745659,0,156,regulation of macroautophagy,BP,
5772,GO:0016242,1,0.834234074352139,0,27,negative regulation of macroautophagy,BP,
5773,GO:0016243,1,0.992457480856118,0,1,regulation of autophagosome size,BP,
5774,GO:0016246,1,0.905820635662798,0,15,RNA interference,BP,
5775,GO:0016247,1,0.48007238932872,0,123,channel regulator activity,MF,
5776,GO:0016248,1,0.822970384237699,0,32,channel inhibitor activity,MF,
5777,GO:0016250,1,0.993312986370029,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5778,GO:0016254,1,0.917789191657141,0,16,preassembly of GPI anchor in ER membrane,BP,
5779,GO:0016255,1,0.958026134812815,0,7,attachment of GPI anchor to protein,BP,
5780,GO:0016256,1,0.98879528732198,0,2,N-glycan processing to lysosome,BP,
5781,GO:0016259,1,0.976079371905809,0,4,selenocysteine metabolic process,BP,
5782,GO:0016260,1,0.988274835385018,0,2,selenocysteine biosynthetic process,BP,
5783,GO:0016262,1,0.981164788150229,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5784,GO:0016263,1,0.99117548873675,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5786,GO:0016266,1,0.71027014709949,0,50,O-glycan processing,BP,
5787,GO:0016267,1,0.99117548873675,0,2,O-glycan processing, core 1,BP,
5788,GO:0016272,1,0.977073978641552,0,7,prefoldin complex,CC,
5789,GO:0016273,1,0.930774804885641,0,12,arginine N-methyltransferase activity,MF,
5790,GO:0016274,1,0.930774804885641,0,12,protein-arginine N-methyltransferase activity,MF,
5791,GO:0016277,1,0.994178112895726,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5792,GO:0016278,1,0.698623684942403,0,51,lysine N-methyltransferase activity,MF,
5793,GO:0016279,1,0.703352586447636,0,50,protein-lysine N-methyltransferase activity,MF,
5794,GO:0016281,1,0.944890740305923,0,9,eukaryotic translation initiation factor 4F complex,CC,
5795,GO:0016282,1,0.992401420323399,0,1,eukaryotic 43S preinitiation complex,CC,
5796,GO:0016286,1,0.97754593340661,0,4,small conductance calcium-activated potassium channel activity,MF,
5797,GO:0016287,1,0.993477841864314,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5798,GO:0016289,1,0.91903161462673,0,17,CoA hydrolase activity,MF,
5799,GO:0016290,1,0.95698751412328,0,9,palmitoyl-CoA hydrolase activity,MF,
5800,GO:0016295,1,0.987005565230565,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5801,GO:0016296,1,0.987005565230565,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5802,GO:0016297,1,0.987005565230565,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5804,GO:0016300,1,0.978654214025555,0,3,tRNA (uracil) methyltransferase activity,MF,
5806,GO:0016303,1,0.769821842561757,0,37,1-phosphatidylinositol-3-kinase activity,MF,
5807,GO:0016307,1,0.898236875440205,0,15,phosphatidylinositol phosphate kinase activity,MF,
5808,GO:0016308,1,0.960003558889247,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5809,GO:0016309,1,0.98530972472246,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5812,GO:0016312,1,0.972234327942527,0,4,inositol bisphosphate phosphatase activity,MF,
5813,GO:0016314,1,0.980273115567554,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5814,GO:0016316,1,0.984288924477132,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5815,GO:0016320,1,0.987906504004537,0,2,endoplasmic reticulum membrane fusion,BP,
5816,GO:0016321,1,0.975229783836168,0,4,female meiosis chromosome segregation,BP,
5817,GO:0016322,1,0.936096972635973,0,10,neuron remodeling,BP,
5820,GO:0016327,1,0.911344049844587,0,16,apicolateral plasma membrane,CC,
5823,GO:0016332,1,0.992463519372069,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5824,GO:0016333,1,0.993015480489423,0,1,morphogenesis of follicular epithelium,BP,
5825,GO:0016334,1,0.993015480489423,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5828,GO:0016340,1,0.983744037062411,0,2,calcium-dependent cell-matrix adhesion,BP,
5830,GO:0016344,1,0.977906119357329,0,3,meiotic chromosome movement towards spindle pole,BP,
5832,GO:0016361,1,0.972536232728568,0,4,activin receptor activity, type I,MF,
5833,GO:0016362,1,0.979568731418938,0,2,activin receptor activity, type II,MF,
5834,GO:0016363,1,0.50454553145941,0,103,nuclear matrix,CC,
5835,GO:0016401,1,0.975752591478092,0,4,palmitoyl-CoA oxidase activity,MF,
5836,GO:0016402,1,0.98760509398276,0,2,pristanoyl-CoA oxidase activity,MF,
5837,GO:0016403,1,0.989035919649693,0,2,dimethylargininase activity,MF,
5838,GO:0016404,1,0.985787842702439,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5839,GO:0016405,1,0.864718550733294,0,22,CoA-ligase activity,MF,
5840,GO:0016406,1,0.958649527131435,0,6,carnitine O-acyltransferase activity,MF,
5841,GO:0016407,1,0.549613950584915,0,94,acetyltransferase activity,MF,
5842,GO:0016408,1,0.910440609155299,0,17,C-acyltransferase activity,MF,
5843,GO:0016409,1,0.782145279670971,0,38,palmitoyltransferase activity,MF,
5844,GO:0016410,1,0.555001803883063,0,92,N-acyltransferase activity,MF,
5845,GO:0016411,1,0.868180660510451,0,21,acylglycerol O-acyltransferase activity,MF,
5846,GO:0016413,1,0.954200834828238,0,7,O-acetyltransferase activity,MF,
5847,GO:0016414,1,0.992672461604809,0,1,O-octanoyltransferase activity,MF,
5848,GO:0016415,1,0.989593940001173,0,2,octanoyltransferase activity,MF,
5849,GO:0016416,1,0.964866252691918,0,5,O-palmitoyltransferase activity,MF,
5850,GO:0016417,1,0.821648641709267,0,31,S-acyltransferase activity,MF,
5851,GO:0016418,1,0.98361786427107,0,2,S-acetyltransferase activity,MF,
5852,GO:0016419,1,0.986562307662375,0,2,S-malonyltransferase activity,MF,
5853,GO:0016420,1,0.986562307662375,0,2,malonyltransferase activity,MF,
5854,GO:0016421,1,0.967235710129492,0,5,CoA carboxylase activity,MF,
5855,GO:0016422,1,0.983721516315065,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5856,GO:0016423,1,0.925180574640846,0,13,tRNA (guanine) methyltransferase activity,MF,
5857,GO:0016426,1,0.981742724780837,0,3,tRNA (adenine) methyltransferase activity,MF,
5858,GO:0016427,1,0.951289380333521,0,8,tRNA (cytosine) methyltransferase activity,MF,
5859,GO:0016428,1,0.975193861241067,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5860,GO:0016429,1,0.981742724780837,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5861,GO:0016433,1,0.968359553386935,0,6,rRNA (adenine) methyltransferase activity,MF,
5862,GO:0016434,1,0.97929755961974,0,3,rRNA (cytosine) methyltransferase activity,MF,
5863,GO:0016435,1,0.981930379011735,0,3,rRNA (guanine) methyltransferase activity,MF,
5864,GO:0016436,1,0.985451822402603,0,2,rRNA (uridine) methyltransferase activity,MF,
5866,GO:0016442,1,0.922502193876763,0,11,RISC complex,CC,
5867,GO:0016444,1,0.710113295013042,0,51,somatic cell DNA recombination,BP,
5868,GO:0016445,1,0.729424738062995,0,48,somatic diversification of immunoglobulins,BP,
5869,GO:0016446,1,0.930673666101764,0,11,somatic hypermutation of immunoglobulin genes,BP,
5870,GO:0016447,1,0.754046931895107,0,43,somatic recombination of immunoglobulin gene segments,BP,
5871,GO:0016453,1,0.980313273404616,0,4,C-acetyltransferase activity,MF,
5872,GO:0016454,1,0.966670372519949,0,5,C-palmitoyltransferase activity,MF,
5875,GO:0016460,1,0.7588898071873,0,29,myosin II complex,CC,
5876,GO:0016461,1,0.931440145596806,0,10,unconventional myosin complex,CC,
5878,GO:0016469,1,0.867845473060357,0,28,proton-transporting two-sector ATPase complex,CC,
5879,GO:0016471,1,0.921215553408208,0,15,vacuolar proton-transporting V-type ATPase complex,CC,
5880,GO:0016476,1,0.979409217193844,0,3,regulation of embryonic cell shape,BP,
5882,GO:0016479,1,0.974066903860821,0,4,negative regulation of transcription by RNA polymerase I,BP,
5883,GO:0016480,1,0.986290619950201,0,3,negative regulation of transcription by RNA polymerase III,BP,
5887,GO:0016487,1,0.992836597858055,0,2,farnesol metabolic process,BP,
5888,GO:0016488,1,0.992836597858055,0,2,farnesol catabolic process,BP,
5890,GO:0016492,1,0.988616675395554,0,2,G-protein coupled neurotensin receptor activity,MF,
5891,GO:0016493,1,0.945526172270463,0,10,C-C chemokine receptor activity,MF,
5892,GO:0016494,1,0.957222201084665,0,8,C-X-C chemokine receptor activity,MF,
5893,GO:0016495,1,0.992732217875346,0,1,C-X3-C chemokine receptor activity,MF,
5894,GO:0016496,1,0.992670948698381,0,1,substance P receptor activity,MF,
5895,GO:0016497,1,0.994146454842301,0,1,substance K receptor activity,MF,
5896,GO:0016499,1,0.990981165460398,0,2,orexin receptor activity,MF,
5897,GO:0016500,1,0.933915218190323,0,10,protein-hormone receptor activity,MF,
5898,GO:0016501,1,0.988097400475969,0,2,prostacyclin receptor activity,MF,
5899,GO:0016502,1,0.900165288446963,0,20,nucleotide receptor activity,MF,
5900,GO:0016503,1,0.996580496560791,0,1,pheromone receptor activity,MF,
5903,GO:0016507,1,0.992867372002513,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5904,GO:0016508,1,0.978954092992085,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5905,GO:0016509,1,0.981537941993206,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5906,GO:0016514,1,0.908163948810391,0,15,SWI/SNF complex,CC,
5907,GO:0016517,1,0.995296707577174,0,1,interleukin-12 receptor activity,MF,
5908,GO:0016519,1,0.995176083189871,0,1,gastric inhibitory peptide receptor activity,MF,
5909,GO:0016520,1,0.98891270949416,0,2,growth hormone-releasing hormone receptor activity,MF,
5910,GO:0016521,1,0.992740900067808,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5912,GO:0016528,1,0.623018141388725,0,68,sarcoplasm,CC,
5913,GO:0016529,1,0.664840557883187,0,59,sarcoplasmic reticulum,CC,
5915,GO:0016531,1,0.979204751786417,0,5,copper chaperone activity,MF,
5916,GO:0016532,1,0.984947402517649,0,3,superoxide dismutase copper chaperone activity,MF,
5917,GO:0016533,1,0.983298039879606,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5918,GO:0016534,1,0.986505822177347,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5919,GO:0016538,1,0.857360774697769,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5920,GO:0016539,1,0.996195995110822,0,1,intein-mediated protein splicing,BP,
5922,GO:0016553,1,0.921266344064086,0,14,base conversion or substitution editing,BP,
5923,GO:0016554,1,0.955737793495597,0,9,cytidine to uridine editing,BP,
5924,GO:0016556,1,0.91820243622951,0,15,mRNA modification,BP,
5925,GO:0016557,1,0.985748264939729,0,3,peroxisome membrane biogenesis,BP,
5927,GO:0016559,1,0.956848282023149,0,9,peroxisome fission,BP,
5929,GO:0016561,1,0.98801214356804,0,2,protein import into peroxisome matrix, translocation,BP,
5930,GO:0016567,1,0.00662697872131986,0,763,protein ubiquitination,BP,
5933,GO:0016571,1,0.42800956253732,0,122,histone methylation,BP,
5934,GO:0016572,1,0.807401130999322,0,34,histone phosphorylation,BP,
5935,GO:0016573,1,0.403784359932424,0,137,histone acetylation,BP,
5936,GO:0016574,1,0.744426842702229,0,43,histone ubiquitination,BP,
5937,GO:0016575,1,0.574093722943786,0,83,histone deacetylation,BP,
5939,GO:0016577,1,0.810320067765178,0,27,histone demethylation,BP,
5940,GO:0016578,1,0.859989066583931,0,22,histone deubiquitination,BP,
5941,GO:0016579,1,0.202934306450385,0,249,protein deubiquitination,BP,
5942,GO:0016580,1,0.920578913487503,0,12,Sin3 complex,CC,
5943,GO:0016581,1,0.88225496816504,0,17,NuRD complex,CC,
5944,GO:0016584,1,0.963651819211623,0,7,nucleosome positioning,BP,
5945,GO:0016586,1,0.983946546469944,0,2,RSC-type complex,CC,
5946,GO:0016589,1,0.952501115165587,0,7,NURF complex,CC,
5947,GO:0016590,1,0.992010447632828,0,1,ACF complex,CC,
5948,GO:0016591,1,0.523567173117793,0,107,DNA-directed RNA polymerase II, holoenzyme,CC,
5949,GO:0016592,1,0.803646412074499,0,36,mediator complex,CC,
5950,GO:0016593,1,0.948520831771674,0,8,Cdc73/Paf1 complex,CC,
5951,GO:0016594,1,0.909352888929455,0,15,glycine binding,MF,
5952,GO:0016595,1,0.929881477599726,0,10,glutamate binding,MF,
5953,GO:0016596,1,0.993301131169352,0,1,thienylcyclohexylpiperidine binding,MF,
5954,GO:0016597,1,0.69849840531492,0,58,amino acid binding,MF,
5955,GO:0016598,1,0.990381111381679,0,2,protein arginylation,BP,
5956,GO:0016600,1,0.934791797747254,0,9,flotillin complex,CC,
5957,GO:0016601,1,0.780148327253809,0,37,Rac protein signal transduction,BP,
5958,GO:0016602,1,0.976493555972396,0,4,CCAAT-binding factor complex,CC,
5959,GO:0016603,1,0.990801222289905,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5961,GO:0016605,1,0.531568144064161,0,94,PML body,CC,
5963,GO:0016608,1,0.994108885315413,0,2,growth hormone-releasing hormone activity,MF,
5965,GO:0016615,1,0.962952423477209,0,7,malate dehydrogenase activity,MF,
5967,GO:0016618,1,0.983519415531196,0,3,hydroxypyruvate reductase activity,MF,
5968,GO:0016620,1,0.818473122903483,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5969,GO:0016623,1,0.988197061655172,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5970,GO:0016624,1,0.952966174194373,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5971,GO:0016627,1,0.738889196451327,0,54,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5972,GO:0016628,1,0.883598123658796,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5973,GO:0016634,1,0.952902979209591,0,8,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5974,GO:0016635,1,0.976182303506669,0,5,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5975,GO:0016638,1,0.877802256743175,0,21,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5976,GO:0016639,1,0.983507536438062,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5977,GO:0016641,1,0.902113717097149,0,16,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5978,GO:0016642,1,0.992470124072084,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5979,GO:0016645,1,0.866409791380123,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5980,GO:0016646,1,0.908924704524611,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5981,GO:0016647,1,0.985256830087603,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5982,GO:0016649,1,0.987031093806899,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5983,GO:0016651,1,0.633657988997078,0,98,oxidoreductase activity, acting on NAD(P)H,MF,
5984,GO:0016652,1,0.989198949778549,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5985,GO:0016653,1,0.918411179034284,0,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
5986,GO:0016655,1,0.825151886406536,0,52,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5987,GO:0016657,1,0.991864217608117,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5988,GO:0016661,1,0.969832422220608,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5989,GO:0016662,1,0.993678504419862,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5990,GO:0016667,1,0.757578105405916,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5991,GO:0016668,1,0.934140406779956,0,13,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5992,GO:0016670,1,0.94935661034035,0,8,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5993,GO:0016671,1,0.948613211843707,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5994,GO:0016672,1,0.993327681997086,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5995,GO:0016675,1,0.921218410598847,0,23,oxidoreductase activity, acting on a heme group of donors,MF,
5996,GO:0016676,1,0.926870888205205,0,22,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5997,GO:0016679,1,0.966068259037784,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5998,GO:0016681,1,0.97223210766193,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5999,GO:0016684,1,0.813279106447521,0,42,oxidoreductase activity, acting on peroxide as acceptor,MF,
6000,GO:0016701,1,0.872164456104187,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
6001,GO:0016702,1,0.872164456104187,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
6002,GO:0016705,1,0.44296763057249,0,130,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,
6003,GO:0016706,1,0.756839022361524,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
6004,GO:0016708,1,0.989323696694354,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6005,GO:0016709,1,0.804186006320005,0,36,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6006,GO:0016711,1,0.993661962459947,0,1,flavonoid 3'-monooxygenase activity,MF,
6007,GO:0016712,1,0.903734993477645,0,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6008,GO:0016713,1,0.991247458133319,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6009,GO:0016714,1,0.963939577613372,0,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6010,GO:0016715,1,0.97143378038605,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6011,GO:0016717,1,0.964843065574969,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6012,GO:0016721,1,0.980971953999442,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6013,GO:0016722,1,0.895964655853999,0,16,oxidoreductase activity, oxidizing metal ions,MF,
6014,GO:0016723,1,0.933263991678707,0,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6015,GO:0016724,1,0.965556383336062,0,5,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6016,GO:0016725,1,0.952843157269648,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
6017,GO:0016726,1,0.984451325457926,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6018,GO:0016727,1,0.992085240994721,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6019,GO:0016728,1,0.977794937981061,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6020,GO:0016730,1,0.995518397400478,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6021,GO:0016731,1,0.995518397400478,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6024,GO:0016742,1,0.950429581791894,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6025,GO:0016743,1,0.979894257160738,0,3,carboxyl- or carbamoyltransferase activity,MF,
6026,GO:0016744,1,0.985282307160912,0,3,transferase activity, transferring aldehyde or ketonic groups,MF,
6027,GO:0016746,1,0.24990607674477,0,220,transferase activity, transferring acyl groups,MF,
6028,GO:0016747,1,0.294914477698146,0,193,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6029,GO:0016748,1,0.982796460656736,0,3,succinyltransferase activity,MF,
6030,GO:0016749,1,0.989567629566123,0,2,N-succinyltransferase activity,MF,
6031,GO:0016751,1,0.993158192156007,0,1,S-succinyltransferase activity,MF,
6032,GO:0016755,1,0.929409534096436,0,12,transferase activity, transferring amino-acyl groups,MF,
6035,GO:0016763,1,0.76593778047356,0,44,transferase activity, transferring pentosyl groups,MF,
6036,GO:0016765,1,0.768924967653017,0,54,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,
6037,GO:0016768,1,0.995975040856157,0,1,spermine synthase activity,MF,
6038,GO:0016769,1,0.892700459578384,0,19,transferase activity, transferring nitrogenous groups,MF,
6041,GO:0016774,1,0.98184379196438,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6042,GO:0016775,1,0.929331474039453,0,12,phosphotransferase activity, nitrogenous group as acceptor,MF,
6043,GO:0016776,1,0.777958902526833,0,41,phosphotransferase activity, phosphate group as acceptor,MF,
6044,GO:0016778,1,0.9730716296435,0,5,diphosphotransferase activity,MF,
6045,GO:0016779,1,0.450069553662709,0,132,nucleotidyltransferase activity,MF,
6046,GO:0016780,1,0.897346993721938,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6047,GO:0016781,1,0.988274835385018,0,2,phosphotransferase activity, paired acceptors,MF,
6048,GO:0016782,1,0.685236918331488,0,66,transferase activity, transferring sulfur-containing groups,MF,
6049,GO:0016783,1,0.949102588177465,0,12,sulfurtransferase activity,MF,
6050,GO:0016784,1,0.996356943742403,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6051,GO:0016785,1,0.9921152450986,0,1,transferase activity, transferring selenium-containing groups,MF,
6054,GO:0016790,1,0.844861089618338,0,32,thiolester hydrolase activity,MF,
6056,GO:0016793,1,0.992714561063159,0,1,triphosphoric monoester hydrolase activity,MF,
6057,GO:0016794,1,0.996838979329863,0,1,diphosphoric monoester hydrolase activity,MF,
6058,GO:0016796,1,0.729603091989114,0,50,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6059,GO:0016798,1,0.549145175565761,0,101,hydrolase activity, acting on glycosyl bonds,MF,
6060,GO:0016799,1,0.897412809064942,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6061,GO:0016801,1,0.923427914732295,0,14,hydrolase activity, acting on ether bonds,MF,
6062,GO:0016802,1,0.97935567774736,0,3,trialkylsulfonium hydrolase activity,MF,
6063,GO:0016803,1,0.942905360271307,0,11,ether hydrolase activity,MF,
6065,GO:0016807,1,0.993301131169352,0,1,cysteine-type carboxypeptidase activity,MF,
6066,GO:0016810,1,0.438781851065471,0,137,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
6067,GO:0016811,1,0.605440402369459,0,84,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6068,GO:0016812,1,0.951901880681931,0,7,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6069,GO:0016813,1,0.945334395894316,0,10,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6070,GO:0016814,1,0.837535779097762,0,30,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6071,GO:0016815,1,0.99651203050754,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6074,GO:0016822,1,0.988765828548623,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6075,GO:0016823,1,0.988765828548623,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6076,GO:0016826,1,0.993312986370029,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6077,GO:0016829,1,0.405637458175784,0,160,lyase activity,MF,
6078,GO:0016830,1,0.761551064042175,0,47,carbon-carbon lyase activity,MF,
6079,GO:0016831,1,0.827087602451339,0,32,carboxy-lyase activity,MF,
6080,GO:0016832,1,0.957162315876277,0,8,aldehyde-lyase activity,MF,
6081,GO:0016833,1,0.964918788266689,0,6,oxo-acid-lyase activity,MF,
6082,GO:0016835,1,0.700897561245485,0,66,carbon-oxygen lyase activity,MF,
6083,GO:0016836,1,0.773353739216555,0,48,hydro-lyase activity,MF,
6084,GO:0016838,1,0.985242015114763,0,3,carbon-oxygen lyase activity, acting on phosphates,MF,
6085,GO:0016840,1,0.937124748646317,0,13,carbon-nitrogen lyase activity,MF,
6086,GO:0016841,1,0.975099672104261,0,5,ammonia-lyase activity,MF,
6087,GO:0016842,1,0.967549091202896,0,7,amidine-lyase activity,MF,
6088,GO:0016843,1,0.993301131169352,0,1,amine-lyase activity,MF,
6089,GO:0016844,1,0.993301131169352,0,1,strictosidine synthase activity,MF,
6090,GO:0016846,1,0.96480849133896,0,9,carbon-sulfur lyase activity,MF,
6091,GO:0016849,1,0.888036525693513,0,16,phosphorus-oxygen lyase activity,MF,
6092,GO:0016853,1,0.48260060766766,0,132,isomerase activity,MF,
6093,GO:0016854,1,0.917411527524979,0,16,racemase and epimerase activity,MF,
6094,GO:0016855,1,0.993980113814259,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6095,GO:0016857,1,0.937116896508839,0,11,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6096,GO:0016859,1,0.843772870881488,0,33,cis-trans isomerase activity,MF,
6097,GO:0016860,1,0.793485971330371,0,43,intramolecular oxidoreductase activity,MF,
6098,GO:0016861,1,0.963006548133323,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6099,GO:0016862,1,0.994111838002731,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6100,GO:0016863,1,0.953631080322236,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6101,GO:0016864,1,0.895469064925936,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6102,GO:0016866,1,0.861459803691276,0,27,intramolecular transferase activity,MF,
6103,GO:0016868,1,0.942492675812028,0,11,intramolecular transferase activity, phosphotransferases,MF,
6104,GO:0016872,1,0.994557222865409,0,1,intramolecular lyase activity,MF,
6106,GO:0016875,1,0.763170060427434,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6107,GO:0016877,1,0.791938362656735,0,36,ligase activity, forming carbon-sulfur bonds,MF,
6108,GO:0016878,1,0.845826809763273,0,26,acid-thiol ligase activity,MF,
6110,GO:0016880,1,0.978065490178639,0,3,acid-ammonia (or amide) ligase activity,MF,
6112,GO:0016882,1,0.989523330276163,0,2,cyclo-ligase activity,MF,
6113,GO:0016884,1,0.937036821942919,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6114,GO:0016885,1,0.955033039176988,0,7,ligase activity, forming carbon-carbon bonds,MF,
6115,GO:0016886,1,0.938283305665506,0,10,ligase activity, forming phosphoric ester bonds,MF,
6117,GO:0016888,1,0.934568320640138,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6118,GO:0016889,1,0.902604326867159,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6119,GO:0016890,1,0.988770681602334,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6120,GO:0016891,1,0.858766826859681,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6121,GO:0016892,1,0.967510327294264,0,8,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6122,GO:0016893,1,0.820193003880755,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6123,GO:0016894,1,0.873248130870878,0,28,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6124,GO:0016895,1,0.891403145609496,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6125,GO:0016896,1,0.816141243839678,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6126,GO:0016898,1,0.988899097315319,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6127,GO:0016899,1,0.9804346984275,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6128,GO:0016900,1,0.993674038969299,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6130,GO:0016903,1,0.776321279405926,0,41,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6131,GO:0016907,1,0.962767755920791,0,6,G-protein coupled acetylcholine receptor activity,MF,
6132,GO:0016909,1,0.981431350797352,0,3,SAP kinase activity,MF,
6133,GO:0016917,1,0.871825301310067,0,20,GABA receptor activity,MF,
6134,GO:0016918,1,0.940236867049005,0,13,retinal binding,MF,
6135,GO:0016920,1,0.99164682249027,0,1,pyroglutamyl-peptidase activity,MF,
6136,GO:0016922,1,0.861737515232981,0,21,ligand-dependent nuclear receptor binding,MF,
6138,GO:0016926,1,0.95219097650963,0,7,protein desumoylation,BP,
6139,GO:0016929,1,0.956008591927025,0,6,SUMO-specific protease activity,MF,
6140,GO:0016933,1,0.969921347677505,0,5,extracellularly glycine-gated ion channel activity,MF,
6141,GO:0016934,1,0.969921347677505,0,5,extracellularly glycine-gated chloride channel activity,MF,
6142,GO:0016935,1,0.985428062871969,0,2,glycine-gated chloride channel complex,CC,
6143,GO:0016936,1,0.984109392204241,0,4,galactoside binding,MF,
6144,GO:0016938,1,0.992997832369012,0,1,kinesin I complex,CC,
6145,GO:0016939,1,0.976990359927648,0,3,kinesin II complex,CC,
6146,GO:0016941,1,0.97872859963624,0,3,natriuretic peptide receptor activity,MF,
6147,GO:0016942,1,0.969469562858078,0,5,insulin-like growth factor binding protein complex,CC,
6148,GO:0016964,1,0.988055294731122,0,1,alpha-2 macroglobulin receptor activity,MF,
6149,GO:0016971,1,0.979700994779665,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6150,GO:0016972,1,0.972207123103373,0,4,thiol oxidase activity,MF,
6151,GO:0016973,1,0.928524354357398,0,12,poly(A)+ mRNA export from nucleus,BP,
6152,GO:0016979,1,0.99644621984912,0,1,lipoate-protein ligase activity,MF,
6153,GO:0016990,1,0.994521917273774,0,1,arginine deiminase activity,MF,
6154,GO:0016992,1,0.996009560096059,0,1,lipoate synthase activity,MF,
6155,GO:0016997,1,0.971587534320376,0,5,alpha-sialidase activity,MF,
6156,GO:0016998,1,0.982910320076518,0,4,cell wall macromolecule catabolic process,BP,
6158,GO:0017000,1,0.906600303620562,0,15,antibiotic biosynthetic process,BP,
6159,GO:0017001,1,0.813452465098729,0,43,antibiotic catabolic process,BP,
6160,GO:0017002,1,0.945256045564365,0,7,activin-activated receptor activity,MF,
6161,GO:0017003,1,0.994489361464139,0,1,protein-heme linkage,BP,
6162,GO:0017004,1,0.824809165506552,0,34,cytochrome complex assembly,BP,
6163,GO:0017005,1,0.992496073151331,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6164,GO:0017006,1,0.994489361464139,0,1,protein-tetrapyrrole linkage,BP,
6165,GO:0017014,1,0.918029682404541,0,13,protein nitrosylation,BP,
6166,GO:0017015,1,0.515774736978684,0,98,regulation of transforming growth factor beta receptor signaling pathway,BP,
6168,GO:0017017,1,0.934327771373808,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6169,GO:0017018,1,0.968681903159793,0,4,myosin phosphatase activity,MF,
6170,GO:0017020,1,0.993131557145256,0,1,myosin phosphatase regulator activity,MF,
6172,GO:0017024,1,0.996936106673741,0,1,myosin I binding,MF,
6173,GO:0017025,1,0.870345128673592,0,25,TBP-class protein binding,MF,
6176,GO:0017040,1,0.970977771952781,0,5,N-acylsphingosine amidohydrolase activity,MF,
6177,GO:0017042,1,0.995991896528435,0,1,glycosylceramidase activity,MF,
6178,GO:0017045,1,0.99661892436362,0,1,corticotropin-releasing hormone activity,MF,
6179,GO:0017046,1,0.79984394473396,0,36,peptide hormone binding,MF,
6182,GO:0017050,1,0.988609706164564,0,2,D-erythro-sphingosine kinase activity,MF,
6183,GO:0017053,1,0.561013121593141,0,82,transcriptional repressor complex,CC,
6184,GO:0017055,1,0.986745981069197,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6185,GO:0017056,1,0.852395658182159,0,23,structural constituent of nuclear pore,MF,
6186,GO:0017057,1,0.987758936650308,0,2,6-phosphogluconolactonase activity,MF,
6187,GO:0017059,1,0.953633288853997,0,8,serine C-palmitoyltransferase complex,CC,
6188,GO:0017060,1,0.982936081305015,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6189,GO:0017061,1,0.992315075699434,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6190,GO:0017062,1,0.948235941460293,0,9,respiratory chain complex III assembly,BP,
6191,GO:0017064,1,0.990229364657098,0,2,fatty acid amide hydrolase activity,MF,
6192,GO:0017065,1,0.996204586818636,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6193,GO:0017069,1,0.811498352115024,0,38,snRNA binding,MF,
6194,GO:0017070,1,0.940557281801808,0,11,U6 snRNA binding,MF,
6195,GO:0017071,1,0.992493740903951,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6196,GO:0017075,1,0.855399688822476,0,22,syntaxin-1 binding,MF,
6198,GO:0017077,1,0.990454184765076,0,2,oxidative phosphorylation uncoupler activity,MF,
6199,GO:0017080,1,0.823217232024794,0,33,sodium channel regulator activity,MF,
6200,GO:0017081,1,0.908719006822628,0,16,chloride channel regulator activity,MF,
6201,GO:0017082,1,0.993301131169352,0,1,mineralocorticoid receptor activity,MF,
6202,GO:0017084,1,0.992547456931827,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6203,GO:0017085,1,0.908267836147593,0,16,response to insecticide,BP,
6204,GO:0017087,1,0.992462511997229,0,1,mitochondrial processing peptidase complex,CC,
6205,GO:0017089,1,0.989643275476071,0,2,glycolipid transporter activity,MF,
6206,GO:0017090,1,0.993019206969008,0,1,meprin A complex,CC,
6207,GO:0017091,1,0.860685282356945,0,24,AU-rich element binding,MF,
6208,GO:0017095,1,0.976437871752131,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6209,GO:0017098,1,0.988098821015586,0,2,sulfonylurea receptor binding,MF,
6210,GO:0017099,1,0.977683242379882,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6211,GO:0017101,1,0.930925428072443,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
6212,GO:0017102,1,0.986551493548226,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6213,GO:0017108,1,0.967355448304931,0,5,5'-flap endonuclease activity,MF,
6214,GO:0017109,1,0.985373189026314,0,2,glutamate-cysteine ligase complex,CC,
6215,GO:0017110,1,0.922336097450712,0,13,nucleoside-diphosphatase activity,MF,
6217,GO:0017112,1,0.707009476275647,0,51,Rab guanyl-nucleotide exchange factor activity,MF,
6218,GO:0017113,1,0.992784179551637,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6219,GO:0017116,1,0.978658556375029,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6220,GO:0017119,1,0.918780847269125,0,13,Golgi transport complex,CC,
6221,GO:0017121,1,0.936424289189841,0,10,phospholipid scrambling,BP,
6223,GO:0017125,1,0.992353428026084,0,1,deoxycytidyl transferase activity,MF,
6224,GO:0017126,1,0.992207892822676,0,1,nucleologenesis,BP,
6225,GO:0017127,1,0.914990360744599,0,15,cholesterol transporter activity,MF,
6226,GO:0017128,1,0.948138511315686,0,8,phospholipid scramblase activity,MF,
6227,GO:0017129,1,0.988412783793868,0,2,triglyceride binding,MF,
6228,GO:0017130,1,0.991735313977066,0,1,poly(C) RNA binding,MF,
6229,GO:0017133,1,0.994311284947471,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6230,GO:0017134,1,0.869501694710791,0,21,fibroblast growth factor binding,MF,
6231,GO:0017136,1,0.902540534321874,0,16,NAD-dependent histone deacetylase activity,MF,
6233,GO:0017143,1,0.987223473073328,0,2,insecticide metabolic process,BP,
6236,GO:0017146,1,0.914057636480518,0,11,NMDA selective glutamate receptor complex,CC,
6239,GO:0017150,1,0.979478429245826,0,4,tRNA dihydrouridine synthase activity,MF,
6240,GO:0017151,1,0.947515345340839,0,8,DEAD/H-box RNA helicase binding,MF,
6241,GO:0017153,1,0.939168218483995,0,9,sodium:dicarboxylate symporter activity,MF,
6242,GO:0017154,1,0.914059334667212,0,11,semaphorin receptor activity,MF,
6243,GO:0017156,1,0.471114495488709,0,110,calcium ion regulated exocytosis,BP,
6245,GO:0017158,1,0.609002779541106,0,73,regulation of calcium ion-dependent exocytosis,BP,
6246,GO:0017159,1,0.983756198143876,0,3,pantetheine hydrolase activity,MF,
6247,GO:0017160,1,0.895803329712604,0,16,Ral GTPase binding,MF,
6248,GO:0017161,1,0.984288924477132,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6249,GO:0017162,1,0.941156713995738,0,9,aryl hydrocarbon receptor binding,MF,
6250,GO:0017166,1,0.923049174513811,0,10,vinculin binding,MF,
6251,GO:0017168,1,0.992455646340497,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6252,GO:0017169,1,0.964937177262845,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6254,GO:0017172,1,0.996128904388862,0,1,cysteine dioxygenase activity,MF,
6255,GO:0017174,1,0.996818767802164,0,1,glycine N-methyltransferase activity,MF,
6256,GO:0017176,1,0.969077063463146,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6257,GO:0017177,1,0.99246386324672,0,1,glucosidase II complex,CC,
6258,GO:0017178,1,0.993301131169352,0,1,diphthine-ammonia ligase activity,MF,
6259,GO:0017182,1,0.951132887992789,0,8,peptidyl-diphthamide metabolic process,BP,
6260,GO:0017183,1,0.951132887992789,0,8,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6261,GO:0017185,1,0.945591467339846,0,8,peptidyl-lysine hydroxylation,BP,
6262,GO:0017186,1,0.990801222289905,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6263,GO:0017187,1,0.961486797019297,0,8,peptidyl-glutamic acid carboxylation,BP,
6264,GO:0017188,1,0.992047983140497,0,1,aspartate N-acetyltransferase activity,MF,
6265,GO:0017196,1,0.962969761109141,0,6,N-terminal peptidyl-methionine acetylation,BP,
6266,GO:0017198,1,0.99325102644693,0,2,N-terminal peptidyl-serine acetylation,BP,
6267,GO:0018002,1,0.99325102644693,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6268,GO:0018008,1,0.984674949137127,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6269,GO:0018009,1,0.994901849628123,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6270,GO:0018011,1,0.993301131169352,0,1,N-terminal peptidyl-alanine methylation,BP,
6271,GO:0018012,1,0.993301131169352,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6272,GO:0018013,1,0.993301131169352,0,1,N-terminal peptidyl-glycine methylation,BP,
6273,GO:0018016,1,0.993301131169352,0,1,N-terminal peptidyl-proline dimethylation,BP,
6274,GO:0018022,1,0.481364434695862,0,104,peptidyl-lysine methylation,BP,
6275,GO:0018023,1,0.790680715455296,0,35,peptidyl-lysine trimethylation,BP,
6276,GO:0018024,1,0.747031523222421,0,41,histone-lysine N-methyltransferase activity,MF,
6277,GO:0018025,1,0.993301131169352,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6278,GO:0018026,1,0.94868438643129,0,8,peptidyl-lysine monomethylation,BP,
6279,GO:0018027,1,0.905888224338339,0,15,peptidyl-lysine dimethylation,BP,
6280,GO:0018032,1,0.992481381771526,0,1,protein amidation,BP,
6281,GO:0018057,1,0.971353310272388,0,4,peptidyl-lysine oxidation,BP,
6282,GO:0018063,1,0.994489361464139,0,1,cytochrome c-heme linkage,BP,
6283,GO:0018065,1,0.957135686716191,0,12,protein-cofactor linkage,BP,
6284,GO:0018076,1,0.96654315597664,0,4,N-terminal peptidyl-lysine acetylation,BP,
6285,GO:0018094,1,0.987362853924657,0,2,protein polyglycylation,BP,
6286,GO:0018095,1,0.940843692107477,0,9,protein polyglutamylation,BP,
6287,GO:0018101,1,0.972412065440938,0,4,protein citrullination,BP,
6288,GO:0018103,1,0.966235966303529,0,5,protein C-linked glycosylation,BP,
6290,GO:0018106,1,0.997012104071378,0,1,peptidyl-histidine phosphorylation,BP,
6293,GO:0018114,1,0.993980113814259,0,1,threonine racemase activity,MF,
6294,GO:0018117,1,0.996060482200124,0,1,protein adenylylation,BP,
6295,GO:0018119,1,0.918029682404541,0,13,peptidyl-cysteine S-nitrosylation,BP,
6296,GO:0018125,1,0.984462918423216,0,3,peptidyl-cysteine methylation,BP,
6297,GO:0018126,1,0.861612156825804,0,22,protein hydroxylation,BP,
6299,GO:0018146,1,0.844580098038338,0,26,keratan sulfate biosynthetic process,BP,
6301,GO:0018153,1,0.988021017492844,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6302,GO:0018158,1,0.935159713027145,0,12,protein oxidation,BP,
6303,GO:0018160,1,0.996365237812487,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6304,GO:0018166,1,0.992255298382966,0,1,C-terminal protein-tyrosinylation,BP,
6305,GO:0018171,1,0.981885380685885,0,4,peptidyl-cysteine oxidation,BP,
6306,GO:0018175,1,0.996060482200124,0,1,protein nucleotidylation,BP,
6307,GO:0018192,1,0.99404713979306,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6309,GO:0018194,1,0.993301131169352,0,1,peptidyl-alanine modification,BP,
6310,GO:0018195,1,0.876359459203606,0,22,peptidyl-arginine modification,BP,
6311,GO:0018196,1,0.779731004281407,0,43,peptidyl-asparagine modification,BP,
6312,GO:0018197,1,0.976840709927512,0,3,peptidyl-aspartic acid modification,BP,
6313,GO:0018198,1,0.762776330955775,0,45,peptidyl-cysteine modification,BP,
6314,GO:0018199,1,0.978931294688739,0,4,peptidyl-glutamine modification,BP,
6316,GO:0018201,1,0.978077683993702,0,3,peptidyl-glycine modification,BP,
6317,GO:0018202,1,0.940419556150499,0,10,peptidyl-histidine modification,BP,
6319,GO:0018206,1,0.937053185092871,0,11,peptidyl-methionine modification,BP,
6320,GO:0018208,1,0.77825451263048,0,45,peptidyl-proline modification,BP,
6323,GO:0018211,1,0.966235966303529,0,5,peptidyl-tryptophan modification,BP,
6325,GO:0018214,1,0.961486797019297,0,8,protein carboxylation,BP,
6326,GO:0018216,1,0.91282757341931,0,15,peptidyl-arginine methylation,BP,
6327,GO:0018217,1,0.992457480856118,0,1,peptidyl-aspartic acid phosphorylation,BP,
6328,GO:0018230,1,0.872529718694148,0,22,peptidyl-L-cysteine S-palmitoylation,BP,
6329,GO:0018231,1,0.872529718694148,0,22,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6330,GO:0018242,1,0.871961980477731,0,20,protein O-linked glycosylation via serine,BP,
6331,GO:0018243,1,0.877850541185268,0,19,protein O-linked glycosylation via threonine,BP,
6332,GO:0018262,1,0.988021017492844,0,2,isopeptide cross-linking,BP,
6333,GO:0018271,1,0.992001434575794,0,1,biotin-protein ligase activity,MF,
6334,GO:0018272,1,0.995869264340929,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6335,GO:0018277,1,0.994287180162626,0,1,protein deamination,BP,
6336,GO:0018279,1,0.786269026830632,0,42,protein N-linked glycosylation via asparagine,BP,
6337,GO:0018282,1,0.985909756812835,0,2,metal incorporation into metallo-sulfur cluster,BP,
6338,GO:0018283,1,0.985909756812835,0,2,iron incorporation into metallo-sulfur cluster,BP,
6339,GO:0018293,1,0.996694115440517,0,1,protein-FAD linkage,BP,
6340,GO:0018298,1,0.956475812860575,0,8,protein-chromophore linkage,BP,
6341,GO:0018307,1,0.990978661936179,0,2,enzyme active site formation,BP,
6342,GO:0018312,1,0.988058732611132,0,2,peptidyl-serine ADP-ribosylation,BP,
6343,GO:0018315,1,0.992433704947594,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6344,GO:0018317,1,0.966235966303529,0,5,protein C-linked glycosylation via tryptophan,BP,
6345,GO:0018322,1,0.992255298382966,0,1,protein tyrosinylation,BP,
6346,GO:0018323,1,0.99691333883606,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6347,GO:0018335,1,0.971194972803642,0,4,protein succinylation,BP,
6348,GO:0018342,1,0.944028477339278,0,9,protein prenylation,BP,
6349,GO:0018343,1,0.989377311108967,0,2,protein farnesylation,BP,
6350,GO:0018344,1,0.959617360695262,0,7,protein geranylgeranylation,BP,
6351,GO:0018345,1,0.818326504283549,0,32,protein palmitoylation,BP,
6352,GO:0018350,1,0.994215206759599,0,1,protein esterification,BP,
6353,GO:0018352,1,0.990161163312067,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6354,GO:0018364,1,0.993799200551584,0,2,peptidyl-glutamine methylation,BP,
6355,GO:0018377,1,0.969880505908843,0,4,protein myristoylation,BP,
6356,GO:0018393,1,0.395891024792346,0,140,internal peptidyl-lysine acetylation,BP,
6357,GO:0018394,1,0.379970242693696,0,147,peptidyl-lysine acetylation,BP,
6358,GO:0018395,1,0.992500861833069,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6359,GO:0018400,1,0.991794204256547,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6360,GO:0018401,1,0.967313412350608,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6361,GO:0018406,1,0.966235966303529,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6363,GO:0018423,1,0.98968230269625,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6364,GO:0018444,1,0.977455868544351,0,3,translation release factor complex,CC,
6365,GO:0018455,1,0.996615511356294,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6366,GO:0018467,1,0.993578414537109,0,1,formaldehyde dehydrogenase activity,MF,
6367,GO:0018478,1,0.994769239365915,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6368,GO:0018479,1,0.990799662927874,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6369,GO:0018549,1,0.995938786538373,0,1,methanethiol oxidase activity,MF,
6370,GO:0018585,1,0.994830238278609,0,1,fluorene oxygenase activity,MF,
6371,GO:0018636,1,0.989525291642526,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6372,GO:0018685,1,0.995893432936279,0,1,alkane 1-monooxygenase activity,MF,
6373,GO:0018733,1,0.996707162065293,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6374,GO:0018738,1,0.996704176262285,0,1,S-formylglutathione hydrolase activity,MF,
6375,GO:0018773,1,0.996000751859802,0,1,acetylpyruvate hydrolase activity,MF,
6376,GO:0018812,1,0.97346982547759,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6377,GO:0018872,1,0.994005796637508,0,1,arsonoacetate metabolic process,BP,
6378,GO:0018874,1,0.995107651509812,0,1,benzoate metabolic process,BP,
6379,GO:0018879,1,0.988384257375811,0,2,biphenyl metabolic process,BP,
6380,GO:0018885,1,0.996018321361949,0,1,carbon tetrachloride metabolic process,BP,
6381,GO:0018894,1,0.987223473073328,0,2,dibenzo-p-dioxin metabolic process,BP,
6382,GO:0018904,1,0.921031479601604,0,16,ether metabolic process,BP,
6383,GO:0018910,1,0.996018321361949,0,1,benzene metabolic process,BP,
6384,GO:0018916,1,0.982364775604423,0,4,nitrobenzene metabolic process,BP,
6385,GO:0018917,1,0.994830238278609,0,1,fluorene metabolic process,BP,
6386,GO:0018931,1,0.996460027391501,0,1,naphthalene metabolic process,BP,
6387,GO:0018958,1,0.584765894677746,0,84,phenol-containing compound metabolic process,BP,
6388,GO:0018963,1,0.989048584028214,0,2,phthalate metabolic process,BP,
6389,GO:0018964,1,0.992432498200643,0,1,propylene metabolic process,BP,
6390,GO:0018969,1,0.993082814903575,0,1,thiocyanate metabolic process,BP,
6391,GO:0018992,1,0.984701732587259,0,2,germ-line sex determination,BP,
6392,GO:0018993,1,0.985985571271478,0,2,somatic sex determination,BP,
6393,GO:0018995,1,0.657985362939685,0,65,host,CC,
6395,GO:0019002,1,0.988332454012229,0,2,GMP binding,MF,
6396,GO:0019003,1,0.708691750839123,0,58,GDP binding,MF,
6397,GO:0019005,1,0.71695794785834,0,55,SCF ubiquitin ligase complex,CC,
6398,GO:0019008,1,0.98890245185812,0,2,molybdopterin synthase complex,CC,
6399,GO:0019034,1,0.984794754464978,0,2,viral replication complex,CC,
6400,GO:0019035,1,0.992092321760209,0,1,viral integration complex,CC,
6401,GO:0019042,1,0.935422657735422,0,11,viral latency,BP,
6402,GO:0019043,1,0.951531944674933,0,9,establishment of viral latency,BP,
6403,GO:0019045,1,0.983078838047952,0,2,latent virus replication,BP,
6404,GO:0019046,1,0.983078838047952,0,2,release from viral latency,BP,
6405,GO:0019048,1,0.802999948570631,0,32,modulation by virus of host morphology or physiology,BP,
6406,GO:0019049,1,0.972720011526572,0,4,evasion or tolerance of host defenses by virus,BP,
6407,GO:0019050,1,0.984235743268643,0,3,suppression by virus of host apoptotic process,BP,
6408,GO:0019054,1,0.869896216917987,0,21,modulation by virus of host process,BP,
6409,GO:0019056,1,0.993120599169405,0,1,modulation by virus of host transcription,BP,
6411,GO:0019060,1,0.992658988004991,0,2,intracellular transport of viral protein in host cell,BP,
6412,GO:0019061,1,0.994524631862251,0,1,uncoating of virus,BP,
6413,GO:0019062,1,0.954616984498033,0,7,virion attachment to host cell,BP,
6414,GO:0019064,1,0.964780947102673,0,6,fusion of virus membrane with host plasma membrane,BP,
6415,GO:0019065,1,0.978723717076292,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6416,GO:0019068,1,0.810178144088457,0,37,virion assembly,BP,
6417,GO:0019072,1,0.984448074483144,0,2,viral genome packaging,BP,
6418,GO:0019074,1,0.984448074483144,0,2,viral RNA genome packaging,BP,
6419,GO:0019075,1,0.986646673054992,0,2,virus maturation,BP,
6420,GO:0019076,1,0.805144533355676,0,33,viral release from host cell,BP,
6421,GO:0019079,1,0.511993260551036,0,106,viral genome replication,BP,
6422,GO:0019080,1,0.396159539765829,0,184,viral gene expression,BP,
6423,GO:0019081,1,0.915489309610683,0,14,viral translation,BP,
6424,GO:0019082,1,0.99244226927251,0,1,viral protein processing,BP,
6425,GO:0019083,1,0.433036646367783,0,170,viral transcription,BP,
6426,GO:0019085,1,0.985079212592017,0,2,early viral transcription,BP,
6427,GO:0019086,1,0.97712008275064,0,4,late viral transcription,BP,
6428,GO:0019087,1,0.981890605184473,0,3,transformation of host cell by virus,BP,
6429,GO:0019088,1,0.996176901233646,0,1,immortalization of host cell by virus,BP,
6430,GO:0019089,1,0.99187803539675,0,1,transmission of virus,BP,
6431,GO:0019098,1,0.836043714513212,0,28,reproductive behavior,BP,
6432,GO:0019100,1,0.984701732587259,0,2,male germ-line sex determination,BP,
6433,GO:0019101,1,0.993058993460782,0,1,female somatic sex determination,BP,
6434,GO:0019102,1,0.992877652548444,0,1,male somatic sex determination,BP,
6435,GO:0019103,1,0.970445187907351,0,6,pyrimidine nucleotide binding,MF,
6436,GO:0019104,1,0.935618581785257,0,15,DNA N-glycosylase activity,MF,
6437,GO:0019107,1,0.984674949137127,0,2,myristoyltransferase activity,MF,
6438,GO:0019115,1,0.995310806423143,0,1,benzaldehyde dehydrogenase activity,MF,
6439,GO:0019118,1,0.99651203050754,0,1,phenanthrene-epoxide hydrolase activity,MF,
6440,GO:0019119,1,0.99651203050754,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6441,GO:0019135,1,0.995546302047212,0,1,deoxyhypusine monooxygenase activity,MF,
6442,GO:0019136,1,0.979129107055635,0,4,deoxynucleoside kinase activity,MF,
6443,GO:0019144,1,0.992966715735034,0,2,ADP-sugar diphosphatase activity,MF,
6444,GO:0019145,1,0.993913943638435,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6445,GO:0019150,1,0.995106329409806,0,1,D-ribulokinase activity,MF,
6446,GO:0019153,1,0.996153993098043,0,1,protein-disulfide reductase (glutathione) activity,MF,
6447,GO:0019158,1,0.96373068129907,0,5,mannokinase activity,MF,
6448,GO:0019166,1,0.986061745755046,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6449,GO:0019171,1,0.991128561445219,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6450,GO:0019184,1,0.912869142693255,0,16,nonribosomal peptide biosynthetic process,BP,
6451,GO:0019185,1,0.985963286546307,0,2,snRNA-activating protein complex,CC,
6452,GO:0019187,1,0.992461598478919,0,1,beta-1,4-mannosyltransferase activity,MF,
6453,GO:0019198,1,0.880872037275741,0,16,transmembrane receptor protein phosphatase activity,MF,
6455,GO:0019200,1,0.86869786941162,0,22,carbohydrate kinase activity,MF,
6456,GO:0019201,1,0.844779708572509,0,25,nucleotide kinase activity,MF,
6457,GO:0019202,1,0.985897995706839,0,2,amino acid kinase activity,MF,
6458,GO:0019203,1,0.952114627173634,0,8,carbohydrate phosphatase activity,MF,
6459,GO:0019205,1,0.746829893224133,0,49,nucleobase-containing compound kinase activity,MF,
6460,GO:0019206,1,0.923739504172171,0,14,nucleoside kinase activity,MF,
6464,GO:0019210,1,0.567224129604553,0,93,kinase inhibitor activity,MF,
6465,GO:0019211,1,0.939759535208822,0,10,phosphatase activator activity,MF,
6467,GO:0019213,1,0.698819530661775,0,55,deacetylase activity,MF,
6468,GO:0019215,1,0.917158431893066,0,13,intermediate filament binding,MF,
6471,GO:0019218,1,0.542753325493255,0,97,regulation of steroid metabolic process,BP,
6476,GO:0019226,1,0.633997802076798,0,67,transmission of nerve impulse,BP,
6477,GO:0019227,1,0.962129572934258,0,6,neuronal action potential propagation,BP,
6478,GO:0019228,1,0.781742673903479,0,34,neuronal action potential,BP,
6480,GO:0019230,1,0.971934603006477,0,4,proprioception,BP,
6481,GO:0019233,1,0.588583478066052,0,84,sensory perception of pain,BP,
6482,GO:0019236,1,0.982031916100685,0,4,response to pheromone,BP,
6483,GO:0019237,1,0.957550092996422,0,6,centromeric DNA binding,MF,
6484,GO:0019238,1,0.964871571223736,0,6,cyclohydrolase activity,MF,
6485,GO:0019239,1,0.845985434603963,0,30,deaminase activity,MF,
6486,GO:0019240,1,0.963830600494375,0,5,citrulline biosynthetic process,BP,
6487,GO:0019242,1,0.995030627496594,0,1,methylglyoxal biosynthetic process,BP,
6488,GO:0019243,1,0.989183905775666,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6489,GO:0019244,1,0.996637964796832,0,1,lactate biosynthetic process from pyruvate,BP,
6490,GO:0019249,1,0.985504360965235,0,3,lactate biosynthetic process,BP,
6491,GO:0019254,1,0.98092570178713,0,3,carnitine metabolic process, CoA-linked,BP,
6492,GO:0019255,1,0.990166211390668,0,2,glucose 1-phosphate metabolic process,BP,
6493,GO:0019262,1,0.9746395935252,0,6,N-acetylneuraminate catabolic process,BP,
6494,GO:0019264,1,0.988682996123051,0,2,glycine biosynthetic process from serine,BP,
6495,GO:0019265,1,0.996145082840474,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6496,GO:0019276,1,0.985640924683826,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6497,GO:0019285,1,0.985067672908262,0,2,glycine betaine biosynthetic process from choline,BP,
6498,GO:0019287,1,0.987462573215577,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6499,GO:0019290,1,0.993040395456706,0,1,siderophore biosynthetic process,BP,
6500,GO:0019303,1,0.993404057073824,0,2,D-ribose catabolic process,BP,
6501,GO:0019317,1,0.942584562739899,0,8,fucose catabolic process,BP,
6504,GO:0019320,1,0.753204570842407,0,47,hexose catabolic process,BP,
6505,GO:0019321,1,0.93488340695529,0,14,pentose metabolic process,BP,
6506,GO:0019322,1,0.981504102872461,0,4,pentose biosynthetic process,BP,
6507,GO:0019323,1,0.977344501617829,0,5,pentose catabolic process,BP,
6508,GO:0019336,1,0.944868398541825,0,9,phenol-containing compound catabolic process,BP,
6509,GO:0019341,1,0.993661962459947,0,1,dibenzo-p-dioxin catabolic process,BP,
6510,GO:0019343,1,0.989573610194807,0,2,cysteine biosynthetic process via cystathionine,BP,
6511,GO:0019344,1,0.983913121151725,0,3,cysteine biosynthetic process,BP,
6512,GO:0019346,1,0.978618702340697,0,4,transsulfuration,BP,
6513,GO:0019348,1,0.974103453266722,0,5,dolichol metabolic process,BP,
6514,GO:0019353,1,0.993436769169749,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6515,GO:0019355,1,0.9803653610122,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6516,GO:0019357,1,0.993301131169352,0,1,nicotinate nucleotide biosynthetic process,BP,
6517,GO:0019358,1,0.993301131169352,0,1,nicotinate nucleotide salvage,BP,
6521,GO:0019364,1,0.98630076939297,0,3,pyridine nucleotide catabolic process,BP,
6522,GO:0019365,1,0.993301131169352,0,1,pyridine nucleotide salvage,BP,
6523,GO:0019367,1,0.960403079992839,0,6,fatty acid elongation, saturated fatty acid,BP,
6524,GO:0019368,1,0.960403079992839,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6525,GO:0019369,1,0.795401326279943,0,41,arachidonic acid metabolic process,BP,
6526,GO:0019370,1,0.947707093066767,0,11,leukotriene biosynthetic process,BP,
6527,GO:0019371,1,0.946929062719698,0,11,cyclooxygenase pathway,BP,
6528,GO:0019372,1,0.92059305551156,0,16,lipoxygenase pathway,BP,
6529,GO:0019373,1,0.945012075737824,0,11,epoxygenase P450 pathway,BP,
6532,GO:0019376,1,0.993062132645521,0,1,galactolipid catabolic process,BP,
6533,GO:0019377,1,0.926239127025175,0,13,glycolipid catabolic process,BP,
6534,GO:0019388,1,0.94864161818917,0,9,galactose catabolic process,BP,
6535,GO:0019389,1,0.993585275983718,0,1,glucuronoside metabolic process,BP,
6536,GO:0019391,1,0.993585275983718,0,1,glucuronoside catabolic process,BP,
6537,GO:0019395,1,0.564923742990946,0,95,fatty acid oxidation,BP,
6538,GO:0019400,1,0.91724164815025,0,15,alditol metabolic process,BP,
6539,GO:0019401,1,0.966038735088538,0,6,alditol biosynthetic process,BP,
6540,GO:0019402,1,0.996513325733551,0,1,galactitol metabolic process,BP,
6541,GO:0019405,1,0.965573177676308,0,5,alditol catabolic process,BP,
6542,GO:0019406,1,0.996460027391501,0,1,hexitol biosynthetic process,BP,
6543,GO:0019407,1,0.993856193451521,0,1,hexitol catabolic process,BP,
6544,GO:0019408,1,0.985934895166604,0,2,dolichol biosynthetic process,BP,
6545,GO:0019413,1,0.985399094514624,0,2,acetate biosynthetic process,BP,
6546,GO:0019417,1,0.985043905760424,0,2,sulfur oxidation,BP,
6547,GO:0019418,1,0.983947633547147,0,4,sulfide oxidation,BP,
6548,GO:0019427,1,0.985399094514624,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6549,GO:0019430,1,0.891709834726972,0,22,removal of superoxide radicals,BP,
6550,GO:0019432,1,0.831174954822661,0,28,triglyceride biosynthetic process,BP,
6551,GO:0019433,1,0.867720011562117,0,26,triglyceride catabolic process,BP,
6554,GO:0019441,1,0.971747302243009,0,6,tryptophan catabolic process to kynurenine,BP,
6555,GO:0019442,1,0.992314299400642,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6556,GO:0019448,1,0.986015500433808,0,3,L-cysteine catabolic process,BP,
6557,GO:0019464,1,0.983934444878912,0,3,glycine decarboxylation via glycine cleavage system,BP,
6558,GO:0019470,1,0.974938921571507,0,4,4-hydroxyproline catabolic process,BP,
6559,GO:0019471,1,0.940156756709964,0,10,4-hydroxyproline metabolic process,BP,
6560,GO:0019474,1,0.974258552709048,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6561,GO:0019477,1,0.974258552709048,0,4,L-lysine catabolic process,BP,
6562,GO:0019478,1,0.992279651859073,0,2,D-amino acid catabolic process,BP,
6563,GO:0019482,1,0.975523499007045,0,4,beta-alanine metabolic process,BP,
6564,GO:0019483,1,0.987895205196681,0,2,beta-alanine biosynthetic process,BP,
6565,GO:0019493,1,0.99530696507739,0,1,arginine catabolic process to proline,BP,
6566,GO:0019509,1,0.973274496686029,0,5,L-methionine salvage from methylthioadenosine,BP,
6567,GO:0019510,1,0.994478518349261,0,1,S-adenosylhomocysteine catabolic process,BP,
6568,GO:0019511,1,0.919609681313112,0,13,peptidyl-proline hydroxylation,BP,
6569,GO:0019516,1,0.990363594838827,0,2,lactate oxidation,BP,
6570,GO:0019518,1,0.996178647990857,0,1,L-threonine catabolic process to glycine,BP,
6571,GO:0019519,1,0.993856193451521,0,1,pentitol metabolic process,BP,
6572,GO:0019520,1,0.988736203262881,0,2,aldonic acid metabolic process,BP,
6573,GO:0019521,1,0.988736203262881,0,2,D-gluconate metabolic process,BP,
6574,GO:0019527,1,0.993856193451521,0,1,pentitol catabolic process,BP,
6575,GO:0019530,1,0.959931477881348,0,6,taurine metabolic process,BP,
6576,GO:0019531,1,0.936304024331475,0,9,oxalate transmembrane transporter activity,MF,
6577,GO:0019532,1,0.932692175821868,0,10,oxalate transport,BP,
6578,GO:0019534,1,0.964505013704589,0,5,toxin transmembrane transporter activity,MF,
6580,GO:0019541,1,0.97442620593956,0,4,propionate metabolic process,BP,
6581,GO:0019542,1,0.985399094514624,0,2,propionate biosynthetic process,BP,
6582,GO:0019543,1,0.98886621968352,0,2,propionate catabolic process,BP,
6583,GO:0019544,1,0.99530696507739,0,1,arginine catabolic process to glutamate,BP,
6584,GO:0019546,1,0.994521917273774,0,1,arginine deiminase pathway,BP,
6585,GO:0019547,1,0.991720959930088,0,2,arginine catabolic process to ornithine,BP,
6586,GO:0019550,1,0.989000260681641,0,2,glutamate catabolic process to aspartate,BP,
6587,GO:0019551,1,0.989000260681641,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6588,GO:0019556,1,0.97597452437601,0,4,histidine catabolic process to glutamate and formamide,BP,
6589,GO:0019557,1,0.97597452437601,0,4,histidine catabolic process to glutamate and formate,BP,
6590,GO:0019563,1,0.971543944765815,0,4,glycerol catabolic process,BP,
6591,GO:0019566,1,0.986646673054992,0,2,arabinose metabolic process,BP,
6592,GO:0019585,1,0.957577787018173,0,8,glucuronate metabolic process,BP,
6593,GO:0019605,1,0.990591543843481,0,2,butyrate metabolic process,BP,
6594,GO:0019614,1,0.949615304593805,0,8,catechol-containing compound catabolic process,BP,
6595,GO:0019626,1,0.956775463803047,0,8,short-chain fatty acid catabolic process,BP,
6596,GO:0019627,1,0.933598395527622,0,13,urea metabolic process,BP,
6598,GO:0019640,1,0.976204530142074,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6599,GO:0019646,1,0.939838053085472,0,16,aerobic electron transport chain,BP,
6600,GO:0019673,1,0.972659678446639,0,7,GDP-mannose metabolic process,BP,
6602,GO:0019676,1,0.987326369467156,0,2,ammonia assimilation cycle,BP,
6603,GO:0019677,1,0.989362877614062,0,2,NAD catabolic process,BP,
6604,GO:0019682,1,0.898740276729578,0,21,glyceraldehyde-3-phosphate metabolic process,BP,
6605,GO:0019692,1,0.86062889822409,0,31,deoxyribose phosphate metabolic process,BP,
6607,GO:0019694,1,0.959931477881348,0,6,alkanesulfonate metabolic process,BP,
6608,GO:0019695,1,0.938509244254551,0,9,choline metabolic process,BP,
6609,GO:0019706,1,0.845023795031889,0,27,protein-cysteine S-palmitoyltransferase activity,MF,
6610,GO:0019707,1,0.845023795031889,0,27,protein-cysteine S-acyltransferase activity,MF,
6611,GO:0019720,1,0.963536219595093,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6613,GO:0019724,1,0.582738910910573,0,91,B cell mediated immunity,BP,
6615,GO:0019730,1,0.776397021128929,0,63,antimicrobial humoral response,BP,
6616,GO:0019731,1,0.902318365714812,0,26,antibacterial humoral response,BP,
6617,GO:0019732,1,0.981494082431425,0,4,antifungal humoral response,BP,
6618,GO:0019740,1,0.969289631132909,0,5,nitrogen utilization,BP,
6619,GO:0019742,1,0.994171506730886,0,1,pentacyclic triterpenoid metabolic process,BP,
6620,GO:0019747,1,0.993618565243679,0,2,regulation of isoprenoid metabolic process,BP,
6621,GO:0019748,1,0.732843820440981,0,56,secondary metabolic process,BP,
6622,GO:0019751,1,0.524023763089584,0,101,polyol metabolic process,BP,
6624,GO:0019755,1,0.95231083796359,0,9,one-carbon compound transport,BP,
6625,GO:0019763,1,0.978518569526594,0,5,immunoglobulin receptor activity,MF,
6626,GO:0019767,1,0.997054857149776,0,1,IgE receptor activity,MF,
6627,GO:0019770,1,0.991987323918987,0,2,IgG receptor activity,MF,
6628,GO:0019772,1,0.996140606907986,0,1,low-affinity IgG receptor activity,MF,
6629,GO:0019773,1,0.977527234707943,0,7,proteasome core complex, alpha-subunit complex,CC,
6630,GO:0019774,1,0.971875303679365,0,9,proteasome core complex, beta-subunit complex,CC,
6631,GO:0019776,1,0.981841534650015,0,3,Atg8 ligase activity,MF,
6632,GO:0019777,1,0.990972145340335,0,2,Atg12 transferase activity,MF,
6633,GO:0019778,1,0.992302199609755,0,1,Atg12 activating enzyme activity,MF,
6634,GO:0019779,1,0.992302199609755,0,1,Atg8 activating enzyme activity,MF,
6635,GO:0019780,1,0.991853376070227,0,1,FAT10 activating enzyme activity,MF,
6636,GO:0019781,1,0.990681365675269,0,2,NEDD8 activating enzyme activity,MF,
6637,GO:0019782,1,0.992618335384394,0,1,ISG15 activating enzyme activity,MF,
6638,GO:0019783,1,0.500420122668681,0,98,ubiquitin-like protein-specific protease activity,MF,
6639,GO:0019784,1,0.966767327901725,0,7,NEDD8-specific protease activity,MF,
6640,GO:0019785,1,0.987649071702441,0,2,ISG15-specific protease activity,MF,
6641,GO:0019787,1,0.0490873215331732,0,446,ubiquitin-like protein transferase activity,MF,
6642,GO:0019788,1,0.972860859394936,0,6,NEDD8 transferase activity,MF,
6643,GO:0019789,1,0.905310840538633,0,16,SUMO transferase activity,MF,
6644,GO:0019797,1,0.980036334309751,0,3,procollagen-proline 3-dioxygenase activity,MF,
6645,GO:0019798,1,0.956725316090368,0,7,procollagen-proline dioxygenase activity,MF,
6646,GO:0019799,1,0.993301131169352,0,1,tubulin N-acetyltransferase activity,MF,
6648,GO:0019805,1,0.98530028417424,0,3,quinolinate biosynthetic process,BP,
6649,GO:0019807,1,0.996484391605516,0,1,aspartoacylase activity,MF,
6650,GO:0019808,1,0.973778486661865,0,5,polyamine binding,MF,
6651,GO:0019809,1,0.98857385519182,0,3,spermidine binding,MF,
6652,GO:0019810,1,0.992663131368205,0,1,putrescine binding,MF,
6653,GO:0019811,1,0.992393455043034,0,1,cocaine binding,MF,
6654,GO:0019814,1,0.976109025088792,0,5,immunoglobulin complex,CC,
6655,GO:0019815,1,0.985684408375997,0,3,B cell receptor complex,CC,
6656,GO:0019825,1,0.85172951387706,0,33,oxygen binding,MF,
6657,GO:0019826,1,0.979217663905901,0,3,oxygen sensor activity,MF,
6659,GO:0019828,1,0.98581079220256,0,3,aspartic-type endopeptidase inhibitor activity,MF,
6660,GO:0019829,1,0.713617054156144,0,52,cation-transporting ATPase activity,MF,
6661,GO:0019834,1,0.988687925080134,0,3,phospholipase A2 inhibitor activity,MF,
6662,GO:0019835,1,0.861897953399345,0,30,cytolysis,BP,
6663,GO:0019836,1,0.988076646067103,0,2,hemolysis by symbiont of host erythrocytes,BP,
6665,GO:0019840,1,0.875890971999903,0,24,isoprenoid binding,MF,
6666,GO:0019841,1,0.951763237674305,0,11,retinol binding,MF,
6667,GO:0019842,1,0.492646692985992,0,119,vitamin binding,MF,
6668,GO:0019843,1,0.778085395880541,0,55,rRNA binding,MF,
6669,GO:0019852,1,0.945512748611071,0,10,L-ascorbic acid metabolic process,BP,
6670,GO:0019853,1,0.991819168172866,0,2,L-ascorbic acid biosynthetic process,BP,
6671,GO:0019855,1,0.956694398486598,0,9,calcium channel inhibitor activity,MF,
6672,GO:0019856,1,0.957277793964284,0,6,pyrimidine nucleobase biosynthetic process,BP,
6673,GO:0019857,1,0.971781283437278,0,3,5-methylcytosine metabolic process,BP,
6674,GO:0019858,1,0.989406668635501,0,2,cytosine metabolic process,BP,
6675,GO:0019859,1,0.982579182626747,0,3,thymine metabolic process,BP,
6676,GO:0019860,1,0.983969772958748,0,3,uracil metabolic process,BP,
6677,GO:0019862,1,0.996206298633968,0,1,IgA binding,MF,
6678,GO:0019863,1,0.986426297300587,0,4,IgE binding,MF,
6679,GO:0019864,1,0.961085043753661,0,9,IgG binding,MF,
6680,GO:0019865,1,0.92809160880021,0,16,immunoglobulin binding,MF,
6683,GO:0019869,1,0.945403751299737,0,9,chloride channel inhibitor activity,MF,
6684,GO:0019870,1,0.958019601596467,0,6,potassium channel inhibitor activity,MF,
6685,GO:0019871,1,0.960867426323401,0,6,sodium channel inhibitor activity,MF,
6686,GO:0019878,1,0.98523667897767,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6687,GO:0019882,1,0.317900854842608,0,207,antigen processing and presentation,BP,
6688,GO:0019883,1,0.934367819089931,0,11,antigen processing and presentation of endogenous antigen,BP,
6689,GO:0019884,1,0.399046826593978,0,168,antigen processing and presentation of exogenous antigen,BP,
6690,GO:0019885,1,0.955486950474405,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6691,GO:0019886,1,0.571918846807589,0,93,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,
6694,GO:0019894,1,0.765050673414722,0,37,kinesin binding,MF,
6695,GO:0019896,1,0.927116806158558,0,11,axonal transport of mitochondrion,BP,
6704,GO:0019905,1,0.550604979482267,0,88,syntaxin binding,MF,
6705,GO:0019907,1,0.963714126402867,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6706,GO:0019908,1,0.908461850509554,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6708,GO:0019912,1,0.989126890570478,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6709,GO:0019915,1,0.690728943020046,0,59,lipid storage,BP,
6710,GO:0019918,1,0.975098390552229,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6711,GO:0019919,1,0.954158633513643,0,8,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6714,GO:0019934,1,0.936269573005079,0,10,cGMP-mediated signaling,BP,
6716,GO:0019941,1,0.0282074065933423,0,549,modification-dependent protein catabolic process,BP,
6717,GO:0019948,1,0.987568319983853,0,2,SUMO activating enzyme activity,MF,
6720,GO:0019956,1,0.854161276025681,0,25,chemokine binding,MF,
6721,GO:0019957,1,0.942953959929253,0,10,C-C chemokine binding,MF,
6722,GO:0019958,1,0.961548474655815,0,6,C-X-C chemokine binding,MF,
6723,GO:0019959,1,0.97980370594131,0,3,interleukin-8 binding,MF,
6724,GO:0019960,1,0.961789760739956,0,5,C-X3-C chemokine binding,MF,
6725,GO:0019961,1,0.984583209611132,0,2,interferon binding,MF,
6726,GO:0019962,1,0.99197537121486,0,1,type I interferon binding,MF,
6727,GO:0019964,1,0.992548661496685,0,1,interferon-gamma binding,MF,
6728,GO:0019966,1,0.959195251337089,0,7,interleukin-1 binding,MF,
6729,GO:0019969,1,0.99248254767358,0,1,interleukin-10 binding,MF,
6730,GO:0019970,1,0.992717156463654,0,1,interleukin-11 binding,MF,
6731,GO:0019972,1,0.996410840777958,0,1,interleukin-12 binding,MF,
6732,GO:0019975,1,0.996410840777958,0,1,interleukin-17 binding,MF,
6733,GO:0019976,1,0.981520763108817,0,3,interleukin-2 binding,MF,
6734,GO:0019981,1,0.985219392564075,0,2,interleukin-6 binding,MF,
6735,GO:0019985,1,0.79448738392344,0,38,translesion synthesis,BP,
6736,GO:0019988,1,0.99335320816281,0,1,charged-tRNA amino acid modification,BP,
6738,GO:0020003,1,0.983807151952306,0,3,symbiont-containing vacuole,CC,
6739,GO:0020005,1,0.990442659390436,0,2,symbiont-containing vacuole membrane,CC,
6740,GO:0020012,1,0.98573096451553,0,2,evasion or tolerance of host immune response,BP,
6741,GO:0020016,1,0.977619539252792,0,3,ciliary pocket,CC,
6742,GO:0020018,1,0.977619539252792,0,3,ciliary pocket membrane,CC,
6743,GO:0020021,1,0.996176901233646,0,1,immortalization of host cell,BP,
6744,GO:0020027,1,0.928468631342814,0,14,hemoglobin metabolic process,BP,
6746,GO:0021501,1,0.99503596063896,0,1,prechordal plate formation,BP,
6747,GO:0021502,1,0.97985657038277,0,3,neural fold elevation formation,BP,
6748,GO:0021503,1,0.991144603495811,0,1,neural fold bending,BP,
6749,GO:0021508,1,0.991752446379505,0,1,floor plate formation,BP,
6750,GO:0021509,1,0.995285144028007,0,1,roof plate formation,BP,
6753,GO:0021512,1,0.992435007577691,0,1,spinal cord anterior/posterior patterning,BP,
6757,GO:0021516,1,0.897071372146785,0,19,dorsal spinal cord development,BP,
6759,GO:0021519,1,0.996613227145749,0,1,spinal cord association neuron specification,BP,
6763,GO:0021523,1,0.973050158157258,0,5,somatic motor neuron differentiation,BP,
6764,GO:0021524,1,0.985400858196856,0,3,visceral motor neuron differentiation,BP,
6765,GO:0021526,1,0.989841234269319,0,2,medial motor column neuron differentiation,BP,
6766,GO:0021527,1,0.940465503790389,0,11,spinal cord association neuron differentiation,BP,
6767,GO:0021528,1,0.993301131169352,0,1,commissural neuron differentiation in spinal cord,BP,
6768,GO:0021529,1,0.983127776571588,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6769,GO:0021530,1,0.983127776571588,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6770,GO:0021532,1,0.794343774489036,0,36,neural tube patterning,BP,
6772,GO:0021534,1,0.936586163493437,0,11,cell proliferation in hindbrain,BP,
6773,GO:0021535,1,0.906750461580348,0,13,cell migration in hindbrain,BP,
6776,GO:0021538,1,0.976887558884328,0,3,epithalamus development,BP,
6777,GO:0021539,1,0.99083402202166,0,2,subthalamus development,BP,
6778,GO:0021540,1,0.96721741666256,0,5,corpus callosum morphogenesis,BP,
6779,GO:0021541,1,0.992438592779795,0,1,ammon gyrus development,BP,
6780,GO:0021542,1,0.90061898310194,0,15,dentate gyrus development,BP,
6782,GO:0021544,1,0.856550204363823,0,23,subpallium development,BP,
6784,GO:0021546,1,0.97128485157027,0,5,rhombomere development,BP,
6785,GO:0021547,1,0.99503596063896,0,1,midbrain-hindbrain boundary initiation,BP,
6786,GO:0021548,1,0.943571648675013,0,9,pons development,BP,
6788,GO:0021550,1,0.993995508641689,0,1,medulla oblongata development,BP,
6789,GO:0021551,1,0.989640903993005,0,1,central nervous system morphogenesis,BP,
6790,GO:0021553,1,0.976310293757216,0,3,olfactory nerve development,BP,
6791,GO:0021554,1,0.929090909699469,0,11,optic nerve development,BP,
6792,GO:0021555,1,0.985232391591953,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6793,GO:0021557,1,0.985067059246662,0,3,oculomotor nerve development,BP,
6794,GO:0021558,1,0.992373935207916,0,2,trochlear nerve development,BP,
6795,GO:0021559,1,0.936913456797134,0,10,trigeminal nerve development,BP,
6796,GO:0021560,1,0.986728912134182,0,2,abducens nerve development,BP,
6797,GO:0021561,1,0.939694087991299,0,9,facial nerve development,BP,
6798,GO:0021562,1,0.960299078154056,0,6,vestibulocochlear nerve development,BP,
6799,GO:0021563,1,0.96290125094822,0,5,glossopharyngeal nerve development,BP,
6800,GO:0021564,1,0.979104916107982,0,3,vagus nerve development,BP,
6801,GO:0021566,1,0.992309639429502,0,1,hypoglossal nerve development,BP,
6802,GO:0021568,1,0.996552546847698,0,1,rhombomere 2 development,BP,
6803,GO:0021569,1,0.989327061514439,0,2,rhombomere 3 development,BP,
6804,GO:0021570,1,0.996155768504029,0,1,rhombomere 4 development,BP,
6805,GO:0021571,1,0.985800030393853,0,2,rhombomere 5 development,BP,
6806,GO:0021572,1,0.992604645642669,0,1,rhombomere 6 development,BP,
6808,GO:0021577,1,0.98620910957825,0,2,hindbrain structural organization,BP,
6809,GO:0021578,1,0.95942709048341,0,6,hindbrain maturation,BP,
6810,GO:0021586,1,0.979039385842809,0,3,pons maturation,BP,
6812,GO:0021589,1,0.98620910957825,0,2,cerebellum structural organization,BP,
6813,GO:0021590,1,0.979972190832906,0,3,cerebellum maturation,BP,
6814,GO:0021591,1,0.851980475057425,0,24,ventricular system development,BP,
6815,GO:0021592,1,0.992222825254083,0,1,fourth ventricle development,BP,
6816,GO:0021593,1,0.993145215099439,0,1,rhombomere morphogenesis,BP,
6817,GO:0021594,1,0.993145215099439,0,1,rhombomere formation,BP,
6818,GO:0021598,1,0.986728912134182,0,2,abducens nerve morphogenesis,BP,
6819,GO:0021599,1,0.986728912134182,0,2,abducens nerve formation,BP,
6820,GO:0021602,1,0.845859431300666,0,25,cranial nerve morphogenesis,BP,
6821,GO:0021603,1,0.95721480722145,0,7,cranial nerve formation,BP,
6822,GO:0021604,1,0.941198343344906,0,9,cranial nerve structural organization,BP,
6823,GO:0021610,1,0.939694087991299,0,9,facial nerve morphogenesis,BP,
6824,GO:0021612,1,0.953186116249538,0,7,facial nerve structural organization,BP,
6825,GO:0021615,1,0.972498688191181,0,4,glossopharyngeal nerve morphogenesis,BP,
6826,GO:0021618,1,0.992309639429502,0,1,hypoglossal nerve morphogenesis,BP,
6827,GO:0021622,1,0.988635980207962,0,2,oculomotor nerve morphogenesis,BP,
6828,GO:0021623,1,0.988635980207962,0,2,oculomotor nerve formation,BP,
6829,GO:0021626,1,0.95942709048341,0,6,central nervous system maturation,BP,
6830,GO:0021631,1,0.956220257524004,0,6,optic nerve morphogenesis,BP,
6831,GO:0021633,1,0.987429709054033,0,2,optic nerve structural organization,BP,
6832,GO:0021634,1,0.992449677325916,0,1,optic nerve formation,BP,
6833,GO:0021636,1,0.963473171500962,0,5,trigeminal nerve morphogenesis,BP,
6834,GO:0021637,1,0.963473171500962,0,5,trigeminal nerve structural organization,BP,
6835,GO:0021639,1,0.995969051413643,0,1,trochlear nerve morphogenesis,BP,
6836,GO:0021642,1,0.995969051413643,0,1,trochlear nerve formation,BP,
6837,GO:0021644,1,0.988862157334637,0,2,vagus nerve morphogenesis,BP,
6838,GO:0021648,1,0.97532542167825,0,4,vestibulocochlear nerve morphogenesis,BP,
6839,GO:0021649,1,0.993967319559355,0,1,vestibulocochlear nerve structural organization,BP,
6840,GO:0021650,1,0.981246130050027,0,3,vestibulocochlear nerve formation,BP,
6841,GO:0021658,1,0.993145215099439,0,1,rhombomere 3 morphogenesis,BP,
6842,GO:0021660,1,0.993145215099439,0,1,rhombomere 3 formation,BP,
6843,GO:0021664,1,0.993145215099439,0,1,rhombomere 5 morphogenesis,BP,
6844,GO:0021666,1,0.993145215099439,0,1,rhombomere 5 formation,BP,
6845,GO:0021670,1,0.933263955003112,0,10,lateral ventricle development,BP,
6847,GO:0021678,1,0.986327472345363,0,3,third ventricle development,BP,
6848,GO:0021679,1,0.985541340294349,0,2,cerebellar molecular layer development,BP,
6849,GO:0021680,1,0.856680567458694,0,21,cerebellar Purkinje cell layer development,BP,
6851,GO:0021682,1,0.992099992299796,0,1,nerve maturation,BP,
6854,GO:0021685,1,0.991570428038369,0,1,cerebellar granular layer structural organization,BP,
6855,GO:0021686,1,0.996071788205092,0,1,cerebellar granular layer maturation,BP,
6856,GO:0021687,1,0.985541340294349,0,2,cerebellar molecular layer morphogenesis,BP,
6857,GO:0021688,1,0.992629034746413,0,1,cerebellar molecular layer formation,BP,
6858,GO:0021691,1,0.983837568607031,0,2,cerebellar Purkinje cell layer maturation,BP,
6859,GO:0021692,1,0.918413735669883,0,11,cerebellar Purkinje cell layer morphogenesis,BP,
6860,GO:0021693,1,0.984260955543156,0,2,cerebellar Purkinje cell layer structural organization,BP,
6861,GO:0021694,1,0.941253029818739,0,8,cerebellar Purkinje cell layer formation,BP,
6865,GO:0021698,1,0.984260955543156,0,2,cerebellar cortex structural organization,BP,
6866,GO:0021699,1,0.979972190832906,0,3,cerebellar cortex maturation,BP,
6868,GO:0021702,1,0.941253029818739,0,8,cerebellar Purkinje cell differentiation,BP,
6869,GO:0021703,1,0.995969051413643,0,1,locus ceruleus development,BP,
6871,GO:0021718,1,0.986505822177347,0,2,superior olivary nucleus development,BP,
6872,GO:0021722,1,0.986505822177347,0,2,superior olivary nucleus maturation,BP,
6873,GO:0021730,1,0.984064252733027,0,2,trigeminal sensory nucleus development,BP,
6874,GO:0021740,1,0.984064252733027,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6875,GO:0021747,1,0.977263618306908,0,3,cochlear nucleus development,BP,
6876,GO:0021750,1,0.993995508641689,0,1,vestibular nucleus development,BP,
6877,GO:0021756,1,0.884769907308755,0,17,striatum development,BP,
6878,GO:0021757,1,0.992496073151331,0,1,caudate nucleus development,BP,
6879,GO:0021758,1,0.992496073151331,0,1,putamen development,BP,
6881,GO:0021761,1,0.525219798519701,0,96,limbic system development,BP,
6883,GO:0021763,1,0.994633344008628,0,1,subthalamic nucleus development,BP,
6884,GO:0021764,1,0.967053709923661,0,4,amygdala development,BP,
6885,GO:0021766,1,0.613465355770613,0,72,hippocampus development,BP,
6886,GO:0021767,1,0.990858875999902,0,1,mammillary body development,BP,
6887,GO:0021768,1,0.992536423099907,0,1,nucleus accumbens development,BP,
6888,GO:0021769,1,0.973690806605829,0,4,orbitofrontal cortex development,BP,
6889,GO:0021771,1,0.992094779355907,0,1,lateral geniculate nucleus development,BP,
6891,GO:0021773,1,0.97801004776335,0,3,striatal medium spiny neuron differentiation,BP,
6892,GO:0021775,1,0.975505059552611,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6893,GO:0021776,1,0.975505059552611,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6894,GO:0021778,1,0.966152450666709,0,5,oligodendrocyte cell fate specification,BP,
6895,GO:0021779,1,0.966152450666709,0,5,oligodendrocyte cell fate commitment,BP,
6896,GO:0021780,1,0.966152450666709,0,5,glial cell fate specification,BP,
6897,GO:0021781,1,0.923443201269711,0,12,glial cell fate commitment,BP,
6899,GO:0021783,1,0.913080432022882,0,14,preganglionic parasympathetic fiber development,BP,
6900,GO:0021784,1,0.989628391127242,0,2,postganglionic parasympathetic fiber development,BP,
6901,GO:0021785,1,0.945005891299611,0,7,branchiomotor neuron axon guidance,BP,
6902,GO:0021793,1,0.992576374188195,0,1,chemorepulsion of branchiomotor axon,BP,
6903,GO:0021794,1,0.923751156342799,0,13,thalamus development,BP,
6905,GO:0021796,1,0.959064768813718,0,6,cerebral cortex regionalization,BP,
6906,GO:0021797,1,0.981758369891687,0,3,forebrain anterior/posterior pattern specification,BP,
6907,GO:0021798,1,0.958004010130069,0,7,forebrain dorsal/ventral pattern formation,BP,
6908,GO:0021799,1,0.842619912131669,0,24,cerebral cortex radially oriented cell migration,BP,
6910,GO:0021801,1,0.883957918232853,0,17,cerebral cortex radial glia guided migration,BP,
6911,GO:0021812,1,0.985797666947427,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6912,GO:0021813,1,0.993702295643353,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6913,GO:0021814,1,0.962260499544725,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6914,GO:0021815,1,0.974611182141543,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6915,GO:0021817,1,0.974611182141543,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6916,GO:0021819,1,0.925575305741018,0,11,layer formation in cerebral cortex,BP,
6917,GO:0021822,1,0.994889710628502,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6918,GO:0021823,1,0.98388831661508,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6919,GO:0021824,1,0.986125103465512,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6920,GO:0021825,1,0.970234676440251,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6922,GO:0021827,1,0.98388831661508,0,2,postnatal olfactory bulb interneuron migration,BP,
6923,GO:0021828,1,0.986125103465512,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6926,GO:0021836,1,0.98388831661508,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6927,GO:0021840,1,0.986769032131022,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6928,GO:0021842,1,0.986769032131022,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6931,GO:0021847,1,0.979037126682215,0,3,ventricular zone neuroblast division,BP,
6932,GO:0021849,1,0.985088475245435,0,2,neuroblast division in subventricular zone,BP,
6934,GO:0021854,1,0.9030747878948,0,18,hypothalamus development,BP,
6935,GO:0021855,1,0.980832140928353,0,3,hypothalamus cell migration,BP,
6936,GO:0021856,1,0.986125103465512,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6937,GO:0021859,1,0.941663793502406,0,8,pyramidal neuron differentiation,BP,
6938,GO:0021860,1,0.949673078685397,0,7,pyramidal neuron development,BP,
6939,GO:0021861,1,0.963125343232346,0,7,forebrain radial glial cell differentiation,BP,
6940,GO:0021869,1,0.960427554906379,0,6,forebrain ventricular zone progenitor cell division,BP,
6941,GO:0021870,1,0.991977922540233,0,1,Cajal-Retzius cell differentiation,BP,
6942,GO:0021871,1,0.875557160644098,0,21,forebrain regionalization,BP,
6944,GO:0021873,1,0.947765183354975,0,7,forebrain neuroblast division,BP,
6945,GO:0021877,1,0.93288277770417,0,10,forebrain neuron fate commitment,BP,
6947,GO:0021881,1,0.992580107827363,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6948,GO:0021882,1,0.989002073822641,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6951,GO:0021886,1,0.983059664136387,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6952,GO:0021888,1,0.983059664136387,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6956,GO:0021893,1,0.989002073822641,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6959,GO:0021896,1,0.981684238406876,0,2,forebrain astrocyte differentiation,BP,
6960,GO:0021897,1,0.981684238406876,0,2,forebrain astrocyte development,BP,
6961,GO:0021898,1,0.981662942909758,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6962,GO:0021902,1,0.955497615458061,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
6963,GO:0021903,1,0.943177524998064,0,10,rostrocaudal neural tube patterning,BP,
6964,GO:0021904,1,0.865780046714349,0,22,dorsal/ventral neural tube patterning,BP,
6965,GO:0021905,1,0.991711616449939,0,1,forebrain-midbrain boundary formation,BP,
6966,GO:0021910,1,0.943909954900025,0,8,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6969,GO:0021914,1,0.96766197924298,0,5,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6971,GO:0021917,1,0.991711616449939,0,1,somatic motor neuron fate commitment,BP,
6972,GO:0021918,1,0.991711616449939,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6973,GO:0021919,1,0.992522930984052,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6974,GO:0021920,1,0.996613227145749,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6975,GO:0021924,1,0.941907234617041,0,10,cell proliferation in external granule layer,BP,
6976,GO:0021930,1,0.941907234617041,0,10,cerebellar granule cell precursor proliferation,BP,
6977,GO:0021932,1,0.937361461417269,0,9,hindbrain radial glia guided cell migration,BP,
6978,GO:0021933,1,0.996071788205092,0,1,radial glia guided migration of cerebellar granule cell,BP,
6979,GO:0021934,1,0.982054933551883,0,2,hindbrain tangential cell migration,BP,
6980,GO:0021935,1,0.982054933551883,0,2,cerebellar granule cell precursor tangential migration,BP,
6981,GO:0021936,1,0.944248570066687,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6982,GO:0021937,1,0.968407946811886,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6983,GO:0021938,1,0.973235298960208,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6984,GO:0021940,1,0.955244044489746,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6985,GO:0021941,1,0.988494813525046,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6986,GO:0021942,1,0.971086905516664,0,4,radial glia guided migration of Purkinje cell,BP,
6987,GO:0021943,1,0.969088865821205,0,4,formation of radial glial scaffolds,BP,
6988,GO:0021952,1,0.841571400344448,0,23,central nervous system projection neuron axonogenesis,BP,
6991,GO:0021955,1,0.814389306188543,0,28,central nervous system neuron axonogenesis,BP,
6992,GO:0021956,1,0.995267107128906,0,1,central nervous system interneuron axonogenesis,BP,
6993,GO:0021957,1,0.957023765451668,0,6,corticospinal tract morphogenesis,BP,
6994,GO:0021960,1,0.962597484180882,0,5,anterior commissure morphogenesis,BP,
6995,GO:0021965,1,0.974688959964478,0,3,spinal cord ventral commissure morphogenesis,BP,
6996,GO:0021966,1,0.988942043889166,0,2,corticospinal neuron axon guidance,BP,
6997,GO:0021972,1,0.992300744963555,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6998,GO:0021978,1,0.930126216451237,0,12,telencephalon regionalization,BP,
6999,GO:0021979,1,0.96199971156345,0,6,hypothalamus cell differentiation,BP,
7000,GO:0021983,1,0.779231483098133,0,41,pituitary gland development,BP,
7001,GO:0021984,1,0.93730738023115,0,12,adenohypophysis development,BP,
7002,GO:0021985,1,0.98601144987011,0,2,neurohypophysis development,BP,
7003,GO:0021986,1,0.976887558884328,0,3,habenula development,BP,
7006,GO:0021993,1,0.992222825254083,0,1,initiation of neural tube closure,BP,
7007,GO:0021997,1,0.98335512539816,0,2,neural plate axis specification,BP,
7008,GO:0021998,1,0.992500861833069,0,1,neural plate mediolateral regionalization,BP,
7009,GO:0021999,1,0.962493072554999,0,6,neural plate anterior/posterior regionalization,BP,
7010,GO:0022007,1,0.97828615073932,0,3,convergent extension involved in neural plate elongation,BP,
7012,GO:0022009,1,0.973989849250344,0,4,central nervous system vasculogenesis,BP,
7015,GO:0022012,1,0.991233207427996,0,1,subpallium cell proliferation in forebrain,BP,
7016,GO:0022013,1,0.991100420811145,0,1,pallium cell proliferation in forebrain,BP,
7017,GO:0022018,1,0.991233207427996,0,1,lateral ganglionic eminence cell proliferation,BP,
7018,GO:0022027,1,0.951181633157314,0,6,interkinetic nuclear migration,BP,
7021,GO:0022030,1,0.883957918232853,0,17,telencephalon glial cell migration,BP,
7023,GO:0022038,1,0.906967834084727,0,15,corpus callosum development,BP,
7024,GO:0022400,1,0.879404925028067,0,20,regulation of rhodopsin mediated signaling pathway,BP,
7025,GO:0022401,1,0.915075993348481,0,16,negative adaptation of signaling pathway,BP,
7033,GO:0022410,1,0.891493903187534,0,22,circadian sleep/wake cycle process,BP,
7035,GO:0022412,1,0.183580330664057,0,264,cellular process involved in reproduction in multicellular organism,BP,
7037,GO:0022417,1,0.97171249661371,0,7,protein maturation by protein folding,BP,
7038,GO:0022600,1,0.62905622373465,0,75,digestive system process,BP,
7042,GO:0022605,1,0.967593992028223,0,6,mammalian oogenesis stage,BP,
7046,GO:0022613,1,0.0848742862882768,0,442,ribonucleoprotein complex biogenesis,BP,
7047,GO:0022614,1,0.963218525492628,0,5,membrane to membrane docking,BP,
7048,GO:0022615,1,0.980773911892772,0,4,protein to membrane docking,BP,
7049,GO:0022616,1,0.84986510879318,0,26,DNA strand elongation,BP,
7051,GO:0022618,1,0.315417579260409,0,195,ribonucleoprotein complex assembly,BP,
7052,GO:0022622,1,0.996992964303392,0,1,root system development,BP,
7053,GO:0022624,1,0.898827533747995,0,24,proteasome accessory complex,CC,
7054,GO:0022625,1,0.793897072752808,0,62,cytosolic large ribosomal subunit,CC,
7056,GO:0022627,1,0.842938870871515,0,45,cytosolic small ribosomal subunit,CC,
7059,GO:0022821,1,0.903700869218242,0,14,potassium ion antiporter activity,MF,
7060,GO:0022824,1,0.704980877829921,0,51,transmitter-gated ion channel activity,MF,
7064,GO:0022835,1,0.704980877829921,0,51,transmitter-gated channel activity,MF,
7068,GO:0022840,1,0.913687529984157,0,16,leak channel activity,MF,
7069,GO:0022841,1,0.927553273555129,0,14,potassium ion leak channel activity,MF,
7070,GO:0022842,1,0.913687529984157,0,16,narrow pore channel activity,MF,
7072,GO:0022848,1,0.921389980577701,0,14,acetylcholine-gated cation-selective channel activity,MF,
7073,GO:0022849,1,0.958203577602796,0,5,glutamate-gated calcium ion channel activity,MF,
7074,GO:0022850,1,0.980335510729892,0,4,serotonin-gated cation-selective channel activity,MF,
7075,GO:0022851,1,0.924279044181505,0,11,GABA-gated chloride ion channel activity,MF,
7076,GO:0022852,1,0.98518328606163,0,2,glycine-gated chloride ion channel activity,MF,
7077,GO:0022853,1,0.708177967175796,0,53,active ion transmembrane transporter activity,MF,
7079,GO:0022858,1,0.966286326900331,0,5,alanine transmembrane transporter activity,MF,
7080,GO:0022884,1,0.928229550952636,0,15,macromolecule transmembrane transporter activity,MF,
7081,GO:0022889,1,0.952176438337901,0,9,serine transmembrane transporter activity,MF,
7083,GO:0022894,1,0.994614307936066,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7088,GO:0023016,1,0.978696086528897,0,3,signal transduction by trans-phosphorylation,BP,
7089,GO:0023019,1,0.904998296529446,0,18,signal transduction involved in regulation of gene expression,BP,
7090,GO:0023021,1,0.98194394684396,0,3,termination of signal transduction,BP,
7091,GO:0023023,1,0.905873474696557,0,20,MHC protein complex binding,MF,
7092,GO:0023024,1,0.985800982261083,0,3,MHC class I protein complex binding,MF,
7093,GO:0023025,1,0.987473727536702,0,2,MHC class Ib protein complex binding,MF,
7094,GO:0023026,1,0.923816815313032,0,16,MHC class II protein complex binding,MF,
7095,GO:0023029,1,0.96636733297188,0,5,MHC class Ib protein binding,MF,
7096,GO:0023030,1,0.987473727536702,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7097,GO:0023035,1,0.954082729229451,0,8,CD40 signaling pathway,BP,
7098,GO:0023041,1,0.963376940893016,0,6,neuronal signal transduction,BP,
7103,GO:0023058,1,0.909365231097202,0,17,adaptation of signaling pathway,BP,
7106,GO:0030002,1,0.935656813467804,0,10,cellular anion homeostasis,BP,
7108,GO:0030004,1,0.502166438154379,0,107,cellular monovalent inorganic cation homeostasis,BP,
7109,GO:0030007,1,0.909461896986939,0,14,cellular potassium ion homeostasis,BP,
7110,GO:0030008,1,0.926997436518961,0,14,TRAPP complex,CC,
7111,GO:0030010,1,0.431791081324684,0,119,establishment of cell polarity,BP,
7112,GO:0030011,1,0.890833507839024,0,17,maintenance of cell polarity,BP,
7113,GO:0030014,1,0.901352038652364,0,15,CCR4-NOT complex,CC,
7114,GO:0030015,1,0.966429361378496,0,5,CCR4-NOT core complex,CC,
7119,GO:0030021,1,0.992833625013786,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
7120,GO:0030023,1,0.957364294612927,0,5,extracellular matrix constituent conferring elasticity,MF,
7121,GO:0030027,1,0.291106217468925,0,177,lamellipodium,CC,
7125,GO:0030032,1,0.695071231587994,0,53,lamellipodium assembly,BP,
7126,GO:0030033,1,0.89131827249478,0,16,microvillus assembly,BP,
7127,GO:0030035,1,0.970433239415694,0,4,microspike assembly,BP,
7129,GO:0030037,1,0.992302441591989,0,1,actin filament reorganization involved in cell cycle,BP,
7130,GO:0030038,1,0.557303586354211,0,86,contractile actin filament bundle assembly,BP,
7132,GO:0030042,1,0.717211485663472,0,47,actin filament depolymerization,BP,
7133,GO:0030043,1,0.978615792520282,0,4,actin filament fragmentation,BP,
7134,GO:0030046,1,0.963128210574093,0,5,parallel actin filament bundle assembly,BP,
7135,GO:0030047,1,0.977873180428844,0,3,actin modification,BP,
7137,GO:0030049,1,0.746946825274801,0,35,muscle filament sliding,BP,
7141,GO:0030056,1,0.951801746339708,0,5,hemidesmosome,CC,
7143,GO:0030060,1,0.9828814312725,0,4,L-malate dehydrogenase activity,MF,
7144,GO:0030061,1,0.968011171766462,0,5,mitochondrial crista,CC,
7145,GO:0030062,1,0.96581234029908,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7146,GO:0030070,1,0.972678742385798,0,4,insulin processing,BP,
7147,GO:0030071,1,0.736826252130411,0,48,regulation of mitotic metaphase/anaphase transition,BP,
7150,GO:0030091,1,0.968106065594527,0,7,protein repair,BP,
7153,GO:0030099,1,0.109618683009268,0,346,myeloid cell differentiation,BP,
7156,GO:0030103,1,0.989829316695101,0,2,vasopressin secretion,BP,
7157,GO:0030104,1,0.68414301696403,0,56,water homeostasis,BP,
7158,GO:0030107,1,0.993137509183141,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7159,GO:0030108,1,0.996356943742403,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7160,GO:0030109,1,0.988671793462584,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7166,GO:0030121,1,0.961649698874546,0,6,AP-1 adaptor complex,CC,
7168,GO:0030123,1,0.932345277188344,0,10,AP-3 adaptor complex,CC,
7169,GO:0030124,1,0.977804812099918,0,4,AP-4 adaptor complex,CC,
7171,GO:0030126,1,0.913598140728331,0,15,COPI vesicle coat,CC,
7172,GO:0030127,1,0.9101260633939,0,14,COPII vesicle coat,CC,
7174,GO:0030130,1,0.92543628496241,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7178,GO:0030134,1,0.613765506181522,0,83,COPII-coated ER to Golgi transport vesicle,CC,
7181,GO:0030137,1,0.861757628961333,0,25,COPI-coated vesicle,CC,
7183,GO:0030140,1,0.824482801454716,0,30,trans-Golgi network transport vesicle,CC,
7185,GO:0030144,1,0.980676714635332,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7186,GO:0030145,1,0.733647569731858,0,48,manganese ion binding,MF,
7188,GO:0030149,1,0.88015850440081,0,22,sphingolipid catabolic process,BP,
7189,GO:0030150,1,0.916276841984123,0,17,protein import into mitochondrial matrix,BP,
7190,GO:0030151,1,0.974590012295922,0,4,molybdenum ion binding,MF,
7193,GO:0030156,1,0.997009462435181,0,1,benzodiazepine receptor binding,MF,
7194,GO:0030157,1,0.924004487011198,0,13,pancreatic juice secretion,BP,
7195,GO:0030158,1,0.976784445515071,0,3,protein xylosyltransferase activity,MF,
7196,GO:0030159,1,0.848792323650848,0,24,receptor signaling complex scaffold activity,MF,
7197,GO:0030160,1,0.969952777695104,0,4,GKAP/Homer scaffold activity,MF,
7201,GO:0030166,1,0.651577449320248,0,60,proteoglycan biosynthetic process,BP,
7202,GO:0030167,1,0.974176364497324,0,4,proteoglycan catabolic process,BP,
7204,GO:0030169,1,0.913277720884733,0,13,low-density lipoprotein particle binding,MF,
7205,GO:0030170,1,0.762999167313068,0,45,pyridoxal phosphate binding,MF,
7206,GO:0030171,1,0.995906953018865,0,1,voltage-gated proton channel activity,MF,
7207,GO:0030172,1,0.990456596085338,0,3,troponin C binding,MF,
7208,GO:0030173,1,0.765274433651514,0,42,integral component of Golgi membrane,CC,
7209,GO:0030174,1,0.964202163682658,0,6,regulation of DNA-dependent DNA replication initiation,BP,
7211,GO:0030176,1,0.441394514866353,0,137,integral component of endoplasmic reticulum membrane,CC,
7212,GO:0030177,1,0.369839089143309,0,160,positive regulation of Wnt signaling pathway,BP,
7215,GO:0030183,1,0.535550445100899,0,96,B cell differentiation,BP,
7216,GO:0030184,1,0.993345078292175,0,1,nitric oxide transmembrane transporter activity,MF,
7217,GO:0030185,1,0.985463474228825,0,3,nitric oxide transport,BP,
7218,GO:0030186,1,0.996365237812487,0,1,melatonin metabolic process,BP,
7219,GO:0030187,1,0.996365237812487,0,1,melatonin biosynthetic process,BP,
7221,GO:0030194,1,0.867628702218744,0,23,positive regulation of blood coagulation,BP,
7223,GO:0030197,1,0.985764993129579,0,2,extracellular matrix constituent, lubricant activity,MF,
7226,GO:0030200,1,0.981734291628346,0,3,heparan sulfate proteoglycan catabolic process,BP,
7227,GO:0030201,1,0.797979700613358,0,31,heparan sulfate proteoglycan metabolic process,BP,
7228,GO:0030202,1,0.939708458547021,0,8,heparin metabolic process,BP,
7231,GO:0030205,1,0.915932022281127,0,13,dermatan sulfate metabolic process,BP,
7232,GO:0030206,1,0.83845256612291,0,25,chondroitin sulfate biosynthetic process,BP,
7233,GO:0030207,1,0.914125728795689,0,14,chondroitin sulfate catabolic process,BP,
7234,GO:0030208,1,0.920775028644163,0,12,dermatan sulfate biosynthetic process,BP,
7235,GO:0030209,1,0.994744803162151,0,1,dermatan sulfate catabolic process,BP,
7236,GO:0030210,1,0.939708458547021,0,8,heparin biosynthetic process,BP,
7237,GO:0030212,1,0.802056321682541,0,34,hyaluronan metabolic process,BP,
7238,GO:0030213,1,0.918021776205614,0,13,hyaluronan biosynthetic process,BP,
7239,GO:0030214,1,0.917221913253703,0,14,hyaluronan catabolic process,BP,
7240,GO:0030215,1,0.859993097802837,0,20,semaphorin receptor binding,MF,
7243,GO:0030218,1,0.52737480898337,0,101,erythrocyte differentiation,BP,
7244,GO:0030219,1,0.641218653306039,0,70,megakaryocyte differentiation,BP,
7245,GO:0030220,1,0.888689023804495,0,18,platelet formation,BP,
7246,GO:0030221,1,0.98867555625971,0,2,basophil differentiation,BP,
7247,GO:0030222,1,0.981552886851017,0,3,eosinophil differentiation,BP,
7248,GO:0030223,1,0.965485674797199,0,6,neutrophil differentiation,BP,
7249,GO:0030224,1,0.822770449335777,0,30,monocyte differentiation,BP,
7250,GO:0030225,1,0.79935594110463,0,37,macrophage differentiation,BP,
7251,GO:0030226,1,0.970387235351976,0,3,apolipoprotein receptor activity,MF,
7253,GO:0030229,1,0.970790489062597,0,4,very-low-density lipoprotein particle receptor activity,MF,
7254,GO:0030233,1,0.996069909566466,0,1,deoxynucleotide transmembrane transporter activity,MF,
7257,GO:0030237,1,0.985574831664369,0,2,female sex determination,BP,
7258,GO:0030238,1,0.913932649636281,0,14,male sex determination,BP,
7260,GO:0030240,1,0.860595564431256,0,10,skeletal muscle thin filament assembly,BP,
7261,GO:0030241,1,0.875928940678963,0,7,skeletal muscle myosin thick filament assembly,BP,
7262,GO:0030242,1,0.963210886918964,0,5,autophagy of peroxisome,BP,
7265,GO:0030249,1,0.982492835055411,0,4,guanylate cyclase regulator activity,MF,
7266,GO:0030250,1,0.982492835055411,0,4,guanylate cyclase activator activity,MF,
7267,GO:0030252,1,0.915363835037385,0,14,growth hormone secretion,BP,
7269,GO:0030259,1,0.960942869520328,0,7,lipid glycosylation,BP,
7271,GO:0030261,1,0.765901037381824,0,27,chromosome condensation,BP,
7272,GO:0030262,1,0.846233699681043,0,28,apoptotic nuclear changes,BP,
7273,GO:0030263,1,0.970942611688887,0,4,apoptotic chromosome condensation,BP,
7274,GO:0030264,1,0.993301131169352,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7275,GO:0030267,1,0.983519415531196,0,3,glyoxylate reductase (NADP) activity,MF,
7276,GO:0030272,1,0.996942727781391,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7277,GO:0030273,1,0.99413856114959,0,1,melanin-concentrating hormone receptor activity,MF,
7278,GO:0030274,1,0.959987808597926,0,6,LIM domain binding,MF,
7279,GO:0030275,1,0.912779882775995,0,15,LRR domain binding,MF,
7280,GO:0030276,1,0.622920342862949,0,69,clathrin binding,MF,
7281,GO:0030277,1,0.915733791881324,0,14,maintenance of gastrointestinal epithelium,BP,
7284,GO:0030280,1,0.969383122749784,0,6,structural constituent of epidermis,MF,
7286,GO:0030283,1,0.996902485895895,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
7287,GO:0030284,1,0.964919993598055,0,5,estrogen receptor activity,MF,
7288,GO:0030285,1,0.894175714992872,0,17,integral component of synaptic vesicle membrane,CC,
7290,GO:0030289,1,0.985452868188343,0,3,protein phosphatase 4 complex,CC,
7291,GO:0030290,1,0.99251155641455,0,1,sphingolipid activator protein activity,MF,
7292,GO:0030291,1,0.828934786583896,0,33,protein serine/threonine kinase inhibitor activity,MF,
7293,GO:0030292,1,0.98247990232489,0,3,protein tyrosine kinase inhibitor activity,MF,
7294,GO:0030294,1,0.994705403002652,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7298,GO:0030299,1,0.95423447081633,0,8,intestinal cholesterol absorption,BP,
7299,GO:0030300,1,0.983110017658817,0,3,regulation of intestinal cholesterol absorption,BP,
7300,GO:0030301,1,0.656308329269541,0,67,cholesterol transport,BP,
7301,GO:0030302,1,0.996069909566466,0,1,deoxynucleotide transport,BP,
7302,GO:0030305,1,0.988290412381055,0,2,heparanase activity,MF,
7303,GO:0030306,1,0.943753730420336,0,8,ADP-ribosylation factor binding,MF,
7306,GO:0030309,1,0.953256538058076,0,8,poly-N-acetyllactosamine metabolic process,BP,
7307,GO:0030311,1,0.960339992749641,0,7,poly-N-acetyllactosamine biosynthetic process,BP,
7308,GO:0030312,1,0.994600712288208,0,1,external encapsulating structure,CC,
7309,GO:0030314,1,0.944751317177452,0,7,junctional membrane complex,CC,
7311,GO:0030316,1,0.599281807917661,0,77,osteoclast differentiation,BP,
7312,GO:0030317,1,0.694858763257374,0,61,flagellated sperm motility,BP,
7314,GO:0030320,1,0.935656813467804,0,10,cellular monovalent inorganic anion homeostasis,BP,
7315,GO:0030321,1,0.970858758526465,0,5,transepithelial chloride transport,BP,
7316,GO:0030322,1,0.926446695078982,0,14,stabilization of membrane potential,BP,
7319,GO:0030325,1,0.889834036486645,0,19,adrenal gland development,BP,
7321,GO:0030327,1,0.978895712905565,0,3,prenylated protein catabolic process,BP,
7322,GO:0030328,1,0.986042984025935,0,2,prenylcysteine catabolic process,BP,
7323,GO:0030329,1,0.986042984025935,0,2,prenylcysteine metabolic process,BP,
7324,GO:0030330,1,0.512528347710651,0,107,DNA damage response, signal transduction by p53 class mediator,BP,
7325,GO:0030331,1,0.778385021416216,0,37,estrogen receptor binding,MF,
7326,GO:0030332,1,0.835226494532504,0,30,cyclin binding,MF,
7330,GO:0030337,1,0.989869749611206,0,2,DNA polymerase processivity factor activity,MF,
7331,GO:0030342,1,0.992738137552516,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7332,GO:0030343,1,0.996121655979269,0,1,vitamin D3 25-hydroxylase activity,MF,
7333,GO:0030345,1,0.992833625013786,0,1,structural constituent of tooth enamel,MF,
7334,GO:0030346,1,0.956209654716857,0,7,protein phosphatase 2B binding,MF,
7335,GO:0030348,1,0.980432263506655,0,3,syntaxin-3 binding,MF,
7336,GO:0030350,1,0.984459661973646,0,2,iron-responsive element binding,MF,
7337,GO:0030351,1,0.993166936961311,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7338,GO:0030366,1,0.992502372491344,0,2,molybdopterin synthase activity,MF,
7339,GO:0030368,1,0.945450087219283,0,8,interleukin-17 receptor activity,MF,
7340,GO:0030369,1,0.985329520641161,0,2,ICAM-3 receptor activity,MF,
7341,GO:0030371,1,0.847442081388184,0,24,translation repressor activity,MF,
7342,GO:0030372,1,0.992342442625979,0,1,high molecular weight B cell growth factor receptor binding,MF,
7343,GO:0030374,1,0.621840987319658,0,68,ligand-dependent nuclear receptor transcription coactivator activity,MF,
7344,GO:0030375,1,0.968987457643347,0,4,thyroid hormone receptor coactivator activity,MF,
7345,GO:0030377,1,0.996409399839959,0,1,urokinase plasminogen activator receptor activity,MF,
7346,GO:0030378,1,0.993980113814259,0,1,serine racemase activity,MF,
7347,GO:0030379,1,0.991664499251414,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7348,GO:0030382,1,0.995872434826374,0,1,sperm mitochondrion organization,BP,
7349,GO:0030387,1,0.996416584606672,0,1,fructosamine-3-kinase activity,MF,
7350,GO:0030388,1,0.975642825472928,0,5,fructose 1,6-bisphosphate metabolic process,BP,
7351,GO:0030389,1,0.993456020760084,0,2,fructosamine metabolic process,BP,
7352,GO:0030393,1,0.996416584606672,0,1,fructoselysine metabolic process,BP,
7353,GO:0030395,1,0.992953918858262,0,2,lactose binding,MF,
7354,GO:0030397,1,0.73961271610895,0,46,membrane disassembly,BP,
7355,GO:0030407,1,0.995515960167866,0,1,formimidoyltransferase activity,MF,
7356,GO:0030409,1,0.995515960167866,0,1,glutamate formimidoyltransferase activity,MF,
7357,GO:0030412,1,0.995515960167866,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7359,GO:0030421,1,0.996934985808316,0,1,defecation,BP,
7360,GO:0030422,1,0.944920210266484,0,9,production of siRNA involved in RNA interference,BP,
7361,GO:0030423,1,0.975252381034096,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7364,GO:0030426,1,0.358853108230395,0,146,growth cone,CC,
7365,GO:0030427,1,0.343338368668742,0,151,site of polarized growth,CC,
7366,GO:0030429,1,0.996338632672028,0,1,kynureninase activity,MF,
7367,GO:0030430,1,0.96497784772179,0,6,host cell cytoplasm,CC,
7368,GO:0030431,1,0.841931142006445,0,30,sleep,BP,
7369,GO:0030432,1,0.958328472507566,0,8,peristalsis,BP,
7370,GO:0030433,1,0.647104866039362,0,70,ubiquitin-dependent ERAD pathway,BP,
7371,GO:0030449,1,0.802042078086108,0,37,regulation of complement activation,BP,
7372,GO:0030450,1,0.985462488528693,0,2,regulation of complement activation, classical pathway,BP,
7373,GO:0030451,1,0.990796430774423,0,1,regulation of complement activation, alternative pathway,BP,
7374,GO:0030473,1,0.959773823907606,0,5,nuclear migration along microtubule,BP,
7375,GO:0030474,1,0.993301131169352,0,1,spindle pole body duplication,BP,
7376,GO:0030478,1,0.970977913284567,0,4,actin cap,CC,
7377,GO:0030479,1,0.950348771735613,0,7,actin cortical patch,CC,
7378,GO:0030485,1,0.988612802288933,0,2,smooth muscle contractile fiber,CC,
7379,GO:0030488,1,0.82923946926082,0,31,tRNA methylation,BP,
7380,GO:0030490,1,0.752452211706143,0,51,maturation of SSU-rRNA,BP,
7381,GO:0030492,1,0.987372498507344,0,4,hemoglobin binding,MF,
7383,GO:0030497,1,0.931853118407487,0,11,fatty acid elongation,BP,
7385,GO:0030501,1,0.792431294776175,0,34,positive regulation of bone mineralization,BP,
7387,GO:0030504,1,0.991236621767589,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7388,GO:0030505,1,0.982824434673487,0,2,inorganic diphosphate transport,BP,
7389,GO:0030506,1,0.865924350740209,0,17,ankyrin binding,MF,
7390,GO:0030507,1,0.829837494276589,0,25,spectrin binding,MF,
7393,GO:0030511,1,0.84910338515168,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7394,GO:0030512,1,0.639533493688983,0,66,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7395,GO:0030513,1,0.809508787480338,0,31,positive regulation of BMP signaling pathway,BP,
7397,GO:0030515,1,0.85630928343138,0,29,snoRNA binding,MF,
7400,GO:0030518,1,0.427873570235847,0,128,intracellular steroid hormone receptor signaling pathway,BP,
7401,GO:0030520,1,0.697319406322103,0,54,intracellular estrogen receptor signaling pathway,BP,
7402,GO:0030521,1,0.664895203156575,0,61,androgen receptor signaling pathway,BP,
7403,GO:0030522,1,0.175492980090973,0,261,intracellular receptor signaling pathway,BP,
7404,GO:0030523,1,0.992422775419686,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7405,GO:0030526,1,0.992330941924007,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7406,GO:0030532,1,0.677702592376102,0,68,small nuclear ribonucleoprotein complex,CC,
7408,GO:0030538,1,0.982767461646895,0,3,embryonic genitalia morphogenesis,BP,
7409,GO:0030539,1,0.888247442633225,0,19,male genitalia development,BP,
7411,GO:0030544,1,0.80544100136834,0,36,Hsp70 protein binding,MF,
7414,GO:0030547,1,0.899175667686587,0,19,receptor inhibitor activity,MF,
7415,GO:0030548,1,0.965631596745263,0,7,acetylcholine receptor regulator activity,MF,
7416,GO:0030549,1,0.996748799772792,0,1,acetylcholine receptor activator activity,MF,
7417,GO:0030550,1,0.976248734279016,0,4,acetylcholine receptor inhibitor activity,MF,
7420,GO:0030553,1,0.913303877783266,0,13,cGMP binding,MF,
7422,GO:0030572,1,0.992472606649392,0,1,phosphatidyltransferase activity,MF,
7423,GO:0030573,1,0.989832187185975,0,2,bile acid catabolic process,BP,
7425,GO:0030575,1,0.919821862740645,0,11,nuclear body organization,BP,
7426,GO:0030576,1,0.980899418544479,0,3,Cajal body organization,BP,
7427,GO:0030578,1,0.969934905349575,0,4,PML body organization,BP,
7428,GO:0030579,1,0.968962603455777,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7429,GO:0030580,1,0.996630186162235,0,1,quinone cofactor methyltransferase activity,MF,
7430,GO:0030581,1,0.992658988004991,0,2,symbiont intracellular protein transport in host,BP,
7431,GO:0030586,1,0.992642954865686,0,1,[methionine synthase] reductase activity,MF,
7432,GO:0030593,1,0.700493865900184,0,69,neutrophil chemotaxis,BP,
7433,GO:0030594,1,0.562610351854589,0,89,neurotransmitter receptor activity,MF,
7435,GO:0030611,1,0.996926999526087,0,1,arsenate reductase activity,MF,
7436,GO:0030613,1,0.990274971787972,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7437,GO:0030614,1,0.990274971787972,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7438,GO:0030616,1,0.991018675731716,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7439,GO:0030617,1,0.985995776142362,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7440,GO:0030618,1,0.959808554520398,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7441,GO:0030619,1,0.962431031391587,0,7,U1 snRNA binding,MF,
7442,GO:0030620,1,0.973132340849688,0,6,U2 snRNA binding,MF,
7443,GO:0030621,1,0.96647090146377,0,5,U4 snRNA binding,MF,
7444,GO:0030622,1,0.986972339280761,0,2,U4atac snRNA binding,MF,
7445,GO:0030623,1,0.99155980925899,0,1,U5 snRNA binding,MF,
7446,GO:0030624,1,0.992418417671425,0,1,U6atac snRNA binding,MF,
7447,GO:0030626,1,0.988033714501845,0,2,U12 snRNA binding,MF,
7448,GO:0030627,1,0.989846533949023,0,2,pre-mRNA 5'-splice site binding,MF,
7449,GO:0030628,1,0.968956404230246,0,6,pre-mRNA 3'-splice site binding,MF,
7450,GO:0030629,1,0.993301131169352,0,1,U6 snRNA 3'-end binding,MF,
7451,GO:0030638,1,0.968307694530493,0,8,polyketide metabolic process,BP,
7452,GO:0030641,1,0.569488796991563,0,89,regulation of cellular pH,BP,
7453,GO:0030643,1,0.958187268717988,0,6,cellular phosphate ion homeostasis,BP,
7454,GO:0030644,1,0.976496709912857,0,4,cellular chloride ion homeostasis,BP,
7455,GO:0030647,1,0.968307694530493,0,8,aminoglycoside antibiotic metabolic process,BP,
7456,GO:0030653,1,0.992276848613409,0,1,beta-lactam antibiotic metabolic process,BP,
7457,GO:0030656,1,0.942542616368929,0,11,regulation of vitamin metabolic process,BP,
7458,GO:0030658,1,0.312480001285163,0,186,transport vesicle membrane,CC,
7462,GO:0030663,1,0.902277603933333,0,18,COPI-coated vesicle membrane,CC,
7465,GO:0030667,1,0.163647625758103,0,282,secretory granule membrane,CC,
7467,GO:0030670,1,0.672467706982832,0,68,phagocytic vesicle membrane,CC,
7468,GO:0030672,1,0.562808482445744,0,91,synaptic vesicle membrane,CC,
7470,GO:0030674,1,0.338186510248524,0,163,protein binding, bridging,MF,
7471,GO:0030676,1,0.885189843537416,0,16,Rac guanyl-nucleotide exchange factor activity,MF,
7472,GO:0030677,1,0.936049987460879,0,13,ribonuclease P complex,CC,
7473,GO:0030678,1,0.983942769127879,0,3,mitochondrial ribonuclease P complex,CC,
7474,GO:0030681,1,0.951333658484033,0,10,multimeric ribonuclease P complex,CC,
7475,GO:0030682,1,0.98573096451553,0,2,evasion or tolerance of host defense response,BP,
7476,GO:0030683,1,0.98573096451553,0,2,evasion or tolerance by virus of host immune response,BP,
7477,GO:0030684,1,0.654246083401901,0,72,preribosome,CC,
7478,GO:0030686,1,0.829306972149207,0,30,90S preribosome,CC,
7479,GO:0030687,1,0.872028102674104,0,24,preribosome, large subunit precursor,CC,
7480,GO:0030688,1,0.929725139195554,0,12,preribosome, small subunit precursor,CC,
7481,GO:0030689,1,0.98243172897636,0,3,Noc complex,CC,
7482,GO:0030690,1,0.993228403794151,0,1,Noc1p-Noc2p complex,CC,
7483,GO:0030691,1,0.993228403794151,0,1,Noc2p-Noc3p complex,CC,
7484,GO:0030692,1,0.989130481313547,0,2,Noc4p-Nop14p complex,CC,
7486,GO:0030696,1,0.992748361192246,0,1,tRNA (m5U54) methyltransferase activity,MF,
7487,GO:0030697,1,0.992748361192246,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7488,GO:0030702,1,0.992455646340497,0,1,chromatin silencing at centromere,BP,
7490,GO:0030718,1,0.988720887821903,0,2,germ-line stem cell population maintenance,BP,
7491,GO:0030719,1,0.986323748024219,0,2,P granule organization,BP,
7492,GO:0030728,1,0.87906499817018,0,19,ovulation,BP,
7493,GO:0030729,1,0.992615890348793,0,1,acetoacetate-CoA ligase activity,MF,
7494,GO:0030730,1,0.918530807659247,0,15,sequestering of triglyceride,BP,
7495,GO:0030731,1,0.996865353565236,0,1,guanidinoacetate N-methyltransferase activity,MF,
7497,GO:0030748,1,0.993786976600625,0,1,amine N-methyltransferase activity,MF,
7499,GO:0030791,1,0.994005796637508,0,1,arsenite methyltransferase activity,MF,
7500,GO:0030792,1,0.994005796637508,0,1,methylarsonite methyltransferase activity,MF,
7501,GO:0030799,1,0.621293829794107,0,81,regulation of cyclic nucleotide metabolic process,BP,
7502,GO:0030800,1,0.847448851771658,0,27,negative regulation of cyclic nucleotide metabolic process,BP,
7503,GO:0030801,1,0.799093411881909,0,43,positive regulation of cyclic nucleotide metabolic process,BP,
7504,GO:0030802,1,0.7123132046074,0,59,regulation of cyclic nucleotide biosynthetic process,BP,
7505,GO:0030803,1,0.867669411311817,0,23,negative regulation of cyclic nucleotide biosynthetic process,BP,
7506,GO:0030804,1,0.845437946726551,0,32,positive regulation of cyclic nucleotide biosynthetic process,BP,
7507,GO:0030805,1,0.976909873962369,0,3,regulation of cyclic nucleotide catabolic process,BP,
7508,GO:0030806,1,0.984783932084435,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7509,GO:0030807,1,0.992005548710546,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7511,GO:0030809,1,0.798475619049767,0,36,negative regulation of nucleotide biosynthetic process,BP,
7514,GO:0030812,1,0.925389216281364,0,12,negative regulation of nucleotide catabolic process,BP,
7516,GO:0030814,1,0.70075586732842,0,61,regulation of cAMP metabolic process,BP,
7517,GO:0030815,1,0.850465732466,0,26,negative regulation of cAMP metabolic process,BP,
7518,GO:0030816,1,0.87570385404486,0,26,positive regulation of cAMP metabolic process,BP,
7519,GO:0030817,1,0.776736314502776,0,43,regulation of cAMP biosynthetic process,BP,
7520,GO:0030818,1,0.870757514482332,0,22,negative regulation of cAMP biosynthetic process,BP,
7521,GO:0030819,1,0.914768920008783,0,17,positive regulation of cAMP biosynthetic process,BP,
7522,GO:0030820,1,0.976909873962369,0,3,regulation of cAMP catabolic process,BP,
7523,GO:0030821,1,0.984783932084435,0,2,negative regulation of cAMP catabolic process,BP,
7524,GO:0030822,1,0.992005548710546,0,1,positive regulation of cAMP catabolic process,BP,
7525,GO:0030823,1,0.881280444113786,0,22,regulation of cGMP metabolic process,BP,
7526,GO:0030824,1,0.996458655415063,0,1,negative regulation of cGMP metabolic process,BP,
7527,GO:0030825,1,0.912631197644577,0,17,positive regulation of cGMP metabolic process,BP,
7528,GO:0030826,1,0.914016886278346,0,17,regulation of cGMP biosynthetic process,BP,
7529,GO:0030827,1,0.996458655415063,0,1,negative regulation of cGMP biosynthetic process,BP,
7530,GO:0030828,1,0.924276974187964,0,15,positive regulation of cGMP biosynthetic process,BP,
7533,GO:0030834,1,0.73456122343541,0,44,regulation of actin filament depolymerization,BP,
7534,GO:0030835,1,0.783615666091042,0,34,negative regulation of actin filament depolymerization,BP,
7535,GO:0030836,1,0.937211142606733,0,10,positive regulation of actin filament depolymerization,BP,
7537,GO:0030838,1,0.587457850406646,0,88,positive regulation of actin filament polymerization,BP,
7538,GO:0030842,1,0.99214385522978,0,1,regulation of intermediate filament depolymerization,BP,
7539,GO:0030844,1,0.99214385522978,0,1,positive regulation of intermediate filament depolymerization,BP,
7540,GO:0030845,1,0.99315298119977,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7541,GO:0030846,1,0.990055841676307,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7542,GO:0030849,1,0.988174276344759,0,2,autosome,CC,
7543,GO:0030850,1,0.724467299713017,0,47,prostate gland development,BP,
7544,GO:0030851,1,0.85705372716688,0,26,granulocyte differentiation,BP,
7545,GO:0030852,1,0.923077365206435,0,13,regulation of granulocyte differentiation,BP,
7546,GO:0030853,1,0.952596709819966,0,7,negative regulation of granulocyte differentiation,BP,
7547,GO:0030854,1,0.961756807325486,0,7,positive regulation of granulocyte differentiation,BP,
7549,GO:0030856,1,0.455750398625977,0,120,regulation of epithelial cell differentiation,BP,
7550,GO:0030857,1,0.808988468688334,0,33,negative regulation of epithelial cell differentiation,BP,
7551,GO:0030858,1,0.726197514502642,0,50,positive regulation of epithelial cell differentiation,BP,
7552,GO:0030859,1,0.884905669625439,0,18,polarized epithelial cell differentiation,BP,
7553,GO:0030860,1,0.986128484001854,0,2,regulation of polarized epithelial cell differentiation,BP,
7554,GO:0030862,1,0.992144600872689,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7560,GO:0030868,1,0.974668246739916,0,5,smooth endoplasmic reticulum membrane,CC,
7561,GO:0030870,1,0.965339959145203,0,5,Mre11 complex,CC,
7562,GO:0030874,1,0.995924480866609,0,1,nucleolar chromatin,CC,
7563,GO:0030877,1,0.914075724975493,0,12,beta-catenin destruction complex,CC,
7564,GO:0030878,1,0.857983808968351,0,25,thyroid gland development,BP,
7566,GO:0030880,1,0.442870438285714,0,134,RNA polymerase complex,CC,
7567,GO:0030881,1,0.965179503456506,0,7,beta-2-microglobulin binding,MF,
7568,GO:0030882,1,0.981306372988231,0,3,lipid antigen binding,MF,
7569,GO:0030883,1,0.981306372988231,0,3,endogenous lipid antigen binding,MF,
7570,GO:0030884,1,0.981306372988231,0,3,exogenous lipid antigen binding,MF,
7571,GO:0030885,1,0.980250394652697,0,5,regulation of myeloid dendritic cell activation,BP,
7572,GO:0030886,1,0.987039525317502,0,3,negative regulation of myeloid dendritic cell activation,BP,
7573,GO:0030887,1,0.996269750547753,0,1,positive regulation of myeloid dendritic cell activation,BP,
7574,GO:0030888,1,0.720224216173801,0,55,regulation of B cell proliferation,BP,
7575,GO:0030889,1,0.905832438544059,0,16,negative regulation of B cell proliferation,BP,
7576,GO:0030890,1,0.811687294240358,0,36,positive regulation of B cell proliferation,BP,
7577,GO:0030891,1,0.975893509880839,0,4,VCB complex,CC,
7578,GO:0030893,1,0.958834247776921,0,6,meiotic cohesin complex,CC,
7579,GO:0030894,1,0.858736442074635,0,26,replisome,CC,
7580,GO:0030895,1,0.989088156137568,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7581,GO:0030896,1,0.971902211099785,0,5,checkpoint clamp complex,CC,
7582,GO:0030897,1,0.901591928272377,0,14,HOPS complex,CC,
7584,GO:0030899,1,0.990357640528941,0,3,calcium-dependent ATPase activity,MF,
7588,GO:0030903,1,0.902102685602128,0,16,notochord development,BP,
7589,GO:0030904,1,0.871615522971241,0,21,retromer complex,CC,
7590,GO:0030905,1,0.974442428440501,0,4,retromer, tubulation complex,CC,
7591,GO:0030906,1,0.97575691789547,0,4,retromer, cargo-selective complex,CC,
7592,GO:0030908,1,0.996195995110822,0,1,protein splicing,BP,
7593,GO:0030910,1,0.971171051538135,0,4,olfactory placode formation,BP,
7594,GO:0030911,1,0.945191465901949,0,8,TPR domain binding,MF,
7596,GO:0030914,1,0.934845866203304,0,11,STAGA complex,CC,
7597,GO:0030915,1,0.970976915205405,0,6,Smc5-Smc6 complex,CC,
7598,GO:0030916,1,0.957372403579466,0,8,otic vesicle formation,BP,
7599,GO:0030917,1,0.961138541323292,0,7,midbrain-hindbrain boundary development,BP,
7600,GO:0030920,1,0.99325102644693,0,2,peptidyl-serine acetylation,BP,
7601,GO:0030934,1,0.973460517412374,0,3,anchoring collagen complex,CC,
7602,GO:0030935,1,0.993621023232784,0,1,sheet-forming collagen trimer,CC,
7603,GO:0030936,1,0.992856680424197,0,1,transmembrane collagen trimer,CC,
7604,GO:0030942,1,0.985313409496884,0,3,endoplasmic reticulum signal peptide binding,MF,
7605,GO:0030943,1,0.982208788348053,0,3,mitochondrion targeting sequence binding,MF,
7606,GO:0030947,1,0.836136683290893,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7607,GO:0030948,1,0.941388828959129,0,9,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7608,GO:0030949,1,0.910650163448069,0,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7609,GO:0030950,1,0.91721992452802,0,14,establishment or maintenance of actin cytoskeleton polarity,BP,
7610,GO:0030951,1,0.971264915596765,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7611,GO:0030952,1,0.890840150242829,0,18,establishment or maintenance of cytoskeleton polarity,BP,
7612,GO:0030953,1,0.948192610764642,0,7,astral microtubule organization,BP,
7613,GO:0030955,1,0.90298298624828,0,14,potassium ion binding,MF,
7614,GO:0030956,1,0.982928265985629,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7615,GO:0030957,1,0.943539996883609,0,10,Tat protein binding,MF,
7616,GO:0030961,1,0.993301131169352,0,1,peptidyl-arginine hydroxylation,BP,
7617,GO:0030964,1,0.855776969073922,0,43,NADH dehydrogenase complex,CC,
7619,GO:0030969,1,0.979563455300745,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7620,GO:0030970,1,0.848765910503146,0,26,retrograde protein transport, ER to cytosol,BP,
7621,GO:0030971,1,0.695111628172593,0,55,receptor tyrosine kinase binding,MF,
7622,GO:0030974,1,0.989668753505271,0,2,thiamine pyrophosphate transmembrane transport,BP,
7623,GO:0030975,1,0.994295209234908,0,1,thiamine binding,MF,
7624,GO:0030976,1,0.967205432020034,0,5,thiamine pyrophosphate binding,MF,
7625,GO:0030977,1,0.995721094910161,0,1,taurine binding,MF,
7626,GO:0030981,1,0.976747405461959,0,3,cortical microtubule cytoskeleton,CC,
7627,GO:0030983,1,0.918112165466008,0,13,mismatched DNA binding,MF,
7628,GO:0030984,1,0.990058035756316,0,2,kininogen binding,MF,
7629,GO:0030990,1,0.815548474649305,0,31,intraciliary transport particle,CC,
7630,GO:0030991,1,0.942107264772561,0,8,intraciliary transport particle A,CC,
7631,GO:0030992,1,0.882113368584344,0,20,intraciliary transport particle B,CC,
7632,GO:0030997,1,0.978806871062472,0,3,regulation of centriole-centriole cohesion,BP,
7633,GO:0031000,1,0.87434652733202,0,18,response to caffeine,BP,
7634,GO:0031001,1,0.993301131169352,0,1,response to brefeldin A,BP,
7635,GO:0031005,1,0.924179378722716,0,11,filamin binding,MF,
7636,GO:0031010,1,0.924696318554011,0,11,ISWI-type complex,CC,
7637,GO:0031011,1,0.926728410443717,0,15,Ino80 complex,CC,
7639,GO:0031013,1,0.979372973198239,0,5,troponin I binding,MF,
7640,GO:0031014,1,0.987917234111541,0,4,troponin T binding,MF,
7642,GO:0031017,1,0.971827840598072,0,5,exocrine pancreas development,BP,
7644,GO:0031021,1,0.982898182030027,0,3,interphase microtubule organizing center,CC,
7645,GO:0031022,1,0.98199575306963,0,2,nuclear migration along microfilament,BP,
7646,GO:0031023,1,0.434073126131151,0,123,microtubule organizing center organization,BP,
7648,GO:0031033,1,0.832290969123536,0,15,myosin filament organization,BP,
7649,GO:0031034,1,0.836500386313122,0,14,myosin filament assembly,BP,
7650,GO:0031038,1,0.99497714214688,0,1,myosin II filament organization,BP,
7651,GO:0031045,1,0.916158077193684,0,13,dense core granule,CC,
7653,GO:0031048,1,0.985749442235048,0,2,chromatin silencing by small RNA,BP,
7654,GO:0031049,1,0.993199948660582,0,1,programmed DNA elimination,BP,
7656,GO:0031052,1,0.993199948660582,0,1,chromosome breakage,BP,
7657,GO:0031053,1,0.93200087708639,0,10,primary miRNA processing,BP,
7658,GO:0031054,1,0.916885857028759,0,13,pre-miRNA processing,BP,
7659,GO:0031055,1,0.846490489031736,0,32,chromatin remodeling at centromere,BP,
7660,GO:0031056,1,0.405445507537827,0,132,regulation of histone modification,BP,
7661,GO:0031057,1,0.778535392031647,0,37,negative regulation of histone modification,BP,
7662,GO:0031058,1,0.580593623457337,0,81,positive regulation of histone modification,BP,
7663,GO:0031060,1,0.66601397416213,0,57,regulation of histone methylation,BP,
7664,GO:0031061,1,0.887740600017954,0,17,negative regulation of histone methylation,BP,
7665,GO:0031062,1,0.794363247036204,0,33,positive regulation of histone methylation,BP,
7666,GO:0031063,1,0.847052246915501,0,25,regulation of histone deacetylation,BP,
7667,GO:0031064,1,0.97386794885509,0,4,negative regulation of histone deacetylation,BP,
7668,GO:0031065,1,0.887643737835627,0,17,positive regulation of histone deacetylation,BP,
7669,GO:0031069,1,0.856589897812457,0,24,hair follicle morphogenesis,BP,
7670,GO:0031071,1,0.994244463790067,0,1,cysteine desulfurase activity,MF,
7671,GO:0031072,1,0.4929813760648,0,110,heat shock protein binding,MF,
7672,GO:0031074,1,0.981537574981999,0,3,nucleocytoplasmic transport complex,CC,
7673,GO:0031076,1,0.760774037515214,0,37,embryonic camera-type eye development,BP,
7674,GO:0031077,1,0.957886063344935,0,7,post-embryonic camera-type eye development,BP,
7675,GO:0031078,1,0.927272663647401,0,11,histone deacetylase activity (H3-K14 specific),MF,
7676,GO:0031080,1,0.935966131690908,0,10,nuclear pore outer ring,CC,
7677,GO:0031081,1,0.985793607386776,0,2,nuclear pore distribution,BP,
7678,GO:0031082,1,0.893760949206554,0,19,BLOC complex,CC,
7679,GO:0031083,1,0.926409136192517,0,14,BLOC-1 complex,CC,
7680,GO:0031084,1,0.978500959941093,0,3,BLOC-2 complex,CC,
7681,GO:0031085,1,0.985986754072364,0,2,BLOC-3 complex,CC,
7682,GO:0031086,1,0.958440787474525,0,7,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7683,GO:0031087,1,0.965290087268332,0,6,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7684,GO:0031088,1,0.962041181150447,0,6,platelet dense granule membrane,CC,
7685,GO:0031089,1,0.946051403600858,0,11,platelet dense granule lumen,CC,
7687,GO:0031091,1,0.595418317006697,0,84,platelet alpha granule,CC,
7688,GO:0031092,1,0.896126130517799,0,16,platelet alpha granule membrane,CC,
7689,GO:0031093,1,0.686391066281874,0,63,platelet alpha granule lumen,CC,
7690,GO:0031094,1,0.914888427241339,0,11,platelet dense tubular network,CC,
7691,GO:0031095,1,0.927008934093369,0,9,platelet dense tubular network membrane,CC,
7697,GO:0031104,1,0.992451364415594,0,1,dendrite regeneration,BP,
7698,GO:0031105,1,0.921569942691216,0,12,septin complex,CC,
7703,GO:0031112,1,0.835366267136446,0,27,positive regulation of microtubule polymerization or depolymerization,BP,
7705,GO:0031114,1,0.833131131316133,0,26,regulation of microtubule depolymerization,BP,
7707,GO:0031116,1,0.849489355117832,0,24,positive regulation of microtubule polymerization,BP,
7708,GO:0031117,1,0.983402608965762,0,3,positive regulation of microtubule depolymerization,BP,
7709,GO:0031118,1,0.968109365626794,0,8,rRNA pseudouridine synthesis,BP,
7710,GO:0031119,1,0.967103732442811,0,7,tRNA pseudouridine synthesis,BP,
7711,GO:0031120,1,0.984387157026507,0,4,snRNA pseudouridine synthesis,BP,
7712,GO:0031122,1,0.688123613395759,0,52,cytoplasmic microtubule organization,BP,
7713,GO:0031123,1,0.476241300166757,0,120,RNA 3'-end processing,BP,
7714,GO:0031124,1,0.570887760535272,0,88,mRNA 3'-end processing,BP,
7715,GO:0031125,1,0.951831005951531,0,12,rRNA 3'-end processing,BP,
7716,GO:0031126,1,0.972067788087047,0,7,snoRNA 3'-end processing,BP,
7717,GO:0031127,1,0.992436627667326,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7718,GO:0031128,1,0.838081399440431,0,28,developmental induction,BP,
7719,GO:0031129,1,0.992245980908204,0,1,inductive cell-cell signaling,BP,
7721,GO:0031134,1,0.981428182981223,0,3,sister chromatid biorientation,BP,
7723,GO:0031145,1,0.697398414722768,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7724,GO:0031146,1,0.705855454193818,0,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7725,GO:0031151,1,0.991514931419275,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7726,GO:0031161,1,0.99276418842986,0,1,phosphatidylinositol catabolic process,BP,
7727,GO:0031163,1,0.907364455028108,0,20,metallo-sulfur cluster assembly,BP,
7728,GO:0031166,1,0.978098271814949,0,3,integral component of vacuolar membrane,CC,
7729,GO:0031167,1,0.903914819808447,0,18,rRNA methylation,BP,
7731,GO:0031177,1,0.985264160160243,0,3,phosphopantetheine binding,MF,
7732,GO:0031179,1,0.992481381771526,0,1,peptide modification,BP,
7733,GO:0031201,1,0.752267557218635,0,49,SNARE complex,CC,
7734,GO:0031204,1,0.981399316778141,0,3,posttranslational protein targeting to membrane, translocation,BP,
7735,GO:0031205,1,0.981263454961242,0,3,endoplasmic reticulum Sec complex,CC,
7736,GO:0031208,1,0.985559526171136,0,2,POZ domain binding,MF,
7737,GO:0031209,1,0.941096867404392,0,8,SCAR complex,CC,
7739,GO:0031211,1,0.953633288853997,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7740,GO:0031213,1,0.984784057026834,0,2,RSF complex,CC,
7742,GO:0031223,1,0.9176400714914,0,11,auditory behavior,BP,
7746,GO:0031227,1,0.429895222916912,0,141,intrinsic component of endoplasmic reticulum membrane,CC,
7747,GO:0031228,1,0.745589793310386,0,46,intrinsic component of Golgi membrane,CC,
7748,GO:0031229,1,0.914022207877022,0,14,intrinsic component of nuclear inner membrane,CC,
7749,GO:0031231,1,0.912131684369872,0,17,intrinsic component of peroxisomal membrane,CC,
7751,GO:0031233,1,0.908176181329095,0,18,intrinsic component of external side of plasma membrane,CC,
7752,GO:0031234,1,0.508987853939149,0,105,extrinsic component of cytoplasmic side of plasma membrane,CC,
7753,GO:0031235,1,0.894767120807442,0,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7754,GO:0031247,1,0.988554549966425,0,2,actin rod assembly,BP,
7755,GO:0031248,1,0.580528413561524,0,85,protein acetyltransferase complex,CC,
7756,GO:0031249,1,0.99412804963196,0,1,denatured protein binding,MF,
7757,GO:0031251,1,0.984389467302033,0,2,PAN complex,CC,
7760,GO:0031254,1,0.922182548538408,0,13,cell trailing edge,CC,
7762,GO:0031257,1,0.993301131169352,0,1,cell trailing edge membrane,CC,
7763,GO:0031258,1,0.856713598376502,0,22,lamellipodium membrane,CC,
7764,GO:0031259,1,0.993301131169352,0,1,uropod membrane,CC,
7765,GO:0031261,1,0.970925622628899,0,5,DNA replication preinitiation complex,CC,
7766,GO:0031262,1,0.983893757177349,0,4,Ndc80 complex,CC,
7767,GO:0031264,1,0.947579358790815,0,9,death-inducing signaling complex,CC,
7768,GO:0031265,1,0.964349816167474,0,6,CD95 death-inducing signaling complex,CC,
7770,GO:0031268,1,0.924453015529406,0,13,pseudopodium organization,BP,
7771,GO:0031269,1,0.924453015529406,0,13,pseudopodium assembly,BP,
7772,GO:0031271,1,0.993301131169352,0,1,lateral pseudopodium assembly,BP,
7773,GO:0031272,1,0.924453015529406,0,13,regulation of pseudopodium assembly,BP,
7774,GO:0031274,1,0.930692251189293,0,12,positive regulation of pseudopodium assembly,BP,
7775,GO:0031275,1,0.993301131169352,0,1,regulation of lateral pseudopodium assembly,BP,
7776,GO:0031279,1,0.774934482425769,0,42,regulation of cyclase activity,BP,
7777,GO:0031280,1,0.873594971932673,0,22,negative regulation of cyclase activity,BP,
7778,GO:0031281,1,0.913373020319538,0,16,positive regulation of cyclase activity,BP,
7779,GO:0031282,1,0.95344568869139,0,9,regulation of guanylate cyclase activity,BP,
7780,GO:0031283,1,0.996458655415063,0,1,negative regulation of guanylate cyclase activity,BP,
7781,GO:0031284,1,0.956835732944779,0,8,positive regulation of guanylate cyclase activity,BP,
7782,GO:0031289,1,0.992872187664583,0,1,actin phosphorylation,BP,
7783,GO:0031290,1,0.867649146159574,0,19,retinal ganglion cell axon guidance,BP,
7784,GO:0031291,1,0.982385197690192,0,3,Ran protein signal transduction,BP,
7786,GO:0031294,1,0.682678273790489,0,68,lymphocyte costimulation,BP,
7787,GO:0031295,1,0.684938849450868,0,67,T cell costimulation,BP,
7788,GO:0031296,1,0.990381972946003,0,3,B cell costimulation,BP,
7789,GO:0031297,1,0.83385695678682,0,27,replication fork processing,BP,
7790,GO:0031298,1,0.947464986438397,0,9,replication fork protection complex,CC,
7791,GO:0031300,1,0.330982474811677,0,182,intrinsic component of organelle membrane,CC,
7792,GO:0031301,1,0.361801500119958,0,167,integral component of organelle membrane,CC,
7793,GO:0031302,1,0.992263439134161,0,1,intrinsic component of endosome membrane,CC,
7794,GO:0031304,1,0.825254960567632,0,35,intrinsic component of mitochondrial inner membrane,CC,
7795,GO:0031305,1,0.825254960567632,0,35,integral component of mitochondrial inner membrane,CC,
7796,GO:0031306,1,0.868838989425107,0,23,intrinsic component of mitochondrial outer membrane,CC,
7797,GO:0031307,1,0.875519895251686,0,22,integral component of mitochondrial outer membrane,CC,
7798,GO:0031308,1,0.993301131169352,0,1,intrinsic component of nuclear outer membrane,CC,
7799,GO:0031309,1,0.993301131169352,0,1,integral component of nuclear outer membrane,CC,
7800,GO:0031310,1,0.978098271814949,0,3,intrinsic component of vacuolar membrane,CC,
7802,GO:0031313,1,0.948497511390681,0,8,extrinsic component of endosome membrane,CC,
7803,GO:0031314,1,0.965567192213179,0,5,extrinsic component of mitochondrial inner membrane,CC,
7805,GO:0031320,1,0.993856193451521,0,1,hexitol dehydrogenase activity,MF,
7813,GO:0031330,1,0.257134569144518,0,208,negative regulation of cellular catabolic process,BP,
7815,GO:0031332,1,0.922502193876763,0,11,RNAi effector complex,CC,
7817,GO:0031334,1,0.230283930634846,0,232,positive regulation of protein complex assembly,BP,
7818,GO:0031335,1,0.988496463797337,0,2,regulation of sulfur amino acid metabolic process,BP,
7819,GO:0031337,1,0.994539565949337,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7820,GO:0031338,1,0.681231320849437,0,57,regulation of vesicle fusion,BP,
7821,GO:0031339,1,0.959669339702592,0,6,negative regulation of vesicle fusion,BP,
7822,GO:0031340,1,0.959936102741534,0,7,positive regulation of vesicle fusion,BP,
7824,GO:0031342,1,0.916584125501907,0,16,negative regulation of cell killing,BP,
7832,GO:0031362,1,0.926707526886743,0,14,anchored component of external side of plasma membrane,CC,
7833,GO:0031365,1,0.837146757091909,0,28,N-terminal protein amino acid modification,BP,
7834,GO:0031369,1,0.84063044729361,0,29,translation initiation factor binding,MF,
7835,GO:0031370,1,0.992353113907669,0,1,eukaryotic initiation factor 4G binding,MF,
7836,GO:0031371,1,0.955773715253871,0,8,ubiquitin conjugating enzyme complex,CC,
7837,GO:0031372,1,0.990113726105623,0,2,UBC13-MMS2 complex,CC,
7838,GO:0031379,1,0.985155289578224,0,2,RNA-directed RNA polymerase complex,CC,
7839,GO:0031380,1,0.992642954865686,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7840,GO:0031386,1,0.930248176185156,0,16,protein tag,MF,
7841,GO:0031389,1,0.993081206805305,0,1,Rad17 RFC-like complex,CC,
7842,GO:0031390,1,0.956395401134022,0,8,Ctf18 RFC-like complex,CC,
7843,GO:0031392,1,0.966990376726827,0,5,regulation of prostaglandin biosynthetic process,BP,
7844,GO:0031393,1,0.985308653142517,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7845,GO:0031394,1,0.981411428763689,0,3,positive regulation of prostaglandin biosynthetic process,BP,
7846,GO:0031396,1,0.343226617136338,0,170,regulation of protein ubiquitination,BP,
7847,GO:0031397,1,0.685446439741709,0,61,negative regulation of protein ubiquitination,BP,
7848,GO:0031398,1,0.545907838637286,0,97,positive regulation of protein ubiquitination,BP,
7853,GO:0031403,1,0.98418260919845,0,2,lithium ion binding,MF,
7854,GO:0031404,1,0.948913193962604,0,9,chloride ion binding,MF,
7855,GO:0031405,1,0.990153871929328,0,1,lipoic acid binding,MF,
7857,GO:0031407,1,0.994279157129522,0,1,oxylipin metabolic process,BP,
7859,GO:0031414,1,0.939388569142976,0,10,N-terminal protein acetyltransferase complex,CC,
7860,GO:0031415,1,0.973835117019385,0,5,NatA complex,CC,
7861,GO:0031416,1,0.988903788798692,0,2,NatB complex,CC,
7862,GO:0031417,1,0.97546428451764,0,3,NatC complex,CC,
7863,GO:0031418,1,0.881643723068884,0,20,L-ascorbic acid binding,MF,
7864,GO:0031419,1,0.942565463236777,0,9,cobalamin binding,MF,
7867,GO:0031427,1,0.974326381120431,0,4,response to methotrexate,BP,
7868,GO:0031428,1,0.983570823797388,0,4,box C/D snoRNP complex,CC,
7869,GO:0031429,1,0.981196971721868,0,5,box H/ACA snoRNP complex,CC,
7870,GO:0031430,1,0.75848214515049,0,29,M band,CC,
7871,GO:0031431,1,0.985744997767118,0,2,Dbf4-dependent protein kinase complex,CC,
7873,GO:0031433,1,0.888590401002872,0,6,telethonin binding,MF,
7875,GO:0031435,1,0.899991517436611,0,15,mitogen-activated protein kinase kinase kinase binding,MF,
7876,GO:0031436,1,0.985366555986282,0,2,BRCA1-BARD1 complex,CC,
7877,GO:0031437,1,0.979522521354592,0,3,regulation of mRNA cleavage,BP,
7878,GO:0031438,1,0.992840440588041,0,1,negative regulation of mRNA cleavage,BP,
7879,GO:0031439,1,0.986587039342734,0,2,positive regulation of mRNA cleavage,BP,
7880,GO:0031440,1,0.863822729614573,0,22,regulation of mRNA 3'-end processing,BP,
7881,GO:0031441,1,0.938711887892008,0,9,negative regulation of mRNA 3'-end processing,BP,
7882,GO:0031442,1,0.944709057684192,0,9,positive regulation of mRNA 3'-end processing,BP,
7883,GO:0031443,1,0.984302466728036,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7884,GO:0031444,1,0.985658233388002,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7885,GO:0031445,1,0.986738377045665,0,2,regulation of heterochromatin assembly,BP,
7886,GO:0031446,1,0.99252563770891,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7887,GO:0031448,1,0.99252563770891,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7888,GO:0031449,1,0.991986201570728,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7889,GO:0031453,1,0.986738377045665,0,2,positive regulation of heterochromatin assembly,BP,
7890,GO:0031455,1,0.985067672908262,0,2,glycine betaine metabolic process,BP,
7891,GO:0031456,1,0.985067672908262,0,2,glycine betaine biosynthetic process,BP,
7892,GO:0031460,1,0.992321595354805,0,1,glycine betaine transport,BP,
7893,GO:0031461,1,0.310132904514937,0,180,cullin-RING ubiquitin ligase complex,CC,
7894,GO:0031462,1,0.916619972818403,0,14,Cul2-RING ubiquitin ligase complex,CC,
7895,GO:0031463,1,0.637690475816033,0,66,Cul3-RING ubiquitin ligase complex,CC,
7896,GO:0031464,1,0.92929190869448,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7897,GO:0031465,1,0.970105044863839,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7898,GO:0031466,1,0.967845655175136,0,6,Cul5-RING ubiquitin ligase complex,CC,
7899,GO:0031467,1,0.972346303890796,0,5,Cul7-RING ubiquitin ligase complex,CC,
7900,GO:0031468,1,0.904436387077229,0,18,nuclear envelope reassembly,BP,
7901,GO:0031475,1,0.99628593652949,0,1,myosin V complex,CC,
7902,GO:0031477,1,0.991541698684007,0,1,myosin VII complex,CC,
7903,GO:0031489,1,0.910525186221094,0,16,myosin V binding,MF,
7904,GO:0031490,1,0.566811174814693,0,91,chromatin DNA binding,MF,
7905,GO:0031491,1,0.716849141913552,0,55,nucleosome binding,MF,
7906,GO:0031492,1,0.837743121890651,0,32,nucleosomal DNA binding,MF,
7907,GO:0031493,1,0.989268861673235,0,2,nucleosomal histone binding,MF,
7908,GO:0031497,1,0.545924592209259,0,108,chromatin assembly,BP,
7909,GO:0031498,1,0.882350306505484,0,19,chromatin disassembly,BP,
7910,GO:0031501,1,0.984534126386715,0,4,mannosyltransferase complex,CC,
7912,GO:0031506,1,0.995805808593524,0,1,cell wall glycoprotein biosynthetic process,BP,
7913,GO:0031507,1,0.945480302618697,0,9,heterochromatin assembly,BP,
7914,GO:0031508,1,0.989555034535714,0,2,pericentric heterochromatin assembly,BP,
7915,GO:0031509,1,0.99608114730034,0,1,telomeric heterochromatin assembly,BP,
7916,GO:0031510,1,0.984004662128536,0,3,SUMO activating enzyme complex,CC,
7918,GO:0031515,1,0.982839687713312,0,3,tRNA (m1A) methyltransferase complex,CC,
7919,GO:0031519,1,0.733072820688772,0,46,PcG protein complex,CC,
7920,GO:0031523,1,0.984578069292727,0,2,Myb complex,CC,
7922,GO:0031527,1,0.88419301180436,0,17,filopodium membrane,CC,
7923,GO:0031528,1,0.86999631219662,0,21,microvillus membrane,CC,
7924,GO:0031529,1,0.762842883010256,0,44,ruffle organization,BP,
7925,GO:0031530,1,0.993036711293047,0,2,gonadotropin-releasing hormone receptor binding,MF,
7926,GO:0031531,1,0.996559931641343,0,1,thyrotropin-releasing hormone receptor binding,MF,
7928,GO:0031533,1,0.991939458536388,0,1,mRNA cap methyltransferase complex,CC,
7929,GO:0031536,1,0.981992346271534,0,4,positive regulation of exit from mitosis,BP,
7930,GO:0031543,1,0.927224255937166,0,12,peptidyl-proline dioxygenase activity,MF,
7931,GO:0031544,1,0.973073545008725,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7932,GO:0031545,1,0.952895065345407,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7933,GO:0031547,1,0.960996700074814,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
7934,GO:0031548,1,0.984706274600101,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7935,GO:0031549,1,0.992191273598105,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7936,GO:0031550,1,0.992456705669087,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7937,GO:0031554,1,0.990055841676307,0,1,regulation of DNA-templated transcription, termination,BP,
7938,GO:0031559,1,0.992434831481106,0,1,oxidosqualene cyclase activity,MF,
7939,GO:0031570,1,0.362214854015332,0,157,DNA integrity checkpoint,BP,
7940,GO:0031571,1,0.652528512586771,0,69,mitotic G1 DNA damage checkpoint,BP,
7941,GO:0031572,1,0.798038165023746,0,32,G2 DNA damage checkpoint,BP,
7942,GO:0031573,1,0.92424512295544,0,14,intra-S DNA damage checkpoint,BP,
7943,GO:0031577,1,0.807908451410242,0,34,spindle checkpoint,BP,
7946,GO:0031581,1,0.921537958287547,0,11,hemidesmosome assembly,BP,
7947,GO:0031583,1,0.995005255875637,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7948,GO:0031584,1,0.972212196452077,0,5,activation of phospholipase D activity,BP,
7949,GO:0031585,1,0.963570638011883,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7950,GO:0031587,1,0.973801938408471,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7951,GO:0031588,1,0.939047356850791,0,9,nucleotide-activated protein kinase complex,CC,
7953,GO:0031590,1,0.986406140724537,0,2,wybutosine metabolic process,BP,
7954,GO:0031591,1,0.986406140724537,0,2,wybutosine biosynthetic process,BP,
7955,GO:0031592,1,0.991336507742264,0,1,centrosomal corona,CC,
7956,GO:0031593,1,0.788833766446311,0,35,polyubiquitin modification-dependent protein binding,MF,
7957,GO:0031594,1,0.68236080371549,0,56,neuromuscular junction,CC,
7958,GO:0031595,1,0.966619607057843,0,8,nuclear proteasome complex,CC,
7959,GO:0031597,1,0.941706041821591,0,12,cytosolic proteasome complex,CC,
7960,GO:0031616,1,0.948874435853239,0,10,spindle pole centrosome,CC,
7961,GO:0031618,1,0.936940213868077,0,9,nuclear pericentric heterochromatin,CC,
7962,GO:0031620,1,0.958047354071244,0,7,regulation of fever generation,BP,
7963,GO:0031622,1,0.965356189218637,0,6,positive regulation of fever generation,BP,
7965,GO:0031624,1,0.785100450387688,0,33,ubiquitin conjugating enzyme binding,MF,
7967,GO:0031626,1,0.992244101759092,0,1,beta-endorphin binding,MF,
7968,GO:0031627,1,0.978750136935153,0,3,telomeric loop formation,BP,
7969,GO:0031628,1,0.956213675159396,0,8,opioid receptor binding,MF,
7970,GO:0031629,1,0.910642585703356,0,16,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7971,GO:0031630,1,0.981412051350276,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7972,GO:0031635,1,0.987937893396754,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7973,GO:0031638,1,0.785548743417073,0,41,zymogen activation,BP,
7974,GO:0031639,1,0.891770243819553,0,20,plasminogen activation,BP,
7975,GO:0031640,1,0.856834366743494,0,37,killing of cells of other organism,BP,
7977,GO:0031642,1,0.955881086276054,0,6,negative regulation of myelination,BP,
7980,GO:0031645,1,0.923840866308417,0,12,negative regulation of neurological system process,BP,
7983,GO:0031648,1,0.759022386453594,0,42,protein destabilization,BP,
7984,GO:0031649,1,0.893132110537857,0,18,heat generation,BP,
7985,GO:0031650,1,0.926778582368733,0,12,regulation of heat generation,BP,
7986,GO:0031651,1,0.99244496107208,0,1,negative regulation of heat generation,BP,
7987,GO:0031652,1,0.940964837535015,0,10,positive regulation of heat generation,BP,
7989,GO:0031658,1,0.96079601449333,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7991,GO:0031663,1,0.744522247621957,0,49,lipopolysaccharide-mediated signaling pathway,BP,
7992,GO:0031664,1,0.881201327781181,0,21,regulation of lipopolysaccharide-mediated signaling pathway,BP,
7993,GO:0031665,1,0.9438110020806,0,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7994,GO:0031666,1,0.954484852075596,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7996,GO:0031668,1,0.242725328789033,0,224,cellular response to extracellular stimulus,BP,
7997,GO:0031669,1,0.286272864832479,0,196,cellular response to nutrient levels,BP,
7998,GO:0031670,1,0.692076868102333,0,59,cellular response to nutrient,BP,
7999,GO:0031672,1,0.708276044869625,0,39,A band,CC,
8000,GO:0031673,1,0.986419105604964,0,1,H zone,CC,
8002,GO:0031681,1,0.945703207423906,0,9,G-protein beta-subunit binding,MF,
8003,GO:0031682,1,0.992882552424549,0,1,G-protein gamma-subunit binding,MF,
8004,GO:0031683,1,0.894368687973433,0,18,G-protein beta/gamma-subunit complex binding,MF,
8005,GO:0031685,1,0.981501552319274,0,3,adenosine receptor binding,MF,
8006,GO:0031686,1,0.992809364092676,0,1,A1 adenosine receptor binding,MF,
8007,GO:0031687,1,0.996128904388862,0,1,A2A adenosine receptor binding,MF,
8008,GO:0031690,1,0.894280418189871,0,18,adrenergic receptor binding,MF,
8009,GO:0031691,1,0.990246510568283,0,2,alpha-1A adrenergic receptor binding,MF,
8010,GO:0031692,1,0.982785956277659,0,3,alpha-1B adrenergic receptor binding,MF,
8011,GO:0031694,1,0.979491995425212,0,4,alpha-2A adrenergic receptor binding,MF,
8012,GO:0031695,1,0.994032894292127,0,1,alpha-2B adrenergic receptor binding,MF,
8013,GO:0031696,1,0.98654411025362,0,2,alpha-2C adrenergic receptor binding,MF,
8014,GO:0031697,1,0.970304328378172,0,4,beta-1 adrenergic receptor binding,MF,
8015,GO:0031698,1,0.974173346060278,0,4,beta-2 adrenergic receptor binding,MF,
8016,GO:0031699,1,0.986080473743059,0,2,beta-3 adrenergic receptor binding,MF,
8017,GO:0031700,1,0.996396341454692,0,1,adrenomedullin receptor binding,MF,
8018,GO:0031701,1,0.92971245442577,0,11,angiotensin receptor binding,MF,
8019,GO:0031702,1,0.934649270158479,0,10,type 1 angiotensin receptor binding,MF,
8020,GO:0031703,1,0.993733497795061,0,1,type 2 angiotensin receptor binding,MF,
8021,GO:0031704,1,0.992697729352287,0,1,apelin receptor binding,MF,
8022,GO:0031705,1,0.985423925942056,0,3,bombesin receptor binding,MF,
8023,GO:0031707,1,0.995005255875637,0,1,endothelin A receptor binding,MF,
8024,GO:0031708,1,0.985423925942056,0,3,endothelin B receptor binding,MF,
8025,GO:0031711,1,0.987026946536555,0,2,bradykinin receptor binding,MF,
8026,GO:0031714,1,0.992261871882962,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8027,GO:0031715,1,0.992261871882962,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8028,GO:0031717,1,0.996071788205092,0,1,cannabinoid receptor binding,MF,
8029,GO:0031718,1,0.996071788205092,0,1,type 1 cannabinoid receptor binding,MF,
8030,GO:0031720,1,0.991183076218718,0,3,haptoglobin binding,MF,
8031,GO:0031724,1,0.996699166694483,0,1,CXCR5 chemokine receptor binding,MF,
8032,GO:0031726,1,0.996982467930466,0,1,CCR1 chemokine receptor binding,MF,
8033,GO:0031727,1,0.987963751145683,0,3,CCR2 chemokine receptor binding,MF,
8034,GO:0031728,1,0.994153158642531,0,2,CCR3 chemokine receptor binding,MF,
8035,GO:0031730,1,0.97438292017379,0,4,CCR5 chemokine receptor binding,MF,
8036,GO:0031731,1,0.994054039708422,0,2,CCR6 chemokine receptor binding,MF,
8037,GO:0031732,1,0.993984711482021,0,2,CCR7 chemokine receptor binding,MF,
8038,GO:0031735,1,0.990695402361314,0,3,CCR10 chemokine receptor binding,MF,
8039,GO:0031737,1,0.992659845080405,0,1,CX3C chemokine receptor binding,MF,
8040,GO:0031739,1,0.994947615481502,0,1,cholecystokinin receptor binding,MF,
8041,GO:0031741,1,0.994947615481502,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8042,GO:0031748,1,0.957368350233055,0,7,D1 dopamine receptor binding,MF,
8043,GO:0031749,1,0.98130247915213,0,3,D2 dopamine receptor binding,MF,
8044,GO:0031750,1,0.989277152506514,0,2,D3 dopamine receptor binding,MF,
8045,GO:0031751,1,0.996019291941946,0,1,D4 dopamine receptor binding,MF,
8046,GO:0031752,1,0.980468101042104,0,3,D5 dopamine receptor binding,MF,
8047,GO:0031753,1,0.993268085345221,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8048,GO:0031755,1,0.993268085345221,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8049,GO:0031762,1,0.990246510568283,0,2,follicle-stimulating hormone receptor binding,MF,
8050,GO:0031763,1,0.996992964303392,0,1,galanin receptor binding,MF,
8051,GO:0031764,1,0.996992964303392,0,1,type 1 galanin receptor binding,MF,
8052,GO:0031765,1,0.996992964303392,0,1,type 2 galanin receptor binding,MF,
8053,GO:0031766,1,0.996992964303392,0,1,type 3 galanin receptor binding,MF,
8054,GO:0031768,1,0.997018312941827,0,1,ghrelin receptor binding,MF,
8055,GO:0031770,1,0.997081962676715,0,1,growth hormone-releasing hormone receptor binding,MF,
8056,GO:0031773,1,0.997019024389068,0,1,kisspeptin receptor binding,MF,
8057,GO:0031775,1,0.991224471578046,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8058,GO:0031779,1,0.985442058425015,0,4,melanocortin receptor binding,MF,
8059,GO:0031780,1,0.991695994158769,0,2,corticotropin hormone receptor binding,MF,
8060,GO:0031781,1,0.985442058425015,0,4,type 3 melanocortin receptor binding,MF,
8061,GO:0031782,1,0.985442058425015,0,4,type 4 melanocortin receptor binding,MF,
8062,GO:0031783,1,0.991695994158769,0,2,type 5 melanocortin receptor binding,MF,
8063,GO:0031798,1,0.991444772480553,0,1,type 1 metabotropic glutamate receptor binding,MF,
8064,GO:0031802,1,0.970149090881613,0,5,type 5 metabotropic glutamate receptor binding,MF,
8065,GO:0031811,1,0.992464458558581,0,1,G-protein coupled nucleotide receptor binding,MF,
8066,GO:0031812,1,0.992464458558581,0,1,P2Y1 nucleotide receptor binding,MF,
8067,GO:0031821,1,0.957309819450105,0,7,G-protein coupled serotonin receptor binding,MF,
8068,GO:0031826,1,0.986544841875349,0,3,type 2A serotonin receptor binding,MF,
8069,GO:0031834,1,0.996759749601354,0,1,neurokinin receptor binding,MF,
8070,GO:0031835,1,0.996759749601354,0,1,substance P receptor binding,MF,
8071,GO:0031838,1,0.987748990108884,0,4,haptoglobin-hemoglobin complex,CC,
8072,GO:0031839,1,0.996976979760557,0,1,type 1 neuromedin U receptor binding,MF,
8073,GO:0031840,1,0.996976979760557,0,1,type 2 neuromedin U receptor binding,MF,
8074,GO:0031841,1,0.997062308027535,0,1,neuropeptide Y receptor binding,MF,
8075,GO:0031848,1,0.934904920691252,0,10,protection from non-homologous end joining at telomere,BP,
8076,GO:0031849,1,0.977524381704069,0,4,olfactory receptor binding,MF,
8077,GO:0031852,1,0.973381723906725,0,4,mu-type opioid receptor binding,MF,
8078,GO:0031858,1,0.992740900067808,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8079,GO:0031859,1,0.995501301342517,0,1,platelet activating factor receptor binding,MF,
8080,GO:0031860,1,0.977100945048125,0,3,telomeric 3' overhang formation,BP,
8081,GO:0031862,1,0.984510641888976,0,2,prostanoid receptor binding,MF,
8082,GO:0031867,1,0.992469134820315,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8083,GO:0031870,1,0.991981746059667,0,1,thromboxane A2 receptor binding,MF,
8084,GO:0031871,1,0.980492536678286,0,3,proteinase activated receptor binding,MF,
8085,GO:0031877,1,0.991791188273253,0,1,somatostatin receptor binding,MF,
8086,GO:0031883,1,0.994995892693117,0,1,taste receptor binding,MF,
8087,GO:0031893,1,0.987207367122487,0,2,vasopressin receptor binding,MF,
8088,GO:0031894,1,0.992446198286932,0,1,V1A vasopressin receptor binding,MF,
8089,GO:0031896,1,0.994721710356596,0,1,V2 vasopressin receptor binding,MF,
8091,GO:0031902,1,0.507232588527194,0,114,late endosome membrane,CC,
8094,GO:0031905,1,0.984011147225659,0,3,early endosome lumen,CC,
8095,GO:0031906,1,0.9792825571728,0,6,late endosome lumen,CC,
8096,GO:0031907,1,0.802004045037274,0,41,microbody lumen,CC,
8097,GO:0031914,1,0.974269550223856,0,4,negative regulation of synaptic plasticity,BP,
8098,GO:0031915,1,0.940772805761031,0,9,positive regulation of synaptic plasticity,BP,
8099,GO:0031929,1,0.513087440767368,0,99,TOR signaling,BP,
8100,GO:0031930,1,0.99637570484358,0,1,mitochondria-nucleus signaling pathway,BP,
8101,GO:0031931,1,0.952792553899256,0,7,TORC1 complex,CC,
8102,GO:0031932,1,0.919199000843276,0,13,TORC2 complex,CC,
8103,GO:0031933,1,0.980906736359375,0,3,telomeric heterochromatin,CC,
8104,GO:0031935,1,0.872225841787411,0,19,regulation of chromatin silencing,BP,
8105,GO:0031936,1,0.942287660627684,0,8,negative regulation of chromatin silencing,BP,
8106,GO:0031937,1,0.944078460106239,0,8,positive regulation of chromatin silencing,BP,
8107,GO:0031938,1,0.991555735204881,0,2,regulation of chromatin silencing at telomere,BP,
8108,GO:0031940,1,0.99608114730034,0,1,positive regulation of chromatin silencing at telomere,BP,
8110,GO:0031943,1,0.945228978496014,0,9,regulation of glucocorticoid metabolic process,BP,
8111,GO:0031944,1,0.96635538800185,0,5,negative regulation of glucocorticoid metabolic process,BP,
8112,GO:0031945,1,0.992464071756125,0,1,positive regulation of glucocorticoid metabolic process,BP,
8113,GO:0031946,1,0.951752295365207,0,7,regulation of glucocorticoid biosynthetic process,BP,
8114,GO:0031947,1,0.96635538800185,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8115,GO:0031948,1,0.992464071756125,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8117,GO:0031953,1,0.930980218249558,0,10,negative regulation of protein autophosphorylation,BP,
8119,GO:0031956,1,0.951234227771213,0,7,medium-chain fatty acid-CoA ligase activity,MF,
8120,GO:0031957,1,0.943122633428834,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8121,GO:0031958,1,0.8878525546001,0,17,corticosteroid receptor signaling pathway,BP,
8122,GO:0031959,1,0.985569171565351,0,2,mineralocorticoid receptor signaling pathway,BP,
8124,GO:0031962,1,0.992035308251592,0,1,mineralocorticoid receptor binding,MF,
8129,GO:0031970,1,0.66559010460802,0,77,organelle envelope lumen,CC,
8136,GO:0031985,1,0.523264514600337,0,99,Golgi cisterna,CC,
8137,GO:0031987,1,0.941567786323884,0,8,locomotion involved in locomotory behavior,BP,
8138,GO:0031989,1,0.996448996988249,0,1,bombesin receptor signaling pathway,BP,
8139,GO:0031990,1,0.985067561883796,0,2,mRNA export from nucleus in response to heat stress,BP,
8140,GO:0031994,1,0.914579960151049,0,13,insulin-like growth factor I binding,MF,
8141,GO:0031995,1,0.952369688753125,0,8,insulin-like growth factor II binding,MF,
8142,GO:0031996,1,0.931973423153204,0,11,thioesterase binding,MF,
8143,GO:0031997,1,0.983676755473194,0,3,N-terminal myristoylation domain binding,MF,
8144,GO:0031998,1,0.89002058655246,0,16,regulation of fatty acid beta-oxidation,BP,
8145,GO:0031999,1,0.970417134255962,0,4,negative regulation of fatty acid beta-oxidation,BP,
8146,GO:0032000,1,0.938989719237126,0,9,positive regulation of fatty acid beta-oxidation,BP,
8147,GO:0032002,1,0.98875361532332,0,2,interleukin-28 receptor complex,CC,
8148,GO:0032006,1,0.574270271523514,0,82,regulation of TOR signaling,BP,
8149,GO:0032007,1,0.77350733958136,0,38,negative regulation of TOR signaling,BP,
8150,GO:0032008,1,0.806286375515222,0,33,positive regulation of TOR signaling,BP,
8151,GO:0032009,1,0.945714891348156,0,8,early phagosome,CC,
8152,GO:0032010,1,0.973948906474514,0,5,phagolysosome,CC,
8153,GO:0032011,1,0.719046427892074,0,44,ARF protein signal transduction,BP,
8154,GO:0032012,1,0.719046427892074,0,44,regulation of ARF protein signal transduction,BP,
8155,GO:0032020,1,0.971397144133394,0,6,ISG15-protein conjugation,BP,
8156,GO:0032021,1,0.97346982547759,0,4,NELF complex,CC,
8157,GO:0032023,1,0.994513774897628,0,1,trypsinogen activation,BP,
8159,GO:0032025,1,0.94821623923768,0,9,response to cobalt ion,BP,
8160,GO:0032026,1,0.888018848638304,0,16,response to magnesium ion,BP,
8161,GO:0032027,1,0.971103251498804,0,5,myosin light chain binding,MF,
8162,GO:0032028,1,0.994979822721855,0,1,myosin head/neck binding,MF,
8163,GO:0032029,1,0.989706228717951,0,1,myosin tail binding,MF,
8164,GO:0032036,1,0.953040326010902,0,9,myosin heavy chain binding,MF,
8165,GO:0032038,1,0.993866072674427,0,2,myosin II heavy chain binding,MF,
8166,GO:0032039,1,0.894481415057768,0,15,integrator complex,CC,
8167,GO:0032040,1,0.828661792642954,0,32,small-subunit processome,CC,
8168,GO:0032041,1,0.927272663647401,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8169,GO:0032042,1,0.896210935035061,0,16,mitochondrial DNA metabolic process,BP,
8170,GO:0032044,1,0.988843576746431,0,2,DSIF complex,CC,
8172,GO:0032048,1,0.915400464417971,0,14,cardiolipin metabolic process,BP,
8173,GO:0032049,1,0.951415356428613,0,8,cardiolipin biosynthetic process,BP,
8174,GO:0032050,1,0.952181981820536,0,7,clathrin heavy chain binding,MF,
8175,GO:0032051,1,0.964620578539547,0,5,clathrin light chain binding,MF,
8176,GO:0032052,1,0.958135758744931,0,10,bile acid binding,MF,
8177,GO:0032053,1,0.985137739376248,0,2,ciliary basal body organization,BP,
8178,GO:0032055,1,0.96209885719227,0,6,negative regulation of translation in response to stress,BP,
8179,GO:0032056,1,0.96155691775591,0,6,positive regulation of translation in response to stress,BP,
8180,GO:0032057,1,0.973155420832554,0,4,negative regulation of translational initiation in response to stress,BP,
8181,GO:0032058,1,0.971308840584641,0,4,positive regulation of translational initiation in response to stress,BP,
8184,GO:0032069,1,0.834262184252835,0,30,regulation of nuclease activity,BP,
8185,GO:0032070,1,0.94563135519448,0,10,regulation of deoxyribonuclease activity,BP,
8186,GO:0032071,1,0.955193283008899,0,8,regulation of endodeoxyribonuclease activity,BP,
8187,GO:0032072,1,0.992568224260111,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8188,GO:0032074,1,0.958031303053706,0,7,negative regulation of nuclease activity,BP,
8189,GO:0032075,1,0.908352625402108,0,16,positive regulation of nuclease activity,BP,
8190,GO:0032076,1,0.990381587664405,0,2,negative regulation of deoxyribonuclease activity,BP,
8191,GO:0032077,1,0.972670095082267,0,5,positive regulation of deoxyribonuclease activity,BP,
8192,GO:0032078,1,0.996935546863581,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8193,GO:0032079,1,0.976042472441913,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8194,GO:0032088,1,0.608786246746928,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8195,GO:0032089,1,0.985359764444635,0,2,NACHT domain binding,MF,
8196,GO:0032090,1,0.989484568471631,0,2,Pyrin domain binding,MF,
8197,GO:0032091,1,0.570737240924304,0,91,negative regulation of protein binding,BP,
8199,GO:0032093,1,0.993301131169352,0,1,SAM domain binding,MF,
8200,GO:0032094,1,0.830736150293551,0,32,response to food,BP,
8201,GO:0032095,1,0.915889766925879,0,17,regulation of response to food,BP,
8202,GO:0032096,1,0.943393714396289,0,11,negative regulation of response to food,BP,
8203,GO:0032097,1,0.989712879011206,0,3,positive regulation of response to food,BP,
8204,GO:0032098,1,0.909854002764509,0,19,regulation of appetite,BP,
8205,GO:0032099,1,0.943393714396289,0,11,negative regulation of appetite,BP,
8206,GO:0032100,1,0.989712879011206,0,3,positive regulation of appetite,BP,
8210,GO:0032104,1,0.879697153550857,0,23,regulation of response to extracellular stimulus,BP,
8211,GO:0032105,1,0.931426604396566,0,13,negative regulation of response to extracellular stimulus,BP,
8212,GO:0032106,1,0.978721026028895,0,5,positive regulation of response to extracellular stimulus,BP,
8213,GO:0032107,1,0.879697153550857,0,23,regulation of response to nutrient levels,BP,
8214,GO:0032108,1,0.931426604396566,0,13,negative regulation of response to nutrient levels,BP,
8215,GO:0032109,1,0.978721026028895,0,5,positive regulation of response to nutrient levels,BP,
8216,GO:0032116,1,0.983812007438011,0,2,SMC loading complex,CC,
8217,GO:0032119,1,0.938492159439838,0,11,sequestering of zinc ion,BP,
8218,GO:0032127,1,0.985265627329528,0,2,dense core granule membrane,CC,
8219,GO:0032129,1,0.988579012414835,0,2,histone deacetylase activity (H3-K9 specific),MF,
8220,GO:0032133,1,0.976343839593581,0,5,chromosome passenger complex,CC,
8221,GO:0032135,1,0.96043438082496,0,6,DNA insertion or deletion binding,MF,
8222,GO:0032137,1,0.979331298413755,0,3,guanine/thymine mispair binding,MF,
8223,GO:0032138,1,0.971047898757842,0,4,single base insertion or deletion binding,MF,
8224,GO:0032139,1,0.981781316324209,0,3,dinucleotide insertion or deletion binding,MF,
8225,GO:0032142,1,0.977722540359755,0,3,single guanine insertion binding,MF,
8226,GO:0032143,1,0.985235374223564,0,2,single thymine insertion binding,MF,
8227,GO:0032144,1,0.992316013745567,0,1,4-aminobutyrate transaminase complex,CC,
8228,GO:0032145,1,0.992316013745567,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8230,GO:0032148,1,0.834823557113336,0,29,activation of protein kinase B activity,BP,
8232,GO:0032154,1,0.699368431516145,0,52,cleavage furrow,CC,
8234,GO:0032156,1,0.914595723920116,0,13,septin cytoskeleton,CC,
8235,GO:0032160,1,0.921569942691216,0,12,septin filament array,CC,
8236,GO:0032173,1,0.992931115265168,0,1,septin collar,CC,
8237,GO:0032181,1,0.985184951217608,0,2,dinucleotide repeat insertion binding,MF,
8238,GO:0032182,1,0.58345034863591,0,83,ubiquitin-like protein binding,MF,
8239,GO:0032183,1,0.898318143256703,0,14,SUMO binding,MF,
8240,GO:0032184,1,0.962717992882865,0,5,SUMO polymer binding,MF,
8242,GO:0032190,1,0.987361999189252,0,3,acrosin binding,MF,
8243,GO:0032194,1,0.992495045100237,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8244,GO:0032196,1,0.8874628803769,0,19,transposition,BP,
8245,GO:0032200,1,0.390700947863308,0,149,telomere organization,BP,
8246,GO:0032201,1,0.857970969771157,0,27,telomere maintenance via semi-conservative replication,BP,
8247,GO:0032202,1,0.978559058712851,0,4,telomere assembly,BP,
8248,GO:0032203,1,0.995615619474342,0,1,telomere formation via telomerase,BP,
8249,GO:0032204,1,0.600126126842274,0,76,regulation of telomere maintenance,BP,
8250,GO:0032205,1,0.782422761176114,0,34,negative regulation of telomere maintenance,BP,
8251,GO:0032206,1,0.730149756933914,0,49,positive regulation of telomere maintenance,BP,
8252,GO:0032207,1,0.993079601576071,0,1,regulation of telomere maintenance via recombination,BP,
8253,GO:0032208,1,0.993079601576071,0,1,negative regulation of telomere maintenance via recombination,BP,
8254,GO:0032210,1,0.711188751069873,0,52,regulation of telomere maintenance via telomerase,BP,
8255,GO:0032211,1,0.876329977856925,0,19,negative regulation of telomere maintenance via telomerase,BP,
8256,GO:0032212,1,0.810851783078518,0,34,positive regulation of telomere maintenance via telomerase,BP,
8257,GO:0032213,1,0.98615182913802,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8258,GO:0032214,1,0.98615182913802,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8259,GO:0032217,1,0.976814846305746,0,4,riboflavin transmembrane transporter activity,MF,
8260,GO:0032218,1,0.980036334309751,0,3,riboflavin transport,BP,
8261,GO:0032222,1,0.956051621390236,0,7,regulation of synaptic transmission, cholinergic,BP,
8262,GO:0032223,1,0.993732292113056,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8263,GO:0032224,1,0.968366838976955,0,5,positive regulation of synaptic transmission, cholinergic,BP,
8265,GO:0032226,1,0.96367743218635,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8266,GO:0032227,1,0.977703142002727,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8268,GO:0032229,1,0.966699286454711,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8269,GO:0032230,1,0.926430124155263,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8270,GO:0032231,1,0.55655626026137,0,86,regulation of actin filament bundle assembly,BP,
8271,GO:0032232,1,0.858141170961923,0,22,negative regulation of actin filament bundle assembly,BP,
8272,GO:0032233,1,0.696373993652169,0,56,positive regulation of actin filament bundle assembly,BP,
8273,GO:0032237,1,0.970760758207655,0,4,activation of store-operated calcium channel activity,BP,
8274,GO:0032239,1,0.8813235588575,0,17,regulation of nucleobase-containing compound transport,BP,
8275,GO:0032240,1,0.982792964568345,0,2,negative regulation of nucleobase-containing compound transport,BP,
8276,GO:0032241,1,0.944393235721549,0,8,positive regulation of nucleobase-containing compound transport,BP,
8277,GO:0032242,1,0.993179305995233,0,1,regulation of nucleoside transport,BP,
8278,GO:0032244,1,0.993179305995233,0,1,positive regulation of nucleoside transport,BP,
8280,GO:0032253,1,0.993301131169352,0,1,dense core granule localization,BP,
8281,GO:0032258,1,0.988199233438432,0,2,protein localization by the Cvt pathway,BP,
8283,GO:0032261,1,0.965667770139757,0,7,purine nucleotide salvage,BP,
8284,GO:0032262,1,0.97351878003082,0,6,pyrimidine nucleotide salvage,BP,
8285,GO:0032263,1,0.991896295476022,0,2,GMP salvage,BP,
8286,GO:0032264,1,0.976976555112733,0,4,IMP salvage,BP,
8287,GO:0032266,1,0.79721317519066,0,33,phosphatidylinositol-3-phosphate binding,MF,
8293,GO:0032273,1,0.486976233677143,0,116,positive regulation of protein polymerization,BP,
8294,GO:0032274,1,0.915254252845707,0,14,gonadotropin secretion,BP,
8295,GO:0032275,1,0.937174788276652,0,10,luteinizing hormone secretion,BP,
8296,GO:0032276,1,0.942218527976391,0,10,regulation of gonadotropin secretion,BP,
8297,GO:0032277,1,0.967467179947144,0,6,negative regulation of gonadotropin secretion,BP,
8298,GO:0032278,1,0.958362858166825,0,7,positive regulation of gonadotropin secretion,BP,
8300,GO:0032280,1,0.944468885760305,0,8,symmetric synapse,CC,
8301,GO:0032281,1,0.84941948027426,0,27,AMPA glutamate receptor complex,CC,
8305,GO:0032289,1,0.98083206730901,0,3,central nervous system myelin formation,BP,
8306,GO:0032290,1,0.962509491865365,0,4,peripheral nervous system myelin formation,BP,
8309,GO:0032296,1,0.972257904446764,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8310,GO:0032298,1,0.994612948298942,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8311,GO:0032299,1,0.986293627884644,0,3,ribonuclease H2 complex,CC,
8312,GO:0032300,1,0.936250255348346,0,9,mismatch repair complex,CC,
8313,GO:0032301,1,0.985235374223564,0,2,MutSalpha complex,CC,
8314,GO:0032302,1,0.985184951217608,0,2,MutSbeta complex,CC,
8315,GO:0032303,1,0.936361823961843,0,11,regulation of icosanoid secretion,BP,
8316,GO:0032304,1,0.992286194551312,0,1,negative regulation of icosanoid secretion,BP,
8317,GO:0032305,1,0.943643755431166,0,10,positive regulation of icosanoid secretion,BP,
8318,GO:0032306,1,0.965216585717161,0,7,regulation of prostaglandin secretion,BP,
8319,GO:0032308,1,0.965216585717161,0,7,positive regulation of prostaglandin secretion,BP,
8320,GO:0032309,1,0.845456220994851,0,28,icosanoid secretion,BP,
8321,GO:0032310,1,0.94356743632484,0,10,prostaglandin secretion,BP,
8322,GO:0032311,1,0.992419917339973,0,2,angiogenin-PRI complex,CC,
8323,GO:0032324,1,0.959736145924035,0,7,molybdopterin cofactor biosynthetic process,BP,
8324,GO:0032328,1,0.946678415062948,0,8,alanine transport,BP,
8325,GO:0032329,1,0.946199698949711,0,10,serine transport,BP,
8328,GO:0032332,1,0.874668930488436,0,19,positive regulation of chondrocyte differentiation,BP,
8329,GO:0032341,1,0.951014071100256,0,7,aldosterone metabolic process,BP,
8330,GO:0032342,1,0.951014071100256,0,7,aldosterone biosynthetic process,BP,
8331,GO:0032344,1,0.959386901077284,0,6,regulation of aldosterone metabolic process,BP,
8332,GO:0032345,1,0.973681755441354,0,4,negative regulation of aldosterone metabolic process,BP,
8333,GO:0032346,1,0.985322806771692,0,2,positive regulation of aldosterone metabolic process,BP,
8334,GO:0032347,1,0.959386901077284,0,6,regulation of aldosterone biosynthetic process,BP,
8335,GO:0032348,1,0.973681755441354,0,4,negative regulation of aldosterone biosynthetic process,BP,
8336,GO:0032349,1,0.985322806771692,0,2,positive regulation of aldosterone biosynthetic process,BP,
8337,GO:0032350,1,0.823146908623595,0,31,regulation of hormone metabolic process,BP,
8338,GO:0032351,1,0.933786185951656,0,11,negative regulation of hormone metabolic process,BP,
8339,GO:0032352,1,0.924097913766836,0,12,positive regulation of hormone metabolic process,BP,
8340,GO:0032353,1,0.936904927808161,0,10,negative regulation of hormone biosynthetic process,BP,
8341,GO:0032354,1,0.903055064414969,0,14,response to follicle-stimulating hormone,BP,
8343,GO:0032356,1,0.939314905396272,0,10,oxidized DNA binding,MF,
8344,GO:0032357,1,0.944074902970488,0,9,oxidized purine DNA binding,MF,
8345,GO:0032358,1,0.996964525762303,0,1,oxidized pyrimidine DNA binding,MF,
8346,GO:0032361,1,0.995256774042177,0,1,pyridoxal phosphate catabolic process,BP,
8347,GO:0032364,1,0.964148990408217,0,6,oxygen homeostasis,BP,
8348,GO:0032365,1,0.824148968420649,0,29,intracellular lipid transport,BP,
8349,GO:0032366,1,0.889919738405774,0,18,intracellular sterol transport,BP,
8350,GO:0032367,1,0.889919738405774,0,18,intracellular cholesterol transport,BP,
8351,GO:0032368,1,0.6010700747599,0,82,regulation of lipid transport,BP,
8352,GO:0032369,1,0.881844365678686,0,19,negative regulation of lipid transport,BP,
8353,GO:0032370,1,0.753828127581251,0,47,positive regulation of lipid transport,BP,
8354,GO:0032371,1,0.809254931638056,0,35,regulation of sterol transport,BP,
8355,GO:0032372,1,0.954415494432274,0,8,negative regulation of sterol transport,BP,
8356,GO:0032373,1,0.890473305417196,0,18,positive regulation of sterol transport,BP,
8357,GO:0032374,1,0.809254931638056,0,35,regulation of cholesterol transport,BP,
8358,GO:0032375,1,0.954415494432274,0,8,negative regulation of cholesterol transport,BP,
8359,GO:0032376,1,0.890473305417196,0,18,positive regulation of cholesterol transport,BP,
8360,GO:0032377,1,0.958754653047166,0,7,regulation of intracellular lipid transport,BP,
8361,GO:0032378,1,0.992496490499478,0,1,negative regulation of intracellular lipid transport,BP,
8362,GO:0032379,1,0.985603225817481,0,3,positive regulation of intracellular lipid transport,BP,
8363,GO:0032380,1,0.958754653047166,0,7,regulation of intracellular sterol transport,BP,
8364,GO:0032381,1,0.992496490499478,0,1,negative regulation of intracellular sterol transport,BP,
8365,GO:0032382,1,0.985603225817481,0,3,positive regulation of intracellular sterol transport,BP,
8366,GO:0032383,1,0.958754653047166,0,7,regulation of intracellular cholesterol transport,BP,
8367,GO:0032384,1,0.992496490499478,0,1,negative regulation of intracellular cholesterol transport,BP,
8368,GO:0032385,1,0.985603225817481,0,3,positive regulation of intracellular cholesterol transport,BP,
8372,GO:0032389,1,0.97212708603998,0,4,MutLalpha complex,CC,
8373,GO:0032391,1,0.803510327508673,0,32,photoreceptor connecting cilium,CC,
8374,GO:0032392,1,0.584833212498816,0,80,DNA geometric change,BP,
8375,GO:0032393,1,0.967974246394086,0,7,MHC class I receptor activity,MF,
8376,GO:0032394,1,0.996189082504901,0,1,MHC class Ib receptor activity,MF,
8377,GO:0032395,1,0.964821669195462,0,9,MHC class II receptor activity,MF,
8378,GO:0032396,1,0.981778924284076,0,3,inhibitory MHC class I receptor activity,MF,
8379,GO:0032397,1,0.996356943742403,0,1,activating MHC class I receptor activity,MF,
8380,GO:0032398,1,0.996002713311197,0,1,MHC class Ib protein complex,CC,
8381,GO:0032400,1,0.851349475718121,0,26,melanosome localization,BP,
8382,GO:0032401,1,0.862358323790657,0,24,establishment of melanosome localization,BP,
8383,GO:0032402,1,0.869746370292296,0,23,melanosome transport,BP,
8384,GO:0032404,1,0.952801740520122,0,8,mismatch repair complex binding,MF,
8385,GO:0032405,1,0.969356644984471,0,5,MutLalpha complex binding,MF,
8386,GO:0032407,1,0.970438551319793,0,5,MutSalpha complex binding,MF,
8388,GO:0032410,1,0.655791712384354,0,67,negative regulation of transporter activity,BP,
8389,GO:0032411,1,0.539457220160448,0,93,positive regulation of transporter activity,BP,
8390,GO:0032412,1,0.244717790015092,0,213,regulation of ion transmembrane transporter activity,BP,
8391,GO:0032413,1,0.68764300243428,0,60,negative regulation of ion transmembrane transporter activity,BP,
8392,GO:0032414,1,0.56824480469167,0,84,positive regulation of ion transmembrane transporter activity,BP,
8393,GO:0032415,1,0.974641175523239,0,5,regulation of sodium:proton antiporter activity,BP,
8394,GO:0032416,1,0.995251600462362,0,1,negative regulation of sodium:proton antiporter activity,BP,
8395,GO:0032417,1,0.97929225925642,0,4,positive regulation of sodium:proton antiporter activity,BP,
8397,GO:0032419,1,0.99463878313656,0,1,extrinsic component of lysosome membrane,CC,
8398,GO:0032420,1,0.769139364707926,0,39,stereocilium,CC,
8399,GO:0032421,1,0.746475098142321,0,44,stereocilium bundle,CC,
8400,GO:0032422,1,0.974074768624979,0,4,purine-rich negative regulatory element binding,MF,
8401,GO:0032423,1,0.97793728020807,0,3,regulation of mismatch repair,BP,
8402,GO:0032425,1,0.9853905101142,0,2,positive regulation of mismatch repair,BP,
8403,GO:0032426,1,0.904612135578516,0,15,stereocilium tip,CC,
8404,GO:0032427,1,0.987247998573902,0,2,GBD domain binding,MF,
8405,GO:0032428,1,0.99251155641455,0,1,beta-N-acetylgalactosaminidase activity,MF,
8409,GO:0032432,1,0.67553021543431,0,56,actin filament bundle,CC,
8410,GO:0032433,1,0.887933963370096,0,16,filopodium tip,CC,
8411,GO:0032434,1,0.487648625029903,0,113,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8412,GO:0032435,1,0.848671415428806,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8413,GO:0032436,1,0.605893570749433,0,78,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8414,GO:0032437,1,0.965232572368384,0,5,cuticular plate,CC,
8415,GO:0032438,1,0.853299696188778,0,26,melanosome organization,BP,
8416,GO:0032440,1,0.996645657810122,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8417,GO:0032444,1,0.976305857595307,0,3,activin responsive factor complex,CC,
8418,GO:0032445,1,0.994400074224895,0,1,fructose import,BP,
8420,GO:0032447,1,0.99404713979306,0,1,protein urmylation,BP,
8421,GO:0032448,1,0.99618387510306,0,1,DNA hairpin binding,MF,
8422,GO:0032449,1,0.967126753443663,0,5,CBM complex,CC,
8423,GO:0032450,1,0.976901605395316,0,3,maltose alpha-glucosidase activity,MF,
8424,GO:0032451,1,0.777772211761697,0,34,demethylase activity,MF,
8425,GO:0032452,1,0.820675348000182,0,25,histone demethylase activity,MF,
8426,GO:0032453,1,0.952252349743386,0,6,histone demethylase activity (H3-K4 specific),MF,
8427,GO:0032454,1,0.911372052964859,0,12,histone demethylase activity (H3-K9 specific),MF,
8430,GO:0032458,1,0.992466110705553,0,1,slow endocytic recycling,BP,
8431,GO:0032459,1,0.807517709072417,0,36,regulation of protein oligomerization,BP,
8432,GO:0032460,1,0.913032486172929,0,14,negative regulation of protein oligomerization,BP,
8433,GO:0032461,1,0.888145754872592,0,21,positive regulation of protein oligomerization,BP,
8434,GO:0032462,1,0.907340757483854,0,17,regulation of protein homooligomerization,BP,
8435,GO:0032463,1,0.941616791474134,0,10,negative regulation of protein homooligomerization,BP,
8436,GO:0032464,1,0.960184768331736,0,7,positive regulation of protein homooligomerization,BP,
8437,GO:0032465,1,0.611235239712767,0,73,regulation of cytokinesis,BP,
8438,GO:0032466,1,0.95920697592021,0,7,negative regulation of cytokinesis,BP,
8439,GO:0032467,1,0.826475664571953,0,29,positive regulation of cytokinesis,BP,
8440,GO:0032468,1,0.992536785547797,0,1,Golgi calcium ion homeostasis,BP,
8441,GO:0032469,1,0.871599712735913,0,21,endoplasmic reticulum calcium ion homeostasis,BP,
8442,GO:0032470,1,0.983815023992608,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8443,GO:0032471,1,0.955864548513175,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8444,GO:0032472,1,0.987920195993939,0,2,Golgi calcium ion transport,BP,
8445,GO:0032473,1,0.990820996121129,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8446,GO:0032474,1,0.978542832715014,0,3,otolith morphogenesis,BP,
8447,GO:0032475,1,0.99357385075076,0,1,otolith formation,BP,
8448,GO:0032479,1,0.479336611339172,0,115,regulation of type I interferon production,BP,
8449,GO:0032480,1,0.753052836092359,0,45,negative regulation of type I interferon production,BP,
8450,GO:0032481,1,0.638814211562924,0,69,positive regulation of type I interferon production,BP,
8451,GO:0032482,1,0.67634324392906,0,68,Rab protein signal transduction,BP,
8452,GO:0032483,1,0.969923164456399,0,4,regulation of Rab protein signal transduction,BP,
8453,GO:0032484,1,0.976790425515894,0,3,Ral protein signal transduction,BP,
8454,GO:0032485,1,0.976790425515894,0,3,regulation of Ral protein signal transduction,BP,
8455,GO:0032486,1,0.90970012052311,0,13,Rap protein signal transduction,BP,
8456,GO:0032487,1,0.976648179873995,0,3,regulation of Rap protein signal transduction,BP,
8457,GO:0032488,1,0.920790461775953,0,14,Cdc42 protein signal transduction,BP,
8458,GO:0032489,1,0.967289545958166,0,6,regulation of Cdc42 protein signal transduction,BP,
8459,GO:0032490,1,0.92400667128385,0,12,detection of molecule of bacterial origin,BP,
8460,GO:0032493,1,0.949680966778588,0,8,response to bacterial lipoprotein,BP,
8461,GO:0032494,1,0.941479435363552,0,10,response to peptidoglycan,BP,
8462,GO:0032495,1,0.906399308325894,0,14,response to muramyl dipeptide,BP,
8464,GO:0032497,1,0.979640992783091,0,4,detection of lipopolysaccharide,BP,
8465,GO:0032498,1,0.992401750145569,0,1,detection of muramyl dipeptide,BP,
8466,GO:0032499,1,0.989257665737349,0,2,detection of peptidoglycan,BP,
8467,GO:0032500,1,0.992401750145569,0,1,muramyl dipeptide binding,MF,
8473,GO:0032508,1,0.626510144456257,0,70,DNA duplex unwinding,BP,
8474,GO:0032509,1,0.88087122051514,0,21,endosome transport via multivesicular body sorting pathway,BP,
8475,GO:0032510,1,0.957164602460339,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8476,GO:0032511,1,0.960512820878724,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8478,GO:0032516,1,0.894193826456515,0,16,positive regulation of phosphoprotein phosphatase activity,BP,
8479,GO:0032525,1,0.950822001475474,0,9,somite rostral/caudal axis specification,BP,
8481,GO:0032527,1,0.775106565476686,0,39,protein exit from endoplasmic reticulum,BP,
8483,GO:0032530,1,0.918391441135523,0,12,regulation of microvillus organization,BP,
8484,GO:0032532,1,0.961104282653257,0,6,regulation of microvillus length,BP,
8485,GO:0032534,1,0.955576516183656,0,6,regulation of microvillus assembly,BP,
8488,GO:0032541,1,0.970848311896558,0,5,cortical endoplasmic reticulum,CC,
8489,GO:0032542,1,0.986366410879255,0,2,sulfiredoxin activity,MF,
8490,GO:0032543,1,0.559589148703321,0,127,mitochondrial translation,BP,
8491,GO:0032545,1,0.98916445411414,0,2,CURI complex,CC,
8494,GO:0032551,1,0.985988118280085,0,2,pyrimidine ribonucleoside binding,MF,
8495,GO:0032552,1,0.968990836351684,0,6,deoxyribonucleotide binding,MF,
8497,GO:0032554,1,0.976441313213708,0,4,purine deoxyribonucleotide binding,MF,
8499,GO:0032556,1,0.992371656135295,0,2,pyrimidine deoxyribonucleotide binding,MF,
8500,GO:0032557,1,0.980939377745585,0,3,pyrimidine ribonucleotide binding,MF,
8501,GO:0032558,1,0.983608562582825,0,3,adenyl deoxyribonucleotide binding,MF,
8503,GO:0032560,1,0.992714561063159,0,1,guanyl deoxyribonucleotide binding,MF,
8505,GO:0032564,1,0.983608562582825,0,3,dATP binding,MF,
8506,GO:0032567,1,0.992714561063159,0,1,dGTP binding,MF,
8508,GO:0032571,1,0.976686991713856,0,4,response to vitamin K,BP,
8509,GO:0032574,1,0.992460070994013,0,1,5'-3' RNA helicase activity,MF,
8510,GO:0032575,1,0.992460070994013,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8511,GO:0032580,1,0.596853731029331,0,78,Golgi cisterna membrane,CC,
8512,GO:0032581,1,0.995643840348478,0,1,ER-dependent peroxisome organization,BP,
8513,GO:0032584,1,0.961261332501944,0,6,growth cone membrane,CC,
8514,GO:0032585,1,0.950106374923535,0,9,multivesicular body membrane,CC,
8515,GO:0032587,1,0.553676093392004,0,85,ruffle membrane,CC,
8518,GO:0032590,1,0.778584523652933,0,37,dendrite membrane,CC,
8519,GO:0032591,1,0.90634813025024,0,13,dendritic spine membrane,CC,
8520,GO:0032592,1,0.688518006205941,0,65,integral component of mitochondrial membrane,CC,
8521,GO:0032593,1,0.956337812038072,0,7,insulin-responsive compartment,CC,
8522,GO:0032594,1,0.856240989296652,0,26,protein transport within lipid bilayer,BP,
8523,GO:0032596,1,0.968722010303294,0,5,protein transport into membrane raft,BP,
8524,GO:0032601,1,0.996613227145749,0,1,connective tissue growth factor production,BP,
8526,GO:0032603,1,0.996925838463949,0,1,fractalkine production,BP,
8528,GO:0032605,1,0.992714561063159,0,1,hepatocyte growth factor production,BP,
8529,GO:0032606,1,0.477596663773974,0,116,type I interferon production,BP,
8530,GO:0032607,1,0.840012615064879,0,26,interferon-alpha production,BP,
8531,GO:0032608,1,0.736670435093504,0,47,interferon-beta production,BP,
8533,GO:0032610,1,0.967221655856481,0,7,interleukin-1 alpha production,BP,
8534,GO:0032611,1,0.705853237122135,0,59,interleukin-1 beta production,BP,
8535,GO:0032612,1,0.661215081622059,0,72,interleukin-1 production,BP,
8536,GO:0032613,1,0.784696996414592,0,42,interleukin-10 production,BP,
8537,GO:0032615,1,0.743440540849583,0,49,interleukin-12 production,BP,
8538,GO:0032616,1,0.899401383806735,0,17,interleukin-13 production,BP,
8539,GO:0032618,1,0.99180126884534,0,2,interleukin-15 production,BP,
8540,GO:0032620,1,0.894209757100718,0,20,interleukin-17 production,BP,
8541,GO:0032621,1,0.945102828559985,0,8,interleukin-18 production,BP,
8542,GO:0032623,1,0.703342373366115,0,56,interleukin-2 production,BP,
8543,GO:0032625,1,0.992515876865537,0,1,interleukin-21 production,BP,
8544,GO:0032627,1,0.967536517943849,0,5,interleukin-23 production,BP,
8545,GO:0032632,1,0.97929410647874,0,3,interleukin-3 production,BP,
8546,GO:0032633,1,0.828475841235813,0,31,interleukin-4 production,BP,
8547,GO:0032634,1,0.905276779500051,0,15,interleukin-5 production,BP,
8549,GO:0032637,1,0.699703400673994,0,61,interleukin-8 production,BP,
8550,GO:0032639,1,0.988928301700179,0,2,TRAIL production,BP,
8552,GO:0032641,1,0.986280157163966,0,2,lymphotoxin A production,BP,
8554,GO:0032643,1,0.996613227145749,0,1,regulation of connective tissue growth factor production,BP,
8555,GO:0032644,1,0.996925838463949,0,1,regulation of fractalkine production,BP,
8557,GO:0032646,1,0.992714561063159,0,1,regulation of hepatocyte growth factor production,BP,
8558,GO:0032647,1,0.843054873190849,0,25,regulation of interferon-alpha production,BP,
8559,GO:0032648,1,0.745237289379985,0,45,regulation of interferon-beta production,BP,
8561,GO:0032650,1,0.970083264708542,0,6,regulation of interleukin-1 alpha production,BP,
8562,GO:0032651,1,0.743381991771785,0,51,regulation of interleukin-1 beta production,BP,
8563,GO:0032652,1,0.69846252739836,0,63,regulation of interleukin-1 production,BP,
8564,GO:0032653,1,0.795518487178158,0,40,regulation of interleukin-10 production,BP,
8565,GO:0032655,1,0.7541135248151,0,47,regulation of interleukin-12 production,BP,
8566,GO:0032656,1,0.902335295857455,0,16,regulation of interleukin-13 production,BP,
8567,GO:0032658,1,0.995783830951291,0,1,regulation of interleukin-15 production,BP,
8568,GO:0032660,1,0.908302876882542,0,17,regulation of interleukin-17 production,BP,
8569,GO:0032661,1,0.959554514178908,0,6,regulation of interleukin-18 production,BP,
8570,GO:0032663,1,0.732441320394231,0,49,regulation of interleukin-2 production,BP,
8571,GO:0032667,1,0.967536517943849,0,5,regulation of interleukin-23 production,BP,
8572,GO:0032672,1,0.986727955959673,0,2,regulation of interleukin-3 production,BP,
8573,GO:0032673,1,0.861858981851625,0,25,regulation of interleukin-4 production,BP,
8574,GO:0032674,1,0.905276779500051,0,15,regulation of interleukin-5 production,BP,
8576,GO:0032677,1,0.726394336889628,0,55,regulation of interleukin-8 production,BP,
8577,GO:0032679,1,0.988928301700179,0,2,regulation of TRAIL production,BP,
8579,GO:0032681,1,0.9934229175149,0,1,regulation of lymphotoxin A production,BP,
8581,GO:0032685,1,0.992662031696478,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8582,GO:0032686,1,0.992714561063159,0,1,negative regulation of hepatocyte growth factor production,BP,
8583,GO:0032687,1,0.966899904254742,0,6,negative regulation of interferon-alpha production,BP,
8584,GO:0032688,1,0.918477379718545,0,14,negative regulation of interferon-beta production,BP,
8585,GO:0032689,1,0.862154197963365,0,26,negative regulation of interferon-gamma production,BP,
8586,GO:0032690,1,0.996419444586326,0,1,negative regulation of interleukin-1 alpha production,BP,
8587,GO:0032691,1,0.92172987494578,0,15,negative regulation of interleukin-1 beta production,BP,
8588,GO:0032692,1,0.891266187310307,0,21,negative regulation of interleukin-1 production,BP,
8589,GO:0032693,1,0.928370550014147,0,14,negative regulation of interleukin-10 production,BP,
8590,GO:0032695,1,0.903865146808132,0,16,negative regulation of interleukin-12 production,BP,
8591,GO:0032696,1,0.980469533280964,0,3,negative regulation of interleukin-13 production,BP,
8592,GO:0032700,1,0.948515238863679,0,9,negative regulation of interleukin-17 production,BP,
8593,GO:0032701,1,0.98878821943536,0,2,negative regulation of interleukin-18 production,BP,
8594,GO:0032703,1,0.891290806727874,0,19,negative regulation of interleukin-2 production,BP,
8595,GO:0032707,1,0.986429344831688,0,2,negative regulation of interleukin-23 production,BP,
8596,GO:0032712,1,0.994397375401436,0,1,negative regulation of interleukin-3 production,BP,
8597,GO:0032713,1,0.966530426178687,0,5,negative regulation of interleukin-4 production,BP,
8598,GO:0032714,1,0.979535058695295,0,3,negative regulation of interleukin-5 production,BP,
8599,GO:0032715,1,0.815901578112296,0,33,negative regulation of interleukin-6 production,BP,
8600,GO:0032717,1,0.912969787175532,0,16,negative regulation of interleukin-8 production,BP,
8601,GO:0032720,1,0.788291875489255,0,43,negative regulation of tumor necrosis factor production,BP,
8603,GO:0032723,1,0.996613227145749,0,1,positive regulation of connective tissue growth factor production,BP,
8604,GO:0032724,1,0.996925838463949,0,1,positive regulation of fractalkine production,BP,
8606,GO:0032727,1,0.871957276910687,0,19,positive regulation of interferon-alpha production,BP,
8607,GO:0032728,1,0.823291925027201,0,29,positive regulation of interferon-beta production,BP,
8609,GO:0032730,1,0.973570160294741,0,5,positive regulation of interleukin-1 alpha production,BP,
8610,GO:0032731,1,0.824286009311311,0,32,positive regulation of interleukin-1 beta production,BP,
8611,GO:0032732,1,0.798003674696888,0,38,positive regulation of interleukin-1 production,BP,
8612,GO:0032733,1,0.851082129940023,0,28,positive regulation of interleukin-10 production,BP,
8613,GO:0032735,1,0.847507184602877,0,29,positive regulation of interleukin-12 production,BP,
8614,GO:0032736,1,0.92032507102026,0,13,positive regulation of interleukin-13 production,BP,
8615,GO:0032738,1,0.995783830951291,0,1,positive regulation of interleukin-15 production,BP,
8616,GO:0032740,1,0.952574784324454,0,9,positive regulation of interleukin-17 production,BP,
8617,GO:0032741,1,0.977593473352434,0,3,positive regulation of interleukin-18 production,BP,
8618,GO:0032743,1,0.82584009599927,0,29,positive regulation of interleukin-2 production,BP,
8619,GO:0032747,1,0.986051361236708,0,2,positive regulation of interleukin-23 production,BP,
8620,GO:0032752,1,0.992287819095937,0,1,positive regulation of interleukin-3 production,BP,
8621,GO:0032753,1,0.886706868569441,0,21,positive regulation of interleukin-4 production,BP,
8622,GO:0032754,1,0.928662488864733,0,11,positive regulation of interleukin-5 production,BP,
8624,GO:0032757,1,0.792686849720888,0,40,positive regulation of interleukin-8 production,BP,
8625,GO:0032759,1,0.988928301700179,0,2,positive regulation of TRAIL production,BP,
8627,GO:0032761,1,0.9934229175149,0,1,positive regulation of lymphotoxin A production,BP,
8628,GO:0032762,1,0.958958527289518,0,7,mast cell cytokine production,BP,
8629,GO:0032763,1,0.971166265497732,0,5,regulation of mast cell cytokine production,BP,
8630,GO:0032764,1,0.988789733078627,0,2,negative regulation of mast cell cytokine production,BP,
8631,GO:0032765,1,0.982178804011182,0,3,positive regulation of mast cell cytokine production,BP,
8632,GO:0032767,1,0.980793592600566,0,3,copper-dependent protein binding,MF,
8634,GO:0032769,1,0.939874405241388,0,10,negative regulation of monooxygenase activity,BP,
8635,GO:0032770,1,0.873237930520367,0,23,positive regulation of monooxygenase activity,BP,
8636,GO:0032771,1,0.992431393876814,0,1,regulation of monophenol monooxygenase activity,BP,
8637,GO:0032773,1,0.992431393876814,0,1,positive regulation of monophenol monooxygenase activity,BP,
8639,GO:0032775,1,0.992489858766722,0,1,DNA methylation on adenine,BP,
8640,GO:0032776,1,0.977251569326108,0,3,DNA methylation on cytosine,BP,
8641,GO:0032777,1,0.976346759293767,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8642,GO:0032780,1,0.933370184321696,0,13,negative regulation of ATPase activity,BP,
8643,GO:0032781,1,0.762272164310147,0,51,positive regulation of ATPase activity,BP,
8644,GO:0032782,1,0.976506103001795,0,4,bile acid secretion,BP,
8645,GO:0032783,1,0.951734563518673,0,6,ELL-EAF complex,CC,
8646,GO:0032784,1,0.774168983280028,0,41,regulation of DNA-templated transcription, elongation,BP,
8647,GO:0032785,1,0.920605917815232,0,13,negative regulation of DNA-templated transcription, elongation,BP,
8648,GO:0032786,1,0.869182783284853,0,23,positive regulation of DNA-templated transcription, elongation,BP,
8650,GO:0032788,1,0.996099695549445,0,1,saturated monocarboxylic acid metabolic process,BP,
8651,GO:0032789,1,0.996099695549445,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8652,GO:0032790,1,0.949781647994321,0,8,ribosome disassembly,BP,
8653,GO:0032792,1,0.970850538742483,0,5,negative regulation of CREB transcription factor activity,BP,
8654,GO:0032793,1,0.906509478182353,0,14,positive regulation of CREB transcription factor activity,BP,
8655,GO:0032794,1,0.902275802266838,0,14,GTPase activating protein binding,MF,
8656,GO:0032795,1,0.982552758850745,0,3,heterotrimeric G-protein binding,MF,
8657,GO:0032796,1,0.987623517970914,0,2,uropod organization,BP,
8658,GO:0032797,1,0.932284288757364,0,12,SMN complex,CC,
8659,GO:0032798,1,0.986646673054992,0,2,Swi5-Sfr1 complex,CC,
8660,GO:0032799,1,0.878393084986059,0,21,low-density lipoprotein receptor particle metabolic process,BP,
8661,GO:0032800,1,0.866073301087833,0,23,receptor biosynthetic process,BP,
8662,GO:0032801,1,0.805806935946794,0,32,receptor catabolic process,BP,
8663,GO:0032802,1,0.923111803332086,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8664,GO:0032803,1,0.970918494633371,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8665,GO:0032804,1,0.988553652878868,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8666,GO:0032805,1,0.9892427007874,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8667,GO:0032806,1,0.866984284957628,0,24,carboxy-terminal domain protein kinase complex,CC,
8668,GO:0032807,1,0.976283187368093,0,4,DNA ligase IV complex,CC,
8670,GO:0032809,1,0.855020989352584,0,23,neuronal cell body membrane,CC,
8671,GO:0032810,1,0.98855271610961,0,2,sterol response element binding,MF,
8672,GO:0032811,1,0.984545085417152,0,3,negative regulation of epinephrine secretion,BP,
8673,GO:0032812,1,0.996925256030712,0,1,positive regulation of epinephrine secretion,BP,
8674,GO:0032813,1,0.793816833868006,0,43,tumor necrosis factor receptor superfamily binding,MF,
8676,GO:0032815,1,0.976681942436955,0,5,negative regulation of natural killer cell activation,BP,
8678,GO:0032817,1,0.967720830904052,0,6,regulation of natural killer cell proliferation,BP,
8679,GO:0032819,1,0.981920398501704,0,4,positive regulation of natural killer cell proliferation,BP,
8681,GO:0032824,1,0.996902801562181,0,1,negative regulation of natural killer cell differentiation,BP,
8683,GO:0032826,1,0.992968745186011,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8684,GO:0032827,1,0.996902801562181,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8685,GO:0032829,1,0.990400938123743,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8686,GO:0032831,1,0.990400938123743,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8687,GO:0032832,1,0.99601637846675,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8688,GO:0032834,1,0.99601637846675,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8690,GO:0032836,1,0.927274949398483,0,10,glomerular basement membrane development,BP,
8692,GO:0032839,1,0.832633795814559,0,27,dendrite cytoplasm,CC,
8693,GO:0032841,1,0.992502012370885,0,1,calcitonin binding,MF,
8694,GO:0032847,1,0.97723061750405,0,4,regulation of cellular pH reduction,BP,
8695,GO:0032848,1,0.992468400805186,0,1,negative regulation of cellular pH reduction,BP,
8696,GO:0032849,1,0.984647780808439,0,3,positive regulation of cellular pH reduction,BP,
8701,GO:0032873,1,0.772556349523188,0,39,negative regulation of stress-activated MAPK cascade,BP,
8703,GO:0032875,1,0.946064176615639,0,7,regulation of DNA endoreduplication,BP,
8704,GO:0032876,1,0.967898805126257,0,4,negative regulation of DNA endoreduplication,BP,
8705,GO:0032877,1,0.984626746902077,0,2,positive regulation of DNA endoreduplication,BP,
8706,GO:0032878,1,0.85308108784076,0,21,regulation of establishment or maintenance of cell polarity,BP,
8709,GO:0032881,1,0.787484401451948,0,33,regulation of polysaccharide metabolic process,BP,
8710,GO:0032885,1,0.798634827270822,0,30,regulation of polysaccharide biosynthetic process,BP,
8712,GO:0032887,1,0.991604937803894,0,1,regulation of spindle elongation,BP,
8713,GO:0032888,1,0.991604937803894,0,1,regulation of mitotic spindle elongation,BP,
8714,GO:0032889,1,0.993863681956695,0,1,regulation of vacuole fusion, non-autophagic,BP,
8715,GO:0032890,1,0.75935490094656,0,42,regulation of organic acid transport,BP,
8716,GO:0032891,1,0.90395447854573,0,15,negative regulation of organic acid transport,BP,
8717,GO:0032892,1,0.872972749344467,0,22,positive regulation of organic acid transport,BP,
8718,GO:0032897,1,0.876744065381343,0,20,negative regulation of viral transcription,BP,
8720,GO:0032899,1,0.98569530949736,0,2,regulation of neurotrophin production,BP,
8721,GO:0032900,1,0.993179305995233,0,1,negative regulation of neurotrophin production,BP,
8722,GO:0032901,1,0.992465141632793,0,1,positive regulation of neurotrophin production,BP,
8724,GO:0032905,1,0.93777138491424,0,10,transforming growth factor beta1 production,BP,
8725,GO:0032906,1,0.944500126414457,0,8,transforming growth factor beta2 production,BP,
8726,GO:0032907,1,0.982726117790254,0,2,transforming growth factor beta3 production,BP,
8727,GO:0032908,1,0.93777138491424,0,10,regulation of transforming growth factor beta1 production,BP,
8728,GO:0032909,1,0.944500126414457,0,8,regulation of transforming growth factor beta2 production,BP,
8729,GO:0032910,1,0.982726117790254,0,2,regulation of transforming growth factor beta3 production,BP,
8730,GO:0032911,1,0.972078688758445,0,4,negative regulation of transforming growth factor beta1 production,BP,
8731,GO:0032912,1,0.985025533673701,0,2,negative regulation of transforming growth factor beta2 production,BP,
8732,GO:0032914,1,0.964717499697787,0,6,positive regulation of transforming growth factor beta1 production,BP,
8733,GO:0032915,1,0.990422573207407,0,2,positive regulation of transforming growth factor beta2 production,BP,
8734,GO:0032916,1,0.982726117790254,0,2,positive regulation of transforming growth factor beta3 production,BP,
8735,GO:0032917,1,0.98857385519182,0,3,polyamine acetylation,BP,
8736,GO:0032918,1,0.98857385519182,0,3,spermidine acetylation,BP,
8737,GO:0032919,1,0.996893837433638,0,1,spermine acetylation,BP,
8738,GO:0032920,1,0.996893837433638,0,1,putrescine acetylation,BP,
8740,GO:0032924,1,0.79265366697685,0,37,activin receptor signaling pathway,BP,
8741,GO:0032925,1,0.869810401724045,0,23,regulation of activin receptor signaling pathway,BP,
8742,GO:0032926,1,0.946605437756201,0,9,negative regulation of activin receptor signaling pathway,BP,
8743,GO:0032927,1,0.946351686334191,0,8,positive regulation of activin receptor signaling pathway,BP,
8745,GO:0032929,1,0.992901737505522,0,2,negative regulation of superoxide anion generation,BP,
8747,GO:0032933,1,0.946689268136955,0,8,SREBP signaling pathway,BP,
8749,GO:0032937,1,0.97971425897714,0,3,SREBP-SCAP-Insig complex,CC,
8752,GO:0032943,1,0.270896485250113,0,224,mononuclear cell proliferation,BP,
8753,GO:0032944,1,0.350708181036963,0,183,regulation of mononuclear cell proliferation,BP,
8754,GO:0032945,1,0.681236430837518,0,64,negative regulation of mononuclear cell proliferation,BP,
8755,GO:0032946,1,0.517226807228018,0,118,positive regulation of mononuclear cell proliferation,BP,
8757,GO:0032954,1,0.984583252215974,0,2,regulation of cytokinetic process,BP,
8759,GO:0032957,1,0.941971689376363,0,8,inositol trisphosphate metabolic process,BP,
8760,GO:0032958,1,0.853894377152343,0,24,inositol phosphate biosynthetic process,BP,
8761,GO:0032959,1,0.956632025338151,0,6,inositol trisphosphate biosynthetic process,BP,
8762,GO:0032960,1,0.971266284643986,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8763,GO:0032962,1,0.978683241457316,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8765,GO:0032964,1,0.804313830080192,0,35,collagen biosynthetic process,BP,
8766,GO:0032965,1,0.850417249820044,0,27,regulation of collagen biosynthetic process,BP,
8767,GO:0032966,1,0.961642957696766,0,7,negative regulation of collagen biosynthetic process,BP,
8768,GO:0032967,1,0.884382156491016,0,20,positive regulation of collagen biosynthetic process,BP,
8769,GO:0032968,1,0.916430415115655,0,14,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8771,GO:0032971,1,0.979619412954144,0,4,regulation of muscle filament sliding,BP,
8772,GO:0032972,1,0.993793975730611,0,2,regulation of muscle filament sliding speed,BP,
8773,GO:0032976,1,0.996978827162998,0,1,release of matrix enzymes from mitochondria,BP,
8774,GO:0032977,1,0.992396383273828,0,1,membrane insertase activity,MF,
8775,GO:0032978,1,0.992396383273828,0,1,protein insertion into membrane from inner side,BP,
8776,GO:0032979,1,0.992396383273828,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8777,GO:0032980,1,0.994143822663991,0,1,keratinocyte activation,BP,
8778,GO:0032981,1,0.801202981078916,0,55,mitochondrial respiratory chain complex I assembly,BP,
8779,GO:0032982,1,0.865582733747809,0,19,myosin filament,CC,
8780,GO:0032983,1,0.962008396381647,0,5,kainate selective glutamate receptor complex,CC,
8781,GO:0032984,1,0.17477263123072,0,295,protein-containing complex disassembly,BP,
8782,GO:0032986,1,0.887942310456787,0,19,protein-DNA complex disassembly,BP,
8783,GO:0032988,1,0.921962428514963,0,13,ribonucleoprotein complex disassembly,BP,
8788,GO:0032994,1,0.831004490698039,0,34,protein-lipid complex,CC,
8789,GO:0032996,1,0.995593082676214,0,1,Bcl3-Bcl10 complex,CC,
8790,GO:0032997,1,0.993007508017019,0,2,Fc receptor complex,CC,
8791,GO:0032998,1,0.993007508017019,0,2,Fc-epsilon receptor I complex,CC,
8793,GO:0033003,1,0.816326681196967,0,35,regulation of mast cell activation,BP,
8794,GO:0033004,1,0.942272219397169,0,11,negative regulation of mast cell activation,BP,
8795,GO:0033005,1,0.917640560942285,0,15,positive regulation of mast cell activation,BP,
8796,GO:0033006,1,0.857172003153783,0,27,regulation of mast cell activation involved in immune response,BP,
8797,GO:0033007,1,0.964260868478541,0,7,negative regulation of mast cell activation involved in immune response,BP,
8798,GO:0033008,1,0.936526798680325,0,12,positive regulation of mast cell activation involved in immune response,BP,
8799,GO:0033010,1,0.953434086358608,0,7,paranodal junction,CC,
8800,GO:0033011,1,0.98986370838677,0,2,perinuclear theca,CC,
8801,GO:0033013,1,0.748434153157453,0,50,tetrapyrrole metabolic process,BP,
8802,GO:0033014,1,0.853462821290842,0,26,tetrapyrrole biosynthetic process,BP,
8803,GO:0033015,1,0.985951138975038,0,4,tetrapyrrole catabolic process,BP,
8804,GO:0033017,1,0.771670251373374,0,36,sarcoplasmic reticulum membrane,CC,
8805,GO:0033018,1,0.956740352505562,0,7,sarcoplasmic reticulum lumen,CC,
8806,GO:0033023,1,0.981863683060806,0,3,mast cell homeostasis,BP,
8807,GO:0033024,1,0.981863683060806,0,3,mast cell apoptotic process,BP,
8808,GO:0033025,1,0.981863683060806,0,3,regulation of mast cell apoptotic process,BP,
8809,GO:0033026,1,0.989268460943027,0,2,negative regulation of mast cell apoptotic process,BP,
8810,GO:0033028,1,0.845020811775456,0,28,myeloid cell apoptotic process,BP,
8811,GO:0033029,1,0.960556658939186,0,6,regulation of neutrophil apoptotic process,BP,
8812,GO:0033030,1,0.985331351294069,0,2,negative regulation of neutrophil apoptotic process,BP,
8813,GO:0033031,1,0.974860305604043,0,4,positive regulation of neutrophil apoptotic process,BP,
8814,GO:0033032,1,0.863381984088123,0,24,regulation of myeloid cell apoptotic process,BP,
8815,GO:0033033,1,0.927499540860592,0,13,negative regulation of myeloid cell apoptotic process,BP,
8816,GO:0033034,1,0.956558487169225,0,7,positive regulation of myeloid cell apoptotic process,BP,
8818,GO:0033037,1,0.992084778446763,0,1,polysaccharide localization,BP,
8819,GO:0033038,1,0.966933787353103,0,10,bitter taste receptor activity,MF,
8820,GO:0033040,1,0.992854331384343,0,1,sour taste receptor activity,MF,
8821,GO:0033041,1,0.993782080934776,0,1,sweet taste receptor activity,MF,
8823,GO:0033044,1,0.134414244513651,0,295,regulation of chromosome organization,BP,
8824,GO:0033045,1,0.632211113637227,0,70,regulation of sister chromatid segregation,BP,
8825,GO:0033046,1,0.78885956654095,0,37,negative regulation of sister chromatid segregation,BP,
8826,GO:0033047,1,0.671631104946206,0,61,regulation of mitotic sister chromatid segregation,BP,
8827,GO:0033048,1,0.795401170251127,0,36,negative regulation of mitotic sister chromatid segregation,BP,
8828,GO:0033058,1,0.974289591994194,0,3,directional locomotion,BP,
8829,GO:0033059,1,0.722692985746901,0,52,cellular pigmentation,BP,
8830,GO:0033061,1,0.947040683464632,0,9,DNA recombinase mediator complex,CC,
8831,GO:0033063,1,0.95986348833082,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8832,GO:0033065,1,0.990599896991845,0,2,Rad51C-XRCC3 complex,CC,
8833,GO:0033076,1,0.986940917232687,0,3,isoquinoline alkaloid metabolic process,BP,
8835,GO:0033078,1,0.984389183055483,0,3,extrathymic T cell differentiation,BP,
8836,GO:0033079,1,0.96144506673427,0,7,immature T cell proliferation,BP,
8837,GO:0033080,1,0.971484356854911,0,5,immature T cell proliferation in thymus,BP,
8839,GO:0033082,1,0.988399753931279,0,2,regulation of extrathymic T cell differentiation,BP,
8840,GO:0033083,1,0.968747887145014,0,6,regulation of immature T cell proliferation,BP,
8841,GO:0033084,1,0.978862630965133,0,4,regulation of immature T cell proliferation in thymus,BP,
8842,GO:0033085,1,0.969858983344135,0,6,negative regulation of T cell differentiation in thymus,BP,
8843,GO:0033087,1,0.984157119884091,0,3,negative regulation of immature T cell proliferation,BP,
8844,GO:0033088,1,0.988172810582923,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8846,GO:0033091,1,0.984345297556635,0,3,positive regulation of immature T cell proliferation,BP,
8847,GO:0033092,1,0.990579552598122,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8848,GO:0033093,1,0.964415712651827,0,5,Weibel-Palade body,CC,
8850,GO:0033108,1,0.674900210650172,0,87,mitochondrial respiratory chain complex assembly,BP,
8851,GO:0033116,1,0.687198312404536,0,62,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8852,GO:0033119,1,0.861571613212443,0,24,negative regulation of RNA splicing,BP,
8853,GO:0033120,1,0.823836258483615,0,30,positive regulation of RNA splicing,BP,
8854,GO:0033121,1,0.976909873962369,0,3,regulation of purine nucleotide catabolic process,BP,
8855,GO:0033122,1,0.984783932084435,0,2,negative regulation of purine nucleotide catabolic process,BP,
8856,GO:0033123,1,0.992005548710546,0,1,positive regulation of purine nucleotide catabolic process,BP,
8857,GO:0033127,1,0.92423706991763,0,13,regulation of histone phosphorylation,BP,
8858,GO:0033128,1,0.985179121719899,0,3,negative regulation of histone phosphorylation,BP,
8859,GO:0033129,1,0.950032687257308,0,8,positive regulation of histone phosphorylation,BP,
8860,GO:0033130,1,0.937502036471025,0,10,acetylcholine receptor binding,MF,
8861,GO:0033131,1,0.950491059895535,0,9,regulation of glucokinase activity,BP,
8862,GO:0033132,1,0.978309015993587,0,4,negative regulation of glucokinase activity,BP,
8863,GO:0033133,1,0.971571673122867,0,5,positive regulation of glucokinase activity,BP,
8865,GO:0033137,1,0.863493711192999,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8867,GO:0033139,1,0.973554153977967,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8868,GO:0033140,1,0.995602592559302,0,1,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8869,GO:0033141,1,0.977855183360226,0,3,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8870,GO:0033142,1,0.994752950453791,0,1,progesterone receptor binding,MF,
8871,GO:0033143,1,0.631724455773533,0,70,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8872,GO:0033144,1,0.820674358258822,0,30,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8873,GO:0033145,1,0.91237523991193,0,15,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8874,GO:0033146,1,0.788309971171406,0,35,regulation of intracellular estrogen receptor signaling pathway,BP,
8875,GO:0033147,1,0.921256913232611,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8876,GO:0033148,1,0.940744992120909,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8877,GO:0033149,1,0.984253086187321,0,2,FFAT motif binding,MF,
8878,GO:0033150,1,0.995422135568505,0,1,cytoskeletal calyx,CC,
8879,GO:0033151,1,0.914243698507857,0,12,V(D)J recombination,BP,
8880,GO:0033152,1,0.970653548375965,0,4,immunoglobulin V(D)J recombination,BP,
8881,GO:0033153,1,0.95909461501982,0,5,T cell receptor V(D)J recombination,BP,
8883,GO:0033158,1,0.882091907312443,0,18,regulation of protein import into nucleus, translocation,BP,
8884,GO:0033159,1,0.97902711730025,0,3,negative regulation of protein import into nucleus, translocation,BP,
8885,GO:0033160,1,0.919518973232807,0,11,positive regulation of protein import into nucleus, translocation,BP,
8886,GO:0033162,1,0.945124331499063,0,11,melanosome membrane,CC,
8887,GO:0033165,1,0.989143928313769,0,2,interphotoreceptor matrix,CC,
8888,GO:0033167,1,0.990397143077809,0,1,ARC complex,CC,
8889,GO:0033168,1,0.990397143077809,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8890,GO:0033169,1,0.905677516548396,0,13,histone H3-K9 demethylation,BP,
8891,GO:0033170,1,0.956241481009885,0,8,protein-DNA loading ATPase activity,MF,
8893,GO:0033176,1,0.882707164765041,0,24,proton-transporting V-type ATPase complex,CC,
8894,GO:0033177,1,0.943230020858771,0,11,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8895,GO:0033178,1,0.942866394047051,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8896,GO:0033179,1,0.946571163839811,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8897,GO:0033180,1,0.950584663071438,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8898,GO:0033181,1,0.990297531952232,0,2,plasma membrane proton-transporting V-type ATPase complex,CC,
8899,GO:0033182,1,0.93181279636501,0,10,regulation of histone ubiquitination,BP,
8900,GO:0033183,1,0.976967870353693,0,3,negative regulation of histone ubiquitination,BP,
8901,GO:0033184,1,0.964649855749739,0,5,positive regulation of histone ubiquitination,BP,
8902,GO:0033185,1,0.99019149291884,0,3,dolichol-phosphate-mannose synthase complex,CC,
8903,GO:0033186,1,0.97858570197306,0,3,CAF-1 complex,CC,
8904,GO:0033188,1,0.980866976730619,0,3,sphingomyelin synthase activity,MF,
8905,GO:0033189,1,0.915745289773723,0,15,response to vitamin A,BP,
8906,GO:0033192,1,0.96394154847906,0,5,calmodulin-dependent protein phosphatase activity,MF,
8907,GO:0033193,1,0.992296107693448,0,1,Lsd1/2 complex,CC,
8908,GO:0033194,1,0.912809863722945,0,16,response to hydroperoxide,BP,
8909,GO:0033197,1,0.932201553578291,0,12,response to vitamin E,BP,
8910,GO:0033198,1,0.831716726326751,0,30,response to ATP,BP,
8911,GO:0033202,1,0.926728410443717,0,15,DNA helicase complex,CC,
8912,GO:0033204,1,0.993971154474826,0,1,ribonuclease P RNA binding,MF,
8913,GO:0033206,1,0.963149477612297,0,5,meiotic cytokinesis,BP,
8915,GO:0033210,1,0.943979479391055,0,9,leptin-mediated signaling pathway,BP,
8916,GO:0033211,1,0.969494911923169,0,5,adiponectin-activated signaling pathway,BP,
8917,GO:0033212,1,0.994263129730359,0,1,iron assimilation,BP,
8918,GO:0033214,1,0.994263129730359,0,1,iron assimilation by chelation and transport,BP,
8919,GO:0033216,1,0.959885066959375,0,6,ferric iron import,BP,
8921,GO:0033220,1,0.970828329519425,0,4,amide-transporting ATPase activity,MF,
8922,GO:0033227,1,0.966584335463017,0,5,dsRNA transport,BP,
8923,GO:0033229,1,0.992481453401396,0,1,cysteine transmembrane transporter activity,MF,
8924,GO:0033231,1,0.992458434284543,0,1,carbohydrate export,BP,
8927,GO:0033235,1,0.93664703045941,0,11,positive regulation of protein sumoylation,BP,
8928,GO:0033238,1,0.70282300612008,0,72,regulation of cellular amine metabolic process,BP,
8929,GO:0033239,1,0.963451786477729,0,5,negative regulation of cellular amine metabolic process,BP,
8930,GO:0033240,1,0.951415307507016,0,9,positive regulation of cellular amine metabolic process,BP,
8931,GO:0033241,1,0.990996315875316,0,1,regulation of cellular amine catabolic process,BP,
8932,GO:0033242,1,0.990996315875316,0,1,negative regulation of cellular amine catabolic process,BP,
8933,GO:0033256,1,0.959755536287417,0,7,I-kappaB/NF-kappaB complex,CC,
8934,GO:0033257,1,0.988473929445262,0,2,Bcl3/NF-kappaB2 complex,CC,
8936,GO:0033262,1,0.919805874626415,0,12,regulation of nuclear cell cycle DNA replication,BP,
8937,GO:0033263,1,0.97036807410907,0,4,CORVET complex,CC,
8938,GO:0033265,1,0.987579478052969,0,2,choline binding,MF,
8944,GO:0033274,1,0.991621391484965,0,1,response to vitamin B2,BP,
8945,GO:0033275,1,0.746946825274801,0,35,actin-myosin filament sliding,BP,
8946,GO:0033276,1,0.920267543367021,0,13,transcription factor TFTC complex,CC,
8947,GO:0033277,1,0.986529570827589,0,2,abortive mitotic cell cycle,BP,
8948,GO:0033278,1,0.963663319604885,0,5,cell proliferation in midbrain,BP,
8949,GO:0033280,1,0.810324976666708,0,33,response to vitamin D,BP,
8950,GO:0033283,1,0.984922840427387,0,2,organic acid-transporting ATPase activity,MF,
8951,GO:0033284,1,0.984922840427387,0,2,carboxylic acid-transporting ATPase activity,MF,
8952,GO:0033285,1,0.984922840427387,0,2,monocarboxylic acid-transporting ATPase activity,MF,
8953,GO:0033290,1,0.992444670107284,0,1,eukaryotic 48S preinitiation complex,CC,
8954,GO:0033291,1,0.997091281613663,0,1,eukaryotic 80S initiation complex,CC,
8955,GO:0033292,1,0.982571300344428,0,2,T-tubule organization,BP,
8956,GO:0033293,1,0.759119217488274,0,51,monocarboxylic acid binding,MF,
8957,GO:0033299,1,0.972471547156387,0,5,secretion of lysosomal enzymes,BP,
8958,GO:0033300,1,0.977676873881228,0,3,dehydroascorbic acid transmembrane transporter activity,MF,
8959,GO:0033301,1,0.992482621961752,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8960,GO:0033306,1,0.988078560326488,0,2,phytol metabolic process,BP,
8961,GO:0033313,1,0.96729312257016,0,5,meiotic cell cycle checkpoint,BP,
8962,GO:0033314,1,0.952481892618569,0,8,mitotic DNA replication checkpoint,BP,
8963,GO:0033316,1,0.99289122331296,0,1,meiotic spindle assembly checkpoint,BP,
8964,GO:0033319,1,0.995017281950064,0,1,UDP-D-xylose metabolic process,BP,
8965,GO:0033320,1,0.995017281950064,0,1,UDP-D-xylose biosynthetic process,BP,
8966,GO:0033326,1,0.985710884643238,0,2,cerebrospinal fluid secretion,BP,
8967,GO:0033327,1,0.939352593330128,0,10,Leydig cell differentiation,BP,
8968,GO:0033328,1,0.992502362147741,0,1,peroxisome membrane targeting sequence binding,MF,
8969,GO:0033341,1,0.985275193191796,0,2,regulation of collagen binding,BP,
8970,GO:0033342,1,0.993866181131306,0,1,negative regulation of collagen binding,BP,
8971,GO:0033343,1,0.991356542416089,0,1,positive regulation of collagen binding,BP,
8972,GO:0033344,1,0.81660581342949,0,32,cholesterol efflux,BP,
8973,GO:0033345,1,0.99424046868296,0,1,asparagine catabolic process via L-aspartate,BP,
8974,GO:0033353,1,0.972148954993924,0,4,S-adenosylmethionine cycle,BP,
8975,GO:0033363,1,0.845637527754452,0,25,secretory granule organization,BP,
8976,GO:0033364,1,0.985522225500019,0,2,mast cell secretory granule organization,BP,
8978,GO:0033366,1,0.996647840153691,0,1,protein localization to secretory granule,BP,
8979,GO:0033367,1,0.996647840153691,0,1,protein localization to mast cell secretory granule,BP,
8980,GO:0033368,1,0.996647840153691,0,1,protease localization to mast cell secretory granule,BP,
8981,GO:0033370,1,0.996647840153691,0,1,maintenance of protein location in mast cell secretory granule,BP,
8982,GO:0033371,1,0.996647840153691,0,1,T cell secretory granule organization,BP,
8983,GO:0033373,1,0.996647840153691,0,1,maintenance of protease location in mast cell secretory granule,BP,
8984,GO:0033374,1,0.996647840153691,0,1,protein localization to T cell secretory granule,BP,
8985,GO:0033375,1,0.996647840153691,0,1,protease localization to T cell secretory granule,BP,
8986,GO:0033377,1,0.996647840153691,0,1,maintenance of protein location in T cell secretory granule,BP,
8987,GO:0033379,1,0.996647840153691,0,1,maintenance of protease location in T cell secretory granule,BP,
8988,GO:0033380,1,0.996647840153691,0,1,granzyme B localization to T cell secretory granule,BP,
8989,GO:0033382,1,0.996647840153691,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8990,GO:0033383,1,0.989594518402589,0,2,geranyl diphosphate metabolic process,BP,
8991,GO:0033384,1,0.989594518402589,0,2,geranyl diphosphate biosynthetic process,BP,
8992,GO:0033385,1,0.993232127558755,0,1,geranylgeranyl diphosphate metabolic process,BP,
8993,GO:0033386,1,0.993232127558755,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8994,GO:0033387,1,0.980933750612083,0,3,putrescine biosynthetic process from ornithine,BP,
8995,GO:0033388,1,0.994733937475265,0,1,putrescine biosynthetic process from arginine,BP,
8996,GO:0033391,1,0.925507629907104,0,11,chromatoid body,CC,
8997,GO:0033396,1,0.995075861974963,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8998,GO:0033477,1,0.995277421179367,0,1,S-methylmethionine metabolic process,BP,
8999,GO:0033483,1,0.947642302108679,0,9,gas homeostasis,BP,
9000,GO:0033484,1,0.982885981702238,0,3,nitric oxide homeostasis,BP,
9001,GO:0033488,1,0.992839298677542,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
9002,GO:0033489,1,0.976237580230606,0,4,cholesterol biosynthetic process via desmosterol,BP,
9003,GO:0033490,1,0.976237580230606,0,4,cholesterol biosynthetic process via lathosterol,BP,
9004,GO:0033499,1,0.990535588341656,0,2,galactose catabolic process via UDP-galactose,BP,
9006,GO:0033503,1,0.974508237616637,0,4,HULC complex,CC,
9007,GO:0033504,1,0.964329820133279,0,5,floor plate development,BP,
9008,GO:0033505,1,0.986834211195032,0,2,floor plate morphogenesis,BP,
9009,GO:0033512,1,0.979993612732472,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
9010,GO:0033514,1,0.994149087961217,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9011,GO:0033522,1,0.849070970437317,0,24,histone H2A ubiquitination,BP,
9012,GO:0033523,1,0.923961077889343,0,12,histone H2B ubiquitination,BP,
9013,GO:0033526,1,0.993436769169749,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
9014,GO:0033539,1,0.920672708932918,0,14,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9015,GO:0033540,1,0.920115564101269,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9016,GO:0033549,1,0.927267763584431,0,12,MAP kinase phosphatase activity,MF,
9017,GO:0033552,1,0.993709469022338,0,1,response to vitamin B3,BP,
9018,GO:0033553,1,0.973090301831967,0,4,rDNA heterochromatin,CC,
9021,GO:0033557,1,0.986646673054992,0,2,Slx1-Slx4 complex,CC,
9022,GO:0033558,1,0.74571623828439,0,44,protein deacetylase activity,MF,
9023,GO:0033559,1,0.623262591826928,0,86,unsaturated fatty acid metabolic process,BP,
9024,GO:0033560,1,0.992463045035186,0,1,folate reductase activity,MF,
9025,GO:0033561,1,0.89240870629469,0,18,regulation of water loss via skin,BP,
9026,GO:0033563,1,0.978720253837409,0,3,dorsal/ventral axon guidance,BP,
9027,GO:0033564,1,0.955020109053202,0,6,anterior/posterior axon guidance,BP,
9028,GO:0033565,1,0.978259437807677,0,3,ESCRT-0 complex,CC,
9029,GO:0033566,1,0.987478550888048,0,2,gamma-tubulin complex localization,BP,
9030,GO:0033567,1,0.972952877868532,0,5,DNA replication, Okazaki fragment processing,BP,
9031,GO:0033570,1,0.985383319895897,0,2,transferrin transmembrane transporter activity,MF,
9033,GO:0033574,1,0.788959728227192,0,41,response to testosterone,BP,
9034,GO:0033577,1,0.98695195056165,0,2,protein glycosylation in endoplasmic reticulum,BP,
9035,GO:0033578,1,0.967438728389983,0,5,protein glycosylation in Golgi,BP,
9036,GO:0033588,1,0.969763345754312,0,5,Elongator holoenzyme complex,CC,
9038,GO:0033591,1,0.968427410137097,0,5,response to L-ascorbic acid,BP,
9039,GO:0033592,1,0.964763622513847,0,5,RNA strand annealing activity,MF,
9040,GO:0033593,1,0.989884075424774,0,1,BRCA2-MAGE-D1 complex,CC,
9042,GO:0033595,1,0.987362196534783,0,2,response to genistein,BP,
9043,GO:0033596,1,0.983276124678616,0,2,TSC1-TSC2 complex,CC,
9044,GO:0033597,1,0.994854591448397,0,1,mitotic checkpoint complex,CC,
9045,GO:0033598,1,0.844094496885661,0,26,mammary gland epithelial cell proliferation,BP,
9046,GO:0033599,1,0.894583175851915,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9047,GO:0033600,1,0.970980074135719,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9048,GO:0033601,1,0.943308791958111,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
9049,GO:0033602,1,0.978091935961653,0,3,negative regulation of dopamine secretion,BP,
9050,GO:0033603,1,0.963465295867131,0,6,positive regulation of dopamine secretion,BP,
9051,GO:0033604,1,0.940760030471922,0,10,negative regulation of catecholamine secretion,BP,
9052,GO:0033605,1,0.941294661465451,0,10,positive regulation of catecholamine secretion,BP,
9053,GO:0033608,1,0.993301131169352,0,1,formyl-CoA transferase activity,MF,
9054,GO:0033609,1,0.993301131169352,0,1,oxalate metabolic process,BP,
9055,GO:0033612,1,0.890492213597968,0,19,receptor serine/threonine kinase binding,MF,
9056,GO:0033613,1,0.628253442437809,0,70,activating transcription factor binding,MF,
9057,GO:0033615,1,0.983481034612146,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9058,GO:0033617,1,0.896552603328916,0,20,mitochondrial respiratory chain complex IV assembly,BP,
9060,GO:0033622,1,0.876350455560315,0,19,integrin activation,BP,
9061,GO:0033623,1,0.93280852542124,0,10,regulation of integrin activation,BP,
9062,GO:0033624,1,0.984206312916939,0,2,negative regulation of integrin activation,BP,
9063,GO:0033625,1,0.968485932453356,0,5,positive regulation of integrin activation,BP,
9064,GO:0033626,1,0.992484065920251,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9065,GO:0033627,1,0.713949998045929,0,52,cell adhesion mediated by integrin,BP,
9066,GO:0033628,1,0.799234357460839,0,37,regulation of cell adhesion mediated by integrin,BP,
9067,GO:0033629,1,0.947491887435663,0,8,negative regulation of cell adhesion mediated by integrin,BP,
9068,GO:0033630,1,0.911292283710527,0,16,positive regulation of cell adhesion mediated by integrin,BP,
9069,GO:0033631,1,0.928982731702026,0,11,cell-cell adhesion mediated by integrin,BP,
9070,GO:0033632,1,0.957637485782801,0,7,regulation of cell-cell adhesion mediated by integrin,BP,
9071,GO:0033633,1,0.992331166861174,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9072,GO:0033634,1,0.982127122843648,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
9073,GO:0033643,1,0.925118258049022,0,12,host cell part,CC,
9074,GO:0033644,1,0.992442474285194,0,1,host cell membrane,CC,
9075,GO:0033646,1,0.945040856705342,0,9,host intracellular part,CC,
9076,GO:0033647,1,0.968025732243648,0,5,host intracellular organelle,CC,
9077,GO:0033648,1,0.968025732243648,0,5,host intracellular membrane-bounded organelle,CC,
9078,GO:0033650,1,0.995851195529539,0,1,host cell mitochondrion,CC,
9079,GO:0033655,1,0.96497784772179,0,6,host cell cytoplasm part,CC,
9080,GO:0033668,1,0.976800344897516,0,4,negative regulation by symbiont of host apoptotic process,BP,
9083,GO:0033676,1,0.996454527798526,0,1,double-stranded DNA-dependent ATPase activity,MF,
9084,GO:0033677,1,0.979454648391006,0,3,DNA/RNA helicase activity,MF,
9085,GO:0033678,1,0.993535404096035,0,1,5'-3' DNA/RNA helicase activity,MF,
9086,GO:0033679,1,0.99237803441513,0,1,3'-5' DNA/RNA helicase activity,MF,
9087,GO:0033680,1,0.985962202121247,0,2,ATP-dependent DNA/RNA helicase activity,MF,
9088,GO:0033681,1,0.99237803441513,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
9089,GO:0033682,1,0.993535404096035,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9090,GO:0033683,1,0.802508826003663,0,39,nucleotide-excision repair, DNA incision,BP,
9091,GO:0033684,1,0.9575076669589,0,7,regulation of luteinizing hormone secretion,BP,
9092,GO:0033685,1,0.983161662713718,0,3,negative regulation of luteinizing hormone secretion,BP,
9093,GO:0033686,1,0.973911191081271,0,4,positive regulation of luteinizing hormone secretion,BP,
9097,GO:0033690,1,0.934760500608616,0,11,positive regulation of osteoblast proliferation,BP,
9100,GO:0033693,1,0.985629707771823,0,2,neurofilament bundle assembly,BP,
9101,GO:0033695,1,0.99544704789982,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9102,GO:0033699,1,0.995207441959663,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9103,GO:0033700,1,0.954702999748564,0,8,phospholipid efflux,BP,
9104,GO:0033735,1,0.99690531501731,0,1,aspartate dehydrogenase activity,MF,
9105,GO:0033737,1,0.993913943638435,0,1,1-pyrroline dehydrogenase activity,MF,
9106,GO:0033743,1,0.978180746105388,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9107,GO:0033745,1,0.981568964924606,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9108,GO:0033746,1,0.992500861833069,0,1,histone demethylase activity (H3-R2 specific),MF,
9109,GO:0033749,1,0.992500861833069,0,1,histone demethylase activity (H4-R3 specific),MF,
9110,GO:0033750,1,0.935954270990026,0,13,ribosome localization,BP,
9111,GO:0033754,1,0.996199438325672,0,1,indoleamine 2,3-dioxygenase activity,MF,
9112,GO:0033762,1,0.743823419009038,0,47,response to glucagon,BP,
9113,GO:0033764,1,0.911804023531417,0,22,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9114,GO:0033765,1,0.988139089146914,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9115,GO:0033768,1,0.993005872133109,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9116,GO:0033778,1,0.992461277037728,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9117,GO:0033781,1,0.99503596063896,0,1,cholesterol 24-hydroxylase activity,MF,
9118,GO:0033787,1,0.993166936961311,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9119,GO:0033791,1,0.994408173418553,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9120,GO:0033798,1,0.99500391878438,0,1,thyroxine 5-deiodinase activity,MF,
9121,GO:0033814,1,0.996435032809324,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9122,GO:0033819,1,0.99689899171961,0,1,lipoyl(octanoyl) transferase activity,MF,
9123,GO:0033823,1,0.992945188475223,0,1,procollagen glucosyltransferase activity,MF,
9124,GO:0033829,1,0.985615849637262,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9125,GO:0033842,1,0.985159255021111,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9126,GO:0033857,1,0.984394782059489,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9127,GO:0033858,1,0.99274182518548,0,1,N-acetylgalactosamine kinase activity,MF,
9128,GO:0033860,1,0.966850874543694,0,7,regulation of NAD(P)H oxidase activity,BP,
9129,GO:0033861,1,0.990898244839151,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9130,GO:0033862,1,0.992949262374859,0,1,UMP kinase activity,MF,
9131,GO:0033864,1,0.975734033660982,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9132,GO:0033865,1,0.809141071366986,0,38,nucleoside bisphosphate metabolic process,BP,
9133,GO:0033866,1,0.911722683393652,0,16,nucleoside bisphosphate biosynthetic process,BP,
9134,GO:0033867,1,0.996068028651457,0,1,Fas-activated serine/threonine kinase activity,MF,
9135,GO:0033869,1,0.996861800316227,0,1,nucleoside bisphosphate catabolic process,BP,
9136,GO:0033871,1,0.995397073095079,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9137,GO:0033872,1,0.989084441267044,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9138,GO:0033875,1,0.809141071366986,0,38,ribonucleoside bisphosphate metabolic process,BP,
9139,GO:0033878,1,0.992471747939201,0,1,hormone-sensitive lipase activity,MF,
9140,GO:0033882,1,0.996740904694734,0,1,choloyl-CoA hydrolase activity,MF,
9141,GO:0033883,1,0.992045475169239,0,2,pyridoxal phosphatase activity,MF,
9142,GO:0033885,1,0.994706762123157,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9143,GO:0033897,1,0.996647840153691,0,1,ribonuclease T2 activity,MF,
9144,GO:0033906,1,0.990141570051418,0,2,hyaluronoglucuronidase activity,MF,
9145,GO:0033919,1,0.99246386324672,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9146,GO:0033925,1,0.992400924180365,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9147,GO:0033961,1,0.995860783147412,0,1,cis-stilbene-oxide hydrolase activity,MF,
9148,GO:0033962,1,0.875443893147575,0,18,cytoplasmic mRNA processing body assembly,BP,
9149,GO:0033967,1,0.99673146754899,0,1,box C/D snoRNA metabolic process,BP,
9150,GO:0033979,1,0.993734703919287,0,1,box H/ACA snoRNA metabolic process,BP,
9151,GO:0033981,1,0.997040928029174,0,1,D-dopachrome decarboxylase activity,MF,
9152,GO:0033989,1,0.993475658848043,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9154,GO:0034014,1,0.994485294736201,0,1,response to triglyceride,BP,
9155,GO:0034030,1,0.911722683393652,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9156,GO:0034031,1,0.996861800316227,0,1,ribonucleoside bisphosphate catabolic process,BP,
9157,GO:0034032,1,0.809141071366986,0,38,purine nucleoside bisphosphate metabolic process,BP,
9158,GO:0034033,1,0.911722683393652,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
9159,GO:0034034,1,0.996861800316227,0,1,purine nucleoside bisphosphate catabolic process,BP,
9160,GO:0034035,1,0.881856337006383,0,23,purine ribonucleoside bisphosphate metabolic process,BP,
9161,GO:0034036,1,0.961027174160211,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9162,GO:0034038,1,0.996713088985209,0,1,deoxyhypusine synthase activity,MF,
9163,GO:0034039,1,0.991145958860092,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9164,GO:0034040,1,0.955719424840397,0,6,lipid-transporting ATPase activity,MF,
9165,GO:0034041,1,0.979095580660778,0,3,sterol-transporting ATPase activity,MF,
9166,GO:0034045,1,0.895204936997835,0,16,phagophore assembly site membrane,CC,
9167,GO:0034046,1,0.950552224083612,0,7,poly(G) binding,MF,
9168,GO:0034056,1,0.971484151784085,0,4,estrogen response element binding,MF,
9169,GO:0034057,1,0.986386006512526,0,2,RNA strand-exchange activity,MF,
9170,GO:0034058,1,0.928712534081011,0,10,endosomal vesicle fusion,BP,
9171,GO:0034059,1,0.978448501683913,0,3,response to anoxia,BP,
9172,GO:0034061,1,0.795808168946319,0,35,DNA polymerase activity,MF,
9173,GO:0034062,1,0.790963053190975,0,43,5'-3' RNA polymerase activity,MF,
9174,GO:0034063,1,0.90568829408959,0,13,stress granule assembly,BP,
9175,GO:0034066,1,0.989914900195671,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9176,GO:0034067,1,0.849662920189601,0,21,protein localization to Golgi apparatus,BP,
9177,GO:0034080,1,0.855440015831417,0,30,CENP-A containing nucleosome assembly,BP,
9178,GO:0034085,1,0.958619617607578,0,6,establishment of sister chromatid cohesion,BP,
9179,GO:0034086,1,0.934371777066029,0,10,maintenance of sister chromatid cohesion,BP,
9180,GO:0034087,1,0.983030977816218,0,2,establishment of mitotic sister chromatid cohesion,BP,
9181,GO:0034088,1,0.934371777066029,0,10,maintenance of mitotic sister chromatid cohesion,BP,
9182,GO:0034091,1,0.962348455759433,0,6,regulation of maintenance of sister chromatid cohesion,BP,
9183,GO:0034092,1,0.977769024904068,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9184,GO:0034093,1,0.984232486174319,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9186,GO:0034098,1,0.93990816855429,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9187,GO:0034101,1,0.507967260738795,0,109,erythrocyte homeostasis,BP,
9192,GO:0034110,1,0.857038161808913,0,23,regulation of homotypic cell-cell adhesion,BP,
9193,GO:0034111,1,0.913351449546012,0,14,negative regulation of homotypic cell-cell adhesion,BP,
9194,GO:0034112,1,0.974547813784965,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9198,GO:0034116,1,0.946202712623931,0,10,positive regulation of heterotypic cell-cell adhesion,BP,
9199,GO:0034117,1,0.997063182261296,0,1,erythrocyte aggregation,BP,
9200,GO:0034118,1,0.997063182261296,0,1,regulation of erythrocyte aggregation,BP,
9201,GO:0034120,1,0.997063182261296,0,1,positive regulation of erythrocyte aggregation,BP,
9202,GO:0034121,1,0.69236843768949,0,57,regulation of toll-like receptor signaling pathway,BP,
9203,GO:0034122,1,0.804870845894296,0,33,negative regulation of toll-like receptor signaling pathway,BP,
9204,GO:0034123,1,0.882685301174216,0,20,positive regulation of toll-like receptor signaling pathway,BP,
9205,GO:0034124,1,0.979371248259497,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9206,GO:0034125,1,0.991394815654287,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9207,GO:0034127,1,0.952615681147003,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9208,GO:0034128,1,0.957095941960638,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9209,GO:0034130,1,0.993165181999932,0,1,toll-like receptor 1 signaling pathway,BP,
9210,GO:0034134,1,0.925842162214706,0,12,toll-like receptor 2 signaling pathway,BP,
9211,GO:0034135,1,0.957184497171342,0,7,regulation of toll-like receptor 2 signaling pathway,BP,
9212,GO:0034136,1,0.977477470026022,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
9213,GO:0034137,1,0.979244321768485,0,4,positive regulation of toll-like receptor 2 signaling pathway,BP,
9214,GO:0034138,1,0.88530804038845,0,19,toll-like receptor 3 signaling pathway,BP,
9215,GO:0034139,1,0.942234532665627,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9216,GO:0034140,1,0.978131157803719,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9217,GO:0034141,1,0.956671495892296,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9218,GO:0034142,1,0.842611029035584,0,28,toll-like receptor 4 signaling pathway,BP,
9219,GO:0034143,1,0.909925155221333,0,15,regulation of toll-like receptor 4 signaling pathway,BP,
9220,GO:0034144,1,0.960823441615363,0,6,negative regulation of toll-like receptor 4 signaling pathway,BP,
9221,GO:0034145,1,0.947047847124566,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9222,GO:0034146,1,0.984901820857152,0,2,toll-like receptor 5 signaling pathway,BP,
9223,GO:0034147,1,0.992411290444428,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9224,GO:0034148,1,0.992411290444428,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9225,GO:0034150,1,0.992045483227231,0,1,toll-like receptor 6 signaling pathway,BP,
9226,GO:0034154,1,0.957756778470454,0,7,toll-like receptor 7 signaling pathway,BP,
9227,GO:0034155,1,0.983637503882602,0,3,regulation of toll-like receptor 7 signaling pathway,BP,
9228,GO:0034156,1,0.995940820722402,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9229,GO:0034157,1,0.987647059262598,0,2,positive regulation of toll-like receptor 7 signaling pathway,BP,
9230,GO:0034158,1,0.992440170094173,0,1,toll-like receptor 8 signaling pathway,BP,
9231,GO:0034162,1,0.872819287788554,0,20,toll-like receptor 9 signaling pathway,BP,
9232,GO:0034163,1,0.958907086868312,0,6,regulation of toll-like receptor 9 signaling pathway,BP,
9233,GO:0034164,1,0.987768322241416,0,2,negative regulation of toll-like receptor 9 signaling pathway,BP,
9234,GO:0034165,1,0.985155321570363,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9235,GO:0034166,1,0.992631625636847,0,1,toll-like receptor 10 signaling pathway,BP,
9236,GO:0034182,1,0.962348455759433,0,6,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9237,GO:0034183,1,0.977769024904068,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9238,GO:0034184,1,0.984232486174319,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9239,GO:0034185,1,0.887437394451169,0,16,apolipoprotein binding,MF,
9240,GO:0034186,1,0.974970816260546,0,4,apolipoprotein A-I binding,MF,
9241,GO:0034188,1,0.982120562409373,0,2,apolipoprotein A-I receptor activity,MF,
9242,GO:0034189,1,0.985056658319042,0,2,very-low-density lipoprotein particle binding,MF,
9243,GO:0034190,1,0.970731158826714,0,5,apolipoprotein receptor binding,MF,
9244,GO:0034191,1,0.978071818613037,0,4,apolipoprotein A-I receptor binding,MF,
9245,GO:0034196,1,0.980265752950194,0,4,acylglycerol transport,BP,
9246,GO:0034197,1,0.980265752950194,0,4,triglyceride transport,BP,
9247,GO:0034198,1,0.771963095797119,0,42,cellular response to amino acid starvation,BP,
9248,GO:0034199,1,0.888899725765464,0,16,activation of protein kinase A activity,BP,
9249,GO:0034201,1,0.968406926448078,0,5,response to oleic acid,BP,
9250,GO:0034203,1,0.992270183155589,0,1,glycolipid translocation,BP,
9252,GO:0034205,1,0.856471996493676,0,23,amyloid-beta formation,BP,
9253,GO:0034211,1,0.990820996121129,0,1,GTP-dependent protein kinase activity,MF,
9254,GO:0034212,1,0.667966150091125,0,60,peptide N-acetyltransferase activity,MF,
9255,GO:0034213,1,0.996240080601274,0,1,quinolinate catabolic process,BP,
9256,GO:0034214,1,0.945428254292808,0,8,protein hexamerization,BP,
9259,GO:0034224,1,0.994596633956972,0,1,cellular response to zinc ion starvation,BP,
9260,GO:0034227,1,0.97679110334648,0,5,tRNA thio-modification,BP,
9261,GO:0034230,1,0.992353532653272,0,1,enkephalin processing,BP,
9262,GO:0034231,1,0.992353532653272,0,1,islet amyloid polypeptide processing,BP,
9263,GO:0034235,1,0.966970208090198,0,6,GPI anchor binding,MF,
9264,GO:0034236,1,0.906906257080292,0,14,protein kinase A catalytic subunit binding,MF,
9265,GO:0034237,1,0.870942553856408,0,18,protein kinase A regulatory subunit binding,MF,
9266,GO:0034238,1,0.992458560539507,0,1,macrophage fusion,BP,
9267,GO:0034239,1,0.992458560539507,0,1,regulation of macrophage fusion,BP,
9268,GO:0034241,1,0.992458560539507,0,1,positive regulation of macrophage fusion,BP,
9269,GO:0034242,1,0.984174931534299,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9270,GO:0034243,1,0.852935987212734,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9271,GO:0034244,1,0.93462633018854,0,11,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9272,GO:0034245,1,0.992471160990459,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9273,GO:0034247,1,0.996601699212043,0,1,snoRNA splicing,BP,
9276,GO:0034250,1,0.44646200704095,0,131,positive regulation of cellular amide metabolic process,BP,
9277,GO:0034255,1,0.994866756232826,0,1,regulation of urea metabolic process,BP,
9278,GO:0034260,1,0.748907208570662,0,44,negative regulation of GTPase activity,BP,
9279,GO:0034271,1,0.980105420509076,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9280,GO:0034272,1,0.980105420509076,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9281,GO:0034274,1,0.977626524549088,0,3,Atg12-Atg5-Atg16 complex,CC,
9282,GO:0034275,1,0.996199438325672,0,1,kynurenic acid metabolic process,BP,
9283,GO:0034276,1,0.996199438325672,0,1,kynurenic acid biosynthetic process,BP,
9285,GO:0034285,1,0.971765046450359,0,4,response to disaccharide,BP,
9286,GO:0034287,1,0.978628510619759,0,4,detection of monosaccharide stimulus,BP,
9287,GO:0034308,1,0.750492327661908,0,51,primary alcohol metabolic process,BP,
9288,GO:0034309,1,0.99691333883606,0,1,primary alcohol biosynthetic process,BP,
9289,GO:0034310,1,0.943816708045373,0,13,primary alcohol catabolic process,BP,
9290,GO:0034311,1,0.90533757558965,0,19,diol metabolic process,BP,
9291,GO:0034312,1,0.918336074917126,0,16,diol biosynthetic process,BP,
9292,GO:0034314,1,0.83329271356112,0,31,Arp2/3 complex-mediated actin nucleation,BP,
9293,GO:0034315,1,0.909834267392147,0,15,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9294,GO:0034316,1,0.972616319824369,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9297,GO:0034331,1,0.930807189453868,0,11,cell junction maintenance,BP,
9300,GO:0034334,1,0.970692424016893,0,4,adherens junction maintenance,BP,
9301,GO:0034338,1,0.975818584541263,0,4,short-chain carboxylesterase activity,MF,
9302,GO:0034340,1,0.643516314594414,0,75,response to type I interferon,BP,
9303,GO:0034341,1,0.399930620543309,0,164,response to interferon-gamma,BP,
9304,GO:0034342,1,0.988263539896803,0,2,response to type III interferon,BP,
9305,GO:0034343,1,0.977958630723152,0,3,type III interferon production,BP,
9306,GO:0034344,1,0.977958630723152,0,3,regulation of type III interferon production,BP,
9307,GO:0034346,1,0.992881937761671,0,1,positive regulation of type III interferon production,BP,
9308,GO:0034349,1,0.910793213989612,0,14,glial cell apoptotic process,BP,
9309,GO:0034350,1,0.94837500225077,0,8,regulation of glial cell apoptotic process,BP,
9310,GO:0034351,1,0.94837500225077,0,8,negative regulation of glial cell apoptotic process,BP,
9311,GO:0034353,1,0.993301131169352,0,1,RNA pyrophosphohydrolase activity,MF,
9312,GO:0034354,1,0.99660517633972,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9313,GO:0034355,1,0.993301131169352,0,1,NAD salvage,BP,
9315,GO:0034358,1,0.841342525497614,0,32,plasma lipoprotein particle,CC,
9316,GO:0034359,1,0.98850857178153,0,1,mature chylomicron,CC,
9317,GO:0034360,1,0.98850857178153,0,1,chylomicron remnant,CC,
9318,GO:0034361,1,0.924788724788188,0,15,very-low-density lipoprotein particle,CC,
9319,GO:0034362,1,0.933594311698601,0,12,low-density lipoprotein particle,CC,
9320,GO:0034363,1,0.979315971169404,0,4,intermediate-density lipoprotein particle,CC,
9321,GO:0034364,1,0.915422338826882,0,21,high-density lipoprotein particle,CC,
9322,GO:0034365,1,0.990685618406933,0,3,discoidal high-density lipoprotein particle,CC,
9323,GO:0034366,1,0.976845090231815,0,6,spherical high-density lipoprotein particle,CC,
9324,GO:0034367,1,0.880306702951554,0,23,protein-containing complex remodeling,BP,
9325,GO:0034368,1,0.886617903085468,0,22,protein-lipid complex remodeling,BP,
9326,GO:0034369,1,0.886617903085468,0,22,plasma lipoprotein particle remodeling,BP,
9327,GO:0034370,1,0.960873039695601,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9328,GO:0034371,1,0.971948400929132,0,5,chylomicron remodeling,BP,
9329,GO:0034372,1,0.972046523783572,0,7,very-low-density lipoprotein particle remodeling,BP,
9330,GO:0034373,1,0.996137914678973,0,1,intermediate-density lipoprotein particle remodeling,BP,
9331,GO:0034374,1,0.937339110534834,0,11,low-density lipoprotein particle remodeling,BP,
9332,GO:0034375,1,0.935773806548299,0,14,high-density lipoprotein particle remodeling,BP,
9333,GO:0034377,1,0.874594956831442,0,22,plasma lipoprotein particle assembly,BP,
9334,GO:0034378,1,0.958197752330522,0,7,chylomicron assembly,BP,
9335,GO:0034379,1,0.943068057733909,0,9,very-low-density lipoprotein particle assembly,BP,
9336,GO:0034380,1,0.937612583904052,0,11,high-density lipoprotein particle assembly,BP,
9337,GO:0034381,1,0.75672732487316,0,47,plasma lipoprotein particle clearance,BP,
9338,GO:0034382,1,0.961944647013696,0,7,chylomicron remnant clearance,BP,
9339,GO:0034383,1,0.82780334480618,0,30,low-density lipoprotein particle clearance,BP,
9340,GO:0034384,1,0.947034194413841,0,10,high-density lipoprotein particle clearance,BP,
9341,GO:0034385,1,0.924788724788188,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9342,GO:0034386,1,0.992316013745567,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9343,GO:0034388,1,0.961788561668947,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9344,GO:0034389,1,0.905103485524993,0,17,lipid particle organization,BP,
9345,GO:0034390,1,0.899729079696418,0,17,smooth muscle cell apoptotic process,BP,
9346,GO:0034391,1,0.899729079696418,0,17,regulation of smooth muscle cell apoptotic process,BP,
9347,GO:0034392,1,0.96961824838857,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9348,GO:0034393,1,0.939995571998137,0,10,positive regulation of smooth muscle cell apoptotic process,BP,
9349,GO:0034394,1,0.713151612824369,0,51,protein localization to cell surface,BP,
9350,GO:0034395,1,0.98886778438402,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9351,GO:0034397,1,0.924810525991325,0,11,telomere localization,BP,
9352,GO:0034398,1,0.959708486105458,0,6,telomere tethering at nuclear periphery,BP,
9353,GO:0034399,1,0.422410786861353,0,128,nuclear periphery,CC,
9354,GO:0034402,1,0.986461516366787,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9357,GO:0034414,1,0.987155002559538,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9358,GO:0034416,1,0.993166936961311,0,1,bisphosphoglycerate phosphatase activity,MF,
9359,GO:0034417,1,0.993166936961311,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9360,GO:0034418,1,0.989026680970919,0,2,urate biosynthetic process,BP,
9361,GO:0034421,1,0.979668820084624,0,3,post-translational protein acetylation,BP,
9362,GO:0034423,1,0.99360366470725,0,1,autophagosome lumen,CC,
9363,GO:0034427,1,0.956402294229009,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9364,GO:0034431,1,0.978556250983495,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9365,GO:0034432,1,0.978556250983495,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9366,GO:0034433,1,0.949903736227368,0,10,steroid esterification,BP,
9367,GO:0034434,1,0.949903736227368,0,10,sterol esterification,BP,
9368,GO:0034435,1,0.949903736227368,0,10,cholesterol esterification,BP,
9369,GO:0034436,1,0.982429388813225,0,3,glycoprotein transport,BP,
9370,GO:0034437,1,0.985508101932843,0,2,glycoprotein transporter activity,MF,
9373,GO:0034441,1,0.992761955667221,0,2,plasma lipoprotein particle oxidation,BP,
9376,GO:0034444,1,0.997000020550096,0,1,regulation of plasma lipoprotein oxidation,BP,
9377,GO:0034445,1,0.997000020550096,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9379,GO:0034447,1,0.959089951862563,0,8,very-low-density lipoprotein particle clearance,BP,
9380,GO:0034448,1,0.975553986366981,0,5,EGO complex,CC,
9381,GO:0034450,1,0.917468404955629,0,13,ubiquitin-ubiquitin ligase activity,MF,
9382,GO:0034451,1,0.826482859215371,0,27,centriolar satellite,CC,
9383,GO:0034452,1,0.923591002204397,0,10,dynactin binding,MF,
9384,GO:0034453,1,0.846966060542145,0,22,microtubule anchoring,BP,
9385,GO:0034454,1,0.929882667475538,0,9,microtubule anchoring at centrosome,BP,
9386,GO:0034455,1,0.985796283198728,0,2,t-UTP complex,CC,
9387,GO:0034456,1,0.98916445411414,0,2,UTP-C complex,CC,
9388,GO:0034457,1,0.987500947892458,0,3,Mpp10 complex,CC,
9389,GO:0034458,1,0.986393396370791,0,2,3'-5' RNA helicase activity,MF,
9390,GO:0034459,1,0.99237803441513,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9391,GO:0034462,1,0.994592555823903,0,1,small-subunit processome assembly,BP,
9392,GO:0034463,1,0.997091281613663,0,1,90S preribosome assembly,BP,
9393,GO:0034464,1,0.943689650198131,0,9,BBSome,CC,
9394,GO:0034465,1,0.977587353906575,0,4,response to carbon monoxide,BP,
9395,GO:0034466,1,0.993314971832317,0,1,chromaffin granule lumen,CC,
9396,GO:0034470,1,0.122278876156005,0,389,ncRNA processing,BP,
9397,GO:0034471,1,0.902478302386776,0,19,ncRNA 5'-end processing,BP,
9398,GO:0034472,1,0.921771338036909,0,15,snRNA 3'-end processing,BP,
9399,GO:0034473,1,0.989340550844604,0,3,U1 snRNA 3'-end processing,BP,
9400,GO:0034474,1,0.991670029617685,0,1,U2 snRNA 3'-end processing,BP,
9401,GO:0034475,1,0.970942987253313,0,8,U4 snRNA 3'-end processing,BP,
9402,GO:0034476,1,0.989340550844604,0,3,U5 snRNA 3'-end processing,BP,
9403,GO:0034477,1,0.993301131169352,0,1,U6 snRNA 3'-end processing,BP,
9404,GO:0034481,1,0.9643259394912,0,6,chondroitin sulfotransferase activity,MF,
9405,GO:0034483,1,0.907185293752711,0,14,heparan sulfate sulfotransferase activity,MF,
9406,GO:0034485,1,0.972287462509784,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9407,GO:0034497,1,0.9134472023095,0,13,protein localization to phagophore assembly site,BP,
9408,GO:0034498,1,0.949568830114558,0,8,early endosome to Golgi transport,BP,
9409,GO:0034499,1,0.984094915268069,0,2,late endosome to Golgi transport,BP,
9410,GO:0034501,1,0.908145285739195,0,16,protein localization to kinetochore,BP,
9411,GO:0034502,1,0.643127786071886,0,70,protein localization to chromosome,BP,
9413,GO:0034505,1,0.900801104146277,0,15,tooth mineralization,BP,
9414,GO:0034506,1,0.992455981102177,0,1,chromosome, centromeric core domain,CC,
9415,GO:0034508,1,0.795052259140627,0,40,centromere complex assembly,BP,
9416,GO:0034511,1,0.970391445541995,0,5,U3 snoRNA binding,MF,
9417,GO:0034513,1,0.981196971721868,0,5,box H/ACA snoRNA binding,MF,
9418,GO:0034515,1,0.985746081602841,0,2,proteasome storage granule,CC,
9419,GO:0034516,1,0.996338632672028,0,1,response to vitamin B6,BP,
9420,GO:0034518,1,0.936071406890024,0,11,RNA cap binding complex,CC,
9421,GO:0034545,1,0.996000751859802,0,1,fumarylpyruvate hydrolase activity,MF,
9422,GO:0034551,1,0.948235941460293,0,9,mitochondrial respiratory chain complex III assembly,BP,
9423,GO:0034552,1,0.993472944424649,0,2,respiratory chain complex II assembly,BP,
9424,GO:0034553,1,0.993472944424649,0,2,mitochondrial respiratory chain complex II assembly,BP,
9425,GO:0034584,1,0.98522735146398,0,2,piRNA binding,MF,
9426,GO:0034587,1,0.910698516741975,0,14,piRNA metabolic process,BP,
9427,GO:0034589,1,0.992429197414442,0,1,hydroxyproline transport,BP,
9428,GO:0034590,1,0.992429197414442,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9429,GO:0034593,1,0.831329176098062,0,25,phosphatidylinositol bisphosphate phosphatase activity,MF,
9430,GO:0034594,1,0.960470362386239,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9431,GO:0034595,1,0.908032760022258,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9432,GO:0034596,1,0.939561504565257,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9433,GO:0034597,1,0.984288924477132,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9435,GO:0034602,1,0.992428878361613,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9436,GO:0034603,1,0.967737623453035,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9437,GO:0034604,1,0.967737623453035,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9438,GO:0034605,1,0.447352265509118,0,121,cellular response to heat,BP,
9442,GO:0034616,1,0.910298702847934,0,14,response to laminar fluid shear stress,BP,
9443,GO:0034617,1,0.973833407122105,0,4,tetrahydrobiopterin binding,MF,
9444,GO:0034618,1,0.963117175409103,0,6,arginine binding,MF,
9447,GO:0034625,1,0.960403079992839,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9448,GO:0034626,1,0.960403079992839,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9449,GO:0034627,1,0.977036505493979,0,4,'de novo' NAD biosynthetic process,BP,
9450,GO:0034628,1,0.9803653610122,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9451,GO:0034629,1,0.860422827918449,0,23,cellular protein-containing complex localization,BP,
9452,GO:0034632,1,0.990101806520995,0,2,retinol transmembrane transporter activity,MF,
9453,GO:0034633,1,0.990101806520995,0,2,retinol transport,BP,
9454,GO:0034634,1,0.991874756835951,0,1,glutathione transmembrane transporter activity,MF,
9455,GO:0034635,1,0.987164539787604,0,2,glutathione transport,BP,
9458,GO:0034640,1,0.992692029237482,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9460,GO:0034643,1,0.87768653422085,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
9461,GO:0034644,1,0.624563793473006,0,74,cellular response to UV,BP,
9463,GO:0034647,1,0.982070413122853,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9464,GO:0034648,1,0.96767599973376,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9465,GO:0034649,1,0.992465141632793,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9466,GO:0034650,1,0.946163055578595,0,8,cortisol metabolic process,BP,
9467,GO:0034651,1,0.950599876542326,0,7,cortisol biosynthetic process,BP,
9468,GO:0034653,1,0.984240766752279,0,3,retinoic acid catabolic process,BP,
9471,GO:0034656,1,0.793318418593902,0,43,nucleobase-containing small molecule catabolic process,BP,
9472,GO:0034657,1,0.975499381108362,0,4,GID complex,CC,
9473,GO:0034660,1,0.0462869378125931,0,546,ncRNA metabolic process,BP,
9474,GO:0034661,1,0.861444217181276,0,24,ncRNA catabolic process,BP,
9475,GO:0034663,1,0.947007542728247,0,9,endoplasmic reticulum chaperone complex,CC,
9476,GO:0034665,1,0.984872245444446,0,2,integrin alpha1-beta1 complex,CC,
9477,GO:0034666,1,0.976862926861423,0,3,integrin alpha2-beta1 complex,CC,
9478,GO:0034667,1,0.984836328263574,0,2,integrin alpha3-beta1 complex,CC,
9479,GO:0034668,1,0.992462052493716,0,1,integrin alpha4-beta1 complex,CC,
9480,GO:0034669,1,0.985318357518583,0,2,integrin alpha4-beta7 complex,CC,
9481,GO:0034670,1,0.990616846062559,0,1,chemotaxis to arachidonic acid,BP,
9482,GO:0034673,1,0.980654955789468,0,3,inhibin-betaglycan-ActRII complex,CC,
9483,GO:0034676,1,0.99207983904212,0,1,integrin alpha6-beta4 complex,CC,
9484,GO:0034677,1,0.992476693661446,0,1,integrin alpha7-beta1 complex,CC,
9485,GO:0034678,1,0.977675631886205,0,3,integrin alpha8-beta1 complex,CC,
9486,GO:0034679,1,0.992458875623846,0,1,integrin alpha9-beta1 complex,CC,
9487,GO:0034680,1,0.984780940028473,0,2,integrin alpha10-beta1 complex,CC,
9488,GO:0034681,1,0.984824035431881,0,2,integrin alpha11-beta1 complex,CC,
9489,GO:0034683,1,0.984077126284462,0,2,integrin alphav-beta3 complex,CC,
9490,GO:0034684,1,0.984345081771726,0,2,integrin alphav-beta5 complex,CC,
9491,GO:0034685,1,0.985912587733306,0,2,integrin alphav-beta6 complex,CC,
9492,GO:0034686,1,0.982784632931916,0,2,integrin alphav-beta8 complex,CC,
9493,GO:0034687,1,0.985329520641161,0,2,integrin alphaL-beta2 complex,CC,
9494,GO:0034688,1,0.985409402214351,0,2,integrin alphaM-beta2 complex,CC,
9495,GO:0034693,1,0.994023847218113,0,1,U11/U12 snRNP,CC,
9496,GO:0034694,1,0.832042780797406,0,29,response to prostaglandin,BP,
9497,GO:0034695,1,0.871550710891776,0,22,response to prostaglandin E,BP,
9498,GO:0034696,1,0.988738680890582,0,2,response to prostaglandin F,BP,
9499,GO:0034698,1,0.838698151032336,0,25,response to gonadotropin,BP,
9500,GO:0034699,1,0.978791565601917,0,3,response to luteinizing hormone,BP,
9503,GO:0034704,1,0.648442273539186,0,60,calcium channel complex,CC,
9505,GO:0034706,1,0.834509354453484,0,23,sodium channel complex,CC,
9506,GO:0034707,1,0.754091551159527,0,43,chloride channel complex,CC,
9507,GO:0034708,1,0.575113497184598,0,88,methyltransferase complex,CC,
9508,GO:0034709,1,0.955776716565973,0,12,methylosome,CC,
9509,GO:0034711,1,0.971954815195465,0,5,inhibin binding,MF,
9510,GO:0034713,1,0.939839719159779,0,9,type I transforming growth factor beta receptor binding,MF,
9511,GO:0034714,1,0.979833045521413,0,3,type III transforming growth factor beta receptor binding,MF,
9512,GO:0034715,1,0.979524262380302,0,6,pICln-Sm protein complex,CC,
9513,GO:0034718,1,0.992181483768738,0,1,SMN-Gemin2 complex,CC,
9514,GO:0034719,1,0.923932405094663,0,17,SMN-Sm protein complex,CC,
9515,GO:0034720,1,0.952252349743386,0,6,histone H3-K4 demethylation,BP,
9516,GO:0034721,1,0.982070413122853,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9517,GO:0034722,1,0.996330141087448,0,1,gamma-glutamyl-peptidase activity,MF,
9518,GO:0034723,1,0.933981913253835,0,14,DNA replication-dependent nucleosome organization,BP,
9519,GO:0034724,1,0.794914793816849,0,41,DNA replication-independent nucleosome organization,BP,
9520,GO:0034727,1,0.992302199609755,0,1,piecemeal microautophagy of the nucleus,BP,
9521,GO:0034728,1,0.51681317335056,0,117,nucleosome organization,BP,
9522,GO:0034729,1,0.98076272742331,0,3,histone H3-K79 methylation,BP,
9523,GO:0034736,1,0.992578354811395,0,1,cholesterol O-acyltransferase activity,MF,
9524,GO:0034739,1,0.991340118192538,0,2,histone deacetylase activity (H4-K16 specific),MF,
9525,GO:0034750,1,0.98486604158579,0,2,Scrib-APC-beta-catenin complex,CC,
9526,GO:0034751,1,0.982504465482943,0,3,aryl hydrocarbon receptor complex,CC,
9527,GO:0034752,1,0.991925574439524,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9528,GO:0034753,1,0.991925574439524,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9529,GO:0034754,1,0.602337966897018,0,91,cellular hormone metabolic process,BP,
9530,GO:0034755,1,0.902028133847288,0,16,iron ion transmembrane transport,BP,
9532,GO:0034757,1,0.988236017378391,0,2,negative regulation of iron ion transport,BP,
9533,GO:0034759,1,0.988236017378391,0,2,regulation of iron ion transmembrane transport,BP,
9534,GO:0034760,1,0.988236017378391,0,2,negative regulation of iron ion transmembrane transport,BP,
9536,GO:0034763,1,0.53871914067158,0,100,negative regulation of transmembrane transport,BP,
9539,GO:0034766,1,0.604461603231058,0,80,negative regulation of ion transmembrane transport,BP,
9541,GO:0034769,1,0.987535623690583,0,2,basement membrane disassembly,BP,
9542,GO:0034770,1,0.953385169670536,0,6,histone H4-K20 methylation,BP,
9543,GO:0034773,1,0.971831612959628,0,4,histone H4-K20 trimethylation,BP,
9545,GO:0034775,1,0.991874756835951,0,1,glutathione transmembrane transport,BP,
9546,GO:0034776,1,0.939448391426867,0,9,response to histamine,BP,
9547,GO:0034777,1,0.994631984237111,0,1,recycling endosome lumen,CC,
9548,GO:0034875,1,0.99544704789982,0,1,caffeine oxidase activity,MF,
9549,GO:0034899,1,0.995050611385119,0,1,trimethylamine monooxygenase activity,MF,
9550,GO:0034959,1,0.992263439134161,0,1,endothelin maturation,BP,
9551,GO:0034963,1,0.99673146754899,0,1,box C/D snoRNA processing,BP,
9552,GO:0034964,1,0.993734703919287,0,1,box H/ACA snoRNA processing,BP,
9553,GO:0034968,1,0.507779018406431,0,96,histone lysine methylation,BP,
9554,GO:0034969,1,0.930226219850788,0,12,histone arginine methylation,BP,
9555,GO:0034970,1,0.986602982202236,0,2,histone H3-R2 methylation,BP,
9556,GO:0034971,1,0.987864138182591,0,2,histone H3-R17 methylation,BP,
9557,GO:0034975,1,0.917767474426051,0,13,protein folding in endoplasmic reticulum,BP,
9559,GO:0034979,1,0.895998580465807,0,17,NAD-dependent protein deacetylase activity,MF,
9560,GO:0034982,1,0.937800128796523,0,12,mitochondrial protein processing,BP,
9561,GO:0034983,1,0.954500852808519,0,7,peptidyl-lysine deacetylation,BP,
9563,GO:0034987,1,0.965286978524768,0,6,immunoglobulin receptor binding,MF,
9564,GO:0034988,1,0.985225869029513,0,2,Fc-gamma receptor I complex binding,MF,
9565,GO:0034991,1,0.975290051185214,0,4,nuclear meiotic cohesin complex,CC,
9566,GO:0034992,1,0.944162151100683,0,7,microtubule organizing center attachment site,CC,
9567,GO:0034993,1,0.944162151100683,0,7,meiotic nuclear membrane microtubule tethering complex,CC,
9568,GO:0034998,1,0.993301131169352,0,1,oligosaccharyltransferase I complex,CC,
9570,GO:0035005,1,0.945814758445982,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9571,GO:0035014,1,0.9434138268061,0,8,phosphatidylinositol 3-kinase regulator activity,MF,
9572,GO:0035019,1,0.650775743442609,0,67,somatic stem cell population maintenance,BP,
9573,GO:0035020,1,0.890805096658686,0,16,regulation of Rac protein signal transduction,BP,
9574,GO:0035021,1,0.969838671534453,0,4,negative regulation of Rac protein signal transduction,BP,
9575,GO:0035022,1,0.973814372907465,0,4,positive regulation of Rac protein signal transduction,BP,
9576,GO:0035023,1,0.400238796309633,0,125,regulation of Rho protein signal transduction,BP,
9577,GO:0035024,1,0.880990617436691,0,18,negative regulation of Rho protein signal transduction,BP,
9578,GO:0035025,1,0.86652480301081,0,23,positive regulation of Rho protein signal transduction,BP,
9579,GO:0035026,1,0.98506365843718,0,2,leading edge cell differentiation,BP,
9580,GO:0035032,1,0.962206165665155,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9581,GO:0035033,1,0.985645451165336,0,3,histone deacetylase regulator activity,MF,
9582,GO:0035034,1,0.987803943031115,0,2,histone acetyltransferase regulator activity,MF,
9583,GO:0035035,1,0.821548126893989,0,29,histone acetyltransferase binding,MF,
9584,GO:0035036,1,0.824065624300135,0,37,sperm-egg recognition,BP,
9585,GO:0035037,1,0.992396894502577,0,1,sperm entry,BP,
9586,GO:0035038,1,0.987303144202806,0,2,female pronucleus assembly,BP,
9587,GO:0035039,1,0.994416276590203,0,1,male pronucleus assembly,BP,
9590,GO:0035054,1,0.980251244491336,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9591,GO:0035061,1,0.969698387729747,0,4,interchromatin granule,CC,
9592,GO:0035063,1,0.98133936528272,0,2,nuclear speck organization,BP,
9593,GO:0035064,1,0.681976181345547,0,56,methylated histone binding,MF,
9594,GO:0035065,1,0.71466891751662,0,52,regulation of histone acetylation,BP,
9595,GO:0035066,1,0.840058136571214,0,28,positive regulation of histone acetylation,BP,
9596,GO:0035067,1,0.897736999036927,0,17,negative regulation of histone acetylation,BP,
9597,GO:0035068,1,0.937493997357568,0,9,micro-ribonucleoprotein complex,CC,
9598,GO:0035082,1,0.705451881388863,0,52,axoneme assembly,BP,
9599,GO:0035087,1,0.97615971185416,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9600,GO:0035088,1,0.741974444989398,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9601,GO:0035089,1,0.89297913222914,0,17,establishment of apical/basal cell polarity,BP,
9602,GO:0035090,1,0.929190871703733,0,12,maintenance of apical/basal cell polarity,BP,
9604,GO:0035092,1,0.960667644284807,0,6,sperm chromatin condensation,BP,
9605,GO:0035093,1,0.971493852651,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9606,GO:0035094,1,0.768786423178291,0,42,response to nicotine,BP,
9607,GO:0035095,1,0.951558967214307,0,7,behavioral response to nicotine,BP,
9608,GO:0035097,1,0.627125708017718,0,68,histone methyltransferase complex,CC,
9609,GO:0035098,1,0.896671197890495,0,16,ESC/E(Z) complex,CC,
9610,GO:0035101,1,0.979110191038487,0,3,FACT complex,CC,
9611,GO:0035102,1,0.92831100281947,0,11,PRC1 complex,CC,
9612,GO:0035106,1,0.979552335865228,0,3,operant conditioning,BP,
9615,GO:0035112,1,0.929430186456499,0,11,genitalia morphogenesis,BP,
9617,GO:0035115,1,0.819623443580843,0,32,embryonic forelimb morphogenesis,BP,
9618,GO:0035116,1,0.844919928667489,0,28,embryonic hindlimb morphogenesis,BP,
9619,GO:0035120,1,0.990001988296496,0,1,post-embryonic appendage morphogenesis,BP,
9620,GO:0035127,1,0.990001988296496,0,1,post-embryonic limb morphogenesis,BP,
9621,GO:0035128,1,0.990001988296496,0,1,post-embryonic forelimb morphogenesis,BP,
9622,GO:0035136,1,0.771946131106657,0,40,forelimb morphogenesis,BP,
9623,GO:0035137,1,0.798064132686772,0,36,hindlimb morphogenesis,BP,
9624,GO:0035145,1,0.886891558701423,0,19,exon-exon junction complex,CC,
9627,GO:0035162,1,0.86686698037116,0,20,embryonic hemopoiesis,BP,
9628,GO:0035166,1,0.978173757199319,0,3,post-embryonic hemopoiesis,BP,
9629,GO:0035173,1,0.90484438564182,0,16,histone kinase activity,MF,
9630,GO:0035174,1,0.961739958714706,0,7,histone serine kinase activity,MF,
9631,GO:0035175,1,0.995940820722402,0,1,histone kinase activity (H3-S10 specific),MF,
9632,GO:0035176,1,0.707028775425528,0,49,social behavior,BP,
9633,GO:0035184,1,0.965997280352056,0,5,histone threonine kinase activity,MF,
9634,GO:0035188,1,0.992673220942937,0,1,hatching,BP,
9635,GO:0035189,1,0.980674386759306,0,3,Rb-E2F complex,CC,
9639,GO:0035197,1,0.931576022326785,0,10,siRNA binding,MF,
9640,GO:0035198,1,0.862591540962127,0,22,miRNA binding,MF,
9641,GO:0035226,1,0.992838159163196,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9642,GO:0035227,1,0.992838159163196,0,1,regulation of glutamate-cysteine ligase activity,BP,
9643,GO:0035229,1,0.992838159163196,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9644,GO:0035234,1,0.952996501516262,0,7,ectopic germ cell programmed cell death,BP,
9645,GO:0035235,1,0.818968819524081,0,26,ionotropic glutamate receptor signaling pathway,BP,
9646,GO:0035238,1,0.993301131169352,0,1,vitamin A biosynthetic process,BP,
9648,GO:0035240,1,0.955275205542411,0,8,dopamine binding,MF,
9649,GO:0035241,1,0.975634568889754,0,4,protein-arginine omega-N monomethyltransferase activity,MF,
9650,GO:0035242,1,0.954158633513643,0,8,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9651,GO:0035243,1,0.975098390552229,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9652,GO:0035246,1,0.930774804885641,0,12,peptidyl-arginine N-methylation,BP,
9653,GO:0035247,1,0.942154453113374,0,10,peptidyl-arginine omega-N-methylation,BP,
9654,GO:0035248,1,0.993129017343472,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9657,GO:0035251,1,0.943643128609714,0,9,UDP-glucosyltransferase activity,MF,
9658,GO:0035252,1,0.95839779397964,0,6,UDP-xylosyltransferase activity,MF,
9659,GO:0035253,1,0.92552571828078,0,11,ciliary rootlet,CC,
9660,GO:0035254,1,0.75299747671471,0,41,glutamate receptor binding,MF,
9661,GO:0035255,1,0.826722270485349,0,27,ionotropic glutamate receptor binding,MF,
9662,GO:0035256,1,0.9548645821965,0,8,G-protein coupled glutamate receptor binding,MF,
9665,GO:0035259,1,0.908179436304413,0,14,glucocorticoid receptor binding,MF,
9666,GO:0035261,1,0.981009587969818,0,2,external genitalia morphogenesis,BP,
9667,GO:0035262,1,0.985532845274658,0,2,gonad morphogenesis,BP,
9668,GO:0035264,1,0.40584065930626,0,132,multicellular organism growth,BP,
9670,GO:0035267,1,0.901903113866411,0,18,NuA4 histone acetyltransferase complex,CC,
9671,GO:0035268,1,0.898114874271173,0,17,protein mannosylation,BP,
9672,GO:0035269,1,0.933966734683132,0,12,protein O-linked mannosylation,BP,
9675,GO:0035276,1,0.987498818308166,0,2,ethanol binding,MF,
9676,GO:0035278,1,0.911100800916058,0,13,miRNA mediated inhibition of translation,BP,
9677,GO:0035279,1,0.985858799896337,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9678,GO:0035280,1,0.952790537481314,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9679,GO:0035281,1,0.989033103764276,0,2,pre-miRNA export from nucleus,BP,
9681,GO:0035283,1,0.985800030393853,0,2,central nervous system segmentation,BP,
9682,GO:0035284,1,0.985800030393853,0,2,brain segmentation,BP,
9683,GO:0035290,1,0.978754502789196,0,3,trunk segmentation,BP,
9686,GO:0035299,1,0.9924147625252,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9690,GO:0035306,1,0.721986153806707,0,48,positive regulation of dephosphorylation,BP,
9691,GO:0035307,1,0.78642987440583,0,36,positive regulation of protein dephosphorylation,BP,
9693,GO:0035312,1,0.959298880209103,0,6,5'-3' exodeoxyribonuclease activity,MF,
9694,GO:0035313,1,0.900782953152006,0,14,wound healing, spreading of epidermal cells,BP,
9695,GO:0035315,1,0.78151688256343,0,36,hair cell differentiation,BP,
9696,GO:0035325,1,0.943448375323598,0,10,Toll-like receptor binding,MF,
9698,GO:0035327,1,0.878766535877214,0,21,transcriptionally active chromatin,CC,
9699,GO:0035329,1,0.748361277100782,0,38,hippo signaling,BP,
9700,GO:0035330,1,0.917976737813241,0,11,regulation of hippo signaling,BP,
9701,GO:0035331,1,0.940194577707756,0,8,negative regulation of hippo signaling,BP,
9702,GO:0035332,1,0.982616907970293,0,2,positive regulation of hippo signaling,BP,
9703,GO:0035333,1,0.916920221190027,0,13,Notch receptor processing, ligand-dependent,BP,
9705,GO:0035336,1,0.868016442096361,0,22,long-chain fatty-acyl-CoA metabolic process,BP,
9706,GO:0035337,1,0.802915103748949,0,35,fatty-acyl-CoA metabolic process,BP,
9707,GO:0035338,1,0.899321129735962,0,16,long-chain fatty-acyl-CoA biosynthetic process,BP,
9708,GO:0035339,1,0.982140518653307,0,4,SPOTS complex,CC,
9709,GO:0035349,1,0.981257186100733,0,3,coenzyme A transmembrane transport,BP,
9710,GO:0035350,1,0.987489459399559,0,2,FAD transmembrane transport,BP,
9711,GO:0035352,1,0.994551789174507,0,1,NAD transmembrane transport,BP,
9712,GO:0035354,1,0.985796231229849,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9713,GO:0035355,1,0.992045483227231,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9714,GO:0035356,1,0.960172316840068,0,7,cellular triglyceride homeostasis,BP,
9715,GO:0035357,1,0.87509471112994,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9716,GO:0035358,1,0.924715697646285,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9717,GO:0035359,1,0.982666874631969,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9718,GO:0035360,1,0.954401489294756,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9719,GO:0035363,1,0.975417739962217,0,4,histone locus body,CC,
9720,GO:0035368,1,0.975081526444484,0,4,selenocysteine insertion sequence binding,MF,
9721,GO:0035370,1,0.988249072077519,0,2,UBC13-UEV1A complex,CC,
9722,GO:0035371,1,0.8669219703512,0,18,microtubule plus-end,CC,
9723,GO:0035372,1,0.910551766249408,0,13,protein localization to microtubule,BP,
9724,GO:0035373,1,0.977499629967892,0,3,chondroitin sulfate proteoglycan binding,MF,
9725,GO:0035374,1,0.9607465379802,0,6,chondroitin sulfate binding,MF,
9726,GO:0035375,1,0.991426381419997,0,1,zymogen binding,MF,
9727,GO:0035376,1,0.962749235050068,0,7,sterol import,BP,
9728,GO:0035377,1,0.98535646344887,0,2,transepithelial water transport,BP,
9729,GO:0035378,1,0.993345078292175,0,1,carbon dioxide transmembrane transport,BP,
9730,GO:0035379,1,0.993345078292175,0,1,carbon dioxide transmembrane transporter activity,MF,
9731,GO:0035381,1,0.954813547409783,0,8,ATP-gated ion channel activity,MF,
9732,GO:0035383,1,0.579466474697694,0,91,thioester metabolic process,BP,
9733,GO:0035384,1,0.735984259807205,0,46,thioester biosynthetic process,BP,
9734,GO:0035385,1,0.948502182711983,0,7,Roundabout signaling pathway,BP,
9735,GO:0035397,1,0.992802943897003,0,1,helper T cell enhancement of adaptive immune response,BP,
9736,GO:0035400,1,0.992216438110316,0,1,histone tyrosine kinase activity,MF,
9737,GO:0035401,1,0.992216438110316,0,1,histone kinase activity (H3-Y41 specific),MF,
9738,GO:0035402,1,0.986428307085821,0,2,histone kinase activity (H3-T11 specific),MF,
9739,GO:0035403,1,0.983282811728134,0,2,histone kinase activity (H3-T6 specific),MF,
9740,GO:0035404,1,0.931683017492698,0,12,histone-serine phosphorylation,BP,
9741,GO:0035405,1,0.965997280352056,0,5,histone-threonine phosphorylation,BP,
9742,GO:0035406,1,0.992216438110316,0,1,histone-tyrosine phosphorylation,BP,
9743,GO:0035407,1,0.986428307085821,0,2,histone H3-T11 phosphorylation,BP,
9744,GO:0035408,1,0.983282811728134,0,2,histone H3-T6 phosphorylation,BP,
9745,GO:0035409,1,0.992216438110316,0,1,histone H3-Y41 phosphorylation,BP,
9746,GO:0035410,1,0.996673490117013,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9747,GO:0035418,1,0.770862749480527,0,35,protein localization to synapse,BP,
9748,GO:0035425,1,0.985775226399255,0,2,autocrine signaling,BP,
9749,GO:0035426,1,0.965037267987008,0,5,extracellular matrix-cell signaling,BP,
9751,GO:0035435,1,0.937569658325206,0,9,phosphate ion transmembrane transport,BP,
9752,GO:0035437,1,0.921959406282696,0,13,maintenance of protein localization in endoplasmic reticulum,BP,
9753,GO:0035438,1,0.995981009207367,0,1,cyclic-di-GMP binding,MF,
9754,GO:0035441,1,0.975925926964647,0,3,cell migration involved in vasculogenesis,BP,
9755,GO:0035442,1,0.989604045914797,0,2,dipeptide transmembrane transport,BP,
9756,GO:0035443,1,0.991874756835951,0,1,tripeptide transmembrane transport,BP,
9757,GO:0035445,1,0.992794512789323,0,1,borate transmembrane transport,BP,
9758,GO:0035455,1,0.884042553290407,0,20,response to interferon-alpha,BP,
9759,GO:0035456,1,0.89972999253414,0,20,response to interferon-beta,BP,
9760,GO:0035457,1,0.931589305246822,0,10,cellular response to interferon-alpha,BP,
9761,GO:0035458,1,0.92571447073154,0,13,cellular response to interferon-beta,BP,
9762,GO:0035459,1,0.874485240134197,0,20,cargo loading into vesicle,BP,
9764,GO:0035469,1,0.963392175598369,0,5,determination of pancreatic left/right asymmetry,BP,
9765,GO:0035470,1,0.991760933642905,0,2,positive regulation of vascular wound healing,BP,
9766,GO:0035473,1,0.971472958804182,0,4,lipase binding,MF,
9767,GO:0035480,1,0.996741839541675,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9768,GO:0035481,1,0.996741839541675,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9769,GO:0035482,1,0.987143863791789,0,4,gastric motility,BP,
9770,GO:0035483,1,0.99107122935354,0,3,gastric emptying,BP,
9771,GO:0035485,1,0.99564851649734,0,1,adenine/guanine mispair binding,MF,
9772,GO:0035490,1,0.992748832094152,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9773,GO:0035491,1,0.992748832094152,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9774,GO:0035493,1,0.908550605344526,0,15,SNARE complex assembly,BP,
9775,GO:0035494,1,0.981485565192698,0,3,SNARE complex disassembly,BP,
9776,GO:0035497,1,0.918449054205196,0,13,cAMP response element binding,MF,
9779,GO:0035500,1,0.985727032082173,0,2,MH2 domain binding,MF,
9780,GO:0035501,1,0.993199948660582,0,1,MH1 domain binding,MF,
9781,GO:0035502,1,0.968810976431873,0,5,metanephric part of ureteric bud development,BP,
9782,GO:0035504,1,0.996317677963613,0,1,regulation of myosin light chain kinase activity,BP,
9783,GO:0035505,1,0.996317677963613,0,1,positive regulation of myosin light chain kinase activity,BP,
9784,GO:0035507,1,0.949580369549872,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9785,GO:0035508,1,0.992129765705068,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9786,GO:0035509,1,0.965094515018816,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9787,GO:0035510,1,0.841180336635944,0,28,DNA dealkylation,BP,
9788,GO:0035511,1,0.972227847737695,0,5,oxidative DNA demethylation,BP,
9789,GO:0035513,1,0.975136739174458,0,4,oxidative RNA demethylation,BP,
9790,GO:0035514,1,0.985596799567616,0,3,DNA demethylase activity,MF,
9791,GO:0035515,1,0.975136739174458,0,4,oxidative RNA demethylase activity,MF,
9792,GO:0035516,1,0.992430397811792,0,1,oxidative DNA demethylase activity,MF,
9793,GO:0035517,1,0.968398078683393,0,4,PR-DUB complex,CC,
9794,GO:0035518,1,0.899489094069425,0,16,histone H2A monoubiquitination,BP,
9795,GO:0035519,1,0.982091409111424,0,4,protein K29-linked ubiquitination,BP,
9796,GO:0035520,1,0.933849456171077,0,9,monoubiquitinated protein deubiquitination,BP,
9797,GO:0035521,1,0.971886764311917,0,4,monoubiquitinated histone deubiquitination,BP,
9798,GO:0035522,1,0.971886764311917,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9799,GO:0035523,1,0.97576495798402,0,3,protein K29-linked deubiquitination,BP,
9800,GO:0035524,1,0.963718652057431,0,5,proline transmembrane transport,BP,
9801,GO:0035525,1,0.993734703919287,0,1,NF-kappaB p50/p65 complex,CC,
9802,GO:0035526,1,0.984842881167784,0,2,retrograde transport, plasma membrane to Golgi,BP,
9803,GO:0035529,1,0.962948148976757,0,7,NADH pyrophosphatase activity,MF,
9804,GO:0035538,1,0.992667572689503,0,1,carbohydrate response element binding,MF,
9805,GO:0035539,1,0.992242494598362,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9806,GO:0035542,1,0.939401361052288,0,9,regulation of SNARE complex assembly,BP,
9807,GO:0035544,1,0.978697666961109,0,3,negative regulation of SNARE complex assembly,BP,
9808,GO:0035545,1,0.99246192225502,0,1,determination of left/right asymmetry in nervous system,BP,
9809,GO:0035546,1,0.960768138419385,0,5,interferon-beta secretion,BP,
9810,GO:0035547,1,0.960768138419385,0,5,regulation of interferon-beta secretion,BP,
9811,GO:0035548,1,0.993137509183141,0,1,negative regulation of interferon-beta secretion,BP,
9812,GO:0035549,1,0.967409257050805,0,4,positive regulation of interferon-beta secretion,BP,
9813,GO:0035552,1,0.982442096812184,0,3,oxidative single-stranded DNA demethylation,BP,
9814,GO:0035553,1,0.981303814297878,0,3,oxidative single-stranded RNA demethylation,BP,
9816,GO:0035561,1,0.864736457185837,0,21,regulation of chromatin binding,BP,
9817,GO:0035562,1,0.948561899773029,0,7,negative regulation of chromatin binding,BP,
9818,GO:0035563,1,0.918508315329656,0,13,positive regulation of chromatin binding,BP,
9819,GO:0035564,1,0.983339263062654,0,2,regulation of kidney size,BP,
9820,GO:0035566,1,0.992449677325916,0,1,regulation of metanephros size,BP,
9822,GO:0035568,1,0.993301131169352,0,1,N-terminal peptidyl-proline methylation,BP,
9823,GO:0035570,1,0.993301131169352,0,1,N-terminal peptidyl-serine methylation,BP,
9824,GO:0035572,1,0.993301131169352,0,1,N-terminal peptidyl-serine dimethylation,BP,
9825,GO:0035573,1,0.993301131169352,0,1,N-terminal peptidyl-serine trimethylation,BP,
9826,GO:0035574,1,0.985337300682894,0,2,histone H4-K20 demethylation,BP,
9827,GO:0035575,1,0.985337300682894,0,2,histone demethylase activity (H4-K20 specific),MF,
9828,GO:0035577,1,0.7042823952239,0,56,azurophil granule membrane,CC,
9829,GO:0035578,1,0.626970164731102,0,85,azurophil granule lumen,CC,
9830,GO:0035579,1,0.567285585656285,0,88,specific granule membrane,CC,
9831,GO:0035580,1,0.732839334002824,0,59,specific granule lumen,CC,
9832,GO:0035581,1,0.946299751376632,0,8,sequestering of extracellular ligand from receptor,BP,
9833,GO:0035582,1,0.977662007044331,0,4,sequestering of BMP in extracellular matrix,BP,
9834,GO:0035583,1,0.972392698250934,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9835,GO:0035584,1,0.898629630619227,0,18,calcium-mediated signaling using intracellular calcium source,BP,
9836,GO:0035585,1,0.98218703688238,0,2,calcium-mediated signaling using extracellular calcium source,BP,
9837,GO:0035586,1,0.884492587711965,0,23,purinergic receptor activity,MF,
9840,GO:0035589,1,0.935206137259947,0,13,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9841,GO:0035590,1,0.893267615412508,0,21,purinergic nucleotide receptor signaling pathway,BP,
9842,GO:0035591,1,0.583448456797105,0,80,signaling adaptor activity,MF,
9844,GO:0035596,1,0.987883904345312,0,2,methylthiotransferase activity,MF,
9845,GO:0035597,1,0.995197005757525,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9846,GO:0035598,1,0.992651971614595,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9847,GO:0035600,1,0.987883904345312,0,2,tRNA methylthiolation,BP,
9848,GO:0035601,1,0.499236477440631,0,105,protein deacylation,BP,
9849,GO:0035602,1,0.992450840146119,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9850,GO:0035603,1,0.992450840146119,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9851,GO:0035604,1,0.992450840146119,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9852,GO:0035605,1,0.996574502845011,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9853,GO:0035606,1,0.993643389992314,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9854,GO:0035607,1,0.984627404595518,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9857,GO:0035610,1,0.970770253500678,0,4,protein side chain deglutamylation,BP,
9858,GO:0035611,1,0.993173103012118,0,1,protein branching point deglutamylation,BP,
9859,GO:0035612,1,0.934905587792471,0,8,AP-2 adaptor complex binding,MF,
9860,GO:0035613,1,0.906667057744013,0,15,RNA stem-loop binding,MF,
9861,GO:0035614,1,0.985808303693513,0,3,snRNA stem-loop binding,MF,
9862,GO:0035615,1,0.928365147810585,0,11,clathrin adaptor activity,MF,
9863,GO:0035616,1,0.977459810561421,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9864,GO:0035617,1,0.980725914166517,0,3,stress granule disassembly,BP,
9865,GO:0035620,1,0.97406394232587,0,4,ceramide transporter activity,MF,
9866,GO:0035621,1,0.987531775474627,0,2,ER to Golgi ceramide transport,BP,
9867,GO:0035622,1,0.99246264441973,0,1,intrahepatic bile duct development,BP,
9868,GO:0035623,1,0.992680920739905,0,1,renal glucose absorption,BP,
9869,GO:0035624,1,0.971973504668157,0,4,receptor transactivation,BP,
9870,GO:0035625,1,0.980491091750817,0,3,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9871,GO:0035627,1,0.954286623743668,0,7,ceramide transport,BP,
9873,GO:0035631,1,0.932062669472625,0,11,CD40 receptor complex,CC,
9875,GO:0035634,1,0.983795369836738,0,3,response to stilbenoid,BP,
9876,GO:0035635,1,0.882424850773944,0,18,entry of bacterium into host cell,BP,
9878,GO:0035638,1,0.992354159586394,0,1,signal maturation,BP,
9880,GO:0035640,1,0.860843775970519,0,23,exploration behavior,BP,
9881,GO:0035641,1,0.919402268511438,0,13,locomotory exploration behavior,BP,
9882,GO:0035642,1,0.992961626442315,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9883,GO:0035643,1,0.995963040842868,0,1,L-DOPA receptor activity,MF,
9884,GO:0035644,1,0.992921892262738,0,1,phosphoanandamide dephosphorylation,BP,
9885,GO:0035645,1,0.992431640771726,0,1,enteric smooth muscle cell differentiation,BP,
9886,GO:0035646,1,0.942523922168563,0,10,endosome to melanosome transport,BP,
9887,GO:0035650,1,0.978919055639873,0,4,AP-1 adaptor complex binding,MF,
9888,GO:0035651,1,0.985660231095649,0,3,AP-3 adaptor complex binding,MF,
9889,GO:0035655,1,0.953185608135201,0,8,interleukin-18-mediated signaling pathway,BP,
9890,GO:0035658,1,0.981342922669378,0,3,Mon1-Ccz1 complex,CC,
9891,GO:0035659,1,0.995934711064646,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9892,GO:0035662,1,0.989963403011052,0,3,Toll-like receptor 4 binding,MF,
9893,GO:0035663,1,0.981109788022153,0,3,Toll-like receptor 2 binding,MF,
9894,GO:0035664,1,0.995783830951291,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9895,GO:0035665,1,0.995783830951291,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9896,GO:0035666,1,0.852530665062651,0,27,TRIF-dependent toll-like receptor signaling pathway,BP,
9897,GO:0035668,1,0.985156970781096,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9898,GO:0035669,1,0.985156970781096,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9899,GO:0035671,1,0.98485162567328,0,3,enone reductase activity,MF,
9900,GO:0035672,1,0.959318163596439,0,6,oligopeptide transmembrane transport,BP,
9901,GO:0035673,1,0.969399239692481,0,4,oligopeptide transmembrane transporter activity,MF,
9902,GO:0035674,1,0.9888727215428,0,2,tricarboxylic acid transmembrane transport,BP,
9903,GO:0035675,1,0.99357385075076,0,1,neuromast hair cell development,BP,
9904,GO:0035684,1,0.997007158152309,0,1,helper T cell extravasation,BP,
9905,GO:0035686,1,0.978983118698706,0,4,sperm fibrous sheath,CC,
9907,GO:0035691,1,0.989025786715634,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9908,GO:0035692,1,0.988900843826344,0,2,macrophage migration inhibitory factor receptor complex,CC,
9909,GO:0035693,1,0.996575705228894,0,1,NOS2-CD74 complex,CC,
9910,GO:0035694,1,0.973938176149169,0,4,mitochondrial protein catabolic process,BP,
9911,GO:0035695,1,0.992428878361613,0,1,mitophagy by induced vacuole formation,BP,
9912,GO:0035696,1,0.978291867415574,0,3,monocyte extravasation,BP,
9913,GO:0035697,1,0.985087530108049,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9914,GO:0035698,1,0.991104955467928,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9915,GO:0035700,1,0.989744871880959,0,2,astrocyte chemotaxis,BP,
9916,GO:0035701,1,0.95899395504075,0,6,hematopoietic stem cell migration,BP,
9917,GO:0035704,1,0.993929133044694,0,1,helper T cell chemotaxis,BP,
9918,GO:0035705,1,0.993929133044694,0,1,T-helper 17 cell chemotaxis,BP,
9919,GO:0035708,1,0.992540479976971,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9920,GO:0035709,1,0.987297109992517,0,2,memory T cell activation,BP,
9921,GO:0035710,1,0.656932947752127,0,66,CD4-positive, alpha-beta T cell activation,BP,
9922,GO:0035711,1,0.989272392102416,0,2,T-helper 1 cell activation,BP,
9923,GO:0035712,1,0.985251645619973,0,2,T-helper 2 cell activation,BP,
9924,GO:0035713,1,0.992540479976971,0,1,response to nitrogen dioxide,BP,
9925,GO:0035715,1,0.993929133044694,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9926,GO:0035716,1,0.993929133044694,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9927,GO:0035717,1,0.987483399110724,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9928,GO:0035718,1,0.992922905744059,0,2,macrophage migration inhibitory factor binding,MF,
9929,GO:0035720,1,0.980522736229,0,3,intraciliary anterograde transport,BP,
9930,GO:0035721,1,0.920933986885877,0,12,intraciliary retrograde transport,BP,
9931,GO:0035722,1,0.78594473550599,0,44,interleukin-12-mediated signaling pathway,BP,
9932,GO:0035723,1,0.915313930223401,0,13,interleukin-15-mediated signaling pathway,BP,
9933,GO:0035724,1,0.991747873577304,0,1,CD24 biosynthetic process,BP,
9934,GO:0035725,1,0.395247455556269,0,133,sodium ion transmembrane transport,BP,
9935,GO:0035726,1,0.95908143468725,0,7,common myeloid progenitor cell proliferation,BP,
9936,GO:0035727,1,0.968913678651334,0,5,lysophosphatidic acid binding,MF,
9937,GO:0035728,1,0.898502756093332,0,16,response to hepatocyte growth factor,BP,
9938,GO:0035729,1,0.911413463883935,0,14,cellular response to hepatocyte growth factor stimulus,BP,
9939,GO:0035730,1,0.996897068870571,0,1,S-nitrosoglutathione binding,MF,
9940,GO:0035731,1,0.996897068870571,0,1,dinitrosyl-iron complex binding,MF,
9941,GO:0035732,1,0.996897068870571,0,1,nitric oxide storage,BP,
9942,GO:0035733,1,0.951746402496226,0,7,hepatic stellate cell activation,BP,
9943,GO:0035735,1,0.77014282791807,0,40,intraciliary transport involved in cilium assembly,BP,
9944,GO:0035739,1,0.966466545022119,0,6,CD4-positive, alpha-beta T cell proliferation,BP,
9945,GO:0035740,1,0.98526715749296,0,3,CD8-positive, alpha-beta T cell proliferation,BP,
9946,GO:0035743,1,0.92672535749326,0,14,CD4-positive, alpha-beta T cell cytokine production,BP,
9947,GO:0035744,1,0.983459044427274,0,4,T-helper 1 cell cytokine production,BP,
9948,GO:0035745,1,0.945675697393058,0,10,T-helper 2 cell cytokine production,BP,
9949,GO:0035746,1,0.996679748692367,0,1,granzyme A production,BP,
9950,GO:0035747,1,0.967030577992119,0,7,natural killer cell chemotaxis,BP,
9951,GO:0035748,1,0.958001264386389,0,6,myelin sheath abaxonal region,CC,
9953,GO:0035750,1,0.992198980396927,0,1,protein localization to myelin sheath abaxonal region,BP,
9954,GO:0035751,1,0.94105320487015,0,12,regulation of lysosomal lumen pH,BP,
9955,GO:0035752,1,0.995502525215866,0,1,lysosomal lumen pH elevation,BP,
9956,GO:0035754,1,0.958126894079807,0,8,B cell chemotaxis,BP,
9957,GO:0035755,1,0.993750423488146,0,1,cardiolipin hydrolase activity,MF,
9958,GO:0035757,1,0.994812632020403,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9959,GO:0035758,1,0.994812632020403,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9960,GO:0035759,1,0.990387184683303,0,2,mesangial cell-matrix adhesion,BP,
9961,GO:0035766,1,0.969695804205339,0,5,cell chemotaxis to fibroblast growth factor,BP,
9962,GO:0035767,1,0.8608800906879,0,23,endothelial cell chemotaxis,BP,
9963,GO:0035768,1,0.969695804205339,0,5,endothelial cell chemotaxis to fibroblast growth factor,BP,
9964,GO:0035770,1,0.295365754150098,0,189,ribonucleoprotein granule,CC,
9965,GO:0035771,1,0.959036562215029,0,7,interleukin-4-mediated signaling pathway,BP,
9966,GO:0035772,1,0.995836183875561,0,1,interleukin-13-mediated signaling pathway,BP,
9967,GO:0035773,1,0.710245269546853,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
9968,GO:0035774,1,0.866729302847415,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9969,GO:0035782,1,0.996679748692367,0,1,mature natural killer cell chemotaxis,BP,
9970,GO:0035783,1,0.992540479976971,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
9971,GO:0035787,1,0.971030898876535,0,4,cell migration involved in kidney development,BP,
9972,GO:0035788,1,0.978662173075826,0,3,cell migration involved in metanephros development,BP,
9973,GO:0035789,1,0.978662173075826,0,3,metanephric mesenchymal cell migration,BP,
9976,GO:0035793,1,0.978662173075826,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9978,GO:0035795,1,0.977039398781199,0,5,negative regulation of mitochondrial membrane permeability,BP,
9979,GO:0035799,1,0.970599503639852,0,4,ureter maturation,BP,
9980,GO:0035800,1,0.988982309262269,0,2,deubiquitinase activator activity,MF,
9981,GO:0035801,1,0.988729491851625,0,2,adrenal cortex development,BP,
9982,GO:0035802,1,0.988729491851625,0,2,adrenal cortex formation,BP,
9983,GO:0035803,1,0.992901129556062,0,2,egg coat formation,BP,
9984,GO:0035805,1,0.994600712288208,0,1,egg coat,CC,
9985,GO:0035809,1,0.89880289573252,0,18,regulation of urine volume,BP,
9986,GO:0035810,1,0.924817015550107,0,12,positive regulation of urine volume,BP,
9987,GO:0035811,1,0.984845384528829,0,3,negative regulation of urine volume,BP,
9988,GO:0035812,1,0.907568963344724,0,16,renal sodium excretion,BP,
9989,GO:0035813,1,0.907568963344724,0,16,regulation of renal sodium excretion,BP,
9990,GO:0035814,1,0.974128969993068,0,5,negative regulation of renal sodium excretion,BP,
9991,GO:0035815,1,0.944221804895154,0,9,positive regulation of renal sodium excretion,BP,
9992,GO:0035821,1,0.508425336470064,0,119,modification of morphology or physiology of other organism,BP,
9993,GO:0035822,1,0.96412244770644,0,5,gene conversion,BP,
9994,GO:0035825,1,0.75366611238171,0,44,homologous recombination,BP,
9995,GO:0035838,1,0.976762982840161,0,3,growing cell tip,CC,
9996,GO:0035841,1,0.98420234511395,0,2,new growing cell tip,CC,
9997,GO:0035844,1,0.975967550604107,0,4,cloaca development,BP,
9998,GO:0035845,1,0.938254459046937,0,9,photoreceptor cell outer segment organization,BP,
10000,GO:0035851,1,0.992971391528307,0,1,Krueppel-associated box domain binding,MF,
10001,GO:0035853,1,0.992402898587312,0,1,chromosome passenger complex localization to spindle midzone,BP,
10002,GO:0035854,1,0.988971287464569,0,2,eosinophil fate commitment,BP,
10003,GO:0035855,1,0.894428512015645,0,15,megakaryocyte development,BP,
10004,GO:0035859,1,0.920170373436697,0,13,Seh1-associated complex,CC,
10005,GO:0035860,1,0.961739945550816,0,5,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
10006,GO:0035861,1,0.816455879495096,0,30,site of double-strand break,CC,
10007,GO:0035862,1,0.991997791072666,0,1,dITP metabolic process,BP,
10008,GO:0035863,1,0.991997791072666,0,1,dITP catabolic process,BP,
10009,GO:0035864,1,0.939452879065082,0,10,response to potassium ion,BP,
10010,GO:0035865,1,0.964395330729608,0,6,cellular response to potassium ion,BP,
10011,GO:0035866,1,0.975235008724538,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
10012,GO:0035867,1,0.965989390114932,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10013,GO:0035868,1,0.976762468859539,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
10014,GO:0035869,1,0.687837708522991,0,58,ciliary transition zone,CC,
10015,GO:0035870,1,0.988815284776624,0,2,dITP diphosphatase activity,MF,
10016,GO:0035871,1,0.938257460788275,0,8,protein K11-linked deubiquitination,BP,
10017,GO:0035872,1,0.794024457553224,0,35,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10018,GO:0035873,1,0.960667593311602,0,6,lactate transmembrane transport,BP,
10019,GO:0035877,1,0.977707958123671,0,4,death effector domain binding,MF,
10020,GO:0035878,1,0.949953997230615,0,8,nail development,BP,
10021,GO:0035879,1,0.980177479549742,0,3,plasma membrane lactate transport,BP,
10022,GO:0035880,1,0.982725590083929,0,3,embryonic nail plate morphogenesis,BP,
10023,GO:0035881,1,0.953863025580913,0,7,amacrine cell differentiation,BP,
10024,GO:0035883,1,0.849148809775006,0,25,enteroendocrine cell differentiation,BP,
10025,GO:0035886,1,0.886480804776856,0,19,vascular smooth muscle cell differentiation,BP,
10026,GO:0035887,1,0.995869264340929,0,1,aortic smooth muscle cell differentiation,BP,
10027,GO:0035890,1,0.805144533355676,0,33,exit from host,BP,
10028,GO:0035891,1,0.805144533355676,0,33,exit from host cell,BP,
10029,GO:0035897,1,0.965506269875094,0,6,proteolysis in other organism,BP,
10030,GO:0035898,1,0.980619396857575,0,3,parathyroid hormone secretion,BP,
10031,GO:0035900,1,0.967528211417366,0,6,response to isolation stress,BP,
10032,GO:0035902,1,0.891009812257183,0,19,response to immobilization stress,BP,
10034,GO:0035905,1,0.974717618318342,0,4,ascending aorta development,BP,
10035,GO:0035907,1,0.939344011794358,0,9,dorsal aorta development,BP,
10036,GO:0035909,1,0.804769513776635,0,30,aorta morphogenesis,BP,
10037,GO:0035910,1,0.974717618318342,0,4,ascending aorta morphogenesis,BP,
10038,GO:0035912,1,0.946299416124461,0,8,dorsal aorta morphogenesis,BP,
10040,GO:0035915,1,0.989336599964488,0,3,pore formation in membrane of other organism,BP,
10041,GO:0035921,1,0.995009266124128,0,1,desmosome disassembly,BP,
10042,GO:0035922,1,0.996151325838614,0,1,foramen ovale closure,BP,
10044,GO:0035925,1,0.91992297908715,0,12,mRNA 3'-UTR AU-rich region binding,MF,
10046,GO:0035927,1,0.978788326925022,0,4,RNA import into mitochondrion,BP,
10047,GO:0035928,1,0.986097727854171,0,3,rRNA import into mitochondrion,BP,
10048,GO:0035929,1,0.905701561954402,0,18,steroid hormone secretion,BP,
10049,GO:0035930,1,0.932180531932862,0,13,corticosteroid hormone secretion,BP,
10050,GO:0035931,1,0.974593751212907,0,4,mineralocorticoid secretion,BP,
10051,GO:0035932,1,0.974593751212907,0,4,aldosterone secretion,BP,
10052,GO:0035933,1,0.956492546792377,0,9,glucocorticoid secretion,BP,
10053,GO:0035934,1,0.983872665898699,0,4,corticosterone secretion,BP,
10054,GO:0035935,1,0.992654096579413,0,1,androgen secretion,BP,
10055,GO:0035936,1,0.984399373318625,0,2,testosterone secretion,BP,
10056,GO:0035938,1,0.980583311850433,0,3,estradiol secretion,BP,
10057,GO:0035939,1,0.98055666596451,0,3,microsatellite binding,MF,
10058,GO:0035945,1,0.993969875847883,0,1,mitochondrial ncRNA surveillance,BP,
10059,GO:0035946,1,0.993969875847883,0,1,mitochondrial mRNA surveillance,BP,
10060,GO:0035947,1,0.963841627895331,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10061,GO:0035948,1,0.97807103724458,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10062,GO:0035962,1,0.981897960608089,0,3,response to interleukin-13,BP,
10063,GO:0035963,1,0.981897960608089,0,3,cellular response to interleukin-13,BP,
10064,GO:0035964,1,0.962925514135919,0,6,COPI-coated vesicle budding,BP,
10065,GO:0035965,1,0.968920637054891,0,5,cardiolipin acyl-chain remodeling,BP,
10068,GO:0035970,1,0.90471351730734,0,16,peptidyl-threonine dephosphorylation,BP,
10069,GO:0035971,1,0.996679748692367,0,1,peptidyl-histidine dephosphorylation,BP,
10070,GO:0035973,1,0.949715306960465,0,7,aggrephagy,BP,
10071,GO:0035976,1,0.975951213426011,0,5,transcription factor AP-1 complex,CC,
10072,GO:0035977,1,0.972866276692725,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10073,GO:0035978,1,0.993199948660582,0,1,histone H2A-S139 phosphorylation,BP,
10074,GO:0035981,1,0.988681980383699,0,2,tongue muscle cell differentiation,BP,
10075,GO:0035983,1,0.973790661459633,0,4,response to trichostatin A,BP,
10076,GO:0035984,1,0.973790661459633,0,4,cellular response to trichostatin A,BP,
10077,GO:0035985,1,0.981075068791179,0,4,senescence-associated heterochromatin focus,CC,
10078,GO:0035986,1,0.98533248712612,0,3,senescence-associated heterochromatin focus assembly,BP,
10079,GO:0035987,1,0.734613640508457,0,45,endodermal cell differentiation,BP,
10080,GO:0035988,1,0.911536275928651,0,14,chondrocyte proliferation,BP,
10081,GO:0035989,1,0.970639801812297,0,5,tendon development,BP,
10082,GO:0035990,1,0.987653944085116,0,3,tendon cell differentiation,BP,
10083,GO:0035992,1,0.987653944085116,0,3,tendon formation,BP,
10084,GO:0035993,1,0.990441763062216,0,2,deltoid tuberosity development,BP,
10085,GO:0035994,1,0.821681684081107,0,18,response to muscle stretch,BP,
10086,GO:0035995,1,0.908233483649209,0,3,detection of muscle stretch,BP,
10087,GO:0035998,1,0.995380704394329,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10088,GO:0035999,1,0.949402754933238,0,9,tetrahydrofolate interconversion,BP,
10089,GO:0036002,1,0.80344456916491,0,35,pre-mRNA binding,MF,
10090,GO:0036003,1,0.858925991423855,0,25,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10091,GO:0036004,1,0.996666110988239,0,1,GAF domain binding,MF,
10092,GO:0036005,1,0.950301511826369,0,8,response to macrophage colony-stimulating factor,BP,
10093,GO:0036006,1,0.950301511826369,0,8,cellular response to macrophage colony-stimulating factor stimulus,BP,
10094,GO:0036009,1,0.99673146754899,0,1,protein-glutamine N-methyltransferase activity,MF,
10095,GO:0036010,1,0.875210886871753,0,18,protein localization to endosome,BP,
10096,GO:0036015,1,0.976033858089448,0,4,response to interleukin-3,BP,
10097,GO:0036016,1,0.976033858089448,0,4,cellular response to interleukin-3,BP,
10098,GO:0036017,1,0.972193486310611,0,7,response to erythropoietin,BP,
10099,GO:0036018,1,0.975035752617475,0,6,cellular response to erythropoietin,BP,
10100,GO:0036019,1,0.880201520714986,0,19,endolysosome,CC,
10101,GO:0036020,1,0.907850724916199,0,14,endolysosome membrane,CC,
10102,GO:0036021,1,0.969574506927438,0,5,endolysosome lumen,CC,
10103,GO:0036022,1,0.983872976989973,0,3,limb joint morphogenesis,BP,
10104,GO:0036023,1,0.983872976989973,0,3,embryonic skeletal limb joint morphogenesis,BP,
10105,GO:0036024,1,0.994421680846751,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10106,GO:0036025,1,0.994421680846751,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10107,GO:0036026,1,0.994421680846751,0,1,protein C inhibitor-PLAT complex,CC,
10108,GO:0036027,1,0.994421680846751,0,1,protein C inhibitor-PLAU complex,CC,
10109,GO:0036028,1,0.994421680846751,0,1,protein C inhibitor-thrombin complex,CC,
10110,GO:0036029,1,0.994421680846751,0,1,protein C inhibitor-KLK3 complex,CC,
10111,GO:0036030,1,0.994421680846751,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10112,GO:0036033,1,0.965233176021318,0,4,mediator complex binding,MF,
10113,GO:0036034,1,0.987871206292204,0,2,mediator complex assembly,BP,
10114,GO:0036035,1,0.890677162316065,0,17,osteoclast development,BP,
10115,GO:0036037,1,0.924370644150319,0,13,CD8-positive, alpha-beta T cell activation,BP,
10116,GO:0036038,1,0.93122142906955,0,13,MKS complex,CC,
10117,GO:0036041,1,0.961963180367521,0,9,long-chain fatty acid binding,MF,
10118,GO:0036042,1,0.983052636379913,0,4,long-chain fatty acyl-CoA binding,MF,
10119,GO:0036046,1,0.992759329403296,0,1,protein demalonylation,BP,
10120,GO:0036047,1,0.992759329403296,0,1,peptidyl-lysine demalonylation,BP,
10121,GO:0036048,1,0.992759329403296,0,1,protein desuccinylation,BP,
10122,GO:0036049,1,0.992759329403296,0,1,peptidyl-lysine desuccinylation,BP,
10123,GO:0036053,1,0.993420795687657,0,1,glomerular endothelium fenestra,CC,
10124,GO:0036054,1,0.992759329403296,0,1,protein-malonyllysine demalonylase activity,MF,
10125,GO:0036055,1,0.992759329403296,0,1,protein-succinyllysine desuccinylase activity,MF,
10126,GO:0036056,1,0.946945443953952,0,7,filtration diaphragm,CC,
10127,GO:0036057,1,0.946945443953952,0,7,slit diaphragm,CC,
10128,GO:0036058,1,0.992455814181637,0,1,filtration diaphragm assembly,BP,
10129,GO:0036060,1,0.992455814181637,0,1,slit diaphragm assembly,BP,
10130,GO:0036064,1,0.505443942444029,0,101,ciliary basal body,CC,
10131,GO:0036065,1,0.843526945014297,0,25,fucosylation,BP,
10132,GO:0036066,1,0.910262412255709,0,14,protein O-linked fucosylation,BP,
10133,GO:0036071,1,0.992645008216672,0,1,N-glycan fucosylation,BP,
10134,GO:0036072,1,0.961353436737417,0,6,direct ossification,BP,
10135,GO:0036075,1,0.845696207630088,0,25,replacement ossification,BP,
10136,GO:0036080,1,0.984502714288858,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
10137,GO:0036085,1,0.992705202879311,0,1,GDP-fucose import into Golgi lumen,BP,
10138,GO:0036088,1,0.996148653594519,0,1,D-serine catabolic process,BP,
10139,GO:0036089,1,0.955220317826881,0,7,cleavage furrow formation,BP,
10140,GO:0036090,1,0.99045668897326,0,2,cleavage furrow ingression,BP,
10141,GO:0036091,1,0.969587977848979,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10142,GO:0036092,1,0.728112566751354,0,44,phosphatidylinositol-3-phosphate biosynthetic process,BP,
10143,GO:0036093,1,0.971923367194414,0,6,germ cell proliferation,BP,
10145,GO:0036100,1,0.988860581976372,0,2,leukotriene catabolic process,BP,
10146,GO:0036101,1,0.988860581976372,0,2,leukotriene B4 catabolic process,BP,
10147,GO:0036102,1,0.988860581976372,0,2,leukotriene B4 metabolic process,BP,
10148,GO:0036105,1,0.992502362147741,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10149,GO:0036109,1,0.928167003608105,0,12,alpha-linolenic acid metabolic process,BP,
10150,GO:0036111,1,0.993475658848043,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10151,GO:0036112,1,0.98280985628364,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10152,GO:0036114,1,0.9962689356949,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10153,GO:0036115,1,0.9962689356949,0,1,fatty-acyl-CoA catabolic process,BP,
10154,GO:0036116,1,0.9962689356949,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10155,GO:0036117,1,0.988812530278694,0,2,hyaluranon cable,CC,
10156,GO:0036118,1,0.981351708021194,0,3,hyaluranon cable assembly,BP,
10157,GO:0036119,1,0.861794025698841,0,21,response to platelet-derived growth factor,BP,
10158,GO:0036120,1,0.867895730855809,0,20,cellular response to platelet-derived growth factor stimulus,BP,
10160,GO:0036123,1,0.965646651569585,0,6,histone H3-K9 dimethylation,BP,
10161,GO:0036124,1,0.904355527129923,0,14,histone H3-K9 trimethylation,BP,
10162,GO:0036125,1,0.992867372002513,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10163,GO:0036126,1,0.687600818360567,0,64,sperm flagellum,CC,
10164,GO:0036128,1,0.957961545641615,0,7,CatSper complex,CC,
10165,GO:0036130,1,0.996673490117013,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10166,GO:0036131,1,0.996673490117013,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10167,GO:0036132,1,0.982694967511307,0,3,13-prostaglandin reductase activity,MF,
10168,GO:0036134,1,0.994965071858846,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10169,GO:0036135,1,0.984955449406499,0,2,Schwann cell migration,BP,
10170,GO:0036137,1,0.988745648061107,0,2,kynurenine aminotransferase activity,MF,
10171,GO:0036138,1,0.991705456451615,0,1,peptidyl-histidine hydroxylation,BP,
10172,GO:0036139,1,0.991705456451615,0,1,peptidyl-histidine dioxygenase activity,MF,
10173,GO:0036140,1,0.991705456451615,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10174,GO:0036143,1,0.996960031865005,0,1,kringle domain binding,MF,
10175,GO:0036145,1,0.995790448456468,0,1,dendritic cell homeostasis,BP,
10176,GO:0036146,1,0.967792954616193,0,5,cellular response to mycotoxin,BP,
10177,GO:0036148,1,0.918394272976768,0,13,phosphatidylglycerol acyl-chain remodeling,BP,
10178,GO:0036149,1,0.945232007039812,0,10,phosphatidylinositol acyl-chain remodeling,BP,
10179,GO:0036150,1,0.912517244457685,0,15,phosphatidylserine acyl-chain remodeling,BP,
10180,GO:0036151,1,0.88145017899231,0,21,phosphatidylcholine acyl-chain remodeling,BP,
10181,GO:0036152,1,0.891081116539829,0,20,phosphatidylethanolamine acyl-chain remodeling,BP,
10182,GO:0036153,1,0.993235863107959,0,1,triglyceride acyl-chain remodeling,BP,
10183,GO:0036155,1,0.967661589564071,0,5,acylglycerol acyl-chain remodeling,BP,
10184,GO:0036156,1,0.95933405186877,0,4,inner dynein arm,CC,
10185,GO:0036157,1,0.937919623875499,0,9,outer dynein arm,CC,
10186,GO:0036158,1,0.899815111345106,0,16,outer dynein arm assembly,BP,
10187,GO:0036159,1,0.906235735912522,0,14,inner dynein arm assembly,BP,
10188,GO:0036164,1,0.996793356298306,0,1,cell-abiotic substrate adhesion,BP,
10189,GO:0036166,1,0.972201054894294,0,4,phenotypic switching,BP,
10190,GO:0036179,1,0.993339008717043,0,1,osteoclast maturation,BP,
10191,GO:0036194,1,0.988751183457984,0,3,muscle cell projection,CC,
10192,GO:0036195,1,0.988751183457984,0,3,muscle cell projection membrane,CC,
10194,GO:0036213,1,0.994780093997994,0,1,contractile ring contraction,BP,
10195,GO:0036215,1,0.985282905752475,0,2,response to stem cell factor,BP,
10196,GO:0036216,1,0.985282905752475,0,2,cellular response to stem cell factor stimulus,BP,
10197,GO:0036219,1,0.997018312941827,0,1,GTP diphosphatase activity,MF,
10198,GO:0036220,1,0.996792089824971,0,1,ITP diphosphatase activity,MF,
10199,GO:0036222,1,0.996792089824971,0,1,XTP diphosphatase activity,MF,
10200,GO:0036228,1,0.986766768833828,0,2,protein localization to nuclear inner membrane,BP,
10201,GO:0036230,1,0.0599276794663747,0,478,granulocyte activation,BP,
10202,GO:0036245,1,0.988709985335194,0,2,cellular response to menadione,BP,
10203,GO:0036250,1,0.995444563568732,0,1,peroxisome transport along microtubule,BP,
10204,GO:0036255,1,0.992470124072084,0,1,response to methylamine,BP,
10205,GO:0036257,1,0.836916755776753,0,31,multivesicular body organization,BP,
10206,GO:0036258,1,0.842616152386221,0,30,multivesicular body assembly,BP,
10207,GO:0036260,1,0.840174586499261,0,32,RNA capping,BP,
10208,GO:0036261,1,0.992486227265391,0,1,7-methylguanosine cap hypermethylation,BP,
10209,GO:0036265,1,0.981490741888525,0,4,RNA (guanine-N7)-methylation,BP,
10210,GO:0036266,1,0.993802933083865,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10211,GO:0036269,1,0.988158603409015,0,2,swimming behavior,BP,
10212,GO:0036270,1,0.87434652733202,0,18,response to diuretic,BP,
10213,GO:0036284,1,0.987788958902214,0,2,tubulobulbar complex,CC,
10214,GO:0036289,1,0.950309894439899,0,7,peptidyl-serine autophosphorylation,BP,
10215,GO:0036290,1,0.992456378204114,0,1,protein trans-autophosphorylation,BP,
10216,GO:0036292,1,0.988965353757418,0,2,DNA rewinding,BP,
10217,GO:0036293,1,0.127185359409765,0,332,response to decreased oxygen levels,BP,
10218,GO:0036294,1,0.315178938141674,0,190,cellular response to decreased oxygen levels,BP,
10219,GO:0036295,1,0.926104190658303,0,13,cellular response to increased oxygen levels,BP,
10220,GO:0036296,1,0.853600014595155,0,27,response to increased oxygen levels,BP,
10221,GO:0036297,1,0.751363862215329,0,44,interstrand cross-link repair,BP,
10222,GO:0036301,1,0.968076055141434,0,5,macrophage colony-stimulating factor production,BP,
10223,GO:0036302,1,0.946632557071081,0,7,atrioventricular canal development,BP,
10224,GO:0036303,1,0.876728483470266,0,18,lymph vessel morphogenesis,BP,
10225,GO:0036304,1,0.988017533815064,0,2,umbilical cord morphogenesis,BP,
10226,GO:0036306,1,0.996151325838614,0,1,embryonic heart tube elongation,BP,
10227,GO:0036309,1,0.974718897178661,0,2,protein localization to M-band,BP,
10228,GO:0036310,1,0.945913830111897,0,8,annealing helicase activity,MF,
10229,GO:0036312,1,0.937089215018825,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10230,GO:0036313,1,0.994101839884845,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10233,GO:0036316,1,0.993426104869907,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10234,GO:0036317,1,0.993301131169352,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10235,GO:0036323,1,0.992354889206928,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10236,GO:0036324,1,0.989188270136459,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10237,GO:0036326,1,0.992354889206928,0,1,VEGF-A-activated receptor activity,MF,
10238,GO:0036327,1,0.992354889206928,0,1,VEGF-B-activated receptor activity,MF,
10239,GO:0036328,1,0.99224369841628,0,1,VEGF-C-activated receptor activity,MF,
10240,GO:0036332,1,0.992354889206928,0,1,placental growth factor-activated receptor activity,MF,
10241,GO:0036333,1,0.993604818381729,0,1,hepatocyte homeostasis,BP,
10242,GO:0036335,1,0.992229161935818,0,1,intestinal stem cell homeostasis,BP,
10243,GO:0036336,1,0.855031419042962,0,26,dendritic cell migration,BP,
10244,GO:0036337,1,0.972470721301671,0,4,Fas signaling pathway,BP,
10245,GO:0036342,1,0.907491523627259,0,15,post-anal tail morphogenesis,BP,
10246,GO:0036343,1,0.98014545312579,0,4,psychomotor behavior,BP,
10247,GO:0036344,1,0.884888796183548,0,19,platelet morphogenesis,BP,
10248,GO:0036345,1,0.989068329529436,0,2,platelet maturation,BP,
10249,GO:0036351,1,0.994413575099473,0,1,histone H2A-K13 ubiquitination,BP,
10250,GO:0036352,1,0.994413575099473,0,1,histone H2A-K15 ubiquitination,BP,
10251,GO:0036353,1,0.954013817104509,0,7,histone H2A-K119 monoubiquitination,BP,
10252,GO:0036361,1,0.993980113814259,0,1,racemase activity, acting on amino acids and derivatives,MF,
10253,GO:0036363,1,0.986249258745394,0,2,transforming growth factor beta activation,BP,
10254,GO:0036367,1,0.993764998892189,0,1,light adaption,BP,
10255,GO:0036369,1,0.98304858499236,0,2,transcription factor catabolic process,BP,
10256,GO:0036371,1,0.991271016916563,0,1,protein localization to T-tubule,BP,
10257,GO:0036372,1,0.996886610073032,0,1,opsin transport,BP,
10258,GO:0036374,1,0.981888104015278,0,3,glutathione hydrolase activity,MF,
10259,GO:0036376,1,0.91127035080605,0,15,sodium ion export across plasma membrane,BP,
10260,GO:0036378,1,0.990096877697302,0,2,calcitriol biosynthetic process from calciol,BP,
10261,GO:0036379,1,0.769298106262019,0,31,myofilament,CC,
10262,GO:0036387,1,0.985056757164688,0,3,pre-replicative complex,CC,
10263,GO:0036388,1,0.985056757164688,0,3,pre-replicative complex assembly,BP,
10264,GO:0036392,1,0.992483603205204,0,1,chemokine (C-C motif) ligand 20 production,BP,
10265,GO:0036393,1,0.993082814903575,0,1,thiocyanate peroxidase activity,MF,
10266,GO:0036396,1,0.986303493271166,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
10267,GO:0036398,1,0.986783030856102,0,2,TCR signalosome,CC,
10268,GO:0036399,1,0.992651266995692,0,1,TCR signalosome assembly,BP,
10269,GO:0036402,1,0.977991640157338,0,6,proteasome-activating ATPase activity,MF,
10270,GO:0036403,1,0.993619862456449,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10271,GO:0036404,1,0.990397143077809,0,1,conversion of ds siRNA to ss siRNA,BP,
10272,GO:0036413,1,0.986982997799131,0,2,histone H3-R26 citrullination,BP,
10273,GO:0036414,1,0.972412065440938,0,4,histone citrullination,BP,
10274,GO:0036435,1,0.989093452494185,0,2,K48-linked polyubiquitin modification-dependent protein binding,MF,
10275,GO:0036438,1,0.973920346158582,0,4,maintenance of lens transparency,BP,
10276,GO:0036440,1,0.99295610486543,0,1,citrate synthase activity,MF,
10277,GO:0036442,1,0.855777134081475,0,27,proton-exporting ATPase activity,MF,
10278,GO:0036444,1,0.945248920120173,0,8,calcium import into the mitochondrion,BP,
10279,GO:0036445,1,0.90731426000706,0,13,neuronal stem cell division,BP,
10280,GO:0036446,1,0.977253016785853,0,3,myofibroblast differentiation,BP,
10281,GO:0036449,1,0.944396601097117,0,7,microtubule minus-end,CC,
10282,GO:0036451,1,0.986646673054992,0,2,cap mRNA methylation,BP,
10283,GO:0036452,1,0.851907215216861,0,28,ESCRT complex,CC,
10284,GO:0036454,1,0.969469562858078,0,5,growth factor complex,CC,
10285,GO:0036455,1,0.996772237029176,0,1,iron-sulfur transferase activity,MF,
10286,GO:0036458,1,0.994744803162151,0,1,hepatocyte growth factor binding,MF,
10287,GO:0036459,1,0.532665865479656,0,88,thiol-dependent ubiquitinyl hydrolase activity,MF,
10288,GO:0036461,1,0.993166648728194,0,2,BLOC-2 complex binding,MF,
10289,GO:0036462,1,0.961802119803032,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10290,GO:0036464,1,0.313370316545264,0,180,cytoplasmic ribonucleoprotein granule,CC,
10291,GO:0036465,1,0.710059562662755,0,49,synaptic vesicle recycling,BP,
10292,GO:0036466,1,0.984786674785344,0,2,synaptic vesicle recycling via endosome,BP,
10293,GO:0036468,1,0.99520874528529,0,1,L-dopa decarboxylase activity,MF,
10294,GO:0036470,1,0.99691333883606,0,1,tyrosine 3-monooxygenase activator activity,MF,
10295,GO:0036471,1,0.99691333883606,0,1,cellular response to glyoxal,BP,
10296,GO:0036473,1,0.632171062512603,0,73,cell death in response to oxidative stress,BP,
10297,GO:0036474,1,0.853874206382974,0,26,cell death in response to hydrogen peroxide,BP,
10298,GO:0036475,1,0.868765657643601,0,21,neuron death in response to oxidative stress,BP,
10299,GO:0036476,1,0.978925421082906,0,4,neuron death in response to hydrogen peroxide,BP,
10301,GO:0036478,1,0.99691333883606,0,1,L-dopa decarboxylase activator activity,MF,
10302,GO:0036479,1,0.990820996121129,0,1,peroxidase inhibitor activity,MF,
10303,GO:0036480,1,0.954061593177517,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10304,GO:0036481,1,0.96924441834649,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10305,GO:0036482,1,0.990472966360711,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10306,GO:0036483,1,0.992389942592625,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10307,GO:0036484,1,0.978754502789196,0,3,trunk neural crest cell migration,BP,
10308,GO:0036486,1,0.978754502789196,0,3,ventral trunk neural crest cell migration,BP,
10309,GO:0036487,1,0.990996315875316,0,1,nitric-oxide synthase inhibitor activity,MF,
10310,GO:0036488,1,0.992614244457933,0,2,CHOP-C/EBP complex,CC,
10311,GO:0036490,1,0.946858138740138,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10312,GO:0036491,1,0.953977471233753,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10313,GO:0036492,1,0.959504864586256,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10314,GO:0036493,1,0.982175457640186,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10315,GO:0036494,1,0.992134276776238,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10316,GO:0036496,1,0.990623259524137,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10317,GO:0036497,1,0.994241800196158,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10318,GO:0036498,1,0.651897724836511,0,67,IRE1-mediated unfolded protein response,BP,
10320,GO:0036500,1,0.940376332580031,0,10,ATF6-mediated unfolded protein response,BP,
10321,GO:0036501,1,0.992417406811551,0,1,UFD1-NPL4 complex,CC,
10322,GO:0036502,1,0.992776075814515,0,1,Derlin-1-VIMP complex,CC,
10323,GO:0036503,1,0.572655311434644,0,89,ERAD pathway,BP,
10324,GO:0036505,1,0.987082926565816,0,2,prosaposin receptor activity,MF,
10325,GO:0036506,1,0.979790460904208,0,3,maintenance of unfolded protein,BP,
10326,GO:0036507,1,0.851033758001847,0,24,protein demannosylation,BP,
10327,GO:0036508,1,0.851033758001847,0,24,protein alpha-1,2-demannosylation,BP,
10328,GO:0036509,1,0.98887030895385,0,2,trimming of terminal mannose on B branch,BP,
10329,GO:0036510,1,0.98091477094794,0,3,trimming of terminal mannose on C branch,BP,
10330,GO:0036511,1,0.98887030895385,0,2,trimming of first mannose on A branch,BP,
10331,GO:0036512,1,0.98887030895385,0,2,trimming of second mannose on A branch,BP,
10332,GO:0036513,1,0.931256248369085,0,11,Derlin-1 retrotranslocation complex,CC,
10333,GO:0036514,1,0.959988908126905,0,5,dopaminergic neuron axon guidance,BP,
10334,GO:0036515,1,0.966750722962038,0,4,serotonergic neuron axon guidance,BP,
10335,GO:0036517,1,0.992057652763443,0,1,chemoattraction of serotonergic neuron axon,BP,
10336,GO:0036518,1,0.985120690588456,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10337,GO:0036524,1,0.99691333883606,0,1,protein deglycase activity,MF,
10338,GO:0036525,1,0.99691333883606,0,1,protein deglycation,BP,
10339,GO:0036526,1,0.99691333883606,0,1,peptidyl-cysteine deglycation,BP,
10340,GO:0036527,1,0.99691333883606,0,1,peptidyl-arginine deglycation,BP,
10341,GO:0036528,1,0.99691333883606,0,1,peptidyl-lysine deglycation,BP,
10342,GO:0036529,1,0.99691333883606,0,1,protein deglycation, glyoxal removal,BP,
10343,GO:0036530,1,0.99691333883606,0,1,protein deglycation, methylglyoxal removal,BP,
10344,GO:0036531,1,0.99691333883606,0,1,glutathione deglycation,BP,
10345,GO:0038001,1,0.975810802383352,0,3,paracrine signaling,BP,
10346,GO:0038002,1,0.992200826527996,0,1,endocrine signaling,BP,
10347,GO:0038003,1,0.948166206284218,0,10,opioid receptor signaling pathway,BP,
10348,GO:0038007,1,0.94588451622572,0,7,netrin-activated signaling pathway,BP,
10349,GO:0038016,1,0.986996475835443,0,2,insulin receptor internalization,BP,
10350,GO:0038018,1,0.984281534715198,0,2,Wnt receptor catabolic process,BP,
10351,GO:0038021,1,0.992434300280692,0,1,leptin receptor activity,MF,
10354,GO:0038025,1,0.984999190117512,0,2,reelin receptor activity,MF,
10355,GO:0038026,1,0.967524136892958,0,4,reelin-mediated signaling pathway,BP,
10356,GO:0038027,1,0.962096735709597,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10357,GO:0038028,1,0.971334460595622,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10360,GO:0038033,1,0.967027130603932,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10363,GO:0038037,1,0.952447321507612,0,8,G-protein coupled receptor dimeric complex,CC,
10364,GO:0038038,1,0.991709906267925,0,1,G-protein coupled receptor homodimeric complex,CC,
10365,GO:0038039,1,0.984549475821154,0,2,G-protein coupled receptor heterodimeric complex,CC,
10366,GO:0038042,1,0.963911886238347,0,7,dimeric G-protein coupled receptor signaling pathway,BP,
10367,GO:0038043,1,0.98757217001565,0,2,interleukin-5-mediated signaling pathway,BP,
10368,GO:0038044,1,0.962976205500488,0,5,transforming growth factor-beta secretion,BP,
10369,GO:0038046,1,0.995810176266341,0,1,enkephalin receptor activity,MF,
10370,GO:0038047,1,0.995597841356715,0,1,morphine receptor activity,MF,
10371,GO:0038048,1,0.992306535089899,0,1,dynorphin receptor activity,MF,
10372,GO:0038049,1,0.981751628661768,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10373,GO:0038051,1,0.99180591099737,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10374,GO:0038052,1,0.985980618296654,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10375,GO:0038060,1,0.992610488389052,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
10377,GO:0038062,1,0.985231810316534,0,2,protein tyrosine kinase collagen receptor activity,MF,
10378,GO:0038063,1,0.930379511432408,0,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10379,GO:0038064,1,0.96918231631896,0,4,collagen receptor activity,MF,
10380,GO:0038065,1,0.915214605446581,0,11,collagen-activated signaling pathway,BP,
10381,GO:0038066,1,0.791692225981979,0,37,p38MAPK cascade,BP,
10386,GO:0038089,1,0.951338080353369,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10388,GO:0038092,1,0.919212378858322,0,15,nodal signaling pathway,BP,
10389,GO:0038093,1,0.344405022069856,0,178,Fc receptor signaling pathway,BP,
10390,GO:0038094,1,0.623299926768865,0,74,Fc-gamma receptor signaling pathway,BP,
10391,GO:0038095,1,0.501124396134889,0,118,Fc-epsilon receptor signaling pathway,BP,
10392,GO:0038096,1,0.633961848358558,0,70,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10393,GO:0038097,1,0.992214624099705,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10394,GO:0038098,1,0.98764663751655,0,2,sequestering of BMP from receptor via BMP binding,BP,
10395,GO:0038100,1,0.983340593837929,0,3,nodal binding,MF,
10396,GO:0038101,1,0.995901764954153,0,1,sequestering of nodal from receptor via nodal binding,BP,
10397,GO:0038107,1,0.965227522005171,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10398,GO:0038108,1,0.973643215747512,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10399,GO:0038109,1,0.985282905752475,0,2,Kit signaling pathway,BP,
10400,GO:0038110,1,0.926390596142282,0,11,interleukin-2-mediated signaling pathway,BP,
10401,GO:0038111,1,0.89415585183718,0,18,interleukin-7-mediated signaling pathway,BP,
10402,GO:0038112,1,0.987341282607998,0,2,interleukin-8-mediated signaling pathway,BP,
10403,GO:0038113,1,0.980828088905818,0,3,interleukin-9-mediated signaling pathway,BP,
10404,GO:0038114,1,0.952462843265326,0,7,interleukin-21-mediated signaling pathway,BP,
10405,GO:0038115,1,0.994812632020403,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10406,GO:0038116,1,0.994812632020403,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10407,GO:0038117,1,0.994812632020403,0,1,C-C motif chemokine 19 receptor activity,MF,
10408,GO:0038118,1,0.996832095044299,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10409,GO:0038121,1,0.994812632020403,0,1,C-C motif chemokine 21 receptor activity,MF,
10410,GO:0038123,1,0.982019962978697,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10411,GO:0038124,1,0.976078977678753,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10414,GO:0038129,1,0.983559607310466,0,3,ERBB3 signaling pathway,BP,
10417,GO:0038133,1,0.995155095916301,0,1,ERBB2-ERBB3 signaling pathway,BP,
10418,GO:0038145,1,0.971481829441232,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10419,GO:0038154,1,0.992717156463654,0,1,interleukin-11-mediated signaling pathway,BP,
10420,GO:0038155,1,0.956904754263317,0,7,interleukin-23-mediated signaling pathway,BP,
10421,GO:0038156,1,0.992330941924007,0,1,interleukin-3-mediated signaling pathway,BP,
10422,GO:0038158,1,0.988629069745465,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10423,GO:0038161,1,0.9830718156787,0,2,prolactin signaling pathway,BP,
10424,GO:0038162,1,0.984512297420409,0,3,erythropoietin-mediated signaling pathway,BP,
10425,GO:0038163,1,0.985182007778912,0,3,thrombopoietin-mediated signaling pathway,BP,
10426,GO:0038164,1,0.9924948420949,0,1,thrombopoietin receptor activity,MF,
10427,GO:0038165,1,0.971554324208736,0,4,oncostatin-M-mediated signaling pathway,BP,
10428,GO:0038166,1,0.948241478568748,0,9,angiotensin-activated signaling pathway,BP,
10429,GO:0038167,1,0.992200542743953,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10430,GO:0038168,1,0.992200542743953,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10431,GO:0038169,1,0.977800598664514,0,4,somatostatin receptor signaling pathway,BP,
10432,GO:0038170,1,0.977800598664514,0,4,somatostatin signaling pathway,BP,
10433,GO:0038171,1,0.953392063554563,0,7,cannabinoid signaling pathway,BP,
10434,GO:0038172,1,0.980666330132928,0,3,interleukin-33-mediated signaling pathway,BP,
10435,GO:0038178,1,0.987692820230951,0,2,complement component C5a signaling pathway,BP,
10437,GO:0038180,1,0.929069945249002,0,12,nerve growth factor signaling pathway,BP,
10438,GO:0038181,1,0.983642002636432,0,3,bile acid receptor activity,MF,
10439,GO:0038182,1,0.996330141087448,0,1,G-protein coupled bile acid receptor activity,MF,
10440,GO:0038183,1,0.983642002636432,0,3,bile acid signaling pathway,BP,
10441,GO:0038184,1,0.996330141087448,0,1,cell surface bile acid receptor signaling pathway,BP,
10442,GO:0038185,1,0.994866756232826,0,1,intracellular bile acid receptor signaling pathway,BP,
10443,GO:0038186,1,0.99236004392278,0,1,lithocholic acid receptor activity,MF,
10444,GO:0038187,1,0.921915704691229,0,14,pattern recognition receptor activity,MF,
10445,GO:0038188,1,0.990964452819406,0,2,cholecystokinin signaling pathway,BP,
10446,GO:0038189,1,0.973689839327475,0,4,neuropilin signaling pathway,BP,
10447,GO:0038190,1,0.986541524139918,0,2,VEGF-activated neuropilin signaling pathway,BP,
10448,GO:0038191,1,0.862315307035646,0,19,neuropilin binding,MF,
10449,GO:0038192,1,0.995176083189871,0,1,gastric inhibitory peptide signaling pathway,BP,
10450,GO:0038193,1,0.994539565949337,0,1,thromboxane A2 signaling pathway,BP,
10451,GO:0038194,1,0.989143560902235,0,2,thyroid-stimulating hormone signaling pathway,BP,
10452,GO:0038195,1,0.996409399839959,0,1,urokinase plasminogen activator signaling pathway,BP,
10453,GO:0038201,1,0.899852362484956,0,16,TOR complex,CC,
10454,GO:0038202,1,0.814363599790533,0,32,TORC1 signaling,BP,
10455,GO:0038203,1,0.955614806551639,0,7,TORC2 signaling,BP,
10456,GO:0039003,1,0.984972388532087,0,2,pronephric field specification,BP,
10457,GO:0039007,1,0.992144600872689,0,1,pronephric nephron morphogenesis,BP,
10458,GO:0039008,1,0.992144600872689,0,1,pronephric nephron tubule morphogenesis,BP,
10459,GO:0039017,1,0.984972388532087,0,2,pattern specification involved in pronephros development,BP,
10460,GO:0039019,1,0.984699634205052,0,2,pronephric nephron development,BP,
10461,GO:0039020,1,0.992144600872689,0,1,pronephric nephron tubule development,BP,
10462,GO:0039022,1,0.992144600872689,0,1,pronephric duct development,BP,
10463,GO:0039023,1,0.992144600872689,0,1,pronephric duct morphogenesis,BP,
10464,GO:0039502,1,0.992241678186921,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
10465,GO:0039503,1,0.992241678186921,0,1,suppression by virus of host innate immune response,BP,
10466,GO:0039506,1,0.98562184571684,0,2,modulation by virus of host molecular function,BP,
10467,GO:0039507,1,0.98562184571684,0,2,suppression by virus of host molecular function,BP,
10468,GO:0039513,1,0.993328946169734,0,1,suppression by virus of host catalytic activity,BP,
10469,GO:0039514,1,0.992241678186921,0,1,suppression by virus of host JAK-STAT cascade,BP,
10470,GO:0039516,1,0.993328946169734,0,1,modulation by virus of host catalytic activity,BP,
10471,GO:0039519,1,0.984508567579508,0,2,modulation by virus of host autophagy,BP,
10472,GO:0039520,1,0.992146537683705,0,1,induction by virus of host autophagy,BP,
10473,GO:0039521,1,0.992302199609755,0,1,suppression by virus of host autophagy,BP,
10474,GO:0039526,1,0.984235743268643,0,3,modulation by virus of host apoptotic process,BP,
10476,GO:0039529,1,0.896574436399023,0,15,RIG-I signaling pathway,BP,
10477,GO:0039530,1,0.950779208451672,0,8,MDA-5 signaling pathway,BP,
10478,GO:0039531,1,0.899016436784215,0,15,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10479,GO:0039532,1,0.9434521723774,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10480,GO:0039533,1,0.96615772224565,0,5,regulation of MDA-5 signaling pathway,BP,
10481,GO:0039534,1,0.982905136572194,0,3,negative regulation of MDA-5 signaling pathway,BP,
10482,GO:0039535,1,0.910347401771072,0,13,regulation of RIG-I signaling pathway,BP,
10483,GO:0039536,1,0.955337186589226,0,7,negative regulation of RIG-I signaling pathway,BP,
10484,GO:0039552,1,0.99215987021606,0,1,RIG-I binding,MF,
10485,GO:0039562,1,0.992241678186921,0,1,suppression by virus of host STAT activity,BP,
10486,GO:0039563,1,0.992241678186921,0,1,suppression by virus of host STAT1 activity,BP,
10487,GO:0039564,1,0.992241678186921,0,1,suppression by virus of host STAT2 activity,BP,
10488,GO:0039650,1,0.993328946169734,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10489,GO:0039656,1,0.981836592938878,0,3,modulation by virus of host gene expression,BP,
10490,GO:0039663,1,0.964780947102673,0,6,membrane fusion involved in viral entry into host cell,BP,
10491,GO:0039689,1,0.980240239728999,0,3,negative stranded viral RNA replication,BP,
10492,GO:0039692,1,0.932265381078393,0,12,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10493,GO:0039694,1,0.846555791694208,0,26,viral RNA genome replication,BP,
10494,GO:0039695,1,0.99237803441513,0,1,DNA-templated viral transcription,BP,
10495,GO:0039702,1,0.89158576147053,0,21,viral budding via host ESCRT complex,BP,
10496,GO:0039706,1,0.936201269224237,0,11,co-receptor binding,MF,
10497,GO:0039713,1,0.992560719356296,0,1,viral factory,CC,
10498,GO:0039714,1,0.992560719356296,0,1,cytoplasmic viral factory,CC,
10499,GO:0040001,1,0.849035668797816,0,24,establishment of mitotic spindle localization,BP,
10502,GO:0040009,1,0.964724832862024,0,5,regulation of growth rate,BP,
10503,GO:0040010,1,0.997018312941827,0,1,positive regulation of growth rate,BP,
10507,GO:0040014,1,0.670897139664857,0,61,regulation of multicellular organism growth,BP,
10508,GO:0040015,1,0.93024894423611,0,11,negative regulation of multicellular organism growth,BP,
10509,GO:0040016,1,0.960165298675845,0,6,embryonic cleavage,BP,
10511,GO:0040018,1,0.827423666160486,0,29,positive regulation of multicellular organism growth,BP,
10513,GO:0040020,1,0.848191326337181,0,26,regulation of meiotic nuclear division,BP,
10515,GO:0040030,1,0.98955245487259,0,2,regulation of molecular function, epigenetic,BP,
10516,GO:0040031,1,0.971299094273653,0,6,snRNA modification,BP,
10517,GO:0040032,1,0.995531771641641,0,1,post-embryonic body morphogenesis,BP,
10518,GO:0040033,1,0.911100800916058,0,13,negative regulation of translation, ncRNA-mediated,BP,
10519,GO:0040034,1,0.92637113273939,0,12,regulation of development, heterochronic,BP,
10520,GO:0040036,1,0.836086526825862,0,26,regulation of fibroblast growth factor receptor signaling pathway,BP,
10521,GO:0040037,1,0.913375109150983,0,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10522,GO:0040038,1,0.976900786195018,0,3,polar body extrusion after meiotic divisions,BP,
10523,GO:0040040,1,0.991983974523548,0,1,thermosensory behavior,BP,
10524,GO:0042000,1,0.994147771284504,0,1,translocation of peptides or proteins into host,BP,
10525,GO:0042007,1,0.996437841363769,0,1,interleukin-18 binding,MF,
10526,GO:0042008,1,0.992528429497788,0,1,interleukin-18 receptor activity,MF,
10527,GO:0042011,1,0.992802943897003,0,1,interleukin-16 binding,MF,
10528,GO:0042012,1,0.992802943897003,0,1,interleukin-16 receptor activity,MF,
10529,GO:0042015,1,0.981012392176771,0,3,interleukin-20 binding,MF,
10530,GO:0042019,1,0.995296707577174,0,1,interleukin-23 binding,MF,
10531,GO:0042020,1,0.995296707577174,0,1,interleukin-23 receptor activity,MF,
10532,GO:0042022,1,0.995296707577174,0,1,interleukin-12 receptor complex,CC,
10533,GO:0042023,1,0.939722970920538,0,8,DNA endoreduplication,BP,
10534,GO:0042025,1,0.979347021986383,0,3,host cell nucleus,CC,
10535,GO:0042026,1,0.850337080510655,0,26,protein refolding,BP,
10536,GO:0042030,1,0.979956965848202,0,3,ATPase inhibitor activity,MF,
10537,GO:0042033,1,0.944512362773513,0,12,chemokine biosynthetic process,BP,
10538,GO:0042035,1,0.584590027793981,0,88,regulation of cytokine biosynthetic process,BP,
10539,GO:0042036,1,0.854897301814076,0,28,negative regulation of cytokine biosynthetic process,BP,
10540,GO:0042040,1,0.992433704947594,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10541,GO:0042043,1,0.911816913532673,0,13,neurexin family protein binding,MF,
10542,GO:0042044,1,0.876972070105384,0,21,fluid transport,BP,
10543,GO:0042045,1,0.950276363991091,0,7,epithelial fluid transport,BP,
10544,GO:0042048,1,0.944933527072945,0,7,olfactory behavior,BP,
10545,GO:0042053,1,0.894430951137213,0,18,regulation of dopamine metabolic process,BP,
10546,GO:0042054,1,0.6962524709436,0,53,histone methyltransferase activity,MF,
10547,GO:0042056,1,0.894165910590219,0,22,chemoattractant activity,MF,
10552,GO:0042069,1,0.894430951137213,0,18,regulation of catecholamine metabolic process,BP,
10553,GO:0042073,1,0.721749648079322,0,50,intraciliary transport,BP,
10554,GO:0042074,1,0.92184047907513,0,13,cell migration involved in gastrulation,BP,
10555,GO:0042078,1,0.983697737087025,0,3,germ-line stem cell division,BP,
10556,GO:0042083,1,0.996176901233646,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10557,GO:0042084,1,0.990259096404492,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10558,GO:0042088,1,0.812176693176929,0,36,T-helper 1 type immune response,BP,
10559,GO:0042089,1,0.562393912431267,0,95,cytokine biosynthetic process,BP,
10560,GO:0042090,1,0.954594160501525,0,7,interleukin-12 biosynthetic process,BP,
10561,GO:0042091,1,0.980431985124638,0,3,interleukin-10 biosynthetic process,BP,
10562,GO:0042092,1,0.827911507403527,0,33,type 2 immune response,BP,
10563,GO:0042093,1,0.733431578130897,0,48,T-helper cell differentiation,BP,
10564,GO:0042094,1,0.890487070603109,0,20,interleukin-2 biosynthetic process,BP,
10565,GO:0042095,1,0.917399373280345,0,15,interferon-gamma biosynthetic process,BP,
10566,GO:0042097,1,0.97846795663292,0,3,interleukin-4 biosynthetic process,BP,
10567,GO:0042098,1,0.400536212113931,0,158,T cell proliferation,BP,
10568,GO:0042100,1,0.667064728698753,0,68,B cell proliferation,BP,
10569,GO:0042101,1,0.900912515803481,0,19,T cell receptor complex,CC,
10570,GO:0042102,1,0.627342432785036,0,84,positive regulation of T cell proliferation,BP,
10571,GO:0042104,1,0.904615685981712,0,19,positive regulation of activated T cell proliferation,BP,
10572,GO:0042105,1,0.980619407057435,0,5,alpha-beta T cell receptor complex,CC,
10573,GO:0042107,1,0.55972783688208,0,96,cytokine metabolic process,BP,
10574,GO:0042108,1,0.724429033241144,0,52,positive regulation of cytokine biosynthetic process,BP,
10575,GO:0042109,1,0.986280157163966,0,2,lymphotoxin A biosynthetic process,BP,
10577,GO:0042113,1,0.286323931639,0,197,B cell activation,BP,
10578,GO:0042116,1,0.683110072040551,0,60,macrophage activation,BP,
10579,GO:0042117,1,0.960920171843399,0,7,monocyte activation,BP,
10580,GO:0042118,1,0.942950584511824,0,9,endothelial cell activation,BP,
10581,GO:0042119,1,0.0616430234452818,0,473,neutrophil activation,BP,
10582,GO:0042126,1,0.975106605293283,0,4,nitrate metabolic process,BP,
10584,GO:0042128,1,0.994365027039753,0,1,nitrate assimilation,BP,
10585,GO:0042129,1,0.469375614007734,0,133,regulation of T cell proliferation,BP,
10586,GO:0042130,1,0.735908746342344,0,51,negative regulation of T cell proliferation,BP,
10587,GO:0042131,1,0.99385993600836,0,1,thiamine phosphate phosphatase activity,MF,
10588,GO:0042132,1,0.996253352559254,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10589,GO:0042133,1,0.454637290004643,0,123,neurotransmitter metabolic process,BP,
10590,GO:0042134,1,0.992163712935824,0,2,rRNA primary transcript binding,MF,
10592,GO:0042136,1,0.591537908024754,0,84,neurotransmitter biosynthetic process,BP,
10593,GO:0042137,1,0.988488766113113,0,2,sequestering of neurotransmitter,BP,
10594,GO:0042138,1,0.980947487534323,0,3,meiotic DNA double-strand break formation,BP,
10595,GO:0042140,1,0.993301131169352,0,1,late meiotic recombination nodule assembly,BP,
10596,GO:0042144,1,0.986235333726666,0,2,vacuole fusion, non-autophagic,BP,
10597,GO:0042147,1,0.616123322351354,0,72,retrograde transport, endosome to Golgi,BP,
10598,GO:0042148,1,0.952255163927751,0,8,strand invasion,BP,
10599,GO:0042149,1,0.78878011771405,0,37,cellular response to glucose starvation,BP,
10602,GO:0042159,1,0.913366709562939,0,14,lipoprotein catabolic process,BP,
10605,GO:0042162,1,0.782141022456863,0,36,telomeric DNA binding,MF,
10606,GO:0042163,1,0.996410840777958,0,1,interleukin-12 beta subunit binding,MF,
10607,GO:0042165,1,0.741579980233221,0,49,neurotransmitter binding,MF,
10608,GO:0042166,1,0.90624746548862,0,16,acetylcholine binding,MF,
10609,GO:0042167,1,0.985951138975038,0,4,heme catabolic process,BP,
10610,GO:0042168,1,0.874683194874084,0,25,heme metabolic process,BP,
10611,GO:0042169,1,0.799902466283519,0,32,SH2 domain binding,MF,
10612,GO:0042171,1,0.884385204306103,0,18,lysophosphatidic acid acyltransferase activity,MF,
10616,GO:0042178,1,0.953448629850008,0,10,xenobiotic catabolic process,BP,
10618,GO:0042181,1,0.831896333425297,0,33,ketone biosynthetic process,BP,
10619,GO:0042182,1,0.967940167342113,0,6,ketone catabolic process,BP,
10620,GO:0042197,1,0.996018321361949,0,1,halogenated hydrocarbon metabolic process,BP,
10621,GO:0042214,1,0.982053370701697,0,3,terpene metabolic process,BP,
10622,GO:0042219,1,0.88669009729832,0,20,cellular modified amino acid catabolic process,BP,
10623,GO:0042220,1,0.763535997336592,0,41,response to cocaine,BP,
10625,GO:0042222,1,0.986720529039778,0,3,interleukin-1 biosynthetic process,BP,
10626,GO:0042223,1,0.992287819095937,0,1,interleukin-3 biosynthetic process,BP,
10627,GO:0042226,1,0.918619897544295,0,14,interleukin-6 biosynthetic process,BP,
10628,GO:0042228,1,0.939594848504526,0,10,interleukin-8 biosynthetic process,BP,
10629,GO:0042231,1,0.988989853402906,0,2,interleukin-13 biosynthetic process,BP,
10630,GO:0042241,1,0.992682484055807,0,1,interleukin-18 biosynthetic process,BP,
10631,GO:0042245,1,0.98619412723998,0,2,RNA repair,BP,
10633,GO:0042247,1,0.993015480489423,0,1,establishment of planar polarity of follicular epithelium,BP,
10634,GO:0042249,1,0.888090559919509,0,17,establishment of planar polarity of embryonic epithelium,BP,
10635,GO:0042253,1,0.982473726022009,0,3,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10636,GO:0042254,1,0.203176178958121,0,309,ribosome biogenesis,BP,
10637,GO:0042255,1,0.785786874756555,0,53,ribosome assembly,BP,
10638,GO:0042256,1,0.974528816880448,0,5,mature ribosome assembly,BP,
10639,GO:0042262,1,0.979772385774989,0,5,DNA protection,BP,
10640,GO:0042264,1,0.98426577381983,0,2,peptidyl-aspartic acid hydroxylation,BP,
10641,GO:0042265,1,0.991705456451615,0,1,peptidyl-asparagine hydroxylation,BP,
10643,GO:0042268,1,0.952958446479523,0,10,regulation of cytolysis,BP,
10645,GO:0042270,1,0.988479349040479,0,2,protection from natural killer cell mediated cytotoxicity,BP,
10646,GO:0042271,1,0.981454481563229,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10647,GO:0042272,1,0.978085627852951,0,3,nuclear RNA export factor complex,CC,
10648,GO:0042273,1,0.724439896261499,0,66,ribosomal large subunit biogenesis,BP,
10649,GO:0042274,1,0.708838194872447,0,67,ribosomal small subunit biogenesis,BP,
10650,GO:0042275,1,0.996284327432505,0,1,error-free postreplication DNA repair,BP,
10651,GO:0042276,1,0.901411424010024,0,19,error-prone translesion synthesis,BP,
10653,GO:0042278,1,0.646102688285696,0,73,purine nucleoside metabolic process,BP,
10654,GO:0042281,1,0.988552716511309,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10655,GO:0042282,1,0.992397911966453,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10656,GO:0042284,1,0.992101584147778,0,2,sphingolipid delta-4 desaturase activity,MF,
10657,GO:0042285,1,0.95839779397964,0,6,xylosyltransferase activity,MF,
10658,GO:0042287,1,0.852467365466838,0,27,MHC protein binding,MF,
10659,GO:0042288,1,0.910231921659857,0,16,MHC class I protein binding,MF,
10660,GO:0042289,1,0.968932935714856,0,6,MHC class II protein binding,MF,
10661,GO:0042292,1,0.99404713979306,0,1,URM1 activating enzyme activity,MF,
10662,GO:0042296,1,0.981532297743858,0,4,ISG15 transferase activity,MF,
10663,GO:0042297,1,0.940856202656405,0,7,vocal learning,BP,
10664,GO:0042301,1,0.934481871308796,0,11,phosphate ion binding,MF,
10668,GO:0042307,1,0.810055378400545,0,30,positive regulation of protein import into nucleus,BP,
10670,GO:0042309,1,0.993314971832317,0,1,homoiothermy,BP,
10672,GO:0042311,1,0.844196306831778,0,28,vasodilation,BP,
10673,GO:0042313,1,0.995005255875637,0,1,protein kinase C deactivation,BP,
10674,GO:0042316,1,0.992276848613409,0,1,penicillin metabolic process,BP,
10675,GO:0042320,1,0.979704218450007,0,5,regulation of circadian sleep/wake cycle, REM sleep,BP,
10676,GO:0042321,1,0.976833236947652,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10677,GO:0042322,1,0.993647213318964,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10678,GO:0042323,1,0.989461222404043,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10682,GO:0042328,1,0.968770672030911,0,4,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10684,GO:0042335,1,0.978852105279575,0,3,cuticle development,BP,
10685,GO:0042339,1,0.819491018932052,0,31,keratan sulfate metabolic process,BP,
10686,GO:0042340,1,0.930180404593452,0,11,keratan sulfate catabolic process,BP,
10687,GO:0042350,1,0.985050724822764,0,3,GDP-L-fucose biosynthetic process,BP,
10688,GO:0042351,1,0.99253244336343,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10689,GO:0042352,1,0.992462578141831,0,1,GDP-L-fucose salvage,BP,
10690,GO:0042354,1,0.942584562739899,0,8,L-fucose metabolic process,BP,
10691,GO:0042355,1,0.942584562739899,0,8,L-fucose catabolic process,BP,
10692,GO:0042356,1,0.99651203050754,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10693,GO:0042357,1,0.990078541805302,0,2,thiamine diphosphate metabolic process,BP,
10695,GO:0042360,1,0.985574738644148,0,3,vitamin E metabolic process,BP,
10696,GO:0042361,1,0.992721963153586,0,1,menaquinone catabolic process,BP,
10697,GO:0042362,1,0.935435715918147,0,12,fat-soluble vitamin biosynthetic process,BP,
10698,GO:0042363,1,0.964110861473767,0,6,fat-soluble vitamin catabolic process,BP,
10699,GO:0042364,1,0.943370005753298,0,9,water-soluble vitamin biosynthetic process,BP,
10700,GO:0042365,1,0.984634482505336,0,3,water-soluble vitamin catabolic process,BP,
10701,GO:0042368,1,0.952680690368774,0,9,vitamin D biosynthetic process,BP,
10702,GO:0042369,1,0.986733612048747,0,2,vitamin D catabolic process,BP,
10703,GO:0042371,1,0.992495045100237,0,1,vitamin K biosynthetic process,BP,
10704,GO:0042373,1,0.975762127520577,0,5,vitamin K metabolic process,BP,
10705,GO:0042374,1,0.989530819676058,0,2,phylloquinone metabolic process,BP,
10706,GO:0042376,1,0.989530819676058,0,2,phylloquinone catabolic process,BP,
10707,GO:0042377,1,0.992721963153586,0,1,vitamin K catabolic process,BP,
10708,GO:0042379,1,0.83117073207992,0,42,chemokine receptor binding,MF,
10709,GO:0042382,1,0.960117841032581,0,6,paraspeckles,CC,
10712,GO:0042392,1,0.98936078232844,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10713,GO:0042393,1,0.312899491799857,0,170,histone binding,MF,
10715,GO:0042401,1,0.904274605309691,0,20,cellular biogenic amine biosynthetic process,BP,
10716,GO:0042402,1,0.902732042159542,0,20,cellular biogenic amine catabolic process,BP,
10717,GO:0042403,1,0.892021229016884,0,17,thyroid hormone metabolic process,BP,
10718,GO:0042404,1,0.99500391878438,0,1,thyroid hormone catabolic process,BP,
10719,GO:0042405,1,0.916141089834699,0,11,nuclear inclusion body,CC,
10720,GO:0042406,1,0.977694420856935,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10721,GO:0042407,1,0.923375412489119,0,15,cristae formation,BP,
10722,GO:0042412,1,0.989597219866688,0,2,taurine biosynthetic process,BP,
10723,GO:0042413,1,0.993944371685244,0,1,carnitine catabolic process,BP,
10724,GO:0042414,1,0.983449760246682,0,3,epinephrine metabolic process,BP,
10725,GO:0042415,1,0.936444911379104,0,10,norepinephrine metabolic process,BP,
10726,GO:0042416,1,0.936631444749479,0,11,dopamine biosynthetic process,BP,
10727,GO:0042417,1,0.80626374841045,0,34,dopamine metabolic process,BP,
10728,GO:0042418,1,0.992257061144098,0,2,epinephrine biosynthetic process,BP,
10729,GO:0042420,1,0.956444993849624,0,7,dopamine catabolic process,BP,
10730,GO:0042421,1,0.962617004400652,0,6,norepinephrine biosynthetic process,BP,
10731,GO:0042423,1,0.89158676936858,0,19,catecholamine biosynthetic process,BP,
10732,GO:0042424,1,0.949615304593805,0,8,catecholamine catabolic process,BP,
10733,GO:0042426,1,0.957540374435203,0,6,choline catabolic process,BP,
10734,GO:0042427,1,0.985262473896099,0,3,serotonin biosynthetic process,BP,
10735,GO:0042428,1,0.934223990576397,0,10,serotonin metabolic process,BP,
10736,GO:0042430,1,0.897767601751609,0,19,indole-containing compound metabolic process,BP,
10737,GO:0042435,1,0.981680724579937,0,4,indole-containing compound biosynthetic process,BP,
10738,GO:0042436,1,0.968447404784614,0,7,indole-containing compound catabolic process,BP,
10739,GO:0042438,1,0.905014470197181,0,15,melanin biosynthetic process,BP,
10740,GO:0042439,1,0.961332771715749,0,6,ethanolamine-containing compound metabolic process,BP,
10741,GO:0042440,1,0.709133974404921,0,58,pigment metabolic process,BP,
10742,GO:0042441,1,0.981169549130346,0,3,eye pigment metabolic process,BP,
10744,GO:0042446,1,0.680466084495742,0,67,hormone biosynthetic process,BP,
10745,GO:0042447,1,0.9258096182029,0,14,hormone catabolic process,BP,
10746,GO:0042448,1,0.932615952864953,0,13,progesterone metabolic process,BP,
10747,GO:0042450,1,0.991355110801182,0,2,arginine biosynthetic process via ornithine,BP,
10748,GO:0042451,1,0.907018789055415,0,21,purine nucleoside biosynthetic process,BP,
10749,GO:0042454,1,0.92105528029815,0,16,ribonucleoside catabolic process,BP,
10750,GO:0042455,1,0.834095239233759,0,36,ribonucleoside biosynthetic process,BP,
10751,GO:0042461,1,0.768888259720284,0,38,photoreceptor cell development,BP,
10752,GO:0042462,1,0.826999200835082,0,28,eye photoreceptor cell development,BP,
10753,GO:0042470,1,0.536978789161731,0,101,melanosome,CC,
10754,GO:0042471,1,0.500878757134362,0,108,ear morphogenesis,BP,
10755,GO:0042472,1,0.556287803337649,0,89,inner ear morphogenesis,BP,
10756,GO:0042473,1,0.948145965480898,0,9,outer ear morphogenesis,BP,
10757,GO:0042474,1,0.900641664918849,0,19,middle ear morphogenesis,BP,
10758,GO:0042475,1,0.626170916943099,0,71,odontogenesis of dentin-containing tooth,BP,
10759,GO:0042476,1,0.502721469730154,0,105,odontogenesis,BP,
10760,GO:0042481,1,0.888600681986763,0,20,regulation of odontogenesis,BP,
10761,GO:0042482,1,0.95934166361909,0,7,positive regulation of odontogenesis,BP,
10762,GO:0042483,1,0.973254386179853,0,4,negative regulation of odontogenesis,BP,
10763,GO:0042487,1,0.948951000776735,0,9,regulation of odontogenesis of dentin-containing tooth,BP,
10764,GO:0042488,1,0.994112311743672,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10765,GO:0042489,1,0.98713728669916,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10766,GO:0042490,1,0.698191302604565,0,53,mechanoreceptor differentiation,BP,
10767,GO:0042491,1,0.821242939124952,0,29,inner ear auditory receptor cell differentiation,BP,
10768,GO:0042492,1,0.958692073459348,0,6,gamma-delta T cell differentiation,BP,
10770,GO:0042494,1,0.962114472555493,0,5,detection of bacterial lipoprotein,BP,
10771,GO:0042495,1,0.985796231229849,0,2,detection of triacyl bacterial lipopeptide,BP,
10772,GO:0042496,1,0.984684754379764,0,2,detection of diacyl bacterial lipopeptide,BP,
10773,GO:0042497,1,0.992580864855787,0,1,triacyl lipopeptide binding,MF,
10774,GO:0042500,1,0.963073553086579,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10775,GO:0042501,1,0.955872805913308,0,7,serine phosphorylation of STAT protein,BP,
10778,GO:0042532,1,0.938138728163169,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10779,GO:0042533,1,0.898025192189992,0,18,tumor necrosis factor biosynthetic process,BP,
10780,GO:0042534,1,0.898025192189992,0,18,regulation of tumor necrosis factor biosynthetic process,BP,
10781,GO:0042535,1,0.932591323777869,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10782,GO:0042536,1,0.974876617196217,0,5,negative regulation of tumor necrosis factor biosynthetic process,BP,
10783,GO:0042537,1,0.918371553333242,0,18,benzene-containing compound metabolic process,BP,
10784,GO:0042538,1,0.958289642077225,0,7,hyperosmotic salinity response,BP,
10785,GO:0042539,1,0.984314643565006,0,2,hypotonic salinity response,BP,
10786,GO:0042541,1,0.953016672275894,0,9,hemoglobin biosynthetic process,BP,
10787,GO:0042542,1,0.484006554521205,0,123,response to hydrogen peroxide,BP,
10788,GO:0042543,1,0.997065104086354,0,1,protein N-linked glycosylation via arginine,BP,
10789,GO:0042546,1,0.995805808593524,0,1,cell wall biogenesis,BP,
10793,GO:0042555,1,0.926251567791978,0,11,MCM complex,CC,
10795,GO:0042559,1,0.93091035161259,0,14,pteridine-containing compound biosynthetic process,BP,
10796,GO:0042560,1,0.973810048538613,0,4,pteridine-containing compound catabolic process,BP,
10798,GO:0042564,1,0.992422224104015,0,1,NLS-dependent protein nuclear import complex,CC,
10799,GO:0042565,1,0.989033103764276,0,2,RNA nuclear export complex,CC,
10800,GO:0042567,1,0.972491791905177,0,4,insulin-like growth factor ternary complex,CC,
10801,GO:0042568,1,0.996893187130542,0,1,insulin-like growth factor binary complex,CC,
10802,GO:0042571,1,0.990287003050083,0,2,immunoglobulin complex, circulating,CC,
10803,GO:0042572,1,0.856017666212098,0,27,retinol metabolic process,BP,
10804,GO:0042573,1,0.906451305265829,0,17,retinoic acid metabolic process,BP,
10805,GO:0042574,1,0.91938856431964,0,13,retinal metabolic process,BP,
10806,GO:0042575,1,0.904893175484389,0,16,DNA polymerase complex,CC,
10807,GO:0042577,1,0.987442743990438,0,2,lipid phosphatase activity,MF,
10810,GO:0042581,1,0.399016684399755,0,154,specific granule,CC,
10811,GO:0042582,1,0.42488170946997,0,147,azurophil granule,CC,
10812,GO:0042583,1,0.947884990027119,0,8,chromaffin granule,CC,
10813,GO:0042584,1,0.959064160235659,0,6,chromaffin granule membrane,CC,
10814,GO:0042585,1,0.994630624471049,0,1,germinal vesicle,CC,
10815,GO:0042586,1,0.996743704416587,0,1,peptide deformylase activity,MF,
10816,GO:0042587,1,0.968751632346671,0,5,glycogen granule,CC,
10817,GO:0042588,1,0.928326929139129,0,12,zymogen granule,CC,
10818,GO:0042589,1,0.9396504693871,0,10,zymogen granule membrane,CC,
10819,GO:0042590,1,0.719139295455503,0,72,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10822,GO:0042594,1,0.356073785896067,0,162,response to starvation,BP,
10823,GO:0042595,1,0.989416250026983,0,2,behavioral response to starvation,BP,
10825,GO:0042599,1,0.916371399916331,0,16,lamellar body,CC,
10826,GO:0042602,1,0.996956470497609,0,1,riboflavin reductase (NADPH) activity,MF,
10827,GO:0042605,1,0.901733422996016,0,21,peptide antigen binding,MF,
10828,GO:0042608,1,0.965531814672256,0,7,T cell receptor binding,MF,
10829,GO:0042609,1,0.961728479077393,0,7,CD4 receptor binding,MF,
10830,GO:0042610,1,0.990041594813673,0,2,CD8 receptor binding,MF,
10831,GO:0042611,1,0.921825763617138,0,22,MHC protein complex,CC,
10832,GO:0042612,1,0.971393100956756,0,8,MHC class I protein complex,CC,
10833,GO:0042613,1,0.948988028526935,0,14,MHC class II protein complex,CC,
10834,GO:0042622,1,0.916217467606932,0,13,photoreceptor outer segment membrane,CC,
10836,GO:0042624,1,0.997026923975853,0,1,ATPase activity, uncoupled,MF,
10837,GO:0042625,1,0.708177967175796,0,53,ATPase coupled ion transmembrane transporter activity,MF,
10838,GO:0042626,1,0.502681530352931,0,97,ATPase activity, coupled to transmembrane movement of substances,MF,
10839,GO:0042627,1,0.954315405008339,0,9,chylomicron,CC,
10840,GO:0042628,1,0.994561298560891,0,1,mating plug formation,BP,
10842,GO:0042631,1,0.985014682749931,0,2,cellular response to water deprivation,BP,
10843,GO:0042632,1,0.724722132244178,0,53,cholesterol homeostasis,BP,
10846,GO:0042635,1,0.937492859864343,0,12,positive regulation of hair cycle,BP,
10847,GO:0042636,1,0.97006901863104,0,4,negative regulation of hair cycle,BP,
10848,GO:0042637,1,0.976586369688277,0,4,catagen,BP,
10849,GO:0042640,1,0.964420450382403,0,5,anagen,BP,
10850,GO:0042641,1,0.629270798686843,0,64,actomyosin,CC,
10851,GO:0042643,1,0.98555414045501,0,2,actomyosin, actin portion,CC,
10852,GO:0042645,1,0.776056852620085,0,41,mitochondrial nucleoid,CC,
10853,GO:0042658,1,0.996575705228894,0,1,MHC class II protein binding, via antigen binding groove,MF,
10855,GO:0042660,1,0.991753800282021,0,1,positive regulation of cell fate specification,BP,
10856,GO:0042661,1,0.967172461609073,0,6,regulation of mesodermal cell fate specification,BP,
10857,GO:0042662,1,0.982225865221192,0,4,negative regulation of mesodermal cell fate specification,BP,
10858,GO:0042663,1,0.986235426497596,0,3,regulation of endodermal cell fate specification,BP,
10859,GO:0042664,1,0.996741839541675,0,1,negative regulation of endodermal cell fate specification,BP,
10862,GO:0042668,1,0.99299030323848,0,2,auditory receptor cell fate determination,BP,
10863,GO:0042670,1,0.949770903327081,0,8,retinal cone cell differentiation,BP,
10865,GO:0042693,1,0.935164689257396,0,12,muscle cell fate commitment,BP,
10866,GO:0042695,1,0.971438849584006,0,5,thelarche,BP,
10868,GO:0042699,1,0.990246510568283,0,2,follicle-stimulating hormone signaling pathway,BP,
10869,GO:0042700,1,0.992377656288372,0,1,luteinizing hormone signaling pathway,BP,
10870,GO:0042701,1,0.97880690198597,0,4,progesterone secretion,BP,
10871,GO:0042704,1,0.985029113683763,0,2,uterine wall breakdown,BP,
10872,GO:0042709,1,0.994305923821445,0,1,succinate-CoA ligase complex,CC,
10873,GO:0042710,1,0.994263129730359,0,1,biofilm formation,BP,
10874,GO:0042711,1,0.92199389924448,0,12,maternal behavior,BP,
10875,GO:0042713,1,0.962726919433692,0,5,sperm ejaculation,BP,
10876,GO:0042719,1,0.97957611898408,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10877,GO:0042720,1,0.993281725714128,0,2,mitochondrial inner membrane peptidase complex,CC,
10878,GO:0042721,1,0.976402570887348,0,5,mitochondrial inner membrane protein insertion complex,CC,
10879,GO:0042723,1,0.959262620489619,0,7,thiamine-containing compound metabolic process,BP,
10880,GO:0042726,1,0.94995352402969,0,8,flavin-containing compound metabolic process,BP,
10881,GO:0042727,1,0.988806002694054,0,2,flavin-containing compound biosynthetic process,BP,
10882,GO:0042728,1,0.992466417663809,0,1,flavin-containing compound catabolic process,BP,
10883,GO:0042730,1,0.88696746243404,0,21,fibrinolysis,BP,
10884,GO:0042731,1,0.974433996854764,0,4,PH domain binding,MF,
10885,GO:0042732,1,0.986317759859187,0,3,D-xylose metabolic process,BP,
10888,GO:0042737,1,0.543921680194689,0,115,drug catabolic process,BP,
10889,GO:0042738,1,0.922072288672736,0,15,exogenous drug catabolic process,BP,
10890,GO:0042742,1,0.452635332442588,0,153,defense response to bacterium,BP,
10892,GO:0042744,1,0.899402942559471,0,21,hydrogen peroxide catabolic process,BP,
10893,GO:0042745,1,0.882570085422299,0,24,circadian sleep/wake cycle,BP,
10894,GO:0042746,1,0.981502724739047,0,4,circadian sleep/wake cycle, wakefulness,BP,
10895,GO:0042747,1,0.965148702264599,0,8,circadian sleep/wake cycle, REM sleep,BP,
10896,GO:0042748,1,0.954454406097836,0,8,circadian sleep/wake cycle, non-REM sleep,BP,
10897,GO:0042749,1,0.913127715254874,0,18,regulation of circadian sleep/wake cycle,BP,
10898,GO:0042752,1,0.550807891751201,0,92,regulation of circadian rhythm,BP,
10899,GO:0042753,1,0.909535114523547,0,16,positive regulation of circadian rhythm,BP,
10900,GO:0042754,1,0.92078163553276,0,13,negative regulation of circadian rhythm,BP,
10901,GO:0042755,1,0.86271201071325,0,25,eating behavior,BP,
10902,GO:0042756,1,0.95350802484607,0,8,drinking behavior,BP,
10903,GO:0042758,1,0.954915918013272,0,8,long-chain fatty acid catabolic process,BP,
10905,GO:0042760,1,0.955669861425422,0,7,very long-chain fatty acid catabolic process,BP,
10906,GO:0042761,1,0.925538361679662,0,12,very long-chain fatty acid biosynthetic process,BP,
10907,GO:0042762,1,0.886909316156261,0,17,regulation of sulfur metabolic process,BP,
10908,GO:0042765,1,0.971183979498364,0,5,GPI-anchor transamidase complex,CC,
10909,GO:0042766,1,0.991213245200891,0,1,nucleosome mobilization,BP,
10910,GO:0042769,1,0.814364744499411,0,37,DNA damage response, detection of DNA damage,BP,
10911,GO:0042770,1,0.448007279642165,0,127,signal transduction in response to DNA damage,BP,
10912,GO:0042771,1,0.780830246084719,0,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10913,GO:0042772,1,0.885001373225396,0,20,DNA damage response, signal transduction resulting in transcription,BP,
10914,GO:0042773,1,0.717901785543991,0,81,ATP synthesis coupled electron transport,BP,
10915,GO:0042774,1,0.993301131169352,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10916,GO:0042775,1,0.722759829740775,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10917,GO:0042776,1,0.986915332573686,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10918,GO:0042779,1,0.987155002559538,0,2,tRNA 3'-trailer cleavage,BP,
10919,GO:0042780,1,0.961388256437394,0,7,tRNA 3'-end processing,BP,
10920,GO:0042781,1,0.987155002559538,0,2,3'-tRNA processing endoribonuclease activity,MF,
10921,GO:0042788,1,0.879868365837595,0,30,polysomal ribosome,CC,
10922,GO:0042789,1,0.888572530610566,0,19,mRNA transcription by RNA polymerase II,BP,
10923,GO:0042790,1,0.928463970411839,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10924,GO:0042791,1,0.961194139175826,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10925,GO:0042795,1,0.674752837208565,0,66,snRNA transcription by RNA polymerase II,BP,
10926,GO:0042796,1,0.96172255654557,0,6,snRNA transcription by RNA polymerase III,BP,
10927,GO:0042797,1,0.961194139175826,0,6,tRNA transcription by RNA polymerase III,BP,
10928,GO:0042799,1,0.989304901090335,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10929,GO:0042800,1,0.897789308789306,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10933,GO:0042806,1,0.977970050587815,0,4,fucose binding,MF,
10934,GO:0042809,1,0.902395336611528,0,15,vitamin D receptor binding,MF,
10936,GO:0042816,1,0.967030078778522,0,5,vitamin B6 metabolic process,BP,
10937,GO:0042819,1,0.979175769319685,0,3,vitamin B6 biosynthetic process,BP,
10938,GO:0042820,1,0.995256774042177,0,1,vitamin B6 catabolic process,BP,
10939,GO:0042822,1,0.979484047443431,0,3,pyridoxal phosphate metabolic process,BP,
10940,GO:0042823,1,0.984152882121059,0,2,pyridoxal phosphate biosynthetic process,BP,
10941,GO:0042824,1,0.973716682963747,0,4,MHC class I peptide loading complex,CC,
10942,GO:0042825,1,0.978142093636883,0,3,TAP complex,CC,
10943,GO:0042826,1,0.501699879119329,0,104,histone deacetylase binding,MF,
10944,GO:0042827,1,0.903222207655283,0,18,platelet dense granule,CC,
10945,GO:0042832,1,0.908756372359233,0,19,defense response to protozoan,BP,
10946,GO:0042834,1,0.950420808740692,0,9,peptidoglycan binding,MF,
10947,GO:0042835,1,0.98487276100002,0,2,BRE binding,MF,
10948,GO:0042839,1,0.996356943742403,0,1,D-glucuronate metabolic process,BP,
10949,GO:0042840,1,0.996356943742403,0,1,D-glucuronate catabolic process,BP,
10950,GO:0042843,1,0.996806652532186,0,1,D-xylose catabolic process,BP,
10951,GO:0042851,1,0.984222232144968,0,3,L-alanine metabolic process,BP,
10952,GO:0042853,1,0.984222232144968,0,3,L-alanine catabolic process,BP,
10954,GO:0042883,1,0.992481453401396,0,1,cysteine transport,BP,
10956,GO:0042887,1,0.812909813381489,0,36,amide transmembrane transporter activity,MF,
10957,GO:0042891,1,0.948939104703767,0,8,antibiotic transport,BP,
10958,GO:0042895,1,0.963457167209371,0,6,antibiotic transmembrane transporter activity,MF,
10959,GO:0042903,1,0.987880202600716,0,2,tubulin deacetylase activity,MF,
10960,GO:0042904,1,0.976229575682027,0,4,9-cis-retinoic acid biosynthetic process,BP,
10961,GO:0042905,1,0.976229575682027,0,4,9-cis-retinoic acid metabolic process,BP,
10962,GO:0042908,1,0.932522661912578,0,9,xenobiotic transport,BP,
10963,GO:0042910,1,0.939641636202197,0,8,xenobiotic transmembrane transporter activity,MF,
10964,GO:0042921,1,0.900866842062749,0,15,glucocorticoid receptor signaling pathway,BP,
10965,GO:0042922,1,0.996976979760557,0,1,neuromedin U receptor binding,MF,
10966,GO:0042923,1,0.90451542676574,0,19,neuropeptide binding,MF,
10967,GO:0042924,1,0.987791087929186,0,2,neuromedin U binding,MF,
10968,GO:0042930,1,0.993301131169352,0,1,enterobactin transport,BP,
10969,GO:0042931,1,0.993301131169352,0,1,enterobactin transmembrane transporter activity,MF,
10970,GO:0042937,1,0.991874756835951,0,1,tripeptide transmembrane transporter activity,MF,
10971,GO:0042938,1,0.989604045914797,0,2,dipeptide transport,BP,
10972,GO:0042939,1,0.987164539787604,0,2,tripeptide transport,BP,
10973,GO:0042940,1,0.956909504014452,0,6,D-amino acid transport,BP,
10974,GO:0042941,1,0.995384487152049,0,1,D-alanine transport,BP,
10975,GO:0042942,1,0.989139413685378,0,2,D-serine transport,BP,
10976,GO:0042946,1,0.993301131169352,0,1,glucoside transport,BP,
10977,GO:0042947,1,0.993301131169352,0,1,glucoside transmembrane transporter activity,MF,
10980,GO:0042974,1,0.852086002176167,0,24,retinoic acid receptor binding,MF,
10981,GO:0042975,1,0.927199444970572,0,11,peroxisome proliferator activated receptor binding,MF,
10982,GO:0042976,1,0.943770346545127,0,9,activation of Janus kinase activity,BP,
10983,GO:0042978,1,0.975630681330677,0,3,ornithine decarboxylase activator activity,MF,
10984,GO:0042979,1,0.965105936421057,0,6,ornithine decarboxylase regulator activity,MF,
10987,GO:0042983,1,0.944631318125315,0,10,amyloid precursor protein biosynthetic process,BP,
10988,GO:0042984,1,0.944631318125315,0,10,regulation of amyloid precursor protein biosynthetic process,BP,
10989,GO:0042985,1,0.971911023917542,0,5,negative regulation of amyloid precursor protein biosynthetic process,BP,
10990,GO:0042986,1,0.987999243327526,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10991,GO:0042987,1,0.810230281436722,0,32,amyloid precursor protein catabolic process,BP,
10992,GO:0042988,1,0.992247721209142,0,1,X11-like protein binding,MF,
10994,GO:0042994,1,0.898708154792672,0,18,cytoplasmic sequestering of transcription factor,BP,
10996,GO:0042996,1,0.959587412558264,0,6,regulation of Golgi to plasma membrane protein transport,BP,
10997,GO:0042997,1,0.974255161323705,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
10998,GO:0042998,1,0.984948710103379,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10999,GO:0042999,1,0.992384264746662,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
11000,GO:0043000,1,0.988811382090614,0,2,Golgi to plasma membrane CFTR protein transport,BP,
11001,GO:0043001,1,0.813005183864901,0,31,Golgi to plasma membrane protein transport,BP,
11002,GO:0043002,1,0.992384264746662,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
11003,GO:0043004,1,0.992384264746662,0,1,cytoplasmic sequestering of CFTR protein,BP,
11006,GO:0043008,1,0.94936033563577,0,8,ATP-dependent protein binding,MF,
11009,GO:0043011,1,0.924674769997226,0,15,myeloid dendritic cell differentiation,BP,
11010,GO:0043012,1,0.993697522556834,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11011,GO:0043014,1,0.834674910304859,0,27,alpha-tubulin binding,MF,
11012,GO:0043015,1,0.838444793812862,0,26,gamma-tubulin binding,MF,
11013,GO:0043016,1,0.9934229175149,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11014,GO:0043017,1,0.9934229175149,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11015,GO:0043020,1,0.957718307707457,0,9,NADPH oxidase complex,CC,
11017,GO:0043022,1,0.740175240811253,0,47,ribosome binding,MF,
11018,GO:0043023,1,0.937487205784973,0,11,ribosomal large subunit binding,MF,
11019,GO:0043024,1,0.918337252744882,0,14,ribosomal small subunit binding,MF,
11021,GO:0043027,1,0.869699367249471,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
11022,GO:0043028,1,0.793372355581241,0,38,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
11023,GO:0043029,1,0.803456260577397,0,37,T cell homeostasis,BP,
11024,GO:0043030,1,0.801490315388759,0,36,regulation of macrophage activation,BP,
11025,GO:0043031,1,0.959901442609264,0,8,negative regulation of macrophage activation,BP,
11026,GO:0043032,1,0.882412108667316,0,21,positive regulation of macrophage activation,BP,
11027,GO:0043033,1,0.991602832809476,0,1,isoamylase complex,CC,
11028,GO:0043034,1,0.862899512681955,0,19,costamere,CC,
11029,GO:0043035,1,0.992473498721916,0,1,chromatin insulator sequence binding,MF,
11030,GO:0043038,1,0.72973760481959,0,53,amino acid activation,BP,
11031,GO:0043039,1,0.735258901562599,0,52,tRNA aminoacylation,BP,
11032,GO:0043041,1,0.992514595947832,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11034,GO:0043044,1,0.691738212815867,0,62,ATP-dependent chromatin remodeling,BP,
11035,GO:0043045,1,0.958949094505135,0,6,DNA methylation involved in embryo development,BP,
11036,GO:0043046,1,0.892441970781468,0,17,DNA methylation involved in gamete generation,BP,
11037,GO:0043047,1,0.930865914649173,0,11,single-stranded telomeric DNA binding,MF,
11038,GO:0043048,1,0.994731220617639,0,1,dolichyl monophosphate biosynthetic process,BP,
11039,GO:0043049,1,0.99284618617602,0,1,otic placode formation,BP,
11040,GO:0043060,1,0.994008371687069,0,1,meiotic metaphase I plate congression,BP,
11042,GO:0043063,1,0.992321479893608,0,1,intercellular bridge organization,BP,
11048,GO:0043073,1,0.925130054097706,0,13,germ cell nucleus,CC,
11049,GO:0043083,1,0.936221362700921,0,9,synaptic cleft,CC,
11050,GO:0043084,1,0.951677227485227,0,7,penile erection,BP,
11054,GO:0043090,1,0.860359674585707,0,22,amino acid import,BP,
11055,GO:0043094,1,0.837545607354937,0,34,cellular metabolic compound salvage,BP,
11056,GO:0043095,1,0.997019024389068,0,1,regulation of GTP cyclohydrolase I activity,BP,
11057,GO:0043096,1,0.979073597243953,0,5,purine nucleobase salvage,BP,
11058,GO:0043097,1,0.94726156508443,0,11,pyrimidine nucleoside salvage,BP,
11059,GO:0043101,1,0.930102590002789,0,14,purine-containing compound salvage,BP,
11060,GO:0043102,1,0.962789270461725,0,7,amino acid salvage,BP,
11061,GO:0043103,1,0.986510800431071,0,3,hypoxanthine salvage,BP,
11062,GO:0043105,1,0.997019024389068,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11063,GO:0043111,1,0.988891945585691,0,2,replication fork arrest,BP,
11065,GO:0043113,1,0.713523951353271,0,49,receptor clustering,BP,
11066,GO:0043114,1,0.819550772206476,0,30,regulation of vascular permeability,BP,
11067,GO:0043116,1,0.929555679238831,0,11,negative regulation of vascular permeability,BP,
11068,GO:0043117,1,0.941505841091972,0,10,positive regulation of vascular permeability,BP,
11069,GO:0043120,1,0.97420258185793,0,5,tumor necrosis factor binding,MF,
11073,GO:0043124,1,0.76310425483718,0,39,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11074,GO:0043125,1,0.975625576022989,0,4,ErbB-3 class receptor binding,MF,
11075,GO:0043126,1,0.996317677963613,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11076,GO:0043128,1,0.996317677963613,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11077,GO:0043129,1,0.953428460043082,0,8,surfactant homeostasis,BP,
11078,GO:0043130,1,0.67113805705722,0,65,ubiquitin binding,MF,
11079,GO:0043131,1,0.992256882334399,0,1,erythrocyte enucleation,BP,
11080,GO:0043132,1,0.987357917786093,0,2,NAD transport,BP,
11081,GO:0043136,1,0.992777080918084,0,1,glycerol-3-phosphatase activity,MF,
11082,GO:0043137,1,0.98000542239128,0,4,DNA replication, removal of RNA primer,BP,
11083,GO:0043138,1,0.920099473301486,0,12,3'-5' DNA helicase activity,MF,
11084,GO:0043139,1,0.958692526285396,0,7,5'-3' DNA helicase activity,MF,
11085,GO:0043140,1,0.947639051833083,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
11086,GO:0043141,1,0.97104883731451,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11087,GO:0043142,1,0.921569067862397,0,13,single-stranded DNA-dependent ATPase activity,MF,
11088,GO:0043144,1,0.968763431973326,0,8,snoRNA processing,BP,
11089,GO:0043149,1,0.557303586354211,0,86,stress fiber assembly,BP,
11090,GO:0043152,1,0.980889463586182,0,4,induction of bacterial agglutination,BP,
11091,GO:0043153,1,0.874036080766384,0,21,entrainment of circadian clock by photoperiod,BP,
11093,GO:0043159,1,0.989041117603393,0,2,acrosomal matrix,CC,
11094,GO:0043161,1,0.0881395442843997,0,387,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
11095,GO:0043162,1,0.896507152990236,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11096,GO:0043163,1,0.986815860709298,0,2,cell envelope organization,BP,
11101,GO:0043171,1,0.847509953490157,0,25,peptide catabolic process,BP,
11102,GO:0043173,1,0.926741609120181,0,15,nucleotide salvage,BP,
11103,GO:0043174,1,0.925023606677742,0,16,nucleoside salvage,BP,
11104,GO:0043175,1,0.795877193784401,0,35,RNA polymerase core enzyme binding,MF,
11105,GO:0043176,1,0.937495358233271,0,11,amine binding,MF,
11108,GO:0043179,1,0.995005255875637,0,1,rhythmic excitation,BP,
11109,GO:0043181,1,0.992505115734521,0,1,vacuolar sequestering,BP,
11110,GO:0043183,1,0.989329622926739,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11112,GO:0043185,1,0.995049280447044,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11113,GO:0043186,1,0.910102487150763,0,14,P granule,CC,
11114,GO:0043189,1,0.901903113866411,0,18,H4/H2A histone acetyltransferase complex,CC,
11115,GO:0043190,1,0.948814903207396,0,7,ATP-binding cassette (ABC) transporter complex,CC,
11116,GO:0043194,1,0.910661661155792,0,12,axon initial segment,CC,
11117,GO:0043195,1,0.642529027645061,0,67,terminal bouton,CC,
11118,GO:0043196,1,0.963311500354523,0,7,varicosity,CC,
11120,GO:0043198,1,0.783478187769648,0,35,dendritic shaft,CC,
11121,GO:0043199,1,0.97491613890588,0,4,sulfate binding,MF,
11123,GO:0043201,1,0.912804303101324,0,12,response to leucine,BP,
11124,GO:0043202,1,0.571687671463882,0,87,lysosomal lumen,CC,
11125,GO:0043203,1,0.962063616204501,0,7,axon hillock,CC,
11130,GO:0043210,1,0.995721094910161,0,1,alkanesulfonate binding,MF,
11131,GO:0043215,1,0.992458434284543,0,1,daunorubicin transport,BP,
11134,GO:0043219,1,0.976563154820753,0,4,lateral loop,CC,
11136,GO:0043221,1,0.992466807612085,0,1,SMC family protein binding,MF,
11137,GO:0043224,1,0.99324535453644,0,2,nuclear SCF ubiquitin ligase complex,CC,
11138,GO:0043225,1,0.911781782600726,0,12,ATPase-coupled anion transmembrane transporter activity,MF,
11148,GO:0043236,1,0.838399930549608,0,26,laminin binding,MF,
11149,GO:0043237,1,0.965612195731302,0,5,laminin-1 binding,MF,
11150,GO:0043240,1,0.943764682244111,0,9,Fanconi anaemia nuclear complex,CC,
11151,GO:0043242,1,0.651431116637856,0,62,negative regulation of protein complex disassembly,BP,
11152,GO:0043243,1,0.815174760368912,0,31,positive regulation of protein complex disassembly,BP,
11153,GO:0043244,1,0.503512056740692,0,98,regulation of protein complex disassembly,BP,
11154,GO:0043247,1,0.916198341241752,0,13,telomere maintenance in response to DNA damage,BP,
11155,GO:0043248,1,0.952650029782778,0,12,proteasome assembly,BP,
11156,GO:0043249,1,0.926441347689624,0,13,erythrocyte maturation,BP,
11157,GO:0043250,1,0.99631297002839,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11158,GO:0043251,1,0.99631297002839,0,1,sodium-dependent organic anion transport,BP,
11159,GO:0043252,1,0.840880971803893,0,27,sodium-independent organic anion transport,BP,
11161,GO:0043255,1,0.624749521847526,0,67,regulation of carbohydrate biosynthetic process,BP,
11162,GO:0043256,1,0.933991451983669,0,8,laminin complex,CC,
11163,GO:0043257,1,0.992045795817864,0,1,laminin-8 complex,CC,
11164,GO:0043259,1,0.973471518210507,0,3,laminin-10 complex,CC,
11165,GO:0043260,1,0.973484072399261,0,3,laminin-11 complex,CC,
11166,GO:0043262,1,0.981689575782759,0,3,adenosine-diphosphatase activity,MF,
11167,GO:0043265,1,0.992769102624606,0,1,ectoplasm,CC,
11168,GO:0043266,1,0.571833428123991,0,83,regulation of potassium ion transport,BP,
11169,GO:0043267,1,0.843606215659872,0,25,negative regulation of potassium ion transport,BP,
11170,GO:0043268,1,0.763939888030057,0,39,positive regulation of potassium ion transport,BP,
11173,GO:0043271,1,0.466695166983441,0,119,negative regulation of ion transport,BP,
11174,GO:0043273,1,0.99218754139873,0,1,CTPase activity,MF,
11175,GO:0043274,1,0.915482402418023,0,13,phospholipase binding,MF,
11176,GO:0043276,1,0.817272683814489,0,29,anoikis,BP,
11177,GO:0043277,1,0.770269334927025,0,41,apoptotic cell clearance,BP,
11178,GO:0043278,1,0.836681820424349,0,30,response to morphine,BP,
11179,GO:0043279,1,0.536294966198962,0,96,response to alkaloid,BP,
11182,GO:0043291,1,0.980309637905403,0,2,RAVE complex,CC,
11184,GO:0043293,1,0.987511633632325,0,2,apoptosome,CC,
11185,GO:0043295,1,0.950226835213864,0,11,glutathione binding,MF,
11189,GO:0043300,1,0.781899518093555,0,41,regulation of leukocyte degranulation,BP,
11190,GO:0043301,1,0.939019673230248,0,11,negative regulation of leukocyte degranulation,BP,
11191,GO:0043302,1,0.888165343216732,0,20,positive regulation of leukocyte degranulation,BP,
11193,GO:0043304,1,0.857172003153783,0,27,regulation of mast cell degranulation,BP,
11194,GO:0043305,1,0.971080058709603,0,6,negative regulation of mast cell degranulation,BP,
11195,GO:0043306,1,0.936526798680325,0,12,positive regulation of mast cell degranulation,BP,
11196,GO:0043307,1,0.974173230792788,0,5,eosinophil activation,BP,
11197,GO:0043308,1,0.978538247292134,0,4,eosinophil degranulation,BP,
11198,GO:0043309,1,0.983604153687976,0,3,regulation of eosinophil degranulation,BP,
11199,GO:0043310,1,0.993929133044694,0,1,negative regulation of eosinophil degranulation,BP,
11200,GO:0043311,1,0.989612612133199,0,2,positive regulation of eosinophil degranulation,BP,
11201,GO:0043312,1,0.0656468241132005,0,462,neutrophil degranulation,BP,
11202,GO:0043313,1,0.944507289657002,0,8,regulation of neutrophil degranulation,BP,
11203,GO:0043314,1,0.98400806801713,0,2,negative regulation of neutrophil degranulation,BP,
11204,GO:0043315,1,0.97236685115362,0,4,positive regulation of neutrophil degranulation,BP,
11205,GO:0043316,1,0.982039616206992,0,3,cytotoxic T cell degranulation,BP,
11206,GO:0043317,1,0.98871613048949,0,2,regulation of cytotoxic T cell degranulation,BP,
11207,GO:0043318,1,0.98871613048949,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11208,GO:0043320,1,0.967724749074442,0,5,natural killer cell degranulation,BP,
11209,GO:0043321,1,0.985593493083554,0,2,regulation of natural killer cell degranulation,BP,
11210,GO:0043323,1,0.985593493083554,0,2,positive regulation of natural killer cell degranulation,BP,
11211,GO:0043324,1,0.981169549130346,0,3,pigment metabolic process involved in developmental pigmentation,BP,
11212,GO:0043325,1,0.873776781995364,0,20,phosphatidylinositol-3,4-bisphosphate binding,MF,
11213,GO:0043328,1,0.982856529070552,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11214,GO:0043330,1,0.83960391967343,0,28,response to exogenous dsRNA,BP,
11216,GO:0043335,1,0.988989889222974,0,2,protein unfolding,BP,
11217,GO:0043337,1,0.992472606649392,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11218,GO:0043353,1,0.949537983749458,0,8,enucleate erythrocyte differentiation,BP,
11219,GO:0043354,1,0.992256882334399,0,1,enucleate erythrocyte maturation,BP,
11220,GO:0043363,1,0.993301131169352,0,1,nucleate erythrocyte differentiation,BP,
11221,GO:0043366,1,0.983251901743268,0,3,beta selection,BP,
11222,GO:0043367,1,0.686839511094913,0,58,CD4-positive, alpha-beta T cell differentiation,BP,
11223,GO:0043368,1,0.84088766872672,0,28,positive T cell selection,BP,
11224,GO:0043369,1,0.895077229464225,0,18,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11225,GO:0043370,1,0.818469517945036,0,32,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11226,GO:0043371,1,0.907837242324917,0,14,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11227,GO:0043372,1,0.886045638943629,0,21,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11228,GO:0043373,1,0.919927757444444,0,14,CD4-positive, alpha-beta T cell lineage commitment,BP,
11229,GO:0043374,1,0.941952136174851,0,9,CD8-positive, alpha-beta T cell differentiation,BP,
11230,GO:0043375,1,0.992468400805186,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11231,GO:0043376,1,0.985021916271328,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11232,GO:0043378,1,0.992463045035186,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11233,GO:0043379,1,0.961570096681622,0,6,memory T cell differentiation,BP,
11234,GO:0043380,1,0.970231490867999,0,5,regulation of memory T cell differentiation,BP,
11235,GO:0043382,1,0.977540175591145,0,4,positive regulation of memory T cell differentiation,BP,
11236,GO:0043383,1,0.93690167139567,0,11,negative T cell selection,BP,
11237,GO:0043385,1,0.99337371634623,0,1,mycotoxin metabolic process,BP,
11238,GO:0043387,1,0.99337371634623,0,1,mycotoxin catabolic process,BP,
11239,GO:0043388,1,0.73177949138905,0,51,positive regulation of DNA binding,BP,
11240,GO:0043392,1,0.736432694816653,0,51,negative regulation of DNA binding,BP,
11242,GO:0043394,1,0.782326006457195,0,35,proteoglycan binding,MF,
11243,GO:0043395,1,0.874483218461402,0,19,heparan sulfate proteoglycan binding,MF,
11244,GO:0043396,1,0.985105898049928,0,2,corticotropin-releasing hormone secretion,BP,
11245,GO:0043397,1,0.985105898049928,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11246,GO:0043398,1,0.981555148359341,0,3,HLH domain binding,MF,
11247,GO:0043400,1,0.976051083014931,0,5,cortisol secretion,BP,
11248,GO:0043401,1,0.30074341104945,0,179,steroid hormone mediated signaling pathway,BP,
11249,GO:0043402,1,0.974266096212014,0,3,glucocorticoid mediated signaling pathway,BP,
11258,GO:0043413,1,0.216903802912724,0,236,macromolecule glycosylation,BP,
11259,GO:0043414,1,0.187709882655507,0,253,macromolecule methylation,BP,
11262,GO:0043418,1,0.980572169279,0,3,homocysteine catabolic process,BP,
11263,GO:0043420,1,0.996338632672028,0,1,anthranilate metabolic process,BP,
11264,GO:0043422,1,0.925380988032157,0,12,protein kinase B binding,MF,
11265,GO:0043423,1,0.992423186758525,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11266,GO:0043425,1,0.850725210721777,0,24,bHLH transcription factor binding,MF,
11267,GO:0043426,1,0.964548871473641,0,5,MRF binding,MF,
11268,GO:0043433,1,0.384060281364047,0,150,negative regulation of DNA binding transcription factor activity,BP,
11270,GO:0043435,1,0.968562131217699,0,5,response to corticotropin-releasing hormone,BP,
11272,GO:0043438,1,0.993113917444604,0,1,acetoacetic acid metabolic process,BP,
11273,GO:0043449,1,0.986141927909958,0,2,cellular alkene metabolic process,BP,
11274,GO:0043455,1,0.934968688266218,0,11,regulation of secondary metabolic process,BP,
11275,GO:0043456,1,0.984397138446713,0,4,regulation of pentose-phosphate shunt,BP,
11276,GO:0043457,1,0.873313892785278,0,21,regulation of cellular respiration,BP,
11277,GO:0043461,1,0.979771049389623,0,4,proton-transporting ATP synthase complex assembly,BP,
11278,GO:0043462,1,0.683227640161561,0,71,regulation of ATPase activity,BP,
11281,GO:0043471,1,0.953561566776191,0,9,regulation of cellular carbohydrate catabolic process,BP,
11283,GO:0043474,1,0.981169549130346,0,3,pigment metabolic process involved in pigmentation,BP,
11284,GO:0043476,1,0.925230308358974,0,12,pigment accumulation,BP,
11285,GO:0043482,1,0.925230308358974,0,12,cellular pigment accumulation,BP,
11286,GO:0043484,1,0.478060864681759,0,112,regulation of RNA splicing,BP,
11287,GO:0043485,1,0.942523922168563,0,10,endosome to pigment granule transport,BP,
11288,GO:0043486,1,0.806985913728953,0,40,histone exchange,BP,
11289,GO:0043487,1,0.388222989085239,0,157,regulation of RNA stability,BP,
11290,GO:0043488,1,0.410792872133722,0,149,regulation of mRNA stability,BP,
11291,GO:0043489,1,0.782199276614762,0,36,RNA stabilization,BP,
11292,GO:0043490,1,0.98522452659535,0,2,malate-aspartate shuttle,BP,
11295,GO:0043495,1,0.939082594653668,0,10,protein membrane anchor,MF,
11296,GO:0043496,1,0.878520449432301,0,21,regulation of protein homodimerization activity,BP,
11297,GO:0043497,1,0.943879292692791,0,10,regulation of protein heterodimerization activity,BP,
11298,GO:0043500,1,0.58393507449229,0,84,muscle adaptation,BP,
11299,GO:0043501,1,0.877224771469368,0,21,skeletal muscle adaptation,BP,
11300,GO:0043502,1,0.633276213473897,0,68,regulation of muscle adaptation,BP,
11301,GO:0043503,1,0.992087055124342,0,2,skeletal muscle fiber adaptation,BP,
11302,GO:0043504,1,0.9783268323782,0,3,mitochondrial DNA repair,BP,
11303,GO:0043506,1,0.587770285602117,0,77,regulation of JUN kinase activity,BP,
11304,GO:0043507,1,0.634949182679156,0,64,positive regulation of JUN kinase activity,BP,
11305,GO:0043508,1,0.922143207700377,0,13,negative regulation of JUN kinase activity,BP,
11306,GO:0043509,1,0.994807211949773,0,1,activin A complex,CC,
11307,GO:0043511,1,0.99126196237231,0,2,inhibin complex,CC,
11308,GO:0043512,1,0.99126196237231,0,2,inhibin A complex,CC,
11309,GO:0043513,1,0.996436438071026,0,1,inhibin B complex,CC,
11310,GO:0043514,1,0.996410840777958,0,1,interleukin-12 complex,CC,
11311,GO:0043515,1,0.966058619737711,0,5,kinetochore binding,MF,
11312,GO:0043516,1,0.841155450231245,0,29,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11313,GO:0043517,1,0.916016161303816,0,14,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11314,GO:0043518,1,0.922059886748214,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11315,GO:0043519,1,0.99497714214688,0,1,regulation of myosin II filament organization,BP,
11316,GO:0043522,1,0.9524921540181,0,9,leucine zipper domain binding,MF,
11319,GO:0043525,1,0.748152459053764,0,46,positive regulation of neuron apoptotic process,BP,
11320,GO:0043527,1,0.975355864611017,0,5,tRNA methyltransferase complex,CC,
11321,GO:0043531,1,0.796432599710421,0,33,ADP binding,MF,
11322,GO:0043532,1,0.991766302163454,0,1,angiostatin binding,MF,
11323,GO:0043533,1,0.963005568188459,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11325,GO:0043535,1,0.59861825102603,0,78,regulation of blood vessel endothelial cell migration,BP,
11327,GO:0043537,1,0.826368865136629,0,29,negative regulation of blood vessel endothelial cell migration,BP,
11328,GO:0043538,1,0.992872187664583,0,1,regulation of actin phosphorylation,BP,
11329,GO:0043539,1,0.825990222730053,0,32,protein serine/threonine kinase activator activity,MF,
11330,GO:0043540,1,0.995874545468219,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11331,GO:0043541,1,0.985406862179127,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11333,GO:0043543,1,0.24992871489236,0,215,protein acylation,BP,
11334,GO:0043544,1,0.992509688600802,0,1,lipoamide binding,MF,
11335,GO:0043545,1,0.959736145924035,0,7,molybdopterin cofactor metabolic process,BP,
11336,GO:0043546,1,0.958518191974275,0,6,molybdopterin cofactor binding,MF,
11338,GO:0043548,1,0.821428412598255,0,27,phosphatidylinositol 3-kinase binding,MF,
11343,GO:0043553,1,0.986549002699139,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11344,GO:0043555,1,0.891306696119124,0,18,regulation of translation in response to stress,BP,
11345,GO:0043558,1,0.91602667985456,0,14,regulation of translational initiation in response to stress,BP,
11346,GO:0043559,1,0.958474222268986,0,5,insulin binding,MF,
11347,GO:0043560,1,0.918693869524321,0,11,insulin receptor substrate binding,MF,
11348,GO:0043562,1,0.948832871168995,0,11,cellular response to nitrogen levels,BP,
11349,GO:0043564,1,0.987485179863954,0,2,Ku70:Ku80 complex,CC,
11351,GO:0043567,1,0.894311330180209,0,18,regulation of insulin-like growth factor receptor signaling pathway,BP,
11352,GO:0043568,1,0.941816848247622,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11353,GO:0043569,1,0.952000633729508,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11354,GO:0043570,1,0.963007009277454,0,5,maintenance of DNA repeat elements,BP,
11356,GO:0043576,1,0.861492354810403,0,22,regulation of respiratory gaseous exchange,BP,
11357,GO:0043578,1,0.970663963963174,0,3,nuclear matrix organization,BP,
11358,GO:0043583,1,0.277197636046739,0,194,ear development,BP,
11359,GO:0043584,1,0.895425114676054,0,16,nose development,BP,
11360,GO:0043585,1,0.976676790621758,0,3,nose morphogenesis,BP,
11362,GO:0043587,1,0.948817930809434,0,8,tongue morphogenesis,BP,
11364,GO:0043589,1,0.940857103161208,0,8,skin morphogenesis,BP,
11365,GO:0043596,1,0.775667954849809,0,41,nuclear replication fork,CC,
11366,GO:0043601,1,0.866229602030598,0,24,nuclear replisome,CC,
11367,GO:0043602,1,0.99390636774115,0,1,nitrate catabolic process,BP,
11370,GO:0043605,1,0.987168855791952,0,3,cellular amide catabolic process,BP,
11371,GO:0043606,1,0.97597452437601,0,4,formamide metabolic process,BP,
11372,GO:0043610,1,0.991018280753426,0,1,regulation of carbohydrate utilization,BP,
11373,GO:0043614,1,0.98471459140625,0,2,multi-eIF complex,CC,
11374,GO:0043615,1,0.961400219889742,0,7,astrocyte cell migration,BP,
11375,GO:0043616,1,0.787487291509672,0,34,keratinocyte proliferation,BP,
11376,GO:0043618,1,0.553826536814364,0,108,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11377,GO:0043619,1,0.932851183953276,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11378,GO:0043620,1,0.533875084055205,0,113,regulation of DNA-templated transcription in response to stress,BP,
11380,GO:0043622,1,0.970273060153153,0,4,cortical microtubule organization,BP,
11381,GO:0043624,1,0.325440946912892,0,199,cellular protein complex disassembly,BP,
11382,GO:0043625,1,0.978159766378492,0,4,delta DNA polymerase complex,CC,
11383,GO:0043626,1,0.996545719021006,0,1,PCNA complex,CC,
11384,GO:0043627,1,0.657292783372718,0,69,response to estrogen,BP,
11385,GO:0043628,1,0.860414666032602,0,28,ncRNA 3'-end processing,BP,
11386,GO:0043629,1,0.991299002523275,0,1,ncRNA polyadenylation,BP,
11387,GO:0043630,1,0.991299002523275,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
11388,GO:0043631,1,0.754490227914524,0,42,RNA polyadenylation,BP,
11389,GO:0043632,1,0.0267840871192525,0,558,modification-dependent macromolecule catabolic process,BP,
11390,GO:0043633,1,0.95849978763265,0,8,polyadenylation-dependent RNA catabolic process,BP,
11391,GO:0043634,1,0.965859861002772,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
11392,GO:0043647,1,0.655348994010925,0,62,inositol phosphate metabolic process,BP,
11393,GO:0043648,1,0.561146547727879,0,98,dicarboxylic acid metabolic process,BP,
11394,GO:0043649,1,0.902302162696734,0,18,dicarboxylic acid catabolic process,BP,
11395,GO:0043650,1,0.927201345010561,0,12,dicarboxylic acid biosynthetic process,BP,
11396,GO:0043651,1,0.911689925104873,0,15,linoleic acid metabolic process,BP,
11397,GO:0043652,1,0.939416825055519,0,11,engulfment of apoptotic cell,BP,
11398,GO:0043653,1,0.951154742980397,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11399,GO:0043654,1,0.963752720051422,0,6,recognition of apoptotic cell,BP,
11400,GO:0043656,1,0.945040856705342,0,9,intracellular region of host,CC,
11401,GO:0043657,1,0.657985362939685,0,65,host cell,CC,
11403,GO:0043679,1,0.470746644910477,0,117,axon terminus,CC,
11404,GO:0043682,1,0.983091726782038,0,2,copper-transporting ATPase activity,MF,
11405,GO:0043686,1,0.984002840169222,0,3,co-translational protein modification,BP,
11407,GO:0043691,1,0.931827658256925,0,13,reverse cholesterol transport,BP,
11408,GO:0043696,1,0.953660440446337,0,7,dedifferentiation,BP,
11409,GO:0043697,1,0.953660440446337,0,7,cell dedifferentiation,BP,
11410,GO:0043733,1,0.996804189000364,0,1,DNA-3-methylbase glycosylase activity,MF,
11411,GO:0043734,1,0.979403024759614,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11412,GO:0043739,1,0.992675510529021,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11413,GO:0043754,1,0.990153871929328,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11414,GO:0043783,1,0.994311284947471,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11415,GO:0043795,1,0.996460027391501,0,1,glyceraldehyde oxidoreductase activity,MF,
11416,GO:0043812,1,0.977088124796662,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11417,GO:0043813,1,0.961068455948563,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11418,GO:0043843,1,0.993782080934776,0,1,ADP-specific glucokinase activity,MF,
11419,GO:0043849,1,0.993048869222115,0,1,Ras palmitoyltransferase activity,MF,
11420,GO:0043855,1,0.937797615291391,0,9,cyclic nucleotide-gated ion channel activity,MF,
11421,GO:0043865,1,0.993291327786763,0,1,methionine transmembrane transporter activity,MF,
11422,GO:0043874,1,0.995225663833074,0,1,acireductone synthase activity,MF,
11423,GO:0043890,1,0.994265799201202,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11424,GO:0043891,1,0.996574502845011,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11425,GO:0043900,1,0.128447576955254,0,340,regulation of multi-organism process,BP,
11426,GO:0043901,1,0.424309333014176,0,144,negative regulation of multi-organism process,BP,
11427,GO:0043902,1,0.379552395673887,0,158,positive regulation of multi-organism process,BP,
11428,GO:0043903,1,0.296891693310088,0,202,regulation of symbiosis, encompassing mutualism through parasitism,BP,
11429,GO:0043914,1,0.992462511997229,0,1,NADPH:sulfur oxidoreductase activity,MF,
11430,GO:0043916,1,0.996804189000364,0,1,DNA-7-methylguanine glycosylase activity,MF,
11431,GO:0043921,1,0.854214003922664,0,24,modulation by host of viral transcription,BP,
11432,GO:0043922,1,0.940820332315083,0,9,negative regulation by host of viral transcription,BP,
11433,GO:0043923,1,0.893748912091338,0,17,positive regulation by host of viral transcription,BP,
11434,GO:0043924,1,0.987191294291013,0,1,suramin binding,MF,
11435,GO:0043928,1,0.845734424663878,0,32,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11437,GO:0043932,1,0.978547141553234,0,4,ossification involved in bone remodeling,BP,
11439,GO:0043946,1,0.995865028577477,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11440,GO:0043947,1,0.995865028577477,0,1,positive regulation by host of symbiont catalytic activity,BP,
11443,GO:0043951,1,0.896560747430994,0,17,negative regulation of cAMP-mediated signaling,BP,
11444,GO:0043954,1,0.791624509742264,0,35,cellular component maintenance,BP,
11445,GO:0043966,1,0.700358009100438,0,56,histone H3 acetylation,BP,
11446,GO:0043967,1,0.66851020810664,0,62,histone H4 acetylation,BP,
11447,GO:0043968,1,0.916896147636243,0,15,histone H2A acetylation,BP,
11448,GO:0043969,1,0.991014724697578,0,1,histone H2B acetylation,BP,
11449,GO:0043970,1,0.918291939062159,0,13,histone H3-K9 acetylation,BP,
11450,GO:0043972,1,0.992358302566728,0,1,histone H3-K23 acetylation,BP,
11451,GO:0043973,1,0.994716275102891,0,1,histone H3-K4 acetylation,BP,
11452,GO:0043974,1,0.977709394502849,0,3,histone H3-K27 acetylation,BP,
11453,GO:0043981,1,0.905798877421928,0,15,histone H4-K5 acetylation,BP,
11454,GO:0043982,1,0.905798877421928,0,15,histone H4-K8 acetylation,BP,
11455,GO:0043983,1,0.95802471663437,0,7,histone H4-K12 acetylation,BP,
11456,GO:0043984,1,0.882045264793969,0,18,histone H4-K16 acetylation,BP,
11457,GO:0043985,1,0.964556562611723,0,6,histone H4-R3 methylation,BP,
11458,GO:0043987,1,0.96565696453325,0,6,histone H3-S10 phosphorylation,BP,
11459,GO:0043988,1,0.982346624209966,0,3,histone H3-S28 phosphorylation,BP,
11460,GO:0043990,1,0.992816960107668,0,1,histone H2A-S1 phosphorylation,BP,
11461,GO:0043994,1,0.992358302566728,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
11462,GO:0043995,1,0.932391709898511,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
11463,GO:0043996,1,0.932391709898511,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
11464,GO:0043997,1,0.992785202661075,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11465,GO:0043998,1,0.992614678060108,0,1,H2A histone acetyltransferase activity,MF,
11466,GO:0044003,1,0.767903556003127,0,40,modification by symbiont of host morphology or physiology,BP,
11467,GO:0044004,1,0.973993419349311,0,5,disruption by symbiont of host cell,BP,
11468,GO:0044007,1,0.99187803539675,0,1,dissemination or transmission of symbiont from host,BP,
11469,GO:0044010,1,0.994263129730359,0,1,single-species biofilm formation,BP,
11470,GO:0044020,1,0.978460386035935,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11471,GO:0044026,1,0.988955657709538,0,2,DNA hypermethylation,BP,
11472,GO:0044027,1,0.996455216953041,0,1,hypermethylation of CpG island,BP,
11473,GO:0044028,1,0.985005455834623,0,2,DNA hypomethylation,BP,
11474,GO:0044029,1,0.985005455834623,0,2,hypomethylation of CpG island,BP,
11475,GO:0044030,1,0.901396639198883,0,15,regulation of DNA methylation,BP,
11476,GO:0044033,1,0.961722110168557,0,7,multi-organism metabolic process,BP,
11477,GO:0044035,1,0.996082080088302,0,1,multi-organism catabolic process,BP,
11478,GO:0044036,1,0.978787065231724,0,5,cell wall macromolecule metabolic process,BP,
11479,GO:0044038,1,0.995805808593524,0,1,cell wall macromolecule biosynthetic process,BP,
11481,GO:0044053,1,0.994147771284504,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11483,GO:0044058,1,0.833245405439206,0,32,regulation of digestive system process,BP,
11484,GO:0044060,1,0.787367525524164,0,40,regulation of endocrine process,BP,
11485,GO:0044062,1,0.889518428581918,0,19,regulation of excretion,BP,
11486,GO:0044065,1,0.907468638416002,0,15,regulation of respiratory system process,BP,
11487,GO:0044068,1,0.846918470864459,0,25,modulation by symbiont of host cellular process,BP,
11488,GO:0044070,1,0.61497519247322,0,73,regulation of anion transport,BP,
11491,GO:0044088,1,0.778677016130394,0,39,regulation of vacuole organization,BP,
11493,GO:0044090,1,0.925773582085764,0,11,positive regulation of vacuole organization,BP,
11494,GO:0044091,1,0.802001318775302,0,32,membrane biogenesis,BP,
11497,GO:0044094,1,0.979347021986383,0,3,host cell nuclear part,CC,
11498,GO:0044105,1,0.996968924963427,0,1,L-xylulose reductase (NAD+) activity,MF,
11499,GO:0044106,1,0.559354341578117,0,113,cellular amine metabolic process,BP,
11500,GO:0044107,1,0.980092184532183,0,4,cellular alcohol metabolic process,BP,
11501,GO:0044108,1,0.980092184532183,0,4,cellular alcohol biosynthetic process,BP,
11502,GO:0044110,1,0.936352758469889,0,14,growth involved in symbiotic interaction,BP,
11503,GO:0044111,1,0.987991606852381,0,2,development involved in symbiotic interaction,BP,
11504,GO:0044115,1,0.996082080088302,0,1,development of symbiont involved in interaction with host,BP,
11505,GO:0044116,1,0.936352758469889,0,14,growth of symbiont involved in interaction with host,BP,
11506,GO:0044117,1,0.93915486101799,0,13,growth of symbiont in host,BP,
11507,GO:0044126,1,0.942074470936149,0,12,regulation of growth of symbiont in host,BP,
11508,GO:0044128,1,0.99227326940829,0,1,positive regulation of growth of symbiont in host,BP,
11509,GO:0044130,1,0.949414293377143,0,11,negative regulation of growth of symbiont in host,BP,
11510,GO:0044133,1,0.997018312941827,0,1,growth of symbiont on or near host,BP,
11511,GO:0044139,1,0.997018312941827,0,1,modulation of growth of symbiont on or near host,BP,
11512,GO:0044140,1,0.997018312941827,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11513,GO:0044144,1,0.939263748639863,0,13,modulation of growth of symbiont involved in interaction with host,BP,
11514,GO:0044145,1,0.996082080088302,0,1,modulation of development of symbiont involved in interaction with host,BP,
11515,GO:0044146,1,0.94658190165091,0,12,negative regulation of growth of symbiont involved in interaction with host,BP,
11516,GO:0044147,1,0.996082080088302,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11517,GO:0044148,1,0.99227326940829,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11518,GO:0044154,1,0.94915152377597,0,8,histone H3-K14 acetylation,BP,
11519,GO:0044179,1,0.988076646067103,0,2,hemolysis in other organism,BP,
11520,GO:0044183,1,0.80059229316394,0,38,protein binding involved in protein folding,MF,
11521,GO:0044190,1,0.995851195529539,0,1,host cell mitochondrial envelope,CC,
11522,GO:0044194,1,0.974163236101182,0,5,cytolytic granule,CC,
11523,GO:0044205,1,0.980382913289575,0,3,'de novo' UMP biosynthetic process,BP,
11524,GO:0044206,1,0.977310031730133,0,5,UMP salvage,BP,
11525,GO:0044207,1,0.992444670107284,0,1,translation initiation ternary complex,CC,
11526,GO:0044208,1,0.985510420788603,0,3,'de novo' AMP biosynthetic process,BP,
11527,GO:0044209,1,0.992141750198908,0,2,AMP salvage,BP,
11528,GO:0044210,1,0.985812196581232,0,2,'de novo' CTP biosynthetic process,BP,
11529,GO:0044211,1,0.987279150145354,0,3,CTP salvage,BP,
11531,GO:0044213,1,0.927804422411504,0,12,intronic transcription regulatory region DNA binding,MF,
11532,GO:0044214,1,0.961286515528029,0,5,spanning component of plasma membrane,CC,
11533,GO:0044215,1,0.637603357379545,0,70,other organism,CC,
11534,GO:0044216,1,0.637603357379545,0,70,other organism cell,CC,
11535,GO:0044217,1,0.637603357379545,0,70,other organism part,CC,
11536,GO:0044218,1,0.968805280269619,0,5,other organism cell membrane,CC,
11537,GO:0044220,1,0.992333854695267,0,1,host cell perinuclear region of cytoplasm,CC,
11538,GO:0044221,1,0.992442474285194,0,1,host cell synapse,CC,
11540,GO:0044228,1,0.992356031822183,0,1,host cell surface,CC,
11541,GO:0044231,1,0.992442474285194,0,1,host cell presynaptic membrane,CC,
11542,GO:0044232,1,0.883306051714394,0,19,organelle membrane contact site,CC,
11543,GO:0044233,1,0.920975338611353,0,13,ER-mitochondrion membrane contact site,CC,
11548,GO:0044245,1,0.982451858554897,0,3,polysaccharide digestion,BP,
11554,GO:0044258,1,0.994215206759599,0,1,intestinal lipid catabolic process,BP,
11562,GO:0044272,1,0.350991664311586,0,167,sulfur compound biosynthetic process,BP,
11563,GO:0044273,1,0.770534907423203,0,43,sulfur compound catabolic process,BP,
11565,GO:0044278,1,0.996978367007285,0,1,cell wall disruption in other organism,BP,
11566,GO:0044279,1,0.968805280269619,0,5,other organism membrane,CC,
11570,GO:0044284,1,0.996933295158151,0,1,mitochondrial crista junction,CC,
11572,GO:0044292,1,0.936624220435805,0,10,dendrite terminus,CC,
11573,GO:0044294,1,0.956243940455684,0,6,dendritic growth cone,CC,
11574,GO:0044295,1,0.860760442806934,0,21,axonal growth cone,CC,
11576,GO:0044298,1,0.855020989352584,0,23,cell body membrane,CC,
11577,GO:0044299,1,0.991837840459756,0,1,C-fiber,CC,
11578,GO:0044300,1,0.962640580542454,0,5,cerebellar mossy fiber,CC,
11579,GO:0044301,1,0.988754381048948,0,2,climbing fiber,CC,
11580,GO:0044302,1,0.967682432934247,0,4,dentate gyrus mossy fiber,CC,
11582,GO:0044305,1,0.9666988019095,0,4,calyx of Held,CC,
11583,GO:0044306,1,0.425568236629934,0,132,neuron projection terminus,CC,
11584,GO:0044307,1,0.989361061248841,0,1,dendritic branch,CC,
11585,GO:0044308,1,0.975953771653556,0,3,axonal spine,CC,
11587,GO:0044313,1,0.975851426044745,0,3,protein K6-linked deubiquitination,BP,
11588,GO:0044314,1,0.982784397688367,0,4,protein K27-linked ubiquitination,BP,
11589,GO:0044316,1,0.986279688276406,0,2,cone cell pedicle,CC,
11590,GO:0044317,1,0.996501600474205,0,1,rod spherule,CC,
11591,GO:0044319,1,0.835612127528552,0,27,wound healing, spreading of cells,BP,
11592,GO:0044320,1,0.904554064849271,0,15,cellular response to leptin stimulus,BP,
11593,GO:0044321,1,0.881476238881807,0,19,response to leptin,BP,
11594,GO:0044322,1,0.834457613557522,0,28,endoplasmic reticulum quality control compartment,CC,
11595,GO:0044323,1,0.970152020853078,0,4,retinoic acid-responsive element binding,MF,
11596,GO:0044324,1,0.996928155524944,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11597,GO:0044325,1,0.45595980686731,0,116,ion channel binding,MF,
11598,GO:0044326,1,0.970970344296998,0,4,dendritic spine neck,CC,
11599,GO:0044327,1,0.948990889660247,0,8,dendritic spine head,CC,
11601,GO:0044332,1,0.946321789959974,0,7,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11602,GO:0044333,1,0.995564375847393,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11603,GO:0044334,1,0.985081578723951,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11604,GO:0044335,1,0.990471962965397,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11605,GO:0044336,1,0.97828625116797,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11606,GO:0044338,1,0.988775355820426,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11607,GO:0044339,1,0.973650243677613,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11608,GO:0044340,1,0.965149521785378,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11609,GO:0044341,1,0.95187948735557,0,7,sodium-dependent phosphate transport,BP,
11610,GO:0044342,1,0.903554843960043,0,16,type B pancreatic cell proliferation,BP,
11611,GO:0044343,1,0.99240612866336,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11612,GO:0044344,1,0.447387772216808,0,125,cellular response to fibroblast growth factor stimulus,BP,
11613,GO:0044345,1,0.99240612866336,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11614,GO:0044346,1,0.884609080286221,0,18,fibroblast apoptotic process,BP,
11615,GO:0044349,1,0.995905916601267,0,1,DNA excision,BP,
11616,GO:0044351,1,0.953930735737378,0,7,macropinocytosis,BP,
11617,GO:0044352,1,0.973233554316722,0,4,pinosome,CC,
11618,GO:0044354,1,0.973233554316722,0,4,macropinosome,CC,
11619,GO:0044355,1,0.996402165196368,0,1,clearance of foreign intracellular DNA,BP,
11620,GO:0044356,1,0.996402165196368,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11621,GO:0044359,1,0.958960337357074,0,8,modulation of molecular function in other organism,BP,
11622,GO:0044362,1,0.966833466299838,0,7,negative regulation of molecular function in other organism,BP,
11623,GO:0044364,1,0.856834366743494,0,37,disruption of cells of other organism,BP,
11624,GO:0044375,1,0.989735421208966,0,3,regulation of peroxisome size,BP,
11625,GO:0044378,1,0.988352367179612,0,2,non-sequence-specific DNA binding, bending,MF,
11628,GO:0044387,1,0.952586526055753,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11629,GO:0044388,1,0.977728204342061,0,5,small protein activating enzyme binding,MF,
11631,GO:0044390,1,0.761972579065732,0,39,ubiquitin-like protein conjugating enzyme binding,MF,
11632,GO:0044391,1,0.503689059524236,0,181,ribosomal subunit,CC,
11633,GO:0044393,1,0.978690126413573,0,3,microspike,CC,
11634,GO:0044396,1,0.965760887148933,0,5,actin cortical patch organization,BP,
11636,GO:0044406,1,0.932906787591299,0,11,adhesion of symbiont to host,BP,
11637,GO:0044407,1,0.994263129730359,0,1,single-species biofilm formation in or on host organism,BP,
11639,GO:0044413,1,0.972720011526572,0,4,avoidance of host defenses,BP,
11640,GO:0044414,1,0.992241678186921,0,1,suppression of host defenses,BP,
11641,GO:0044415,1,0.972720011526572,0,4,evasion or tolerance of host defenses,BP,
11642,GO:0044416,1,0.994725786414989,0,1,induction by symbiont of host defense response,BP,
11643,GO:0044417,1,0.951651493463513,0,9,translocation of molecules into host,BP,
11668,GO:0044450,1,0.333057385309226,0,160,microtubule organizing center part,CC,
11670,GO:0044452,1,0.358095194727859,0,170,nucleolar part,CC,
11671,GO:0044453,1,0.907893577432966,0,15,nuclear membrane part,CC,
11672,GO:0044454,1,0.045269619709522,0,481,nuclear chromosome part,CC,
11675,GO:0044458,1,0.888670879093167,0,20,motile cilium assembly,BP,
11679,GO:0044467,1,0.987013944430764,0,2,glial cell-derived neurotrophic factor secretion,BP,
11680,GO:0044495,1,0.996976979760557,0,1,modulation of blood pressure in other organism,BP,
11681,GO:0044497,1,0.996976979760557,0,1,positive regulation of blood pressure in other organism,BP,
11682,GO:0044501,1,0.984950770472193,0,2,modulation of signal transduction in other organism,BP,
11683,GO:0044508,1,0.992780109687875,0,1,glucagon-like peptide 1 receptor activity,MF,
11684,GO:0044524,1,0.995869264340929,0,1,protein sulfhydration,BP,
11685,GO:0044528,1,0.975247576092743,0,4,regulation of mitochondrial mRNA stability,BP,
11686,GO:0044530,1,0.979251720971507,0,3,supraspliceosomal complex,CC,
11687,GO:0044531,1,0.965971179225275,0,6,modulation of programmed cell death in other organism,BP,
11688,GO:0044532,1,0.965971179225275,0,6,modulation of apoptotic process in other organism,BP,
11689,GO:0044533,1,0.985748597638974,0,3,positive regulation of apoptotic process in other organism,BP,
11690,GO:0044537,1,0.99578603907695,0,1,regulation of circulating fibrinogen levels,BP,
11691,GO:0044539,1,0.958230741736022,0,7,long-chain fatty acid import,BP,
11692,GO:0044540,1,0.995869264340929,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11693,GO:0044545,1,0.969209759186709,0,5,NSL complex,CC,
11694,GO:0044546,1,0.919515420092753,0,12,NLRP3 inflammasome complex assembly,BP,
11695,GO:0044547,1,0.966843743597512,0,5,DNA topoisomerase binding,MF,
11696,GO:0044548,1,0.921325475098801,0,14,S100 protein binding,MF,
11697,GO:0044549,1,0.997019024389068,0,1,GTP cyclohydrolase binding,MF,
11698,GO:0044550,1,0.867649424906179,0,22,secondary metabolite biosynthetic process,BP,
11699,GO:0044557,1,0.95961706813696,0,7,relaxation of smooth muscle,BP,
11700,GO:0044558,1,0.992293648364596,0,1,uterine smooth muscle relaxation,BP,
11701,GO:0044565,1,0.98935742771792,0,2,dendritic cell proliferation,BP,
11702,GO:0044571,1,0.984703923384966,0,4,[2Fe-2S] cluster assembly,BP,
11703,GO:0044594,1,0.993475658848043,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11704,GO:0044595,1,0.996630186162235,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11705,GO:0044596,1,0.996630186162235,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11706,GO:0044597,1,0.968307694530493,0,8,daunorubicin metabolic process,BP,
11707,GO:0044598,1,0.968307694530493,0,8,doxorubicin metabolic process,BP,
11708,GO:0044599,1,0.993301131169352,0,1,AP-5 adaptor complex,CC,
11709,GO:0044601,1,0.996060482200124,0,1,protein denucleotidylation,BP,
11710,GO:0044602,1,0.996060482200124,0,1,protein deadenylylation,BP,
11711,GO:0044603,1,0.996060482200124,0,1,protein adenylylhydrolase activity,MF,
11712,GO:0044609,1,0.988236778818523,0,2,DBIRD complex,CC,
11713,GO:0044610,1,0.994551789174507,0,1,FMN transmembrane transporter activity,MF,
11714,GO:0044611,1,0.976615513843167,0,3,nuclear pore inner ring,CC,
11715,GO:0044613,1,0.937068832501441,0,11,nuclear pore central transport channel,CC,
11716,GO:0044614,1,0.9684662119449,0,4,nuclear pore cytoplasmic filaments,CC,
11717,GO:0044615,1,0.939509949962817,0,8,nuclear pore nuclear basket,CC,
11718,GO:0044620,1,0.994083656276557,0,2,ACP phosphopantetheine attachment site binding,MF,
11719,GO:0044648,1,0.993301131169352,0,1,histone H3-K4 dimethylation,BP,
11720,GO:0044650,1,0.944444263961307,0,9,adhesion of symbiont to host cell,BP,
11721,GO:0044651,1,0.996609787493915,0,1,adhesion of symbiont to host epithelial cell,BP,
11722,GO:0044657,1,0.994160037817392,0,2,pore formation in membrane of other organism during symbiotic interaction,BP,
11723,GO:0044665,1,0.833278556516865,0,28,MLL1/2 complex,CC,
11724,GO:0044666,1,0.933187590914821,0,10,MLL3/4 complex,CC,
11725,GO:0044691,1,0.975333101182529,0,3,tooth eruption,BP,
11728,GO:0044713,1,0.997018312941827,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11729,GO:0044714,1,0.997018312941827,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11730,GO:0044715,1,0.996692083228201,0,1,8-oxo-dGDP phosphatase activity,MF,
11731,GO:0044721,1,0.995444563568732,0,1,protein import into peroxisome matrix, substrate release,BP,
11732,GO:0044722,1,0.992466034638323,0,1,renal phosphate excretion,BP,
11733,GO:0044725,1,0.990079556284606,0,1,chromatin reprogramming in the zygote,BP,
11734,GO:0044727,1,0.990079556284606,0,1,DNA demethylation of male pronucleus,BP,
11735,GO:0044728,1,0.609168287405347,0,74,DNA methylation or demethylation,BP,
11736,GO:0044729,1,0.985754786646405,0,2,hemi-methylated DNA-binding,MF,
11737,GO:0044730,1,0.996082080088302,0,1,bone sialoprotein binding,MF,
11738,GO:0044732,1,0.993301131169352,0,1,mitotic spindle pole body,CC,
11739,GO:0044736,1,0.980036334309751,0,3,acid-sensing ion channel activity,MF,
11741,GO:0044752,1,0.979838376199555,0,3,response to human chorionic gonadotropin,BP,
11742,GO:0044753,1,0.983957130310007,0,2,amphisome,CC,
11743,GO:0044754,1,0.954428073844683,0,8,autolysosome,CC,
11744,GO:0044764,1,0.808475356142526,0,33,multi-organism cellular process,BP,
11745,GO:0044766,1,0.649921585452817,0,69,multi-organism transport,BP,
11746,GO:0044769,1,0.896591701451884,0,20,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11748,GO:0044771,1,0.985886044527364,0,2,meiotic cell cycle phase transition,BP,
11750,GO:0044773,1,0.534638689646513,0,100,mitotic DNA damage checkpoint,BP,
11751,GO:0044774,1,0.514117654432061,0,106,mitotic DNA integrity checkpoint,BP,
11752,GO:0044778,1,0.988772153350078,0,2,meiotic DNA integrity checkpoint,BP,
11753,GO:0044779,1,0.99289122331296,0,1,meiotic spindle checkpoint,BP,
11755,GO:0044783,1,0.647657544913374,0,70,G1 DNA damage checkpoint,BP,
11756,GO:0044784,1,0.720167998513936,0,51,metaphase/anaphase transition of cell cycle,BP,
11757,GO:0044785,1,0.99289122331296,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11758,GO:0044786,1,0.704293359045224,0,57,cell cycle DNA replication,BP,
11759,GO:0044788,1,0.879447120930355,0,20,modulation by host of viral process,BP,
11760,GO:0044789,1,0.962582323145709,0,5,modulation by host of viral release from host cell,BP,
11761,GO:0044791,1,0.962582323145709,0,5,positive regulation by host of viral release from host cell,BP,
11762,GO:0044793,1,0.962091885228182,0,6,negative regulation by host of viral process,BP,
11763,GO:0044794,1,0.919849425567519,0,13,positive regulation by host of viral process,BP,
11764,GO:0044795,1,0.996742772781831,0,1,trans-Golgi network to recycling endosome transport,BP,
11765,GO:0044796,1,0.996545719021006,0,1,DNA polymerase processivity factor complex,CC,
11766,GO:0044798,1,0.32514342326979,0,176,nuclear transcription factor complex,CC,
11767,GO:0044800,1,0.964780947102673,0,6,multi-organism membrane fusion,BP,
11768,GO:0044803,1,0.957366180197032,0,7,multi-organism membrane organization,BP,
11769,GO:0044804,1,0.885044876672953,0,19,autophagy of nucleus,BP,
11770,GO:0044805,1,0.977338100251238,0,3,late nucleophagy,BP,
11771,GO:0044806,1,0.948887480899513,0,7,G-quadruplex DNA unwinding,BP,
11772,GO:0044815,1,0.774450638683556,0,54,DNA packaging complex,CC,
11773,GO:0044818,1,0.840234334214385,0,26,mitotic G2/M transition checkpoint,BP,
11774,GO:0044819,1,0.652528512586771,0,69,mitotic G1/S transition checkpoint,BP,
11775,GO:0044821,1,0.967222582222153,0,5,meiotic telomere tethering at nuclear periphery,BP,
11776,GO:0044827,1,0.921609456470938,0,12,modulation by host of viral genome replication,BP,
11777,GO:0044828,1,0.972091593285272,0,4,negative regulation by host of viral genome replication,BP,
11778,GO:0044829,1,0.954011017904585,0,7,positive regulation by host of viral genome replication,BP,
11779,GO:0044830,1,0.985541721621177,0,2,modulation by host of viral RNA genome replication,BP,
11783,GO:0044848,1,0.941831445582398,0,9,biological phase,BP,
11784,GO:0044849,1,0.922892640701418,0,14,estrous cycle,BP,
11785,GO:0044851,1,0.941831445582398,0,9,hair cycle phase,BP,
11787,GO:0044854,1,0.977055232353994,0,4,plasma membrane raft assembly,BP,
11788,GO:0044855,1,0.993380955444874,0,1,plasma membrane raft distribution,BP,
11789,GO:0044856,1,0.993380955444874,0,1,plasma membrane raft localization,BP,
11790,GO:0044857,1,0.977055232353994,0,4,plasma membrane raft organization,BP,
11791,GO:0044858,1,0.993380955444874,0,1,plasma membrane raft polarization,BP,
11792,GO:0044860,1,0.974966019992014,0,4,protein localization to plasma membrane raft,BP,
11793,GO:0044861,1,0.987652598114016,0,2,protein transport into plasma membrane raft,BP,
11794,GO:0044866,1,0.99542713020967,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11795,GO:0044867,1,0.99542713020967,0,1,modulation by host of viral catalytic activity,BP,
11796,GO:0044868,1,0.987323607972939,0,2,modulation by host of viral molecular function,BP,
11797,GO:0044869,1,0.99542713020967,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11798,GO:0044870,1,0.99542713020967,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11799,GO:0044871,1,0.99542713020967,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11802,GO:0044878,1,0.981727109945323,0,4,mitotic cytokinesis checkpoint,BP,
11803,GO:0045002,1,0.961558240479858,0,6,double-strand break repair via single-strand annealing,BP,
11804,GO:0045003,1,0.940881250386197,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11805,GO:0045004,1,0.983972651943551,0,2,DNA replication proofreading,BP,
11806,GO:0045005,1,0.803916208866538,0,33,DNA-dependent DNA replication maintenance of fidelity,BP,
11807,GO:0045006,1,0.94670122705974,0,12,DNA deamination,BP,
11808,GO:0045007,1,0.987978149515445,0,3,depurination,BP,
11809,GO:0045008,1,0.961397350792742,0,8,depyrimidination,BP,
11810,GO:0045009,1,0.945124331499063,0,11,chitosome,CC,
11811,GO:0045010,1,0.754464630908091,0,45,actin nucleation,BP,
11812,GO:0045016,1,0.99260871805565,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11814,GO:0045019,1,0.931230344209032,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11815,GO:0045022,1,0.780024081334181,0,37,early endosome to late endosome transport,BP,
11816,GO:0045023,1,0.751150046911227,0,42,G0 to G1 transition,BP,
11817,GO:0045025,1,0.986397853053107,0,2,mitochondrial degradosome,CC,
11818,GO:0045026,1,0.856909135829877,0,28,plasma membrane fusion,BP,
11819,GO:0045027,1,0.994995892693117,0,1,DNA end binding,MF,
11820,GO:0045028,1,0.935206137259947,0,13,G-protein coupled purinergic nucleotide receptor activity,MF,
11821,GO:0045029,1,0.989593909979245,0,2,UDP-activated nucleotide receptor activity,MF,
11822,GO:0045030,1,0.996086735528508,0,1,UTP-activated nucleotide receptor activity,MF,
11823,GO:0045031,1,0.988178892454458,0,2,ATP-activated adenosine receptor activity,MF,
11824,GO:0045032,1,0.992809364092676,0,1,ADP-activated adenosine receptor activity,MF,
11825,GO:0045039,1,0.975574415731846,0,6,protein import into mitochondrial inner membrane,BP,
11826,GO:0045040,1,0.971802212344364,0,6,protein import into mitochondrial outer membrane,BP,
11827,GO:0045041,1,0.990725628536373,0,2,protein import into mitochondrial intermembrane space,BP,
11828,GO:0045046,1,0.960790528006527,0,6,protein import into peroxisome membrane,BP,
11829,GO:0045047,1,0.690014790433201,0,100,protein targeting to ER,BP,
11830,GO:0045048,1,0.971049529066226,0,5,protein insertion into ER membrane,BP,
11831,GO:0045053,1,0.951469984610414,0,5,protein retention in Golgi apparatus,BP,
11832,GO:0045054,1,0.97830606741629,0,4,constitutive secretory pathway,BP,
11834,GO:0045056,1,0.903992981466518,0,15,transcytosis,BP,
11835,GO:0045058,1,0.767326881432745,0,42,T cell selection,BP,
11836,GO:0045059,1,0.951218544510577,0,9,positive thymic T cell selection,BP,
11837,GO:0045060,1,0.94401738765735,0,10,negative thymic T cell selection,BP,
11838,GO:0045061,1,0.895590952471186,0,18,thymic T cell selection,BP,
11839,GO:0045062,1,0.99594285253968,0,1,extrathymic T cell selection,BP,
11840,GO:0045063,1,0.897473926459564,0,17,T-helper 1 cell differentiation,BP,
11841,GO:0045064,1,0.921183981630282,0,14,T-helper 2 cell differentiation,BP,
11842,GO:0045065,1,0.98179467397924,0,3,cytotoxic T cell differentiation,BP,
11843,GO:0045066,1,0.84752281582316,0,26,regulatory T cell differentiation,BP,
11844,GO:0045069,1,0.604607553850071,0,81,regulation of viral genome replication,BP,
11845,GO:0045070,1,0.808257794381227,0,32,positive regulation of viral genome replication,BP,
11846,GO:0045071,1,0.748761596863581,0,49,negative regulation of viral genome replication,BP,
11847,GO:0045072,1,0.920391376474379,0,14,regulation of interferon-gamma biosynthetic process,BP,
11848,GO:0045073,1,0.947591854659516,0,11,regulation of chemokine biosynthetic process,BP,
11849,GO:0045074,1,0.980431985124638,0,3,regulation of interleukin-10 biosynthetic process,BP,
11850,GO:0045075,1,0.954594160501525,0,7,regulation of interleukin-12 biosynthetic process,BP,
11851,GO:0045076,1,0.904352451679749,0,17,regulation of interleukin-2 biosynthetic process,BP,
11852,GO:0045077,1,0.978907862598867,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
11853,GO:0045078,1,0.940235561309884,0,10,positive regulation of interferon-gamma biosynthetic process,BP,
11854,GO:0045079,1,0.989683556105286,0,3,negative regulation of chemokine biosynthetic process,BP,
11855,GO:0045080,1,0.957474044199315,0,8,positive regulation of chemokine biosynthetic process,BP,
11856,GO:0045081,1,0.992501896253982,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11857,GO:0045082,1,0.987839850868745,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
11858,GO:0045083,1,0.992450553739421,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11859,GO:0045084,1,0.969539210178895,0,5,positive regulation of interleukin-12 biosynthetic process,BP,
11860,GO:0045085,1,0.982243539996831,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
11861,GO:0045086,1,0.925045638151428,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
11865,GO:0045091,1,0.936034543218788,0,11,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11866,GO:0045092,1,0.992505361271522,0,1,interleukin-18 receptor complex,CC,
11867,GO:0045095,1,0.885696179584637,0,22,keratin filament,CC,
11868,GO:0045098,1,0.9859165440281,0,3,type III intermediate filament,CC,
11869,GO:0045103,1,0.796455082132642,0,34,intermediate filament-based process,BP,
11870,GO:0045104,1,0.802442512104394,0,33,intermediate filament cytoskeleton organization,BP,
11871,GO:0045105,1,0.99214385522978,0,1,intermediate filament polymerization or depolymerization,BP,
11872,GO:0045106,1,0.99214385522978,0,1,intermediate filament depolymerization,BP,
11873,GO:0045108,1,0.99214385522978,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11874,GO:0045109,1,0.897415045831138,0,17,intermediate filament organization,BP,
11875,GO:0045110,1,0.966706708896689,0,5,intermediate filament bundle assembly,BP,
11877,GO:0045112,1,0.969396391413331,0,5,integrin biosynthetic process,BP,
11878,GO:0045113,1,0.978076084741009,0,4,regulation of integrin biosynthetic process,BP,
11879,GO:0045116,1,0.930412533046755,0,14,protein neddylation,BP,
11880,GO:0045117,1,0.893340702765598,0,19,azole transport,BP,
11881,GO:0045120,1,0.920785576033086,0,12,pronucleus,CC,
11883,GO:0045123,1,0.742211188903033,0,48,cellular extravasation,BP,
11886,GO:0045127,1,0.99619081393184,0,1,N-acetylglucosamine kinase activity,MF,
11887,GO:0045128,1,0.992754525211575,0,1,negative regulation of reciprocal meiotic recombination,BP,
11888,GO:0045130,1,0.993419735698767,0,1,keratan sulfotransferase activity,MF,
11889,GO:0045131,1,0.992954731089057,0,1,pre-mRNA branch point binding,MF,
11890,GO:0045132,1,0.638596146875895,0,70,meiotic chromosome segregation,BP,
11891,GO:0045134,1,0.974310463644466,0,4,uridine-diphosphatase activity,MF,
11892,GO:0045136,1,0.947354348964273,0,9,development of secondary sexual characteristics,BP,
11894,GO:0045141,1,0.932054188412552,0,10,meiotic telomere clustering,BP,
11895,GO:0045142,1,0.98489624159757,0,2,triplex DNA binding,MF,
11896,GO:0045143,1,0.745945405233516,0,46,homologous chromosome segregation,BP,
11897,GO:0045144,1,0.960256534664803,0,7,meiotic sister chromatid segregation,BP,
11898,GO:0045145,1,0.986063136632001,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11899,GO:0045153,1,0.996689022328069,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11900,GO:0045155,1,0.988873699911257,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11901,GO:0045159,1,0.968550508747064,0,6,myosin II binding,MF,
11906,GO:0045167,1,0.995934711064646,0,1,asymmetric protein localization involved in cell fate determination,BP,
11907,GO:0045168,1,0.989045849842012,0,2,cell-cell signaling involved in cell fate commitment,BP,
11908,GO:0045171,1,0.712116161403961,0,54,intercellular bridge,CC,
11909,GO:0045174,1,0.993327681997086,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11913,GO:0045179,1,0.959103565745776,0,7,apical cortex,CC,
11914,GO:0045180,1,0.960015504629239,0,5,basal cortex,CC,
11915,GO:0045182,1,0.71781437135916,0,50,translation regulator activity,MF,
11916,GO:0045183,1,0.993301131169352,0,1,translation factor activity, non-nucleic acid binding,MF,
11919,GO:0045186,1,0.991498435264618,0,1,zonula adherens assembly,BP,
11920,GO:0045187,1,0.920205095959735,0,17,regulation of circadian sleep/wake cycle, sleep,BP,
11921,GO:0045188,1,0.963074841156554,0,7,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11922,GO:0045190,1,0.776966969547283,0,39,isotype switching,BP,
11923,GO:0045191,1,0.840409142441364,0,27,regulation of isotype switching,BP,
11924,GO:0045196,1,0.978917062059744,0,3,establishment or maintenance of neuroblast polarity,BP,
11925,GO:0045197,1,0.757587789402569,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11926,GO:0045198,1,0.918951955917795,0,13,establishment of epithelial cell apical/basal polarity,BP,
11927,GO:0045199,1,0.929190871703733,0,12,maintenance of epithelial cell apical/basal polarity,BP,
11928,GO:0045200,1,0.978917062059744,0,3,establishment of neuroblast polarity,BP,
11930,GO:0045204,1,0.977371105784341,0,3,MAPK export from nucleus,BP,
11931,GO:0045208,1,0.992514878697255,0,1,MAPK phosphatase export from nucleus,BP,
11932,GO:0045209,1,0.992514878697255,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11933,GO:0045210,1,0.984271355514411,0,2,FasL biosynthetic process,BP,
11935,GO:0045212,1,0.993732292113056,0,1,neurotransmitter receptor biosynthetic process,BP,
11936,GO:0045213,1,0.984197998437689,0,3,neurotransmitter receptor metabolic process,BP,
11939,GO:0045217,1,0.938188081159977,0,10,cell-cell junction maintenance,BP,
11940,GO:0045218,1,0.978386213413414,0,3,zonula adherens maintenance,BP,
11941,GO:0045219,1,0.992174518590779,0,1,regulation of FasL biosynthetic process,BP,
11942,GO:0045221,1,0.992174518590779,0,1,negative regulation of FasL biosynthetic process,BP,
11943,GO:0045222,1,0.996740904694734,0,1,CD4 biosynthetic process,BP,
11944,GO:0045223,1,0.996740904694734,0,1,regulation of CD4 biosynthetic process,BP,
11945,GO:0045225,1,0.996740904694734,0,1,negative regulation of CD4 biosynthetic process,BP,
11946,GO:0045226,1,0.98129026634516,0,3,extracellular polysaccharide biosynthetic process,BP,
11947,GO:0045229,1,0.986815860709298,0,2,external encapsulating structure organization,BP,
11948,GO:0045234,1,0.995779407853721,0,1,protein palmitoleylation,BP,
11949,GO:0045236,1,0.930748599130061,0,16,CXCR chemokine receptor binding,MF,
11950,GO:0045239,1,0.919806083022942,0,13,tricarboxylic acid cycle enzyme complex,CC,
11951,GO:0045240,1,0.929014193050749,0,11,dihydrolipoyl dehydrogenase complex,CC,
11952,GO:0045244,1,0.994305923821445,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11953,GO:0045251,1,0.994311284947471,0,1,electron transfer flavoprotein complex,CC,
11954,GO:0045252,1,0.953141675248515,0,7,oxoglutarate dehydrogenase complex,CC,
11955,GO:0045254,1,0.955054595970421,0,7,pyruvate dehydrogenase complex,CC,
11956,GO:0045257,1,0.981008682933304,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11957,GO:0045259,1,0.991230023435624,0,2,proton-transporting ATP synthase complex,CC,
11958,GO:0045263,1,0.996472287793259,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11959,GO:0045271,1,0.855776969073922,0,43,respiratory chain complex I,CC,
11960,GO:0045272,1,0.986522053715984,0,3,plasma membrane respiratory chain complex I,CC,
11961,GO:0045273,1,0.981008682933304,0,4,respiratory chain complex II,CC,
11962,GO:0045274,1,0.994196639149985,0,1,plasma membrane respiratory chain complex II,CC,
11963,GO:0045275,1,0.951118670915537,0,11,respiratory chain complex III,CC,
11964,GO:0045277,1,0.957646337459728,0,14,respiratory chain complex IV,CC,
11965,GO:0045281,1,0.981008682933304,0,4,succinate dehydrogenase complex,CC,
11966,GO:0045282,1,0.994196639149985,0,1,plasma membrane succinate dehydrogenase complex,CC,
11967,GO:0045283,1,0.981008682933304,0,4,fumarate reductase complex,CC,
11968,GO:0045292,1,0.902327922583524,0,17,mRNA cis splicing, via spliceosome,BP,
11969,GO:0045293,1,0.986303493271166,0,3,mRNA editing complex,CC,
11970,GO:0045294,1,0.920803376780424,0,11,alpha-catenin binding,MF,
11971,GO:0045295,1,0.912043732184821,0,11,gamma-catenin binding,MF,
11973,GO:0045297,1,0.994561298560891,0,1,post-mating behavior,BP,
11974,GO:0045298,1,0.966158814599831,0,5,tubulin complex,CC,
11975,GO:0045309,1,0.739298122652472,0,44,protein phosphorylated amino acid binding,MF,
11977,GO:0045322,1,0.978892170120713,0,3,unmethylated CpG binding,MF,
11978,GO:0045323,1,0.98101984252769,0,3,interleukin-1 receptor complex,CC,
11979,GO:0045324,1,0.941152999615356,0,11,late endosome to vacuole transport,BP,
11980,GO:0045329,1,0.970629938513459,0,5,carnitine biosynthetic process,BP,
11984,GO:0045335,1,0.487590009205281,0,119,phagocytic vesicle,CC,
11985,GO:0045337,1,0.976487799337066,0,4,farnesyl diphosphate biosynthetic process,BP,
11986,GO:0045338,1,0.97158182616163,0,5,farnesyl diphosphate metabolic process,BP,
11987,GO:0045340,1,0.99691333883606,0,1,mercury ion binding,MF,
11988,GO:0045341,1,0.962853419194306,0,5,MHC class I biosynthetic process,BP,
11989,GO:0045342,1,0.937812219048534,0,11,MHC class II biosynthetic process,BP,
11990,GO:0045343,1,0.962853419194306,0,5,regulation of MHC class I biosynthetic process,BP,
11991,GO:0045345,1,0.962853419194306,0,5,positive regulation of MHC class I biosynthetic process,BP,
11992,GO:0045346,1,0.944934400415787,0,10,regulation of MHC class II biosynthetic process,BP,
11993,GO:0045347,1,0.974199683345908,0,5,negative regulation of MHC class II biosynthetic process,BP,
11994,GO:0045348,1,0.966181566543366,0,6,positive regulation of MHC class II biosynthetic process,BP,
11995,GO:0045349,1,0.963096713996026,0,6,interferon-alpha biosynthetic process,BP,
11996,GO:0045350,1,0.94255922455498,0,9,interferon-beta biosynthetic process,BP,
11997,GO:0045351,1,0.934483087586052,0,11,type I interferon biosynthetic process,BP,
11998,GO:0045352,1,0.995788244913725,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11999,GO:0045353,1,0.995788244913725,0,1,interleukin-1 Type II receptor antagonist activity,MF,
12000,GO:0045354,1,0.963096713996026,0,6,regulation of interferon-alpha biosynthetic process,BP,
12001,GO:0045355,1,0.992457496557256,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
12002,GO:0045356,1,0.970418382475597,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
12003,GO:0045357,1,0.94255922455498,0,9,regulation of interferon-beta biosynthetic process,BP,
12004,GO:0045358,1,0.992481215549603,0,2,negative regulation of interferon-beta biosynthetic process,BP,
12005,GO:0045359,1,0.949703672645044,0,7,positive regulation of interferon-beta biosynthetic process,BP,
12006,GO:0045360,1,0.986720529039778,0,3,regulation of interleukin-1 biosynthetic process,BP,
12007,GO:0045362,1,0.986720529039778,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
12008,GO:0045366,1,0.99221280620546,0,1,regulation of interleukin-13 biosynthetic process,BP,
12009,GO:0045368,1,0.99221280620546,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
12010,GO:0045381,1,0.992682484055807,0,1,regulation of interleukin-18 biosynthetic process,BP,
12011,GO:0045399,1,0.992287819095937,0,1,regulation of interleukin-3 biosynthetic process,BP,
12012,GO:0045401,1,0.992287819095937,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
12013,GO:0045402,1,0.97846795663292,0,3,regulation of interleukin-4 biosynthetic process,BP,
12014,GO:0045403,1,0.992677817528563,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12015,GO:0045404,1,0.98568641145155,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12016,GO:0045408,1,0.925277597142513,0,13,regulation of interleukin-6 biosynthetic process,BP,
12017,GO:0045409,1,0.975843922744579,0,4,negative regulation of interleukin-6 biosynthetic process,BP,
12018,GO:0045410,1,0.956795290459856,0,7,positive regulation of interleukin-6 biosynthetic process,BP,
12019,GO:0045414,1,0.946794798001472,0,9,regulation of interleukin-8 biosynthetic process,BP,
12020,GO:0045415,1,0.979972353884035,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12021,GO:0045416,1,0.963174554877601,0,6,positive regulation of interleukin-8 biosynthetic process,BP,
12022,GO:0045423,1,0.985675665256371,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12023,GO:0045425,1,0.985675665256371,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12024,GO:0045428,1,0.746328187479069,0,47,regulation of nitric oxide biosynthetic process,BP,
12025,GO:0045429,1,0.801574938786702,0,35,positive regulation of nitric oxide biosynthetic process,BP,
12026,GO:0045444,1,0.286416276480467,0,193,fat cell differentiation,BP,
12029,GO:0045448,1,0.975373194542287,0,4,mitotic cell cycle, embryonic,BP,
12031,GO:0045454,1,0.710482240749479,0,63,cell redox homeostasis,BP,
12032,GO:0045471,1,0.500965054780581,0,116,response to ethanol,BP,
12033,GO:0045472,1,0.938458180302912,0,10,response to ether,BP,
12034,GO:0045475,1,0.928548745024006,0,10,locomotor rhythm,BP,
12035,GO:0045485,1,0.992412963983008,0,1,omega-6 fatty acid desaturase activity,MF,
12036,GO:0045494,1,0.806016706969479,0,31,photoreceptor cell maintenance,BP,
12037,GO:0045495,1,0.910102487150763,0,14,pole plasm,CC,
12038,GO:0045499,1,0.856078710171584,0,21,chemorepellent activity,MF,
12040,GO:0045504,1,0.913350558057745,0,14,dynein heavy chain binding,MF,
12042,GO:0045509,1,0.985432077307421,0,2,interleukin-27 receptor activity,MF,
12043,GO:0045513,1,0.996410840777958,0,1,interleukin-27 binding,MF,
12044,GO:0045519,1,0.996840493206443,0,1,interleukin-23 receptor binding,MF,
12045,GO:0045523,1,0.993614814699612,0,2,interleukin-27 receptor binding,MF,
12046,GO:0045540,1,0.761551263992046,0,41,regulation of cholesterol biosynthetic process,BP,
12047,GO:0045541,1,0.974772505711209,0,5,negative regulation of cholesterol biosynthetic process,BP,
12048,GO:0045542,1,0.964412399870351,0,5,positive regulation of cholesterol biosynthetic process,BP,
12049,GO:0045545,1,0.958374942485641,0,6,syndecan binding,MF,
12050,GO:0045550,1,0.992836597858055,0,2,geranylgeranyl reductase activity,MF,
12051,GO:0045553,1,0.992897492119062,0,1,TRAIL biosynthetic process,BP,
12052,GO:0045554,1,0.992897492119062,0,1,regulation of TRAIL biosynthetic process,BP,
12053,GO:0045556,1,0.992897492119062,0,1,positive regulation of TRAIL biosynthetic process,BP,
12054,GO:0045569,1,0.977494611105774,0,4,TRAIL binding,MF,
12055,GO:0045575,1,0.987450529762165,0,2,basophil activation,BP,
12057,GO:0045577,1,0.841868337989831,0,27,regulation of B cell differentiation,BP,
12058,GO:0045578,1,0.97297178853262,0,5,negative regulation of B cell differentiation,BP,
12059,GO:0045579,1,0.923285234507429,0,13,positive regulation of B cell differentiation,BP,
12061,GO:0045581,1,0.83675511283024,0,28,negative regulation of T cell differentiation,BP,
12063,GO:0045583,1,0.98856592294853,0,2,regulation of cytotoxic T cell differentiation,BP,
12064,GO:0045585,1,0.98856592294853,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12065,GO:0045586,1,0.96981666830986,0,4,regulation of gamma-delta T cell differentiation,BP,
12066,GO:0045588,1,0.977194031376782,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12067,GO:0045589,1,0.857978780422084,0,24,regulation of regulatory T cell differentiation,BP,
12068,GO:0045590,1,0.980643191938889,0,3,negative regulation of regulatory T cell differentiation,BP,
12069,GO:0045591,1,0.947130565051899,0,10,positive regulation of regulatory T cell differentiation,BP,
12073,GO:0045598,1,0.486064734587773,0,111,regulation of fat cell differentiation,BP,
12074,GO:0045599,1,0.752280083845104,0,43,negative regulation of fat cell differentiation,BP,
12075,GO:0045600,1,0.710167532575964,0,54,positive regulation of fat cell differentiation,BP,
12076,GO:0045601,1,0.816807249854596,0,30,regulation of endothelial cell differentiation,BP,
12077,GO:0045602,1,0.943135362915004,0,8,negative regulation of endothelial cell differentiation,BP,
12078,GO:0045603,1,0.90560439490883,0,15,positive regulation of endothelial cell differentiation,BP,
12079,GO:0045604,1,0.736861030933083,0,48,regulation of epidermal cell differentiation,BP,
12080,GO:0045605,1,0.946996246669996,0,9,negative regulation of epidermal cell differentiation,BP,
12081,GO:0045606,1,0.879728385567729,0,20,positive regulation of epidermal cell differentiation,BP,
12082,GO:0045607,1,0.957672759494333,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
12083,GO:0045608,1,0.979944087513423,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
12084,GO:0045616,1,0.812834022977704,0,31,regulation of keratinocyte differentiation,BP,
12085,GO:0045617,1,0.975847487176846,0,4,negative regulation of keratinocyte differentiation,BP,
12086,GO:0045618,1,0.910437334833857,0,14,positive regulation of keratinocyte differentiation,BP,
12088,GO:0045620,1,0.807803497966677,0,35,negative regulation of lymphocyte differentiation,BP,
12090,GO:0045622,1,0.850884070182761,0,26,regulation of T-helper cell differentiation,BP,
12091,GO:0045623,1,0.914640940806891,0,13,negative regulation of T-helper cell differentiation,BP,
12092,GO:0045624,1,0.912862010594482,0,16,positive regulation of T-helper cell differentiation,BP,
12093,GO:0045625,1,0.944629617978406,0,10,regulation of T-helper 1 cell differentiation,BP,
12094,GO:0045626,1,0.979077771376067,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12095,GO:0045627,1,0.967884607756225,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12096,GO:0045628,1,0.934821364888615,0,11,regulation of T-helper 2 cell differentiation,BP,
12097,GO:0045629,1,0.97612004569012,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12098,GO:0045630,1,0.957701407367071,0,7,positive regulation of T-helper 2 cell differentiation,BP,
12099,GO:0045631,1,0.957672759494333,0,7,regulation of mechanoreceptor differentiation,BP,
12100,GO:0045632,1,0.976599448656185,0,4,negative regulation of mechanoreceptor differentiation,BP,
12101,GO:0045634,1,0.951168869222343,0,7,regulation of melanocyte differentiation,BP,
12102,GO:0045636,1,0.959807464539183,0,5,positive regulation of melanocyte differentiation,BP,
12103,GO:0045637,1,0.275776704686962,0,201,regulation of myeloid cell differentiation,BP,
12104,GO:0045638,1,0.63546958894798,0,73,negative regulation of myeloid cell differentiation,BP,
12105,GO:0045639,1,0.624824056719832,0,74,positive regulation of myeloid cell differentiation,BP,
12106,GO:0045643,1,0.992499734709547,0,1,regulation of eosinophil differentiation,BP,
12107,GO:0045645,1,0.992499734709547,0,1,positive regulation of eosinophil differentiation,BP,
12108,GO:0045646,1,0.761798263366068,0,42,regulation of erythrocyte differentiation,BP,
12109,GO:0045647,1,0.950883099063952,0,8,negative regulation of erythrocyte differentiation,BP,
12110,GO:0045648,1,0.836845619065247,0,27,positive regulation of erythrocyte differentiation,BP,
12111,GO:0045649,1,0.895280424252519,0,19,regulation of macrophage differentiation,BP,
12112,GO:0045650,1,0.969318880273403,0,6,negative regulation of macrophage differentiation,BP,
12113,GO:0045651,1,0.92364190393079,0,13,positive regulation of macrophage differentiation,BP,
12114,GO:0045652,1,0.720812975143381,0,54,regulation of megakaryocyte differentiation,BP,
12115,GO:0045653,1,0.971355026686608,0,8,negative regulation of megakaryocyte differentiation,BP,
12116,GO:0045654,1,0.968763083751422,0,6,positive regulation of megakaryocyte differentiation,BP,
12117,GO:0045655,1,0.9001531405636,0,16,regulation of monocyte differentiation,BP,
12118,GO:0045656,1,0.958010955240812,0,6,negative regulation of monocyte differentiation,BP,
12119,GO:0045657,1,0.951174696871432,0,8,positive regulation of monocyte differentiation,BP,
12120,GO:0045658,1,0.980241062916465,0,3,regulation of neutrophil differentiation,BP,
12121,GO:0045659,1,0.98488793745799,0,2,negative regulation of neutrophil differentiation,BP,
12122,GO:0045660,1,0.995282570963835,0,1,positive regulation of neutrophil differentiation,BP,
12124,GO:0045662,1,0.879849335819128,0,23,negative regulation of myoblast differentiation,BP,
12125,GO:0045663,1,0.892831057563076,0,17,positive regulation of myoblast differentiation,BP,
12132,GO:0045670,1,0.70492142000722,0,53,regulation of osteoclast differentiation,BP,
12133,GO:0045671,1,0.844284742015487,0,24,negative regulation of osteoclast differentiation,BP,
12134,GO:0045672,1,0.898684435555202,0,17,positive regulation of osteoclast differentiation,BP,
12135,GO:0045682,1,0.650916142674229,0,68,regulation of epidermis development,BP,
12136,GO:0045683,1,0.925523527598026,0,12,negative regulation of epidermis development,BP,
12137,GO:0045684,1,0.827301615273467,0,32,positive regulation of epidermis development,BP,
12141,GO:0045703,1,0.996673490117013,0,1,ketoreductase activity,MF,
12142,GO:0045713,1,0.94440031838186,0,9,low-density lipoprotein particle receptor biosynthetic process,BP,
12143,GO:0045714,1,0.948561458639573,0,8,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12144,GO:0045715,1,0.984077126284462,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12145,GO:0045716,1,0.979214807496856,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12146,GO:0045717,1,0.920088108109448,0,13,negative regulation of fatty acid biosynthetic process,BP,
12147,GO:0045719,1,0.963548801614237,0,5,negative regulation of glycogen biosynthetic process,BP,
12148,GO:0045720,1,0.988628907337569,0,2,negative regulation of integrin biosynthetic process,BP,
12149,GO:0045721,1,0.9427655511715,0,9,negative regulation of gluconeogenesis,BP,
12150,GO:0045722,1,0.936503433109012,0,9,positive regulation of gluconeogenesis,BP,
12152,GO:0045724,1,0.883994415442135,0,18,positive regulation of cilium assembly,BP,
12153,GO:0045725,1,0.903760409884338,0,13,positive regulation of glycogen biosynthetic process,BP,
12154,GO:0045726,1,0.9851778904124,0,2,positive regulation of integrin biosynthetic process,BP,
12155,GO:0045727,1,0.505666163146282,0,112,positive regulation of translation,BP,
12156,GO:0045728,1,0.994839712531381,0,1,respiratory burst after phagocytosis,BP,
12157,GO:0045730,1,0.882722231898935,0,23,respiratory burst,BP,
12159,GO:0045736,1,0.827676834371708,0,30,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12161,GO:0045738,1,0.863267493327742,0,22,negative regulation of DNA repair,BP,
12164,GO:0045741,1,0.93488126824034,0,10,positive regulation of epidermal growth factor-activated receptor activity,BP,
12165,GO:0045742,1,0.814706212059325,0,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,
12166,GO:0045743,1,0.965383436780937,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12170,GO:0045747,1,0.745620873963494,0,44,positive regulation of Notch signaling pathway,BP,
12171,GO:0045751,1,0.992682484055807,0,1,negative regulation of Toll signaling pathway,BP,
12172,GO:0045759,1,0.965294788936,0,6,negative regulation of action potential,BP,
12173,GO:0045760,1,0.931897785981488,0,10,positive regulation of action potential,BP,
12174,GO:0045761,1,0.82902466785433,0,30,regulation of adenylate cyclase activity,BP,
12175,GO:0045762,1,0.969626860852578,0,5,positive regulation of adenylate cyclase activity,BP,
12176,GO:0045763,1,0.983350998581945,0,2,negative regulation of cellular amino acid metabolic process,BP,
12177,GO:0045764,1,0.986379674842193,0,3,positive regulation of cellular amino acid metabolic process,BP,
12180,GO:0045769,1,0.990113178612835,0,1,negative regulation of asymmetric cell division,BP,
12181,GO:0045773,1,0.758706600288343,0,37,positive regulation of axon extension,BP,
12182,GO:0045776,1,0.8045159706379,0,36,negative regulation of blood pressure,BP,
12183,GO:0045777,1,0.835286879206945,0,31,positive regulation of blood pressure,BP,
12185,GO:0045779,1,0.948660417390405,0,9,negative regulation of bone resorption,BP,
12190,GO:0045792,1,0.942315464152939,0,9,negative regulation of cell size,BP,
12191,GO:0045793,1,0.93701244638062,0,10,positive regulation of cell size,BP,
12192,GO:0045794,1,0.961701384175604,0,5,negative regulation of cell volume,BP,
12193,GO:0045795,1,0.991716742709361,0,1,positive regulation of cell volume,BP,
12194,GO:0045796,1,0.993517530070233,0,1,negative regulation of intestinal cholesterol absorption,BP,
12195,GO:0045799,1,0.979135598543843,0,3,positive regulation of chromatin assembly or disassembly,BP,
12196,GO:0045806,1,0.763928257102925,0,45,negative regulation of endocytosis,BP,
12198,GO:0045813,1,0.995741448477009,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12199,GO:0045814,1,0.575356476410729,0,90,negative regulation of gene expression, epigenetic,BP,
12200,GO:0045815,1,0.71126521151588,0,57,positive regulation of gene expression, epigenetic,BP,
12201,GO:0045819,1,0.99246198731969,0,1,positive regulation of glycogen catabolic process,BP,
12202,GO:0045820,1,0.939696899442684,0,10,negative regulation of glycolytic process,BP,
12204,GO:0045822,1,0.88587234738682,0,19,negative regulation of heart contraction,BP,
12205,GO:0045823,1,0.813602246586624,0,34,positive regulation of heart contraction,BP,
12206,GO:0045824,1,0.786030285445967,0,39,negative regulation of innate immune response,BP,
12207,GO:0045827,1,0.996673490117013,0,1,negative regulation of isoprenoid metabolic process,BP,
12208,GO:0045829,1,0.974543383691226,0,4,negative regulation of isotype switching,BP,
12209,GO:0045830,1,0.885881686672183,0,19,positive regulation of isotype switching,BP,
12212,GO:0045835,1,0.94286091967889,0,9,negative regulation of meiotic nuclear division,BP,
12213,GO:0045836,1,0.933888212366133,0,11,positive regulation of meiotic nuclear division,BP,
12214,GO:0045837,1,0.954712409644935,0,9,negative regulation of membrane potential,BP,
12215,GO:0045838,1,0.936844554809731,0,11,positive regulation of membrane potential,BP,
12216,GO:0045839,1,0.752106456972184,0,46,negative regulation of mitotic nuclear division,BP,
12217,GO:0045840,1,0.74402827066899,0,45,positive regulation of mitotic nuclear division,BP,
12218,GO:0045841,1,0.815962918270532,0,32,negative regulation of mitotic metaphase/anaphase transition,BP,
12219,GO:0045842,1,0.95087076534179,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
12222,GO:0045848,1,0.994866756232826,0,1,positive regulation of nitrogen utilization,BP,
12223,GO:0045851,1,0.767272349912068,0,48,pH reduction,BP,
12224,GO:0045852,1,0.973740100752576,0,4,pH elevation,BP,
12229,GO:0045869,1,0.949866367675044,0,9,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12230,GO:0045870,1,0.992092321760209,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12231,GO:0045872,1,0.99533634115783,0,1,positive regulation of rhodopsin gene expression,BP,
12232,GO:0045875,1,0.969744765579182,0,4,negative regulation of sister chromatid cohesion,BP,
12233,GO:0045876,1,0.948178854639712,0,8,positive regulation of sister chromatid cohesion,BP,
12234,GO:0045879,1,0.814610803417641,0,29,negative regulation of smoothened signaling pathway,BP,
12235,GO:0045880,1,0.810791300822629,0,30,positive regulation of smoothened signaling pathway,BP,
12236,GO:0045887,1,0.991553425722746,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12239,GO:0045898,1,0.922529207236859,0,14,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12240,GO:0045899,1,0.942122671966302,0,11,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12241,GO:0045900,1,0.976498886607071,0,4,negative regulation of translational elongation,BP,
12242,GO:0045901,1,0.974391582725627,0,4,positive regulation of translational elongation,BP,
12243,GO:0045903,1,0.988919836295704,0,3,positive regulation of translational fidelity,BP,
12244,GO:0045905,1,0.981307859953332,0,3,positive regulation of translational termination,BP,
12245,GO:0045906,1,0.94832098974528,0,7,negative regulation of vasoconstriction,BP,
12247,GO:0045910,1,0.850381595259642,0,23,negative regulation of DNA recombination,BP,
12248,GO:0045911,1,0.860137755250483,0,23,positive regulation of DNA recombination,BP,
12249,GO:0045912,1,0.811418025690605,0,32,negative regulation of carbohydrate metabolic process,BP,
12251,GO:0045914,1,0.979767375949859,0,3,negative regulation of catecholamine metabolic process,BP,
12252,GO:0045915,1,0.965474561322062,0,6,positive regulation of catecholamine metabolic process,BP,
12253,GO:0045916,1,0.958614137819698,0,6,negative regulation of complement activation,BP,
12254,GO:0045917,1,0.980564442657743,0,3,positive regulation of complement activation,BP,
12255,GO:0045918,1,0.986380105529239,0,3,negative regulation of cytolysis,BP,
12256,GO:0045919,1,0.966121622882613,0,7,positive regulation of cytolysis,BP,
12257,GO:0045920,1,0.843535624118084,0,27,negative regulation of exocytosis,BP,
12258,GO:0045921,1,0.6191709142357,0,76,positive regulation of exocytosis,BP,
12259,GO:0045922,1,0.884617086769845,0,19,negative regulation of fatty acid metabolic process,BP,
12261,GO:0045924,1,0.968764374899451,0,5,regulation of female receptivity,BP,
12262,GO:0045925,1,0.994134617520726,0,1,positive regulation of female receptivity,BP,
12266,GO:0045931,1,0.425637679659395,0,130,positive regulation of mitotic cell cycle,BP,
12267,GO:0045932,1,0.886759912488828,0,19,negative regulation of muscle contraction,BP,
12268,GO:0045933,1,0.767819015194498,0,44,positive regulation of muscle contraction,BP,
12273,GO:0045938,1,0.973887254905799,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12274,GO:0045939,1,0.876557078270731,0,22,negative regulation of steroid metabolic process,BP,
12275,GO:0045940,1,0.892482328229546,0,19,positive regulation of steroid metabolic process,BP,
12276,GO:0045943,1,0.866011020521896,0,21,positive regulation of transcription by RNA polymerase I,BP,
12278,GO:0045945,1,0.9235729493481,0,11,positive regulation of transcription by RNA polymerase III,BP,
12279,GO:0045947,1,0.889260650298065,0,19,negative regulation of translational initiation,BP,
12280,GO:0045948,1,0.843197934891719,0,26,positive regulation of translational initiation,BP,
12281,GO:0045950,1,0.981803866335263,0,3,negative regulation of mitotic recombination,BP,
12282,GO:0045953,1,0.947120398829501,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12284,GO:0045955,1,0.937303720295774,0,9,negative regulation of calcium ion-dependent exocytosis,BP,
12285,GO:0045956,1,0.864351017847729,0,22,positive regulation of calcium ion-dependent exocytosis,BP,
12286,GO:0045957,1,0.990796430774423,0,1,negative regulation of complement activation, alternative pathway,BP,
12287,GO:0045959,1,0.985462488528693,0,2,negative regulation of complement activation, classical pathway,BP,
12288,GO:0045963,1,0.979767375949859,0,3,negative regulation of dopamine metabolic process,BP,
12289,GO:0045964,1,0.965474561322062,0,6,positive regulation of dopamine metabolic process,BP,
12290,GO:0045967,1,0.980754306664123,0,2,negative regulation of growth rate,BP,
12291,GO:0045974,1,0.911100800916058,0,13,regulation of translation, ncRNA-mediated,BP,
12292,GO:0045976,1,0.98508611547731,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12293,GO:0045977,1,0.996390485593893,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12294,GO:0045980,1,0.750588818698036,0,47,negative regulation of nucleotide metabolic process,BP,
12296,GO:0045986,1,0.928242275669101,0,12,negative regulation of smooth muscle contraction,BP,
12297,GO:0045987,1,0.831840611665977,0,30,positive regulation of smooth muscle contraction,BP,
12298,GO:0045988,1,0.951811988971077,0,7,negative regulation of striated muscle contraction,BP,
12299,GO:0045989,1,0.92231585298908,0,14,positive regulation of striated muscle contraction,BP,
12300,GO:0045990,1,0.970536707254737,0,5,carbon catabolite regulation of transcription,BP,
12301,GO:0045991,1,0.970536707254737,0,5,carbon catabolite activation of transcription,BP,
12303,GO:0045993,1,0.992405087241669,0,1,negative regulation of translational initiation by iron,BP,
12304,GO:0045994,1,0.98821103299344,0,2,positive regulation of translational initiation by iron,BP,
12306,GO:0046005,1,0.993825708152333,0,2,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12307,GO:0046006,1,0.838404158244531,0,32,regulation of activated T cell proliferation,BP,
12308,GO:0046007,1,0.933879892200584,0,11,negative regulation of activated T cell proliferation,BP,
12309,GO:0046010,1,0.986080863380383,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12310,GO:0046013,1,0.989345278980222,0,2,regulation of T cell homeostatic proliferation,BP,
12311,GO:0046015,1,0.974750726985188,0,5,regulation of transcription by glucose,BP,
12312,GO:0046016,1,0.978654001142693,0,4,positive regulation of transcription by glucose,BP,
12313,GO:0046030,1,0.923550536603601,0,11,inositol trisphosphate phosphatase activity,MF,
12315,GO:0046032,1,0.996262397770855,0,1,ADP catabolic process,BP,
12316,GO:0046033,1,0.938244253330364,0,11,AMP metabolic process,BP,
12318,GO:0046035,1,0.996652184032161,0,1,CMP metabolic process,BP,
12319,GO:0046036,1,0.944905527295957,0,13,CTP metabolic process,BP,
12320,GO:0046037,1,0.870808943511661,0,21,GMP metabolic process,BP,
12321,GO:0046038,1,0.996440642047876,0,1,GMP catabolic process,BP,
12322,GO:0046039,1,0.845804189765395,0,30,GTP metabolic process,BP,
12323,GO:0046040,1,0.922170346389542,0,13,IMP metabolic process,BP,
12324,GO:0046041,1,0.990397729750091,0,2,ITP metabolic process,BP,
12325,GO:0046048,1,0.99302822103216,0,1,UDP metabolic process,BP,
12326,GO:0046049,1,0.945689747080996,0,10,UMP metabolic process,BP,
12327,GO:0046051,1,0.956553317644592,0,10,UTP metabolic process,BP,
12328,GO:0046054,1,0.99687648987947,0,1,dGMP metabolic process,BP,
12329,GO:0046056,1,0.985857788572164,0,2,dADP metabolic process,BP,
12330,GO:0046058,1,0.577067484311666,0,86,cAMP metabolic process,BP,
12331,GO:0046060,1,0.978169095091812,0,5,dATP metabolic process,BP,
12332,GO:0046061,1,0.986048975514868,0,3,dATP catabolic process,BP,
12333,GO:0046065,1,0.99677880066022,0,1,dCTP metabolic process,BP,
12334,GO:0046066,1,0.990198327532451,0,2,dGDP metabolic process,BP,
12335,GO:0046068,1,0.760208452944861,0,42,cGMP metabolic process,BP,
12336,GO:0046069,1,0.9591026732092,0,6,cGMP catabolic process,BP,
12337,GO:0046070,1,0.981921332614608,0,4,dGTP metabolic process,BP,
12338,GO:0046072,1,0.989732068931043,0,2,dTDP metabolic process,BP,
12339,GO:0046073,1,0.985462849402617,0,3,dTMP metabolic process,BP,
12340,GO:0046075,1,0.982564002873824,0,4,dTTP metabolic process,BP,
12341,GO:0046077,1,0.989732068931043,0,2,dUDP metabolic process,BP,
12342,GO:0046078,1,0.979404691721348,0,5,dUMP metabolic process,BP,
12343,GO:0046079,1,0.996175152280907,0,1,dUMP catabolic process,BP,
12344,GO:0046080,1,0.995578762176172,0,1,dUTP metabolic process,BP,
12345,GO:0046081,1,0.995578762176172,0,1,dUTP catabolic process,BP,
12346,GO:0046083,1,0.988929361647114,0,3,adenine metabolic process,BP,
12347,GO:0046084,1,0.988929361647114,0,3,adenine biosynthetic process,BP,
12348,GO:0046085,1,0.947980341022263,0,9,adenosine metabolic process,BP,
12349,GO:0046086,1,0.987608513621899,0,2,adenosine biosynthetic process,BP,
12350,GO:0046087,1,0.962440489092569,0,8,cytidine metabolic process,BP,
12351,GO:0046090,1,0.996256649183377,0,1,deoxyadenosine metabolic process,BP,
12352,GO:0046092,1,0.992283307581362,0,1,deoxycytidine metabolic process,BP,
12353,GO:0046098,1,0.977076829511795,0,4,guanine metabolic process,BP,
12354,GO:0046099,1,0.991896295476022,0,2,guanine biosynthetic process,BP,
12355,GO:0046100,1,0.976948168040565,0,5,hypoxanthine metabolic process,BP,
12356,GO:0046101,1,0.981424741069466,0,4,hypoxanthine biosynthetic process,BP,
12357,GO:0046102,1,0.984244454593428,0,3,inosine metabolic process,BP,
12358,GO:0046103,1,0.990035057679202,0,2,inosine biosynthetic process,BP,
12359,GO:0046104,1,0.981334963951226,0,3,thymidine metabolic process,BP,
12360,GO:0046108,1,0.989903774481056,0,2,uridine metabolic process,BP,
12361,GO:0046110,1,0.980765577474267,0,3,xanthine metabolic process,BP,
12362,GO:0046111,1,0.996256649183377,0,1,xanthine biosynthetic process,BP,
12363,GO:0046112,1,0.887395200636128,0,19,nucleobase biosynthetic process,BP,
12364,GO:0046113,1,0.959730073593136,0,6,nucleobase catabolic process,BP,
12365,GO:0046116,1,0.986509954226983,0,3,queuosine metabolic process,BP,
12366,GO:0046121,1,0.985017771054546,0,3,deoxyribonucleoside catabolic process,BP,
12367,GO:0046122,1,0.993130074321232,0,2,purine deoxyribonucleoside metabolic process,BP,
12368,GO:0046124,1,0.996256649183377,0,1,purine deoxyribonucleoside catabolic process,BP,
12369,GO:0046125,1,0.981334963951226,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12370,GO:0046127,1,0.992784179551637,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12371,GO:0046128,1,0.657724181513747,0,70,purine ribonucleoside metabolic process,BP,
12372,GO:0046129,1,0.907018789055415,0,21,purine ribonucleoside biosynthetic process,BP,
12373,GO:0046130,1,0.967878735525828,0,6,purine ribonucleoside catabolic process,BP,
12374,GO:0046131,1,0.859415643778704,0,30,pyrimidine ribonucleoside metabolic process,BP,
12375,GO:0046132,1,0.905083293213164,0,20,pyrimidine ribonucleoside biosynthetic process,BP,
12376,GO:0046133,1,0.951638670502532,0,10,pyrimidine ribonucleoside catabolic process,BP,
12377,GO:0046134,1,0.882691134638795,0,25,pyrimidine nucleoside biosynthetic process,BP,
12378,GO:0046135,1,0.903798104655508,0,20,pyrimidine nucleoside catabolic process,BP,
12379,GO:0046136,1,0.992360152950919,0,2,positive regulation of vitamin metabolic process,BP,
12380,GO:0046137,1,0.967947811473555,0,6,negative regulation of vitamin metabolic process,BP,
12381,GO:0046144,1,0.996148653594519,0,1,D-alanine family amino acid metabolic process,BP,
12382,GO:0046146,1,0.968730443725001,0,7,tetrahydrobiopterin metabolic process,BP,
12383,GO:0046148,1,0.738714233259475,0,50,pigment biosynthetic process,BP,
12384,GO:0046149,1,0.985951138975038,0,4,pigment catabolic process,BP,
12385,GO:0046160,1,0.984641342938846,0,2,heme a metabolic process,BP,
12386,GO:0046164,1,0.790587091933941,0,41,alcohol catabolic process,BP,
12387,GO:0046165,1,0.456143340131508,0,126,alcohol biosynthetic process,BP,
12388,GO:0046166,1,0.991368475683503,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12389,GO:0046167,1,0.982911631143413,0,2,glycerol-3-phosphate biosynthetic process,BP,
12391,GO:0046173,1,0.731238999020755,0,52,polyol biosynthetic process,BP,
12392,GO:0046174,1,0.890627600983579,0,17,polyol catabolic process,BP,
12393,GO:0046176,1,0.993301131169352,0,1,aldonic acid catabolic process,BP,
12394,GO:0046177,1,0.993301131169352,0,1,D-gluconate catabolic process,BP,
12395,GO:0046184,1,0.916166366134515,0,13,aldehyde biosynthetic process,BP,
12396,GO:0046185,1,0.94989455882884,0,10,aldehyde catabolic process,BP,
12397,GO:0046189,1,0.798721692578593,0,36,phenol-containing compound biosynthetic process,BP,
12398,GO:0046203,1,0.992693256990088,0,2,spermidine catabolic process,BP,
12399,GO:0046204,1,0.996893837433638,0,1,nor-spermidine metabolic process,BP,
12400,GO:0046208,1,0.982784188546811,0,4,spermine catabolic process,BP,
12401,GO:0046209,1,0.680665411360554,0,61,nitric oxide metabolic process,BP,
12402,GO:0046210,1,0.99390636774115,0,1,nitric oxide catabolic process,BP,
12403,GO:0046218,1,0.968447404784614,0,7,indolalkylamine catabolic process,BP,
12404,GO:0046219,1,0.981680724579937,0,4,indolalkylamine biosynthetic process,BP,
12405,GO:0046222,1,0.99337371634623,0,1,aflatoxin metabolic process,BP,
12406,GO:0046223,1,0.99337371634623,0,1,aflatoxin catabolic process,BP,
12407,GO:0046226,1,0.992541833568182,0,2,coumarin catabolic process,BP,
12408,GO:0046247,1,0.993147797100392,0,1,terpene catabolic process,BP,
12409,GO:0046271,1,0.992541833568182,0,2,phenylpropanoid catabolic process,BP,
12410,GO:0046272,1,0.994706762123157,0,1,stilbene catabolic process,BP,
12411,GO:0046292,1,0.982724900138845,0,3,formaldehyde metabolic process,BP,
12412,GO:0046293,1,0.992347933347364,0,1,formaldehyde biosynthetic process,BP,
12413,GO:0046294,1,0.99030353524436,0,2,formaldehyde catabolic process,BP,
12414,GO:0046295,1,0.99691333883606,0,1,glycolate biosynthetic process,BP,
12415,GO:0046296,1,0.995859720278206,0,1,glycolate catabolic process,BP,
12416,GO:0046305,1,0.989597219866688,0,2,alkanesulfonate biosynthetic process,BP,
12417,GO:0046316,1,0.993301131169352,0,1,gluconokinase activity,MF,
12418,GO:0046317,1,0.992268375099963,0,1,regulation of glucosylceramide biosynthetic process,BP,
12419,GO:0046318,1,0.992268375099963,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12420,GO:0046320,1,0.825858220618363,0,28,regulation of fatty acid oxidation,BP,
12421,GO:0046321,1,0.901093755777459,0,15,positive regulation of fatty acid oxidation,BP,
12422,GO:0046322,1,0.950438103232386,0,8,negative regulation of fatty acid oxidation,BP,
12425,GO:0046325,1,0.930122606711749,0,12,negative regulation of glucose import,BP,
12426,GO:0046326,1,0.776759069176335,0,36,positive regulation of glucose import,BP,
12427,GO:0046327,1,0.98886621968352,0,2,glycerol biosynthetic process from pyruvate,BP,
12429,GO:0046329,1,0.818808935282448,0,30,negative regulation of JNK cascade,BP,
12431,GO:0046331,1,0.989045849842012,0,2,lateral inhibition,BP,
12432,GO:0046332,1,0.585286872741447,0,74,SMAD binding,MF,
12433,GO:0046333,1,0.986236723096999,0,2,octopamine metabolic process,BP,
12434,GO:0046337,1,0.887599189490729,0,18,phosphatidylethanolamine metabolic process,BP,
12435,GO:0046338,1,0.985982126571482,0,2,phosphatidylethanolamine catabolic process,BP,
12436,GO:0046339,1,0.920824584194363,0,12,diacylglycerol metabolic process,BP,
12437,GO:0046340,1,0.978114819153335,0,3,diacylglycerol catabolic process,BP,
12438,GO:0046341,1,0.921631796907602,0,12,CDP-diacylglycerol metabolic process,BP,
12439,GO:0046348,1,0.935786135636929,0,13,amino sugar catabolic process,BP,
12440,GO:0046349,1,0.924237778523282,0,13,amino sugar biosynthetic process,BP,
12441,GO:0046351,1,0.978365622010603,0,4,disaccharide biosynthetic process,BP,
12442,GO:0046355,1,0.992623937227321,0,1,mannan catabolic process,BP,
12443,GO:0046356,1,0.991771415904077,0,2,acetyl-CoA catabolic process,BP,
12444,GO:0046359,1,0.995461921104387,0,1,butyrate catabolic process,BP,
12445,GO:0046360,1,0.994958360817384,0,1,2-oxobutyrate biosynthetic process,BP,
12446,GO:0046361,1,0.994958360817384,0,1,2-oxobutyrate metabolic process,BP,
12448,GO:0046365,1,0.723977343326353,0,56,monosaccharide catabolic process,BP,
12449,GO:0046368,1,0.977804551900323,0,4,GDP-L-fucose metabolic process,BP,
12450,GO:0046370,1,0.990337743761919,0,2,fructose biosynthetic process,BP,
12451,GO:0046373,1,0.986646673054992,0,2,L-arabinose metabolic process,BP,
12452,GO:0046379,1,0.98129026634516,0,3,extracellular polysaccharide metabolic process,BP,
12453,GO:0046380,1,0.992473391987395,0,1,N-acetylneuraminate biosynthetic process,BP,
12454,GO:0046381,1,0.996658647993507,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12455,GO:0046385,1,0.949068353290593,0,11,deoxyribose phosphate biosynthetic process,BP,
12456,GO:0046386,1,0.911808446648077,0,19,deoxyribose phosphate catabolic process,BP,
12458,GO:0046391,1,0.98202398126728,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
12461,GO:0046398,1,0.972203468901579,0,4,UDP-glucuronate metabolic process,BP,
12462,GO:0046403,1,0.995905916601267,0,1,polynucleotide 3'-phosphatase activity,MF,
12463,GO:0046404,1,0.98358997765909,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12464,GO:0046415,1,0.953908571926027,0,8,urate metabolic process,BP,
12465,GO:0046416,1,0.98630575953559,0,3,D-amino acid metabolic process,BP,
12467,GO:0046426,1,0.74588624748258,0,45,negative regulation of JAK-STAT cascade,BP,
12470,GO:0046436,1,0.996148653594519,0,1,D-alanine metabolic process,BP,
12471,GO:0046437,1,0.993980113814259,0,1,D-amino acid biosynthetic process,BP,
12472,GO:0046439,1,0.958549963055198,0,7,L-cysteine metabolic process,BP,
12473,GO:0046440,1,0.974258552709048,0,4,L-lysine metabolic process,BP,
12474,GO:0046443,1,0.995332519286809,0,1,FAD metabolic process,BP,
12475,GO:0046444,1,0.993443196935179,0,1,FMN metabolic process,BP,
12476,GO:0046448,1,0.99407312798456,0,1,tropane alkaloid metabolic process,BP,
12477,GO:0046449,1,0.969576964165919,0,4,creatinine metabolic process,BP,
12478,GO:0046452,1,0.984359178540783,0,3,dihydrofolate metabolic process,BP,
12479,GO:0046456,1,0.818765920458005,0,38,icosanoid biosynthetic process,BP,
12480,GO:0046457,1,0.893556094845033,0,22,prostanoid biosynthetic process,BP,
12481,GO:0046459,1,0.913143286751636,0,16,short-chain fatty acid metabolic process,BP,
12482,GO:0046460,1,0.821598538675289,0,30,neutral lipid biosynthetic process,BP,
12483,GO:0046461,1,0.833294437051335,0,32,neutral lipid catabolic process,BP,
12484,GO:0046462,1,0.989117297417135,0,2,monoacylglycerol metabolic process,BP,
12485,GO:0046463,1,0.821598538675289,0,30,acylglycerol biosynthetic process,BP,
12486,GO:0046464,1,0.833294437051335,0,32,acylglycerol catabolic process,BP,
12487,GO:0046465,1,0.959551932080771,0,7,dolichyl diphosphate metabolic process,BP,
12488,GO:0046466,1,0.866294660276271,0,25,membrane lipid catabolic process,BP,
12490,GO:0046469,1,0.96532218261211,0,6,platelet activating factor metabolic process,BP,
12492,GO:0046471,1,0.840910744104474,0,27,phosphatidylglycerol metabolic process,BP,
12497,GO:0046477,1,0.958658084463462,0,7,glycosylceramide catabolic process,BP,
12498,GO:0046478,1,0.992338946920648,0,1,lactosylceramide metabolic process,BP,
12499,GO:0046479,1,0.930943609884769,0,12,glycosphingolipid catabolic process,BP,
12501,GO:0046485,1,0.949445864898477,0,9,ether lipid metabolic process,BP,
12503,GO:0046487,1,0.963654646204449,0,7,glyoxylate metabolic process,BP,
12505,GO:0046490,1,0.982433004222649,0,4,isopentenyl diphosphate metabolic process,BP,
12506,GO:0046491,1,0.99695022923682,0,1,L-methylmalonyl-CoA metabolic process,BP,
12507,GO:0046493,1,0.994083656276557,0,2,lipid A metabolic process,BP,
12508,GO:0046495,1,0.994151722015676,0,1,nicotinamide riboside metabolic process,BP,
12510,GO:0046497,1,0.993301131169352,0,1,nicotinate nucleotide metabolic process,BP,
12511,GO:0046498,1,0.966070728885379,0,6,S-adenosylhomocysteine metabolic process,BP,
12512,GO:0046499,1,0.992663131368205,0,1,S-adenosylmethioninamine metabolic process,BP,
12513,GO:0046500,1,0.932294725836939,0,12,S-adenosylmethionine metabolic process,BP,
12514,GO:0046501,1,0.946236728234014,0,10,protoporphyrinogen IX metabolic process,BP,
12515,GO:0046502,1,0.991350270962457,0,2,uroporphyrinogen III metabolic process,BP,
12517,GO:0046504,1,0.970315755154716,0,5,glycerol ether biosynthetic process,BP,
12518,GO:0046511,1,0.987192734013102,0,2,sphinganine biosynthetic process,BP,
12519,GO:0046512,1,0.947995738911422,0,9,sphingosine biosynthetic process,BP,
12521,GO:0046514,1,0.92284611616981,0,14,ceramide catabolic process,BP,
12522,GO:0046519,1,0.920338321823487,0,14,sphingoid metabolic process,BP,
12523,GO:0046520,1,0.94085142044331,0,10,sphingoid biosynthetic process,BP,
12524,GO:0046521,1,0.995597841356715,0,1,sphingoid catabolic process,BP,
12525,GO:0046523,1,0.992804541133618,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12526,GO:0046525,1,0.995907988839144,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12527,GO:0046526,1,0.993856193451521,0,1,D-xylulose reductase activity,MF,
12528,GO:0046527,1,0.899348991179717,0,16,glucosyltransferase activity,MF,
12529,GO:0046530,1,0.698864653037591,0,52,photoreceptor cell differentiation,BP,
12530,GO:0046532,1,0.961275101074088,0,6,regulation of photoreceptor cell differentiation,BP,
12531,GO:0046533,1,0.961275101074088,0,6,negative regulation of photoreceptor cell differentiation,BP,
12532,GO:0046538,1,0.984397138446713,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12533,GO:0046539,1,0.996930452377055,0,1,histamine N-methyltransferase activity,MF,
12534,GO:0046540,1,0.883674531238847,0,23,U4/U6 x U5 tri-snRNP complex,CC,
12535,GO:0046541,1,0.946938717210687,0,10,saliva secretion,BP,
12536,GO:0046543,1,0.957467113420037,0,7,development of secondary female sexual characteristics,BP,
12537,GO:0046544,1,0.99226940896956,0,1,development of secondary male sexual characteristics,BP,
12540,GO:0046548,1,0.952304709986503,0,7,retinal rod cell development,BP,
12541,GO:0046549,1,0.949770903327081,0,8,retinal cone cell development,BP,
12542,GO:0046554,1,0.996582881323823,0,1,malate dehydrogenase (NADP+) activity,MF,
12543,GO:0046556,1,0.986646673054992,0,2,alpha-L-arabinofuranosidase activity,MF,
12544,GO:0046570,1,0.996636858816454,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12545,GO:0046573,1,0.988677855338752,0,3,lactonohydrolase activity,MF,
12546,GO:0046577,1,0.992476391447755,0,1,long-chain-alcohol oxidase activity,MF,
12549,GO:0046580,1,0.720992722997641,0,46,negative regulation of Ras protein signal transduction,BP,
12550,GO:0046581,1,0.957045903973958,0,6,intercellular canaliculus,CC,
12551,GO:0046586,1,0.989869454182597,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12552,GO:0046587,1,0.99291862897504,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12553,GO:0046588,1,0.996929306471584,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12554,GO:0046592,1,0.991055953142148,0,2,polyamine oxidase activity,MF,
12555,GO:0046596,1,0.863084571403997,0,26,regulation of viral entry into host cell,BP,
12556,GO:0046597,1,0.914114693783516,0,16,negative regulation of viral entry into host cell,BP,
12557,GO:0046598,1,0.951496561175794,0,9,positive regulation of viral entry into host cell,BP,
12558,GO:0046599,1,0.888539982573663,0,17,regulation of centriole replication,BP,
12559,GO:0046600,1,0.945231891543642,0,8,negative regulation of centriole replication,BP,
12560,GO:0046601,1,0.977849660323436,0,3,positive regulation of centriole replication,BP,
12561,GO:0046602,1,0.936743526488143,0,10,regulation of mitotic centrosome separation,BP,
12562,GO:0046603,1,0.996414434403517,0,1,negative regulation of mitotic centrosome separation,BP,
12563,GO:0046604,1,0.973220523607945,0,4,positive regulation of mitotic centrosome separation,BP,
12564,GO:0046605,1,0.694151413883784,0,54,regulation of centrosome cycle,BP,
12565,GO:0046606,1,0.916544893473853,0,14,negative regulation of centrosome cycle,BP,
12566,GO:0046607,1,0.931761326811219,0,10,positive regulation of centrosome cycle,BP,
12567,GO:0046618,1,0.968592369540858,0,5,drug export,BP,
12568,GO:0046619,1,0.98462716554054,0,2,optic placode formation involved in camera-type eye formation,BP,
12572,GO:0046623,1,0.991874756835951,0,1,sphingolipid-translocating ATPase activity,MF,
12573,GO:0046624,1,0.946321906579287,0,9,sphingolipid transporter activity,MF,
12575,GO:0046626,1,0.731092521407603,0,48,regulation of insulin receptor signaling pathway,BP,
12576,GO:0046627,1,0.822042824269759,0,31,negative regulation of insulin receptor signaling pathway,BP,
12577,GO:0046628,1,0.923314329034616,0,11,positive regulation of insulin receptor signaling pathway,BP,
12578,GO:0046629,1,0.930276807242242,0,11,gamma-delta T cell activation,BP,
12579,GO:0046631,1,0.513875681502241,0,106,alpha-beta T cell activation,BP,
12580,GO:0046632,1,0.58562872219101,0,83,alpha-beta T cell differentiation,BP,
12581,GO:0046633,1,0.874471569525476,0,23,alpha-beta T cell proliferation,BP,
12582,GO:0046634,1,0.665975627236018,0,67,regulation of alpha-beta T cell activation,BP,
12583,GO:0046635,1,0.769866430935293,0,45,positive regulation of alpha-beta T cell activation,BP,
12584,GO:0046636,1,0.852718707888174,0,25,negative regulation of alpha-beta T cell activation,BP,
12585,GO:0046637,1,0.746923817055273,0,47,regulation of alpha-beta T cell differentiation,BP,
12586,GO:0046638,1,0.818164610125364,0,34,positive regulation of alpha-beta T cell differentiation,BP,
12587,GO:0046639,1,0.896443571641431,0,16,negative regulation of alpha-beta T cell differentiation,BP,
12588,GO:0046640,1,0.891907680405289,0,20,regulation of alpha-beta T cell proliferation,BP,
12589,GO:0046641,1,0.917183262413488,0,16,positive regulation of alpha-beta T cell proliferation,BP,
12590,GO:0046642,1,0.972654540400116,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12591,GO:0046643,1,0.955838022019947,0,6,regulation of gamma-delta T cell activation,BP,
12592,GO:0046645,1,0.963110152736632,0,5,positive regulation of gamma-delta T cell activation,BP,
12594,GO:0046651,1,0.274582385208533,0,222,lymphocyte proliferation,BP,
12595,GO:0046653,1,0.898622707201589,0,18,tetrahydrofolate metabolic process,BP,
12596,GO:0046654,1,0.958027731977055,0,7,tetrahydrofolate biosynthetic process,BP,
12597,GO:0046655,1,0.88224697419635,0,20,folic acid metabolic process,BP,
12598,GO:0046657,1,0.989327610931666,0,2,folic acid catabolic process,BP,
12599,GO:0046658,1,0.810058946483773,0,38,anchored component of plasma membrane,CC,
12602,GO:0046666,1,0.980742812106643,0,4,retinal cell programmed cell death,BP,
12603,GO:0046668,1,0.988044299085738,0,2,regulation of retinal cell programmed cell death,BP,
12604,GO:0046671,1,0.992468400805186,0,1,negative regulation of retinal cell programmed cell death,BP,
12605,GO:0046676,1,0.798115428263991,0,36,negative regulation of insulin secretion,BP,
12606,GO:0046677,1,0.171800524362779,0,290,response to antibiotic,BP,
12607,GO:0046680,1,0.995022622318697,0,1,response to DDT,BP,
12609,GO:0046684,1,0.979786827423406,0,4,response to pyrethroid,BP,
12610,GO:0046685,1,0.847491189926915,0,29,response to arsenic-containing substance,BP,
12612,GO:0046687,1,0.996797135125448,0,1,response to chromate,BP,
12613,GO:0046688,1,0.863809299862746,0,30,response to copper ion,BP,
12614,GO:0046689,1,0.955358485366104,0,8,response to mercury ion,BP,
12615,GO:0046690,1,0.99254237541719,0,1,response to tellurium ion,BP,
12616,GO:0046691,1,0.993144355918925,0,1,intracellular canaliculus,CC,
12617,GO:0046695,1,0.985638565490556,0,3,SLIK (SAGA-like) complex,CC,
12618,GO:0046696,1,0.972852823609819,0,5,lipopolysaccharide receptor complex,CC,
12621,GO:0046703,1,0.970124890833054,0,7,natural killer cell lectin-like receptor binding,MF,
12622,GO:0046707,1,0.988289787768226,0,2,IDP metabolic process,BP,
12623,GO:0046709,1,0.988289787768226,0,2,IDP catabolic process,BP,
12624,GO:0046710,1,0.910138643988533,0,13,GDP metabolic process,BP,
12625,GO:0046711,1,0.99687648987947,0,1,GDP biosynthetic process,BP,
12626,GO:0046713,1,0.992794512789323,0,1,borate transport,BP,
12627,GO:0046715,1,0.992794512789323,0,1,active borate transmembrane transporter activity,MF,
12629,GO:0046717,1,0.530804652978598,0,99,acid secretion,BP,
12631,GO:0046719,1,0.95662781135985,0,7,regulation by virus of viral protein levels in host cell,BP,
12632,GO:0046724,1,0.989724221063825,0,2,oxalic acid secretion,BP,
12633,GO:0046725,1,0.992513754170342,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12634,GO:0046726,1,0.970976288615186,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12635,GO:0046730,1,0.994725786414989,0,1,induction of host immune response by virus,BP,
12636,GO:0046732,1,0.994725786414989,0,1,active induction of host immune response by virus,BP,
12637,GO:0046745,1,0.993301131169352,0,1,viral capsid secondary envelopment,BP,
12638,GO:0046755,1,0.87537670173298,0,24,viral budding,BP,
12640,GO:0046778,1,0.988638641194922,0,2,modification by virus of host mRNA processing,BP,
12641,GO:0046782,1,0.693896067451521,0,60,regulation of viral transcription,BP,
12642,GO:0046784,1,0.957256119102154,0,8,viral mRNA export from host cell nucleus,BP,
12644,GO:0046786,1,0.992317416669214,0,1,viral replication complex formation and maintenance,BP,
12645,GO:0046789,1,0.992714561063159,0,1,host cell surface receptor binding,MF,
12646,GO:0046790,1,0.966996175031885,0,5,virion binding,MF,
12647,GO:0046794,1,0.697386830737709,0,56,transport of virus,BP,
12648,GO:0046811,1,0.989170126014587,0,2,histone deacetylase inhibitor activity,MF,
12649,GO:0046812,1,0.992714561063159,0,1,host cell surface binding,MF,
12650,GO:0046813,1,0.967880001063003,0,5,receptor-mediated virion attachment to host cell,BP,
12653,GO:0046824,1,0.686271701885662,0,55,positive regulation of nucleocytoplasmic transport,BP,
12654,GO:0046825,1,0.776567770559107,0,39,regulation of protein export from nucleus,BP,
12655,GO:0046826,1,0.962614434361185,0,7,negative regulation of protein export from nucleus,BP,
12656,GO:0046827,1,0.878766535826726,0,20,positive regulation of protein export from nucleus,BP,
12657,GO:0046831,1,0.894127157840398,0,15,regulation of RNA export from nucleus,BP,
12658,GO:0046832,1,0.982792964568345,0,2,negative regulation of RNA export from nucleus,BP,
12659,GO:0046833,1,0.950882302533032,0,7,positive regulation of RNA export from nucleus,BP,
12661,GO:0046835,1,0.845669007231183,0,26,carbohydrate phosphorylation,BP,
12662,GO:0046836,1,0.972310469954394,0,5,glycolipid transport,BP,
12663,GO:0046838,1,0.925966049044472,0,11,phosphorylated carbohydrate dephosphorylation,BP,
12664,GO:0046839,1,0.835788145705012,0,24,phospholipid dephosphorylation,BP,
12665,GO:0046847,1,0.678448790553478,0,54,filopodium assembly,BP,
12666,GO:0046848,1,0.997067771279448,0,1,hydroxyapatite binding,MF,
12672,GO:0046855,1,0.932671328700979,0,10,inositol phosphate dephosphorylation,BP,
12673,GO:0046856,1,0.840243806111534,0,23,phosphatidylinositol dephosphorylation,BP,
12674,GO:0046864,1,0.990101806520995,0,2,isoprenoid transport,BP,
12675,GO:0046865,1,0.990101806520995,0,2,terpenoid transport,BP,
12676,GO:0046870,1,0.970152360464611,0,5,cadmium ion binding,MF,
12679,GO:0046874,1,0.981595062486628,0,4,quinolinate metabolic process,BP,
12681,GO:0046877,1,0.969143900952598,0,6,regulation of saliva secretion,BP,
12682,GO:0046878,1,0.982868734328357,0,3,positive regulation of saliva secretion,BP,
12684,GO:0046880,1,0.96122944212912,0,6,regulation of follicle-stimulating hormone secretion,BP,
12685,GO:0046881,1,0.96122944212912,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12686,GO:0046882,1,0.984039525476796,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12688,GO:0046884,1,0.953875107404064,0,7,follicle-stimulating hormone secretion,BP,
12689,GO:0046885,1,0.85560355055561,0,24,regulation of hormone biosynthetic process,BP,
12690,GO:0046886,1,0.942499840701961,0,9,positive regulation of hormone biosynthetic process,BP,
12692,GO:0046888,1,0.707361263511338,0,57,negative regulation of hormone secretion,BP,
12695,GO:0046898,1,0.973846253946142,0,4,response to cycloheximide,BP,
12696,GO:0046899,1,0.986928933988417,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12697,GO:0046900,1,0.990304114896296,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12698,GO:0046901,1,0.993952009125385,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12703,GO:0046911,1,0.996721868208233,0,1,metal chelating activity,MF,
12704,GO:0046912,1,0.964672783251299,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12708,GO:0046920,1,0.947093990497986,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12709,GO:0046921,1,0.992645008216672,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12710,GO:0046922,1,0.98548676182973,0,2,peptide-O-fucosyltransferase activity,MF,
12711,GO:0046923,1,0.973901088273523,0,5,ER retention sequence binding,MF,
12712,GO:0046928,1,0.696990477584957,0,52,regulation of neurotransmitter secretion,BP,
12713,GO:0046929,1,0.929353990588333,0,10,negative regulation of neurotransmitter secretion,BP,
12714,GO:0046930,1,0.917582235614064,0,15,pore complex,CC,
12715,GO:0046931,1,0.90140013854428,0,16,pore complex assembly,BP,
12716,GO:0046933,1,0.988830962310155,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12718,GO:0046935,1,0.964564769896577,0,5,1-phosphatidylinositol-3-kinase regulator activity,MF,
12720,GO:0046940,1,0.970168646298183,0,5,nucleoside monophosphate phosphorylation,BP,
12722,GO:0046943,1,0.410573968792844,0,137,carboxylic acid transmembrane transporter activity,MF,
12723,GO:0046946,1,0.9784645608709,0,3,hydroxylysine metabolic process,BP,
12724,GO:0046947,1,0.9784645608709,0,3,hydroxylysine biosynthetic process,BP,
12725,GO:0046949,1,0.843308199800894,0,27,fatty-acyl-CoA biosynthetic process,BP,
12726,GO:0046950,1,0.934844023131587,0,11,cellular ketone body metabolic process,BP,
12727,GO:0046951,1,0.945966199069287,0,9,ketone body biosynthetic process,BP,
12728,GO:0046952,1,0.975908130425979,0,4,ketone body catabolic process,BP,
12729,GO:0046958,1,0.956413903716946,0,6,nonassociative learning,BP,
12730,GO:0046959,1,0.969047314789346,0,4,habituation,BP,
12731,GO:0046960,1,0.986904005415871,0,2,sensitization,BP,
12732,GO:0046961,1,0.896591701451884,0,20,proton-transporting ATPase activity, rotational mechanism,MF,
12733,GO:0046963,1,0.990267687668501,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12734,GO:0046964,1,0.990267687668501,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12735,GO:0046965,1,0.906643902843965,0,15,retinoid X receptor binding,MF,
12736,GO:0046966,1,0.836874676519827,0,27,thyroid hormone receptor binding,MF,
12737,GO:0046967,1,0.985499624124741,0,2,cytosol to ER transport,BP,
12738,GO:0046968,1,0.984951137622373,0,2,peptide antigen transport,BP,
12739,GO:0046969,1,0.988579012414835,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12740,GO:0046970,1,0.995397073095079,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12741,GO:0046972,1,0.932391709898511,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12742,GO:0046974,1,0.963725031106812,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12743,GO:0046975,1,0.956583828478036,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12744,GO:0046976,1,0.966114750726216,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12745,GO:0046977,1,0.974824095069824,0,4,TAP binding,MF,
12746,GO:0046978,1,0.974824095069824,0,4,TAP1 binding,MF,
12747,GO:0046979,1,0.98223547593926,0,3,TAP2 binding,MF,
12748,GO:0046980,1,0.992455981102177,0,1,tapasin binding,MF,
12751,GO:0046984,1,0.976777764298902,0,4,regulation of hemoglobin biosynthetic process,BP,
12752,GO:0046985,1,0.984254321236688,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12753,GO:0046986,1,0.992405087241669,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12754,GO:0046996,1,0.993301131169352,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
12755,GO:0046997,1,0.985502173610602,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12756,GO:0047006,1,0.992918854537755,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12757,GO:0047012,1,0.996150435644657,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12758,GO:0047015,1,0.996902485895895,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12759,GO:0047016,1,0.994763810616296,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12760,GO:0047017,1,0.989996673612369,0,2,prostaglandin-F synthase activity,MF,
12761,GO:0047020,1,0.996673490117013,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12762,GO:0047021,1,0.996655423776818,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12763,GO:0047023,1,0.986263631734964,0,4,androsterone dehydrogenase activity,MF,
12764,GO:0047025,1,0.989452748315849,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12765,GO:0047035,1,0.978882051151977,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12766,GO:0047042,1,0.99648839158523,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12767,GO:0047045,1,0.990120918328543,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12768,GO:0047057,1,0.993674038969299,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12769,GO:0047066,1,0.996909045761111,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12770,GO:0047086,1,0.986263631734964,0,4,ketosteroid monooxygenase activity,MF,
12771,GO:0047105,1,0.993913943638435,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12772,GO:0047115,1,0.986365045675136,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12773,GO:0047117,1,0.991128561445219,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12774,GO:0047127,1,0.996499631305736,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12775,GO:0047130,1,0.992041729878396,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12776,GO:0047131,1,0.992041729878396,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12777,GO:0047134,1,0.971485424070137,0,6,protein-disulfide reductase activity,MF,
12778,GO:0047144,1,0.939340040614733,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12779,GO:0047150,1,0.989229882049943,0,2,betaine-homocysteine S-methyltransferase activity,MF,
12780,GO:0047159,1,0.992460766758692,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12781,GO:0047166,1,0.995474271950551,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12782,GO:0047173,1,0.992323437932328,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12783,GO:0047179,1,0.993530885886187,0,2,platelet-activating factor acetyltransferase activity,MF,
12784,GO:0047184,1,0.970516703535329,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12785,GO:0047186,1,0.992464996166423,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12786,GO:0047191,1,0.992460766758692,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12787,GO:0047192,1,0.980252209350522,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12788,GO:0047220,1,0.993279655817699,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12789,GO:0047223,1,0.993157321795175,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12790,GO:0047237,1,0.978229941213533,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12791,GO:0047238,1,0.963365716239939,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12792,GO:0047256,1,0.992449078772832,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12794,GO:0047273,1,0.992627749865872,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12795,GO:0047275,1,0.987383773383125,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12796,GO:0047277,1,0.995392043033052,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12797,GO:0047280,1,0.992385632629884,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12798,GO:0047288,1,0.988303229823864,0,2,monosialoganglioside sialyltransferase activity,MF,
12799,GO:0047290,1,0.996064259986781,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12800,GO:0047291,1,0.994429790342927,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12801,GO:0047293,1,0.996075538658658,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12802,GO:0047298,1,0.992316013745567,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12803,GO:0047322,1,0.98312422863284,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12804,GO:0047323,1,0.994912631612779,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12805,GO:0047325,1,0.992669443467321,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12806,GO:0047326,1,0.995761624930694,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12807,GO:0047341,1,0.99256775817539,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12808,GO:0047349,1,0.992173790526161,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
12809,GO:0047369,1,0.993301131169352,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12810,GO:0047372,1,0.934805048136232,0,11,acylglycerol lipase activity,MF,
12811,GO:0047374,1,0.98446332380976,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12812,GO:0047389,1,0.984952188368973,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12813,GO:0047390,1,0.992461727690553,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12815,GO:0047394,1,0.994623825744948,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12816,GO:0047395,1,0.993022200579954,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12817,GO:0047408,1,0.988404068909874,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12818,GO:0047409,1,0.988404068909874,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12819,GO:0047429,1,0.951062924387031,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12820,GO:0047444,1,0.996658647993507,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12821,GO:0047451,1,0.991128561445219,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12822,GO:0047464,1,0.992285693639057,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12824,GO:0047485,1,0.52263985648048,0,106,protein N-terminus binding,MF,
12825,GO:0047493,1,0.980866976730619,0,3,ceramide cholinephosphotransferase activity,MF,
12827,GO:0047497,1,0.87768653422085,0,19,mitochondrion transport along microtubule,BP,
12828,GO:0047498,1,0.958056979621581,0,7,calcium-dependent phospholipase A2 activity,MF,
12829,GO:0047499,1,0.964817136954621,0,6,calcium-independent phospholipase A2 activity,MF,
12830,GO:0047522,1,0.982694967511307,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12831,GO:0047536,1,0.994661899343857,0,1,2-aminoadipate transaminase activity,MF,
12832,GO:0047545,1,0.99197537121486,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12833,GO:0047555,1,0.918860080649284,0,12,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12834,GO:0047560,1,0.992244370523612,0,1,3-dehydrosphinganine reductase activity,MF,
12835,GO:0047578,1,0.994052328523411,0,1,4-hydroxyglutamate transaminase activity,MF,
12836,GO:0047598,1,0.993554549492272,0,1,7-dehydrocholesterol reductase activity,MF,
12837,GO:0047617,1,0.92615312209266,0,15,acyl-CoA hydrolase activity,MF,
12838,GO:0047620,1,0.993022200579954,0,1,acylglycerol kinase activity,MF,
12839,GO:0047621,1,0.996000751859802,0,1,acylpyruvate hydrolase activity,MF,
12840,GO:0047623,1,0.984959633322113,0,2,adenosine-phosphate deaminase activity,MF,
12841,GO:0047631,1,0.980145192774893,0,5,ADP-ribose diphosphatase activity,MF,
12842,GO:0047635,1,0.988031489449761,0,2,alanine-oxo-acid transaminase activity,MF,
12843,GO:0047658,1,0.99596705023946,0,1,alpha-amino-acid esterase activity,MF,
12844,GO:0047661,1,0.993980113814259,0,1,amino-acid racemase activity,MF,
12845,GO:0047676,1,0.992247453761663,0,1,arachidonate-CoA ligase activity,MF,
12846,GO:0047685,1,0.996307453740588,0,1,amine sulfotransferase activity,MF,
12847,GO:0047693,1,0.997018312941827,0,1,ATP diphosphatase activity,MF,
12848,GO:0047696,1,0.986791869202579,0,2,beta-adrenergic receptor kinase activity,MF,
12849,GO:0047704,1,0.995292855846941,0,1,bile-salt sulfotransferase activity,MF,
12850,GO:0047708,1,0.991843446718309,0,2,biotinidase activity,MF,
12851,GO:0047710,1,0.989195080348463,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12852,GO:0047718,1,0.989349882668893,0,3,indanol dehydrogenase activity,MF,
12853,GO:0047726,1,0.99390636774115,0,1,iron-cytochrome-c reductase activity,MF,
12855,GO:0047734,1,0.993301131169352,0,1,CDP-glycerol diphosphatase activity,MF,
12856,GO:0047743,1,0.996704176262285,0,1,chlordecone reductase activity,MF,
12857,GO:0047747,1,0.994268469383774,0,1,cholate-CoA ligase activity,MF,
12858,GO:0047750,1,0.993639683728922,0,2,cholestenol delta-isomerase activity,MF,
12859,GO:0047751,1,0.988139089146914,0,2,cholestenone 5-alpha-reductase activity,MF,
12860,GO:0047756,1,0.977852876132574,0,4,chondroitin 4-sulfotransferase activity,MF,
12861,GO:0047757,1,0.98334191138923,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12862,GO:0047760,1,0.970771581597626,0,5,butyrate-CoA ligase activity,MF,
12863,GO:0047777,1,0.992077520282848,0,1,(3S)-citramalyl-CoA lyase activity,MF,
12864,GO:0047787,1,0.996673490117013,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12865,GO:0047800,1,0.992482920807434,0,1,cysteamine dioxygenase activity,MF,
12866,GO:0047801,1,0.99491801959074,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12867,GO:0047837,1,0.996806652532186,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12868,GO:0047840,1,0.99677880066022,0,1,dCTP diphosphatase activity,MF,
12869,GO:0047844,1,0.966176315026332,0,7,deoxycytidine deaminase activity,MF,
12870,GO:0047856,1,0.996707162065293,0,1,dihydrocoumarin hydrolase activity,MF,
12871,GO:0047860,1,0.996623450255418,0,1,diiodophenylpyruvate reductase activity,MF,
12872,GO:0047865,1,0.992819151442585,0,1,dimethylglycine dehydrogenase activity,MF,
12873,GO:0047874,1,0.994963729950636,0,1,dolichyldiphosphatase activity,MF,
12874,GO:0047888,1,0.995389525839338,0,1,fatty acid peroxidase activity,MF,
12875,GO:0047894,1,0.98917971874152,0,3,flavonol 3-sulfotransferase activity,MF,
12876,GO:0047915,1,0.995996821978594,0,1,ganglioside galactosyltransferase activity,MF,
12877,GO:0047933,1,0.991122751280723,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12878,GO:0047936,1,0.990883996459635,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12879,GO:0047939,1,0.996356943742403,0,1,L-glucuronate reductase activity,MF,
12880,GO:0047946,1,0.995078515718236,0,1,glutamine N-acyltransferase activity,MF,
12881,GO:0047961,1,0.991590605827911,0,2,glycine N-acyltransferase activity,MF,
12882,GO:0047963,1,0.992567525681996,0,1,glycine N-choloyltransferase activity,MF,
12883,GO:0047969,1,0.995859720278206,0,1,glyoxylate oxidase activity,MF,
12884,GO:0047977,1,0.98780263065196,0,2,hepoxilin-epoxide hydrolase activity,MF,
12885,GO:0047982,1,0.995869264340929,0,1,homocysteine desulfhydrase activity,MF,
12886,GO:0047988,1,0.995508638316602,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12887,GO:0047992,1,0.993301131169352,0,1,hydroxylysine kinase activity,MF,
12888,GO:0048002,1,0.385478598619346,0,175,antigen processing and presentation of peptide antigen,BP,
12889,GO:0048003,1,0.966437958090933,0,5,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12890,GO:0048006,1,0.992474593146254,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12891,GO:0048007,1,0.966437958090933,0,5,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12893,GO:0048009,1,0.803440534512769,0,31,insulin-like growth factor receptor signaling pathway,BP,
12894,GO:0048010,1,0.553136669749718,0,91,vascular endothelial growth factor receptor signaling pathway,BP,
12896,GO:0048012,1,0.906087316050497,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12897,GO:0048013,1,0.567943204460425,0,87,ephrin receptor signaling pathway,BP,
12898,GO:0048014,1,0.977173278260129,0,3,Tie signaling pathway,BP,
12903,GO:0048019,1,0.936989812369922,0,12,receptor antagonist activity,MF,
12904,GO:0048020,1,0.913737421974498,0,21,CCR chemokine receptor binding,MF,
12905,GO:0048021,1,0.957985816154592,0,6,regulation of melanin biosynthetic process,BP,
12906,GO:0048022,1,0.983854387187819,0,2,negative regulation of melanin biosynthetic process,BP,
12907,GO:0048023,1,0.973711306078755,0,4,positive regulation of melanin biosynthetic process,BP,
12908,GO:0048024,1,0.618298532131587,0,75,regulation of mRNA splicing, via spliceosome,BP,
12909,GO:0048025,1,0.88545348327441,0,19,negative regulation of mRNA splicing, via spliceosome,BP,
12910,GO:0048026,1,0.912667108404106,0,16,positive regulation of mRNA splicing, via spliceosome,BP,
12911,GO:0048027,1,0.876587478308817,0,23,mRNA 5'-UTR binding,MF,
12912,GO:0048029,1,0.679779081993937,0,64,monosaccharide binding,MF,
12913,GO:0048030,1,0.988998074290116,0,3,disaccharide binding,MF,
12914,GO:0048033,1,0.992931778905928,0,1,heme o metabolic process,BP,
12915,GO:0048034,1,0.992931778905928,0,1,heme O biosynthetic process,BP,
12917,GO:0048038,1,0.936953600127781,0,14,quinone binding,MF,
12918,GO:0048039,1,0.974525775576024,0,6,ubiquinone binding,MF,
12919,GO:0048040,1,0.995017281950064,0,1,UDP-glucuronate decarboxylase activity,MF,
12921,GO:0048048,1,0.776446167399025,0,34,embryonic eye morphogenesis,BP,
12922,GO:0048050,1,0.968626098370682,0,6,post-embryonic eye morphogenesis,BP,
12924,GO:0048069,1,0.954501058218545,0,7,eye pigmentation,BP,
12925,GO:0048070,1,0.901555842934954,0,15,regulation of developmental pigmentation,BP,
12926,GO:0048073,1,0.984907372887018,0,2,regulation of eye pigmentation,BP,
12927,GO:0048075,1,0.992428365147659,0,1,positive regulation of eye pigmentation,BP,
12928,GO:0048087,1,0.936969957711378,0,9,positive regulation of developmental pigmentation,BP,
12929,GO:0048096,1,0.940226881596161,0,9,chromatin-mediated maintenance of transcription,BP,
12930,GO:0048101,1,0.987342257326669,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12931,GO:0048102,1,0.95889998263505,0,7,autophagic cell death,BP,
12933,GO:0048104,1,0.967328652727125,0,4,establishment of body hair or bristle planar orientation,BP,
12934,GO:0048105,1,0.967328652727125,0,4,establishment of body hair planar orientation,BP,
12935,GO:0048133,1,0.983697737087025,0,3,male germ-line stem cell asymmetric division,BP,
12940,GO:0048147,1,0.8556408990541,0,27,negative regulation of fibroblast proliferation,BP,
12941,GO:0048148,1,0.910310311745823,0,15,behavioral response to cocaine,BP,
12942,GO:0048149,1,0.938764016044855,0,10,behavioral response to ethanol,BP,
12943,GO:0048156,1,0.935812084471051,0,11,tau protein binding,MF,
12944,GO:0048160,1,0.992377656288372,0,1,primary follicle stage,BP,
12945,GO:0048162,1,0.985738965468846,0,3,multi-layer follicle stage,BP,
12946,GO:0048165,1,0.98457959068172,0,2,fused antrum stage,BP,
12949,GO:0048169,1,0.835045859215346,0,26,regulation of long-term neuronal synaptic plasticity,BP,
12950,GO:0048170,1,0.964522075398604,0,5,positive regulation of long-term neuronal synaptic plasticity,BP,
12951,GO:0048172,1,0.898547862900168,0,15,regulation of short-term neuronal synaptic plasticity,BP,
12952,GO:0048174,1,0.992451244311811,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
12953,GO:0048175,1,0.992714561063159,0,1,hepatocyte growth factor biosynthetic process,BP,
12954,GO:0048176,1,0.992714561063159,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12955,GO:0048178,1,0.992714561063159,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12956,GO:0048179,1,0.979944656765737,0,3,activin receptor complex,CC,
12957,GO:0048180,1,0.994807211949773,0,1,activin complex,CC,
12958,GO:0048185,1,0.922917844765402,0,12,activin binding,MF,
12959,GO:0048188,1,0.920105443695794,0,12,Set1C/COMPASS complex,CC,
12960,GO:0048193,1,0.106314105206759,0,335,Golgi vesicle transport,BP,
12961,GO:0048194,1,0.600228908360676,0,78,Golgi vesicle budding,BP,
12962,GO:0048199,1,0.6416503958887,0,70,vesicle targeting, to, from or within Golgi,BP,
12963,GO:0048200,1,0.962925514135919,0,6,Golgi transport vesicle coating,BP,
12964,GO:0048203,1,0.988610706191092,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12965,GO:0048205,1,0.962925514135919,0,6,COPI coating of Golgi vesicle,BP,
12966,GO:0048207,1,0.675436727014871,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
12967,GO:0048208,1,0.675436727014871,0,62,COPII vesicle coating,BP,
12968,GO:0048209,1,0.987095215649351,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12969,GO:0048210,1,0.979746870170235,0,4,Golgi vesicle fusion to target membrane,BP,
12970,GO:0048211,1,0.985788613424649,0,2,Golgi vesicle docking,BP,
12971,GO:0048213,1,0.989059954288294,0,2,Golgi vesicle prefusion complex stabilization,BP,
12972,GO:0048227,1,0.950943551652435,0,8,plasma membrane to endosome transport,BP,
12974,GO:0048237,1,0.987261147885126,0,3,rough endoplasmic reticulum lumen,CC,
12975,GO:0048239,1,0.98807515760054,0,2,negative regulation of DNA recombination at telomere,BP,
12976,GO:0048240,1,0.897126326349526,0,20,sperm capacitation,BP,
12977,GO:0048241,1,0.977223608326284,0,5,epinephrine transport,BP,
12978,GO:0048242,1,0.981517369087419,0,4,epinephrine secretion,BP,
12979,GO:0048243,1,0.92541902673115,0,13,norepinephrine secretion,BP,
12980,GO:0048244,1,0.996029930200386,0,1,phytanoyl-CoA dioxygenase activity,MF,
12981,GO:0048245,1,0.951655719966179,0,11,eosinophil chemotaxis,BP,
12982,GO:0048246,1,0.855909628488737,0,29,macrophage chemotaxis,BP,
12983,GO:0048247,1,0.817942085543345,0,41,lymphocyte chemotaxis,BP,
12984,GO:0048248,1,0.980815087804449,0,5,CXCR3 chemokine receptor binding,MF,
12985,GO:0048250,1,0.991851398602596,0,2,iron import into the mitochondrion,BP,
12986,GO:0048251,1,0.939435084702176,0,9,elastic fiber assembly,BP,
12987,GO:0048254,1,0.980802408408104,0,4,snoRNA localization,BP,
12988,GO:0048255,1,0.802183625343297,0,32,mRNA stabilization,BP,
12989,GO:0048256,1,0.954698754456314,0,7,flap endonuclease activity,MF,
12990,GO:0048257,1,0.987504721215315,0,2,3'-flap endonuclease activity,MF,
12993,GO:0048261,1,0.902719422243992,0,17,negative regulation of receptor-mediated endocytosis,BP,
12996,GO:0048264,1,0.992919932360521,0,1,determination of ventral identity,BP,
12997,GO:0048265,1,0.847988662914934,0,26,response to pain,BP,
12998,GO:0048266,1,0.923244040754429,0,12,behavioral response to pain,BP,
12999,GO:0048268,1,0.89780220955688,0,16,clathrin coat assembly,BP,
13000,GO:0048269,1,0.988284250682505,0,2,methionine adenosyltransferase complex,CC,
13001,GO:0048270,1,0.995037293463337,0,1,methionine adenosyltransferase regulator activity,MF,
13002,GO:0048273,1,0.961383986567646,0,6,mitogen-activated protein kinase p38 binding,MF,
13004,GO:0048280,1,0.954611873721889,0,8,vesicle fusion with Golgi apparatus,BP,
13005,GO:0048284,1,0.32841616449544,0,175,organelle fusion,BP,
13007,GO:0048286,1,0.774808607599902,0,36,lung alveolus development,BP,
13008,GO:0048289,1,0.960791566922713,0,6,isotype switching to IgE isotypes,BP,
13009,GO:0048290,1,0.964196849436905,0,6,isotype switching to IgA isotypes,BP,
13010,GO:0048291,1,0.929815459446172,0,11,isotype switching to IgG isotypes,BP,
13011,GO:0048293,1,0.960791566922713,0,6,regulation of isotype switching to IgE isotypes,BP,
13012,GO:0048294,1,0.979532980857973,0,3,negative regulation of isotype switching to IgE isotypes,BP,
13013,GO:0048295,1,0.980871070435791,0,3,positive regulation of isotype switching to IgE isotypes,BP,
13014,GO:0048296,1,0.971376724047197,0,5,regulation of isotype switching to IgA isotypes,BP,
13015,GO:0048297,1,0.994907241611646,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13016,GO:0048298,1,0.976350277750362,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13017,GO:0048302,1,0.935042650976658,0,10,regulation of isotype switching to IgG isotypes,BP,
13018,GO:0048304,1,0.954457932661872,0,7,positive regulation of isotype switching to IgG isotypes,BP,
13019,GO:0048305,1,0.915086657190346,0,18,immunoglobulin secretion,BP,
13021,GO:0048308,1,0.91614841434513,0,15,organelle inheritance,BP,
13022,GO:0048311,1,0.888196251257488,0,16,mitochondrion distribution,BP,
13023,GO:0048312,1,0.943368599833688,0,8,intracellular distribution of mitochondria,BP,
13024,GO:0048313,1,0.922332185043735,0,14,Golgi inheritance,BP,
13025,GO:0048318,1,0.960824252535004,0,7,axial mesoderm development,BP,
13026,GO:0048319,1,0.979582899074711,0,3,axial mesoderm morphogenesis,BP,
13027,GO:0048320,1,0.987657810726567,0,2,axial mesoderm formation,BP,
13028,GO:0048321,1,0.995041290819372,0,1,axial mesodermal cell differentiation,BP,
13029,GO:0048322,1,0.995041290819372,0,1,axial mesodermal cell fate commitment,BP,
13030,GO:0048327,1,0.995041290819372,0,1,axial mesodermal cell fate specification,BP,
13033,GO:0048338,1,0.992500861833069,0,1,mesoderm structural organization,BP,
13034,GO:0048339,1,0.890598794245372,0,17,paraxial mesoderm development,BP,
13035,GO:0048340,1,0.938269764793917,0,9,paraxial mesoderm morphogenesis,BP,
13036,GO:0048341,1,0.9622758874401,0,6,paraxial mesoderm formation,BP,
13037,GO:0048342,1,0.996010535887288,0,1,paraxial mesodermal cell differentiation,BP,
13038,GO:0048343,1,0.996010535887288,0,1,paraxial mesodermal cell fate commitment,BP,
13039,GO:0048352,1,0.992500861833069,0,1,paraxial mesoderm structural organization,BP,
13040,GO:0048364,1,0.996992964303392,0,1,root development,BP,
13041,GO:0048365,1,0.648878430170762,0,60,Rac GTPase binding,MF,
13042,GO:0048368,1,0.918724236037073,0,15,lateral mesoderm development,BP,
13043,GO:0048369,1,0.974788829930862,0,4,lateral mesoderm morphogenesis,BP,
13044,GO:0048370,1,0.974788829930862,0,4,lateral mesoderm formation,BP,
13045,GO:0048371,1,0.978555822553275,0,3,lateral mesodermal cell differentiation,BP,
13046,GO:0048372,1,0.984677036040533,0,2,lateral mesodermal cell fate commitment,BP,
13047,GO:0048377,1,0.984677036040533,0,2,lateral mesodermal cell fate specification,BP,
13048,GO:0048378,1,0.984677036040533,0,2,regulation of lateral mesodermal cell fate specification,BP,
13049,GO:0048382,1,0.977471051057363,0,4,mesendoderm development,BP,
13050,GO:0048384,1,0.84320170780984,0,28,retinoic acid receptor signaling pathway,BP,
13051,GO:0048385,1,0.915789545180492,0,15,regulation of retinoic acid receptor signaling pathway,BP,
13052,GO:0048386,1,0.973295724723981,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13053,GO:0048387,1,0.951860913783909,0,8,negative regulation of retinoic acid receptor signaling pathway,BP,
13054,GO:0048388,1,0.984557145303533,0,3,endosomal lumen acidification,BP,
13055,GO:0048389,1,0.9913400671599,0,2,intermediate mesoderm development,BP,
13056,GO:0048390,1,0.99578603907695,0,1,intermediate mesoderm morphogenesis,BP,
13057,GO:0048391,1,0.99578603907695,0,1,intermediate mesoderm formation,BP,
13058,GO:0048392,1,0.99578603907695,0,1,intermediate mesodermal cell differentiation,BP,
13059,GO:0048403,1,0.976475846714107,0,3,brain-derived neurotrophic factor binding,MF,
13067,GO:0048476,1,0.975512698385159,0,5,Holliday junction resolvase complex,CC,
13068,GO:0048477,1,0.654961341094014,0,67,oogenesis,BP,
13069,GO:0048478,1,0.955336161085662,0,7,replication fork protection,BP,
13072,GO:0048485,1,0.87055306140221,0,20,sympathetic nervous system development,BP,
13073,GO:0048486,1,0.910366191044245,0,15,parasympathetic nervous system development,BP,
13075,GO:0048488,1,0.753221349059782,0,40,synaptic vesicle endocytosis,BP,
13076,GO:0048489,1,0.455650735079691,0,116,synaptic vesicle transport,BP,
13077,GO:0048490,1,0.903718454540604,0,17,anterograde synaptic vesicle transport,BP,
13078,GO:0048495,1,0.963522922108863,0,5,Roundabout binding,MF,
13079,GO:0048496,1,0.968450479012695,0,4,maintenance of animal organ identity,BP,
13080,GO:0048499,1,0.97911560389334,0,4,synaptic vesicle membrane organization,BP,
13081,GO:0048500,1,0.954175272207031,0,9,signal recognition particle,CC,
13082,GO:0048505,1,0.929541098553262,0,11,regulation of timing of cell differentiation,BP,
13084,GO:0048512,1,0.796490727725402,0,39,circadian behavior,BP,
13087,GO:0048515,1,0.52371836448812,0,105,spermatid differentiation,BP,
13091,GO:0048521,1,0.938364445024174,0,13,negative regulation of behavior,BP,
13094,GO:0048524,1,0.542240068404765,0,100,positive regulation of viral process,BP,
13095,GO:0048525,1,0.611128771469327,0,80,negative regulation of viral process,BP,
13096,GO:0048531,1,0.919578709261794,0,14,beta-1,3-galactosyltransferase activity,MF,
13097,GO:0048532,1,0.900049756163888,0,15,anatomical structure arrangement,BP,
13099,GO:0048535,1,0.918812567183382,0,15,lymph node development,BP,
13100,GO:0048536,1,0.812290734818504,0,33,spleen development,BP,
13101,GO:0048537,1,0.96632177047268,0,6,mucosal-associated lymphoid tissue development,BP,
13102,GO:0048538,1,0.747324051880236,0,43,thymus development,BP,
13103,GO:0048539,1,0.957043020184739,0,7,bone marrow development,BP,
13104,GO:0048541,1,0.96632177047268,0,6,Peyer's patch development,BP,
13107,GO:0048548,1,0.942615792027992,0,9,regulation of pinocytosis,BP,
13108,GO:0048549,1,0.971745775545373,0,4,positive regulation of pinocytosis,BP,
13109,GO:0048550,1,0.970031851990904,0,5,negative regulation of pinocytosis,BP,
13111,GO:0048560,1,0.98947903741088,0,2,establishment of anatomical structure orientation,BP,
13112,GO:0048561,1,0.994671417242112,0,1,establishment of animal organ orientation,BP,
13114,GO:0048563,1,0.953047207381697,0,8,post-embryonic animal organ morphogenesis,BP,
13117,GO:0048567,1,0.993784527936572,0,1,ectodermal digestive tract morphogenesis,BP,
13119,GO:0048569,1,0.905292531053563,0,15,post-embryonic animal organ development,BP,
13120,GO:0048570,1,0.948954126873783,0,8,notochord morphogenesis,BP,
13126,GO:0048592,1,0.400284283063053,0,132,eye morphogenesis,BP,
13127,GO:0048593,1,0.509556497844452,0,98,camera-type eye morphogenesis,BP,
13128,GO:0048596,1,0.825818850572366,0,25,embryonic camera-type eye morphogenesis,BP,
13129,GO:0048597,1,0.988362245256398,0,3,post-embryonic camera-type eye morphogenesis,BP,
13131,GO:0048599,1,0.785997658159992,0,38,oocyte development,BP,
13134,GO:0048611,1,0.986807575866726,0,2,embryonic ectodermal digestive tract development,BP,
13135,GO:0048613,1,0.993784527936572,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13136,GO:0048617,1,0.935430540985924,0,9,embryonic foregut morphogenesis,BP,
13137,GO:0048619,1,0.980172201312026,0,3,embryonic hindgut morphogenesis,BP,
13138,GO:0048625,1,0.969337869577871,0,5,myoblast fate commitment,BP,
13139,GO:0048627,1,0.989177773347029,0,2,myoblast development,BP,
13140,GO:0048630,1,0.954344737849409,0,7,skeletal muscle tissue growth,BP,
13141,GO:0048631,1,0.962931839715016,0,5,regulation of skeletal muscle tissue growth,BP,
13142,GO:0048632,1,0.985032957528586,0,2,negative regulation of skeletal muscle tissue growth,BP,
13143,GO:0048633,1,0.977566548677365,0,3,positive regulation of skeletal muscle tissue growth,BP,
13152,GO:0048643,1,0.868999075044864,0,21,positive regulation of skeletal muscle tissue development,BP,
13161,GO:0048664,1,0.972249401549311,0,6,neuron fate determination,BP,
13165,GO:0048668,1,0.848192781666383,0,25,collateral sprouting,BP,
13166,GO:0048669,1,0.981195289439615,0,3,collateral sprouting in absence of injury,BP,
13167,GO:0048670,1,0.88904492931472,0,19,regulation of collateral sprouting,BP,
13168,GO:0048671,1,0.944497713396143,0,8,negative regulation of collateral sprouting,BP,
13169,GO:0048672,1,0.94132247644379,0,11,positive regulation of collateral sprouting,BP,
13170,GO:0048673,1,0.996180392553914,0,1,collateral sprouting of intact axon in response to injury,BP,
13171,GO:0048674,1,0.994075732844041,0,1,collateral sprouting of injured axon,BP,
13173,GO:0048677,1,0.977589381069571,0,3,axon extension involved in regeneration,BP,
13175,GO:0048679,1,0.863398400828715,0,22,regulation of axon regeneration,BP,
13176,GO:0048680,1,0.960102098160719,0,7,positive regulation of axon regeneration,BP,
13177,GO:0048681,1,0.920850701057369,0,12,negative regulation of axon regeneration,BP,
13178,GO:0048682,1,0.971796517453417,0,4,sprouting of injured axon,BP,
13179,GO:0048683,1,0.996180392553914,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13180,GO:0048685,1,0.996180392553914,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13181,GO:0048686,1,0.979577410205031,0,3,regulation of sprouting of injured axon,BP,
13182,GO:0048687,1,0.987236665650623,0,2,positive regulation of sprouting of injured axon,BP,
13183,GO:0048688,1,0.98636396996396,0,2,negative regulation of sprouting of injured axon,BP,
13184,GO:0048689,1,0.994075732844041,0,1,formation of growth cone in injured axon,BP,
13185,GO:0048690,1,0.985416169383536,0,2,regulation of axon extension involved in regeneration,BP,
13186,GO:0048691,1,0.993120599169405,0,1,positive regulation of axon extension involved in regeneration,BP,
13187,GO:0048692,1,0.992242756370313,0,1,negative regulation of axon extension involved in regeneration,BP,
13188,GO:0048693,1,0.994075732844041,0,1,regulation of collateral sprouting of injured axon,BP,
13189,GO:0048694,1,0.994075732844041,0,1,positive regulation of collateral sprouting of injured axon,BP,
13190,GO:0048696,1,0.99632392611263,0,1,regulation of collateral sprouting in absence of injury,BP,
13191,GO:0048697,1,0.99632392611263,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13194,GO:0048702,1,0.949716466275795,0,7,embryonic neurocranium morphogenesis,BP,
13195,GO:0048703,1,0.937369502089404,0,9,embryonic viscerocranium morphogenesis,BP,
13203,GO:0048712,1,0.929999981138409,0,11,negative regulation of astrocyte differentiation,BP,
13205,GO:0048714,1,0.905324610865061,0,17,positive regulation of oligodendrocyte differentiation,BP,
13206,GO:0048715,1,0.934135305264156,0,11,negative regulation of oligodendrocyte differentiation,BP,
13208,GO:0048730,1,0.841859037948189,0,27,epidermis morphogenesis,BP,
13214,GO:0048739,1,0.840606707357039,0,13,cardiac muscle fiber development,BP,
13215,GO:0048741,1,0.834144688793159,0,28,skeletal muscle fiber development,BP,
13216,GO:0048742,1,0.941108408045953,0,9,regulation of skeletal muscle fiber development,BP,
13217,GO:0048743,1,0.9623577617724,0,6,positive regulation of skeletal muscle fiber development,BP,
13218,GO:0048745,1,0.872632406947962,0,19,smooth muscle tissue development,BP,
13219,GO:0048747,1,0.650758548977969,0,52,muscle fiber development,BP,
13220,GO:0048749,1,0.992456080829907,0,1,compound eye development,BP,
13221,GO:0048752,1,0.955235635489439,0,7,semicircular canal morphogenesis,BP,
13222,GO:0048753,1,0.846862400682193,0,27,pigment granule organization,BP,
13224,GO:0048755,1,0.935572296562291,0,9,branching morphogenesis of a nerve,BP,
13225,GO:0048757,1,0.942523922168563,0,10,pigment granule maturation,BP,
13227,GO:0048763,1,0.955642810455226,0,4,calcium-induced calcium release activity,MF,
13228,GO:0048764,1,0.996992964303392,0,1,trichoblast maturation,BP,
13229,GO:0048765,1,0.996992964303392,0,1,root hair cell differentiation,BP,
13230,GO:0048767,1,0.996992964303392,0,1,root hair elongation,BP,
13231,GO:0048769,1,0.897330458868125,0,4,sarcomerogenesis,BP,
13232,GO:0048770,1,0.536978789161731,0,101,pigment granule,CC,
13234,GO:0048786,1,0.7664899640612,0,34,presynaptic active zone,CC,
13235,GO:0048787,1,0.964979251952965,0,5,presynaptic active zone membrane,CC,
13236,GO:0048788,1,0.94291253286271,0,6,cytoskeleton of presynaptic active zone,CC,
13237,GO:0048789,1,0.992315544998241,0,1,cytoskeletal matrix organization at active zone,BP,
13238,GO:0048790,1,0.996316110732579,0,1,maintenance of presynaptic active zone structure,BP,
13239,GO:0048791,1,0.775700949658289,0,37,calcium ion-regulated exocytosis of neurotransmitter,BP,
13240,GO:0048792,1,0.992563628948966,0,1,spontaneous exocytosis of neurotransmitter,BP,
13241,GO:0048793,1,0.957179633653986,0,6,pronephros development,BP,
13244,GO:0048807,1,0.98639194486976,0,3,female genitalia morphogenesis,BP,
13245,GO:0048808,1,0.982177409275279,0,3,male genitalia morphogenesis,BP,
13249,GO:0048817,1,0.984744965897682,0,2,negative regulation of hair follicle maturation,BP,
13250,GO:0048818,1,0.970885297631622,0,5,positive regulation of hair follicle maturation,BP,
13251,GO:0048819,1,0.941831445582398,0,9,regulation of hair follicle maturation,BP,
13252,GO:0048820,1,0.891722275766116,0,16,hair follicle maturation,BP,
13253,GO:0048821,1,0.840621890538947,0,28,erythrocyte development,BP,
13254,GO:0048822,1,0.978581915721662,0,3,enucleate erythrocyte development,BP,
13255,GO:0048823,1,0.993301131169352,0,1,nucleate erythrocyte development,BP,
13256,GO:0048839,1,0.324182506086949,0,168,inner ear development,BP,
13257,GO:0048840,1,0.966640368538191,0,5,otolith development,BP,
13258,GO:0048841,1,0.809646198734846,0,27,regulation of axon extension involved in axon guidance,BP,
13259,GO:0048842,1,0.944239696189542,0,7,positive regulation of axon extension involved in axon guidance,BP,
13260,GO:0048843,1,0.866496823016953,0,19,negative regulation of axon extension involved in axon guidance,BP,
13262,GO:0048845,1,0.932705735612951,0,10,venous blood vessel morphogenesis,BP,
13263,GO:0048846,1,0.777987950455935,0,32,axon extension involved in axon guidance,BP,
13264,GO:0048850,1,0.984007649435047,0,2,hypophysis morphogenesis,BP,
13265,GO:0048852,1,0.978913049463049,0,3,diencephalon morphogenesis,BP,
13266,GO:0048853,1,0.924180858072846,0,13,forebrain morphogenesis,BP,
13267,GO:0048854,1,0.782024892497069,0,35,brain morphogenesis,BP,
13268,GO:0048855,1,0.991886219207067,0,1,adenohypophysis morphogenesis,BP,
13272,GO:0048859,1,0.976028521796571,0,5,formation of anatomical boundary,BP,
13273,GO:0048861,1,0.971942732603175,0,4,leukemia inhibitory factor signaling pathway,BP,
13276,GO:0048865,1,0.958039980385358,0,8,stem cell fate commitment,BP,
13277,GO:0048866,1,0.979621155230777,0,4,stem cell fate specification,BP,
13278,GO:0048867,1,0.9854591415893,0,3,stem cell fate determination,BP,
13282,GO:0048872,1,0.243705491872767,0,225,homeostasis of number of cells,BP,
13283,GO:0048873,1,0.843782413891611,0,27,homeostasis of number of cells within a tissue,BP,
13284,GO:0048874,1,0.992651266995692,0,1,homeostasis of number of cells in a free-living population,BP,
13285,GO:0048875,1,0.942003361397682,0,10,chemical homeostasis within a tissue,BP,
13287,GO:0048880,1,0.971884217707287,0,4,sensory system development,BP,
13288,GO:0048882,1,0.99357385075076,0,1,lateral line development,BP,
13289,GO:0048884,1,0.99357385075076,0,1,neuromast development,BP,
13290,GO:0048886,1,0.99357385075076,0,1,neuromast hair cell differentiation,BP,
13291,GO:0048925,1,0.99357385075076,0,1,lateral line system development,BP,
13292,GO:0048934,1,0.914053987454449,0,13,peripheral nervous system neuron differentiation,BP,
13293,GO:0048935,1,0.914053987454449,0,13,peripheral nervous system neuron development,BP,
13294,GO:0048936,1,0.981426105362749,0,3,peripheral nervous system neuron axonogenesis,BP,
13295,GO:0050000,1,0.632267236828759,0,71,chromosome localization,BP,
13296,GO:0050011,1,0.996166374536362,0,1,itaconyl-CoA hydratase activity,MF,
13297,GO:0050023,1,0.995604965343576,0,1,L-fuconate dehydratase activity,MF,
13298,GO:0050031,1,0.994149087961217,0,1,L-pipecolate oxidase activity,MF,
13299,GO:0050038,1,0.996968924963427,0,1,L-xylulose reductase (NADP+) activity,MF,
13300,GO:0050046,1,0.993301131169352,0,1,lathosterol oxidase activity,MF,
13301,GO:0050051,1,0.988860581976372,0,2,leukotriene-B4 20-monooxygenase activity,MF,
13302,GO:0050072,1,0.958422516081783,0,7,m7G(5')pppN diphosphatase activity,MF,
13303,GO:0050080,1,0.994747519122485,0,1,malonyl-CoA decarboxylase activity,MF,
13304,GO:0050104,1,0.996316110732579,0,1,L-gulonate 3-dehydrogenase activity,MF,
13305,GO:0050115,1,0.992323437932328,0,1,myosin-light-chain-phosphatase activity,MF,
13306,GO:0050119,1,0.983824529445139,0,2,N-acetylglucosamine deacetylase activity,MF,
13307,GO:0050121,1,0.996354671002664,0,1,N-acylglucosamine 2-epimerase activity,MF,
13308,GO:0050124,1,0.992473391987395,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13309,GO:0050129,1,0.992713700058719,0,1,N-formylglutamate deformylase activity,MF,
13310,GO:0050135,1,0.9926843300588,0,2,NAD(P)+ nucleosidase activity,MF,
13311,GO:0050136,1,0.874586678911802,0,38,NADH dehydrogenase (quinone) activity,MF,
13312,GO:0050144,1,0.993301131169352,0,1,nucleoside deoxyribosyltransferase activity,MF,
13313,GO:0050145,1,0.970168646298183,0,5,nucleoside phosphate kinase activity,MF,
13314,GO:0050146,1,0.992210423152949,0,1,nucleoside phosphotransferase activity,MF,
13315,GO:0050152,1,0.996620058489318,0,1,omega-amidase activity,MF,
13316,GO:0050178,1,0.994111838002731,0,2,phenylpyruvate tautomerase activity,MF,
13317,GO:0050185,1,0.986532738906569,0,2,phosphatidylinositol deacylase activity,MF,
13318,GO:0050197,1,0.994416276590203,0,1,phytanate-CoA ligase activity,MF,
13319,GO:0050201,1,0.992462578141831,0,1,fucokinase activity,MF,
13320,GO:0050211,1,0.979685095950809,0,3,procollagen galactosyltransferase activity,MF,
13321,GO:0050220,1,0.984441434357038,0,4,prostaglandin-E synthase activity,MF,
13322,GO:0050221,1,0.996655423776818,0,1,prostaglandin-E2 9-reductase activity,MF,
13323,GO:0050252,1,0.98657207231553,0,2,retinol O-fatty-acyltransferase activity,MF,
13324,GO:0050253,1,0.985644100935041,0,2,retinyl-palmitate esterase activity,MF,
13325,GO:0050254,1,0.989680079199138,0,2,rhodopsin kinase activity,MF,
13326,GO:0050262,1,0.986646673054992,0,2,ribosylnicotinamide kinase activity,MF,
13327,GO:0050265,1,0.977528239254256,0,3,RNA uridylyltransferase activity,MF,
13328,GO:0050277,1,0.992468959800951,0,1,sedoheptulokinase activity,MF,
13329,GO:0050290,1,0.992353741789137,0,1,sphingomyelin phosphodiesterase D activity,MF,
13330,GO:0050291,1,0.956113769308575,0,7,sphingosine N-acyltransferase activity,MF,
13331,GO:0050294,1,0.984484281405475,0,4,steroid sulfotransferase activity,MF,
13332,GO:0050308,1,0.952114627173634,0,8,sugar-phosphatase activity,MF,
13333,GO:0050309,1,0.981908319341345,0,3,sugar-terminal-phosphatase activity,MF,
13334,GO:0050313,1,0.996893837433638,0,1,sulfur dioxygenase activity,MF,
13336,GO:0050333,1,0.995759391964784,0,1,thiamin-triphosphatase activity,MF,
13337,GO:0050337,1,0.997056797276697,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13338,GO:0050346,1,0.993301131169352,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13339,GO:0050347,1,0.98865634785945,0,2,trans-octaprenyltranstransferase activity,MF,
13340,GO:0050353,1,0.993147797100392,0,1,trimethyllysine dioxygenase activity,MF,
13341,GO:0050355,1,0.992404684548203,0,1,triphosphatase activity,MF,
13342,GO:0050379,1,0.992285693639057,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13343,GO:0050405,1,0.98312422863284,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13344,GO:0050421,1,0.993678504419862,0,1,nitrite reductase (NO-forming) activity,MF,
13345,GO:0050427,1,0.881856337006383,0,23,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13346,GO:0050428,1,0.961027174160211,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13347,GO:0050429,1,0.991857002894985,0,1,calcium-dependent phospholipase C activity,MF,
13348,GO:0050431,1,0.870457511199726,0,19,transforming growth factor beta binding,MF,
13349,GO:0050432,1,0.789917590208489,0,39,catecholamine secretion,BP,
13350,GO:0050433,1,0.808867827592091,0,36,regulation of catecholamine secretion,BP,
13351,GO:0050434,1,0.7820823196353,0,41,positive regulation of viral transcription,BP,
13352,GO:0050435,1,0.802594880185569,0,32,amyloid-beta metabolic process,BP,
13353,GO:0050436,1,0.984769528081655,0,2,microfibril binding,MF,
13354,GO:0050444,1,0.992642954865686,0,1,aquacobalamin reductase (NADPH) activity,MF,
13355,GO:0050459,1,0.993301131169352,0,1,ethanolamine-phosphate phospho-lyase activity,MF,
13356,GO:0050462,1,0.996658647993507,0,1,N-acetylneuraminate synthase activity,MF,
13357,GO:0050473,1,0.979645170353227,0,3,arachidonate 15-lipoxygenase activity,MF,
13358,GO:0050479,1,0.993301131169352,0,1,glyceryl-ether monooxygenase activity,MF,
13359,GO:0050480,1,0.994893758025159,0,1,imidazolonepropionase activity,MF,
13360,GO:0050482,1,0.893445115734823,0,19,arachidonic acid secretion,BP,
13361,GO:0050497,1,0.987883904345312,0,2,transferase activity, transferring alkylthio groups,MF,
13362,GO:0050501,1,0.97667406444929,0,4,hyaluronan synthase activity,MF,
13363,GO:0050508,1,0.977701742309446,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13364,GO:0050509,1,0.985134117091165,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13365,GO:0050510,1,0.970664392363595,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13366,GO:0050512,1,0.995027959827431,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13367,GO:0050528,1,0.994209897610073,0,1,acyloxyacyl hydrolase activity,MF,
13368,GO:0050542,1,0.975800322070384,0,6,icosanoid binding,MF,
13369,GO:0050543,1,0.976734581655332,0,6,icosatetraenoic acid binding,MF,
13370,GO:0050544,1,0.979874886294239,0,5,arachidonic acid binding,MF,
13371,GO:0050560,1,0.992601219484349,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13372,GO:0050561,1,0.99246297790169,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13373,GO:0050567,1,0.982928265985629,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13374,GO:0050571,1,0.99613251519293,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13375,GO:0050577,1,0.99651203050754,0,1,GDP-L-fucose synthase activity,MF,
13376,GO:0050610,1,0.993327681997086,0,2,methylarsonate reductase activity,MF,
13377,GO:0050613,1,0.988670335016718,0,2,delta14-sterol reductase activity,MF,
13378,GO:0050614,1,0.992431021941977,0,1,delta24-sterol reductase activity,MF,
13379,GO:0050632,1,0.996435032809324,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13380,GO:0050646,1,0.995842631975229,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13381,GO:0050647,1,0.995842631975229,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13382,GO:0050648,1,0.995842631975229,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13383,GO:0050650,1,0.817279623440175,0,30,chondroitin sulfate proteoglycan biosynthetic process,BP,
13384,GO:0050651,1,0.903688185891867,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13385,GO:0050652,1,0.992482178755659,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13386,GO:0050653,1,0.984998912779946,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13388,GO:0050655,1,0.898934125720619,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13389,GO:0050656,1,0.959498427818371,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13390,GO:0050657,1,0.310212618352906,0,180,nucleic acid transport,BP,
13391,GO:0050658,1,0.310212618352906,0,180,RNA transport,BP,
13392,GO:0050659,1,0.984512152953276,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13393,GO:0050660,1,0.611692367851602,0,77,flavin adenine dinucleotide binding,MF,
13394,GO:0050661,1,0.773314234118566,0,44,NADP binding,MF,
13397,GO:0050664,1,0.922421223275873,0,13,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13398,GO:0050665,1,0.934181707292363,0,11,hydrogen peroxide biosynthetic process,BP,
13399,GO:0050666,1,0.988496463797337,0,2,regulation of homocysteine metabolic process,BP,
13400,GO:0050667,1,0.916597562475511,0,14,homocysteine metabolic process,BP,
13401,GO:0050668,1,0.994539565949337,0,1,positive regulation of homocysteine metabolic process,BP,
13402,GO:0050670,1,0.352808013349116,0,182,regulation of lymphocyte proliferation,BP,
13403,GO:0050671,1,0.520311105369097,0,117,positive regulation of lymphocyte proliferation,BP,
13404,GO:0050672,1,0.681236430837518,0,64,negative regulation of lymphocyte proliferation,BP,
13406,GO:0050674,1,0.997046014162549,0,1,urothelial cell proliferation,BP,
13407,GO:0050675,1,0.997046014162549,0,1,regulation of urothelial cell proliferation,BP,
13408,GO:0050677,1,0.997046014162549,0,1,positive regulation of urothelial cell proliferation,BP,
13412,GO:0050681,1,0.76177967800101,0,41,androgen receptor binding,MF,
13413,GO:0050682,1,0.977269284309386,0,3,AF-2 domain binding,MF,
13414,GO:0050683,1,0.992449592516283,0,1,AF-1 domain binding,MF,
13415,GO:0050684,1,0.482852901045575,0,112,regulation of mRNA processing,BP,
13416,GO:0050685,1,0.86384431503576,0,25,positive regulation of mRNA processing,BP,
13417,GO:0050686,1,0.825157185276467,0,29,negative regulation of mRNA processing,BP,
13418,GO:0050687,1,0.877466154550668,0,21,negative regulation of defense response to virus,BP,
13419,GO:0050688,1,0.693819694527925,0,58,regulation of defense response to virus,BP,
13420,GO:0050689,1,0.976384024367955,0,5,negative regulation of defense response to virus by host,BP,
13421,GO:0050690,1,0.841772350913467,0,29,regulation of defense response to virus by virus,BP,
13422,GO:0050691,1,0.827293013142875,0,32,regulation of defense response to virus by host,BP,
13423,GO:0050692,1,0.980734403787751,0,3,DBD domain binding,MF,
13424,GO:0050693,1,0.965068862097566,0,6,LBD domain binding,MF,
13425,GO:0050694,1,0.978792279874015,0,4,galactose 3-O-sulfotransferase activity,MF,
13426,GO:0050698,1,0.98650591282123,0,2,proteoglycan sulfotransferase activity,MF,
13427,GO:0050699,1,0.836719017073081,0,30,WW domain binding,MF,
13428,GO:0050700,1,0.930200196716061,0,12,CARD domain binding,MF,
13429,GO:0050701,1,0.772856607832708,0,44,interleukin-1 secretion,BP,
13430,GO:0050702,1,0.790940054338901,0,39,interleukin-1 beta secretion,BP,
13431,GO:0050703,1,0.976584651606741,0,5,interleukin-1 alpha secretion,BP,
13432,GO:0050704,1,0.810563255440162,0,37,regulation of interleukin-1 secretion,BP,
13433,GO:0050705,1,0.97947367009717,0,4,regulation of interleukin-1 alpha secretion,BP,
13434,GO:0050706,1,0.827068478443069,0,33,regulation of interleukin-1 beta secretion,BP,
13437,GO:0050709,1,0.532878045511264,0,102,negative regulation of protein secretion,BP,
13438,GO:0050710,1,0.743065636645194,0,49,negative regulation of cytokine secretion,BP,
13439,GO:0050711,1,0.940121373346017,0,11,negative regulation of interleukin-1 secretion,BP,
13440,GO:0050712,1,0.996419444586326,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13441,GO:0050713,1,0.956285486864475,0,8,negative regulation of interleukin-1 beta secretion,BP,
13444,GO:0050716,1,0.857687051097482,0,26,positive regulation of interleukin-1 secretion,BP,
13445,GO:0050717,1,0.982993963823713,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13446,GO:0050718,1,0.866686769497264,0,24,positive regulation of interleukin-1 beta secretion,BP,
13447,GO:0050719,1,0.996964772637378,0,1,interleukin-1 alpha biosynthetic process,BP,
13448,GO:0050720,1,0.989724893070802,0,2,interleukin-1 beta biosynthetic process,BP,
13449,GO:0050721,1,0.996964772637378,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13450,GO:0050722,1,0.989724893070802,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13451,GO:0050725,1,0.989724893070802,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13452,GO:0050726,1,0.996964772637378,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13458,GO:0050732,1,0.762261792881292,0,44,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13459,GO:0050733,1,0.967471385630476,0,5,RS domain binding,MF,
13461,GO:0050747,1,0.97170639801785,0,5,positive regulation of lipoprotein metabolic process,BP,
13463,GO:0050750,1,0.886682399997993,0,18,low-density lipoprotein particle receptor binding,MF,
13464,GO:0050751,1,0.996925838463949,0,1,fractalkine biosynthetic process,BP,
13465,GO:0050752,1,0.996925838463949,0,1,regulation of fractalkine biosynthetic process,BP,
13466,GO:0050754,1,0.996925838463949,0,1,positive regulation of fractalkine biosynthetic process,BP,
13467,GO:0050755,1,0.944512362773513,0,12,chemokine metabolic process,BP,
13468,GO:0050756,1,0.996925838463949,0,1,fractalkine metabolic process,BP,
13469,GO:0050757,1,0.990385900580309,0,2,thymidylate synthase biosynthetic process,BP,
13470,GO:0050758,1,0.990385900580309,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13471,GO:0050760,1,0.993591008221841,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13472,GO:0050764,1,0.668532610317588,0,68,regulation of phagocytosis,BP,
13473,GO:0050765,1,0.93064711699613,0,13,negative regulation of phagocytosis,BP,
13474,GO:0050766,1,0.751096478180297,0,49,positive regulation of phagocytosis,BP,
13482,GO:0050774,1,0.904098912477969,0,15,negative regulation of dendrite morphogenesis,BP,
13483,GO:0050775,1,0.789416397451868,0,32,positive regulation of dendrite morphogenesis,BP,
13485,GO:0050777,1,0.487751135236812,0,118,negative regulation of immune response,BP,
13487,GO:0050779,1,0.839704334084828,0,24,RNA destabilization,BP,
13488,GO:0050780,1,0.917809609265136,0,13,dopamine receptor binding,MF,
13489,GO:0050783,1,0.99407312798456,0,1,cocaine metabolic process,BP,
13490,GO:0050785,1,0.996541344831229,0,1,advanced glycation end-product receptor activity,MF,
13491,GO:0050786,1,0.96523529536682,0,10,RAGE receptor binding,MF,
13492,GO:0050787,1,0.989213778598633,0,2,detoxification of mercury ion,BP,
13495,GO:0050792,1,0.337276730950333,0,178,regulation of viral process,BP,
13500,GO:0050798,1,0.815175543274156,0,36,activated T cell proliferation,BP,
13502,GO:0050802,1,0.898405338421662,0,21,circadian sleep/wake cycle, sleep,BP,
13503,GO:0050803,1,0.321369667257731,0,160,regulation of synapse structure or activity,BP,
13505,GO:0050805,1,0.633255483910688,0,66,negative regulation of synaptic transmission,BP,
13507,GO:0050807,1,0.34587675428887,0,150,regulation of synapse organization,BP,
13509,GO:0050810,1,0.609866755223516,0,77,regulation of steroid biosynthetic process,BP,
13511,GO:0050812,1,0.9110260704596,0,13,regulation of acyl-CoA biosynthetic process,BP,
13512,GO:0050815,1,0.964914482436516,0,6,phosphoserine residue binding,MF,
13513,GO:0050816,1,0.981338982481535,0,3,phosphothreonine residue binding,MF,
13517,GO:0050820,1,0.860658263398428,0,24,positive regulation of coagulation,BP,
13518,GO:0050821,1,0.403400513839865,0,147,protein stabilization,BP,
13519,GO:0050822,1,0.992535343312675,0,1,peptide stabilization,BP,
13520,GO:0050823,1,0.992535343312675,0,1,peptide antigen stabilization,BP,
13521,GO:0050829,1,0.8038462508312,0,47,defense response to Gram-negative bacterium,BP,
13522,GO:0050830,1,0.782901443900383,0,53,defense response to Gram-positive bacterium,BP,
13523,GO:0050832,1,0.899800971952565,0,26,defense response to fungus,BP,
13524,GO:0050833,1,0.975099758147644,0,4,pyruvate transmembrane transporter activity,MF,
13527,GO:0050847,1,0.941392779073972,0,8,progesterone receptor signaling pathway,BP,
13529,GO:0050849,1,0.901018231617339,0,17,negative regulation of calcium-mediated signaling,BP,
13533,GO:0050853,1,0.716492133863904,0,52,B cell receptor signaling pathway,BP,
13534,GO:0050854,1,0.720615665057876,0,52,regulation of antigen receptor-mediated signaling pathway,BP,
13535,GO:0050855,1,0.874814863053877,0,20,regulation of B cell receptor signaling pathway,BP,
13536,GO:0050856,1,0.810202664053999,0,35,regulation of T cell receptor signaling pathway,BP,
13537,GO:0050857,1,0.883752786107681,0,20,positive regulation of antigen receptor-mediated signaling pathway,BP,
13538,GO:0050858,1,0.88025875346515,0,22,negative regulation of antigen receptor-mediated signaling pathway,BP,
13539,GO:0050859,1,0.971337837553023,0,5,negative regulation of B cell receptor signaling pathway,BP,
13540,GO:0050860,1,0.901337580494884,0,18,negative regulation of T cell receptor signaling pathway,BP,
13541,GO:0050861,1,0.954268066441347,0,7,positive regulation of B cell receptor signaling pathway,BP,
13542,GO:0050862,1,0.933345193551649,0,12,positive regulation of T cell receptor signaling pathway,BP,
13544,GO:0050864,1,0.525291349918514,0,106,regulation of B cell activation,BP,
13548,GO:0050868,1,0.587371073484571,0,87,negative regulation of T cell activation,BP,
13549,GO:0050869,1,0.828499958224353,0,31,negative regulation of B cell activation,BP,
13551,GO:0050871,1,0.667906811513105,0,68,positive regulation of B cell activation,BP,
13552,GO:0050872,1,0.927457439335394,0,12,white fat cell differentiation,BP,
13553,GO:0050873,1,0.821684366446667,0,33,brown fat cell differentiation,BP,
13556,GO:0050879,1,0.749692094772341,0,47,multicellular organismal movement,BP,
13558,GO:0050881,1,0.749692094772341,0,47,musculoskeletal movement,BP,
13559,GO:0050882,1,0.950447829886947,0,6,voluntary musculoskeletal movement,BP,
13560,GO:0050883,1,0.993995508641689,0,1,musculoskeletal movement, spinal reflex action,BP,
13561,GO:0050884,1,0.910557185406319,0,14,neuromuscular process controlling posture,BP,
13563,GO:0050886,1,0.644965081330588,0,72,endocrine process,BP,
13565,GO:0050891,1,0.701341659667519,0,52,multicellular organismal water homeostasis,BP,
13566,GO:0050892,1,0.844362792819544,0,26,intestinal absorption,BP,
13567,GO:0050893,1,0.975554291828454,0,4,sensory processing,BP,
13568,GO:0050894,1,0.991791188273253,0,1,determination of affect,BP,
13570,GO:0050897,1,0.991997791072666,0,1,cobalt ion binding,MF,
13572,GO:0050901,1,0.864714119456733,0,24,leukocyte tethering or rolling,BP,
13573,GO:0050902,1,0.986558193586959,0,2,leukocyte adhesive activation,BP,
13574,GO:0050904,1,0.985011306015528,0,2,diapedesis,BP,
13577,GO:0050907,1,0.828772373319533,0,43,detection of chemical stimulus involved in sensory perception,BP,
13578,GO:0050908,1,0.910301494269286,0,14,detection of light stimulus involved in visual perception,BP,
13579,GO:0050909,1,0.795520729198183,0,44,sensory perception of taste,BP,
13580,GO:0050910,1,0.933222223430299,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13581,GO:0050911,1,0.929467419582657,0,18,detection of chemical stimulus involved in sensory perception of smell,BP,
13582,GO:0050912,1,0.904601760798286,0,23,detection of chemical stimulus involved in sensory perception of taste,BP,
13583,GO:0050913,1,0.890603962411332,0,25,sensory perception of bitter taste,BP,
13584,GO:0050915,1,0.973031854399701,0,4,sensory perception of sour taste,BP,
13585,GO:0050916,1,0.972815676107235,0,4,sensory perception of sweet taste,BP,
13586,GO:0050917,1,0.965766021564806,0,5,sensory perception of umami taste,BP,
13587,GO:0050918,1,0.737852238057642,0,51,positive chemotaxis,BP,
13588,GO:0050919,1,0.761468011884836,0,36,negative chemotaxis,BP,
13590,GO:0050921,1,0.506951945736047,0,121,positive regulation of chemotaxis,BP,
13592,GO:0050923,1,0.968804199901064,0,4,regulation of negative chemotaxis,BP,
13593,GO:0050924,1,0.992300744963555,0,1,positive regulation of negative chemotaxis,BP,
13594,GO:0050925,1,0.983626350383974,0,2,negative regulation of negative chemotaxis,BP,
13595,GO:0050926,1,0.861824205061404,0,25,regulation of positive chemotaxis,BP,
13596,GO:0050927,1,0.868585625742377,0,24,positive regulation of positive chemotaxis,BP,
13597,GO:0050928,1,0.99222696368551,0,1,negative regulation of positive chemotaxis,BP,
13598,GO:0050929,1,0.992300744963555,0,1,induction of negative chemotaxis,BP,
13599,GO:0050930,1,0.938966112748199,0,13,induction of positive chemotaxis,BP,
13601,GO:0050932,1,0.938461023146829,0,9,regulation of pigment cell differentiation,BP,
13602,GO:0050942,1,0.94698540542604,0,7,positive regulation of pigment cell differentiation,BP,
13603,GO:0050951,1,0.882520139601071,0,19,sensory perception of temperature stimulus,BP,
13604,GO:0050953,1,0.345373306577088,0,167,sensory perception of light stimulus,BP,
13606,GO:0050955,1,0.984624334282742,0,2,thermoception,BP,
13607,GO:0050957,1,0.954856701691861,0,6,equilibrioception,BP,
13608,GO:0050960,1,0.992447442233007,0,1,detection of temperature stimulus involved in thermoception,BP,
13609,GO:0050961,1,0.915746740096824,0,14,detection of temperature stimulus involved in sensory perception,BP,
13610,GO:0050962,1,0.910301494269286,0,14,detection of light stimulus involved in sensory perception,BP,
13611,GO:0050965,1,0.915746740096824,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13612,GO:0050966,1,0.945374625767855,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13613,GO:0050968,1,0.985798644112311,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13615,GO:0050975,1,0.98344824559202,0,3,sensory perception of touch,BP,
13616,GO:0050976,1,0.98708505008948,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13618,GO:0050992,1,0.994907241611646,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13619,GO:0050993,1,0.994907241611646,0,1,dimethylallyl diphosphate metabolic process,BP,
13620,GO:0050994,1,0.765914822884932,0,43,regulation of lipid catabolic process,BP,
13621,GO:0050995,1,0.898675545274441,0,17,negative regulation of lipid catabolic process,BP,
13622,GO:0050996,1,0.901943878752128,0,17,positive regulation of lipid catabolic process,BP,
13624,GO:0050998,1,0.918409718602501,0,12,nitric-oxide synthase binding,MF,
13626,GO:0051000,1,0.897565904398826,0,17,positive regulation of nitric-oxide synthase activity,BP,
13627,GO:0051001,1,0.966089972215833,0,6,negative regulation of nitric-oxide synthase activity,BP,
13629,GO:0051005,1,0.984456705949466,0,3,negative regulation of lipoprotein lipase activity,BP,
13630,GO:0051006,1,0.968230047499856,0,7,positive regulation of lipoprotein lipase activity,BP,
13631,GO:0051010,1,0.896173676419652,0,13,microtubule plus-end binding,MF,
13632,GO:0051011,1,0.927877453684527,0,9,microtubule minus-end binding,MF,
13633,GO:0051012,1,0.988215346731083,0,2,microtubule sliding,BP,
13634,GO:0051013,1,0.95418531610218,0,7,microtubule severing,BP,
13635,GO:0051014,1,0.950302280021849,0,8,actin filament severing,BP,
13637,GO:0051016,1,0.913886533915561,0,14,barbed-end actin filament capping,BP,
13638,GO:0051017,1,0.39098150862965,0,139,actin filament bundle assembly,BP,
13640,GO:0051019,1,0.838283959592852,0,26,mitogen-activated protein kinase binding,MF,
13642,GO:0051021,1,0.97305539117839,0,5,GDP-dissociation inhibitor binding,MF,
13643,GO:0051022,1,0.976654162773572,0,4,Rho GDP-dissociation inhibitor binding,MF,
13644,GO:0051023,1,0.931160677915274,0,15,regulation of immunoglobulin secretion,BP,
13645,GO:0051024,1,0.960505529088982,0,9,positive regulation of immunoglobulin secretion,BP,
13646,GO:0051025,1,0.986462088635745,0,2,negative regulation of immunoglobulin secretion,BP,
13647,GO:0051026,1,0.962929638186912,0,6,chiasma assembly,BP,
13648,GO:0051028,1,0.400080900512045,0,138,mRNA transport,BP,
13649,GO:0051029,1,0.970742697920974,0,6,rRNA transport,BP,
13650,GO:0051030,1,0.983757527245478,0,4,snRNA transport,BP,
13651,GO:0051031,1,0.805465781364893,0,32,tRNA transport,BP,
13652,GO:0051032,1,0.984810286936975,0,2,nucleic acid transmembrane transporter activity,MF,
13653,GO:0051033,1,0.984810286936975,0,2,RNA transmembrane transporter activity,MF,
13654,GO:0051036,1,0.973124058661818,0,5,regulation of endosome size,BP,
13655,GO:0051040,1,0.985474660697112,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13656,GO:0051041,1,0.992659845080405,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13657,GO:0051042,1,0.992762238217727,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13658,GO:0051043,1,0.877074409461818,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13659,GO:0051044,1,0.922100152443922,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13660,GO:0051045,1,0.951210662321982,0,8,negative regulation of membrane protein ectodomain proteolysis,BP,
13670,GO:0051055,1,0.760687036543051,0,44,negative regulation of lipid biosynthetic process,BP,
13673,GO:0051058,1,0.689226925546323,0,52,negative regulation of small GTPase mediated signal transduction,BP,
13674,GO:0051059,1,0.853488082778236,0,28,NF-kappaB binding,MF,
13675,GO:0051066,1,0.991455425499039,0,2,dihydrobiopterin metabolic process,BP,
13676,GO:0051068,1,0.992509688600802,0,1,dihydrolipoamide metabolic process,BP,
13677,GO:0051081,1,0.73961271610895,0,46,nuclear envelope disassembly,BP,
13678,GO:0051082,1,0.538218847167537,0,108,unfolded protein binding,MF,
13679,GO:0051083,1,0.99062480874865,0,2,'de novo' cotranslational protein folding,BP,
13680,GO:0051084,1,0.820571198231799,0,32,'de novo' posttranslational protein folding,BP,
13681,GO:0051085,1,0.846391920679544,0,27,chaperone cofactor-dependent protein refolding,BP,
13682,GO:0051086,1,0.995351598596425,0,1,chaperone mediated protein folding independent of cofactor,BP,
13684,GO:0051088,1,0.977603566575591,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13685,GO:0051089,1,0.992461727690553,0,1,constitutive protein ectodomain proteolysis,BP,
13691,GO:0051095,1,0.94359321771211,0,9,regulation of helicase activity,BP,
13692,GO:0051096,1,0.960988266847225,0,6,positive regulation of helicase activity,BP,
13693,GO:0051097,1,0.981906224358389,0,3,negative regulation of helicase activity,BP,
13696,GO:0051100,1,0.408228897506743,0,147,negative regulation of binding,BP,
13697,GO:0051101,1,0.514321243369635,0,110,regulation of DNA binding,BP,
13698,GO:0051102,1,0.99245412319183,0,1,DNA ligation involved in DNA recombination,BP,
13699,GO:0051103,1,0.938484558845963,0,11,DNA ligation involved in DNA repair,BP,
13700,GO:0051105,1,0.962575951193126,0,6,regulation of DNA ligation,BP,
13701,GO:0051106,1,0.969284400986809,0,5,positive regulation of DNA ligation,BP,
13702,GO:0051107,1,0.993081206805305,0,1,negative regulation of DNA ligation,BP,
13705,GO:0051120,1,0.980513748690027,0,3,hepoxilin A3 synthase activity,MF,
13706,GO:0051121,1,0.968310917722823,0,5,hepoxilin metabolic process,BP,
13707,GO:0051122,1,0.968310917722823,0,5,hepoxilin biosynthetic process,BP,
13708,GO:0051123,1,0.837179643166583,0,31,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13709,GO:0051124,1,0.924410013925145,0,10,synaptic growth at neuromuscular junction,BP,
13710,GO:0051125,1,0.834204172880412,0,27,regulation of actin nucleation,BP,
13711,GO:0051126,1,0.962334912819814,0,7,negative regulation of actin nucleation,BP,
13712,GO:0051127,1,0.894793640947758,0,15,positive regulation of actin nucleation,BP,
13716,GO:0051131,1,0.899241191882221,0,18,chaperone-mediated protein complex assembly,BP,
13717,GO:0051132,1,0.959764633829425,0,8,NK T cell activation,BP,
13718,GO:0051133,1,0.971012001120807,0,6,regulation of NK T cell activation,BP,
13719,GO:0051134,1,0.995540255346228,0,1,negative regulation of NK T cell activation,BP,
13720,GO:0051135,1,0.97536300119849,0,5,positive regulation of NK T cell activation,BP,
13721,GO:0051136,1,0.96056760842001,0,6,regulation of NK T cell differentiation,BP,
13722,GO:0051138,1,0.971844578991838,0,4,positive regulation of NK T cell differentiation,BP,
13723,GO:0051139,1,0.984694849202312,0,2,metal ion:proton antiporter activity,MF,
13724,GO:0051140,1,0.986285513095966,0,3,regulation of NK T cell proliferation,BP,
13725,GO:0051142,1,0.986285513095966,0,3,positive regulation of NK T cell proliferation,BP,
13726,GO:0051145,1,0.720383229408915,0,51,smooth muscle cell differentiation,BP,
13731,GO:0051150,1,0.846244604672558,0,26,regulation of smooth muscle cell differentiation,BP,
13732,GO:0051151,1,0.930360897358906,0,11,negative regulation of smooth muscle cell differentiation,BP,
13733,GO:0051152,1,0.93723547761706,0,11,positive regulation of smooth muscle cell differentiation,BP,
13737,GO:0051156,1,0.866898902165285,0,26,glucose 6-phosphate metabolic process,BP,
13738,GO:0051160,1,0.993856193451521,0,1,L-xylitol catabolic process,BP,
13739,GO:0051164,1,0.993856193451521,0,1,L-xylitol metabolic process,BP,
13740,GO:0051167,1,0.976204530142074,0,5,xylulose 5-phosphate metabolic process,BP,
13741,GO:0051168,1,0.292316810274902,0,191,nuclear export,BP,
13748,GO:0051176,1,0.979505943272871,0,3,positive regulation of sulfur metabolic process,BP,
13749,GO:0051177,1,0.965489775565306,0,6,meiotic sister chromatid cohesion,BP,
13753,GO:0051182,1,0.94765094950652,0,8,coenzyme transport,BP,
13754,GO:0051184,1,0.871112055881697,0,20,cofactor transmembrane transporter activity,MF,
13755,GO:0051185,1,0.961643631472893,0,6,coenzyme transmembrane transporter activity,MF,
13757,GO:0051187,1,0.797383303715124,0,45,cofactor catabolic process,BP,
13759,GO:0051189,1,0.959736145924035,0,7,prosthetic group metabolic process,BP,
13760,GO:0051192,1,0.994083656276557,0,2,prosthetic group binding,MF,
13763,GO:0051195,1,0.91061954330498,0,16,negative regulation of cofactor metabolic process,BP,
13766,GO:0051198,1,0.939696899442684,0,10,negative regulation of coenzyme metabolic process,BP,
13767,GO:0051204,1,0.825616889907553,0,34,protein insertion into mitochondrial membrane,BP,
13771,GO:0051213,1,0.576635054763796,0,85,dioxygenase activity,MF,
13773,GO:0051219,1,0.599211794355636,0,74,phosphoprotein binding,MF,
13774,GO:0051220,1,0.859165276934092,0,24,cytoplasmic sequestering of protein,BP,
13778,GO:0051225,1,0.486430300847922,0,106,spindle assembly,BP,
13779,GO:0051228,1,0.992251454273805,0,1,mitotic spindle disassembly,BP,
13780,GO:0051230,1,0.992251454273805,0,1,spindle disassembly,BP,
13781,GO:0051231,1,0.931188948229795,0,11,spindle elongation,BP,
13782,GO:0051232,1,0.994255125639043,0,1,meiotic spindle elongation,BP,
13783,GO:0051233,1,0.812099032443575,0,31,spindle midzone,CC,
13786,GO:0051236,1,0.302197142661037,0,183,establishment of RNA localization,BP,
13787,GO:0051238,1,0.928081880181768,0,14,sequestering of metal ion,BP,
13795,GO:0051250,1,0.492029418776522,0,117,negative regulation of lymphocyte activation,BP,
13800,GO:0051255,1,0.938596999390235,0,10,spindle midzone assembly,BP,
13801,GO:0051256,1,0.951321565533222,0,8,mitotic spindle midzone assembly,BP,
13802,GO:0051257,1,0.994008371687069,0,1,meiotic spindle midzone assembly,BP,
13805,GO:0051260,1,0.159012810203644,0,295,protein homooligomerization,BP,
13806,GO:0051261,1,0.512531061371203,0,96,protein depolymerization,BP,
13807,GO:0051262,1,0.473648977054712,0,125,protein tetramerization,BP,
13808,GO:0051264,1,0.993235863107959,0,1,mono-olein transacylation activity,MF,
13809,GO:0051265,1,0.993235863107959,0,1,diolein transacylation activity,MF,
13810,GO:0051267,1,0.992677817528563,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13816,GO:0051280,1,0.930352637807623,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13820,GO:0051284,1,0.9184271281031,0,14,positive regulation of sequestering of calcium ion,BP,
13821,GO:0051286,1,0.948969724090496,0,7,cell tip,CC,
13823,GO:0051289,1,0.640353894191953,0,75,protein homotetramerization,BP,
13824,GO:0051290,1,0.85519239775278,0,28,protein heterotetramerization,BP,
13825,GO:0051291,1,0.54028435191177,0,100,protein heterooligomerization,BP,
13826,GO:0051292,1,0.931236234791748,0,10,nuclear pore complex assembly,BP,
13827,GO:0051293,1,0.78548382917404,0,34,establishment of spindle localization,BP,
13828,GO:0051294,1,0.838637252031636,0,26,establishment of spindle orientation,BP,
13829,GO:0051295,1,0.968580934625377,0,4,establishment of meiotic spindle localization,BP,
13830,GO:0051298,1,0.647168795297397,0,62,centrosome duplication,BP,
13831,GO:0051299,1,0.898449306061152,0,16,centrosome separation,BP,
13832,GO:0051300,1,0.993301131169352,0,1,spindle pole body organization,BP,
13834,GO:0051302,1,0.410791748683452,0,138,regulation of cell division,BP,
13835,GO:0051303,1,0.637239246146749,0,70,establishment of chromosome localization,BP,
13836,GO:0051304,1,0.614643277788908,0,75,chromosome separation,BP,
13837,GO:0051305,1,0.954974309183696,0,6,chromosome movement towards spindle pole,BP,
13838,GO:0051306,1,0.708523706600975,0,54,mitotic sister chromatid separation,BP,
13839,GO:0051307,1,0.898500506391011,0,16,meiotic chromosome separation,BP,
13840,GO:0051308,1,0.993301131169352,0,1,male meiosis chromosome separation,BP,
13841,GO:0051310,1,0.709616257772675,0,55,metaphase plate congression,BP,
13842,GO:0051311,1,0.994008371687069,0,1,meiotic metaphase plate congression,BP,
13843,GO:0051315,1,0.920603441681236,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
13844,GO:0051316,1,0.987918733776558,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13845,GO:0051321,1,0.270932233380525,0,202,meiotic cell cycle,BP,
13848,GO:0051339,1,0.775699548887535,0,42,regulation of lyase activity,BP,
13849,GO:0051340,1,0.955636092326734,0,9,regulation of ligase activity,BP,
13851,GO:0051342,1,0.954237040989601,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13852,GO:0051343,1,0.976677324462055,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13853,GO:0051344,1,0.970076815524072,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13858,GO:0051349,1,0.91713537689866,0,15,positive regulation of lyase activity,BP,
13859,GO:0051350,1,0.864275410087516,0,24,negative regulation of lyase activity,BP,
13860,GO:0051351,1,0.966700778261941,0,7,positive regulation of ligase activity,BP,
13861,GO:0051352,1,0.98855819564704,0,2,negative regulation of ligase activity,BP,
13862,GO:0051353,1,0.78264349476564,0,41,positive regulation of oxidoreductase activity,BP,
13863,GO:0051354,1,0.893757710802067,0,20,negative regulation of oxidoreductase activity,BP,
13864,GO:0051355,1,0.992471847285516,0,1,proprioception involved in equilibrioception,BP,
13865,GO:0051365,1,0.980270633890745,0,3,cellular response to potassium ion starvation,BP,
13867,GO:0051373,1,0.972053284743487,0,5,FATZ binding,MF,
13868,GO:0051377,1,0.977838004279537,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13869,GO:0051378,1,0.937495358233271,0,11,serotonin binding,MF,
13870,GO:0051379,1,0.961375884226326,0,7,epinephrine binding,MF,
13871,GO:0051380,1,0.971217935548626,0,5,norepinephrine binding,MF,
13872,GO:0051382,1,0.913287730290747,0,14,kinetochore assembly,BP,
13873,GO:0051383,1,0.88437771331038,0,19,kinetochore organization,BP,
13875,GO:0051385,1,0.849268006881965,0,28,response to mineralocorticoid,BP,
13876,GO:0051386,1,0.942890145803814,0,9,regulation of neurotrophin TRK receptor signaling pathway,BP,
13877,GO:0051387,1,0.982970524758122,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13878,GO:0051388,1,0.970820726215481,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13879,GO:0051389,1,0.982355933101984,0,2,inactivation of MAPKK activity,BP,
13880,GO:0051391,1,0.992460608132532,0,1,tRNA acetylation,BP,
13881,GO:0051392,1,0.992460608132532,0,1,tRNA N-acetyltransferase activity,MF,
13886,GO:0051409,1,0.939836934407742,0,10,response to nitrosative stress,BP,
13887,GO:0051410,1,0.972652065272673,0,5,detoxification of nitrogen compound,BP,
13888,GO:0051412,1,0.907156688537493,0,16,response to corticosterone,BP,
13889,GO:0051413,1,0.993901324201247,0,1,response to cortisone,BP,
13890,GO:0051414,1,0.965611226543446,0,5,response to cortisol,BP,
13891,GO:0051415,1,0.963826880477219,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13892,GO:0051417,1,0.993301131169352,0,1,microtubule nucleation by spindle pole body,BP,
13893,GO:0051418,1,0.947599012602409,0,7,microtubule nucleation by microtubule organizing center,BP,
13894,GO:0051424,1,0.995659008820807,0,1,corticotropin-releasing hormone binding,MF,
13895,GO:0051425,1,0.968777204867596,0,4,PTB domain binding,MF,
13897,GO:0051428,1,0.920841996673443,0,17,peptide hormone receptor binding,MF,
13898,GO:0051429,1,0.978079617598714,0,5,corticotropin-releasing hormone receptor binding,MF,
13899,GO:0051430,1,0.981667781596543,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13900,GO:0051431,1,0.990046703035167,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13901,GO:0051433,1,0.992392233939906,0,1,BH2 domain binding,MF,
13902,GO:0051434,1,0.972295489759111,0,5,BH3 domain binding,MF,
13903,GO:0051438,1,0.732650962421521,0,51,regulation of ubiquitin-protein transferase activity,BP,
13904,GO:0051443,1,0.820883998153956,0,32,positive regulation of ubiquitin-protein transferase activity,BP,
13905,GO:0051444,1,0.927109351102827,0,14,negative regulation of ubiquitin-protein transferase activity,BP,
13906,GO:0051445,1,0.786365046258547,0,38,regulation of meiotic cell cycle,BP,
13907,GO:0051446,1,0.914092911400302,0,14,positive regulation of meiotic cell cycle,BP,
13908,GO:0051447,1,0.915072795203083,0,14,negative regulation of meiotic cell cycle,BP,
13909,GO:0051450,1,0.8956015676407,0,18,myoblast proliferation,BP,
13910,GO:0051451,1,0.932418788336818,0,11,myoblast migration,BP,
13911,GO:0051452,1,0.771147913305854,0,47,intracellular pH reduction,BP,
13912,GO:0051453,1,0.584276480851133,0,85,regulation of intracellular pH,BP,
13913,GO:0051454,1,0.973740100752576,0,4,intracellular pH elevation,BP,
13914,GO:0051455,1,0.993301131169352,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13915,GO:0051456,1,0.994581681901921,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13916,GO:0051457,1,0.865245108261172,0,22,maintenance of protein location in nucleus,BP,
13917,GO:0051458,1,0.9656405019002,0,7,corticotropin secretion,BP,
13918,GO:0051459,1,0.971693715802366,0,6,regulation of corticotropin secretion,BP,
13919,GO:0051460,1,0.995659008820807,0,1,negative regulation of corticotropin secretion,BP,
13920,GO:0051461,1,0.975931300245241,0,5,positive regulation of corticotropin secretion,BP,
13921,GO:0051462,1,0.976051083014931,0,5,regulation of cortisol secretion,BP,
13922,GO:0051463,1,0.991912611128137,0,1,negative regulation of cortisol secretion,BP,
13923,GO:0051464,1,0.984010490686083,0,4,positive regulation of cortisol secretion,BP,
13924,GO:0051466,1,0.992697729352287,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13926,GO:0051481,1,0.932846144879342,0,9,negative regulation of cytosolic calcium ion concentration,BP,
13927,GO:0051482,1,0.853377555739739,0,27,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
13928,GO:0051489,1,0.759550043727432,0,39,regulation of filopodium assembly,BP,
13929,GO:0051490,1,0.989230723398236,0,2,negative regulation of filopodium assembly,BP,
13930,GO:0051491,1,0.819830089886691,0,28,positive regulation of filopodium assembly,BP,
13931,GO:0051492,1,0.600481731096842,0,75,regulation of stress fiber assembly,BP,
13934,GO:0051495,1,0.280996662262951,0,199,positive regulation of cytoskeleton organization,BP,
13935,GO:0051496,1,0.735348748762449,0,47,positive regulation of stress fiber assembly,BP,
13936,GO:0051497,1,0.872577696409635,0,20,negative regulation of stress fiber assembly,BP,
13937,GO:0051499,1,0.989833705528101,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13938,GO:0051500,1,0.989833705528101,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13940,GO:0051525,1,0.966765882476247,0,5,NFAT protein binding,MF,
13941,GO:0051536,1,0.704632812599417,0,61,iron-sulfur cluster binding,MF,
13942,GO:0051537,1,0.90099580685605,0,20,2 iron, 2 sulfur cluster binding,MF,
13943,GO:0051538,1,0.98270826738188,0,3,3 iron, 4 sulfur cluster binding,MF,
13944,GO:0051539,1,0.789428414756868,0,40,4 iron, 4 sulfur cluster binding,MF,
13945,GO:0051540,1,0.704632812599417,0,61,metal cluster binding,MF,
13946,GO:0051541,1,0.975101597193208,0,4,elastin metabolic process,BP,
13947,GO:0051542,1,0.985475315428497,0,2,elastin biosynthetic process,BP,
13948,GO:0051543,1,0.994300565237022,0,1,regulation of elastin biosynthetic process,BP,
13949,GO:0051545,1,0.994300565237022,0,1,negative regulation of elastin biosynthetic process,BP,
13950,GO:0051546,1,0.913576518881282,0,14,keratinocyte migration,BP,
13951,GO:0051547,1,0.940402972447438,0,9,regulation of keratinocyte migration,BP,
13952,GO:0051548,1,0.992145346119027,0,1,negative regulation of keratinocyte migration,BP,
13953,GO:0051549,1,0.947852157876795,0,8,positive regulation of keratinocyte migration,BP,
13954,GO:0051552,1,0.991902207274696,0,1,flavone metabolic process,BP,
13955,GO:0051560,1,0.873605154113607,0,21,mitochondrial calcium ion homeostasis,BP,
13956,GO:0051561,1,0.942350077512339,0,10,positive regulation of mitochondrial calcium ion concentration,BP,
13957,GO:0051562,1,0.983195783007258,0,3,negative regulation of mitochondrial calcium ion concentration,BP,
13958,GO:0051563,1,0.984582972361232,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13959,GO:0051567,1,0.810061938217642,0,29,histone H3-K9 methylation,BP,
13960,GO:0051568,1,0.719394850841652,0,48,histone H3-K4 methylation,BP,
13961,GO:0051569,1,0.846836295025256,0,24,regulation of histone H3-K4 methylation,BP,
13962,GO:0051570,1,0.866447726475704,0,20,regulation of histone H3-K9 methylation,BP,
13963,GO:0051571,1,0.898301228569905,0,15,positive regulation of histone H3-K4 methylation,BP,
13964,GO:0051572,1,0.979118110136801,0,3,negative regulation of histone H3-K4 methylation,BP,
13965,GO:0051573,1,0.933086832244627,0,10,negative regulation of histone H3-K9 methylation,BP,
13966,GO:0051574,1,0.937132887725409,0,9,positive regulation of histone H3-K9 methylation,BP,
13967,GO:0051575,1,0.965813675663719,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13968,GO:0051580,1,0.914877572375696,0,15,regulation of neurotransmitter uptake,BP,
13969,GO:0051581,1,0.975439362757606,0,4,negative regulation of neurotransmitter uptake,BP,
13970,GO:0051582,1,0.980995742151118,0,4,positive regulation of neurotransmitter uptake,BP,
13971,GO:0051583,1,0.939715573126902,0,11,dopamine uptake involved in synaptic transmission,BP,
13972,GO:0051584,1,0.964210942187278,0,7,regulation of dopamine uptake involved in synaptic transmission,BP,
13973,GO:0051585,1,0.992742752447207,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13974,GO:0051586,1,0.986370463737395,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13975,GO:0051588,1,0.576536802135706,0,84,regulation of neurotransmitter transport,BP,
13976,GO:0051589,1,0.879039808642573,0,19,negative regulation of neurotransmitter transport,BP,
13977,GO:0051590,1,0.848409813359475,0,26,positive regulation of neurotransmitter transport,BP,
13980,GO:0051593,1,0.943024851411472,0,11,response to folic acid,BP,
13981,GO:0051594,1,0.978628510619759,0,4,detection of glucose,BP,
13982,GO:0051595,1,0.985217772609978,0,3,response to methylglyoxal,BP,
13983,GO:0051596,1,0.989183905775666,0,2,methylglyoxal catabolic process,BP,
13984,GO:0051597,1,0.955468475060259,0,7,response to methylmercury,BP,
13985,GO:0051598,1,0.992382425474556,0,1,meiotic recombination checkpoint,BP,
13986,GO:0051599,1,0.965112483688761,0,5,response to hydrostatic pressure,BP,
13987,GO:0051601,1,0.948330319822858,0,8,exocyst localization,BP,
13988,GO:0051602,1,0.787945632470537,0,39,response to electrical stimulus,BP,
13989,GO:0051603,1,0.017141839672043,0,627,proteolysis involved in cellular protein catabolic process,BP,
13992,GO:0051607,1,0.316571352583643,0,188,defense response to virus,BP,
13993,GO:0051608,1,0.94637567808888,0,10,histamine transport,BP,
13994,GO:0051610,1,0.972947918587964,0,4,serotonin uptake,BP,
13995,GO:0051611,1,0.980406958537195,0,3,regulation of serotonin uptake,BP,
13996,GO:0051612,1,0.980406958537195,0,3,negative regulation of serotonin uptake,BP,
13997,GO:0051615,1,0.992121613368112,0,1,histamine uptake,BP,
13998,GO:0051620,1,0.992742752447207,0,1,norepinephrine uptake,BP,
13999,GO:0051621,1,0.992742752447207,0,1,regulation of norepinephrine uptake,BP,
14000,GO:0051622,1,0.992742752447207,0,1,negative regulation of norepinephrine uptake,BP,
14001,GO:0051639,1,0.943618779593224,0,8,actin filament network formation,BP,
14004,GO:0051642,1,0.844993373491641,0,22,centrosome localization,BP,
14005,GO:0051643,1,0.960295231863737,0,5,endoplasmic reticulum localization,BP,
14006,GO:0051645,1,0.915314580760697,0,13,Golgi localization,BP,
14007,GO:0051646,1,0.762146725761921,0,39,mitochondrion localization,BP,
14008,GO:0051647,1,0.849690646927552,0,22,nucleus localization,BP,
14013,GO:0051653,1,0.760891818739203,0,38,spindle localization,BP,
14014,GO:0051654,1,0.87768653422085,0,19,establishment of mitochondrion localization,BP,
14016,GO:0051657,1,0.92449606165642,0,10,maintenance of organelle location,BP,
14017,GO:0051659,1,0.987144700861331,0,2,maintenance of mitochondrion location,BP,
14018,GO:0051660,1,0.969992959820053,0,4,establishment of centrosome localization,BP,
14019,GO:0051661,1,0.958273365751778,0,5,maintenance of centrosome location,BP,
14020,GO:0051664,1,0.985793607386776,0,2,nuclear pore localization,BP,
14022,GO:0051666,1,0.965760887148933,0,5,actin cortical patch localization,BP,
14024,GO:0051673,1,0.974315104620744,0,7,membrane disruption in other organism,BP,
14026,GO:0051683,1,0.960055615864347,0,7,establishment of Golgi localization,BP,
14027,GO:0051684,1,0.977131281367878,0,3,maintenance of Golgi location,BP,
14028,GO:0051685,1,0.993301131169352,0,1,maintenance of ER location,BP,
14029,GO:0051686,1,0.989496331893906,0,1,establishment of ER localization,BP,
14030,GO:0051691,1,0.995991896528435,0,1,cellular oligosaccharide metabolic process,BP,
14031,GO:0051692,1,0.995991896528435,0,1,cellular oligosaccharide catabolic process,BP,
14032,GO:0051693,1,0.802372699561087,0,31,actin filament capping,BP,
14033,GO:0051694,1,0.960574756635971,0,6,pointed-end actin filament capping,BP,
14034,GO:0051695,1,0.992392932805626,0,1,actin filament uncapping,BP,
14035,GO:0051697,1,0.979307037896799,0,4,protein delipidation,BP,
14037,GO:0051702,1,0.690959551323693,0,64,interaction with symbiont,BP,
14038,GO:0051703,1,0.707028775425528,0,49,intraspecies interaction between organisms,BP,
14040,GO:0051705,1,0.646042780736594,0,63,multi-organism behavior,BP,
14042,GO:0051708,1,0.992658988004991,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14043,GO:0051709,1,0.948500988526696,0,10,regulation of killing of cells of other organism,BP,
14044,GO:0051710,1,0.996902801562181,0,1,regulation of cytolysis in other organism,BP,
14045,GO:0051712,1,0.955414651141192,0,9,positive regulation of killing of cells of other organism,BP,
14046,GO:0051714,1,0.996902801562181,0,1,positive regulation of cytolysis in other organism,BP,
14047,GO:0051715,1,0.982140077828739,0,4,cytolysis in other organism,BP,
14049,GO:0051717,1,0.985365399938567,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14050,GO:0051721,1,0.828800411747575,0,27,protein phosphatase 2A binding,MF,
14051,GO:0051722,1,0.994029015219302,0,1,protein C-terminal methylesterase activity,MF,
14052,GO:0051723,1,0.994029015219302,0,1,protein methylesterase activity,MF,
14053,GO:0051724,1,0.994551789174507,0,1,NAD transmembrane transporter activity,MF,
14054,GO:0051725,1,0.977524094170927,0,4,protein de-ADP-ribosylation,BP,
14056,GO:0051728,1,0.992945188475223,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14057,GO:0051729,1,0.992945188475223,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14058,GO:0051731,1,0.975495974527014,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14059,GO:0051732,1,0.995863968126632,0,1,polyribonucleotide kinase activity,MF,
14060,GO:0051733,1,0.98358997765909,0,3,polydeoxyribonucleotide kinase activity,MF,
14061,GO:0051734,1,0.98358997765909,0,3,ATP-dependent polynucleotide kinase activity,MF,
14062,GO:0051736,1,0.995863968126632,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14063,GO:0051747,1,0.993114823734449,0,2,cytosine C-5 DNA demethylase activity,MF,
14064,GO:0051748,1,0.994880262686372,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14065,GO:0051750,1,0.996630186162235,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14066,GO:0051754,1,0.972840689205161,0,4,meiotic sister chromatid cohesion, centromeric,BP,
14067,GO:0051758,1,0.991865890349899,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14068,GO:0051764,1,0.92529391275026,0,11,actin crosslink formation,BP,
14069,GO:0051765,1,0.988461815957535,0,2,inositol tetrakisphosphate kinase activity,MF,
14070,GO:0051766,1,0.961825059854072,0,6,inositol trisphosphate kinase activity,MF,
14071,GO:0051767,1,0.898079549815115,0,17,nitric-oxide synthase biosynthetic process,BP,
14072,GO:0051769,1,0.898079549815115,0,17,regulation of nitric-oxide synthase biosynthetic process,BP,
14073,GO:0051770,1,0.911433087136902,0,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,
14074,GO:0051771,1,0.985362908076541,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14075,GO:0051775,1,0.935729790614819,0,11,response to redox state,BP,
14076,GO:0051780,1,0.99244707801265,0,1,behavioral response to nutrient,BP,
14077,GO:0051781,1,0.643733522088858,0,71,positive regulation of cell division,BP,
14080,GO:0051784,1,0.714101939119518,0,54,negative regulation of nuclear division,BP,
14081,GO:0051785,1,0.698426240215204,0,55,positive regulation of nuclear division,BP,
14082,GO:0051786,1,0.992627749865872,0,1,all-trans-retinol 13,14-reductase activity,MF,
14083,GO:0051787,1,0.848377839687551,0,26,misfolded protein binding,MF,
14084,GO:0051788,1,0.861499418716881,0,23,response to misfolded protein,BP,
14085,GO:0051790,1,0.977114716314855,0,4,short-chain fatty acid biosynthetic process,BP,
14086,GO:0051791,1,0.948287941612027,0,10,medium-chain fatty acid metabolic process,BP,
14087,GO:0051792,1,0.975549670373871,0,5,medium-chain fatty acid biosynthetic process,BP,
14088,GO:0051793,1,0.972863844776767,0,5,medium-chain fatty acid catabolic process,BP,
14089,GO:0051794,1,0.976586369688277,0,4,regulation of timing of catagen,BP,
14090,GO:0051795,1,0.984035389824573,0,3,positive regulation of timing of catagen,BP,
14091,GO:0051796,1,0.992431393876814,0,1,negative regulation of timing of catagen,BP,
14092,GO:0051797,1,0.895564681374764,0,18,regulation of hair follicle development,BP,
14093,GO:0051798,1,0.94462196352657,0,11,positive regulation of hair follicle development,BP,
14094,GO:0051799,1,0.977338152234243,0,3,negative regulation of hair follicle development,BP,
14095,GO:0051800,1,0.9878496189609,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14096,GO:0051801,1,0.988076646067103,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14097,GO:0051805,1,0.98573096451553,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14099,GO:0051807,1,0.98573096451553,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14100,GO:0051808,1,0.994147771284504,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14101,GO:0051817,1,0.564646104387675,0,93,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14102,GO:0051818,1,0.93996136718288,0,15,disruption of cells of other organism involved in symbiotic interaction,BP,
14103,GO:0051821,1,0.99187803539675,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14104,GO:0051823,1,0.937734555451183,0,9,regulation of synapse structural plasticity,BP,
14106,GO:0051832,1,0.972720011526572,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14107,GO:0051833,1,0.992241678186921,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
14108,GO:0051834,1,0.972720011526572,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14109,GO:0051835,1,0.974151144626694,0,4,positive regulation of synapse structural plasticity,BP,
14110,GO:0051836,1,0.951651493463513,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
14111,GO:0051851,1,0.708690787153375,0,60,modification by host of symbiont morphology or physiology,BP,
14112,GO:0051852,1,0.961761638557157,0,11,disruption by host of symbiont cells,BP,
14114,GO:0051864,1,0.940953557221777,0,8,histone demethylase activity (H3-K36 specific),MF,
14115,GO:0051865,1,0.69135561704158,0,54,protein autoubiquitination,BP,
14116,GO:0051866,1,0.989179245280518,0,2,general adaptation syndrome,BP,
14117,GO:0051867,1,0.996628508127084,0,1,general adaptation syndrome, behavioral process,BP,
14118,GO:0051870,1,0.986131096850621,0,3,methotrexate binding,MF,
14119,GO:0051873,1,0.967413250503617,0,9,killing by host of symbiont cells,BP,
14120,GO:0051875,1,0.844136484248555,0,27,pigment granule localization,BP,
14121,GO:0051877,1,0.986476502987261,0,2,pigment granule aggregation in cell center,BP,
14122,GO:0051879,1,0.813618828107247,0,32,Hsp90 protein binding,MF,
14123,GO:0051880,1,0.946021458829538,0,7,G-quadruplex DNA binding,MF,
14126,GO:0051883,1,0.945486201982388,0,13,killing of cells in other organism involved in symbiotic interaction,BP,
14127,GO:0051884,1,0.964420450382403,0,5,regulation of timing of anagen,BP,
14128,GO:0051885,1,0.986638791512005,0,2,positive regulation of timing of anagen,BP,
14129,GO:0051886,1,0.992255562649337,0,1,negative regulation of timing of anagen,BP,
14130,GO:0051890,1,0.958476558431765,0,6,regulation of cardioblast differentiation,BP,
14131,GO:0051891,1,0.965785184078002,0,5,positive regulation of cardioblast differentiation,BP,
14132,GO:0051892,1,0.992435183188494,0,1,negative regulation of cardioblast differentiation,BP,
14134,GO:0051894,1,0.849899280418624,0,23,positive regulation of focal adhesion assembly,BP,
14138,GO:0051898,1,0.769886435168357,0,39,negative regulation of protein kinase B signaling,BP,
14141,GO:0051901,1,0.958086750627828,0,8,positive regulation of mitochondrial depolarization,BP,
14143,GO:0051903,1,0.993578414537109,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14144,GO:0051904,1,0.862379144533884,0,24,pigment granule transport,BP,
14145,GO:0051905,1,0.855053033478357,0,25,establishment of pigment granule localization,BP,
14146,GO:0051908,1,0.992713700058719,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14147,GO:0051916,1,0.992976323146227,0,1,granulocyte colony-stimulating factor binding,MF,
14148,GO:0051917,1,0.942985491610722,0,10,regulation of fibrinolysis,BP,
14149,GO:0051918,1,0.959267128121999,0,7,negative regulation of fibrinolysis,BP,
14150,GO:0051919,1,0.984031680201665,0,3,positive regulation of fibrinolysis,BP,
14151,GO:0051920,1,0.970423946831619,0,8,peroxiredoxin activity,MF,
14152,GO:0051923,1,0.922179902225791,0,15,sulfation,BP,
14154,GO:0051926,1,0.739393616061004,0,50,negative regulation of calcium ion transport,BP,
14156,GO:0051930,1,0.823061744848853,0,31,regulation of sensory perception of pain,BP,
14157,GO:0051931,1,0.823061744848853,0,31,regulation of sensory perception,BP,
14159,GO:0051933,1,0.976651857094489,0,3,amino acid neurotransmitter reuptake,BP,
14160,GO:0051934,1,0.939715573126902,0,11,catecholamine uptake involved in synaptic transmission,BP,
14161,GO:0051935,1,0.976651857094489,0,3,glutamate reuptake,BP,
14162,GO:0051937,1,0.732316588931992,0,52,catecholamine transport,BP,
14163,GO:0051938,1,0.91763723958999,0,12,L-glutamate import,BP,
14164,GO:0051939,1,0.992399759950823,0,1,gamma-aminobutyric acid import,BP,
14165,GO:0051940,1,0.964210942187278,0,7,regulation of catecholamine uptake involved in synaptic transmission,BP,
14166,GO:0051941,1,0.984122069062058,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14167,GO:0051944,1,0.986370463737395,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14168,GO:0051945,1,0.992742752447207,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14169,GO:0051946,1,0.984122069062058,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14170,GO:0051952,1,0.678809200664483,0,64,regulation of amine transport,BP,
14171,GO:0051953,1,0.884383915473438,0,20,negative regulation of amine transport,BP,
14172,GO:0051954,1,0.841277856319031,0,28,positive regulation of amine transport,BP,
14173,GO:0051955,1,0.83155227941095,0,28,regulation of amino acid transport,BP,
14174,GO:0051956,1,0.939706476984819,0,10,negative regulation of amino acid transport,BP,
14175,GO:0051957,1,0.911512813584879,0,14,positive regulation of amino acid transport,BP,
14176,GO:0051958,1,0.985084848697347,0,2,methotrexate transport,BP,
14181,GO:0051963,1,0.565316292698285,0,78,regulation of synapse assembly,BP,
14182,GO:0051964,1,0.953136398478027,0,6,negative regulation of synapse assembly,BP,
14183,GO:0051965,1,0.653359311146226,0,59,positive regulation of synapse assembly,BP,
14185,GO:0051967,1,0.933131502836876,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14187,GO:0051969,1,0.926906695481252,0,13,regulation of transmission of nerve impulse,BP,
14188,GO:0051970,1,0.983834401362005,0,3,negative regulation of transmission of nerve impulse,BP,
14189,GO:0051971,1,0.969137782534501,0,5,positive regulation of transmission of nerve impulse,BP,
14192,GO:0051974,1,0.945570607838927,0,9,negative regulation of telomerase activity,BP,
14193,GO:0051977,1,0.994757023416527,0,1,lysophospholipid transport,BP,
14194,GO:0051978,1,0.994757023416527,0,1,lysophospholipid transporter activity,MF,
14195,GO:0051983,1,0.548623046698756,0,90,regulation of chromosome segregation,BP,
14196,GO:0051984,1,0.850152171218003,0,24,positive regulation of chromosome segregation,BP,
14197,GO:0051985,1,0.78885956654095,0,37,negative regulation of chromosome segregation,BP,
14198,GO:0051987,1,0.969836249653032,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14199,GO:0051988,1,0.923007764464539,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
14200,GO:0051990,1,0.988107494643517,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14201,GO:0051996,1,0.99497714214688,0,1,squalene synthase activity,MF,
14202,GO:0051998,1,0.963352347500869,0,6,protein carboxyl O-methyltransferase activity,MF,
14203,GO:0052025,1,0.994160037817392,0,2,modification by symbiont of host cell membrane,BP,
14204,GO:0052026,1,0.993120599169405,0,1,modulation by symbiont of host transcription,BP,
14205,GO:0052027,1,0.984950770472193,0,2,modulation by symbiont of host signal transduction pathway,BP,
14206,GO:0052029,1,0.992241678186921,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
14207,GO:0052031,1,0.98700796019725,0,2,modulation by symbiont of host defense response,BP,
14208,GO:0052037,1,0.992241678186921,0,1,negative regulation by symbiont of host defense response,BP,
14209,GO:0052040,1,0.965971179225275,0,6,modulation by symbiont of host programmed cell death,BP,
14210,GO:0052041,1,0.976800344897516,0,4,negative regulation by symbiont of host programmed cell death,BP,
14211,GO:0052042,1,0.985748597638974,0,3,positive regulation by symbiont of host programmed cell death,BP,
14212,GO:0052043,1,0.994160037817392,0,2,modification by symbiont of host cellular component,BP,
14213,GO:0052047,1,0.985477004520483,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14214,GO:0052053,1,0.993328946169734,0,1,negative regulation by symbiont of host catalytic activity,BP,
14215,GO:0052055,1,0.98562184571684,0,2,modulation by symbiont of host molecular function,BP,
14216,GO:0052056,1,0.98562184571684,0,2,negative regulation by symbiont of host molecular function,BP,
14217,GO:0052066,1,0.991694482489942,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14218,GO:0052097,1,0.992651266995692,0,1,interspecies quorum sensing,BP,
14219,GO:0052106,1,0.992651266995692,0,1,quorum sensing involved in interaction with host,BP,
14220,GO:0052111,1,0.994160037817392,0,2,modification by symbiont of host structure,BP,
14221,GO:0052126,1,0.805144533355676,0,33,movement in host environment,BP,
14222,GO:0052148,1,0.993328946169734,0,1,modulation by symbiont of host catalytic activity,BP,
14223,GO:0052150,1,0.96929256786878,0,5,modulation by symbiont of host apoptotic process,BP,
14224,GO:0052151,1,0.989137270521395,0,2,positive regulation by symbiont of host apoptotic process,BP,
14225,GO:0052167,1,0.992241678186921,0,1,modulation by symbiont of host innate immune response,BP,
14226,GO:0052170,1,0.992241678186921,0,1,negative regulation by symbiont of host innate immune response,BP,
14227,GO:0052173,1,0.968828742551092,0,5,response to defenses of other organism involved in symbiotic interaction,BP,
14228,GO:0052182,1,0.994260460976323,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14229,GO:0052185,1,0.994160037817392,0,2,modification of structure of other organism involved in symbiotic interaction,BP,
14230,GO:0052188,1,0.994160037817392,0,2,modification of cellular component in other organism involved in symbiotic interaction,BP,
14231,GO:0052190,1,0.991694482489942,0,1,modulation by symbiont of host phagocytosis,BP,
14232,GO:0052191,1,0.991694482489942,0,1,positive regulation by symbiont of host phagocytosis,BP,
14233,GO:0052192,1,0.805144533355676,0,33,movement in environment of other organism involved in symbiotic interaction,BP,
14234,GO:0052199,1,0.988786265967223,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14235,GO:0052200,1,0.968828742551092,0,5,response to host defenses,BP,
14236,GO:0052203,1,0.984697182804656,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14237,GO:0052204,1,0.966833466299838,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14238,GO:0052205,1,0.958960337357074,0,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14239,GO:0052212,1,0.994260460976323,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14240,GO:0052213,1,0.994260460976323,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14241,GO:0052214,1,0.996082080088302,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14242,GO:0052227,1,0.996082080088302,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14243,GO:0052229,1,0.996082080088302,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14244,GO:0052231,1,0.991694482489942,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14245,GO:0052248,1,0.965971179225275,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14246,GO:0052250,1,0.984950770472193,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14247,GO:0052251,1,0.994725786414989,0,1,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14248,GO:0052255,1,0.98700796019725,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14249,GO:0052261,1,0.992241678186921,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
14250,GO:0052306,1,0.992241678186921,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14251,GO:0052309,1,0.992241678186921,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14252,GO:0052312,1,0.848327907441785,0,25,modulation of transcription in other organism involved in symbiotic interaction,BP,
14253,GO:0052314,1,0.990728939706214,0,2,phytoalexin metabolic process,BP,
14254,GO:0052330,1,0.985748597638974,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14255,GO:0052331,1,0.988076646067103,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14256,GO:0052332,1,0.994160037817392,0,2,modification by organism of membrane in other organism involved in symbiotic interaction,BP,
14257,GO:0052360,1,0.996082080088302,0,1,catabolism by host of symbiont macromolecule,BP,
14258,GO:0052361,1,0.996082080088302,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14259,GO:0052362,1,0.996082080088302,0,1,catabolism by host of symbiont protein,BP,
14260,GO:0052363,1,0.996082080088302,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14261,GO:0052364,1,0.996082080088302,0,1,catabolism by host of substance in symbiont,BP,
14262,GO:0052370,1,0.991694482489942,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14263,GO:0052381,1,0.994912631612779,0,1,tRNA dimethylallyltransferase activity,MF,
14264,GO:0052403,1,0.99542713020967,0,1,negative regulation by host of symbiont catalytic activity,BP,
14265,GO:0052405,1,0.980940389903076,0,5,negative regulation by host of symbiont molecular function,BP,
14266,GO:0052416,1,0.996082080088302,0,1,metabolism by host of symbiont macromolecule,BP,
14267,GO:0052417,1,0.996082080088302,0,1,metabolism by host of symbiont protein,BP,
14268,GO:0052418,1,0.996082080088302,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14269,GO:0052419,1,0.996082080088302,0,1,metabolism by host of substance in symbiont,BP,
14270,GO:0052422,1,0.991310870844578,0,2,modulation by host of symbiont catalytic activity,BP,
14271,GO:0052428,1,0.972953584242916,0,6,modulation by host of symbiont molecular function,BP,
14272,GO:0052433,1,0.965971179225275,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14273,GO:0052472,1,0.854214003922664,0,24,modulation by host of symbiont transcription,BP,
14274,GO:0052490,1,0.976800344897516,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14275,GO:0052493,1,0.992241678186921,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
14276,GO:0052501,1,0.985748597638974,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14277,GO:0052509,1,0.994725786414989,0,1,positive regulation by symbiont of host defense response,BP,
14278,GO:0052510,1,0.994725786414989,0,1,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14279,GO:0052522,1,0.991694482489942,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14282,GO:0052550,1,0.996000751859802,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14283,GO:0052552,1,0.98700796019725,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14284,GO:0052553,1,0.98700796019725,0,2,modulation by symbiont of host immune response,BP,
14285,GO:0052561,1,0.992241678186921,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14286,GO:0052562,1,0.992241678186921,0,1,negative regulation by symbiont of host immune response,BP,
14287,GO:0052564,1,0.976609041927076,0,4,response to immune response of other organism involved in symbiotic interaction,BP,
14288,GO:0052567,1,0.996000751859802,0,1,response to defense-related host reactive oxygen species production,BP,
14289,GO:0052572,1,0.976609041927076,0,4,response to host immune response,BP,
14290,GO:0052590,1,0.992029502670851,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14291,GO:0052591,1,0.992029502670851,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14292,GO:0052593,1,0.986136572972466,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14293,GO:0052594,1,0.986136572972466,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14294,GO:0052595,1,0.986136572972466,0,2,aliphatic-amine oxidase activity,MF,
14295,GO:0052596,1,0.986136572972466,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14296,GO:0052629,1,0.912228026518632,0,12,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14297,GO:0052642,1,0.98960477255693,0,2,lysophosphatidic acid phosphatase activity,MF,
14299,GO:0052650,1,0.962680024381832,0,8,NADP-retinol dehydrogenase activity,MF,
14300,GO:0052651,1,0.989117297417135,0,2,monoacylglycerol catabolic process,BP,
14301,GO:0052652,1,0.625580900428235,0,77,cyclic purine nucleotide metabolic process,BP,
14302,GO:0052654,1,0.987362207660561,0,2,L-leucine transaminase activity,MF,
14303,GO:0052655,1,0.987362207660561,0,2,L-valine transaminase activity,MF,
14304,GO:0052656,1,0.987362207660561,0,2,L-isoleucine transaminase activity,MF,
14305,GO:0052657,1,0.996440642047876,0,1,guanine phosphoribosyltransferase activity,MF,
14306,GO:0052658,1,0.957386812346281,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14307,GO:0052659,1,0.935860520167922,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14308,GO:0052666,1,0.99536680713459,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14310,GO:0052692,1,0.996436438071026,0,1,raffinose alpha-galactosidase activity,MF,
14311,GO:0052695,1,0.980923965134096,0,3,cellular glucuronidation,BP,
14312,GO:0052717,1,0.991925574439524,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
14313,GO:0052718,1,0.991925574439524,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
14314,GO:0052723,1,0.967077140655471,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14315,GO:0052724,1,0.967077140655471,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14316,GO:0052725,1,0.992669443467321,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14317,GO:0052726,1,0.992669443467321,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14318,GO:0052731,1,0.994978482513214,0,1,phosphocholine phosphatase activity,MF,
14319,GO:0052732,1,0.994978482513214,0,1,phosphoethanolamine phosphatase activity,MF,
14320,GO:0052735,1,0.980035437677784,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
14321,GO:0052739,1,0.987632600923746,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14322,GO:0052740,1,0.991756051716185,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14323,GO:0052742,1,0.736339622062059,0,43,phosphatidylinositol kinase activity,MF,
14324,GO:0052743,1,0.922155193280133,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14325,GO:0052744,1,0.891759119211894,0,15,phosphatidylinositol monophosphate phosphatase activity,MF,
14326,GO:0052745,1,0.872663366540723,0,19,inositol phosphate phosphatase activity,MF,
14327,GO:0052746,1,0.985139235675551,0,2,inositol phosphorylation,BP,
14328,GO:0052794,1,0.982861081901788,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14329,GO:0052795,1,0.982861081901788,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14330,GO:0052796,1,0.982861081901788,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14331,GO:0052798,1,0.99500391878438,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14334,GO:0052810,1,0.986063977657721,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14335,GO:0052811,1,0.971081685549641,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14336,GO:0052812,1,0.978451852677482,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14338,GO:0052815,1,0.98933240196681,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14339,GO:0052816,1,0.992567525681996,0,1,long-chain acyl-CoA hydrolase activity,MF,
14340,GO:0052817,1,0.992567525681996,0,1,very long chain acyl-CoA hydrolase activity,MF,
14341,GO:0052821,1,0.996804189000364,0,1,DNA-7-methyladenine glycosylase activity,MF,
14342,GO:0052822,1,0.996804189000364,0,1,DNA-3-methylguanine glycosylase activity,MF,
14343,GO:0052825,1,0.992669443467321,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14344,GO:0052826,1,0.993166936961311,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14345,GO:0052827,1,0.985885952869342,0,2,inositol pentakisphosphate phosphatase activity,MF,
14346,GO:0052828,1,0.984288924477132,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14347,GO:0052829,1,0.995021287493055,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14348,GO:0052830,1,0.992669443467321,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14349,GO:0052831,1,0.992669443467321,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14350,GO:0052832,1,0.973513003680732,0,4,inositol monophosphate 3-phosphatase activity,MF,
14351,GO:0052833,1,0.973513003680732,0,4,inositol monophosphate 4-phosphatase activity,MF,
14352,GO:0052834,1,0.973513003680732,0,4,inositol monophosphate phosphatase activity,MF,
14353,GO:0052835,1,0.992669443467321,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14354,GO:0052836,1,0.98241068428103,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14355,GO:0052839,1,0.98241068428103,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14356,GO:0052840,1,0.978556250983495,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14357,GO:0052841,1,0.978556250983495,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14358,GO:0052842,1,0.978556250983495,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14359,GO:0052843,1,0.978556250983495,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14360,GO:0052844,1,0.978556250983495,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14361,GO:0052845,1,0.978556250983495,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14362,GO:0052846,1,0.978556250983495,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14363,GO:0052847,1,0.978556250983495,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14364,GO:0052848,1,0.978556250983495,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14365,GO:0052851,1,0.966961711771361,0,5,ferric-chelate reductase (NADPH) activity,MF,
14366,GO:0052852,1,0.995859720278206,0,1,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14367,GO:0052853,1,0.995859720278206,0,1,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14368,GO:0052854,1,0.995859720278206,0,1,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14369,GO:0052856,1,0.996880574856505,0,1,NADHX epimerase activity,MF,
14370,GO:0052857,1,0.996880574856505,0,1,NADPHX epimerase activity,MF,
14371,GO:0052858,1,0.992512646799534,0,1,peptidyl-lysine acetyltransferase activity,MF,
14372,GO:0052866,1,0.812687766213642,0,28,phosphatidylinositol phosphate phosphatase activity,MF,
14373,GO:0052870,1,0.992938451068819,0,1,tocopherol omega-hydroxylase activity,MF,
14374,GO:0052871,1,0.992938451068819,0,1,alpha-tocopherol omega-hydroxylase activity,MF,
14375,GO:0052884,1,0.993643172738194,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14376,GO:0052885,1,0.993643172738194,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14377,GO:0052890,1,0.995461921104387,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14378,GO:0052894,1,0.995069224053367,0,1,norspermine:oxygen oxidoreductase activity,MF,
14379,GO:0052895,1,0.995069224053367,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14380,GO:0052899,1,0.99596705023946,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14381,GO:0052901,1,0.991055953142148,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14382,GO:0052902,1,0.99596705023946,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14383,GO:0052903,1,0.99596705023946,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14384,GO:0052904,1,0.99596705023946,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14385,GO:0052905,1,0.980036334309751,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14386,GO:0052906,1,0.99222337829369,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14387,GO:0052907,1,0.993301131169352,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14388,GO:0052909,1,0.993301131169352,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14389,GO:0052917,1,0.994252459065971,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14390,GO:0052918,1,0.991911799389732,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14391,GO:0052925,1,0.996288346226013,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14392,GO:0052926,1,0.991911799389732,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14393,GO:0052927,1,0.994521917273774,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14394,GO:0052928,1,0.994521917273774,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14395,GO:0052929,1,0.994521917273774,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14399,GO:0055005,1,0.980599864568942,0,3,ventricular cardiac myofibril assembly,BP,
14403,GO:0055009,1,0.961553895612325,0,6,atrial cardiac muscle tissue morphogenesis,BP,
14405,GO:0055011,1,0.991443091439326,0,2,atrial cardiac muscle cell differentiation,BP,
14406,GO:0055012,1,0.906676241070999,0,15,ventricular cardiac muscle cell differentiation,BP,
14408,GO:0055014,1,0.991443091439326,0,2,atrial cardiac muscle cell development,BP,
14409,GO:0055015,1,0.942448378857019,0,10,ventricular cardiac muscle cell development,BP,
14411,GO:0055018,1,0.99578603907695,0,1,regulation of cardiac muscle fiber development,BP,
14412,GO:0055020,1,0.99578603907695,0,1,positive regulation of cardiac muscle fiber development,BP,
14415,GO:0055023,1,0.815539214900827,0,29,positive regulation of cardiac muscle tissue growth,BP,
14419,GO:0055028,1,0.991604937803894,0,1,cortical microtubule,CC,
14420,GO:0055029,1,0.453038974977419,0,131,nuclear DNA-directed RNA polymerase complex,CC,
14423,GO:0055048,1,0.991604937803894,0,1,anastral spindle assembly,BP,
14424,GO:0055056,1,0.940185269664907,0,9,D-glucose transmembrane transporter activity,MF,
14425,GO:0055057,1,0.90731426000706,0,13,neuroblast division,BP,
14426,GO:0055059,1,0.95734298790875,0,6,asymmetric neuroblast division,BP,
14427,GO:0055062,1,0.937186442879807,0,9,phosphate ion homeostasis,BP,
14428,GO:0055064,1,0.917336963927657,0,12,chloride ion homeostasis,BP,
14430,GO:0055067,1,0.39627397147896,0,143,monovalent inorganic cation homeostasis,BP,
14431,GO:0055069,1,0.836485031849655,0,33,zinc ion homeostasis,BP,
14434,GO:0055073,1,0.989546885642899,0,2,cadmium ion homeostasis,BP,
14436,GO:0055075,1,0.826303500309207,0,27,potassium ion homeostasis,BP,
14438,GO:0055077,1,0.9862754096927,0,2,gap junction hemi-channel activity,MF,
14439,GO:0055078,1,0.766309933062561,0,41,sodium ion homeostasis,BP,
14441,GO:0055081,1,0.746152272169137,0,44,anion homeostasis,BP,
14443,GO:0055083,1,0.859665644852248,0,21,monovalent inorganic anion homeostasis,BP,
14446,GO:0055087,1,0.981503261047013,0,3,Ski complex,CC,
14447,GO:0055088,1,0.551704495357479,0,96,lipid homeostasis,BP,
14448,GO:0055089,1,0.924116519593002,0,12,fatty acid homeostasis,BP,
14449,GO:0055090,1,0.871947004776532,0,25,acylglycerol homeostasis,BP,
14450,GO:0055091,1,0.954468052194455,0,8,phospholipid homeostasis,BP,
14451,GO:0055092,1,0.724722132244178,0,53,sterol homeostasis,BP,
14452,GO:0055093,1,0.885186981238038,0,20,response to hyperoxia,BP,
14453,GO:0055094,1,0.862522476029453,0,23,response to lipoprotein particle,BP,
14454,GO:0055095,1,0.98015041303263,0,3,lipoprotein particle mediated signaling,BP,
14455,GO:0055096,1,0.98015041303263,0,3,low-density lipoprotein particle mediated signaling,BP,
14456,GO:0055100,1,0.97997255467912,0,3,adiponectin binding,MF,
14457,GO:0055102,1,0.953860551749784,0,11,lipase inhibitor activity,MF,
14459,GO:0055105,1,0.978118768808117,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14460,GO:0055106,1,0.922313417966172,0,16,ubiquitin-protein transferase regulator activity,MF,
14461,GO:0055108,1,0.995318480480322,0,1,Golgi to transport vesicle transport,BP,
14462,GO:0055111,1,0.992115548877983,0,1,ingression involved in gastrulation with mouth forming second,BP,
14463,GO:0055113,1,0.990071811429346,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14465,GO:0055117,1,0.625614463570137,0,69,regulation of cardiac muscle contraction,BP,
14466,GO:0055118,1,0.959328593360924,0,6,negative regulation of cardiac muscle contraction,BP,
14467,GO:0055119,1,0.895034796392354,0,17,relaxation of cardiac muscle,BP,
14468,GO:0055120,1,0.99683593418832,0,1,striated muscle dense body,CC,
14470,GO:0055129,1,0.979519233812798,0,4,L-proline biosynthetic process,BP,
14471,GO:0055130,1,0.996148653594519,0,1,D-alanine catabolic process,BP,
14472,GO:0055131,1,0.966176104079929,0,6,C3HC4-type RING finger domain binding,MF,
14473,GO:0060001,1,0.991051754603911,0,1,minus-end directed microfilament motor activity,MF,
14474,GO:0060002,1,0.982001891573903,0,2,plus-end directed microfilament motor activity,MF,
14475,GO:0060003,1,0.983091726782038,0,2,copper ion export,BP,
14477,GO:0060005,1,0.970414988829,0,4,vestibular reflex,BP,
14478,GO:0060007,1,0.992443585820669,0,1,linear vestibuloocular reflex,BP,
14479,GO:0060008,1,0.892724555028683,0,17,Sertoli cell differentiation,BP,
14480,GO:0060009,1,0.915674311692983,0,13,Sertoli cell development,BP,
14481,GO:0060010,1,0.99262551819128,0,1,Sertoli cell fate commitment,BP,
14482,GO:0060011,1,0.981830302833977,0,3,Sertoli cell proliferation,BP,
14483,GO:0060012,1,0.95621336821407,0,7,synaptic transmission, glycinergic,BP,
14484,GO:0060013,1,0.943165909334312,0,8,righting reflex,BP,
14485,GO:0060014,1,0.993058993460782,0,1,granulosa cell differentiation,BP,
14486,GO:0060017,1,0.959740919262101,0,6,parathyroid gland development,BP,
14487,GO:0060018,1,0.977796712387237,0,3,astrocyte fate commitment,BP,
14488,GO:0060019,1,0.937644413343061,0,12,radial glial cell differentiation,BP,
14489,GO:0060020,1,0.951942521493306,0,8,Bergmann glial cell differentiation,BP,
14490,GO:0060021,1,0.566525441671573,0,83,roof of mouth development,BP,
14491,GO:0060022,1,0.956931912331156,0,6,hard palate development,BP,
14492,GO:0060023,1,0.964618230145901,0,5,soft palate development,BP,
14493,GO:0060024,1,0.972100966122214,0,4,rhythmic synaptic transmission,BP,
14494,GO:0060025,1,0.977767948054388,0,3,regulation of synaptic activity,BP,
14495,GO:0060026,1,0.905128944950876,0,15,convergent extension,BP,
14496,GO:0060027,1,0.945258330822008,0,8,convergent extension involved in gastrulation,BP,
14497,GO:0060028,1,0.954965053110557,0,7,convergent extension involved in axis elongation,BP,
14498,GO:0060029,1,0.96267577350391,0,6,convergent extension involved in organogenesis,BP,
14499,GO:0060031,1,0.987542950546026,0,2,mediolateral intercalation,BP,
14500,GO:0060032,1,0.98435645508011,0,2,notochord regression,BP,
14501,GO:0060033,1,0.937159328438209,0,10,anatomical structure regression,BP,
14502,GO:0060037,1,0.854280850341445,0,24,pharyngeal system development,BP,
14504,GO:0060039,1,0.86658628725472,0,19,pericardium development,BP,
14505,GO:0060040,1,0.980373834688856,0,4,retinal bipolar neuron differentiation,BP,
14507,GO:0060042,1,0.751801249237397,0,41,retina morphogenesis in camera-type eye,BP,
14510,GO:0060045,1,0.853110864588106,0,22,positive regulation of cardiac muscle cell proliferation,BP,
14511,GO:0060046,1,0.941616769673636,0,12,regulation of acrosome reaction,BP,
14514,GO:0060049,1,0.919895657592761,0,13,regulation of protein glycosylation,BP,
14515,GO:0060050,1,0.940711689789933,0,9,positive regulation of protein glycosylation,BP,
14516,GO:0060051,1,0.989150815772508,0,2,negative regulation of protein glycosylation,BP,
14517,GO:0060052,1,0.961651334612339,0,6,neurofilament cytoskeleton organization,BP,
14518,GO:0060053,1,0.985986086742492,0,2,neurofilament cytoskeleton,CC,
14520,GO:0060055,1,0.882872117908473,0,19,angiogenesis involved in wound healing,BP,
14521,GO:0060056,1,0.950340296538637,0,8,mammary gland involution,BP,
14522,GO:0060057,1,0.981882629804724,0,3,apoptotic process involved in mammary gland involution,BP,
14523,GO:0060058,1,0.981882629804724,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14524,GO:0060059,1,0.944803243255358,0,7,embryonic retina morphogenesis in camera-type eye,BP,
14525,GO:0060060,1,0.991628373979247,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14526,GO:0060061,1,0.988178898897591,0,2,Spemann organizer formation,BP,
14527,GO:0060064,1,0.99632392611263,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14528,GO:0060065,1,0.875016176484936,0,19,uterus development,BP,
14529,GO:0060066,1,0.988531907418351,0,2,oviduct development,BP,
14530,GO:0060067,1,0.992057652763443,0,1,cervix development,BP,
14534,GO:0060072,1,0.984456163209975,0,2,large conductance calcium-activated potassium channel activity,MF,
14535,GO:0060073,1,0.952466330188305,0,7,micturition,BP,
14536,GO:0060074,1,0.879322920717163,0,17,synapse maturation,BP,
14537,GO:0060075,1,0.950279054981374,0,7,regulation of resting membrane potential,BP,
14538,GO:0060076,1,0.80314760763421,0,29,excitatory synapse,CC,
14539,GO:0060077,1,0.903318576720558,0,15,inhibitory synapse,CC,
14540,GO:0060078,1,0.418784477804838,0,125,regulation of postsynaptic membrane potential,BP,
14541,GO:0060079,1,0.485853012086384,0,105,excitatory postsynaptic potential,BP,
14542,GO:0060080,1,0.897847252045921,0,15,inhibitory postsynaptic potential,BP,
14543,GO:0060081,1,0.933521391401101,0,11,membrane hyperpolarization,BP,
14544,GO:0060083,1,0.977210692912442,0,3,smooth muscle contraction involved in micturition,BP,
14545,GO:0060084,1,0.97980413731358,0,3,synaptic transmission involved in micturition,BP,
14546,GO:0060086,1,0.986141883822367,0,2,circadian temperature homeostasis,BP,
14547,GO:0060087,1,0.974878590275721,0,5,relaxation of vascular smooth muscle,BP,
14548,GO:0060088,1,0.936777171665414,0,10,auditory receptor cell stereocilium organization,BP,
14550,GO:0060090,1,0.295066859607985,0,182,molecular adaptor activity,MF,
14551,GO:0060091,1,0.957761387964453,0,7,kinocilium,CC,
14552,GO:0060092,1,0.992697729352287,0,1,regulation of synaptic transmission, glycinergic,BP,
14553,GO:0060099,1,0.931776971030365,0,11,regulation of phagocytosis, engulfment,BP,
14554,GO:0060100,1,0.94209400015159,0,9,positive regulation of phagocytosis, engulfment,BP,
14555,GO:0060101,1,0.995540255346228,0,1,negative regulation of phagocytosis, engulfment,BP,
14556,GO:0060112,1,0.992688517400585,0,2,generation of ovulation cycle rhythm,BP,
14557,GO:0060113,1,0.72049267933652,0,48,inner ear receptor cell differentiation,BP,
14558,GO:0060117,1,0.888149755452498,0,17,auditory receptor cell development,BP,
14559,GO:0060119,1,0.78272916356025,0,36,inner ear receptor cell development,BP,
14560,GO:0060120,1,0.970695616042284,0,5,inner ear receptor cell fate commitment,BP,
14561,GO:0060122,1,0.86170543850278,0,23,inner ear receptor cell stereocilium organization,BP,
14562,GO:0060123,1,0.934979519896139,0,11,regulation of growth hormone secretion,BP,
14563,GO:0060124,1,0.95955840892858,0,8,positive regulation of growth hormone secretion,BP,
14564,GO:0060125,1,0.983934125177087,0,2,negative regulation of growth hormone secretion,BP,
14565,GO:0060126,1,0.983684866542888,0,3,somatotropin secreting cell differentiation,BP,
14566,GO:0060127,1,0.994633344008628,0,1,prolactin secreting cell differentiation,BP,
14567,GO:0060128,1,0.989621971698628,0,2,corticotropin hormone secreting cell differentiation,BP,
14568,GO:0060129,1,0.982163444066594,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14569,GO:0060133,1,0.996502910874224,0,1,somatotropin secreting cell development,BP,
14570,GO:0060134,1,0.917400061683042,0,12,prepulse inhibition,BP,
14572,GO:0060136,1,0.965550616497402,0,6,embryonic process involved in female pregnancy,BP,
14573,GO:0060137,1,0.951329714321937,0,8,maternal process involved in parturition,BP,
14574,GO:0060139,1,0.989137270521395,0,2,positive regulation of apoptotic process by virus,BP,
14575,GO:0060142,1,0.905766453390902,0,18,regulation of syncytium formation by plasma membrane fusion,BP,
14576,GO:0060143,1,0.912979484097976,0,16,positive regulation of syncytium formation by plasma membrane fusion,BP,
14579,GO:0060149,1,0.910803184973907,0,14,negative regulation of posttranscriptional gene silencing,BP,
14580,GO:0060151,1,0.984871398001824,0,2,peroxisome localization,BP,
14581,GO:0060152,1,0.984871398001824,0,2,microtubule-based peroxisome localization,BP,
14582,GO:0060154,1,0.983231755409733,0,3,cellular process regulating host cell cycle in response to virus,BP,
14583,GO:0060155,1,0.955934886522868,0,8,platelet dense granule organization,BP,
14585,GO:0060157,1,0.970380479938235,0,5,urinary bladder development,BP,
14586,GO:0060158,1,0.950165999328215,0,9,phospholipase C-activating dopamine receptor signaling pathway,BP,
14587,GO:0060159,1,0.943761614574109,0,9,regulation of dopamine receptor signaling pathway,BP,
14588,GO:0060160,1,0.986825554384485,0,2,negative regulation of dopamine receptor signaling pathway,BP,
14589,GO:0060161,1,0.970583063310674,0,4,positive regulation of dopamine receptor signaling pathway,BP,
14590,GO:0060163,1,0.990706235143793,0,2,subpallium neuron fate commitment,BP,
14591,GO:0060164,1,0.983142783715078,0,3,regulation of timing of neuron differentiation,BP,
14592,GO:0060165,1,0.993995508641689,0,1,regulation of timing of subpallium neuron differentiation,BP,
14593,GO:0060166,1,0.98306006244221,0,3,olfactory pit development,BP,
14596,GO:0060169,1,0.996256649183377,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14597,GO:0060170,1,0.61195137379352,0,72,ciliary membrane,CC,
14598,GO:0060171,1,0.981721031956502,0,2,stereocilium membrane,CC,
14600,GO:0060174,1,0.927689241332776,0,11,limb bud formation,BP,
14601,GO:0060175,1,0.991634648484819,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14602,GO:0060177,1,0.992599248135765,0,1,regulation of angiotensin metabolic process,BP,
14603,GO:0060178,1,0.994570809837383,0,1,regulation of exocyst localization,BP,
14604,GO:0060179,1,0.974767265727923,0,4,male mating behavior,BP,
14605,GO:0060180,1,0.96227261162957,0,6,female mating behavior,BP,
14606,GO:0060183,1,0.992697729352287,0,1,apelin receptor signaling pathway,BP,
14607,GO:0060184,1,0.992945188475223,0,1,cell cycle switching,BP,
14608,GO:0060187,1,0.984630753504696,0,2,cell pole,CC,
14610,GO:0060192,1,0.940867708658518,0,11,negative regulation of lipase activity,BP,
14612,GO:0060197,1,0.983696194621233,0,3,cloacal septation,BP,
14613,GO:0060198,1,0.931001709330034,0,12,clathrin-sculpted vesicle,CC,
14614,GO:0060199,1,0.976662124978275,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14615,GO:0060200,1,0.982898040918226,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14616,GO:0060201,1,0.982898040918226,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14617,GO:0060203,1,0.976662124978275,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14619,GO:0060211,1,0.926127819424271,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14620,GO:0060212,1,0.995700567959264,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14621,GO:0060213,1,0.926127819424271,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14622,GO:0060214,1,0.979523784545107,0,4,endocardium formation,BP,
14623,GO:0060215,1,0.946574508142076,0,8,primitive hemopoiesis,BP,
14624,GO:0060216,1,0.864040904843271,0,21,definitive hemopoiesis,BP,
14625,GO:0060217,1,0.992296107693448,0,1,hemangioblast cell differentiation,BP,
14626,GO:0060218,1,0.636067364830163,0,89,hematopoietic stem cell differentiation,BP,
14627,GO:0060219,1,0.904542684384873,0,15,camera-type eye photoreceptor cell differentiation,BP,
14628,GO:0060221,1,0.981688571928959,0,3,retinal rod cell differentiation,BP,
14629,GO:0060228,1,0.990765591814549,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14630,GO:0060229,1,0.946173710574926,0,10,lipase activator activity,MF,
14631,GO:0060230,1,0.993723058154977,0,2,lipoprotein lipase activator activity,MF,
14633,GO:0060232,1,0.981434798064019,0,3,delamination,BP,
14634,GO:0060235,1,0.969636406757106,0,4,lens induction in camera-type eye,BP,
14635,GO:0060236,1,0.780809471876251,0,36,regulation of mitotic spindle organization,BP,
14636,GO:0060242,1,0.948961472003792,0,8,contact inhibition,BP,
14637,GO:0060243,1,0.99243730895738,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14638,GO:0060244,1,0.981627530615592,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14639,GO:0060245,1,0.992479643238667,0,1,detection of cell density,BP,
14640,GO:0060246,1,0.992479643238667,0,1,detection of cell density by contact stimulus,BP,
14641,GO:0060248,1,0.992479643238667,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14644,GO:0060252,1,0.928568434406507,0,11,positive regulation of glial cell proliferation,BP,
14646,GO:0060254,1,0.995716548218036,0,1,regulation of N-terminal protein palmitoylation,BP,
14648,GO:0060259,1,0.902876150669467,0,17,regulation of feeding behavior,BP,
14649,GO:0060260,1,0.8480600234313,0,27,regulation of transcription initiation from RNA polymerase II promoter,BP,
14650,GO:0060261,1,0.889712153605036,0,20,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14651,GO:0060262,1,0.995716548218036,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14652,GO:0060263,1,0.94977413256274,0,10,regulation of respiratory burst,BP,
14653,GO:0060264,1,0.98729998688109,0,3,regulation of respiratory burst involved in inflammatory response,BP,
14654,GO:0060265,1,0.992646486165052,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14655,GO:0060266,1,0.991591043024565,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
14656,GO:0060267,1,0.978997062377397,0,4,positive regulation of respiratory burst,BP,
14657,GO:0060268,1,0.983377904505889,0,3,negative regulation of respiratory burst,BP,
14659,GO:0060272,1,0.931463527928747,0,12,embryonic skeletal joint morphogenesis,BP,
14660,GO:0060278,1,0.982028235339201,0,3,regulation of ovulation,BP,
14661,GO:0060279,1,0.987559213058454,0,2,positive regulation of ovulation,BP,
14662,GO:0060280,1,0.994400074224895,0,1,negative regulation of ovulation,BP,
14663,GO:0060281,1,0.937543842339657,0,10,regulation of oocyte development,BP,
14664,GO:0060282,1,0.974449523383625,0,4,positive regulation of oocyte development,BP,
14665,GO:0060283,1,0.97432064305593,0,4,negative regulation of oocyte development,BP,
14668,GO:0060287,1,0.943238628825092,0,9,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14669,GO:0060290,1,0.961069319969365,0,6,transdifferentiation,BP,
14670,GO:0060291,1,0.616288327345744,0,70,long-term synaptic potentiation,BP,
14671,GO:0060292,1,0.823190801052181,0,28,long term synaptic depression,BP,
14672,GO:0060293,1,0.910102487150763,0,14,germ plasm,CC,
14673,GO:0060294,1,0.919435707031318,0,16,cilium movement involved in cell motility,BP,
14674,GO:0060295,1,0.967833862128625,0,5,regulation of cilium movement involved in cell motility,BP,
14675,GO:0060296,1,0.967833862128625,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14676,GO:0060297,1,0.960637613626758,0,5,regulation of sarcomere organization,BP,
14677,GO:0060298,1,0.979306190617701,0,3,positive regulation of sarcomere organization,BP,
14678,GO:0060300,1,0.978225579636067,0,4,regulation of cytokine activity,BP,
14679,GO:0060301,1,0.993967319559355,0,1,positive regulation of cytokine activity,BP,
14680,GO:0060302,1,0.991657738409944,0,2,negative regulation of cytokine activity,BP,
14681,GO:0060304,1,0.954051451919136,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14682,GO:0060305,1,0.99315298119977,0,1,regulation of cell diameter,BP,
14685,GO:0060309,1,0.996995071867497,0,1,elastin catabolic process,BP,
14686,GO:0060310,1,0.996995071867497,0,1,regulation of elastin catabolic process,BP,
14687,GO:0060311,1,0.996995071867497,0,1,negative regulation of elastin catabolic process,BP,
14688,GO:0060312,1,0.948247372757065,0,8,regulation of blood vessel remodeling,BP,
14689,GO:0060313,1,0.981050697379161,0,3,negative regulation of blood vessel remodeling,BP,
14690,GO:0060314,1,0.856036207073345,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14691,GO:0060315,1,0.942410340569156,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14692,GO:0060316,1,0.953323184007622,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14693,GO:0060317,1,0.821763083718241,0,31,cardiac epithelial to mesenchymal transition,BP,
14694,GO:0060318,1,0.966988712912737,0,5,definitive erythrocyte differentiation,BP,
14695,GO:0060319,1,0.97439371843068,0,4,primitive erythrocyte differentiation,BP,
14697,GO:0060323,1,0.795866105880617,0,34,head morphogenesis,BP,
14698,GO:0060324,1,0.725759566764072,0,46,face development,BP,
14699,GO:0060325,1,0.818521053984632,0,29,face morphogenesis,BP,
14701,GO:0060327,1,0.993349137943859,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14702,GO:0060330,1,0.87672753930674,0,23,regulation of response to interferon-gamma,BP,
14703,GO:0060331,1,0.971022101281582,0,6,negative regulation of response to interferon-gamma,BP,
14704,GO:0060332,1,0.961469769075999,0,6,positive regulation of response to interferon-gamma,BP,
14705,GO:0060333,1,0.621258128867336,0,84,interferon-gamma-mediated signaling pathway,BP,
14706,GO:0060334,1,0.87672753930674,0,23,regulation of interferon-gamma-mediated signaling pathway,BP,
14707,GO:0060335,1,0.961469769075999,0,6,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14708,GO:0060336,1,0.971022101281582,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14709,GO:0060337,1,0.661122721768138,0,71,type I interferon signaling pathway,BP,
14710,GO:0060338,1,0.819289939046239,0,30,regulation of type I interferon-mediated signaling pathway,BP,
14711,GO:0060339,1,0.954459239508674,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
14712,GO:0060340,1,0.934681643965456,0,10,positive regulation of type I interferon-mediated signaling pathway,BP,
14714,GO:0060342,1,0.988905893867687,0,2,photoreceptor inner segment membrane,CC,
14716,GO:0060345,1,0.992603497008377,0,1,spleen trabecula formation,BP,
14718,GO:0060347,1,0.9320147260636,0,12,heart trabecula formation,BP,
14720,GO:0060349,1,0.585774844956636,0,80,bone morphogenesis,BP,
14721,GO:0060350,1,0.721495497636884,0,48,endochondral bone morphogenesis,BP,
14722,GO:0060351,1,0.849973426163581,0,24,cartilage development involved in endochondral bone morphogenesis,BP,
14723,GO:0060352,1,0.961486649037693,0,7,cell adhesion molecule production,BP,
14724,GO:0060353,1,0.975445089111836,0,5,regulation of cell adhesion molecule production,BP,
14725,GO:0060354,1,0.996934985808316,0,1,negative regulation of cell adhesion molecule production,BP,
14726,GO:0060355,1,0.978444718251284,0,4,positive regulation of cell adhesion molecule production,BP,
14727,GO:0060359,1,0.510220434195007,0,106,response to ammonium ion,BP,
14728,GO:0060363,1,0.953339907342496,0,8,cranial suture morphogenesis,BP,
14729,GO:0060364,1,0.973661503125081,0,4,frontal suture morphogenesis,BP,
14730,GO:0060366,1,0.991233207427996,0,1,lambdoid suture morphogenesis,BP,
14731,GO:0060367,1,0.991233207427996,0,1,sagittal suture morphogenesis,BP,
14732,GO:0060368,1,0.96323023151041,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14733,GO:0060369,1,0.974259870974073,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14734,GO:0060370,1,0.988938001077186,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14736,GO:0060372,1,0.950866915684309,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14738,GO:0060374,1,0.962811699148673,0,5,mast cell differentiation,BP,
14739,GO:0060375,1,0.985029751933207,0,2,regulation of mast cell differentiation,BP,
14740,GO:0060377,1,0.992677817528563,0,1,negative regulation of mast cell differentiation,BP,
14741,GO:0060378,1,0.987212440797364,0,2,regulation of brood size,BP,
14743,GO:0060380,1,0.9950970686153,0,1,regulation of single-stranded telomeric DNA binding,BP,
14744,GO:0060381,1,0.9950970686153,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14745,GO:0060382,1,0.984371538342227,0,2,regulation of DNA strand elongation,BP,
14746,GO:0060383,1,0.992451083350298,0,1,positive regulation of DNA strand elongation,BP,
14747,GO:0060384,1,0.831024193034237,0,25,innervation,BP,
14748,GO:0060385,1,0.965828370741358,0,5,axonogenesis involved in innervation,BP,
14749,GO:0060386,1,0.992091091922694,0,1,synapse assembly involved in innervation,BP,
14751,GO:0060390,1,0.893201543218479,0,17,regulation of SMAD protein signal transduction,BP,
14752,GO:0060391,1,0.913280387830155,0,13,positive regulation of SMAD protein signal transduction,BP,
14753,GO:0060392,1,0.985637312785919,0,3,negative regulation of SMAD protein signal transduction,BP,
14756,GO:0060395,1,0.674284043826918,0,60,SMAD protein signal transduction,BP,
14757,GO:0060396,1,0.874774179624455,0,19,growth hormone receptor signaling pathway,BP,
14758,GO:0060397,1,0.917031944568205,0,12,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14759,GO:0060398,1,0.973857668022239,0,4,regulation of growth hormone receptor signaling pathway,BP,
14760,GO:0060399,1,0.981341681741316,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14761,GO:0060400,1,0.992375181713343,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14764,GO:0060404,1,0.99249364207351,0,1,axonemal microtubule depolymerization,BP,
14765,GO:0060405,1,0.966434177806768,0,5,regulation of penile erection,BP,
14766,GO:0060406,1,0.977827373606368,0,3,positive regulation of penile erection,BP,
14767,GO:0060407,1,0.996256649183377,0,1,negative regulation of penile erection,BP,
14769,GO:0060412,1,0.785368102573612,0,35,ventricular septum morphogenesis,BP,
14770,GO:0060413,1,0.904686707027852,0,14,atrial septum morphogenesis,BP,
14771,GO:0060414,1,0.976649226743225,0,3,aorta smooth muscle tissue morphogenesis,BP,
14773,GO:0060416,1,0.807923833081333,0,30,response to growth hormone,BP,
14776,GO:0060421,1,0.793178632934648,0,33,positive regulation of heart growth,BP,
14777,GO:0060422,1,0.994470389246358,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14778,GO:0060423,1,0.980430796072408,0,3,foregut regionalization,BP,
14779,GO:0060424,1,0.980430796072408,0,3,lung field specification,BP,
14780,GO:0060425,1,0.725679067091713,0,50,lung morphogenesis,BP,
14781,GO:0060426,1,0.969361802531858,0,5,lung vasculature development,BP,
14782,GO:0060428,1,0.803334813232321,0,34,lung epithelium development,BP,
14784,GO:0060430,1,0.954115057787497,0,7,lung saccule development,BP,
14785,GO:0060431,1,0.969057391548174,0,5,primary lung bud formation,BP,
14786,GO:0060432,1,0.997046014162549,0,1,lung pattern specification process,BP,
14787,GO:0060433,1,0.941988626268955,0,10,bronchus development,BP,
14788,GO:0060434,1,0.986196946222231,0,2,bronchus morphogenesis,BP,
14789,GO:0060435,1,0.99361232825486,0,2,bronchiole development,BP,
14790,GO:0060436,1,0.997046014162549,0,1,bronchiole morphogenesis,BP,
14791,GO:0060437,1,0.969706103923532,0,5,lung growth,BP,
14792,GO:0060438,1,0.882305441392358,0,19,trachea development,BP,
14793,GO:0060439,1,0.933014979915606,0,11,trachea morphogenesis,BP,
14794,GO:0060440,1,0.963047247390893,0,6,trachea formation,BP,
14795,GO:0060441,1,0.832509165042566,0,29,epithelial tube branching involved in lung morphogenesis,BP,
14796,GO:0060442,1,0.921709679127716,0,12,branching involved in prostate gland morphogenesis,BP,
14797,GO:0060443,1,0.739058281219437,0,43,mammary gland morphogenesis,BP,
14798,GO:0060444,1,0.851893028410437,0,22,branching involved in mammary gland duct morphogenesis,BP,
14799,GO:0060445,1,0.862016758981414,0,22,branching involved in salivary gland morphogenesis,BP,
14800,GO:0060447,1,0.984766383539428,0,3,bud outgrowth involved in lung branching,BP,
14801,GO:0060448,1,0.978582374842373,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14802,GO:0060449,1,0.959859178018283,0,7,bud elongation involved in lung branching,BP,
14803,GO:0060452,1,0.939142374249777,0,11,positive regulation of cardiac muscle contraction,BP,
14804,GO:0060453,1,0.944283139656087,0,10,regulation of gastric acid secretion,BP,
14805,GO:0060454,1,0.98515574124535,0,2,positive regulation of gastric acid secretion,BP,
14806,GO:0060455,1,0.978956881114998,0,5,negative regulation of gastric acid secretion,BP,
14807,GO:0060456,1,0.947560147982317,0,10,positive regulation of digestive system process,BP,
14808,GO:0060457,1,0.93134829950037,0,13,negative regulation of digestive system process,BP,
14809,GO:0060458,1,0.990003921198436,0,2,right lung development,BP,
14810,GO:0060459,1,0.985935736781372,0,3,left lung development,BP,
14811,GO:0060460,1,0.989700970386619,0,2,left lung morphogenesis,BP,
14812,GO:0060461,1,0.993784527936572,0,1,right lung morphogenesis,BP,
14813,GO:0060462,1,0.960305656814673,0,6,lung lobe development,BP,
14814,GO:0060463,1,0.960305656814673,0,6,lung lobe morphogenesis,BP,
14815,GO:0060465,1,0.985203097310467,0,2,pharynx development,BP,
14816,GO:0060466,1,0.991747873577304,0,1,activation of meiosis involved in egg activation,BP,
14817,GO:0060467,1,0.991095879439145,0,2,negative regulation of fertilization,BP,
14818,GO:0060474,1,0.989712631874527,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
14819,GO:0060478,1,0.977789975686077,0,4,acrosomal vesicle exocytosis,BP,
14820,GO:0060479,1,0.878417934944934,0,21,lung cell differentiation,BP,
14821,GO:0060480,1,0.988736908071605,0,3,lung goblet cell differentiation,BP,
14822,GO:0060481,1,0.981284501956892,0,4,lobar bronchus epithelium development,BP,
14823,GO:0060482,1,0.973887619594611,0,5,lobar bronchus development,BP,
14824,GO:0060484,1,0.951231499195199,0,8,lung-associated mesenchyme development,BP,
14826,GO:0060486,1,0.972947368072278,0,4,Clara cell differentiation,BP,
14827,GO:0060487,1,0.885004252958058,0,20,lung epithelial cell differentiation,BP,
14828,GO:0060488,1,0.982161113569982,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14829,GO:0060489,1,0.982161113569982,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14830,GO:0060490,1,0.982161113569982,0,2,lateral sprouting involved in lung morphogenesis,BP,
14832,GO:0060492,1,0.980430796072408,0,3,lung induction,BP,
14833,GO:0060495,1,0.997046014162549,0,1,cell-cell signaling involved in lung development,BP,
14834,GO:0060496,1,0.997046014162549,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14835,GO:0060501,1,0.959346091202138,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14836,GO:0060502,1,0.933882847951971,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14837,GO:0060503,1,0.99578603907695,0,1,bud dilation involved in lung branching,BP,
14838,GO:0060509,1,0.964097304485889,0,5,Type I pneumocyte differentiation,BP,
14839,GO:0060510,1,0.972398619759983,0,5,Type II pneumocyte differentiation,BP,
14840,GO:0060512,1,0.833672191836903,0,27,prostate gland morphogenesis,BP,
14841,GO:0060513,1,0.939860704538091,0,10,prostatic bud formation,BP,
14842,GO:0060514,1,0.992877652548444,0,1,prostate induction,BP,
14843,GO:0060515,1,0.992877652548444,0,1,prostate field specification,BP,
14844,GO:0060516,1,0.988687014269142,0,2,primary prostatic bud elongation,BP,
14845,GO:0060517,1,0.99246264441973,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14846,GO:0060520,1,0.992877652548444,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14847,GO:0060523,1,0.980662099653278,0,3,prostate epithelial cord elongation,BP,
14848,GO:0060525,1,0.920999782355833,0,11,prostate glandular acinus development,BP,
14849,GO:0060526,1,0.956556334481677,0,6,prostate glandular acinus morphogenesis,BP,
14850,GO:0060527,1,0.956556334481677,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14851,GO:0060528,1,0.97024523770206,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14852,GO:0060529,1,0.984883462974171,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14853,GO:0060532,1,0.984946461549089,0,2,bronchus cartilage development,BP,
14854,GO:0060534,1,0.944338310737219,0,8,trachea cartilage development,BP,
14855,GO:0060535,1,0.972527986288883,0,4,trachea cartilage morphogenesis,BP,
14856,GO:0060536,1,0.931967341569957,0,11,cartilage morphogenesis,BP,
14859,GO:0060539,1,0.955484078528003,0,7,diaphragm development,BP,
14861,GO:0060542,1,0.992076901588569,0,1,regulation of strand invasion,BP,
14863,GO:0060545,1,0.987952647227806,0,2,positive regulation of necroptotic process,BP,
14867,GO:0060556,1,0.956391629731931,0,8,regulation of vitamin D biosynthetic process,BP,
14868,GO:0060557,1,0.992360152950919,0,2,positive regulation of vitamin D biosynthetic process,BP,
14869,GO:0060558,1,0.965066853322152,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14870,GO:0060559,1,0.992360152950919,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14872,GO:0060561,1,0.859420919410196,0,23,apoptotic process involved in morphogenesis,BP,
14874,GO:0060563,1,0.719960355275734,0,50,neuroepithelial cell differentiation,BP,
14875,GO:0060566,1,0.990055841676307,0,1,positive regulation of DNA-templated transcription, termination,BP,
14877,GO:0060572,1,0.899897261702739,0,17,morphogenesis of an epithelial bud,BP,
14879,GO:0060574,1,0.98005652401601,0,4,intestinal epithelial cell maturation,BP,
14880,GO:0060575,1,0.908355516368129,0,16,intestinal epithelial cell differentiation,BP,
14881,GO:0060576,1,0.948335494277522,0,10,intestinal epithelial cell development,BP,
14882,GO:0060577,1,0.990805109687224,0,2,pulmonary vein morphogenesis,BP,
14883,GO:0060578,1,0.994633344008628,0,1,superior vena cava morphogenesis,BP,
14885,GO:0060580,1,0.995070552042379,0,1,ventral spinal cord interneuron fate determination,BP,
14887,GO:0060582,1,0.995070552042379,0,1,cell fate determination involved in pattern specification,BP,
14888,GO:0060584,1,0.9841447298656,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
14889,GO:0060585,1,0.9841447298656,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14890,GO:0060586,1,0.949681334512702,0,8,multicellular organismal iron ion homeostasis,BP,
14894,GO:0060590,1,0.790604829338117,0,41,ATPase regulator activity,MF,
14895,GO:0060591,1,0.973367167830985,0,4,chondroblast differentiation,BP,
14896,GO:0060592,1,0.954822559040515,0,7,mammary gland formation,BP,
14897,GO:0060594,1,0.980843067869887,0,3,mammary gland specification,BP,
14898,GO:0060595,1,0.989518922686381,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14899,GO:0060596,1,0.977597081514767,0,3,mammary placode formation,BP,
14900,GO:0060598,1,0.996662922858795,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14901,GO:0060599,1,0.984991289245888,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14902,GO:0060600,1,0.932642834574041,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14903,GO:0060601,1,0.916109613132743,0,13,lateral sprouting from an epithelium,BP,
14904,GO:0060602,1,0.884866190882368,0,19,branch elongation of an epithelium,BP,
14905,GO:0060603,1,0.806011051807742,0,30,mammary gland duct morphogenesis,BP,
14906,GO:0060605,1,0.970029395631086,0,5,tube lumen cavitation,BP,
14908,GO:0060611,1,0.994112311743672,0,1,mammary gland fat development,BP,
14909,GO:0060612,1,0.790267724899567,0,36,adipose tissue development,BP,
14910,GO:0060613,1,0.953861355270093,0,7,fat pad development,BP,
14911,GO:0060615,1,0.989518922686381,0,2,mammary gland bud formation,BP,
14912,GO:0060620,1,0.993301131169352,0,1,regulation of cholesterol import,BP,
14913,GO:0060623,1,0.987558859953043,0,2,regulation of chromosome condensation,BP,
14915,GO:0060628,1,0.922440055762653,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
14916,GO:0060629,1,0.993163430041399,0,1,regulation of homologous chromosome segregation,BP,
14917,GO:0060631,1,0.952970542611721,0,7,regulation of meiosis I,BP,
14918,GO:0060632,1,0.860373753384571,0,23,regulation of microtubule-based movement,BP,
14919,GO:0060633,1,0.965902874082184,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14920,GO:0060638,1,0.952535721184496,0,8,mesenchymal-epithelial cell signaling,BP,
14921,GO:0060644,1,0.90007744787525,0,16,mammary gland epithelial cell differentiation,BP,
14922,GO:0060648,1,0.9851647773654,0,3,mammary gland bud morphogenesis,BP,
14923,GO:0060661,1,0.991876511630965,0,2,submandibular salivary gland formation,BP,
14924,GO:0060662,1,0.970029395631086,0,5,salivary gland cavitation,BP,
14925,GO:0060664,1,0.974624510793739,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14926,GO:0060665,1,0.977054129549417,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14927,GO:0060666,1,0.961490633161367,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14928,GO:0060667,1,0.989518922686381,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14929,GO:0060668,1,0.992501780374214,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14930,GO:0060669,1,0.862788484179219,0,23,embryonic placenta morphogenesis,BP,
14931,GO:0060670,1,0.941943627283756,0,10,branching involved in labyrinthine layer morphogenesis,BP,
14932,GO:0060671,1,0.988585922938542,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14933,GO:0060672,1,0.988585922938542,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14934,GO:0060674,1,0.823585962029564,0,29,placenta blood vessel development,BP,
14937,GO:0060677,1,0.948100340209589,0,7,ureteric bud elongation,BP,
14938,GO:0060678,1,0.994559939956312,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14939,GO:0060681,1,0.973940308234746,0,4,branch elongation involved in ureteric bud branching,BP,
14940,GO:0060683,1,0.993307046402168,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14941,GO:0060684,1,0.961973746671327,0,7,epithelial-mesenchymal cell signaling,BP,
14942,GO:0060685,1,0.962086220063473,0,6,regulation of prostatic bud formation,BP,
14943,GO:0060686,1,0.97269114814852,0,4,negative regulation of prostatic bud formation,BP,
14944,GO:0060687,1,0.952517747577443,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
14946,GO:0060689,1,0.979845303019546,0,3,cell differentiation involved in salivary gland development,BP,
14947,GO:0060690,1,0.995733554041714,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14948,GO:0060691,1,0.995733554041714,0,1,epithelial cell maturation involved in salivary gland development,BP,
14949,GO:0060693,1,0.947126098887642,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14950,GO:0060694,1,0.995615619474342,0,1,regulation of cholesterol transporter activity,BP,
14951,GO:0060696,1,0.967874579897133,0,6,regulation of phospholipid catabolic process,BP,
14952,GO:0060697,1,0.990306992709769,0,2,positive regulation of phospholipid catabolic process,BP,
14953,GO:0060698,1,0.985334863671568,0,2,endoribonuclease inhibitor activity,MF,
14954,GO:0060699,1,0.976128225308666,0,4,regulation of endoribonuclease activity,BP,
14955,GO:0060700,1,0.947030560949428,0,9,regulation of ribonuclease activity,BP,
14956,GO:0060701,1,0.985334863671568,0,2,negative regulation of ribonuclease activity,BP,
14957,GO:0060702,1,0.985334863671568,0,2,negative regulation of endoribonuclease activity,BP,
14958,GO:0060703,1,0.993426104869907,0,1,deoxyribonuclease inhibitor activity,MF,
14959,GO:0060706,1,0.870391201348927,0,22,cell differentiation involved in embryonic placenta development,BP,
14960,GO:0060707,1,0.931308672204586,0,11,trophoblast giant cell differentiation,BP,
14961,GO:0060708,1,0.982565452558215,0,3,spongiotrophoblast differentiation,BP,
14962,GO:0060709,1,0.993135804905899,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14963,GO:0060710,1,0.955712575575447,0,7,chorio-allantoic fusion,BP,
14964,GO:0060711,1,0.760065663544265,0,43,labyrinthine layer development,BP,
14965,GO:0060712,1,0.914258391467332,0,14,spongiotrophoblast layer development,BP,
14966,GO:0060713,1,0.889703888923683,0,19,labyrinthine layer morphogenesis,BP,
14967,GO:0060715,1,0.980487035938805,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14968,GO:0060716,1,0.887873274327917,0,19,labyrinthine layer blood vessel development,BP,
14969,GO:0060717,1,0.952191475221314,0,7,chorion development,BP,
14970,GO:0060718,1,0.964028314595769,0,5,chorionic trophoblast cell differentiation,BP,
14971,GO:0060720,1,0.988236259754271,0,2,spongiotrophoblast cell proliferation,BP,
14972,GO:0060721,1,0.988236259754271,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14973,GO:0060722,1,0.988236259754271,0,2,cell proliferation involved in embryonic placenta development,BP,
14974,GO:0060723,1,0.988236259754271,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14975,GO:0060729,1,0.967334682709712,0,5,intestinal epithelial structure maintenance,BP,
14976,GO:0060730,1,0.986319835751636,0,2,regulation of intestinal epithelial structure maintenance,BP,
14977,GO:0060731,1,0.992651266995692,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14978,GO:0060732,1,0.939472218493531,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14979,GO:0060733,1,0.984682069723509,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14980,GO:0060734,1,0.992371902240144,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14981,GO:0060735,1,0.996509434378335,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14982,GO:0060736,1,0.920313688474563,0,11,prostate gland growth,BP,
14983,GO:0060737,1,0.973269003691017,0,4,prostate gland morphogenetic growth,BP,
14984,GO:0060738,1,0.98902922021989,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14985,GO:0060739,1,0.991456207629103,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14986,GO:0060740,1,0.836120018245213,0,26,prostate gland epithelium morphogenesis,BP,
14987,GO:0060741,1,0.984307484307865,0,3,prostate gland stromal morphogenesis,BP,
14988,GO:0060742,1,0.922866346514587,0,11,epithelial cell differentiation involved in prostate gland development,BP,
14989,GO:0060743,1,0.979628038971697,0,3,epithelial cell maturation involved in prostate gland development,BP,
14990,GO:0060744,1,0.971438849584006,0,5,mammary gland branching involved in thelarche,BP,
14991,GO:0060745,1,0.950959922417411,0,6,mammary gland branching involved in pregnancy,BP,
14992,GO:0060746,1,0.914885652509815,0,13,parental behavior,BP,
14993,GO:0060748,1,0.974639710798328,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14994,GO:0060749,1,0.894933430697058,0,17,mammary gland alveolus development,BP,
14995,GO:0060750,1,0.972157227724384,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14996,GO:0060751,1,0.967028358168036,0,5,branch elongation involved in mammary gland duct branching,BP,
14997,GO:0060752,1,0.993517530070233,0,1,intestinal phytosterol absorption,BP,
14998,GO:0060753,1,0.9693383032766,0,6,regulation of mast cell chemotaxis,BP,
14999,GO:0060754,1,0.972874021798355,0,5,positive regulation of mast cell chemotaxis,BP,
15000,GO:0060759,1,0.397675677503224,0,150,regulation of response to cytokine stimulus,BP,
15001,GO:0060760,1,0.747631672373003,0,47,positive regulation of response to cytokine stimulus,BP,
15002,GO:0060761,1,0.758852220940279,0,48,negative regulation of response to cytokine stimulus,BP,
15003,GO:0060762,1,0.975865194957043,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
15004,GO:0060763,1,0.986036042985542,0,2,mammary duct terminal end bud growth,BP,
15005,GO:0060764,1,0.988842925124172,0,2,cell-cell signaling involved in mammary gland development,BP,
15006,GO:0060765,1,0.85233317861564,0,25,regulation of androgen receptor signaling pathway,BP,
15007,GO:0060766,1,0.931993866772682,0,11,negative regulation of androgen receptor signaling pathway,BP,
15008,GO:0060767,1,0.933673787765617,0,11,epithelial cell proliferation involved in prostate gland development,BP,
15009,GO:0060768,1,0.940769191920332,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
15010,GO:0060769,1,0.981747930483329,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
15011,GO:0060770,1,0.967169759935075,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
15012,GO:0060775,1,0.987542950546026,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
15013,GO:0060781,1,0.996195995110822,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
15014,GO:0060782,1,0.996195995110822,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
15015,GO:0060783,1,0.996195995110822,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
15016,GO:0060784,1,0.99246264441973,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
15017,GO:0060788,1,0.910337847092789,0,14,ectodermal placode formation,BP,
15018,GO:0060789,1,0.966876467694519,0,6,hair follicle placode formation,BP,
15020,GO:0060796,1,0.990688090465703,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15021,GO:0060800,1,0.981193241887401,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15022,GO:0060802,1,0.995041290819372,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15023,GO:0060803,1,0.99633478060087,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15024,GO:0060804,1,0.992762238217727,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15025,GO:0060806,1,0.995984976409043,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15026,GO:0060807,1,0.994332754053465,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15027,GO:0060809,1,0.98549166434922,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15028,GO:0060816,1,0.982924225070499,0,2,random inactivation of X chromosome,BP,
15029,GO:0060819,1,0.983805288784165,0,2,inactivation of X chromosome by genetic imprinting,BP,
15030,GO:0060821,1,0.991043110066508,0,1,inactivation of X chromosome by DNA methylation,BP,
15031,GO:0060823,1,0.985088330862928,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15032,GO:0060825,1,0.991593951502797,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15033,GO:0060827,1,0.992452802027794,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15035,GO:0060829,1,0.992452802027794,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15036,GO:0060830,1,0.981865247675186,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15037,GO:0060831,1,0.908897058282823,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15038,GO:0060836,1,0.943785928447613,0,8,lymphatic endothelial cell differentiation,BP,
15039,GO:0060837,1,0.944183251665389,0,9,blood vessel endothelial cell differentiation,BP,
15040,GO:0060838,1,0.978871833005861,0,3,lymphatic endothelial cell fate commitment,BP,
15041,GO:0060839,1,0.953545831121205,0,7,endothelial cell fate commitment,BP,
15043,GO:0060841,1,0.890027794838848,0,16,venous blood vessel development,BP,
15044,GO:0060842,1,0.96158738917616,0,6,arterial endothelial cell differentiation,BP,
15045,GO:0060843,1,0.990798481679787,0,1,venous endothelial cell differentiation,BP,
15046,GO:0060844,1,0.986969846169612,0,2,arterial endothelial cell fate commitment,BP,
15047,GO:0060846,1,0.981014961468374,0,3,blood vessel endothelial cell fate commitment,BP,
15048,GO:0060847,1,0.981014961468374,0,3,endothelial cell fate specification,BP,
15049,GO:0060849,1,0.985363029235112,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15051,GO:0060853,1,0.992629034746413,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15052,GO:0060856,1,0.937971786678674,0,10,establishment of blood-brain barrier,BP,
15053,GO:0060857,1,0.994519202913462,0,1,establishment of glial blood-brain barrier,BP,
15054,GO:0060872,1,0.939839878956663,0,9,semicircular canal development,BP,
15055,GO:0060873,1,0.991233207427996,0,1,anterior semicircular canal development,BP,
15056,GO:0060875,1,0.991233207427996,0,1,lateral semicircular canal development,BP,
15057,GO:0060876,1,0.991144262788011,0,2,semicircular canal formation,BP,
15058,GO:0060879,1,0.997046014162549,0,1,semicircular canal fusion,BP,
15059,GO:0060896,1,0.939364442520301,0,9,neural plate pattern specification,BP,
15060,GO:0060897,1,0.955272341666968,0,7,neural plate regionalization,BP,
15061,GO:0060900,1,0.914120682376197,0,12,embryonic camera-type eye formation,BP,
15062,GO:0060901,1,0.992431393876814,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15063,GO:0060903,1,0.973503855271887,0,4,positive regulation of meiosis I,BP,
15064,GO:0060904,1,0.992459819061843,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15065,GO:0060907,1,0.9580733301376,0,7,positive regulation of macrophage cytokine production,BP,
15066,GO:0060911,1,0.943062845780795,0,10,cardiac cell fate commitment,BP,
15067,GO:0060912,1,0.987671456303028,0,2,cardiac cell fate specification,BP,
15068,GO:0060913,1,0.984581140726368,0,3,cardiac cell fate determination,BP,
15070,GO:0060915,1,0.989518922686381,0,2,mesenchymal cell differentiation involved in lung development,BP,
15071,GO:0060916,1,0.965415103029723,0,5,mesenchymal cell proliferation involved in lung development,BP,
15074,GO:0060922,1,0.98759098048717,0,2,atrioventricular node cell differentiation,BP,
15075,GO:0060923,1,0.964300359607366,0,6,cardiac muscle cell fate commitment,BP,
15077,GO:0060927,1,0.995461921104387,0,1,cardiac pacemaker cell fate commitment,BP,
15078,GO:0060928,1,0.98759098048717,0,2,atrioventricular node cell development,BP,
15079,GO:0060929,1,0.995461921104387,0,1,atrioventricular node cell fate commitment,BP,
15081,GO:0060932,1,0.987848437452847,0,2,His-Purkinje system cell differentiation,BP,
15082,GO:0060935,1,0.978676258080742,0,3,cardiac fibroblast cell differentiation,BP,
15083,GO:0060936,1,0.978676258080742,0,3,cardiac fibroblast cell development,BP,
15084,GO:0060938,1,0.978676258080742,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15085,GO:0060939,1,0.978676258080742,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15086,GO:0060940,1,0.986700708972416,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15087,GO:0060947,1,0.944944366845025,0,8,cardiac vascular smooth muscle cell differentiation,BP,
15088,GO:0060948,1,0.977022362605207,0,3,cardiac vascular smooth muscle cell development,BP,
15089,GO:0060956,1,0.960002306839158,0,6,endocardial cell differentiation,BP,
15090,GO:0060957,1,0.992986285104771,0,1,endocardial cell fate commitment,BP,
15092,GO:0060965,1,0.925296979537455,0,12,negative regulation of gene silencing by miRNA,BP,
15094,GO:0060967,1,0.910803184973907,0,14,negative regulation of gene silencing by RNA,BP,
15096,GO:0060969,1,0.858188948959327,0,22,negative regulation of gene silencing,BP,
15097,GO:0060971,1,0.974011069545028,0,4,embryonic heart tube left/right pattern formation,BP,
15098,GO:0060972,1,0.86955494484791,0,21,left/right pattern formation,BP,
15100,GO:0060974,1,0.993587975109465,0,2,cell migration involved in heart formation,BP,
15101,GO:0060975,1,0.996741839541675,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15104,GO:0060978,1,0.978107330486895,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15105,GO:0060979,1,0.967156102709221,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
15106,GO:0060980,1,0.992495045100237,0,1,cell migration involved in coronary vasculogenesis,BP,
15107,GO:0060981,1,0.992090476747306,0,1,cell migration involved in coronary angiogenesis,BP,
15109,GO:0060986,1,0.769047805420607,0,43,endocrine hormone secretion,BP,
15110,GO:0060987,1,0.994400074224895,0,1,lipid tube,CC,
15111,GO:0060988,1,0.986881927186339,0,2,lipid tube assembly,BP,
15112,GO:0060992,1,0.925687758249077,0,11,response to fungicide,BP,
15114,GO:0060994,1,0.988302309702801,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15115,GO:0060995,1,0.985132087117943,0,2,cell-cell signaling involved in kidney development,BP,
15116,GO:0060996,1,0.542193613305261,0,84,dendritic spine development,BP,
15117,GO:0060997,1,0.700563842262089,0,48,dendritic spine morphogenesis,BP,
15118,GO:0060998,1,0.630750790765768,0,63,regulation of dendritic spine development,BP,
15119,GO:0060999,1,0.750386314685312,0,39,positive regulation of dendritic spine development,BP,
15120,GO:0061000,1,0.921502264903341,0,11,negative regulation of dendritic spine development,BP,
15121,GO:0061001,1,0.776950101222974,0,34,regulation of dendritic spine morphogenesis,BP,
15122,GO:0061002,1,0.958288635256188,0,6,negative regulation of dendritic spine morphogenesis,BP,
15123,GO:0061003,1,0.877815113420146,0,17,positive regulation of dendritic spine morphogenesis,BP,
15124,GO:0061004,1,0.951984326003151,0,9,pattern specification involved in kidney development,BP,
15127,GO:0061009,1,0.973482874938609,0,5,common bile duct development,BP,
15128,GO:0061010,1,0.980741021287851,0,3,gall bladder development,BP,
15129,GO:0061011,1,0.99584477650475,0,1,hepatic duct development,BP,
15130,GO:0061013,1,0.354029559998714,0,170,regulation of mRNA catabolic process,BP,
15131,GO:0061014,1,0.758365440109255,0,39,positive regulation of mRNA catabolic process,BP,
15132,GO:0061015,1,0.992790128728267,0,2,snRNA import into nucleus,BP,
15133,GO:0061017,1,0.99584477650475,0,1,hepatoblast differentiation,BP,
15135,GO:0061025,1,0.252284191516847,0,216,membrane fusion,BP,
15136,GO:0061026,1,0.989640903993005,0,1,cardiac muscle tissue regeneration,BP,
15137,GO:0061027,1,0.988017533815064,0,2,umbilical cord development,BP,
15138,GO:0061028,1,0.770041583264453,0,38,establishment of endothelial barrier,BP,
15140,GO:0061030,1,0.982852864965704,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15141,GO:0061031,1,0.985551323583251,0,3,endodermal digestive tract morphogenesis,BP,
15142,GO:0061032,1,0.987249003031901,0,2,visceral serous pericardium development,BP,
15143,GO:0061033,1,0.989530037271396,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15144,GO:0061034,1,0.984732959722936,0,2,olfactory bulb mitral cell layer development,BP,
15146,GO:0061036,1,0.825813648898859,0,27,positive regulation of cartilage development,BP,
15148,GO:0061038,1,0.95821845279614,0,6,uterus morphogenesis,BP,
15149,GO:0061040,1,0.991018675731716,0,1,female gonad morphogenesis,BP,
15151,GO:0061042,1,0.945848720908683,0,9,vascular wound healing,BP,
15152,GO:0061043,1,0.977096077088627,0,4,regulation of vascular wound healing,BP,
15153,GO:0061044,1,0.992748832094152,0,1,negative regulation of vascular wound healing,BP,
15155,GO:0061046,1,0.965088024220727,0,6,regulation of branching involved in lung morphogenesis,BP,
15156,GO:0061047,1,0.976298449089437,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15157,GO:0061048,1,0.996028001164838,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15158,GO:0061049,1,0.895003329683085,0,17,cell growth involved in cardiac muscle cell development,BP,
15159,GO:0061050,1,0.931546863376886,0,11,regulation of cell growth involved in cardiac muscle cell development,BP,
15160,GO:0061051,1,0.956030415784968,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15161,GO:0061052,1,0.97440224082952,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15163,GO:0061054,1,0.987792032883689,0,2,dermatome development,BP,
15165,GO:0061056,1,0.979667015846286,0,4,sclerotome development,BP,
15167,GO:0061072,1,0.939791265759723,0,9,iris morphogenesis,BP,
15168,GO:0061073,1,0.980889752974812,0,3,ciliary body morphogenesis,BP,
15169,GO:0061074,1,0.968607648772887,0,5,regulation of neural retina development,BP,
15170,GO:0061075,1,0.989002073822641,0,2,positive regulation of neural retina development,BP,
15171,GO:0061076,1,0.992773073925503,0,1,negative regulation of neural retina development,BP,
15172,GO:0061077,1,0.657850192617946,0,71,chaperone-mediated protein folding,BP,
15173,GO:0061078,1,0.997062308027535,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15174,GO:0061081,1,0.938225665274007,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15175,GO:0061082,1,0.874666038538286,0,22,myeloid leukocyte cytokine production,BP,
15176,GO:0061083,1,0.974112596423819,0,4,regulation of protein refolding,BP,
15177,GO:0061084,1,0.974112596423819,0,4,negative regulation of protein refolding,BP,
15178,GO:0061085,1,0.941703292928465,0,9,regulation of histone H3-K27 methylation,BP,
15179,GO:0061086,1,0.974665625505445,0,4,negative regulation of histone H3-K27 methylation,BP,
15180,GO:0061087,1,0.96047210990861,0,6,positive regulation of histone H3-K27 methylation,BP,
15181,GO:0061088,1,0.944013053986602,0,9,regulation of sequestering of zinc ion,BP,
15182,GO:0061090,1,0.994183401789575,0,1,positive regulation of sequestering of zinc ion,BP,
15183,GO:0061091,1,0.976147660429771,0,3,regulation of phospholipid translocation,BP,
15184,GO:0061092,1,0.976147660429771,0,3,positive regulation of phospholipid translocation,BP,
15187,GO:0061099,1,0.86058105098586,0,24,negative regulation of protein tyrosine kinase activity,BP,
15188,GO:0061100,1,0.993995508641689,0,1,lung neuroendocrine cell differentiation,BP,
15189,GO:0061101,1,0.958272846478187,0,8,neuroendocrine cell differentiation,BP,
15190,GO:0061102,1,0.990407442330532,0,2,stomach neuroendocrine cell differentiation,BP,
15191,GO:0061103,1,0.993995508641689,0,1,carotid body glomus cell differentiation,BP,
15192,GO:0061104,1,0.987247640327046,0,2,adrenal chromaffin cell differentiation,BP,
15193,GO:0061105,1,0.996390485593893,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15194,GO:0061106,1,0.996390485593893,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15195,GO:0061107,1,0.983420671296316,0,3,seminal vesicle development,BP,
15196,GO:0061108,1,0.994561298560891,0,1,seminal vesicle epithelium development,BP,
15197,GO:0061110,1,0.978802001255271,0,3,dense core granule biogenesis,BP,
15198,GO:0061113,1,0.977792782531412,0,3,pancreas morphogenesis,BP,
15199,GO:0061114,1,0.99284618617602,0,1,branching involved in pancreas morphogenesis,BP,
15200,GO:0061115,1,0.997046014162549,0,1,lung proximal/distal axis specification,BP,
15202,GO:0061133,1,0.974421263616179,0,6,endopeptidase activator activity,MF,
15205,GO:0061136,1,0.353930772333093,0,165,regulation of proteasomal protein catabolic process,BP,
15207,GO:0061140,1,0.95566788401913,0,9,lung secretory cell differentiation,BP,
15208,GO:0061141,1,0.981574177955076,0,3,lung ciliated cell differentiation,BP,
15209,GO:0061143,1,0.993165181999932,0,1,alveolar primary septum development,BP,
15210,GO:0061144,1,0.992806143572439,0,1,alveolar secondary septum development,BP,
15211,GO:0061145,1,0.984946461549089,0,2,lung smooth muscle development,BP,
15212,GO:0061146,1,0.980929399754064,0,3,Peyer's patch morphogenesis,BP,
15213,GO:0061149,1,0.99578603907695,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15214,GO:0061150,1,0.99578603907695,0,1,renal system segmentation,BP,
15215,GO:0061151,1,0.99578603907695,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15216,GO:0061152,1,0.9892764753033,0,2,trachea submucosa development,BP,
15217,GO:0061153,1,0.9892764753033,0,2,trachea gland development,BP,
15218,GO:0061154,1,0.912339851265608,0,15,endothelial tube morphogenesis,BP,
15219,GO:0061155,1,0.99578603907695,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15221,GO:0061157,1,0.851785266545982,0,22,mRNA destabilization,BP,
15222,GO:0061158,1,0.913362512990477,0,12,3'-UTR-mediated mRNA destabilization,BP,
15223,GO:0061162,1,0.876502664263611,0,19,establishment of monopolar cell polarity,BP,
15225,GO:0061179,1,0.954718372840892,0,9,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15226,GO:0061180,1,0.643530307687269,0,64,mammary gland epithelium development,BP,
15227,GO:0061181,1,0.992437421742524,0,1,regulation of chondrocyte development,BP,
15228,GO:0061183,1,0.987792032883689,0,2,regulation of dermatome development,BP,
15229,GO:0061184,1,0.992464071756125,0,1,positive regulation of dermatome development,BP,
15230,GO:0061185,1,0.995292855846941,0,1,negative regulation of dermatome development,BP,
15231,GO:0061187,1,0.984244459077322,0,2,regulation of chromatin silencing at rDNA,BP,
15232,GO:0061188,1,0.984244459077322,0,2,negative regulation of chromatin silencing at rDNA,BP,
15233,GO:0061189,1,0.996195995110822,0,1,positive regulation of sclerotome development,BP,
15234,GO:0061190,1,0.996195995110822,0,1,regulation of sclerotome development,BP,
15235,GO:0061193,1,0.9968737390535,0,1,taste bud development,BP,
15236,GO:0061196,1,0.960001312697484,0,6,fungiform papilla development,BP,
15237,GO:0061197,1,0.96527538208211,0,5,fungiform papilla morphogenesis,BP,
15238,GO:0061198,1,0.979497206942073,0,3,fungiform papilla formation,BP,
15239,GO:0061200,1,0.953926323515186,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15240,GO:0061202,1,0.953926323515186,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15241,GO:0061205,1,0.985680228192079,0,2,paramesonephric duct development,BP,
15242,GO:0061209,1,0.97607882134204,0,4,cell proliferation involved in mesonephros development,BP,
15244,GO:0061216,1,0.99578603907695,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15247,GO:0061227,1,0.9913400671599,0,2,pattern specification involved in mesonephros development,BP,
15248,GO:0061245,1,0.741974444989398,0,45,establishment or maintenance of bipolar cell polarity,BP,
15249,GO:0061289,1,0.985132087117943,0,2,Wnt signaling pathway involved in kidney development,BP,
15250,GO:0061290,1,0.985132087117943,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15252,GO:0061299,1,0.939150300527789,0,9,retina vasculature morphogenesis in camera-type eye,BP,
15253,GO:0061300,1,0.987860142095552,0,2,cerebellum vasculature development,BP,
15254,GO:0061301,1,0.991543121789408,0,1,cerebellum vasculature morphogenesis,BP,
15256,GO:0061303,1,0.955055255223985,0,8,cornea development in camera-type eye,BP,
15257,GO:0061304,1,0.968260974466272,0,4,retinal blood vessel morphogenesis,BP,
15258,GO:0061307,1,0.940368377981108,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15259,GO:0061308,1,0.940368377981108,0,11,cardiac neural crest cell development involved in heart development,BP,
15260,GO:0061309,1,0.951716774792067,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15261,GO:0061311,1,0.859564777915599,0,24,cell surface receptor signaling pathway involved in heart development,BP,
15262,GO:0061312,1,0.967409979536768,0,6,BMP signaling pathway involved in heart development,BP,
15263,GO:0061314,1,0.938621351883332,0,9,Notch signaling involved in heart development,BP,
15264,GO:0061316,1,0.982705076391322,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15265,GO:0061317,1,0.990064699454403,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15266,GO:0061318,1,0.901444425670467,0,15,renal filtration cell differentiation,BP,
15267,GO:0061323,1,0.907484267253261,0,15,cell proliferation involved in heart morphogenesis,BP,
15268,GO:0061324,1,0.99256729355413,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15269,GO:0061325,1,0.977456954863802,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15273,GO:0061339,1,0.876502664263611,0,19,establishment or maintenance of monopolar cell polarity,BP,
15274,GO:0061341,1,0.984323015348648,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15275,GO:0061343,1,0.969566749257808,0,4,cell adhesion involved in heart morphogenesis,BP,
15276,GO:0061346,1,0.984323015348648,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15277,GO:0061347,1,0.992057652763443,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15278,GO:0061348,1,0.992057652763443,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15279,GO:0061349,1,0.992057652763443,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15280,GO:0061350,1,0.992057652763443,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15282,GO:0061354,1,0.992057652763443,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15283,GO:0061355,1,0.974826220229382,0,4,Wnt protein secretion,BP,
15284,GO:0061356,1,0.974826220229382,0,4,regulation of Wnt protein secretion,BP,
15285,GO:0061357,1,0.979137484264436,0,3,positive regulation of Wnt protein secretion,BP,
15286,GO:0061358,1,0.995597841356715,0,1,negative regulation of Wnt protein secretion,BP,
15287,GO:0061360,1,0.992449677325916,0,1,optic chiasma development,BP,
15288,GO:0061364,1,0.976705031603741,0,3,apoptotic process involved in luteolysis,BP,
15289,GO:0061365,1,0.968230047499856,0,7,positive regulation of triglyceride lipase activity,BP,
15290,GO:0061366,1,0.982153111057968,0,3,behavioral response to chemical pain,BP,
15291,GO:0061368,1,0.982153111057968,0,3,behavioral response to formalin induced pain,BP,
15292,GO:0061369,1,0.992464071756125,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15293,GO:0061370,1,0.969061087658506,0,6,testosterone biosynthetic process,BP,
15295,GO:0061373,1,0.990858875999902,0,1,mammillary axonal complex development,BP,
15296,GO:0061377,1,0.894933430697058,0,17,mammary gland lobule development,BP,
15298,GO:0061384,1,0.810317007669689,0,31,heart trabecula morphogenesis,BP,
15299,GO:0061386,1,0.983054021509078,0,2,closure of optic fissure,BP,
15301,GO:0061394,1,0.991089663106001,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15302,GO:0061395,1,0.995925506558483,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15303,GO:0061400,1,0.993301131169352,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15304,GO:0061402,1,0.987553332153131,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15305,GO:0061408,1,0.982207705410372,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15306,GO:0061418,1,0.679778822027727,0,74,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15307,GO:0061419,1,0.963980081157913,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15308,GO:0061428,1,0.97618386982284,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15310,GO:0061433,1,0.995397073095079,0,1,cellular response to caloric restriction,BP,
15311,GO:0061436,1,0.90449712731359,0,16,establishment of skin barrier,BP,
15316,GO:0061441,1,0.986293560615826,0,2,renal artery morphogenesis,BP,
15317,GO:0061443,1,0.985045754699664,0,2,endocardial cushion cell differentiation,BP,
15318,GO:0061444,1,0.992003966929778,0,1,endocardial cushion cell development,BP,
15319,GO:0061445,1,0.992986285104771,0,1,endocardial cushion cell fate commitment,BP,
15321,GO:0061450,1,0.947380993698816,0,10,trophoblast cell migration,BP,
15323,GO:0061459,1,0.991474662180335,0,1,L-arginine transmembrane transporter activity,MF,
15324,GO:0061462,1,0.799481373542796,0,35,protein localization to lysosome,BP,
15325,GO:0061469,1,0.946415590598148,0,8,regulation of type B pancreatic cell proliferation,BP,
15326,GO:0061470,1,0.971154365023075,0,4,T follicular helper cell differentiation,BP,
15327,GO:0061474,1,0.993818958188301,0,1,phagolysosome membrane,CC,
15328,GO:0061476,1,0.963308890129015,0,5,response to anticoagulant,BP,
15329,GO:0061478,1,0.914206820832743,0,12,response to platelet aggregation inhibitor,BP,
15330,GO:0061481,1,0.996964525762303,0,1,response to TNF agonist,BP,
15331,GO:0061484,1,0.971860864332973,0,4,hematopoietic stem cell homeostasis,BP,
15332,GO:0061485,1,0.991501667490928,0,1,memory T cell proliferation,BP,
15333,GO:0061495,1,0.993301131169352,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
15335,GO:0061505,1,0.984392572558478,0,2,DNA topoisomerase II activity,MF,
15336,GO:0061507,1,0.995981009207367,0,1,cyclic-GMP-AMP binding,MF,
15337,GO:0061508,1,0.993301131169352,0,1,CDP phosphorylation,BP,
15338,GO:0061511,1,0.97392472412218,0,4,centriole elongation,BP,
15339,GO:0061512,1,0.805653485804413,0,34,protein localization to cilium,BP,
15340,GO:0061513,1,0.980351961643986,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15341,GO:0061515,1,0.660059496130922,0,63,myeloid cell development,BP,
15342,GO:0061517,1,0.98678825598684,0,2,macrophage proliferation,BP,
15343,GO:0061518,1,0.98678825598684,0,2,microglial cell proliferation,BP,
15344,GO:0061519,1,0.992507871372103,0,1,macrophage homeostasis,BP,
15345,GO:0061523,1,0.99249364207351,0,1,cilium disassembly,BP,
15346,GO:0061525,1,0.94482582165836,0,8,hindgut development,BP,
15347,GO:0061526,1,0.975237568698687,0,4,acetylcholine secretion,BP,
15348,GO:0061528,1,0.992316013745567,0,1,aspartate secretion,BP,
15349,GO:0061534,1,0.989401604703967,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15350,GO:0061535,1,0.974390746403046,0,3,glutamate secretion, neurotransmission,BP,
15351,GO:0061536,1,0.992697729352287,0,1,glycine secretion,BP,
15352,GO:0061537,1,0.992697729352287,0,1,glycine secretion, neurotransmission,BP,
15353,GO:0061542,1,0.996630186162235,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15354,GO:0061547,1,0.985381093994009,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15355,GO:0061548,1,0.918220570425589,0,12,ganglion development,BP,
15356,GO:0061549,1,0.944421587380146,0,8,sympathetic ganglion development,BP,
15357,GO:0061550,1,0.964582736588507,0,5,cranial ganglion development,BP,
15358,GO:0061551,1,0.971808042576669,0,4,trigeminal ganglion development,BP,
15359,GO:0061552,1,0.993967319559355,0,1,ganglion morphogenesis,BP,
15361,GO:0061565,1,0.993301131169352,0,1,dAMP phosphorylation,BP,
15362,GO:0061566,1,0.993301131169352,0,1,CMP phosphorylation,BP,
15363,GO:0061567,1,0.993301131169352,0,1,dCMP phosphorylation,BP,
15364,GO:0061568,1,0.993301131169352,0,1,GDP phosphorylation,BP,
15365,GO:0061569,1,0.993301131169352,0,1,UDP phosphorylation,BP,
15366,GO:0061570,1,0.993301131169352,0,1,dCDP phosphorylation,BP,
15367,GO:0061571,1,0.993301131169352,0,1,TDP phosphorylation,BP,
15368,GO:0061572,1,0.39098150862965,0,139,actin filament bundle organization,BP,
15369,GO:0061574,1,0.982216296085807,0,3,ASAP complex,CC,
15370,GO:0061575,1,0.985599992736832,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15371,GO:0061577,1,0.923647653505875,0,11,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15372,GO:0061578,1,0.933439268144838,0,10,Lys63-specific deubiquitinase activity,MF,
15373,GO:0061580,1,0.992448731632843,0,1,colon epithelial cell migration,BP,
15374,GO:0061582,1,0.984421782391261,0,2,intestinal epithelial cell migration,BP,
15375,GO:0061588,1,0.964296562529661,0,5,calcium activated phospholipid scrambling,BP,
15376,GO:0061589,1,0.972055781305972,0,4,calcium activated phosphatidylserine scrambling,BP,
15377,GO:0061590,1,0.964296562529661,0,5,calcium activated phosphatidylcholine scrambling,BP,
15378,GO:0061591,1,0.964296562529661,0,5,calcium activated galactosylceramide scrambling,BP,
15379,GO:0061598,1,0.992433704947594,0,1,molybdopterin adenylyltransferase activity,MF,
15380,GO:0061599,1,0.992433704947594,0,1,molybdopterin molybdotransferase activity,MF,
15381,GO:0061604,1,0.99404713979306,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15382,GO:0061605,1,0.99404713979306,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15383,GO:0061608,1,0.947874780208596,0,9,nuclear import signal receptor activity,MF,
15384,GO:0061609,1,0.994109692256162,0,1,fructose-1-phosphate aldolase activity,MF,
15385,GO:0061611,1,0.995805808593524,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15387,GO:0061615,1,0.869163519077998,0,25,glycolytic process through fructose-6-phosphate,BP,
15388,GO:0061617,1,0.959213206395881,0,8,MICOS complex,CC,
15389,GO:0061618,1,0.989853916695493,0,1,sublamina densa,CC,
15390,GO:0061620,1,0.869163519077998,0,25,glycolytic process through glucose-6-phosphate,BP,
15391,GO:0061621,1,0.872208965982956,0,24,canonical glycolysis,BP,
15392,GO:0061622,1,0.989242029991364,0,2,glycolytic process through glucose-1-phosphate,BP,
15393,GO:0061623,1,0.996513325733551,0,1,glycolytic process from galactose,BP,
15394,GO:0061624,1,0.976137610755857,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15395,GO:0061626,1,0.959556931080893,0,7,pharyngeal arch artery morphogenesis,BP,
15396,GO:0061627,1,0.995277421179367,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15397,GO:0061628,1,0.976739919431588,0,3,H3K27me3 modified histone binding,MF,
15398,GO:0061629,1,0.972731712675421,0,5,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15399,GO:0061630,1,0.23752938214808,0,212,ubiquitin protein ligase activity,MF,
15400,GO:0061631,1,0.853798190546855,0,27,ubiquitin conjugating enzyme activity,MF,
15401,GO:0061635,1,0.956388765894918,0,8,regulation of protein complex stability,BP,
15403,GO:0061641,1,0.855440015831417,0,30,CENP-A containing chromatin organization,BP,
15404,GO:0061642,1,0.992057652763443,0,1,chemoattraction of axon,BP,
15405,GO:0061643,1,0.977806386496309,0,3,chemorepulsion of axon,BP,
15406,GO:0061645,1,0.950348771735613,0,7,endocytic patch,CC,
15407,GO:0061646,1,0.992309639429502,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15408,GO:0061647,1,0.752639684087844,0,40,histone H3-K9 modification,BP,
15409,GO:0061649,1,0.979332592584167,0,3,ubiquitin modification-dependent histone binding,MF,
15410,GO:0061650,1,0.850975295337346,0,28,ubiquitin-like protein conjugating enzyme activity,MF,
15411,GO:0061656,1,0.996699166694483,0,1,SUMO conjugating enzyme activity,MF,
15412,GO:0061659,1,0.230523821728202,0,217,ubiquitin-like protein ligase activity,MF,
15413,GO:0061663,1,0.991546677566348,0,1,NEDD8 ligase activity,MF,
15414,GO:0061665,1,0.970938483416672,0,5,SUMO ligase activity,MF,
15415,GO:0061668,1,0.961600404583371,0,6,mitochondrial ribosome assembly,BP,
15416,GO:0061669,1,0.975250431462753,0,3,spontaneous neurotransmitter secretion,BP,
15417,GO:0061670,1,0.996316110732579,0,1,evoked neurotransmitter secretion,BP,
15418,GO:0061673,1,0.966103693191023,0,5,mitotic spindle astral microtubule,CC,
15419,GO:0061676,1,0.959717174335608,0,6,importin-alpha family protein binding,MF,
15420,GO:0061682,1,0.994346191406774,0,1,seminal vesicle morphogenesis,BP,
15421,GO:0061684,1,0.927531069480847,0,12,chaperone-mediated autophagy,BP,
15422,GO:0061685,1,0.993301131169352,0,1,diphthine methylesterase activity,MF,
15423,GO:0061687,1,0.950413974515023,0,13,detoxification of inorganic compound,BP,
15424,GO:0061689,1,0.974603902448692,0,4,tricellular tight junction,CC,
15425,GO:0061690,1,0.996730514936444,0,1,lipoamidase activity,MF,
15427,GO:0061697,1,0.992759329403296,0,1,protein-glutaryllysine deglutarylase activity,MF,
15428,GO:0061698,1,0.992759329403296,0,1,protein deglutarylation,BP,
15429,GO:0061699,1,0.992759329403296,0,1,peptidyl-lysine deglutarylation,BP,
15430,GO:0061700,1,0.943587267115161,0,9,GATOR2 complex,CC,
15431,GO:0061702,1,0.935774735313739,0,12,inflammasome complex,CC,
15432,GO:0061709,1,0.991784645675912,0,1,reticulophagy,BP,
15433,GO:0061711,1,0.990657030154311,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15434,GO:0061712,1,0.992651971614595,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15435,GO:0061713,1,0.99683593418832,0,1,anterior neural tube closure,BP,
15436,GO:0061714,1,0.993620468134864,0,2,folic acid receptor activity,MF,
15437,GO:0061718,1,0.872208965982956,0,24,glucose catabolic process to pyruvate,BP,
15438,GO:0061723,1,0.985893059495018,0,2,glycophagy,BP,
15439,GO:0061724,1,0.959025480724036,0,6,lipophagy,BP,
15440,GO:0061726,1,0.606169890008039,0,80,mitochondrion disassembly,BP,
15441,GO:0061727,1,0.989183905775666,0,2,methylglyoxal catabolic process to lactate,BP,
15442,GO:0061731,1,0.977794937981061,0,3,ribonucleoside-diphosphate reductase activity,MF,
15443,GO:0061732,1,0.962103719722817,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15444,GO:0061733,1,0.69833426108345,0,52,peptide-lysine-N-acetyltransferase activity,MF,
15445,GO:0061734,1,0.959565665316182,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15446,GO:0061736,1,0.992096467319248,0,1,engulfment of target by autophagosome,BP,
15447,GO:0061737,1,0.975661529493505,0,5,leukotriene signaling pathway,BP,
15448,GO:0061738,1,0.982641147138765,0,3,late endosomal microautophagy,BP,
15449,GO:0061739,1,0.973975357494145,0,4,protein lipidation involved in autophagosome assembly,BP,
15450,GO:0061740,1,0.980914122476169,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15451,GO:0061741,1,0.988374788070736,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15452,GO:0061743,1,0.977787257201482,0,4,motor learning,BP,
15453,GO:0061744,1,0.972606212211529,0,5,motor behavior,BP,
15454,GO:0061749,1,0.984529656607783,0,2,forked DNA-dependent helicase activity,MF,
15455,GO:0061750,1,0.994386584782081,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15456,GO:0061752,1,0.988490017336609,0,2,telomeric repeat-containing RNA binding,MF,
15457,GO:0061753,1,0.992096467319248,0,1,substrate localization to autophagosome,BP,
15458,GO:0061756,1,0.845768972546137,0,27,leukocyte adhesion to vascular endothelial cell,BP,
15459,GO:0061757,1,0.989085132916003,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15460,GO:0061760,1,0.990062841540039,0,2,antifungal innate immune response,BP,
15461,GO:0061762,1,0.971614581350377,0,4,CAMKK-AMPK signaling cascade,BP,
15462,GO:0061763,1,0.986960986492367,0,2,multivesicular body-lysosome fusion,BP,
15463,GO:0061767,1,0.992035308251592,0,1,negative regulation of lung blood pressure,BP,
15464,GO:0061768,1,0.99232936328927,0,1,magnesium:sodium antiporter activity,MF,
15465,GO:0061769,1,0.986646673054992,0,2,ribosylnicotinate kinase activity,MF,
15466,GO:0061770,1,0.994839712531381,0,1,translation elongation factor binding,MF,
15467,GO:0061771,1,0.984418886680637,0,3,response to caloric restriction,BP,
15468,GO:0061772,1,0.992571051650007,0,1,drug transport across blood-nerve barrier,BP,
15469,GO:0061778,1,0.880159575701023,0,18,intracellular chloride channel activity,MF,
15470,GO:0061780,1,0.990447545964753,0,1,mitotic cohesin loading,BP,
15471,GO:0061782,1,0.992451244311811,0,1,vesicle fusion with vesicle,BP,
15472,GO:0061783,1,0.987147747141292,0,4,peptidoglycan muralytic activity,MF,
15473,GO:0061789,1,0.973926968383382,0,3,dense core granule priming,BP,
15474,GO:0061792,1,0.977101954885207,0,3,secretory granule maturation,BP,
15475,GO:0061798,1,0.99244496107208,0,1,GTP 3',8'-cyclase activity,MF,
15476,GO:0061799,1,0.99244496107208,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15477,GO:0061809,1,0.9926843300588,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15478,GO:0061811,1,0.996344003942889,0,1,ADP-ribosyl cyclase activity,MF,
15479,GO:0061812,1,0.996344003942889,0,1,cyclic ADP-ribose hydrolase,MF,
15480,GO:0061817,1,0.977038749369191,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
15481,GO:0061819,1,0.979483289499251,0,3,telomeric DNA-containing double minutes formation,BP,
15482,GO:0061820,1,0.943527533638401,0,8,telomeric D-loop disassembly,BP,
15483,GO:0061821,1,0.969736608803112,0,4,telomeric D-loop binding,MF,
15484,GO:0061825,1,0.992462314336551,0,1,podosome core,CC,
15485,GO:0061827,1,0.971629222743759,0,5,sperm head,CC,
15486,GO:0061828,1,0.991444772480553,0,1,apical tubulobulbar complex,CC,
15487,GO:0061829,1,0.991444772480553,0,1,basal tubulobulbar complex,CC,
15488,GO:0061832,1,0.991379075374384,0,1,basal ectoplasmic specialization,CC,
15489,GO:0061833,1,0.987130512505068,0,2,protein localization to tricellular tight junction,BP,
15490,GO:0061842,1,0.835382205311404,0,24,microtubule organizing center localization,BP,
15491,GO:0061844,1,0.883173810037967,0,34,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15492,GO:0061845,1,0.992669443467321,0,1,neuron projection branch point,CC,
15493,GO:0061846,1,0.992669443467321,0,1,dendritic spine cytoplasm,CC,
15494,GO:0061847,1,0.994435198688561,0,1,response to cholecystokinin,BP,
15495,GO:0061849,1,0.984529656607783,0,2,telomeric G-quadruplex DNA binding,MF,
15496,GO:0061850,1,0.996941089164012,0,1,growth cone leading edge,CC,
15497,GO:0061851,1,0.993413388751613,0,1,leading edge of lamellipodium,CC,
15498,GO:0061853,1,0.992293648364596,0,1,regulation of neuroblast migration,BP,
15499,GO:0061855,1,0.992293648364596,0,1,negative regulation of neuroblast migration,BP,
15500,GO:0061857,1,0.98581749373465,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15501,GO:0061880,1,0.995957009106906,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15502,GO:0061881,1,0.995957009106906,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15503,GO:0061884,1,0.99516559747793,0,1,regulation of mini excitatory postsynaptic potential,BP,
15504,GO:0061885,1,0.99516559747793,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
15505,GO:0061888,1,0.97320296282421,0,4,regulation of astrocyte activation,BP,
15506,GO:0061889,1,0.992224483224459,0,1,negative regulation of astrocyte activation,BP,
15507,GO:0061890,1,0.980830961116235,0,3,positive regulation of astrocyte activation,BP,
15508,GO:0061896,1,0.9923659963557,0,1,all-trans retinol 3,4-desaturase activity,MF,
15509,GO:0061897,1,0.9923659963557,0,1,all-trans retinal 3,4-desaturase activity,MF,
15510,GO:0061898,1,0.9923659963557,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15511,GO:0061899,1,0.9923659963557,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15513,GO:0061901,1,0.995371865589806,0,1,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15514,GO:0061903,1,0.995371865589806,0,1,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15515,GO:0061912,1,0.758114977528324,0,40,selective autophagy,BP,
15517,GO:0061920,1,0.991014724697578,0,1,protein propionyltransferase activity,MF,
15518,GO:0061921,1,0.991014724697578,0,1,peptidyl-lysine propionylation,BP,
15519,GO:0061930,1,0.992256882334399,0,1,regulation of erythrocyte enucleation,BP,
15520,GO:0061931,1,0.992256882334399,0,1,positive regulation of erythrocyte enucleation,BP,
15521,GO:0061944,1,0.99242494787057,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15522,GO:0061945,1,0.981361163904096,0,3,regulation of protein K48-linked ubiquitination,BP,
15523,GO:0061951,1,0.774450713527839,0,39,establishment of protein localization to plasma membrane,BP,
15524,GO:0061953,1,0.981742724780837,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15525,GO:0061971,1,0.721495497636884,0,48,replacement bone morphogenesis,BP,
15526,GO:0061980,1,0.815104442044672,0,30,regulatory RNA binding,MF,
15527,GO:0061981,1,0.996338632672028,0,1,3-hydroxykynureninase activity,MF,
15528,GO:0061982,1,0.53850658089542,0,98,meiosis I cell cycle process,BP,
15529,GO:0061983,1,0.953050898144707,0,8,meiosis II cell cycle process,BP,
15530,GO:0061986,1,0.99415435700058,0,1,negative regulation of transcription by glucose,BP,
15531,GO:0061987,1,0.99415435700058,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15532,GO:0062009,1,0.931152220357586,0,10,secondary palate development,BP,
15535,GO:0062014,1,0.536036214897247,0,100,negative regulation of small molecule metabolic process,BP,
15536,GO:0065001,1,0.975487986241217,0,4,specification of axis polarity,BP,
15539,GO:0065004,1,0.33098290418535,0,192,protein-DNA complex assembly,BP,
15540,GO:0065005,1,0.86310603819005,0,24,protein-lipid complex assembly,BP,
15541,GO:0065006,1,0.993416986470028,0,2,protein-carbohydrate complex assembly,BP,
15545,GO:0065010,1,0.972721248553267,0,5,extracellular membrane-bounded organelle,CC,
15546,GO:0070001,1,0.901893379914462,0,18,aspartic-type peptidase activity,MF,
15547,GO:0070003,1,0.941330707331773,0,18,threonine-type peptidase activity,MF,
15548,GO:0070004,1,0.993301131169352,0,1,cysteine-type exopeptidase activity,MF,
15549,GO:0070006,1,0.875049906405076,0,19,metalloaminopeptidase activity,MF,
15552,GO:0070012,1,0.98741014787903,0,2,oligopeptidase activity,MF,
15554,GO:0070016,1,0.92685066588028,0,10,armadillo repeat domain binding,MF,
15555,GO:0070022,1,0.96976151980216,0,4,transforming growth factor beta receptor complex,CC,
15556,GO:0070025,1,0.993678504419862,0,1,carbon monoxide binding,MF,
15557,GO:0070026,1,0.990594984476689,0,2,nitric oxide binding,MF,
15558,GO:0070032,1,0.979992669149573,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15559,GO:0070033,1,0.982296097200999,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15560,GO:0070034,1,0.869646034591141,0,22,telomerase RNA binding,MF,
15561,GO:0070035,1,0.530594840870252,0,91,purine NTP-dependent helicase activity,MF,
15562,GO:0070037,1,0.99683286578865,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15563,GO:0070039,1,0.992257145941235,0,1,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15564,GO:0070042,1,0.992885635096529,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15565,GO:0070044,1,0.97811158456355,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15566,GO:0070050,1,0.946489654401447,0,10,neuron cellular homeostasis,BP,
15567,GO:0070051,1,0.978544709664371,0,3,fibrinogen binding,MF,
15568,GO:0070052,1,0.984867481690745,0,2,collagen V binding,MF,
15569,GO:0070053,1,0.981062854138039,0,3,thrombospondin receptor activity,MF,
15570,GO:0070054,1,0.979563455300745,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15571,GO:0070055,1,0.979563455300745,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15573,GO:0070060,1,0.990875904700605,0,1,'de novo' actin filament nucleation,BP,
15574,GO:0070061,1,0.97055394559879,0,5,fructose binding,MF,
15576,GO:0070063,1,0.70261965647332,0,54,RNA polymerase binding,MF,
15577,GO:0070064,1,0.879649553880706,0,18,proline-rich region binding,MF,
15578,GO:0070069,1,0.90342263768697,0,25,cytochrome complex,CC,
15579,GO:0070070,1,0.928691590304809,0,10,proton-transporting V-type ATPase complex assembly,BP,
15580,GO:0070071,1,0.909890795077611,0,14,proton-transporting two-sector ATPase complex assembly,BP,
15581,GO:0070072,1,0.928691590304809,0,10,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15582,GO:0070075,1,0.997046014162549,0,1,tear secretion,BP,
15583,GO:0070076,1,0.823472943606595,0,25,histone lysine demethylation,BP,
15584,GO:0070077,1,0.992500861833069,0,1,histone arginine demethylation,BP,
15585,GO:0070078,1,0.992500861833069,0,1,histone H3-R2 demethylation,BP,
15586,GO:0070079,1,0.992500861833069,0,1,histone H4-R3 demethylation,BP,
15587,GO:0070080,1,0.989313360702134,0,2,titin Z domain binding,MF,
15588,GO:0070081,1,0.972465256461201,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15589,GO:0070083,1,0.972465256461201,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15590,GO:0070085,1,0.207054950632581,0,243,glycosylation,BP,
15591,GO:0070086,1,0.977944375312225,0,4,ubiquitin-dependent endocytosis,BP,
15592,GO:0070087,1,0.951866816198212,0,6,chromo shadow domain binding,MF,
15593,GO:0070091,1,0.961953849977836,0,7,glucagon secretion,BP,
15594,GO:0070092,1,0.965122571918383,0,6,regulation of glucagon secretion,BP,
15595,GO:0070093,1,0.986169633989082,0,3,negative regulation of glucagon secretion,BP,
15596,GO:0070094,1,0.993721460979981,0,1,positive regulation of glucagon secretion,BP,
15597,GO:0070095,1,0.983429179284207,0,3,fructose-6-phosphate binding,MF,
15598,GO:0070096,1,0.992588626619601,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15599,GO:0070097,1,0.953357268829565,0,6,delta-catenin binding,MF,
15600,GO:0070098,1,0.725452423953982,0,63,chemokine-mediated signaling pathway,BP,
15601,GO:0070099,1,0.95365184236274,0,7,regulation of chemokine-mediated signaling pathway,BP,
15602,GO:0070100,1,0.968797851482791,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
15603,GO:0070101,1,0.984371302953713,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15605,GO:0070103,1,0.985917141179337,0,3,regulation of interleukin-6-mediated signaling pathway,BP,
15606,GO:0070104,1,0.995952976172901,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15607,GO:0070105,1,0.989923809203972,0,2,positive regulation of interleukin-6-mediated signaling pathway,BP,
15609,GO:0070110,1,0.980583635366983,0,3,ciliary neurotrophic factor receptor complex,CC,
15610,GO:0070119,1,0.992447802773971,0,1,ciliary neurotrophic factor binding,MF,
15611,GO:0070120,1,0.966870242000545,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15612,GO:0070121,1,0.992144600872689,0,1,Kupffer's vesicle development,BP,
15613,GO:0070122,1,0.96620029344663,0,5,isopeptidase activity,MF,
15614,GO:0070123,1,0.991868519643295,0,1,transforming growth factor beta receptor activity, type III,MF,
15615,GO:0070124,1,0.99020663770835,0,2,mitochondrial translational initiation,BP,
15616,GO:0070125,1,0.720359478479952,0,84,mitochondrial translational elongation,BP,
15617,GO:0070126,1,0.712517232816896,0,86,mitochondrial translational termination,BP,
15618,GO:0070127,1,0.950284754516079,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
15619,GO:0070129,1,0.901720644831177,0,18,regulation of mitochondrial translation,BP,
15620,GO:0070130,1,0.993301131169352,0,1,negative regulation of mitochondrial translation,BP,
15621,GO:0070131,1,0.938746781443643,0,11,positive regulation of mitochondrial translation,BP,
15622,GO:0070137,1,0.969129132414417,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
15623,GO:0070138,1,0.977696791143036,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15624,GO:0070139,1,0.969129132414417,0,4,SUMO-specific endopeptidase activity,MF,
15625,GO:0070140,1,0.977696791143036,0,3,SUMO-specific isopeptidase activity,MF,
15627,GO:0070142,1,0.96476830075886,0,5,synaptic vesicle budding,BP,
15628,GO:0070143,1,0.992342876865244,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15629,GO:0070145,1,0.992601219484349,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15630,GO:0070150,1,0.989517616050866,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
15631,GO:0070159,1,0.994231153446526,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15634,GO:0070162,1,0.959414680299804,0,6,adiponectin secretion,BP,
15635,GO:0070163,1,0.959414680299804,0,6,regulation of adiponectin secretion,BP,
15636,GO:0070164,1,0.973195621598527,0,4,negative regulation of adiponectin secretion,BP,
15637,GO:0070165,1,0.985843471513402,0,2,positive regulation of adiponectin secretion,BP,
15638,GO:0070166,1,0.937509118161539,0,9,enamel mineralization,BP,
15641,GO:0070169,1,0.789224525062634,0,35,positive regulation of biomineral tissue development,BP,
15642,GO:0070170,1,0.974726336072016,0,4,regulation of tooth mineralization,BP,
15643,GO:0070171,1,0.985938083112259,0,2,negative regulation of tooth mineralization,BP,
15644,GO:0070172,1,0.988630013433869,0,2,positive regulation of tooth mineralization,BP,
15645,GO:0070176,1,0.995750437877257,0,1,DRM complex,CC,
15646,GO:0070178,1,0.990151711280622,0,2,D-serine metabolic process,BP,
15647,GO:0070179,1,0.993980113814259,0,1,D-serine biosynthetic process,BP,
15648,GO:0070180,1,0.997058218157506,0,1,large ribosomal subunit rRNA binding,MF,
15649,GO:0070181,1,0.963013023536803,0,8,small ribosomal subunit rRNA binding,MF,
15650,GO:0070182,1,0.901269790471707,0,16,DNA polymerase binding,MF,
15651,GO:0070183,1,0.993216383436839,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15652,GO:0070184,1,0.994839712531381,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15653,GO:0070187,1,0.964370112360088,0,6,shelterin complex,CC,
15654,GO:0070189,1,0.965965946140486,0,7,kynurenine metabolic process,BP,
15655,GO:0070191,1,0.988747405029375,0,2,methionine-R-sulfoxide reductase activity,MF,
15656,GO:0070192,1,0.698868139229715,0,55,chromosome organization involved in meiotic cell cycle,BP,
15657,GO:0070193,1,0.88954173374902,0,19,synaptonemal complex organization,BP,
15658,GO:0070194,1,0.988158376341989,0,2,synaptonemal complex disassembly,BP,
15659,GO:0070195,1,0.992421251447022,0,1,growth hormone receptor complex,CC,
15660,GO:0070197,1,0.967222582222153,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15661,GO:0070198,1,0.839317134920197,0,27,protein localization to chromosome, telomeric region,BP,
15662,GO:0070199,1,0.873676436288606,0,23,establishment of protein localization to chromosome,BP,
15663,GO:0070200,1,0.910710792532619,0,15,establishment of protein localization to telomere,BP,
15665,GO:0070202,1,0.938685007048812,0,11,regulation of establishment of protein localization to chromosome,BP,
15666,GO:0070203,1,0.945019285315441,0,10,regulation of establishment of protein localization to telomere,BP,
15667,GO:0070206,1,0.739750551405945,0,48,protein trimerization,BP,
15668,GO:0070207,1,0.846358631427863,0,28,protein homotrimerization,BP,
15669,GO:0070208,1,0.926032600401897,0,11,protein heterotrimerization,BP,
15670,GO:0070209,1,0.992611081854854,0,1,ASTRA complex,CC,
15671,GO:0070212,1,0.970368541755639,0,4,protein poly-ADP-ribosylation,BP,
15672,GO:0070213,1,0.969313161956642,0,4,protein auto-ADP-ribosylation,BP,
15673,GO:0070221,1,0.983947633547147,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15674,GO:0070227,1,0.697042171606689,0,63,lymphocyte apoptotic process,BP,
15675,GO:0070228,1,0.764399088498362,0,48,regulation of lymphocyte apoptotic process,BP,
15676,GO:0070229,1,0.855409125658164,0,27,negative regulation of lymphocyte apoptotic process,BP,
15677,GO:0070230,1,0.930432755623514,0,14,positive regulation of lymphocyte apoptotic process,BP,
15678,GO:0070231,1,0.788002135701348,0,43,T cell apoptotic process,BP,
15679,GO:0070232,1,0.854656875041256,0,29,regulation of T cell apoptotic process,BP,
15680,GO:0070233,1,0.908973822027535,0,17,negative regulation of T cell apoptotic process,BP,
15681,GO:0070234,1,0.951533492527927,0,10,positive regulation of T cell apoptotic process,BP,
15682,GO:0070235,1,0.972906118784621,0,5,regulation of activation-induced cell death of T cells,BP,
15683,GO:0070236,1,0.977352164675151,0,4,negative regulation of activation-induced cell death of T cells,BP,
15684,GO:0070238,1,0.99601637846675,0,1,activated T cell autonomous cell death,BP,
15685,GO:0070239,1,0.99601637846675,0,1,regulation of activated T cell autonomous cell death,BP,
15686,GO:0070241,1,0.99601637846675,0,1,positive regulation of activated T cell autonomous cell death,BP,
15687,GO:0070242,1,0.905036485562864,0,17,thymocyte apoptotic process,BP,
15688,GO:0070243,1,0.933936693107673,0,12,regulation of thymocyte apoptotic process,BP,
15689,GO:0070244,1,0.962179702731693,0,7,negative regulation of thymocyte apoptotic process,BP,
15690,GO:0070245,1,0.970658464532856,0,5,positive regulation of thymocyte apoptotic process,BP,
15691,GO:0070246,1,0.996595868151916,0,1,natural killer cell apoptotic process,BP,
15692,GO:0070247,1,0.996595868151916,0,1,regulation of natural killer cell apoptotic process,BP,
15693,GO:0070251,1,0.994416276590203,0,1,pristanate-CoA ligase activity,MF,
15695,GO:0070253,1,0.983883358471433,0,4,somatostatin secretion,BP,
15696,GO:0070254,1,0.943334901236385,0,10,mucus secretion,BP,
15697,GO:0070255,1,0.946166806339073,0,9,regulation of mucus secretion,BP,
15698,GO:0070256,1,0.989461222404043,0,2,negative regulation of mucus secretion,BP,
15699,GO:0070257,1,0.962510294922621,0,6,positive regulation of mucus secretion,BP,
15700,GO:0070259,1,0.985846952604234,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15701,GO:0070260,1,0.993301131169352,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15702,GO:0070262,1,0.913794204717338,0,16,peptidyl-serine dephosphorylation,BP,
15705,GO:0070267,1,0.992509425920938,0,1,oncosis,BP,
15707,GO:0070269,1,0.955208067971183,0,9,pyroptosis,BP,
15708,GO:0070273,1,0.866097637679386,0,22,phosphatidylinositol-4-phosphate binding,MF,
15709,GO:0070274,1,0.991531795457556,0,2,RES complex,CC,
15710,GO:0070278,1,0.968073723211504,0,5,extracellular matrix constituent secretion,BP,
15711,GO:0070279,1,0.762999167313068,0,45,vitamin B6 binding,MF,
15712,GO:0070280,1,0.992470124072084,0,1,pyridoxal binding,MF,
15713,GO:0070283,1,0.996009560096059,0,1,radical SAM enzyme activity,MF,
15714,GO:0070286,1,0.809522937066325,0,30,axonemal dynein complex assembly,BP,
15715,GO:0070287,1,0.992499290341661,0,1,ferritin receptor activity,MF,
15716,GO:0070288,1,0.993633232305479,0,2,ferritin complex,CC,
15717,GO:0070290,1,0.967226593112999,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15718,GO:0070291,1,0.981162284347393,0,3,N-acylethanolamine metabolic process,BP,
15719,GO:0070292,1,0.985125598575737,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15720,GO:0070293,1,0.916911332010372,0,15,renal absorption,BP,
15721,GO:0070294,1,0.973340660717398,0,4,renal sodium ion absorption,BP,
15722,GO:0070295,1,0.983154301017622,0,3,renal water absorption,BP,
15723,GO:0070296,1,0.809872587747575,0,31,sarcoplasmic reticulum calcium ion transport,BP,
15724,GO:0070300,1,0.887604899301673,0,18,phosphatidic acid binding,MF,
15725,GO:0070301,1,0.605526186812853,0,82,cellular response to hydrogen peroxide,BP,
15727,GO:0070303,1,0.772556349523188,0,39,negative regulation of stress-activated protein kinase signaling cascade,BP,
15729,GO:0070305,1,0.954079060452506,0,6,response to cGMP,BP,
15730,GO:0070306,1,0.840021935427783,0,26,lens fiber cell differentiation,BP,
15731,GO:0070307,1,0.932882490937663,0,11,lens fiber cell development,BP,
15732,GO:0070309,1,0.973766494978832,0,4,lens fiber cell morphogenesis,BP,
15735,GO:0070316,1,0.761282609307669,0,40,regulation of G0 to G1 transition,BP,
15736,GO:0070317,1,0.780373769428463,0,36,negative regulation of G0 to G1 transition,BP,
15737,GO:0070318,1,0.975598203437509,0,4,positive regulation of G0 to G1 transition,BP,
15738,GO:0070320,1,0.993518643021933,0,1,inward rectifier potassium channel inhibitor activity,MF,
15739,GO:0070324,1,0.961875470435918,0,7,thyroid hormone binding,MF,
15740,GO:0070325,1,0.864452305306275,0,21,lipoprotein particle receptor binding,MF,
15741,GO:0070326,1,0.975409661695991,0,4,very-low-density lipoprotein particle receptor binding,MF,
15742,GO:0070327,1,0.957897533390175,0,7,thyroid hormone transport,BP,
15743,GO:0070328,1,0.871947004776532,0,25,triglyceride homeostasis,BP,
15744,GO:0070329,1,0.988274835385018,0,2,tRNA seleno-modification,BP,
15745,GO:0070330,1,0.914713698857419,0,16,aromatase activity,MF,
15746,GO:0070335,1,0.991625233266281,0,1,aspartate binding,MF,
15747,GO:0070336,1,0.98543056018364,0,2,flap-structured DNA binding,MF,
15748,GO:0070337,1,0.992076901588569,0,1,3'-flap-structured DNA binding,MF,
15749,GO:0070339,1,0.965317477116505,0,6,response to bacterial lipopeptide,BP,
15750,GO:0070340,1,0.97795353584721,0,3,detection of bacterial lipopeptide,BP,
15751,GO:0070341,1,0.944948535791776,0,9,fat cell proliferation,BP,
15752,GO:0070343,1,0.986142422195357,0,3,white fat cell proliferation,BP,
15753,GO:0070344,1,0.944948535791776,0,9,regulation of fat cell proliferation,BP,
15754,GO:0070345,1,0.964576591332371,0,5,negative regulation of fat cell proliferation,BP,
15755,GO:0070346,1,0.987131886049724,0,3,positive regulation of fat cell proliferation,BP,
15756,GO:0070350,1,0.986142422195357,0,3,regulation of white fat cell proliferation,BP,
15757,GO:0070352,1,0.993664564940767,0,2,positive regulation of white fat cell proliferation,BP,
15758,GO:0070358,1,0.963122978960916,0,6,actin polymerization-dependent cell motility,BP,
15759,GO:0070365,1,0.927085355683041,0,13,hepatocyte differentiation,BP,
15760,GO:0070366,1,0.991925638737438,0,2,regulation of hepatocyte differentiation,BP,
15761,GO:0070367,1,0.995168220404596,0,1,negative regulation of hepatocyte differentiation,BP,
15762,GO:0070368,1,0.996741839541675,0,1,positive regulation of hepatocyte differentiation,BP,
15763,GO:0070369,1,0.9763995396499,0,3,beta-catenin-TCF7L2 complex,CC,
15764,GO:0070370,1,0.975985827186553,0,5,cellular heat acclimation,BP,
15767,GO:0070373,1,0.688135960039324,0,58,negative regulation of ERK1 and ERK2 cascade,BP,
15769,GO:0070375,1,0.979673584338754,0,3,ERK5 cascade,BP,
15770,GO:0070376,1,0.993084425873539,0,1,regulation of ERK5 cascade,BP,
15771,GO:0070377,1,0.993084425873539,0,1,negative regulation of ERK5 cascade,BP,
15772,GO:0070381,1,0.985105910178057,0,2,endosome to plasma membrane transport vesicle,CC,
15774,GO:0070383,1,0.959562453664803,0,8,DNA cytosine deamination,BP,
15775,GO:0070384,1,0.975454818185232,0,4,Harderian gland development,BP,
15776,GO:0070390,1,0.995934711064646,0,1,transcription export complex 2,CC,
15777,GO:0070391,1,0.942585806515156,0,11,response to lipoteichoic acid,BP,
15778,GO:0070392,1,0.996832095044299,0,1,detection of lipoteichoic acid,BP,
15779,GO:0070401,1,0.990690978450227,0,2,NADP+ binding,MF,
15780,GO:0070402,1,0.927923380112025,0,13,NADPH binding,MF,
15781,GO:0070403,1,0.924870642686039,0,14,NAD+ binding,MF,
15782,GO:0070404,1,0.987441567001165,0,3,NADH binding,MF,
15784,GO:0070407,1,0.992787255670845,0,1,oxidation-dependent protein catabolic process,BP,
15785,GO:0070408,1,0.992083390260703,0,1,carbamoyl phosphate metabolic process,BP,
15786,GO:0070409,1,0.992083390260703,0,1,carbamoyl phosphate biosynthetic process,BP,
15787,GO:0070410,1,0.915294419216448,0,12,co-SMAD binding,MF,
15788,GO:0070411,1,0.920547211757242,0,11,I-SMAD binding,MF,
15789,GO:0070412,1,0.841916680450308,0,23,R-SMAD binding,MF,
15790,GO:0070413,1,0.992991315674563,0,1,trehalose metabolism in response to stress,BP,
15791,GO:0070417,1,0.953424260843098,0,7,cellular response to cold,BP,
15792,GO:0070418,1,0.992251587208662,0,1,DNA-dependent protein kinase complex,CC,
15793,GO:0070419,1,0.953187784493363,0,7,nonhomologous end joining complex,CC,
15794,GO:0070423,1,0.797904570242171,0,34,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15795,GO:0070424,1,0.943018676884817,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15796,GO:0070425,1,0.985386341487026,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15797,GO:0070426,1,0.980259204039669,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15798,GO:0070427,1,0.974678839656712,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15799,GO:0070428,1,0.984586657249639,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15800,GO:0070429,1,0.992411290444428,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15801,GO:0070430,1,0.992116156280336,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15802,GO:0070431,1,0.932969283737396,0,11,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15803,GO:0070432,1,0.965931078917741,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15804,GO:0070433,1,0.985386341487026,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15805,GO:0070434,1,0.980259204039669,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15807,GO:0070436,1,0.985157372748922,0,2,Grb2-EGFR complex,CC,
15808,GO:0070442,1,0.996489721076576,0,1,integrin alphaIIb-beta3 complex,CC,
15811,GO:0070446,1,0.995397073095079,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15813,GO:0070458,1,0.985817961949584,0,3,cellular detoxification of nitrogen compound,BP,
15815,GO:0070460,1,0.992466417663809,0,1,thyroid-stimulating hormone secretion,BP,
15816,GO:0070461,1,0.860581133640267,0,23,SAGA-type complex,CC,
15817,GO:0070462,1,0.99249364207351,0,1,plus-end specific microtubule depolymerization,BP,
15818,GO:0070463,1,0.992546264412167,0,1,tubulin-dependent ATPase activity,MF,
15819,GO:0070469,1,0.727151584347829,0,81,respiratory chain,CC,
15820,GO:0070470,1,0.980796102189963,0,4,plasma membrane respiratory chain,CC,
15821,GO:0070471,1,0.950896721769752,0,8,uterine smooth muscle contraction,BP,
15822,GO:0070472,1,0.956895855748159,0,7,regulation of uterine smooth muscle contraction,BP,
15823,GO:0070473,1,0.995384487152049,0,1,negative regulation of uterine smooth muscle contraction,BP,
15824,GO:0070474,1,0.96133472888591,0,6,positive regulation of uterine smooth muscle contraction,BP,
15825,GO:0070475,1,0.961696066416457,0,7,rRNA base methylation,BP,
15826,GO:0070476,1,0.997058218157506,0,1,rRNA (guanine-N7)-methylation,BP,
15827,GO:0070478,1,0.992442063365152,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15828,GO:0070481,1,0.993052749048945,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15829,GO:0070482,1,0.111504764664896,0,354,response to oxygen levels,BP,
15830,GO:0070483,1,0.992727725152831,0,1,detection of hypoxia,BP,
15831,GO:0070486,1,0.93095172940562,0,12,leukocyte aggregation,BP,
15832,GO:0070487,1,0.966393343638158,0,5,monocyte aggregation,BP,
15833,GO:0070488,1,0.994155185994209,0,2,neutrophil aggregation,BP,
15834,GO:0070489,1,0.987900643829004,0,2,T cell aggregation,BP,
15835,GO:0070491,1,0.669405743783311,0,62,repressing transcription factor binding,MF,
15836,GO:0070492,1,0.947134121835138,0,10,oligosaccharide binding,MF,
15837,GO:0070493,1,0.920121449842572,0,12,thrombin-activated receptor signaling pathway,BP,
15838,GO:0070494,1,0.980769114889017,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15839,GO:0070495,1,0.980769114889017,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15841,GO:0070506,1,0.987076967682958,0,2,high-density lipoprotein particle receptor activity,MF,
15843,GO:0070508,1,0.962749235050068,0,7,cholesterol import,BP,
15844,GO:0070509,1,0.634816913646381,0,65,calcium ion import,BP,
15845,GO:0070510,1,0.991630989478024,0,1,regulation of histone H4-K20 methylation,BP,
15846,GO:0070512,1,0.991630989478024,0,1,positive regulation of histone H4-K20 methylation,BP,
15847,GO:0070513,1,0.950067846003992,0,10,death domain binding,MF,
15848,GO:0070522,1,0.972920447883535,0,4,ERCC4-ERCC1 complex,CC,
15849,GO:0070524,1,0.996449690049739,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15850,GO:0070525,1,0.933475217700387,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15852,GO:0070528,1,0.840215548896909,0,27,protein kinase C signaling,BP,
15853,GO:0070530,1,0.886102006517946,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15854,GO:0070531,1,0.965842927276422,0,5,BRCA1-A complex,CC,
15855,GO:0070534,1,0.763536834098075,0,42,protein K63-linked ubiquitination,BP,
15856,GO:0070535,1,0.963881419806965,0,5,histone H2A K63-linked ubiquitination,BP,
15857,GO:0070536,1,0.842515566739621,0,24,protein K63-linked deubiquitination,BP,
15858,GO:0070537,1,0.979846212770891,0,3,histone H2A K63-linked deubiquitination,BP,
15859,GO:0070538,1,0.993242215145507,0,2,oleic acid binding,MF,
15860,GO:0070539,1,0.992531136232836,0,1,linoleic acid binding,MF,
15861,GO:0070541,1,0.980938736592097,0,3,response to platinum ion,BP,
15862,GO:0070542,1,0.627769157172679,0,75,response to fatty acid,BP,
15863,GO:0070543,1,0.995073207414637,0,1,response to linoleic acid,BP,
15864,GO:0070544,1,0.940953557221777,0,8,histone H3-K36 demethylation,BP,
15865,GO:0070545,1,0.981511014681121,0,3,PeBoW complex,CC,
15866,GO:0070547,1,0.993322940911282,0,1,L-tyrosine aminotransferase activity,MF,
15867,GO:0070548,1,0.98402842818528,0,2,L-glutamine aminotransferase activity,MF,
15868,GO:0070550,1,0.990447545964753,0,1,rDNA condensation,BP,
15869,GO:0070551,1,0.993301131169352,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15870,GO:0070552,1,0.981143301432187,0,3,BRISC complex,CC,
15871,GO:0070553,1,0.993301131169352,0,1,nicotinic acid receptor activity,MF,
15872,GO:0070554,1,0.987298517037413,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
15874,GO:0070557,1,0.991285472410307,0,2,PCNA-p21 complex,CC,
15875,GO:0070560,1,0.986499505322345,0,2,protein secretion by platelet,BP,
15876,GO:0070561,1,0.940040417934296,0,9,vitamin D receptor signaling pathway,BP,
15877,GO:0070562,1,0.960519104661456,0,6,regulation of vitamin D receptor signaling pathway,BP,
15878,GO:0070563,1,0.987322482031317,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15879,GO:0070564,1,0.988895090124604,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15880,GO:0070566,1,0.837772064779128,0,27,adenylyltransferase activity,MF,
15881,GO:0070567,1,0.948960185435207,0,9,cytidylyltransferase activity,MF,
15882,GO:0070568,1,0.97049052910818,0,5,guanylyltransferase activity,MF,
15883,GO:0070569,1,0.95656897735041,0,7,uridylyltransferase activity,MF,
15884,GO:0070570,1,0.840718781347163,0,26,regulation of neuron projection regeneration,BP,
15885,GO:0070571,1,0.90782832395415,0,14,negative regulation of neuron projection regeneration,BP,
15886,GO:0070572,1,0.955528775664707,0,8,positive regulation of neuron projection regeneration,BP,
15887,GO:0070573,1,0.981972573251479,0,3,metallodipeptidase activity,MF,
15888,GO:0070574,1,0.973090660628538,0,4,cadmium ion transmembrane transport,BP,
15889,GO:0070576,1,0.986445650012211,0,2,vitamin D 24-hydroxylase activity,MF,
15890,GO:0070577,1,0.875451084046891,0,17,lysine-acetylated histone binding,MF,
15891,GO:0070578,1,0.945282901882083,0,9,RISC-loading complex,CC,
15892,GO:0070579,1,0.965673436826609,0,4,methylcytosine dioxygenase activity,MF,
15893,GO:0070584,1,0.884481226785988,0,21,mitochondrion morphogenesis,BP,
15894,GO:0070585,1,0.361676107362715,0,177,protein localization to mitochondrion,BP,
15898,GO:0070589,1,0.995805808593524,0,1,cellular component macromolecule biosynthetic process,BP,
15899,GO:0070593,1,0.983983173891393,0,2,dendrite self-avoidance,BP,
15900,GO:0070601,1,0.936995901532966,0,10,centromeric sister chromatid cohesion,BP,
15901,GO:0070602,1,0.974653895820854,0,4,regulation of centromeric sister chromatid cohesion,BP,
15902,GO:0070603,1,0.619448301351601,0,73,SWI/SNF superfamily-type complex,CC,
15903,GO:0070611,1,0.993596753435299,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15904,GO:0070612,1,0.993596753435299,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15906,GO:0070615,1,0.992451839530803,0,1,nucleosome-dependent ATPase activity,MF,
15907,GO:0070618,1,0.993482214888794,0,1,Grb2-Sos complex,CC,
15908,GO:0070625,1,0.995049280447044,0,1,zymogen granule exocytosis,BP,
15909,GO:0070626,1,0.996348587845657,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15910,GO:0070627,1,0.992444082065594,0,1,ferrous iron import,BP,
15911,GO:0070628,1,0.889303130398365,0,21,proteasome binding,MF,
15912,GO:0070631,1,0.993301131169352,0,1,spindle pole body localization,BP,
15913,GO:0070632,1,0.993301131169352,0,1,establishment of spindle pole body localization,BP,
15914,GO:0070633,1,0.906068852970865,0,15,transepithelial transport,BP,
15915,GO:0070634,1,0.987161508646838,0,2,transepithelial ammonium transport,BP,
15916,GO:0070637,1,0.994151722015676,0,1,pyridine nucleoside metabolic process,BP,
15917,GO:0070638,1,0.994151722015676,0,1,pyridine nucleoside catabolic process,BP,
15918,GO:0070640,1,0.982291805168561,0,3,vitamin D3 metabolic process,BP,
15919,GO:0070643,1,0.996121655979269,0,1,vitamin D 25-hydroxylase activity,MF,
15920,GO:0070644,1,0.977120154702209,0,3,vitamin D response element binding,MF,
15921,GO:0070646,1,0.185367081898982,0,264,protein modification by small protein removal,BP,
15923,GO:0070649,1,0.976900786195018,0,3,formin-nucleated actin cable assembly,BP,
15924,GO:0070651,1,0.993052749048945,0,1,nonfunctional rRNA decay,BP,
15925,GO:0070652,1,0.954600771542243,0,8,HAUS complex,CC,
15926,GO:0070653,1,0.996934985808316,0,1,high-density lipoprotein particle receptor binding,MF,
15928,GO:0070662,1,0.977461008692185,0,3,mast cell proliferation,BP,
15931,GO:0070665,1,0.507845482916951,0,121,positive regulation of leukocyte proliferation,BP,
15932,GO:0070666,1,0.985097500295318,0,2,regulation of mast cell proliferation,BP,
15933,GO:0070667,1,0.992851408755463,0,1,negative regulation of mast cell proliferation,BP,
15934,GO:0070668,1,0.985097500295318,0,2,positive regulation of mast cell proliferation,BP,
15935,GO:0070669,1,0.916993236757335,0,13,response to interleukin-2,BP,
15936,GO:0070670,1,0.839003284372092,0,30,response to interleukin-4,BP,
15937,GO:0070671,1,0.775466843123984,0,46,response to interleukin-12,BP,
15938,GO:0070672,1,0.908211403876565,0,14,response to interleukin-15,BP,
15939,GO:0070673,1,0.934111277911126,0,11,response to interleukin-18,BP,
15940,GO:0070676,1,0.986906527383325,0,3,intralumenal vesicle formation,BP,
15941,GO:0070678,1,0.993497593357099,0,1,preprotein binding,MF,
15943,GO:0070681,1,0.982928265985629,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15944,GO:0070682,1,0.983322898224752,0,3,proteasome regulatory particle assembly,BP,
15945,GO:0070684,1,0.996762002101017,0,1,seminal clot liquefaction,BP,
15946,GO:0070685,1,0.994967755220664,0,1,macropinocytic cup,CC,
15947,GO:0070694,1,0.993301131169352,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15948,GO:0070695,1,0.961832731376558,0,5,FHF complex,CC,
15949,GO:0070696,1,0.894402347898924,0,18,transmembrane receptor protein serine/threonine kinase binding,MF,
15950,GO:0070697,1,0.967329001668431,0,6,activin receptor binding,MF,
15951,GO:0070698,1,0.98819398291182,0,2,type I activin receptor binding,MF,
15952,GO:0070699,1,0.986561422965482,0,2,type II activin receptor binding,MF,
15953,GO:0070700,1,0.924635377236919,0,12,BMP receptor binding,MF,
15954,GO:0070704,1,0.98576439445561,0,2,sterol desaturase activity,MF,
15955,GO:0070715,1,0.992651266995692,0,1,sodium-dependent organic cation transport,BP,
15956,GO:0070717,1,0.853826843725851,0,23,poly-purine tract binding,MF,
15957,GO:0070722,1,0.99253751423776,0,1,Tle3-Aes complex,CC,
15959,GO:0070724,1,0.992762238217727,0,1,BMP receptor complex,CC,
15961,GO:0070728,1,0.95265830485875,0,7,leucine binding,MF,
15962,GO:0070733,1,0.996060482200124,0,1,protein adenylyltransferase activity,MF,
15963,GO:0070734,1,0.883730894549096,0,19,histone H3-K27 methylation,BP,
15964,GO:0070735,1,0.987362853924657,0,2,protein-glycine ligase activity,MF,
15965,GO:0070736,1,0.992575392955464,0,1,protein-glycine ligase activity, initiating,MF,
15966,GO:0070739,1,0.953583464640101,0,7,protein-glutamic acid ligase activity,MF,
15967,GO:0070740,1,0.953583464640101,0,7,tubulin-glutamic acid ligase activity,MF,
15969,GO:0070742,1,0.908069241549075,0,14,C2H2 zinc finger domain binding,MF,
15970,GO:0070743,1,0.996840493206443,0,1,interleukin-23 complex,CC,
15971,GO:0070757,1,0.92833479525245,0,11,interleukin-35-mediated signaling pathway,BP,
15972,GO:0070761,1,0.971964406850967,0,5,pre-snoRNP complex,CC,
15973,GO:0070762,1,0.993301131169352,0,1,nuclear pore transmembrane ring,CC,
15974,GO:0070765,1,0.962698078854116,0,6,gamma-secretase complex,CC,
15975,GO:0070772,1,0.992802943897003,0,1,PAS complex,CC,
15976,GO:0070773,1,0.996531261015071,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15977,GO:0070774,1,0.992417116191499,0,1,phytoceramidase activity,MF,
15978,GO:0070775,1,0.951474779442938,0,7,H3 histone acetyltransferase complex,CC,
15979,GO:0070776,1,0.951474779442938,0,7,MOZ/MORF histone acetyltransferase complex,CC,
15980,GO:0070777,1,0.967419855787756,0,4,D-aspartate transport,BP,
15981,GO:0070778,1,0.960022079850857,0,6,L-aspartate transmembrane transport,BP,
15982,GO:0070779,1,0.967419855787756,0,4,D-aspartate import across plasma membrane,BP,
15983,GO:0070780,1,0.98936078232844,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
15984,GO:0070781,1,0.988089343686693,0,2,response to biotin,BP,
15985,GO:0070782,1,0.994847829738843,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
15986,GO:0070813,1,0.974504626836418,0,5,hydrogen sulfide metabolic process,BP,
15987,GO:0070814,1,0.977541750234253,0,4,hydrogen sulfide biosynthetic process,BP,
15988,GO:0070815,1,0.971125263551519,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15989,GO:0070816,1,0.912095546720517,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
15990,GO:0070818,1,0.995867147666841,0,1,protoporphyrinogen oxidase activity,MF,
15991,GO:0070820,1,0.400976109388927,0,155,tertiary granule,CC,
15992,GO:0070821,1,0.633575678932954,0,70,tertiary granule membrane,CC,
15993,GO:0070822,1,0.904655401072783,0,15,Sin3-type complex,CC,
15994,GO:0070826,1,0.992444082065594,0,1,paraferritin complex,CC,
15995,GO:0070827,1,0.970319796572212,0,4,chromatin maintenance,BP,
15996,GO:0070828,1,0.905119880034069,0,15,heterochromatin organization,BP,
15997,GO:0070829,1,0.984046703390528,0,2,heterochromatin maintenance,BP,
15999,GO:0070831,1,0.942853447954286,0,8,basement membrane assembly,BP,
16000,GO:0070836,1,0.981309079583827,0,3,caveola assembly,BP,
16001,GO:0070837,1,0.977676873881228,0,3,dehydroascorbic acid transport,BP,
16003,GO:0070839,1,0.985125842683926,0,2,divalent metal ion export,BP,
16004,GO:0070840,1,0.856241580996689,0,20,dynein complex binding,MF,
16005,GO:0070841,1,0.875630872061385,0,20,inclusion body assembly,BP,
16006,GO:0070842,1,0.974484201236619,0,4,aggresome assembly,BP,
16007,GO:0070843,1,0.992448731632843,0,1,misfolded protein transport,BP,
16008,GO:0070844,1,0.992448731632843,0,1,polyubiquitinated protein transport,BP,
16009,GO:0070845,1,0.992448731632843,0,1,polyubiquitinated misfolded protein transport,BP,
16010,GO:0070846,1,0.992448731632843,0,1,Hsp90 deacetylation,BP,
16011,GO:0070847,1,0.961769609573129,0,8,core mediator complex,CC,
16015,GO:0070852,1,0.957306963709137,0,6,cell body fiber,CC,
16016,GO:0070853,1,0.983000410689233,0,2,myosin VI binding,MF,
16017,GO:0070856,1,0.991979834820283,0,1,myosin VI light chain binding,MF,
16018,GO:0070857,1,0.948918540584507,0,8,regulation of bile acid biosynthetic process,BP,
16019,GO:0070858,1,0.981131634860497,0,3,negative regulation of bile acid biosynthetic process,BP,
16020,GO:0070859,1,0.981499284195664,0,3,positive regulation of bile acid biosynthetic process,BP,
16021,GO:0070860,1,0.994437903450565,0,1,RNA polymerase I core factor complex,CC,
16022,GO:0070861,1,0.853889352991843,0,23,regulation of protein exit from endoplasmic reticulum,BP,
16023,GO:0070862,1,0.938252163304602,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
16024,GO:0070863,1,0.924684623218533,0,11,positive regulation of protein exit from endoplasmic reticulum,BP,
16025,GO:0070873,1,0.829024093938804,0,26,regulation of glycogen metabolic process,BP,
16026,GO:0070874,1,0.963548801614237,0,5,negative regulation of glycogen metabolic process,BP,
16027,GO:0070875,1,0.896940703024337,0,14,positive regulation of glycogen metabolic process,BP,
16028,GO:0070876,1,0.972585444625262,0,4,SOSS complex,CC,
16029,GO:0070877,1,0.985760272049731,0,2,microprocessor complex,CC,
16030,GO:0070878,1,0.941108952554838,0,8,primary miRNA binding,MF,
16031,GO:0070883,1,0.971789357787848,0,5,pre-miRNA binding,MF,
16033,GO:0070885,1,0.977849778104315,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
16036,GO:0070888,1,0.818244981380744,0,31,E-box binding,MF,
16037,GO:0070889,1,0.987938778371483,0,2,platelet alpha granule organization,BP,
16038,GO:0070890,1,0.991687952864058,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16039,GO:0070891,1,0.981441278554597,0,4,lipoteichoic acid binding,MF,
16040,GO:0070892,1,0.995073207414637,0,1,lipoteichoic acid receptor activity,MF,
16041,GO:0070893,1,0.985509195135326,0,2,transposon integration,BP,
16042,GO:0070894,1,0.985509195135326,0,2,regulation of transposon integration,BP,
16043,GO:0070895,1,0.985509195135326,0,2,negative regulation of transposon integration,BP,
16044,GO:0070897,1,0.776652159444205,0,42,DNA-templated transcriptional preinitiation complex assembly,BP,
16045,GO:0070898,1,0.990022427432828,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16046,GO:0070899,1,0.992925171652627,0,1,mitochondrial tRNA wobble uridine modification,BP,
16047,GO:0070900,1,0.953451070562094,0,9,mitochondrial tRNA modification,BP,
16048,GO:0070901,1,0.978247698623839,0,4,mitochondrial tRNA methylation,BP,
16049,GO:0070902,1,0.99602606982278,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16050,GO:0070903,1,0.995341432335947,0,1,mitochondrial tRNA thio-modification,BP,
16051,GO:0070904,1,0.991687952864058,0,1,transepithelial L-ascorbic acid transport,BP,
16052,GO:0070905,1,0.981545925533194,0,3,serine binding,MF,
16053,GO:0070911,1,0.832994373226096,0,32,global genome nucleotide-excision repair,BP,
16054,GO:0070914,1,0.931996925485507,0,11,UV-damage excision repair,BP,
16055,GO:0070915,1,0.972317397755578,0,5,lysophosphatidic acid receptor activity,MF,
16058,GO:0070922,1,0.94161175756792,0,9,small RNA loading onto RISC,BP,
16060,GO:0070926,1,0.992466729052647,0,1,regulation of ATP:ADP antiporter activity,BP,
16061,GO:0070931,1,0.99209001525427,0,1,Golgi-associated vesicle lumen,CC,
16062,GO:0070932,1,0.874927592561793,0,20,histone H3 deacetylation,BP,
16063,GO:0070933,1,0.940026465945016,0,9,histone H4 deacetylation,BP,
16064,GO:0070934,1,0.963731393118287,0,5,CRD-mediated mRNA stabilization,BP,
16065,GO:0070935,1,0.900880372860285,0,15,3'-UTR-mediated mRNA stabilization,BP,
16066,GO:0070936,1,0.727875310777369,0,49,protein K48-linked ubiquitination,BP,
16067,GO:0070937,1,0.956450616849372,0,6,CRD-mediated mRNA stability complex,CC,
16069,GO:0070939,1,0.977765182785738,0,3,Dsl1/NZR complex,CC,
16070,GO:0070940,1,0.967197298098407,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16071,GO:0070942,1,0.9659513483708,0,8,neutrophil mediated cytotoxicity,BP,
16072,GO:0070943,1,0.976497161077149,0,6,neutrophil mediated killing of symbiont cell,BP,
16073,GO:0070944,1,0.980032473218662,0,5,neutrophil mediated killing of bacterium,BP,
16074,GO:0070945,1,0.986093324245746,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16075,GO:0070946,1,0.996919361622295,0,1,neutrophil mediated killing of gram-positive bacterium,BP,
16076,GO:0070947,1,0.993324366850566,0,2,neutrophil mediated killing of fungus,BP,
16077,GO:0070948,1,0.9788451622991,0,4,regulation of neutrophil mediated cytotoxicity,BP,
16078,GO:0070949,1,0.989530255190146,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
16079,GO:0070950,1,0.993112254326442,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16080,GO:0070951,1,0.993112254326442,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16081,GO:0070953,1,0.996393417544675,0,1,regulation of neutrophil mediated killing of fungus,BP,
16082,GO:0070960,1,0.989530255190146,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
16083,GO:0070961,1,0.989530255190146,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16084,GO:0070962,1,0.993112254326442,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16085,GO:0070963,1,0.993112254326442,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16086,GO:0070965,1,0.996393417544675,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
16087,GO:0070966,1,0.977616383046142,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16088,GO:0070970,1,0.929247074666962,0,10,interleukin-2 secretion,BP,
16089,GO:0070971,1,0.891160404120479,0,17,endoplasmic reticulum exit site,CC,
16090,GO:0070972,1,0.565123721368825,0,129,protein localization to endoplasmic reticulum,BP,
16091,GO:0070973,1,0.958753289176444,0,6,protein localization to endoplasmic reticulum exit site,BP,
16092,GO:0070974,1,0.992877652548444,0,1,POU domain binding,MF,
16093,GO:0070975,1,0.991543833171843,0,1,FHA domain binding,MF,
16094,GO:0070976,1,0.993432496128069,0,1,TIR domain binding,MF,
16096,GO:0070979,1,0.863885523883532,0,27,protein K11-linked ubiquitination,BP,
16097,GO:0070981,1,0.99438119234837,0,1,L-asparagine biosynthetic process,BP,
16098,GO:0070982,1,0.99438119234837,0,1,L-asparagine metabolic process,BP,
16099,GO:0070984,1,0.992444377104057,0,1,SET domain binding,MF,
16100,GO:0070985,1,0.992783742266171,0,2,TFIIK complex,CC,
16101,GO:0070986,1,0.913824665165434,0,13,left/right axis specification,BP,
16102,GO:0070987,1,0.90333646159362,0,18,error-free translesion synthesis,BP,
16103,GO:0070988,1,0.665351484852464,0,59,demethylation,BP,
16104,GO:0070989,1,0.926127803384698,0,12,oxidative demethylation,BP,
16105,GO:0070990,1,0.97588491864106,0,6,snRNP binding,MF,
16106,GO:0070991,1,0.980011875308658,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
16107,GO:0070992,1,0.98996501414687,0,2,translation initiation complex,CC,
16108,GO:0070993,1,0.984902907345084,0,2,translation preinitiation complex,CC,
16109,GO:0070995,1,0.980053014464426,0,3,NADPH oxidation,BP,
16110,GO:0070996,1,0.988351096371041,0,3,type 1 melanocortin receptor binding,MF,
16112,GO:0071000,1,0.989898757219025,0,2,response to magnetism,BP,
16113,GO:0071001,1,0.982859594718865,0,3,U4/U6 snRNP,CC,
16114,GO:0071004,1,0.904394194928138,0,17,U2-type prespliceosome,CC,
16115,GO:0071005,1,0.994750234888056,0,1,U2-type precatalytic spliceosome,CC,
16116,GO:0071006,1,0.981398019601614,0,3,U2-type catalytic step 1 spliceosome,CC,
16117,GO:0071007,1,0.86029047993401,0,29,U2-type catalytic step 2 spliceosome,CC,
16118,GO:0071008,1,0.976193812831434,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16119,GO:0071010,1,0.882228651293209,0,22,prespliceosome,CC,
16120,GO:0071011,1,0.845763584321243,0,31,precatalytic spliceosome,CC,
16121,GO:0071012,1,0.963606071436234,0,6,catalytic step 1 spliceosome,CC,
16122,GO:0071013,1,0.563861824233995,0,97,catalytic step 2 spliceosome,CC,
16123,GO:0071014,1,0.949733353443269,0,9,post-mRNA release spliceosomal complex,CC,
16124,GO:0071020,1,0.991787157353072,0,2,post-spliceosomal complex,CC,
16125,GO:0071021,1,0.99594285253968,0,1,U2-type post-spliceosomal complex,CC,
16126,GO:0071025,1,0.928939013785243,0,15,RNA surveillance,BP,
16127,GO:0071026,1,0.993969875847883,0,1,cytoplasmic RNA surveillance,BP,
16128,GO:0071027,1,0.941120930050588,0,13,nuclear RNA surveillance,BP,
16129,GO:0071028,1,0.941120930050588,0,13,nuclear mRNA surveillance,BP,
16130,GO:0071029,1,0.974339876825469,0,6,nuclear ncRNA surveillance,BP,
16131,GO:0071030,1,0.989247563180083,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16132,GO:0071031,1,0.9915051549101,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16133,GO:0071033,1,0.976854899724635,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16134,GO:0071034,1,0.976426648679405,0,4,CUT catabolic process,BP,
16135,GO:0071035,1,0.974339876825469,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16136,GO:0071038,1,0.980935318424032,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16137,GO:0071042,1,0.981803427295629,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16138,GO:0071043,1,0.976426648679405,0,4,CUT metabolic process,BP,
16139,GO:0071044,1,0.925503098432978,0,11,histone mRNA catabolic process,BP,
16140,GO:0071045,1,0.996069909566466,0,1,nuclear histone mRNA catabolic process,BP,
16141,GO:0071046,1,0.974339876825469,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16142,GO:0071047,1,0.981803427295629,0,4,polyadenylation-dependent mRNA catabolic process,BP,
16143,GO:0071048,1,0.989247563180083,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16144,GO:0071049,1,0.9915051549101,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16145,GO:0071051,1,0.981406280910691,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16146,GO:0071062,1,0.980874867341774,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16147,GO:0071065,1,0.985789756300624,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16148,GO:0071071,1,0.924175152072124,0,13,regulation of phospholipid biosynthetic process,BP,
16149,GO:0071072,1,0.971701741336897,0,4,negative regulation of phospholipid biosynthetic process,BP,
16150,GO:0071073,1,0.956493316021216,0,8,positive regulation of phospholipid biosynthetic process,BP,
16151,GO:0071074,1,0.995484123700655,0,1,eukaryotic initiation factor eIF2 binding,MF,
16152,GO:0071077,1,0.981257186100733,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16153,GO:0071103,1,0.232956846631716,0,221,DNA conformation change,BP,
16154,GO:0071104,1,0.977810250668922,0,4,response to interleukin-9,BP,
16155,GO:0071105,1,0.989293315935043,0,2,response to interleukin-11,BP,
16156,GO:0071106,1,0.981257186100733,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16158,GO:0071108,1,0.832782744068425,0,24,protein K48-linked deubiquitination,BP,
16159,GO:0071109,1,0.982271809925948,0,2,superior temporal gyrus development,BP,
16160,GO:0071110,1,0.992001434575794,0,1,histone biotinylation,BP,
16161,GO:0071133,1,0.992760296811159,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16162,GO:0071139,1,0.985628288339434,0,2,resolution of recombination intermediates,BP,
16163,GO:0071140,1,0.985628288339434,0,2,resolution of mitotic recombination intermediates,BP,
16164,GO:0071141,1,0.937601293829252,0,8,SMAD protein complex,CC,
16165,GO:0071144,1,0.982431364676314,0,2,heteromeric SMAD protein complex,CC,
16166,GO:0071148,1,0.983041028256936,0,2,TEAD-1-YAP complex,CC,
16167,GO:0071149,1,0.987079309397817,0,2,TEAD-2-YAP complex,CC,
16168,GO:0071156,1,0.524560313075863,0,107,regulation of cell cycle arrest,BP,
16169,GO:0071157,1,0.889335585150713,0,21,negative regulation of cell cycle arrest,BP,
16170,GO:0071158,1,0.595460002850986,0,84,positive regulation of cell cycle arrest,BP,
16171,GO:0071159,1,0.990718050011369,0,2,NF-kappaB complex,CC,
16172,GO:0071163,1,0.985709235894022,0,3,DNA replication preinitiation complex assembly,BP,
16173,GO:0071164,1,0.992486227265391,0,1,RNA trimethylguanosine synthase activity,MF,
16174,GO:0071166,1,0.462057033870114,0,123,ribonucleoprotein complex localization,BP,
16175,GO:0071168,1,0.882870576019932,0,20,protein localization to chromatin,BP,
16176,GO:0071169,1,0.965845895011967,0,7,establishment of protein localization to chromatin,BP,
16177,GO:0071173,1,0.822160143332049,0,31,spindle assembly checkpoint,BP,
16178,GO:0071174,1,0.822160143332049,0,31,mitotic spindle checkpoint,BP,
16179,GO:0071203,1,0.965353317909654,0,5,WASH complex,CC,
16180,GO:0071204,1,0.967302899011285,0,6,histone pre-mRNA 3'end processing complex,CC,
16183,GO:0071207,1,0.988314459670675,0,2,histone pre-mRNA stem-loop binding,MF,
16184,GO:0071208,1,0.986228695189375,0,4,histone pre-mRNA DCP binding,MF,
16185,GO:0071209,1,0.987277244804628,0,3,U7 snRNA binding,MF,
16186,GO:0071211,1,0.973159886576024,0,4,protein targeting to vacuole involved in autophagy,BP,
16188,GO:0071215,1,0.992422500170589,0,1,cellular response to abscisic acid stimulus,BP,
16189,GO:0071216,1,0.327391378549841,0,184,cellular response to biotic stimulus,BP,
16190,GO:0071217,1,0.992458434284543,0,1,cellular response to external biotic stimulus,BP,
16191,GO:0071218,1,0.871702332883606,0,21,cellular response to misfolded protein,BP,
16192,GO:0071219,1,0.373409844489485,0,165,cellular response to molecule of bacterial origin,BP,
16193,GO:0071220,1,0.965317477116505,0,6,cellular response to bacterial lipoprotein,BP,
16194,GO:0071221,1,0.965317477116505,0,6,cellular response to bacterial lipopeptide,BP,
16195,GO:0071222,1,0.391389224918371,0,157,cellular response to lipopolysaccharide,BP,
16196,GO:0071223,1,0.942585806515156,0,11,cellular response to lipoteichoic acid,BP,
16197,GO:0071224,1,0.969476213702196,0,5,cellular response to peptidoglycan,BP,
16198,GO:0071225,1,0.964384658930376,0,5,cellular response to muramyl dipeptide,BP,
16199,GO:0071226,1,0.985960988365223,0,2,cellular response to molecule of fungal origin,BP,
16200,GO:0071228,1,0.99679922116085,0,1,cellular response to tumor cell,BP,
16203,GO:0071231,1,0.993620468134864,0,2,cellular response to folic acid,BP,
16204,GO:0071233,1,0.934198158960705,0,9,cellular response to leucine,BP,
16205,GO:0071236,1,0.440319118628874,0,128,cellular response to antibiotic,BP,
16207,GO:0071242,1,0.715878429171134,0,53,cellular response to ammonium ion,BP,
16208,GO:0071243,1,0.922493654141551,0,16,cellular response to arsenic-containing substance,BP,
16209,GO:0071245,1,0.992496595387783,0,1,cellular response to carbon monoxide,BP,
16210,GO:0071247,1,0.996797135125448,0,1,cellular response to chromate,BP,
16212,GO:0071250,1,0.991902207274696,0,1,cellular response to nitrite,BP,
16214,GO:0071256,1,0.98500673223686,0,4,translocon complex,CC,
16215,GO:0071257,1,0.923058418246911,0,12,cellular response to electrical stimulus,BP,
16216,GO:0071258,1,0.99244707801265,0,1,cellular response to gravity,BP,
16217,GO:0071259,1,0.989898757219025,0,2,cellular response to magnetism,BP,
16219,GO:0071262,1,0.984682069723509,0,2,regulation of translational initiation in response to starvation,BP,
16220,GO:0071264,1,0.984682069723509,0,2,positive regulation of translational initiation in response to starvation,BP,
16221,GO:0071265,1,0.958810671339411,0,8,L-methionine biosynthetic process,BP,
16222,GO:0071266,1,0.995869264340929,0,1,'de novo' L-methionine biosynthetic process,BP,
16223,GO:0071267,1,0.962789270461725,0,7,L-methionine salvage,BP,
16224,GO:0071268,1,0.994478518349261,0,1,homocysteine biosynthetic process,BP,
16225,GO:0071275,1,0.994864053664453,0,1,cellular response to aluminum ion,BP,
16228,GO:0071279,1,0.983712566988553,0,3,cellular response to cobalt ion,BP,
16229,GO:0071280,1,0.92135414252726,0,18,cellular response to copper ion,BP,
16231,GO:0071283,1,0.991917887973752,0,2,cellular response to iron(III) ion,BP,
16232,GO:0071284,1,0.969179005692607,0,4,cellular response to lead ion,BP,
16233,GO:0071285,1,0.938040358753653,0,12,cellular response to lithium ion,BP,
16234,GO:0071286,1,0.952170009023892,0,6,cellular response to magnesium ion,BP,
16235,GO:0071287,1,0.939887925398989,0,9,cellular response to manganese ion,BP,
16236,GO:0071288,1,0.993345078292175,0,1,cellular response to mercury ion,BP,
16237,GO:0071294,1,0.925650630831875,0,17,cellular response to zinc ion,BP,
16238,GO:0071295,1,0.83639650591347,0,28,cellular response to vitamin,BP,
16239,GO:0071298,1,0.99256775817539,0,1,cellular response to L-ascorbic acid,BP,
16241,GO:0071301,1,0.991546677566348,0,1,cellular response to vitamin B1,BP,
16242,GO:0071305,1,0.884508628130448,0,19,cellular response to vitamin D,BP,
16243,GO:0071306,1,0.987665918230291,0,2,cellular response to vitamin E,BP,
16244,GO:0071307,1,0.986647481136074,0,2,cellular response to vitamin K,BP,
16246,GO:0071312,1,0.811292678293059,0,31,cellular response to alkaloid,BP,
16247,GO:0071313,1,0.930589794532062,0,8,cellular response to caffeine,BP,
16248,GO:0071314,1,0.985596740840032,0,3,cellular response to cocaine,BP,
16249,GO:0071315,1,0.977577535347761,0,4,cellular response to morphine,BP,
16250,GO:0071316,1,0.957158878358485,0,8,cellular response to nicotine,BP,
16251,GO:0071317,1,0.977577535347761,0,4,cellular response to isoquinoline alkaloid,BP,
16252,GO:0071318,1,0.92187125232482,0,13,cellular response to ATP,BP,
16254,GO:0071321,1,0.954079060452506,0,6,cellular response to cGMP,BP,
16255,GO:0071322,1,0.463083468520452,0,121,cellular response to carbohydrate stimulus,BP,
16256,GO:0071324,1,0.992295371236997,0,1,cellular response to disaccharide stimulus,BP,
16257,GO:0071326,1,0.48813628995394,0,113,cellular response to monosaccharide stimulus,BP,
16258,GO:0071329,1,0.992295371236997,0,1,cellular response to sucrose stimulus,BP,
16259,GO:0071331,1,0.491818609336304,0,112,cellular response to hexose stimulus,BP,
16260,GO:0071332,1,0.969453698847725,0,5,cellular response to fructose stimulus,BP,
16261,GO:0071333,1,0.497840842927548,0,110,cellular response to glucose stimulus,BP,
16262,GO:0071335,1,0.991876511630965,0,2,hair follicle cell proliferation,BP,
16263,GO:0071336,1,0.991876511630965,0,2,regulation of hair follicle cell proliferation,BP,
16264,GO:0071338,1,0.991876511630965,0,2,positive regulation of hair follicle cell proliferation,BP,
16265,GO:0071339,1,0.833278556516865,0,28,MLL1 complex,CC,
16266,GO:0071340,1,0.934894057451629,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16267,GO:0071344,1,0.992761032296139,0,2,diphosphate metabolic process,BP,
16269,GO:0071346,1,0.438162024487934,0,146,cellular response to interferon-gamma,BP,
16271,GO:0071348,1,0.992346221517564,0,1,cellular response to interleukin-11,BP,
16272,GO:0071349,1,0.78594473550599,0,44,cellular response to interleukin-12,BP,
16273,GO:0071350,1,0.915313930223401,0,13,cellular response to interleukin-15,BP,
16274,GO:0071351,1,0.953185608135201,0,8,cellular response to interleukin-18,BP,
16275,GO:0071352,1,0.919825275827574,0,12,cellular response to interleukin-2,BP,
16276,GO:0071353,1,0.848164897394094,0,28,cellular response to interleukin-4,BP,
16278,GO:0071355,1,0.980828088905818,0,3,cellular response to interleukin-9,BP,
16280,GO:0071357,1,0.661122721768138,0,71,cellular response to type I interferon,BP,
16282,GO:0071360,1,0.92186432639893,0,13,cellular response to exogenous dsRNA,BP,
16283,GO:0071361,1,0.916260583833502,0,13,cellular response to ethanol,BP,
16284,GO:0071362,1,0.96620943125121,0,5,cellular response to ether,BP,
16287,GO:0071371,1,0.890545411692054,0,16,cellular response to gonadotropin stimulus,BP,
16288,GO:0071372,1,0.929860066210257,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16289,GO:0071373,1,0.986816952082257,0,2,cellular response to luteinizing hormone stimulus,BP,
16292,GO:0071376,1,0.968562131217699,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16293,GO:0071377,1,0.797675678618688,0,36,cellular response to glucagon stimulus,BP,
16294,GO:0071378,1,0.869098529556441,0,20,cellular response to growth hormone stimulus,BP,
16295,GO:0071379,1,0.864702512691889,0,21,cellular response to prostaglandin stimulus,BP,
16296,GO:0071380,1,0.895534029907899,0,16,cellular response to prostaglandin E stimulus,BP,
16300,GO:0071386,1,0.976108004209545,0,3,cellular response to corticosterone stimulus,BP,
16301,GO:0071387,1,0.992244101759092,0,1,cellular response to cortisol stimulus,BP,
16302,GO:0071389,1,0.95655061540434,0,7,cellular response to mineralocorticoid stimulus,BP,
16303,GO:0071391,1,0.920457433598502,0,12,cellular response to estrogen stimulus,BP,
16306,GO:0071394,1,0.944289072500912,0,9,cellular response to testosterone stimulus,BP,
16307,GO:0071395,1,0.986263631734964,0,4,cellular response to jasmonic acid stimulus,BP,
16310,GO:0071398,1,0.721380582395109,0,49,cellular response to fatty acid,BP,
16311,GO:0071400,1,0.986174596911257,0,2,cellular response to oleic acid,BP,
16312,GO:0071401,1,0.994485294736201,0,1,cellular response to triglyceride,BP,
16313,GO:0071402,1,0.850013397628464,0,25,cellular response to lipoprotein particle stimulus,BP,
16314,GO:0071403,1,0.985519250868243,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16315,GO:0071404,1,0.890908498814587,0,18,cellular response to low-density lipoprotein particle stimulus,BP,
16317,GO:0071409,1,0.979695983172027,0,3,cellular response to cycloheximide,BP,
16318,GO:0071412,1,0.994505634712308,0,1,cellular response to genistein,BP,
16319,GO:0071413,1,0.994505634712308,0,1,cellular response to hydroxyisoflavone,BP,
16320,GO:0071415,1,0.923174014202508,0,9,cellular response to purine-containing compound,BP,
16322,GO:0071418,1,0.996519773532753,0,1,cellular response to amine stimulus,BP,
16323,GO:0071420,1,0.948854891712323,0,7,cellular response to histamine,BP,
16324,GO:0071421,1,0.970855469419915,0,4,manganese ion transmembrane transport,BP,
16325,GO:0071422,1,0.980810940647604,0,3,succinate transmembrane transport,BP,
16326,GO:0071423,1,0.995537833604515,0,1,malate transmembrane transport,BP,
16327,GO:0071424,1,0.993301131169352,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16328,GO:0071425,1,0.883454950704082,0,19,hematopoietic stem cell proliferation,BP,
16329,GO:0071426,1,0.464515143516835,0,122,ribonucleoprotein complex export from nucleus,BP,
16330,GO:0071427,1,0.511627717564268,0,104,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16331,GO:0071428,1,0.924602201871261,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16332,GO:0071431,1,0.811493101976235,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16333,GO:0071435,1,0.926285778897834,0,12,potassium ion export,BP,
16334,GO:0071437,1,0.90466588567406,0,14,invadopodium,CC,
16335,GO:0071438,1,0.967329188625829,0,5,invadopodium membrane,CC,
16336,GO:0071439,1,0.9408672027716,0,9,clathrin complex,CC,
16337,GO:0071440,1,0.960990100631123,0,6,regulation of histone H3-K14 acetylation,BP,
16338,GO:0071441,1,0.992468656963127,0,1,negative regulation of histone H3-K14 acetylation,BP,
16339,GO:0071442,1,0.974816924751907,0,4,positive regulation of histone H3-K14 acetylation,BP,
16340,GO:0071444,1,0.997101430005498,0,1,cellular response to pheromone,BP,
16341,GO:0071447,1,0.952336165418402,0,8,cellular response to hydroperoxide,BP,
16342,GO:0071449,1,0.996924087352934,0,1,cellular response to lipid hydroperoxide,BP,
16343,GO:0071450,1,0.88538742894723,0,24,cellular response to oxygen radical,BP,
16344,GO:0071451,1,0.88538742894723,0,24,cellular response to superoxide,BP,
16345,GO:0071453,1,0.288237064099971,0,205,cellular response to oxygen levels,BP,
16346,GO:0071454,1,0.99152708568041,0,1,cellular response to anoxia,BP,
16347,GO:0071455,1,0.96034449207189,0,6,cellular response to hyperoxia,BP,
16348,GO:0071456,1,0.332947424848806,0,183,cellular response to hypoxia,BP,
16349,GO:0071458,1,0.968750573227612,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16350,GO:0071459,1,0.887382259715824,0,20,protein localization to chromosome, centromeric region,BP,
16351,GO:0071460,1,0.993190395301346,0,2,cellular response to cell-matrix adhesion,BP,
16352,GO:0071461,1,0.989952162639997,0,2,cellular response to redox state,BP,
16353,GO:0071462,1,0.977409328260697,0,3,cellular response to water stimulus,BP,
16354,GO:0071464,1,0.992280151234642,0,1,cellular response to hydrostatic pressure,BP,
16357,GO:0071468,1,0.94108897898167,0,9,cellular response to acidic pH,BP,
16358,GO:0071469,1,0.988200397524544,0,2,cellular response to alkaline pH,BP,
16360,GO:0071471,1,0.992400924180365,0,1,cellular response to non-ionic osmotic stress,BP,
16362,GO:0071474,1,0.932365357846828,0,11,cellular hyperosmotic response,BP,
16363,GO:0071475,1,0.976566989450315,0,4,cellular hyperosmotic salinity response,BP,
16364,GO:0071476,1,0.951266606110059,0,7,cellular hypotonic response,BP,
16365,GO:0071477,1,0.984314643565006,0,2,cellular hypotonic salinity response,BP,
16366,GO:0071478,1,0.351948304381014,0,164,cellular response to radiation,BP,
16367,GO:0071479,1,0.655751923638691,0,66,cellular response to ionizing radiation,BP,
16368,GO:0071480,1,0.843056113991651,0,27,cellular response to gamma radiation,BP,
16369,GO:0071481,1,0.910715879502697,0,13,cellular response to X-ray,BP,
16370,GO:0071482,1,0.509326306541119,0,106,cellular response to light stimulus,BP,
16371,GO:0071483,1,0.985164778240319,0,2,cellular response to blue light,BP,
16372,GO:0071484,1,0.984925147518771,0,2,cellular response to light intensity,BP,
16373,GO:0071485,1,0.992642954865686,0,1,cellular response to absence of light,BP,
16374,GO:0071486,1,0.992225586617662,0,1,cellular response to high light intensity,BP,
16375,GO:0071492,1,0.981185756825315,0,3,cellular response to UV-A,BP,
16376,GO:0071493,1,0.958452772815243,0,8,cellular response to UV-B,BP,
16377,GO:0071494,1,0.972471304632065,0,4,cellular response to UV-C,BP,
16380,GO:0071498,1,0.890877288711397,0,18,cellular response to fluid shear stress,BP,
16381,GO:0071499,1,0.958691266723612,0,7,cellular response to laminar fluid shear stress,BP,
16382,GO:0071500,1,0.966058327713245,0,6,cellular response to nitrosative stress,BP,
16383,GO:0071501,1,0.939387495974555,0,9,cellular response to sterol depletion,BP,
16384,GO:0071502,1,0.971897711996229,0,5,cellular response to temperature stimulus,BP,
16385,GO:0071503,1,0.970280100720663,0,4,response to heparin,BP,
16386,GO:0071504,1,0.970280100720663,0,4,cellular response to heparin,BP,
16387,GO:0071505,1,0.985939395909377,0,2,response to mycophenolic acid,BP,
16388,GO:0071506,1,0.985939395909377,0,2,cellular response to mycophenolic acid,BP,
16389,GO:0071514,1,0.862858265373417,0,22,genetic imprinting,BP,
16390,GO:0071526,1,0.783564997281993,0,32,semaphorin-plexin signaling pathway,BP,
16391,GO:0071527,1,0.994281830794387,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16392,GO:0071528,1,0.992465361576728,0,1,tRNA re-export from nucleus,BP,
16393,GO:0071529,1,0.993723864774709,0,1,cementum mineralization,BP,
16394,GO:0071532,1,0.962873376899868,0,5,ankyrin repeat binding,MF,
16395,GO:0071535,1,0.974578173401485,0,4,RING-like zinc finger domain binding,MF,
16396,GO:0071538,1,0.994435198688561,0,1,SH2 domain-mediated complex assembly,BP,
16397,GO:0071539,1,0.81888279933746,0,27,protein localization to centrosome,BP,
16398,GO:0071540,1,0.992211685584974,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16399,GO:0071541,1,0.967187886144462,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16400,GO:0071542,1,0.821197418841197,0,32,dopaminergic neuron differentiation,BP,
16401,GO:0071543,1,0.978556250983495,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16402,GO:0071544,1,0.996531261015071,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16403,GO:0071545,1,0.922409479407063,0,12,inositol phosphate catabolic process,BP,
16404,GO:0071546,1,0.957550772760697,0,6,pi-body,CC,
16405,GO:0071547,1,0.968265909856292,0,5,piP-body,CC,
16408,GO:0071550,1,0.953543872137592,0,9,death-inducing signaling complex assembly,BP,
16409,GO:0071553,1,0.985720945121673,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16410,GO:0071554,1,0.978787065231724,0,5,cell wall organization or biogenesis,BP,
16411,GO:0071556,1,0.893644570500113,0,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16412,GO:0071557,1,0.962020965137366,0,5,histone H3-K27 demethylation,BP,
16413,GO:0071558,1,0.962020965137366,0,5,histone demethylase activity (H3-K27 specific),MF,
16414,GO:0071559,1,0.241391717270602,0,212,response to transforming growth factor beta,BP,
16415,GO:0071560,1,0.249546221170302,0,208,cellular response to transforming growth factor beta stimulus,BP,
16416,GO:0071561,1,0.992283181692808,0,1,nucleus-vacuole junction,CC,
16417,GO:0071564,1,0.925265869199537,0,12,npBAF complex,CC,
16418,GO:0071565,1,0.911130538718255,0,14,nBAF complex,CC,
16419,GO:0071566,1,0.993004404210335,0,1,UFM1 activating enzyme activity,MF,
16420,GO:0071567,1,0.991153361850886,0,2,UFM1 hydrolase activity,MF,
16421,GO:0071568,1,0.990096076835215,0,2,UFM1 transferase activity,MF,
16422,GO:0071569,1,0.969326707188543,0,6,protein ufmylation,BP,
16423,GO:0071573,1,0.99302445305145,0,1,shelterin complex assembly,BP,
16424,GO:0071577,1,0.879177534713181,0,20,zinc ion transmembrane transport,BP,
16425,GO:0071578,1,0.954864796473696,0,7,zinc ion import across plasma membrane,BP,
16426,GO:0071579,1,0.988413600330177,0,2,regulation of zinc ion transport,BP,
16427,GO:0071580,1,0.995223063991604,0,1,regulation of zinc ion transmembrane transport,BP,
16428,GO:0071581,1,0.995223063991604,0,1,regulation of zinc ion transmembrane import,BP,
16429,GO:0071582,1,0.995223063991604,0,1,negative regulation of zinc ion transport,BP,
16430,GO:0071583,1,0.995223063991604,0,1,negative regulation of zinc ion transmembrane transport,BP,
16431,GO:0071584,1,0.995223063991604,0,1,negative regulation of zinc ion transmembrane import,BP,
16432,GO:0071585,1,0.995223063991604,0,1,detoxification of cadmium ion,BP,
16433,GO:0071586,1,0.989139441752049,0,2,CAAX-box protein processing,BP,
16434,GO:0071593,1,0.976431217370649,0,4,lymphocyte aggregation,BP,
16435,GO:0071595,1,0.986646673054992,0,2,Nem1-Spo7 phosphatase complex,CC,
16436,GO:0071596,1,0.975141598733811,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16437,GO:0071598,1,0.969006621400874,0,5,neuronal ribonucleoprotein granule,CC,
16438,GO:0071599,1,0.909113533530845,0,15,otic vesicle development,BP,
16439,GO:0071600,1,0.943308756813624,0,10,otic vesicle morphogenesis,BP,
16440,GO:0071602,1,0.992417116191499,0,1,phytosphingosine biosynthetic process,BP,
16441,GO:0071603,1,0.971526031161817,0,4,endothelial cell-cell adhesion,BP,
16442,GO:0071604,1,0.833249632787556,0,28,transforming growth factor beta production,BP,
16444,GO:0071606,1,0.995310806423143,0,1,chemokine (C-C motif) ligand 4 production,BP,
16445,GO:0071608,1,0.973723101552245,0,4,macrophage inflammatory protein-1 alpha production,BP,
16446,GO:0071609,1,0.936522437742688,0,10,chemokine (C-C motif) ligand 5 production,BP,
16447,GO:0071610,1,0.993901324201247,0,1,chemokine (C-C motif) ligand 1 production,BP,
16448,GO:0071611,1,0.971377396624322,0,5,granulocyte colony-stimulating factor production,BP,
16449,GO:0071612,1,0.98971766326214,0,1,IP-10 production,BP,
16450,GO:0071613,1,0.990596090226756,0,2,granzyme B production,BP,
16451,GO:0071614,1,0.99560970525256,0,1,linoleic acid epoxygenase activity,MF,
16452,GO:0071616,1,0.735984259807205,0,46,acyl-CoA biosynthetic process,BP,
16453,GO:0071617,1,0.884385204306103,0,18,lysophospholipid acyltransferase activity,MF,
16454,GO:0071619,1,0.994528704161581,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16455,GO:0071621,1,0.644604329981264,0,83,granulocyte chemotaxis,BP,
16456,GO:0071622,1,0.805772399751801,0,43,regulation of granulocyte chemotaxis,BP,
16457,GO:0071623,1,0.985652919457008,0,2,negative regulation of granulocyte chemotaxis,BP,
16458,GO:0071624,1,0.872596960943672,0,30,positive regulation of granulocyte chemotaxis,BP,
16459,GO:0071625,1,0.877397668361957,0,17,vocalization behavior,BP,
16460,GO:0071626,1,0.996627947902722,0,1,mastication,BP,
16461,GO:0071629,1,0.996069909566466,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16462,GO:0071630,1,0.97763415334051,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16463,GO:0071633,1,0.993156452182036,0,1,dihydroceramidase activity,MF,
16464,GO:0071634,1,0.839654207923941,0,27,regulation of transforming growth factor beta production,BP,
16465,GO:0071635,1,0.955503170447633,0,7,negative regulation of transforming growth factor beta production,BP,
16466,GO:0071636,1,0.900522322059314,0,17,positive regulation of transforming growth factor beta production,BP,
16469,GO:0071639,1,0.964113970364404,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16470,GO:0071640,1,0.973723101552245,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
16471,GO:0071641,1,0.987880790368364,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16472,GO:0071642,1,0.985670432772237,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16473,GO:0071643,1,0.995310806423143,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16474,GO:0071644,1,0.995310806423143,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16475,GO:0071649,1,0.940285283116033,0,9,regulation of chemokine (C-C motif) ligand 5 production,BP,
16476,GO:0071650,1,0.985521840750353,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16477,GO:0071651,1,0.954105691838737,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16478,GO:0071652,1,0.993901324201247,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16479,GO:0071654,1,0.993901324201247,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16480,GO:0071655,1,0.975377790512935,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16481,GO:0071656,1,0.994397375401436,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16482,GO:0071657,1,0.980874364068007,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16483,GO:0071658,1,0.98971766326214,0,1,regulation of IP-10 production,BP,
16484,GO:0071660,1,0.98971766326214,0,1,positive regulation of IP-10 production,BP,
16485,GO:0071661,1,0.990596090226756,0,2,regulation of granzyme B production,BP,
16486,GO:0071663,1,0.990596090226756,0,2,positive regulation of granzyme B production,BP,
16487,GO:0071664,1,0.969168673503575,0,4,catenin-TCF7L2 complex,CC,
16488,GO:0071665,1,0.992596190531154,0,1,gamma-catenin-TCF7L2 complex,CC,
16489,GO:0071670,1,0.952828239822298,0,8,smooth muscle cell chemotaxis,BP,
16490,GO:0071671,1,0.967398901025698,0,6,regulation of smooth muscle cell chemotaxis,BP,
16491,GO:0071672,1,0.981838318195391,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16492,GO:0071673,1,0.982381684005112,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16496,GO:0071677,1,0.913934914357503,0,17,positive regulation of mononuclear cell migration,BP,
16497,GO:0071678,1,0.991425651577895,0,1,olfactory bulb axon guidance,BP,
16498,GO:0071679,1,0.940611365742949,0,8,commissural neuron axon guidance,BP,
16499,GO:0071680,1,0.962186011993123,0,5,response to indole-3-methanol,BP,
16500,GO:0071681,1,0.962186011993123,0,5,cellular response to indole-3-methanol,BP,
16501,GO:0071682,1,0.910974639726965,0,19,endocytic vesicle lumen,CC,
16502,GO:0071684,1,0.992673220942937,0,1,organism emergence from protective structure,BP,
16503,GO:0071688,1,0.842843913055017,0,13,striated muscle myosin thick filament assembly,BP,
16504,GO:0071691,1,0.991696542335507,0,1,cardiac muscle thin filament assembly,BP,
16505,GO:0071692,1,0.960543135464204,0,6,protein localization to extracellular region,BP,
16506,GO:0071694,1,0.960543135464204,0,6,maintenance of protein location in extracellular region,BP,
16508,GO:0071696,1,0.904840710139218,0,15,ectodermal placode development,BP,
16509,GO:0071697,1,0.910337847092789,0,14,ectodermal placode morphogenesis,BP,
16510,GO:0071698,1,0.971171051538135,0,4,olfactory placode development,BP,
16511,GO:0071699,1,0.971171051538135,0,4,olfactory placode morphogenesis,BP,
16512,GO:0071701,1,0.992330491612537,0,1,regulation of MAPK export from nucleus,BP,
16517,GO:0071707,1,0.996627947902722,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16518,GO:0071709,1,0.82567359603059,0,27,membrane assembly,BP,
16519,GO:0071711,1,0.873479740621346,0,19,basement membrane organization,BP,
16520,GO:0071712,1,0.926949719808662,0,12,ER-associated misfolded protein catabolic process,BP,
16521,GO:0071713,1,0.992361773595713,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
16522,GO:0071714,1,0.992438093863437,0,1,icosanoid transmembrane transporter activity,MF,
16523,GO:0071715,1,0.826269401109714,0,31,icosanoid transport,BP,
16524,GO:0071723,1,0.951852054729856,0,8,lipopeptide binding,MF,
16525,GO:0071724,1,0.976078977678753,0,4,response to diacyl bacterial lipopeptide,BP,
16526,GO:0071725,1,0.982019962978697,0,3,response to triacyl bacterial lipopeptide,BP,
16527,GO:0071726,1,0.976078977678753,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16528,GO:0071727,1,0.982019962978697,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16529,GO:0071731,1,0.899695871935726,0,18,response to nitric oxide,BP,
16530,GO:0071732,1,0.91474189304137,0,15,cellular response to nitric oxide,BP,
16531,GO:0071733,1,0.976001962493892,0,4,transcriptional activation by promoter-enhancer looping,BP,
16532,GO:0071763,1,0.959798668371085,0,6,nuclear membrane organization,BP,
16533,GO:0071765,1,0.992439523035366,0,1,nuclear inner membrane organization,BP,
16536,GO:0071774,1,0.431539280328851,0,130,response to fibroblast growth factor,BP,
16537,GO:0071782,1,0.887561305831123,0,18,endoplasmic reticulum tubular network,CC,
16538,GO:0071786,1,0.906275137353571,0,15,endoplasmic reticulum tubular network organization,BP,
16539,GO:0071787,1,0.97565841618644,0,4,endoplasmic reticulum tubular network formation,BP,
16540,GO:0071789,1,0.993301131169352,0,1,spindle pole body localization to nuclear envelope,BP,
16541,GO:0071790,1,0.993301131169352,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
16542,GO:0071791,1,0.986088271119051,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16543,GO:0071796,1,0.996601699212043,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16544,GO:0071797,1,0.975219845433632,0,4,LUBAC complex,CC,
16545,GO:0071798,1,0.970017986050447,0,5,response to prostaglandin D,BP,
16546,GO:0071799,1,0.970017986050447,0,5,cellular response to prostaglandin D stimulus,BP,
16547,GO:0071800,1,0.876236459415059,0,20,podosome assembly,BP,
16548,GO:0071801,1,0.915450313318145,0,13,regulation of podosome assembly,BP,
16549,GO:0071802,1,0.992441752828675,0,1,negative regulation of podosome assembly,BP,
16550,GO:0071803,1,0.940367479557768,0,9,positive regulation of podosome assembly,BP,
16554,GO:0071812,1,0.992781123773047,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16555,GO:0071813,1,0.873059053287569,0,21,lipoprotein particle binding,MF,
16556,GO:0071814,1,0.873059053287569,0,21,protein-lipid complex binding,MF,
16557,GO:0071816,1,0.979223117955388,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16558,GO:0071817,1,0.973569804682812,0,5,MMXD complex,CC,
16559,GO:0071818,1,0.982869481954939,0,3,BAT3 complex,CC,
16560,GO:0071819,1,0.989586125121561,0,2,DUBm complex,CC,
16561,GO:0071820,1,0.996390485593893,0,1,N-box binding,MF,
16562,GO:0071821,1,0.988566307140999,0,2,FANCM-MHF complex,CC,
16563,GO:0071823,1,0.993416986470028,0,2,protein-carbohydrate complex subunit organization,BP,
16564,GO:0071824,1,0.2787377126144,0,219,protein-DNA complex subunit organization,BP,
16565,GO:0071825,1,0.788711550467651,0,39,protein-lipid complex subunit organization,BP,
16566,GO:0071826,1,0.29333310533386,0,207,ribonucleoprotein complex subunit organization,BP,
16567,GO:0071827,1,0.79922012027989,0,37,plasma lipoprotein particle organization,BP,
16568,GO:0071830,1,0.961944647013696,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16569,GO:0071837,1,0.89453234569632,0,17,HMG box domain binding,MF,
16570,GO:0071838,1,0.960095945172544,0,6,cell proliferation in bone marrow,BP,
16571,GO:0071839,1,0.976871277101758,0,4,apoptotic process in bone marrow,BP,
16573,GO:0071846,1,0.997036467993302,0,1,actin filament debranching,BP,
16574,GO:0071847,1,0.985236338082266,0,2,TNFSF11-mediated signaling pathway,BP,
16575,GO:0071848,1,0.992781123773047,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16576,GO:0071850,1,0.91649533547051,0,14,mitotic cell cycle arrest,BP,
16577,GO:0071855,1,0.904239296936914,0,23,neuropeptide receptor binding,MF,
16578,GO:0071863,1,0.959952347272308,0,6,regulation of cell proliferation in bone marrow,BP,
16579,GO:0071864,1,0.959952347272308,0,6,positive regulation of cell proliferation in bone marrow,BP,
16580,GO:0071865,1,0.975318793650418,0,4,regulation of apoptotic process in bone marrow,BP,
16581,GO:0071866,1,0.975318793650418,0,4,negative regulation of apoptotic process in bone marrow,BP,
16582,GO:0071867,1,0.782949179328568,0,35,response to monoamine,BP,
16583,GO:0071868,1,0.796456918859197,0,32,cellular response to monoamine stimulus,BP,
16584,GO:0071869,1,0.782949179328568,0,35,response to catecholamine,BP,
16585,GO:0071870,1,0.796456918859197,0,32,cellular response to catecholamine stimulus,BP,
16586,GO:0071871,1,0.897991908206512,0,15,response to epinephrine,BP,
16587,GO:0071872,1,0.91346211346253,0,12,cellular response to epinephrine stimulus,BP,
16588,GO:0071873,1,0.978632201276488,0,3,response to norepinephrine,BP,
16589,GO:0071874,1,0.986622783384684,0,2,cellular response to norepinephrine stimulus,BP,
16590,GO:0071875,1,0.871729641435728,0,21,adrenergic receptor signaling pathway,BP,
16591,GO:0071877,1,0.996531261015071,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16592,GO:0071878,1,0.983530172431687,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16593,GO:0071879,1,0.978982815463264,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16594,GO:0071880,1,0.886076909761232,0,18,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16595,GO:0071881,1,0.989023849800734,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16596,GO:0071882,1,0.992466729052647,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16597,GO:0071885,1,0.990232503031599,0,2,N-terminal protein N-methyltransferase activity,MF,
16598,GO:0071886,1,0.985129076462313,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16599,GO:0071887,1,0.580532955340414,0,93,leukocyte apoptotic process,BP,
16600,GO:0071888,1,0.94624187910614,0,9,macrophage apoptotic process,BP,
16601,GO:0071889,1,0.844745060995362,0,25,14-3-3 protein binding,MF,
16602,GO:0071890,1,0.992239516859189,0,1,bicarbonate binding,MF,
16603,GO:0071893,1,0.99578603907695,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16604,GO:0071894,1,0.987515597672003,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16605,GO:0071895,1,0.961059219296414,0,6,odontoblast differentiation,BP,
16606,GO:0071896,1,0.967371005223897,0,4,protein localization to adherens junction,BP,
16608,GO:0071898,1,0.981618599071884,0,3,regulation of estrogen receptor binding,BP,
16609,GO:0071899,1,0.981618599071884,0,3,negative regulation of estrogen receptor binding,BP,
16613,GO:0071907,1,0.950621672984328,0,7,determination of digestive tract left/right asymmetry,BP,
16614,GO:0071908,1,0.992191560118167,0,1,determination of intestine left/right asymmetry,BP,
16615,GO:0071909,1,0.992191560118167,0,1,determination of stomach left/right asymmetry,BP,
16616,GO:0071910,1,0.955952058182584,0,6,determination of liver left/right asymmetry,BP,
16617,GO:0071914,1,0.984987454489748,0,2,prominosome,CC,
16618,GO:0071918,1,0.973821317598015,0,4,urea transmembrane transport,BP,
16619,GO:0071920,1,0.988634321535472,0,2,cleavage body,CC,
16620,GO:0071921,1,0.965853912663102,0,5,cohesin loading,BP,
16621,GO:0071922,1,0.972369582967889,0,4,regulation of cohesin loading,BP,
16622,GO:0071926,1,0.972387443442759,0,4,endocannabinoid signaling pathway,BP,
16623,GO:0071929,1,0.986134165168467,0,2,alpha-tubulin acetylation,BP,
16624,GO:0071930,1,0.978044044271401,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16625,GO:0071931,1,0.982821011354005,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16626,GO:0071933,1,0.948894734570792,0,8,Arp2/3 complex binding,MF,
16627,GO:0071934,1,0.98115863754553,0,3,thiamine transmembrane transport,BP,
16628,GO:0071936,1,0.939593319396854,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16629,GO:0071938,1,0.993165181999932,0,1,vitamin A transport,BP,
16630,GO:0071939,1,0.993165181999932,0,1,vitamin A import,BP,
16631,GO:0071941,1,0.928333834600179,0,14,nitrogen cycle metabolic process,BP,
16632,GO:0071942,1,0.981863866161846,0,3,XPC complex,CC,
16634,GO:0071947,1,0.977758252977054,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16635,GO:0071949,1,0.854302666206127,0,25,FAD binding,MF,
16636,GO:0071951,1,0.99335320816281,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16637,GO:0071953,1,0.975816679412784,0,4,elastic fiber,CC,
16638,GO:0071954,1,0.992540479976971,0,1,chemokine (C-C motif) ligand 11 production,BP,
16639,GO:0071955,1,0.984077259503035,0,2,recycling endosome to Golgi transport,BP,
16640,GO:0071960,1,0.996941089164012,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16641,GO:0071962,1,0.985192109237464,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16642,GO:0071963,1,0.995866088424157,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
16643,GO:0071971,1,0.956732495661323,0,7,extracellular exosome assembly,BP,
16644,GO:0071976,1,0.992640917849161,0,1,cell gliding,BP,
16645,GO:0071985,1,0.841014571814896,0,28,multivesicular body sorting pathway,BP,
16646,GO:0071986,1,0.96096803396173,0,6,Ragulator complex,CC,
16647,GO:0071987,1,0.970726111959353,0,4,WD40-repeat domain binding,MF,
16648,GO:0071988,1,0.991604937803894,0,1,protein localization to spindle pole body,BP,
16649,GO:0071997,1,0.991874756835951,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16651,GO:0072003,1,0.981400527826777,0,3,kidney rudiment formation,BP,
16652,GO:0072004,1,0.984972388532087,0,2,kidney field specification,BP,
16654,GO:0072007,1,0.958671153146114,0,7,mesangial cell differentiation,BP,
16655,GO:0072008,1,0.962972116979975,0,6,glomerular mesangial cell differentiation,BP,
16657,GO:0072010,1,0.883140344358342,0,18,glomerular epithelium development,BP,
16658,GO:0072011,1,0.989457306683047,0,2,glomerular endothelium development,BP,
16660,GO:0072014,1,0.965337191498324,0,5,proximal tubule development,BP,
16661,GO:0072015,1,0.93508870570644,0,9,glomerular visceral epithelial cell development,BP,
16662,GO:0072016,1,0.993599055136015,0,1,glomerular parietal epithelial cell development,BP,
16663,GO:0072017,1,0.91807424494133,0,11,distal tubule development,BP,
16664,GO:0072019,1,0.994893758025159,0,1,proximal convoluted tubule development,BP,
16665,GO:0072021,1,0.977249118966441,0,3,ascending thin limb development,BP,
16666,GO:0072023,1,0.996320806190388,0,1,thick ascending limb development,BP,
16667,GO:0072024,1,0.996320806190388,0,1,macula densa development,BP,
16668,GO:0072025,1,0.975297987134516,0,4,distal convoluted tubule development,BP,
16669,GO:0072027,1,0.993836291135137,0,1,connecting tubule development,BP,
16671,GO:0072033,1,0.937826567496951,0,8,renal vesicle formation,BP,
16672,GO:0072034,1,0.977962247456884,0,3,renal vesicle induction,BP,
16673,GO:0072036,1,0.992479643238667,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16674,GO:0072038,1,0.968991296641091,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16675,GO:0072039,1,0.977540242017556,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16676,GO:0072040,1,0.977540242017556,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16677,GO:0072044,1,0.918840575379334,0,12,collecting duct development,BP,
16678,GO:0072046,1,0.996374215644472,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16679,GO:0072047,1,0.975915587110322,0,5,proximal/distal pattern formation involved in nephron development,BP,
16680,GO:0072048,1,0.951984326003151,0,9,renal system pattern specification,BP,
16681,GO:0072049,1,0.973591883804736,0,5,comma-shaped body morphogenesis,BP,
16682,GO:0072050,1,0.959238468214861,0,7,S-shaped body morphogenesis,BP,
16683,GO:0072051,1,0.996320806190388,0,1,juxtaglomerular apparatus development,BP,
16684,GO:0072053,1,0.985086250811908,0,2,renal inner medulla development,BP,
16685,GO:0072054,1,0.985086250811908,0,2,renal outer medulla development,BP,
16686,GO:0072055,1,0.992280151234642,0,1,renal cortex development,BP,
16687,GO:0072059,1,0.992280151234642,0,1,cortical collecting duct development,BP,
16688,GO:0072060,1,0.992463519372069,0,1,outer medullary collecting duct development,BP,
16689,GO:0072061,1,0.982044021234583,0,3,inner medullary collecting duct development,BP,
16690,GO:0072069,1,0.981347912751228,0,3,DCT cell differentiation,BP,
16691,GO:0072070,1,0.936200430244063,0,10,loop of Henle development,BP,
16692,GO:0072071,1,0.991941842957499,0,2,kidney interstitial fibroblast differentiation,BP,
16694,GO:0072074,1,0.890011875622364,0,18,kidney mesenchyme development,BP,
16695,GO:0072075,1,0.90941933289697,0,14,metanephric mesenchyme development,BP,
16696,GO:0072076,1,0.978189934996878,0,3,nephrogenic mesenchyme development,BP,
16701,GO:0072081,1,0.975915587110322,0,5,specification of nephron tubule identity,BP,
16702,GO:0072086,1,0.980293101015433,0,4,specification of loop of Henle identity,BP,
16707,GO:0072092,1,0.973475824567645,0,3,ureteric bud invasion,BP,
16708,GO:0072093,1,0.966152899448153,0,4,metanephric renal vesicle formation,BP,
16709,GO:0072095,1,0.981330171088548,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16710,GO:0072096,1,0.99578603907695,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16711,GO:0072097,1,0.99578603907695,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16712,GO:0072098,1,0.9913400671599,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16713,GO:0072099,1,0.99578603907695,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16714,GO:0072100,1,0.99578603907695,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16715,GO:0072101,1,0.99578603907695,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16719,GO:0072106,1,0.975527851877821,0,4,regulation of ureteric bud formation,BP,
16720,GO:0072107,1,0.975527851877821,0,4,positive regulation of ureteric bud formation,BP,
16721,GO:0072108,1,0.974643787780369,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16722,GO:0072109,1,0.91475899138575,0,14,glomerular mesangium development,BP,
16723,GO:0072110,1,0.943406449085121,0,9,glomerular mesangial cell proliferation,BP,
16724,GO:0072111,1,0.891291146641006,0,18,cell proliferation involved in kidney development,BP,
16725,GO:0072112,1,0.901444425670467,0,15,glomerular visceral epithelial cell differentiation,BP,
16726,GO:0072114,1,0.992144600872689,0,1,pronephros morphogenesis,BP,
16727,GO:0072124,1,0.950931790885236,0,8,regulation of glomerular mesangial cell proliferation,BP,
16728,GO:0072125,1,0.981282381096221,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16729,GO:0072126,1,0.969076475306172,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16730,GO:0072127,1,0.994559939956312,0,1,renal capsule development,BP,
16731,GO:0072128,1,0.994559939956312,0,1,renal capsule morphogenesis,BP,
16732,GO:0072129,1,0.994559939956312,0,1,renal capsule formation,BP,
16733,GO:0072130,1,0.994559939956312,0,1,renal capsule specification,BP,
16734,GO:0072131,1,0.973557206102183,0,4,kidney mesenchyme morphogenesis,BP,
16735,GO:0072132,1,0.749271579511287,0,45,mesenchyme morphogenesis,BP,
16736,GO:0072133,1,0.973557206102183,0,4,metanephric mesenchyme morphogenesis,BP,
16737,GO:0072134,1,0.983541381376296,0,2,nephrogenic mesenchyme morphogenesis,BP,
16738,GO:0072135,1,0.981277666389129,0,3,kidney mesenchymal cell proliferation,BP,
16739,GO:0072136,1,0.981277666389129,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16740,GO:0072137,1,0.965161629100892,0,4,condensed mesenchymal cell proliferation,BP,
16741,GO:0072138,1,0.983111353880269,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16742,GO:0072139,1,0.98610911899127,0,2,glomerular parietal epithelial cell differentiation,BP,
16743,GO:0072141,1,0.991941842957499,0,2,renal interstitial fibroblast development,BP,
16744,GO:0072143,1,0.965022581225308,0,6,mesangial cell development,BP,
16745,GO:0072144,1,0.969351741231762,0,5,glomerular mesangial cell development,BP,
16747,GO:0072156,1,0.972913698649535,0,3,distal tubule morphogenesis,BP,
16748,GO:0072160,1,0.903890062148727,0,13,nephron tubule epithelial cell differentiation,BP,
16749,GO:0072161,1,0.957687114777393,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16750,GO:0072162,1,0.973229584208039,0,4,metanephric mesenchymal cell differentiation,BP,
16753,GO:0072165,1,0.995535410121131,0,1,anterior mesonephric tubule development,BP,
16754,GO:0072166,1,0.988493807227961,0,2,posterior mesonephric tubule development,BP,
16755,GO:0072167,1,0.995535410121131,0,1,specification of mesonephric tubule identity,BP,
16756,GO:0072168,1,0.995535410121131,0,1,specification of anterior mesonephric tubule identity,BP,
16757,GO:0072169,1,0.995535410121131,0,1,specification of posterior mesonephric tubule identity,BP,
16758,GO:0072170,1,0.858664806618453,0,22,metanephric tubule development,BP,
16761,GO:0072173,1,0.928493605009842,0,11,metanephric tubule morphogenesis,BP,
16762,GO:0072174,1,0.959768484394271,0,6,metanephric tubule formation,BP,
16764,GO:0072176,1,0.915371865333658,0,13,nephric duct development,BP,
16765,GO:0072177,1,0.963151382763035,0,6,mesonephric duct development,BP,
16766,GO:0072178,1,0.937517261207758,0,10,nephric duct morphogenesis,BP,
16767,GO:0072179,1,0.977639856480942,0,4,nephric duct formation,BP,
16768,GO:0072180,1,0.986440219311555,0,3,mesonephric duct morphogenesis,BP,
16769,GO:0072181,1,0.996374215644472,0,1,mesonephric duct formation,BP,
16770,GO:0072182,1,0.918353711872086,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16771,GO:0072183,1,0.988082240986997,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16772,GO:0072184,1,0.995535410121131,0,1,renal vesicle progenitor cell differentiation,BP,
16773,GO:0072185,1,0.989850494828371,0,2,metanephric cap development,BP,
16774,GO:0072186,1,0.989850494828371,0,2,metanephric cap morphogenesis,BP,
16775,GO:0072189,1,0.91671074055837,0,13,ureter development,BP,
16776,GO:0072190,1,0.983867309587822,0,3,ureter urothelium development,BP,
16777,GO:0072191,1,0.978113105922723,0,4,ureter smooth muscle development,BP,
16778,GO:0072192,1,0.99578603907695,0,1,ureter epithelial cell differentiation,BP,
16779,GO:0072193,1,0.978113105922723,0,4,ureter smooth muscle cell differentiation,BP,
16780,GO:0072194,1,0.984091406688114,0,3,kidney smooth muscle tissue development,BP,
16781,GO:0072195,1,0.996195995110822,0,1,kidney smooth muscle cell differentiation,BP,
16782,GO:0072197,1,0.981236175397807,0,3,ureter morphogenesis,BP,
16783,GO:0072198,1,0.985542614119851,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16784,GO:0072199,1,0.985542614119851,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16785,GO:0072200,1,0.99578603907695,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16786,GO:0072201,1,0.950093191300946,0,8,negative regulation of mesenchymal cell proliferation,BP,
16788,GO:0072203,1,0.936494290841183,0,10,cell proliferation involved in metanephros development,BP,
16789,GO:0072204,1,0.985132087117943,0,2,cell-cell signaling involved in metanephros development,BP,
16790,GO:0072205,1,0.948153987450053,0,7,metanephric collecting duct development,BP,
16791,GO:0072206,1,0.996320806190388,0,1,metanephric juxtaglomerular apparatus development,BP,
16792,GO:0072207,1,0.845800082334513,0,24,metanephric epithelium development,BP,
16793,GO:0072208,1,0.987849670254959,0,2,metanephric smooth muscle tissue development,BP,
16794,GO:0072209,1,0.986578723021252,0,2,metanephric mesangial cell differentiation,BP,
16796,GO:0072213,1,0.994559939956312,0,1,metanephric capsule development,BP,
16797,GO:0072214,1,0.992280151234642,0,1,metanephric cortex development,BP,
16798,GO:0072215,1,0.875029374677596,0,20,regulation of metanephros development,BP,
16799,GO:0072216,1,0.923771577848035,0,12,positive regulation of metanephros development,BP,
16800,GO:0072217,1,0.956450270381701,0,7,negative regulation of metanephros development,BP,
16801,GO:0072218,1,0.977249118966441,0,3,metanephric ascending thin limb development,BP,
16802,GO:0072219,1,0.992280151234642,0,1,metanephric cortical collecting duct development,BP,
16803,GO:0072221,1,0.975297987134516,0,4,metanephric distal convoluted tubule development,BP,
16804,GO:0072223,1,0.964828322667526,0,5,metanephric glomerular mesangium development,BP,
16806,GO:0072227,1,0.996320806190388,0,1,metanephric macula densa development,BP,
16807,GO:0072229,1,0.994893758025159,0,1,metanephric proximal convoluted tubule development,BP,
16808,GO:0072233,1,0.996320806190388,0,1,metanephric thick ascending limb development,BP,
16809,GO:0072234,1,0.874192028690507,0,19,metanephric nephron tubule development,BP,
16810,GO:0072235,1,0.956624618970999,0,6,metanephric distal tubule development,BP,
16811,GO:0072236,1,0.969882342717471,0,4,metanephric loop of Henle development,BP,
16812,GO:0072237,1,0.98344244763332,0,2,metanephric proximal tubule development,BP,
16814,GO:0072240,1,0.981347912751228,0,3,metanephric DCT cell differentiation,BP,
16815,GO:0072243,1,0.867240027354336,0,20,metanephric nephron epithelium development,BP,
16816,GO:0072244,1,0.99205858703797,0,1,metanephric glomerular epithelium development,BP,
16817,GO:0072248,1,0.99205858703797,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16818,GO:0072249,1,0.99205858703797,0,1,metanephric glomerular visceral epithelial cell development,BP,
16819,GO:0072254,1,0.986578723021252,0,2,metanephric glomerular mesangial cell differentiation,BP,
16820,GO:0072255,1,0.993113085520367,0,1,metanephric glomerular mesangial cell development,BP,
16821,GO:0072257,1,0.94320219818448,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16822,GO:0072258,1,0.995535410121131,0,1,metanephric interstitial fibroblast differentiation,BP,
16823,GO:0072259,1,0.995535410121131,0,1,metanephric interstitial fibroblast development,BP,
16824,GO:0072262,1,0.977956776707867,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16825,GO:0072265,1,0.994559939956312,0,1,metanephric capsule morphogenesis,BP,
16826,GO:0072266,1,0.994559939956312,0,1,metanephric capsule formation,BP,
16827,GO:0072267,1,0.994559939956312,0,1,metanephric capsule specification,BP,
16828,GO:0072268,1,0.979378101814163,0,4,pattern specification involved in metanephros development,BP,
16829,GO:0072272,1,0.989152644014017,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16831,GO:0072274,1,0.99205858703797,0,1,metanephric glomerular basement membrane development,BP,
16835,GO:0072278,1,0.980466064189745,0,3,metanephric comma-shaped body morphogenesis,BP,
16836,GO:0072282,1,0.945269753712222,0,8,metanephric nephron tubule morphogenesis,BP,
16838,GO:0072284,1,0.966012357839105,0,5,metanephric S-shaped body morphogenesis,BP,
16839,GO:0072285,1,0.992479643238667,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16840,GO:0072286,1,0.993836291135137,0,1,metanephric connecting tubule development,BP,
16841,GO:0072287,1,0.988490526129818,0,1,metanephric distal tubule morphogenesis,BP,
16842,GO:0072289,1,0.970578905649481,0,4,metanephric nephron tubule formation,BP,
16843,GO:0072298,1,0.970795866555482,0,4,regulation of metanephric glomerulus development,BP,
16844,GO:0072299,1,0.992927147032978,0,1,negative regulation of metanephric glomerulus development,BP,
16845,GO:0072300,1,0.977712701336512,0,3,positive regulation of metanephric glomerulus development,BP,
16846,GO:0072301,1,0.985754786646405,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16847,GO:0072302,1,0.992927147032978,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16848,GO:0072303,1,0.992777080918084,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16849,GO:0072304,1,0.984972388532087,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16850,GO:0072305,1,0.984972388532087,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16851,GO:0072307,1,0.94320219818448,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16852,GO:0072308,1,0.992513754170342,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16853,GO:0072309,1,0.984972388532087,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16854,GO:0072310,1,0.929099084418045,0,10,glomerular epithelial cell development,BP,
16855,GO:0072311,1,0.895668112328752,0,16,glomerular epithelial cell differentiation,BP,
16856,GO:0072312,1,0.99205858703797,0,1,metanephric glomerular epithelial cell differentiation,BP,
16857,GO:0072313,1,0.99205858703797,0,1,metanephric glomerular epithelial cell development,BP,
16858,GO:0072318,1,0.959437377821145,0,6,clathrin coat disassembly,BP,
16859,GO:0072319,1,0.954427049254226,0,7,vesicle uncoating,BP,
16860,GO:0072320,1,0.972902523907341,0,4,volume-sensitive chloride channel activity,MF,
16861,GO:0072321,1,0.952442603830577,0,10,chaperone-mediated protein transport,BP,
16862,GO:0072329,1,0.485726412510482,0,123,monocarboxylic acid catabolic process,BP,
16866,GO:0072334,1,0.992635567496564,0,2,UDP-galactose transmembrane transport,BP,
16868,GO:0072338,1,0.958204769355617,0,6,cellular lactam metabolic process,BP,
16869,GO:0072340,1,0.99596705023946,0,1,cellular lactam catabolic process,BP,
16871,GO:0072343,1,0.992243540853592,0,2,pancreatic stellate cell proliferation,BP,
16872,GO:0072344,1,0.975649300284475,0,4,rescue of stalled ribosome,BP,
16873,GO:0072345,1,0.959893393669615,0,6,NAADP-sensitive calcium-release channel activity,MF,
16874,GO:0072347,1,0.66860787176218,0,64,response to anesthetic,BP,
16875,GO:0072348,1,0.817961652305274,0,30,sulfur compound transport,BP,
16876,GO:0072349,1,0.915638807949615,0,13,modified amino acid transmembrane transporter activity,MF,
16877,GO:0072350,1,0.811832446826373,0,36,tricarboxylic acid metabolic process,BP,
16878,GO:0072354,1,0.995940820722402,0,1,histone kinase activity (H3-T3 specific),MF,
16879,GO:0072355,1,0.995940820722402,0,1,histone H3-T3 phosphorylation,BP,
16880,GO:0072356,1,0.992455981102177,0,1,chromosome passenger complex localization to kinetochore,BP,
16881,GO:0072357,1,0.952961799099898,0,7,PTW/PP1 phosphatase complex,CC,
16884,GO:0072361,1,0.981924963921382,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16885,GO:0072362,1,0.991333532660692,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16886,GO:0072363,1,0.99051003413633,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16887,GO:0072364,1,0.981659234556814,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16888,GO:0072365,1,0.991065283675357,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16889,GO:0072366,1,0.99051003413633,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16890,GO:0072367,1,0.967660411930962,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
16891,GO:0072368,1,0.983825941659244,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
16892,GO:0072369,1,0.983571473393651,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
16893,GO:0072376,1,0.682979936532959,0,67,protein activation cascade,BP,
16894,GO:0072378,1,0.889568461727401,0,21,blood coagulation, fibrin clot formation,BP,
16895,GO:0072379,1,0.982869481954939,0,3,ER membrane insertion complex,CC,
16896,GO:0072382,1,0.988362859233933,0,1,minus-end-directed vesicle transport along microtubule,BP,
16897,GO:0072383,1,0.945846303079113,0,7,plus-end-directed vesicle transport along microtubule,BP,
16899,GO:0072385,1,0.966084040470621,0,4,minus-end-directed organelle transport along microtubule,BP,
16900,GO:0072386,1,0.938350140230815,0,8,plus-end-directed organelle transport along microtubule,BP,
16901,GO:0072387,1,0.987833735569887,0,2,flavin adenine dinucleotide metabolic process,BP,
16902,GO:0072388,1,0.995332519286809,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16903,GO:0072389,1,0.992466417663809,0,1,flavin adenine dinucleotide catabolic process,BP,
16904,GO:0072393,1,0.915711650981598,0,11,microtubule anchoring at microtubule organizing center,BP,
16905,GO:0072395,1,0.627577298322927,0,74,signal transduction involved in cell cycle checkpoint,BP,
16906,GO:0072396,1,0.964594068381375,0,5,response to cell cycle checkpoint signaling,BP,
16907,GO:0072401,1,0.633276395556411,0,73,signal transduction involved in DNA integrity checkpoint,BP,
16908,GO:0072402,1,0.964594068381375,0,5,response to DNA integrity checkpoint signaling,BP,
16909,GO:0072413,1,0.683446964607997,0,62,signal transduction involved in mitotic cell cycle checkpoint,BP,
16910,GO:0072414,1,0.991649600218825,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16911,GO:0072422,1,0.633276395556411,0,73,signal transduction involved in DNA damage checkpoint,BP,
16912,GO:0072423,1,0.964594068381375,0,5,response to DNA damage checkpoint signaling,BP,
16913,GO:0072425,1,0.922891247029439,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16914,GO:0072428,1,0.99559070054452,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16915,GO:0072429,1,0.981927469880201,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16916,GO:0072431,1,0.688318018545909,0,61,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16917,GO:0072432,1,0.991649600218825,0,1,response to G1 DNA damage checkpoint signaling,BP,
16918,GO:0072434,1,0.983043574279331,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16919,GO:0072487,1,0.972874806937732,0,4,MSL complex,CC,
16920,GO:0072488,1,0.934463585734429,0,12,ammonium transmembrane transport,BP,
16921,GO:0072492,1,0.995851195529539,0,1,host cell mitochondrial intermembrane space,CC,
16923,GO:0072498,1,0.921471244024886,0,14,embryonic skeletal joint development,BP,
16924,GO:0072501,1,0.958187268717988,0,6,cellular divalent inorganic anion homeostasis,BP,
16925,GO:0072502,1,0.958187268717988,0,6,cellular trivalent inorganic anion homeostasis,BP,
16927,GO:0072505,1,0.937186442879807,0,9,divalent inorganic anion homeostasis,BP,
16928,GO:0072506,1,0.937186442879807,0,9,trivalent inorganic anion homeostasis,BP,
16930,GO:0072509,1,0.859829411107227,0,23,divalent inorganic cation transmembrane transporter activity,MF,
16934,GO:0072513,1,0.975648463072934,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
16935,GO:0072517,1,0.992560719356296,0,1,host cell viral assembly compartment,CC,
16936,GO:0072518,1,0.991868191082303,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
16937,GO:0072520,1,0.929870712557009,0,11,seminiferous tubule development,BP,
16940,GO:0072523,1,0.733222283759024,0,49,purine-containing compound catabolic process,BP,
16943,GO:0072526,1,0.972209780902941,0,6,pyridine-containing compound catabolic process,BP,
16944,GO:0072527,1,0.658227331713772,0,77,pyrimidine-containing compound metabolic process,BP,
16945,GO:0072528,1,0.818710013913052,0,39,pyrimidine-containing compound biosynthetic process,BP,
16946,GO:0072529,1,0.833476240379213,0,34,pyrimidine-containing compound catabolic process,BP,
16947,GO:0072530,1,0.95500389160142,0,8,purine-containing compound transmembrane transport,BP,
16948,GO:0072531,1,0.947337178877077,0,9,pyrimidine-containing compound transmembrane transport,BP,
16949,GO:0072534,1,0.983558309499143,0,2,perineuronal net,CC,
16950,GO:0072535,1,0.987064530009849,0,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,
16951,GO:0072536,1,0.995296707577174,0,1,interleukin-23 receptor complex,CC,
16952,GO:0072537,1,0.938339877529177,0,9,fibroblast activation,BP,
16953,GO:0072538,1,0.898496332146511,0,17,T-helper 17 type immune response,BP,
16954,GO:0072539,1,0.90514976138922,0,16,T-helper 17 cell differentiation,BP,
16955,GO:0072540,1,0.946912093222131,0,10,T-helper 17 cell lineage commitment,BP,
16956,GO:0072542,1,0.960494558610155,0,7,protein phosphatase activator activity,MF,
16957,GO:0072544,1,0.995963040842868,0,1,L-DOPA binding,MF,
16958,GO:0072545,1,0.990823368747567,0,2,tyrosine binding,MF,
16959,GO:0072546,1,0.934216574916269,0,10,ER membrane protein complex,CC,
16960,GO:0072553,1,0.959170904389934,0,6,terminal button organization,BP,
16961,GO:0072554,1,0.98692653705179,0,2,blood vessel lumenization,BP,
16962,GO:0072556,1,0.992442474285194,0,1,other organism presynaptic membrane,CC,
16963,GO:0072557,1,0.982747038950056,0,4,IPAF inflammasome complex,CC,
16964,GO:0072558,1,0.982695570642176,0,4,NLRP1 inflammasome complex,CC,
16965,GO:0072559,1,0.959944851324211,0,8,NLRP3 inflammasome complex,CC,
16966,GO:0072560,1,0.989586687921893,0,2,type B pancreatic cell maturation,BP,
16968,GO:0072563,1,0.988940889606053,0,2,endothelial microparticle,CC,
16969,GO:0072564,1,0.991120574338375,0,2,blood microparticle formation,BP,
16970,GO:0072566,1,0.98856716294806,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
16972,GO:0072570,1,0.992680531132686,0,1,ADP-D-ribose binding,MF,
16973,GO:0072572,1,0.994891059877186,0,1,poly-ADP-D-ribose binding,MF,
16974,GO:0072573,1,0.992411290444428,0,1,tolerance induction to lipopolysaccharide,BP,
16975,GO:0072574,1,0.91569702655864,0,14,hepatocyte proliferation,BP,
16976,GO:0072575,1,0.91569702655864,0,14,epithelial cell proliferation involved in liver morphogenesis,BP,
16977,GO:0072576,1,0.908131968680126,0,15,liver morphogenesis,BP,
16978,GO:0072577,1,0.735134107059606,0,47,endothelial cell apoptotic process,BP,
16979,GO:0072578,1,0.928214715324983,0,10,neurotransmitter-gated ion channel clustering,BP,
16980,GO:0072579,1,0.992433704947594,0,1,glycine receptor clustering,BP,
16981,GO:0072583,1,0.755979704230272,0,38,clathrin-dependent endocytosis,BP,
16983,GO:0072586,1,0.992399090563915,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
16984,GO:0072587,1,0.992399090563915,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
16985,GO:0072588,1,0.981196971721868,0,5,box H/ACA RNP complex,CC,
16986,GO:0072589,1,0.984630613266768,0,4,box H/ACA scaRNP complex,CC,
16987,GO:0072590,1,0.98240191344122,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16988,GO:0072591,1,0.992059209736127,0,1,citrate-L-glutamate ligase activity,MF,
16989,GO:0072592,1,0.976174905851535,0,5,oxygen metabolic process,BP,
16992,GO:0072595,1,0.772190483229509,0,40,maintenance of protein localization in organelle,BP,
16993,GO:0072599,1,0.665084745143161,0,104,establishment of protein localization to endoplasmic reticulum,BP,
16994,GO:0072602,1,0.961740246214872,0,6,interleukin-4 secretion,BP,
16995,GO:0072603,1,0.962492505931548,0,6,interleukin-5 secretion,BP,
16997,GO:0072606,1,0.8609805166856,0,26,interleukin-8 secretion,BP,
16998,GO:0072608,1,0.959171873588728,0,8,interleukin-10 secretion,BP,
16999,GO:0072610,1,0.949287842936263,0,9,interleukin-12 secretion,BP,
17000,GO:0072611,1,0.960016784513087,0,7,interleukin-13 secretion,BP,
17001,GO:0072615,1,0.99020138350917,0,2,interleukin-17 secretion,BP,
17002,GO:0072616,1,0.992457704592145,0,1,interleukin-18 secretion,BP,
17003,GO:0072619,1,0.992515876865537,0,1,interleukin-21 secretion,BP,
17004,GO:0072641,1,0.946430596267678,0,7,type I interferon secretion,BP,
17005,GO:0072642,1,0.952973636814328,0,6,interferon-alpha secretion,BP,
17007,GO:0072655,1,0.369665362440947,0,174,establishment of protein localization to mitochondrion,BP,
17008,GO:0072656,1,0.968188360302667,0,5,maintenance of protein location in mitochondrion,BP,
17010,GO:0072658,1,0.990536791773208,0,1,maintenance of protein location in membrane,BP,
17012,GO:0072660,1,0.990536791773208,0,1,maintenance of protein location in plasma membrane,BP,
17015,GO:0072665,1,0.702365666098997,0,54,protein localization to vacuole,BP,
17017,GO:0072669,1,0.967639210218596,0,7,tRNA-splicing ligase complex,CC,
17018,GO:0072671,1,0.993802933083865,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17019,GO:0072672,1,0.954526044986658,0,7,neutrophil extravasation,BP,
17021,GO:0072674,1,0.968308725074936,0,4,multinuclear osteoclast differentiation,BP,
17022,GO:0072675,1,0.968308725074936,0,4,osteoclast fusion,BP,
17024,GO:0072677,1,0.933557565339398,0,14,eosinophil migration,BP,
17026,GO:0072679,1,0.974233666201345,0,5,thymocyte migration,BP,
17027,GO:0072680,1,0.992760296811159,0,1,extracellular matrix-dependent thymocyte migration,BP,
17028,GO:0072681,1,0.992760296811159,0,1,fibronectin-dependent thymocyte migration,BP,
17029,GO:0072682,1,0.992573932395067,0,1,eosinophil extravasation,BP,
17030,GO:0072683,1,0.982138856303452,0,4,T cell extravasation,BP,
17031,GO:0072684,1,0.992470873265131,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17032,GO:0072686,1,0.553755555475636,0,85,mitotic spindle,CC,
17033,GO:0072687,1,0.970315700929355,0,5,meiotic spindle,CC,
17034,GO:0072695,1,0.98807515760054,0,2,regulation of DNA recombination at telomere,BP,
17036,GO:0072698,1,0.729611461813133,0,43,protein localization to microtubule cytoskeleton,BP,
17037,GO:0072702,1,0.992120856478714,0,1,response to methyl methanesulfonate,BP,
17038,GO:0072703,1,0.992120856478714,0,1,cellular response to methyl methanesulfonate,BP,
17039,GO:0072706,1,0.993756489052647,0,1,response to sodium dodecyl sulfate,BP,
17040,GO:0072707,1,0.993756489052647,0,1,cellular response to sodium dodecyl sulfate,BP,
17041,GO:0072708,1,0.970741789672764,0,5,response to sorbitol,BP,
17042,GO:0072709,1,0.983683146939786,0,3,cellular response to sorbitol,BP,
17043,GO:0072710,1,0.942244189827348,0,8,response to hydroxyurea,BP,
17044,GO:0072711,1,0.948602231129229,0,7,cellular response to hydroxyurea,BP,
17045,GO:0072714,1,0.995878759521773,0,1,response to selenite ion,BP,
17046,GO:0072715,1,0.995878759521773,0,1,cellular response to selenite ion,BP,
17047,GO:0072716,1,0.975827515395983,0,4,response to actinomycin D,BP,
17048,GO:0072717,1,0.982409762082998,0,3,cellular response to actinomycin D,BP,
17049,GO:0072718,1,0.941578657738276,0,9,response to cisplatin,BP,
17050,GO:0072719,1,0.961829032920685,0,6,cellular response to cisplatin,BP,
17051,GO:0072720,1,0.986646673054992,0,2,response to dithiothreitol,BP,
17052,GO:0072721,1,0.993301131169352,0,1,cellular response to dithiothreitol,BP,
17053,GO:0072733,1,0.983687423573761,0,3,response to staurosporine,BP,
17054,GO:0072734,1,0.983687423573761,0,3,cellular response to staurosporine,BP,
17055,GO:0072737,1,0.988599218940027,0,2,response to diamide,BP,
17056,GO:0072738,1,0.988599218940027,0,2,cellular response to diamide,BP,
17057,GO:0072739,1,0.98885890630328,0,2,response to anisomycin,BP,
17058,GO:0072740,1,0.995528129272164,0,1,cellular response to anisomycin,BP,
17060,GO:0072749,1,0.995727898881487,0,1,cellular response to cytochalasin B,BP,
17061,GO:0072750,1,0.996608637381519,0,1,cellular response to leptomycin B,BP,
17062,GO:0072752,1,0.991810583853996,0,1,cellular response to rapamycin,BP,
17063,GO:0072755,1,0.992477060932001,0,1,cellular response to benomyl,BP,
17064,GO:0072757,1,0.973070676365549,0,4,cellular response to camptothecin,BP,
17065,GO:0075044,1,0.96556881946664,0,5,autophagy of host cells involved in interaction with symbiont,BP,
17066,GO:0075071,1,0.96556881946664,0,5,autophagy involved in symbiotic interaction,BP,
17067,GO:0075109,1,0.992241678186921,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
17068,GO:0075111,1,0.992241678186921,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
17069,GO:0075112,1,0.992241678186921,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17070,GO:0075114,1,0.992241678186921,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17071,GO:0075136,1,0.968828742551092,0,5,response to host,BP,
17072,GO:0075341,1,0.994469034676449,0,1,host cell PML body,CC,
17073,GO:0075509,1,0.978723717076292,0,3,endocytosis involved in viral entry into host cell,BP,
17074,GO:0075519,1,0.99702457422885,0,1,microtubule-dependent intracellular transport of viral material,BP,
17075,GO:0075521,1,0.99702457422885,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17076,GO:0075522,1,0.937192864472827,0,10,IRES-dependent viral translational initiation,BP,
17077,GO:0075525,1,0.972871000563297,0,5,viral translational termination-reinitiation,BP,
17078,GO:0075528,1,0.98700796019725,0,2,modulation by virus of host immune response,BP,
17079,GO:0075606,1,0.99702457422885,0,1,transport of viral material towards nucleus,BP,
17080,GO:0075713,1,0.956007162517477,0,8,establishment of integrated proviral latency,BP,
17081,GO:0075732,1,0.984560910030941,0,2,viral penetration into host nucleus,BP,
17082,GO:0075733,1,0.712601349089477,0,53,intracellular transport of virus,BP,
17083,GO:0080008,1,0.801307549460959,0,34,Cul4-RING E3 ubiquitin ligase complex,CC,
17084,GO:0080009,1,0.943649867853768,0,10,mRNA methylation,BP,
17085,GO:0080019,1,0.987257508094376,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17086,GO:0080023,1,0.986646673054992,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
17087,GO:0080025,1,0.864463780311694,0,22,phosphatidylinositol-3,5-bisphosphate binding,MF,
17088,GO:0080033,1,0.991902207274696,0,1,response to nitrite,BP,
17089,GO:0080048,1,0.993301131169352,0,1,GDP-D-glucose phosphorylase activity,MF,
17090,GO:0080058,1,0.996517200073745,0,1,protein deglutathionylation,BP,
17091,GO:0080084,1,0.964828334589093,0,5,5S rDNA binding,MF,
17093,GO:0080101,1,0.996874428829302,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17094,GO:0080111,1,0.870007700476759,0,22,DNA demethylation,BP,
17095,GO:0080120,1,0.989139441752049,0,2,CAAX-box protein maturation,BP,
17096,GO:0080121,1,0.987365817602503,0,2,AMP transport,BP,
17097,GO:0080122,1,0.981257186100733,0,3,AMP transmembrane transporter activity,MF,
17098,GO:0080129,1,0.99679922116085,0,1,proteasome core complex assembly,BP,
17102,GO:0080144,1,0.988007085116809,0,2,amino acid homeostasis,BP,
17103,GO:0080146,1,0.995869264340929,0,1,L-cysteine desulfhydrase activity,MF,
17104,GO:0080147,1,0.996992964303392,0,1,root hair cell development,BP,
17105,GO:0080154,1,0.920702974463173,0,16,regulation of fertilization,BP,
17106,GO:0080163,1,0.994205917894418,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17107,GO:0080171,1,0.694831981359599,0,58,lytic vacuole organization,BP,
17108,GO:0080182,1,0.899081553345475,0,16,histone H3-K4 trimethylation,BP,
17110,GO:0085018,1,0.993345078292175,0,1,maintenance of symbiont-containing vacuole by host,BP,
17111,GO:0085020,1,0.96162491855097,0,7,protein K6-linked ubiquitination,BP,
17113,GO:0085032,1,0.992652678083078,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17117,GO:0086004,1,0.776159826437953,0,33,regulation of cardiac muscle cell contraction,BP,
17118,GO:0086005,1,0.801493954631101,0,29,ventricular cardiac muscle cell action potential,BP,
17119,GO:0086006,1,0.965003391652655,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17120,GO:0086007,1,0.957337393396514,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17121,GO:0086008,1,0.924594335039322,0,12,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
17123,GO:0086010,1,0.701891878693552,0,45,membrane depolarization during action potential,BP,
17124,GO:0086011,1,0.852784688710703,0,24,membrane repolarization during action potential,BP,
17125,GO:0086012,1,0.856020270956818,0,20,membrane depolarization during cardiac muscle cell action potential,BP,
17126,GO:0086013,1,0.870597824717743,0,21,membrane repolarization during cardiac muscle cell action potential,BP,
17128,GO:0086015,1,0.931379426228587,0,8,SA node cell action potential,BP,
17129,GO:0086016,1,0.924559343098528,0,9,AV node cell action potential,BP,
17130,GO:0086017,1,0.980317145164196,0,3,Purkinje myocyte action potential,BP,
17131,GO:0086018,1,0.931379426228587,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
17133,GO:0086020,1,0.991449676693652,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17134,GO:0086021,1,0.991449676693652,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17135,GO:0086023,1,0.954768241847626,0,6,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17136,GO:0086024,1,0.991268002483297,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17138,GO:0086027,1,0.924559343098528,0,9,AV node cell to bundle of His cell signaling,BP,
17139,GO:0086028,1,0.958906359919057,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
17140,GO:0086029,1,0.961414576180076,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
17141,GO:0086030,1,0.995147209540272,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
17142,GO:0086036,1,0.948472591007633,0,8,regulation of cardiac muscle cell membrane potential,BP,
17143,GO:0086037,1,0.992515162529586,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17144,GO:0086038,1,0.993301131169352,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17145,GO:0086039,1,0.991224471578046,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17146,GO:0086040,1,0.99238690032398,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17147,GO:0086041,1,0.991595808765489,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17148,GO:0086042,1,0.948219965026328,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
17149,GO:0086043,1,0.958906359919057,0,6,bundle of His cell action potential,BP,
17150,GO:0086045,1,0.957051268219211,0,5,membrane depolarization during AV node cell action potential,BP,
17151,GO:0086046,1,0.957605895017683,0,5,membrane depolarization during SA node cell action potential,BP,
17152,GO:0086047,1,0.980317145164196,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17153,GO:0086048,1,0.976236380286871,0,3,membrane depolarization during bundle of His cell action potential,BP,
17154,GO:0086050,1,0.993144355918925,0,1,membrane repolarization during bundle of His cell action potential,BP,
17155,GO:0086052,1,0.993144355918925,0,1,membrane repolarization during SA node cell action potential,BP,
17156,GO:0086053,1,0.991449676693652,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
17157,GO:0086056,1,0.972966830277683,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17158,GO:0086057,1,0.992467609606892,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17159,GO:0086059,1,0.982953839641501,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17160,GO:0086060,1,0.991127787119566,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17161,GO:0086061,1,0.991127787119566,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17162,GO:0086062,1,0.987773014986282,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17163,GO:0086063,1,0.991127787119566,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17167,GO:0086067,1,0.91664763863572,0,10,AV node cell to bundle of His cell communication,BP,
17168,GO:0086068,1,0.961414576180076,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
17169,GO:0086069,1,0.908092121919637,0,13,bundle of His cell to Purkinje myocyte communication,BP,
17170,GO:0086070,1,0.923409967216194,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
17171,GO:0086072,1,0.994000650188958,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17172,GO:0086073,1,0.953945821254858,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
17174,GO:0086077,1,0.991449676693652,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17176,GO:0086082,1,0.994000650188958,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17177,GO:0086083,1,0.960969117652669,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
17178,GO:0086087,1,0.993144355918925,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17179,GO:0086089,1,0.972385963499819,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17180,GO:0086090,1,0.993144355918925,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17181,GO:0086091,1,0.769626875204281,0,35,regulation of heart rate by cardiac conduction,BP,
17182,GO:0086092,1,0.988358303606593,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17183,GO:0086096,1,0.996531261015071,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17184,GO:0086097,1,0.986821777432475,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17185,GO:0086098,1,0.98602113269506,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17186,GO:0086100,1,0.984958440945941,0,2,endothelin receptor signaling pathway,BP,
17187,GO:0086103,1,0.934899633178374,0,10,G-protein coupled receptor signaling pathway involved in heart process,BP,
17188,GO:0089700,1,0.97005137004634,0,4,protein kinase D signaling,BP,
17189,GO:0089701,1,0.976266249170266,0,5,U2AF,CC,
17190,GO:0089709,1,0.981702963792284,0,3,L-histidine transmembrane transport,BP,
17191,GO:0089717,1,0.924816203455846,0,10,spanning component of membrane,CC,
17192,GO:0089718,1,0.877573744740462,0,19,amino acid import across plasma membrane,BP,
17193,GO:0089720,1,0.958865111800827,0,9,caspase binding,MF,
17194,GO:0090009,1,0.94542692415257,0,9,primitive streak formation,BP,
17195,GO:0090010,1,0.995041290819372,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17196,GO:0090022,1,0.849053231279421,0,34,regulation of neutrophil chemotaxis,BP,
17197,GO:0090023,1,0.875365870810102,0,29,positive regulation of neutrophil chemotaxis,BP,
17198,GO:0090024,1,0.985652919457008,0,2,negative regulation of neutrophil chemotaxis,BP,
17200,GO:0090026,1,0.932775022139131,0,13,positive regulation of monocyte chemotaxis,BP,
17202,GO:0090030,1,0.93913972781054,0,9,regulation of steroid hormone biosynthetic process,BP,
17203,GO:0090031,1,0.979317690295595,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17204,GO:0090032,1,0.96635538800185,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17205,GO:0090034,1,0.988622622082831,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17206,GO:0090035,1,0.988622622082831,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17207,GO:0090036,1,0.89953511100446,0,15,regulation of protein kinase C signaling,BP,
17208,GO:0090037,1,0.949914434952022,0,8,positive regulation of protein kinase C signaling,BP,
17209,GO:0090038,1,0.985318954026792,0,2,negative regulation of protein kinase C signaling,BP,
17210,GO:0090042,1,0.943801561431658,0,9,tubulin deacetylation,BP,
17211,GO:0090043,1,0.955386120134819,0,7,regulation of tubulin deacetylation,BP,
17212,GO:0090044,1,0.996145082840474,0,1,positive regulation of tubulin deacetylation,BP,
17213,GO:0090045,1,0.947597637664242,0,8,positive regulation of deacetylase activity,BP,
17214,GO:0090049,1,0.800519076058772,0,34,regulation of cell migration involved in sprouting angiogenesis,BP,
17215,GO:0090050,1,0.891695138006603,0,18,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17216,GO:0090051,1,0.90450614815898,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17217,GO:0090063,1,0.972738510699788,0,4,positive regulation of microtubule nucleation,BP,
17218,GO:0090065,1,0.9924574167577,0,1,regulation of production of siRNA involved in RNA interference,BP,
17220,GO:0090067,1,0.992393455043034,0,1,regulation of thalamus size,BP,
17221,GO:0090068,1,0.205515438447855,0,244,positive regulation of cell cycle process,BP,
17222,GO:0090069,1,0.91464612854639,0,13,regulation of ribosome biogenesis,BP,
17223,GO:0090070,1,0.94943601180235,0,8,positive regulation of ribosome biogenesis,BP,
17224,GO:0090071,1,0.970920992637365,0,4,negative regulation of ribosome biogenesis,BP,
17225,GO:0090073,1,0.944824074433876,0,9,positive regulation of protein homodimerization activity,BP,
17226,GO:0090074,1,0.966320909303791,0,5,negative regulation of protein homodimerization activity,BP,
17227,GO:0090075,1,0.846608265700403,0,27,relaxation of muscle,BP,
17228,GO:0090076,1,0.984778081277721,0,2,relaxation of skeletal muscle,BP,
17229,GO:0090077,1,0.827274645603623,0,29,foam cell differentiation,BP,
17230,GO:0090079,1,0.850632657019487,0,24,translation regulator activity, nucleic acid binding,MF,
17231,GO:0090080,1,0.981462075329423,0,3,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17232,GO:0090081,1,0.992497018470544,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17233,GO:0090082,1,0.992497018470544,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17234,GO:0090083,1,0.905765921728305,0,15,regulation of inclusion body assembly,BP,
17235,GO:0090084,1,0.932549688767765,0,10,negative regulation of inclusion body assembly,BP,
17236,GO:0090085,1,0.934413154485006,0,11,regulation of protein deubiquitination,BP,
17237,GO:0090086,1,0.988991754853805,0,3,negative regulation of protein deubiquitination,BP,
17239,GO:0090088,1,0.989604045914797,0,2,regulation of oligopeptide transport,BP,
17240,GO:0090089,1,0.989604045914797,0,2,regulation of dipeptide transport,BP,
17242,GO:0090091,1,0.962887647201851,0,5,positive regulation of extracellular matrix disassembly,BP,
17244,GO:0090094,1,0.989850494828371,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17245,GO:0090095,1,0.994289855855815,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17246,GO:0090096,1,0.994289855855815,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17247,GO:0090100,1,0.533763342912594,0,96,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17249,GO:0090102,1,0.746826959315678,0,43,cochlea development,BP,
17250,GO:0090103,1,0.86904583129118,0,22,cochlea morphogenesis,BP,
17251,GO:0090107,1,0.982013428355846,0,3,regulation of high-density lipoprotein particle assembly,BP,
17252,GO:0090108,1,0.995075861974963,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17254,GO:0090110,1,0.910485591869578,0,13,cargo loading into COPII-coated vesicle,BP,
17255,GO:0090113,1,0.994815341582593,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17256,GO:0090114,1,0.640123012519224,0,69,COPII-coated vesicle budding,BP,
17257,GO:0090116,1,0.977251569326108,0,3,C-5 methylation of cytosine,BP,
17258,GO:0090118,1,0.964788792906365,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17259,GO:0090119,1,0.987651275390887,0,2,vesicle-mediated cholesterol transport,BP,
17260,GO:0090122,1,0.99522046304718,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17261,GO:0090128,1,0.928113423361665,0,10,regulation of synapse maturation,BP,
17262,GO:0090129,1,0.942525272324537,0,8,positive regulation of synapse maturation,BP,
17264,GO:0090131,1,0.975567627974302,0,5,mesenchyme migration,BP,
17266,GO:0090133,1,0.996837078837226,0,1,mesendoderm migration,BP,
17267,GO:0090134,1,0.996837078837226,0,1,cell migration involved in mesendoderm migration,BP,
17268,GO:0090135,1,0.982514724452493,0,3,actin filament branching,BP,
17270,GO:0090138,1,0.992491332837494,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17271,GO:0090140,1,0.864972519806843,0,21,regulation of mitochondrial fission,BP,
17272,GO:0090141,1,0.913634438469671,0,14,positive regulation of mitochondrial fission,BP,
17273,GO:0090148,1,0.917791642879242,0,12,membrane fission,BP,
17274,GO:0090149,1,0.986818406291805,0,2,mitochondrial membrane fission,BP,
17276,GO:0090151,1,0.948058371030228,0,12,establishment of protein localization to mitochondrial membrane,BP,
17277,GO:0090153,1,0.929388594940525,0,13,regulation of sphingolipid biosynthetic process,BP,
17278,GO:0090154,1,0.952957699926059,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17279,GO:0090155,1,0.978889683755966,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17280,GO:0090156,1,0.986518146974328,0,3,cellular sphingolipid homeostasis,BP,
17281,GO:0090158,1,0.963081773786196,0,6,endoplasmic reticulum membrane organization,BP,
17282,GO:0090160,1,0.947168252444035,0,8,Golgi to lysosome transport,BP,
17283,GO:0090161,1,0.922552810678155,0,11,Golgi ribbon formation,BP,
17284,GO:0090162,1,0.8239421168939,0,28,establishment of epithelial cell polarity,BP,
17285,GO:0090164,1,0.985030578779495,0,2,asymmetric Golgi ribbon formation,BP,
17286,GO:0090166,1,0.966599371996602,0,6,Golgi disassembly,BP,
17287,GO:0090168,1,0.97585505342937,0,4,Golgi reassembly,BP,
17288,GO:0090169,1,0.840142530806607,0,25,regulation of spindle assembly,BP,
17289,GO:0090170,1,0.977834211748901,0,4,regulation of Golgi inheritance,BP,
17290,GO:0090171,1,0.992469759015209,0,1,chondrocyte morphogenesis,BP,
17291,GO:0090174,1,0.368175760903055,0,154,organelle membrane fusion,BP,
17293,GO:0090176,1,0.992124637503995,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17294,GO:0090177,1,0.899855479208826,0,15,establishment of planar polarity involved in neural tube closure,BP,
17295,GO:0090178,1,0.90285356693879,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17296,GO:0090179,1,0.909792208670887,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17297,GO:0090181,1,0.716781054654292,0,51,regulation of cholesterol metabolic process,BP,
17298,GO:0090182,1,0.991314197120294,0,2,regulation of secretion of lysosomal enzymes,BP,
17302,GO:0090186,1,0.95608347344305,0,7,regulation of pancreatic juice secretion,BP,
17303,GO:0090187,1,0.992161761444505,0,2,positive regulation of pancreatic juice secretion,BP,
17304,GO:0090188,1,0.963639617692602,0,5,negative regulation of pancreatic juice secretion,BP,
17308,GO:0090192,1,0.93231883215052,0,11,regulation of glomerulus development,BP,
17309,GO:0090193,1,0.950112060586377,0,8,positive regulation of glomerulus development,BP,
17310,GO:0090194,1,0.981282381096221,0,3,negative regulation of glomerulus development,BP,
17314,GO:0090198,1,0.993112254326442,0,1,negative regulation of chemokine secretion,BP,
17315,GO:0090199,1,0.799005530182667,0,42,regulation of release of cytochrome c from mitochondria,BP,
17316,GO:0090200,1,0.864162304931603,0,28,positive regulation of release of cytochrome c from mitochondria,BP,
17317,GO:0090201,1,0.919843003350813,0,15,negative regulation of release of cytochrome c from mitochondria,BP,
17318,GO:0090202,1,0.976001962493892,0,4,gene looping,BP,
17319,GO:0090204,1,0.984992860996784,0,3,protein localization to nuclear pore,BP,
17320,GO:0090205,1,0.957678948372049,0,6,positive regulation of cholesterol metabolic process,BP,
17321,GO:0090206,1,0.974772505711209,0,5,negative regulation of cholesterol metabolic process,BP,
17322,GO:0090207,1,0.865715663888607,0,25,regulation of triglyceride metabolic process,BP,
17323,GO:0090208,1,0.915603833878075,0,16,positive regulation of triglyceride metabolic process,BP,
17324,GO:0090209,1,0.962895308742029,0,6,negative regulation of triglyceride metabolic process,BP,
17325,GO:0090210,1,0.986103499466347,0,2,regulation of establishment of blood-brain barrier,BP,
17326,GO:0090212,1,0.986103499466347,0,2,negative regulation of establishment of blood-brain barrier,BP,
17327,GO:0090214,1,0.988236259754271,0,2,spongiotrophoblast layer developmental growth,BP,
17329,GO:0090219,1,0.979420256876601,0,3,negative regulation of lipid kinase activity,BP,
17330,GO:0090220,1,0.932054188412552,0,10,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17331,GO:0090222,1,0.983169486586268,0,2,centrosome-templated microtubule nucleation,BP,
17332,GO:0090224,1,0.763150305732277,0,39,regulation of spindle organization,BP,
17333,GO:0090226,1,0.996970370494348,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17334,GO:0090230,1,0.970768518742256,0,4,regulation of centromere complex assembly,BP,
17335,GO:0090231,1,0.91187785500404,0,15,regulation of spindle checkpoint,BP,
17336,GO:0090232,1,0.95098036150227,0,8,positive regulation of spindle checkpoint,BP,
17337,GO:0090233,1,0.993502007861344,0,1,negative regulation of spindle checkpoint,BP,
17338,GO:0090234,1,0.978259395906092,0,3,regulation of kinetochore assembly,BP,
17339,GO:0090235,1,0.945985084575294,0,7,regulation of metaphase plate congression,BP,
17340,GO:0090237,1,0.967265456579565,0,5,regulation of arachidonic acid secretion,BP,
17341,GO:0090238,1,0.974785167245169,0,4,positive regulation of arachidonic acid secretion,BP,
17342,GO:0090239,1,0.932081935723766,0,12,regulation of histone H4 acetylation,BP,
17343,GO:0090240,1,0.961797945880628,0,7,positive regulation of histone H4 acetylation,BP,
17344,GO:0090241,1,0.97275548598078,0,5,negative regulation of histone H4 acetylation,BP,
17345,GO:0090244,1,0.974154802511504,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17346,GO:0090245,1,0.968625285121899,0,4,axis elongation involved in somitogenesis,BP,
17347,GO:0090246,1,0.99240612866336,0,1,convergent extension involved in somitogenesis,BP,
17348,GO:0090247,1,0.993704684941535,0,1,cell motility involved in somitogenic axis elongation,BP,
17349,GO:0090249,1,0.993704684941535,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17350,GO:0090251,1,0.989878939933553,0,1,protein localization involved in establishment of planar polarity,BP,
17351,GO:0090257,1,0.274324563695086,0,200,regulation of muscle system process,BP,
17352,GO:0090258,1,0.977686812551557,0,3,negative regulation of mitochondrial fission,BP,
17353,GO:0090259,1,0.964534372865698,0,5,regulation of retinal ganglion cell axon guidance,BP,
17354,GO:0090260,1,0.984814043969405,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17355,GO:0090261,1,0.981100773160121,0,4,positive regulation of inclusion body assembly,BP,
17356,GO:0090263,1,0.468922139791361,0,126,positive regulation of canonical Wnt signaling pathway,BP,
17357,GO:0090264,1,0.990092926489004,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17358,GO:0090265,1,0.993929133044694,0,1,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17359,GO:0090266,1,0.918640716546611,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17360,GO:0090267,1,0.958030129197753,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17361,GO:0090269,1,0.958167129240809,0,6,fibroblast growth factor production,BP,
17362,GO:0090270,1,0.958167129240809,0,6,regulation of fibroblast growth factor production,BP,
17363,GO:0090271,1,0.976743411725068,0,3,positive regulation of fibroblast growth factor production,BP,
17364,GO:0090272,1,0.980986023702121,0,3,negative regulation of fibroblast growth factor production,BP,
17365,GO:0090273,1,0.989833566453955,0,2,regulation of somatostatin secretion,BP,
17366,GO:0090274,1,0.989833566453955,0,2,positive regulation of somatostatin secretion,BP,
17370,GO:0090279,1,0.844125976605032,0,28,regulation of calcium ion import,BP,
17371,GO:0090280,1,0.914198264901748,0,15,positive regulation of calcium ion import,BP,
17372,GO:0090281,1,0.978415961730373,0,5,negative regulation of calcium ion import,BP,
17373,GO:0090282,1,0.992908294175076,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17374,GO:0090283,1,0.980831295803777,0,3,regulation of protein glycosylation in Golgi,BP,
17375,GO:0090284,1,0.991590181339505,0,1,positive regulation of protein glycosylation in Golgi,BP,
17376,GO:0090285,1,0.989150815772508,0,2,negative regulation of protein glycosylation in Golgi,BP,
17377,GO:0090286,1,0.950532998134817,0,6,cytoskeletal anchoring at nuclear membrane,BP,
17381,GO:0090290,1,0.996841247976018,0,1,positive regulation of osteoclast proliferation,BP,
17383,GO:0090292,1,0.970663963963174,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17384,GO:0090293,1,0.994866756232826,0,1,nitrogen catabolite regulation of transcription,BP,
17385,GO:0090294,1,0.994866756232826,0,1,nitrogen catabolite activation of transcription,BP,
17386,GO:0090296,1,0.975154441453535,0,4,regulation of mitochondrial DNA replication,BP,
17387,GO:0090297,1,0.99661665079849,0,1,positive regulation of mitochondrial DNA replication,BP,
17388,GO:0090298,1,0.978465683654343,0,3,negative regulation of mitochondrial DNA replication,BP,
17389,GO:0090299,1,0.996033781357412,0,1,regulation of neural crest formation,BP,
17390,GO:0090301,1,0.996033781357412,0,1,negative regulation of neural crest formation,BP,
17394,GO:0090306,1,0.972266127871297,0,4,spindle assembly involved in meiosis,BP,
17395,GO:0090307,1,0.659393750312424,0,62,mitotic spindle assembly,BP,
17396,GO:0090308,1,0.947630573724135,0,7,regulation of methylation-dependent chromatin silencing,BP,
17397,GO:0090309,1,0.97031156231533,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17398,GO:0090310,1,0.984014327205835,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
17399,GO:0090311,1,0.786584343835812,0,36,regulation of protein deacetylation,BP,
17400,GO:0090312,1,0.87424007951716,0,20,positive regulation of protein deacetylation,BP,
17401,GO:0090313,1,0.821523606087498,0,31,regulation of protein targeting to membrane,BP,
17402,GO:0090314,1,0.844432880481325,0,27,positive regulation of protein targeting to membrane,BP,
17403,GO:0090315,1,0.968675634692712,0,5,negative regulation of protein targeting to membrane,BP,
17404,GO:0090316,1,0.316660332949673,0,179,positive regulation of intracellular protein transport,BP,
17407,GO:0090323,1,0.997062308027535,0,1,prostaglandin secretion involved in immune response,BP,
17408,GO:0090324,1,0.968472212568694,0,5,negative regulation of oxidative phosphorylation,BP,
17409,GO:0090325,1,0.97878756709102,0,3,regulation of locomotion involved in locomotory behavior,BP,
17410,GO:0090326,1,0.992641595044173,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17411,GO:0090327,1,0.99244496107208,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17412,GO:0090329,1,0.745261435074767,0,45,regulation of DNA-dependent DNA replication,BP,
17413,GO:0090330,1,0.884951274526274,0,18,regulation of platelet aggregation,BP,
17414,GO:0090331,1,0.931403285609868,0,11,negative regulation of platelet aggregation,BP,
17415,GO:0090335,1,0.921226253977053,0,12,regulation of brown fat cell differentiation,BP,
17416,GO:0090336,1,0.962992513556922,0,6,positive regulation of brown fat cell differentiation,BP,
17417,GO:0090340,1,0.995075861974963,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17418,GO:0090341,1,0.99621991507235,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17419,GO:0090342,1,0.773194809775725,0,39,regulation of cell aging,BP,
17420,GO:0090343,1,0.948215395806975,0,10,positive regulation of cell aging,BP,
17421,GO:0090344,1,0.861971946135653,0,21,negative regulation of cell aging,BP,
17422,GO:0090345,1,0.990106323581404,0,2,cellular organohalogen metabolic process,BP,
17423,GO:0090346,1,0.990106323581404,0,2,cellular organofluorine metabolic process,BP,
17424,GO:0090347,1,0.996176901233646,0,1,regulation of cellular organohalogen metabolic process,BP,
17425,GO:0090348,1,0.996176901233646,0,1,regulation of cellular organofluorine metabolic process,BP,
17426,GO:0090349,1,0.996176901233646,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17427,GO:0090350,1,0.996176901233646,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17428,GO:0090360,1,0.982570094286648,0,3,platelet-derived growth factor production,BP,
17429,GO:0090361,1,0.982570094286648,0,3,regulation of platelet-derived growth factor production,BP,
17430,GO:0090362,1,0.987419830626119,0,2,positive regulation of platelet-derived growth factor production,BP,
17431,GO:0090365,1,0.994777380711111,0,1,regulation of mRNA modification,BP,
17432,GO:0090367,1,0.994777380711111,0,1,negative regulation of mRNA modification,BP,
17433,GO:0090370,1,0.981059564295642,0,3,negative regulation of cholesterol efflux,BP,
17434,GO:0090381,1,0.992497018470544,0,2,regulation of heart induction,BP,
17435,GO:0090382,1,0.797094136005191,0,40,phagosome maturation,BP,
17436,GO:0090383,1,0.872237464292348,0,26,phagosome acidification,BP,
17437,GO:0090385,1,0.961065355419517,0,7,phagosome-lysosome fusion,BP,
17438,GO:0090386,1,0.983930414938901,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17439,GO:0090387,1,0.983930414938901,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17440,GO:0090389,1,0.991445135932274,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17441,GO:0090394,1,0.930669493576141,0,10,negative regulation of excitatory postsynaptic potential,BP,
17442,GO:0090398,1,0.692449244327046,0,58,cellular senescence,BP,
17443,GO:0090399,1,0.914813397280692,0,13,replicative senescence,BP,
17444,GO:0090400,1,0.948126303820264,0,8,stress-induced premature senescence,BP,
17445,GO:0090402,1,0.98855374063741,0,2,oncogene-induced cell senescence,BP,
17446,GO:0090403,1,0.972460058851902,0,4,oxidative stress-induced premature senescence,BP,
17448,GO:0090409,1,0.994486650238802,0,1,malonyl-CoA synthetase activity,MF,
17449,GO:0090410,1,0.994486650238802,0,1,malonate catabolic process,BP,
17450,GO:0090416,1,0.993767434115936,0,1,nicotinate transmembrane transporter activity,MF,
17451,GO:0090420,1,0.996460027391501,0,1,naphthalene-containing compound metabolic process,BP,
17452,GO:0090422,1,0.989668753505271,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17453,GO:0090425,1,0.99284618617602,0,1,acinar cell differentiation,BP,
17454,GO:0090427,1,0.982004215099393,0,3,activation of meiosis,BP,
17455,GO:0090435,1,0.960367086968222,0,7,protein localization to nuclear envelope,BP,
17456,GO:0090461,1,0.992431021941977,0,1,glutamate homeostasis,BP,
17457,GO:0090472,1,0.99244226927251,0,1,dibasic protein processing,BP,
17458,GO:0090480,1,0.977906591169002,0,3,purine nucleotide-sugar transmembrane transport,BP,
17459,GO:0090481,1,0.939976643670412,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17460,GO:0090482,1,0.86914627861966,0,22,vitamin transmembrane transporter activity,MF,
17461,GO:0090493,1,0.939715573126902,0,11,catecholamine uptake,BP,
17462,GO:0090494,1,0.939715573126902,0,11,dopamine uptake,BP,
17463,GO:0090498,1,0.979860952631802,0,3,extrinsic component of Golgi membrane,CC,
17464,GO:0090500,1,0.971110279362668,0,5,endocardial cushion to mesenchymal transition,BP,
17465,GO:0090501,1,0.471427204368797,0,129,RNA phosphodiester bond hydrolysis,BP,
17466,GO:0090502,1,0.703558481001806,0,62,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17467,GO:0090503,1,0.80491790094837,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17468,GO:0090504,1,0.827300576172665,0,28,epiboly,BP,
17469,GO:0090505,1,0.835612127528552,0,27,epiboly involved in wound healing,BP,
17472,GO:0090527,1,0.919828168403461,0,11,actin filament reorganization,BP,
17473,GO:0090529,1,0.995635638159014,0,1,cell septum assembly,BP,
17474,GO:0090533,1,0.914897624149476,0,15,cation-transporting ATPase complex,CC,
17475,GO:0090534,1,0.995940820722402,0,1,calcium ion-transporting ATPase complex,CC,
17476,GO:0090537,1,0.984626287068474,0,2,CERF complex,CC,
17477,GO:0090541,1,0.985769954639244,0,2,MIT domain binding,MF,
17478,GO:0090543,1,0.836267283778318,0,26,Flemming body,CC,
17479,GO:0090545,1,0.88225496816504,0,17,CHD-type complex,CC,
17480,GO:0090554,1,0.96722577718,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17481,GO:0090555,1,0.98393240571061,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17482,GO:0090556,1,0.982120562409373,0,2,phosphatidylserine-translocating ATPase activity,MF,
17483,GO:0090557,1,0.939283290592214,0,8,establishment of endothelial intestinal barrier,BP,
17484,GO:0090558,1,0.996992964303392,0,1,plant epidermis development,BP,
17486,GO:0090560,1,0.994846477106831,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17487,GO:0090568,1,0.814169056000369,0,29,nuclear transcriptional repressor complex,CC,
17488,GO:0090571,1,0.976963507891317,0,4,RNA polymerase II transcription repressor complex,CC,
17489,GO:0090575,1,0.397018696736777,0,147,RNA polymerase II transcription factor complex,CC,
17490,GO:0090576,1,0.944459435510673,0,8,RNA polymerase III transcription factor complex,CC,
17491,GO:0090579,1,0.976001962493892,0,4,dsDNA loop formation,BP,
17492,GO:0090594,1,0.959157011449108,0,7,inflammatory response to wounding,BP,
17493,GO:0090596,1,0.217395058278909,0,229,sensory organ morphogenesis,BP,
17494,GO:0090598,1,0.982177409275279,0,3,male anatomical structure morphogenesis,BP,
17495,GO:0090599,1,0.96139377774714,0,5,alpha-glucosidase activity,MF,
17496,GO:0090600,1,0.99246386324672,0,1,alpha-1,3-glucosidase activity,MF,
17497,GO:0090601,1,0.992256882334399,0,1,enucleation,BP,
17498,GO:0090611,1,0.971527471233396,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17499,GO:0090615,1,0.987881104287331,0,2,mitochondrial mRNA processing,BP,
17500,GO:0090616,1,0.992382517855332,0,1,mitochondrial mRNA 3'-end processing,BP,
17501,GO:0090624,1,0.993301131169352,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17502,GO:0090625,1,0.993301131169352,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17503,GO:0090627,1,0.996992964303392,0,1,plant epidermal cell differentiation,BP,
17505,GO:0090634,1,0.996292351867762,0,1,microglial cell mediated cytotoxicity,BP,
17506,GO:0090646,1,0.935109336526678,0,12,mitochondrial tRNA processing,BP,
17507,GO:0090647,1,0.954901676570033,0,7,modulation of age-related behavioral decline,BP,
17508,GO:0090648,1,0.991928808058787,0,1,response to environmental enrichment,BP,
17509,GO:0090649,1,0.964333550268562,0,5,response to oxygen-glucose deprivation,BP,
17510,GO:0090650,1,0.964333550268562,0,5,cellular response to oxygen-glucose deprivation,BP,
17511,GO:0090651,1,0.99175921131154,0,1,apical cytoplasm,CC,
17512,GO:0090656,1,0.903235796433306,0,14,t-circle formation,BP,
17513,GO:0090657,1,0.930407970800486,0,10,telomeric loop disassembly,BP,
17515,GO:0090661,1,0.984630613266768,0,4,box H/ACA telomerase RNP complex,CC,
17516,GO:0090662,1,0.845235493846503,0,29,ATP hydrolysis coupled transmembrane transport,BP,
17517,GO:0090663,1,0.993352634665799,0,2,galanin-activated signaling pathway,BP,
17518,GO:0090665,1,0.877539900361379,0,20,glycoprotein complex,CC,
17519,GO:0090666,1,0.979613781319898,0,4,scaRNA localization to Cajal body,BP,
17520,GO:0090667,1,0.991365235562567,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17521,GO:0090668,1,0.991365235562567,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17522,GO:0090669,1,0.97514396919035,0,4,telomerase RNA stabilization,BP,
17523,GO:0090670,1,0.902567762712821,0,19,RNA localization to Cajal body,BP,
17524,GO:0090671,1,0.902567762712821,0,19,telomerase RNA localization to Cajal body,BP,
17525,GO:0090672,1,0.902567762712821,0,19,telomerase RNA localization,BP,
17526,GO:0090673,1,0.991555199850057,0,1,endothelial cell-matrix adhesion,BP,
17527,GO:0090675,1,0.99243730895738,0,1,intermicrovillar adhesion,BP,
17528,GO:0090677,1,0.98875036000349,0,2,reversible differentiation,BP,
17529,GO:0090678,1,0.98875036000349,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17530,GO:0090685,1,0.902567762712821,0,19,RNA localization to nucleus,BP,
17531,GO:0090694,1,0.983812007438011,0,2,Scc2-Scc4 cohesin loading complex,CC,
17532,GO:0090713,1,0.961570096681622,0,6,immunological memory process,BP,
17533,GO:0090715,1,0.961570096681622,0,6,immunological memory formation process,BP,
17534,GO:0090722,1,0.977541635830029,0,4,receptor-receptor interaction,MF,
17535,GO:0090723,1,0.912322940955408,0,14,growth cone part,CC,
17536,GO:0090724,1,0.982101106129904,0,3,central region of growth cone,CC,
17537,GO:0090725,1,0.996941089164012,0,1,peripheral region of growth cone,CC,
17538,GO:0090731,1,0.996721868208233,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17539,GO:0090734,1,0.798891866961087,0,33,site of DNA damage,CC,
17540,GO:0090735,1,0.940881250386197,0,10,DNA repair complex assembly,BP,
17541,GO:0090737,1,0.903235796433306,0,14,telomere maintenance via telomere trimming,BP,
17542,GO:0090741,1,0.945124331499063,0,11,pigment granule membrane,CC,
17543,GO:0093001,1,0.99270352792991,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17544,GO:0095500,1,0.879696914461968,0,21,acetylcholine receptor signaling pathway,BP,
17546,GO:0097003,1,0.987409138599739,0,2,adipokinetic hormone receptor activity,MF,
17547,GO:0097006,1,0.635315651156637,0,74,regulation of plasma lipoprotein particle levels,BP,
17548,GO:0097009,1,0.891938360348772,0,18,energy homeostasis,BP,
17549,GO:0097010,1,0.978726339751421,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17550,GO:0097011,1,0.949071057465683,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17551,GO:0097012,1,0.949071057465683,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17552,GO:0097013,1,0.988161655521832,0,3,phagocytic vesicle lumen,CC,
17554,GO:0097016,1,0.978458535325244,0,4,L27 domain binding,MF,
17555,GO:0097017,1,0.987332255888173,0,2,renal protein absorption,BP,
17556,GO:0097018,1,0.993911416934456,0,1,renal albumin absorption,BP,
17557,GO:0097020,1,0.992597852240173,0,1,COPII adaptor activity,MF,
17558,GO:0097021,1,0.982989784111055,0,3,lymphocyte migration into lymphoid organs,BP,
17559,GO:0097022,1,0.994812632020403,0,1,lymphocyte migration into lymph node,BP,
17560,GO:0097025,1,0.970863508644764,0,5,MPP7-DLG1-LIN7 complex,CC,
17561,GO:0097026,1,0.980196868244706,0,4,dendritic cell dendrite assembly,BP,
17562,GO:0097027,1,0.962992004273177,0,7,ubiquitin-protein transferase activator activity,MF,
17563,GO:0097028,1,0.823395874546179,0,37,dendritic cell differentiation,BP,
17564,GO:0097029,1,0.981940143684609,0,4,mature conventional dendritic cell differentiation,BP,
17566,GO:0097036,1,0.996410840777958,0,1,regulation of plasma membrane sterol distribution,BP,
17567,GO:0097037,1,0.99256272724588,0,1,heme export,BP,
17568,GO:0097038,1,0.926581001056371,0,11,perinuclear endoplasmic reticulum,CC,
17569,GO:0097039,1,0.965426868038264,0,5,protein linear polyubiquitination,BP,
17570,GO:0097045,1,0.9923456845475,0,1,phosphatidylserine exposure on blood platelet,BP,
17571,GO:0097048,1,0.945581947552905,0,10,dendritic cell apoptotic process,BP,
17573,GO:0097050,1,0.921168790704491,0,12,type B pancreatic cell apoptotic process,BP,
17574,GO:0097051,1,0.976518288206626,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17575,GO:0097052,1,0.985125059960986,0,3,L-kynurenine metabolic process,BP,
17576,GO:0097053,1,0.996338632672028,0,1,L-kynurenine catabolic process,BP,
17577,GO:0097055,1,0.988069979907779,0,2,agmatine biosynthetic process,BP,
17578,GO:0097056,1,0.978810705002501,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17579,GO:0097057,1,0.991419574777076,0,2,TRAF2-GSTP1 complex,CC,
17581,GO:0097059,1,0.99106899270676,0,2,CNTFR-CLCF1 complex,CC,
17583,GO:0097061,1,0.620033633802147,0,66,dendritic spine organization,BP,
17584,GO:0097062,1,0.890488511035557,0,17,dendritic spine maintenance,BP,
17585,GO:0097064,1,0.791547104026426,0,36,ncRNA export from nucleus,BP,
17586,GO:0097065,1,0.960163705847285,0,6,anterior head development,BP,
17587,GO:0097066,1,0.855199180898932,0,24,response to thyroid hormone,BP,
17588,GO:0097067,1,0.897351460438902,0,16,cellular response to thyroid hormone stimulus,BP,
17589,GO:0097068,1,0.963604422600741,0,5,response to thyroxine,BP,
17590,GO:0097069,1,0.985373189026314,0,2,cellular response to thyroxine stimulus,BP,
17591,GO:0097070,1,0.964605516494096,0,5,ductus arteriosus closure,BP,
17592,GO:0097084,1,0.952806898759723,0,8,vascular smooth muscle cell development,BP,
17593,GO:0097086,1,0.992492859017199,0,1,amniotic stem cell differentiation,BP,
17594,GO:0097089,1,0.990468144269296,0,2,methyl-branched fatty acid metabolic process,BP,
17596,GO:0097091,1,0.932831038350894,0,9,synaptic vesicle clustering,BP,
17597,GO:0097094,1,0.904656846514997,0,15,craniofacial suture morphogenesis,BP,
17598,GO:0097100,1,0.971290338627397,0,5,supercoiled DNA binding,MF,
17599,GO:0097101,1,0.981014961468374,0,3,blood vessel endothelial cell fate specification,BP,
17600,GO:0097102,1,0.986640361054216,0,2,endothelial tip cell fate specification,BP,
17601,GO:0097104,1,0.917072009347687,0,11,postsynaptic membrane assembly,BP,
17602,GO:0097105,1,0.926396321639889,0,10,presynaptic membrane assembly,BP,
17603,GO:0097106,1,0.887860201456625,0,15,postsynaptic density organization,BP,
17604,GO:0097107,1,0.94268901459501,0,7,postsynaptic density assembly,BP,
17605,GO:0097108,1,0.976540016163969,0,3,hedgehog family protein binding,MF,
17606,GO:0097109,1,0.963514642225377,0,5,neuroligin family protein binding,MF,
17608,GO:0097111,1,0.983647621201517,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17609,GO:0097112,1,0.985360467611207,0,2,gamma-aminobutyric acid receptor clustering,BP,
17610,GO:0097113,1,0.951743830621082,0,7,AMPA glutamate receptor clustering,BP,
17611,GO:0097114,1,0.970748745696526,0,4,NMDA glutamate receptor clustering,BP,
17612,GO:0097115,1,0.992315544998241,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17613,GO:0097116,1,0.975236272839716,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17614,GO:0097117,1,0.991619294515908,0,1,guanylate kinase-associated protein clustering,BP,
17615,GO:0097118,1,0.967194586908,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17616,GO:0097119,1,0.93200667086541,0,9,postsynaptic density protein 95 clustering,BP,
17618,GO:0097123,1,0.990135796811615,0,2,cyclin A1-CDK2 complex,CC,
17619,GO:0097124,1,0.987901737123872,0,2,cyclin A2-CDK2 complex,CC,
17620,GO:0097125,1,0.99090696307691,0,2,cyclin B1-CDK1 complex,CC,
17621,GO:0097129,1,0.984935608176275,0,3,cyclin D2-CDK4 complex,CC,
17622,GO:0097134,1,0.990221223685546,0,2,cyclin E1-CDK2 complex,CC,
17623,GO:0097135,1,0.988040569657001,0,2,cyclin E2-CDK2 complex,CC,
17624,GO:0097136,1,0.96360604016994,0,6,Bcl-2 family protein complex,CC,
17625,GO:0097144,1,0.996978827162998,0,1,BAX complex,CC,
17626,GO:0097145,1,0.994747519122485,0,1,BAK complex,CC,
17627,GO:0097149,1,0.977793043967253,0,3,centralspindlin complex,CC,
17628,GO:0097150,1,0.844527397790809,0,22,neuronal stem cell population maintenance,BP,
17629,GO:0097151,1,0.946250847113603,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17630,GO:0097152,1,0.929790509489044,0,12,mesenchymal cell apoptotic process,BP,
17631,GO:0097153,1,0.938460146055353,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17633,GO:0097155,1,0.974612585323308,0,3,fasciculation of sensory neuron axon,BP,
17634,GO:0097156,1,0.984387359981442,0,2,fasciculation of motor neuron axon,BP,
17635,GO:0097157,1,0.948040842415407,0,8,pre-mRNA intronic binding,MF,
17636,GO:0097158,1,0.996071788205092,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17638,GO:0097161,1,0.991891120856937,0,1,DH domain binding,MF,
17639,GO:0097162,1,0.992654096579413,0,1,MADS box domain binding,MF,
17641,GO:0097165,1,0.968810499630974,0,5,nuclear stress granule,CC,
17642,GO:0097166,1,0.986408152837488,0,2,lens epithelial cell proliferation,BP,
17643,GO:0097167,1,0.975385776378578,0,4,circadian regulation of translation,BP,
17644,GO:0097168,1,0.987288930059247,0,2,mesenchymal stem cell proliferation,BP,
17645,GO:0097169,1,0.98343109400201,0,5,AIM2 inflammasome complex,CC,
17646,GO:0097176,1,0.980749832102829,0,4,epoxide metabolic process,BP,
17647,GO:0097177,1,0.985990986891615,0,3,mitochondrial ribosome binding,MF,
17648,GO:0097178,1,0.811659860127395,0,34,ruffle assembly,BP,
17649,GO:0097179,1,0.984405275104795,0,4,protease inhibitor complex,CC,
17650,GO:0097180,1,0.990507667552033,0,2,serine protease inhibitor complex,CC,
17651,GO:0097181,1,0.994421680846751,0,1,protein C inhibitor-coagulation factor V complex,CC,
17652,GO:0097182,1,0.994421680846751,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17653,GO:0097183,1,0.994421680846751,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17654,GO:0097186,1,0.894603832906247,0,16,amelogenesis,BP,
17655,GO:0097187,1,0.981139321911859,0,3,dentinogenesis,BP,
17661,GO:0097195,1,0.982310796165008,0,3,pilomotor reflex,BP,
17662,GO:0097196,1,0.9887449183195,0,2,Shu complex,CC,
17663,GO:0097197,1,0.956232035793188,0,7,tetraspanin-enriched microdomain,CC,
17664,GO:0097198,1,0.984129076252361,0,2,histone H3-K36 trimethylation,BP,
17665,GO:0097199,1,0.971152363838157,0,6,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17666,GO:0097200,1,0.944137576737343,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17667,GO:0097201,1,0.928795272672007,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17668,GO:0097202,1,0.922481867174969,0,13,activation of cysteine-type endopeptidase activity,BP,
17670,GO:0097208,1,0.96616525342922,0,6,alveolar lamellar body,CC,
17671,GO:0097209,1,0.975651632312708,0,4,epidermal lamellar body,CC,
17672,GO:0097210,1,0.969028917353311,0,5,response to gonadotropin-releasing hormone,BP,
17673,GO:0097211,1,0.969028917353311,0,5,cellular response to gonadotropin-releasing hormone,BP,
17674,GO:0097212,1,0.98705282415493,0,3,lysosomal membrane organization,BP,
17675,GO:0097213,1,0.991695871086669,0,2,regulation of lysosomal membrane permeability,BP,
17676,GO:0097214,1,0.997057747766949,0,1,positive regulation of lysosomal membrane permeability,BP,
17677,GO:0097222,1,0.992382517855332,0,1,mitochondrial mRNA polyadenylation,BP,
17678,GO:0097223,1,0.436874598681999,0,140,sperm part,CC,
17679,GO:0097224,1,0.991451282073981,0,2,sperm connecting piece,CC,
17680,GO:0097225,1,0.917398368886521,0,16,sperm midpiece,CC,
17681,GO:0097226,1,0.994497496855314,0,1,sperm mitochondrial sheath,CC,
17682,GO:0097227,1,0.967578178902703,0,5,sperm annulus,CC,
17683,GO:0097228,1,0.887339671333951,0,18,sperm principal piece,CC,
17684,GO:0097229,1,0.996555015822489,0,1,sperm end piece,CC,
17685,GO:0097231,1,0.995928580069295,0,1,cell motility in response to calcium ion,BP,
17686,GO:0097232,1,0.98446680696161,0,2,lamellar body membrane,CC,
17687,GO:0097233,1,0.98446680696161,0,2,alveolar lamellar body membrane,CC,
17688,GO:0097237,1,0.302973604846528,0,204,cellular response to toxic substance,BP,
17689,GO:0097238,1,0.993384178866001,0,2,cellular response to methylglyoxal,BP,
17690,GO:0097240,1,0.967222582222153,0,5,chromosome attachment to the nuclear envelope,BP,
17691,GO:0097241,1,0.988429940515633,0,2,hematopoietic stem cell migration to bone marrow,BP,
17692,GO:0097242,1,0.866606185345806,0,19,amyloid-beta clearance,BP,
17693,GO:0097252,1,0.980248826761591,0,3,oligodendrocyte apoptotic process,BP,
17694,GO:0097254,1,0.994959703324487,0,1,renal tubular secretion,BP,
17695,GO:0097255,1,0.973019102894331,0,6,R2TP complex,CC,
17696,GO:0097258,1,0.992938451068819,0,1,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17697,GO:0097259,1,0.992938451068819,0,1,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17698,GO:0097260,1,0.993486597202038,0,1,eoxin A4 synthase activity,MF,
17700,GO:0097267,1,0.973972228077568,0,4,omega-hydroxylase P450 pathway,BP,
17701,GO:0097272,1,0.988165748585227,0,2,ammonia homeostasis,BP,
17702,GO:0097273,1,0.992078138827051,0,1,creatinine homeostasis,BP,
17703,GO:0097274,1,0.984686831529934,0,2,urea homeostasis,BP,
17704,GO:0097275,1,0.992078138827051,0,1,cellular ammonia homeostasis,BP,
17705,GO:0097276,1,0.992078138827051,0,1,cellular creatinine homeostasis,BP,
17706,GO:0097277,1,0.992078138827051,0,1,cellular urea homeostasis,BP,
17707,GO:0097278,1,0.983762335718053,0,3,complement-dependent cytotoxicity,BP,
17708,GO:0097283,1,0.971334002431622,0,5,keratinocyte apoptotic process,BP,
17709,GO:0097284,1,0.926754189962024,0,12,hepatocyte apoptotic process,BP,
17711,GO:0097291,1,0.995251600462362,0,1,renal phosphate ion absorption,BP,
17712,GO:0097296,1,0.929367148254176,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17713,GO:0097298,1,0.992462314336551,0,1,regulation of nucleus size,BP,
17717,GO:0097309,1,0.986646673054992,0,2,cap1 mRNA methylation,BP,
17718,GO:0097310,1,0.993301131169352,0,1,cap2 mRNA methylation,BP,
17719,GO:0097320,1,0.888809869437632,0,17,plasma membrane tubulation,BP,
17720,GO:0097322,1,0.954581011405446,0,7,7SK snRNA binding,MF,
17721,GO:0097323,1,0.989505169924197,0,2,B cell adhesion,BP,
17722,GO:0097324,1,0.983178186704709,0,2,melanocyte migration,BP,
17723,GO:0097325,1,0.985363505417955,0,2,melanocyte proliferation,BP,
17724,GO:0097326,1,0.992249190269564,0,1,melanocyte adhesion,BP,
17726,GO:0097329,1,0.918038577854209,0,12,response to antimetabolite,BP,
17727,GO:0097332,1,0.98189182338844,0,3,response to antipsychotic drug,BP,
17728,GO:0097338,1,0.984951086020459,0,2,response to clozapine,BP,
17729,GO:0097340,1,0.915621170666652,0,13,inhibition of cysteine-type endopeptidase activity,BP,
17730,GO:0097341,1,0.915621170666652,0,13,zymogen inhibition,BP,
17731,GO:0097342,1,0.962902096785251,0,6,ripoptosome,CC,
17732,GO:0097343,1,0.976221216439833,0,3,ripoptosome assembly,BP,
17733,GO:0097344,1,0.989095557967474,0,2,Rix1 complex,CC,
17735,GO:0097346,1,0.879398387996436,0,23,INO80-type complex,CC,
17736,GO:0097350,1,0.968206920290318,0,5,neutrophil clearance,BP,
17737,GO:0097352,1,0.813759741515144,0,34,autophagosome maturation,BP,
17738,GO:0097354,1,0.944028477339278,0,9,prenylation,BP,
17739,GO:0097359,1,0.982503498492649,0,2,UDP-glucosylation,BP,
17741,GO:0097361,1,0.977138003140486,0,4,CIA complex,CC,
17742,GO:0097362,1,0.986545067515344,0,2,MCM8-MCM9 complex,CC,
17743,GO:0097363,1,0.985517946247989,0,2,protein O-GlcNAc transferase activity,MF,
17744,GO:0097366,1,0.769192959648192,0,42,response to bronchodilator,BP,
17746,GO:0097368,1,0.973812211351407,0,4,establishment of Sertoli cell barrier,BP,
17747,GO:0097371,1,0.951463495304761,0,7,MDM2/MDM4 family protein binding,MF,
17748,GO:0097372,1,0.995924480866609,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17749,GO:0097374,1,0.993967319559355,0,1,sensory neuron axon guidance,BP,
17750,GO:0097376,1,0.990920928874314,0,2,interneuron axon guidance,BP,
17751,GO:0097377,1,0.994464971460437,0,1,spinal cord interneuron axon guidance,BP,
17752,GO:0097378,1,0.994464971460437,0,1,dorsal spinal cord interneuron axon guidance,BP,
17753,GO:0097380,1,0.994464971460437,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17754,GO:0097381,1,0.910324952321742,0,15,photoreceptor disc membrane,CC,
17755,GO:0097382,1,0.991997791072666,0,1,deoxynucleoside-diphosphatase activity,MF,
17756,GO:0097383,1,0.991997791072666,0,1,dIDP diphosphatase activity,MF,
17757,GO:0097384,1,0.96050889355657,0,7,cellular lipid biosynthetic process,BP,
17758,GO:0097386,1,0.898642641827612,0,16,glial cell projection,CC,
17759,GO:0097393,1,0.990001988296496,0,1,telomeric repeat-containing RNA transcription,BP,
17760,GO:0097394,1,0.990001988296496,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17761,GO:0097396,1,0.968099602839896,0,5,response to interleukin-17,BP,
17762,GO:0097398,1,0.968099602839896,0,5,cellular response to interleukin-17,BP,
17763,GO:0097400,1,0.968099602839896,0,5,interleukin-17-mediated signaling pathway,BP,
17764,GO:0097401,1,0.99295610486543,0,1,synaptic vesicle lumen acidification,BP,
17765,GO:0097402,1,0.98622152177898,0,2,neuroblast migration,BP,
17766,GO:0097403,1,0.992907013820507,0,1,cellular response to raffinose,BP,
17767,GO:0097409,1,0.99536807227086,0,1,glial cytoplasmic inclusion,CC,
17768,GO:0097411,1,0.966024486152973,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17769,GO:0097413,1,0.962377640522738,0,7,Lewy body,CC,
17770,GO:0097414,1,0.99536807227086,0,1,classical Lewy body,CC,
17771,GO:0097418,1,0.963828005931069,0,5,neurofibrillary tangle,CC,
17773,GO:0097422,1,0.966948796712211,0,5,tubular endosome,CC,
17774,GO:0097425,1,0.974668246739916,0,5,smooth endoplasmic reticulum part,CC,
17775,GO:0097427,1,0.960073023569931,0,6,microtubule bundle,CC,
17776,GO:0097428,1,0.962002911624484,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17777,GO:0097431,1,0.838356782674459,0,25,mitotic spindle pole,CC,
17778,GO:0097433,1,0.969852016639974,0,5,dense body,CC,
17781,GO:0097441,1,0.964460863612437,0,5,basal dendrite,CC,
17782,GO:0097442,1,0.976714374138628,0,3,CA3 pyramidal cell dendrite,CC,
17783,GO:0097443,1,0.956384272675242,0,6,sorting endosome,CC,
17784,GO:0097444,1,0.992261741095616,0,1,spine apparatus,CC,
17786,GO:0097449,1,0.936169961596308,0,10,astrocyte projection,CC,
17787,GO:0097450,1,0.976222523264828,0,4,astrocyte end-foot,CC,
17788,GO:0097451,1,0.984964372985463,0,2,glial limiting end-foot,CC,
17789,GO:0097452,1,0.977558514217474,0,4,GAIT complex,CC,
17791,GO:0097454,1,0.97984882346933,0,3,Schwann cell microvillus,CC,
17792,GO:0097457,1,0.974641856586594,0,3,hippocampal mossy fiber,CC,
17794,GO:0097462,1,0.99536807227086,0,1,Lewy neurite,CC,
17795,GO:0097466,1,0.972866276692725,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17796,GO:0097468,1,0.934073842285639,0,12,programmed cell death in response to reactive oxygen species,BP,
17797,GO:0097470,1,0.961555930669918,0,5,ribbon synapse,CC,
17799,GO:0097473,1,0.992225586617662,0,1,retinal rod cell apoptotic process,BP,
17800,GO:0097475,1,0.962144384684642,0,5,motor neuron migration,BP,
17801,GO:0097476,1,0.983547915537013,0,2,spinal cord motor neuron migration,BP,
17802,GO:0097477,1,0.983547915537013,0,2,lateral motor column neuron migration,BP,
17803,GO:0097479,1,0.431290216979813,0,123,synaptic vesicle localization,BP,
17804,GO:0097480,1,0.455650735079691,0,116,establishment of synaptic vesicle localization,BP,
17805,GO:0097484,1,0.818405484478197,0,29,dendrite extension,BP,
17807,GO:0097486,1,0.982810660101122,0,5,multivesicular body lumen,CC,
17810,GO:0097490,1,0.971113894790185,0,4,sympathetic neuron projection extension,BP,
17811,GO:0097491,1,0.971113894790185,0,4,sympathetic neuron projection guidance,BP,
17812,GO:0097493,1,0.808414956033699,0,17,structural molecule activity conferring elasticity,MF,
17813,GO:0097494,1,0.975409902470323,0,4,regulation of vesicle size,BP,
17814,GO:0097497,1,0.992753094597018,0,1,blood vessel endothelial cell delamination,BP,
17815,GO:0097498,1,0.987549590542267,0,2,endothelial tube lumen extension,BP,
17816,GO:0097499,1,0.946086780212774,0,9,protein localization to non-motile cilium,BP,
17817,GO:0097500,1,0.97423428737811,0,4,receptor localization to non-motile cilium,BP,
17818,GO:0097501,1,0.950589304325268,0,13,stress response to metal ion,BP,
17819,GO:0097502,1,0.840586578568883,0,29,mannosylation,BP,
17820,GO:0097503,1,0.88025203729211,0,20,sialylation,BP,
17821,GO:0097504,1,0.930011505444439,0,12,Gemini of coiled bodies,CC,
17822,GO:0097505,1,0.99208616581714,0,1,Rad6-Rad18 complex,CC,
17823,GO:0097506,1,0.976972216093084,0,5,deaminated base DNA N-glycosylase activity,MF,
17824,GO:0097510,1,0.995127456303825,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17825,GO:0097512,1,0.969970096761171,0,6,cardiac myofibril,CC,
17826,GO:0097513,1,0.974868658427501,0,3,myosin II filament,CC,
17827,GO:0097517,1,0.692427456483193,0,52,contractile actin filament bundle,CC,
17828,GO:0097524,1,0.977546348921021,0,3,sperm plasma membrane,CC,
17829,GO:0097525,1,0.71240581344488,0,61,spliceosomal snRNP complex,CC,
17830,GO:0097526,1,0.869186430833801,0,28,spliceosomal tri-snRNP complex,CC,
17831,GO:0097527,1,0.966812865819654,0,6,necroptotic signaling pathway,BP,
17833,GO:0097530,1,0.601736690109417,0,94,granulocyte migration,BP,
17834,GO:0097531,1,0.936916144680519,0,11,mast cell migration,BP,
17835,GO:0097532,1,0.988626701577414,0,2,stress response to acid chemical,BP,
17836,GO:0097533,1,0.988626701577414,0,2,cellular stress response to acid chemical,BP,
17837,GO:0097534,1,0.991425651577895,0,1,lymphoid lineage cell migration,BP,
17838,GO:0097535,1,0.991425651577895,0,1,lymphoid lineage cell migration into thymus,BP,
17839,GO:0097536,1,0.994959703324487,0,1,thymus epithelium morphogenesis,BP,
17840,GO:0097539,1,0.925957615566124,0,10,ciliary transition fiber,CC,
17841,GO:0097541,1,0.993301131169352,0,1,axonemal basal plate,CC,
17842,GO:0097542,1,0.753365611543359,0,43,ciliary tip,CC,
17843,GO:0097543,1,0.985378721766102,0,2,ciliary inversin compartment,CC,
17844,GO:0097546,1,0.834379708283591,0,27,ciliary base,CC,
17845,GO:0097550,1,0.969652812980979,0,6,transcriptional preinitiation complex,CC,
17847,GO:0097573,1,0.996517200073745,0,1,glutathione oxidoreductase activity,MF,
17848,GO:0097574,1,0.98454237083574,0,2,lateral part of cell,CC,
17849,GO:0097575,1,0.98454237083574,0,2,lateral cell cortex,CC,
17850,GO:0097576,1,0.986235333726666,0,2,vacuole fusion,BP,
17851,GO:0097577,1,0.988914750344125,0,3,sequestering of iron ion,BP,
17853,GO:0097598,1,0.985541608651386,0,2,sperm cytoplasmic droplet,CC,
17854,GO:0097602,1,0.899464343204572,0,17,cullin family protein binding,MF,
17855,GO:0097603,1,0.988202772057595,0,2,temperature-gated ion channel activity,MF,
17856,GO:0097604,1,0.995723365047967,0,1,temperature-gated cation channel activity,MF,
17857,GO:0097617,1,0.912564297464257,0,13,annealing activity,MF,
17858,GO:0097621,1,0.994459555014854,0,1,monoamine oxidase activity,MF,
17859,GO:0097623,1,0.956096795584143,0,7,potassium ion export across plasma membrane,BP,
17860,GO:0097625,1,0.991474662180335,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17861,GO:0097626,1,0.991474662180335,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17862,GO:0097627,1,0.991474662180335,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17863,GO:0097629,1,0.967512994845414,0,5,extrinsic component of omegasome membrane,CC,
17864,GO:0097630,1,0.993301131169352,0,1,intrinsic component of omegasome membrane,CC,
17865,GO:0097631,1,0.993301131169352,0,1,integral component of omegasome membrane,CC,
17866,GO:0097632,1,0.985585617420428,0,2,extrinsic component of phagophore assembly site membrane,CC,
17867,GO:0097635,1,0.98466372450813,0,2,extrinsic component of autophagosome membrane,CC,
17868,GO:0097636,1,0.98553279491409,0,2,intrinsic component of autophagosome membrane,CC,
17869,GO:0097637,1,0.98553279491409,0,2,integral component of autophagosome membrane,CC,
17870,GO:0097638,1,0.971677567846538,0,4,L-arginine import across plasma membrane,BP,
17871,GO:0097639,1,0.985261032086837,0,2,L-lysine import across plasma membrane,BP,
17872,GO:0097640,1,0.991474662180335,0,1,L-ornithine import across plasma membrane,BP,
17873,GO:0097642,1,0.969103112304166,0,6,calcitonin family receptor activity,MF,
17874,GO:0097643,1,0.983063723507728,0,4,amylin receptor activity,MF,
17875,GO:0097644,1,0.978875814356497,0,4,calcitonin family binding,MF,
17876,GO:0097646,1,0.97197200230233,0,6,calcitonin family receptor signaling pathway,BP,
17877,GO:0097647,1,0.979520465986149,0,5,amylin receptor signaling pathway,BP,
17878,GO:0097648,1,0.952447321507612,0,8,G-protein coupled receptor complex,CC,
17879,GO:0097651,1,0.969499880427897,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17880,GO:0097655,1,0.993301131169352,0,1,serpin family protein binding,MF,
17882,GO:0097676,1,0.975887341086981,0,3,histone H3-K36 dimethylation,BP,
17883,GO:0097677,1,0.966999504259133,0,5,STAT family protein binding,MF,
17884,GO:0097679,1,0.991080970514727,0,2,other organism cytoplasm,CC,
17885,GO:0097680,1,0.979729016463922,0,3,double-strand break repair via classical nonhomologous end joining,BP,
17886,GO:0097681,1,0.979935501824482,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
17887,GO:0097682,1,0.994982502663484,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17888,GO:0097688,1,0.951743830621082,0,7,glutamate receptor clustering,BP,
17889,GO:0097689,1,0.992603497008377,0,1,iron channel activity,MF,
17890,GO:0097692,1,0.991925897931231,0,1,histone H3-K4 monomethylation,BP,
17891,GO:0097694,1,0.974470184847367,0,3,establishment of RNA localization to telomere,BP,
17892,GO:0097695,1,0.974470184847367,0,3,establishment of protein-containing complex localization to telomere,BP,
17894,GO:0097698,1,0.996331689657986,0,1,telomere maintenance via base-excision repair,BP,
17895,GO:0097699,1,0.992406606593718,0,1,vascular endothelial cell response to fluid shear stress,BP,
17896,GO:0097707,1,0.996909045761111,0,1,ferroptosis,BP,
17898,GO:0097709,1,0.962198215656187,0,6,connective tissue replacement,BP,
17900,GO:0097712,1,0.993301131169352,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17903,GO:0097722,1,0.684910378922888,0,63,sperm motility,BP,
17904,GO:0097724,1,0.995681025552109,0,1,sperm flagellum movement,BP,
17905,GO:0097726,1,0.996774872982897,0,1,LEM domain binding,MF,
17906,GO:0097729,1,0.687600818360567,0,64,9+2 motile cilium,CC,
17907,GO:0097730,1,0.475383618102741,0,111,non-motile cilium,CC,
17908,GO:0097731,1,0.559201052409784,0,87,9+0 non-motile cilium,CC,
17909,GO:0097732,1,0.957761387964453,0,7,9+2 non-motile cilium,CC,
17910,GO:0097733,1,0.559201052409784,0,87,photoreceptor cell cilium,CC,
17911,GO:0097734,1,0.898224021762308,0,18,extracellular exosome biogenesis,BP,
17912,GO:0097742,1,0.973329196660529,0,4,de novo centriole assembly,BP,
17913,GO:0097745,1,0.983942769127879,0,3,mitochondrial tRNA 5'-end processing,BP,
17915,GO:0097747,1,0.790963053190975,0,43,RNA polymerase activity,MF,
17916,GO:0097749,1,0.985329722875358,0,2,membrane tubulation,BP,
17917,GO:0097752,1,0.979999941829987,0,3,regulation of DNA stability,BP,
17918,GO:0097753,1,0.985914379065648,0,2,membrane bending,BP,
17921,GO:0098501,1,0.977540305528384,0,5,polynucleotide dephosphorylation,BP,
17922,GO:0098502,1,0.988906269370781,0,3,DNA dephosphorylation,BP,
17923,GO:0098503,1,0.995905916601267,0,1,DNA 3' dephosphorylation,BP,
17924,GO:0098504,1,0.995905916601267,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
17925,GO:0098505,1,0.938327306675384,0,10,G-rich strand telomeric DNA binding,MF,
17926,GO:0098506,1,0.995905916601267,0,1,polynucleotide 3' dephosphorylation,BP,
17927,GO:0098507,1,0.988507861631692,0,2,polynucleotide 5' dephosphorylation,BP,
17928,GO:0098508,1,0.988599940773906,0,2,endothelial to hematopoietic transition,BP,
17929,GO:0098518,1,0.984460340815977,0,3,polynucleotide phosphatase activity,MF,
17930,GO:0098519,1,0.969769004927195,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
17931,GO:0098528,1,0.967421885231517,0,5,skeletal muscle fiber differentiation,BP,
17932,GO:0098530,1,0.992076901588569,0,1,positive regulation of strand invasion,BP,
17933,GO:0098531,1,0.728893016887765,0,46,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
17934,GO:0098532,1,0.960129158181745,0,7,histone H3-K27 trimethylation,BP,
17935,GO:0098533,1,0.868026229991031,0,22,ATPase dependent transmembrane transport complex,CC,
17936,GO:0098534,1,0.804711092911016,0,32,centriole assembly,BP,
17937,GO:0098535,1,0.973329196660529,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17938,GO:0098536,1,0.973575319578378,0,4,deuterosome,CC,
17939,GO:0098542,1,0.139810050146426,0,343,defense response to other organism,BP,
17940,GO:0098543,1,0.923205469756136,0,11,detection of other organism,BP,
17941,GO:0098547,1,0.994592555823903,0,1,lumenal side of Golgi membrane,CC,
17943,GO:0098553,1,0.893644570500113,0,25,lumenal side of endoplasmic reticulum membrane,CC,
17944,GO:0098554,1,0.935337100960975,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
17945,GO:0098556,1,0.984305689309286,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17946,GO:0098559,1,0.981404288012076,0,3,cytoplasmic side of early endosome membrane,CC,
17947,GO:0098560,1,0.987152486804054,0,2,cytoplasmic side of late endosome membrane,CC,
17948,GO:0098562,1,0.28714186185832,0,191,cytoplasmic side of membrane,CC,
17949,GO:0098563,1,0.85336176612462,0,26,intrinsic component of synaptic vesicle membrane,CC,
17950,GO:0098573,1,0.683250958517956,0,66,intrinsic component of mitochondrial membrane,CC,
17951,GO:0098574,1,0.969704711336283,0,5,cytoplasmic side of lysosomal membrane,CC,
17952,GO:0098575,1,0.989797259055418,0,2,lumenal side of lysosomal membrane,CC,
17953,GO:0098576,1,0.977141001002185,0,4,lumenal side of membrane,CC,
17954,GO:0098577,1,0.991735313977066,0,1,inactive sex chromosome,CC,
17955,GO:0098581,1,0.900527072179782,0,16,detection of external biotic stimulus,BP,
17956,GO:0098582,1,0.984578527602045,0,2,innate vocalization behavior,BP,
17957,GO:0098583,1,0.996627947902722,0,1,learned vocalization behavior,BP,
17958,GO:0098586,1,0.772156579948058,0,40,cellular response to virus,BP,
17962,GO:0098592,1,0.978097509736654,0,3,cytoplasmic side of apical plasma membrane,CC,
17963,GO:0098594,1,0.997008698462441,0,1,mucin granule,CC,
17964,GO:0098595,1,0.994600712288208,0,1,perivitelline space,CC,
17965,GO:0098596,1,0.940856202656405,0,7,imitative learning,BP,
17966,GO:0098597,1,0.930878349208795,0,8,observational learning,BP,
17967,GO:0098598,1,0.937681571087043,0,8,learned vocalization behavior or vocal learning,BP,
17968,GO:0098599,1,0.944837816436748,0,10,palmitoyl hydrolase activity,MF,
17969,GO:0098601,1,0.992576374188195,0,1,selenomethionine adenosyltransferase activity,MF,
17971,GO:0098619,1,0.99551108062081,0,1,selenocysteine-tRNA ligase activity,MF,
17972,GO:0098621,1,0.9921152450986,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
17973,GO:0098625,1,0.992472555229464,0,1,methylselenol reductase activity,MF,
17974,GO:0098626,1,0.992472555229464,0,1,methylseleninic acid reductase activity,MF,
17975,GO:0098629,1,0.993301131169352,0,1,trans-Golgi network membrane organization,BP,
17978,GO:0098633,1,0.993846230011101,0,1,collagen fibril binding,MF,
17979,GO:0098634,1,0.950683346919824,0,7,cell-matrix adhesion mediator activity,MF,
17980,GO:0098636,1,0.773943608516083,0,35,protein complex involved in cell adhesion,CC,
17981,GO:0098637,1,0.992462052493716,0,1,protein complex involved in cell-matrix adhesion,CC,
17982,GO:0098639,1,0.961314287062685,0,5,collagen binding involved in cell-matrix adhesion,MF,
17983,GO:0098640,1,0.988945761680541,0,2,integrin binding involved in cell-matrix adhesion,MF,
17984,GO:0098641,1,0.903785835719195,0,19,cadherin binding involved in cell-cell adhesion,MF,
17985,GO:0098642,1,0.944092654653843,0,7,network-forming collagen trimer,CC,
17986,GO:0098643,1,0.910597698732232,0,12,banded collagen fibril,CC,
17987,GO:0098644,1,0.851732445355348,0,20,complex of collagen trimers,CC,
17988,GO:0098645,1,0.944092654653843,0,7,collagen network,CC,
17989,GO:0098646,1,0.993621023232784,0,1,collagen sheet,CC,
17990,GO:0098647,1,0.979899515349452,0,3,collagen beaded filament,CC,
17991,GO:0098648,1,0.990815273091548,0,1,collagen anchoring fibril,CC,
17992,GO:0098651,1,0.936738287388794,0,8,basement membrane collagen trimer,CC,
17993,GO:0098652,1,0.990815273091548,0,1,collagen type VII anchoring fibril,CC,
17997,GO:0098659,1,0.715451564298649,0,48,inorganic cation import across plasma membrane,BP,
17999,GO:0098661,1,0.52508950707559,0,93,inorganic anion transmembrane transport,BP,
18001,GO:0098664,1,0.931703363454642,0,13,G-protein coupled serotonin receptor signaling pathway,BP,
18002,GO:0098679,1,0.981924963921382,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18003,GO:0098680,1,0.9924574167577,0,1,template-free RNA nucleotidyltransferase,MF,
18004,GO:0098687,1,0.131269862169517,0,310,chromosomal region,CC,
18005,GO:0098693,1,0.739095366774763,0,42,regulation of synaptic vesicle cycle,BP,
18006,GO:0098698,1,0.94268901459501,0,7,postsynaptic specialization assembly,BP,
18007,GO:0098700,1,0.952020695574107,0,8,neurotransmitter loading into synaptic vesicle,BP,
18008,GO:0098703,1,0.913235118566994,0,13,calcium ion import across plasma membrane,BP,
18009,GO:0098704,1,0.994400074224895,0,1,carbohydrate import across plasma membrane,BP,
18010,GO:0098705,1,0.99234761313249,0,1,copper ion import across plasma membrane,BP,
18011,GO:0098706,1,0.969605881927372,0,4,ferric iron import across plasma membrane,BP,
18012,GO:0098711,1,0.957876320898466,0,6,iron ion import across plasma membrane,BP,
18013,GO:0098712,1,0.924152198708474,0,11,L-glutamate import across plasma membrane,BP,
18014,GO:0098713,1,0.994554505936448,0,1,leucine import across plasma membrane,BP,
18015,GO:0098719,1,0.900978581664595,0,14,sodium ion import across plasma membrane,BP,
18016,GO:0098722,1,0.941729099946942,0,9,asymmetric stem cell division,BP,
18017,GO:0098725,1,0.993301131169352,0,1,symmetric cell division,BP,
18019,GO:0098728,1,0.983697737087025,0,3,germline stem cell asymmetric division,BP,
18020,GO:0098732,1,0.497144826128423,0,106,macromolecule deacylation,BP,
18021,GO:0098734,1,0.944837816436748,0,10,macromolecule depalmitoylation,BP,
18022,GO:0098735,1,0.963687750190606,0,4,positive regulation of the force of heart contraction,BP,
18023,GO:0098736,1,0.990996315875316,0,1,negative regulation of the force of heart contraction,BP,
18026,GO:0098743,1,0.895540610556276,0,18,cell aggregation,BP,
18027,GO:0098745,1,0.995874545468219,0,1,Dcp1-Dcp2 complex,CC,
18028,GO:0098746,1,0.992339385993615,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18029,GO:0098748,1,0.928365147810585,0,11,endocytic adaptor activity,MF,
18030,GO:0098749,1,0.992378600311424,0,1,cerebellar neuron development,BP,
18031,GO:0098751,1,0.796539823367886,0,32,bone cell development,BP,
18032,GO:0098754,1,0.607077241291852,0,100,detoxification,BP,
18033,GO:0098756,1,0.952462843265326,0,7,response to interleukin-21,BP,
18034,GO:0098757,1,0.952462843265326,0,7,cellular response to interleukin-21,BP,
18035,GO:0098758,1,0.980208853863844,0,3,response to interleukin-8,BP,
18036,GO:0098759,1,0.980208853863844,0,3,cellular response to interleukin-8,BP,
18037,GO:0098760,1,0.88844854327436,0,19,response to interleukin-7,BP,
18038,GO:0098761,1,0.88844854327436,0,19,cellular response to interleukin-7,BP,
18039,GO:0098770,1,0.98231911588931,0,2,FBXO family protein binding,MF,
18043,GO:0098779,1,0.946724065385845,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
18044,GO:0098780,1,0.892137931657121,0,17,response to mitochondrial depolarisation,BP,
18045,GO:0098781,1,0.567356863173743,0,94,ncRNA transcription,BP,
18046,GO:0098782,1,0.995723365047967,0,1,mechanosensitived potassium channel activity,MF,
18047,GO:0098787,1,0.910343349811861,0,14,mRNA cleavage involved in mRNA processing,BP,
18048,GO:0098789,1,0.929350407071553,0,11,pre-mRNA cleavage required for polyadenylation,BP,
18050,GO:0098792,1,0.932746968913849,0,10,xenophagy,BP,
18053,GO:0098795,1,0.985858799896337,0,2,mRNA cleavage involved in gene silencing,BP,
18056,GO:0098798,1,0.385875436812224,0,217,mitochondrial protein complex,CC,
18057,GO:0098799,1,0.93951203269072,0,12,outer mitochondrial membrane protein complex,CC,
18058,GO:0098800,1,0.651167866218812,0,100,inner mitochondrial membrane protein complex,CC,
18061,GO:0098803,1,0.77248560111798,0,69,respiratory chain complex,CC,
18063,GO:0098808,1,0.988701166861222,0,2,mRNA cap binding,MF,
18064,GO:0098809,1,0.993678504419862,0,1,nitrite reductase activity,MF,
18065,GO:0098810,1,0.906347567168188,0,16,neurotransmitter reuptake,BP,
18066,GO:0098813,1,0.153320416415819,0,279,nuclear chromosome segregation,BP,
18067,GO:0098814,1,0.964629858672448,0,5,spontaneous synaptic transmission,BP,
18068,GO:0098815,1,0.760939110682305,0,38,modulation of excitatory postsynaptic potential,BP,
18069,GO:0098816,1,0.99516559747793,0,1,mini excitatory postsynaptic potential,BP,
18070,GO:0098821,1,0.962888609157537,0,5,BMP receptor activity,MF,
18071,GO:0098822,1,0.99404713979306,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18072,GO:0098826,1,0.975504056455607,0,4,endoplasmic reticulum tubular network membrane,CC,
18074,GO:0098828,1,0.946250847113603,0,7,modulation of inhibitory postsynaptic potential,BP,
18075,GO:0098829,1,0.991848755080535,0,1,intestinal folate absorption,BP,
18076,GO:0098830,1,0.992336742575057,0,1,presynaptic endosome,CC,
18077,GO:0098831,1,0.918313112846876,0,9,presynaptic active zone cytoplasmic component,CC,
18078,GO:0098833,1,0.992308209475243,0,1,presynaptic endocytic zone,CC,
18079,GO:0098835,1,0.992308209475243,0,1,presynaptic endocytic zone membrane,CC,
18080,GO:0098837,1,0.982708375986868,0,3,postsynaptic recycling endosome,CC,
18081,GO:0098838,1,0.993181085075676,0,1,reduced folate transmembrane transport,BP,
18082,GO:0098839,1,0.789984338045219,0,32,postsynaptic density membrane,CC,
18083,GO:0098840,1,0.973176970874576,0,4,protein transport along microtubule,BP,
18084,GO:0098842,1,0.988847504811067,0,2,postsynaptic early endosome,CC,
18085,GO:0098843,1,0.962749430152645,0,6,postsynaptic endocytic zone,CC,
18086,GO:0098844,1,0.976794856278203,0,3,postsynaptic endocytic zone membrane,CC,
18087,GO:0098845,1,0.964399958627883,0,6,postsynaptic endosome,CC,
18088,GO:0098847,1,0.92223141608125,0,13,sequence-specific single stranded DNA binding,MF,
18089,GO:0098850,1,0.995397073095079,0,1,extrinsic component of synaptic vesicle membrane,CC,
18091,GO:0098855,1,0.976552269957359,0,3,HCN channel complex,CC,
18092,GO:0098856,1,0.95423447081633,0,8,intestinal lipid absorption,BP,
18096,GO:0098868,1,0.850918747219892,0,24,bone growth,BP,
18097,GO:0098869,1,0.656248289573808,0,82,cellular oxidant detoxification,BP,
18098,GO:0098870,1,0.962129572934258,0,6,action potential propagation,BP,
18099,GO:0098871,1,0.995973046720617,0,1,postsynaptic actin cytoskeleton,CC,
18100,GO:0098875,1,0.992355201306378,0,1,epididymosome,CC,
18101,GO:0098876,1,0.635040491444003,0,68,vesicle-mediated transport to the plasma membrane,BP,
18102,GO:0098877,1,0.936592031864543,0,10,neurotransmitter receptor transport to plasma membrane,BP,
18103,GO:0098878,1,0.703868616827152,0,51,neurotransmitter receptor complex,CC,
18104,GO:0098881,1,0.975025566105209,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18105,GO:0098883,1,0.995741448477009,0,1,synapse disassembly,BP,
18106,GO:0098884,1,0.976794856278203,0,3,postsynaptic neurotransmitter receptor internalization,BP,
18107,GO:0098885,1,0.991598619748373,0,1,modification of postsynaptic actin cytoskeleton,BP,
18108,GO:0098886,1,0.98561417418795,0,2,modification of dendritic spine,BP,
18109,GO:0098887,1,0.972786859003121,0,4,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18110,GO:0098888,1,0.991583489317272,0,1,extrinsic component of presynaptic membrane,CC,
18111,GO:0098889,1,0.972487257156885,0,4,intrinsic component of presynaptic membrane,CC,
18112,GO:0098890,1,0.991583489317272,0,1,extrinsic component of postsynaptic membrane,CC,
18113,GO:0098895,1,0.992441856564074,0,1,postsynaptic endosome membrane,CC,
18114,GO:0098900,1,0.720745283953809,0,44,regulation of action potential,BP,
18115,GO:0098901,1,0.81837581401919,0,25,regulation of cardiac muscle cell action potential,BP,
18116,GO:0098902,1,0.972012855314025,0,4,regulation of membrane depolarization during action potential,BP,
18117,GO:0098903,1,0.942052530000665,0,8,regulation of membrane repolarization during action potential,BP,
18118,GO:0098904,1,0.981267996574228,0,2,regulation of AV node cell action potential,BP,
18119,GO:0098905,1,0.996970370494348,0,1,regulation of bundle of His cell action potential,BP,
18120,GO:0098907,1,0.978572968816946,0,2,regulation of SA node cell action potential,BP,
18121,GO:0098908,1,0.975057732811548,0,4,regulation of neuronal action potential,BP,
18122,GO:0098909,1,0.950811133779379,0,7,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18123,GO:0098910,1,0.955289106096754,0,5,regulation of atrial cardiac muscle cell action potential,BP,
18124,GO:0098911,1,0.890892488008361,0,14,regulation of ventricular cardiac muscle cell action potential,BP,
18125,GO:0098912,1,0.972628844839556,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18126,GO:0098914,1,0.959204108767027,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18127,GO:0098915,1,0.922009439354058,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18129,GO:0098917,1,0.952194075434542,0,7,retrograde trans-synaptic signaling,BP,
18130,GO:0098918,1,0.995727898881487,0,1,structural constituent of synapse,MF,
18131,GO:0098920,1,0.985535298115803,0,2,retrograde trans-synaptic signaling by lipid,BP,
18132,GO:0098921,1,0.985535298115803,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
18133,GO:0098923,1,0.991623836653499,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18134,GO:0098924,1,0.991623836653499,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18135,GO:0098926,1,0.991689672185962,0,1,postsynaptic signal transduction,BP,
18137,GO:0098928,1,0.973454107351972,0,2,presynaptic signal transduction,BP,
18138,GO:0098930,1,0.739518336193268,0,45,axonal transport,BP,
18139,GO:0098935,1,0.961110414709597,0,5,dendritic transport,BP,
18140,GO:0098936,1,0.924504190736628,0,10,intrinsic component of postsynaptic membrane,CC,
18141,GO:0098937,1,0.961110414709597,0,5,anterograde dendritic transport,BP,
18142,GO:0098939,1,0.99183253725965,0,1,dendritic transport of mitochondrion,BP,
18143,GO:0098942,1,0.992315544998241,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18144,GO:0098943,1,0.964755531795546,0,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18145,GO:0098945,1,0.992419276287048,0,1,intrinsic component of presynaptic active zone membrane,CC,
18146,GO:0098948,1,0.965360810387674,0,4,intrinsic component of postsynaptic specialization membrane,CC,
18147,GO:0098953,1,0.957576460240743,0,8,receptor diffusion trapping,BP,
18148,GO:0098957,1,0.972853503349267,0,4,anterograde axonal transport of mitochondrion,BP,
18149,GO:0098960,1,0.77290379999418,0,37,postsynaptic neurotransmitter receptor activity,MF,
18150,GO:0098961,1,0.991692421616366,0,1,dendritic transport of ribonucleoprotein complex,BP,
18151,GO:0098963,1,0.991692421616366,0,1,dendritic transport of messenger ribonucleoprotein complex,BP,
18152,GO:0098964,1,0.991692421616366,0,1,anterograde dendritic transport of messenger ribonucleoprotein complex,BP,
18153,GO:0098967,1,0.975025566105209,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18154,GO:0098968,1,0.992241678186921,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18155,GO:0098969,1,0.943539161662305,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
18156,GO:0098970,1,0.957576460240743,0,8,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18157,GO:0098971,1,0.969027490781999,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18158,GO:0098972,1,0.99183253725965,0,1,anterograde dendritic transport of mitochondrion,BP,
18159,GO:0098973,1,0.995727898881487,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18160,GO:0098974,1,0.995727898881487,0,1,postsynaptic actin cytoskeleton organization,BP,
18161,GO:0098976,1,0.93939241581324,0,8,excitatory chemical synaptic transmission,BP,
18162,GO:0098978,1,0.953580312154732,0,6,glutamatergic synapse,CC,
18163,GO:0098982,1,0.962617245812783,0,5,GABA-ergic synapse,CC,
18164,GO:0098983,1,0.969528910177912,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18166,GO:0098985,1,0.953580312154732,0,6,asymmetric, glutamatergic, excitatory synapse,CC,
18167,GO:0098988,1,0.954629857839462,0,6,G-protein coupled glutamate receptor activity,MF,
18168,GO:0098989,1,0.987936774352453,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18169,GO:0098992,1,0.994003222803113,0,1,neuronal dense core vesicle,CC,
18170,GO:0098993,1,0.954407739965799,0,9,anchored component of synaptic vesicle membrane,CC,
18171,GO:0098999,1,0.992441856564074,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18172,GO:0099003,1,0.393599826388084,0,135,vesicle-mediated transport in synapse,BP,
18173,GO:0099004,1,0.968760898403061,0,5,calmodulin dependent kinase signaling pathway,BP,
18174,GO:0099010,1,0.977332411535146,0,3,modification of postsynaptic structure,BP,
18175,GO:0099011,1,0.959035414415436,0,5,neuronal dense core vesicle exocytosis,BP,
18176,GO:0099022,1,0.989312846554209,0,2,vesicle tethering,BP,
18177,GO:0099023,1,0.626541281471082,0,69,tethering complex,CC,
18178,GO:0099024,1,0.72504597023781,0,53,plasma membrane invagination,BP,
18179,GO:0099038,1,0.992321133298754,0,1,ceramide-translocating ATPase activity,MF,
18180,GO:0099039,1,0.984257638814584,0,2,sphingolipid translocation,BP,
18181,GO:0099040,1,0.992321133298754,0,1,ceramide translocation,BP,
18182,GO:0099044,1,0.989312846554209,0,2,vesicle tethering to endoplasmic reticulum,BP,
18183,GO:0099046,1,0.996402165196368,0,1,clearance of foreign intracellular nucleic acids,BP,
18184,GO:0099050,1,0.993392394526503,0,1,vesicle scission,BP,
18185,GO:0099053,1,0.980707345942608,0,3,activating signal cointegrator 1 complex,CC,
18186,GO:0099054,1,0.874281596503612,0,18,presynapse assembly,BP,
18187,GO:0099055,1,0.924504190736628,0,10,integral component of postsynaptic membrane,CC,
18188,GO:0099056,1,0.972487257156885,0,4,integral component of presynaptic membrane,CC,
18189,GO:0099059,1,0.992419276287048,0,1,integral component of presynaptic active zone membrane,CC,
18190,GO:0099060,1,0.965360810387674,0,4,integral component of postsynaptic specialization membrane,CC,
18191,GO:0099061,1,0.97273697286096,0,3,integral component of postsynaptic density membrane,CC,
18192,GO:0099068,1,0.875817598645659,0,17,postsynapse assembly,BP,
18193,GO:0099072,1,0.882499701046772,0,20,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,
18194,GO:0099073,1,0.985089231808859,0,2,mitochondrion-derived vesicle,CC,
18195,GO:0099074,1,0.986228534348123,0,2,mitochondrion to lysosome transport,BP,
18196,GO:0099075,1,0.986228534348123,0,2,mitochondrion-derived vesicle mediated transport,BP,
18197,GO:0099077,1,0.992079220915459,0,1,histone-dependent DNA binding,MF,
18198,GO:0099078,1,0.982601885912581,0,4,BORC complex,CC,
18201,GO:0099082,1,0.981884562543511,0,3,retrograde trans-synaptic signaling by neuropeptide,BP,
18202,GO:0099083,1,0.989353782077906,0,2,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18203,GO:0099084,1,0.887860201456625,0,15,postsynaptic specialization organization,BP,
18204,GO:0099086,1,0.82794858939044,0,31,synaptonemal structure,CC,
18205,GO:0099089,1,0.989496331893906,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18206,GO:0099093,1,0.985522312330106,0,2,calcium export from the mitochondrion,BP,
18208,GO:0099095,1,0.882967091996487,0,18,ligand-gated anion channel activity,MF,
18209,GO:0099098,1,0.992692029237482,0,1,microtubule polymerization based movement,BP,
18210,GO:0099103,1,0.979128964949732,0,4,channel activator activity,MF,
18211,GO:0099104,1,0.979128964949732,0,4,potassium channel activator activity,MF,
18212,GO:0099106,1,0.588161655550095,0,86,ion channel regulator activity,MF,
18214,GO:0099116,1,0.922161429997932,0,16,tRNA 5'-end processing,BP,
18215,GO:0099118,1,0.973176970874576,0,4,microtubule-based protein transport,BP,
18216,GO:0099122,1,0.979026205606676,0,3,RNA polymerase II C-terminal domain binding,MF,
18217,GO:0099130,1,0.994663259074361,0,1,estrogen binding,MF,
18218,GO:0099131,1,0.847734045805255,0,28,ATP hydrolysis coupled ion transmembrane transport,BP,
18219,GO:0099132,1,0.738016323745311,0,45,ATP hydrolysis coupled cation transmembrane transport,BP,
18220,GO:0099133,1,0.911781782600726,0,12,ATP hydrolysis coupled anion transmembrane transport,BP,
18221,GO:0099142,1,0.99195842197487,0,1,intracellularly ATP-gated ion channel activity,MF,
18222,GO:0099146,1,0.97273697286096,0,3,intrinsic component of postsynaptic density membrane,CC,
18223,GO:0099159,1,0.991598619748373,0,1,regulation of modification of postsynaptic structure,BP,
18224,GO:0099163,1,0.991623836653499,0,1,synaptic signaling by nitric oxide,BP,
18225,GO:0099170,1,0.97881735615612,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
18226,GO:0099172,1,0.864393503812939,0,20,presynapse organization,BP,
18227,GO:0099173,1,0.503039164202651,0,97,postsynapse organization,BP,
18228,GO:0099174,1,0.962953711409489,0,5,regulation of presynapse organization,BP,
18229,GO:0099175,1,0.689009823834322,0,53,regulation of postsynapse organization,BP,
18231,GO:0099186,1,0.995727898881487,0,1,structural constituent of postsynapse,MF,
18232,GO:0099188,1,0.995727898881487,0,1,postsynaptic cytoskeleton organization,BP,
18233,GO:0099240,1,0.924504190736628,0,10,intrinsic component of synaptic membrane,CC,
18234,GO:0099243,1,0.991583489317272,0,1,extrinsic component of synaptic membrane,CC,
18235,GO:0099400,1,0.990820996121129,0,1,caveola neck,CC,
18236,GO:0099402,1,0.996992964303392,0,1,plant organ development,BP,
18237,GO:0099403,1,0.980769719219505,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18238,GO:0099404,1,0.980769719219505,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18239,GO:0099500,1,0.910642585703356,0,16,vesicle fusion to plasma membrane,BP,
18240,GO:0099501,1,0.562808482445744,0,91,exocytic vesicle membrane,CC,
18242,GO:0099504,1,0.408641083766878,0,128,synaptic vesicle cycle,BP,
18243,GO:0099509,1,0.986670799604189,0,3,regulation of presynaptic cytosolic calcium ion concentration,BP,
18246,GO:0099514,1,0.903718454540604,0,17,synaptic vesicle cytoskeletal transport,BP,
18248,GO:0099516,1,0.675204747733947,0,56,ion antiporter activity,MF,
18249,GO:0099517,1,0.903718454540604,0,17,synaptic vesicle transport along microtubule,BP,
18251,GO:0099519,1,0.993301131169352,0,1,dense core granule cytoskeletal transport,BP,
18252,GO:0099522,1,0.995173463265661,0,1,region of cytosol,CC,
18253,GO:0099523,1,0.995173463265661,0,1,presynaptic cytosol,CC,
18254,GO:0099524,1,0.995173463265661,0,1,postsynaptic cytosol,CC,
18255,GO:0099525,1,0.959035414415436,0,5,presynaptic dense core vesicle exocytosis,BP,
18256,GO:0099526,1,0.973454107351972,0,2,presynapse to nucleus signaling pathway,BP,
18257,GO:0099527,1,0.991689672185962,0,1,postsynapse to nucleus signaling pathway,BP,
18258,GO:0099528,1,0.854970822405425,0,26,G-protein coupled neurotransmitter receptor activity,MF,
18259,GO:0099529,1,0.786194341923497,0,35,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18260,GO:0099530,1,0.98313699760533,0,2,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18261,GO:0099531,1,0.367702690116764,0,149,presynaptic process involved in chemical synaptic transmission,BP,
18262,GO:0099532,1,0.9837097215174,0,2,synaptic vesicle endosomal processing,BP,
18265,GO:0099538,1,0.973669196358078,0,4,synaptic signaling via neuropeptide,BP,
18266,GO:0099540,1,0.973669196358078,0,4,trans-synaptic signaling by neuropeptide,BP,
18267,GO:0099541,1,0.961962033377701,0,5,trans-synaptic signaling by lipid,BP,
18268,GO:0099542,1,0.961962033377701,0,5,trans-synaptic signaling by endocannabinoid,BP,
18269,GO:0099543,1,0.991623836653499,0,1,trans-synaptic signaling by soluble gas,BP,
18270,GO:0099545,1,0.984699297022393,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18271,GO:0099547,1,0.97881735615612,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18272,GO:0099548,1,0.991623836653499,0,1,trans-synaptic signaling by nitric oxide,BP,
18273,GO:0099550,1,0.950256280819903,0,7,trans-synaptic signaling, modulating synaptic transmission,BP,
18274,GO:0099551,1,0.981076571237633,0,3,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18275,GO:0099552,1,0.976084333028978,0,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18276,GO:0099553,1,0.976084333028978,0,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18277,GO:0099557,1,0.992325385720723,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18278,GO:0099558,1,0.992653437954435,0,2,maintenance of synapse structure,BP,
18279,GO:0099560,1,0.976117285102306,0,3,synaptic membrane adhesion,BP,
18280,GO:0099563,1,0.925492131502526,0,11,modification of synaptic structure,BP,
18281,GO:0099565,1,0.435382593548608,0,120,chemical synaptic transmission, postsynaptic,BP,
18282,GO:0099566,1,0.975356758288682,0,3,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18284,GO:0099569,1,0.935850955086917,0,7,presynaptic cytoskeleton,CC,
18285,GO:0099571,1,0.995973046720617,0,1,postsynaptic cytoskeleton,CC,
18287,GO:0099578,1,0.97881735615612,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18288,GO:0099580,1,0.984285892294908,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18289,GO:0099583,1,0.975356758288682,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18290,GO:0099587,1,0.715451564298649,0,48,inorganic ion import across plasma membrane,BP,
18291,GO:0099589,1,0.931703363454642,0,13,serotonin receptor activity,MF,
18292,GO:0099590,1,0.937514247936973,0,11,neurotransmitter receptor internalization,BP,
18293,GO:0099601,1,0.747280512326426,0,44,regulation of neurotransmitter receptor activity,BP,
18294,GO:0099602,1,0.965631596745263,0,7,neurotransmitter receptor regulator activity,MF,
18295,GO:0099604,1,0.80240988883729,0,27,ligand-gated calcium channel activity,MF,
18296,GO:0099606,1,0.991065871143919,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18297,GO:0099607,1,0.991065871143919,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18298,GO:0099609,1,0.984177120175445,0,2,microtubule lateral binding,MF,
18300,GO:0099617,1,0.992582389285086,0,1,matrix side of mitochondrial inner membrane,CC,
18303,GO:0099624,1,0.933352565256317,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18305,GO:0099628,1,0.957576460240743,0,8,neurotransmitter receptor diffusion trapping,BP,
18306,GO:0099631,1,0.993492786312883,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18307,GO:0099632,1,0.895947375691473,0,18,protein transport within plasma membrane,BP,
18308,GO:0099634,1,0.780986445200038,0,34,postsynaptic specialization membrane,CC,
18309,GO:0099637,1,0.895947375691473,0,18,neurotransmitter receptor transport,BP,
18310,GO:0099638,1,0.965626650962672,0,5,endosome to plasma membrane protein transport,BP,
18311,GO:0099639,1,0.965626650962672,0,5,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18312,GO:0099640,1,0.988653717557579,0,2,axo-dendritic protein transport,BP,
18313,GO:0099641,1,0.996936106673741,0,1,anterograde axonal protein transport,BP,
18314,GO:0099643,1,0.388661240474797,0,139,signal release from synapse,BP,
18315,GO:0099699,1,0.924504190736628,0,10,integral component of synaptic membrane,CC,
18317,GO:0100001,1,0.992194706378963,0,1,regulation of skeletal muscle contraction by action potential,BP,
18318,GO:0100002,1,0.993135804905899,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18319,GO:0100012,1,0.992497018470544,0,2,regulation of heart induction by canonical Wnt signaling pathway,BP,
18320,GO:0100057,1,0.99145493844251,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18321,GO:0101002,1,0.353911806246873,0,179,ficolin-1-rich granule,CC,
18322,GO:0101003,1,0.700556179277558,0,56,ficolin-1-rich granule membrane,CC,
18323,GO:0101005,1,0.532665865479656,0,88,ubiquitinyl hydrolase activity,MF,
18324,GO:0101006,1,0.98598680074517,0,3,protein histidine phosphatase activity,MF,
18325,GO:0101020,1,0.985113960995693,0,3,estrogen 16-alpha-hydroxylase activity,MF,
18326,GO:0101023,1,0.907745655584519,0,14,vascular endothelial cell proliferation,BP,
18327,GO:0101030,1,0.996545095529736,0,1,tRNA-guanine transglycosylation,BP,
18328,GO:0101031,1,0.93382032464962,0,12,chaperone complex,CC,
18329,GO:0102005,1,0.99630191187714,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18330,GO:0102007,1,0.988677855338752,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18331,GO:0102008,1,0.992292908080913,0,1,cytosolic dipeptidase activity,MF,
18332,GO:0102009,1,0.995525698873282,0,1,proline dipeptidase activity,MF,
18333,GO:0102076,1,0.993147797100392,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18334,GO:0102077,1,0.990229364657098,0,2,oleamide hydrolase activity,MF,
18335,GO:0102084,1,0.987440731538708,0,2,L-dopa O-methyltransferase activity,MF,
18336,GO:0102092,1,0.984394782059489,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18338,GO:0102113,1,0.991705456451615,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18339,GO:0102121,1,0.981299484372816,0,3,ceramidase activity,MF,
18340,GO:0102131,1,0.991128561445219,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18341,GO:0102132,1,0.991128561445219,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18342,GO:0102148,1,0.984298383811497,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
18343,GO:0102158,1,0.97346982547759,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18344,GO:0102166,1,0.992262656016188,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18345,GO:0102167,1,0.992262656016188,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18346,GO:0102200,1,0.992241408381996,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
18347,GO:0102250,1,0.978377349657531,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18348,GO:0102279,1,0.992323437932328,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18349,GO:0102336,1,0.960403079992839,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18350,GO:0102337,1,0.960403079992839,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18351,GO:0102338,1,0.960403079992839,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18352,GO:0102339,1,0.993823902579241,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18353,GO:0102340,1,0.993823902579241,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18354,GO:0102341,1,0.993823902579241,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18355,GO:0102342,1,0.993823902579241,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18356,GO:0102343,1,0.97346982547759,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18357,GO:0102344,1,0.97346982547759,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18358,GO:0102345,1,0.97346982547759,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18359,GO:0102389,1,0.99354439408096,0,1,polyprenol reductase activity,MF,
18360,GO:0102390,1,0.993585275983718,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18361,GO:0102391,1,0.951234227771213,0,7,decanoate-CoA ligase activity,MF,
18362,GO:0102420,1,0.985115745393023,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18363,GO:0102483,1,0.995991896528435,0,1,scopolin beta-glucosidase activity,MF,
18364,GO:0102485,1,0.977539905058318,0,3,dATP phosphohydrolase activity,MF,
18365,GO:0102486,1,0.977539905058318,0,3,dCTP phosphohydrolase activity,MF,
18366,GO:0102487,1,0.977539905058318,0,3,dUTP phosphohydrolase activity,MF,
18367,GO:0102488,1,0.977539905058318,0,3,dTTP phosphohydrolase activity,MF,
18368,GO:0102489,1,0.977539905058318,0,3,GTP phosphohydrolase activity,MF,
18369,GO:0102490,1,0.977539905058318,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18370,GO:0102491,1,0.977539905058318,0,3,dGTP phosphohydrolase activity,MF,
18371,GO:0102499,1,0.978377349657531,0,3,SHG alpha-glucan phosphorylase activity,MF,
18372,GO:0102500,1,0.991602832809476,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18373,GO:0102521,1,0.99261347256243,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18374,GO:0102522,1,0.99469316969247,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18375,GO:0102524,1,0.993301131169352,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18376,GO:0102555,1,0.99689899171961,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18377,GO:0102567,1,0.913663965870126,0,15,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
18378,GO:0102568,1,0.913663965870126,0,15,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
18379,GO:0102571,1,0.992262656016188,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18380,GO:0102704,1,0.9930684450796,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18381,GO:0102707,1,0.993786976600625,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18382,GO:0102751,1,0.988367730115849,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18383,GO:0102752,1,0.992800822324919,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18384,GO:0102756,1,0.960403079992839,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18385,GO:0102758,1,0.996729560700568,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18386,GO:0102769,1,0.996090449691365,0,1,dihydroceramide glucosyltransferase activity,MF,
18387,GO:0102773,1,0.99240818721171,0,1,dihydroceramide kinase activity,MF,
18388,GO:0102797,1,0.992305815492825,0,1,geranial:oxygen oxidoreductase activity,MF,
18389,GO:0102798,1,0.992305815492825,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18390,GO:0102867,1,0.993379919360459,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18391,GO:0102938,1,0.987440731538708,0,2,orcinol O-methyltransferase activity,MF,
18392,GO:0102953,1,0.981888104015278,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18393,GO:0102965,1,0.987257508094376,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18394,GO:0102991,1,0.971948924502999,0,6,myristoyl-CoA hydrolase activity,MF,
18395,GO:0103025,1,0.990888155496655,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18396,GO:0103045,1,0.995070552042379,0,1,methione N-acyltransferase activity,MF,
18397,GO:0103046,1,0.992292908080913,0,1,alanylglutamate dipeptidase activity,MF,
18398,GO:0103053,1,0.990643076173354,0,2,1-ethyladenine demethylase activity,MF,
18399,GO:0103066,1,0.996150435644657,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18400,GO:0103067,1,0.996150435644657,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18401,GO:0103068,1,0.981888104015278,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18402,GO:0103073,1,0.990229364657098,0,2,anandamide amidohydrolase activity,MF,
18405,GO:0106001,1,0.958598405583246,0,6,intestinal hexose absorption,BP,
18406,GO:0106003,1,0.925146125268674,0,11,amyloid-beta complex,CC,
18407,GO:0106004,1,0.992386880423274,0,2,tRNA (guanine-N7)-methylation,BP,
18408,GO:0106005,1,0.991939458536388,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18409,GO:0106014,1,0.989539597882091,0,2,regulation of inflammatory response to wounding,BP,
18410,GO:0106015,1,0.989539597882091,0,2,negative regulation of inflammatory response to wounding,BP,
18411,GO:0106017,1,0.972327479156576,0,4,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18412,GO:0106018,1,0.891433726159524,0,15,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18413,GO:0106019,1,0.928303234737247,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18414,GO:0106020,1,0.987074317571891,0,2,regulation of vesicle docking,BP,
18415,GO:0106022,1,0.99246301144962,0,1,positive regulation of vesicle docking,BP,
18416,GO:0106027,1,0.605834872320849,0,69,neuron projection organization,BP,
18417,GO:0106028,1,0.992325385720723,0,1,neuron projection retraction,BP,
18419,GO:0106044,1,0.99691333883606,0,1,guanine deglycation,BP,
18420,GO:0106045,1,0.99691333883606,0,1,guanine deglycation, methylglyoxal removal,BP,
18421,GO:0106046,1,0.99691333883606,0,1,guanine deglycation, glyoxal removal,BP,
18422,GO:0106049,1,0.964461520623719,0,6,regulation of cellular response to osmotic stress,BP,
18423,GO:0106050,1,0.99536680713459,0,1,tRNA 2'-O-methyltransferase activity,MF,
18425,GO:0106057,1,0.977849778104315,0,3,negative regulation of calcineurin-mediated signaling,BP,
18427,GO:0106064,1,0.992077520282848,0,1,regulation of cobalamin metabolic process,BP,
18428,GO:0106068,1,0.970976915205405,0,6,SUMO ligase complex,CC,
18429,GO:0106070,1,0.936678266046044,0,10,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18430,GO:0106071,1,0.969453652481169,0,5,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18431,GO:0106072,1,0.958176417069266,0,7,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18432,GO:0106073,1,0.983339215139278,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18433,GO:0106074,1,0.929127769016286,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18434,GO:0106075,1,0.992785202661075,0,1,peptide N-succinyltransferase activity,MF,
18435,GO:0106077,1,0.971194972803642,0,4,histone succinylation,BP,
18436,GO:0106078,1,0.992785202661075,0,1,histone succinyltransferase activity,MF,
18437,GO:0106083,1,0.944162151100683,0,7,nuclear membrane protein complex,CC,
18438,GO:0106088,1,0.991719474084904,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18439,GO:0106089,1,0.991719474084904,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18440,GO:0106094,1,0.944162151100683,0,7,nuclear membrane microtubule tethering complex,CC,
18441,GO:0106101,1,0.995643840348478,0,1,ER-dependent peroxisome localization,BP,
18442,GO:0106104,1,0.977778078055538,0,3,regulation of glutamate receptor clustering,BP,
18443,GO:0110008,1,0.992865576286734,0,1,ncRNA deadenylation,BP,
18444,GO:0110009,1,0.976900786195018,0,3,formin-nucleated actin cable organization,BP,
18445,GO:0110011,1,0.959841143888677,0,5,regulation of basement membrane organization,BP,
18446,GO:0110017,1,0.993040089609704,0,2,cap-independent translational initiation of linear mRNA,BP,
18447,GO:0110020,1,0.571512707198882,0,81,regulation of actomyosin structure organization,BP,
18448,GO:0110021,1,0.980125202679909,0,3,cardiac muscle myoblast proliferation,BP,
18449,GO:0110022,1,0.980125202679909,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18450,GO:0110024,1,0.980125202679909,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18451,GO:0110025,1,0.992860222261977,0,1,DNA strand resection involved in replication fork processing,BP,
18452,GO:0110026,1,0.992860222261977,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18453,GO:0110028,1,0.991604937803894,0,1,positive regulation of mitotic spindle organization,BP,
18454,GO:0110029,1,0.992754525211575,0,1,negative regulation of meiosis I,BP,
18456,GO:0110057,1,0.992163989909713,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18457,GO:0110059,1,0.992163989909713,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18458,GO:0110075,1,0.996909045761111,0,1,regulation of ferroptosis,BP,
18459,GO:0110076,1,0.996909045761111,0,1,negative regulation of ferroptosis,BP,
18460,GO:0110095,1,0.987246492772259,0,3,cellular detoxification of aldehyde,BP,
18461,GO:0110096,1,0.978535057719777,0,5,cellular response to aldehyde,BP,
18462,GO:0120009,1,0.969096010118105,0,5,intermembrane lipid transfer,BP,
18463,GO:0120012,1,0.992187253738381,0,1,intermembrane sphingolipid transfer,BP,
18464,GO:0120013,1,0.969096010118105,0,5,intermembrane lipid transfer activity,MF,
18465,GO:0120016,1,0.992187253738381,0,1,intermembrane sphingolipid transfer activity,MF,
18466,GO:0120017,1,0.992187253738381,0,1,intermembrane ceramide transfer activity,MF,
18470,GO:0120033,1,0.885831941539863,0,20,negative regulation of plasma membrane bounded cell projection assembly,BP,
18476,GO:0120043,1,0.992353950766882,0,1,stereocilium shaft,CC,
18477,GO:0120044,1,0.992353950766882,0,1,stereocilium base,CC,
18478,GO:0120048,1,0.993301131169352,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18479,GO:0120049,1,0.993301131169352,0,1,snRNA (adenine-N6)-methylation,BP,
18480,GO:0120054,1,0.997018312941827,0,1,intestinal motility,BP,
18481,GO:0120055,1,0.997018312941827,0,1,small intestinal transit,BP,
18482,GO:0120057,1,0.997018312941827,0,1,regulation of small intestinal transit,BP,
18483,GO:0120058,1,0.997018312941827,0,1,positive regulation of small intestinal transit,BP,
18484,GO:0120060,1,0.996976979760557,0,1,regulation of gastric emptying,BP,
18485,GO:0120061,1,0.996976979760557,0,1,negative regulation of gastric emptying,BP,
18486,GO:0120063,1,0.989249357485497,0,2,stomach smooth muscle contraction,BP,
18487,GO:0120064,1,0.992249190269564,0,1,stomach pylorus smooth muscle contraction,BP,
18488,GO:0120065,1,0.992249190269564,0,1,pyloric antrum smooth muscle contraction,BP,
18489,GO:0120068,1,0.996976979760557,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18490,GO:0120069,1,0.996976979760557,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18491,GO:0120071,1,0.992249190269564,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18492,GO:0120072,1,0.992249190269564,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18493,GO:0120077,1,0.991719474084904,0,1,angiogenic sprout fusion,BP,
18494,GO:0120078,1,0.991719474084904,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18495,GO:0120092,1,0.992598409380679,0,1,crotonyl-CoA hydratase activity,MF,
18496,GO:0120093,1,0.992598409380679,0,1,regulation of peptidyl-lysine crotonylation,BP,
18497,GO:0120094,1,0.992598409380679,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18498,GO:0120103,1,0.934938555709426,0,9,centriolar subdistal appendage,CC,
18499,GO:0120108,1,0.995207441959663,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
18500,GO:0120111,1,0.637991412389464,0,67,neuron projection cytoplasm,CC,
18501,GO:0120114,1,0.641409295117441,0,79,Sm-like protein family complex,CC,
18502,GO:0140007,1,0.977427885574494,0,4,KICSTOR complex,CC,
18503,GO:0140009,1,0.98503134314209,0,2,L-aspartate import across plasma membrane,BP,
18504,GO:0140013,1,0.401127418140598,0,143,meiotic nuclear division,BP,
18506,GO:0140029,1,0.621239530549073,0,76,exocytic process,BP,
18507,GO:0140030,1,0.455256009834784,0,113,modification-dependent protein binding,MF,
18508,GO:0140031,1,0.987463326479149,0,2,phosphorylation-dependent protein binding,MF,
18509,GO:0140033,1,0.875451084046891,0,17,acetylation-dependent protein binding,MF,
18510,GO:0140034,1,0.681976181345547,0,56,methylation-dependent protein binding,MF,
18511,GO:0140035,1,0.965223879696457,0,5,ubiquitination-like modification-dependent protein binding,MF,
18512,GO:0140036,1,0.965223879696457,0,5,ubiquitin-dependent protein binding,MF,
18513,GO:0140041,1,0.99691333883606,0,1,cellular detoxification of methylglyoxal,BP,
18514,GO:0140049,1,0.996037623304787,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18515,GO:0140051,1,0.996037623304787,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18516,GO:0140052,1,0.96657388750195,0,5,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18517,GO:0140053,1,0.482691977318453,0,151,mitochondrial gene expression,BP,
18520,GO:0140059,1,0.96657106857239,0,5,dendrite arborization,BP,
18521,GO:0140064,1,0.991014724697578,0,1,peptide crotonyltransferase activity,MF,
18522,GO:0140065,1,0.991014724697578,0,1,peptide butyryltransferase activity,MF,
18523,GO:0140066,1,0.983678953270075,0,2,peptidyl-lysine crotonylation,BP,
18524,GO:0140067,1,0.991014724697578,0,1,peptidyl-lysine butyrylation,BP,
18525,GO:0140068,1,0.991014724697578,0,1,histone crotonyltransferase activity,MF,
18526,GO:0140069,1,0.991014724697578,0,1,histone butyryltransferase activity,MF,
18527,GO:0140074,1,0.99224865643856,0,1,cardiac endothelial to mesenchymal transition,BP,
18528,GO:0140078,1,0.952725334913175,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18529,GO:0140080,1,0.952725334913175,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18531,GO:0140097,1,0.313987750178952,0,181,catalytic activity, acting on DNA,MF,
18532,GO:0140098,1,0.127316770523942,0,338,catalytic activity, acting on RNA,MF,
18533,GO:0140101,1,0.508699153811988,0,115,catalytic activity, acting on a tRNA,MF,
18534,GO:0140102,1,0.918585705302301,0,15,catalytic activity, acting on a rRNA,MF,
18535,GO:0140103,1,0.87972241266631,0,20,catalytic activity, acting on a glycoprotein,MF,
18538,GO:0140112,1,0.888001907797914,0,20,extracellular vesicle biogenesis,BP,
18539,GO:0140115,1,0.86477154187914,0,23,export across plasma membrane,BP,
18540,GO:0140131,1,0.936548379307268,0,12,positive regulation of lymphocyte chemotaxis,BP,
18541,GO:0140135,1,0.973658648695224,0,4,mechanosensitive cation channel activity,MF,
18542,GO:0140142,1,0.889466145137719,0,18,nucleocytoplasmic carrier activity,MF,
18543,GO:0140161,1,0.959187325251559,0,8,monocarboxylate:sodium symporter activity,MF,
18544,GO:0140192,1,0.982694791407151,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18545,GO:0140193,1,0.996531261015071,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18546,GO:0140194,1,0.996531261015071,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18547,GO:0140196,1,0.991623836653499,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18548,GO:0140199,1,0.990996315875316,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18549,GO:0140200,1,0.991268002483297,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18550,GO:0150003,1,0.972231942957863,0,4,regulation of spontaneous synaptic transmission,BP,
18551,GO:0150005,1,0.940863711911995,0,11,enzyme activator complex,CC,
18552,GO:0150011,1,0.947744687469907,0,7,regulation of neuron projection arborization,BP,
18553,GO:0150012,1,0.947744687469907,0,7,positive regulation of neuron projection arborization,BP,
18554,GO:0150018,1,0.978577272365737,0,3,basal dendrite development,BP,
18555,GO:0150019,1,0.978577272365737,0,3,basal dendrite morphogenesis,BP,
18556,GO:0150020,1,0.978577272365737,0,3,basal dendrite arborization,BP,
18557,GO:0150024,1,0.995073207414637,0,1,oxidised low-density lipoprotein particle clearance,BP,
18558,GO:0150025,1,0.995073207414637,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18559,GO:0150031,1,0.991868191082303,0,1,regulation of protein localization to lysosome,BP,
18560,GO:0150033,1,0.991868191082303,0,1,negative regulation of protein localization to lysosome,BP,
18561,GO:0150034,1,0.178264729385636,0,255,distal axon,CC,
18563,GO:1900003,1,0.971902536341926,0,6,regulation of serine-type endopeptidase activity,BP,
18564,GO:1900004,1,0.971902536341926,0,6,negative regulation of serine-type endopeptidase activity,BP,
18565,GO:1900005,1,0.990796430774423,0,1,positive regulation of serine-type endopeptidase activity,BP,
18566,GO:1900006,1,0.621115182423943,0,65,positive regulation of dendrite development,BP,
18567,GO:1900010,1,0.995659008820807,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18568,GO:1900011,1,0.995659008820807,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18571,GO:1900017,1,0.922079394490891,0,13,positive regulation of cytokine production involved in inflammatory response,BP,
18574,GO:1900024,1,0.755022438592379,0,44,regulation of substrate adhesion-dependent cell spreading,BP,
18575,GO:1900025,1,0.921259876051331,0,12,negative regulation of substrate adhesion-dependent cell spreading,BP,
18576,GO:1900026,1,0.825886068949483,0,31,positive regulation of substrate adhesion-dependent cell spreading,BP,
18577,GO:1900027,1,0.865231109399886,0,24,regulation of ruffle assembly,BP,
18578,GO:1900028,1,0.974925646472522,0,5,negative regulation of ruffle assembly,BP,
18579,GO:1900029,1,0.933942086665173,0,11,positive regulation of ruffle assembly,BP,
18580,GO:1900034,1,0.608605877085816,0,75,regulation of cellular response to heat,BP,
18581,GO:1900035,1,0.993420795687657,0,1,negative regulation of cellular response to heat,BP,
18582,GO:1900036,1,0.994359642736786,0,1,positive regulation of cellular response to heat,BP,
18583,GO:1900037,1,0.931075216222682,0,12,regulation of cellular response to hypoxia,BP,
18584,GO:1900038,1,0.95761805186716,0,7,negative regulation of cellular response to hypoxia,BP,
18585,GO:1900039,1,0.989328216693563,0,2,positive regulation of cellular response to hypoxia,BP,
18586,GO:1900040,1,0.949576879315925,0,7,regulation of interleukin-2 secretion,BP,
18587,GO:1900041,1,0.972313195326589,0,4,negative regulation of interleukin-2 secretion,BP,
18588,GO:1900042,1,0.976623014586028,0,3,positive regulation of interleukin-2 secretion,BP,
18589,GO:1900044,1,0.932913544647769,0,9,regulation of protein K63-linked ubiquitination,BP,
18590,GO:1900045,1,0.962203537541305,0,5,negative regulation of protein K63-linked ubiquitination,BP,
18593,GO:1900048,1,0.867628702218744,0,23,positive regulation of hemostasis,BP,
18594,GO:1900052,1,0.996673490117013,0,1,regulation of retinoic acid biosynthetic process,BP,
18595,GO:1900053,1,0.996673490117013,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18596,GO:1900060,1,0.978889683755966,0,4,negative regulation of ceramide biosynthetic process,BP,
18597,GO:1900062,1,0.992483374191618,0,1,regulation of replicative cell aging,BP,
18598,GO:1900063,1,0.977494594297881,0,3,regulation of peroxisome organization,BP,
18599,GO:1900073,1,0.99618994849153,0,1,regulation of neuromuscular synaptic transmission,BP,
18600,GO:1900075,1,0.99618994849153,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18602,GO:1900077,1,0.810198508237139,0,33,negative regulation of cellular response to insulin stimulus,BP,
18603,GO:1900078,1,0.832374464962276,0,26,positive regulation of cellular response to insulin stimulus,BP,
18604,GO:1900081,1,0.990996315875316,0,1,regulation of arginine catabolic process,BP,
18605,GO:1900082,1,0.990996315875316,0,1,negative regulation of arginine catabolic process,BP,
18607,GO:1900085,1,0.993518643021933,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18609,GO:1900087,1,0.842874436563169,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18610,GO:1900094,1,0.965227522005171,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18611,GO:1900095,1,0.990254426735876,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18612,GO:1900098,1,0.995733554041714,0,1,regulation of plasma cell differentiation,BP,
18613,GO:1900100,1,0.995733554041714,0,1,positive regulation of plasma cell differentiation,BP,
18615,GO:1900102,1,0.929917603168574,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18617,GO:1900104,1,0.981351708021194,0,3,regulation of hyaluranon cable assembly,BP,
18618,GO:1900106,1,0.981351708021194,0,3,positive regulation of hyaluranon cable assembly,BP,
18619,GO:1900107,1,0.962448315783375,0,7,regulation of nodal signaling pathway,BP,
18620,GO:1900108,1,0.985684061470297,0,3,negative regulation of nodal signaling pathway,BP,
18621,GO:1900109,1,0.986630774343606,0,3,regulation of histone H3-K9 dimethylation,BP,
18622,GO:1900110,1,0.992637225573399,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18623,GO:1900111,1,0.993949461983346,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18624,GO:1900112,1,0.939387027602215,0,9,regulation of histone H3-K9 trimethylation,BP,
18625,GO:1900113,1,0.970273545631432,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18626,GO:1900114,1,0.984491633007935,0,2,positive regulation of histone H3-K9 trimethylation,BP,
18627,GO:1900115,1,0.913556919312765,0,15,extracellular regulation of signal transduction,BP,
18628,GO:1900116,1,0.913556919312765,0,15,extracellular negative regulation of signal transduction,BP,
18630,GO:1900118,1,0.957011472226368,0,7,negative regulation of execution phase of apoptosis,BP,
18633,GO:1900121,1,0.937301822815186,0,11,negative regulation of receptor binding,BP,
18635,GO:1900125,1,0.949988488516091,0,7,regulation of hyaluronan biosynthetic process,BP,
18636,GO:1900126,1,0.978506980098435,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18637,GO:1900127,1,0.970861589862434,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18638,GO:1900130,1,0.992502362147741,0,1,regulation of lipid binding,BP,
18639,GO:1900131,1,0.992502362147741,0,1,negative regulation of lipid binding,BP,
18640,GO:1900133,1,0.979018570470636,0,3,regulation of renin secretion into blood stream,BP,
18641,GO:1900134,1,0.992472147985982,0,1,negative regulation of renin secretion into blood stream,BP,
18642,GO:1900135,1,0.986445436648596,0,2,positive regulation of renin secretion into blood stream,BP,
18643,GO:1900138,1,0.988767787658594,0,2,negative regulation of phospholipase A2 activity,BP,
18644,GO:1900139,1,0.992286194551312,0,1,negative regulation of arachidonic acid secretion,BP,
18645,GO:1900141,1,0.993911416934456,0,1,regulation of oligodendrocyte apoptotic process,BP,
18646,GO:1900142,1,0.993911416934456,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18647,GO:1900145,1,0.974408836987056,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18648,GO:1900146,1,0.992615319411526,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18649,GO:1900147,1,0.984955449406499,0,2,regulation of Schwann cell migration,BP,
18650,GO:1900148,1,0.993301131169352,0,1,negative regulation of Schwann cell migration,BP,
18651,GO:1900149,1,0.991598619748373,0,1,positive regulation of Schwann cell migration,BP,
18652,GO:1900150,1,0.989452565095948,0,2,regulation of defense response to fungus,BP,
18653,GO:1900151,1,0.89946051571667,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18654,GO:1900152,1,0.995700567959264,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18655,GO:1900153,1,0.89946051571667,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18660,GO:1900159,1,0.994263129730359,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18661,GO:1900161,1,0.993270968388128,0,1,regulation of phospholipid scramblase activity,BP,
18662,GO:1900163,1,0.993270968388128,0,1,positive regulation of phospholipid scramblase activity,BP,
18663,GO:1900164,1,0.965227522005171,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18664,GO:1900165,1,0.951984103143262,0,7,negative regulation of interleukin-6 secretion,BP,
18665,GO:1900166,1,0.987013944430764,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18666,GO:1900168,1,0.987013944430764,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18667,GO:1900169,1,0.982316774765602,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18668,GO:1900170,1,0.993301131169352,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18669,GO:1900175,1,0.974408836987056,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18670,GO:1900176,1,0.992615319411526,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18674,GO:1900186,1,0.981208763778804,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18675,GO:1900190,1,0.994263129730359,0,1,regulation of single-species biofilm formation,BP,
18676,GO:1900191,1,0.994263129730359,0,1,negative regulation of single-species biofilm formation,BP,
18677,GO:1900193,1,0.960649126143971,0,7,regulation of oocyte maturation,BP,
18678,GO:1900194,1,0.982590923597839,0,3,negative regulation of oocyte maturation,BP,
18679,GO:1900195,1,0.990052155842944,0,2,positive regulation of oocyte maturation,BP,
18680,GO:1900200,1,0.984972388532087,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18681,GO:1900204,1,0.984972388532087,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18682,GO:1900205,1,0.984972388532087,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18683,GO:1900208,1,0.992231599641599,0,2,regulation of cardiolipin metabolic process,BP,
18684,GO:1900210,1,0.992231599641599,0,2,positive regulation of cardiolipin metabolic process,BP,
18685,GO:1900211,1,0.984972388532087,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18686,GO:1900212,1,0.984972388532087,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18687,GO:1900214,1,0.984972388532087,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18688,GO:1900215,1,0.984972388532087,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18689,GO:1900217,1,0.984972388532087,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18690,GO:1900218,1,0.984972388532087,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18691,GO:1900220,1,0.984044368184553,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18692,GO:1900221,1,0.928853352870008,0,10,regulation of amyloid-beta clearance,BP,
18693,GO:1900222,1,0.980485863100319,0,3,negative regulation of amyloid-beta clearance,BP,
18694,GO:1900223,1,0.953367910692295,0,6,positive regulation of amyloid-beta clearance,BP,
18695,GO:1900224,1,0.985408547046198,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18696,GO:1900225,1,0.926533537751221,0,11,regulation of NLRP3 inflammasome complex assembly,BP,
18697,GO:1900226,1,0.973371122277945,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18698,GO:1900227,1,0.958183771105347,0,6,positive regulation of NLRP3 inflammasome complex assembly,BP,
18699,GO:1900228,1,0.994263129730359,0,1,regulation of single-species biofilm formation in or on host organism,BP,
18700,GO:1900229,1,0.994263129730359,0,1,negative regulation of single-species biofilm formation in or on host organism,BP,
18701,GO:1900238,1,0.978662173075826,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18702,GO:1900239,1,0.972201054894294,0,4,regulation of phenotypic switching,BP,
18703,GO:1900241,1,0.993113085520367,0,1,positive regulation of phenotypic switching,BP,
18704,GO:1900242,1,0.941197709806181,0,8,regulation of synaptic vesicle endocytosis,BP,
18705,GO:1900243,1,0.992231900912871,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18706,GO:1900244,1,0.970830699447265,0,4,positive regulation of synaptic vesicle endocytosis,BP,
18707,GO:1900245,1,0.976694061112222,0,3,positive regulation of MDA-5 signaling pathway,BP,
18708,GO:1900246,1,0.961276199429061,0,5,positive regulation of RIG-I signaling pathway,BP,
18709,GO:1900247,1,0.936145871435898,0,10,regulation of cytoplasmic translational elongation,BP,
18710,GO:1900248,1,0.984251134768779,0,2,negative regulation of cytoplasmic translational elongation,BP,
18711,GO:1900259,1,0.995528129272164,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18712,GO:1900260,1,0.995528129272164,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18713,GO:1900262,1,0.970361422297252,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18714,GO:1900264,1,0.970361422297252,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18715,GO:1900271,1,0.804005782437598,0,31,regulation of long-term synaptic potentiation,BP,
18716,GO:1900272,1,0.947624036146719,0,8,negative regulation of long-term synaptic potentiation,BP,
18717,GO:1900273,1,0.884829622360056,0,16,positive regulation of long-term synaptic potentiation,BP,
18719,GO:1900275,1,0.984737781238355,0,2,negative regulation of phospholipase C activity,BP,
18720,GO:1900276,1,0.992560719356296,0,1,regulation of proteinase activated receptor activity,BP,
18721,GO:1900279,1,0.992540479976971,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18722,GO:1900281,1,0.992540479976971,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18723,GO:1900363,1,0.921683654176474,0,12,regulation of mRNA polyadenylation,BP,
18724,GO:1900364,1,0.944682740349837,0,8,negative regulation of mRNA polyadenylation,BP,
18725,GO:1900365,1,0.979448431976018,0,3,positive regulation of mRNA polyadenylation,BP,
18726,GO:1900368,1,0.976661697075265,0,3,regulation of RNA interference,BP,
18727,GO:1900369,1,0.98434861677286,0,2,negative regulation of RNA interference,BP,
18728,GO:1900370,1,0.992192132911163,0,1,positive regulation of RNA interference,BP,
18730,GO:1900372,1,0.798475619049767,0,36,negative regulation of purine nucleotide biosynthetic process,BP,
18732,GO:1900376,1,0.9497961276268,0,7,regulation of secondary metabolite biosynthetic process,BP,
18733,GO:1900377,1,0.983854387187819,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
18734,GO:1900378,1,0.965388585980962,0,5,positive regulation of secondary metabolite biosynthetic process,BP,
18736,GO:1900387,1,0.995009266124128,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18738,GO:1900402,1,0.939023098887284,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18739,GO:1900407,1,0.662764635017957,0,66,regulation of cellular response to oxidative stress,BP,
18740,GO:1900408,1,0.785643053047104,0,39,negative regulation of cellular response to oxidative stress,BP,
18741,GO:1900409,1,0.915020139164808,0,15,positive regulation of cellular response to oxidative stress,BP,
18742,GO:1900424,1,0.930115255979799,0,12,regulation of defense response to bacterium,BP,
18743,GO:1900425,1,0.969548283438825,0,5,negative regulation of defense response to bacterium,BP,
18744,GO:1900426,1,0.968687889097421,0,6,positive regulation of defense response to bacterium,BP,
18745,GO:1900449,1,0.751744675803637,0,42,regulation of glutamate receptor signaling pathway,BP,
18746,GO:1900450,1,0.992325385720723,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18747,GO:1900451,1,0.936441147760678,0,9,positive regulation of glutamate receptor signaling pathway,BP,
18748,GO:1900452,1,0.917338497112255,0,12,regulation of long term synaptic depression,BP,
18749,GO:1900453,1,0.982240639955824,0,3,negative regulation of long term synaptic depression,BP,
18750,GO:1900454,1,0.964333459306824,0,5,positive regulation of long term synaptic depression,BP,
18751,GO:1900477,1,0.995057263180666,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18752,GO:1900533,1,0.9962689356949,0,1,palmitic acid metabolic process,BP,
18753,GO:1900535,1,0.9962689356949,0,1,palmitic acid biosynthetic process,BP,
18755,GO:1900543,1,0.752930585525035,0,46,negative regulation of purine nucleotide metabolic process,BP,
18757,GO:1900558,1,0.995335067531889,0,1,austinol metabolic process,BP,
18758,GO:1900560,1,0.995335067531889,0,1,austinol biosynthetic process,BP,
18759,GO:1900561,1,0.995335067531889,0,1,dehydroaustinol metabolic process,BP,
18760,GO:1900563,1,0.995335067531889,0,1,dehydroaustinol biosynthetic process,BP,
18761,GO:1900619,1,0.980345646829303,0,3,acetate ester metabolic process,BP,
18762,GO:1900620,1,0.99357385075076,0,1,acetate ester biosynthetic process,BP,
18763,GO:1900623,1,0.977341366856611,0,3,regulation of monocyte aggregation,BP,
18764,GO:1900625,1,0.977341366856611,0,3,positive regulation of monocyte aggregation,BP,
18765,GO:1900673,1,0.980921287119177,0,3,olefin metabolic process,BP,
18766,GO:1900719,1,0.992293648364596,0,1,regulation of uterine smooth muscle relaxation,BP,
18767,GO:1900721,1,0.992293648364596,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18768,GO:1900736,1,0.981574037680031,0,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18769,GO:1900737,1,0.992560719356296,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18770,GO:1900738,1,0.988931830253116,0,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18771,GO:1900739,1,0.84235195159496,0,30,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18772,GO:1900740,1,0.84235195159496,0,30,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18773,GO:1900744,1,0.820383128114812,0,31,regulation of p38MAPK cascade,BP,
18774,GO:1900745,1,0.880743183385573,0,21,positive regulation of p38MAPK cascade,BP,
18775,GO:1900746,1,0.936596756494491,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18776,GO:1900747,1,0.98093000919392,0,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18777,GO:1900748,1,0.968234375838825,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18779,GO:1900753,1,0.992422085764475,0,1,doxorubicin transport,BP,
18780,GO:1900756,1,0.984922214770512,0,2,protein processing in phagocytic vesicle,BP,
18781,GO:1900825,1,0.980039832723794,0,3,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18782,GO:1900827,1,0.990536791773208,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18783,GO:1900864,1,0.953451070562094,0,9,mitochondrial RNA modification,BP,
18784,GO:1901004,1,0.99662232143384,0,1,ubiquinone-6 metabolic process,BP,
18785,GO:1901006,1,0.99662232143384,0,1,ubiquinone-6 biosynthetic process,BP,
18786,GO:1901016,1,0.717541934963932,0,49,regulation of potassium ion transmembrane transporter activity,BP,
18787,GO:1901017,1,0.902901817269957,0,15,negative regulation of potassium ion transmembrane transporter activity,BP,
18788,GO:1901018,1,0.862786599414035,0,22,positive regulation of potassium ion transmembrane transporter activity,BP,
18789,GO:1901019,1,0.610777201859415,0,77,regulation of calcium ion transmembrane transporter activity,BP,
18790,GO:1901020,1,0.838734362525093,0,31,negative regulation of calcium ion transmembrane transporter activity,BP,
18791,GO:1901021,1,0.815443211980278,0,31,positive regulation of calcium ion transmembrane transporter activity,BP,
18792,GO:1901026,1,0.976221216439833,0,3,ripoptosome assembly involved in necroptotic process,BP,
18796,GO:1901031,1,0.806664353598776,0,35,regulation of response to reactive oxygen species,BP,
18797,GO:1901032,1,0.900471261055574,0,17,negative regulation of response to reactive oxygen species,BP,
18798,GO:1901033,1,0.957783893392689,0,8,positive regulation of response to reactive oxygen species,BP,
18799,GO:1901052,1,0.992630650743975,0,1,sarcosine metabolic process,BP,
18800,GO:1901053,1,0.992630650743975,0,1,sarcosine catabolic process,BP,
18801,GO:1901068,1,0.741556785289779,0,50,guanosine-containing compound metabolic process,BP,
18802,GO:1901069,1,0.996440642047876,0,1,guanosine-containing compound catabolic process,BP,
18803,GO:1901070,1,0.944590648354732,0,14,guanosine-containing compound biosynthetic process,BP,
18804,GO:1901071,1,0.874463690580643,0,22,glucosamine-containing compound metabolic process,BP,
18805,GO:1901072,1,0.95301502741252,0,9,glucosamine-containing compound catabolic process,BP,
18806,GO:1901073,1,0.984748638698277,0,2,glucosamine-containing compound biosynthetic process,BP,
18807,GO:1901074,1,0.985264531920878,0,2,regulation of engulfment of apoptotic cell,BP,
18808,GO:1901076,1,0.991724590482864,0,1,positive regulation of engulfment of apoptotic cell,BP,
18809,GO:1901077,1,0.936984311231475,0,11,regulation of relaxation of muscle,BP,
18810,GO:1901078,1,0.980448681137412,0,3,negative regulation of relaxation of muscle,BP,
18811,GO:1901079,1,0.981783141460944,0,3,positive regulation of relaxation of muscle,BP,
18812,GO:1901080,1,0.992293648364596,0,1,regulation of relaxation of smooth muscle,BP,
18813,GO:1901082,1,0.992293648364596,0,1,positive regulation of relaxation of smooth muscle,BP,
18814,GO:1901086,1,0.992276848613409,0,1,benzylpenicillin metabolic process,BP,
18815,GO:1901090,1,0.988208647591894,0,2,regulation of protein tetramerization,BP,
18816,GO:1901091,1,0.988208647591894,0,2,negative regulation of protein tetramerization,BP,
18817,GO:1901093,1,0.988208647591894,0,2,regulation of protein homotetramerization,BP,
18818,GO:1901094,1,0.988208647591894,0,2,negative regulation of protein homotetramerization,BP,
18819,GO:1901096,1,0.932425649344879,0,10,regulation of autophagosome maturation,BP,
18820,GO:1901097,1,0.97954494336535,0,3,negative regulation of autophagosome maturation,BP,
18821,GO:1901098,1,0.951174142184518,0,7,positive regulation of autophagosome maturation,BP,
18826,GO:1901142,1,0.950707320181585,0,7,insulin metabolic process,BP,
18827,GO:1901143,1,0.98484836719913,0,2,insulin catabolic process,BP,
18828,GO:1901145,1,0.977540242017556,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18829,GO:1901147,1,0.984972388532087,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18830,GO:1901159,1,0.976204530142074,0,5,xylulose 5-phosphate biosynthetic process,BP,
18831,GO:1901160,1,0.917036349532741,0,13,primary amino compound metabolic process,BP,
18832,GO:1901162,1,0.973506463939886,0,5,primary amino compound biosynthetic process,BP,
18833,GO:1901163,1,0.947380993698816,0,10,regulation of trophoblast cell migration,BP,
18834,GO:1901164,1,0.975404495875196,0,5,negative regulation of trophoblast cell migration,BP,
18835,GO:1901165,1,0.971277217566136,0,5,positive regulation of trophoblast cell migration,BP,
18836,GO:1901166,1,0.978754502789196,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
18839,GO:1901186,1,0.805242382252371,0,34,positive regulation of ERBB signaling pathway,BP,
18840,GO:1901187,1,0.98623317209982,0,2,regulation of ephrin receptor signaling pathway,BP,
18841,GO:1901189,1,0.994299225992807,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18842,GO:1901193,1,0.996769143995664,0,1,regulation of formation of translation preinitiation complex,BP,
18843,GO:1901194,1,0.996769143995664,0,1,negative regulation of formation of translation preinitiation complex,BP,
18844,GO:1901201,1,0.907375791233079,0,13,regulation of extracellular matrix assembly,BP,
18845,GO:1901202,1,0.994316648574401,0,1,negative regulation of extracellular matrix assembly,BP,
18846,GO:1901203,1,0.933724121805294,0,9,positive regulation of extracellular matrix assembly,BP,
18847,GO:1901207,1,0.985104834845016,0,2,regulation of heart looping,BP,
18848,GO:1901208,1,0.992590221216984,0,1,negative regulation of heart looping,BP,
18849,GO:1901210,1,0.992590221216984,0,1,regulation of cardiac chamber formation,BP,
18850,GO:1901211,1,0.992590221216984,0,1,negative regulation of cardiac chamber formation,BP,
18854,GO:1901216,1,0.610616335481863,0,76,positive regulation of neuron death,BP,
18855,GO:1901219,1,0.992590221216984,0,1,regulation of cardiac chamber morphogenesis,BP,
18856,GO:1901220,1,0.992590221216984,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18858,GO:1901223,1,0.946307010137846,0,9,negative regulation of NIK/NF-kappaB signaling,BP,
18861,GO:1901229,1,0.993704684941535,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18862,GO:1901231,1,0.993704684941535,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18863,GO:1901232,1,0.993704684941535,0,1,regulation of convergent extension involved in axis elongation,BP,
18864,GO:1901233,1,0.993704684941535,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18865,GO:1901246,1,0.990233735556238,0,2,regulation of lung ciliated cell differentiation,BP,
18866,GO:1901247,1,0.996613227145749,0,1,negative regulation of lung ciliated cell differentiation,BP,
18867,GO:1901248,1,0.993599055136015,0,1,positive regulation of lung ciliated cell differentiation,BP,
18868,GO:1901249,1,0.996613227145749,0,1,regulation of lung goblet cell differentiation,BP,
18869,GO:1901251,1,0.996613227145749,0,1,positive regulation of lung goblet cell differentiation,BP,
18870,GO:1901252,1,0.989353159457683,0,2,regulation of intracellular transport of viral material,BP,
18871,GO:1901253,1,0.996910278869543,0,1,negative regulation of intracellular transport of viral material,BP,
18872,GO:1901254,1,0.992419702874023,0,1,positive regulation of intracellular transport of viral material,BP,
18873,GO:1901255,1,0.987963586081766,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18874,GO:1901256,1,0.968076055141434,0,5,regulation of macrophage colony-stimulating factor production,BP,
18875,GO:1901257,1,0.994397375401436,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18876,GO:1901258,1,0.980874364068007,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18879,GO:1901269,1,0.994083656276557,0,2,lipooligosaccharide metabolic process,BP,
18880,GO:1901271,1,0.994083656276557,0,2,lipooligosaccharide biosynthetic process,BP,
18881,GO:1901291,1,0.995477969390821,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18884,GO:1901295,1,0.990064699454403,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18885,GO:1901296,1,0.995741448477009,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18886,GO:1901297,1,0.994299225992807,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18887,GO:1901298,1,0.942092805273376,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18888,GO:1901299,1,0.964916819013246,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18889,GO:1901300,1,0.976354829697661,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18890,GO:1901301,1,0.985856522999508,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18891,GO:1901303,1,0.993426104869907,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18892,GO:1901304,1,0.99596705023946,0,1,regulation of spermidine biosynthetic process,BP,
18893,GO:1901307,1,0.99596705023946,0,1,positive regulation of spermidine biosynthetic process,BP,
18894,GO:1901314,1,0.976967870353693,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18895,GO:1901315,1,0.976967870353693,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18896,GO:1901317,1,0.958663644641823,0,9,regulation of flagellated sperm motility,BP,
18897,GO:1901318,1,0.995445805928028,0,1,negative regulation of flagellated sperm motility,BP,
18898,GO:1901321,1,0.992497018470544,0,2,positive regulation of heart induction,BP,
18899,GO:1901328,1,0.995727898881487,0,1,response to cytochalasin B,BP,
18900,GO:1901329,1,0.980965388963745,0,3,regulation of odontoblast differentiation,BP,
18901,GO:1901331,1,0.992748832094152,0,1,positive regulation of odontoblast differentiation,BP,
18902,GO:1901337,1,0.99354439408096,0,1,thioester transport,BP,
18903,GO:1901338,1,0.921572485297986,0,14,catecholamine binding,MF,
18904,GO:1901339,1,0.952005784335782,0,7,regulation of store-operated calcium channel activity,BP,
18905,GO:1901340,1,0.992448070760553,0,1,negative regulation of store-operated calcium channel activity,BP,
18906,GO:1901341,1,0.966254270123051,0,5,positive regulation of store-operated calcium channel activity,BP,
18909,GO:1901344,1,0.996608637381519,0,1,response to leptomycin B,BP,
18910,GO:1901350,1,0.99165359000771,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18911,GO:1901355,1,0.986694803069812,0,2,response to rapamycin,BP,
18916,GO:1901373,1,0.996435032809324,0,1,lipid hydroperoxide transport,BP,
18917,GO:1901374,1,0.959389326107719,0,7,acetate ester transport,BP,
18918,GO:1901375,1,0.983753563125591,0,3,acetate ester transmembrane transporter activity,MF,
18919,GO:1901376,1,0.99337371634623,0,1,organic heteropentacyclic compound metabolic process,BP,
18920,GO:1901377,1,0.99337371634623,0,1,organic heteropentacyclic compound catabolic process,BP,
18921,GO:1901379,1,0.630154282254508,0,69,regulation of potassium ion transmembrane transport,BP,
18922,GO:1901380,1,0.884768576102768,0,18,negative regulation of potassium ion transmembrane transport,BP,
18923,GO:1901381,1,0.803928265793197,0,32,positive regulation of potassium ion transmembrane transport,BP,
18925,GO:1901383,1,0.986133440808357,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18926,GO:1901385,1,0.831695952888081,0,31,regulation of voltage-gated calcium channel activity,BP,
18927,GO:1901386,1,0.935813048534672,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18928,GO:1901387,1,0.954525622520394,0,8,positive regulation of voltage-gated calcium channel activity,BP,
18929,GO:1901388,1,0.993816488377012,0,1,regulation of transforming growth factor beta activation,BP,
18930,GO:1901389,1,0.993816488377012,0,1,negative regulation of transforming growth factor beta activation,BP,
18931,GO:1901401,1,0.992077520282848,0,1,regulation of tetrapyrrole metabolic process,BP,
18932,GO:1901407,1,0.947863619645046,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18933,GO:1901409,1,0.960983790149292,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18934,GO:1901419,1,0.992422500170589,0,1,regulation of response to alcohol,BP,
18935,GO:1901421,1,0.992422500170589,0,1,positive regulation of response to alcohol,BP,
18936,GO:1901474,1,0.956039734200751,0,7,azole transmembrane transporter activity,MF,
18937,GO:1901475,1,0.975099758147644,0,4,pyruvate transmembrane transport,BP,
18938,GO:1901490,1,0.971823259096301,0,4,regulation of lymphangiogenesis,BP,
18939,GO:1901491,1,0.984614915933069,0,2,negative regulation of lymphangiogenesis,BP,
18940,GO:1901492,1,0.98701055025242,0,2,positive regulation of lymphangiogenesis,BP,
18941,GO:1901503,1,0.970315755154716,0,5,ether biosynthetic process,BP,
18942,GO:1901505,1,0.814834406472312,0,34,carbohydrate derivative transmembrane transporter activity,MF,
18943,GO:1901509,1,0.974260175509209,0,4,regulation of endothelial tube morphogenesis,BP,
18944,GO:1901522,1,0.857294145544086,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
18945,GO:1901523,1,0.98223556413322,0,3,icosanoid catabolic process,BP,
18946,GO:1901524,1,0.91231976717317,0,13,regulation of mitophagy,BP,
18947,GO:1901525,1,0.963679960603789,0,5,negative regulation of mitophagy,BP,
18948,GO:1901526,1,0.946724065385845,0,8,positive regulation of mitophagy,BP,
18949,GO:1901529,1,0.970359059945634,0,4,positive regulation of anion channel activity,BP,
18950,GO:1901532,1,0.641793979153285,0,88,regulation of hematopoietic progenitor cell differentiation,BP,
18951,GO:1901533,1,0.961483776570403,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18952,GO:1901534,1,0.985074520771086,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18953,GO:1901535,1,0.959701034190999,0,5,regulation of DNA demethylation,BP,
18954,GO:1901536,1,0.985869062730338,0,2,negative regulation of DNA demethylation,BP,
18955,GO:1901537,1,0.973460769802822,0,3,positive regulation of DNA demethylation,BP,
18956,GO:1901538,1,0.958949094505135,0,6,changes to DNA methylation involved in embryo development,BP,
18957,GO:1901545,1,0.992907013820507,0,1,response to raffinose,BP,
18958,GO:1901550,1,0.926609180741064,0,12,regulation of endothelial cell development,BP,
18959,GO:1901551,1,0.992441125735774,0,1,negative regulation of endothelial cell development,BP,
18960,GO:1901552,1,0.968838433529865,0,5,positive regulation of endothelial cell development,BP,
18961,GO:1901555,1,0.991693795646297,0,1,response to paclitaxel,BP,
18962,GO:1901557,1,0.992458434284543,0,1,response to fenofibrate,BP,
18963,GO:1901558,1,0.987552962810819,0,2,response to metformin,BP,
18964,GO:1901561,1,0.992477060932001,0,1,response to benomyl,BP,
18965,GO:1901563,1,0.965545129341737,0,5,response to camptothecin,BP,
18969,GO:1901567,1,0.882702912559326,0,24,fatty acid derivative binding,MF,
18970,GO:1901568,1,0.467491257619117,0,132,fatty acid derivative metabolic process,BP,
18971,GO:1901569,1,0.954989253227546,0,8,fatty acid derivative catabolic process,BP,
18972,GO:1901570,1,0.647758000042607,0,75,fatty acid derivative biosynthetic process,BP,
18973,GO:1901571,1,0.826269401109714,0,31,fatty acid derivative transport,BP,
18976,GO:1901580,1,0.990001988296496,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18977,GO:1901581,1,0.990001988296496,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18978,GO:1901582,1,0.990001988296496,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18979,GO:1901585,1,0.993208135551421,0,1,regulation of acid-sensing ion channel activity,BP,
18980,GO:1901588,1,0.992367189526949,0,1,dendritic microtubule,CC,
18981,GO:1901594,1,0.992447442233007,0,1,response to capsazepine,BP,
18984,GO:1901607,1,0.703054446279542,0,59,alpha-amino acid biosynthetic process,BP,
18985,GO:1901608,1,0.996553782258356,0,1,regulation of vesicle transport along microtubule,BP,
18986,GO:1901609,1,0.996553782258356,0,1,negative regulation of vesicle transport along microtubule,BP,
18987,GO:1901611,1,0.944550265091707,0,10,phosphatidylglycerol binding,MF,
18988,GO:1901612,1,0.960193347227037,0,7,cardiolipin binding,MF,
18990,GO:1901616,1,0.727952017524156,0,54,organic hydroxy compound catabolic process,BP,
18991,GO:1901617,1,0.262313233001394,0,215,organic hydroxy compound biosynthetic process,BP,
18993,GO:1901620,1,0.953308013489358,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18994,GO:1901621,1,0.964955272219204,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18995,GO:1901622,1,0.993723864774709,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18996,GO:1901623,1,0.913934161444494,0,17,regulation of lymphocyte chemotaxis,BP,
18997,GO:1901624,1,0.985678466855612,0,3,negative regulation of lymphocyte chemotaxis,BP,
18998,GO:1901626,1,0.934698446365371,0,11,regulation of postsynaptic membrane organization,BP,
18999,GO:1901627,1,0.994356951383179,0,1,negative regulation of postsynaptic membrane organization,BP,
19000,GO:1901628,1,0.978511560545712,0,4,positive regulation of postsynaptic membrane organization,BP,
19001,GO:1901629,1,0.988062335325937,0,2,regulation of presynaptic membrane organization,BP,
19002,GO:1901630,1,0.996721868208233,0,1,negative regulation of presynaptic membrane organization,BP,
19003,GO:1901631,1,0.991312283082682,0,1,positive regulation of presynaptic membrane organization,BP,
19004,GO:1901639,1,0.991997791072666,0,1,XDP catabolic process,BP,
19005,GO:1901640,1,0.991997791072666,0,1,XTP binding,MF,
19006,GO:1901641,1,0.991997791072666,0,1,ITP binding,MF,
19007,GO:1901642,1,0.966295096786023,0,6,nucleoside transmembrane transport,BP,
19012,GO:1901656,1,0.978338075974176,0,3,glycoside transport,BP,
19013,GO:1901657,1,0.468781852346399,0,134,glycosyl compound metabolic process,BP,
19014,GO:1901658,1,0.832755993759979,0,35,glycosyl compound catabolic process,BP,
19015,GO:1901659,1,0.80236050980295,0,43,glycosyl compound biosynthetic process,BP,
19016,GO:1901660,1,0.942676914153069,0,8,calcium ion export,BP,
19017,GO:1901661,1,0.884026476125123,0,27,quinone metabolic process,BP,
19018,GO:1901662,1,0.989530819676058,0,2,quinone catabolic process,BP,
19019,GO:1901663,1,0.937933634399064,0,14,quinone biosynthetic process,BP,
19020,GO:1901664,1,0.98348382382125,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
19021,GO:1901666,1,0.98348382382125,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
19022,GO:1901668,1,0.981808864905989,0,4,regulation of superoxide dismutase activity,BP,
19023,GO:1901671,1,0.988431036022926,0,3,positive regulation of superoxide dismutase activity,BP,
19024,GO:1901673,1,0.883371383080555,0,19,regulation of mitotic spindle assembly,BP,
19025,GO:1901674,1,0.977709394502849,0,3,regulation of histone H3-K27 acetylation,BP,
19026,GO:1901675,1,0.99177977360175,0,1,negative regulation of histone H3-K27 acetylation,BP,
19027,GO:1901676,1,0.992463112320595,0,1,positive regulation of histone H3-K27 acetylation,BP,
19028,GO:1901678,1,0.932638264261153,0,11,iron coordination entity transport,BP,
19029,GO:1901679,1,0.953969018079696,0,8,nucleotide transmembrane transport,BP,
19030,GO:1901680,1,0.990660807007433,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19032,GO:1901682,1,0.832107881879311,0,27,sulfur compound transmembrane transporter activity,MF,
19033,GO:1901685,1,0.937418889535891,0,18,glutathione derivative metabolic process,BP,
19034,GO:1901687,1,0.937418889535891,0,18,glutathione derivative biosynthetic process,BP,
19039,GO:1901702,1,0.974951392553545,0,5,salt transmembrane transporter activity,MF,
19040,GO:1901706,1,0.993709469022338,0,1,mesenchymal cell differentiation involved in bone development,BP,
19041,GO:1901707,1,0.996608637381519,0,1,leptomycin B binding,MF,
19042,GO:1901722,1,0.932549623438931,0,11,regulation of cell proliferation involved in kidney development,BP,
19043,GO:1901723,1,0.967848090536917,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19044,GO:1901724,1,0.963541102765654,0,6,positive regulation of cell proliferation involved in kidney development,BP,
19045,GO:1901725,1,0.938084402968732,0,8,regulation of histone deacetylase activity,BP,
19046,GO:1901726,1,0.990114538571785,0,1,negative regulation of histone deacetylase activity,BP,
19047,GO:1901727,1,0.954669597673949,0,6,positive regulation of histone deacetylase activity,BP,
19048,GO:1901731,1,0.986758186368489,0,2,positive regulation of platelet aggregation,BP,
19049,GO:1901739,1,0.923402979638128,0,15,regulation of myoblast fusion,BP,
19050,GO:1901740,1,0.992106934906241,0,2,negative regulation of myoblast fusion,BP,
19051,GO:1901741,1,0.930754972807799,0,13,positive regulation of myoblast fusion,BP,
19052,GO:1901748,1,0.981888104015278,0,3,leukotriene D4 metabolic process,BP,
19053,GO:1901750,1,0.981888104015278,0,3,leukotriene D4 biosynthetic process,BP,
19054,GO:1901751,1,0.994279157129522,0,1,leukotriene A4 metabolic process,BP,
19055,GO:1901796,1,0.351440997565272,0,167,regulation of signal transduction by p53 class mediator,BP,
19057,GO:1901798,1,0.888377388140029,0,20,positive regulation of signal transduction by p53 class mediator,BP,
19058,GO:1901799,1,0.756804149613337,0,44,negative regulation of proteasomal protein catabolic process,BP,
19059,GO:1901800,1,0.53596889807151,0,99,positive regulation of proteasomal protein catabolic process,BP,
19060,GO:1901804,1,0.994178112895726,0,1,beta-glucoside metabolic process,BP,
19061,GO:1901805,1,0.994178112895726,0,1,beta-glucoside catabolic process,BP,
19062,GO:1901810,1,0.993301131169352,0,1,beta-carotene metabolic process,BP,
19063,GO:1901825,1,0.993643172738194,0,1,zeaxanthin metabolic process,BP,
19064,GO:1901827,1,0.993643172738194,0,1,zeaxanthin biosynthetic process,BP,
19065,GO:1901834,1,0.995874545468219,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19066,GO:1901835,1,0.995874545468219,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19067,GO:1901836,1,0.933660787343158,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19068,GO:1901837,1,0.990260294224086,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19069,GO:1901838,1,0.942849471292696,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19070,GO:1901841,1,0.939891312465522,0,11,regulation of high voltage-gated calcium channel activity,BP,
19071,GO:1901842,1,0.983065072653264,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19072,GO:1901843,1,0.978365544287616,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
19073,GO:1901844,1,0.944122312161333,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19074,GO:1901846,1,0.992398586566524,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19075,GO:1901856,1,0.987217918314522,0,2,negative regulation of cellular respiration,BP,
19076,GO:1901857,1,0.970312778015614,0,6,positive regulation of cellular respiration,BP,
19077,GO:1901858,1,0.960289931642145,0,6,regulation of mitochondrial DNA metabolic process,BP,
19078,GO:1901859,1,0.978465683654343,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
19079,GO:1901860,1,0.988545971447529,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
19083,GO:1901873,1,0.985149737165208,0,2,regulation of post-translational protein modification,BP,
19084,GO:1901874,1,0.985149737165208,0,2,negative regulation of post-translational protein modification,BP,
19085,GO:1901876,1,0.992968961052941,0,2,regulation of calcium ion binding,BP,
19086,GO:1901877,1,0.992968961052941,0,2,negative regulation of calcium ion binding,BP,
19087,GO:1901879,1,0.600414827165616,0,73,regulation of protein depolymerization,BP,
19088,GO:1901880,1,0.675718206801762,0,56,negative regulation of protein depolymerization,BP,
19089,GO:1901881,1,0.911667774552143,0,15,positive regulation of protein depolymerization,BP,
19092,GO:1901890,1,0.811339257534908,0,30,positive regulation of cell junction assembly,BP,
19093,GO:1901894,1,0.950750566701015,0,8,regulation of calcium-transporting ATPase activity,BP,
19094,GO:1901895,1,0.980456256890034,0,3,negative regulation of calcium-transporting ATPase activity,BP,
19095,GO:1901896,1,0.972611272664677,0,4,positive regulation of calcium-transporting ATPase activity,BP,
19096,GO:1901897,1,0.954835347500146,0,7,regulation of relaxation of cardiac muscle,BP,
19097,GO:1901898,1,0.983766558914763,0,2,negative regulation of relaxation of cardiac muscle,BP,
19098,GO:1901899,1,0.989408715354742,0,2,positive regulation of relaxation of cardiac muscle,BP,
19099,GO:1901906,1,0.978556250983495,0,4,diadenosine pentaphosphate metabolic process,BP,
19100,GO:1901907,1,0.978556250983495,0,4,diadenosine pentaphosphate catabolic process,BP,
19101,GO:1901908,1,0.978556250983495,0,4,diadenosine hexaphosphate metabolic process,BP,
19102,GO:1901909,1,0.978556250983495,0,4,diadenosine hexaphosphate catabolic process,BP,
19103,GO:1901910,1,0.978556250983495,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19104,GO:1901911,1,0.978556250983495,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19105,GO:1901917,1,0.99335320816281,0,1,regulation of exoribonuclease activity,BP,
19106,GO:1901919,1,0.99335320816281,0,1,positive regulation of exoribonuclease activity,BP,
19107,GO:1901950,1,0.993301131169352,0,1,dense core granule transport,BP,
19108,GO:1901962,1,0.994652381026544,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19109,GO:1901963,1,0.988384329085746,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19110,GO:1901964,1,0.99578603907695,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19111,GO:1901970,1,0.95087076534179,0,8,positive regulation of mitotic sister chromatid separation,BP,
19112,GO:1901976,1,0.819443164641457,0,32,regulation of cell cycle checkpoint,BP,
19113,GO:1901977,1,0.963999150739457,0,6,negative regulation of cell cycle checkpoint,BP,
19114,GO:1901978,1,0.937845008819314,0,10,positive regulation of cell cycle checkpoint,BP,
19115,GO:1901979,1,0.981094657540253,0,3,regulation of inward rectifier potassium channel activity,BP,
19116,GO:1901980,1,0.990484031183416,0,1,positive regulation of inward rectifier potassium channel activity,BP,
19118,GO:1901983,1,0.663862049473848,0,65,regulation of protein acetylation,BP,
19119,GO:1901984,1,0.871752112197513,0,23,negative regulation of protein acetylation,BP,
19120,GO:1901985,1,0.80372418633517,0,35,positive regulation of protein acetylation,BP,
19121,GO:1901986,1,0.996458655415063,0,1,response to ketamine,BP,
19124,GO:1901989,1,0.639857834774276,0,72,positive regulation of cell cycle phase transition,BP,
19127,GO:1901992,1,0.684753123227747,0,61,positive regulation of mitotic cell cycle phase transition,BP,
19128,GO:1901993,1,0.985886044527364,0,2,regulation of meiotic cell cycle phase transition,BP,
19129,GO:1901994,1,0.985886044527364,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19130,GO:1901998,1,0.806070170312728,0,36,toxin transport,BP,
19131,GO:1902001,1,0.904002228858964,0,14,fatty acid transmembrane transport,BP,
19132,GO:1902003,1,0.883156009198748,0,18,regulation of amyloid-beta formation,BP,
19133,GO:1902004,1,0.935191821560438,0,10,positive regulation of amyloid-beta formation,BP,
19134,GO:1902010,1,0.992540856473463,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19135,GO:1902017,1,0.77530059019577,0,39,regulation of cilium assembly,BP,
19136,GO:1902018,1,0.943072410623623,0,9,negative regulation of cilium assembly,BP,
19137,GO:1902019,1,0.967833862128625,0,5,regulation of cilium-dependent cell motility,BP,
19138,GO:1902022,1,0.970002450275218,0,5,L-lysine transport,BP,
19139,GO:1902023,1,0.96262887304107,0,6,L-arginine transport,BP,
19140,GO:1902031,1,0.969674945139924,0,6,regulation of NADP metabolic process,BP,
19141,GO:1902033,1,0.95675813384133,0,7,regulation of hematopoietic stem cell proliferation,BP,
19142,GO:1902035,1,0.970262373795542,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19143,GO:1902036,1,0.677901249422435,0,79,regulation of hematopoietic stem cell differentiation,BP,
19144,GO:1902037,1,0.980184923396935,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19145,GO:1902038,1,0.992559616321823,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19147,GO:1902042,1,0.821503492445397,0,34,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19149,GO:1902044,1,0.986734915911483,0,2,regulation of Fas signaling pathway,BP,
19150,GO:1902045,1,0.994305923821445,0,1,negative regulation of Fas signaling pathway,BP,
19151,GO:1902047,1,0.967793237149413,0,6,polyamine transmembrane transport,BP,
19152,GO:1902065,1,0.931202660026047,0,11,response to L-glutamate,BP,
19153,GO:1902071,1,0.996723801118176,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19154,GO:1902073,1,0.996723801118176,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19155,GO:1902074,1,0.930292460317124,0,13,response to salt,BP,
19156,GO:1902075,1,0.963926993012537,0,7,cellular response to salt,BP,
19157,GO:1902076,1,0.989781933522228,0,1,regulation of lateral motor column neuron migration,BP,
19158,GO:1902078,1,0.989781933522228,0,1,positive regulation of lateral motor column neuron migration,BP,
19159,GO:1902080,1,0.995940820722402,0,1,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19160,GO:1902081,1,0.995940820722402,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19161,GO:1902083,1,0.962031733501162,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19162,GO:1902093,1,0.963051287170671,0,8,positive regulation of flagellated sperm motility,BP,
19163,GO:1902098,1,0.99236004392278,0,1,calcitriol binding,MF,
19164,GO:1902099,1,0.736826252130411,0,48,regulation of metaphase/anaphase transition of cell cycle,BP,
19165,GO:1902100,1,0.815962918270532,0,32,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19166,GO:1902101,1,0.95087076534179,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19167,GO:1902102,1,0.99289122331296,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19168,GO:1902103,1,0.99289122331296,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19170,GO:1902106,1,0.616529236370203,0,76,negative regulation of leukocyte differentiation,BP,
19173,GO:1902109,1,0.988216719192836,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19175,GO:1902115,1,0.359683880360556,0,149,regulation of organelle assembly,BP,
19176,GO:1902116,1,0.818670648964902,0,31,negative regulation of organelle assembly,BP,
19177,GO:1902117,1,0.659481457690559,0,58,positive regulation of organelle assembly,BP,
19178,GO:1902121,1,0.99236004392278,0,1,lithocholic acid binding,MF,
19179,GO:1902122,1,0.994866756232826,0,1,chenodeoxycholic acid binding,MF,
19180,GO:1902159,1,0.988965795452086,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19181,GO:1902161,1,0.99195842197487,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19182,GO:1902162,1,0.986708199516335,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19183,GO:1902164,1,0.986708199516335,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19184,GO:1902165,1,0.932247931026442,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19185,GO:1902166,1,0.941600735160614,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19186,GO:1902167,1,0.997057274143711,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19187,GO:1902170,1,0.893482462045534,0,18,cellular response to reactive nitrogen species,BP,
19188,GO:1902172,1,0.971334002431622,0,5,regulation of keratinocyte apoptotic process,BP,
19189,GO:1902174,1,0.982327773014573,0,3,positive regulation of keratinocyte apoptotic process,BP,
19190,GO:1902175,1,0.857345813952729,0,26,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19191,GO:1902176,1,0.902238643706814,0,18,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19192,GO:1902177,1,0.971899156946734,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19193,GO:1902178,1,0.99242976839589,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19194,GO:1902186,1,0.823039173634838,0,29,regulation of viral release from host cell,BP,
19195,GO:1902187,1,0.904426771930864,0,14,negative regulation of viral release from host cell,BP,
19196,GO:1902188,1,0.910865502809951,0,15,positive regulation of viral release from host cell,BP,
19197,GO:1902202,1,0.976322419614819,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19198,GO:1902203,1,0.99230292516214,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19199,GO:1902204,1,0.995234754518826,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19200,GO:1902205,1,0.995952976172901,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19201,GO:1902206,1,0.995952976172901,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19202,GO:1902211,1,0.993301131169352,0,1,regulation of prolactin signaling pathway,BP,
19203,GO:1902213,1,0.993301131169352,0,1,positive regulation of prolactin signaling pathway,BP,
19204,GO:1902214,1,0.983295950041991,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19205,GO:1902215,1,0.995952976172901,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19206,GO:1902216,1,0.987292076687259,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19207,GO:1902217,1,0.996557477416704,0,1,erythrocyte apoptotic process,BP,
19208,GO:1902218,1,0.964461520623719,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19209,GO:1902219,1,0.967561555393342,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19210,GO:1902220,1,0.996797135125448,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19211,GO:1902221,1,0.954424694969346,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19212,GO:1902222,1,0.954424694969346,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19213,GO:1902224,1,0.928402107128409,0,12,ketone body metabolic process,BP,
19214,GO:1902226,1,0.986417585698558,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19215,GO:1902227,1,0.992260176706301,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19216,GO:1902228,1,0.994112311743672,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19217,GO:1902229,1,0.833016599872616,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19218,GO:1902230,1,0.862412834027299,0,28,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19219,GO:1902231,1,0.972781304924434,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19220,GO:1902232,1,0.995952976172901,0,1,regulation of positive thymic T cell selection,BP,
19221,GO:1902233,1,0.995952976172901,0,1,negative regulation of positive thymic T cell selection,BP,
19223,GO:1902236,1,0.902615154726461,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19225,GO:1902238,1,0.992441856564074,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19226,GO:1902239,1,0.992441856564074,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19227,GO:1902250,1,0.996557477416704,0,1,regulation of erythrocyte apoptotic process,BP,
19228,GO:1902251,1,0.996557477416704,0,1,negative regulation of erythrocyte apoptotic process,BP,
19229,GO:1902253,1,0.884777893879003,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19230,GO:1902254,1,0.906478266818158,0,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19231,GO:1902255,1,0.986463870444522,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19232,GO:1902256,1,0.980932598473696,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19233,GO:1902257,1,0.988599527542166,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19234,GO:1902259,1,0.908979760450659,0,15,regulation of delayed rectifier potassium channel activity,BP,
19235,GO:1902260,1,0.958823617805198,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19236,GO:1902261,1,0.972442202698458,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19237,GO:1902262,1,0.973255912499409,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19238,GO:1902263,1,0.980213343663133,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19239,GO:1902267,1,0.97515024784179,0,5,regulation of polyamine transmembrane transport,BP,
19240,GO:1902268,1,0.989215128955935,0,3,negative regulation of polyamine transmembrane transport,BP,
19241,GO:1902269,1,0.985783374583976,0,2,positive regulation of polyamine transmembrane transport,BP,
19242,GO:1902271,1,0.99236004392278,0,1,D3 vitamins binding,MF,
19243,GO:1902275,1,0.335935994705405,0,157,regulation of chromatin organization,BP,
19244,GO:1902282,1,0.95020949697984,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19245,GO:1902283,1,0.992456378204114,0,1,negative regulation of primary amine oxidase activity,BP,
19246,GO:1902284,1,0.777987950455935,0,32,neuron projection extension involved in neuron projection guidance,BP,
19247,GO:1902285,1,0.900057412850279,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19248,GO:1902287,1,0.907144577926885,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19249,GO:1902292,1,0.99672089930035,0,1,cell cycle DNA replication initiation,BP,
19250,GO:1902296,1,0.992644321946956,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19251,GO:1902298,1,0.984556340027404,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19252,GO:1902299,1,0.985056757164688,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19253,GO:1902302,1,0.967583070062403,0,5,regulation of potassium ion export,BP,
19254,GO:1902303,1,0.985621820451376,0,2,negative regulation of potassium ion export,BP,
19255,GO:1902304,1,0.989328242178327,0,2,positive regulation of potassium ion export,BP,
19256,GO:1902305,1,0.700777486799437,0,55,regulation of sodium ion transmembrane transport,BP,
19257,GO:1902306,1,0.919269582581838,0,12,negative regulation of sodium ion transmembrane transport,BP,
19258,GO:1902307,1,0.891501655958011,0,18,positive regulation of sodium ion transmembrane transport,BP,
19259,GO:1902308,1,0.970581732488049,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19260,GO:1902309,1,0.980054990041814,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19261,GO:1902310,1,0.990335972872337,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19263,GO:1902315,1,0.99672089930035,0,1,nuclear cell cycle DNA replication initiation,BP,
19264,GO:1902319,1,0.992644321946956,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19265,GO:1902336,1,0.986541524139918,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19266,GO:1902337,1,0.941516510174284,0,9,regulation of apoptotic process involved in morphogenesis,BP,
19267,GO:1902338,1,0.966393199796552,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19268,GO:1902339,1,0.981882629804724,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19269,GO:1902356,1,0.995537833604515,0,1,oxaloacetate(2-) transmembrane transport,BP,
19270,GO:1902358,1,0.925667849528423,0,11,sulfate transmembrane transport,BP,
19271,GO:1902359,1,0.988496514838496,0,2,Notch signaling pathway involved in somitogenesis,BP,
19272,GO:1902362,1,0.993252817825733,0,1,melanocyte apoptotic process,BP,
19273,GO:1902363,1,0.991604937803894,0,1,regulation of protein localization to spindle pole body,BP,
19274,GO:1902365,1,0.991604937803894,0,1,positive regulation of protein localization to spindle pole body,BP,
19275,GO:1902366,1,0.988496514838496,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19276,GO:1902367,1,0.988496514838496,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19277,GO:1902369,1,0.732767536588044,0,45,negative regulation of RNA catabolic process,BP,
19278,GO:1902373,1,0.762862274858373,0,39,negative regulation of mRNA catabolic process,BP,
19279,GO:1902378,1,0.993967319559355,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19280,GO:1902379,1,0.992057652763443,0,1,chemoattractant activity involved in axon guidance,MF,
19281,GO:1902380,1,0.99412804963196,0,1,positive regulation of endoribonuclease activity,BP,
19282,GO:1902387,1,0.993301131169352,0,1,ceramide 1-phosphate binding,MF,
19283,GO:1902388,1,0.993301131169352,0,1,ceramide 1-phosphate transporter activity,MF,
19284,GO:1902389,1,0.993301131169352,0,1,ceramide 1-phosphate transport,BP,
19285,GO:1902396,1,0.992463656391737,0,1,protein localization to bicellular tight junction,BP,
19286,GO:1902400,1,0.688318018545909,0,61,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19287,GO:1902402,1,0.683446964607997,0,62,signal transduction involved in mitotic DNA damage checkpoint,BP,
19288,GO:1902403,1,0.683446964607997,0,62,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19289,GO:1902410,1,0.963963541434563,0,6,mitotic cytokinetic process,BP,
19290,GO:1902412,1,0.971497467852361,0,4,regulation of mitotic cytokinesis,BP,
19291,GO:1902414,1,0.943197281606083,0,8,protein localization to cell junction,BP,
19292,GO:1902415,1,0.949707442417214,0,9,regulation of mRNA binding,BP,
19293,GO:1902416,1,0.960402067233041,0,7,positive regulation of mRNA binding,BP,
19294,GO:1902423,1,0.986641375466763,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19295,GO:1902425,1,0.986641375466763,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19296,GO:1902426,1,0.993502007861344,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19297,GO:1902430,1,0.940200777237182,0,9,negative regulation of amyloid-beta formation,BP,
19298,GO:1902442,1,0.992479914758703,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19299,GO:1902443,1,0.992479914758703,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19300,GO:1902444,1,0.996713580212856,0,1,riboflavin binding,MF,
19301,GO:1902445,1,0.988545073863793,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19302,GO:1902455,1,0.960246125294897,0,6,negative regulation of stem cell population maintenance,BP,
19303,GO:1902459,1,0.948523040618858,0,7,positive regulation of stem cell population maintenance,BP,
19304,GO:1902460,1,0.992386176993495,0,1,regulation of mesenchymal stem cell proliferation,BP,
19305,GO:1902462,1,0.992386176993495,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19306,GO:1902463,1,0.992238999915327,0,2,protein localization to cell leading edge,BP,
19307,GO:1902464,1,0.992414315554874,0,1,regulation of histone H3-K27 trimethylation,BP,
19308,GO:1902466,1,0.992414315554874,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19309,GO:1902473,1,0.944902051127415,0,8,regulation of protein localization to synapse,BP,
19310,GO:1902474,1,0.951277839966675,0,7,positive regulation of protein localization to synapse,BP,
19311,GO:1902475,1,0.743016639310461,0,44,L-alpha-amino acid transmembrane transport,BP,
19312,GO:1902476,1,0.590963611491853,0,77,chloride transmembrane transport,BP,
19313,GO:1902480,1,0.994120176226197,0,1,protein localization to mitotic spindle,BP,
19314,GO:1902488,1,0.991018280753426,0,1,cholangiocyte apoptotic process,BP,
19315,GO:1902490,1,0.995310806423143,0,1,regulation of sperm capacitation,BP,
19316,GO:1902493,1,0.580528413561524,0,85,acetyltransferase complex,CC,
19319,GO:1902498,1,0.967241323731221,0,4,regulation of protein autoubiquitination,BP,
19320,GO:1902499,1,0.984050006472518,0,2,positive regulation of protein autoubiquitination,BP,
19321,GO:1902504,1,0.992950625600058,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19322,GO:1902510,1,0.965588346889261,0,7,regulation of apoptotic DNA fragmentation,BP,
19323,GO:1902511,1,0.993426104869907,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19324,GO:1902512,1,0.988615855353027,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19325,GO:1902513,1,0.957022330487919,0,7,regulation of organelle transport along microtubule,BP,
19326,GO:1902514,1,0.940275195467956,0,9,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19327,GO:1902523,1,0.977965618224222,0,3,positive regulation of protein K63-linked ubiquitination,BP,
19328,GO:1902524,1,0.988852645482214,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19329,GO:1902525,1,0.974991884087944,0,5,regulation of protein monoubiquitination,BP,
19330,GO:1902527,1,0.982375394288092,0,4,positive regulation of protein monoubiquitination,BP,
19331,GO:1902528,1,0.99115982774244,0,1,regulation of protein linear polyubiquitination,BP,
19332,GO:1902530,1,0.99115982774244,0,1,positive regulation of protein linear polyubiquitination,BP,
19336,GO:1902544,1,0.989662038556584,0,2,regulation of DNA N-glycosylase activity,BP,
19337,GO:1902546,1,0.996964525762303,0,1,positive regulation of DNA N-glycosylase activity,BP,
19338,GO:1902547,1,0.929382803172189,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19339,GO:1902548,1,0.973378209878648,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19341,GO:1902555,1,0.84900145499784,0,29,endoribonuclease complex,CC,
19342,GO:1902559,1,0.990267687668501,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19343,GO:1902560,1,0.991864217608117,0,2,GMP reductase complex,CC,
19344,GO:1902562,1,0.783746839118001,0,39,H4 histone acetyltransferase complex,CC,
19345,GO:1902563,1,0.936661240424081,0,10,regulation of neutrophil activation,BP,
19346,GO:1902564,1,0.975837362365399,0,4,negative regulation of neutrophil activation,BP,
19347,GO:1902565,1,0.97236685115362,0,4,positive regulation of neutrophil activation,BP,
19348,GO:1902566,1,0.979216775336102,0,4,regulation of eosinophil activation,BP,
19349,GO:1902567,1,0.989496182000985,0,2,negative regulation of eosinophil activation,BP,
19350,GO:1902568,1,0.989612612133199,0,2,positive regulation of eosinophil activation,BP,
19351,GO:1902569,1,0.995540255346228,0,1,negative regulation of activation of Janus kinase activity,BP,
19352,GO:1902570,1,0.94559751733256,0,10,protein localization to nucleolus,BP,
19353,GO:1902571,1,0.971902536341926,0,6,regulation of serine-type peptidase activity,BP,
19354,GO:1902572,1,0.971902536341926,0,6,negative regulation of serine-type peptidase activity,BP,
19355,GO:1902573,1,0.990796430774423,0,1,positive regulation of serine-type peptidase activity,BP,
19356,GO:1902576,1,0.974462735398114,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19357,GO:1902579,1,0.649921585452817,0,69,multi-organism localization,BP,
19358,GO:1902581,1,0.972091129229464,0,5,multi-organism cellular localization,BP,
19359,GO:1902583,1,0.972091129229464,0,5,multi-organism intracellular transport,BP,
19360,GO:1902594,1,0.984560910030941,0,2,multi-organism nuclear import,BP,
19361,GO:1902595,1,0.989962058793896,0,2,regulation of DNA replication origin binding,BP,
19362,GO:1902600,1,0.549210921454815,0,111,proton transmembrane transport,BP,
19363,GO:1902603,1,0.978479540673574,0,4,carnitine transmembrane transport,BP,
19364,GO:1902605,1,0.993367536560483,0,1,heterotrimeric G-protein complex assembly,BP,
19365,GO:1902606,1,0.993600128220392,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19366,GO:1902608,1,0.993600128220392,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19367,GO:1902612,1,0.993357288908453,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19368,GO:1902613,1,0.993357288908453,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19369,GO:1902616,1,0.99558354304503,0,1,acyl carnitine transmembrane transport,BP,
19370,GO:1902617,1,0.969626517420129,0,5,response to fluoride,BP,
19371,GO:1902618,1,0.99201565497273,0,1,cellular response to fluoride,BP,
19372,GO:1902622,1,0.830570492036389,0,37,regulation of neutrophil migration,BP,
19373,GO:1902623,1,0.985652919457008,0,2,negative regulation of neutrophil migration,BP,
19374,GO:1902624,1,0.856316329990897,0,32,positive regulation of neutrophil migration,BP,
19375,GO:1902626,1,0.990268129400949,0,3,assembly of large subunit precursor of preribosome,BP,
19376,GO:1902629,1,0.996509434378335,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19377,GO:1902630,1,0.983804234258225,0,2,regulation of membrane hyperpolarization,BP,
19378,GO:1902631,1,0.991683995715294,0,1,negative regulation of membrane hyperpolarization,BP,
19379,GO:1902636,1,0.990591686978962,0,2,kinociliary basal body,CC,
19380,GO:1902652,1,0.456796713217585,0,123,secondary alcohol metabolic process,BP,
19381,GO:1902653,1,0.668915971235084,0,63,secondary alcohol biosynthetic process,BP,
19382,GO:1902656,1,0.913235118566994,0,13,calcium ion import into cytosol,BP,
19383,GO:1902659,1,0.984897833958762,0,3,regulation of glucose mediated signaling pathway,BP,
19384,GO:1902661,1,0.984897833958762,0,3,positive regulation of glucose mediated signaling pathway,BP,
19385,GO:1902667,1,0.7587017790574,0,36,regulation of axon guidance,BP,
19386,GO:1902668,1,0.853318754765278,0,21,negative regulation of axon guidance,BP,
19387,GO:1902669,1,0.939721517165959,0,8,positive regulation of axon guidance,BP,
19390,GO:1902683,1,0.983592595226146,0,3,regulation of receptor localization to synapse,BP,
19391,GO:1902684,1,0.996553782258356,0,1,negative regulation of receptor localization to synapse,BP,
19392,GO:1902685,1,0.992432862471095,0,1,positive regulation of receptor localization to synapse,BP,
19394,GO:1902691,1,0.992806143572439,0,1,respiratory basal cell differentiation,BP,
19396,GO:1902710,1,0.885190993934779,0,18,GABA receptor complex,CC,
19397,GO:1902711,1,0.892275861094733,0,17,GABA-A receptor complex,CC,
19399,GO:1902714,1,0.988324142154988,0,2,negative regulation of interferon-gamma secretion,BP,
19402,GO:1902723,1,0.97836589390698,0,3,negative regulation of skeletal muscle satellite cell proliferation,BP,
19403,GO:1902724,1,0.98458009180529,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19404,GO:1902725,1,0.977693886846492,0,3,negative regulation of satellite cell differentiation,BP,
19405,GO:1902728,1,0.98458009180529,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19406,GO:1902730,1,0.978481617383083,0,3,positive regulation of proteoglycan biosynthetic process,BP,
19407,GO:1902731,1,0.975584451495862,0,3,negative regulation of chondrocyte proliferation,BP,
19408,GO:1902732,1,0.985279543735149,0,3,positive regulation of chondrocyte proliferation,BP,
19409,GO:1902737,1,0.992419702874023,0,1,dendritic filopodium,CC,
19410,GO:1902739,1,0.952973636814328,0,6,regulation of interferon-alpha secretion,BP,
19411,GO:1902741,1,0.952973636814328,0,6,positive regulation of interferon-alpha secretion,BP,
19412,GO:1902742,1,0.82150688583841,0,29,apoptotic process involved in development,BP,
19414,GO:1902744,1,0.970097061890267,0,4,negative regulation of lamellipodium organization,BP,
19416,GO:1902746,1,0.980464023865591,0,3,regulation of lens fiber cell differentiation,BP,
19417,GO:1902747,1,0.995323590067318,0,1,negative regulation of lens fiber cell differentiation,BP,
19418,GO:1902748,1,0.990858875999902,0,1,positive regulation of lens fiber cell differentiation,BP,
19420,GO:1902750,1,0.598402609050566,0,96,negative regulation of cell cycle G2/M phase transition,BP,
19421,GO:1902751,1,0.854672253741932,0,25,positive regulation of cell cycle G2/M phase transition,BP,
19422,GO:1902766,1,0.992039786567238,0,2,skeletal muscle satellite cell migration,BP,
19423,GO:1902767,1,0.986756899213672,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19424,GO:1902769,1,0.990087293368145,0,1,regulation of choline O-acetyltransferase activity,BP,
19425,GO:1902771,1,0.990087293368145,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19426,GO:1902773,1,0.992882552424549,0,1,GTPase activator complex,CC,
19427,GO:1902774,1,0.954971743960912,0,7,late endosome to lysosome transport,BP,
19428,GO:1902775,1,0.978020272524347,0,3,mitochondrial large ribosomal subunit assembly,BP,
19429,GO:1902803,1,0.829223406233515,0,27,regulation of synaptic vesicle transport,BP,
19430,GO:1902804,1,0.977751090556249,0,4,negative regulation of synaptic vesicle transport,BP,
19431,GO:1902805,1,0.976764841582552,0,3,positive regulation of synaptic vesicle transport,BP,
19434,GO:1902808,1,0.808542760296515,0,34,positive regulation of cell cycle G1/S phase transition,BP,
19435,GO:1902809,1,0.981864836557863,0,3,regulation of skeletal muscle fiber differentiation,BP,
19436,GO:1902811,1,0.988681980383699,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19437,GO:1902816,1,0.972311833690308,0,4,regulation of protein localization to microtubule,BP,
19438,GO:1902817,1,0.972311833690308,0,4,negative regulation of protein localization to microtubule,BP,
19439,GO:1902822,1,0.975835768772501,0,4,regulation of late endosome to lysosome transport,BP,
19440,GO:1902823,1,0.983529437224617,0,2,negative regulation of late endosome to lysosome transport,BP,
19441,GO:1902824,1,0.99217883967139,0,2,positive regulation of late endosome to lysosome transport,BP,
19442,GO:1902838,1,0.992256882334399,0,1,regulation of nuclear migration along microtubule,BP,
19443,GO:1902846,1,0.991604937803894,0,1,positive regulation of mitotic spindle elongation,BP,
19444,GO:1902847,1,0.993168694928202,0,1,regulation of neuronal signal transduction,BP,
19445,GO:1902850,1,0.432836866235143,0,125,microtubule cytoskeleton organization involved in mitosis,BP,
19446,GO:1902855,1,0.934214815332663,0,10,regulation of non-motile cilium assembly,BP,
19447,GO:1902856,1,0.984809667640832,0,2,negative regulation of non-motile cilium assembly,BP,
19448,GO:1902857,1,0.954434605584319,0,7,positive regulation of non-motile cilium assembly,BP,
19449,GO:1902858,1,0.994893758025159,0,1,propionyl-CoA metabolic process,BP,
19450,GO:1902860,1,0.994893758025159,0,1,propionyl-CoA biosynthetic process,BP,
19451,GO:1902866,1,0.961296063126632,0,6,regulation of retina development in camera-type eye,BP,
19452,GO:1902867,1,0.992773073925503,0,1,negative regulation of retina development in camera-type eye,BP,
19453,GO:1902868,1,0.989002073822641,0,2,positive regulation of retina development in camera-type eye,BP,
19454,GO:1902869,1,0.981853808547708,0,3,regulation of amacrine cell differentiation,BP,
19455,GO:1902870,1,0.992773073925503,0,1,negative regulation of amacrine cell differentiation,BP,
19456,GO:1902871,1,0.989002073822641,0,2,positive regulation of amacrine cell differentiation,BP,
19457,GO:1902882,1,0.630109022354071,0,74,regulation of response to oxidative stress,BP,
19458,GO:1902883,1,0.774689306642598,0,41,negative regulation of response to oxidative stress,BP,
19459,GO:1902884,1,0.909898780548486,0,16,positive regulation of response to oxidative stress,BP,
19460,GO:1902889,1,0.991735313977066,0,1,protein localization to spindle microtubule,BP,
19461,GO:1902890,1,0.996992964303392,0,1,regulation of root hair elongation,BP,
19462,GO:1902891,1,0.996992964303392,0,1,negative regulation of root hair elongation,BP,
19464,GO:1902894,1,0.919689818531834,0,11,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19466,GO:1902896,1,0.978751553414224,0,3,terminal web assembly,BP,
19467,GO:1902897,1,0.980401680432734,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19468,GO:1902902,1,0.938261676258159,0,11,negative regulation of autophagosome assembly,BP,
19471,GO:1902905,1,0.323259947044948,0,178,positive regulation of supramolecular fiber organization,BP,
19472,GO:1902908,1,0.988424672089796,0,2,regulation of melanosome transport,BP,
19473,GO:1902910,1,0.992431393876814,0,1,positive regulation of melanosome transport,BP,
19475,GO:1902912,1,0.993301131169352,0,1,pyruvate kinase complex,CC,
19476,GO:1902913,1,0.992748832094152,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19477,GO:1902914,1,0.894682550816214,0,16,regulation of protein polyubiquitination,BP,
19478,GO:1902915,1,0.954911884066754,0,6,negative regulation of protein polyubiquitination,BP,
19479,GO:1902916,1,0.945070806697487,0,9,positive regulation of protein polyubiquitination,BP,
19480,GO:1902930,1,0.680296030878363,0,59,regulation of alcohol biosynthetic process,BP,
19481,GO:1902931,1,0.94871582048242,0,9,negative regulation of alcohol biosynthetic process,BP,
19482,GO:1902932,1,0.899088364010381,0,17,positive regulation of alcohol biosynthetic process,BP,
19484,GO:1902937,1,0.980096241710604,0,3,inward rectifier potassium channel complex,CC,
19485,GO:1902938,1,0.977996241269894,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19486,GO:1902939,1,0.993089276040451,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19487,GO:1902941,1,0.984465610397309,0,2,regulation of voltage-gated chloride channel activity,BP,
19488,GO:1902943,1,0.984465610397309,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19489,GO:1902946,1,0.939517307625058,0,8,protein localization to early endosome,BP,
19490,GO:1902947,1,0.961073437793658,0,6,regulation of tau-protein kinase activity,BP,
19491,GO:1902948,1,0.990087293368145,0,1,negative regulation of tau-protein kinase activity,BP,
19492,GO:1902949,1,0.975343815272077,0,4,positive regulation of tau-protein kinase activity,BP,
19493,GO:1902950,1,0.945377632043227,0,9,regulation of dendritic spine maintenance,BP,
19494,GO:1902951,1,0.980596063451907,0,3,negative regulation of dendritic spine maintenance,BP,
19495,GO:1902952,1,0.981581487918243,0,3,positive regulation of dendritic spine maintenance,BP,
19496,GO:1902953,1,0.972915360620278,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19497,GO:1902954,1,0.981635929075194,0,2,regulation of early endosome to recycling endosome transport,BP,
19498,GO:1902955,1,0.990087293368145,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19499,GO:1902956,1,0.983284144301658,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19500,GO:1902957,1,0.992742752447207,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19501,GO:1902958,1,0.990472966360711,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19502,GO:1902959,1,0.946892941854773,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19503,GO:1902960,1,0.984542304702136,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19504,GO:1902961,1,0.961765609002162,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19505,GO:1902962,1,0.982633901059893,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19506,GO:1902963,1,0.982633901059893,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19507,GO:1902965,1,0.952617300442024,0,6,regulation of protein localization to early endosome,BP,
19508,GO:1902966,1,0.952617300442024,0,6,positive regulation of protein localization to early endosome,BP,
19509,GO:1902969,1,0.943785769371289,0,9,mitotic DNA replication,BP,
19510,GO:1902975,1,0.99672089930035,0,1,mitotic DNA replication initiation,BP,
19511,GO:1902977,1,0.995456969647794,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19512,GO:1902983,1,0.992644321946956,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19513,GO:1902988,1,0.97553296499503,0,3,neurofibrillary tangle assembly,BP,
19514,GO:1902990,1,0.981452921870786,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19515,GO:1902991,1,0.85646092179487,0,23,regulation of amyloid precursor protein catabolic process,BP,
19516,GO:1902992,1,0.927139849136708,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
19517,GO:1902993,1,0.924604546954732,0,12,positive regulation of amyloid precursor protein catabolic process,BP,
19518,GO:1902994,1,0.988473305060932,0,2,regulation of phospholipid efflux,BP,
19519,GO:1902995,1,0.988473305060932,0,2,positive regulation of phospholipid efflux,BP,
19520,GO:1902996,1,0.983323006497752,0,2,regulation of neurofibrillary tangle assembly,BP,
19521,GO:1902997,1,0.990087293368145,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19522,GO:1902998,1,0.993168694928202,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19523,GO:1903000,1,0.996721868208233,0,1,regulation of lipid transport across blood brain barrier,BP,
19524,GO:1903002,1,0.996721868208233,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19525,GO:1903003,1,0.96058661558934,0,6,positive regulation of protein deubiquitination,BP,
19526,GO:1903004,1,0.992466417663809,0,1,regulation of protein K63-linked deubiquitination,BP,
19527,GO:1903006,1,0.992466417663809,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19528,GO:1903007,1,0.992466417663809,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19529,GO:1903008,1,0.53310941300864,0,100,organelle disassembly,BP,
19532,GO:1903012,1,0.959364038620722,0,7,positive regulation of bone development,BP,
19533,GO:1903015,1,0.99143716463811,0,2,regulation of exo-alpha-sialidase activity,BP,
19534,GO:1903016,1,0.99542713020967,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19535,GO:1903017,1,0.995991896528435,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19536,GO:1903018,1,0.789109443099593,0,40,regulation of glycoprotein metabolic process,BP,
19537,GO:1903019,1,0.938150961663736,0,12,negative regulation of glycoprotein metabolic process,BP,
19538,GO:1903020,1,0.874784767164134,0,21,positive regulation of glycoprotein metabolic process,BP,
19539,GO:1903025,1,0.951174512726636,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19540,GO:1903026,1,0.979395779551463,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19541,GO:1903027,1,0.98612739764143,0,2,regulation of opsonization,BP,
19542,GO:1903028,1,0.991464901289709,0,1,positive regulation of opsonization,BP,
19543,GO:1903031,1,0.989238232532194,0,2,regulation of microtubule plus-end binding,BP,
19544,GO:1903033,1,0.989238232532194,0,2,positive regulation of microtubule plus-end binding,BP,
19549,GO:1903038,1,0.567298367499826,0,94,negative regulation of leukocyte cell-cell adhesion,BP,
19551,GO:1903044,1,0.952129659391719,0,8,protein localization to membrane raft,BP,
19552,GO:1903045,1,0.992110682235662,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19553,GO:1903046,1,0.366081069541498,0,156,meiotic cell cycle process,BP,
19555,GO:1903050,1,0.299717384770212,0,190,regulation of proteolysis involved in cellular protein catabolic process,BP,
19556,GO:1903051,1,0.701841738570699,0,56,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19557,GO:1903052,1,0.489267889377345,0,112,positive regulation of proteolysis involved in cellular protein catabolic process,BP,
19558,GO:1903053,1,0.819866408099246,0,28,regulation of extracellular matrix organization,BP,
19559,GO:1903054,1,0.966078009192737,0,6,negative regulation of extracellular matrix organization,BP,
19560,GO:1903055,1,0.898604348569695,0,15,positive regulation of extracellular matrix organization,BP,
19561,GO:1903056,1,0.986858437051306,0,2,regulation of melanosome organization,BP,
19562,GO:1903059,1,0.970577450798817,0,5,regulation of protein lipidation,BP,
19563,GO:1903060,1,0.995716548218036,0,1,negative regulation of protein lipidation,BP,
19564,GO:1903061,1,0.974753873342418,0,4,positive regulation of protein lipidation,BP,
19565,GO:1903069,1,0.94754727489958,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19566,GO:1903070,1,0.983417436378321,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19567,GO:1903071,1,0.958130840173471,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19568,GO:1903072,1,0.99691333883606,0,1,regulation of death-inducing signaling complex assembly,BP,
19569,GO:1903073,1,0.99691333883606,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19571,GO:1903077,1,0.867853981399282,0,22,negative regulation of protein localization to plasma membrane,BP,
19573,GO:1903080,1,0.996832095044299,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19574,GO:1903082,1,0.996832095044299,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19575,GO:1903093,1,0.98522714359397,0,3,regulation of protein K48-linked deubiquitination,BP,
19576,GO:1903094,1,0.993525417926199,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19577,GO:1903095,1,0.985760272049731,0,2,ribonuclease III complex,CC,
19578,GO:1903096,1,0.99289122331296,0,1,protein localization to meiotic spindle midzone,BP,
19579,GO:1903108,1,0.992268375099963,0,1,regulation of mitochondrial transcription,BP,
19580,GO:1903109,1,0.992268375099963,0,1,positive regulation of mitochondrial transcription,BP,
19581,GO:1903115,1,0.755277789606443,0,38,regulation of actin filament-based movement,BP,
19582,GO:1903116,1,0.97748691285904,0,3,positive regulation of actin filament-based movement,BP,
19584,GO:1903121,1,0.976566200735999,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19585,GO:1903122,1,0.99691333883606,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19586,GO:1903123,1,0.990820996121129,0,1,regulation of thioredoxin peroxidase activity,BP,
19587,GO:1903124,1,0.990820996121129,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19588,GO:1903125,1,0.990820996121129,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19589,GO:1903126,1,0.994909936862563,0,1,negative regulation of centriole-centriole cohesion,BP,
19590,GO:1903131,1,0.822770449335777,0,30,mononuclear cell differentiation,BP,
19591,GO:1903135,1,0.982853547087509,0,3,cupric ion binding,MF,
19592,GO:1903136,1,0.968168618136593,0,6,cuprous ion binding,MF,
19593,GO:1903140,1,0.926609180741064,0,12,regulation of establishment of endothelial barrier,BP,
19594,GO:1903141,1,0.992441125735774,0,1,negative regulation of establishment of endothelial barrier,BP,
19595,GO:1903142,1,0.968838433529865,0,5,positive regulation of establishment of endothelial barrier,BP,
19596,GO:1903143,1,0.985886265503875,0,3,adrenomedullin receptor complex,CC,
19597,GO:1903146,1,0.749645373672853,0,44,regulation of autophagy of mitochondrion,BP,
19598,GO:1903147,1,0.954579618736827,0,7,negative regulation of autophagy of mitochondrion,BP,
19599,GO:1903165,1,0.993468036731548,0,1,response to polycyclic arene,BP,
19600,GO:1903167,1,0.99691333883606,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19601,GO:1903168,1,0.99691333883606,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19604,GO:1903173,1,0.988078560326488,0,2,fatty alcohol metabolic process,BP,
19605,GO:1903176,1,0.99691333883606,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19606,GO:1903178,1,0.99691333883606,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19607,GO:1903179,1,0.989577410802733,0,2,regulation of dopamine biosynthetic process,BP,
19608,GO:1903181,1,0.989577410802733,0,2,positive regulation of dopamine biosynthetic process,BP,
19609,GO:1903182,1,0.996699166694483,0,1,regulation of SUMO transferase activity,BP,
19610,GO:1903184,1,0.99691333883606,0,1,L-dopa metabolic process,BP,
19611,GO:1903185,1,0.99691333883606,0,1,L-dopa biosynthetic process,BP,
19612,GO:1903189,1,0.99691333883606,0,1,glyoxal metabolic process,BP,
19613,GO:1903195,1,0.99691333883606,0,1,regulation of L-dopa biosynthetic process,BP,
19614,GO:1903197,1,0.99691333883606,0,1,positive regulation of L-dopa biosynthetic process,BP,
19615,GO:1903198,1,0.99691333883606,0,1,regulation of L-dopa decarboxylase activity,BP,
19616,GO:1903200,1,0.99691333883606,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19617,GO:1903201,1,0.699534830820902,0,57,regulation of oxidative stress-induced cell death,BP,
19618,GO:1903202,1,0.785643053047104,0,39,negative regulation of oxidative stress-induced cell death,BP,
19619,GO:1903203,1,0.871597461760849,0,20,regulation of oxidative stress-induced neuron death,BP,
19620,GO:1903204,1,0.905924970736722,0,15,negative regulation of oxidative stress-induced neuron death,BP,
19621,GO:1903205,1,0.861211556790041,0,24,regulation of hydrogen peroxide-induced cell death,BP,
19622,GO:1903206,1,0.900471261055574,0,17,negative regulation of hydrogen peroxide-induced cell death,BP,
19623,GO:1903207,1,0.978925421082906,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19624,GO:1903208,1,0.978925421082906,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19625,GO:1903209,1,0.922878810065001,0,13,positive regulation of oxidative stress-induced cell death,BP,
19626,GO:1903210,1,0.991902207274696,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19627,GO:1903214,1,0.60916542336176,0,82,regulation of protein targeting to mitochondrion,BP,
19628,GO:1903215,1,0.975012472711663,0,4,negative regulation of protein targeting to mitochondrion,BP,
19629,GO:1903216,1,0.987581210450437,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19630,GO:1903217,1,0.987581210450437,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19631,GO:1903223,1,0.969460325170349,0,4,positive regulation of oxidative stress-induced neuron death,BP,
19632,GO:1903224,1,0.969352891547449,0,5,regulation of endodermal cell differentiation,BP,
19633,GO:1903225,1,0.979681320753717,0,3,negative regulation of endodermal cell differentiation,BP,
19634,GO:1903232,1,0.976295674000131,0,5,melanosome assembly,BP,
19635,GO:1903233,1,0.983600901779398,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19636,GO:1903236,1,0.962191726948095,0,8,regulation of leukocyte tethering or rolling,BP,
19637,GO:1903237,1,0.98637050390722,0,4,negative regulation of leukocyte tethering or rolling,BP,
19638,GO:1903238,1,0.975490594520918,0,4,positive regulation of leukocyte tethering or rolling,BP,
19639,GO:1903242,1,0.94049636267632,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19640,GO:1903243,1,0.954837829913172,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19641,GO:1903244,1,0.984987372790287,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19642,GO:1903248,1,0.990996315875316,0,1,regulation of citrulline biosynthetic process,BP,
19643,GO:1903249,1,0.990996315875316,0,1,negative regulation of citrulline biosynthetic process,BP,
19644,GO:1903251,1,0.958519429171009,0,7,multi-ciliated epithelial cell differentiation,BP,
19645,GO:1903265,1,0.956759641101219,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19646,GO:1903276,1,0.980999426021475,0,4,regulation of sodium ion export across plasma membrane,BP,
19647,GO:1903278,1,0.980999426021475,0,4,positive regulation of sodium ion export across plasma membrane,BP,
19648,GO:1903279,1,0.980244739963969,0,3,regulation of calcium:sodium antiporter activity,BP,
19649,GO:1903280,1,0.992168095656771,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19650,GO:1903281,1,0.987983502394766,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19651,GO:1903282,1,0.992742752447207,0,1,regulation of glutathione peroxidase activity,BP,
19652,GO:1903284,1,0.992742752447207,0,1,positive regulation of glutathione peroxidase activity,BP,
19653,GO:1903285,1,0.992742752447207,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19654,GO:1903286,1,0.976298821501838,0,4,regulation of potassium ion import,BP,
19655,GO:1903288,1,0.983884693701842,0,3,positive regulation of potassium ion import,BP,
19656,GO:1903292,1,0.985616250904697,0,2,protein localization to Golgi membrane,BP,
19657,GO:1903293,1,0.746750571705447,0,44,phosphatase complex,CC,
19658,GO:1903294,1,0.984830014508717,0,2,regulation of glutamate secretion, neurotransmission,BP,
19659,GO:1903296,1,0.984830014508717,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
19660,GO:1903297,1,0.971290612392188,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19661,GO:1903298,1,0.971290612392188,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19662,GO:1903299,1,0.950491059895535,0,9,regulation of hexokinase activity,BP,
19663,GO:1903300,1,0.978309015993587,0,4,negative regulation of hexokinase activity,BP,
19664,GO:1903301,1,0.971571673122867,0,5,positive regulation of hexokinase activity,BP,
19665,GO:1903305,1,0.466740452011189,0,117,regulation of regulated secretory pathway,BP,
19666,GO:1903306,1,0.880109265060496,0,20,negative regulation of regulated secretory pathway,BP,
19667,GO:1903307,1,0.750496531903806,0,46,positive regulation of regulated secretory pathway,BP,
19668,GO:1903311,1,0.181389815180021,0,273,regulation of mRNA metabolic process,BP,
19669,GO:1903312,1,0.625838017820849,0,69,negative regulation of mRNA metabolic process,BP,
19670,GO:1903313,1,0.660099940898505,0,63,positive regulation of mRNA metabolic process,BP,
19671,GO:1903314,1,0.994866756232826,0,1,regulation of nitrogen cycle metabolic process,BP,
19673,GO:1903318,1,0.800824725162893,0,35,negative regulation of protein maturation,BP,
19677,GO:1903322,1,0.490828114339582,0,114,positive regulation of protein modification by small protein conjugation or removal,BP,
19678,GO:1903332,1,0.957940473622197,0,7,regulation of protein folding,BP,
19679,GO:1903333,1,0.971250170336862,0,5,negative regulation of protein folding,BP,
19680,GO:1903335,1,0.975835768772501,0,4,regulation of vacuolar transport,BP,
19681,GO:1903336,1,0.983529437224617,0,2,negative regulation of vacuolar transport,BP,
19682,GO:1903337,1,0.99217883967139,0,2,positive regulation of vacuolar transport,BP,
19683,GO:1903347,1,0.972425769399015,0,4,negative regulation of bicellular tight junction assembly,BP,
19684,GO:1903348,1,0.978519699064014,0,3,positive regulation of bicellular tight junction assembly,BP,
19685,GO:1903349,1,0.961029530451008,0,6,omegasome membrane,CC,
19686,GO:1903350,1,0.91673508318874,0,13,response to dopamine,BP,
19687,GO:1903351,1,0.91673508318874,0,13,cellular response to dopamine,BP,
19688,GO:1903352,1,0.96144362751141,0,6,L-ornithine transmembrane transport,BP,
19689,GO:1903358,1,0.904143922317684,0,15,regulation of Golgi organization,BP,
19690,GO:1903361,1,0.964741706726868,0,7,protein localization to basolateral plasma membrane,BP,
19692,GO:1903363,1,0.655442315875507,0,67,negative regulation of cellular protein catabolic process,BP,
19696,GO:1903371,1,0.970167878837258,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
19697,GO:1903373,1,0.978565326015744,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19698,GO:1903375,1,0.986125103465512,0,2,facioacoustic ganglion development,BP,
19699,GO:1903376,1,0.954061593177517,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19700,GO:1903377,1,0.975955751259186,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19701,GO:1903378,1,0.985002438896418,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19702,GO:1903381,1,0.992389942592625,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19703,GO:1903382,1,0.992389942592625,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19704,GO:1903383,1,0.990472966360711,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19705,GO:1903384,1,0.990472966360711,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19706,GO:1903385,1,0.984826698300685,0,2,regulation of homophilic cell adhesion,BP,
19707,GO:1903387,1,0.992222271832907,0,1,positive regulation of homophilic cell adhesion,BP,
19710,GO:1903393,1,0.836905715855433,0,25,positive regulation of adherens junction organization,BP,
19711,GO:1903394,1,0.994316648574401,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19712,GO:1903400,1,0.966114496200261,0,5,L-arginine transmembrane transport,BP,
19713,GO:1903401,1,0.970002450275218,0,5,L-lysine transmembrane transport,BP,
19714,GO:1903402,1,0.992466034638323,0,1,regulation of renal phosphate excretion,BP,
19715,GO:1903403,1,0.992466034638323,0,1,negative regulation of renal phosphate excretion,BP,
19716,GO:1903405,1,0.952866827182945,0,9,protein localization to nuclear body,BP,
19717,GO:1903406,1,0.992496595387783,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19718,GO:1903408,1,0.992496595387783,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19719,GO:1903409,1,0.594839156035207,0,83,reactive oxygen species biosynthetic process,BP,
19720,GO:1903412,1,0.985896552763443,0,3,response to bile acid,BP,
19721,GO:1903413,1,0.985896552763443,0,3,cellular response to bile acid,BP,
19722,GO:1903414,1,0.992603497008377,0,1,iron cation export,BP,
19723,GO:1903416,1,0.960483173665819,0,6,response to glycoside,BP,
19724,GO:1903420,1,0.991874100778478,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19725,GO:1903421,1,0.896540349906251,0,15,regulation of synaptic vesicle recycling,BP,
19726,GO:1903422,1,0.984682448726329,0,2,negative regulation of synaptic vesicle recycling,BP,
19727,GO:1903423,1,0.948112974465129,0,7,positive regulation of synaptic vesicle recycling,BP,
19728,GO:1903426,1,0.671415485710716,0,65,regulation of reactive oxygen species biosynthetic process,BP,
19729,GO:1903427,1,0.885739025725472,0,21,negative regulation of reactive oxygen species biosynthetic process,BP,
19730,GO:1903428,1,0.767877220957066,0,42,positive regulation of reactive oxygen species biosynthetic process,BP,
19731,GO:1903429,1,0.87945954074816,0,20,regulation of cell maturation,BP,
19732,GO:1903430,1,0.960774968090693,0,7,negative regulation of cell maturation,BP,
19733,GO:1903431,1,0.951017677825766,0,7,positive regulation of cell maturation,BP,
19734,GO:1903432,1,0.854947196320173,0,25,regulation of TORC1 signaling,BP,
19735,GO:1903433,1,0.985765784434807,0,2,regulation of constitutive secretory pathway,BP,
19736,GO:1903434,1,0.99246736580299,0,1,negative regulation of constitutive secretory pathway,BP,
19737,GO:1903435,1,0.993248084539787,0,1,positive regulation of constitutive secretory pathway,BP,
19738,GO:1903436,1,0.984583252215974,0,2,regulation of mitotic cytokinetic process,BP,
19739,GO:1903438,1,0.984583252215974,0,2,positive regulation of mitotic cytokinetic process,BP,
19740,GO:1903439,1,0.975488238776077,0,5,calcitonin family receptor complex,CC,
19741,GO:1903440,1,0.983063723507728,0,4,amylin receptor complex,CC,
19742,GO:1903441,1,0.94852390848392,0,8,protein localization to ciliary membrane,BP,
19743,GO:1903442,1,0.992470124072084,0,1,response to lipoic acid,BP,
19744,GO:1903444,1,0.992753094597018,0,1,negative regulation of brown fat cell differentiation,BP,
19745,GO:1903445,1,0.986594794236591,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19746,GO:1903450,1,0.991074089122571,0,1,regulation of G1 to G0 transition,BP,
19747,GO:1903452,1,0.991074089122571,0,1,positive regulation of G1 to G0 transition,BP,
19748,GO:1903461,1,0.992805074701418,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19749,GO:1903463,1,0.980358600160769,0,3,regulation of mitotic cell cycle DNA replication,BP,
19750,GO:1903464,1,0.988148471753329,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19751,GO:1903465,1,0.992117673868286,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19752,GO:1903487,1,0.985033924354901,0,3,regulation of lactation,BP,
19753,GO:1903489,1,0.992456099462085,0,2,positive regulation of lactation,BP,
19754,GO:1903490,1,0.984583252215974,0,2,positive regulation of mitotic cytokinesis,BP,
19755,GO:1903494,1,0.996884610584346,0,1,response to dehydroepiandrosterone,BP,
19756,GO:1903496,1,0.996884610584346,0,1,response to 11-deoxycorticosterone,BP,
19757,GO:1903504,1,0.918640716546611,0,14,regulation of mitotic spindle checkpoint,BP,
19763,GO:1903513,1,0.848765910503146,0,26,endoplasmic reticulum to cytosol transport,BP,
19764,GO:1903514,1,0.818670478886354,0,29,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19765,GO:1903515,1,0.991224471578046,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19766,GO:1903516,1,0.980621843913444,0,3,regulation of single strand break repair,BP,
19767,GO:1903517,1,0.993079601576071,0,1,negative regulation of single strand break repair,BP,
19768,GO:1903518,1,0.987456330328865,0,2,positive regulation of single strand break repair,BP,
19769,GO:1903519,1,0.981882629804724,0,3,regulation of mammary gland involution,BP,
19770,GO:1903521,1,0.981882629804724,0,3,positive regulation of mammary gland involution,BP,
19772,GO:1903523,1,0.833699957138139,0,27,negative regulation of blood circulation,BP,
19774,GO:1903525,1,0.961818344744524,0,5,regulation of membrane tubulation,BP,
19775,GO:1903526,1,0.984965449353047,0,2,negative regulation of membrane tubulation,BP,
19776,GO:1903527,1,0.976503237225786,0,3,positive regulation of membrane tubulation,BP,
19778,GO:1903531,1,0.376503205861826,0,159,negative regulation of secretion by cell,BP,
19780,GO:1903533,1,0.497211288836241,0,114,regulation of protein targeting,BP,
19781,GO:1903537,1,0.987498250250008,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19782,GO:1903538,1,0.987498250250008,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19783,GO:1903539,1,0.918461361226901,0,12,protein localization to postsynaptic membrane,BP,
19784,GO:1903540,1,0.943539161662305,0,9,establishment of protein localization to postsynaptic membrane,BP,
19785,GO:1903541,1,0.919009335182492,0,14,regulation of exosomal secretion,BP,
19786,GO:1903542,1,0.987267259613942,0,2,negative regulation of exosomal secretion,BP,
19787,GO:1903543,1,0.919009335182492,0,14,positive regulation of exosomal secretion,BP,
19788,GO:1903544,1,0.992571051650007,0,1,response to butyrate,BP,
19789,GO:1903545,1,0.992571051650007,0,1,cellular response to butyrate,BP,
19790,GO:1903546,1,0.962267077132655,0,6,protein localization to photoreceptor outer segment,BP,
19791,GO:1903547,1,0.993441679659556,0,2,regulation of growth hormone activity,BP,
19792,GO:1903551,1,0.96307121332616,0,6,regulation of extracellular exosome assembly,BP,
19793,GO:1903553,1,0.973539539309664,0,4,positive regulation of extracellular exosome assembly,BP,
19795,GO:1903556,1,0.780814419616306,0,45,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
19798,GO:1903564,1,0.969577468969447,0,4,regulation of protein localization to cilium,BP,
19799,GO:1903565,1,0.992578354811395,0,1,negative regulation of protein localization to cilium,BP,
19800,GO:1903566,1,0.976828908633793,0,3,positive regulation of protein localization to cilium,BP,
19801,GO:1903567,1,0.986891572758026,0,2,regulation of protein localization to ciliary membrane,BP,
19802,GO:1903568,1,0.992578354811395,0,1,negative regulation of protein localization to ciliary membrane,BP,
19803,GO:1903569,1,0.994271140272981,0,1,positive regulation of protein localization to ciliary membrane,BP,
19804,GO:1903570,1,0.99252960416424,0,1,regulation of protein kinase D signaling,BP,
19805,GO:1903572,1,0.99252960416424,0,1,positive regulation of protein kinase D signaling,BP,
19806,GO:1903573,1,0.779233230726713,0,40,negative regulation of response to endoplasmic reticulum stress,BP,
19807,GO:1903575,1,0.988980003810668,0,2,cornified envelope assembly,BP,
19808,GO:1903576,1,0.995081168639373,0,1,response to L-arginine,BP,
19810,GO:1903579,1,0.888648431386815,0,19,negative regulation of ATP metabolic process,BP,
19812,GO:1903584,1,0.992418417671425,0,1,regulation of histone deubiquitination,BP,
19813,GO:1903586,1,0.992418417671425,0,1,positive regulation of histone deubiquitination,BP,
19816,GO:1903589,1,0.968563004029031,0,5,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19817,GO:1903593,1,0.987862606551229,0,3,regulation of histamine secretion by mast cell,BP,
19818,GO:1903595,1,0.987862606551229,0,3,positive regulation of histamine secretion by mast cell,BP,
19819,GO:1903596,1,0.97266208721642,0,4,regulation of gap junction assembly,BP,
19820,GO:1903597,1,0.992599248135765,0,1,negative regulation of gap junction assembly,BP,
19821,GO:1903598,1,0.979915726400134,0,3,positive regulation of gap junction assembly,BP,
19822,GO:1903599,1,0.893027852622218,0,17,positive regulation of autophagy of mitochondrion,BP,
19823,GO:1903608,1,0.963216257981005,0,6,protein localization to cytoplasmic stress granule,BP,
19824,GO:1903609,1,0.993518643021933,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19825,GO:1903610,1,0.995445805928028,0,1,regulation of calcium-dependent ATPase activity,BP,
19826,GO:1903611,1,0.995445805928028,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19827,GO:1903613,1,0.992203376693281,0,1,regulation of protein tyrosine phosphatase activity,BP,
19828,GO:1903615,1,0.992203376693281,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19829,GO:1903618,1,0.9924574167577,0,1,regulation of transdifferentiation,BP,
19830,GO:1903620,1,0.9924574167577,0,1,positive regulation of transdifferentiation,BP,
19831,GO:1903621,1,0.995400841836756,0,1,protein localization to photoreceptor connecting cilium,BP,
19832,GO:1903624,1,0.951595878856836,0,9,regulation of DNA catabolic process,BP,
19833,GO:1903625,1,0.9889015391623,0,2,negative regulation of DNA catabolic process,BP,
19834,GO:1903626,1,0.978751604394526,0,4,positive regulation of DNA catabolic process,BP,
19835,GO:1903627,1,0.995445805928028,0,1,regulation of dUTP diphosphatase activity,BP,
19836,GO:1903629,1,0.995445805928028,0,1,positive regulation of dUTP diphosphatase activity,BP,
19837,GO:1903630,1,0.99214361060677,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19838,GO:1903631,1,0.995445805928028,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19839,GO:1903632,1,0.996682855097367,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19840,GO:1903633,1,0.995445805928028,0,1,regulation of leucine-tRNA ligase activity,BP,
19841,GO:1903634,1,0.995445805928028,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19842,GO:1903636,1,0.997062308027535,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19843,GO:1903638,1,0.997062308027535,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19844,GO:1903639,1,0.997071630022652,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19845,GO:1903640,1,0.997071630022652,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19846,GO:1903644,1,0.99087468120207,0,2,regulation of chaperone-mediated protein folding,BP,
19847,GO:1903645,1,0.997062308027535,0,1,negative regulation of chaperone-mediated protein folding,BP,
19848,GO:1903649,1,0.871861032292775,0,20,regulation of cytoplasmic transport,BP,
19849,GO:1903650,1,0.993497437782781,0,2,negative regulation of cytoplasmic transport,BP,
19850,GO:1903651,1,0.933039800233861,0,9,positive regulation of cytoplasmic transport,BP,
19851,GO:1903659,1,0.990450440006203,0,2,regulation of complement-dependent cytotoxicity,BP,
19852,GO:1903660,1,0.990450440006203,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19855,GO:1903672,1,0.820371588268262,0,31,positive regulation of sprouting angiogenesis,BP,
19856,GO:1903673,1,0.995466866228212,0,1,mitotic cleavage furrow formation,BP,
19857,GO:1903674,1,0.995484123700655,0,1,regulation of cap-dependent translational initiation,BP,
19858,GO:1903676,1,0.995484123700655,0,1,positive regulation of cap-dependent translational initiation,BP,
19859,GO:1903677,1,0.984135012958762,0,3,regulation of cap-independent translational initiation,BP,
19860,GO:1903679,1,0.984135012958762,0,3,positive regulation of cap-independent translational initiation,BP,
19861,GO:1903689,1,0.950244934226641,0,6,regulation of wound healing, spreading of epidermal cells,BP,
19862,GO:1903690,1,0.967469591018702,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19863,GO:1903691,1,0.982202245086761,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19864,GO:1903697,1,0.992605222437207,0,1,negative regulation of microvillus assembly,BP,
19865,GO:1903699,1,0.989700982772333,0,1,tarsal gland development,BP,
19866,GO:1903701,1,0.992245578666776,0,1,substantia propria of cornea development,BP,
19867,GO:1903704,1,0.9924574167577,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19869,GO:1903707,1,0.501029478960161,0,114,negative regulation of hemopoiesis,BP,
19871,GO:1903709,1,0.989700982772333,0,1,uterine gland development,BP,
19872,GO:1903712,1,0.992481453401396,0,1,cysteine transmembrane transport,BP,
19873,GO:1903715,1,0.959382445255149,0,6,regulation of aerobic respiration,BP,
19874,GO:1903717,1,0.992083390260703,0,1,response to ammonia,BP,
19875,GO:1903718,1,0.992083390260703,0,1,cellular response to ammonia,BP,
19876,GO:1903719,1,0.98436532269859,0,3,regulation of I-kappaB phosphorylation,BP,
19877,GO:1903721,1,0.98436532269859,0,3,positive regulation of I-kappaB phosphorylation,BP,
19878,GO:1903722,1,0.989542120543233,0,2,regulation of centriole elongation,BP,
19879,GO:1903723,1,0.996930452377055,0,1,negative regulation of centriole elongation,BP,
19880,GO:1903724,1,0.992589156573249,0,1,positive regulation of centriole elongation,BP,
19882,GO:1903726,1,0.95582755499169,0,7,negative regulation of phospholipid metabolic process,BP,
19884,GO:1903729,1,0.928199774498005,0,11,regulation of plasma membrane organization,BP,
19885,GO:1903742,1,0.996553782258356,0,1,regulation of anterograde synaptic vesicle transport,BP,
19886,GO:1903743,1,0.996553782258356,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19887,GO:1903747,1,0.502833776967434,0,115,regulation of establishment of protein localization to mitochondrion,BP,
19888,GO:1903748,1,0.956418879333618,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19889,GO:1903749,1,0.537623642324042,0,104,positive regulation of establishment of protein localization to mitochondrion,BP,
19890,GO:1903750,1,0.977562097284235,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19891,GO:1903751,1,0.977562097284235,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19892,GO:1903753,1,0.965565203758471,0,5,negative regulation of p38MAPK cascade,BP,
19893,GO:1903755,1,0.996699166694483,0,1,positive regulation of SUMO transferase activity,BP,
19894,GO:1903756,1,0.986644431311248,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19895,GO:1903758,1,0.986644431311248,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19896,GO:1903759,1,0.992753094597018,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19897,GO:1903760,1,0.977327699313315,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19898,GO:1903762,1,0.98492148108445,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19900,GO:1903764,1,0.982199463800364,0,3,regulation of potassium ion export across plasma membrane,BP,
19901,GO:1903765,1,0.992849662453293,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19902,GO:1903766,1,0.996959526653871,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19903,GO:1903767,1,0.993782080934776,0,1,sweet taste receptor complex,CC,
19904,GO:1903768,1,0.993782080934776,0,1,taste receptor complex,CC,
19905,GO:1903770,1,0.993079601576071,0,1,negative regulation of beta-galactosidase activity,BP,
19906,GO:1903772,1,0.974642389467595,0,5,regulation of viral budding via host ESCRT complex,BP,
19907,GO:1903774,1,0.984479878336,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19908,GO:1903775,1,0.987540699547536,0,2,regulation of DNA double-strand break processing,BP,
19909,GO:1903778,1,0.99188556516431,0,1,protein localization to vacuolar membrane,BP,
19910,GO:1903779,1,0.623135398957927,0,69,regulation of cardiac conduction,BP,
19911,GO:1903781,1,0.977480113371846,0,3,positive regulation of cardiac conduction,BP,
19912,GO:1903786,1,0.99337371634623,0,1,regulation of glutathione biosynthetic process,BP,
19913,GO:1903788,1,0.99337371634623,0,1,positive regulation of glutathione biosynthetic process,BP,
19914,GO:1903789,1,0.94916682936963,0,8,regulation of amino acid transmembrane transport,BP,
19915,GO:1903792,1,0.858036431755187,0,22,negative regulation of anion transport,BP,
19916,GO:1903793,1,0.8064271782555,0,34,positive regulation of anion transport,BP,
19917,GO:1903795,1,0.95414918027522,0,6,regulation of inorganic anion transmembrane transport,BP,
19918,GO:1903796,1,0.984168986320616,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19919,GO:1903797,1,0.984465610397309,0,2,positive regulation of inorganic anion transmembrane transport,BP,
19921,GO:1903799,1,0.943850008403453,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19923,GO:1903801,1,0.994554505936448,0,1,L-leucine import across plasma membrane,BP,
19924,GO:1903803,1,0.99544704789982,0,1,L-glutamine import across plasma membrane,BP,
19925,GO:1903804,1,0.993123957620565,0,1,glycine import across plasma membrane,BP,
19926,GO:1903814,1,0.996959526653871,0,1,regulation of collecting lymphatic vessel constriction,BP,
19927,GO:1903815,1,0.996959526653871,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19928,GO:1903817,1,0.952606425967949,0,8,negative regulation of voltage-gated potassium channel activity,BP,
19929,GO:1903818,1,0.913728313592058,0,13,positive regulation of voltage-gated potassium channel activity,BP,
19930,GO:1903823,1,0.993079601576071,0,1,telomere single strand break repair,BP,
19931,GO:1903824,1,0.993079601576071,0,1,negative regulation of telomere single strand break repair,BP,
19933,GO:1903826,1,0.961806665646523,0,6,arginine transmembrane transport,BP,
19937,GO:1903830,1,0.895714502731195,0,16,magnesium ion transmembrane transport,BP,
19938,GO:1903831,1,0.879696914461968,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19939,GO:1903837,1,0.993995508641689,0,1,regulation of mRNA 3'-UTR binding,BP,
19940,GO:1903839,1,0.993995508641689,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19941,GO:1903844,1,0.510533302943062,0,100,regulation of cellular response to transforming growth factor beta stimulus,BP,
19942,GO:1903845,1,0.633048868858702,0,68,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
19943,GO:1903846,1,0.84910338515168,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19944,GO:1903847,1,0.983295029750405,0,2,regulation of aorta morphogenesis,BP,
19945,GO:1903849,1,0.983295029750405,0,2,positive regulation of aorta morphogenesis,BP,
19946,GO:1903850,1,0.993539894707994,0,1,regulation of cristae formation,BP,
19947,GO:1903852,1,0.993539894707994,0,1,positive regulation of cristae formation,BP,
19948,GO:1903859,1,0.869492539887883,0,20,regulation of dendrite extension,BP,
19949,GO:1903860,1,0.983707707978248,0,3,negative regulation of dendrite extension,BP,
19950,GO:1903861,1,0.8839118619075,0,17,positive regulation of dendrite extension,BP,
19951,GO:1903862,1,0.970054797890826,0,6,positive regulation of oxidative phosphorylation,BP,
19952,GO:1903867,1,0.940096627072396,0,9,extraembryonic membrane development,BP,
19953,GO:1903874,1,0.977580258625352,0,3,ferrous iron transmembrane transport,BP,
19954,GO:1903881,1,0.992483603205204,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19955,GO:1903883,1,0.992483603205204,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19956,GO:1903884,1,0.992483603205204,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19957,GO:1903886,1,0.992483603205204,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19958,GO:1903888,1,0.996992964303392,0,1,regulation of plant epidermal cell differentiation,BP,
19959,GO:1903889,1,0.996992964303392,0,1,negative regulation of plant epidermal cell differentiation,BP,
19960,GO:1903891,1,0.972799592826384,0,4,regulation of ATF6-mediated unfolded protein response,BP,
19961,GO:1903892,1,0.986174747411009,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
19962,GO:1903893,1,0.993934207175261,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
19963,GO:1903894,1,0.922346091572454,0,13,regulation of IRE1-mediated unfolded protein response,BP,
19964,GO:1903895,1,0.972730812580847,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
19965,GO:1903896,1,0.955473241225896,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
19967,GO:1903898,1,0.969405553052484,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19969,GO:1903900,1,0.460473792829187,0,125,regulation of viral life cycle,BP,
19970,GO:1903901,1,0.657426929783974,0,69,negative regulation of viral life cycle,BP,
19971,GO:1903902,1,0.706128384947058,0,55,positive regulation of viral life cycle,BP,
19972,GO:1903903,1,0.978630496806993,0,3,regulation of establishment of T cell polarity,BP,
19973,GO:1903905,1,0.985152275713508,0,2,positive regulation of establishment of T cell polarity,BP,
19974,GO:1903906,1,0.993380955444874,0,1,regulation of plasma membrane raft polarization,BP,
19975,GO:1903909,1,0.948798142668682,0,8,regulation of receptor clustering,BP,
19976,GO:1903910,1,0.994356951383179,0,1,negative regulation of receptor clustering,BP,
19977,GO:1903911,1,0.976551572652283,0,4,positive regulation of receptor clustering,BP,
19978,GO:1903912,1,0.9745384659377,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19979,GO:1903916,1,0.994241800196158,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19980,GO:1903917,1,0.994241800196158,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19981,GO:1903918,1,0.991485483417084,0,1,regulation of actin filament severing,BP,
19982,GO:1903919,1,0.991485483417084,0,1,negative regulation of actin filament severing,BP,
19983,GO:1903921,1,0.984922214770512,0,2,regulation of protein processing in phagocytic vesicle,BP,
19984,GO:1903923,1,0.984922214770512,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19985,GO:1903924,1,0.994663259074361,0,1,estradiol binding,MF,
19986,GO:1903925,1,0.99559070054452,0,1,response to bisphenol A,BP,
19987,GO:1903926,1,0.99559070054452,0,1,cellular response to bisphenol A,BP,
19988,GO:1903929,1,0.987068430862261,0,2,primary palate development,BP,
19989,GO:1903935,1,0.973433253779983,0,5,response to sodium arsenite,BP,
19990,GO:1903936,1,0.973433253779983,0,5,cellular response to sodium arsenite,BP,
19991,GO:1903937,1,0.992306535089899,0,1,response to acrylamide,BP,
19992,GO:1903939,1,0.992611081854854,0,1,regulation of TORC2 signaling,BP,
19993,GO:1903943,1,0.995364275820927,0,1,regulation of hepatocyte apoptotic process,BP,
19994,GO:1903944,1,0.995364275820927,0,1,negative regulation of hepatocyte apoptotic process,BP,
19995,GO:1903946,1,0.992849662453293,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19996,GO:1903947,1,0.98492148108445,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19997,GO:1903949,1,0.984968441255486,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19998,GO:1903952,1,0.992459315935848,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19999,GO:1903954,1,0.992459315935848,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
20000,GO:1903955,1,0.638754393501314,0,74,positive regulation of protein targeting to mitochondrion,BP,
20001,GO:1903959,1,0.846543654350274,0,23,regulation of anion transmembrane transport,BP,
20002,GO:1903960,1,0.924688472836566,0,11,negative regulation of anion transmembrane transport,BP,
20003,GO:1903961,1,0.959020836782495,0,6,positive regulation of anion transmembrane transport,BP,
20004,GO:1903963,1,0.893445115734823,0,19,arachidonate transport,BP,
20005,GO:1903964,1,0.982468059936649,0,3,monounsaturated fatty acid metabolic process,BP,
20006,GO:1903965,1,0.996495019902472,0,1,monounsaturated fatty acid catabolic process,BP,
20007,GO:1903966,1,0.985924215119869,0,2,monounsaturated fatty acid biosynthetic process,BP,
20008,GO:1903969,1,0.986417585698558,0,3,regulation of response to macrophage colony-stimulating factor,BP,
20009,GO:1903970,1,0.992260176706301,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
20010,GO:1903971,1,0.994112311743672,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
20011,GO:1903972,1,0.986417585698558,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20012,GO:1903973,1,0.992260176706301,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20013,GO:1903974,1,0.994112311743672,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
20014,GO:1903975,1,0.9531286037489,0,9,regulation of glial cell migration,BP,
20015,GO:1903976,1,0.980512343689254,0,4,negative regulation of glial cell migration,BP,
20016,GO:1903977,1,0.979774576675365,0,3,positive regulation of glial cell migration,BP,
20017,GO:1903978,1,0.940795836238386,0,9,regulation of microglial cell activation,BP,
20018,GO:1903979,1,0.989044184284354,0,2,negative regulation of microglial cell activation,BP,
20019,GO:1903980,1,0.957731667812364,0,7,positive regulation of microglial cell activation,BP,
20020,GO:1903984,1,0.97959051509968,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
20021,GO:1903988,1,0.992603497008377,0,1,ferrous iron export across plasma membrane,BP,
20022,GO:1903995,1,0.991087543114421,0,2,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20023,GO:1903997,1,0.991087543114421,0,2,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
20024,GO:1903998,1,0.977431793860175,0,4,regulation of eating behavior,BP,
20025,GO:1903999,1,0.989241598879898,0,2,negative regulation of eating behavior,BP,
20026,GO:1904000,1,0.988063096408522,0,2,positive regulation of eating behavior,BP,
20027,GO:1904008,1,0.996458655415063,0,1,response to monosodium glutamate,BP,
20028,GO:1904009,1,0.996458655415063,0,1,cellular response to monosodium glutamate,BP,
20029,GO:1904010,1,0.996458655415063,0,1,response to Aroclor 1254,BP,
20030,GO:1904016,1,0.97037965000238,0,4,response to Thyroglobulin triiodothyronine,BP,
20031,GO:1904017,1,0.983724290895493,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20034,GO:1904020,1,0.981509974549684,0,3,regulation of G-protein coupled receptor internalization,BP,
20035,GO:1904021,1,0.988730803633919,0,2,negative regulation of G-protein coupled receptor internalization,BP,
20036,GO:1904022,1,0.992697729352287,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20037,GO:1904026,1,0.987188157894757,0,2,regulation of collagen fibril organization,BP,
20038,GO:1904027,1,0.993846230011101,0,1,negative regulation of collagen fibril organization,BP,
20039,GO:1904028,1,0.993301131169352,0,1,positive regulation of collagen fibril organization,BP,
20041,GO:1904030,1,0.819541059753399,0,32,negative regulation of cyclin-dependent protein kinase activity,BP,
20044,GO:1904036,1,0.79427139844919,0,35,negative regulation of epithelial cell apoptotic process,BP,
20045,GO:1904037,1,0.849640625389925,0,26,positive regulation of epithelial cell apoptotic process,BP,
20046,GO:1904041,1,0.992642954865686,0,1,regulation of cystathionine beta-synthase activity,BP,
20047,GO:1904042,1,0.992642954865686,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20048,GO:1904044,1,0.976804836020077,0,4,response to aldosterone,BP,
20049,GO:1904045,1,0.994698606978855,0,1,cellular response to aldosterone,BP,
20050,GO:1904046,1,0.992465757876314,0,2,negative regulation of vascular endothelial growth factor production,BP,
20051,GO:1904047,1,0.981988525623966,0,3,S-adenosyl-L-methionine binding,MF,
20052,GO:1904048,1,0.982935334879482,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20053,GO:1904049,1,0.990471531562301,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20054,GO:1904050,1,0.99239205876905,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20055,GO:1904054,1,0.991018280753426,0,1,regulation of cholangiocyte proliferation,BP,
20056,GO:1904056,1,0.991018280753426,0,1,positive regulation of cholangiocyte proliferation,BP,
20057,GO:1904057,1,0.989803128200467,0,2,negative regulation of sensory perception of pain,BP,
20058,GO:1904058,1,0.969968790990817,0,5,positive regulation of sensory perception of pain,BP,
20059,GO:1904059,1,0.981096258059432,0,2,regulation of locomotor rhythm,BP,
20061,GO:1904063,1,0.653697467512136,0,69,negative regulation of cation transmembrane transport,BP,
20063,GO:1904071,1,0.983695382507545,0,2,presynaptic active zone assembly,BP,
20064,GO:1904073,1,0.991584722829338,0,1,regulation of trophectodermal cell proliferation,BP,
20065,GO:1904075,1,0.991584722829338,0,1,positive regulation of trophectodermal cell proliferation,BP,
20066,GO:1904090,1,0.984405275104795,0,4,peptidase inhibitor complex,CC,
20067,GO:1904098,1,0.981197439599982,0,3,regulation of protein O-linked glycosylation,BP,
20068,GO:1904100,1,0.981197439599982,0,3,positive regulation of protein O-linked glycosylation,BP,
20069,GO:1904106,1,0.993331957894849,0,1,protein localization to microvillus,BP,
20070,GO:1904115,1,0.765534313350451,0,40,axon cytoplasm,CC,
20071,GO:1904116,1,0.977842939748655,0,3,response to vasopressin,BP,
20072,GO:1904117,1,0.977842939748655,0,3,cellular response to vasopressin,BP,
20073,GO:1904118,1,0.992800822324919,0,1,regulation of otic vesicle morphogenesis,BP,
20074,GO:1904120,1,0.992800822324919,0,1,positive regulation of otic vesicle morphogenesis,BP,
20075,GO:1904121,1,0.980001573894956,0,3,phosphatidylethanolamine transporter activity,MF,
20076,GO:1904124,1,0.986801110728843,0,3,microglial cell migration,BP,
20077,GO:1904139,1,0.986801110728843,0,3,regulation of microglial cell migration,BP,
20078,GO:1904140,1,0.996292351867762,0,1,negative regulation of microglial cell migration,BP,
20079,GO:1904141,1,0.994112311743672,0,1,positive regulation of microglial cell migration,BP,
20080,GO:1904149,1,0.996292351867762,0,1,regulation of microglial cell mediated cytotoxicity,BP,
20081,GO:1904151,1,0.996292351867762,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
20082,GO:1904152,1,0.922185492114461,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20083,GO:1904153,1,0.944464658390425,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20084,GO:1904154,1,0.983773248302463,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20085,GO:1904155,1,0.992610784911899,0,1,DN2 thymocyte differentiation,BP,
20086,GO:1904156,1,0.992610784911899,0,1,DN3 thymocyte differentiation,BP,
20087,GO:1904158,1,0.977975697792537,0,3,axonemal central apparatus assembly,BP,
20088,GO:1904167,1,0.99030165213988,0,1,regulation of thyroid hormone receptor activity,BP,
20089,GO:1904168,1,0.99030165213988,0,1,negative regulation of thyroid hormone receptor activity,BP,
20092,GO:1904177,1,0.965351220222034,0,6,regulation of adipose tissue development,BP,
20093,GO:1904179,1,0.968591303963989,0,5,positive regulation of adipose tissue development,BP,
20095,GO:1904181,1,0.94184985075509,0,10,positive regulation of membrane depolarization,BP,
20096,GO:1904182,1,0.996730514936444,0,1,regulation of pyruvate dehydrogenase activity,BP,
20097,GO:1904192,1,0.991018280753426,0,1,regulation of cholangiocyte apoptotic process,BP,
20098,GO:1904193,1,0.991018280753426,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20099,GO:1904195,1,0.991018280753426,0,1,regulation of granulosa cell proliferation,BP,
20100,GO:1904197,1,0.991018280753426,0,1,positive regulation of granulosa cell proliferation,BP,
20101,GO:1904199,1,0.992452802027794,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
20102,GO:1904200,1,0.991018280753426,0,1,iodide transmembrane transport,BP,
20103,GO:1904201,1,0.991018280753426,0,1,regulation of iodide transport,BP,
20104,GO:1904202,1,0.991018280753426,0,1,negative regulation of iodide transport,BP,
20105,GO:1904204,1,0.983020756037415,0,2,regulation of skeletal muscle hypertrophy,BP,
20106,GO:1904205,1,0.991930746845922,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20107,GO:1904206,1,0.991018280753426,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20110,GO:1904210,1,0.996483054439126,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20111,GO:1904211,1,0.988125783609905,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20112,GO:1904212,1,0.991018280753426,0,1,regulation of iodide transmembrane transport,BP,
20113,GO:1904213,1,0.991018280753426,0,1,negative regulation of iodide transmembrane transport,BP,
20114,GO:1904217,1,0.98353414457496,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20115,GO:1904219,1,0.98353414457496,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20116,GO:1904220,1,0.976944442408343,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20117,GO:1904222,1,0.98353414457496,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20118,GO:1904226,1,0.994769239365915,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20119,GO:1904227,1,0.994769239365915,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20120,GO:1904229,1,0.991617546258839,0,1,regulation of succinate dehydrogenase activity,BP,
20121,GO:1904231,1,0.991617546258839,0,1,positive regulation of succinate dehydrogenase activity,BP,
20122,GO:1904232,1,0.991617546258839,0,1,regulation of aconitate hydratase activity,BP,
20123,GO:1904234,1,0.991617546258839,0,1,positive regulation of aconitate hydratase activity,BP,
20124,GO:1904235,1,0.991166366526383,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20125,GO:1904237,1,0.991166366526383,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20126,GO:1904238,1,0.958671153146114,0,7,pericyte cell differentiation,BP,
20127,GO:1904239,1,0.996483054439126,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20128,GO:1904240,1,0.996483054439126,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20129,GO:1904245,1,0.988740811610954,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20130,GO:1904246,1,0.995874545468219,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20131,GO:1904247,1,0.992837022042302,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20132,GO:1904251,1,0.937628582940151,0,10,regulation of bile acid metabolic process,BP,
20133,GO:1904252,1,0.981131634860497,0,3,negative regulation of bile acid metabolic process,BP,
20134,GO:1904253,1,0.981499284195664,0,3,positive regulation of bile acid metabolic process,BP,
20135,GO:1904259,1,0.959841143888677,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20136,GO:1904261,1,0.959841143888677,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20137,GO:1904262,1,0.931309676222847,0,11,negative regulation of TORC1 signaling,BP,
20138,GO:1904263,1,0.947561524004379,0,9,positive regulation of TORC1 signaling,BP,
20139,GO:1904265,1,0.991922661716488,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20140,GO:1904266,1,0.991598619748373,0,1,regulation of Schwann cell chemotaxis,BP,
20141,GO:1904268,1,0.991598619748373,0,1,positive regulation of Schwann cell chemotaxis,BP,
20142,GO:1904271,1,0.994008371687069,0,1,L-proline import across plasma membrane,BP,
20143,GO:1904274,1,0.994665978507157,0,1,tricellular tight junction assembly,BP,
20144,GO:1904282,1,0.995399585953174,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20145,GO:1904283,1,0.995399585953174,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20146,GO:1904288,1,0.971020755064003,0,4,BAT3 complex binding,MF,
20147,GO:1904289,1,0.985398522985488,0,2,regulation of mitotic DNA damage checkpoint,BP,
20148,GO:1904290,1,0.99239483963848,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20149,GO:1904292,1,0.83786945830896,0,27,regulation of ERAD pathway,BP,
20150,GO:1904293,1,0.921745955005361,0,13,negative regulation of ERAD pathway,BP,
20151,GO:1904294,1,0.917756139948504,0,13,positive regulation of ERAD pathway,BP,
20152,GO:1904298,1,0.99244707801265,0,1,regulation of transcytosis,BP,
20153,GO:1904300,1,0.99244707801265,0,1,positive regulation of transcytosis,BP,
20154,GO:1904301,1,0.99244707801265,0,1,regulation of maternal process involved in parturition,BP,
20155,GO:1904303,1,0.99244707801265,0,1,positive regulation of maternal process involved in parturition,BP,
20156,GO:1904304,1,0.972290246956719,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20157,GO:1904306,1,0.972290246956719,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20158,GO:1904313,1,0.992459819061843,0,1,response to methamphetamine hydrochloride,BP,
20159,GO:1904315,1,0.786194341923497,0,35,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20160,GO:1904316,1,0.99244707801265,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20161,GO:1904317,1,0.99244707801265,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20162,GO:1904321,1,0.918132663033502,0,11,response to forskolin,BP,
20163,GO:1904322,1,0.918132663033502,0,11,cellular response to forskolin,BP,
20164,GO:1904323,1,0.993071618371732,0,1,regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20165,GO:1904325,1,0.993071618371732,0,1,positive regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20166,GO:1904327,1,0.985128382251558,0,2,protein localization to cytosolic proteasome complex,BP,
20167,GO:1904328,1,0.993413388751613,0,1,regulation of myofibroblast contraction,BP,
20168,GO:1904338,1,0.9495076530474,0,9,regulation of dopaminergic neuron differentiation,BP,
20169,GO:1904339,1,0.987867684205502,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20170,GO:1904340,1,0.981359305303128,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20171,GO:1904341,1,0.992249190269564,0,1,regulation of colon smooth muscle contraction,BP,
20172,GO:1904343,1,0.992249190269564,0,1,positive regulation of colon smooth muscle contraction,BP,
20173,GO:1904344,1,0.997018312941827,0,1,regulation of gastric mucosal blood circulation,BP,
20174,GO:1904346,1,0.997018312941827,0,1,positive regulation of gastric mucosal blood circulation,BP,
20175,GO:1904347,1,0.989290373603278,0,2,regulation of small intestine smooth muscle contraction,BP,
20176,GO:1904349,1,0.989290373603278,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20178,GO:1904351,1,0.979855481190658,0,3,negative regulation of protein catabolic process in the vacuole,BP,
20180,GO:1904353,1,0.839441824928148,0,26,regulation of telomere capping,BP,
20181,GO:1904354,1,0.94042283235379,0,8,negative regulation of telomere capping,BP,
20182,GO:1904355,1,0.89973170281343,0,17,positive regulation of telomere capping,BP,
20183,GO:1904356,1,0.680138005149468,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20184,GO:1904357,1,0.836216278201395,0,25,negative regulation of telomere maintenance via telomere lengthening,BP,
20185,GO:1904358,1,0.798606612858736,0,36,positive regulation of telomere maintenance via telomere lengthening,BP,
20186,GO:1904373,1,0.996245073633555,0,1,response to kainic acid,BP,
20188,GO:1904376,1,0.855624230551954,0,24,negative regulation of protein localization to cell periphery,BP,
20190,GO:1904378,1,0.979790460904208,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20191,GO:1904379,1,0.985128382251558,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20192,GO:1904380,1,0.877848963110944,0,20,endoplasmic reticulum mannose trimming,BP,
20193,GO:1904381,1,0.977515161066618,0,3,Golgi apparatus mannose trimming,BP,
20194,GO:1904382,1,0.972866276692725,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20195,GO:1904383,1,0.987994801742584,0,2,response to sodium phosphate,BP,
20196,GO:1904385,1,0.88218470122181,0,20,cellular response to angiotensin,BP,
20197,GO:1904386,1,0.963604422600741,0,5,response to L-phenylalanine derivative,BP,
20198,GO:1904387,1,0.985373189026314,0,2,cellular response to L-phenylalanine derivative,BP,
20199,GO:1904389,1,0.996245073633555,0,1,rod bipolar cell differentiation,BP,
20200,GO:1904391,1,0.996245073633555,0,1,response to ciliary neurotrophic factor,BP,
20201,GO:1904393,1,0.982015900834022,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20202,GO:1904394,1,0.994356951383179,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20203,GO:1904395,1,0.987589640364763,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20204,GO:1904396,1,0.946978618456099,0,8,regulation of neuromuscular junction development,BP,
20205,GO:1904397,1,0.990622994052025,0,2,negative regulation of neuromuscular junction development,BP,
20206,GO:1904398,1,0.979246811375739,0,3,positive regulation of neuromuscular junction development,BP,
20207,GO:1904399,1,0.996245073633555,0,1,heparan sulfate binding,MF,
20208,GO:1904400,1,0.992817507062025,0,1,response to Thyroid stimulating hormone,BP,
20209,GO:1904404,1,0.991546677566348,0,1,response to formaldehyde,BP,
20210,GO:1904406,1,0.931230344209032,0,12,negative regulation of nitric oxide metabolic process,BP,
20211,GO:1904407,1,0.801574938786702,0,35,positive regulation of nitric oxide metabolic process,BP,
20212,GO:1904408,1,0.996756579508189,0,1,melatonin binding,MF,
20213,GO:1904412,1,0.992500861833069,0,1,regulation of cardiac ventricle development,BP,
20214,GO:1904414,1,0.992500861833069,0,1,positive regulation of cardiac ventricle development,BP,
20215,GO:1904415,1,0.960547421291871,0,6,regulation of xenophagy,BP,
20216,GO:1904417,1,0.960547421291871,0,6,positive regulation of xenophagy,BP,
20217,GO:1904424,1,0.931471737723999,0,10,regulation of GTP binding,BP,
20218,GO:1904425,1,0.992475856132256,0,1,negative regulation of GTP binding,BP,
20219,GO:1904426,1,0.985201854743665,0,2,positive regulation of GTP binding,BP,
20221,GO:1904428,1,0.979072072967944,0,3,negative regulation of tubulin deacetylation,BP,
20222,GO:1904429,1,0.958002899768137,0,6,regulation of t-circle formation,BP,
20223,GO:1904430,1,0.978184375873087,0,3,negative regulation of t-circle formation,BP,
20224,GO:1904431,1,0.97937312069884,0,3,positive regulation of t-circle formation,BP,
20225,GO:1904432,1,0.992293687616951,0,2,regulation of ferrous iron binding,BP,
20226,GO:1904434,1,0.992293687616951,0,2,positive regulation of ferrous iron binding,BP,
20227,GO:1904435,1,0.992293687616951,0,2,regulation of transferrin receptor binding,BP,
20228,GO:1904437,1,0.992293687616951,0,2,positive regulation of transferrin receptor binding,BP,
20230,GO:1904448,1,0.992316013745567,0,1,regulation of aspartate secretion,BP,
20231,GO:1904450,1,0.992316013745567,0,1,positive regulation of aspartate secretion,BP,
20232,GO:1904454,1,0.991336507742264,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20233,GO:1904455,1,0.98428374819431,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20234,GO:1904456,1,0.99558354304503,0,1,negative regulation of neuronal action potential,BP,
20235,GO:1904457,1,0.994178112895726,0,1,positive regulation of neuronal action potential,BP,
20236,GO:1904464,1,0.995889252543629,0,1,regulation of matrix metallopeptidase secretion,BP,
20237,GO:1904465,1,0.995889252543629,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20238,GO:1904467,1,0.900267081859388,0,17,regulation of tumor necrosis factor secretion,BP,
20239,GO:1904468,1,0.973135432639733,0,5,negative regulation of tumor necrosis factor secretion,BP,
20240,GO:1904469,1,0.925140468018346,0,12,positive regulation of tumor necrosis factor secretion,BP,
20241,GO:1904475,1,0.983740197303042,0,2,regulation of Ras GTPase binding,BP,
20242,GO:1904477,1,0.991891120856937,0,1,positive regulation of Ras GTPase binding,BP,
20243,GO:1904478,1,0.972850352918744,0,5,regulation of intestinal absorption,BP,
20244,GO:1904479,1,0.990621957375484,0,2,negative regulation of intestinal absorption,BP,
20245,GO:1904481,1,0.994034187898137,0,1,response to tetrahydrofolate,BP,
20246,GO:1904482,1,0.994034187898137,0,1,cellular response to tetrahydrofolate,BP,
20247,GO:1904491,1,0.982636337244195,0,4,protein localization to ciliary transition zone,BP,
20251,GO:1904499,1,0.99256729355413,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20252,GO:1904501,1,0.99256729355413,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20253,GO:1904502,1,0.964196706796696,0,5,regulation of lipophagy,BP,
20254,GO:1904504,1,0.964196706796696,0,5,positive regulation of lipophagy,BP,
20255,GO:1904505,1,0.972024694258794,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20256,GO:1904506,1,0.972024694258794,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20257,GO:1904515,1,0.992611081854854,0,1,positive regulation of TORC2 signaling,BP,
20258,GO:1904526,1,0.94431508196437,0,9,regulation of microtubule binding,BP,
20259,GO:1904527,1,0.978690081374534,0,3,negative regulation of microtubule binding,BP,
20260,GO:1904528,1,0.965796276081458,0,6,positive regulation of microtubule binding,BP,
20261,GO:1904529,1,0.984987165207852,0,2,regulation of actin filament binding,BP,
20262,GO:1904530,1,0.992812063834621,0,1,negative regulation of actin filament binding,BP,
20263,GO:1904531,1,0.992119038566604,0,1,positive regulation of actin filament binding,BP,
20264,GO:1904533,1,0.97864298241203,0,3,regulation of telomeric loop disassembly,BP,
20265,GO:1904534,1,0.98615182913802,0,2,negative regulation of telomeric loop disassembly,BP,
20266,GO:1904535,1,0.992386810063373,0,1,positive regulation of telomeric loop disassembly,BP,
20267,GO:1904542,1,0.993539894707994,0,1,regulation of free ubiquitin chain polymerization,BP,
20268,GO:1904544,1,0.993539894707994,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20269,GO:1904550,1,0.995083820733258,0,1,response to arachidonic acid,BP,
20270,GO:1904555,1,0.994008371687069,0,1,L-proline transmembrane transport,BP,
20271,GO:1904556,1,0.994008371687069,0,1,L-tryptophan transmembrane transport,BP,
20272,GO:1904562,1,0.983042720393583,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20273,GO:1904565,1,0.992783668844607,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20274,GO:1904566,1,0.992783668844607,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20275,GO:1904567,1,0.99291862897504,0,1,response to wortmannin,BP,
20276,GO:1904568,1,0.99291862897504,0,1,cellular response to wortmannin,BP,
20277,GO:1904569,1,0.995878759521773,0,1,regulation of selenocysteine incorporation,BP,
20278,GO:1904570,1,0.995878759521773,0,1,negative regulation of selenocysteine incorporation,BP,
20279,GO:1904572,1,0.995878759521773,0,1,negative regulation of mRNA binding,BP,
20280,GO:1904573,1,0.995878759521773,0,1,regulation of selenocysteine insertion sequence binding,BP,
20281,GO:1904574,1,0.995878759521773,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20282,GO:1904576,1,0.989248278214076,0,2,response to tunicamycin,BP,
20283,GO:1904577,1,0.989248278214076,0,2,cellular response to tunicamycin,BP,
20284,GO:1904578,1,0.982664406419639,0,3,response to thapsigargin,BP,
20285,GO:1904579,1,0.982664406419639,0,3,cellular response to thapsigargin,BP,
20286,GO:1904580,1,0.988810517617033,0,2,regulation of intracellular mRNA localization,BP,
20287,GO:1904582,1,0.988810517617033,0,2,positive regulation of intracellular mRNA localization,BP,
20288,GO:1904585,1,0.994842418642098,0,1,response to putrescine,BP,
20289,GO:1904586,1,0.994842418642098,0,1,cellular response to putrescine,BP,
20290,GO:1904587,1,0.962641929793034,0,6,response to glycoprotein,BP,
20291,GO:1904588,1,0.996652184032161,0,1,cellular response to glycoprotein,BP,
20294,GO:1904591,1,0.79559258974015,0,33,positive regulation of protein import,BP,
20295,GO:1904594,1,0.990055841676307,0,1,regulation of termination of RNA polymerase II transcription,BP,
20296,GO:1904595,1,0.990055841676307,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20297,GO:1904596,1,0.996541344831229,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20298,GO:1904597,1,0.996541344831229,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20299,GO:1904599,1,0.996541344831229,0,1,advanced glycation end-product binding,MF,
20300,GO:1904602,1,0.990348191243833,0,2,serotonin-activated cation-selective channel complex,CC,
20301,GO:1904603,1,0.996541344831229,0,1,regulation of advanced glycation end-product receptor activity,BP,
20302,GO:1904604,1,0.996541344831229,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20303,GO:1904606,1,0.99256775817539,0,1,fat cell apoptotic process,BP,
20304,GO:1904612,1,0.977355000442031,0,3,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20305,GO:1904613,1,0.984426789683114,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20306,GO:1904616,1,0.984987165207852,0,2,regulation of actin binding,BP,
20307,GO:1904617,1,0.992812063834621,0,1,negative regulation of actin binding,BP,
20308,GO:1904618,1,0.992119038566604,0,1,positive regulation of actin binding,BP,
20309,GO:1904627,1,0.989763884523674,0,2,response to phorbol 13-acetate 12-myristate,BP,
20310,GO:1904628,1,0.989763884523674,0,2,cellular response to phorbol 13-acetate 12-myristate,BP,
20311,GO:1904631,1,0.994618386927319,0,1,response to glucoside,BP,
20312,GO:1904633,1,0.991902207274696,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20313,GO:1904635,1,0.991902207274696,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20314,GO:1904636,1,0.974189638230155,0,4,response to ionomycin,BP,
20315,GO:1904637,1,0.974189638230155,0,4,cellular response to ionomycin,BP,
20316,GO:1904638,1,0.991902207274696,0,1,response to resveratrol,BP,
20317,GO:1904639,1,0.991902207274696,0,1,cellular response to resveratrol,BP,
20318,GO:1904640,1,0.982431587520622,0,3,response to methionine,BP,
20321,GO:1904647,1,0.990869220670755,0,1,response to rotenone,BP,
20322,GO:1904649,1,0.99256775817539,0,1,regulation of fat cell apoptotic process,BP,
20323,GO:1904651,1,0.99256775817539,0,1,positive regulation of fat cell apoptotic process,BP,
20325,GO:1904666,1,0.909995142860358,0,19,regulation of ubiquitin protein ligase activity,BP,
20326,GO:1904667,1,0.974004753430967,0,7,negative regulation of ubiquitin protein ligase activity,BP,
20327,GO:1904668,1,0.934299503393191,0,12,positive regulation of ubiquitin protein ligase activity,BP,
20328,GO:1904672,1,0.963314193827807,0,5,regulation of somatic stem cell population maintenance,BP,
20329,GO:1904673,1,0.977540242017556,0,3,negative regulation of somatic stem cell population maintenance,BP,
20330,GO:1904674,1,0.985450511877071,0,2,positive regulation of somatic stem cell population maintenance,BP,
20331,GO:1904675,1,0.993022200579954,0,1,regulation of somatic stem cell division,BP,
20332,GO:1904677,1,0.993022200579954,0,1,positive regulation of somatic stem cell division,BP,
20333,GO:1904680,1,0.883391877648684,0,22,peptide transmembrane transporter activity,MF,
20334,GO:1904681,1,0.993468036731548,0,1,response to 3-methylcholanthrene,BP,
20336,GO:1904684,1,0.96753346507047,0,4,negative regulation of metalloendopeptidase activity,BP,
20338,GO:1904688,1,0.972142465487769,0,5,regulation of cytoplasmic translational initiation,BP,
20339,GO:1904689,1,0.996769143995664,0,1,negative regulation of cytoplasmic translational initiation,BP,
20340,GO:1904690,1,0.975294323194626,0,4,positive regulation of cytoplasmic translational initiation,BP,
20341,GO:1904691,1,0.994920712808265,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20342,GO:1904692,1,0.992495453707813,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20343,GO:1904693,1,0.976317180044665,0,3,midbrain morphogenesis,BP,
20344,GO:1904694,1,0.976125928177037,0,3,negative regulation of vascular smooth muscle contraction,BP,
20345,GO:1904695,1,0.995466866228212,0,1,positive regulation of vascular smooth muscle contraction,BP,
20347,GO:1904701,1,0.995741448477009,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20348,GO:1904705,1,0.787591022960598,0,36,regulation of vascular smooth muscle cell proliferation,BP,
20349,GO:1904706,1,0.92127471972818,0,14,negative regulation of vascular smooth muscle cell proliferation,BP,
20350,GO:1904707,1,0.851665386089756,0,23,positive regulation of vascular smooth muscle cell proliferation,BP,
20352,GO:1904711,1,0.995741448477009,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20353,GO:1904713,1,0.984182981546225,0,2,beta-catenin destruction complex binding,MF,
20354,GO:1904714,1,0.952738475887042,0,8,regulation of chaperone-mediated autophagy,BP,
20355,GO:1904715,1,0.982883457886581,0,3,negative regulation of chaperone-mediated autophagy,BP,
20356,GO:1904716,1,0.994276484150943,0,1,positive regulation of chaperone-mediated autophagy,BP,
20357,GO:1904717,1,0.977778078055538,0,3,regulation of AMPA glutamate receptor clustering,BP,
20358,GO:1904719,1,0.994067921519655,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20359,GO:1904720,1,0.987010095810383,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20360,GO:1904721,1,0.992840440588041,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20361,GO:1904722,1,0.99412804963196,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20362,GO:1904723,1,0.995741448477009,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20363,GO:1904724,1,0.781617275944754,0,52,tertiary granule lumen,CC,
20364,GO:1904729,1,0.983110017658817,0,3,regulation of intestinal lipid absorption,BP,
20365,GO:1904730,1,0.993517530070233,0,1,negative regulation of intestinal lipid absorption,BP,
20366,GO:1904732,1,0.988236142148247,0,2,regulation of electron transfer activity,BP,
20367,GO:1904734,1,0.997085858048303,0,1,positive regulation of electron transfer activity,BP,
20368,GO:1904738,1,0.886203193102155,0,16,vascular associated smooth muscle cell migration,BP,
20369,GO:1904742,1,0.974592543220624,0,4,regulation of telomeric DNA binding,BP,
20370,GO:1904743,1,0.982507039631347,0,2,negative regulation of telomeric DNA binding,BP,
20371,GO:1904744,1,0.99194606648985,0,2,positive regulation of telomeric DNA binding,BP,
20372,GO:1904746,1,0.966393199796552,0,5,negative regulation of apoptotic process involved in development,BP,
20373,GO:1904747,1,0.981882629804724,0,3,positive regulation of apoptotic process involved in development,BP,
20374,GO:1904748,1,0.941516510174284,0,9,regulation of apoptotic process involved in development,BP,
20375,GO:1904749,1,0.970423407189426,0,5,regulation of protein localization to nucleolus,BP,
20376,GO:1904750,1,0.991790182429373,0,1,negative regulation of protein localization to nucleolus,BP,
20377,GO:1904751,1,0.978458184818876,0,4,positive regulation of protein localization to nucleolus,BP,
20378,GO:1904752,1,0.886203193102155,0,16,regulation of vascular associated smooth muscle cell migration,BP,
20379,GO:1904753,1,0.965733802540997,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20380,GO:1904754,1,0.917676106762708,0,11,positive regulation of vascular associated smooth muscle cell migration,BP,
20381,GO:1904760,1,0.977253016785853,0,3,regulation of myofibroblast differentiation,BP,
20382,GO:1904761,1,0.984680991665922,0,2,negative regulation of myofibroblast differentiation,BP,
20383,GO:1904762,1,0.992457672685138,0,1,positive regulation of myofibroblast differentiation,BP,
20384,GO:1904764,1,0.995173463265661,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20385,GO:1904766,1,0.991707853106549,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20386,GO:1904768,1,0.989323579381388,0,2,all-trans-retinol binding,MF,
20387,GO:1904772,1,0.993604818381729,0,1,response to tetrachloromethane,BP,
20388,GO:1904776,1,0.955848103149237,0,6,regulation of protein localization to cell cortex,BP,
20389,GO:1904777,1,0.993301131169352,0,1,negative regulation of protein localization to cell cortex,BP,
20390,GO:1904778,1,0.962296974855774,0,5,positive regulation of protein localization to cell cortex,BP,
20391,GO:1904779,1,0.950008280757555,0,7,regulation of protein localization to centrosome,BP,
20392,GO:1904781,1,0.955612184169368,0,6,positive regulation of protein localization to centrosome,BP,
20393,GO:1904782,1,0.992325385720723,0,1,negative regulation of NMDA glutamate receptor activity,BP,
20394,GO:1904783,1,0.985914346785805,0,2,positive regulation of NMDA glutamate receptor activity,BP,
20395,GO:1904784,1,0.992162814263397,0,1,NLRP1 inflammasome complex assembly,BP,
20396,GO:1904790,1,0.99302445305145,0,1,regulation of shelterin complex assembly,BP,
20397,GO:1904792,1,0.99302445305145,0,1,positive regulation of shelterin complex assembly,BP,
20398,GO:1904793,1,0.99256729355413,0,1,regulation of euchromatin binding,BP,
20399,GO:1904796,1,0.966644852941656,0,5,regulation of core promoter binding,BP,
20400,GO:1904797,1,0.991977922540233,0,1,negative regulation of core promoter binding,BP,
20401,GO:1904798,1,0.974464176587998,0,4,positive regulation of core promoter binding,BP,
20402,GO:1904799,1,0.992460513116018,0,1,regulation of neuron remodeling,BP,
20403,GO:1904800,1,0.992460513116018,0,1,negative regulation of neuron remodeling,BP,
20404,GO:1904803,1,0.997057274143711,0,1,regulation of translation involved in cellular response to UV,BP,
20405,GO:1904806,1,0.986646673054992,0,2,regulation of protein oxidation,BP,
20406,GO:1904808,1,0.986646673054992,0,2,positive regulation of protein oxidation,BP,
20407,GO:1904812,1,0.992460608132532,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20408,GO:1904813,1,0.506469890964271,0,123,ficolin-1-rich granule lumen,CC,
20409,GO:1904814,1,0.928397359216549,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20410,GO:1904815,1,0.988515243767176,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20411,GO:1904816,1,0.939190750575508,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20412,GO:1904823,1,0.98281725536332,0,3,purine nucleobase transmembrane transport,BP,
20413,GO:1904826,1,0.99145493844251,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20414,GO:1904828,1,0.99145493844251,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20415,GO:1904829,1,0.995869264340929,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20416,GO:1904831,1,0.995869264340929,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20417,GO:1904833,1,0.988431036022926,0,3,positive regulation of removal of superoxide radicals,BP,
20418,GO:1904835,1,0.993967319559355,0,1,dorsal root ganglion morphogenesis,BP,
20419,GO:1904837,1,0.798403039813006,0,34,beta-catenin-TCF complex assembly,BP,
20420,GO:1904842,1,0.994839712531381,0,1,response to nitroglycerin,BP,
20421,GO:1904843,1,0.994839712531381,0,1,cellular response to nitroglycerin,BP,
20422,GO:1904844,1,0.984369077066821,0,3,response to L-glutamine,BP,
20423,GO:1904845,1,0.984369077066821,0,3,cellular response to L-glutamine,BP,
20424,GO:1904847,1,0.969695804205339,0,5,regulation of cell chemotaxis to fibroblast growth factor,BP,
20425,GO:1904848,1,0.996699166694483,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20426,GO:1904849,1,0.980290244040716,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20427,GO:1904850,1,0.99302445305145,0,1,negative regulation of establishment of protein localization to telomere,BP,
20428,GO:1904851,1,0.951661056975249,0,9,positive regulation of establishment of protein localization to telomere,BP,
20429,GO:1904854,1,0.987025957632733,0,2,proteasome core complex binding,MF,
20430,GO:1904861,1,0.906276419000565,0,13,excitatory synapse assembly,BP,
20431,GO:1904862,1,0.977240143214685,0,3,inhibitory synapse assembly,BP,
20432,GO:1904863,1,0.99247250392464,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20433,GO:1904864,1,0.99247250392464,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20434,GO:1904867,1,0.952866827182945,0,9,protein localization to Cajal body,BP,
20435,GO:1904868,1,0.981316744276501,0,2,telomerase catalytic core complex assembly,BP,
20436,GO:1904869,1,0.957064881435709,0,8,regulation of protein localization to Cajal body,BP,
20437,GO:1904871,1,0.957064881435709,0,8,positive regulation of protein localization to Cajal body,BP,
20438,GO:1904872,1,0.906546469629795,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20439,GO:1904874,1,0.927654691737489,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20440,GO:1904875,1,0.988076754824368,0,2,regulation of DNA ligase activity,BP,
20441,GO:1904876,1,0.993081206805305,0,1,negative regulation of DNA ligase activity,BP,
20442,GO:1904877,1,0.994961045682826,0,1,positive regulation of DNA ligase activity,BP,
20443,GO:1904878,1,0.990314899610755,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20444,GO:1904879,1,0.98683156947145,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20445,GO:1904880,1,0.979618494574241,0,3,response to hydrogen sulfide,BP,
20446,GO:1904881,1,0.985572587844558,0,2,cellular response to hydrogen sulfide,BP,
20447,GO:1904882,1,0.981316744276501,0,2,regulation of telomerase catalytic core complex assembly,BP,
20448,GO:1904884,1,0.981316744276501,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20449,GO:1904885,1,0.961071542514601,0,5,beta-catenin destruction complex assembly,BP,
20450,GO:1904886,1,0.879102860254807,0,18,beta-catenin destruction complex disassembly,BP,
20451,GO:1904887,1,0.990820996121129,0,1,Wnt signalosome assembly,BP,
20453,GO:1904889,1,0.989262792521482,0,2,regulation of excitatory synapse assembly,BP,
20454,GO:1904891,1,0.989262792521482,0,2,positive regulation of excitatory synapse assembly,BP,
20456,GO:1904893,1,0.74588624748258,0,45,negative regulation of STAT cascade,BP,
20458,GO:1904895,1,0.996028001164838,0,1,ESCRT complex assembly,BP,
20459,GO:1904896,1,0.941526360612525,0,10,ESCRT complex disassembly,BP,
20460,GO:1904897,1,0.992624884499763,0,1,regulation of hepatic stellate cell proliferation,BP,
20461,GO:1904899,1,0.992624884499763,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20462,GO:1904902,1,0.996028001164838,0,1,ESCRT III complex assembly,BP,
20463,GO:1904903,1,0.941526360612525,0,10,ESCRT III complex disassembly,BP,
20464,GO:1904907,1,0.980769719219505,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20465,GO:1904908,1,0.980769719219505,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20466,GO:1904910,1,0.99302445305145,0,1,regulation of establishment of RNA localization to telomere,BP,
20467,GO:1904911,1,0.99302445305145,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20468,GO:1904913,1,0.99302445305145,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20469,GO:1904914,1,0.99302445305145,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20470,GO:1904923,1,0.922363103903683,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20471,GO:1904924,1,0.994171506730886,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20472,GO:1904925,1,0.927774845150745,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20473,GO:1904928,1,0.982805247383175,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20474,GO:1904929,1,0.956039810779845,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20475,GO:1904933,1,0.992057652763443,0,1,regulation of cell proliferation in midbrain,BP,
20476,GO:1904934,1,0.992057652763443,0,1,negative regulation of cell proliferation in midbrain,BP,
20478,GO:1904938,1,0.959988908126905,0,5,planar cell polarity pathway involved in axon guidance,BP,
20479,GO:1904947,1,0.99289938505805,0,1,folic acid import into mitochondrion,BP,
20480,GO:1904948,1,0.907927992610404,0,15,midbrain dopaminergic neuron differentiation,BP,
20481,GO:1904949,1,0.533242640868881,0,96,ATPase complex,CC,
20484,GO:1904953,1,0.936817460222482,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20485,GO:1904954,1,0.982117628778685,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20486,GO:1904955,1,0.992057652763443,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20487,GO:1904956,1,0.972374444967433,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20488,GO:1904958,1,0.984451331253016,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20489,GO:1904959,1,0.988236142148247,0,2,regulation of cytochrome-c oxidase activity,BP,
20490,GO:1904960,1,0.997085858048303,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20491,GO:1904970,1,0.977694044136916,0,3,brush border assembly,BP,
20492,GO:1904971,1,0.99237803441513,0,1,regulation of viral translation,BP,
20493,GO:1904973,1,0.99237803441513,0,1,positive regulation of viral translation,BP,
20494,GO:1904975,1,0.984774158932996,0,2,response to bleomycin,BP,
20495,GO:1904976,1,0.984774158932996,0,2,cellular response to bleomycin,BP,
20496,GO:1904977,1,0.993112254326442,0,1,lymphatic endothelial cell migration,BP,
20497,GO:1904978,1,0.978782238475777,0,3,regulation of endosome organization,BP,
20498,GO:1904979,1,0.99463878313656,0,1,negative regulation of endosome organization,BP,
20499,GO:1904980,1,0.991643347764653,0,1,positive regulation of endosome organization,BP,
20500,GO:1904983,1,0.994928789313872,0,1,glycine import into mitochondrion,BP,
20501,GO:1904990,1,0.994084858307382,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20502,GO:1904992,1,0.994084858307382,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20503,GO:1904994,1,0.937393552640453,0,12,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20504,GO:1904995,1,0.979494256632651,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20505,GO:1904996,1,0.957027005322759,0,7,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20506,GO:1904997,1,0.989085132916003,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20507,GO:1904998,1,0.993029733083786,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20508,GO:1904999,1,0.996028001164838,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20509,GO:1905000,1,0.991110917911804,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20510,GO:1905005,1,0.958532382978587,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20511,GO:1905006,1,0.987822459912811,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20512,GO:1905007,1,0.962825700921465,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20513,GO:1905008,1,0.993733497795061,0,1,regulation of L-lysine import across plasma membrane,BP,
20514,GO:1905010,1,0.993733497795061,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20515,GO:1905024,1,0.970337814337232,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20516,GO:1905025,1,0.992849662453293,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20517,GO:1905026,1,0.98492148108445,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20518,GO:1905030,1,0.992208033586699,0,1,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20519,GO:1905031,1,0.961709711921048,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20520,GO:1905032,1,0.992849662453293,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20521,GO:1905033,1,0.98492148108445,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20522,GO:1905034,1,0.993034285934045,0,1,regulation of antifungal innate immune response,BP,
20523,GO:1905035,1,0.993034285934045,0,1,negative regulation of antifungal innate immune response,BP,
20524,GO:1905037,1,0.553612168902498,0,91,autophagosome organization,BP,
20525,GO:1905038,1,0.929388594940525,0,13,regulation of membrane lipid metabolic process,BP,
20527,GO:1905040,1,0.993967319559355,0,1,otic placode development,BP,
20528,GO:1905041,1,0.994614307936066,0,1,regulation of epithelium regeneration,BP,
20529,GO:1905042,1,0.994614307936066,0,1,negative regulation of epithelium regeneration,BP,
20530,GO:1905044,1,0.993301131169352,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20531,GO:1905045,1,0.993301131169352,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20533,GO:1905049,1,0.95731397224087,0,6,negative regulation of metallopeptidase activity,BP,
20535,GO:1905051,1,0.99279163270913,0,2,regulation of base-excision repair,BP,
20536,GO:1905053,1,0.99279163270913,0,2,positive regulation of base-excision repair,BP,
20537,GO:1905062,1,0.993438909336245,0,1,positive regulation of cardioblast proliferation,BP,
20538,GO:1905063,1,0.946351174154145,0,8,regulation of vascular smooth muscle cell differentiation,BP,
20539,GO:1905064,1,0.979277545217392,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20540,GO:1905065,1,0.966384080689814,0,5,positive regulation of vascular smooth muscle cell differentiation,BP,
20541,GO:1905066,1,0.990064699454403,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20542,GO:1905067,1,0.995741448477009,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20543,GO:1905068,1,0.994299225992807,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20544,GO:1905069,1,0.987304318948509,0,2,allantois development,BP,
20545,GO:1905071,1,0.977087402062355,0,3,occluding junction disassembly,BP,
20546,GO:1905073,1,0.977087402062355,0,3,regulation of occluding junction disassembly,BP,
20547,GO:1905075,1,0.977087402062355,0,3,positive regulation of occluding junction disassembly,BP,
20548,GO:1905076,1,0.995310806423143,0,1,regulation of interleukin-17 secretion,BP,
20549,GO:1905077,1,0.995310806423143,0,1,negative regulation of interleukin-17 secretion,BP,
20550,GO:1905089,1,0.989465273482725,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20551,GO:1905090,1,0.989465273482725,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20552,GO:1905097,1,0.959264229340014,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
20553,GO:1905098,1,0.975123672001604,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20554,GO:1905099,1,0.991891120856937,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20555,GO:1905103,1,0.992457480856118,0,1,integral component of lysosomal membrane,CC,
20557,GO:1905123,1,0.984866842829547,0,2,regulation of glucosylceramidase activity,BP,
20558,GO:1905132,1,0.99289122331296,0,1,regulation of meiotic chromosome separation,BP,
20559,GO:1905133,1,0.99289122331296,0,1,negative regulation of meiotic chromosome separation,BP,
20560,GO:1905143,1,0.996230036590866,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20561,GO:1905144,1,0.879696914461968,0,21,response to acetylcholine,BP,
20562,GO:1905145,1,0.879696914461968,0,21,cellular response to acetylcholine,BP,
20564,GO:1905150,1,0.977264095438843,0,3,regulation of voltage-gated sodium channel activity,BP,
20565,GO:1905152,1,0.992035465021538,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20566,GO:1905153,1,0.924533529951981,0,12,regulation of membrane invagination,BP,
20567,GO:1905154,1,0.98780644110784,0,2,negative regulation of membrane invagination,BP,
20568,GO:1905155,1,0.94209400015159,0,9,positive regulation of membrane invagination,BP,
20569,GO:1905161,1,0.992231900912871,0,1,protein localization to phagocytic vesicle,BP,
20570,GO:1905162,1,0.992231900912871,0,1,regulation of phagosome maturation,BP,
20572,GO:1905166,1,0.979855481190658,0,3,negative regulation of lysosomal protein catabolic process,BP,
20574,GO:1905168,1,0.992484299639667,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
20575,GO:1905169,1,0.992231900912871,0,1,regulation of protein localization to phagocytic vesicle,BP,
20576,GO:1905171,1,0.992231900912871,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20577,GO:1905172,1,0.99237803441513,0,1,RISC complex binding,MF,
20578,GO:1905174,1,0.98875036000349,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
20579,GO:1905176,1,0.993113085520367,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20580,GO:1905202,1,0.986346342231241,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20581,GO:1905203,1,0.988940129605826,0,2,regulation of connective tissue replacement,BP,
20582,GO:1905204,1,0.996541344831229,0,1,negative regulation of connective tissue replacement,BP,
20583,GO:1905205,1,0.9923726782887,0,1,positive regulation of connective tissue replacement,BP,
20584,GO:1905206,1,0.96899785828172,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20588,GO:1905214,1,0.934611366029312,0,11,regulation of RNA binding,BP,
20589,GO:1905215,1,0.995878759521773,0,1,negative regulation of RNA binding,BP,
20590,GO:1905216,1,0.952898580464258,0,8,positive regulation of RNA binding,BP,
20591,GO:1905217,1,0.992817507062025,0,1,response to astaxanthin,BP,
20592,GO:1905222,1,0.992773572844186,0,1,atrioventricular canal morphogenesis,BP,
20593,GO:1905223,1,0.991890794281823,0,1,epicardium morphogenesis,BP,
20594,GO:1905224,1,0.984681751629794,0,2,clathrin-coated pit assembly,BP,
20595,GO:1905225,1,0.989493487045897,0,2,response to thyrotropin-releasing hormone,BP,
20596,GO:1905226,1,0.996609787493915,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20597,GO:1905229,1,0.996652184032161,0,1,cellular response to thyrotropin-releasing hormone,BP,
20598,GO:1905230,1,0.992458434284543,0,1,response to borneol,BP,
20599,GO:1905231,1,0.992458434284543,0,1,cellular response to borneol,BP,
20600,GO:1905232,1,0.965024126457163,0,5,cellular response to L-glutamate,BP,
20601,GO:1905233,1,0.992458434284543,0,1,response to codeine,BP,
20602,GO:1905235,1,0.992458434284543,0,1,response to quercetin,BP,
20603,GO:1905237,1,0.992458434284543,0,1,response to cyclosporin A,BP,
20604,GO:1905239,1,0.992290928420123,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20605,GO:1905240,1,0.992290928420123,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20606,GO:1905242,1,0.986129540485348,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20607,GO:1905243,1,0.993493187999537,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20608,GO:1905244,1,0.943906111423584,0,8,regulation of modification of synaptic structure,BP,
20609,GO:1905245,1,0.946892941854773,0,8,regulation of aspartic-type peptidase activity,BP,
20610,GO:1905246,1,0.984542304702136,0,2,negative regulation of aspartic-type peptidase activity,BP,
20611,GO:1905247,1,0.961765609002162,0,6,positive regulation of aspartic-type peptidase activity,BP,
20612,GO:1905255,1,0.991859638400539,0,1,regulation of RNA binding transcription factor activity,BP,
20613,GO:1905258,1,0.993174840294775,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20614,GO:1905259,1,0.993174840294775,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20615,GO:1905267,1,0.987155002559538,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20616,GO:1905268,1,0.733490485017998,0,45,negative regulation of chromatin organization,BP,
20617,GO:1905269,1,0.55118836933016,0,88,positive regulation of chromatin organization,BP,
20618,GO:1905271,1,0.997045739084385,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20619,GO:1905273,1,0.997045739084385,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20620,GO:1905274,1,0.991598619748373,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20621,GO:1905276,1,0.880735565802043,0,18,regulation of epithelial tube formation,BP,
20622,GO:1905277,1,0.992847921596484,0,1,negative regulation of epithelial tube formation,BP,
20623,GO:1905278,1,0.975527851877821,0,4,positive regulation of epithelial tube formation,BP,
20624,GO:1905279,1,0.984182981546225,0,2,regulation of retrograde transport, endosome to Golgi,BP,
20625,GO:1905285,1,0.992500861833069,0,1,fibrous ring of heart morphogenesis,BP,
20626,GO:1905286,1,0.981420042050843,0,3,serine-type peptidase complex,CC,
20627,GO:1905288,1,0.957050459805832,0,6,vascular associated smooth muscle cell apoptotic process,BP,
20628,GO:1905289,1,0.990820996121129,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20629,GO:1905292,1,0.980611765508821,0,3,regulation of neural crest cell differentiation,BP,
20630,GO:1905294,1,0.980611765508821,0,3,positive regulation of neural crest cell differentiation,BP,
20631,GO:1905301,1,0.99239205876905,0,1,regulation of macropinocytosis,BP,
20632,GO:1905302,1,0.99239205876905,0,1,negative regulation of macropinocytosis,BP,
20633,GO:1905304,1,0.991018675731716,0,1,regulation of cardiac myofibril assembly,BP,
20634,GO:1905305,1,0.991018675731716,0,1,negative regulation of cardiac myofibril assembly,BP,
20635,GO:1905309,1,0.990447545964753,0,1,positive regulation of cohesin loading,BP,
20636,GO:1905310,1,0.980611765508821,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20637,GO:1905312,1,0.980611765508821,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20638,GO:1905313,1,0.994725786414989,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20639,GO:1905314,1,0.902897646004197,0,15,semi-lunar valve development,BP,
20640,GO:1905317,1,0.992370342052644,0,1,inferior endocardial cushion morphogenesis,BP,
20641,GO:1905319,1,0.993301131169352,0,1,mesenchymal stem cell migration,BP,
20642,GO:1905320,1,0.993301131169352,0,1,regulation of mesenchymal stem cell migration,BP,
20643,GO:1905322,1,0.993301131169352,0,1,positive regulation of mesenchymal stem cell migration,BP,
20644,GO:1905323,1,0.959507725503488,0,6,telomerase holoenzyme complex assembly,BP,
20645,GO:1905327,1,0.996195995110822,0,1,tracheoesophageal septum formation,BP,
20649,GO:1905333,1,0.990065345570457,0,3,regulation of gastric motility,BP,
20650,GO:1905335,1,0.988831084214506,0,1,regulation of aggrephagy,BP,
20651,GO:1905337,1,0.988831084214506,0,1,positive regulation of aggrephagy,BP,
20652,GO:1905340,1,0.977658809938053,0,4,regulation of protein localization to kinetochore,BP,
20653,GO:1905341,1,0.993502007861344,0,1,negative regulation of protein localization to kinetochore,BP,
20654,GO:1905342,1,0.977658809938053,0,4,positive regulation of protein localization to kinetochore,BP,
20655,GO:1905344,1,0.993301131169352,0,1,prostaglandin catabolic process,BP,
20656,GO:1905348,1,0.84900145499784,0,29,endonuclease complex,CC,
20657,GO:1905349,1,0.992844017778536,0,2,ciliary transition zone assembly,BP,
20658,GO:1905354,1,0.886416691511117,0,22,exoribonuclease complex,CC,
20659,GO:1905355,1,0.992261741095616,0,1,spine apparatus assembly,BP,
20660,GO:1905359,1,0.99289122331296,0,1,protein localization to meiotic spindle,BP,
20661,GO:1905360,1,0.828227516204903,0,33,GTPase complex,CC,
20662,GO:1905365,1,0.99463878313656,0,1,regulation of intralumenal vesicle formation,BP,
20663,GO:1905366,1,0.99463878313656,0,1,negative regulation of intralumenal vesicle formation,BP,
20664,GO:1905368,1,0.664669387793204,0,83,peptidase complex,CC,
20665,GO:1905369,1,0.743668613683325,0,63,endopeptidase complex,CC,
20666,GO:1905370,1,0.994171506730886,0,1,serine-type endopeptidase complex,CC,
20667,GO:1905371,1,0.988302330669034,0,2,ceramide phosphoethanolamine metabolic process,BP,
20668,GO:1905373,1,0.988302330669034,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20669,GO:1905383,1,0.985958968766392,0,3,protein localization to presynapse,BP,
20670,GO:1905384,1,0.988989477203366,0,2,regulation of protein localization to presynapse,BP,
20671,GO:1905386,1,0.988989477203366,0,2,positive regulation of protein localization to presynapse,BP,
20672,GO:1905392,1,0.996992964303392,0,1,plant organ morphogenesis,BP,
20673,GO:1905394,1,0.980607399318051,0,3,retromer complex binding,MF,
20674,GO:1905395,1,0.981961580262193,0,3,response to flavonoid,BP,
20675,GO:1905397,1,0.991581544949985,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20676,GO:1905402,1,0.991581544949985,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20677,GO:1905403,1,0.995310806423143,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20678,GO:1905404,1,0.996253352559254,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20679,GO:1905405,1,0.990447545964753,0,1,regulation of mitotic cohesin loading,BP,
20680,GO:1905406,1,0.990447545964753,0,1,positive regulation of mitotic cohesin loading,BP,
20681,GO:1905407,1,0.988215666196787,0,2,regulation of creatine transmembrane transporter activity,BP,
20682,GO:1905408,1,0.988215666196787,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20683,GO:1905419,1,0.995681025552109,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20684,GO:1905421,1,0.996992964303392,0,1,regulation of plant organ morphogenesis,BP,
20685,GO:1905422,1,0.996992964303392,0,1,negative regulation of plant organ morphogenesis,BP,
20686,GO:1905424,1,0.988662099633861,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20687,GO:1905426,1,0.988662099633861,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20688,GO:1905429,1,0.987529417693261,0,2,response to glycine,BP,
20689,GO:1905430,1,0.995059922536059,0,1,cellular response to glycine,BP,
20690,GO:1905432,1,0.992451244311811,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20691,GO:1905433,1,0.992451244311811,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20692,GO:1905435,1,0.993301131169352,0,1,regulation of histone H3-K4 trimethylation,BP,
20693,GO:1905437,1,0.993301131169352,0,1,positive regulation of histone H3-K4 trimethylation,BP,
20694,GO:1905438,1,0.988460366948807,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20695,GO:1905443,1,0.992400426348429,0,1,regulation of clathrin coat assembly,BP,
20696,GO:1905445,1,0.992400426348429,0,1,positive regulation of clathrin coat assembly,BP,
20697,GO:1905446,1,0.974341539996974,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20698,GO:1905447,1,0.992742752447207,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20699,GO:1905448,1,0.981465663238592,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20700,GO:1905449,1,0.987600657407109,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20701,GO:1905451,1,0.987600657407109,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20702,GO:1905456,1,0.953584704412905,0,7,regulation of lymphoid progenitor cell differentiation,BP,
20703,GO:1905457,1,0.983852617401495,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20704,GO:1905458,1,0.992459378806887,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20705,GO:1905459,1,0.957050459805832,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20706,GO:1905460,1,0.991584722829338,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20707,GO:1905461,1,0.965175663877748,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20708,GO:1905462,1,0.9846024832119,0,2,regulation of DNA duplex unwinding,BP,
20709,GO:1905463,1,0.992092321760209,0,1,negative regulation of DNA duplex unwinding,BP,
20710,GO:1905464,1,0.992451083350298,0,1,positive regulation of DNA duplex unwinding,BP,
20711,GO:1905468,1,0.992231900912871,0,1,regulation of clathrin-coated pit assembly,BP,
20712,GO:1905469,1,0.992231900912871,0,1,negative regulation of clathrin-coated pit assembly,BP,
20713,GO:1905474,1,0.99632392611263,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20715,GO:1905476,1,0.829662072292875,0,29,negative regulation of protein localization to membrane,BP,
20717,GO:1905483,1,0.989781933522228,0,1,regulation of motor neuron migration,BP,
20718,GO:1905485,1,0.989781933522228,0,1,positive regulation of motor neuron migration,BP,
20719,GO:1905502,1,0.996709144316227,0,1,acetyl-CoA binding,MF,
20720,GO:1905508,1,0.811993982063321,0,28,protein localization to microtubule organizing center,BP,
20721,GO:1905512,1,0.993767434115936,0,1,regulation of short-term synaptic potentiation,BP,
20722,GO:1905513,1,0.993767434115936,0,1,negative regulation of short-term synaptic potentiation,BP,
20723,GO:1905515,1,0.729404423395252,0,48,non-motile cilium assembly,BP,
20724,GO:1905516,1,0.952568062527293,0,8,positive regulation of fertilization,BP,
20725,GO:1905517,1,0.833981492314965,0,33,macrophage migration,BP,
20726,GO:1905518,1,0.992315544998241,0,1,regulation of presynaptic active zone assembly,BP,
20727,GO:1905520,1,0.992315544998241,0,1,positive regulation of presynaptic active zone assembly,BP,
20728,GO:1905521,1,0.889988044585307,0,20,regulation of macrophage migration,BP,
20729,GO:1905522,1,0.975197426773302,0,5,negative regulation of macrophage migration,BP,
20730,GO:1905523,1,0.935317205205478,0,11,positive regulation of macrophage migration,BP,
20731,GO:1905524,1,0.991430211237281,0,1,negative regulation of protein autoubiquitination,BP,
20732,GO:1905535,1,0.992235718776325,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20733,GO:1905537,1,0.992235718776325,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20734,GO:1905538,1,0.99237803441513,0,1,polysome binding,MF,
20735,GO:1905541,1,0.993733497795061,0,1,regulation of L-arginine import across plasma membrane,BP,
20736,GO:1905546,1,0.994505634712308,0,1,cellular response to phenylpropanoid,BP,
20737,GO:1905547,1,0.99608114730034,0,1,regulation of telomeric heterochromatin assembly,BP,
20738,GO:1905549,1,0.99608114730034,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20739,GO:1905550,1,0.990741056061206,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20740,GO:1905552,1,0.990741056061206,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20741,GO:1905553,1,0.984816085722834,0,3,regulation of blood vessel branching,BP,
20742,GO:1905555,1,0.988230750004616,0,2,positive regulation blood vessel branching,BP,
20743,GO:1905562,1,0.907745655584519,0,14,regulation of vascular endothelial cell proliferation,BP,
20744,GO:1905563,1,0.980009903715251,0,3,negative regulation of vascular endothelial cell proliferation,BP,
20745,GO:1905564,1,0.926276636099078,0,11,positive regulation of vascular endothelial cell proliferation,BP,
20746,GO:1905572,1,0.993186440489305,0,1,ganglioside GM1 transport to membrane,BP,
20747,GO:1905573,1,0.988696124953048,0,2,ganglioside GM1 binding,MF,
20748,GO:1905574,1,0.993186440489305,0,1,ganglioside GM2 binding,MF,
20749,GO:1905575,1,0.993186440489305,0,1,ganglioside GM3 binding,MF,
20751,GO:1905577,1,0.993186440489305,0,1,ganglioside GP1c binding,MF,
20752,GO:1905578,1,0.994075732844041,0,1,regulation of ERBB3 signaling pathway,BP,
20753,GO:1905580,1,0.994075732844041,0,1,positive regulation of ERBB3 signaling pathway,BP,
20754,GO:1905581,1,0.996082080088302,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20755,GO:1905589,1,0.993733497795061,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20756,GO:1905590,1,0.992780109687875,0,1,fibronectin fibril organization,BP,
20757,GO:1905594,1,0.996756579508189,0,1,resveratrol binding,MF,
20758,GO:1905595,1,0.988607663860593,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20759,GO:1905596,1,0.992496490499478,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20760,GO:1905597,1,0.996082080088302,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20761,GO:1905598,1,0.992496490499478,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20762,GO:1905599,1,0.996082080088302,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20763,GO:1905600,1,0.981707056137216,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20764,GO:1905601,1,0.992496490499478,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20765,GO:1905602,1,0.989129843104226,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20766,GO:1905603,1,0.992293648364596,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20767,GO:1905604,1,0.992293648364596,0,1,negative regulation of maintenance of permeability of blood-brain barrier,BP,
20768,GO:1905606,1,0.970269329160262,0,4,regulation of presynapse assembly,BP,
20769,GO:1905608,1,0.992315544998241,0,1,positive regulation of presynapse assembly,BP,
20770,GO:1905610,1,0.992235718776325,0,1,regulation of mRNA cap binding,BP,
20771,GO:1905612,1,0.992235718776325,0,1,positive regulation of mRNA cap binding,BP,
20772,GO:1905616,1,0.985588324398871,0,2,regulation of miRNA mediated inhibition of translation,BP,
20773,GO:1905618,1,0.985588324398871,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20774,GO:1905634,1,0.963758805097902,0,5,regulation of protein localization to chromatin,BP,
20775,GO:1905636,1,0.996645657810122,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20776,GO:1905642,1,0.993301131169352,0,1,negative regulation of DNA methylation,BP,
20777,GO:1905643,1,0.992017389001123,0,1,positive regulation of DNA methylation,BP,
20778,GO:1905647,1,0.994008371687069,0,1,proline import across plasma membrane,BP,
20779,GO:1905651,1,0.976959481374052,0,3,regulation of artery morphogenesis,BP,
20780,GO:1905653,1,0.976959481374052,0,3,positive regulation of artery morphogenesis,BP,
20781,GO:1905661,1,0.987368419681524,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20782,GO:1905663,1,0.987368419681524,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20783,GO:1905664,1,0.97767493543775,0,4,regulation of calcium ion import across plasma membrane,BP,
20784,GO:1905665,1,0.989067776333309,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20785,GO:1905666,1,0.933590053193604,0,9,regulation of protein localization to endosome,BP,
20786,GO:1905668,1,0.933590053193604,0,9,positive regulation of protein localization to endosome,BP,
20787,GO:1905671,1,0.981945493783564,0,3,regulation of lysosome organization,BP,
20788,GO:1905672,1,0.994864053664453,0,1,negative regulation of lysosome organization,BP,
20789,GO:1905687,1,0.992079220915459,0,1,regulation of diacylglycerol kinase activity,BP,
20790,GO:1905689,1,0.992079220915459,0,1,positive regulation of diacylglycerol kinase activity,BP,
20791,GO:1905693,1,0.994866756232826,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20792,GO:1905695,1,0.994866756232826,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20793,GO:1905696,1,0.984672321259637,0,2,regulation of polysome binding,BP,
20794,GO:1905698,1,0.99237803441513,0,1,positive regulation of polysome binding,BP,
20795,GO:1905705,1,0.991693795646297,0,1,cellular response to paclitaxel,BP,
20796,GO:1905709,1,0.977039398781199,0,5,negative regulation of membrane permeability,BP,
20798,GO:1905711,1,0.992472606649392,0,1,response to phosphatidylethanolamine,BP,
20799,GO:1905719,1,0.986408587188176,0,2,protein localization to perinuclear region of cytoplasm,BP,
20800,GO:1905720,1,0.991604937803894,0,1,cytoplasmic microtubule bundle,CC,
20801,GO:1905747,1,0.996627947902722,0,1,negative regulation of saliva secretion,BP,
20802,GO:1905748,1,0.996627947902722,0,1,hard palate morphogenesis,BP,
20803,GO:1905764,1,0.979483289499251,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20804,GO:1905765,1,0.979483289499251,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20805,GO:1905767,1,0.99175549201606,0,1,regulation of double-stranded telomeric DNA binding,BP,
20806,GO:1905768,1,0.99175549201606,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20807,GO:1905770,1,0.967172461609073,0,6,regulation of mesodermal cell differentiation,BP,
20808,GO:1905771,1,0.982225865221192,0,4,negative regulation of mesodermal cell differentiation,BP,
20809,GO:1905773,1,0.977096323088019,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
20810,GO:1905774,1,0.992451083350298,0,1,regulation of DNA helicase activity,BP,
20811,GO:1905776,1,0.992451083350298,0,1,positive regulation of DNA helicase activity,BP,
20812,GO:1905777,1,0.979596134659666,0,3,regulation of exonuclease activity,BP,
20813,GO:1905778,1,0.98615182913802,0,2,negative regulation of exonuclease activity,BP,
20814,GO:1905779,1,0.99335320816281,0,1,positive regulation of exonuclease activity,BP,
20815,GO:1905793,1,0.982373246703614,0,2,protein localization to pericentriolar material,BP,
20816,GO:1905794,1,0.990468510977441,0,1,response to puromycin,BP,
20817,GO:1905795,1,0.990468510977441,0,1,cellular response to puromycin,BP,
20818,GO:1905799,1,0.99703180153148,0,1,regulation of intraciliary retrograde transport,BP,
20819,GO:1905802,1,0.993158192156007,0,1,regulation of cellular response to manganese ion,BP,
20820,GO:1905809,1,0.858539361840672,0,22,negative regulation of synapse organization,BP,
20821,GO:1905818,1,0.704436041053826,0,55,regulation of chromosome separation,BP,
20822,GO:1905819,1,0.813525094483251,0,33,negative regulation of chromosome separation,BP,
20823,GO:1905820,1,0.942883977076097,0,9,positive regulation of chromosome separation,BP,
20824,GO:1905832,1,0.965754179620836,0,4,positive regulation of spindle assembly,BP,
20825,GO:1905838,1,0.98615182913802,0,2,regulation of telomeric D-loop disassembly,BP,
20826,GO:1905839,1,0.98615182913802,0,2,negative regulation of telomeric D-loop disassembly,BP,
20827,GO:1905843,1,0.990023344797912,0,1,regulation of cellular response to gamma radiation,BP,
20828,GO:1905853,1,0.996721868208233,0,1,regulation of heparan sulfate binding,BP,
20829,GO:1905855,1,0.996721868208233,0,1,positive regulation of heparan sulfate binding,BP,
20830,GO:1905858,1,0.996721868208233,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20831,GO:1905860,1,0.996721868208233,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20832,GO:1905863,1,0.98407859697465,0,2,invadopodium organization,BP,
20834,GO:1905874,1,0.973565873863304,0,4,regulation of postsynaptic density organization,BP,
20835,GO:1905875,1,0.993028976710542,0,1,negative regulation of postsynaptic density organization,BP,
20836,GO:1905878,1,0.99060395892698,0,1,invadopodium disassembly,BP,
20837,GO:1905879,1,0.937543842339657,0,10,regulation of oogenesis,BP,
20838,GO:1905880,1,0.97432064305593,0,4,negative regulation of oogenesis,BP,
20839,GO:1905881,1,0.974449523383625,0,4,positive regulation of oogenesis,BP,
20840,GO:1905890,1,0.996721868208233,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20841,GO:1905891,1,0.993168694928202,0,1,regulation of cellular response to thapsigargin,BP,
20842,GO:1905892,1,0.993168694928202,0,1,negative regulation of cellular response to thapsigargin,BP,
20843,GO:1905894,1,0.993168694928202,0,1,regulation of cellular response to tunicamycin,BP,
20844,GO:1905895,1,0.993168694928202,0,1,negative regulation of cellular response to tunicamycin,BP,
20847,GO:1905899,1,0.996195995110822,0,1,regulation of smooth muscle tissue development,BP,
20848,GO:1905900,1,0.996195995110822,0,1,negative regulation of smooth muscle tissue development,BP,
20849,GO:1905901,1,0.996195995110822,0,1,positive regulation of smooth muscle tissue development,BP,
20850,GO:1905902,1,0.967172461609073,0,6,regulation of mesoderm formation,BP,
20851,GO:1905903,1,0.982225865221192,0,4,negative regulation of mesoderm formation,BP,
20852,GO:1905906,1,0.959212685026181,0,7,regulation of amyloid fibril formation,BP,
20853,GO:1905907,1,0.982515165074325,0,3,negative regulation of amyloid fibril formation,BP,
20854,GO:1905908,1,0.974649612959225,0,4,positive regulation of amyloid fibril formation,BP,
20855,GO:1905912,1,0.995649684299019,0,1,regulation of calcium ion export across plasma membrane,BP,
20856,GO:1905913,1,0.995649684299019,0,1,negative regulation of calcium ion export across plasma membrane,BP,
20857,GO:1905918,1,0.994837006052574,0,1,regulation of CoA-transferase activity,BP,
20858,GO:1905920,1,0.994837006052574,0,1,positive regulation of CoA-transferase activity,BP,
20859,GO:1905927,1,0.99060395892698,0,1,regulation of invadopodium disassembly,BP,
20860,GO:1905929,1,0.99060395892698,0,1,positive regulation of invadopodium disassembly,BP,
20861,GO:1905936,1,0.983327154943877,0,4,regulation of germ cell proliferation,BP,
20862,GO:1905937,1,0.986400616460478,0,3,negative regulation of germ cell proliferation,BP,
20863,GO:1905938,1,0.996884610584346,0,1,positive regulation of germ cell proliferation,BP,
20864,GO:1905939,1,0.902384851293195,0,18,regulation of gonad development,BP,
20865,GO:1905940,1,0.968810072805075,0,5,negative regulation of gonad development,BP,
20866,GO:1905941,1,0.944688453308802,0,10,positive regulation of gonad development,BP,
20867,GO:1905942,1,0.994075732844041,0,1,regulation of formation of growth cone in injured axon,BP,
20868,GO:1905943,1,0.994075732844041,0,1,negative regulation of formation of growth cone in injured axon,BP,
20869,GO:1905952,1,0.510611372410411,0,109,regulation of lipid localization,BP,
20870,GO:1905953,1,0.818404374547039,0,31,negative regulation of lipid localization,BP,
20871,GO:1905954,1,0.667954264182136,0,66,positive regulation of lipid localization,BP,
20872,GO:1905957,1,0.992422500170589,0,1,regulation of cellular response to alcohol,BP,
20873,GO:1905959,1,0.992422500170589,0,1,positive regulation of cellular response to alcohol,BP,
20874,GO:1905961,1,0.953633288853997,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
20875,GO:1990000,1,0.918343693462845,0,14,amyloid fibril formation,BP,
20876,GO:1990001,1,0.932633857968887,0,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
20877,GO:1990003,1,0.991997791072666,0,1,IDP phosphatase activity,MF,
20878,GO:1990005,1,0.989264817925374,0,2,granular vesicle,CC,
20879,GO:1990008,1,0.995936749986247,0,1,neurosecretory vesicle,CC,
20880,GO:1990009,1,0.984769954795349,0,2,retinal cell apoptotic process,BP,
20882,GO:1990023,1,0.914886735859478,0,12,mitotic spindle midzone,CC,
20883,GO:1990026,1,0.984873591500063,0,2,hippocampal mossy fiber expansion,CC,
20884,GO:1990030,1,0.992463349054209,0,1,pericellular basket,CC,
20885,GO:1990031,1,0.99275024804731,0,1,pinceau fiber,CC,
20886,GO:1990032,1,0.99240281686251,0,1,parallel fiber,CC,
20887,GO:1990034,1,0.965225411348604,0,5,calcium ion export across plasma membrane,BP,
20888,GO:1990036,1,0.987200544786174,0,2,calcium ion import into sarcoplasmic reticulum,BP,
20889,GO:1990037,1,0.986150674410029,0,3,Lewy body core,CC,
20890,GO:1990038,1,0.99536807227086,0,1,Lewy body corona,CC,
20891,GO:1990046,1,0.99661665079849,0,1,stress-induced mitochondrial fusion,BP,
20892,GO:1990047,1,0.994511061252315,0,1,spindle matrix,CC,
20893,GO:1990048,1,0.993301131169352,0,1,anterograde neuronal dense core vesicle transport,BP,
20894,GO:1990050,1,0.984410508974031,0,4,phosphatidic acid transporter activity,MF,
20895,GO:1990051,1,0.98474476515398,0,2,activation of protein kinase C activity,BP,
20896,GO:1990070,1,0.996997565436003,0,1,TRAPPI protein complex,CC,
20897,GO:1990071,1,0.988703351565658,0,2,TRAPPII protein complex,CC,
20898,GO:1990072,1,0.990318600386849,0,2,TRAPPIII protein complex,CC,
20899,GO:1990074,1,0.992530793644473,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20900,GO:1990075,1,0.967546293960985,0,4,periciliary membrane compartment,CC,
20901,GO:1990079,1,0.996871661429499,0,1,cartilage homeostasis,BP,
20902,GO:1990086,1,0.972241699220808,0,4,lens fiber cell apoptotic process,BP,
20903,GO:1990089,1,0.704413730512956,0,52,response to nerve growth factor,BP,
20904,GO:1990090,1,0.717903428624678,0,49,cellular response to nerve growth factor stimulus,BP,
20905,GO:1990108,1,0.984446425056027,0,2,protein linear deubiquitination,BP,
20906,GO:1990111,1,0.982005179271823,0,4,spermatoproteasome complex,CC,
20907,GO:1990112,1,0.986646673054992,0,2,RQC complex,CC,
20908,GO:1990116,1,0.986646673054992,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
20909,GO:1990117,1,0.996978827162998,0,1,B cell receptor apoptotic signaling pathway,BP,
20910,GO:1990124,1,0.944482680280725,0,8,messenger ribonucleoprotein complex,CC,
20911,GO:1990126,1,0.900253731196014,0,16,retrograde transport, endosome to plasma membrane,BP,
20912,GO:1990127,1,0.992441856564074,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20913,GO:1990130,1,0.968663510223201,0,5,GATOR1 complex,CC,
20914,GO:1990131,1,0.97976057364794,0,4,Gtr1-Gtr2 GTPase complex,CC,
20915,GO:1990134,1,0.992286569911025,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20916,GO:1990136,1,0.99389880456401,0,1,linoleate 9S-lipoxygenase activity,MF,
20918,GO:1990144,1,0.967658415979564,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20919,GO:1990145,1,0.98533653530265,0,2,maintenance of translational fidelity,BP,
20920,GO:1990164,1,0.986065248883937,0,2,histone H2A phosphorylation,BP,
20921,GO:1990165,1,0.995207441959663,0,1,single-strand break-containing DNA binding,MF,
20922,GO:1990166,1,0.994291193952458,0,1,protein localization to site of double-strand break,BP,
20923,GO:1990167,1,0.983829691278827,0,2,protein K27-linked deubiquitination,BP,
20924,GO:1990168,1,0.984293777630877,0,2,protein K33-linked deubiquitination,BP,
20925,GO:1990169,1,0.962413862703542,0,11,stress response to copper ion,BP,
20926,GO:1990170,1,0.995223063991604,0,1,stress response to cadmium ion,BP,
20927,GO:1990172,1,0.992045483227231,0,1,G-protein coupled receptor catabolic process,BP,
20928,GO:1990173,1,0.94549961395322,0,10,protein localization to nucleoplasm,BP,
20929,GO:1990174,1,0.992467609606892,0,1,phosphodiesterase decapping endonuclease activity,MF,
20930,GO:1990175,1,0.992462183180466,0,1,EH domain binding,MF,
20932,GO:1990180,1,0.984799067088321,0,3,mitochondrial tRNA 3'-end processing,BP,
20933,GO:1990182,1,0.904179024703436,0,17,exosomal secretion,BP,
20934,GO:1990183,1,0.996959526653871,0,1,lymphatic vascular process in circulatory system,BP,
20935,GO:1990186,1,0.996959526653871,0,1,regulation of lymphatic vessel size,BP,
20936,GO:1990188,1,0.993623346292385,0,1,euchromatin binding,MF,
20937,GO:1990189,1,0.985915031222572,0,3,peptide-serine-N-acetyltransferase activity,MF,
20938,GO:1990190,1,0.99325102644693,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20939,GO:1990192,1,0.996959526653871,0,1,collecting lymphatic vessel constriction,BP,
20941,GO:1990226,1,0.965935945587036,0,6,histone methyltransferase binding,MF,
20943,GO:1990239,1,0.959621715324169,0,6,steroid hormone binding,MF,
20944,GO:1990246,1,0.97346982547759,0,4,uniplex complex,CC,
20945,GO:1990247,1,0.94832226402709,0,7,N6-methyladenosine-containing RNA binding,MF,
20946,GO:1990253,1,0.937995821349986,0,9,cellular response to leucine starvation,BP,
20947,GO:1990254,1,0.969216261364746,0,5,keratin filament binding,MF,
20948,GO:1990256,1,0.989686659318807,0,1,signal clustering,BP,
20949,GO:1990258,1,0.99673146754899,0,1,histone glutamine methylation,BP,
20950,GO:1990259,1,0.99673146754899,0,1,histone-glutamine methyltransferase activity,MF,
20951,GO:1990261,1,0.993301131169352,0,1,pre-mRNA catabolic process,BP,
20952,GO:1990262,1,0.993357288908453,0,1,anti-Mullerian hormone signaling pathway,BP,
20953,GO:1990264,1,0.987279447536765,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20954,GO:1990266,1,0.661826705683292,0,78,neutrophil migration,BP,
20955,GO:1990267,1,0.992696090740811,0,1,response to transition metal nanoparticle,BP,
20956,GO:1990268,1,0.992696090740811,0,1,response to gold nanoparticle,BP,
20957,GO:1990269,1,0.987186079264905,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20958,GO:1990275,1,0.993101515110498,0,1,preribosome binding,MF,
20959,GO:1990280,1,0.991735313977066,0,1,RNA localization to chromatin,BP,
20960,GO:1990298,1,0.994854591448397,0,1,bub1-bub3 complex,CC,
20961,GO:1990314,1,0.945138312897427,0,8,cellular response to insulin-like growth factor stimulus,BP,
20962,GO:1990316,1,0.941953660096383,0,8,Atg1/ULK1 kinase complex,CC,
20963,GO:1990332,1,0.992456378204114,0,1,Ire1 complex,CC,
20964,GO:1990349,1,0.995256774042177,0,1,gap junction-mediated intercellular transport,BP,
20966,GO:1990356,1,0.996699166694483,0,1,sumoylated E2 ligase complex,CC,
20967,GO:1990357,1,0.984320862570285,0,3,terminal web,CC,
20968,GO:1990379,1,0.99149589993023,0,2,lipid transport across blood brain barrier,BP,
20969,GO:1990380,1,0.943429241885401,0,7,Lys48-specific deubiquitinase activity,MF,
20970,GO:1990381,1,0.91363695945271,0,13,ubiquitin-specific protease binding,MF,
20971,GO:1990384,1,0.996615511356294,0,1,hyaloid vascular plexus regression,BP,
20972,GO:1990386,1,0.995318480480322,0,1,mitotic cleavage furrow ingression,BP,
20973,GO:1990390,1,0.992548661496685,0,1,protein K33-linked ubiquitination,BP,
20974,GO:1990391,1,0.795353713974609,0,33,DNA repair complex,CC,
20975,GO:1990393,1,0.96481813662493,0,5,3M complex,CC,
20976,GO:1990399,1,0.994614307936066,0,1,epithelium regeneration,BP,
20977,GO:1990401,1,0.993307046402168,0,1,embryonic lung development,BP,
20978,GO:1990402,1,0.994725786414989,0,1,embryonic liver development,BP,
20979,GO:1990403,1,0.933796173293254,0,10,embryonic brain development,BP,
20980,GO:1990404,1,0.988058732611132,0,2,protein ADP-ribosylase activity,MF,
20981,GO:1990405,1,0.960007516175108,0,6,protein antigen binding,MF,
20982,GO:1990406,1,0.989248659726597,0,2,CGRP receptor complex,CC,
20983,GO:1990407,1,0.996929880053779,0,1,calcitonin gene-related peptide binding,MF,
20984,GO:1990408,1,0.989248659726597,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
20985,GO:1990409,1,0.989309570406517,0,2,adrenomedullin binding,MF,
20986,GO:1990410,1,0.982332941236071,0,4,adrenomedullin receptor signaling pathway,BP,
20987,GO:1990414,1,0.972785905921665,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
20988,GO:1990415,1,0.981454871415504,0,3,Pex17p-Pex14p docking complex,CC,
20989,GO:1990416,1,0.943963451567782,0,8,cellular response to brain-derived neurotrophic factor stimulus,BP,
20990,GO:1990418,1,0.982091214455658,0,3,response to insulin-like growth factor stimulus,BP,
20991,GO:1990421,1,0.990001988296496,0,1,subtelomeric heterochromatin,CC,
20992,GO:1990423,1,0.977607841249706,0,3,RZZ complex,CC,
20993,GO:1990425,1,0.976192229036157,0,3,ryanodine receptor complex,CC,
20994,GO:1990426,1,0.984556340027404,0,2,mitotic recombination-dependent replication fork processing,BP,
20995,GO:1990427,1,0.991541698684007,0,1,stereocilia tip-link density,CC,
20996,GO:1990428,1,0.984914723370295,0,2,miRNA transport,BP,
20997,GO:1990429,1,0.981454871415504,0,3,peroxisomal importomer complex,CC,
20998,GO:1990430,1,0.972931649533419,0,4,extracellular matrix protein binding,MF,
20999,GO:1990435,1,0.991541698684007,0,1,upper tip-link density,CC,
21000,GO:1990439,1,0.993005137829643,0,1,MAP kinase serine/threonine phosphatase activity,MF,
21001,GO:1990440,1,0.938765501520858,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21002,GO:1990441,1,0.975626053983534,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
21003,GO:1990442,1,0.990123743106465,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
21004,GO:1990446,1,0.984318304903985,0,4,U1 snRNP binding,MF,
21005,GO:1990448,1,0.991804908939325,0,1,exon-exon junction complex binding,MF,
21006,GO:1990452,1,0.985227939439024,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
21007,GO:1990454,1,0.944277232124879,0,7,L-type voltage-gated calcium channel complex,CC,
21008,GO:1990456,1,0.992469222875694,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
21010,GO:1990460,1,0.980322046314711,0,3,leptin receptor binding,MF,
21011,GO:1990462,1,0.953894649030844,0,7,omegasome,CC,
21012,GO:1990478,1,0.995439590269419,0,1,response to ultrasound,BP,
21013,GO:1990481,1,0.97815877571092,0,4,mRNA pseudouridine synthesis,BP,
21014,GO:1990498,1,0.982895196069072,0,2,mitotic spindle microtubule,CC,
21015,GO:1990502,1,0.984535171112006,0,2,dense core granule maturation,BP,
21016,GO:1990504,1,0.951342292070016,0,6,dense core granule exocytosis,BP,
21017,GO:1990505,1,0.984556340027404,0,2,mitotic DNA replication maintenance of fidelity,BP,
21018,GO:1990511,1,0.971828633120134,0,4,piRNA biosynthetic process,BP,
21019,GO:1990518,1,0.99237803441513,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
21020,GO:1990519,1,0.988774287912728,0,2,pyrimidine nucleotide import into mitochondrion,BP,
21021,GO:1990523,1,0.973594521531513,0,4,bone regeneration,BP,
21022,GO:1990535,1,0.961921377089374,0,5,neuron projection maintenance,BP,
21023,GO:1990539,1,0.994400074224895,0,1,fructose import across plasma membrane,BP,
21024,GO:1990542,1,0.684868799514345,0,67,mitochondrial transmembrane transport,BP,
21025,GO:1990546,1,0.996145082840474,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21026,GO:1990564,1,0.97367734668764,0,5,protein polyufmylation,BP,
21027,GO:1990565,1,0.996012485730794,0,1,HSP90-CDC37 chaperone complex,CC,
21028,GO:1990569,1,0.986638549374941,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
21029,GO:1990570,1,0.993301131169352,0,1,GDP-mannose transmembrane transport,BP,
21030,GO:1990572,1,0.9924574167577,0,1,TERT-RMRP complex,CC,
21031,GO:1990573,1,0.943321255748879,0,9,potassium ion import across plasma membrane,BP,
21032,GO:1990575,1,0.986775591733889,0,2,mitochondrial L-ornithine transmembrane transport,BP,
21033,GO:1990578,1,0.992066051135821,0,1,perinuclear endoplasmic reticulum membrane,CC,
21034,GO:1990579,1,0.992456378204114,0,1,peptidyl-serine trans-autophosphorylation,BP,
21035,GO:1990583,1,0.995318480480322,0,1,phospholipase D activator activity,MF,
21036,GO:1990584,1,0.990776158825815,0,3,cardiac Troponin complex,CC,
21037,GO:1990589,1,0.986580188413366,0,2,ATF4-CREB1 transcription factor complex,CC,
21038,GO:1990590,1,0.990032916648155,0,2,ATF1-ATF4 transcription factor complex,CC,
21039,GO:1990592,1,0.97367734668764,0,5,protein K69-linked ufmylation,BP,
21040,GO:1990597,1,0.979503571348119,0,3,AIP1-IRE1 complex,CC,
21041,GO:1990599,1,0.979483289499251,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21042,GO:1990603,1,0.992642954865686,0,1,dark adaptation,BP,
21043,GO:1990604,1,0.979342639068617,0,3,IRE1-TRAF2-ASK1 complex,CC,
21044,GO:1990613,1,0.992528429497788,0,1,mitochondrial membrane fusion,BP,
21045,GO:1990617,1,0.992866047765504,0,2,CHOP-ATF4 complex,CC,
21046,GO:1990619,1,0.988579012414835,0,2,histone H3-K9 deacetylation,BP,
21047,GO:1990622,1,0.992087494086528,0,2,CHOP-ATF3 complex,CC,
21048,GO:1990630,1,0.992456378204114,0,1,IRE1-RACK1-PP2A complex,CC,
21049,GO:1990635,1,0.973925654076573,0,4,proximal dendrite,CC,
21050,GO:1990637,1,0.980504154634843,0,3,response to prolactin,BP,
21051,GO:1990641,1,0.984960055170963,0,3,response to iron ion starvation,BP,
21052,GO:1990646,1,0.99291862897504,0,1,cellular response to prolactin,BP,
21053,GO:1990654,1,0.992315896610485,0,1,sebum secreting cell proliferation,BP,
21054,GO:1990666,1,0.984778714943553,0,2,PCSK9-LDLR complex,CC,
21055,GO:1990667,1,0.988607663860593,0,2,PCSK9-AnxA2 complex,CC,
21056,GO:1990668,1,0.970284683776295,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21057,GO:1990682,1,0.986613741276066,0,2,CSF1-CSF1R complex,CC,
21058,GO:1990696,1,0.98453427186234,0,2,USH2 complex,CC,
21059,GO:1990697,1,0.994668697898109,0,1,protein depalmitoleylation,BP,
21060,GO:1990698,1,0.988271443766687,0,2,palmitoleoyltransferase activity,MF,
21061,GO:1990699,1,0.994668697898109,0,1,palmitoleyl hydrolase activity,MF,
21062,GO:1990700,1,0.992461341155129,0,1,nucleolar chromatin organization,BP,
21063,GO:1990705,1,0.991018280753426,0,1,cholangiocyte proliferation,BP,
21064,GO:1990707,1,0.990001988296496,0,1,nuclear subtelomeric heterochromatin,CC,
21065,GO:1990708,1,0.992306535089899,0,1,conditioned place preference,BP,
21066,GO:1990709,1,0.980070937354089,0,3,presynaptic active zone organization,BP,
21068,GO:1990715,1,0.992453763698341,0,1,mRNA CDS binding,MF,
21069,GO:1990716,1,0.978328813386794,0,3,axonemal central apparatus,CC,
21070,GO:1990718,1,0.990634129590451,0,1,axonemal central pair projection,CC,
21071,GO:1990723,1,0.982694600683863,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21072,GO:1990726,1,0.982450954446635,0,5,Lsm1-7-Pat1 complex,CC,
21073,GO:1990729,1,0.995364275820927,0,1,primary miRNA modification,BP,
21074,GO:1990730,1,0.985041741975291,0,2,VCP-NSFL1C complex,CC,
21075,GO:1990736,1,0.992452802027794,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
21076,GO:1990737,1,0.980860112388146,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21077,GO:1990739,1,0.991018280753426,0,1,granulosa cell proliferation,BP,
21078,GO:1990742,1,0.981987790131544,0,3,microvesicle,CC,
21079,GO:1990743,1,0.973945926068662,0,4,protein sialylation,BP,
21080,GO:1990744,1,0.995364275820927,0,1,primary miRNA methylation,BP,
21081,GO:1990745,1,0.978281376769733,0,3,EARP complex,CC,
21082,GO:1990748,1,0.642833994689886,0,86,cellular detoxification,BP,
21083,GO:1990751,1,0.991598619748373,0,1,Schwann cell chemotaxis,BP,
21084,GO:1990752,1,0.817820483797736,0,25,microtubule end,CC,
21085,GO:1990755,1,0.993301131169352,0,1,mitotic spindle microtubule depolymerization,BP,
21086,GO:1990756,1,0.983223888440251,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
21087,GO:1990758,1,0.995670619379712,0,1,mitotic sister chromatid biorientation,BP,
21088,GO:1990761,1,0.976785979201984,0,3,growth cone lamellipodium,CC,
21089,GO:1990763,1,0.963349947563671,0,6,arrestin family protein binding,MF,
21090,GO:1990764,1,0.993413388751613,0,1,myofibroblast contraction,BP,
21091,GO:1990765,1,0.992249190269564,0,1,colon smooth muscle contraction,BP,
21092,GO:1990768,1,0.997018312941827,0,1,gastric mucosal blood circulation,BP,
21094,GO:1990770,1,0.989290373603278,0,2,small intestine smooth muscle contraction,BP,
21095,GO:1990771,1,0.991975690231696,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21096,GO:1990773,1,0.995889252543629,0,1,matrix metallopeptidase secretion,BP,
21097,GO:1990774,1,0.89356920321625,0,18,tumor necrosis factor secretion,BP,
21098,GO:1990776,1,0.861516112566878,0,23,response to angiotensin,BP,
21099,GO:1990777,1,0.841342525497614,0,32,lipoprotein particle,CC,
21102,GO:1990784,1,0.992455239517092,0,1,response to dsDNA,BP,
21103,GO:1990785,1,0.975964842937455,0,3,response to water-immersion restraint stress,BP,
21104,GO:1990786,1,0.992455239517092,0,1,cellular response to dsDNA,BP,
21105,GO:1990791,1,0.979448055771554,0,3,dorsal root ganglion development,BP,
21106,GO:1990796,1,0.993008816195332,0,1,photoreceptor cell terminal bouton,CC,
21107,GO:1990809,1,0.975501391197388,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21108,GO:1990812,1,0.97870751002046,0,3,growth cone filopodium,CC,
21109,GO:1990817,1,0.994521917273774,0,1,RNA adenylyltransferase activity,MF,
21110,GO:1990822,1,0.951218124674881,0,8,basic amino acid transmembrane transport,BP,
21111,GO:1990823,1,0.540405884213364,0,92,response to leukemia inhibitory factor,BP,
21112,GO:1990825,1,0.946477417594562,0,9,sequence-specific mRNA binding,MF,
21113,GO:1990828,1,0.994842418642098,0,1,hepatocyte dedifferentiation,BP,
21114,GO:1990829,1,0.995370601499107,0,1,C-rich single-stranded DNA binding,MF,
21115,GO:1990830,1,0.540405884213364,0,92,cellular response to leukemia inhibitory factor,BP,
21116,GO:1990832,1,0.995173463265661,0,1,slow axonal transport,BP,
21117,GO:1990833,1,0.995173463265661,0,1,clathrin-uncoating ATPase activity,MF,
21118,GO:1990834,1,0.974930679744796,0,4,response to odorant,BP,
21120,GO:1990839,1,0.986908520110689,0,2,response to endothelin,BP,
21122,GO:1990843,1,0.991902207274696,0,1,subsarcolemmal mitochondrion,CC,
21123,GO:1990844,1,0.991902207274696,0,1,interfibrillar mitochondrion,CC,
21124,GO:1990845,1,0.922977248471614,0,13,adaptive thermogenesis,BP,
21125,GO:1990851,1,0.97565937600325,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21126,GO:1990859,1,0.994435198688561,0,1,cellular response to endothelin,BP,
21127,GO:1990868,1,0.965589722488066,0,5,response to chemokine,BP,
21128,GO:1990869,1,0.965589722488066,0,5,cellular response to chemokine,BP,
21129,GO:1990874,1,0.787591022960598,0,36,vascular smooth muscle cell proliferation,BP,
21130,GO:1990876,1,0.991801232517507,0,1,cytoplasmic side of nuclear pore,CC,
21131,GO:1990879,1,0.986646673054992,0,2,CST complex,CC,
21132,GO:1990882,1,0.992460608132532,0,1,rRNA acetylation,BP,
21133,GO:1990883,1,0.992460608132532,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21134,GO:1990884,1,0.992460608132532,0,1,RNA acetylation,BP,
21135,GO:1990889,1,0.995602592559302,0,1,H4K20me3 modified histone binding,MF,
21137,GO:1990907,1,0.919785578722054,0,11,beta-catenin-TCF complex,CC,
21138,GO:1990909,1,0.92538836934225,0,10,Wnt signalosome,CC,
21139,GO:1990910,1,0.984317933255806,0,3,response to hypobaric hypoxia,BP,
21140,GO:1990911,1,0.97577295859201,0,4,response to psychosocial stress,BP,
21141,GO:1990913,1,0.993816488377012,0,1,sperm head plasma membrane,CC,
21142,GO:1990917,1,0.993816488377012,0,1,ooplasm,CC,
21143,GO:1990918,1,0.985738503600596,0,2,double-strand break repair involved in meiotic recombination,BP,
21144,GO:1990922,1,0.992624884499763,0,1,hepatic stellate cell proliferation,BP,
21145,GO:1990923,1,0.981704915472936,0,3,PET complex,CC,
21146,GO:1990926,1,0.981391427456089,0,3,short-term synaptic potentiation,BP,
21147,GO:1990927,1,0.98468520821532,0,2,calcium ion regulated lysosome exocytosis,BP,
21148,GO:1990928,1,0.984336867127796,0,2,response to amino acid starvation,BP,
21149,GO:1990930,1,0.996195995110822,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21150,GO:1990931,1,0.992430397811792,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
21151,GO:1990936,1,0.98875036000349,0,2,vascular smooth muscle cell dedifferentiation,BP,
21152,GO:1990938,1,0.992457480856118,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21154,GO:1990948,1,0.98288938335911,0,5,ubiquitin ligase inhibitor activity,MF,
21155,GO:1990955,1,0.992451083350298,0,1,G-rich single-stranded DNA binding,MF,
21156,GO:1990962,1,0.992458434284543,0,1,drug transport across blood-brain barrier,BP,
21157,GO:1990963,1,0.992458434284543,0,1,establishment of blood-retinal barrier,BP,
21158,GO:1990966,1,0.974300988335685,0,4,ATP generation from poly-ADP-D-ribose,BP,
21159,GO:1990967,1,0.98916705606535,0,2,multi-organism toxin transport,BP,
21160,GO:1990968,1,0.991859638400539,0,1,modulation by host of RNA binding by virus,BP,
21161,GO:1990969,1,0.991859638400539,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21162,GO:1990971,1,0.992462052493716,0,1,EMILIN complex,CC,
21163,GO:1990983,1,0.993716658778486,0,1,tRNA demethylation,BP,
21164,GO:1990984,1,0.993716658778486,0,1,tRNA demethylase activity,MF,
21165,GO:2000001,1,0.905207281055974,0,16,regulation of DNA damage checkpoint,BP,
21166,GO:2000002,1,0.970306166154269,0,5,negative regulation of DNA damage checkpoint,BP,
21167,GO:2000003,1,0.993301131169352,0,1,positive regulation of DNA damage checkpoint,BP,
21168,GO:2000004,1,0.99578603907695,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21169,GO:2000005,1,0.99578603907695,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21170,GO:2000006,1,0.99578603907695,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21171,GO:2000007,1,0.99578603907695,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21172,GO:2000008,1,0.806720867049153,0,33,regulation of protein localization to cell surface,BP,
21173,GO:2000009,1,0.926135112736369,0,12,negative regulation of protein localization to cell surface,BP,
21174,GO:2000010,1,0.917698910647986,0,13,positive regulation of protein localization to cell surface,BP,
21175,GO:2000011,1,0.994717633968953,0,1,regulation of adaxial/abaxial pattern formation,BP,
21176,GO:2000015,1,0.978253171155926,0,4,regulation of determination of dorsal identity,BP,
21177,GO:2000016,1,0.992541747988967,0,2,negative regulation of determination of dorsal identity,BP,
21178,GO:2000017,1,0.98560517087028,0,2,positive regulation of determination of dorsal identity,BP,
21179,GO:2000018,1,0.950820284932596,0,8,regulation of male gonad development,BP,
21180,GO:2000019,1,0.992464071756125,0,1,negative regulation of male gonad development,BP,
21181,GO:2000020,1,0.958043240569388,0,7,positive regulation of male gonad development,BP,
21184,GO:2000035,1,0.953469393491117,0,8,regulation of stem cell division,BP,
21185,GO:2000036,1,0.840616291209654,0,24,regulation of stem cell population maintenance,BP,
21186,GO:2000040,1,0.98773435973019,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
21187,GO:2000041,1,0.98773435973019,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
21188,GO:2000042,1,0.934809254622797,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
21189,GO:2000043,1,0.994332754053465,0,1,regulation of cardiac cell fate specification,BP,
21191,GO:2000047,1,0.944199927297536,0,10,regulation of cell-cell adhesion mediated by cadherin,BP,
21192,GO:2000048,1,0.980381626747136,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21193,GO:2000049,1,0.963101751101531,0,6,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21194,GO:2000050,1,0.856408919624838,0,22,regulation of non-canonical Wnt signaling pathway,BP,
21195,GO:2000051,1,0.955344102531894,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
21196,GO:2000052,1,0.923956503085264,0,12,positive regulation of non-canonical Wnt signaling pathway,BP,
21197,GO:2000053,1,0.977508074031861,0,3,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21198,GO:2000054,1,0.986912697518545,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21199,GO:2000055,1,0.990471962965397,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21200,GO:2000056,1,0.995564375847393,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21201,GO:2000057,1,0.995564375847393,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21202,GO:2000058,1,0.420310278369164,0,135,regulation of ubiquitin-dependent protein catabolic process,BP,
21203,GO:2000059,1,0.796537287994686,0,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21204,GO:2000060,1,0.555993219676147,0,90,positive regulation of ubiquitin-dependent protein catabolic process,BP,
21205,GO:2000061,1,0.996195995110822,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21206,GO:2000062,1,0.996195995110822,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21207,GO:2000063,1,0.996195995110822,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21208,GO:2000064,1,0.958969097897305,0,6,regulation of cortisol biosynthetic process,BP,
21209,GO:2000065,1,0.973681755441354,0,4,negative regulation of cortisol biosynthetic process,BP,
21210,GO:2000066,1,0.992464071756125,0,1,positive regulation of cortisol biosynthetic process,BP,
21211,GO:2000067,1,0.996992964303392,0,1,regulation of root morphogenesis,BP,
21212,GO:2000074,1,0.954055293267752,0,8,regulation of type B pancreatic cell development,BP,
21213,GO:2000077,1,0.986452733132141,0,2,negative regulation of type B pancreatic cell development,BP,
21214,GO:2000078,1,0.986416829217486,0,3,positive regulation of type B pancreatic cell development,BP,
21215,GO:2000079,1,0.99240612866336,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21216,GO:2000080,1,0.99240612866336,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21217,GO:2000095,1,0.917892030695891,0,13,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21218,GO:2000096,1,0.949259018179938,0,8,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21221,GO:2000101,1,0.993022200579954,0,1,regulation of mammary stem cell proliferation,BP,
21222,GO:2000103,1,0.993022200579954,0,1,positive regulation of mammary stem cell proliferation,BP,
21223,GO:2000104,1,0.878672067644603,0,19,negative regulation of DNA-dependent DNA replication,BP,
21224,GO:2000105,1,0.909125612451766,0,14,positive regulation of DNA-dependent DNA replication,BP,
21225,GO:2000106,1,0.645693807532822,0,75,regulation of leukocyte apoptotic process,BP,
21226,GO:2000107,1,0.778319540474928,0,43,negative regulation of leukocyte apoptotic process,BP,
21227,GO:2000108,1,0.869466805126276,0,24,positive regulation of leukocyte apoptotic process,BP,
21228,GO:2000109,1,0.956337345738165,0,7,regulation of macrophage apoptotic process,BP,
21229,GO:2000110,1,0.980373528836919,0,3,negative regulation of macrophage apoptotic process,BP,
21230,GO:2000111,1,0.981231145681563,0,3,positive regulation of macrophage apoptotic process,BP,
21233,GO:2000114,1,0.872760939651338,0,18,regulation of establishment of cell polarity,BP,
21236,GO:2000118,1,0.985468315953477,0,2,regulation of sodium-dependent phosphate transport,BP,
21237,GO:2000119,1,0.992968588174509,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21238,GO:2000121,1,0.94539360180662,0,10,regulation of removal of superoxide radicals,BP,
21239,GO:2000124,1,0.986661184098635,0,2,regulation of endocannabinoid signaling pathway,BP,
21241,GO:2000136,1,0.903982086380809,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21242,GO:2000137,1,0.98539543810041,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21243,GO:2000138,1,0.967427335367181,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21244,GO:2000142,1,0.795416117461313,0,36,regulation of DNA-templated transcription, initiation,BP,
21245,GO:2000143,1,0.958630912067515,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21246,GO:2000144,1,0.84723306395519,0,27,positive regulation of DNA-templated transcription, initiation,BP,
21250,GO:2000152,1,0.982578323169387,0,4,regulation of ubiquitin-specific protease activity,BP,
21251,GO:2000156,1,0.98562275669546,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21252,GO:2000157,1,0.993525417926199,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21253,GO:2000158,1,0.988982309262269,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21254,GO:2000167,1,0.992191560118167,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21255,GO:2000169,1,0.947653580604408,0,7,regulation of peptidyl-cysteine S-nitrosylation,BP,
21256,GO:2000170,1,0.985060361474117,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21257,GO:2000171,1,0.828803783522818,0,26,negative regulation of dendrite development,BP,
21258,GO:2000172,1,0.970444709669518,0,4,regulation of branching morphogenesis of a nerve,BP,
21259,GO:2000173,1,0.992460513116018,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21260,GO:2000174,1,0.992459378806887,0,1,regulation of pro-T cell differentiation,BP,
21261,GO:2000176,1,0.992459378806887,0,1,positive regulation of pro-T cell differentiation,BP,
21263,GO:2000178,1,0.877539125321317,0,20,negative regulation of neural precursor cell proliferation,BP,
21266,GO:2000182,1,0.977225259906048,0,3,regulation of progesterone biosynthetic process,BP,
21267,GO:2000184,1,0.991902207274696,0,1,positive regulation of progesterone biosynthetic process,BP,
21268,GO:2000191,1,0.899870139304326,0,16,regulation of fatty acid transport,BP,
21269,GO:2000192,1,0.961978232213249,0,5,negative regulation of fatty acid transport,BP,
21270,GO:2000193,1,0.943643755431166,0,10,positive regulation of fatty acid transport,BP,
21271,GO:2000194,1,0.935205945671057,0,12,regulation of female gonad development,BP,
21272,GO:2000195,1,0.976168247447099,0,4,negative regulation of female gonad development,BP,
21273,GO:2000196,1,0.986066535985309,0,3,positive regulation of female gonad development,BP,
21274,GO:2000197,1,0.957270243430688,0,6,regulation of ribonucleoprotein complex localization,BP,
21275,GO:2000199,1,0.992812605529755,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21276,GO:2000200,1,0.992812605529755,0,1,regulation of ribosomal subunit export from nucleus,BP,
21277,GO:2000202,1,0.992812605529755,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21278,GO:2000206,1,0.992812605529755,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21279,GO:2000208,1,0.992812605529755,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21280,GO:2000209,1,0.866769701316131,0,21,regulation of anoikis,BP,
21281,GO:2000210,1,0.970190279087576,0,6,positive regulation of anoikis,BP,
21282,GO:2000211,1,0.987191888653225,0,2,regulation of glutamate metabolic process,BP,
21283,GO:2000212,1,0.992285944156944,0,1,negative regulation of glutamate metabolic process,BP,
21284,GO:2000213,1,0.994866756232826,0,1,positive regulation of glutamate metabolic process,BP,
21285,GO:2000224,1,0.986044884387254,0,3,regulation of testosterone biosynthetic process,BP,
21286,GO:2000225,1,0.989336289426539,0,2,negative regulation of testosterone biosynthetic process,BP,
21287,GO:2000226,1,0.996390485593893,0,1,regulation of pancreatic A cell differentiation,BP,
21288,GO:2000227,1,0.996390485593893,0,1,negative regulation of pancreatic A cell differentiation,BP,
21289,GO:2000229,1,0.992243540853592,0,2,regulation of pancreatic stellate cell proliferation,BP,
21290,GO:2000230,1,0.995615619474342,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21291,GO:2000231,1,0.996613227145749,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21292,GO:2000232,1,0.928115528350867,0,11,regulation of rRNA processing,BP,
21293,GO:2000233,1,0.98521016724968,0,2,negative regulation of rRNA processing,BP,
21294,GO:2000234,1,0.94943601180235,0,8,positive regulation of rRNA processing,BP,
21295,GO:2000241,1,0.501220312199732,0,115,regulation of reproductive process,BP,
21296,GO:2000242,1,0.772323169160502,0,44,negative regulation of reproductive process,BP,
21297,GO:2000243,1,0.746022821423434,0,47,positive regulation of reproductive process,BP,
21299,GO:2000251,1,0.906634689751125,0,18,positive regulation of actin cytoskeleton reorganization,BP,
21300,GO:2000252,1,0.967943641426841,0,7,negative regulation of feeding behavior,BP,
21301,GO:2000253,1,0.966360024752604,0,5,positive regulation of feeding behavior,BP,
21302,GO:2000254,1,0.983327154943877,0,4,regulation of male germ cell proliferation,BP,
21303,GO:2000255,1,0.986400616460478,0,3,negative regulation of male germ cell proliferation,BP,
21304,GO:2000256,1,0.996884610584346,0,1,positive regulation of male germ cell proliferation,BP,
21305,GO:2000257,1,0.802042078086108,0,37,regulation of protein activation cascade,BP,
21306,GO:2000258,1,0.958614137819698,0,6,negative regulation of protein activation cascade,BP,
21307,GO:2000259,1,0.980564442657743,0,3,positive regulation of protein activation cascade,BP,
21308,GO:2000269,1,0.901850645488124,0,15,regulation of fibroblast apoptotic process,BP,
21309,GO:2000270,1,0.952425294768221,0,7,negative regulation of fibroblast apoptotic process,BP,
21310,GO:2000271,1,0.949967210140739,0,7,positive regulation of fibroblast apoptotic process,BP,
21311,GO:2000272,1,0.83670005467296,0,28,negative regulation of signaling receptor activity,BP,
21313,GO:2000275,1,0.98255568853952,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21314,GO:2000276,1,0.990797621947579,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21315,GO:2000277,1,0.99691333883606,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21318,GO:2000280,1,0.996992964303392,0,1,regulation of root development,BP,
21319,GO:2000282,1,0.987937157663114,0,2,regulation of cellular amino acid biosynthetic process,BP,
21320,GO:2000283,1,0.990996315875316,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21321,GO:2000284,1,0.99691333883606,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21322,GO:2000286,1,0.979984202440126,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21324,GO:2000288,1,0.945963550120323,0,9,positive regulation of myoblast proliferation,BP,
21326,GO:2000291,1,0.91771561773706,0,14,regulation of myoblast proliferation,BP,
21327,GO:2000295,1,0.986392213410059,0,3,regulation of hydrogen peroxide catabolic process,BP,
21328,GO:2000296,1,0.993603521574319,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21329,GO:2000297,1,0.977721719187902,0,3,negative regulation of synapse maturation,BP,
21330,GO:2000298,1,0.986844491832856,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21331,GO:2000299,1,0.992600090552002,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21332,GO:2000300,1,0.837516902197976,0,25,regulation of synaptic vesicle exocytosis,BP,
21333,GO:2000301,1,0.981132959742666,0,3,negative regulation of synaptic vesicle exocytosis,BP,
21334,GO:2000302,1,0.976764841582552,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21335,GO:2000303,1,0.929388594940525,0,13,regulation of ceramide biosynthetic process,BP,
21336,GO:2000304,1,0.952957699926059,0,8,positive regulation of ceramide biosynthetic process,BP,
21337,GO:2000307,1,0.987064530009849,0,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21338,GO:2000308,1,0.994263129730359,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21339,GO:2000309,1,0.992760296811159,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21340,GO:2000310,1,0.882525658264833,0,18,regulation of NMDA receptor activity,BP,
21341,GO:2000311,1,0.849639869532166,0,24,regulation of AMPA receptor activity,BP,
21342,GO:2000312,1,0.978570811879592,0,3,regulation of kainate selective glutamate receptor activity,BP,
21343,GO:2000313,1,0.991593951502797,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21344,GO:2000314,1,0.996033781357412,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21345,GO:2000316,1,0.944824874695644,0,9,regulation of T-helper 17 type immune response,BP,
21346,GO:2000317,1,0.966668920279554,0,5,negative regulation of T-helper 17 type immune response,BP,
21347,GO:2000318,1,0.977410652395257,0,4,positive regulation of T-helper 17 type immune response,BP,
21348,GO:2000319,1,0.951817695387482,0,8,regulation of T-helper 17 cell differentiation,BP,
21349,GO:2000320,1,0.966668920279554,0,5,negative regulation of T-helper 17 cell differentiation,BP,
21350,GO:2000321,1,0.984642084326917,0,3,positive regulation of T-helper 17 cell differentiation,BP,
21351,GO:2000322,1,0.947284742276288,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21352,GO:2000323,1,0.959154780567379,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21353,GO:2000324,1,0.987629820895644,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21354,GO:2000325,1,0.991948470662901,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21355,GO:2000327,1,0.991948470662901,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21356,GO:2000328,1,0.97882897827616,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21357,GO:2000329,1,0.986572781892665,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21358,GO:2000330,1,0.992151906074205,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21359,GO:2000331,1,0.985159063702414,0,2,regulation of terminal button organization,BP,
21360,GO:2000332,1,0.991120574338375,0,2,regulation of blood microparticle formation,BP,
21361,GO:2000334,1,0.991120574338375,0,2,positive regulation of blood microparticle formation,BP,
21362,GO:2000338,1,0.98856716294806,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21363,GO:2000340,1,0.98856716294806,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21365,GO:2000342,1,0.987352336376045,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21367,GO:2000344,1,0.959976755550462,0,7,positive regulation of acrosome reaction,BP,
21368,GO:2000345,1,0.933091502371843,0,11,regulation of hepatocyte proliferation,BP,
21369,GO:2000346,1,0.98009405231567,0,3,negative regulation of hepatocyte proliferation,BP,
21370,GO:2000347,1,0.966521240677441,0,6,positive regulation of hepatocyte proliferation,BP,
21371,GO:2000348,1,0.965458969530974,0,6,regulation of CD40 signaling pathway,BP,
21372,GO:2000349,1,0.987703686655803,0,2,negative regulation of CD40 signaling pathway,BP,
21373,GO:2000350,1,0.996832095044299,0,1,positive regulation of CD40 signaling pathway,BP,
21374,GO:2000351,1,0.773539171005474,0,40,regulation of endothelial cell apoptotic process,BP,
21375,GO:2000352,1,0.843096245480789,0,26,negative regulation of endothelial cell apoptotic process,BP,
21376,GO:2000353,1,0.917638444480027,0,14,positive regulation of endothelial cell apoptotic process,BP,
21377,GO:2000354,1,0.968186426628649,0,6,regulation of ovarian follicle development,BP,
21378,GO:2000355,1,0.990649109910493,0,2,negative regulation of ovarian follicle development,BP,
21379,GO:2000356,1,0.996195995110822,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21380,GO:2000357,1,0.996195995110822,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21381,GO:2000358,1,0.996195995110822,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21382,GO:2000359,1,0.991095879439145,0,2,regulation of binding of sperm to zona pellucida,BP,
21383,GO:2000360,1,0.991095879439145,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21384,GO:2000361,1,0.984809124992519,0,2,regulation of prostaglandin-E synthase activity,BP,
21385,GO:2000363,1,0.984809124992519,0,2,positive regulation of prostaglandin-E synthase activity,BP,
21386,GO:2000367,1,0.991904465867638,0,2,regulation of acrosomal vesicle exocytosis,BP,
21387,GO:2000368,1,0.991904465867638,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21388,GO:2000369,1,0.88141621775312,0,16,regulation of clathrin-dependent endocytosis,BP,
21389,GO:2000370,1,0.970076314155647,0,4,positive regulation of clathrin-dependent endocytosis,BP,
21390,GO:2000371,1,0.966506463377889,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21391,GO:2000373,1,0.966506463377889,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21392,GO:2000374,1,0.989143262994754,0,3,regulation of oxygen metabolic process,BP,
21393,GO:2000376,1,0.993965768067095,0,2,positive regulation of oxygen metabolic process,BP,
21395,GO:2000378,1,0.767125414366564,0,45,negative regulation of reactive oxygen species metabolic process,BP,
21397,GO:2000380,1,0.920867738377885,0,15,regulation of mesoderm development,BP,
21398,GO:2000381,1,0.9590505298454,0,8,negative regulation of mesoderm development,BP,
21399,GO:2000382,1,0.97887443354657,0,4,positive regulation of mesoderm development,BP,
21402,GO:2000386,1,0.988956740525447,0,2,positive regulation of ovarian follicle development,BP,
21403,GO:2000387,1,0.996476339746668,0,1,regulation of antral ovarian follicle growth,BP,
21404,GO:2000388,1,0.996476339746668,0,1,positive regulation of antral ovarian follicle growth,BP,
21405,GO:2000389,1,0.978268041314662,0,3,regulation of neutrophil extravasation,BP,
21406,GO:2000391,1,0.978268041314662,0,3,positive regulation of neutrophil extravasation,BP,
21408,GO:2000393,1,0.985608430272461,0,2,negative regulation of lamellipodium morphogenesis,BP,
21410,GO:2000395,1,0.993134196055899,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21411,GO:2000397,1,0.993134196055899,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21414,GO:2000403,1,0.871332141285123,0,26,positive regulation of lymphocyte migration,BP,
21417,GO:2000406,1,0.88793338830248,0,22,positive regulation of T cell migration,BP,
21418,GO:2000407,1,0.985087530108049,0,3,regulation of T cell extravasation,BP,
21419,GO:2000409,1,0.989588657950691,0,2,positive regulation of T cell extravasation,BP,
21420,GO:2000410,1,0.984476092649325,0,3,regulation of thymocyte migration,BP,
21421,GO:2000412,1,0.989463833505259,0,2,positive regulation of thymocyte migration,BP,
21422,GO:2000413,1,0.992760296811159,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21423,GO:2000415,1,0.992760296811159,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21424,GO:2000416,1,0.974716181860549,0,4,regulation of eosinophil migration,BP,
21425,GO:2000417,1,0.988146962921711,0,2,negative regulation of eosinophil migration,BP,
21426,GO:2000418,1,0.986409790236101,0,2,positive regulation of eosinophil migration,BP,
21427,GO:2000419,1,0.992573932395067,0,1,regulation of eosinophil extravasation,BP,
21428,GO:2000420,1,0.992573932395067,0,1,negative regulation of eosinophil extravasation,BP,
21429,GO:2000422,1,0.99360366470725,0,1,regulation of eosinophil chemotaxis,BP,
21430,GO:2000424,1,0.99360366470725,0,1,positive regulation of eosinophil chemotaxis,BP,
21431,GO:2000425,1,0.942298310514439,0,9,regulation of apoptotic cell clearance,BP,
21432,GO:2000426,1,0.988435031881564,0,2,negative regulation of apoptotic cell clearance,BP,
21433,GO:2000427,1,0.955584569775568,0,7,positive regulation of apoptotic cell clearance,BP,
21434,GO:2000434,1,0.993905510611783,0,2,regulation of protein neddylation,BP,
21435,GO:2000435,1,0.993905510611783,0,2,negative regulation of protein neddylation,BP,
21436,GO:2000437,1,0.978291867415574,0,3,regulation of monocyte extravasation,BP,
21437,GO:2000438,1,0.991747873577304,0,1,negative regulation of monocyte extravasation,BP,
21438,GO:2000439,1,0.986433191196601,0,2,positive regulation of monocyte extravasation,BP,
21439,GO:2000446,1,0.992424409694686,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21440,GO:2000449,1,0.985087530108049,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21441,GO:2000451,1,0.989588657950691,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21442,GO:2000452,1,0.991104955467928,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21443,GO:2000454,1,0.995633290276296,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21444,GO:2000458,1,0.989744871880959,0,2,regulation of astrocyte chemotaxis,BP,
21445,GO:2000463,1,0.834361961356585,0,25,positive regulation of excitatory postsynaptic potential,BP,
21446,GO:2000464,1,0.993929133044694,0,1,positive regulation of astrocyte chemotaxis,BP,
21447,GO:2000465,1,0.956698893261091,0,6,regulation of glycogen (starch) synthase activity,BP,
21448,GO:2000466,1,0.97924836922363,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21449,GO:2000467,1,0.978702629391156,0,3,positive regulation of glycogen (starch) synthase activity,BP,
21450,GO:2000468,1,0.983629675622571,0,2,regulation of peroxidase activity,BP,
21451,GO:2000469,1,0.990820996121129,0,1,negative regulation of peroxidase activity,BP,
21452,GO:2000470,1,0.992742752447207,0,1,positive regulation of peroxidase activity,BP,
21453,GO:2000471,1,0.986261299490465,0,2,regulation of hematopoietic stem cell migration,BP,
21454,GO:2000473,1,0.986261299490465,0,2,positive regulation of hematopoietic stem cell migration,BP,
21455,GO:2000474,1,0.986595030676174,0,2,regulation of opioid receptor signaling pathway,BP,
21456,GO:2000479,1,0.915979330887573,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21457,GO:2000480,1,0.953616899205719,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21458,GO:2000481,1,0.970681897741371,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21459,GO:2000482,1,0.883309360587319,0,22,regulation of interleukin-8 secretion,BP,
21460,GO:2000483,1,0.957990145363453,0,7,negative regulation of interleukin-8 secretion,BP,
21462,GO:2000485,1,0.98663556219586,0,2,regulation of glutamine transport,BP,
21463,GO:2000486,1,0.99256775817539,0,1,negative regulation of glutamine transport,BP,
21464,GO:2000487,1,0.994023847218113,0,1,positive regulation of glutamine transport,BP,
21465,GO:2000489,1,0.958614859755908,0,6,regulation of hepatic stellate cell activation,BP,
21466,GO:2000490,1,0.98790557105282,0,2,negative regulation of hepatic stellate cell activation,BP,
21467,GO:2000491,1,0.970354397739977,0,4,positive regulation of hepatic stellate cell activation,BP,
21468,GO:2000492,1,0.992950625600058,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21469,GO:2000494,1,0.992950625600058,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21470,GO:2000501,1,0.982321405501153,0,5,regulation of natural killer cell chemotaxis,BP,
21471,GO:2000502,1,0.993207527108214,0,2,negative regulation of natural killer cell chemotaxis,BP,
21472,GO:2000503,1,0.989040206492733,0,3,positive regulation of natural killer cell chemotaxis,BP,
21473,GO:2000504,1,0.986647877014346,0,2,positive regulation of blood vessel remodeling,BP,
21474,GO:2000508,1,0.963502784296631,0,8,regulation of dendritic cell chemotaxis,BP,
21475,GO:2000510,1,0.963502784296631,0,8,positive regulation of dendritic cell chemotaxis,BP,
21476,GO:2000511,1,0.996679748692367,0,1,regulation of granzyme A production,BP,
21477,GO:2000513,1,0.996679748692367,0,1,positive regulation of granzyme A production,BP,
21478,GO:2000514,1,0.785559621180302,0,39,regulation of CD4-positive, alpha-beta T cell activation,BP,
21479,GO:2000515,1,0.89022644797067,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21480,GO:2000516,1,0.863939484172636,0,25,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21481,GO:2000517,1,0.996679748692367,0,1,regulation of T-helper 1 cell activation,BP,
21482,GO:2000518,1,0.996679748692367,0,1,negative regulation of T-helper 1 cell activation,BP,
21483,GO:2000520,1,0.985732417794993,0,3,regulation of immunological synapse formation,BP,
21484,GO:2000521,1,0.990872930814602,0,2,negative regulation of immunological synapse formation,BP,
21485,GO:2000522,1,0.994812632020403,0,1,positive regulation of immunological synapse formation,BP,
21486,GO:2000523,1,0.987391406693834,0,2,regulation of T cell costimulation,BP,
21487,GO:2000525,1,0.987391406693834,0,2,positive regulation of T cell costimulation,BP,
21488,GO:2000526,1,0.994812632020403,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21489,GO:2000527,1,0.996946508336822,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21490,GO:2000529,1,0.996946508336822,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21491,GO:2000532,1,0.993911416934456,0,1,regulation of renal albumin absorption,BP,
21492,GO:2000533,1,0.993911416934456,0,1,negative regulation of renal albumin absorption,BP,
21493,GO:2000535,1,0.958976337143114,0,6,regulation of entry of bacterium into host cell,BP,
21494,GO:2000536,1,0.991694482489942,0,1,negative regulation of entry of bacterium into host cell,BP,
21495,GO:2000537,1,0.98912783119325,0,2,regulation of B cell chemotaxis,BP,
21496,GO:2000538,1,0.98912783119325,0,2,positive regulation of B cell chemotaxis,BP,
21497,GO:2000539,1,0.993919001235632,0,1,regulation of protein geranylgeranylation,BP,
21498,GO:2000541,1,0.993919001235632,0,1,positive regulation of protein geranylgeranylation,BP,
21500,GO:2000543,1,0.978089327233835,0,4,positive regulation of gastrulation,BP,
21501,GO:2000544,1,0.969695804205339,0,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21502,GO:2000545,1,0.996699166694483,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21503,GO:2000546,1,0.980290244040716,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21504,GO:2000547,1,0.988828222544565,0,3,regulation of dendritic cell dendrite assembly,BP,
21505,GO:2000548,1,0.996946508336822,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21506,GO:2000549,1,0.997029226734812,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21507,GO:2000551,1,0.957096672247888,0,8,regulation of T-helper 2 cell cytokine production,BP,
21508,GO:2000552,1,0.990163731949653,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21509,GO:2000553,1,0.966607837441889,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21510,GO:2000554,1,0.996679748692367,0,1,regulation of T-helper 1 cell cytokine production,BP,
21511,GO:2000556,1,0.996679748692367,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21512,GO:2000557,1,0.996679748692367,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21513,GO:2000558,1,0.996679748692367,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21514,GO:2000559,1,0.991747873577304,0,1,regulation of CD24 biosynthetic process,BP,
21515,GO:2000560,1,0.991747873577304,0,1,positive regulation of CD24 biosynthetic process,BP,
21516,GO:2000561,1,0.966466545022119,0,6,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21517,GO:2000562,1,0.980620724551843,0,4,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21518,GO:2000563,1,0.978382367047293,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21519,GO:2000564,1,0.98526715749296,0,3,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21520,GO:2000566,1,0.992695595653107,0,2,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21521,GO:2000567,1,0.994717633968953,0,1,regulation of memory T cell activation,BP,
21522,GO:2000568,1,0.994717633968953,0,1,positive regulation of memory T cell activation,BP,
21523,GO:2000569,1,0.992656955884143,0,1,regulation of T-helper 2 cell activation,BP,
21524,GO:2000570,1,0.992656955884143,0,1,positive regulation of T-helper 2 cell activation,BP,
21525,GO:2000571,1,0.992540479976971,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21526,GO:2000572,1,0.992540479976971,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21528,GO:2000574,1,0.949514725029144,0,9,regulation of microtubule motor activity,BP,
21529,GO:2000576,1,0.96988348615406,0,6,positive regulation of microtubule motor activity,BP,
21530,GO:2000580,1,0.976426057593913,0,5,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21531,GO:2000582,1,0.976426057593913,0,5,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21532,GO:2000583,1,0.99246852849483,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21533,GO:2000584,1,0.99246852849483,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21536,GO:2000588,1,0.984047217488944,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21537,GO:2000589,1,0.978662173075826,0,3,regulation of metanephric mesenchymal cell migration,BP,
21538,GO:2000591,1,0.978662173075826,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21539,GO:2000592,1,0.984972388532087,0,2,regulation of metanephric DCT cell differentiation,BP,
21540,GO:2000594,1,0.984972388532087,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21541,GO:2000595,1,0.992449677325916,0,1,regulation of optic nerve formation,BP,
21542,GO:2000597,1,0.992449677325916,0,1,positive regulation of optic nerve formation,BP,
21543,GO:2000601,1,0.959115775218972,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21544,GO:2000606,1,0.992847921596484,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21545,GO:2000607,1,0.992847921596484,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21546,GO:2000609,1,0.976127919083487,0,4,regulation of thyroid hormone generation,BP,
21547,GO:2000611,1,0.980487325109832,0,3,positive regulation of thyroid hormone generation,BP,
21548,GO:2000612,1,0.992466417663809,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21549,GO:2000615,1,0.931259932042744,0,11,regulation of histone H3-K9 acetylation,BP,
21550,GO:2000616,1,0.987843081669881,0,2,negative regulation of histone H3-K9 acetylation,BP,
21551,GO:2000617,1,0.955312052651251,0,7,positive regulation of histone H3-K9 acetylation,BP,
21552,GO:2000618,1,0.965909940380188,0,5,regulation of histone H4-K16 acetylation,BP,
21553,GO:2000619,1,0.981897986161969,0,3,negative regulation of histone H4-K16 acetylation,BP,
21554,GO:2000620,1,0.983720273751065,0,2,positive regulation of histone H4-K16 acetylation,BP,
21555,GO:2000622,1,0.969990833748244,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21556,GO:2000623,1,0.969990833748244,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21557,GO:2000625,1,0.985856072188533,0,2,regulation of miRNA catabolic process,BP,
21558,GO:2000627,1,0.985856072188533,0,2,positive regulation of miRNA catabolic process,BP,
21559,GO:2000628,1,0.955559045844788,0,7,regulation of miRNA metabolic process,BP,
21560,GO:2000630,1,0.969117520823938,0,5,positive regulation of miRNA metabolic process,BP,
21561,GO:2000631,1,0.992677817528563,0,1,regulation of pre-miRNA processing,BP,
21562,GO:2000632,1,0.992677817528563,0,1,negative regulation of pre-miRNA processing,BP,
21564,GO:2000638,1,0.985954944884303,0,2,regulation of SREBP signaling pathway,BP,
21565,GO:2000639,1,0.985954944884303,0,2,negative regulation of SREBP signaling pathway,BP,
21566,GO:2000641,1,0.894770535137488,0,17,regulation of early endosome to late endosome transport,BP,
21567,GO:2000642,1,0.993497437782781,0,2,negative regulation of early endosome to late endosome transport,BP,
21568,GO:2000643,1,0.942387145558258,0,8,positive regulation of early endosome to late endosome transport,BP,
21569,GO:2000644,1,0.941098361257852,0,9,regulation of receptor catabolic process,BP,
21570,GO:2000645,1,0.980996277734039,0,3,negative regulation of receptor catabolic process,BP,
21571,GO:2000646,1,0.966254238385892,0,5,positive regulation of receptor catabolic process,BP,
21572,GO:2000647,1,0.934315290421868,0,10,negative regulation of stem cell proliferation,BP,
21574,GO:2000649,1,0.743707500677602,0,46,regulation of sodium ion transmembrane transporter activity,BP,
21575,GO:2000650,1,0.922020103684413,0,11,negative regulation of sodium ion transmembrane transporter activity,BP,
21576,GO:2000651,1,0.916695118008663,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21577,GO:2000653,1,0.978040541242793,0,3,regulation of genetic imprinting,BP,
21578,GO:2000654,1,0.992468656963127,0,1,regulation of cellular response to testosterone stimulus,BP,
21579,GO:2000655,1,0.992468656963127,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21580,GO:2000656,1,0.995564375847393,0,1,regulation of apolipoprotein binding,BP,
21581,GO:2000657,1,0.995564375847393,0,1,negative regulation of apolipoprotein binding,BP,
21582,GO:2000659,1,0.963510721515874,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
21583,GO:2000660,1,0.975515777625902,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21584,GO:2000661,1,0.992317416669214,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21585,GO:2000662,1,0.962492505931548,0,6,regulation of interleukin-5 secretion,BP,
21586,GO:2000663,1,0.99249841260001,0,1,negative regulation of interleukin-5 secretion,BP,
21587,GO:2000664,1,0.969769634317854,0,5,positive regulation of interleukin-5 secretion,BP,
21588,GO:2000665,1,0.960016784513087,0,7,regulation of interleukin-13 secretion,BP,
21589,GO:2000666,1,0.987844031048376,0,2,negative regulation of interleukin-13 secretion,BP,
21590,GO:2000667,1,0.971833862963103,0,5,positive regulation of interleukin-13 secretion,BP,
21591,GO:2000668,1,0.945581947552905,0,10,regulation of dendritic cell apoptotic process,BP,
21592,GO:2000669,1,0.964179705968564,0,7,negative regulation of dendritic cell apoptotic process,BP,
21593,GO:2000670,1,0.980718575959869,0,3,positive regulation of dendritic cell apoptotic process,BP,
21596,GO:2000674,1,0.933129523316141,0,11,regulation of type B pancreatic cell apoptotic process,BP,
21597,GO:2000675,1,0.958771823686589,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21598,GO:2000676,1,0.973266625622851,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
21599,GO:2000677,1,0.757343937689511,0,44,regulation of transcription regulatory region DNA binding,BP,
21600,GO:2000678,1,0.897069679937236,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21601,GO:2000679,1,0.873994192610827,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21602,GO:2000683,1,0.986096001995904,0,2,regulation of cellular response to X-ray,BP,
21603,GO:2000685,1,0.993199948660582,0,1,positive regulation of cellular response to X-ray,BP,
21604,GO:2000690,1,0.992435183188494,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21605,GO:2000691,1,0.992435183188494,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21606,GO:2000696,1,0.902189330355961,0,15,regulation of epithelial cell differentiation involved in kidney development,BP,
21607,GO:2000697,1,0.977719640739112,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21608,GO:2000698,1,0.967295272191915,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21609,GO:2000699,1,0.992847921596484,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21610,GO:2000701,1,0.992847921596484,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21611,GO:2000702,1,0.992847921596484,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21612,GO:2000703,1,0.992847921596484,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21613,GO:2000705,1,0.978802001255271,0,3,regulation of dense core granule biogenesis,BP,
21614,GO:2000706,1,0.992492859017199,0,1,negative regulation of dense core granule biogenesis,BP,
21615,GO:2000707,1,0.986206660010234,0,2,positive regulation of dense core granule biogenesis,BP,
21616,GO:2000718,1,0.996941089164012,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21617,GO:2000719,1,0.996941089164012,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21618,GO:2000721,1,0.976949379523239,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21619,GO:2000722,1,0.978710803505941,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21620,GO:2000723,1,0.993519756533237,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21621,GO:2000724,1,0.985095456663213,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21625,GO:2000729,1,0.989713678083381,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21626,GO:2000733,1,0.992847921596484,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21627,GO:2000734,1,0.992847921596484,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21629,GO:2000737,1,0.878467455614519,0,18,negative regulation of stem cell differentiation,BP,
21630,GO:2000738,1,0.891333657365607,0,17,positive regulation of stem cell differentiation,BP,
21632,GO:2000740,1,0.992492859017199,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21633,GO:2000741,1,0.968597849272252,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21634,GO:2000742,1,0.99503596063896,0,1,regulation of anterior head development,BP,
21635,GO:2000744,1,0.99503596063896,0,1,positive regulation of anterior head development,BP,
21636,GO:2000752,1,0.993270968388128,0,1,regulation of glucosylceramide catabolic process,BP,
21637,GO:2000753,1,0.993270968388128,0,1,positive regulation of glucosylceramide catabolic process,BP,
21638,GO:2000754,1,0.993270968388128,0,1,regulation of sphingomyelin catabolic process,BP,
21639,GO:2000755,1,0.993270968388128,0,1,positive regulation of sphingomyelin catabolic process,BP,
21640,GO:2000756,1,0.693422968942058,0,57,regulation of peptidyl-lysine acetylation,BP,
21641,GO:2000757,1,0.87785633124262,0,21,negative regulation of peptidyl-lysine acetylation,BP,
21642,GO:2000758,1,0.833600407032934,0,29,positive regulation of peptidyl-lysine acetylation,BP,
21643,GO:2000759,1,0.992326640558294,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21644,GO:2000761,1,0.992326640558294,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21645,GO:2000763,1,0.994281830794387,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21646,GO:2000764,1,0.994281830794387,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21647,GO:2000765,1,0.864649306227613,0,22,regulation of cytoplasmic translation,BP,
21648,GO:2000766,1,0.95104216374981,0,7,negative regulation of cytoplasmic translation,BP,
21649,GO:2000767,1,0.954394545770665,0,7,positive regulation of cytoplasmic translation,BP,
21650,GO:2000768,1,0.992462314336551,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21651,GO:2000772,1,0.805328524209816,0,33,regulation of cellular senescence,BP,
21652,GO:2000773,1,0.891255026454613,0,16,negative regulation of cellular senescence,BP,
21653,GO:2000774,1,0.955125100108243,0,9,positive regulation of cellular senescence,BP,
21654,GO:2000775,1,0.995022622318697,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21655,GO:2000777,1,0.989699628790936,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21657,GO:2000779,1,0.716651414107438,0,50,regulation of double-strand break repair,BP,
21658,GO:2000780,1,0.871942635728592,0,20,negative regulation of double-strand break repair,BP,
21659,GO:2000781,1,0.91857195667519,0,12,positive regulation of double-strand break repair,BP,
21660,GO:2000785,1,0.796958984424528,0,35,regulation of autophagosome assembly,BP,
21661,GO:2000786,1,0.929417742113458,0,10,positive regulation of autophagosome assembly,BP,
21662,GO:2000790,1,0.983789631536903,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21663,GO:2000791,1,0.983789631536903,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21664,GO:2000793,1,0.976790706391339,0,3,cell proliferation involved in heart valve development,BP,
21665,GO:2000794,1,0.943782475751181,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21666,GO:2000795,1,0.99125592678702,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21667,GO:2000797,1,0.992492859017199,0,1,regulation of amniotic stem cell differentiation,BP,
21668,GO:2000798,1,0.992492859017199,0,1,negative regulation of amniotic stem cell differentiation,BP,
21669,GO:2000800,1,0.996037623304787,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21670,GO:2000802,1,0.996037623304787,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21671,GO:2000804,1,0.990055841676307,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21672,GO:2000806,1,0.990055841676307,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21673,GO:2000807,1,0.946020728093486,0,7,regulation of synaptic vesicle clustering,BP,
21674,GO:2000808,1,0.992145346119027,0,1,negative regulation of synaptic vesicle clustering,BP,
21675,GO:2000809,1,0.961872347015213,0,5,positive regulation of synaptic vesicle clustering,BP,
21677,GO:2000811,1,0.897831240339627,0,15,negative regulation of anoikis,BP,
21678,GO:2000812,1,0.992465658203193,0,1,regulation of barbed-end actin filament capping,BP,
21679,GO:2000816,1,0.813525094483251,0,33,negative regulation of mitotic sister chromatid separation,BP,
21680,GO:2000818,1,0.988992850365101,0,2,negative regulation of myoblast proliferation,BP,
21681,GO:2000819,1,0.986024293501984,0,2,regulation of nucleotide-excision repair,BP,
21682,GO:2000820,1,0.9801295882611,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21685,GO:2000823,1,0.969512803092763,0,6,regulation of androgen receptor activity,BP,
21686,GO:2000824,1,0.987274076231074,0,2,negative regulation of androgen receptor activity,BP,
21687,GO:2000825,1,0.982012165677176,0,4,positive regulation of androgen receptor activity,BP,
21688,GO:2000826,1,0.809282776719012,0,32,regulation of heart morphogenesis,BP,
21689,GO:2000827,1,0.993969875847883,0,1,mitochondrial RNA surveillance,BP,
21690,GO:2000828,1,0.987684300721604,0,2,regulation of parathyroid hormone secretion,BP,
21691,GO:2000830,1,0.992117673868286,0,1,positive regulation of parathyroid hormone secretion,BP,
21692,GO:2000831,1,0.91820589760041,0,16,regulation of steroid hormone secretion,BP,
21693,GO:2000832,1,0.984634101889275,0,2,negative regulation of steroid hormone secretion,BP,
21694,GO:2000833,1,0.957444209971927,0,9,positive regulation of steroid hormone secretion,BP,
21695,GO:2000834,1,0.992654096579413,0,1,regulation of androgen secretion,BP,
21696,GO:2000836,1,0.992654096579413,0,1,positive regulation of androgen secretion,BP,
21697,GO:2000843,1,0.984399373318625,0,2,regulation of testosterone secretion,BP,
21698,GO:2000845,1,0.984399373318625,0,2,positive regulation of testosterone secretion,BP,
21699,GO:2000846,1,0.932180531932862,0,13,regulation of corticosteroid hormone secretion,BP,
21700,GO:2000847,1,0.984634101889275,0,2,negative regulation of corticosteroid hormone secretion,BP,
21701,GO:2000848,1,0.967359969244065,0,7,positive regulation of corticosteroid hormone secretion,BP,
21702,GO:2000849,1,0.956492546792377,0,9,regulation of glucocorticoid secretion,BP,
21703,GO:2000850,1,0.984634101889275,0,2,negative regulation of glucocorticoid secretion,BP,
21704,GO:2000851,1,0.980821513386038,0,5,positive regulation of glucocorticoid secretion,BP,
21705,GO:2000852,1,0.983872665898699,0,4,regulation of corticosterone secretion,BP,
21706,GO:2000854,1,0.993389515142333,0,2,positive regulation of corticosterone secretion,BP,
21707,GO:2000855,1,0.974593751212907,0,4,regulation of mineralocorticoid secretion,BP,
21708,GO:2000857,1,0.986277989219264,0,2,positive regulation of mineralocorticoid secretion,BP,
21709,GO:2000858,1,0.974593751212907,0,4,regulation of aldosterone secretion,BP,
21710,GO:2000860,1,0.986277989219264,0,2,positive regulation of aldosterone secretion,BP,
21711,GO:2000864,1,0.980583311850433,0,3,regulation of estradiol secretion,BP,
21712,GO:2000866,1,0.98861538488834,0,2,positive regulation of estradiol secretion,BP,
21713,GO:2000870,1,0.992309550045707,0,2,regulation of progesterone secretion,BP,
21714,GO:2000872,1,0.99707786060116,0,1,positive regulation of progesterone secretion,BP,
21715,GO:2000878,1,0.989604045914797,0,2,positive regulation of oligopeptide transport,BP,
21716,GO:2000880,1,0.989604045914797,0,2,positive regulation of dipeptide transport,BP,
21717,GO:2000896,1,0.99275644032942,0,1,amylopectin metabolic process,BP,
21718,GO:2000909,1,0.993301131169352,0,1,regulation of sterol import,BP,
21719,GO:2000969,1,0.96260272982085,0,5,positive regulation of AMPA receptor activity,BP,
21720,GO:2000970,1,0.99415435700058,0,1,regulation of detection of glucose,BP,
21721,GO:2000971,1,0.99415435700058,0,1,negative regulation of detection of glucose,BP,
21722,GO:2000973,1,0.960832984480428,0,6,regulation of pro-B cell differentiation,BP,
21723,GO:2000974,1,0.983852617401495,0,3,negative regulation of pro-B cell differentiation,BP,
21724,GO:2000977,1,0.978582491320519,0,4,regulation of forebrain neuron differentiation,BP,
21725,GO:2000978,1,0.99299030323848,0,2,negative regulation of forebrain neuron differentiation,BP,
21726,GO:2000979,1,0.99284618617602,0,1,positive regulation of forebrain neuron differentiation,BP,
21727,GO:2000980,1,0.957672759494333,0,7,regulation of inner ear receptor cell differentiation,BP,
21728,GO:2000981,1,0.976599448656185,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21729,GO:2000983,1,0.993719060190191,0,2,regulation of ATP citrate synthase activity,BP,
21730,GO:2000984,1,0.993719060190191,0,2,negative regulation of ATP citrate synthase activity,BP,
21732,GO:2001012,1,0.957687114777393,0,7,mesenchymal cell differentiation involved in renal system development,BP,
21733,GO:2001013,1,0.969868476633089,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21736,GO:2001016,1,0.966730484867532,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21738,GO:2001021,1,0.674763650686304,0,65,negative regulation of response to DNA damage stimulus,BP,
21740,GO:2001023,1,0.637374121669357,0,74,regulation of response to drug,BP,
21741,GO:2001024,1,0.852658117426452,0,25,negative regulation of response to drug,BP,
21742,GO:2001025,1,0.869597737714972,0,25,positive regulation of response to drug,BP,
21743,GO:2001026,1,0.89766092012487,0,16,regulation of endothelial cell chemotaxis,BP,
21744,GO:2001027,1,0.979692919017617,0,3,negative regulation of endothelial cell chemotaxis,BP,
21745,GO:2001028,1,0.923241591678103,0,12,positive regulation of endothelial cell chemotaxis,BP,
21746,GO:2001029,1,0.992151590280108,0,1,regulation of cellular glucuronidation,BP,
21747,GO:2001031,1,0.992151590280108,0,1,positive regulation of cellular glucuronidation,BP,
21748,GO:2001032,1,0.923173207507095,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
21749,GO:2001033,1,0.971325527130636,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21750,GO:2001034,1,0.964261198073314,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21751,GO:2001035,1,0.988681980383699,0,2,regulation of tongue muscle cell differentiation,BP,
21752,GO:2001037,1,0.988681980383699,0,2,positive regulation of tongue muscle cell differentiation,BP,
21753,GO:2001038,1,0.842549764231262,0,27,regulation of cellular response to drug,BP,
21754,GO:2001039,1,0.900471261055574,0,17,negative regulation of cellular response to drug,BP,
21755,GO:2001040,1,0.962504546614023,0,6,positive regulation of cellular response to drug,BP,
21756,GO:2001044,1,0.924070437320806,0,13,regulation of integrin-mediated signaling pathway,BP,
21757,GO:2001045,1,0.984475220723312,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21758,GO:2001046,1,0.961841664716228,0,6,positive regulation of integrin-mediated signaling pathway,BP,
21759,GO:2001049,1,0.995285144028007,0,1,regulation of tendon cell differentiation,BP,
21760,GO:2001051,1,0.995285144028007,0,1,positive regulation of tendon cell differentiation,BP,
21761,GO:2001053,1,0.937281483559094,0,11,regulation of mesenchymal cell apoptotic process,BP,
21762,GO:2001054,1,0.946585936599411,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
21763,GO:2001055,1,0.990176110458171,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21765,GO:2001057,1,0.667740224665098,0,64,reactive nitrogen species metabolic process,BP,
21766,GO:2001065,1,0.996538835066422,0,1,mannan binding,MF,
21767,GO:2001069,1,0.987117397977023,0,2,glycogen binding,MF,
21768,GO:2001070,1,0.986274255226659,0,2,starch binding,MF,
21769,GO:2001074,1,0.988736096975037,0,2,regulation of metanephric ureteric bud development,BP,
21770,GO:2001076,1,0.988736096975037,0,2,positive regulation of metanephric ureteric bud development,BP,
21771,GO:2001106,1,0.983740197303042,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21772,GO:2001108,1,0.991891120856937,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21773,GO:2001109,1,0.986408152837488,0,2,regulation of lens epithelial cell proliferation,BP,
21774,GO:2001111,1,0.986408152837488,0,2,positive regulation of lens epithelial cell proliferation,BP,
21775,GO:2001112,1,0.99230292516214,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21776,GO:2001113,1,0.99230292516214,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21778,GO:2001136,1,0.992606962762338,0,1,negative regulation of endocytic recycling,BP,
21779,GO:2001137,1,0.967931073200328,0,4,positive regulation of endocytic recycling,BP,
21780,GO:2001138,1,0.952110579920047,0,8,regulation of phospholipid transport,BP,
21781,GO:2001140,1,0.952110579920047,0,8,positive regulation of phospholipid transport,BP,
21783,GO:2001142,1,0.993767434115936,0,1,nicotinate transport,BP,
21784,GO:2001144,1,0.994777380711111,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21785,GO:2001145,1,0.994777380711111,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21786,GO:2001148,1,0.989604045914797,0,2,regulation of dipeptide transmembrane transport,BP,
21787,GO:2001150,1,0.989604045914797,0,2,positive regulation of dipeptide transmembrane transport,BP,
21788,GO:2001151,1,0.992697729352287,0,1,regulation of renal water transport,BP,
21789,GO:2001153,1,0.992697729352287,0,1,positive regulation of renal water transport,BP,
21790,GO:2001160,1,0.989156739022538,0,2,regulation of histone H3-K79 methylation,BP,
21791,GO:2001162,1,0.989156739022538,0,2,positive regulation of histone H3-K79 methylation,BP,
21792,GO:2001163,1,0.994528704161581,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21793,GO:2001165,1,0.994528704161581,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21794,GO:2001166,1,0.966674384977832,0,5,regulation of histone H2B ubiquitination,BP,
21795,GO:2001168,1,0.971621479606056,0,4,positive regulation of histone H2B ubiquitination,BP,
21797,GO:2001170,1,0.920366322653396,0,13,negative regulation of ATP biosynthetic process,BP,
21799,GO:2001173,1,0.994909936862563,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
21800,GO:2001176,1,0.987871206292204,0,2,regulation of mediator complex assembly,BP,
21801,GO:2001178,1,0.987871206292204,0,2,positive regulation of mediator complex assembly,BP,
21802,GO:2001179,1,0.965826644637875,0,7,regulation of interleukin-10 secretion,BP,
21803,GO:2001180,1,0.981297450341251,0,3,negative regulation of interleukin-10 secretion,BP,
21804,GO:2001181,1,0.984237417270699,0,4,positive regulation of interleukin-10 secretion,BP,
21805,GO:2001182,1,0.957084833498099,0,7,regulation of interleukin-12 secretion,BP,
21806,GO:2001183,1,0.981239858348939,0,3,negative regulation of interleukin-12 secretion,BP,
21807,GO:2001184,1,0.982744262995607,0,3,positive regulation of interleukin-12 secretion,BP,
21808,GO:2001185,1,0.959409523136233,0,7,regulation of CD8-positive, alpha-beta T cell activation,BP,
21809,GO:2001186,1,0.988568338196961,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21810,GO:2001187,1,0.985213123504937,0,3,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21811,GO:2001188,1,0.976739735737331,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21812,GO:2001189,1,0.984072426644601,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21813,GO:2001190,1,0.992549871433778,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21814,GO:2001191,1,0.993137509183141,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21815,GO:2001193,1,0.993137509183141,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21816,GO:2001197,1,0.959841143888677,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21817,GO:2001198,1,0.950578577414566,0,10,regulation of dendritic cell differentiation,BP,
21818,GO:2001199,1,0.971644899118927,0,6,negative regulation of dendritic cell differentiation,BP,
21819,GO:2001200,1,0.977724857078461,0,4,positive regulation of dendritic cell differentiation,BP,
21820,GO:2001201,1,0.976739281137617,0,3,regulation of transforming growth factor-beta secretion,BP,
21821,GO:2001202,1,0.9843638706472,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21822,GO:2001203,1,0.992255562649337,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21823,GO:2001204,1,0.929101776370662,0,11,regulation of osteoclast development,BP,
21824,GO:2001205,1,0.96256391143817,0,5,negative regulation of osteoclast development,BP,
21825,GO:2001206,1,0.981634409921675,0,3,positive regulation of osteoclast development,BP,
21826,GO:2001207,1,0.992471847285516,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21827,GO:2001208,1,0.992471847285516,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
21828,GO:2001212,1,0.917716657958178,0,14,regulation of vasculogenesis,BP,
21829,GO:2001213,1,0.992085240994721,0,1,negative regulation of vasculogenesis,BP,
21830,GO:2001214,1,0.943587527695881,0,10,positive regulation of vasculogenesis,BP,
21831,GO:2001222,1,0.797556395313322,0,29,regulation of neuron migration,BP,
21832,GO:2001223,1,0.942935559762596,0,8,negative regulation of neuron migration,BP,
21833,GO:2001224,1,0.897956678929677,0,13,positive regulation of neuron migration,BP,
21834,GO:2001225,1,0.934066490915519,0,10,regulation of chloride transport,BP,
21835,GO:2001226,1,0.978609714981536,0,3,negative regulation of chloride transport,BP,
21836,GO:2001228,1,0.978962124166791,0,2,regulation of response to gamma radiation,BP,
21837,GO:2001229,1,0.988828470779563,0,1,negative regulation of response to gamma radiation,BP,
21846,GO:2001241,1,0.933034474612071,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21848,GO:2001243,1,0.594780744837818,0,90,negative regulation of intrinsic apoptotic signaling pathway,BP,
21850,GO:2001245,1,0.981788346057798,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21851,GO:2001246,1,0.992460766758692,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21852,GO:2001247,1,0.992427458960228,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21853,GO:2001248,1,0.994866756232826,0,1,regulation of ammonia assimilation cycle,BP,
21854,GO:2001250,1,0.994866756232826,0,1,positive regulation of ammonia assimilation cycle,BP,
21855,GO:2001251,1,0.454619477287606,0,116,negative regulation of chromosome organization,BP,
21856,GO:2001252,1,0.36261948937388,0,152,positive regulation of chromosome organization,BP,
21857,GO:2001253,1,0.992919932360521,0,1,regulation of histone H3-K36 trimethylation,BP,
21858,GO:2001256,1,0.928666806165352,0,12,regulation of store-operated calcium entry,BP,
21859,GO:2001257,1,0.395708487270067,0,141,regulation of cation channel activity,BP,
21860,GO:2001258,1,0.813699204676538,0,36,negative regulation of cation channel activity,BP,
21861,GO:2001259,1,0.693607273943797,0,54,positive regulation of cation channel activity,BP,
21862,GO:2001260,1,0.994281830794387,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21863,GO:2001262,1,0.994281830794387,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21865,GO:2001268,1,0.978069035456185,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21867,GO:2001270,1,0.976716897402038,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21868,GO:2001271,1,0.97969136183399,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21869,GO:2001272,1,0.996964525762303,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21871,GO:2001274,1,0.97914042283475,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21872,GO:2001275,1,0.892991978425558,0,16,positive regulation of glucose import in response to insulin stimulus,BP,
21873,GO:2001279,1,0.966990376726827,0,5,regulation of unsaturated fatty acid biosynthetic process,BP,
21874,GO:2001280,1,0.981411428763689,0,3,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21875,GO:2001286,1,0.972648401655815,0,4,regulation of caveolin-mediated endocytosis,BP,
21876,GO:2001287,1,0.988787355690793,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21877,GO:2001288,1,0.99115982774244,0,1,positive regulation of caveolin-mediated endocytosis,BP,
21878,GO:2001293,1,0.985605651875145,0,2,malonyl-CoA metabolic process,BP,
21879,GO:2001294,1,0.994747519122485,0,1,malonyl-CoA catabolic process,BP,
21880,GO:2001295,1,0.990810363332533,0,1,malonyl-CoA biosynthetic process,BP,
21881,GO:2001300,1,0.969252307105764,0,6,lipoxin metabolic process,BP,
21882,GO:2001301,1,0.969252307105764,0,6,lipoxin biosynthetic process,BP,
21883,GO:2001302,1,0.98780263065196,0,2,lipoxin A4 metabolic process,BP,
21884,GO:2001303,1,0.98780263065196,0,2,lipoxin A4 biosynthetic process,BP,
21885,GO:2001304,1,0.994279157129522,0,1,lipoxin B4 metabolic process,BP,
21886,GO:2001306,1,0.994279157129522,0,1,lipoxin B4 biosynthetic process,BP,
21887,GO:2001311,1,0.995718822631804,0,1,lysobisphosphatidic acid metabolic process,BP,
3961,GO:0008207,1,0.851653708247992,0,29,C21-steroid hormone metabolic process,BP,
11326,GO:0043536,1,0.730195826691155,0,48,positive regulation of blood vessel endothelial cell migration,BP,
19056,GO:1901797,1,0.862593210492031,0,26,negative regulation of signal transduction by p53 class mediator,BP,
3801,GO:0007566,1,0.769861950142011,0,43,embryo implantation,BP,
10475,GO:0039528,1,0.87130713723919,0,20,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
15224,GO:0061178,1,0.740925159008801,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
10591,GO:0042135,1,0.870094981058913,0,21,neurotransmitter catabolic process,BP,
13639,GO:0051018,1,0.704964955108829,0,47,protein kinase A binding,MF,
14078,GO:0051782,1,0.90935353853243,0,14,negative regulation of cell division,BP,
17016,GO:0072666,1.00000000000001,0.758675282459205,0,42,establishment of protein localization to vacuole,BP,
